0001567892-15-000047.txt : 20151124 0001567892-15-000047.hdr.sgml : 20151124 20151124170910 ACCESSION NUMBER: 0001567892-15-000047 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20150925 FILED AS OF DATE: 20151124 DATE AS OF CHANGE: 20151124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 151253446 BUSINESS ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 353 1 8808180 MAIL ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 10-K 1 mnk10-k92515.htm 10-K 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 _________________________________
FORM 10-K
 _______________________________
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended September 25, 2015
or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____

Commission File Number : 001-35803
 _________________________________
Mallinckrodt public limited company
(Exact name of registrant as specified in its charter)
 _________________________________
Ireland
 
98-1088325
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
Perth House, Millennium Way,
Chesterfield, Derbyshire, United Kingdom, S41 8ND
 
(Address of principal executive offices) (Zip Code)
 
Telephone: +44 424 626 3051
 
(Registrant's telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act: 
Title of each class
 
Name of each exchange on which registered
Ordinary shares, par value $0.20 per share
 
New York Stock Exchange
 
 
 
Securities registered pursuant to section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act:
Large accelerated filer
 
x
 
 
Accelerated filer
 
o
 
 
 
 
 
Non-accelerated filer
 
o
(Do not check if smaller reporting company)
 
Smaller reporting company
 
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o      No  x
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant (assuming solely for the purposes of this calculation that all directors and executive officers of the Registrant are "affiliates") as of March 27, 2015, the last business day of the Registrant's most recently completed second fiscal quarter, was approximately $15,146.4 million (based upon the closing price of $129.61 per share as reported by the New York Stock Exchange on that date).
The number of shares of the registrant's common stock outstanding as of November 16, 2015 was 115,947,044.
DOCUMENTS INCORPORATED BY REFERENCE
Certain portions of the registrant's definitive proxy statement for its annual meeting of shareholders, to be filed with the Securities and Exchange Commission within 120 days after September 25, 2015, are incorporated by reference into Part III of this report.




MALLINCKRODT PLC
INDEX TO FORM 10-K
 
 
 
 
 
PART I
 
Item 1.
Business.
Item 1A.
Risk Factors.
Item 1B.
Unresolved Staff Comments.
Item 2.
Properties.
Item 3.
Legal Proceedings.
Item 4.
Mine Safety Disclosures.
 
 
 
 
PART II
 
Item 5.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Item 6.
Selected Financial Data.
Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations.
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
Item 8.
Financial Statements and Supplementary Data.
Item 9.
Changes In and Disagreements With Accountants on Accounting and Financial Disclosure.
Item 9A.
Controls and Procedures.
Item 9B.
Other Information.
 
 
 
 
PART III
 
Item 10.
Directors, Executive Officers and Corporate Governance.
Item 11.
Executive Compensation.
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Item 13.
Certain Relationships and Related Transactions, and Director Independence.
Item 14.
Principal Accounting Fees and Services.
 
 
 
 
PART IV
 
Item 15.
Exhibits, Financial Statement Schedules.
 
 
 
Signatures
Exhibit Index








Presentation of Information
Unless the context requires otherwise, references to "Mallinckrodt plc," "Mallinckrodt," "we," "us," "our" and "the Company" refer to Mallinckrodt plc, an Irish public limited company, and its consolidated subsidiaries for periods subsequent to its separation from Covidien plc on June 28, 2013. For periods prior to June 28, 2013, these terms refer to the combined historical business and operations of Covidien plc's Pharmaceuticals business as it was historically managed as part of Covidien plc. Unless the context requires otherwise, references to "Covidien" refer to Mallinckrodt's former parent company, Covidien plc, an Irish public limited company, and its consolidated subsidiaries (which was subsequently acquired by Medtronic plc). References in this Annual Report on Form 10-K to the "Separation" refer to the legal separation and transfer of Covidien's Pharmaceuticals business to Mallinckrodt plc through a dividend distribution to Covidien shareholders on June 28, 2013. References to "dollars" or "$" refer to United States dollars.

Trademarks and Trade Names
Mallinckrodt owns or has rights to use trademarks and trade names that it uses in conjunction with the operation of its business. One of the more important trademarks that it owns or has rights to use that appears in this Annual Report on Form 10-K is "Mallinckrodt," which is a registered trademark or the subject of pending trademark applications in the United States and other jurisdictions. Solely for convenience, the Company only uses the ™ or ® symbols the first time any trademark or trade name is mentioned. Such references are not intended to indicate in any way that the Company will not assert, to the fullest extent permitted under applicable law, its rights to its trademarks and trade names. Each trademark or trade name of any other company appearing in this Annual Report on Form 10-K is, to the Company's knowledge, owned by such other company.

Forward-Looking Statements
The Company has made forward-looking statements in this Annual Report on Form 10-K that are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements include, but are not limited to, information concerning the Company's possible or assumed future results of operations, business strategies, financing plans, competitive position, potential growth opportunities, potential operating performance improvements, the effects of competition and the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believe," "expect," "plan," "intend," "project," "anticipate," "estimate," "predict," "potential," "continue," "may," "should" or the negative of these terms or similar expressions.
Forward-looking statements involve risks, uncertainties and assumptions. Actual results may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any forward-looking statements.
The risk factors included in Item 1A. of this Annual Report on Form 10-K could cause the Company's results to differ materially from those expressed in forward-looking statements. There may be other risks and uncertainties that the Company is unable to predict at this time or that the Company currently does not expect to have a material adverse effect on its business.
These forward-looking statements are made as of the filing date of this Annual Report on Form 10-K. The Company expressly disclaims any obligation to update these forward-looking statements other than as required by law.


3



PART I

Item 1.
Business.
Overview
Mallinckrodt plc and its subsidiaries (collectively, "Mallinckrodt" or "the Company"), is a global specialty biopharmaceutical and nuclear imaging business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and nuclear imaging agents. Therapeutic areas of focus include autoimmune and rare disease specialty areas (including neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; pain management; and central nervous system drugs. The Company also supports the diagnosis of disease with nuclear medicine imaging agents. The Company believes its experience in the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities have created compelling competitive advantages that it anticipates will sustain future revenue growth.
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its global contrast media and delivery systems ("CMDS") business to Guerbet S.A. ("Guerbet"), which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which was renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:
•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and active pharmaceutical ingredients ("API") consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).
For further information on our products and segments, refer to "Our Businesses and Product Strategies" within this Item 1. Business.

History and Development
The Company's Specialty Generics segment can trace its development from the founding of G. Mallinckrodt & Co. in 1867 (predecessor of today's API business). We expanded from the controlled substance API business into controlled substance generics and branded specialty pharmaceuticals. Our Nuclear Imaging segment traces its origins to 1966 with technetium generators, and has subsequently expanded into "cold" kits and other radioisotopes.
Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien plc ("Covidien"). On June 28, 2013, Covidien shareholders of record received one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien held as of the record date, June 19, 2013, and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing our legal separation from Covidien ("the Separation").
Subsequent to the Separation, Mallinckrodt completed multiple acquisitions of specialty pharmaceuticals and specialty biopharmaceuticals businesses within our Specialty Brands segment. The Company believes these acquisitions have created a foundation and framework for future growth. In addition to these acquisitions, we also implemented significant actions under our 2013 restructuring program intended to improve our long-term profit margins and yield efficiencies from our spending on selling, general and administrative expenses ("SG&A"). In July 2015, Mallinckrodt announced that it had entered into a definitive agreement to sell its CMDS business in order to further increase the Company's focus on specialty pharmaceuticals.
In May 2015, the Board of Directors of the Company approved the migration of our principal executive offices to Perth House, Millennium Way, Chesterfield, Derbyshire, United Kingdom, where they are currently located. Our telephone number at this location is +44 424 626 3051. Our U.S. headquarters is located at 675 James S. McDonnell Boulevard, Hazelwood, Missouri 63042. Our telephone number at this location is (314) 654-2000.


4



Our Competitive Strengths
We believe we have the following strengths:
•
Ability to successfully execute strategies to drive growth. We completed multiple acquisitions throughout fiscal 2015 and 2014 that created a framework for future organic volume growth and business development. We successfully completed the integration of our acquisitions, except for our acquisition of Therakos, Inc. ("Therakos") which was acquired on September 25, 2015, and generated synergies from these transactions, primarily associated with SG&A. We expect to realize further synergies in SG&A expenses during fiscal 2016. We continue to realign our cost structure due to the changing nature of our business and look for opportunities to achieve operating efficiencies. We have taken restructuring actions that have generated further savings, substantially within our SG&A expenses. These acquisitions and restructuring actions further diversified Mallinckrodt, significantly increasing our scale, net sales, profitability and cash flow.
•
Expertise in highly regulated raw materials and strong regulatory relationships. We have expertise in the acquisition and importation of highly regulated raw materials, such as opioids, other controlled substances and radioisotopes. For example, in calendar 2014, we estimated that we received approximately 27% of the U.S. Drug Enforcement Administration's ("DEA") total annual quota for controlled substances that we manufacture. Based on IMS Health data for the same period, our Specialty Generics business had an approximately 21% market share of DEA Schedules II and III opioid and oral solid dose medications. The acquisition of certain raw materials and the processing of them into finished products requires a close collaboration with a wide variety of regulatory authorities including the DEA, U.S. Food and Drug Administration ("FDA"), U.S. Department of Agriculture ("USDA"), U.S. Nuclear Regulatory Commission ("NRC"), European Medicines Agency and Irish Medicines Board, among many others. We have a long history of working closely with regulatory agencies to ensure ongoing, reliable access to these highly regulated materials.
•
Specialized chemistry, development and formulation expertise which supports our operations. We have specialized chemistry expertise in the formulation of new drug combinations, reformulation of existing drugs, and manufacture of controlled substances into a wide range of products, such as tablets, capsules, oral liquids, injectable and intrathecal products.
•
Distinctive high-quality manufacturing and distribution skills with vertical integration where there are competitive advantages. We have expertise in the manufacturing of complex substances including those that come from naturally derived sources. Our manufacturing and supply chain capabilities enable highly efficient controlled substance tableting, packaging and distribution. We own one of the world's largest DEA Schedule C-II vault storage capacities for raw materials, intermediates and finished dosages. In our Nuclear Imaging segment, we have the capability to process Mo-99 for use in our Ultra-Technekow DTE generators and to manufacture cyclotron-derived isotopes such as thallium-201, indium-111, gallium-67, germanium-68 and iodine-123. Where appropriate, we have also pursued selective vertical integration initiatives to ensure our manufacturing and supply chain benefit from cost and productivity efficiencies, such as using several of our API products to provide the raw materials for some of our generic products.
•
Diversified business model with increasing shift towards high-margin Specialty Brands business with high cash flow conversion. We have a diverse portfolio across our three different reportable segments, Specialty Generics, Nuclear Imaging and the increasingly significant Specialty Brands. In July 2015, we further progressed our shift toward high-margin pharmaceuticals with the announcement that we entered into a definitive agreement to sell our CMDS business. In the fourth quarter of fiscal 2015, net sales from our Specialty Brands segment represented 53.9% of net sales from our reportable segments compared with 31.9% in the fourth quarter of fiscal 2014. We expect the Specialty Brands percentage to increase in fiscal 2016 due to the inclusion of full year results from our fiscal 2015 acquisitions, organic volume growth in Specialty Brands and increased competition in Specialty Generics. Specialty Brands segment operating income increased from 16.4% in the fourth quarter of fiscal 2014 to 46.2% in the fourth quarter of fiscal 2015. The increased revenues and segment operating income positions us for strong cash flow generation, enabling us to potentially decrease debt leverage over time.
•
An extensive portfolio of specialty generic products and controlled substance API for pain. Our Specialty Generics products are focused on pain and attention deficit hyperactivity disorder ("ADHD") while our APIs are for a broad range of products. We believe this business offers the broadest product line of opioid and other controlled substances available (primarily DEA Schedules II and III), and we focus in a number of therapeutic areas with high technical barriers and long product life-cycles.
While we have set forth our competitive strengths above, our business involves numerous risks and uncertainties which may prevent us from executing our strategies. These risks include, among others, risks relating to: DEA regulation of the availability of API controlled substances; drug products under development and marketed drug products; the highly exacting and complex nature of our manufacturing processes; the limited global supply of fission-produced Mo-99 for use in our Ultra-Technekow DTE generators and the aging global infrastructure of nuclear reactors; our customer concentration; cost-containment efforts of our customers, purchasing groups, third-party payers and governmental organizations; developing or commercializing new products; expanding commercial

5



opportunities for existing products; adapting to a changing technology and diagnostic treatment landscape; protecting our intellectual property rights or being subject to claims that we infringe on the intellectual property rights of others; the successful integration of acquisitions; the ability to grow net sales from existing and acquired products; and significant competition. For a more complete description of the risks associated with our business, see Item 1A. Risk Factors included within this Annual Report on Form 10-K.

Our Businesses and Product Strategies
We manage our business in three reportable segments: Specialty Brands, Specialty Generics and Nuclear Imaging. Management measures and evaluates our operating segments based on segment net sales and operating income. Information regarding the product portfolios and business strategies of these segments is included in the following discussion. Financial information regarding each of our reportable segments, as well as other geographical information, is included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Note 21 of Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Specialty Brands
Our Specialty Brands segment markets branded pharmaceutical and biopharmaceutical products for autoimmune and rare diseases (including in the specialty areas of neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; and central nervous system drugs. In fiscal 2015, our Specialty Brands segment accounted for 49.2% of net sales from our operating segments.
We started our Specialty Brands product portfolio in 2001 and shifted our focus to pain management with the 2010 launch of EXALGO® (hydromorphone HCl) extended-release tablets (CII) ("Exalgo"). Our exclusivity period for Exalgo expired and generic competition entered the market beginning in May 2014. In fiscal 2014, we significantly expanded our Specialty Brands product portfolio, with the March 2014 acquisition of OFIRMEV® (acetaminophen) injection ("Ofirmev") and the August 2014 acquisition of H.P. Acthar® Gel ("Acthar"). In fiscal 2015, we continued to diversify our Specialty Brands product portfolio with the April 2015 acquisition of INOMAX® (nitric oxide) for inhalation ("Inomax") and immunotherapy treatment with the September 2015 acquisition of Therakos, Inc. ("Therakos"). Our long-term strategy is to increase patient access and appropriate utilization of our existing products, develop new and follow-on formulations for recently acquired products, advance pipeline products and bring them to market and selectively acquire or license products that are strategically aligned with our product portfolio to expand the size and profitability of our Specialty Brands segment.
We promote our branded products directly to physicians in their offices, hospitals and ambulatory surgical centers (including rheumatologists, neurologists, nephrologists, pulmonoligists, neonatologists, surgeons, and pharmacy directors) with our own direct sales force of over 550 sales representatives as of September 25, 2015. Our products are purchased by independent wholesale drug distributors, specialty pharmaceutical distributors, retail pharmacy chains and hospital procurement departments, among others, and are eventually dispensed by prescription to patients. We also contract directly with payer organizations to gain access to drug formularies and allow patients access to these medications.
The following is a description of select products in our Specialty Brands product portfolio:
•
Acthar is an injectable biopharmaceutical drug approved by the FDA for use in 19 indications. The product currently generates substantially all of its net sales from nine of the on-label indications including the treatment of proteinuria in nephrotic syndrome of the idiopathic type ("NS"); the treatment of acute exacerbations of multiple sclerosis ("MS") in adults; the treatment of infantile spasms ("IS") in infants and children under two years of age; the treatment of the pulmonology indication of sarcoidosis; and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders, dermatomyositis and polymyositis. We may initiate commercial efforts for other approved indications where there is high unmet medical need. The currently approved indications of Acthar are not subject to patent or other exclusivity, with the exception of IS which was granted orphan drug status from the FDA upon its approval in October 2010.
•
Ofirmev is a proprietary intravenous formulation of acetaminophen indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. This product is marketed to hospitals and ambulatory surgical centers and provides us with an expanded presence in these channels. Ofirmev is protected by two patents listed in the Orange Book: Approved Drug Products with Therapeutic Equivalence ("the Orange Book") that expire in August 2017 and June 2021 and we have the potential to obtain an additional six months of exclusivity for each patent if the FDA grants pediatric exclusivity. Settlement agreements have been reached in association with certain challenges to these patents, which allow for generic competition to Ofirmev in December 2020, or earlier under certain circumstances.


6



•
Inomax is a vasodilator that, in conjunction with ventilatory support and other appropriate agents, is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks) neonates with hypoxic respiratory failure ("HRF") associated with clinical or echocardiographic evidence of pulmonary hypertension. Inomax is marketed as part of the Inomax Total Care Package, which includes the drug product, proprietary drug-delivery systems, technical and clinical assistance, 24/7/365 customer service, emergency supply and delivery and on-site training. The Inomax Total Care Package maintains a number of patents, the latest of which expire in 2031, that contain claims to nitric oxide delivery systems expressly required by the drug labeling for administration of Inomax, covering a number of important functions, including patient safety and product performance features.
•
Therakos immunotherapy is focused on providing innovative immunotherapy treatment platforms that enhance the ability of a patient's immune system to fight disease. Therakos is the global leader in autologous immunotherapy delivered through extracorporeal photopheresis ("ECP"). Therakos provides the only integrated ECP system in the world. ECP involves drawing a portion of blood from the patient, separating white blood cells from plasma and red blood cells, which are returned to the patient, and treating the white blood cells with a Ultraviolet-A ("UVA") light activated drug. The treated white blood cells are immediately re-administered back into the patient. ECP is approved by the FDA for use in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (“CTCL”) that is unresponsive to other forms of treatment. Outside the United States, ECP is approved to treat several other serious diseases that arise from immune system imbalances. Therakos’ product suite, which is sold to hospitals, clinics, academic centers and blood banks, includes an installed system, a disposable procedural kit used for each treatment and a drug, UVADEX ® (methoxsalen) Sterile Solution (“UVADEX”), as well as instrument accessories and instrument maintenance and repair services.
•
Exalgo is a long-acting, once-daily form of hydromorphone. Our exclusivity period for branded Exalgo expired and generic competition entered the market whereupon we launched our own generic form of Exalgo in May 2014.

Specialty Generics
Our Specialty Generics segment markets drugs that include a variety of product formulations containing hydrocodone, oxycodone and several other controlled substances. While our pipeline is limited, we do have products in development that are primarily focused on controlled substances. Our API business, which is included in the Specialty Generics segment, provides bulk API products, including opioids and acetaminophen, to a wide variety of pharmaceutical companies, many of which are direct competitors of our Specialty Generics finished dosage business. In addition, we use our API for internal manufacturing of our finished dosage products. In fiscal 2015, our Specialty Generics segment accounted for 37.9% of net sales from our operating segments.
We are among the world's largest manufacturers of bulk acetaminophen and the only producer of acetaminophen outside of Asia. We manufacture controlled substances under DEA quota restrictions and in calendar 2014 we estimated that we received approximately 27% of the total DEA quota provided to the U.S. market for the controlled substances we manufacture. We believe that our market position in the API business and allocation of opioid raw materials from the DEA is a competitive advantage for our API business and, in turn, for our Specialty Generics business. The strategy for our API business is based on manufacturing large volumes of high-quality product and customized product offerings, responsive technical services and timely delivery to our customers.
We believe our Specialty Generics segment represents the broadest product line of opioid and other controlled substances (primarily DEA Schedules II and III) currently available from a single manufacturer. Historically, our primary competition has been other U.S. participants due to importation restrictions on controlled substance API and finished products.
We market our products principally through independent channels, including drug distributors, specialty pharmaceutical distributors, retail pharmacy chains, food store chains with pharmacies, pharmaceutical benefit managers that have mail order pharmacies and hospital buying groups.
The following is a list of significant products and product families in our Specialty Generics product portfolio:
•
hydrocodone (API) and hydrocodone-containing tablets;
•
oxycodone (API) and oxycodone-containing tablets;
•
methylphenidate HCl extended-release tablets USP (CII) ("Methylphenidate ER") under a class BX-rating issued by the FDA in November 2014 and;
•
other controlled substances, including acetaminophen (API) products.



Nuclear Imaging

7



During the fourth quarter of fiscal 2015, the Company announced that it entered into a definitive agreement to sell its CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.
Our Nuclear Imaging segment develops, manufactures and markets products which provide radiopharmaceuticals used in single photon emission computed tomography ("SPECT") imaging for myocardial perfusion, cardiac imaging and bone scans. In fiscal 2015, our Nuclear Imaging segment accounted for 12.8% of net sales from our operating segments. We are focused on driving operating efficiencies in the Nuclear Imaging segment to maximize operating margins and cash flow.
Our Nuclear Imaging business manufactures radioactive isotopes for the diagnosis and treatment of disease. Our nuclear radiopharmaceutical product offering includes both "hot" radioisotopes and "cold" kits (tagging agents that are paired with "hot" radioisotopes for diagnostic procedures). We have significant expertise in managing the highly regulated radioactive materials used to manufacture the isotope generators and in dealing with products (isotopes) with an extremely short half-life, which precludes stockpiling and requires exacting execution along all aspects of the supply chain. We believe that our investment in Tc-99m generators in North America and Europe, our own Mo-99 processing facility in the Netherlands and a very well-coordinated logistics network provides us with a competitive advantage. Our strategy for our Nuclear Imaging business is focused on bolstering the Tc-99m/Mo-99 supply chain through supplier diversification and driving efficiencies to maximize operating margins and cash flow. We have entered into agreements to obtain Mo-99 from the Maria nuclear research reactor in Poland, the High Flux Reactor in the Netherlands and the BR2 reactor in Belgium, and are also able to purchase finished Mo-99 from other suppliers in the marketplace, with whom we do not have long-term supply agreements. Going forward, we will continue to seek further diversification of our supplier base.
In 2004, the U.S. National Security Administration established its Global Threat Initiative to, as quickly as possible, identify, secure and remove or facilitate the disposition of vulnerable, high-risk nuclear and radiological materials around the world. One key initiative identified was the conversion by research reactors and isotope production facilities of low enriched uranium ("LEU") from highly enriched uranium ("HEU"). We currently use HEU targets for the production of Mo-99, but ultimately intend to eliminate the use of HEU in favor of using LEU and have begun the process of converting our Mo-99 production operation in the Netherlands to LEU targets. For a discussion of how Mo-99 is used in our business, refer to "Raw Materials" within this Item 1. Business and Item 1A. Risk Factors. We primarily market our nuclear radiopharmaceutical products to nuclear radiopharmacies in the U.S. and to hospitals in Europe.
The following are significant products in our Nuclear Imaging product portfolio:
•
Ultra-Technekow DTE is a dry-ship, top eluting Tc-99m radioisotope generator that provides an on-site isotope source of Tc-99m solution that is combined by a nuclear pharmacist with various "cold" kit targeting agents to prepare an individualized radiopharmaceutical dose. The prepared Tc-99m radiopharmaceutical is used in procedures using SPECT. SPECT radiopharmaceutical scans are the most common of all radiopharmaceutical scans and are used in a number of applications, including myocardial perfusion imaging and bone scans. Tc-99m is a decay product of Mo-99, the parent isotope contained in the Tc-99m generator. We are one of only a limited number of manufacturers of Tc-99m generators in North America and Europe, and the only one on either continent that has its own Mo-99 processing facility, which provides cost and raw material supply advantages.
•
Octreoscan™ (kit for the preparation of indium In-111 pentetreotide) is a unique molecular imaging agent used for the localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors. The product was approved by the FDA in June 1994 and is sold primarily in the U.S. and Europe. There are three Orange Book-listed patents for the drug product and usage in detection of neuroendocrine tumors. The last patent expires in September 2017.

Industry Overview and Trends
We believe our businesses are well positioned in attractive markets based on a global broadening of access to healthcare, increased demand for pharmaceutical products from emerging markets and the medical industry's continued focus on diagnostic imaging for the early diagnosis of diseases.
We expect that the specialty pharmaceuticals market in the U.S. will likely grow in the low-to-mid single digits in the near-term. With respect to branded drugs, most disease areas are addressed by products of a small group of companies that can create extensions of existing brands. Pain management represents the largest therapeutic prescription market in the U.S., with pain medications accounting for approximately one out of every ten dispensed prescriptions. Pain management is a time-tested therapeutic area, and pain products have been available on the U.S. market since the 1920s.
We believe our experience in satisfying the regulatory requirements relating to raw materials for nuclear radiopharmaceuticals provides competitive advantages versus other potential competitors. Currently, nuclear imaging tends to be concentrated in developed markets due to its high capital-intensity requirements.

8




Competition
Specialty Brands and Specialty Generics
Several of our Specialty Brands products do not face direct competition from similar products, but instead compete against alternative forms of treatment that a prescriber may utilize. For example, Acthar, has limited direct competition due to the unique nature of the product; however, it generally is prescribed by physicians when numerous alternative treatments have not yielded favorable outcomes for patients. Our Specialty Generics products compete with products manufactured by many other companies in highly competitive markets, primarily throughout the U.S. Our competitors vary depending upon therapeutic and product categories. Major competitors of our Specialty Generics products include Allergan, Inc. (formerly Actavis, Inc.), Endo Health Solutions Inc., Johnson & Johnson (including its Noramco, Inc. subsidiary), Johnson Matthey plc, Mylan N.V., Pfizer Inc., Purdue Pharma L.P. and Teva Pharmaceutical Industries Ltd., among others. Our secure sources of raw opioid material, vertically integrated manufacturing capabilities, broad offerings of API controlled substances and acetaminophen, comprehensive generic controlled substance product line and established relationships with independent retail pharmacies enable us to compete effectively with larger generics manufacturers. In addition, we believe that our experience with the FDA, DEA and Risk Evaluation and Mitigation Strategies ("REMS") provides us the knowledge to successfully operate in this highly competitive and highly regulated environment.
The competitive landscape in the acquisition and in-licensing of pharmaceutical products has intensified in recent years, reflecting both a reduction in the number of compounds available and an increase in the number of companies and the collective resources bidding on available assets. The ability to effectively compete in product development, acquisitions and in-licensing is important to our long-term growth strategy. In addition to product development and acquisitions, other competitive factors in the pharmaceutical industry include product efficacy, safety, ease of use, price, demonstrated cost-effectiveness, third-party reimbursement, marketing effectiveness, customer service, reliability of supply, reputation and access to technical information.
The highly competitive environment of our Specialty Brands segment requires us to continually seek out new products to treat diseases and conditions in areas of high unmet medical needs, create technological innovations and to market our products effectively. Most new products that we introduce must compete with other products already on the market, as well as other products that are subsequently developed by competitors. For our branded products, we may be granted market exclusivity either through the FDA, the U.S. Patent Office or similar agencies internationally. Regulatory exclusivity is granted by the FDA for new innovations, such as new clinical data, a new chemical entity or orphan drugs, and patents are issued for inventions, such as composition of matter or method of use. While patents offer a longer period of exclusivity, there are more bases to challenge patent-conferred exclusivity than with regulatory exclusivity. Generally, once market exclusivity expires on our branded products, competition will likely intensify as generic forms of the product are launched. Products which do not benefit from regulatory or patent exclusivity must rely on other competitive advantages, such as confidentiality agreements or product formulation trade secrets for difficult to replicate products.
Manufacturers of generic pharmaceuticals typically invest far less in R&D than research-based pharmaceutical companies, allowing generic versions to typically be significantly less expensive than the related branded products. The generic form of a drug may also enjoy a preferred position relative to the branded version under third-party reimbursement programs, or be routinely dispensed in substitution for the branded form by pharmacies. If competitors introduce new products, delivery systems or processes with therapeutic or cost advantages, our products can be subject to progressive price reductions, decreased sales volume or both. To successfully compete for business with managed care and pharmacy benefits management organizations, we must often demonstrate that our branded products offer not only superior health outcomes but also cost advantages, as compared with other forms of care. Certain of our Specialty Brands products are specialized pharmaceuticals or biopharmaceuticals, for example Acthar, that may not be prescribed unless a clear benefit in efficacy or safety is demonstrated or until lower-cost alternatives have failed to provide positive patient outcomes or are not well tolerated by the patient.
In our Specialty Generics segment, we face intense competition from other generic drug manufacturers, brand-name pharmaceutical companies marketing authorized generics, existing branded equivalents and manufacturers of therapeutically similar drugs. The competition varies depending on the specific product category and dosage strength, and we believe that our competitive advantages include our ability to introduce new generic versions of brand-name drug products, our formulation expertise and drug delivery technology, our access to controlled substance API, our quality and cost-effective production, our customer service and the breadth of our generic product line. Among the large generic controlled substance providers, we are the only generic manufacturer that has its own controlled substance API manufacturing capability, and we believe the vertical integration and production of our own API confers certain competitive advantages that might not be available to other pharmaceutical companies. New drugs and future developments in improved or advanced drug delivery technologies or other therapeutic techniques may provide therapeutic or cost advantages to products we market. The maintenance of profitable operations in generic pharmaceuticals depends, in part, on our ability to select, develop and timely launch new generic products, to manufacture such new products in a cost efficient, high-quality manner and implement and drive market volume.
As a result of consolidation among wholesale distributors and rapid growth of large retail drug store chains, a small number of large wholesale distributors and retail drug store chains control a significant share of the market, and the number of independent drug

9



stores and small drug store chains has decreased. This has resulted in customers gaining more purchasing power. Consequently, there is heightened competition among generic drug producers for the business of this smaller and more selective customer base.
In our API business, we believe that our competitive advantages include our manufacturing capabilities in controlled substances that enable high-speed, high-volume tableting, packaging and distribution. Additionally, we believe we offer customers reliability of supply and broad-based technical customer service.

Nuclear Imaging
In Nuclear Imaging, we compete primarily on the ability of our products to capture market share. While we believe that the number of procedures using nuclear imaging may grow in emerging markets, due in part to increasing infrastructure and access to healthcare, we expect that our ability to effectively compete with other providers of nuclear imaging will be impacted by ongoing pricing pressures. We believe that our key product characteristics, such as proven efficacy, reliability and safety, coupled with our core competencies such as our efficient manufacturing processes and established distribution network, are important factors that may distinguish us from our competitors.
The market for imaging agents is highly competitive. Major competitors to our Nuclear Imaging business include, among others:
•
for radiopharmaceutical generators sold in the U.S.: Lantheus Medical Imaging, Inc.;
•
for radiopharmaceutical generators sold in Europe: GE Healthcare, IBA Group, and POLATOM; and
•
for radiopharmaceutical SPECT "cold" kits: Lantheus Medical Imaging, Inc., GE Healthcare, Bracco Imaging S.p.A. and IBA Group.
Our current or future products could be rendered obsolete or uneconomical as a result of the competition described above and the factors described in "Intellectual Property" included within this Item 1. Business, as well as any of the risk factors described in Item 1A. Risk Factors included within this Annual Report on Form 10-K. Our failure to compete effectively could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

Intellectual Property
We own or license a number of patents in the U.S. and other countries covering certain products and have also developed brand names and trademarks for other products. Generally, our Specialty Brands business relies upon patent protection to ensure market exclusivity for the life of the patent. We consider the overall protection of our patents, trademarks and license rights to be of material value and act to protect these rights from infringement. However, our business is not materially dependent upon any single patent, trademark or license or any group of patents, trademarks or licenses.
The majority of an innovative product's commercial value is usually realized during the period in which the product has market exclusivity. In the branded pharmaceutical industry, an innovator product's market exclusivity is generally determined by two forms of intellectual property: patent rights held by the innovator company and any regulatory forms of exclusivity to which the innovator is entitled. In the U.S. and some other countries, when market exclusivity expires and generic versions of a product are approved and marketed, there often are very substantial and rapid declines in the branded product's sales. The rate of this decline varies by country and by therapeutic category; however, following patent expiration, branded products often continue to have some market viability based upon the goodwill of the product name, which typically benefits from trademark protection or is based on the difficulties associated with replicating the product formulation or bioavailability. Acthar is not subject to patent or other exclusivity, with the exception of infantile spasms ("IS") which was granted orphan drug status from the FDA upon its approval in October 2010. Acthar's commercial durability therefore relies partially upon product formulation trade secrets, confidentiality agreements and trademark and copyright laws. These items may not prevent competitors from independently developing similar technology or duplicating our product.
Patents are a key determinant of market exclusivity for most branded pharmaceuticals. Patents provide the innovator with the right to exclude others from practicing an invention related to the product. Patents may cover, among other things, the active ingredient(s), various uses of a drug product, pharmaceutical formulations, drug delivery mechanisms, and processes for (or intermediates useful in) the manufacture of products. Protection for individual products extends for varying periods in accordance with the expiration dates of patents in the various countries. The protection afforded, which may also vary from country to country, depends upon the type of patent, its scope of coverage and the availability of meaningful legal remedies in the country.
Many developed countries provide certain non-patent incentives for the development of pharmaceuticals. For example, the U.S., European Union ("E.U.") and Japan each provide for a minimum period of time after the approval of certain new drugs during which the regulatory agency may not rely upon the innovator's data to approve a competitor's generic copy. Regulatory exclusivity is also available in certain markets as incentives for research on new indications, orphan drugs (drugs that demonstrate promise for the diagnosis or treatment of rare diseases or conditions) and medicines that may be useful in treating pediatric patients. Regulatory

10



exclusivity is independent of any patent rights and can be particularly important when a drug lacks broad patent protection. However, most regulatory forms of exclusivity do not prevent a competitor from gaining regulatory approval prior to the expiration of regulatory exclusivity on the basis of the competitor's own safety and efficacy data on its drug, even when that drug is identical to that marketed by the innovator.
We estimate the likely market exclusivity period for each of our branded products on a case-by-case basis. It is not possible to predict with certainty the length of market exclusivity for any of our branded products because of the complex interaction between patent and regulatory forms of exclusivity, the relative success or lack thereof by potential competitors' experience in product development and inherent uncertainties concerning patent litigation. There can be no assurance that a particular product will enjoy market exclusivity for the full period of time that we currently estimate or that the exclusivity will be limited to the estimate.
In addition to patents and regulatory forms of exclusivity, we also market products with trademarks. Trademarks have no effect on market exclusivity for a product, but are considered to have marketing value. Trademark protection continues in some countries as long as used; in other countries, as long as registered. Registrations of such trademarks are for fixed terms and subject to renewal as provided by the laws of the particular country.

Research and Development
We devote significant resources to the research and development of products and proprietary drug technologies. We incurred R&D expenses from continuing operations of $185.1 million, $163.5 million and $157.9 million in fiscal 2015, 2014 and 2013, respectively. We expect to continue to invest in R&D activities, as well as enter into license agreements and business development opportunities to supplement our internal R&D initiatives. We intend to focus our R&D investments in the specialty pharmaceuticals and biopharmaceuticals areas, specifically investments to support our Specialty Brands and Specialty Generics segments, where we believe there is the greatest opportunity for growth and profitability.
Specialty Brands. We devote significant R&D resources for our branded products. A number of our branded products are protected by patents and have enjoyed market exclusivity. Our R&D strategy focuses on generating clinical and health economic data associated with our currently marketed products as well as generating clinical data in support of new indications for existing products, label expansion opportunities for Inomax and Therakos immunotherapy and development of pipeline products.
In accordance with a Pediatric Research Equity Act requirement included in the New Drug Application ("NDA") approval for Ofirmev, Cadence Pharmaceuticals, Inc. ("Cadence") began enrolling patients in 2012 in a post-marketing efficacy study of Ofirmev in infants and neonates. The data from this study will be used to satisfy a formal written request Cadence received from the FDA under Section 505A of the U.S. Food, Drug and Cosmetic Act that was made as part of the approval process for Ofirmev. The study is completed and is anticipated to be filed with the FDA in calendar 2016. Upon acceptance by the FDA of the data from this study, Ofirmev may be eligible for an additional six months of marketing exclusivity in the U.S. The FDA is also currently reviewing a supplemental NDA that would enable us to offer Ofirmev in flexible intravenous bags.
Specialty Generics. In regard to specialty generic product development, we are focused on controlled substances with difficult-to-replicate pharmacokinetic profiles and the development of products with abuse deterrent properties. As of September 25, 2015, we had various Abbreviated New Drug Applications ("ANDAs") on file with the FDA.
Nuclear Imaging. Our R&D efforts in our Nuclear Imaging segment are focused on driving efficiency and regulatory compliance.

Regulatory Matters
Quality Assurance Requirements
The FDA enforces regulations to ensure that the methods used in, and the facilities and controls used for, the manufacture, processing, packaging and holding of drugs and medical devices conform to current good manufacturing practice ("cGMP"). The cGMP regulations that the FDA enforces are comprehensive and cover all aspects of manufacturing operations, from receipt of raw materials to finished product distribution, and are designed to ensure that the finished products meet all the required identity, strength, quality and purity characteristics. The cGMP regulations for devices, called the Quality System Regulations, are also comprehensive and cover all aspects of device manufacture, from pre-production design validation to installation and servicing, insofar as they bear upon the safe and effective use of the device and whether the device otherwise meets the requirements of the U.S. Federal Food, Drug and Cosmetic Act ("the FFDCA"). Other regulatory authorities have their own cGMP rules. Ensuring compliance requires a continuous commitment of time, money and effort in all operational areas.
The FDA conducts pre-approval inspections of facilities engaged in the development, manufacture, processing, packaging, testing and holding of the drugs subject to NDAs and ANDAs. If the FDA concludes that the facilities to be used do not or did not meet cGMP, good laboratory practice ("GLP") or good clinical practice ("GCP") requirements, it will not approve the application. Corrective actions to remedy the deficiencies must be performed and are usually verified in a subsequent inspection. In addition, manufacturers of both pharmaceutical products and API used to formulate the drug also ordinarily undergo a pre-approval inspection,

11



although the inspection can be waived when the manufacturer has had a passing cGMP inspection in the immediate past. Failure of any facility to pass a pre-approval inspection will result in delayed approval and could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
The FDA also conducts periodic inspections of drug and device facilities to assess their cGMP status. If the FDA were to find serious cGMP non-compliance during such an inspection, it could take regulatory actions that could materially adversely affect our business, results of operations, financial condition and cash flows. Additionally, imported API and other components needed to manufacture products could be rejected by U.S. Customs and Border Protection, usually after conferring with the FDA. In the case of domestic facilities, the FDA could initiate product seizures or, in some instances, require product recalls and seek to enjoin a product's manufacture and distribution. In certain circumstances, violations could support civil penalties and criminal prosecutions. In addition, if the FDA concludes that a company is not in compliance with cGMP requirements, sanctions may be imposed that include preventing that company from receiving the necessary licenses to export its products and classifying that company as an "unacceptable supplier," thereby disqualifying that company from selling products to federal agencies.

United States
In general, drug manufacturers operate in a highly regulated environment. In the U.S., we must comply with laws, regulations, guidance documents and standards promulgated by the FDA, the Department of Health and Human Services ("DHHS"), the DEA, the Environmental Protection Agency ("EPA"), the NRC, the Customs Service and state boards of pharmacy.
The FDA's authority to regulate the safety and efficacy of pharmaceuticals comes from the FFDCA. In addition to reviewing NDAs, for branded drugs, and ANDAs, for generic drugs, the FDA has the authority to ensure that pharmaceutical products introduced into interstate commerce are neither "adulterated" nor "misbranded." Adulterated means that the product may cause or has caused injury to patients when used as intended because it fails to comply with cGMP. Misbranded means that the labels of, or promotional materials for, the product contain false or misleading information. Failure to comply with applicable FDA and other federal and state regulations could result in product recalls or seizures, partial or complete suspension of manufacturing or distribution, refusal to approve pending NDAs or ANDAs, monetary fines, civil penalties or criminal prosecution.
In order to market and sell a new prescription drug product in the U.S., a drug manufacturer must file with the FDA a NDA that shows the safety and effectiveness of (a) a new chemical entity that serves as the API, known as a 505(b)(1) NDA; or (b) a product that has significant differences from an already approved one, known as a 505(b)(2) NDA. Alternatively, in order to market and sell a generic version of an already approved drug product, a drug manufacturer must file an ANDA that shows that the generic version is "therapeutically equivalent," or behaves almost the same when taken by a patient to the branded drug product and, therefore, is substitutable.
For all pharmaceuticals sold in the U.S., the FDA also regulates sales and marketing to ensure that drug product claims made by manufacturers are neither false nor misleading. Manufacturers are required to file copies of all product-specific promotional materials to the FDA's Office of Prescription Drug Promotion prior to their first use. In general, such advertising does not require FDA prior approval. Failure to implement a robust internal company review process and comply with FDA regulations regarding advertising and promotion increases the risk of enforcement action by either the FDA or the U.S. Department of Justice.
For both NDAs and ANDAs, the manufacture, marketing and selling of certain drug products may be limited by quota grants for controlled substances by the DEA. Refer to "Drug Enforcement Administration" within this Item 1. Business for further information.
NDA Process. The path leading to FDA approval of a NDA for a new chemical entity begins when the drug product is merely a chemical formulation in the laboratory. In general, the process involves the following steps:
•
Completion of formulation, laboratory and animal testing in accordance with GLP that fully characterizes the drug product from a pre-clinical perspective and provides preliminary evidence that the drug product is safe to test in human beings;
•
Filing with the FDA an Investigational New Drug Application that will permit the conduct of clinical trials (testing in human beings under adequate and well-controlled conditions);
•
Designing and conducting clinical trials to show the safety and efficacy of the drug product in accordance with GCP;
•
Submitting the NDA for FDA review, which provides a complete characterization of the drug product;
•
Satisfactory completion of FDA pre-approval inspections regarding the conduct of the clinical trials and the manufacturing processes at the designated facility in accordance with cGMP;
•
If applicable, satisfactory completion of a FDA Advisory Committee meeting in which the Agency requests help from outside experts in evaluating the NDA;
•
Final FDA approval of the full prescribing information, labeling and packaging of the drug product; and

12



•
Ongoing monitoring and reporting of adverse events related to the drug product, implementation of a REMS program, if applicable, and conduct of any required Phase IV studies.

Clinical trials are typically conducted in four sequential phases, although they may overlap. The four phases are as follows:
•
Phase I trials are typically small (less than 100 healthy volunteers) and are designed to determine the toxicity and maximum safe dose of the drug product.
•
Phase II trials usually involve 100 to 300 participants and are designed to determine whether the drug product produces any clinically significant effects in patients with the intended disease or condition. If the results of these trials show promise, then a larger Phase III trial may be conducted.
•
Phase III trials are often multi-institution studies that involve a large number of participants and are designed to show efficacy. Phase III (and some Phase II) trials are designed to be pivotal, or confirmatory trials. The goal of a pivotal trial is to establish the safety and efficacy of a drug product by eliminating biases and increasing statistical power.
•
In some cases, the FDA requires Phase IV trials, which are usually performed after the NDA has been approved. Such post-marketing surveillance is intended to obtain more information about the risks of harm, benefits and optimal use of the drug product by observing the results of the drug product in a large number of patients.
 A drug manufacturer may conduct clinical trials either in the U.S. or outside the U.S., but in all cases must comply with GCP, which includes (a) a legally effective informed consent process when enrolling participants; (b) an independent review by an Institutional Review Board to minimize and manage the risks of harm to participants; and (c) ongoing monitoring and reporting of adverse events related to the drug product.
In addition, a drug manufacturer may decide to conduct a clinical trial of a drug product on pediatric patients in order to obtain a form of marketing exclusivity as permitted under the Best Pharmaceuticals for Children Act ("BPCA"). Alternatively, the FDA may require a drug manufacturer, using its authority under the Pediatric Research Equity Act, to conduct a pediatric clinical trial. The goal of conducting pediatric clinical trials is to gather data on how drug products should best be administered to this patient population.
The path leading to FDA approval of a NDA for a drug product that has significant differences from an already approved one is somewhat shorter. The FDA requires a drug manufacturer to submit data from either already published reports or newly conducted studies that show the safety and efficacy of those differences. Significant differences include different dosage strengths or route of administration.
Under the U.S. Prescription Drug User Fee Act, the FDA has the authority to collect fees from drug manufacturers who submit NDAs for review and approval. These user fees help the FDA fund the drug approval process. For fiscal 2015, the user fee rate has been set at $2,374,200 for a 505(b)(1) NDA and $1,187,100 for a NDA not requiring a complete clinical data package, generally a 505(b)(2) NDA. We expense these fees as they are incurred. The average review time for a NDA is approximately six months for priority review and ten months for standard review.
ANDA Process. The path leading to FDA approval of an ANDA is much different from that of a NDA. By statute, the FDA waives the requirement for a drug manufacturer to complete pre-clinical studies and clinical trials and instead focuses on data from bioequivalence studies. Bioequivalence studies generally involve comparing the absorption rate and concentration levels of a generic drug in the human body to that of the branded drug or Reference Listed Drug ("RLD"). In the event that the generic drug behaves in the same manner in the human body as the RLD, the two drug products are considered bioequivalent. The FDA considers a generic drug therapeutically equivalent, and therefore substitutable, if it also contains the same active ingredients, dosage form, route of administration and strength.
In 2010, U.S. Congress passed into law the Generic Drug User Fee Act to address the FDA's backlog, which at the time was over 2,000 ANDAs. This legislation granted the FDA authority to collect, for the first time, user fees from generic drug manufacturers who submit ANDAs for review and approval, and the fees collected will help the FDA fund the drug approval process. For fiscal 2015, the user fee rate is set at $76,030 for an ANDA and $38,020 for a prior approval supplement to an ANDA. These fees are expensed as incurred. The FDA has set goal dates by fiscal year for ANDA submissions to improve the average review time. Fiscal 2016 has a target of approving 75% of ANDA submissions within 15 months of submission.
Aside from the backlog described above, the timing of FDA approval of ANDAs depends on other factors, including whether an ANDA holder has challenged any listed patents to the RLD and whether the RLD is entitled to one or more periods of marketing exclusivity under the FFDCA (such as pediatric exclusivity under the BPCA). In general, the FDA will not approve (but will continue to review) an ANDA in which the RLD holder has sued, within 45 days of receiving notice of the ANDA filing, the ANDA holder for patent infringement until either the litigation has been resolved or 30 months has elapsed, whichever is later.
Patent and Non-Patent Exclusivity Periods. A sponsor of a NDA is required to identify in its application any patent that claims the drug or a use of the drug subject to the application. Upon NDA approval, the FDA lists these patents in the Orange Book. Any person that files a Section 505(b)(2) NDA, the type of NDA that relies upon the data in the application for which the patents are listed, or an

13



ANDA to secure approval of a generic version of a previous drug, must make a certification in respect to listed patents. The FDA may not approve such an application for the drug until expiration of the listed patents unless the generic applicant certifies that the listed patents are invalid, unenforceable or not infringed by the proposed generic drug and gives notice to the holder of the NDA for the RLD of the bases upon which the patents are challenged, and the holder of the RLD does not sue the later applicant for patent infringement within 45 days of receipt of notice. If an infringement suit is filed, the FDA may not approve the later application until the earliest of: (a) 30 months after receipt of the notice by the holder of the NDA for the RLD; (b) entry of an appellate court judgment holding the patent invalid, unenforceable or not infringed; (c) such time as the court may order; or (d) the expiration of the patent.
One of the key motivators for challenging patents is the 180-day market exclusivity period ("generic exclusivity") granted to the developer of a generic version of a product that is the first to make a Paragraph IV certification and that prevails in litigation with the manufacturer of the branded product over the applicable patent(s) or is not sued. For a variety of reasons, there are situations in which a company may not be able to take advantage of an award of generic exclusivity. The determination of when generic exclusivity begins and ends is very complicated.
The holder of the NDA for the RLD may also be entitled to certain non-patent exclusivity during which the FDA cannot approve an application for a competing generic product or 505(b)(2) NDA product. Generally, if the RLD is a new chemical entity, the FDA may not accept for filing any application that references the innovator's NDA for five years from the approval of the innovator's NDA. However, this five-year period is shortened to four years where a filer's ANDA includes a Paragraph IV certification. In other cases, where the innovator has provided certain clinical study information, the FDA may accept for filing, but may not approve, an application that references the innovator's NDA for a period of three years from the approval of the innovator's NDA.
Certain additional periods of exclusivity may be available if the RLD is indicated for use in a rare disease or condition or is studied for pediatric indications.
Risk Evaluation and Mitigation Strategies ("REMS"). For certain drug products or classes, such as transmucosal immediate-release fentanyl products and extended-release and long-acting opioids, the FDA has the authority to require the manufacturer to provide a REMS that is intended to ensure that the benefits of a drug product (or class of drug products) outweigh the risks of harm. The FDA may require that a REMS include elements to ensure safe use to mitigate a specific serious risk of harm, such as requiring that the prescriber have particular training or experience or that the drug product is dispensed in certain healthcare settings. The FDA has the authority to impose civil penalties on or take other enforcement action against any drug manufacturer who fails to properly implement an approved REMS program. Separately, a drug manufacturer cannot use an approved REMS program to delay generic competition.
In December 2011, the FDA approved a single, class-wide REMS program for transmucosal immediate-release fentanyl ("TIRF") products (called "the TIRF REMS Access Program") in order to ease the burden on the healthcare system. TIRF products are opioids used to manage pain in adults with cancer who routinely take other opioid pain medicines around-the-clock. We were part of the original industry working group that collaborated to develop and implement the TIRF REMS Access Program. The goals of this program are to ensure patient access to important medications and mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors by: (a) prescribing and dispensing only to appropriate patients, including use only in opioid-tolerant patients; (b) preventing inappropriate conversion between fentanyl products; (c) preventing accidental exposure to children and others for whom such products were not prescribed; and (d) educating prescribers, pharmacists and patients on the potential for misuse, abuse, addiction and overdose. This program started in March 2012 and requires manufacturers, distributors, prescribers, dispensers and patients to enroll in a real-time database that maintains a closed-distribution system.
In February 2009, the FDA requested that drug manufacturers help develop a single, shared REMS for extended-release and long-acting opioid products that contain fentanyl, hydromorphone, methadone, morphine, oxycodone and oxymorphone. In April 2009, the FDA announced that the "REMS would be intended to ensure that the benefits of these drugs continue to outweigh the risks associated with: (1) use of high doses of long-acting opioids and extended-release opioid products in non-opioid-tolerant and inappropriately selected individuals; (2) abuse; (3) misuse; and (4) overdose, both accidental and intentional." We were part of the original industry working group that collaborated to develop and implement this REMS program. In July 2012, the FDA approved a class-wide REMS program (called "the Extended-Release and Long-Acting Opioid Analgesics REMS") that affected more than 30 extended-release and long-acting opioid analgesics (both branded and generic products). This REMS program requires drug manufacturers to make available training on appropriate prescribing practices for healthcare professionals who prescribe these opioid analgesics and to distribute educational materials on their safe use to prescribers and patients.
Drug Enforcement Administration. The DEA is the federal agency responsible for domestic enforcement of the Controlled Substances Act of 1970 ("CSA"). The CSA classifies drugs and other substances based on identified potential for abuse. Schedule I controlled substances, such as heroin and LSD, have a high abuse potential and have no currently accepted medical use; thus, they cannot be lawfully marketed or sold. Opioids, such as oxycodone, oxymorphone, morphine, fentanyl and hydrocodone, are either Schedule II or III controlled substances. Consequently, the manufacture, storage, distribution and sale of these substances are highly regulated.
The DEA regulates the availability of API, products under development and marketed drug products that are Schedule II or III by setting annual quotas. Every year, we must apply to the DEA for manufacturing quota to manufacture API and procurement quota to

14



manufacture finished dosage products. Given that the DEA has discretion to grant or deny our manufacturing and procurement quota requests, the quota the DEA grants may be insufficient to meet our commercial and R&D needs. To date in calendar 2015, manufacturing and procurement quotas granted by the DEA have been sufficient to meet our sales and inventory requirements on most products. During calendar 2012, the initial hydrocodone manufacturing and procurement quota grants we received from the DEA were below the amounts requested and were therefore insufficient to meet customer demand. While we were granted additional quota, these shortfalls did result in lost sales of hydrocodone products, the amount of which was not significant. Future delay or refusal by the DEA to grant, in whole or in part, our quota requests could delay or result in stopping the manufacture of our marketed drug products, new product launches or the conduct of bioequivalence studies and clinical trials.
In August 2014, the DEA issued its final rule to reschedule hydrocodone combination products (such as Vicodin® (registered trademark of AbbVie Inc.) from Schedule III to Schedule II, which was effective on October 6, 2014. In accordance with the final rule, we have discontinued sales of Schedule III labeled products and launched Schedule II labeled products. The effects of the rescheduling resulted in increased returns of Schedule III labeled product, which did not have a material impact to our financial condition, results of operations and cash flows.
DEA regulations make it extremely difficult for a manufacturer in the U.S. to import finished dosage forms of controlled substances manufactured outside the U.S. These rules reflect a broader enforcement approach by the DEA to regulate the manufacture, distribution and dispensing of legally produced controlled substances. Accordingly, drug manufacturers who market and sell finished dosage forms of controlled substances in the U.S. typically manufacture or have them manufactured in the U.S.
The DEA also requires drug manufacturers to design and implement a system that identifies suspicious orders of controlled substances, such as those of unusual size, those that deviate substantially from a normal pattern and those of unusual frequency, prior to completion of the sale. A compliant suspicious order monitoring ("SOM") system includes well-defined due diligence, "know your customer" efforts and order monitoring.
To meet its responsibilities, the DEA conducts periodic inspections of registered establishments that handle controlled substances. Annual registration is required for any facility that manufactures, tests, distributes, dispenses, imports or exports any controlled substance. The facilities must have the security, control and accounting mechanisms required by the DEA to prevent loss and diversion. Failure to maintain compliance, particularly as manifested in loss or diversion, can result in regulatory action that could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. The DEA may seek civil penalties, refuse to renew necessary registrations or initiate proceedings to revoke those registrations. In certain circumstances, violations could lead to criminal proceedings.
Individual states also regulate controlled substances, and we, as well as our third-party API suppliers and manufacturers, are subject to such regulation by several states with respect to the manufacture and distribution of these products.
We and, to our knowledge, our third-party API suppliers, dosage form manufacturers, distributors and researchers have all necessary registrations, and we believe all registrants operate in conformity with applicable registration requirements, under controlled substance laws.
Government Benefit Programs. Statutory and regulatory requirements for Medicaid, Medicare, Tricare and other government healthcare programs govern provider reimbursement levels, including requiring that all pharmaceutical companies pay rebates to individual states based on a percentage of their net sales arising from Medicaid program-reimbursed products. The federal and state governments may continue to enact measures in the future aimed at containing or reducing payment levels for prescription pharmaceuticals paid for in whole or in part with government funds. We cannot predict the nature of such measures, which could have material adverse consequences for the pharmaceutical industry as a whole and, consequently, also for us. However, we believe we have provided for our best estimate of potential refunds based on current information available.
From time to time, legislative changes are made to government healthcare programs that impact our business. For example, the Medicare Prescription Drug Improvement and Modernization Act of 2003 created a new prescription drug coverage program for people with Medicare through a new system of private market drug benefit plans. This law provides a prescription drug benefit to seniors and individuals with disabilities in the Medicare program ("Medicare Part D"). Congress continues to examine various Medicare policy proposals that may result in pressure on the prices of prescription drugs in the Medicare program.
In addition, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, "the Healthcare Reform Act") provided for major changes to the U.S. healthcare system, which impacted the delivery and payment for healthcare services in the U.S. Several provisions of the Healthcare Reform Act have already taken effect, including the elimination of lifetime caps and no rescission of policies or denial of coverage due to preexisting conditions, improving patients' ability to obtain and maintain health insurance. While significant components of the Healthcare Reform Act have been implemented, various other aspects are ongoing and there may still be challenges and uncertainties ahead. Such a comprehensive reform measure requires expanded implementation efforts on the part of federal and state agencies embarking on rule-making to develop the specific components of their new authority. We continue to closely monitor the implementation of the Healthcare Reform Act and related legislative and regulatory developments. To date our business has been most notably impacted by rebates from the Medicaid Fee-For-Service Program and Medicaid Managed Care plans and the imposition of an annual fee on

15



branded prescription pharmaceutical manufacturers. Medicaid provisions reduced net sales by $82.3 million, $43.5 million, and $15.5 million in fiscal 2015, 2014, and 2013, respectively. The fiscal 2015 increase in provisions for Medicaid payments is primarily attributable to a $41.7 million increase associated with Acthar, as fiscal 2015 included a full year of results for the product, which was partially offset by lower net sales of Methylphenidate ER. The fiscal 2014 increase in provisions for Medicaid payments is primarily attributable to a $17.0 million increase in the Specialty Generics segment driven by increased Medicaid utilization and net sales of Methylphenidate ER. Fiscal 2014, also reflects a $5.2 million increase due to the addition of Acthar that was part of the acquisition of Questcor Pharmaceuticals, Inc. ("Questcor") on August 14, 2014. The Company was also impacted by the annual fee on branded prescription pharmaceutical manufactures, which is not tax deductible, and recorded expense of $20.0 million, $0.9 million, and $0.1 million in fiscal 2015, 2014, and 2013, respectively, within selling, general and administrative expenses. The fee increased in fiscal 2015 due to the inclusion of a full year of results associated with Acthar. We expect this branded pharmaceutical fee and Medicaid provisions to increase in future periods at rates that are consistent with net sales growth. There are a number of other provisions in the legislation that collectively are expected to have an immaterial impact to the Company.

Healthcare Fraud and Abuse Laws
We are subject to various federal, state and local laws targeting fraud and abuse in the healthcare industry. For example, in the U.S., there are federal and state anti-kickback laws that prohibit the payment or receipt of kickbacks, bribes or other remuneration intended to induce the purchase or recommendation of healthcare products and services or reward past purchases or recommendations, including the U.S. Anti-Kickback Statute and similar state statutes, the False Claims Act and the Health Insurance Portability and Accountability Act of 1996. Violations of these laws can lead to civil and criminal penalties, including fines, imprisonment and exclusion from participation in federal healthcare programs. These laws apply to hospitals, physicians and other potential purchasers of our products and are potentially applicable to us as both a manufacturer and a supplier of products reimbursed by federal healthcare programs. In addition, some states in the U.S. have enacted compliance and reporting requirements aimed at drug manufacturers.
We are also subject to the Foreign Corrupt Practices Act of 1977 and similar worldwide anti-bribery laws in non-U.S. jurisdictions, such as the United Kingdom ("U.K.") Bribery Act of 2010, which generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the U.S. are with governmental entities and are therefore subject to such anti-bribery laws. Our policies mandate compliance with these anti-bribery laws; however, we operate in many parts of the world that have experienced governmental corruption to some degree and, in certain circumstances, strict compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance programs, our internal control policies and procedures may not protect us from reckless or criminal acts committed by our employees or agents.

Compliance Programs
In order to systematically and comprehensively mitigate the risks of non-compliance with regulatory requirements described within this Item 1. Business, we have developed what we believe to be a robust compliance program based on the April 2003 Office of the Inspector General ("OIG") Compliance Program Guidance for Pharmaceutical Manufacturers, the U.S. Federal Sentencing Guidelines, the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals, the Code of Ethics of the Advanced Medical Technology Association, the U.K. Anti-Bribery guidance, and other relevant guidance from government and national or regional industry codes of behavior. We conduct ongoing compliance training programs for all employees and maintain a 24-hour ethics and compliance reporting hotline with a strict policy of non-retaliation. We further demonstrated our commitment to our compliance programs by the addition of a Chief Compliance Officer who reports directly to the Chief Executive Officer and the Compliance Committee of our Board of Directors. The Compliance function is independent of the manufacturing and commercial operations functions and is responsible for implementing our compliance programs.
As part of our compliance program, we have implemented internal cross-functional processes to review and approve product-specific promotional materials, presentations and external communications to address the risk of misbranding or mislabeling our products through our promotional efforts. In addition, we have established programs to monitor promotional speaker activities and field sales representatives, which includes a "ride along" program for field sales representatives similar to those included in recent Corporate Integrity Agreements from the OIG in order to obtain first-hand observations of how approved promotional and other materials are used, as well as monitoring of sales representative expenses. We have also implemented a comprehensive controlled substances compliance program, including anti-diversion efforts that go beyond the DEA's SOM requirements and we regularly assist federal, state and local law enforcement and prosecutors in the U.S. by providing information and testimony on our products and placebos for use by the DEA and other law enforcement agencies in investigations and at trial. As part of this program, we also work with some of our customers to help develop and implement what we believe are best practices for SOM and other anti-diversion activities.

16



We believe our compliance program design also addresses our FDA, healthcare anti-kickback, anti-fraud, and anti-bribery-related risks. We believe we have complied with reporting obligations of the U.S. Federal Physician Payment Sunshine Act and relevant state disclosure laws and have implemented a program across the Company to track and report data per Centers for Medicare and Medicaid Services ("CMS") guidance and state disclosure requirements.

Outside the United States
Outside the U.S., we must comply with laws, guidelines and standards promulgated by other regulatory authorities that regulate the development, testing, manufacturing, marketing and selling of pharmaceuticals, including, but not limited to, Health Canada, the Medicines and Healthcare Products Regulatory Agency in the U.K., the Irish Medicines Board, the European Medicines Agency and member states of the E.U., the State Food and Drug Administration in China, the Therapeutic Goods Administration in Australia, the New Zealand Medicines and Medical Devices Safety Authority, the Ministry of Health and Welfare in Japan, the European Pharmacopoeia of the Council of Europe and the International Conference on Harmonization. Although international harmonization efforts continue, many laws, guidelines and standards differ by region or country.
We currently market our products in Canada, in various countries in the E.U., and in the Latin American, Middle Eastern, African and Asia-Pacific regions. The approval requirements and process vary by country, and the time required to obtain marketing authorization may vary from that required for FDA approval. Certain drug products and variations in drug product lines also must meet country-specific and other local regulatory requirements. The following discussion highlights some of the differences in the approval process in other regions or countries outside the U.S.
European Union. Marketing authorizations are obtained either pursuant to a centralized or decentralized procedure. The centralized procedure, which provides for a single marketing authorization valid for all E.U. member states, is mandatory for the approval of certain drug products and is optional for novel drug products that are in the interest of patient health. Under the centralized procedure, a single marketing authorization application is submitted for review to the European Medicines Agency, which makes a recommendation on the application to the European Commission, who determines whether or not to approve the application. The decentralized procedure provides for concurrent mutual recognition of national approval decisions, and is available for products that are not subject to the centralized procedure.
The E.U. has also adopted directives and other laws that govern the labeling, marketing, advertising, supply, distribution and drug safety monitoring and reporting of drug products. Such directives set regulatory standards throughout the E.U. and permit member states to supplement such standards with additional requirements.
European governments also regulate drug prices through the control of national healthcare systems that fund a large part of such costs to patients. Many regulate the pricing of a new drug product at launch through direct price controls or reference pricing and, recently, some have also imposed additional cost-containment measures on drug products. Such differences in national pricing regimes may create price differentials between E.U. member states. Many European governments also advocate generic substitution by requiring or permitting prescribers or pharmacists to substitute a different company's generic version of a brand drug product that was prescribed, and patients are unlikely to take a drug product that is not reimbursed by their government.
Emerging Markets. Many emerging markets continue to evolve their regulatory review and oversight processes. At present, such countries typically require prior regulatory approval or marketing authorization from large, developed markets (such as the U.S.) before they will initiate or complete their review. Some countries also require the applicant to conduct local clinical trials as a condition of marketing authorization. Many emerging markets continue to implement measures to control drug product prices, such as implementing direct price controls or advocating the prescribing and use of generic drugs.

Environmental
Our operations, like those of other pharmaceutical companies, involve the use of substances regulated under environmental laws, primarily in manufacturing processes and, as such, we are subject to numerous federal, state, local and non-U.S. environmental protection and health and safety laws and regulations. We cannot provide assurance that we have been or will be in full compliance with environmental, health and safety laws and regulations at all times. Certain environmental laws assess strict (i.e., can be imposed regardless of fault) and joint and several liability on current or previous owners of real property and current or previous owners or operators of facilities for the costs of investigation, removal or remediation of hazardous substances or materials at such properties or at properties at which parties have disposed of hazardous substances. We have, from time to time, received notification from the EPA and from state environmental agencies in the U.S. that conditions at a number of sites where the disposal of hazardous substances requires investigation, cleanup and other possible remedial actions. These agencies may require that we reimburse the government for costs incurred at these sites or otherwise pay for the cost of investigation and cleanup of these sites including compensation for damage to natural resources. We have projects underway at a number of current and former manufacturing facilities to investigate and remediate environmental contamination resulting from past operations, as further described in Item 3. Legal Proceedings and Note 19

17



to Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
Environmental laws are complex, change frequently and generally have become more stringent over time. We believe that our operations currently comply in all material respects with applicable environmental laws and regulations, and have planned for future capital and operating expenditures to comply with these laws and to address liabilities arising from past or future releases of, or exposures to, hazardous substances. However, we cannot provide assurance that our costs of complying with current or future environmental protection, health and safety laws and regulations will not exceed our estimates or have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
Further, we cannot provide assurance that we will not be subject to additional environmental claims for personal injury or cleanup in the future based on our past, present or future business activities. While it is not feasible to predict the outcome of all pending environmental matters, it is reasonably possible that there will be a need for future provisions for environmental costs that, in management's opinion, are not likely to have a material adverse effect on our financial condition, but could be material to the results of operations in any one accounting period.
Certain radiological licenses at certain manufacturing sites owned by us require the establishment of decommissioning programs which will require remediation in accordance with regulatory requirements upon cessation of operations at these sites.

Raw Materials
We contract with various third-party manufacturers and suppliers, most notably related to our Specialty Brands products, to provide us with raw materials used in our products, finished goods and certain services. If, for any reason, we are unable to obtain sufficient quantities of any of the raw materials, finished goods, services or components required for our products, it could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
The active ingredients in the majority of our current Specialty Generics products and products in development, including oxycodone, oxymorphone, morphine, fentanyl and hydrocodone, are listed by the DEA as Schedule II or III substances under the CSA. Consequently, their manufacture, shipment, storage, sale and use are subject to a high degree of regulation and the DEA limits both the availability of these active ingredients and the production of these products. As discussed in "Regulatory Matters" within this Item 1. Business, we must annually apply to the DEA for procurement and production quotas in order to obtain and produce these substances. The DEA has complete discretion to adjust these quotas from time to time during the calendar year and, as a result, our procurement and production quotas may not be sufficient to meet commercial demand or to conduct bioequivalence studies and clinical trials. Any delay or refusal by the DEA in granting, in whole or in part, our quota requests for controlled substances could delay or result in the stoppage of the manufacture of our pharmaceutical products, our clinical trials or product launches and could require us to allocate product among our customers.
Our radiopharmaceutical product offering includes "hot" radioisotopes including Mo-99, a critical ingredient of our Ultra-Technekow DTE Tc-99m generators. Mo-99 is produced in nuclear research reactors utilizing HEU or LEU targets. These targets, either tubular or flat and of varying sizes, are fabricated from HEU or LEU and, in either case, are aluminum. The targets are placed in or near the core of the nuclear reactor where fission reactions occur resulting in the production of Mo-99 and other isotopes. This process, which takes approximately six days, is known as target irradiation. There are currently eight reactors around the world producing the global supply of Mo-99. We have agreements to obtain Mo-99 from three of these reactors and we rely predominantly on two of these reactors for our Mo-99 supply. These reactors are subject to scheduled and unscheduled shutdowns which can have a significant impact on the amount of Mo-99 available for processing. Mo-99 produced at these reactors is then finished at one of five processing sites located throughout the world, including our processing facility located in the Netherlands. At the processing facility, the targets are dissolved and chemically separated. In this process, the Mo-99 is isolated as a radiochemical. We transport finished Mo-99 from our processing facility in the Netherlands to our facility in Maryland Heights, Missouri, where it, together with Mo-99 received from other third-party processors, is loaded into our Tc-99m generators. Mo-99 has a 66 hour half-life and degrades into, among other things, Tc-99m, which has a half-life of only six hours. The radiopharmacies or hospitals prepare dosages from the Tc-99m generators for use in SPECT imaging medical procedures.
In November 2012, the High Flux Reactor ("HFR") in the Netherlands, one of two primary reactors we utilize, experienced an unscheduled shutdown. We were able to receive increased target irradiations from the two other reactors and purchased additional Mo-99 from other sources to continue meeting customer orders; however, the additional Mo-99 we procured from alternative sources came at a higher than normal cost. The HFR resumed production in June 2013.
In October 2013, the HFR experienced another unscheduled shutdown. In addition, our own Mo-99 processing facility in the Netherlands also experienced a shutdown. We received increased target irradiations from other reactors, purchased additional Mo-99 from other sources and outsourced Mo-99 processing to continue meeting customer orders; however, the additional Mo-99 and processing services we procured from alternative sources came at a higher than normal cost. The HFR resumed production of medical isotopes and irradiation of materials in February 2014 and the Mo-99 processing facility resumed production in April 2014.

18



In September 2015, the HFR experienced an unscheduled shutdown. We expect this disruption will have minimal impact to patients as we intend to obtain target irradiations from other reactors to meet patient needs. Similar to prior periods, the shutdown is expected to result in higher costs as we obtain irradiations from alternative sources. We expect this disruption will negatively impact operating income by approximately $10.0 million to $15.0 million during the first quarter of fiscal 2016, but somewhat less impact is expected in future quarters as the reactor is expected to return to full production in the first half of fiscal 2016. Our Mo-99 processing facility continues to operate as scheduled.

Sales, Marketing and Customers
Sales and Marketing
We market our branded, generic and nuclear products to physicians (including rheumatologists, neurologists, nephrologists, pulmonologists, neonatologists and surgeons), pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, specialty pharmacies, radiologists and radiology technicians. We distribute these products through independent channels, including wholesale drug distributors, specialty pharmaceutical distributors, retail pharmacy chains, hospital networks, ambulatory surgical centers and governmental agencies. In addition, we contract with GPOs and managed care organizations to improve access to our products. We sell and distribute API directly or through distributors to other pharmaceutical companies. In the U.S., we market and distribute our nuclear imaging products to radiopharmacies which, in turn, supply hospitals and standalone imaging centers with patient-customized doses. Outside the U.S., we market and distribute our nuclear imaging products to hospitals.
For further information on our sales and marketing strategies, refer to "Our Businesses and Product Strategies" included within this Item 1. Business.

Customers
Net sales to distributors that accounted for more than 10% of our total net sales in fiscal 2015, 2014 and 2013 were as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
CuraScript
31
%
 
6
%
 
—
%
McKesson Corporation
18
%
 
21
%
 
19
%
Cardinal Health, Inc.
14
%
 
22
%
 
24
%
AmerisourceBergen Corporation
9
%
 
14
%
 
11
%

No other customer accounted for 10% or more of our net sales in the past three fiscal years.

Manufacturing and Distribution
We presently have thirteen manufacturing sites, including nine located in the U.S., as well as sites in Canada, Ireland and the Netherlands, which handle production, assembly, quality assurance testing, packaging and sterilization of our products. Four of these manufacturing sites relate to our CMDS business and are to be sold in our transaction with Guerbet, which is expected to be completed during the first quarter of fiscal year 2016. We estimate that our manufacturing production by region in fiscal 2015 (as measured by cost of production) was as follows:
U.S.
72
%
Europe
16
%
Canada
12
%
We maintain distribution centers in 18 countries. In addition, in certain countries outside the U.S. we utilize third-party distribution centers. Products generally are delivered to these distribution centers from our manufacturing facilities and then subsequently delivered to the customer. In some instances, product, such as nuclear medicine, is delivered directly from our manufacturing facility to the customer. We contract with a wide range of transport providers to deliver our products by road, rail, sea and air.
We utilize contract manufacturing organizations ("CMOs") to manufacture certain of our finished goods that are available for resale. We most frequently utilize CMOs in the manufacture of our Brands products, including Acthar (for finish and filling of the product), Ofirmev and Therakos immunotherapy products.

19




Backlog
At September 25, 2015, the backlog of firm orders was less than 1% of net sales. We anticipate that substantially all of the backlog as of September 25, 2015 will be shipped during fiscal 2016.


Seasonality
We have historically experienced fluctuations in our business resulting from seasonality. DEA quotas for raw materials and final dosage products are allocated in each calendar year to companies and may impact our sales until the DEA grants additional quotas, if any. Impacts from quota limitations are most commonly experienced during the third and fourth calendar quarters, which represent our fourth and first fiscal quarters, respectively. As a result, net sales of DEA controlled products have historically been higher during the second and third fiscal quarters as compared with the first and fourth fiscal quarters. Acthar has experienced lower net sales during the first calendar quarter, our second fiscal quarter, which we believe is partially attributable to certain medical conditions being exacerbated by warm temperatures and effects of annual insurance deductibles. Lastly, we have experienced lower operating cash flows during our first fiscal quarter as we pay annual employee compensation and have experienced lower net sales in DEA controlled products. While we have experienced these fluctuations in the past, they may not be indicative of what we will experience in the future.

Employees
At September 25, 2015, we had approximately 5,700 employees, approximately 4,400 of which are based in the U.S. Certain of these employees are represented by unions or work councils. We believe that we generally have a good relationship with our employees, and with the unions and work councils that represent certain employees.

Executive Officers
Set forth below are the names, ages as of November 1, 2015, and current positions of our executive officers.
Name
Age
Title
Mark Trudeau
54
President, Chief Executive Officer and Director
Matthew Harbaugh
45
Senior Vice President and Chief Financial Officer
Terrance Carlson
62
Senior Vice President and General Counsel - Interim
Meredith Fischer
62
Senior Vice President, Communications and Public Affairs
Raymond Furey
47
Senior Vice President and Chief Compliance Officer
Hugh O'Neill
52
Senior Vice President and President, Autoimmune and Rare Diseases
Gary Phillips
49
Senior Vice President and Chief Strategy Officer
Steven Romano
56
Senior Vice President and Chief Scientific Officer

Frank Scholz
46
Senior Vice President of Global Operations
Ian Watkins
53
Senior Vice President and Chief Human Resources Officer

Set forth below is a brief description of the position and business experience of each of our executive officers.
Mark Trudeau is our President and Chief Executive Officer, and also serves on our board of directors. In anticipation of the Separation, Mr. Trudeau joined Covidien in February 2012 as a Senior Vice President and President of its Pharmaceuticals business. He joined Covidien from Bayer HealthCare Pharmaceuticals LLC USA, the U.S. healthcare business of Bayer AG, where he served as Chief Executive Officer. He simultaneously served as President of Bayer HealthCare Pharmaceuticals, the U.S. organization of Bayer’s global pharmaceuticals business. In addition, he served as Interim President of the global specialty medicine business unit from January to August 2010. Prior to joining Bayer in 2009, Mr. Trudeau headed the Immunoscience Division at Bristol-Myers Squibb. During his 10-plus years at Bristol-Myers Squibb, he served in multiple senior roles, including President of the Asia/Pacific region, President and General Manager of Canada and General Manager/Managing Director in the United Kingdom. Mr. Trudeau was also with Abbott Laboratories, serving in a variety of executive positions, from 1988 to 1998. Mr. Trudeau holds a Bachelor’s degree in chemical engineering and a M.B.A., both from the University of Michigan.
Matthew Harbaugh is our Senior Vice President and Chief Financial Officer. Mr. Harbaugh previously served as Vice President, Finance of Covidien’s Pharmaceuticals business, a position he had held from July 2008 until June 2013, when Mallinckrodt became an independent public company. He also served as Interim President of Covidien’s Pharmaceuticals business from November 2010 to January 2012. Mr. Harbaugh joined Covidien’s Pharmaceuticals business in August 2007 as its Vice President and Controller, Global

20



Finance for the Global Medical Imaging business. Mr. Harbaugh was a Lead Finance Executive with Cerberus Capital Management, L.P. from April 2007 until August 2007. Mr. Harbaugh worked for Monsanto from 1997 to 2007 serving in senior U.S. roles in treasury, investor relations, financial planning and analysis and strategy, in addition to two international assignments in Canada and Argentina.
Terrance Carlson is our Senior Vice President and General Counsel - Interim. Mr. Carlson joined Mallinckrodt in June 2015. Since June 2012, Mr. Carlson has been an independent legal advisor focused on the healthcare and medical device space. From 2010 to 2012, Mr. Carlson served as Vice President and General Counsel at Synthes, Inc., a medical device manufacturer. Prior to joining Synthes, he served as Senior Vice President, General Counsel and Secretary of Medtronic, Inc., a medical device manufacturer. Mr. Carlson previously served in senior legal roles at PerkinElmer, Inc. and AlliedSignal Inc., and as a partner in the law firm of Gibson, Dunn & Crutcher.
Meredith Fischer is our Senior Vice President, Communications and Public Affairs. In anticipation of our spin transaction with Covidien plc Ms. Fischer joined Covidien in February 2013 as Vice President, Communications and Public Affairs for its Pharmaceuticals business. Ms. Fischer was employed by Bayer Corporation from 2001 until February 2013, where she served as Vice President of Communications and Public Policy for Bayer HealthCare and Bayer HealthCare Pharmaceuticals, North America. In that role, Ms. Fischer supported Bayer HealthCare’s U.S. pharmaceutical and animal health divisions and the company’s global medical care and consumer care businesses. She was also Vice President of Marketing and Communications at Pitney Bowes, where she was responsible for product marketing, sales communications and the establishment of professional best practices.
Raymond Furey is our Senior Vice President and Chief Compliance Officer, a role he assumed in August 2014. Previously, Mr. Furey served Questcor Pharmaceuticals, Inc. as Chief Compliance Officer since October 2011 and as its Senior Vice President since May 23, 2013. Mr. Furey has over 25 years of experience in the pharmaceutical industry. Prior to joining Questcor, Mr. Furey served as the Corporate Compliance Officer for OSI Pharmaceuticals and prior to OSI, he served 17 years in various capacities for Genentech, including healthcare compliance, commercial operations, finance, regulatory compliance and manufacturing.
Hugh O'Neill is our Senior Vice President and President, Autoimmune and Rare Diseases. From September 2013 to April 2015, he served as Senior Vice President and President, U.S. Specialty Pharmaceuticals. Prior to joining Mallinckrodt in September 2013, Mr. O’Neill worked at Sanofi-Aventis for ten years where he held various commercial leadership positions including Vice President of Commercial Excellence from June 2012 to July 2013, General Manager, President of Sanofi-Aventis Canada from June 2009 to May 2012, and Vice President Market Access and Business Development from 2006 to 2009. Mr. O’Neill joined Sanofi in 2003 as its Vice President, United States Managed Markets. Mr. O’Neill previously served in a variety of positions of increasing responsibility for Sandoz Pharmaceuticals, Forest Laboratories, Novartis Pharmaceuticals and Pfizer.
Gary Phillips, M.D. is our Senior Vice President and Chief Strategy Officer (a role he also held from October 2013 to August 2014). He served as Senior Vice President and President of our Autoimmune and Rare Disease business from August 2014 to January 2015. Before joining Mallinckrodt, Dr. Phillips served as head of Global Health and Healthcare Industries for the World Economic Forum in Geneva, Switzerland from January 2012 to September 2013. Previously, Dr. Phillips served as President of Reckitt Benckiser Pharmaceuticals North America from 2011 to 2012, as Head, Portfolio Strategy, Business Intelligence and Innovation at Merck Serono from 2008 to 2011, and as President of US Pharmaceuticals and Surgical and Bausch & Lomb from 2002 to 2008. Dr. Phillips has also held positions of leadership at Novartis Pharmaceuticals, Wyeth-Ayerst and Gensia Pharmaceuticals. Dr. Phillips serves as a director of Aldeyra Therapeutics, Inc. and Inotek Pharmaceuticals Corp.
Steven Romano is our Senior Vice President and Chief Scientific Officer. Dr. Romano joined Mallinckrodt in May 2015 and has executive responsibility for research and development (R&D), medical affairs and regulatory affairs functions. Dr. Romano is a board-certified psychiatrist with more than 20 years of experience in the pharmaceutical industry. Previously, Dr. Romano spent 16 years at Pfizer, Inc. where he held a series of senior medical and R&D roles of increasing responsibility, culminating in his most recent position as Senior Vice President, Head, Global Medicines Development, Global Innovative Pharmaceuticals Business. Prior to joining Pfizer, he spent four years at Eli Lilly & Co. After receiving his A.B. in Biology from Washington University in St. Louis and his medical degree from the University of Missouri-Columbia, Dr. Romano completed his residency and fellowship at New York Hospital-Cornell Medical Center, continuing on the faculty of the medical school for six additional years.
Frank Scholz is our Senior Vice President of Global Operations. He joined Mallinckrodt in March 2014. His responsibilities include global manufacturing operations, quality, procurement and supply chain, in addition to leading the global operations transformation. Prior to joining Mallinckrodt, Dr. Scholz was a partner with McKinsey & Co, a global management consulting firm first in its Hamburg, Germany office and then in its Chicago, Illinois office. Dr. Scholz was a leader in McKinsey’s global pharmaceutical and operations practices. He joined McKinsey in 1997. Prior to joining McKinsey, Dr. Scholz was a research assistant at the Institute for Management and Accounting at the University of Hanover, Germany. 
Ian Watkins is our Senior Vice President and Chief Human Resources Officer. Mr. Watkins joined Covidien’s Pharmaceuticals business in September 2012 as the Chief Human Resources Officer. Mr. Watkins served as Vice President, Global Human Resources at Synthes, Inc. from June 2007 to September 2012, which was acquired by Johnson & Johnson. Mr. Watkins served as Senior Vice President, Human Resources from 2003 to 2006 for Andrx Corporation, which is now part of Allergan, Inc. (formerly Actavis, Inc. and Watson Pharmaceuticals, Inc.)

21




Available Information
Our website address is www.mallinckrodt.com. We are not including the information contained on our website as part of, or incorporating it by reference into, this filing. We make available to the public on our website, free of charge, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after such material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission ("SEC"). Our reports filed with, or furnished to, the SEC may be read and copied at the SEC's Public Reference Room at 100 F Street, N.E. Washington, DC 20549. Investors may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. These filings are also available on the SEC's website at www.sec.gov.
We use our website at www.mallinckrodt.com as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. We also use our website to expedite public access to time-critical information regarding our company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the Investor Relations page of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of our website.

22



Item 1A.
Risk Factors.
You should carefully consider the risks described below in addition to all other information provided to you in this Annual Report on Form 10-K. Our competitive position, business, financial condition, results of operations and cash flows could be affected by the factors set forth below, any one of which could cause our actual results to vary materially from recent results or from our anticipated future results. The risks and uncertainties described below are those that we currently believe may materially affect our company.

Risks Related to Our Business
We operate in a rapidly changing environment that involves a number of risks, some of which are beyond our control. The following discussion highlights some of these risks and others are discussed elsewhere in this Annual Report on Form 10-K. These and other risks could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

Extensive laws and regulations govern the industry in which we operate and changes to those laws and regulations may materially adversely affect us.
The development, manufacture, marketing, sale, promotion, and distribution of our products are subject to comprehensive government regulation that governs and influences the development, testing, manufacturing, processing, packaging, holding, record keeping, safety, efficacy, approval, advertising, promotion, sale, distribution and import/export of our products. Under these laws and regulations, we are subject to periodic inspection of our facilities, procedures and operations and/or the testing of our products by the FDA, the DEA and similar authorities within and outside the U.S., which conduct periodic inspections to confirm that we are in compliance with all applicable requirements. If we are found to have violated one or more applicable laws or regulations, we could be subject to a variety of fines, penalties, and related administrative sanctions, and our competitive position, business, financial condition, results of operations and cash flows could be materially adversely affected. We are also required to report adverse events associated with our products to the FDA and other regulatory authorities. Unexpected or serious health or safety concerns associated with our products, including Acthar, could result in reduced sales of the affected products, product liability claims, labeling changes, recalls, market withdrawals or other regulatory actions, including withdrawal of product approvals, any of which could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
In addition, changes in laws, regulations and regulatory actions could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We may be unable to identify, acquire or close acquisition targets successfully.
Part of our business strategy includes evaluating potential business development opportunities to grow the business through merger, acquisition or other business combinations. The process to evaluate potential targets may be complex, time-consuming and expensive. Once a potential target is identified, we may not be able to conclude negotiations of a potential transaction on terms that are satisfactory to us, which could result in a significant diversion of management and other employee time, as well as substantial out-of-pocket costs. In addition, there are a number of risks and uncertainties relating to our ability to close a potential transaction.

Any acquisitions of technologies, products and businesses, including our recently completed acquisition of Therakos, may be difficult to integrate in the expected time frame and may adversely affect our business, financial condition and the results of operations.
We regularly review potential acquisitions of technologies, products and businesses complementary to our business. Acquisitions typically entail many risks and could result in difficulties in integrating operations, personnel, technologies and products. If we are not able to successfully integrate our acquisitions in the expected time frame, we may not obtain the advantages and synergies that such acquisitions were intended to create, which may have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. Moreover, the due diligence that we conduct in conjunction with an acquisition may not sufficiently discover risks and contingent liabilities associated with the acquisition target and, consequently, we may consummate an acquisition for which the risks and contingent liabilities are greater than were projected. In addition, in connection with acquisitions, we could experience disruption in our business, technology and information systems, and our customers, licensors, suppliers and employees and may face difficulties in managing the expanded operations of a significantly larger and more complex company. There is also a risk that key employees of companies that we acquire or key employees necessary to successfully commercialize technologies and products that we acquire may seek employment elsewhere, including

23



with our competitors. Furthermore, there may be overlap between our products or customers and the companies which we acquire that may create conflicts in relationships or other commitments detrimental to the integrated businesses. Additionally, the time between our expenditures to acquire new products, technologies or businesses and the subsequent generation of revenues from those acquired products, technologies or businesses (or the timing of revenue recognition related to licensing agreements and/or strategic collaborations) could cause fluctuations in our financial performance from period to period. Finally, if we are unable to successfully integrate products, technologies, businesses or personnel that we acquire, we could incur significant impairment charges or other adverse financial consequences. Many of these factors are outside of our control and any one of them could result in increased costs, decreases in the amount of expected revenues and diversion of management’s time and energy, which could materially impact our business, financial condition and results of operations.

We have significant levels of goodwill and intangible assets which utilize our future projections of cash flows in impairment testing. Should we experience unfavorable variances from these projections these assets may have an increased risk of future impairment charges.
Our recent acquisitions have significantly increased goodwill and intangible assets, which were $3,649.4 million and $9,666.3 million, respectively, at September 25, 2015. At least annually, we review the carrying value of our goodwill and non-amortizing intangible assets, and for amortizing intangible assets when indicators of impairment are present. Conditions that could indicate impairment and necessitate an evaluation of goodwill and/or intangible assets include, but are not limited to, a significant adverse change in the business climate, legal or regulatory environment, or the deterioration of our market capitalization.
In performing our impairment tests, we utilize our future projections of cash flows. Projections of future cash flows are inherently subjective and reflect assumptions that may or may not ultimately be realized. Significant assumptions utilized in our projections include, but are not limited to, our evaluation of the market opportunity for our products, the current and future competitive landscape and resulting impacts to product pricing, future regulatory actions or the lack thereof, planned strategic initiatives, the ability to achieve cost synergies from acquisitions, the realization of benefits associated with our existing and anticipated patents and regulatory approvals. Given the inherent subjectivity and uncertainty in projections, we could experience significant unfavorable variances in future periods or revise our projections downward. This would result in an increased risk that that our goodwill and intangible assets may be impaired. If an impairment were recognized, this could have a material impact to our financial condition and results of operations.
We may be unable to successfully develop or commercialize new products or expand commercial opportunities for existing products or adapt to a changing technology and diagnostic treatment landscape and, as a result, our results of operations may suffer.
Our future results of operations will depend, to a significant extent, upon our ability to successfully develop and commercialize new products or expand commercial opportunities for existing products in a timely manner. There are numerous difficulties in developing and commercializing new products, including:
•
developing, testing and manufacturing products in compliance with regulatory and quality standards in a timely manner;
•
receiving requisite regulatory approvals for such products in a timely manner, or at all;
•
the availability, on commercially reasonable terms, of raw materials, including API and other key ingredients;
•
developing and commercializing a new product is time-consuming, costly and subject to numerous factors, including legal actions brought by our competitors, that may delay or prevent the development and commercialization of new products;
•
unanticipated costs;
•
payment of prescription drug user fees to the FDA to defray the costs of review and approval of marketing applications for branded and generic drugs;
•
experiencing delays as a result of limited resources at the FDA or other regulatory authorities;
•
changing review and approval policies and standards at the FDA or other regulatory authorities; 
•
potential delays in the commercialization of generic products by up to 30 months resulting from the listing of patents with the FDA; and
•
effective execution of the product launches in a manner that is consistent with anticipated costs.


24



As a result of these and other difficulties, products currently in development by us may or may not receive timely regulatory approvals, or approvals at all, as to one or more dosage strengths. This risk is heightened with respect to the development of proprietary branded products due to the uncertainties, higher costs and length of time associated with R&D of such products and the inherent unproven market acceptance of such products. Moreover, the FDA regulates the facilities, processes and procedures used to manufacture and market pharmaceutical products in the U.S. Manufacturing facilities must be registered with the FDA and all products made in such facilities must be manufactured in accordance with cGMP regulations enforced by the FDA. Compliance with cGMP regulations requires the dedication of substantial resources and requires significant expenditures. The FDA periodically inspects both our facilities and procedures to ensure compliance. The FDA may cause a suspension or withdrawal of product approvals if regulatory standards are not maintained. In the event an approved manufacturing facility for a particular drug is required by the FDA to curtail or cease operations, or otherwise becomes inoperable, obtaining the required FDA authorization to manufacture at the same or a different manufacturing site could result in production delays, which could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
With respect to generic products for which we are the first developer to have its application accepted for filing by the FDA, and which filing includes a certification that the applicable patent(s) are invalid, unenforceable and/or not infringed (known as a "Paragraph IV certification"), our ability to obtain and realize the full benefits of 180-days of market exclusivity is dependent upon a number of factors, including, for example, being the first to file, the status of any litigation that might be brought against us as a result of our filing or our not meeting regulatory, manufacturing or quality requirements or standards. If any of our products are not timely approved, or if we are unable to obtain and realize the full benefits of market exclusivity period for our products, or if our products cannot be successfully manufactured or timely commercialized, our results of operations could be materially adversely affected. In addition, we cannot guarantee that any investment we make in developing products will be recouped, even if we are successful in commercializing those products. Finally, once developed and approved, new products may fail to achieve commercial acceptance due to the price of the product, third-party reimbursement of the product and the effectiveness of sales and marketing efforts to support the product.

We may be unable to protect our intellectual property rights, intellectual property rights may be limited or we may be subject to claims that we infringe on the intellectual property rights of others.
We rely on a combination of patents, trademarks, trade secrets, proprietary know-how, market exclusivity gained from the regulatory approval process and other intellectual property to support our business strategy, most notably in relation to Acthar, Ofirmev, Inomax and Therakos immunotherapy products. However, our efforts to protect our intellectual property rights may not be sufficient. If we do not obtain sufficient protection for our intellectual property, or if we are unable to effectively enforce our intellectual property rights, our competitiveness could be impaired, which could adversely affect our business, financial condition and results of operations.
The composition patent for Acthar has expired and we have no patent-based market exclusivity with respect to any indication or condition we might target. We rely on trade secrets and proprietary know-how to protect the commercial viability and value of Acthar. We currently obtain such protection, in part, through confidentiality and proprietary information agreements. These agreements may not provide meaningful protection or adequate remedies for proprietary technology in the event of unauthorized use or disclosure of confidential and proprietary information. The parties may not comply with or may breach these agreements. Furthermore, our trade secrets may otherwise become known to, or be independently developed by, competitors.
The active ingredient in Ofirmev is acetaminophen. Patent protection is not available for the acetaminophen molecule itself in the territories licensed to us, which include the U.S. and Canada. As a result, competitors who obtain the requisite regulatory approval can offer products with the same active ingredient as Ofirmev so long as the competitors do not infringe any process or formulation patents that Cadence has in-licensed from Bristol-Myers Squibb Company ("BMS") and its licensor, SCR Pharmatop S.A. ("Pharmatop") or that we subsequently obtain.
Certain patents related to the use of therapeutic nitric oxide for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction expired in 2013. Prior to their expiration, Ikaria, Inc. ("Ikaria") depended, in part, upon these patents to provide it with exclusive marketing rights for its product for some period of time. Ikaria has obtained new patents, which expire at various dates through 2031, on methods of identifying patients at risk of serious adverse events when nitric oxide is administered to patients with particular heart conditions which the FDA has approved for inclusion on the Inomax warning label, and that may have the effect of inhibiting development of competitive generic products.
Extracorporeal photopheresis is autologous immune cell therapy for skin manifestations of CTCL. In the ECP process, blood is drawn from the patient, the leukocytes are separated, and the plasma and red blood cells are immediately returned to the patient. The separated leukocytes are treated with UVADEX followed by UVA radiation in the photopheresis instrument. Patents related to the methoxsalen composition have expired. UVADEX is sold as a sterile solution of 20 mcg/mL in 10 mL amber glass vials and is approved to be used in combination with the Therakos ECP Systems to extracorporeally treat leukocytes. Therakos manufactures two systems, the CELLEX® Photopheresis System ("CELLEX"), which is the only FDA-approved closed ECP system, and the

25



UVAR XTS® Photopheresis System ("UVAR XTS"). In addition, disposable, sterile kits are supplied to be used with each of the systems. The kits are single use and discarded after a treatment. Certain key patents related to the UVAR XTS system, disposable kit and overall photopheresis method expire in 2020. Key patents related to the CELLEX system, disposable kit and overall photopheresis method expire in 2023. We continue to pursue additional patentable enhancements to the Therakos ECP system. A patent application was filed in 2015 relating to improvements to the CELLEX system, disposable kit and overall photopheresis method, that if approved may offer patent protection through approximately 2035.
Our pending patent applications may not result in the issuance of patents, or the patents issued to or licensed by us in the past or in the future may be challenged or circumvented by competitors. Existing patents may be found to be invalid or insufficiently broad to preclude our competitors from using methods or making or selling products similar or identical to those covered by our patents and patent applications. Regulatory agencies may refuse to grant us the market exclusivity that we were anticipating, or may unexpectedly grant market exclusivity rights to other parties. In addition, our ability to obtain and enforce intellectual property rights is limited by the unique laws of each country. In some countries it may be particularly difficult to adequately obtain or enforce intellectual property rights, which could make it easier for competitors to capture market share in such countries by utilizing technologies and product features that are similar or identical to those developed or licensed by us. Competitors also may harm our sales by designing products that mirror the capabilities of our products or technology without infringing our patents. Competitors may diminish the value of our trade secrets by reverse engineering or by independent invention. Additionally, current or former employees may improperly disclose such trade secrets to competitors or other third parties. We may not become aware of any such improper disclosure, and, in the event we do become aware, we may not have an adequate remedy available to us.
We operate in an industry characterized by extensive patent litigation, and we may from time to time be a party to such litigation. Such litigation and related matters are described in Note 19 of the Notes to Consolidated and Combined financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
The pursuit of or defense against patent infringement is costly and time-consuming and we may not know the outcomes of such litigation for protracted periods of time. We may be unsuccessful in our efforts to enforce our patent or other intellectual property rights. In addition, patent litigation can result in significant damage awards, including the possibility of treble damages and injunctions. Additionally, we could be forced to stop manufacturing and selling certain products, or we may need to enter into license agreements that require us to make significant royalty or up-front payments in order to continue selling the affected products. Given the nature of our industry, we are likely to face additional claims of patent infringement in the future. A successful claim of patent or other intellectual property infringement against us could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

The DEA regulates the availability of controlled substances that are API, drug products under development and marketed drug products. At times, the procurement and manufacturing quotas granted by the DEA may be insufficient to meet our commercial and R&D needs.
The DEA is the U.S. federal agency responsible for domestic enforcement of the CSA. The CSA classifies drugs and other substances based on identified potential for abuse. Schedule I controlled substances, such as heroin and LSD, have a high abuse potential and have no currently accepted medical use; thus, they cannot be lawfully marketed or sold. Schedule II controlled substances include molecules such as oxycodone, oxymorphone, morphine, fentanyl, and hydrocodone. The manufacture, storage, distribution and sale of these controlled substances are permitted, but highly regulated. The DEA regulates the availability of API, products under development and marketed drug products that are Schedule II by setting annual quotas. Every year, we must apply to the DEA for manufacturing quota to manufacture API and procurement quota to manufacture finished dosage products. Given that the DEA has discretion to grant or deny our manufacturing and procurement quota requests, the quota the DEA grants may be insufficient to meet our commercial and R&D needs. To date in calendar 2015, manufacturing and procurement quotas granted by the DEA have been sufficient to meet our sales and inventory requirements on most products. However, during calendar 2012, the initial hydrocodone manufacturing and procurement quota grants we received from the DEA were below the amounts requested and were insufficient to meet customer demand. While we were granted additional quota, these shortfalls did result in lost sales of hydrocodone products, the amount of which was not significant. Future delay or refusal by the DEA to grant, in whole or in part, our quota requests could delay or result in stopping the manufacture of our marketed drug products, new product launches or the conduct of bioequivalence studies and clinical trials. Such delay or refusal also could require us to allocate marketed drug products among our customers. These factors, along with any delay or refusal by the DEA to provide customers who purchase API from us with sufficient quota, could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.


26



Our customer concentration may materially adversely affect our financial condition and results of operations.
We sell a significant amount of our products to a limited number of independent wholesale drug distributors, large pharmacy chains and specialty pharmaceutical distributors. In turn, these wholesale drug distributors, large pharmacy chains and specialty pharmaceutical distributors supply products to pharmacies, hospitals, governmental agencies and physicians. Sales to four of our distributors that supply our products to many end user customers, AmerisourceBergen, Cardinal Health, Inc., CuraScript Inc. and McKesson Corporation, each accounted for 10% or more of our total net sales in at least one of the past three fiscal years. If we were to lose the business of these distributors, if these distributors failed to fulfill their obligations, or if these distributors were to experience difficulty in paying us on a timely basis, this could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

Our product concentration may materially adversely affect our financial condition and results of operations.
We sell a wide variety of products including branded pharmaceuticals, branded biopharmaceuticals and specialty generic pharmaceuticals, API and nuclear imaging agents. However, our fiscal 2015 and 2014 acquisitions brought a small number of relatively significant products, most notably Acthar and to a lesser extent, Ofirmev and Inomax, that represent a significant percentage of our net sales. Our ability to maintain and increase net sales from these products depends on several factors, including:
•
our ability to increase market demand for products through our own marketing and support of our sales force;
•
our ability to implement and maintain pricing and continue to maintain or increase market volume demand for these products;
•
our ability to maintain confidentiality of the proprietary know-how and trade secrets relating to Acthar;
•
our ability to maintain and defend the patent protection and regulatory exclusivity of Ofirmev and Inomax;
•
our ability to continue to procure raw materials or finished goods, as applicable, of Acthar, Ofirmev, Inomax and Therakos immunotherapy from internal and third-party manufacturers in sufficient quantities and at acceptable quality and pricing levels in order to meet commercial demand;
•
our ability to maintain fees and discounts payable to the wholesalers and distributors and group purchasing organizations, at commercially reasonable levels;
•
whether the FTC, DOJ or third parties seek to challenge and are successful in challenging patents or patent-related settlement agreements or our sales and marketing practices;
•
warnings or limitations that may be required to be added to FDA-approved labeling;
•
the occurrence of adverse side effects related to or emergence of new information related to the therapeutic efficacy of these products, and any resulting product liability claims or product recalls; and
•
our ability to achieve hospital formulary acceptance, and maintain reimbursement levels by third-party payers.
Moreover, net sales of Acthar may also be materially impacted by the decrease in the relatively small number of prescriptions written for Acthar as compared to other products in our portfolio, given Acthar’s use in treating rare diseases. Any disruption in our ability to generate net sales from Acthar could have an adverse impact on our business, financial condition, results of operations and cash flows.

Cost-containment efforts of our customers, purchasing groups, third-party payers and governmental organizations could materially adversely affect our net sales and results of operations.
In an effort to reduce cost, many existing and potential customers for our products within the U.S. have become members of GPOs and integrated delivery networks ("IDNs"). GPOs and IDNs negotiate pricing arrangements with healthcare product manufacturers and distributors and offer the negotiated prices to affiliated hospitals and other members. GPOs and IDNs typically award contracts on a category-by-category basis through a competitive bidding process. Bids are generally solicited from multiple manufacturers with the intention of driving down pricing. Due to the highly competitive nature of the GPO and IDN contracting processes, there is no assurance that we will be able to obtain or maintain contracts with major GPOs and IDNs across our product portfolio. Furthermore, the increasing leverage of organized buying groups may reduce market prices for our products, thereby reducing our profitability. While having a contract with a GPO or IDN for a given product can facilitate sales to members of that GPO or IDN, having a contract is no assurance that sales volume of those products will be maintained. GPOs and IDNs increasingly are awarding contracts to multiple suppliers for the same product category. Even when we are the sole contracted supplier of a GPO or IDN for a certain product, members of the GPO or IDN generally are free to purchase from other suppliers.

27



Furthermore, GPO and IDN contracts typically are terminable without cause upon 60 to 90 days prior notice. Accordingly, our net sales and results of operations may be negatively affected by the loss of a contract with a GPO or IDN. In addition, although we have contracts with many major GPOs and IDNs, the members of such groups may choose to purchase from our competitors, which could result in a decline in our net sales and results of operations. Distributors of our products are also forming strategic alliances and negotiating terms of sale more aggressively in an effort to increase their profitability. Failure to negotiate distribution arrangements having advantageous pricing and other terms of sale could cause us to lose market share to our competitors and could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. Outside the U.S., we have experienced pricing pressure due to the concentration of purchasing power in centralized governmental healthcare authorities and increased efforts by such authorities to lower healthcare costs. We frequently are required to engage in competitive bidding for the sale of our products to governmental purchasing agents. Our failure to offer acceptable prices to these customers could materially adversely affect our business, financial condition, results of operations and cash flows.

Sales of our products are affected by the reimbursement practices of public and private insurers. In addition, reimbursement criteria or policies and the use of tender systems outside the U.S. could reduce prices for our products or reduce our market opportunities.
Sales of our products, depend, in part, on the extent to which the costs of our products are reimbursed by governmental health administration authorities, private health coverage insurers and other third-party payers. The ability of patients to obtain appropriate reimbursement for products and services from these third-party payers affects the selection of products they purchase and the prices they are willing to pay. In the U.S., there have been, and we expect there will continue to be, a number of state and federal proposals that limit the amount that third-party payers may pay to reimburse the cost of drugs, for example with respect to Acthar. We believe the increasing emphasis on managed care in the U.S. has and will continue to put pressure on the usage and reimbursement of Acthar.
Reimbursement of highly-specialized products, such as Acthar, is typically reviewed and approved or denied on a patient-by-patient, case-by-case basis, after careful review of details regarding a patient’s health and treatment history that is provided to the insurance carriers through a prior authorization submission, and appeal submission, if applicable. During this case-by-case review, the reviewer may refer to coverage guidelines issued by that carrier. These coverage guidelines are subject to on-going review by insurance carriers. Because of the large number of carriers, there are a large number of guideline updates issued each year.
In addition, demand for new products may be limited unless we obtain reimbursement approval from governmental and private third-party payers prior to introduction. Reimbursement criteria, which vary by country, are becoming increasingly stringent and require management expertise and significant attention to obtain and maintain qualification for reimbursement.
In addition, a number of markets in which we operate have implemented or may implement tender systems in an effort to lower prices. Under such tender systems, manufacturers submit bids which establish prices for products. The company that wins the tender receives preferential reimbursement for a period of time. Accordingly, the tender system often results in companies underbidding one another by proposing low pricing in order to win the tender. Certain other countries may consider implementation of a tender system. Even if a tender system is ultimately not implemented, the anticipation of such could result in price reductions. Failing to win tenders, or the implementation of similar systems in other markets leading to price declines, could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
We are unable to predict what additional legislation or regulation or changes in third party coverage and reimbursement policies may be enacted or issued in the future or what effect such legislation, regulation and policy changes would have on our business.

Clinical trials demonstrating the efficacy for Acthar are limited. The absence of such clinical trial data could cause physicians not to prescribe Acthar, which could negatively impact our business, financial condition, results of operations and cash flows.
Our net sales of Acthar, which has and is expected to comprise a significant portion of our overall product portfolio, could be negatively impacted by the level of clinical data available on the product. Acthar was originally approved by the FDA in 1952, prior to the enactment of the 1962 Kefauver Harris Amendment, or the “Drug Efficacy Amendment,” to the Food, Drug, and Cosmetic Act. This Amendment introduced the requirement that drug manufacturers provide proof of the effectiveness (in addition to the previously required proof of safety) of their drugs in order to obtain FDA approval. As such, the FDA’s original approval in 1952 was based on safety data as clinical trials evaluating efficacy were not then required. In the 1970s, the FDA reviewed the safety and efficacy of Acthar during its approval of Acthar for the treatment of acute exacerbations in multiple sclerosis and evaluated all other previous indications on the label through the Drug Efficacy Study Implementation (“DESI”) process. In this process, the medical and scientific merits of the label and each indication on the label were evaluated based on publications, information from sponsors, and the judgment of the FDA. The label obtained after the DESI review and the addition of the multiple sclerosis indication is the Acthar label that was used until the most recent changes in 2010.

28



In 2010, in connection with its review of a supplemental NDA for use of Acthar in treatment of infantile spasms, the FDA again reviewed evidence of safety and efficacy of Acthar, and added the IS indication to the label of approved indications while maintaining approval of Acthar for treatment of acute exacerbations in multiple sclerosis and 17 other indications. In conjunction with its decision to retain these 19 indications on a modernized Acthar label, the FDA eliminated approximately 30 other indications from the label. The FDA review included a medical and scientific review of Acthar and each indication and an evaluation of available clinical and non-clinical literature as of the date of the review. The FDA did not require additional clinical trials for Acthar.
Accordingly, evidence of efficacy is based on physician's clinical experience with Acthar and does not include clinical trials except for the multiple sclerosis and infantile spasms indications. Despite recent increases in Acthar prescriptions for several of its on-label indications, this limited clinical data of efficacy could impact future sales of Acthar. We have initiated Phase 4 clinical trials to supplement the non-clinical evidence supporting the use of Acthar in the treatment of the on-label indications of idiopathic membranous nephropathy and systemic lupus erythematosus. The completion of such ongoing or future clinical trials to provide further evidence on the efficacy of Acthar in the treatment of its approved indications could take several years to complete and will require the expenditure of significant time and financial and management resources. Such clinical trials may not result in data that supports the use of Acthar to treat any of its approved indications. In addition, a clinical trial to evaluate the use of Acthar to treat indications not on the current Acthar label may not provide a basis to pursue adding such indications to the current Acthar label.

Our reporting and payment obligations under the Medicare and Medicaid rebate programs, and other governmental purchasing and rebate programs, are complex. Any determination of failure to comply with these obligations or those relating to healthcare fraud and abuse laws could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
The regulations regarding reporting and payment obligations with respect to Medicare and Medicaid reimbursement programs, and rebates and other governmental programs, are complex. Because our processes for these calculations and the judgments used in making these calculations involve subjective decisions and complex methodologies, these accruals may have a higher inherent risk for material changes in estimates. In addition, they are subject to review and challenge by the applicable governmental agencies, and it is possible that such reviews could result in material adjustments to amounts previously paid.
Any governmental agencies that have commenced, or may commence, an investigation of Mallinckrodt relating to the sales, marketing, pricing, quality or manufacturing of pharmaceutical products could seek to impose, based on a claim of violation of fraud and false claims laws or otherwise, civil and/or criminal sanctions, including fines, penalties and possible exclusion from federal healthcare programs including Medicare and Medicaid. Some of the applicable laws may impose liability even in the absence of specific intent to defraud. Furthermore, should there be ambiguity with regard to how to properly calculate and report payments, and even in the absence of any such ambiguity, a governmental authority may take a position contrary to a position we have taken, and may impose civil and/or criminal sanctions. For example, from time to time, state attorneys general have brought cases against us that allege generally that we and numerous other pharmaceuticals companies reported false pricing information in connection with certain drugs that are reimbursable under Medicaid, resulting in overpayment by state Medicaid programs for those drugs, and generally seek monetary damages and attorneys' fees. For example, we are named as a defendant in State of Utah v. Actavis US, Inc., et al., filed May 8, 2008, which is pending in the Third Judicial Circuit of Salt Lake County, Utah. While we intend to contest this case and explore other options as appropriate, any such penalties or sanctions that we might become subject to in this or other actions could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We may not achieve the anticipated benefits of price increases enacted on our pharmaceutical products, which may adversely affect our business.
From time to time, we may initiate price increases on certain of our pharmaceutical products. There is no guarantee that our customers will be receptive to these price increases and continue to purchase the products at historical quantities. If customers do not maintain or increase existing sales volumes after price increases are enacted, and we are unable to replace lost sales with orders from other customers, it could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.


29



We may not achieve some or all of the expected benefits of our restructuring activities and our restructuring activities may adversely affect our business.
From time to time, we initiate restructuring activities as we continue to realign our cost structure due to the changing nature of our business and look for opportunities to achieve operating efficiencies that will reduce costs. We may not be able to obtain the cost savings and benefits that were initially anticipated when we launched our restructuring program. Additionally, as a result of our restructuring activities we may experience a loss of continuity, loss of accumulated knowledge and/or inefficiency during transitional periods. Reorganizations and restructurings can require a significant amount of management and other employees' time and focus, which may divert attention from operating and growing our business. If we fail to achieve some or all of the expected benefits of our restructuring activities, it could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

The manufacture of our products is highly exacting and complex, and our business could suffer if we, or our suppliers, encounter manufacturing or supply problems.
The manufacture of our products is highly exacting and complex, due in part to strict regulatory and manufacturing requirements. Problems may arise during manufacturing for a variety of reasons including equipment malfunction, failure to follow specific protocols and procedures, defective raw materials and environmental factors. If a batch of finished product fails to meet quality standards during a production run, then that entire batch of product may have to be discarded. These problems could lead to backorders, increased costs (including contractual damages for failure to meet supply requirements), lost revenue, damage to customer relationships, time and expense spent investigating, correcting and preventing the root causes and, depending on the root causes, similar losses with respect to other products. If manufacturing problems are not discovered before the product is released to the market, we also could incur product recall and product liability costs. If we incur a product recall or product liability costs involving one of our products, such product could receive reduced market acceptance and thus reduced product demand and could harm our reputation and our ability to market our products in the future. Significant manufacturing problems could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We face significant competition and may not be able to compete effectively.
The industries in which we operate are highly competitive. Competition takes many forms, such as price reductions on products that are comparable to our own, development, acquisition or in-licensing of new products that may be more cost-effective than or have performance superior to our products, and the introduction of generic versions when our proprietary products lose their patent protection or market exclusivity. This competition may limit the effectiveness of any price increases we initiate. Following any price increase by us, competitors may elect to maintain a lower price point that may result in a decline in our sales volume. We are currently experiencing and expect continued increased competition in our Specialty Generics segment, such that we believe fiscal 2016 net sales in this segment will decrease approximately 15% to 20% compared with fiscal 2015 results. For further discussion on the competitive nature of our business, as well as the intellectual property rights and market exclusivity that play a key role in our business, refer to Item 1. Business included within this Annual Report on Form 10-K. Our failure to compete effectively could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We may incur product liability losses and other litigation liability.
We are or may be involved in various legal proceedings and certain government inquiries and investigations, including with respect to, but not limited to, patent infringement, product liability, antitrust matters, securities class action lawsuits, breach of contract, Medicare and Medicaid reimbursement claims, promotional practices and compliance with laws relating to the manufacturing and sale of controlled substances, such as those relating to the operation of a suspicious order monitoring program. Such proceedings, inquiries and investigations may involve claims for, or the possibility of, fines and penalties involving substantial amounts of money or other relief, including but not limited to civil or criminal fines and penalties, changes in business practices and exclusion from participation in various government healthcare-related programs. If any of these legal proceedings, inquiries or investigations were to result in an adverse outcome, the impact could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
With respect to product liability and clinical trial risks, in the ordinary course of business we are subject to liability claims and lawsuits, including potential class actions, alleging that our marketed products or products in development have caused, or could cause, serious adverse events or other injury. Any such claim brought against us, with or without merit, could be costly to defend and could result in an increase in our insurance premiums. We retain liability for $12.5 million per claim of the first $25 million of a loss in our primary liability policies and purchase an additional $150 million using a combination of umbrella/excess liability

30



policies. We believe this coverage level is adequate to address our current risk exposure. However, some claims brought against us might not be covered by our insurance policies. Moreover, where the claim is covered by our insurance, if our insurance coverage is inadequate, we would have to pay the amount of any settlement or judgment that is in excess of our policy limits. We may not be able to obtain insurance on terms acceptable to us or at all since insurance varies in cost and can be difficult to obtain. Our failure to maintain adequate insurance coverage or successfully defend against product liability claims could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We are involved in an ongoing government investigation by the United States Department of Justice involving Questcor’s promotional practices and related matters, the results of which may have a material adverse effect on our sales, financial condition, results of operations and cash flows.
In September 2012, Questcor received a subpoena from the United States Attorney’s Office ("USAO") for the Eastern District of Pennsylvania, requesting documents pertaining to an investigation of its promotional practices. Additionally, the USAO for the Southern District of New York and the SEC are also participating in the investigation to review Questcor’s promotional practices and related matters. We are cooperating with the USAO and the SEC with regard to this investigation.
If some of Questcor’s existing business practices are challenged as unlawful, we may have to change those practices, which could have a material adverse effect on our business, financial condition and results of operations. If, as a result of this investigation, we are found to have violated one or more applicable laws, we could be subject to a variety of fines, penalties, and related administrative sanctions, and our business, financial condition and results of operations could be materially adversely affected.

Our operations expose us to the risk of material health, safety and environmental liabilities, litigation and violations.
We are subject to numerous federal, state, local and non-U.S. environmental protection and health and safety laws and regulations governing, among other things:
•
the generation, storage, use and transportation of hazardous materials;
•
emissions or discharges of substances into the environment;
•
investigation and remediation of hazardous substances or materials at various sites;
•
chemical constituents in products and end-of-life disposal, mandatory recycling and take-back programs; and
•
the health and safety of our employees.
We may not have been, or we may not at all times be, in full compliance with environmental and health and safety laws and regulations. In the event a regulatory authority concludes that we are not in full compliance with these laws, we could be fined, criminally charged or otherwise sanctioned. Environmental laws are becoming more stringent, including outside the U.S., resulting in increased costs and compliance burdens.
Certain environmental laws assess liability on current or previous owners of real property and current or previous owners or operators of facilities for the costs of investigation, removal or remediation of hazardous substances or materials at such properties or at properties at which parties have disposed of hazardous substances. Liability for investigative, removal and remedial costs under certain federal and state laws is retroactive, strict (i.e., can be imposed regardless of fault) and joint and several. In addition to cleanup actions brought by governmental authorities, private parties could bring personal injury or other claims due to the presence of, or exposure to, hazardous substances. Certain radiological licenses at certain manufacturing sites owned by us require the establishment of decommissioning programs which will require remediation in accordance with regulatory requirements upon cessation of operations at such sites. The costs under these programs may exceed amounts we have accrued as asset retirement obligations. We have received notification from the EPA and similar state environmental agencies that conditions at a number of sites where the disposal of hazardous substances requires investigation, cleanup and other possible remedial action. These agencies may require that we reimburse the government for its costs incurred at these sites or otherwise pay for the costs of investigation and cleanup of these sites, including by providing compensation for natural resource damage claims arising from such sites.
In the ordinary course of our business planning process, we take into account our known environmental matters as we plan for our future capital requirements and operating expenditures. The ultimate cost of site cleanup and timing of future cash outflows is difficult to predict, given the uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods
We concluded that, as of September 25, 2015, it was probable that we would incur remedial costs in the range of $39.8 million to $113.1 million. We also concluded that, as of September 25, 2015, the best estimate within this range was $76.5 million. For further information on our environmental obligations, refer to Item 3. Legal Proceedings and Note 19 of Notes to Consolidated

31



and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K. Based upon information known to date, we believe our current capital and operating plans are adequate to address costs associated with the investigation, cleanup and potential remedial action for our known environmental matters.
While we have planned for future capital and operating expenditures to comply with environmental laws, our costs of complying with current or future environmental protection and health and safety laws and regulations, or our liabilities arising from past or future releases of, or exposures to, hazardous substances may exceed our estimates or could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. We may also be subject to additional environmental claims for personal injury or cost recovery actions for remediation of facilities in the future based on our past, present or future business activities.

If we are unable to retain our key personnel, we may be unable to maintain or expand our business.
Because of the specialized scientific nature of our business, our ability to develop products and to compete with our current and future competitors will remain highly dependent, in large part, upon our ability to attract and retain qualified scientific, technical, regulatory and commercial personnel. The loss of key scientific, technical, regulatory and commercial personnel, or the failure to recruit additional key scientific, technical, regulatory and commercial personnel, could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. There is intense competition for qualified personnel in the areas of our activities, and we may not be able to continue to attract and retain the qualified personnel necessary for the development of our business.

Our global operations expose us to risks and challenges associated with conducting business internationally.
We operate globally with offices or activities in Europe, Africa, Asia, South America, Australia and North America. We face several risks inherent in conducting business internationally, including compliance with international and U.S. laws and regulations that apply to our international operations. These laws and regulations include data privacy requirements, labor relations laws, tax laws, anti-competition regulations, import and trade restrictions, export requirements, U.S. laws such as the Foreign Corrupt Practices Act of 1977 and local laws which also prohibit corrupt payments to governmental officials or certain payments or remunerations to customers. Given the high level of complexity of these laws, there is a risk that some provisions may be violated, for example inadvertently or through fraudulent or negligent behavior of individual employees, our failure to comply with certain formal documentation requirements or otherwise. Violations of these laws and regulations could result in fines or criminal sanctions against us, our officers or our employees, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, our business and our results of operations.
In addition to the foregoing, engaging in international business inherently involves a number of other difficulties and risks, including:
•
potentially longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain non-U.S. legal systems;
•
political and economic instability;
•
potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements and trade barriers;
•
failure to successfully implement our new non-U.S. operating structure, and difficulties and costs of staffing and managing non-U.S. operations;
•
exposure to global economic conditions; and
•
exposure to potentially unfavorable movements in foreign currency exchange rates associated with international net sales and operating expense and intercompany debt financings.
These or other factors or any combination of them may have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.


32



The global supply of fission-produced Mo-99 is limited. Our inability to obtain and/or to timely transport Mo-99 to our Tc-99m generator production facilities could prevent us from delivering our Ultra-Technekow DTE Tc-99m generators to our customers in the required quantities, within the required timeframe, or at all, which could result in order cancellations and decreased revenues or increased costs if we procure supply from other sources.
Mo-99 is a critical ingredient of our Tc-99m generators. As described in Item 1. Business of this Annual Report on Form 10-K, the manufacturing process is complex, can be vulnerable due to the limited number of reactors and Mo-99 processing facilities worldwide, and is subject to short product half-lives. Given the product's radioactive decay, if we encounter delays in transporting Mo-99 to our generator facilities, or if the generator facilities experience unscheduled shutdowns or delays in loading Mo-99, we may be limited in the amount of Ultra-Technekow DTE generators that we are able to manufacture, distribute and sell, which could have a material adverse effect on our competitive position, business, financial condition, results of operation and cash flows.
In fiscal 2013 and fiscal 2014, the HFR in the Netherlands, one of two primary reactors we utilize, experienced unscheduled shutdowns and in fiscal 2014 our own Mo-99 processing facility in the Netherlands experienced a shutdown. We were able to receive increased target irradiations from other reactors and purchased additional Mo-99 from other sources to continue meeting customer orders; however, the additional Mo-99 we procured from alternative sources came at a higher than normal cost. In addition, in September 2015 the HFR experienced another unscheduled shutdown which is expected to result in higher costs through the duration of the shutdown as we obtain irradiations from alternative sources. We expect this disruption will negatively impact operating income by approximately $10.0 million to $15.0 million during the first quarter of fiscal 2016, but somewhat less impact is expected in future quarters as the reactor is expected to return to full production in the first half of fiscal 2016.
Future unplanned shutdowns of nuclear reactors that we use to irradiate targets and processing facilities could impact the amount of available Mo-99, which could result in global shortages, continued increased raw material costs and decreased sales. While we are pursuing additional sources of Mo-99 from potential producers around the world to augment our current supply, it is not certain whether these possible additional sources of Mo-99 will produce commercial quantities of Mo-99 for our business, or that these suppliers, together with our current suppliers, will be able to deliver a sufficient quantity of Mo-99 to meet our needs. Mo-99 prices may also be impacted by higher operating costs of nuclear reactors and the elimination of governmental subsidies of nuclear reactors. Ongoing increased raw material and manufacturing costs may limit the profitability of the Nuclear Imaging segment.

Inomax and ECP are each marketed by us in the U.S. for only one indication. We will not be permitted to market these products in the U.S. for any other indication unless we receive FDA approval for any such indication. If we do not receive approval to market these products for additional uses, our ability to grow revenues may be materially adversely affected.
Inomax is approved for sale in the U.S. only for the treatment of HRF associated with pulmonary hypertension in term and near-term infants, and ECP is approved for sale in the U.S. only for the palliative treatment of the skin manifestations of CTCL in persons who have not been responsive to other forms of treatment. In order to market these products in the U.S. for any other indications, we will need to conduct appropriate clinical trials, obtain positive results from those trials, and obtain regulatory approval for such proposed indications. Obtaining regulatory approval is uncertain, time consuming and expensive. Even well-conducted studies of effective drugs will sometimes appear to be negative in either safety or efficacy results. The regulatory review and approval process to obtain marketing approval for a new indication can take many years, often requires multiple clinical trials and requires the expenditure of substantial resources. This process can vary substantially based on the type, complexity, novelty and indication of the product candidate involved. The FDA and other regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that any data submitted is insufficient for approval and require additional studies or clinical trials. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit or prevent regulatory approval of a new indication for a product candidate. If we do not receive approval to market these products in the U.S. for additional indications, we will not be permitted to market them for any other indication and our ability to grow revenues may be materially adversely affected.

A significant portion of our revenues from Inomax and ECP is derived from unapproved uses. We have no control over physicians’ use of these products for unapproved uses, we are not permitted to promote or market these products for unapproved uses and we cannot assure you that physicians will continue to prescribe these products for unapproved uses at the same rate, or at all.
The FDA and other foreign regulatory authorities approve drugs and medical devices for the treatment of specific indications, and products may only be promoted or marketed for the indications for which they have been approved. However, the FDA does not attempt to regulate physicians’ use of approved products, and physicians are free to prescribe most approved products for purposes outside the indication for which they have been approved. This practice is sometimes referred to as “off-label” use. While physicians are free to prescribe approved products for unapproved uses, it is unlawful for drug and device manufacturers to market

33



or promote a product for an unapproved use.The laws and regulations relating to the promotion of products for unapproved uses are complex and subject to substantial interpretation by the FDA and other government agencies. Promotion of a product for unapproved use is prohibited; however, certain activities that we and others in the pharmaceutical industry engage in are permitted by the FDA.
Over the past several years, a significant number of pharmaceutical and biotechnology companies have been the target of inquiries and investigations by various federal and state regulatory, investigative, prosecutorial and administrative entities in connection with the promotion of products for unapproved uses and other sales practices, including the Department of Justice and various U.S. Attorneys’ Offices, the Office of Inspector General of the Department of Health and Human Services, the FDA, the Federal Trade Commission and various state Attorneys General offices. These investigations have alleged violations of various federal and state laws and regulations, including claims asserting antitrust violations, violations of the Food, Drug and Cosmetic Act, the False Claims Act, the Prescription Drug Marketing Act, anti-kickback laws, and other alleged violations in connection with the promotion of products for unapproved uses, pricing and Medicare and/or Medicaid reimbursement. Many of these investigations originate as “qui tam” actions under the False Claims Act. Under the False Claims Act, any individual can bring a claim on behalf of the government alleging that a person or entity has presented a false claim, or caused a false claim to be submitted, to the government for payment. The person bringing a "qui tam" suit is entitled to a share of any recovery or settlement. Qui tam suits, also commonly referred to as “whistleblower suits,” are often brought by current or former employees. In a qui tam suit, the government must decide whether to intervene and prosecute the case. If the government declines to intervene and prosecute the case, the individual may pursue the case alone.
If the FDA or any other governmental agency initiates an enforcement action against us or if we are the subject of a qui tam suit and it is determined that we violated prohibitions relating to the promotion of products for unapproved uses in connection with past or future activities, we could be subject to substantial civil or criminal fines or damage awards and other sanctions such as consent decrees and corporate integrity agreements pursuant to which our activities would be subject to ongoing scrutiny and monitoring to ensure compliance with applicable laws and regulations. Any such fines, awards or other sanctions could have an adverse effect on our revenue, business, financial prospects and reputation.

Our business depends on the continued effectiveness and availability of our information technology infrastructure, and failures of this infrastructure could harm our operations.
To remain competitive in our industry, we must employ information technologies to support manufacturing processes, quality processes, distribution, R&D and regulatory applications that capture, manage and analyze, in compliance with applicable regulatory requirements, the large streams of data generated in our clinical trials. We rely extensively on technology to allow concurrent work sharing around the world. As with all information technology, our systems are vulnerable to potential damage or interruptions from fires, blackouts, telecommunications failures and other unexpected events, as well as physical and electronic break-ins, sabotage, piracy or intentional acts of vandalism. Given the extensive reliance of our business on technology, any substantial disruption or resulting loss of data that is not avoided or corrected by our backup measures could harm our business, operations and financial condition. In addition, any unauthorized access, disclosure or other loss of information could result in legal claims or proceedings, liability under laws that protect the privacy of personal information, and regulatory penalties, disrupt our operations, and damage our reputation, and cause a loss of confidence in our products and services, which could adversely affect our business.

Potential indemnification liabilities to Covidien pursuant to the separation and distribution agreement could materially adversely affect us.
The separation and distribution agreement that we entered into with Covidien in connection with the Separation provided for, among other things, the principal corporate transactions required to effect the Separation, certain conditions to the distribution and provisions governing the relationship between us and Covidien following the Separation. The separation and distribution agreement was filed with the SEC as Exhibit 2.1 to our Current Report on Form 8-K on July 1, 2013. Among other things, the separation and distribution agreement provides for indemnification obligations principally designed to place financial responsibility for the obligations and liabilities of our business with us and financial responsibility for the obligations and liabilities of Covidien's remaining business with Covidien, among other indemnities. If we are required to indemnify Covidien under the circumstances set forth in the separation and distribution agreement, we may be subject to substantial liabilities. These potential indemnification obligations could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.




34



Risks Related to Our Indebtedness

Our substantial indebtedness could adversely affect our financial condition and prevent us from fulfilling our obligations.
We have substantial indebtedness, which could adversely affect our ability to fulfill our financial obligations and have a negative impact on our financing options and liquidity position. As of September 25, 2015, we had $6,606.5 million of total debt.
Our degree of debt leverage could have significant consequences, including the following:
•
making it more difficult for us to satisfy our obligations with respect to our debt;
•
limiting our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions or other corporate requirements;
•
requiring a substantial portion of our cash flows to be dedicated to debt service payments instead of other purposes, thereby reducing the amount of cash flows available for working capital, capital expenditures, acquisitions and other general corporate purposes;
•
limiting our ability to refinance our indebtedness on terms acceptable to us or at all;
•
imposing restrictive covenants on our operations;
•
placing us at a competitive disadvantage to other less leveraged competitors;
•
making us more vulnerable to economic downturns and limiting our ability to withstand competitive pressures;
•
limiting our flexibility in planning for and reacting to changes in the industry in which we compete; and
•
increasing our costs of borrowing.
In addition, the documents that govern the terms of our indebtedness contain restrictive covenants that limit our ability to engage in activities that may be in our long-term best interest. Our failure to comply with those covenants could result in an event of default which, if not cured or waived, could result in the acceleration of repayment of our debt.

We may not be able to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.
Our ability to make scheduled payments on or to refinance our debt obligations depends on our financial condition and operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities sufficient to permit us to fund our day-to-day operations or to pay the principal, premium, if any, and interest on our indebtedness.
If our cash flows and capital resources are insufficient to fund our debt service obligations and other cash requirements, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We may not be able to effect any such alternative measures, if necessary, on commercially reasonable terms or at all and, even if successful, such alternative actions may not allow us to meet our scheduled debt service obligations. The agreements governing our indebtedness restrict (a) our ability to dispose of assets and use the proceeds from any such dispositions and (b) our ability to raise debt capital to be used to repay our indebtedness when it becomes due. We may not be able to consummate those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations then due.
Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations.
If we cannot make scheduled payments on our debt, we will be in default and, as a result, lenders under any of our indebtedness could declare essentially all outstanding principal and interest to be due and payable, the lenders under our existing credit facilities could terminate their commitments to loan money, our secured lenders could foreclose against the assets securing such borrowings and we could be forced into bankruptcy or liquidation.

Despite current and anticipated indebtedness levels, we may still be able to incur substantially more debt. This could further exacerbate the risks described above.
We may be able to incur substantial additional indebtedness in the future. Although agreements governing our indebtedness restrict the incurrence of additional indebtedness, these restrictions are and will be subject to a number of qualifications and exceptions

35



and the additional indebtedness incurred in compliance with these restrictions could be substantial. If new debt is added to our current debt levels, the related risks that we now face could intensify.

The terms of the agreements that govern our indebtedness restrict our current and future operations, particularly our ability to respond to changes or to pursue our business strategies.
The agreements that govern the terms of our indebtedness contain a number of restrictive covenants that impose significant operating and financial restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including limitations or restrictions on our ability to:
•
incur, assume or guarantee additional indebtedness;
•
declare or pay dividends, make other distributions with respect to equity interests, or purchase or otherwise acquire or retire equity interests
•
make any principal payment on, or redeem or repurchase, subordinated debt;
•
make loans, advances or other investments;
•
sell or otherwise dispose of assets, including capital stock of subsidiaries;
•
incur liens;
•
enter into transactions with affiliates;
•
enter into sale and leaseback transactions; and
•
consolidate or merge with or into, or sell all or substantially all of our assets to, another person or entity.
In addition, the restrictive covenants in the credit agreement governing our senior secured credit facilities require us to comply with a financial maintenance covenant in certain circumstances. Our ability to satisfy this financial maintenance covenant can be affected by events beyond our control and we cannot assure you that we will be able to comply.
A breach of the covenants under the agreements that govern the terms of any of our indebtedness could result in an event of default under the applicable indebtedness. Such default may allow the creditors to accelerate the related debt and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. In addition, an event of default under the credit agreement that governs our senior secured credit facilities would permit the lenders under such facilities to terminate all commitments to extend further credit thereunder. Furthermore, if we are unable to repay the amounts due and payable under our senior secured credit facilities, those lenders will be able to proceed against the collateral granted to them to secure that indebtedness. If our debtholders accelerate the repayment of our borrowings, we may not have sufficient assets to repay that indebtedness.
As a result of these restrictions, we may be:
•
limited in how we conduct our business;
•
unable to raise additional debt or equity financing to operate during general economic or business downturns; or
•
unable to compete effectively, execute our growth strategy or take advantage of new business opportunities.
These restrictions may affect our ability to grow in accordance with our plans.

Our variable-rate indebtedness exposes us to interest rate risk, which could cause our debt service obligations to increase significantly.

Certain of our indebtedness, including borrowings under our senior secured credit facilities and our receivables securitization, are subject to variable rates of interest and expose us to interest rate risk. If interest rates increase, our debt service obligations on the variable-rate indebtedness would increase and our net income would decrease, even though the amount borrowed under the facilities remained the same. As of September 25, 2015, we had $1,978.5 million outstanding variable-rate debt on our senior secured term loans, $500.0 million outstanding on our revolving credit facility and $153.0 million outstanding variable-rate debt on our receivables securitization. An unfavorable movement in interest rates, primarily LIBOR, could result in higher interest expense and cash payments for the Company. Although we may enter into interest rate swaps, involving the exchange of floating for fixed-rate interest payments, to reduce interest rate volatility, we cannot provide assurance that we will enter into such arrangements or that they will successfully mitigate such interest rate volatility.


36



Our current debt levels and challenges in the commercial and credit environment may materially adversely affect our ability to issue debt on acceptable terms and our future access to capital.
Our ability to issue debt or enter into other financing arrangements on acceptable terms could be materially adversely affected by our current debt levels or if there is a material decline in the demand for our products or in the solvency of our customers or suppliers or other significantly unfavorable changes in economic conditions occur. In addition, volatility in the world financial markets could increase borrowing costs or affect our ability to access the capital markets, which could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.

We may need additional financing in the future to meet our capital needs or to make acquisitions, and such financing may not be available on favorable or acceptable terms, and may be dilutive to existing shareholders.
We may need to seek additional financing for general corporate purposes. For example, we may need to increase our investment in R&D activities or need funds to make acquisitions. We may be unable to obtain any desired additional financing on terms that are favorable or acceptable to us. Depending on market conditions, adequate funds may not be available to us on acceptable terms and we may be unable to fund our expansion, successfully develop or enhance products, or respond to competitive pressures, any of which could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. If we raise additional funds through the issuance of equity securities, our shareholders will experience dilution of their ownership interest.

A lowering or withdrawal of the ratings assigned to our debt by rating agencies may increase our future borrowing costs and reduce our access to capital.
Our debt currently has a non-investment grade rating from Standard & Poor's Corporation ("S&P") and Moody's Investor Services, Inc. ("Moody's"). Any rating assigned could be lowered or withdrawn entirely by a rating agency if, in that rating agency's judgment, future circumstances relating to the basis of the rating, such as adverse changes, so warrant. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of the notes. Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain additional debt financing.


Risks Related to Tax Matters

If the distribution completed in connection with the Separation fails to qualify as a tax-free transaction for U.S. federal income tax purposes, then Mallinckrodt and Mallinckrodt's shareholders could be subject to significant tax liability or tax indemnity obligations.
Covidien received a U.S. Internal Revenue Service ("IRS") ruling substantially to the effect that, for U.S. federal income tax purposes, (i) certain transactions effected in connection with the Separation qualified as transactions under Sections 355 and 368(a) of the U.S. Internal Revenue Code ("the Code"), and (ii) the distribution of Mallinckrodt shares qualified as a transaction under Sections 355 and 368(a)(1)(D) of the Code. In addition to obtaining the IRS ruling, Covidien received a tax opinion from Skadden, Arps, Slate, Meagher & Flom LLP, which relied on the effectiveness of the IRS ruling, substantially to the effect that, for U.S. federal income tax purposes, the distribution and certain transactions entered into in connection with the distribution qualified as transactions under Sections 355 and 368(a) of the Code.
The IRS ruling and tax opinion rely on certain facts and assumptions, certain representations from Covidien and us regarding the past and future conduct of our respective businesses and other matters, and certain undertakings made by Covidien and us. Notwithstanding the IRS ruling and tax opinion, the IRS could determine on audit that the distribution should be treated as a taxable transaction if it determines that any of these facts, assumptions, representations or undertakings is not correct or has been violated, or that the distribution should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the distribution, or if the IRS were to disagree with the conclusions of the tax opinion that are not covered by the IRS ruling. If the distribution is ultimately determined to be taxable, the distribution could be treated as a taxable dividend to shareholders of Mallinckrodt, who acquired their shares through distribution to Covidien shareholders at the Separation date, for U.S. federal income tax purposes, and they could incur significant U.S. federal income tax liability. In addition, Covidien or we could incur significant U.S. federal income tax liabilities or tax indemnification obligations, whether under applicable law or the tax matters agreement ("the Tax Matters Agreement") that we entered into with Covidien, if it is ultimately determined that certain related transactions undertaken in anticipation of the distribution are taxable.


37



We could have significant tax liabilities under the Tax Matters Agreement with Covidien for periods during which our subsidiaries and operations were those of Covidien and of Tyco International Ltd.
Our tax returns are subject to examination by various tax authorities, including the IRS. The IRS is examining our U.S. federal income tax returns for periods during which certain of our subsidiaries and operations were those of Covidien. In addition, the IRS continues to examine the U.S. federal income tax returns of Tyco International Ltd. ("Tyco International") for periods during which certain of our subsidiaries and operations were those of Tyco International. Our potential liability under the Tax Matters Agreement with Covidien for any taxes related to periods prior to the Separation (after taking into account certain tax benefits realized by us), including those which are subject to the provisions of the tax sharing agreement by and among Covidien, Tyco International and TE Connectivity Ltd. ("the Tyco Tax Sharing Agreement"), is anticipated to be approximately $91.0 million, excluding associated tax benefits from such payments, or $65.4 million, net of associated tax benefits, and will be subject to an overall limitation of $200.0 million, net of associated tax benefits. Payments to date qualifying under the overall limitation of $200.0 million are $51.6 million, net of associated tax benefits. For further information on the Tax Matters Agreement, refer to our Current Report on Form 8-K filed with the SEC on July 1, 2013.
The resolution of the matters arising during periods in which certain of our subsidiaries and operations were subsidiaries and operations of Covidien will be subject to the provisions of the Tax Matters Agreement. Under this agreement, Covidien has the right to administer, control and settle, in its sole and absolute discretion, all tax audits that do not relate solely to non-U.S. taxes for periods prior to the Separation that are not covered by the Tyco Tax Sharing Agreement. The outcome of any such examination, and any associated litigation which might arise, is uncertain and could result in a significant increase in our liability for taxes arising during these periods, subject to the overall $200.0 million limitation described above. The timing and outcome of such examination or litigation is highly uncertain and could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. Under the Tax Matters Agreement, Covidien agreed to provide to us information it receives related to examinations of tax matters for which we may be liable but we will not otherwise be permitted to control or participate in the settlement or defense of such examinations.
The resolution of the matters arising during periods in which certain of our subsidiaries and operations were subsidiaries and operations of Tyco International will be subject to the provisions of the Tax Matters Agreement and the Tyco Tax Sharing Agreement. Under the Tyco Tax Sharing Agreement, Covidien, Tyco International and TE Connectivity Ltd. are responsible for 42%, 27% and 31%, respectively, of U.S. income tax liabilities prior to the 2007 separation of Covidien, Tyco International and TE Connectivity Ltd. We are not a party to the Tyco Tax Sharing Agreement. Under the Tax Matters Agreement we will, however, be liable for certain taxes relating to our subsidiaries and operations arising during periods governed by the Tyco Tax Sharing Agreement. Although we will be liable to Covidien for certain taxes arising during periods governed by the Tyco Tax Sharing Agreement, we will not be liable to Tyco International or TE Connectivity Ltd. under the Tyco Tax Sharing Agreement, nor will we share in the receivable that Covidien has from Tyco International or TE Connectivity Ltd. In addition, Covidien will retain all reimbursements from Tyco International or TE Connectivity Ltd. pursuant to the Tyco Tax Sharing Agreement, including reimbursements for taxes that are borne by us pursuant to the Tax Matters Agreement.
Under the Tyco Tax Sharing Agreement, Tyco International has the right to administer, control and settle all U.S. income tax audits for periods prior to the separation from Tyco International. In connection with such examinations, tax authorities, including the IRS, have proposed tax adjustments. Tyco International has appealed certain of the proposed tax adjustments and all but one of the matters associated with the proposed tax adjustments has been resolved. With respect to the remaining unresolved matter, Tyco International is contesting the adjustments through litigation. The outcome of any such litigation is uncertain and could result in a significant increase in our liability for taxes arising during these periods, subject to the overall $200 million limitation described above. While we believe that the amounts recorded as income taxes payable related to these adjustments are adequate, the timing and outcome of such litigation is highly uncertain and could have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows. Under the Tax Matters Agreement, Covidien has agreed to provide to us information it receives from Tyco International related to examinations of tax matters for which we may be liable that are governed by the Tyco Tax Sharing Agreement.

Our status as a foreign corporation for U.S. federal tax purposes could be affected by a change in law.
We believe that, under current law, we are treated as a foreign corporation for U.S. federal tax purposes. However, changes to the inversion rules in Section 7874 or the U.S. Treasury Regulations promulgated thereunder or other IRS guidance could adversely affect our status as a foreign corporation for U.S. federal tax purposes, and any such changes could have prospective or retroactive application to us and our shareholders and affiliates. In addition, recent legislative proposals have aimed to expand the scope of U.S. corporate tax residence, and such legislation, if passed, could have an adverse effect on us. For example, in February 2015, the President of the United States proposed legislation which would amend the anti-inversion rules. Although its application is limited to transaction closing after 2015, no assurance can be given that such proposal will not be changed in the legislative process to apply to prior transactions. Additionally, in September 2014, legislation was introduced in the U.S. Senate that seeks to address the practice of earnings stripping by companies that move their domicile overseas. Furthermore, the Department of the Treasury and the IRS provided

38



notice in September 2014 and November 2015 that the agencies intend to issue regulations to reduce the tax benefits of or preclude entirely certain inversion transactions. In the November 2015 notice, the Secretary of the Treasury communicated the intention to explore potential guidance on earnings stripping and take further action in the coming months.

Future changes to U.S. and foreign tax laws could adversely affect us.
The Group of Twenty ("the G20"), the Organization for Economic Co-operation and Development ("the OECD"), the U.S. Congress and Treasury Department and other government agencies in jurisdictions where we and our affiliates do business have had an extended focus on issues related to the taxation of multinational corporations. As a result, the tax laws in the U.S. and other countries in which we and our affiliates do business could change on a prospective or retroactive basis, and any such changes could adversely affect us and our affiliates. One example, is in the area of "base erosion and profit shifting," where payments are made between affiliates from a jurisdiction with high tax rates to a jurisdiction with lower tax rates. In October 2015, the OECD presented the final package of measures for a comprehensive, coherent and co-ordinated reform of the international tax rules.

We may not be able to maintain a competitive worldwide effective corporate tax rate.
We cannot give any assurance as to what our effective tax rate will be in the future, because of, among other things, uncertainty regarding the tax policies of the jurisdictions where we operate. Our actual effective tax rate may vary from our expectation and that variance may be material. Additionally, the tax laws of the United Kingdom and other jurisdictions could change in the future, and such changes could cause a material change in our effective tax rate.

The change in our tax residency could have a negative effect on our future profitability and taxes on dividends.

Under current Irish legislation, a company is regarded as resident in Ireland for tax purposes if it is centrally managed and controlled in Ireland, or, in certain circumstances, if it is incorporated in Ireland. Under current U.K. legislation, a company is regarded as resident in the U.K. for tax purposes if it is centrally managed and controlled in the U.K. Where a company is treated as tax resident under the domestic laws of both the U.K. and Ireland then the provisions of article 4(3) of the Double Tax Convention between Ireland and the U.K. provide that such company shall be treated as resident only in the jurisdiction in which its place of effective management is situated.  Since May 2015, we have managed, and we intend to continue to manage, the affairs of Mallinckrodt plc so that it is effectively managed and controlled in the U.K. and therefore be treated as resident only in the U.K. for tax purposes, by operation of the Double Taxation Convention.  However, we cannot provide assurance that Mallinckrodt plc will continue to be resident only in the U.K. for tax purposes.  It is possible that in the future, whether as a result of a change in law or a change in the practice or conduct of the affairs of any relevant tax authority, Mallinckrodt plc could become, or be regarded as having become resident in a jurisdiction other than the U.K.  If Mallinckrodt plc were considered to be a tax resident of Ireland, it could become liable for Irish corporation tax and any dividends paid by it could be subject to Irish dividend withholding tax.

Our installment sale arrangements result in a deferral of tax obligations payable to the IRS, which are subject to variable-rate interest rate risk, which could result in higher cost associated with deferring these tax obligation.
As part of the integration of Questcor, the Company entered into an internal installment sale transaction related to certain Acthar intangible assets during the fiscal year ended September 25, 2015. The installment sale transaction resulted in a taxable gain. In accordance with Internal Revenue Code Section 453 the gain is considered taxable in the period in which installment payments are received. The U.S. Internal Revenue Service ("IRS") charges interest based on the deferred tax liability outstanding as of the end of a company's fiscal year, regardless of amounts outstanding during the fiscal year. The interest payable on the deferred tax liability is subject to fluctuations in interest rates, which may increase in future periods. As of September 25, 2015, the Company had an aggregate $1,447.4 million of interest bearing U.S. deferred tax liabilities associated with outstanding installment notes.


Risks Related to Our Jurisdiction of Incorporation

Irish law differs from the laws in effect in the U.S. and may afford less protection to holders of our securities.
It may not be possible to enforce court judgments obtained in the U.S. against us in Ireland based on the civil liability provisions of the U.S. federal or state securities laws. In addition, there is some uncertainty as to whether the courts of Ireland would recognize or enforce judgments of U.S. courts obtained against us or our directors or officers based on the civil liabilities provisions of the U.S. federal or state securities laws or hear actions against us or those persons based on those laws. We have been advised the U.S.

39



currently does not have a treaty with Ireland providing for the reciprocal recognition and enforcement of judgments in civil and commercial matters. Therefore, a final judgment for the payment of money rendered by any U.S. federal or state court based on civil liability, whether or not based solely on U.S. federal or state securities laws, would not automatically be enforceable in Ireland.
A judgment obtained against us will be enforced by the courts of Ireland if the following general requirements are met: (i) U.S. courts must have had jurisdiction in relation to the particular defendant according to Irish conflict of law rules (the submission to jurisdiction by the defendant would satisfy this rule) and (ii) the judgment must be final and conclusive and the decree must be final and unalterable in the court which pronounces it. A judgment can be final and conclusive even if it is subject to appeal or even if an appeal is pending. Where however the effect of lodging an appeal under the applicable law is to stay execution of the judgment, it is possible that in the meantime the judgment may not be actionable in Ireland. It remains to be determined whether final judgment given in default of appearance is final and conclusive. However, Irish courts may refuse to enforce a judgment of the U.S. courts which meets the above requirements for one of the following reasons: (i) if the judgment is not for a definite sum of money; (ii) if the judgment was obtained by fraud; (iii) the enforcement of the judgment in Ireland would be contrary to natural or constitutional justice; (iv) the judgment is contrary to Irish public policy or involves certain U.S. laws which will not be enforced in Ireland; or (v) jurisdiction cannot be obtained by the Irish courts over the judgment debtors in the enforcement proceedings by personal service in Ireland or outside Ireland under Order 11 of the Ireland Superior Courts Rules.
As an Irish company, we are governed by the Irish Companies Act, which differ in some material respects from laws generally applicable to U.S. corporations and shareholders, including, among others, differences relating to interested director and officer transactions and shareholder lawsuits. Likewise, the duties of directors and officers of an Irish company generally are owed to the company only. Shareholders of Irish companies generally do not have a personal right of action against directors or officers of the company and may exercise such rights of action on behalf of the company only in limited circumstances. Accordingly, holders of our securities may have more difficulty protecting their interests than would holders of securities of a corporation incorporated in a jurisdiction of the U.S.

Irish law imposes restrictions on certain aspects of capital management.
Irish law allows our shareholders to pre-authorize shares to be issued by our board of directors without further shareholder approval for up to a maximum of five years. Our current authorization will therefore lapse approximately five years after the date of the Separation, June 28, 2013, unless renewed by shareholders, and we cannot guarantee that such renewal will always be approved. Additionally, subject to specified exceptions, including the opt-out that is included in our articles of association, Irish law grants statutory pre-emptive rights to existing shareholders to subscribe for new issuances of shares for cash. This opt-out also expires approximately five years after the Separation, unless renewed by further shareholder approval, and we cannot guarantee that such renewal of the opt-out from pre-emptive rights will always be approved. We cannot provide assurance that these Irish legal restrictions will not interfere with our capital management.


Risks Related to Our Ordinary Shares

Our share price may fluctuate significantly.
The market price of our ordinary shares may fluctuate significantly due to a number of factors, some of which may be beyond our control, including:
•
actual or anticipated fluctuations in our results of operations;
•
changes in earnings estimated by securities analysts or our ability to meet those estimates;
•
perceived impacts to our results from acquisitions of products, licenses rights or businesses;
•
the operating and share price performance of comparable companies;
•
actual or anticipated sales of our ordinary shares;
•
changes to the regulatory and legal environment in which we operate; and
•
U.S. and worldwide economic conditions.
Volatility can also occur from short sellers becoming active in our stock.  It is generally in the short seller’s interest for the price of a stock to decline.  Prior to our acquisition of Questcor, Questcor experienced high levels of short interest in its stock.  It has been alleged that short sellers may take various actions aimed at attempting to cause harm to a company’s business or reputation in an effort to cause such company’s stock to decline.  Short sellers have recently been active in our stock.

40



In addition, when the market price of a company's ordinary shares drops significantly, shareholders often institute securities class action lawsuits against the company. A lawsuit against us could cause us to incur substantial costs and could divert the time and attention of our management and other resources.
Furthermore, we cannot guarantee that an active trading market for our ordinary shares will continue to exist.

Your percentage of ownership in Mallinckrodt may be diluted.
Your percentage ownership in Mallinckrodt may be diluted because of equity issuances for acquisitions, capital market transactions or otherwise, including equity awards granted to our directors, officers and employees. Such issuances may have a dilutive effect on our earnings per share, which could materially adversely affect the market price of our ordinary shares. For example, we issued approximately 57 million ordinary shares in connection with the completion of our acquisition of Questcor in August 2014. In addition, our articles of association entitle our board of directors, without shareholder approval, to cause us to issue preferred shares with such terms as our board of directors may determine. Preferred shares may be preferred as to dividends, rights on a winding up or voting in such manner as our board of directors may resolve. The preferred shares may also be redeemable at the option of the holder of the preferred shares or at the option of us, and may be convertible into or exchangeable for shares of any other class or classes of our shares, depending on the terms of such preferred shares. The terms of one or more classes or series of preferred shares could dilute the voting power or reduce the value of our ordinary shares. For example, we could grant the holders of preferred shares the right to elect some number of our board of directors in all events or on the happening of specified events or the right to veto specified transactions. Similarly, the repurchase or redemption rights or liquidation preferences we could assign to holders of preferred shares could affect the residual value of our ordinary shares.

Certain provisions in our articles of association, among other things, could prevent or delay an acquisition of us, which could decrease the trading price of our ordinary shares.
Our articles of association contain provisions that could have the effect of deterring coercive takeover practices, inadequate takeover bids and unsolicited offers. These provisions include, among others:
•
provisions of our articles of association which allow our board of directors to adopt a shareholder rights plan (commonly known as a "poison pill") upon such terms and conditions as the board of directors deems expedient and in the best interests of our company;
•
a provision of our articles of association which generally prohibits us from engaging in a business combination with an interested shareholder for a period of three years following the date the person became an interested shareholder, subject to certain exceptions;
•
rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings;
•
the right of our board of directors to issue preferred shares without shareholder approval in certain circumstances, subject to applicable law; and
•
the ability of our board of directors to fill vacancies on our board of directors in certain circumstances.
We believe these provisions will provide some protection to our shareholders from coercive or otherwise unfair takeover tactics. These provisions are not intended to make us immune from takeovers. However, these provisions will apply even if a takeover offer may be considered beneficial by some shareholders and could delay or prevent an acquisition that our board of directors determines is not in the best interests of our company and its shareholders. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.
In addition, several mandatory provisions of Irish law could prevent or delay an acquisition of us. For example, Irish law does not permit shareholders of an Irish public limited company to take action by written consent with less than unanimous consent. We are also subject to various provisions of Irish law relating to mandatory bids, voluntary bids, requirements to make a cash offer and minimum price requirements, as well as substantial acquisition rules and rules requiring the disclosure of interests in our ordinary shares in certain circumstances. Also, Irish companies, including us, may only alter their memorandum of association and articles of association with the approval of the holders of at least 75% of the company's shares present and voting in person or by proxy at a general meeting of the company.
The agreements that we entered into with Covidien in connection with the Separation generally required Covidien's consent to any assignment by us of our rights and obligations under the agreements. The consent and termination rights set forth in these agreements might discourage, delay or prevent a change of control that shareholders may consider favorable.
Moreover, an acquisition or further issuance of our ordinary shares after the Separation could trigger the application of Section 355(e) of the Code, even if the distribution and certain related transactions undertaken in connection therewith otherwise qualify for tax-free treatment. Under Section 355(e) of the Code, we or Covidien could incur tax upon certain transactions undertaken

41



in anticipation of the distribution if 50% or more, by vote or value, of our ordinary shares or Covidien ordinary shares are acquired or issued as part of a plan or series of related transactions that include the separation. The process for determining whether an acquisition or issuance triggering these provisions has occurred is complex, inherently factual and subject to interpretation. Any acquisitions or issuances of our ordinary shares or Covidien ordinary shares within two years after the distribution are presumed to be part of such a plan, although we or Covidien, as applicable, may be able to rebut that presumption. Moreover, under the Tax Matters Agreement that we entered into with Covidien, we will be restricted from engaging in certain transactions within two years of the distribution which potentially could trigger application of Section 355(e) of the Code. During such period, these restrictions may limit the ability that we, or a potential acquirer of us, have to pursue certain strategic transactions that might increase the value of our ordinary shares.

Item 1B.
Unresolved Staff Comments.
None.

Item 2.
Properties.
Our principal executive offices are located at a facility in Chesterfield, United Kingdom. Our U.S. headquarters are located in a facility in Hazelwood, Missouri, which we own. As of September 25, 2015, we owned a total of fifteen facilities in three countries. Four of our owned facilities relate to our CMDS business and are to be sold in our transaction with Guerbet, which is expected to be completed during the first quarter of fiscal year 2016. Our owned facilities consist of approximately 3.1 million square feet, and our leased facilities consist of approximately 1.6 million square feet. CMDS facilities consist of 0.5 million of the total square feet of owned facilities and 0.2 million square feet of leased facilities. We have thirteen manufacturing sites, two of which are used by our Nuclear Imaging segment, seven of which are used by our Specialty Brands and Specialty Generics segments, four of which are used by the CMDS business. We have two manufacturing sites in Canada, one manufacturing site in each of Ireland and the Netherlands and nine manufacturing sites in the U.S. We believe all of these facilities are well-maintained and suitable for the operations conducted in them.

Item 3.
Legal Proceedings.
 We are subject to various legal proceedings and claims, including patent infringement claims, product liability matters, environmental matters, employment disputes, contractual disputes and other commercial disputes. We believe that these legal proceedings and claims likely will be resolved over an extended period of time. Although it is not feasible to predict the outcome of these matters, we believe, unless indicated in Note 19 of the Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data, that their ultimate resolution will not have a material adverse effect on our financial condition, results of operations and cash flows. For further information on pending legal proceedings, refer to Note 19 of the Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Item 4.
Mine Safety Disclosures.
 Not applicable.

42



PART II

Item 5.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information
Our ordinary shares are traded on the New York Stock Exchange ("NYSE") under the ticker symbol "MNK." The following table presents the high and low closing prices of our ordinary shares for the periods indicated, as reported by the NYSE.
 
 
FY2015
 
FY2014
 
 
High
Low
 
High
Low
First Quarter
 
$
99.73

$
83.19

 
$
53.47

$
42.01

Second Quarter
 
132.51

93.89

 
72.81

50.70

Third Quarter
 
130.13

113.18

 
82.70

60.28

Fourth Quarter
 
126.51

68.45

 
90.00

68.12


There were approximately 3,166 shareholders of record of our ordinary shares as of November 16, 2015.

Dividends and Issuer Purchase of Equity Securities
Under Irish law, we can only pay dividends and repurchase shares out of distributable reserves. Upon completion of the Separation, we did not have any distributable reserves. On July 22, 2013, we filed a petition with the High Court of Ireland seeking the court's confirmation of a reduction of our share premium so that it can be treated as distributable for the purposes of Irish law. On September 9, 2013, the High Court of Ireland approved this petition and, upon approval, our share premium is treated as distributable reserves and our share premium balance was reclassified into additional paid-in capital. We did not declare or pay any dividends and we do not currently intend to pay dividends in the foreseeable future.
During the quarter ended September 25, 2015, we repurchased 839,964 of our ordinary shares related to both our $300.0 million share repurchase program, announced on January 23, 2015, and the satisfaction of tax withholding obligations in connection with the vesting of restricted stock issued to employees as follows:
Period
 
Total Number of Shares Purchased
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under The Plans or Programs
6/27/2015 - 7/24/2015
 
7,584

 
$
118.00

 
—

 
$
300.0

7/25/2015 - 8/28/2015
 
589,678

 
93.48

 
588,361

 
245.0

8/29/2015 - 9/25/2015
 
242,702

 
85.74

 
235,231

 
225.0

6/27/2015 - 9/25/2015
 
839,964

 
91.46

 
 
 
 


43



Performance Graph
The following performance graph and related information shall not be deemed "soliciting material" or to be "filed" with the United States Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933 or Securities Exchange Act of 1934, each as amended, except to the extent that we specifically incorporate it by reference into such filing.
The following graph compares the changes, for the period indicated, in the cumulative total value of $100 hypothetically invested in each of (a) Mallinckrodt ordinary shares, (b) the Russell 1000 index and (c) the NYSE Pharmaceutical Index. This graph covers the period from June 17, 2013, the first day our ordinary shares began "when-issued" trading on the NYSE, through September 25, 2015.

Comparison of Cumulative Total Return*
Among Mallinckrodt plc, the Russell 1000 Index and NYSE Pharmaceutical Index
*$100.00 invested on June 17, 2013 in shares or index.

Performance Graph Data
 
 
Mallinckrodt
 
Russell 1000 Index
 
NYSE Pharmaceutical Index
June 17, 2013
 
$
100.00

 
$
100.00

 
$
100.00

September 27, 2013
 
96.82

 
104.02

 
100.18

September 26, 2014
 
200.00

 
121.42

 
124.26

September 25, 2015
 
152.11

 
118.54

 
122.72


The share price performance included in this graph is not necessarily indicative of future share price performance.

Information regarding securities authorized for issuance under equity compensation plans will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.


44



Item 6.
Selected Financial Data.
The following table sets forth selected financial data as of and for the fiscal years ended September 25, 2015, September 26, 2014, September 27, 2013, September 28, 2012 and September 30, 2011. This selected financial data reflects the consolidated position of Mallinckrodt plc and its consolidated subsidiaries (collectively, "Mallinckrodt") as an independent, publicly-traded company for periods on or after its legal separation from Covidien plc ("Covidien") on June 28, 2013. Selected financial data for periods prior to June 28, 2013 reflect the combined historical business and operations of Covidien's Pharmaceuticals business as it was historically managed as part of Covidien.
The consolidated statement of income data for fiscal 2015 and 2014, the consolidated and combined statement of income data for fiscal 2013, and the consolidated balance sheet data as of September 25, 2015 and September 26, 2014 were derived from our consolidated and combined financial statements and accompanying notes included elsewhere in this Annual Report on Form 10-K. The September 27, 2013 and September 28, 2012 balance sheets were derived from our audited combined financial statements that are not included in this Annual Report on Form 10-K. In fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet. Accordingly, the combined statement of income data for fiscal 2012 and 2011 and balance sheet as of September 30, 2011 are derived from our unaudited consolidated financial statements that are not included in this annual report, as amounts have been recast to reflect the CMDS business as a discontinued operation.
This selected financial information should be read in conjunction with our consolidated and combined financial statements and accompanying notes and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. Our historical results for periods prior to June 28, 2013 are not necessarily indicative of the results of operations or financial condition that would have been obtained had we operated as an independent, publicly-traded company for the entirety of the periods presented, nor are they necessarily indicative of our future performance as an independent, publicly-traded company.
(in millions, except per share data)
Fiscal Year (1)
 
2015
 
2014
 
2013
 
2012
 
2011
 
 
 
 
 
 
 
 
 
 
Consolidated and Combined Statement of Income Data:
 
 
 
 
 
 
 
 
 
Net sales
$
3,346.9

 
$
2,082.0

 
$
1,712.3

 
$
1,533.0

 
$
1,423.7

Gross profit
1,853.6

 
1,060.2

 
822.3

 
718.9

 
663.0

Research and development expenses (2)
185.1

 
163.5

 
157.9

 
138.4

 
134.7

Operating income (loss) (3) (4)
461.8

 
(75.9
)
 
73.5

 
122.8

 
130.7

Income (loss) from continuing operations before income taxes
215.3

 
(153.9
)
 
55.7

 
123.7

 
133.2

Income (loss) from continuing operations
308.2

 
(143.8
)
 
8.2

 
58.5

 
71.4

 
 
 
 
 
 
 
 
 
 
Share Data (5):
 
 
 
 
 
 
 
 
 
Basic income (loss) from continuing operations per share
$
2.64

 
$
(2.22
)
 
$
0.14

 
$
1.01

 
$
1.24

Diluted income (loss) from continuing operations per share
2.61

 
(2.22
)
 
0.14

 
1.01

 
1.24

Cash dividends per ordinary share
—

 
—

 
—

 
—

 
—

 
September 25, 2015
 
September 26, 2014
 
September 27, 2013
 
September 28, 2012
 
September 30, 2011
 
 
 
 
 
 
 
 
 
 
Consolidated and Combined Balance Sheet Data:
 
 
 
 
 
 
 
 
 
Total assets
$
16,404.1

 
$
12,787.3

 
$
3,556.6

 
$
2,898.9

 
$
2,832.2

Long-term debt
6,474.3

 
3,874.0

 
918.3

 
8.9

 
10.4

Shareholders' equity
5,311.2

 
4,958.0

 
1,255.6

 
1,891.9

 
1,788.7


(1)
Fiscal 2011 included 53 weeks. All other fiscal years presented include 52 weeks.
(2)
Fiscal 2014 and 2013 each include a $5.0 million charge related to milestone payments related to the acceptance of pipeline products for filing with the FDA.
(3)
Fiscal 2015, 2014, 2013, 2012, and 2011 include restructuring charges, net, of $40.4 million, $81.4 million, $23.7 million, $8.4 million and $11.5 million, respectively. Fiscal 2015 includes $86.3 million of environmental and legal charges, $80.6 million of incremental equity costs associated with the Questcor Acquisition and $53.4 million of transaction costs associated with the Ikaria Acquisition and the Therakos Acquisition. Fiscal 2014 includes $151.6 million of non-restructuring impairment charges, $49.6 million of environmental and legal charges and $65.1 million of transaction costs associated with the Cadence Acquisition and the Questcor Acquisition. Fiscal 2013 and 2012 include costs related to the build-out of our corporate infrastructure of $70.6 million and $10.7 million, respectively. Fiscal 2014, 2013, 2012 and 2011 include separation related costs of $9.6 million, $74.2 million, $25.5 million and $2.9 million, respectively.
(4)
Fiscal 2013, 2012, and 2011 include expense allocations from Covidien of $39.6 million, $49.2 million and $56.3 million, respectively, which relate to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. Effective with the legal separation from Covidien on June 28, 2013, we have assumed responsibility for all of these functions and related costs.
(5)
The computation of basic and diluted earnings per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien.


45



Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated and combined financial statements and the accompanying notes included in this Annual Report on Form 10-K. The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs and involve risks, uncertainties and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed in Item 1A. Risk Factors and "Forward-Looking Statements" included within this Annual Report on Form 10-K.

Overview
We are a global specialty biopharmaceutical and nuclear imaging business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and nuclear imaging agents. Therapeutic areas of focus include autoimmune and rare disease specialty areas (including neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; and central nervous system drugs. The Company also supports the diagnosis of disease with nuclear medicine imaging agents. The Company believes its experience in the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities have created compelling competitive advantages that it anticipates will sustain future revenue growth.
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which was renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:
•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and API consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).
For further information on our business and products, refer to Item 1. Business included within this Annual Report on Form 10-K.

Significant Events
Separation from Covidien
Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien. On June 28, 2013, Covidien shareholders of record received one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien held as of the record date, June 19, 2013, and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing its legal separation from Covidien.
Our consolidated and combined financial statements reflect the consolidated financial position of Mallinckrodt plc and its subsidiaries as an independent publicly-traded company for periods subsequent to June 28, 2013, and as a combined reporting entity of Covidien, including operations relating to Covidien's Pharmaceuticals business, for periods prior to June 28, 2013. Our results for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that are included with our fiscal 2013 results, may not be indicative of our future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had we operated as an independent, publicly-traded company for the entirety of the periods presented, including as a result of changes in our capitalization in connection with the Separation. The combined financial statements for periods prior to June 28, 2013 include expense allocations related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. The amounts allocated were $39.6 million in fiscal 2013. Management considers the bases on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, us during the periods presented; however, the allocations may not reflect the expense we would have incurred as an independent, publicly-traded company. These allocations have not recurred following the completion of the Separation on June 28, 2013, as we have been performing these functions using our own resources or purchased services, certain of which were being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between us

46



and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services were rendered may not have been as favorable as those allocated to us by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.

Acquisitions
On September 25, 2015, we acquired Therakos through the acquisition of all the outstanding common stock of TGG Medical Solutions, Inc., the parent holding company of Therakos, in a transaction valued at approximately $1.3 billion, net of cash acquired ("the Therakos Acquisition"). Consideration for the transaction consisted of approximately $1.0 billion in cash paid to TGG Medical Solutions, Inc. shareholders and the assumption of approximately $0.3 billion of Therakos third-party debt, which was repaid in conjunction with the Therakos Acquisition. The acquisition and immediate repayment of debt was funded through the issuance of $750.0 million aggregate principal amount of senior unsecured notes, a $500.0 million borrowing under our revolving credit facility and cash on hand. Therakos' primary immunotherapy products relate to the administering of extracorporeal photopheresis therapies through their UVAR XTS® and CELLEX.
In April 2015, we acquired Ikaria through the acquisition of all the outstanding common stock of Compound Holdings II, Inc., the parent holding company of Ikaria, in a transaction valued at approximately $2.3 billion, net of cash acquired ("the Ikaria Acquisition"). Consideration for the transaction consisted of approximately $1.2 billion in cash paid to Compound Holdings II, Inc. shareholders and the assumption of approximately $1.1 billion of Ikaria third-party debt, which was repaid in conjunction with the Ikaria Acquisition. The acquisition and immediate repayment of debt was funded through the issuance of $1.4 billion aggregate principal amount of senior unsecured notes, a $240.0 million borrowing under a revolving credit facility, which was subsequently repaid following the transaction, and cash on hand. Ikaria's primary product is Inomax, a vital treatment option in neonatal critical care.
In August 2014, we acquired Questcor, a biopharmaceutical company, for total consideration of approximately $5.9 billion ("the Questcor Acquisition"). The acquisition was funded through the issuance of approximately 57 million common shares, proceeds from the issuance of $900.0 million aggregate principle of senior unsecured notes, proceeds from the issuance of $700.0 million senior secured term loan facility, $150.0 million of cash from a receivable securitization program and cash on hand. Questcor's primary product, Acthar, is focused on the treatment of patients with serious, difficult-to-treat autoimmune and rare diseases. Acthar is an injectable drug that is approved by the FDA for use in 19 indications, including the areas of neurology, rheumatology, nephrology and pulmonology. As part of the acquisition, we also acquired BioVectra, Inc. ("BioVectra"), a specialty contract manufacturer that provides services to the global pharmaceuticals and biotechnology industry.
In March 2014, we acquired Cadence, a biopharmaceutical company focused on commercializing products principally for use in the hospital setting for approximately $1.3 billion ("the Cadence Acquisition"). The acquisition was primarily funded through a $1.3 billion senior secured term loan credit facility. Cadence's sole product, Ofirmev, is a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The Cadence Acquisition added a growth product to the Specialty Brands product portfolio and provided us the opportunity to expand our reach into the hospital market, in which Cadence had an established presence.

License of Intellectual Property
We were involved in patent disputes with a counterparty relating to certain intellectual property related to extended-release oxymorphone. In December 2013, the counterparty agreed to pay us an upfront cash payment of $4.0 million and contractually obligated future payments of $8.0 million through July 2018, in exchange for the withdrawal of all claims associated with the intellectual property and a license to utilize our intellectual property. We completed the earnings process associated with the agreement and recorded an $11.7 million gain, included within gain on divestiture and license, during fiscal 2014.

Divestitures
During the fourth quarter of fiscal 2015, we announced that we entered into a definitive agreement to sell our global CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which was renamed Nuclear Imaging.





47



Royalty and Milestone Payments
We are required to pay royalties and milestone payments for various product acquisitions and license agreements we entered into with third parties. We incurred royalty expense of $92.3 million, $56.3 million, and $49.8 million in fiscal 2015, 2014 and 2013, respectively, under our product acquisitions and license agreements, including those discussed below.
We acquired the exclusive development and commercialization rights to Ofirmev in the U.S. and Canada, as well as the rights to the patents and technology. Under this license agreement, we may be obligated to make future milestone payments of up to $25.0 million upon the achievement of certain levels of net sales, in addition to on-going royalties on the sales of the product. Through fiscal 2015, $10.0 million of milestone payments had been made.
For Exalgo, we may be obligated to make payments of up to $73.0 million based on the successful completion of specified development and regulatory milestones. Through fiscal 2015, $65.0 million of these payments had been made, with $55.0 million being capitalized as an intangible asset. We are also required to pay royalties on sales of the product. In January 2014, the Company purchased royalty rights associated with Exalgo for $7.2 million, which was capitalized as an intangible asset.
In fiscal 2009, we entered into a licensing agreement to utilize Depomed's Acuform gastric retentive drug delivery technology for the exclusive development of four products. Under this license agreement, the Company may be obligated to pay up to $64.0 million in development milestone payments. Through fiscal 2015, approximately $22.0 million of these payments had been made. During fiscal 2014, upon approval by the FDA of Xartemis XR, we made a milestone payment of $10.0 million, which was capitalized as an intangible asset.
In 2009, we entered into a licensing agreement with Nuvo which granted rights to market and distribute Pennsaid and Pennsaid 2%. We were responsible for all future development activities and expenses and were required to make milestone payments of up to $120.0 million based upon the successful completion of specified regulatory and sales milestones. We paid $15.0 million of these payments, all of which were capitalized as an intangible asset as the payment related to the fiscal 2010 FDA approval of the Pennsaid NDA. During the fourth quarter of fiscal 2014, we reached an agreement in principle with Nuvo to settle various claims associated with our license of Pennsaid. As part of the legal settlement, the Company agreed to return the license to Nuvo, which resulted in the Company recording an impairment of $11.1 million during the fourth quarter of fiscal 2014.

Nuclear Imaging
In November 2012, the HFR in the Netherlands, one of two primary reactors we utilize, experienced an unscheduled shutdown. We were able to receive increased target irradiations from the two other reactors and purchased additional Mo-99 from other sources to continue meeting customer orders; however, the additional Mo-99 we procured from alternative sources came at a higher than normal cost. The HFR resumed production in June 2013.
In October 2013, the HFR experienced an unscheduled shutdown. In addition, our own Mo-99 processing facility in the Netherlands also experienced a shutdown. We received increased target irradiations from other reactors, purchased additional Mo-99 from other sources and outsourced Mo-99 processing to continue meeting customer orders; however, the additional Mo-99 and processing services we procured from alternative sources came at a higher than normal cost. The HFR resumed production of medical isotopes and irradiation of materials in February 2014 and the Mo-99 processing facility resumed production in April 2014.
In September 2015, the HFR experienced another unscheduled shutdown. We expect this disruption will have minimal impact to patients as we intend to obtain target irradiations from other reactors to meet patient needs. Similar to prior periods, the shutdown is expected to result in higher costs as we obtain irradiations from alternative sources. We expect this disruption will negatively impact operating income by approximately $10.0 million to $15.0 million during the first quarter of fiscal 2016, but somewhat less impact is expected in future quarters as the reactor is expected to return to full production in the first half of fiscal 2016. Our Mo-99 processing facility continues to operate as scheduled. Ongoing increased raw material and manufacturing costs may limit the profitability of the Nuclear Imaging segment.

Lower Passaic River Environmental Reserve
In April 2014, the EPA issued its revised Focused Feasibility Study ("FFS"), with remedial alternatives to address cleanup of the lower 8-mile stretch of the Lower Passaic River Study Area ("the River"), which also included a "no action" option. The EPA estimated the cost for the alternatives to range from $365.0 million to $3.2 billion. The EPA's preferred approach would involve bank-to-bank dredging of the lower 8-mile stretch of the River and installing an engineered cap at a discounted, estimated cost of $1.7 billion. Based on the issuance of the EPA's revised FFS, we recorded a $23.1 million accrual in the second quarter of fiscal 2014 representing the estimate of our allocable share of the joint and several remediation liability resulting from this matter.
In April 2015, the Lower Passaic Cooperating Parties Group ("CPG") presented a draft of the remedial investigation and feasibility study ("RI/FS") of the River to the EPA. The CPG's RI/FS included alternatives that ranged from "no action," targeted remediation of the entire 17-mile stretch of the River to remedial actions consistent with the EPA's preferred approach for the lower 8-

48



mile stretch of the River and also included remediation alternatives for the upper 9-mile stretch of the River. The discounted cost estimates for the CPG remediation alternatives ranged from $483.4 million to $2.7 billion. We recorded an additional charge of $13.3 million in the second quarter of fiscal 2015 based on our estimate of our allocable share of the joint and several remediation liability resulting from this matter.
Despite the issuance of the revised FFS by the EPA and the RI/FS by the CPG, there are many uncertainties associated with the final agreed-upon remediation and our allocable share of the remediation. As of November 20, 2015, the Company withdrew from the CPG, but remains liable for its obligations under the two above-referenced AOCs, as well as potential future liabilities. Given those uncertainties, the amounts accrued may not be indicative of the amounts for which the Company may be ultimately responsible and will be refined as events in the remediation process occur.

Business Factors Influencing the Results of Operations

Products
As a result of acquisitions in fiscal 2015 and 2014, we obtained the sales and marketing rights to Inomax on April 16, 2015; Acthar on August 14, 2014; and Ofirmev on March 19, 2014. The addition of these products to our Specialty Brands product portfolio provided us with three products that significantly contributed to the net sales and operating income within this segment. Net sales of these products were $1,485.5 million during the fiscal year ended September 25, 2015 compared with $247.3 million in the fiscal year ended September 26, 2014. Our cost of sales for fiscal 2015 and 2014 included $44.1 million and $25.7 million, respectively, of expense recognition associated with the fair value adjustments of acquired inventory and $515.0 million and $120.3 million, respectively, of amortization associated with intangibles recognized from these acquisitions. Additionally, we expensed $53.4 million and $65.1 million of transaction costs, respectfully, in fiscal 2015 and 2014 associated with our transactions, including the Therakos acquisition on September 25, 2015, which are reflected in SG&A in our consolidated statement of income.
In December 2012, we received approval from the FDA to manufacture Methylphenidate ER. In July 2013, a competitor received FDA approval to manufacture Methylphenidate ER and entered the marketplace. In November 2014, we were informed by the FDA that it believes that our Methylphenidate ER products may not be therapeutically equivalent to the category reference listed drug and the FDA reclassified Methylphenidate ER from freely substitutable at the pharmacy level (class AB) to presumed to be therapeutically inequivalent (class BX). The FDA has indicated that it has not identified any serious safety concerns with the products. We continue to market our Methylphenidate ER products as a class BX-rated drug. The FDA's action to reclassify our Methylphenidate ER products had, and is expected to continue to have a negative impact on net sales and operating income unless the FDA reverses its decision. Net sales of Methylphenidate ER were $136.5 million, $209.6 million and $148.3 million in fiscal 2015, 2014 and 2013, respectively.
In May 2014, we launched an authorized generic version of Exalgo, and subsequently additional competitors entered the market. Net sales of Exalgo were $39.4 million, $76.1 million and $126.1 million in fiscal 2015, 2014 and 2013, respectively. Net sales across the branded and authorized generic products during fiscal 2015 were less than those of the branded products during fiscal 2014.

Restructuring Initiatives
We continue to realign our cost structure due to the changing nature of our business and look for opportunities to achieve operating efficiencies. In July 2013 our board of directors approved a restructuring program in the amount of $100.0 million to $125.0 million ("the 2013 Mallinckrodt Program") that was planned to occur over a three-year period from the approval of the program, with a two-year cost recovery period. Through September 25, 2015, we incurred restructuring charges of $96.9 million under the 2013 Mallinckrodt Program, which have and are expected to continue to generate savings, substantially within our SG&A expenses. In addition to the 2013 Mallinckrodt Program, we have taken restructuring actions to generate synergies from our acquisitions.


49



Results of Operations
Fiscal Year Ended September 25, 2015 Compared with Fiscal Year Ended September 26, 2014

Net Sales
Net sales by geographic area are as follows (dollars in millions): 

Fiscal Year



2015

2014

Percentage
Change
U.S.
$
2,973.2


$
1,780.9


66.9
 %
Europe, Middle East and Africa
236.2


250.3


(5.6
)
Other
137.5


50.8


170.7

Net sales
$
3,346.9


$
2,082.0


60.8


Net sales in fiscal 2015 increased $1,264.9 million, or 60.8%, to $3,346.9 million, compared with $2,082.0 million in fiscal 2014. This increase was primarily attributable to the inclusion of a full year of net sales of Acthar and Ofirmev, following their acquisition in fiscal 2014, and the April 2015 acquisition of Inomax. Specialty Generics net sales increased due to higher net sales of hydrocodone-related products and the inclusion of a full year of net sales from BioVectra, partially offset by decreased net sales of Methylphenidate ER. Net sales in the Nuclear Imaging segment decreased slightly from fiscal 2014. For further information on changes in our net sales, refer to "Business Segment Results" within this Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Operating Income
Gross profit. Gross profit for fiscal 2015 increased $793.4 million, or 74.8%, to $1,853.6 million, compared with $1,060.2 million in fiscal 2014. The increase in gross profit primarily resulted from increased net sales from Acthar, Ofirmev and Inomax. These increases were partially offset by a $390.2 million increase in amortization, primarily associated with Acthar, Ofirmev and Inomax intangibles, and an $18.4 million increase of expense recognition associated with fair value adjustments of inventory acquired, primarily related to Acthar and Inomax. Gross profit in the Nuclear Imaging segment increased $48.7 million from fiscal 2014, when the segment experienced unscheduled shutdowns of our Mo-99 processing facility and the HFR that supplies us with Mo-99. Overall, gross profit margin was 55.4% during fiscal 2015, compared with 50.9% during fiscal 2014.
Selling, general and administrative expenses. SG&A expenses for fiscal 2015 were $1,169.8 million, compared with $745.0 million for fiscal 2014, an increase of $424.8 million, or 57.0%. The increase primarily resulted from the addition of $377.1 million of costs associated with our fiscal 2015 and 2014 acquisitions, $73.0 million in legal charges related to Questcor shareholder litigation, DEA investigative matters and Synacthen related litigation and a $67.6 million increase in share-based compensation associated with Questcor unvested equity awards that were converted into Mallinckrodt awards at the date of the Questcor Acquisition. These factors, were partially offset by an $11.5 million legal settlement related to Ofirmev during fiscal 2014, $15.0 million in other legal settlements in fiscal 2014, a $9.8 million decrease in environmental charges related to the Lower Passaic River environmental reserve and an $11.7 million decrease in transaction costs. The remaining decrease in SG&A expenses was primarily attributable to benefits from restructuring actions. SG&A expenses were 35.0% of net sales for fiscal 2015 and 35.8% of net sales for fiscal 2014.
Research and development expenses. R&D expenses increased $21.6 million, or 13.2%, to $185.1 million in fiscal 2015, compared with $163.5 million in fiscal 2014. Current R&D activities focus on performing clinical studies and publishing clinical and non-clinical experiences and evidence that support health economic and patient outcomes. As a percentage of our net sales, R&D expenses were 5.5% and 7.9% in fiscal 2015 and 2014, respectively.
Separation costs. During fiscal 2014, we incurred separation costs of $9.6 million, primarily related to our transition services agreement with our former parent, our costs to implement information and accounting systems, and share-based compensation related to the conversion of equity awards associated with the separation from our former parent.
Restructuring and related charges, net. During fiscal 2015, we recorded $40.7 million of restructuring and related charges, net, of which $0.3 million related to accelerated depreciation and was included in cost of sales. The remaining $40.4 million primarily related to $9.8 million of accelerated share-based compensation associated with Questcor unvested equity awards that were converted into Mallinckrodt awards at the date of the Questcor Acquisition and employee severance and benefits within the

50



Specialty Brands and Specialty Generics segments. During fiscal 2014, we recorded restructuring and related charges, net of $81.9 million, of which $0.5 million related to accelerated depreciation and was included in cost of sales. The remaining $81.4 million primarily related to $35.1 million of accelerated share-based compensation associated with Questcor employees, employee severance and benefits incurred across all our segments, and a $2.3 million asset impairment.
Non-restructuring impairment charges. During fiscal 2014, we recorded $151.6 million of non-restructuring impairment charges. The charges consisted of $119.5 million associated with impairment of goodwill in the Nuclear Imaging segment, $19.2 million of property, plant & equipment, and intangible asset impairments of $12.8 million, which primarily relate to the impairment of Pennsaid intangibles upon the return of our product rights to Nuvo as part of a legal settlement.
Gain on divestiture and license. During fiscal 2015 and 2014, we recorded gains on divestiture and license of $3.5 million and $15.0 million, respectively. The $15.0 million gain recorded during fiscal 2014 primarily resulted from an $11.7 million gain from the license of extended-release oxymorphone intellectual property to a third-party. The remaining gain in both periods primarily related to the sale of the rights to market TussiCaps™ extended-release capsules in fiscal 2011.

Non-Operating Items
Interest expense and interest income. During fiscal 2015 and fiscal 2014, net interest expense was $254.6 million and $81.1 million, respectively. The increase in net interest expense was primarily related to the issuance of approximately $1.3 billion of debt associated with the Cadence Acquisition, approximately $1.8 billion of debt associated with the Questcor Acquisition, approximately $1.4 billion of debt associated with the Ikaria Acquisition, approximately $1.3 billion of debt associated with the Therakos Acquisition and $36.5 million of interest accrued on deferred tax liabilities associated with outstanding installment notes. Interest expense during fiscal 2015 and 2014 included $23.4 million and $7.7 million, respectively, of non-cash interest expense.
Other income, net. During fiscal 2015 and 2014, we recorded other income, net of $8.1 million and $3.1 million, respectively, which represents miscellaneous items, including gains and losses on foreign currency intercompany financing transactions and related hedging instruments.
Provision for (benefit from) income taxes. In fiscal 2015, we recognized an income tax benefit of $92.9 million on income from continuing operations before income taxes of $215.3 million. In fiscal 2014, income tax benefit was $10.1 million on a loss from continuing operations before income taxes of $153.9 million. Our effective tax rate was negative 43.1% compared with 6.6% for fiscal 2015 and 2014, respectively. Our effective tax rate for fiscal 2015 was impacted by receiving a $10.4 million tax benefit on $53.4 million of transaction costs, $14.1 million of tax benefit associated with $40.7 million of restructuring costs, $6.6 million of tax benefit associated with accrued income tax liabilities and uncertain tax positions, $8.1 million of tax benefit associated with U.S. credits, and $138.6 million of tax benefit associated with the rate difference between U.K. and non-U.K. jurisdictions. Our effective tax rate for fiscal 2014 was impacted by receiving a $17.4 million tax benefit on $74.7 million of transaction and Separation costs, $25.3 million of tax benefit associated with $81.9 million of restructuring costs, $9.4 million of tax benefit associated with accrued income tax liabilities and uncertain tax positions, $4.1 million of tax benefit associated with the U.S. Domestic manufacturing deduction, $20.0 million of tax expense associated with an adjustment to the Company’s wholly owned partnership investment, $6.8 million of tax benefit associated with the $138.5 million impairment of tangible and intangible assets and goodwill, and $3.5 million of tax benefit associated with the rate difference between U.S. and non-U.S. jurisdictions (excluding impact of above referenced impairments).
Income (loss) from discontinued operations, net of income taxes. We recorded income of $16.5 million and a loss of $175.5 million on discontinued operations, net of income taxes, during fiscal 2015 and 2014, respectively. The income in fiscal 2015 primarily related to the expiration of a $22.5 million tax indemnification obligation associated with a business that was originally disposed of in fiscal 1997 and a $5.9 million loss from our CMDS business which is classified as held for sale. Fiscal 2014 primarily reflects a $174.8 million loss from our CMDS business, primarily related to $204.0 million of goodwill, intangible and property, plant and equipment impairment charges and $47.2 million of restructuring charges. The remaining amounts, in both periods, were related to indemnification obligations provided to the purchaser of our Specialty Chemicals business (formerly known as Mallinckrodt Baker), which was sold during fiscal 2010.


51



Fiscal Year Ended September 26, 2014 Compared with Fiscal Year Ended September 27, 2013

Net Sales
Net sales by geographic area are as follows (dollars in millions): 
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
U.S.
$
1,780.9

 
$
1,421.6

 
25.3
%
Europe, Middle East and Africa
250.3

 
250.1

 
0.1

Other
50.8

 
40.6

 
25.1

Net sales
$
2,082.0

 
$
1,712.3

 
21.6


Net sales in fiscal 2014 increased $369.7 million, or 21.6%, to $2,082.0 million, compared with $1,712.3 million in fiscal 2013. This increase was primarily attributable to increased net sales in our Specialty Generics segment, driven by strategic initiatives on certain specialty controlled substance generics and increased Methylphenidate ER net sales. Specialty Brands net sales also contributed to the increase due to net sales of the fiscal 2014 acquisitions of Acthar and Ofirmev. These increases were partially offset by a decrease in Nuclear Imaging net sales. For further information on changes in our net sales, refer to "Business Segment Results" within this Item 7.

Operating Income
Gross profit. Gross profit for fiscal 2014 increased $237.9 million, or 28.9%, to $1,060.2 million, compared with $822.3 million in fiscal 2013. The increase in gross profit primarily resulted from increased net sales from strategic initiatives and a further shift in net sales to the higher margin Specialty Brands segment, including the newly acquired Acthar and Ofirmev products. These increases were partially offset by a $126.9 million increase in amortization primarily associated with Acthar and Ofirmev, $25.7 million of expense recognition associated with the fair value adjustment of acquired Acthar and Ofirmev inventory, a $16.7 million increase in inventory provision expense and higher raw material costs in the Nuclear Imaging segment, including the unscheduled shutdowns of our Mo-99 processing facility and the HFR that supplies us with Mo-99. Overall, gross profit margin was 50.9% in fiscal 2014, compared with 48.0% in fiscal 2013. The fiscal 2014 profit margin includes the increased amortization and expense recognition of inventory fair value adjustments.
Selling, general and administrative expenses. SG&A expenses for fiscal 2014 were $745.0 million, compared with $495.9 million for fiscal 2013, an increase of $249.1 million, or 50.2%. The increase primarily resulted from higher internal and third-party expenses associated with being an independent, publicly-traded company, $93.0 million from the inclusion of SG&A costs associated with Acthar and Ofirmev, $65.1 million of transaction costs associated with our fiscal 2014 acquisitions, a $23.1 million environmental remediation charge, and $29.6 million of higher selling expenses in our Brands business related to the launch of Xartemis XR and Pennsaid 2%. These increases were partially offset by benefits from restructuring actions and certain prior year costs that did not recur in fiscal 2014. In fiscal 2013, SG&A expenses included higher legal settlement costs and $39.6 million of allocations from Covidien for general corporate expenses. These allocations are generally consistent with functions we have developed in our corporate build-out and ceased following the completion of the Separation on June 28, 2013. SG&A expenses were 35.8% of net sales for fiscal 2014 and 29.0% of net sales for fiscal 2013.
Research and development expenses. R&D expenses increased $5.6 million, or 3.5%, to $163.5 million in fiscal 2014, compared with $157.9 million in fiscal 2013. As products, such as Xartemis XR, Pennsaid 2% and MNK-155, moved toward or through the FDA review process, we devoted additional resources to other potential products in our R&D pipeline and the pursuit of abuse-deterrent labeling for Xartemis XR. As a percentage of our net sales, R&D expenses were 7.9% and 9.2% fiscal 2014 and 2013, respectively.
Separation costs. During fiscal 2014 and 2013, we incurred separation costs of $9.6 million and $74.2 million, respectively, primarily related to legal, accounting, tax and other professional fees. Separation costs were higher in fiscal 2013 as we approached and completed the Separation on June 28, 2013. We continued to incur costs related to the Separation as a result of our transition services agreement with Covidien, our costs to implement information and accounting systems, share-based compensation related to the conversion of Covidien awards to Mallinckrodt awards, and other transitional costs.
Restructuring and related charges, net. During fiscal 2014, we recorded restructuring and related charges, net of $81.9 million, of which $0.5 million related to accelerated depreciation and was included in cost of sales. The remaining $81.4 million primarily

52



related to $35.1 million of accelerated share-based compensation associated with Questcor employees, severance and benefits incurred across all our segments, and a $2.3 million asset impairment. During fiscal 2013, we recorded restructuring and related charges, net of $26.3 million, of which $2.6 million related to accelerated depreciation and was included in cost of sales. The remaining $23.7 million primarily related to severance and employee benefit costs incurred across all our segments.
Non-restructuring impairment charges. During fiscal 2014, we recorded $151.6 million of non-restructuring impairment charges. The charges consisted of $119.5 million associated with impairment of goodwill in the Nuclear Imaging segment, $19.2 million of property, plant & equipment, and intangible asset impairments of $12.8 million, which primarily relate to the impairment of Pennsaid intangibles upon the return of our product rights to Nuvo as part of a legal settlement.
Gain on divestitures. During fiscal 2014 and 2013, we recorded gains on divestiture and license of $15.0 million and $2.9 million, respectively. The $15.0 million gain recorded during fiscal 2014 primarily resulted from an $11.7 million gain from the license of extended-release oxymorphone intellectual property to a third-party.

Non-Operating Items
Interest expense and interest income. During fiscal 2014 and 2013, net interest expense was $81.1 million and $19.2 million, respectively. Net interest expense is primarily attributable to our $900.0 million issuance of senior unsecured notes in April 2013, $1.3 billion of debt associated with our March 2014 acquisition of Cadence and approximately $1.8 billion of debt associated with our August 2014 acquisition of Questcor. Interest expense during fiscal 2014 and 2013 included $7.7 million and $1.1 million, respectively, of non-cash interest expense.
Other income, net. During fiscal 2014 and 2013, we recorded other income, net, of $3.1 million and $1.4 million, respectively, which represents miscellaneous items, including gains and losses on foreign currency intercompany financing transactions and related hedging instruments.
Provision for (benefit from) income taxes. In fiscal 2014, we recognized an income tax benefit of $10.1 million on a loss from continuing operations before income taxes of $153.9 million. In fiscal 2013, income tax expense was $47.5 million on income from continuing operations before income taxes of $55.7 million. Our effective tax rate was 6.6% compared with 85.3% for fiscal 2014 and 2013, respectively. Our effective tax rate for fiscal 2014 was impacted by receiving a $17.4 million tax benefit on $74.7 million of transaction and Separation costs, $25.3 million of tax benefit associated with $81.9 million of restructuring costs, $9.4 million of tax benefit associated with accrued income tax liabilities and uncertain tax positions, $4.1 million of tax benefit associated with the U.S. Domestic manufacturing deduction, $20.0 million of tax expense associated with an adjustment to the Company’s wholly owned partnership investment, $6.8 million of tax benefit associated with the $138.5 million impairment of tangible and intangible assets and goodwill, and $3.5 million of tax benefit associated with the rate difference between U.S. and non-U.S. jurisdictions (excluding impact of above referenced impairments). Our effective tax rate for fiscal 2013 was impacted by receiving a $4.2 million tax benefit on $74.2 million of separation costs due to the tax-free status of the Separation, $9.7 million of tax expense associated with uncertain tax positions, $2.5 million of tax benefit associated with the U.S. Domestic manufacturing deduction, and $3.3 million of tax expense associated with the rate difference between U.S. and non-U.S. jurisdictions, which includes the benefit of intercompany debt transferred to the Company at the Separation.
Income (loss) from discontinued operations, net of income taxes. We recorded a loss of $175.5 million and income of $50.6 million from discontinued operations, net of income taxes, during fiscal 2014 and 2013, respectively. Fiscal 2014 reflected a $174.8 million loss from our CMDS business, primarily related to $204.0 million of goodwill, intangible and property, plant and equipment impairment charges and $47.2 million of restructuring charges. Fiscal 2013 reflected $49.6 million of income from our CMDS business. The remaining amounts in each period related to indemnification obligations to the purchaser of our Specialty Chemicals business (formerly known as Mallinckrodt Baker), which was sold during fiscal 2010.


Business Segment Results
The businesses included within our reportable segments are described below:
Specialty Brands
•
includes biopharmaceutical drugs for autoimmune and rare diseases and pharmaceutical drugs for immunotherapy and neonatal respiratory critical care, and central nervous system drugs.
Specialty Generics
•
produces specialty generic pharmaceuticals and API consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients.

53



Nuclear Imaging
•
manufactures and markets radioactive isotopes and associated pharmaceuticals used for the diagnosis and treatment of disease.
Management measures and evaluates the Company's operating segments based on segment net sales and operating income. Management excludes corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include revenues and certain expenses associated with sales of products to Guerbet, intangible asset amortization, net restructuring and related charges, non-restructuring impairments and separation costs. Although these amounts are excluded from segment operating income, as applicable, they are included in reported consolidated and combined operating income and in the reconciliations presented below. Selected information by business segment is as follows:

Fiscal Year Ended September 25, 2015 Compared with Fiscal Year Ended September 26, 2014

Net Sales
Net sales by segment are shown in the following table (dollars in millions): 
 
Fiscal Year
 
 
 
2015
 
2014
 
Percentage
Change
Specialty Brands
$
1,622.8

 
$
413.5

 
292.5
 %
Specialty Generics
1,251.6

 
1,199.4

 
4.4

Nuclear Imaging
423.8

 
431.7

 
(1.8
)
Net sales of operating segments
3,298.2

 
2,044.6

 
61.3

Other (1)
48.7

 
37.4

 
30.2

Net sales
$
3,346.9

 
$
2,082.0

 
60.8

(1)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.

Specialty Brands. Net sales for fiscal 2015 increased $1,209.3 million, or 292.5%, to $1,622.8 million, compared with $413.5 million for fiscal 2014. The increase in net sales was primarily driven by the inclusion of a full year of net sales of Acthar and Ofirmev, following their acquisition in fiscal 2014, which increased net sales by $914.4 million and $138.6 million, respectively. The April 2015 acquisition of Inomax further increased net sales by $185.2 million. These factors were partially offset by a $36.7 million decline in net sales from branded Exalgo products following the loss of exclusivity in May 2014.


Net sales for Specialty Brands by geography are as follows (dollars in millions):

Fiscal Year



2015
 
2014

Percentage
Change
U.S.
$
1,610.3


$
413.1


289.8
%
Europe, Middle East and Africa
9.9


0.4


2,375.0

Other
2.6


—


—

Net sales
$
1,622.8


$
413.5


292.5



54



Net sales for Specialty Brands by key products are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2015
 
2014
 
Percentage Change
Acthar
$
1,037.3

 
$
122.9

 
744.0
 %
Ofirmev
263.0

 
124.4

 
111.4

Inomax
185.2

 
—

 
—

Exalgo
39.4

 
76.1

 
(48.2
)
Other
97.9

 
90.1

 
8.7

Specialty Brands
$
1,622.8

 
$
413.5

 
292.5


Specialty Generics. Net sales for fiscal 2015 increased $52.2 million, or 4.4%, to $1,251.6 million, compared with $1,199.4 million for fiscal 2014. The increase in net sales was primarily driven by a $67.8 million increase in net sales of hydrocodone-related products and $72.5 million from the acquisition of BioVectra in August 2014. These increases were partially offset by a $73.1 million decrease in Methylphenidate ER and a $12.3 million decrease in other controlled substances. The increase in net sales of hydrocodone-related products was related to the conversion from Schedule III to Schedule II by the DEA in October 2014. Net sales of oxycodone-related products reflect the implementation of strategic initiatives during fiscal 2014, which also resulted in $24.4 million of payments during fiscal 2014 as a consequence of these initiatives. The decrease in Methylphenidate ER net sales was primarily attributable to the reclassification of these products by the FDA to therapeutically inequivalent status. Net sales in the Specialty Generics segment are expected to decrease approximately 15% to 20% in fiscal 2016 due to increased competition and market pricing pressures.

Net sales for Specialty Generics by geography are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2015
 
2014
 
Percentage
Change
U.S.
$
1,036.7

 
$
1,071.9

 
(3.3
)%
Europe, Middle East and Africa
100.5

 
103.0

 
(2.4
)
Other
114.4

 
24.5

 
366.9

Net sales
$
1,251.6

 
$
1,199.4

 
4.4


Net sales for Specialty Generics by key products are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2015
 
2014
 
Percentage Change
Hydrocodone (API) and hydrocodone-containing tablets
$
167.2

 
$
99.4

 
68.2
 %
Oxycodone (API) and oxycodone-containing tablets
154.6

 
155.2

 
(0.4
)
Methylphenidate ER
136.5

 
209.6

 
(34.9
)
Other controlled substances
572.2

 
584.5

 
(2.1
)
Other
221.1

 
150.7

 
46.7

       Specialty Generics
$
1,251.6

 
$
1,199.4

 
4.4


Nuclear Imaging. Net sales for fiscal 2015 decreased $7.9 million, or 1.8%, to $423.8 million compared with $431.7 million for fiscal 2014. The decrease was primarily driven by a $22.8 million unfavorable impact from exchange rates, particularly by changes in the Euro and Canadian Dollar.

55



Net sales for Nuclear Imaging by geography are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2015
 
2014
 
Percentage
Change
U.S.
$
277.5

 
$
258.5

 
7.4
 %
Europe, Middle East and Africa
125.8

 
146.9

 
(14.4
)
Other
20.5

 
26.3

 
(22.1
)
Net sales
$
423.8

 
$
431.7

 
(1.8
)

Operating Income
Operating income by segment and as a percentage of segment net sales for fiscal 2015 and 2014 is shown in the following table (dollars in millions):
 
Fiscal Year
 
2015
 
2014
Specialty Brands
$
651.3

40.1
%
 
$
(50.6
)
(12.2
)%
Specialty Generics
622.0

49.7

 
617.4

51.5

Nuclear Imaging
66.4

15.7

 
(16.7
)
(3.9
)
Segment operating income
1,339.7

40.6

 
550.1

26.9

Unallocated amounts:
 
 
 
 
 
Corporate and allocated expenses
(286.9
)
 
 
(228.1
)
 
Intangible asset amortization
(550.3
)
 
 
(154.8
)
 
Restructuring and related charges, net (1)
(40.7
)
 
 
(81.9
)
 
Non-restructuring impairment charges
—

 
 
(151.6
)
 
Separation costs
—

 
 
(9.6
)
 
Total operating income (loss)
$
461.8

 
 
$
(75.9
)
 
(1)
Includes restructuring-related accelerated depreciation.

Specialty Brands. Operating income for fiscal 2015 increased $701.9 million to $651.3 million, compared with a $50.6 million loss for fiscal 2014. Our operating margin increased to 40.1% for fiscal 2015, compared with negative 12.2% for fiscal 2014. The increase in operating income and margin was impacted by the $1,209.3 million increase in net sales, primarily attributable to the timing of acquisitions of Acthar, Ofirmev and Inomax. These higher net sales were partially offset by a $309.4 million increase in selling, general and administrative costs primarily associated with these acquisitions, a $67.6 million increase in share-based compensation expense associated with Questcor unvested equity awards that were converted into Mallinckrodt awards at the date of the Questcor Acquisition, and a $28.4 million increase in research and development. The operating loss for fiscal 2014 reflected selling and marketing expenses incurred principally to support Xartemis XR.
Specialty Generics. Operating income for fiscal 2015 increased $4.6 million to $622.0 million, compared with $617.4 million for fiscal 2014. Our operating margin decreased to 49.7% for fiscal 2015, compared with 51.5% for fiscal 2014. The increase in operating income was impacted by the higher gross profit from the $52.2 million increase in net sales partially offset by an $11.7 million gain in fiscal 2014 from the license of extended-release oxymorphone intellectual property. The decrease in the operating margin was primarily attributable to lower net sales of high-margin Methylphenidate ER in fiscal 2015.
Nuclear Imaging. Operating income for fiscal 2015 increased $83.1 million to $66.4 million, compared with a $16.7 million loss in fiscal 2014. Our operating margin increased to 15.7% for fiscal 2015, compared with negative 3.9% for fiscal 2014. The increase in operating income and margin was primarily attributable to a $48.7 million increase in gross profit, despite lower net sales, due to higher costs in fiscal 2014 from the unscheduled shutdown of our Mo-99 processing facility and the HFR that supplies our Mo-99. In addition, there was a $26.0 million decrease in selling, general and administrative costs primarily due to benefits from restructuring actions. We expect that another unscheduled HFR shutdown, commencing in September 2015, will negatively impact operating income by approximately $10.0 million to $15.0 million during the first quarter of fiscal 2016 and a lesser impact during the second quarter of fiscal 2016.
Corporate and allocated expenses. Corporate and allocated expenses were $286.9 million and $228.1 million for fiscal 2015 and 2014, respectively. Fiscal 2015 included $73.0 million in legal charges related to Questcor shareholder litigation, DEA

56



investigation matters and Synacthen related litigation, a $13.3 million environmental remediation charge and $53.4 million of transaction costs associated with the Ikaria and Therakos acquisitions. Fiscal 2014 included a $23.1 million environmental remediation charge, an $11.5 million settlement agreement accrual and $65.1 million in transaction costs primarily related to the Questcor and Cadence acquisitions. The remaining increase was primarily attributable to higher professional fees associated with strategic initiatives.

Fiscal Year Ended September 26, 2014 Compared with Fiscal Year Ended September 27, 2013

Net Sales
Net sales by segment are shown in the following table (dollars in millions): 
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
Specialty Brands
$
413.5

 
$
206.4

 
100.3
 %
Specialty Generics
1,199.4

 
1,011.2

 
18.6

Nuclear Imaging
431.7

 
437.6

 
(1.3
)
Net sales of operating segments
2,044.6

 
1,655.2

 
23.5

Other (1)
37.4

 
57.1

 
(34.5
)
Net sales
$
2,082.0

 
$
1,712.3

 
21.6

(1)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.

Specialty Brands. Net sales for fiscal 2014 increased $207.1 million, or 100.3%, to $413.5 million, compared with $206.4 million for fiscal 2013. The increase in net sales was primarily driven by $124.4 million of net sales of Ofirmev and $122.9 million of net sales from Acthar. These increases were partially offset by a $50.0 million decrease in net sales for branded Exalgo as we launched an authorized generic version and a competitor entered the market.

Net sales for Specialty Brands by geography are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
U.S.
$
413.1

 
$
206.4

 
100.1
%
Europe, Middle East and Africa
0.4

 
—

 
—

Other
—

 
—

 
—

Net sales
$
413.5

 
$
206.4

 
100.3

Net sales for Specialty Brands by key products are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
Acthar
$
122.9

 
$
—

 
—
 %
Ofirmev
124.4

 
—

 
—

Exalgo
76.1

 
126.1

 
(39.7
)
Other
90.1

 
80.3

 
12.2

Specialty Brands
$
413.5

 
$
206.4

 
100.3



57



Specialty Generics. Net sales for fiscal 2014 increased $188.2 million, or 18.6%, to $1,199.4 million, compared with $1,011.2 million for fiscal 2013. The increase in net sales was primarily driven by a $157.4 million net sales increase from other controlled substances and oxycodone-related products, following certain strategic initiatives that offset lower volume, and a $61.3 million increase in Methylphenidate ER from favorable comparisons due to timing of the product launch in fiscal 2013. These increases were partially offset by a $40.6 million decrease in hydrocodone-related products due to increased competition and lower pricing.

Net sales for Specialty Generics by geography are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
U.S.
$
1,071.9

 
$
891.5

 
20.2
 %
Europe, Middle East and Africa
103.0

 
104.1

 
(1.1
)
Other
24.5

 
15.6

 
57.1

Net sales
$
1,199.4

 
$
1,011.2

 
18.6


Net sales for Specialty Generics by key products are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
Hydrocodone (API) and hydrocodone-containing tablets
$
99.4

 
$
140.0

 
(29.0
)%
Oxycodone (API) and oxycodone-containing tablets
155.2

 
139.0

 
11.7

Methylphendiate ER
209.6

 
148.3

 
41.3

Other controlled substances
584.5

 
443.3

 
31.9

Other
150.7

 
140.6

 
7.2

       Specialty Generics
$
1,199.4

 
$
1,011.2

 
18.6


Nuclear Imaging. Net sales for fiscal 2014 decreased $5.9 million, or 1.3%, to $431.7 million compared with $437.6 million for fiscal 2013. Nuclear sales decreased only slightly despite supply chain disruptions in fiscal 2014.

Net sales for Nuclear Imaging by geography are as follows (dollars in millions):
 
Fiscal Year
 
 
 
2014
 
2013
 
Percentage
Change
U.S.
$
258.5

 
$
264.0

 
(2.1
)%
Europe, Middle East and Africa
146.9

 
146.0

 
0.6

Other
26.3

 
27.6

 
(4.7
)
Net sales
$
431.7

 
$
437.6

 
(1.3
)

58



Operating Income
Operating income by segment and as a percentage of segment net sales for fiscal 2014 and 2013 is shown in the following table (dollars in millions):
 
Fiscal Year
 
2014
 
2013
Specialty Brands
$
(50.6
)
(12.2
)%
 
$
(36.2
)
(17.5
)%
Specialty Generics
617.4

51.5

 
347.9

34.4

Nuclear Imaging
(16.7
)
(3.9
)
 
24.5

5.6

Segment operating income
550.1

26.9

 
336.2

20.3

Unallocated amounts:
 
 
 
 
 
Corporate and allocated expenses
(228.1
)
 
 
(134.3
)
 
Intangible asset amortization
(154.8
)
 
 
(27.9
)
 
Restructuring and related charges, net (1)
(81.9
)
 
 
(26.3
)
 
Non-restructuring impairment charges
(151.6
)
 
 
—

 
Separation costs
(9.6
)
 
 
(74.2
)
 
Total operating (loss) income
$
(75.9
)
 
 
$
73.5

 
(1)
Includes restructuring-related accelerated depreciation.

Specialty Brands. Operating income for fiscal 2014 decreased $14.4 million to a loss of $50.6 million, compared with a loss of $36.2 million for fiscal 2013. Our operating margin improved to negative 12.2% for fiscal 2014, compared with negative 17.5% for fiscal 2013. The most significant impact to the Specialty Brands segment was associated with the inclusion of Acthar and Ofirmev, which were acquired in August 2014 and March 2014, respectively. The increased loss was attributable to including $25.7 million of expense recognition associated with the fair value adjustment of acquired Acthar and Ofirmev inventory in fiscal 2014. The Specialty Brands segment experienced a $160.9 million increase in selling, general and administrative costs that includes $91.4 million of costs associated with the inclusion of Acthar and Ofirmev and higher expenses associated with the launch of Xartemis XR. These higher expenses were partially offset by the $207.1 million increase in Specialty Brands net sales in fiscal 2014 compared with fiscal 2013.
Specialty Generics. Operating income for fiscal 2014 increased $269.5 million to $617.4 million, compared with $347.9 million for fiscal 2013. Our operating margin increased to 51.5% for fiscal 2014, compared with 34.4% for fiscal 2013. The increase in operating income and margin was primarily due to benefits from strategic initiatives on certain specialty controlled substance generic products. In addition, the Specialty Generics segment recognized an $11.7 million gain on the license of intellectual property to a third-party in fiscal 2014.
Nuclear Imaging. Operating income for fiscal 2014 decreased $41.2 million to a $16.7 million loss, compared with $24.5 million of income in fiscal 2013. Our operating margin decreased to negative 3.9% for fiscal 2014, compared with 5.6% for fiscal 2013. The decrease in operating income and margin was primarily attributable to unscheduled shutdowns of our Mo-99 processing facility and the HFR, which decreased operating income by approximately $21.0 million compared to the prior year period, and lower net sales.
Corporate and allocated expenses. Corporate and allocated expenses were $228.1 million and $134.3 million for fiscal 2014 and 2013, respectively. The increase primarily resulted from $65.1 million of transaction costs associated with our Questcor and Cadence acquisitions, a $23.1 million environmental remediation charge, increased internal and third-party costs of being an independent publicly-traded company, which was partially offset by certain prior year costs that did not recur in fiscal 2014. We were allocated general corporate expenses of $39.6 million during fiscal 2013 for certain services provided by Covidien. These allocations ceased in periods following the completion of the Separation on June 28, 2013.

Liquidity and Capital Resources
Significant factors driving our liquidity position include cash flows generated from operating activities, financing transactions, capital expenditures and cash paid in connection with acquisitions and license agreements. Historically, we have typically generated, and expect to continue to generate, positive cash flow from operations. Through June 28, 2013, as part of Covidien, our cash was swept regularly by Covidien at its discretion. Covidien also funded our operating and investing activities as needed prior to the Separation. The cash and cash equivalents held by Covidien at the corporate level were not specifically identifiable or otherwise allocable to us and, as such, were not reflected on the combined balance sheets for dates prior to June 28, 2013. Cash flows related to

59



financing activities prior to the Separation reflect changes in Covidien's investments in us. Transfers of cash to and from Covidien were reflected as a component of parent company investment within parent company equity on our combined balance sheets through June 28, 2013. Our cash flows for periods prior to June 28, 2013, may not be indicative of our future performance and do not necessarily represent the cash flows that would have been generated had we operated as an independent, publicly-traded company for the entirety of the periods presented.
Effective June 28, 2013, we no longer participated in cash management and funding arrangements with Covidien and our ability to fund our capital needs is impacted by our ongoing ability to generate cash from operations and access to capital markets. We believe that our future cash from operations, borrowing capacity under our revolving credit facility and access to capital markets will provide adequate resources to fund our working capital needs, capital expenditures and strategic investments.
In fiscal 2016, we intend to fund capital expenditures with cash generated from operations. At September 25, 2015, we had capital expenditure commitments of $25.2 million.
A summary of our cash flows from operating, investing and financing activities is provided in the following table (dollars in millions):
 
Fiscal Year
 
2015
 
2014
 
2013
Net cash (used in) provided by:
 
 
 
 
 
Operating activities
$
896.4

 
$
373.4

 
$
135.9

Investing activities
(2,296.6
)
 
(2,890.8
)
 
(234.7
)
Financing activities
1,069.9

 
2,953.9

 
373.0

Effect of currency exchange rate changes on cash and cash equivalents
(11.6
)
 
(4.2
)
 
1.3

Net (decrease) increase in cash and cash equivalents
$
(341.9
)
 
$
432.3

 
$
275.5


Operating Activities
Net cash provided by operating activities of $896.4 million for fiscal 2015 was primarily attributable to income from continuing operations, as adjusted for non-cash items, and a $33.4 million inflow from net investment in working capital. The working capital inflow was primarily driven by a $61.3 million decrease in inventory as we reduced inventory levels in fiscal 2015, a $30.2 million increase in net tax related balances and a $20.4 million increase in accounts payable after completing our fiscal 2015 acquisitions. These increases were offset by $79.2 million decrease in other assets and liabilities, which was driven primarily by increased restructuring and royalty payments in fiscal 2015.
Net cash provided by operating activities of $373.4 million for fiscal 2014 was primarily attributable to income from continuing operations, as adjusted for non-cash items, and a $66.9 million inflow from net investment in working capital. The working capital inflow was primarily driven by a $56.0 million decrease in inventory as we reduced inventory levels in fiscal 2014 and a $110.5 million increase in other accrued liabilities. The increase in other accrued liabilities includes higher incentive compensation reserves, current year accruals for unpaid legal settlements and higher accrued interest balances reflecting our fiscal 2014 financing transactions, all of which were partially offset by declines in accrued branded rebates following the introduction of generic alternatives to Exalgo. These increases were offset by $54.8 million in payments to taxing authorities, a $51.3 million increase in accounts receivable driven by increased net sales and a $32.9 million decrease in accounts payable after completing our fiscal 2014 acquisitions.
Net cash provided by operating activities of $135.9 million for fiscal 2013 was primarily attributable to income from continuing operations, as adjusted for non-cash items, partially offset by a $79.0 million outflow from net investment in working capital. The working capital outflow was primarily driven by a $181.2 million increase in accounts receivable and a $16.0 million outflow in other working capital accounts, partially offset by a $60.7 million increase in income taxes payable, which was substantially settled through parent company investment, a $27.7 million decrease in inventory and a $22.6 million increase in accrued and other liabilities. The increase in accounts receivable was primarily attributable to the fact that $95.6 million of accounts receivable in certain jurisdictions outside the U.S. were retained by Covidien through parent company investment, which is included within the financing section of the consolidated and combined statement of cash flows.

Investing Activities
Net cash used in investing activities decreased $594.2 million to $2,296.6 million for fiscal 2015, compared with $2,890.8 million for fiscal 2014. The decrease primarily resulted from fiscal 2015 payments, net of cash acquired, of $978.4 million and $1,176.3 million related to the acquisitions of Therakos and Ikaria, respectively; compared with fiscal 2014 payments, net of cash acquired, of $1,490.5 million and $1,286.0 million related to the acquisition of Questcor and Cadence, respectively, and $17.3 million for the acquisition of other intangible assets. This decrease was partially offset by a $24.7 million decrease in other cash inflows, which

60



included proceeds from the sale of investments and assets in the prior year, and a $20.2 million increase in capital expenditures in fiscal 2015 compared with fiscal 2014.
Net cash used in investing activities increased $2,656.1 million to $2,890.8 million for fiscal 2014, compared with $234.7 million for fiscal 2013. The increase primarily resulted from fiscal 2014 payments, net of cash acquired, of $1,490.5 million and $1,286.0 million related to the acquisition of Questcor and Cadence, respectively, and $17.3 million for the acquisition of other intangible assets; compared with an $88.1 million payment made during fiscal 2013 to acquire CNS Therapeutics. This net increase was partially offset by a $29.5 million increase in other cash inflows, which include proceeds from the sale of investments and assets, and a $20.1 million decrease in capital expenditures in fiscal 2014 compared with fiscal 2013.

Financing Activities
Net cash provided by financing activities decreased $1,884.0 million to $1,069.9 million for fiscal 2015, compared with $2,953.9 million for fiscal 2014. The decrease largely resulted from $1,848.4 million of cash outflows from the repayment of external debt and capital leases, offset by $2,970.1 million of cash proceeds, net of financing costs, from the issuance of external debt to fund the Ikaria and Therakos acquisitions and increases in the accounts receivable securitization facility. Comparatively, fiscal 2014 included only $34.8 million of cash outflows from the repayment of external debt and capital leases, offset by $2,971.5 million of cash proceeds, net of financing costs, from the issuance of external debt to fund the Cadence and Questcor acquisitions. The increased debt repayment was most significantly impacted by the assumption and immediate repayment of $1,118.5 million of Ikaria third-party debt and $344.8 million of Therakos third-party debt, and the repayment of the $240.0 million of fiscal 2015 borrowings under the revolving credit facility. Additionally, there was $28.1 million of cash outflows resulting from payments of the BioVectra and Synacthen contingent considerations in fiscal 2015. These increases in cash outflows were partially offset by a $33.8 million increase in cash inflows from the excess tax benefit derived from share-based compensation and proceeds from stock option exercises.
Net cash provided by financing activities was $2,953.9 million for fiscal 2014, compared with net cash provided by financing activities of $373.0 million for fiscal 2013. The $2,580.9 million increase in cash provided by financing activities resulted from the receipt of $2,971.5 million of cash proceeds, net of financing costs, from the issuance of external debt used to fund the Cadence and Questcor acquisitions compared with $886.1 million from the issuance of debt in the prior year. This net increase was partially offset by a $33.5 million increase in debt and capital lease repayments, primarily related to debt assumed in the Cadence acquisition, and prior year net transfers to Covidien of $515.9 million, which reflected the remittance of the net proceeds from the issuance of debt partially offset by funding of the CNS Therapeutics, Inc. acquisition and funding of capital expenditures.

Inflation
Inflationary pressures have had an adverse effect on us through higher raw material and fuel costs, primarily in our Nuclear Imaging segment as noted previously. We have entered into commodity swap contracts in the past to mitigate the impact of rising prices and may do so in the future. If these contracts are not effective or we are not able to achieve price increases on our products, we may continue to be impacted by these increased costs.

Foreign Currency
Certain net sales and costs of our international operations are denominated in the local currency of the respective countries. As such, profits from these subsidiaries may be impacted by fluctuations in the value of these local currencies relative to the U.S. dollar. We also have significant intercompany financing arrangements that may result in gains and losses in our results of operations. In an effort to mitigate the impact of currency exchange rate effects we may hedge certain operational and intercompany transactions; however, our hedging strategies may not fully offset gains and losses recognized in our results of operations.

Concentration of Credit and Other Risks
Financial instruments that potentially subject us to concentrations of credit risk primarily consist of accounts receivable. We generally do not require collateral from customers. A portion of our accounts receivable outside the U.S. includes sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries' national economies.



61



Debt and Capitalization
At September 25, 2015, total debt principal was $6,606.5 million compared with total debt principal at September 26, 2014 of $3,980.8 million. The increase in total debt principal resulted from financing transactions to fund our fiscal 2015 acquisitions. Total debt principal at September 25, 2015 is comprised of $1,978.5 million of variable rate term loans, $3,972.7 million of fixed rate instruments, $500.0 million of borrowings under our variable rate revolving credit facility, $153.0 million of borrowings under a variable rate receivable securitization program and $2.3 million of capital lease obligations. The variable-rate term loan interest rates are based on LIBOR, subject to a minimum LIBOR level of 0.75% with interest payments generally expected to be payable every 90 days, and requires quarterly principal payments equal to 0.25% of the original principal amount. As of September 25, 2015 our fixed-rate instruments had a weighted-average interest rate of 5.2% and pay interest at various dates throughout the fiscal year. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the Revolver was 2.6%, which is determined as LIBOR plus margin of 2.25%. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the Receivable Securitization was 1.0%, which is determined as the one month LIBOR rate plus a margin of 0.80%. The receivable securitization has a capacity of $250.0 million that may, subject to certain conditions, be increased to $300.0 million.
At September 25, 2015, $22.3 million of our total debt is classified as current as these payments are expected to be made within the next fiscal year.
In addition to the borrowing capacity under our receivable securitization program, we have a $500.0 million revolving credit facility. At September 25, 2015, we had fully utilized our revolving credit facility. As such the was no additional borrowing capacity under our revolving credit facility.
As of September 25, 2015, we were, and expect to remain, in compliance with the provisions and covenants associated with our debt agreements.

In November 2015, our Board of Directors authorized us to reduce our outstanding debt at our discretion. As market conditions warrant, we may from time to time repurchase debt securities issued by us, in the open market, in privately negotiated transactions, by tender offer or otherwise. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements and other factors. The amounts involved may be material.
For additional information regarding our debt agreements, refer to Note 12 of Notes to the Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Capitalization
Shareholders' equity was $5,311.2 million, at September 25, 2015, compared with $4,958.0 million, at September 26, 2014. The increase in shareholder's equity is primarily attributed to fiscal year 2015 net income, share-based compensation, share option exercises and changes in accumulated other comprehensive income, partially offset by repurchases of common shares
In January 2015, our Board of Directors approved a share repurchase program of up to $300.0 million of ordinary shares. Through September 25, 2015, the Company has repurchased approximately 0.8 million shares under this program at an aggregate purchase price of $75.0 million. In November 2015, our Board of Directors approved an incremental share repurchase program of up to $500.0 million of ordinary shares, which supplements the January 2015 program. As market conditions warrant, we may from time to time repurchase equity securities issued by us, in the open market.

Dividends
We currently do not anticipate paying any cash dividends for the foreseeable future, as we intend to retain earnings to finance R&D, acquisitions and the operation and expansion of our business. The recommendation, declaration and payment of dividends in the future by us will be subject to the sole discretion of our board of directors and will depend upon many factors, including our financial condition, earnings, capital requirements of our operating subsidiaries, covenants associated with certain of our debt obligations, legal requirements, regulatory constraints and other factors deemed relevant by our board of directors. Moreover, if we determine to pay dividends in the future, there can be no assurance that we will continue to pay such dividends.



62



Commitments and Contingencies
Contractual Obligations
The following table summarizes our contractual obligations as of September 25, 2015 (in millions):
 
Payments Due By Period
 
Total
 
Less than 1 year
 
1 - 3 years
 
3 - 5 years
 
More than 5 years
Long-term debt obligations
$
6,604.2

 
$
21.0

 
$
495.2

 
$
1,242.4

 
$
4,845.6

Interest on long-term debt obligations (1)
1,935.6

 
269.5

 
575.2

 
527.7

 
563.2

Capital lease obligations (1)
2.3

 
1.3

 
1.0

 
—

 
—

Operating lease obligations
95.0

 
21.1

 
32.7

 
20.6

 
20.6

Purchase obligations (2)
235.0

 
125.9

 
101.2

 
7.9

 
—

Total contractual obligations
$
8,872.1

 
$
438.8

 
$
1,205.3

 
$
1,798.6

 
$
5,429.4

(1)
Interest on debt and capital lease obligations are projected for future periods using interest rates in effect as of September 25, 2015. Certain of these projected interest payments may differ in the future based on changes in market interest rates.
(2)
Purchase obligations consist of commitments for purchases of goods and services made in the normal course of business to meet operational and capital requirements.
The preceding table does not include other liabilities of $556.8 million, primarily consisting of obligations under our pension and postretirement benefit plans, unrecognized tax benefits for uncertain tax positions and related accrued interest and penalties, contingent consideration liabilities, environmental liabilities and asset retirement obligations, because the timing of their future cash outflow is uncertain. The most significant of these liabilities are discussed below.
Non-current income taxes payable, primarily related to unrecognized tax benefits, is included within other income tax liabilities on the consolidated and combined balance sheet and, as of September 25, 2015, was $121.3 million. Payment of these liabilities is uncertain and, even if payments are determined to be necessary, they are subject to the timing of rulings by the Internal Revenue Service of tax positions we take. For further information on income tax related matters, refer to Note 7 of Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
As of September 25, 2015, we had net unfunded pension and postretirement benefit obligations of $55.6 million and $52.2 million, respectively. The timing and amounts of long-term funding requirements for pension and postretirement obligations are uncertain. The Company does not anticipate making material involuntary contributions in fiscal 2016, but may elect to make voluntary contributions to its defined pension plans or its postretirement benefit plans during fiscal 2016.
We are involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including decontamination and decommissioning of radioactive materials and removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of cleanup and timing of future cash outlays is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations and alternative cleanup methods. As of September 25, 2015, we believe that it is probable that we will incur investigation and remedial costs of approximately $76.5 million, of which $3.2 million is included in accrued and other current liabilities on our consolidated balance sheet at September 25, 2015. Note 19 of Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K provides additional information regarding environmental matters, including asset retirement obligations.

Legal Proceedings
We are subject to various legal proceedings and claims, including patent infringement claims, product liability matters, environmental matters, employment disputes, contractual disputes and other commercial disputes, including those described in Note 19 of the Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data. Although it is not feasible to predict the outcome of these matters, management believes that their ultimate resolution will not have a material adverse effect on our financial condition, results of operations and cash flows.

Guarantees
In disposing of assets or businesses, we have historically provided representations, warranties and indemnities to cover various risks and liabilities, including unknown damage to the assets, environmental risks involved in the sale of real estate, liability to investigate and remediate environmental contamination at waste disposal sites and manufacturing facilities, and unidentified tax liabilities related to periods prior to disposition. The Company assesses the probability of potential liabilities related to such

63



representations, warranties and indemnities and adjusts potential liabilities as a result of changes in facts and circumstances. The Company has no reason to believe that these uncertainties would have a material adverse effect on its financial condition, results of operations and cash flows. These representations, warranties and indemnities are discussed in Note 18 of the Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Off-Balance Sheet Arrangements
We are required to provide the U.S. Nuclear Regulatory Commission financial assurance demonstrating our ability to fund the decommissioning of our Maryland Heights, Missouri radiopharmaceuticals production facility upon closure, though we do not intend to close this facility. We have provided this financial assurance in the form of surety bonds totaling $57.2 million. As of September 25, 2015, we had various other letters of credit and guarantee and surety bonds totaling $39.4 million.
In April 2015, the Company terminated a letter of credit to guarantee decommissioning costs associated with its Saint Louis, Missouri plant and placed $21.1 million of restricted cash on deposit with a trustee. This restricted cash is included within prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 25, 2015.
We exchanged title to $88.0 million of our plant assets in return for an equal amount of Industrial Revenue Bonds ("IRB") issued by Saint Louis County. We also simultaneously leased such assets back from Saint Louis County under a capital lease expiring through December 2025, the terms of which provide us with the right of offset against the IRBs.The lease also provides an option for us to repurchase the assets at the end of the lease for nominal consideration. These transactions collectively result in a property tax abatement ten years from the date the property is placed in service. Due to right of offset, the capital lease obligation and IRB asset are recorded net in the consolidated balance sheets. The Company expects that the right of offset will be applied to payments required under these arrangements.
In addition, the Separation and Distribution Agreement provides for cross-indemnities principally designed to place financial responsibility of the obligations and liabilities of our business with us and financial responsibility for the obligations and liabilities of Covidien's remaining business with Covidien, among other indemnities.

Critical Accounting Policies and Estimates
The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP"). The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. The following accounting policies are based on, among other things, judgments and assumptions made by management that include inherent risks and uncertainties. Management's estimates are based on the relevant information available at the end of each period.

Revenue Recognition
We recognize revenue for product sales when title and risk of loss have transferred from us to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and related services, based on contract terms or legal requirements in non-U.S. jurisdictions. We sell products through independent channels, including direct to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. We establish contracts with wholesalers, chain stores, government agencies, institutions, managed care organizations and group purchasing organizations that provide for rebates, sales incentives, distribution service agreements ("DSAs") fees, fees for services and administration fees. Direct rebates and fees are paid based on direct customer's purchases from us, including DSA fees paid to wholesalers under our DSAs. Indirect rebates and fees are paid based on products purchased from a wholesaler under a contract with us. We enter into agreements with some indirect customers to establish contract pricing for certain products. These indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, we may enter into agreements with wholesalers at a contract price to offer our products to other indirect customers. Under either arrangement, we provide credit to the wholesaler for any difference between the contracted price with the indirect customer and the wholesaler's invoice price. Such credit is called a chargeback.
When we recognize net sales, we simultaneously record an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of our products and other competitive factors. We adjust reserves for rebates and chargebacks, product returns and other sales deductions to reflect differences between estimated and actual experience. Such adjustments impact the amount of sales we recognize in the period of adjustment.

64



Sales return reserves for new products are estimated and primarily based on our historical sales return experience with similar products, such as those within the same product line or those within the same or similar therapeutic category. In limited circumstances, where the new product is not an extension of an existing product line or where we have no historical experience with products in a similar therapeutic category (such that we cannot reliably estimate expected returns), we would defer recognition of revenue until the right of return no longer exists or until we have developed sufficient historical experience to estimate sales returns. When establishing sales return reserves for new products, we also consider estimated levels of inventory in the distribution channel and projected demand. The following table reflects activity in our sales reserve accounts (dollars in millions):
 
Rebates and Chargebacks
 
Product Returns
 
Other Sales Deductions
 
Total
Balance at September 28, 2012
$
188.0

 
$
34.7

 
$
12.3

 
$
235.0

Provisions
1,081.7

 
33.4

 
56.8

 
1,171.9

Payments or credits
(1,046.6
)
 
(18.9
)
 
(53.7
)
 
(1,119.2
)
Balance at September 27, 2013
223.1

 
49.2

 
15.4

 
287.7

Provisions
1,543.8

 
86.1

 
91.0

 
1,720.9

Payments or credits
(1,507.6
)
 
(33.3
)
 
(93.4
)
 
(1,634.3
)
Acquisitions
30.1

 
0.5

 
—

 
30.6

Balance at September 26, 2014
289.4

 
102.5

 
13.0

 
404.9

Provisions
2,080.1

 
13.0

 
94.7

 
2,187.8

Payments or credits
(2,059.1
)
 
(43.9
)
 
(91.7
)
 
(2,194.7
)
Acquisitions
0.2

 
1.1

 
—

 
1.3

Balance at September 25, 2015
$
310.6

 
$
72.7

 
$
16.0

 
$
399.3

Provisions presented in the table above are recorded as reductions to net sales.
Total provisions for fiscal 2015 increased $466.9 million compared with fiscal 2014. The increase in rebates and chargebacks of $536.3 million primarily related to a $456.1 million increase in Specialty Generics rebates and chargebacks following strategic pricing actions and a $38.8 million increase in Medicaid provisions related to including a full year of Acthar results in fiscal 2015. Provisions for returns decreased by $73.1 million due to a $53.5 million decrease in Specialty Brands and a $19.5 million decrease in Specialty Generics, primarily due to hydrocodone rescheduling. The Specialty Brands decrease reflected a fiscal 2014 charge of $33.8 million provision for Exalgo following loss of exclusivity on the product, while fiscal 2015 included a $9.0 million favorable change in estimate associated with the Exalgo returns reserves based on returns activity to date. Other sales deductions increased by $3.7 million, primarily attributable to the Specialty Generics strategic pricing actions.
Total provisions recorded in fiscal 2014 increased by $549.0 million compared with fiscal 2013. The increase in rebates and chargebacks of $462.1 million primarily related to a $450.0 million increase in Specialty Generics rebates and chargebacks following strategic pricing actions and a full year of Methylphenidate ER that increased both gross sales, and rebates and chargebacks. The remaining difference primarily included a $30.1 million increase associated with fiscal 2014 acquisitions that was partially offset by a decrease in Nuclear Imaging on lower volume. Provisions for returns increased by $52.7 million primarily attributable to a $33.8 million provision for potential Exalgo returns following the loss of exclusivity during fiscal 2014. Other sales deductions increased by $34.2 million, primarily attributable to the Specialty Generics strategic pricing actions.

 Goodwill and Other Intangible Assets
In performing goodwill assessments, management relies on a number of factors including operating results, business plans, economic projections, anticipated future cash flows, transactions and market place data. There are inherent uncertainties related to these factors and judgment in applying them to the analysis of goodwill impairment. Since judgment is involved in performing goodwill valuation analyses, there is risk that the carrying value of our goodwill may be overstated or understated. We perform our goodwill valuations using an income approach based on the present value of future cash flows of each reporting unit. This approach incorporates many assumptions including future growth rates, discount factors and income tax rates. Changes in economic and operating conditions impacting these assumptions could result in goodwill impairment in future periods.
We test goodwill during the fourth quarter of each year for impairment, or more frequently if certain indicators are present or changes in circumstances suggest that impairment may exist. We utilize a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. We estimate the fair value of our reporting units through internal analyses and valuation, using an income approach based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, we will perform the second step of the goodwill impairment to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. To determine the implied fair value of goodwill, we allocate the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of

65



the value of a reporting unit over the amounts assigned to its assets and liabilities represents the implied fair value of goodwill. The results of our annual goodwill impairment test for fiscal 2015 showed that the fair value of our Specialty Brands and Specialty Generics reporting units' exceeded their respective carrying values. In fiscal 2014, a goodwill impairment was recorded related to our former Global Medical Imaging reporting unit (which included the CMDS business that is now presented as a discontinued operation and the remaining Nuclear Imaging reporting unit). For further information on our goodwill impairment analysis, refer to Notes 2 and 11 of the Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
Intangible assets include completed technology, licenses, trademarks and in-process research and development. We record intangible assets at cost and amortize finite-lived intangible assets, generally using the straight-line method over eight to thirty years. When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset to its carrying value. We utilize similar assumptions as utilized in our goodwill valuation. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets with their carrying value. The fair value of the intangible asset is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the present value of future cash flows. Changes in economic and operating conditions impacting these assumptions could result in goodwill impairment in future periods. We assess the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. No impairments of intangible assets were recorded in fiscal 2015. Impairments of an intangible assets, most notably associated with our CMDS business that is now presented as a discontinued operation, were recorded in fiscal 2014. For more information on our intangible impairment analysis, refer to Notes 2, 10 and 11 of the Notes to the Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.

Acquisitions
Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. These valuations rely on a number of factors including operating results, business plans, economic projections, anticipated future cash flows, transactions and market place data. There are inherent uncertainties related to these factors and judgment in applying them to estimate the fair value of individual assets acquired in a business combination. Due to these inherent uncertainties, there is risk that the carrying value of our recorded intangible assets and goodwill may be overstated or understated, which may result in an increased risk of impairment in future periods. We perform our intangible asset valuations using an income approach based on the present value of future cash flows. This approach incorporates many assumptions including future growth rates, discount factors and income tax rates. Changes in economic and operating conditions impacting these assumptions could result in impairment in future periods.
The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.
The fair value of in-process research and development ("IPR&D") is determined using the discounted cash flow method. In determining the fair value of IPR&D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.
The fair value attributable to IPR&D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.

Contingencies
We are involved, either as a plaintiff or a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters, as further discussed in Note 19 of Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on form 10-K. Accruals recorded for various contingencies, including legal proceedings, self-insurance and other claims, are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel, internal and/or external technical consultants and actuarially determined estimates. When a range is established

66



but a best estimate cannot be made, we record the minimum loss contingency amount. These estimates are often initially developed substantially earlier than the ultimate loss is known, and the estimates are reevaluated each accounting period as additional information becomes available. When we are initially unable to develop a best estimate of loss, we record the minimum amount of loss, which could be zero. As information becomes known, additional loss provisions are recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, our best estimate is changed to a lower amount. We record receivables from third-party insurers up to the amount of the related liability when we have determined that existing insurance policies will provide reimbursement. In making this determination, we consider applicable deductibles, policy limits and the historical payment experience of the insurance carriers. Receivables are not netted against the related liabilities for financial statement presentation.

Income Taxes
In determining income for financial statement purposes, we must make certain estimates and judgments. These estimates and judgments affect the calculation of certain tax liabilities and the determination of the recoverability of certain of the deferred tax assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense.
Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In evaluating our ability to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative losses in the most recent years and our forecast of future taxable income. In estimating future taxable income, we develop assumptions including the amount of future state, federal and international pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.
We determine whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not realized on the uncertain tax position, an income tax liability is established. We adjust these liabilities as a result of changing facts and circumstances; however; due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the tax liabilities. A significant portion of our potential tax liabilities are recorded in non-current income taxes payable, which is included in other liabilities on our consolidated balance sheets, as payment is not expected within one year.
The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across our global operations. Changes in tax laws and rates could affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes, however, which would have a material adverse effect on our competitive position, business, financial condition, results of operations and cash flows.
We believe that we will generate sufficient future taxable income in the appropriate jurisdictions to realize the tax benefits related to the net deferred tax assets on our consolidated balance sheets. However, any reduction in future taxable income, including any future restructuring activities, may require that we record an additional valuation allowance against our deferred tax assets. An increase in the valuation allowance would result in additional income tax expense in such period and could have a significant impact on our future earnings. Our income tax expense recorded in the future may also be reduced to the extent of decreases in our valuation allowances.

Recently Issued Accounting Standards
Refer to Note 3 of Notes to Consolidated and Combined Financial Statements included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K for a discussion regarding recently issued accounting standards and their estimated impact on our financial condition, results of operations and cash flows.


Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
Our operations include activities in the U.S. and countries outside of the U.S. These operations expose us to a variety of market risks, including the effects of changes in interest rates and currency exchange rates. We monitor and manage these financial exposures as an integral part of our overall risk management program. We do not utilize derivative instruments for trading or speculative purposes.


67



Interest Rate Risk
Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which bear interest based on LIBOR plus margin. As of September 25, 2015, our outstanding debt included $1,978.5 million variable-rate debt on our senior secured term loan, $500.0 million on our senior unsecured revolving credit facility and $153.0 million variable-rate debt on our receivables securitization program. Assuming a one percent increase in the applicable interest rates, in excess of applicable minimum floors, annual interest expense would increase by approximately $26.3 million.
The remaining outstanding debt as of September 25, 2015 is fixed-rate debt. Changes in market interest rates generally affect the fair value of fixed-rate debt, but do not impact earnings or cash flows.

Currency Risk
Certain net sales and costs of our international operations are denominated in the local currency of the respective countries. As such, profits from these subsidiaries may be impacted by fluctuations in the value of these local currencies relative to the U.S. dollar. We also have significant intercompany financing arrangements that may result in gains and losses in our results of operations. In an effort to mitigate the impact of currency exchange rate effects we may hedge certain operational and intercompany transactions; however, our hedging strategies may not fully offset gains and losses recognized in our results of operations.
The consolidated statement of income is exposed to currency risk from intercompany financing arrangements, which primarily consist of intercompany debt and intercompany cash pooling, where the denominated currency of the transaction differs from the functional currency of one or more of our subsidiaries. We performed a sensitivity analysis for these arrangements as of September 25, 2015 that measures the potential unfavorable impact to income from continuing operations before income taxes from a hypothetical 10% adverse movement in foreign exchange rates relative to the U.S. dollar, with all other variables held constant. The aggregate potential unfavorable impact from a hypothetical 10% adverse change in foreign exchange rates was $20.0 million as of September 25, 2015. This hypothetical loss does not reflect any hypothetical benefits that would be derived from hedging activities, including cash holdings in similar foreign currencies, that we have historically utilized to mitigate our exposure to movements in foreign exchange rates.
The financial results of our non-U.S. operations are translated into U.S. dollars, further exposing us to currency exchange rate fluctuations. We have performed a sensitivity analysis as of September 25, 2015 that measures the change in the net financial position arising from a hypothetical 10% adverse movement in the exchange rates of the Euro, the Mexican Peso and the Canadian Dollar, our most widely used foreign currencies, relative to the U.S. dollar, with all other variables held constant. The aggregate potential change in net financial position from a hypothetical 10% adverse change in the above currencies was $41.6 million as of September 25, 2015. The change in the net financial position associated with the translation of these currencies is generally recorded as an unrealized gain or loss on foreign currency translation within accumulated other comprehensive income in shareholders' equity of our consolidated balance sheets.

68



Item 8.
Financial Statements and Supplementary Data.
INDEX TO FINANCIAL STATEMENTS
Consolidated and Combined Financial Statements
 
 
 
Report of Independent Registered Public Accounting Firm.
Consolidated Statements of Income for the fiscal years ended September 25, 2015 and September 26, 2014 and the Consolidated and Combined Statement of Income for the fiscal year ended September 27, 2013.
Consolidated Statements of Comprehensive Income for the fiscal years ended September 26, 2015 and September 26, 2014 and the Consolidated and Combined Statement of Comprehensive Income for the fiscal year ended September 27, 2013.
Consolidated Balance Sheets as of September 25, 2015 and September 26, 2014.
Consolidated Statements of Cash Flows for the fiscal years ended September 25, 2015 and September 26, 2014 and the Consolidated and Combined Statement of Cash Flows for the fiscal year ended September 27, 2013.
Consolidated Statement of Changes in Shareholders' Equity for the period from September 27, 2013 to September 25, 2015 and the Consolidated and Combined Statement of Changes in Shareholders' Equity for the period from September 28, 2012 to September 27, 2013.
Notes to Consolidated and Combined Financial Statements.


69






REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of Mallinckrodt plc:

We have audited the accompanying consolidated balance sheets of Mallinckrodt plc and subsidiaries (the "Company") as of September 25, 2015 and September 26, 2014, and the related consolidated and combined statements of income, comprehensive income, changes in shareholders' equity, and cash flows for each of the three fiscal years in the period ended September 25, 2015. Our audits also included the financial statement schedule listed in the Index at Item 15. These financial statements and financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated and combined financial statements present fairly, in all material respects, the financial position of Mallinckrodt plc and subsidiaries as of September 25, 2015 and September 26, 2014, and the results of their operations and their cash flows for each of the three years in the period ended September 25, 2015, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

As discussed in Note 1 to the consolidated and combined financial statements, the Company’s combined financial statements for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company’s fiscal 2013 results, may not be indicative of the Company’s future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had it operated as an independent, publicly-traded company for the entirety of the periods presented.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of September 25, 2015, based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated November 24, 2015 expressed an unqualified opinion on the Company's internal control over financial reporting.



/s/ DELOITTE & TOUCHE LLP
St. Louis, Missouri
November 24, 2015



70




MALLINCKRODT PLC
CONSOLIDATED AND COMBINED STATEMENTS OF INCOME
(in millions, except per share data)

 
Fiscal Year
 
2015
 
2014
 
2013
Net sales
$
3,346.9

 
$
2,082.0

 
$
1,712.3

Cost of sales
1,493.3

 
1,021.8

 
890.0

Gross profit
1,853.6

 
1,060.2

 
822.3

 
 
 
 
 
 
Selling, general and administrative expenses
1,169.8

 
745.0

 
495.9

Research and development expenses
185.1

 
163.5

 
157.9

Restructuring charges, net
40.4

 
81.4

 
23.7

Separation costs
—

 
9.6

 
74.2

Non-restructuring impairment charges
—

 
151.6

 
—

Gain on divestiture and license
(3.5
)
 
(15.0
)
 
(2.9
)
Operating income (loss)
461.8

 
(75.9
)
 
73.5

 
 
 
 
 
 
Interest expense
(255.6
)
 
(82.6
)
 
(19.5
)
Interest income
1.0

 
1.5

 
0.3

Other income, net
8.1

 
3.1

 
1.4

Income (loss) from continuing operations before income taxes
215.3

 
(153.9
)
 
55.7

 
 
 
 
 
 
Provision for (benefit from) income taxes
(92.9
)
 
(10.1
)
 
47.5

Income (loss) from continuing operations
308.2

 
(143.8
)
 
8.2

 
 
 
 
 
 
Income (loss) from discontinued operations, net of tax expense (benefit) of $11.5, $(34.7), and $21.1
16.5

 
(175.5
)
 
50.6

 
 
 
 
 
 
Net income (loss)
$
324.7

 
$
(319.3
)
 
$
58.8

 
 
 
 
 
 
Basic earnings per share (Note 8):
 
 
 
 
 
Income (loss) from continuing operations
$
2.64

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations, net of income taxes
0.14

 
(2.70
)
 
0.88

Net income (loss)
$
2.78

 
$
(4.92
)
 
$
1.02

 
 
 
 
 
 
Basic weighted-average shares outstanding
115.8

 
64.9

 
57.7

 
 
 
 
 
 
Diluted earnings per share (Note 8):
 
 
 
 
 
Income (loss) from continuing operations
$
2.61

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations, net of income taxes
0.14

 
(2.70
)
 
0.88

Net income (loss)
$
2.75

 
$
(4.92
)
 
$
1.02

 
 
 
 
 
 
Diluted weighted-average shares outstanding
117.2

 
64.9

 
57.8


See Notes to Consolidated and Combined Financial Statements.



71



MALLINCKRODT PLC
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)


 
Fiscal Year
 
2015
 
2014
 
2013
Net income (loss)
$
324.7

 
$
(319.3
)
 
$
58.8

Other comprehensive income (loss), net of tax
 
 
 
 
 
Currency translation adjustments
(70.8
)
 
(27.6
)
 
1.5

Unrecognized gain (loss) on derivatives, net of tax (benefit) expense of $0.2, $0.2 and $-
0.4

 
0.5

 
(7.3
)
Unrecognized gain (loss) on benefit plans, net of tax (benefit) expense of $(2.1), $(7.3) and $23.9
5.6

 
(15.7
)
 
34.2

Total other comprehensive income (loss), net of tax
(64.8
)
 
(42.8
)
 
28.4

Comprehensive income (loss)
$
259.9

 
$
(362.1
)
 
$
87.2


See Notes to Consolidated and Combined Financial Statements.


72



MALLINCKRODT PLC
CONSOLIDATED BALANCE SHEETS
(in millions, except share data)

 
September 25,
2015
 
September 26,
2014
Assets
 
 
 
Current Assets:
 
 
 
Cash and cash equivalents
$
365.9

 
$
707.8

Accounts receivable, less allowance for doubtful accounts of $4.7 and $3.7
548.5

 
476.6

Inventories
281.8

 
306.4

Deferred income taxes
142.7

 
152.3

Prepaid expenses and other current assets
207.3

 
227.1

Current assets held for sale
299.9

 
200.8

Total current assets
1,846.1

 
2,071.0

Property, plant and equipment, net
991.3

 
886.8

Goodwill
3,649.4

 
2,401.9

Intangible assets, net
9,666.3

 
7,082.2

Long-term assets held for sale
—

 
111.2

Other assets
251.0

 
234.2

Total Assets
$
16,404.1

 
$
12,787.3

Liabilities and Shareholders' Equity
 
 
 
Current Liabilities:
 
 
 
Current maturities of long-term debt
$
22.3

 
$
21.2

Accounts payable
133.0

 
110.7

Accrued payroll and payroll-related costs
103.7

 
116.3

Accrued royalties
29.3

 
67.7

Accrued and other current liabilities
568.3

 
529.9

Current liabilities held for sale
72.8

 
59.0

Total current liabilities
929.4

 
904.8

Long-term debt
6,474.3

 
3,874.0

Pension and postretirement benefits
116.7

 
116.2

Environmental liabilities
73.3

 
59.2

Deferred income taxes
3,132.4

 
2,399.6

Other income tax liabilities
121.3

 
122.6

Long-term liabilities held for sale
—

 
9.7

Other liabilities
245.5

 
343.2

Total Liabilities
11,092.9

 
7,829.3

Commitments and contingencies (Note 19)

 

Shareholders' Equity:
 
 
 
Preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding
—

 
—

Ordinary A shares, €1.00 par value, 40,000 authorized; none issued or outstanding
—

 
—

Ordinary shares, $0.20 par value, 500,000,000 authorized; 117,513,370 and 116,160,353 issued;
116,283,149 and 115,929,588 outstanding
23.5

 
23.2

Ordinary shares held in treasury at cost, 1,230,221 and 230,765
(109.7
)
 
(17.5
)
Additional paid-in capital
5,357.6

 
5,172.4

Retained earnings (deficit)
38.9

 
(285.8
)
Accumulated other comprehensive income
0.9

 
65.7

Total Shareholders' Equity
5,311.2

 
4,958.0

Total Liabilities and Shareholders' Equity
$
16,404.1

 
$
12,787.3


See Notes to Consolidated and Combined Financial Statements.



73



MALLINCKRODT PLC
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS
(in millions)

 
Fiscal Year
 
2015
 
2014
 
2013
Cash Flows From Operating Activities:
 
 
 
 
 
Net income (loss)
$
324.7

 
$
(319.3
)
 
$
58.8

Adjustments to reconcile net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization
672.5

 
275.9

 
139.6

Share-based compensation
117.0

 
67.7

 
16.2

Deferred income taxes
(191.6
)
 
(107.5
)
 
(9.0
)
Non-cash impairment charges
—

 
381.2

 
—

Inventory provisions
—

 
32.1

 
15.5

Other non-cash items
(59.6
)
 
(23.6
)
 
(6.2
)
Changes in assets and liabilities, net of the effects of acquisitions:
 
 
 
 
 
Accounts receivable, net
0.7

 
(51.3
)
 
(181.2
)
Inventories
61.3

 
56.0

 
27.7

Accounts payable
20.4

 
(32.9
)
 
7.2

Income taxes
30.2

 
(54.8
)
 
60.7

Other
(79.2
)
 
149.9

 
6.6

Net cash provided by operating activities
896.4

 
373.4

 
135.9

Cash Flows From Investing Activities:
 
 
 
 
 
Capital expenditures
(148.0
)
 
(127.8
)
 
(147.9
)
Acquisitions and intangibles, net of cash acquired
(2,154.7
)
 
(2,793.8
)
 
(88.1
)
Restricted cash
3.1

 
4.1

 
—

Other
3.0

 
26.7

 
1.3

Net cash used in investing activities
(2,296.6
)
 
(2,890.8
)
 
(234.7
)
Cash Flows From Financing Activities:
 
 
 
 
 
Issuance of external debt
3,010.0

 
3,043.2

 
898.1

Repayment of external debt and capital leases
(1,848.4
)
 
(34.8
)
 
(1.3
)
Excess tax benefit from share-based compensation
34.1

 
8.9

 
3.4

Debt financing costs
(39.9
)
 
(71.7
)
 
(12.0
)
Net transfers to parent
—

 
—

 
(515.9
)
Proceeds from exercise of share options
34.4

 
25.8

 
0.6

Repurchase of shares
(92.2
)
 
(17.5
)
 
—

Other
(28.1
)
 
—

 
0.1

Net cash provided by financing activities
1,069.9

 
2,953.9

 
373.0

Effect of currency rate changes on cash
(11.6
)
 
(4.2
)
 
1.3

Net (decrease) increase in cash and cash equivalents
(341.9
)
 
432.3

 
275.5

Cash and cash equivalents at beginning of period
707.8

 
275.5

 
—

Cash and cash equivalents at end of period
$
365.9

 
$
707.8

 
$
275.5

 
 
 
 
 
 
Supplemental Disclosures of Cash Flow Information:
 
 
 
 
 
Cash paid for interest
$
200.5

 
$
57.2

 
$
0.8

Cash paid for income taxes, net
123.8

 
128.0

 
15.0


See Notes to Consolidated and Combined Financial Statements.


74



MALLINCKRODT PLC
CONSOLIDATED AND COMBINED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
(in millions)
 
 
Ordinary Shares
 
Treasury Shares
 
Additional Paid-In Capital
 
Retained Earnings
 
Contributed
Surplus
 
Parent
Company
Investment
 
Accumulated
Other
Comprehensive
Income
 
Total
Shareholders'
Equity
 
Number
 
Par
 Value
 
Number
 
Amount
 
Balance at September 28, 2012
—

 
$
—

 
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
1,807.0

 
$
84.9

 
$
1,891.9

Net income
—

 
—

 
—

 
—

 
—

 
33.5

 
—

 
25.3

 
—

 
58.8

Currency translation adjustments
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
1.5

 
1.5

Change in derivatives, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(7.3
)
 
(7.3
)
Minimum pension liability, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
34.2

 
34.2

Net transfers to parent
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(515.9
)
 
—

 
(515.9
)
Separation related adjustments
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(209.9
)
 
(4.8
)
 
(214.7
)
Transfer of parent company investment to contributed surplus
—

 
—

 
—

 
—

 
—

 
—

 
1,106.5

 
(1,106.5
)
 
—

 
—

Transfer of contributed surplus to distributable reserves
—

 
—

 
—

 
—

 
1,095.0

 
—

 
(1,095.0
)
 
—

 
—

 
—

Share options exercised
—

 
—

 
—

 
—

 
0.6

 
—

 
—

 
—

 
—

 
0.6

Share-based compensation
—

 
—

 
—

 
—

 
6.5

 
—

 
—

 
—

 
—

 
6.5

Issuance of ordinary shares
57.7

 
11.5

 
—

 
—

 
—

 
—

 
(11.5
)
 
—

 
—

 
—

Balance at September 27, 2013
57.7

 
$
11.5

 
—

 
$
—

 
$
1,102.1

 
$
33.5

 
$
—

 
$
—

 
$
108.5

 
$
1,255.6

Net loss
—

 
—

 
—

 
—

 
—

 
(319.3
)
 
—

 
—

 
—

 
(319.3
)
Currency translation adjustments
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(27.6
)
 
(27.6
)
Change in derivatives, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
0.5

 
0.5

Minimum pension liability, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(15.7
)
 
(15.7
)
Ordinary shares issued in connection with the Questcor acquisition
57.3

 
11.4

 
—

 
—

 
3,968.2

 
—

 
—

 
—

 
—

 
3,979.6

Share options exercised
0.8

 
0.2

 
—

 
—

 
25.6

 
—

 
—

 
—

 
—

 
25.8

Vesting of restricted shares
0.4

 
0.1

 
—

 
—

 
(0.1
)
 
—

 
—

 
—

 
—

 
—

Excess tax benefit from share-based compensation
—

 
—

 
—

 
—

 
8.9

 
—

 
—

 
—

 
—

 
8.9

Share-based compensation
—

 
—

 
—

 
—

 
67.7

 
—

 
—

 
—

 
—

 
67.7

Repurchase of ordinary shares
—

 
—

 
0.2

 
(17.5
)
 
—

 
—

 
—

 
—

 
—

 
(17.5
)
Balance at September 26, 2014
116.2

 
$
23.2

 
0.2

 
$
(17.5
)
 
$
5,172.4

 
$
(285.8
)
 
$
—

 
$
—

 
$
65.7

 
$
4,958.0

Net income
—

 
—

 
—

 
—

 
—

 
324.7

 
—

 
—

 
—

 
324.7

Currency translation adjustments
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(70.8
)
 
(70.8
)
Change in derivatives, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
0.4

 
0.4

Minimum pension liability, net of tax
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
5.6

 
5.6

Share options exercised
1.2

 
0.2

 
—

 
—

 
34.2

 
—

 
—

 
—

 
—

 
34.4

Vesting of restricted shares
1.3

 
0.3

 
—

 
—

 
(0.3
)
 
—

 
—

 
—

 
—

 
—

Shares canceled
(1.2
)
 
(0.2
)
 
—

 
—

 
0.2

 
—

 
—

 
—

 
—

 
—

Excess tax benefit from share-based compensation
—

 
—

 
—

 
—

 
34.1

 
—

 
—

 
—

 
—

 
34.1

Share-based compensation
—

 
—

 
—

 
—

 
117.0

 
—

 
—

 
—

 
—

 
117.0

Repurchase of ordinary shares
—

 
—

 
1.0

 
(92.2
)
 
—

 
—

 
—

 
—

 
—

 
(92.2
)
Balance at September 25, 2015
117.5

 
$
23.5

 
1.2

 
$
(109.7
)
 
$
5,357.6

 
$
38.9

 
$
—

 
$
—

 
$
0.9

 
$
5,311.2

 

See Notes to Consolidated and Combined Financial Statements.


75



MALLINCKRODT PLC
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
(dollars in millions, expect share data and where indicated)

1.
Background and Basis of Presentation
Background
Mallinckrodt plc and its subsidiaries (collectively, "Mallinckrodt" or "the Company"), is a global specialty biopharmaceutical and nuclear imaging business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and nuclear imaging agents. Therapeutic areas of focus include autoimmune and rare disease specialty areas (including neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; and central nervous system drugs. The Company also supports the diagnosis of disease with nuclear medicine imaging agents.
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its global contrast media and delivery systems ("CMDS") business to Guerbet S.A. ("Guerbet"), which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:
•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and active pharmaceutical ingredients ("API") consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).
In May 2015, the Board of Directors of Mallinckrodt plc approved the migration of the Company’s principal executive offices from Ireland to the United Kingdom. The Company remains incorporated in Ireland and continues to be subject to U.S. Securities and Exchange Commission ("SEC") reporting requirements and the applicable corporate governance rules of the New York Stock Exchange. 
Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien plc ("Covidien"), which was subsequently acquired by Medtronic plc. On June 28, 2013, Covidien shareholders of record received one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien held as of the record date, June 19, 2013, and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing its legal separation from Covidien ("the Separation").

Basis of Presentation
The accompanying consolidated and combined financial statements reflect the consolidated financial position of the Company as an independent, publicly-traded company for periods subsequent to June 28, 2013, and as a combined reporting entity of Covidien, including operations relating to Covidien's Pharmaceuticals business, for periods prior to June 28, 2013.
The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP"). The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ from those estimates. The consolidated and combined financial statements include the accounts of the Company, its wholly-owned subsidiaries and entities in which they own or control more than fifty percent of the voting shares, or have the ability to control through similar rights. The results of entities disposed of are included in the consolidated and combined financial statements up to the date of disposal and, where appropriate, these operations have been reflected as discontinued operations. Divestitures of product lines not representing businesses have been reflected in operating income. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments necessary for a fair presentation have been included in the results reported.

76



As a result of the Company's classification of the CMDS business as held for sale and the change in reportable segments, certain amounts from prior years have been revised to conform to the current year presentation,.
The Company's combined financial statements for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company's fiscal 2013 results, may not be indicative of its future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had it operated as an independent, publicly-traded company for the entirety of the periods presented, including as a result of changes in the Company's capitalization in connection with the Separation. The combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were $39.6 million for fiscal 2013 and were included within selling, general and administrative expenses. Management considers the bases on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, the Company during the periods presented; however, the allocations may not reflect the expense the Company would have incurred as an independent, publicly-traded company. Actual costs that may have been incurred if the Company had been a standalone company would depend on a number of factors, including organizational structure, what functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. The Company is unable to determine what those costs would have been had the Company been independent during the applicable periods. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services were rendered may not have been as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.
The combined balance sheets prior to June 28, 2013 included certain assets and liabilities that have historically been recorded at the Covidien corporate level but are specifically identifiable or otherwise allocable to the Company. Covidien's debt and related interest expense were not allocated to the Company since the Company was not the legal obligor of such debt and Covidien's borrowings were not directly attributable to the Company's business. Debt incurred by the Company directly has been included in the combined financial statements. Intercompany transactions between the Company and Covidien, prior to the Separation, have been included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The total net effect of the settlement of these intercompany transactions was reflected in the combined statements of cash flows as a financing activity and in the combined balance sheet as parent company investment.
Prior to June 28, 2013, Covidien's investment in the Pharmaceuticals business is shown as parent company investment in the combined financial statements. On June 28, 2013, Covidien completed a distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien. Upon completion of the Separation, the Company had 57,694,885 ordinary shares outstanding at a par value of $0.20 per share. After Separation adjustments were recorded, the remaining parent company investment balance, which included all earnings prior to the Separation, was transferred to contributed surplus.
Under Irish law, the Company can only pay dividends and repurchase shares out of distributable reserves, as discussed further in the Company's information statement filed with the SEC as Exhibit 99.2 to the Company's Current Report on Form 8-K filed on July 1, 2013. Upon completion of the Separation, the Company did not have any distributable reserves. On July 22, 2013, the Company filed a petition with the High Court of Ireland seeking the court's confirmation of a reduction of the Company's share premium so that it can be treated as distributable for the purposes of Irish law. On September 9, 2013, the High Court of Ireland approved this petition and the High Court's order and minutes were filed with the Registrar of Companies. Upon this filing, the Company's share premium is treated as distributable reserves and the share premium balance was reclassified into additional paid-in capital within the consolidated balance sheet. Net income subsequent to the Separation has been included in retained earnings and is included in distributable reserves.

Fiscal Year
The Company reports its results based on a "52-53 week" year ending on the last Friday of September. Fiscal 2015, 2014 and 2013 each consisted of 52 weeks. Unless otherwise indicated, fiscal 2015, 2014 and 2013 refer to the Company's fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013, respectively. Fiscal 2016 will consist of 53 weeks and will end on September 30, 2016.



77



2.
Summary of Significant Accounting Policies
Revenue Recognition
The Company recognizes revenue for product sales when title and risk of loss have transferred from the Company to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and any related services, based on contract terms or legal requirements in non-U.S. jurisdictions. The Company sells products through independent channels, including directly to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. Chargebacks and rebates represent credits that are provided to certain distributors and customers for either the difference between the Company's contracted price with a customer and the distributor's invoice price paid to the Company or for contractually agreed volume price discounts. When the Company recognizes net sales, it simultaneously records an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of the Company's products and other competitive factors. The Company adjusts these reserves to reflect differences between estimated activity and actual experience. Such adjustments impact the amount of net sales recognized by the Company in the period of adjustment.
Taxes collected from customers relating to product sales and remitted to governmental authorities are accounted for on a net basis. Accordingly, such taxes are excluded from both net sales and expenses.

Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises to the customer's premises, are classified as selling, general and administrative expenses. Handling costs, which are costs incurred to store, move and prepare product for shipment, are classified as cost of sales. Shipping costs included in selling, general and administrative expenses in continuing operations were $42.3 million, $47.8 million and $46.9 million in fiscal 2015, 2014 and 2013, respectively.

Research and Development
Internal research and development costs are expensed as incurred. Research and development expenses include salary and benefits, allocated overhead and occupancy costs, clinical trial and related clinical manufacturing costs, contract services and other costs.
Upfront and milestone payments made to third parties under license arrangements are expensed as incurred up to the point of regulatory approval of the product. Milestone payments made to third parties upon or subsequent to regulatory approval are capitalized as an intangible asset and amortized to cost of sales over the estimated useful life of the related product.

Currency Translation
For the Company's non-U.S. subsidiaries that transact in a functional currency other than U.S. dollars, assets and liabilities are translated into U.S. dollars using fiscal year-end exchange rates. Revenues and expenses are translated at the average exchange rates in effect during the related month. The net effect of these translation adjustments is shown in the consolidated and combined financial statements as a component of accumulated other comprehensive income. For subsidiaries operating in highly inflationary environments or where the functional currency is different from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date the assets and liabilities were acquired or assumed, while monetary assets and liabilities are translated at fiscal year-end exchange rates. Translation adjustments of these subsidiaries are included in net income. Gains and losses resulting from foreign currency transactions are included in net income. During fiscal 2015 and 2014, $30.7 million and $3.8 million of foreign currency gains, respectively, were included within net income from continuing operations. During fiscal 2013, $12.8 million of foreign currency losses were included within net income from continuing operations. The Company entered into derivative instruments to mitigate the exposure of movements in certain of these foreign currency transactions and recognized a $24.8 million loss in fiscal 2015, a $6.3 million loss in fiscal 2014, and a $10.1 million gain in fiscal 2013 within net income from continuing operations.

Cash and Cash Equivalents
The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents.

78




Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects an estimate of losses inherent in the Company's accounts receivable portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectible. Trade accounts receivable are also presented net of reserves related to chargebacks and non-branded rebates payable to customers for whom we have trade accounts receivable and the right of offset exists.

Inventories
Inventories are recorded at the lower of cost or market value, primarily using the first-in, first-out convention. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete or slow-moving based on changes in customer demand, technology developments or other economic factors.

Property, Plant and Equipment
Property, plant and equipment are stated at cost. Major renewals and improvements are capitalized, while routine maintenance and repairs are expensed as incurred. Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:
Buildings
10
to
45 years
Leasehold improvements
1
to
20 years
Capitalized software
1
to
10 years
Machinery and equipment
1
to
20 years

 The Company capitalizes certain computer software and development costs incurred in connection with developing or obtaining software for internal use.
Upon retirement or other disposal of property, plant and equipment, the cost and related amount of accumulated depreciation are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds is included in net income.
The Company assesses the recoverability of assets or asset groups using undiscounted cash flows whenever events or circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If an asset or asset group is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value of the asset or asset group and its fair value.

Acquisitions
Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.
The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.
The fair value of in-process research and development ("IPR&D") is determined using the discounted cash flow method. In determining the fair value of IPR&D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.
The fair value attributable to IPR&D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset

79



is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.
Goodwill and Other Intangible Assets
Goodwill represents the excess of the purchase price of an acquired entity over the amounts assigned to assets and liabilities assumed in a business combination. The Company tests goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The impairment test is comprised of a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. The Company estimates the fair value of its reporting units through internal analyses and valuation, utilizing an income approach (a level three measurement technique) based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, the Company will perform the second step of the goodwill impairment test to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. The implied fair value of goodwill is determined in the same manner that the amount of goodwill recognized in a business combination is determined, with the Company allocating the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of the value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill.
Intangible assets acquired in a business combination are recorded at fair value, while intangible assets acquired in other transactions are recorded at cost. Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:
Completed technology
5
to
25 years
License agreements
8
to
30 years
Trademarks
13
to
30 years
Customer relationships
 
 
12 years
Amortization expense related to completed technology and certain other intangible assets is included in cost of sales, while amortization expense related to intangible assets that contribute to the Company's ability to sell, market and distribute products is included in selling, general and administrative expenses.
When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset, or the asset group they are part of, to its carrying value. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets, or the asset group they are part of, with their carrying value. The fair value of the intangible asset, or the asset group they are part of, is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, or the asset group they are part of, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the fair value of the asset. The Company assesses the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. The Company annually tests the indefinite-lived intangible assets for impairment by comparing the fair value of the assets, estimated using an income approach, with their carrying value and records an impairment when the carrying value exceeds the fair value.

Contingencies
The Company is subject to various patent, product liability, government investigations, environmental liability and other legal proceedings in the ordinary course of business. The Company records accruals for contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company discounts environmental liabilities using a risk-free rate of return when the obligation is fixed or reasonably determinable. The impact of the discount in the consolidated balance sheets was not material in any period presented. Legal fees, other than those pertaining to environmental and asbestos matters, are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. Assets and liabilities are not netted for financial statement presentation.

Share-Based Compensation
The Company recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, the requisite service period (generally the vesting period). For more information about our share-based awards, refer to Note 15.

80



Income Taxes
Income taxes for periods prior to the Separation were calculated on a separate tax return basis (inclusive of certain loss benefits), although the Company's operations had historically been included in Covidien's U.S. federal and state tax returns or the tax returns of non-U.S. jurisdictions. Accordingly, the income taxes presented for periods prior to June 28, 2013 do not necessarily reflect the results that would have occurred as an independent, publicly-traded company. With the exception of certain non-U.S. entities, the Company did not maintain taxes payable to or from Covidien and the Company was deemed to settle the annual current tax balances immediately with the legal tax-paying entities in the respective jurisdictions. These settlements were reflected as changes in parent company investment.
Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been reflected in the consolidated and combined financial statements. Deferred tax assets and liabilities are determined based on the differences between the book and tax bases of assets and liabilities and operating loss carryforwards, using tax rates expected to be in effect for the years in which the differences are expected to reverse. A valuation allowance is provided to reduce net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities are also recorded for deferred tax obligations related to installment sale arrangements. The deferral of tax payments to the IRS are subject to interest, which is accrued and included within interest expense.
The Company determines whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not expected to be realized on the uncertain tax position, an income tax liability is established. Interest and penalties on income tax obligations, associated with uncertain tax positions, are included in the provision for income taxes.
The calculation of the Company's tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across the Company's global operations. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from current estimates of the tax liabilities. If the Company's estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary. A significant portion of these potential tax liabilities are recorded in other income tax liabilities on the consolidated balance sheets as payment is not expected within one year.

Parent Company Investment
Parent company investment in periods prior to the Separation represents Covidien's historical investment in the Company, the Company's accumulated net earnings after income taxes for periods prior to that date, and the net effect of transactions with and allocations from Covidien.

3.
Recently Issued Accounting Standards
The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2011-11 in December 2011, "Disclosures about Offsetting Assets and Liabilities," which was clarified in January 2013 by ASU 2013-01 "Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities." This guidance provides new disclosure requirements about instruments and transactions eligible for offset in the statement of financial position, as well as instruments and transactions subject to an agreement similar to a netting agreement, to enable users of financial statements to understand the effects or potential effects of those arrangements on an entity's financial position. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-02, "Reporting Amounts Classified out of Accumulated Other Comprehensive Income," in February 2013. This guidance requires an entity to present, either on the face of the statement of income or separately in the notes to the financial statements, the effects on net income of significant amounts reclassified out of each component of accumulated other comprehensive income, if those amounts are required to be reclassified to net income in their entirety in the same reporting period. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date," in February 2013. This update provides guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date, except for obligations addressed within existing guidance. An entity is required to measure those obligations as the sum of the amount the entity has agreed to pay on the basis of its arrangement among its co-obligors, and any additional amounts it

81



expects to pay on behalf of its co-obligors. The guidance also requires the entity to disclose the nature and amount of those obligations. The guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," in July 2013. This update provides guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, to eliminate diversity in practice in the presentation of unrecognized tax benefits in those instances. This guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity," in April 2014. Under the new guidance, only disposals representing a strategic shift in a company's operations and financial results should be reported as discontinued operations, with expanded disclosures. In addition, disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify as a discontinued operation is required. This guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 with the classification of the CMDS business as held for sale.
FASB issued ASU 2014-09, "Revenue from Contracts with Customers," in May 2014. The issuance of ASU 2014-09 and International Financial Reporting Standards ("IFRS") 15, "Revenue from Contracts with Customers," completes the joint effort by FASB and the International Accounting Standards Board to clarify the principles for recognizing revenue and develop a common revenue standard for U.S. GAAP and IFRS. Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted in the first quarter of fiscal 2018. The Company continues to assess the potential impact of the guidance.
FASB issued ASU 2015-03, "Interest - Imputation of Interest," in April 2015. The issuance of ASU 2015-03 is part of the FASB's initiative to simplify the presentation of debt issuance costs. Under the new guidance, debt issuance costs related to a recognized debt liability must be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amortization of such costs should continue to be calculated using the interest method and be reported as interest expense. The guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 and reclassified debt issuance costs, of $103.1 million at September 25, 2015, and expanded disclosure.
FASB issued ASU 2015-11, "Simplifying the Measurement of Inventory," in July 2015. The issuance of ASU 2015-11 is part of the FASB's initiative to more closely align the measurement of inventory between GAAP and IFRS. Under the new guidance, inventory must be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.
FASB issued ASU 2015-16, "Simplifying the Accounting for Measurement-Period Adjustments," in September 2015. Under the new guidance, the requirement to restate prior period financial statements for measurement period adjustments following a business combination is eliminated. The cumulative impact of a measurement period adjustment (including the impact on prior periods) should be recognized in the reporting period in which the adjustment is identified. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.

    
4.
Discontinued Operations and Divestitures
Discontinued Operations
CMDS: During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet in a transaction valued at approximately $270.0 million, which is expected to be completed during the first quarter of fiscal 2016. As of September 25, 2015, the CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.


82



Subsequent to the sale of the CMDS business, the Company will continue to supply certain products under a supply agreement with Guerbet.
The following table summarizes the financial results of the CMDS discontinued operations for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013 as presented in the consolidated statements of operations and comprehensive income:
 
Fiscal Year
Major line items constituting income (loss) from discontinued operations
2015
 
2014
 
2013
Net sales
$
413.8

 
$
495.8

 
$
549.3

Cost of sales
306.4

 
352.9

 
346.7

Selling, general and administrative
97.5

 
97.1

 
114.0

Restructuring charges, net
0.3

 
47.2

 
9.5

Non-restructuring impairment charges
—

 
204.0

 
—

Other
4.7

 
4.1

 
8.4

Income (loss) from discontinued operations

4.9

 
(209.5
)
 
70.7

Income tax expense (benefit)
10.8

 
(34.7
)
 
21.1

 
 
 
 
 
 
Income (loss) from discontinued operations net of tax
$
(5.9
)
 
$
(174.8
)
 
$
49.6


The fiscal 2014 non-restructuring impairment charge of $204.0 million includes charges of $51.4 million associated with property, plant and equipment, $52.4 million associated with intangible assets and $100.2 million associated with goodwill. Further discussion of these impairment charges are included within Notes 10 and 11.
The fiscal 2015 income tax expense of $10.8 million was impacted by approximately $10.0 million of tax expense related to taxes paid, or anticipated to be paid, in connection with the disposition. The fiscal 2014 income tax benefit of $34.7 million was impacted by receiving a tax benefit of $36.2 million on impairment of $204.0 million, by $3.0 million of tax expense associated with the rate difference between U.S. and non-U.S. jurisdictions, $2.5 million of tax benefit associated with nonrecurring valuation allowances, $0.9 million of tax expense associated with accrued income tax liabilities and uncertain tax positions, and $2.0 million of tax expense associated with permanently nondeductible, nontaxable, and other items. The fiscal 2013 income tax expense of $21.1 million was impacted by $0.7 million of tax benefit associated with the rate difference between U.S. and non-U.S. jurisdictions and $2.9 million of tax benefit associated with permanently nondeductible, nontaxable, and other items. Fiscal 2015 reflects $14.9 million of International current income tax expense, $4.4 million of International deferred income tax benefit, and none being allocable to the Domestic income tax provision. Fiscal 2014 reflects $10.4 million of Domestic current income tax expense, $6.6 million of International current income tax benefit, $35.6 million of Domestic deferred income tax benefit, and $3.0 million of International deferred income tax benefit. Fiscal 2013 reflects $5.6 million of Domestic current income tax expense, $10.7 million of International current income tax expense, $5.4 million of Domestic deferred income tax expense, and $0.5 million of International deferred income tax benefit. Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and 2013.


83



The following table summarizes the assets and liabilities of the CMDS business that are classified as held for sale on the consolidated balance sheets as of September 25, 2015 and September 26, 2014:
 
September 25, 2015
 
September 26, 2014
Carrying amounts of major classes of assets included as part of discontinued operations
 
 
 
Accounts receivable
$
68.5

 
$
68.9

Inventories
86.3

 
90.2

Property, plant and equipment, net
60.3

 
62.4

Intangible assets, net
27.7

 
30.0

Other current and non-current assets
57.1

 
60.5

Total assets classified as held for sale in the balance sheet
$
299.9

 
$
312.0

 
 
 
 
Carrying amounts of major classes of liabilities included as part of discontinued operations
 
 
 
Accounts payable
$
22.0

 
$
18.0

Other current and non-current liabilities
50.8

 
50.7

Total liabilities classified as held for sale in the balance sheet
$
72.8

 
$
68.7


The following table summarizes significant cash and non-cash transactions of the CMDS business that are included within the consolidated statements of cash flows for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013:
 
Fiscal Year
 
2015
 
2014
 
2013
Depreciation
$
15.5

 
$
18.9

 
$
16.0

Amortization
2.3

 
7.5

 
7.5

Capital expenditures
9.5

 
12.3

 
17.4

Non-cash impairment charges
—

 
204.0

 
—

All other notes to the consolidated financial statements that were impacted by this discontinued operation have been reclassified accordingly.
Mallinckrodt Baker: During fiscal 2010, the Specialty Chemicals business (formerly known as "Mallinckrodt Baker"), which was part of the Company's Specialty Pharmaceuticals segment, was sold because its products and customer bases were not aligned with the Company's long-term strategic objectives. This business met the discontinued operations criteria and, accordingly, was included in discontinued operations for all periods presented. During fiscal 2015, 2014 and 2013, the Company recorded a loss, net of tax, of $0.1 million, a loss of $0.7 million, and a gain of $1.0 million, respectively. These gains and losses were primarily related to the indemnification obligations to the purchaser, which are discussed in Note 18.
Other: Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a $22.5 million benefit, during fiscal 2015, in discontinued operations within the consolidated and combined statement of income.

License of Intellectual Property
The Company was involved in patent disputes with a counterparty relating to certain intellectual property related to extended-release oxymorphone. In December 2013, the counterparty agreed to pay the Company an upfront cash payment of $4.0 million and contractually obligated future payments of $8.0 million through July 2018, in exchange for the withdrawal of all claims associated with the intellectual property and a license to utilize the Company's intellectual property. The Company has completed the earnings process associated with the agreement and recorded an $11.7 million gain, included within gains on divestiture and license, during fiscal 2014.



84



5.
Acquisitions and License Agreements
Business Acquisitions
Therakos, Inc.
On September 25, 2015, the Company acquired Therakos, Inc. ("Therakos") through the acquisition of all the outstanding common stock of TGG Medical Solutions, Inc., the parent holding company of Therakos, in a transaction valued at approximately $1.3 billion, net of cash acquired ("the Therakos Acquisition"). Consideration for the transaction consisted of approximately $1.0 billion in cash paid to TGG Medical Solutions, Inc. shareholders and the assumption of approximately $0.3 billion of Therakos third-party debt, which was repaid in conjunction with the Therakos Acquisition. The acquisition and repayment of debt was funded through the issuance of $750.0 million aggregate principal amount of senior unsecured notes, a $500.0 million borrowing under a revolving credit facility and cash on hand. Therakos' primary immunotherapy products relate to the administering of extracorporeal photopheresis therapies through its UVAR XTS® and CellexTM Photopheresis Systems, which accelerates the Company's growth in its Specialty Brands segment.

Ikaria, Inc.
On April 16, 2015, the Company acquired Ikaria, Inc. ("Ikaria") through the acquisition of all the outstanding common stock of Compound Holdings II, Inc., the parent holding company of Ikaria, in a transaction valued at approximately $2.3 billion, net of cash acquired ("the Ikaria Acquisition"). Consideration for the transaction consisted of approximately $1.2 billion in cash paid to Compound Holdings II, Inc. shareholders and the assumption of approximately $1.1 billion of Ikaria third-party debt, which was repaid in conjunction with the Ikaria Acquisition. The acquisition and repayment of debt was funded through the issuance of $1.4 billion aggregate principal amount of senior unsecured notes, a $240.0 million borrowing under the Revolver, which was repaid subsequent to the transaction, and cash on hand. Ikaria's primary product is INOMAX® (nitric oxide) for inhalation, a vital treatment option in neonatal critical care.


Questcor Pharmaceuticals
On August 14, 2014, the Company acquired all of the outstanding common stock of Questcor Pharmaceuticals, Inc. ("Questcor"), a biopharmaceutical company, for total consideration of approximately $5.9 billion, comprised of cash consideration of $30.00 per share, 0.897 ordinary shares of the Company for each share of Questcor common stock owned and the portion of outstanding equity awards deemed to have been earned as of August 14, 2014 ("the Questcor Acquisition"). The acquisition was funded through the issuance of approximately 57 million common shares, proceeds from the issuance of $900.0 million aggregate principal of senior unsecured notes, proceeds from a $700.0 million senior secured term loan facility, $150.0 million of cash from a receivable securitization program, as further discussed in Note 12, and cash on hand. H.P. Acthar® Gel (repository corticotropin injection) ("Acthar"), Questcor's primary product, is focused on the treatment of patients with serious, difficult-to-treat autoimmune and rare diseases. Acthar is an injectable drug that is approved by the U.S. Food and Drug Administration ("FDA") for use in 19 indications, including the areas of neurology, rheumatology, nephrology and pulmonology. Questcor also supplies specialty contract manufacturing services to the global pharmaceutical and biotechnology industry through its wholly-owned subsidiary, BioVectra Inc.

Cadence Pharmaceuticals
On March 19, 2014, the Company acquired all of the outstanding common stock of Cadence Pharmaceuticals, Inc. ("Cadence"), a biopharmaceutical company focused on commercializing products principally for use in the hospital setting, for total consideration of $14.00 per share in cash, or approximately $1.3 billion ("the Cadence Acquisition"). The acquisition was primarily funded through a $1.3 billion senior secured term loan credit facility, as further discussed in Note 12. Cadence's sole product, OFIRMEV® (acetaminophen) injection ("Ofirmev"), is a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The Cadence Acquisition added a growth product to the Specialty Brands product portfolio and provided us the opportunity to expand our reach into the hospital market, in which Cadence had an established presence.

CNS Therapeutics
On October 1, 2012, the Company acquired all the outstanding equity of CNS Therapeutics, Inc. ("CNS Therapeutics"), a specialty pharmaceuticals company focused on developing and commercializing intrathecal products for site-specific administration to the central nervous system to treat neurological disorders and intractable chronic pain, for total consideration, net of cash acquired, of

85



$95.0 million. The total consideration was comprised of an upfront cash payment of $88.1 million (net of cash acquired of $3.6 million) and the fair value of contingent consideration of $6.9 million. This contingent consideration, which could potentially total a maximum of $9.0 million, is discussed further in Note 20.

Fair Value Allocation
The following amounts represent the preliminary allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Therakos Acquisition and Ikaria Acquisition and final allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Cadence Acquisition, Questcor Acquisition and CNS Therapeutics acquisition:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Cash
$
41.3

 
$
77.3

 
$
445.1

 
$
43.2

 
$
3.6

Inventory
23.5

 
26.3

 
67.9

 
21.0

 
—

Intangible assets
1,170.0

 
1,971.0

 
5,601.1

 
1,300.0

 
91.9

Goodwill (non-tax deductible)
437.2

 
792.4

 
1,789.4

 
318.1

 
24.5

Other assets, current and non-current (1)
42.1

 
172.9

 
274.3

 
18.0

 
9.7

Total assets acquired
1,714.1

 
3,039.9

 
8,177.8

 
1,700.3

 
129.7

Current liabilities
24.7

 
32.6

 
168.9

 
48.8

 
4.0

Unpaid purchase consideration (current)
—

 
—

 
128.8

 
—

 
—

Other liabilities (non-current)
0.6

 
9.1

 
186.8

 
—

 
—

Deferred tax liabilities, net (non-current)
324.3

 
623.6

 
1,906.8

 
292.3

 
27.1

Contingent consideration (non-current)
—

 
—

 
—

 
—

 
6.9

Total debt
344.8

 
1,121.0

 
—

 
30.0

 
—

Total liabilities assumed
694.4

 
1,786.3

 
2,391.3

 
371.1

 
38.0

Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7


(1)
This amount includes $22.0 million, $73.8 million, $87.3 million, $14.7 million and $3.3 million of accounts receivable for the Therakos Acquisition, Ikaria Acquisition, Questcor Acquisition, Cadence Acquisition, and CNS Therapeutics, respectively, which is also the gross contractual value.

The following reconciles the total consideration to net assets acquired:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Total consideration, net of cash
$
978.4

 
$
1,176.3

 
$
5,470.2

 
$
1,286.0

 
$
95.0

Plus: cash assumed in acquisition
41.3

 
77.3

 
445.1

 
43.2

 
3.6

Total consideration
1,019.7

 
1,253.6

 
5,915.3

 
1,329.2

 
98.6

Less: unpaid purchase consideration
—

 
—

 
(128.8
)
 
—

 
—

Less: contingent consideration
—

 
—

 
—

 
—

 
(6.9
)
Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7


Intangible assets acquired consist of the following:  
Therakos
Amount
 
Amortization Period
Completed technology
$
1,170.0

 
15 years
The completed technology intangible asset relates to extracorporeal photopheresis treatment therapies. The fair value of the intangible asset was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of the asset based on market participant expectations of cash flows the asset would generate. The cash flows were discounted commensurate with the level of risk associated with each asset or its projected cash flows. The completed technology intangible asset utilized a discount rate of 17.0%. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

86



Ikaria
Amount
 
Amortization Period
Completed technology
$
1,820.0

 
15 years
Trademark
70.0

 
22 years
In-process research and development - terlipressin
81.0

 
Non-Amortizable
 
$
1,971.0

 
 
The completed technology and trademark intangible assets relate to Inomax. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, trademark and in-process research and development ("IPR&D") terlipressin intangibles utilized discount rates of 14.5%, 14.5%, and 17.0%, respectively. The IPR&D discount rate for terlipressin was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

Questcor
Amount
 
Weighted-Average Amortization Period
Completed technology
$
5,343.3

 
18 years
Trademark
5.2

 
13 years
Customer relationships
34.3

 
12 years
In-process research and development - Synacthen
218.3

 
Non-Amortizable
 
$
5,601.1

 
 
The completed technology intangible asset relates to Acthar. The trademark and customer relationship intangible assets relate to BioVectra, Inc., a wholly-owned subsidiary of Questcor. The in-process research and development relates to the U.S. development of Synacthen, a synthetic pharmaceutical product. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, customer relationships, trademark and in-process research and development intangibles utilized discount rates of 14.5%, 10.0%, 10.0% and 16.0%, respectively. The in-process research and development discount rate was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. The majority of assets acquired are included within the Company's Specialty Brands segment. Assets related to BioVectra, Inc. are included within the Company's Specialty Generics segment.

Cadence
Amount
 
Amortization Period
Completed technology
$
1,300.0

 
8 years
The completed technology intangible asset relates to Ofirmev, the rights to which have been in-licensed from Bristol-Myers Squibb Company ("BMS"). The fair value of the intangible asset was determined using the income approach. The cash flows were discounted at a 13.0% rate. For more information on the BMS license agreement, refer to "License Agreement" below. The excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.



87



CNS Therapeutics
Amount
 
Weighted-Average Amortization Period
Completed technology
$
73.1

 
13 years
Trademark
0.2

 
3 years
In-process research and development
18.6

 
Non-Amortizable
 
$
91.9

 
 
The in-process research and development projects primarily relate to certain investigational intrathecal pain products. As of the date of acquisition, these pain products were in various stages of development, with further development, testing, clinical trials and regulatory submission required in order to bring them to market. At the acquisition date, the total cost to complete these products was estimated to be approximately $18.0 million. The Company expects that regulatory approvals will occur between 2016 and 2019. The valuation of the in-process research and development was determined using, among other factors, appraisals primarily based on the discounted cash flow method. The cash flows were discounted at a 35% rate, which was considered commensurate with the risks and stages of development of the pain products. Future residual cash flows that could be generated from the products were determined based upon management's estimate of future revenue and expected profitability of the products. These projected cash flows were then discounted to their present values taking into account management's estimate of future expenses that would be necessary to bring the products to completion. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

Financial Results - The amount of net sales and earnings included in the Company's results for the periods presented were as follows:
Net sales
2015
 
2014
Ikaria
$
191.9

 
$
—

Questcor
1,125.9

 
129.2

Cadence
263.0

 
124.4

 
$
1,580.8

 
$
253.6

Operating income (loss)


 
 
Ikaria
$
47.1

 
$
—

Questcor
223.3

 
17.4

Cadence
(97.3
)
 
(66.9
)
 
$
173.1

 
$
(49.5
)

The amount of amortization on acquired intangible assets included within operating income (loss) for the periods presented was as follows:
Intangible asset amortization
2015
 
2014
Ikaria
$
57.1

 
$
—

Questcor
301.4

 
34.9

Cadence
162.5

 
85.9

 
$
521.0

 
$
120.8

During fiscal 2015 and 2014, the Company recognized $44.1 million and $25.7 million, respectively, of expense primarily associated with fair value adjustments of acquired inventory. This expense was included within cost of sales.

Acquisition-Related Costs - Acquisition-related costs incurred in fiscal 2015 and 2014 for each of the fiscal 2015 and 2014 acquisitions discussed above were as follows:
Acquisition-related costs
2015
 
2014
Therakos
$
22.5

 
$
—

Ikaria
30.9

 
—

Questcor
—

 
47.5

Cadence
—

 
17.6

 
$
53.4

 
$
65.1


88



Unaudited Pro Forma Financial Information - The following unaudited pro forma information presents a summary of the results of operations for the periods indicated as if the Questcor Acquisition and Cadence Acquisition had been completed as of September 29, 2012 and the Ikaria Acquisition and Therakos Acquisition as of September 28, 2013. The pro forma financial information is based on the historical financial information for the Company, Ikaria, Questcor and Cadence, along with certain pro forma adjustments. These pro forma adjustments consist primarily of:
•
non-recurring costs related to the step-up in fair value of acquired inventory and transaction costs related to the acquisitions;
•
increased amortization expense related to the intangible assets acquired in the acquisitions;
•
elimination of direct acquisition transaction costs from the period of acquisition;
•
increased interest expense to reflect the fixed rate unsecured notes and revolving credit facility (utilizing the interest rate in effect at the date of the acquisition of 2.6%) entered into in connection with the Therakos Acquisition, the fixed rate unsecured notes entered into in connection with the Ikaria Acquisition (assuming no interest related to the revolving credit facility which was paid down subsequent to the Ikaria Acquisition), the fixed-rate senior unsecured notes and variable-rate term loan entered into in connection with the acquisition of Questcor (utilizing the interest rate in effect at the date of acquisition of 3.50%), and the variable-rate term loan and revolving credit facility entered into in connection with the Cadence Acquisition (utilizing the interest rate in effect at the date of acquisition of 3.50%) including interest and amortization of deferred financing costs and original issue discount; and
•
the related income tax effects.
The following unaudited pro forma information has been prepared for comparative purposes only and is not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor is it necessarily an indication of future operating results. In addition, the unaudited pro forma information does not reflect the cost of any integration activities, benefits from any synergies that may be derived from the acquisition or revenue growth that may be anticipated.
 
2015
 
2014
Net sales
$
3,755.8

 
$
3,598.1

Income (loss) from continuing operations
359.9

 
(63.1
)
 
 
 
 
Basic earnings (loss) per share from continuing operations
$
3.11

 
$
(0.55
)
Diluted earnings (loss) from per share continuing operations
3.07

 
(0.55
)

License Agreements
Ofirmev
As part of the Cadence Acquisition, the Company acquired the exclusive development and commercialization rights to Ofirmev in the U.S. and Canada, as well as the rights to the patents and technology, which were originally in-licensed by Cadence from BMS in March 2006. BMS sublicensed these rights to Cadence under a license agreement with SCR Pharmatop S.A. ("Pharmatop"), and the Company has the right to grant sublicenses to third parties. Under this license agreement, the Company may be obligated to make future milestone payments of up to $25.0 million upon the achievement of certain levels of net sales, of which $10.0 million was paid during fiscal 2015. In addition, the Company is obligated to pay royalties on sales of the product. During fiscal 2015 and 2014, the Company paid royalties of $43.9 million and $13.2 million respectively.

Exalgo
In 2009, the Company's Specialty Brands segment acquired the rights to market and distribute the pain management drug EXALGO® (hydromorphone HCl) extended-release tablets (CII) ("Exalgo") in the U.S. Under the license agreement, the Company is obligated to make additional payments of up to $73.0 million based on the successful completion of specified development and regulatory milestones. Through fiscal 2015, $65.0 million of additional payments had been made, with $55.0 million being capitalized as an intangible asset. The Company is also required to pay royalties on sales of the product. During fiscal 2015, 2014 and 2013, the Company paid royalties of $3.2 million, $22.0 million and $24.0 million, respectively.
In January 2014, the Company purchased certain royalty rights associated with Exalgo for $7.2 million, which have been capitalized as an intangible asset.



89



Depomed
In 2009, the Company's Specialty Brands segment licensed worldwide rights to utilize Depomed, Inc.'s ("Depomed") Acuform gastric retentive drug delivery technology for the exclusive development of four products. Under this license agreement, the Company may be obligated to pay up to $64.0 million in development milestone payments. Through fiscal 2015, approximately $22.0 million of these payments have been made by the Company. During fiscal 2014, upon approval by the FDA for XARTEMIS™ XR (oxycodone HCl and acetaminophen) extended release tablets CII ("Xartemis XR"), the Company made a milestone payment of $10.0 million, which has been capitalized as an intangible asset.

Pennsaid
In 2009, the Company's Specialty Brands segment entered into a licensing agreement which granted it rights to market and distribute Pennsaid and Pennsaid 2%, a formulation of diclofenac sodium topical solution which was approved in February 2014 by the FDA and indicated for the treatment of pain associated with osteoarthritis of the knee. The Company was responsible for future development activities and expenses and were required to make milestone payments of up to $120.0 million based upon the successful completion of specified regulatory and sales milestones. Through fiscal 2015, $15.0 million of these payments were made, all of which were capitalized as an intangible asset. The Company is also required to pay royalties on sales of the products under this agreement. During fiscal 2015, 2014 and 2013, the Company paid royalties of $1.8 million, $4.3 million and $3.9 million, respectively.
During the fourth quarter of fiscal 2014, the Company reached an agreement in principle with Nuvo to settle various claims associated with our license of Pennsaid obtained from Nuvo. As part of the legal settlement, the Company agreed to return the license to Nuvo, which resulted in the Company recording an impairment of $11.1 million during the fourth quarter of fiscal 2014.



6.
Restructuring and Related Charges
During fiscal 2013, the Company launched a restructuring program designed to improve its cost structure ("the 2013 Mallinckrodt Program"). The 2013 Mallinckrodt Program includes actions across all segments, as well as within corporate functions. The Company expects to incur charges of $100.0 million to $125.0 million under this program as the specific actions required to execute on these initiatives are identified and approved, most of which are expected to be incurred by the end of fiscal 2016.
Prior to Separation, Covidien initiated restructuring programs, which also applied to its Pharmaceutical business. These programs were substantially completed as of September 26, 2014.
Net restructuring and related charges by segment within continuing operations are as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Specialty Brands
$
36.5

 
$
57.0

 
$
5.2

Specialty Generics
4.5

 
9.8

 
11.2

Nuclear Imaging
(4.6
)
 
13.7

 
6.9

Corporate
4.3

 
1.4

 
3.0

Restructuring and related charges, net
40.7

 
81.9

 
26.3

Less: accelerated depreciation
(0.3
)
 
(0.5
)
 
(2.6
)
Restructuring charges, net
$
40.4

 
$
81.4

 
$
23.7



90



Net restructuring and related charges by program within continuing operations are comprised of the following:
 
Fiscal Year
 
2015
 
2014
 
2013
2013 Mallinckrodt Program
$
7.4

 
$
27.3

 
$
8.5

Acquisition programs
33.6

 
56.4

 
—

Other programs
(0.3
)
 
(1.8
)
 
17.8

Total programs
40.7

 
81.9

 
26.3

Less: non-cash charges, including impairments and accelerated share based compensation expense
(10.1
)
 
(38.0
)
 
(2.6
)
Total charges expected to be settled in cash
$
30.6

 
$
43.9

 
$
23.7


Non-cash charges in fiscal 2015 and fiscal 2014 include $9.8 million and $35.1 million, respectively, of accelerated share based compensation expense related to employee terminations, primarily related to our Questcor acquisition, and fiscal 2014 includes $2.3 million of property, plant and equipment asset impairments.
The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of $8.5 million in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:
 
2013 Mallinckrodt Program
 
Acquisition Programs
 
Other Programs
 
Total
Balance at September 28, 2012
$
—

 
$
—

 
$
8.9

 
$
8.9

Charges from continuing operations
8.5

 
—

 
17.6

 
26.1

Charges from discontinued operations
6.4

 
—

 
3.3

 
9.7

Changes in estimate from continuing operations
—

 
—

 
(2.4
)
 
(2.4
)
Changes in estimate from discontinued operations
—

 
—

 
(0.2
)
 
(0.2
)
Cash payments
—

 
—

 
(15.1
)
 
(15.1
)
Reclassifications (1)
—

 
—

 
(1.5
)
 
(1.5
)
Balance at September 27, 2013
14.9

 
—

 
10.6

 
25.5

Charges from continuing operations
32.9

 
22.9

 
1.4

 
57.2

Charges from discontinued operations
25.3

 
—

 
1.1

 
26.4

Changes in estimate from continuing operations
(7.6
)
 
(1.6
)
 
(4.1
)
 
(13.3
)
Changes in estimate from discontinued operations
(1.8
)
 
—

 
(0.7
)
 
(2.5
)
Cash payments
(34.8
)
 
(13.4
)
 
(6.8
)
 
(55.0
)
Reclassifications (1)
(1.3
)
 
—

 
(1.0
)
 
(2.3
)
Currency translation
(1.0
)
 
—

 
(0.1
)
 
(1.1
)
Balance at September 26, 2014
26.6

 
7.9

 
0.4

 
34.9

Charges from continuing operations
15.4

 
25.3

 
—

 
40.7

Charges from discontinued operations
1.0

 
—

 
—

 
1.0

Changes in estimate from continuing operations
(8.3
)
 
(1.5
)
 
(0.3
)
 
(10.1
)
Changes in estimate from discontinued operations
(0.6
)
 
—

 
—

 
(0.6
)
Cash payments
(22.5
)
 
(21.7
)
 
(0.1
)
 
(44.3
)
Reclassifications (1)
(3.0
)
 
—

 
—

 
(3.0
)
Currency translation
(0.6
)
 
—

 
—

 
(0.6
)
Balance at September 25, 2015
$
8.0

 
$
10.0

 
$
—

 
$
18.0

(1)
Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.


91



Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:
Specialty Brands
$
4.0

Specialty Generics
15.6

Nuclear Imaging (including CMDS)
67.3

Corporate
10.0

 
$
96.9

Substantially all of the restructuring reserves are included in accrued and other current liabilities on the Company's consolidated balance sheets.

7.
Income Taxes
In May 2015, the activities of the Company's principal executive offices were relocated from Ireland to the U.K. which resulted in a change in the Company's tax residence to the U.K. Mallinckrodt plc remains incorporated in Ireland. The tax regime applicable to holding companies resident in the U.K. allows Mallinckrodt plc to continue to have flexibility in structuring its subsidiary operations and enhanced global cash management. The Company continues to be subject to taxation in various tax jurisdictions worldwide. As a result of the integration of acquired intellectual property, the Company's income and assets are no longer concentrated in a single tax jurisdiction. Accordingly, in 2015 the Company reports the U.K. tax jurisdiction as its Domestic jurisdiction and the International jurisdiction represents areas outside the U.K. tax jurisdiction.
The Domestic and International components of income from continuing operations before income taxes were as follows(1):
 
2015
 
2014
 
2013
Domestic
$
(107.0
)
 
$
(159.9
)
 
$
34.7

International
322.3

 
6.0

 
21.0

Total
$
215.3

 
$
(153.9
)
 
$
55.7

(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.

Significant components of income taxes related to continuing operations are as follows(1):
 
2015
 
2014
 
2013
Current:
 
 
 
 
 
Domestic 
$
0.3

 
$
40.9

 
$
49.3

International 
95.1

 
17.9

 
12.1

Current income tax provision
95.4

 
58.8

 
61.4

Deferred:
 
 
 
 
 
Domestic 
$
(0.8
)
 
$
(49.7
)
 
$
(18.3
)
International 
(187.5
)
 
(19.2
)
 
4.4

Deferred income tax (benefit) provision
(188.3
)
 
(68.9
)
 
(13.9
)
 
$
(92.9
)
 
$
(10.1
)
 
$
47.5

(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.

The fiscal 2015 International current income tax provision reflects a utilization of $7.0 million of net operating losses (primarily in the U.S.) and $14.3 million of U.S. credits. The net operating loss utilization is comprised of $4.8 million of net operating losses acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to net operating losses carried forward from fiscal 2014. The U.S. credit utilization is comprised of $7.2 million of credits acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to credits carried forward or generated during fiscal 2015.
The fiscal 2014 Domestic current income tax provision reflects a utilization of $221.3 million of net operating losses (primarily in the U.S.) and $8.6 million of U.S. credits. The net operating loss utilization is comprised of $187.8 million of net operating losses acquired in conjunction with the Cadence Acquisition and the remainder utilization relating to net operating losses carried forward.
The Company has a provincial tax holiday in Canada that expires on April 1, 2017. The tax holiday reduced International tax expense by $5.1 million and $0.3 million for the fiscal years 2015 and 2014, respectively.

92



The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:
 
2015
 
2014
 
2013
Provision for income taxes at Domestic statutory income tax rate (1)
$
43.1

 
$
(53.8
)
 
$
19.5

   Adjustments to reconcile to income tax provision:
 
 
 
 
 
U.S. state income tax provision, net (6)
—

 
(6.1
)
 
3.7

Rate difference between Domestic and International jurisdictions (2) (3)
(138.6
)
 
(10.6
)
 
3.3

U.S. manufacturing deduction (6)
—

 
(4.1
)
 
(2.5
)
Valuation allowances, nonrecurring
(2.1
)
 
0.1

 
3.4

Adjustments to accrued income tax liabilities and uncertain tax positions (3)
(6.8
)
 
(1.5
)
 
5.0

Interest and penalties on accrued income tax liabilities and uncertain tax positions (3)
0.2

 
(7.9
)
 
4.7

Investment in partnership
—

 
20.0

 
—

Credits, principally research and orphan drug (4)
(8.1
)
 
(0.8
)
 
(6.3
)
Impairments, nondeductible
—

 
41.8

 
—

Permanently nondeductible and nontaxable items (5)
16.4

 
13.8

 
15.3

Other
3.0

 
(1.0
)
 
1.4

Provision for income taxes
$
(92.9
)
 
$
(10.1
)
 
$
47.5

(1)
The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014 and 2013.
(2)
Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
(3)
Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
(4)
During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately $2.3 million of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014.
(5)
Includes the impact of nondeductible transaction and separation costs.
(6)
For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.

The rate difference between Domestic and International jurisdictions changed from $10.6 million of tax benefit to $138.6 million of tax benefit for fiscal 2014 to fiscal 2015, respectively. The rate difference between Domestic and International jurisdictions would have been $32.1 million of tax benefit in fiscal 2014 if the referenced rate would have been the U.K. statutory rate of 21%. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the $128.0 million increase to tax benefit, $21.5 million of tax benefit can be attributed to the change in the referenced rate from U.S. to U.K, $35.0 million of tax benefit to the change in operating income, $22.5 million of tax expense to the change in amortization, $31.8 million of tax benefit to the U.S. state tax benefit associated with the impact of recent acquisitions, integration thereof, and legislative changes, and $62.2 million of tax benefit related to acquisition and other non-acquisition related items.
The rate difference between Domestic and International jurisdictions changed from $3.3 million of tax expense to $10.6 million of tax benefit for fiscal 2013 to fiscal 2014, respectively. The rate difference between Domestic and International jurisdictions would have been $10.0 million of tax expense and $32.1 million of tax benefit if the referenced rate would have been the U.K. statutory rate of 23% and 21% for fiscal 2013 and 2014 respectively. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions and the benefit of intercompany debt transferred to the Company at Separation, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the $13.9 million decrease in tax expense, $10.8 million of tax expense can be attributed to the change in operating income, $14.0 million of tax expense to the change in amortization, and $38.7 million of tax benefit related to acquisition and other non-acquisition related items.

93




As of September 25, 2015, September 26, 2014 and September 27, 2013, the amounts of unrecognized tax benefits for which the Company is legally and directly liable and would be required to remit cash if not sustained were $89.2 million, $82.0 million and $100.1 million, respectively. For periods prior to the Separation, the Company's operations had been included in tax returns filed by Covidien or certain of its subsidiaries not included in the Company's historical combined financial statements. As a result, some U.S. uncertain tax positions related to the Company's operations resulted in unrecognized tax benefits that are obligations of entities not included in the combined financial statements for periods prior to June 28, 2013. Because the activities that gave rise to these unrecognized tax benefits relate to the Company's operations, the impact of these items (presented in the table below) were charged to the income tax provision through parent company investment, which was a component of parent company equity in the combined balance sheets.
The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:
 
2015
 
2014
 
2013
Balance at beginning of fiscal year
$
82.0

 
$
100.1

 
$
165.5

Unrecognized tax benefits retained by Covidien
—

 
—

 
(153.7
)
Unrecognized tax benefits transferred from Covidien
—

 
—

 
84.2

Additions related to current year tax positions
4.5

 
3.2

 
3.5

Additions related to prior period tax positions
19.9

 
30.6

 
6.6

Reductions related to prior period tax positions
(7.7
)
 
(33.0
)
 
(4.3
)
Settlements
(7.8
)
 
(6.9
)
 
(1.6
)
Lapse of statute of limitations
(1.7
)
 
(12.0
)
 
(0.1
)
Balance at end of fiscal year
89.2

 
82.0

 
100.1


During fiscal 2015, the Company made a payment of $8.9 million ($7.4 million of tax and $1.5 million of interest) to the U.S. Internal Revenue Service ("IRS") in connection with the settlement of certain tax matters for 2008 and 2009. During fiscal 2014, the Company made a payment of $35.9 million ($27.3 million of tax and $8.6 million of interest) to the IRS in connection with the settlement of certain tax matters for 2005 through 2007.
Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:
 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
1.3

 
$
6.5

Other income tax liabilities
80.0

 
70.7

Deferred income taxes (non-current liability)
7.9

 
4.8

 
$
89.2

 
$
82.0


Included within total unrecognized tax benefits at September 25, 2015, September 26, 2014 and September 27, 2013, were $87.4 million, $82.0 million and $96.3 million, respectively, of unrecognized tax benefits, which if favorably settled would benefit the effective tax rate. The remaining unrecognized tax benefits for each period would be offset by the write-off of related deferred and other tax assets, if recognized. During fiscal 2015, the Company recorded $5.7 million of additional interest through tax provision and acquisition accounting and decreased interest $9.3 million related to cash payments related to settlements as well as reductions related to prior periods. During fiscal 2014 and 2013, the Company accrued additional interest of $7.0 million and $2.4 million, respectively. The total amount of accrued interest related to uncertain tax positions was $41.7 million, $45.1 million and $62.1 million, respectively.
It is reasonably possible that within the next twelve months, as a result of the resolution of various Domestic and International examinations and appeals and the expiration of various statutes of limitation, that the unrecognized tax benefits could decrease by up to $17.5 million. Interest and penalties could decrease by up to $8.8 million.
Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown.

94



 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
19.8

 
$
13.1

Other income tax liabilities
121.3

 
122.6

 
$
141.1

 
$
135.7

At September 25, 2015, other assets includes $52.2 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes $8.7 million of tax payments associated with current deferred intercompany transactions, and $81.3 million of receivables associated with tax payments on account with the taxing authorities. At September 26, 2014, other assets includes $14.8 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of $60.0 million associated with the Questcor acquisition and tax payments of $0.6 million associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.
 
September 25, 2015
 
September 26, 2014
Other assets
$
52.2

 
$
14.8

Prepaid expenses and other current assets
90.0

 
63.4

 
$
142.2

 
$
78.2


Covidien continues to be examined by various taxing authorities for periods the Company was included within the consolidated results of Covidien. In connection with the Separation, the Company entered into a tax matters agreement ("the Tax Matters Agreement") with Covidien that generally governs Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including, but not limited to, ordinary course of business taxes. For further information on the Tax Matters Agreement, refer to Note 17.
As of September 25, 2015, the earliest open year for U.S. federal and state tax jurisdictions is 1996. Additionally, a number of tax periods from 2009 to present are subject to examination by tax authorities in various jurisdictions, including Ireland, Luxembourg, Switzerland, and the U.K.
Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:
 
September 25, 2015
 
September 26, 2014
Deferred tax assets:
 
 
 
Accrued liabilities and reserves
$
92.5

 
$
68.9

Inventories
23.2

 
21.4

Tax loss and credit carryforwards
163.3

 
93.8

Environmental liabilities
23.6

 
29.5

Rebate reserves
48.5

 
41.1

Expired product
26.3

 
39.0

Postretirement benefits
33.8

 
34.5

Federal and state benefit of uncertain tax positions and interest
33.6

 
29.5

Share-based compensation
18.9

 
28.1

Intangible assets
105.7

 
9.6

Other
20.2

 
32.0

 
589.6

 
427.4

Deferred tax liabilities:
 
 
 
Property, plant and equipment
(140.1
)
 
(121.6
)
Intangible assets
(1,550.7
)
 
(2,177.9
)
Installment sale
(1,465.3
)
 
(93.6
)
Investment in partnership
(187.9
)
 
(191.3
)
 
(3,344.0
)
 
(2,584.4
)
Net deferred tax (liability) before valuation allowances
(2,754.4
)
 
(2,157.0
)
Valuation allowances
(233.0
)
 
(76.9
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)

95




Deferred taxes are reported in the following consolidated and combined balance sheet captions in the amounts shown:
 
September 25, 2015
 
September 26, 2014
Deferred income taxes (current asset)
$
142.7

 
$
152.3

Other non-current assets
7.0

 
13.4

Accrued and other current liabilities
(4.7
)
 
—

Deferred income taxes (non-current liability)
(3,132.4
)
 
(2,399.6
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)

The Company's current deferred tax asset decreased from $152.3 million at September 26, 2014 to $142.7 million at September 25, 2015 primarily due to changes in inventory valuation as a result of profits in intercompany inventory, the increase in deferred tax assets from the Ikaria Acquisition, and decreases to operational deferred tax assets due to normal operating activities. Additionally, the Company's non-current deferred tax liability increased from $2,399.6 million at September 26, 2014 to $3,132.4 million at September 25, 2015, primarily due to $623.6 million related to the Ikaria Acquisition, $324.3 million related to the Therakos Acquisition, offset by $54.3 million of decreases associated with the amortization of intangibles, $105.4 million of decreases associated with the payment of internal installment sale obligations, and approximately $44.0 million of decreases related to other impacts of recent acquisitions and integration.

The Ikaria Acquisition resulted in a net deferred tax liability increase of $596.9 million. Significant components of this increase include $620.2 million of deferred tax liabilities associated with intangibles and $17.5 million of deferred tax liability associated with property, plant and equipment, partially offset by $21.7 million of deferred tax assets associated with U.S. tax credits, $13.1 million of deferred tax assets associated with financing repayments and $4.9 million of deferred tax assets associated with U.S. net operating losses.
The Therakos Acquisition resulted in a net deferred tax liability increase of $324.3 million. Significant components of this increase include $334.1 million of deferred tax liabilities associated with intangibles partially offset by $13.5 million of deferred tax assets predominately associated with U.S. net operating losses.

As a part of the Questcor integration, the Company entered into an internal installment sale transaction during the three months ended December 26, 2014. The Questcor internal installment sale transaction resulted in a decrease of $1,488.7 million to the deferred tax liability associated with the Acthar intangible asset, a $1,515.9 million increase to the deferred tax liability associated with an installment sale note receivable, a $25.3 million increase to deferred tax charge, and a $1.9 million increase to prepaid taxes.
At September 25, 2015, the Company had approximately $126.0 million of net operating loss carryforwards in certain non-U.K. jurisdictions, of which $91.4 million have no expiration and the remaining $34.6 million will expire in future years through 2025. The Company had $19.6 million of U.K. net operating loss carryforwards at September 25, 2015, which have no expiration date.
At September 25, 2015 the Company also had $16.3 million of tax credits available to reduce future income taxes payable, primarily in jurisdictions within the U.S., of which $3.1 million have no expiration and the remainder expire during fiscal 2016 through 2034.
The deferred tax asset valuation allowances of $233.0 million and $76.9 million at September 25, 2015 and September 26, 2014, respectively, relate principally to the uncertainty of the utilization of certain deferred tax assets, primarily International net operating losses and intangible assets. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets.
The tax residency change impacts the Company’s analysis of its cumulative unrepatriated earnings. As of September 25, 2015, the cumulative amount of undistributed earnings of the Company's subsidiaries that may be subject to tax, but are considered to be indefinitely reinvested, was $369.0 million. It is not practicable to determine the cumulative amount of tax liability that would arise if these indefinitely reinvested earnings were remitted due to a variety of factors including the complexity of the Company's global legal entity structure as well as the timing, extent, and nature of any hypothetical repatriation of unremitted earnings. The net decrease in such undistributed earnings as compared to the period ended September 26, 2014 was attributable to the impact of the tax residency change and associated jurisdictions that could be remitted in a tax-free manner as well as the removal of the earnings for the entities classified as held for sale. These decreases were partially offset by an increase in unrepatriated earnings associated with income and losses attributed to the current year activity.

The Company has accrued a $0.7 million deferred tax liability associated with approximately $13.4 million of unrepatriated earnings that are not indefinitely reinvested on assets from continuing operations. The Company has also accrued a $6.5 million

96



deferred tax liability associated with approximately $41.3 million of unrepatriated earnings that are not indefinitely reinvested related to assets held for sale.

8.
Earnings (Loss) per Share

In fiscal 2015 and 2014, basic and diluted earnings (loss) per share were computed using the two-class method. The two-class method is an earnings allocation that determines earnings per share for each class of common stock and participating securities according to dividends declared and participation rights in undistributed earnings. The Company’s restricted stock awards, issued in conjunction with the Questcor Acquisition in August 2014, are considered participating securities as holders are entitled to receive non-forfeitable dividends during the vesting term. Diluted earnings per share includes securities that could potentially dilute basic earnings per share during a reporting period, for which the Company includes all share-based compensation awards other than participating securities. Dilutive securities, including participating securities, are not included in the computation of loss per share when the Company reports a net loss from continuing operations as the impact would be anti-dilutive.
In periods prior to fiscal 2014, basic earnings (loss) per share was computed by dividing net income by the number of weighted-average shares outstanding during the period. Diluted earnings (loss) per share was computed using the weighted-average shares outstanding and, if dilutive, potential ordinary shares outstanding during the period. Potential ordinary shares represent the incremental ordinary shares issuable for restricted share units and share option exercises. The Company calculated the dilutive effect of outstanding restricted share units and share options on earnings (loss) per share by application of the treasury stock method.
The computations of basic and diluted earnings (loss) per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien. The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.
 
2015
 
2014
 
2013
Earnings (loss) per share numerator:
 
 
 
 
 
Income (loss) from continuing operations attributable to common shareholders before allocation of earnings to participating securities
$
308.2

 
$
(143.8
)
 
$
8.2

Less: earnings allocated to participating securities
2.5

 
—

 
—

Income (loss) from continuing operations attributable to common shareholders, after earnings allocated to participating securities
305.7

 
(143.8
)
 
8.2

 
 
 
 
 
 
Income (loss) from discontinued operations
16.5

 
(175.5
)
 
50.6

Less: earnings from discontinued operations allocated to participating securities
0.1

 
—

 
—

Income (loss) from discontinued operations attributable to common shareholders, after allocation of earnings to participating securities
16.4

 
(175.5
)
 
50.6

Net income (loss) attributable to common shareholders, after allocation of earnings to participating securities
$
322.1

 
$
(319.3
)
 
$
58.8

Earnings (loss) per share denominator:
 
 
 
 
 
Weighted-average shares outstanding - basic
115.8

 
64.9

 
57.7

Impact of dilutive securities
1.4

 
—

 
0.1

Weighted-average shares outstanding - diluted
117.2

 
64.9

 
57.8

Basic earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.64

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.78

 
$
(4.92
)
 
$
1.02

Diluted earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.61

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.75

 
$
(4.92
)
 
$
1.02


The computation of diluted earnings per share for fiscal 2015, 2014 and 2013 excludes approximately 0.1 million, 5.7 million and 0.5 million, respectively, of equity awards because the effect would have been anti-dilutive. As the Company incurred a net loss in

97



fiscal 2014, there was no allocation of the undistributed loss to participating securities because the effect would have been anti-dilutive to basic and diluted earnings per share.

9.
Inventories
Inventories are comprised of the following at the end of each period: 
 
September 25,
2015
 
September 26,
2014
Raw materials and supplies
$
66.3

 
$
57.5

Work in process
124.2

 
184.7

Finished goods
91.3

 
64.2

Inventories
$
281.8

 
$
306.4



10.
Property, Plant and Equipment
The gross carrying amount and accumulated depreciation of property, plant and equipment at the end of each period was as follows:
 
September 25, 2015
 
September 26, 2014
Land
$
49.8

 
$
47.3

Buildings
333.7

 
289.4

Capitalized software
120.2

 
94.5

Machinery and equipment
1,220.0

 
1,041.6

Construction in process
146.9

 
196.2

 
1,870.6

 
1,669.0

Less: accumulated depreciation
(879.3
)
 
(782.2
)
Property, plant and equipment, net
$
991.3

 
$
886.8


The amounts above include property under capital leases of $14.8 million and $16.9 million at September 25, 2015 and September 26, 2014, respectively, consisting primarily of buildings. Accumulated amortization of capitalized leased assets was $14.6 million and $15.8 million at the end of fiscal 2015 and 2014, respectively.
Depreciation expense, including amounts related to capitalized leased assets, for continuing operations was $103.9 million, $94.7 million and $88.1 million for fiscal 2015, 2014 and 2013, respectively.

Long-Lived Asset Impairment Analysis
In fiscal 2014, the Company recorded long-lived asset impairment charges related to our CMDS asset group. During the fourth quarter of fiscal 2014, the Company received notification that we lost preferred supplier status with a significant group purchasing organization ("GPO") and that a related-party supply contract was terminated by the Company. The Company determined that these events constituted a triggering event with respect to our CMDS asset group assessed the recoverability of the CMDS asset group. The Company determined that the undiscounted cash flows of this asset group were less than its net book value. This would require the Company to record an impairment charge if the fair value of the CMDS asset group was less than its net book value.
The Company determined the fair value of the CMDS asset group using the income approach, a level three measurement technique. For purposes of determining fair value the Company made various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a weighted-average cost of capital ("WACC") determined from relevant market comparisons, adjusted upward for specific risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the asset group represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows.

98



The Company's projections in the CMDS asset group included long-term net sales and operating income at lower than historical levels. The decrease in net sales and operating income is reflective of the notification of the loss of a significant customer, termination of a supply contract with a related party and increased competition in the marketplace. The Company utilized a WACC of 8.0%, which reflects the lower inherent risk with the decreasing revenue trends. These assumptions resulted in a fair value of the CMDS asset group that was less than its net book value. Therefore, the Company recorded impairment charges of $65.9 million and $52.4 million to the property, plant and equipment and long-lived amortizing intangible assets, respectively, included in the CMDS asset group. The Company announced that it had entered into a definitive agreement to sell its CMDS business, therefore the business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified $51.4 million of the impairment charge associated with property, plant and equipment to discontinued operations as certain assets are expected to be retained by the Company based upon the terms of the Company's agreement with Guerbet. The Company reclassified $52.4 million of the impairment charge associated with intangible assets to discontinued operations.


11.
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill by segment were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated Impairment
 
Gross
Carrying
Amount
 
Accumulated Impairment
Specialty Brands
$
3,442.4

 
$
—

 
$
2,194.9

 
$
—

Specialty Generics
207.0

 
—

 
207.0

 
—

Nuclear Imaging
119.5

 
(119.5
)
 
119.5

 
(119.5
)
Total
$
3,768.9

 
$
(119.5
)
 
$
2,521.4

 
$
(119.5
)

During the fiscal year ended September 25, 2015, the gross carrying value of goodwill in the Specialty Brands segment increased by $1,247.5 million, attributable to $792.4 million from the Ikaria Acquisition, $437.2 million from the Therakos Acquisition and $17.9 million resulting from adjustments to the Questcor Acquisition purchase price allocation.

Goodwill Impairment Analysis
The Company has identified the Specialty Brands, Specialty Generics and the Nuclear Imaging businesses as representing both segments and reporting units. For purposes of assessing impairment and the recoverability of goodwill for each reporting unit the Company makes various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a WACC determined from relevant market comparisons, adjusted upward for specific reporting unit risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the reporting unit represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows. The fair values of the reporting units were assessed for reasonableness by aggregating the fair values and comparing this to the Company's market capitalization with a control premium.
The Company's projections in its Specialty Brands reporting unit include long-term revenue and operating income at levels higher than historical levels, which is primarily associated with revenue growth for Acthar, Inomax and Ofirmev. The projections also reflect the potential impacts from the future loss of exclusivity related to Ofirmev. The Company utilized a WACC of 12.0%. These assumptions resulted in a fair value of the Specialty Brands reporting unit in excess of its net book value. Should the Specialty Brands reporting unit fail to experience growth in the aforementioned products, revise its long-term projections for these products downward or market conditions dictate utilization of higher discount rates, the Specialty Brands reporting unit could be subject to impairment in future periods.
The Company's projections in its Specialty Generics and API reporting unit include long-term revenue and operating income at levels lower than historical levels primarily attributable to increased competition. The Company utilized a WACC of 11.0%. These assumptions resulted in a fair value of the Specialty Generics and API reporting unit in excess of its net book value.
In fiscal 2014, the Company recorded goodwill impairment charges related to our former Global Medical Imaging reporting unit (which included the CMDS business that is now included within discontinued operations and the remaining Nuclear Imaging reporting unit). The Company recorded an impairment charge related to goodwill in fiscal 2014 of $219.7 million, which eliminated all goodwill balances related to the Global Medical Imaging reporting unit. In fiscal 2015, the Company announced that it had entered into a

99



definitive agreement to sell its CMDS business, therefore the business was deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified $100.2 million of the impairment charge to discontinued operations.
The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Amortizable:
 
 
 
 
 
 
 
Completed technology
$
9,896.0

 
$
765.8

 
$
6,906.0

 
$
235.6

Licenses
185.1

 
99.8

 
185.1

 
87.3

Customer relationships
28.1

 
4.4

 
33.8

 
0.6

Trademarks
82.1

 
6.2

 
13.0

 
4.1

Other
6.7

 
6.7

 
6.7

 
5.0

Total
$
10,198.0

 
$
882.9

 
$
7,144.6

 
$
332.6

Non-Amortizable:
 
 
 
 
 
 
 
Trademarks
$
35.0

 
 
 
$
35.0

 
 
In-process research and development
316.2

 
 
 
235.2

 
 
Total
$
351.2

 
 
 
$
270.2

 
 

Finite-lived intangible asset amortization expense within continuing operations was $550.3 million, $154.8 million and $27.9 million in fiscal 2015, 2014 and 2013, respectively. The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:
 
 
Fiscal 2016
$
693.7

Fiscal 2017
691.9

Fiscal 2018
682.9

Fiscal 2019
682.6

Fiscal 2020
682.0




100



12.
Debt
Debt was comprised of the following at the end of each period:
 
September 25, 2015
 
September 26, 2014
 
Principal
 
Unamortized Discount and Debt Issuance Costs
 
Principal
 
Unamortized Discount and Debt Issuance Costs
Current maturities of long-term debt:
 
 
 
 
 
 
 
2.85% term loan due April 2016
$
—

 
$
—

 
$
0.4

 
$
—

Term loans due March 2021
20.0

 
—

 
18.2

 
—

4.00% term loan due February 2022
1.0

 
—

 
1.2

 
—

Capital lease obligation and vendor financing agreements
1.3

 
—

 
1.4

 
—

Total current debt
22.3

 
—

 
21.2

 
—

Long-term debt:
 
 
 
 
 
 
 
Variable rate receivable securitization
153.0

 
0.8

 
150.0

 
1.0

2.85% term loan due April 2016
—

 
—

 
2.7

 
—

3.50% notes due April 2018
300.0

 
1.7

 
300.0

 
2.4

4.88% notes due April 2020
700.0

 
11.3

 
—

 
—

Term loans due March 2021
1,958.5

 
44.1

 
1,978.5

 
52.4

4.00% term loan due February 2022
6.9

 
—

 
9.6

 
—

9.50% debentures due May 2022
10.4

 
—

 
10.4

 
—

5.75% notes due August 2022
900.0

 
14.4

 
900.0

 
16.4

8.00% debentures due March 2023
4.4

 
—

 
8.0

 
—

4.75% notes due April 2023
600.0

 
7.1

 
600.0

 
7.9

5.625% notes due October 2023
750.0

 
13.7

 
—

 
—

5.50% notes due April 2025
700.0

 
11.9

 
—

 
—

Revolving credit facility
500.0

 
4.9

 
—

 
5.5

Capital lease obligation and vendor financing agreements
1.0

 
—

 
0.4

 
—

Total long-term debt
6,584.2

 
109.9

 
3,959.6

 
85.6

Total debt
$
6,606.5

 
$
109.9

 
$
3,980.8

 
$
85.6


In November 2012, Mallinckrodt International Finance S.A. ("MIFSA") was formed as a 100% owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations. At the time of the Separation, MIFSA became a 100% owned subsidiary of the Company.
In April 2013, MIFSA issued $300.0 million aggregate principal amount of 3.50% senior unsecured notes due April 2018 and $600.0 million aggregate principal amount of 4.75% senior unsecured notes due April 2023 (collectively, "the Notes"). Mallinckrodt plc has fully and unconditionally guaranteed the Notes on an unsecured and unsubordinated basis. The Notes are subject to an indenture which contains covenants limiting the ability of MIFSA, its restricted subsidiaries (as defined in the Notes) and Mallinckrodt plc, as guarantor, to incur certain liens or enter into sale and lease-back transactions. It also restricts Mallinckrodt plc and MIFSA's ability to merge or consolidate with any other person or sell or convey all or substantially all of their assets to any one person. MIFSA may redeem all of the Notes at any time, and some of the Notes from time to time, at a redemption price equal to the principal amount of the Notes redeemed plus a make-whole premium. MIFSA will pay interest on the Notes semiannually in arrears on April 15 and October 15 of each year, which commenced on October 15, 2013. The net proceeds to MIFSA from the issuance and sale of the Notes was $889.3 million, the majority of which was retained by Covidien per the terms of the Separation and Distribution Agreement.
In March 2014, MIFSA and Mallinckrodt CB LLC ("MCB"), each a wholly-owned subsidiary of the Company, entered into senior secured credit facilities consisting of a $1.3 billion term loan facility due 2021 ("the Term Loan") and a $250.0 million revolving credit facility due 2019 ("the Revolver") (collectively, "the Facilities"). The Facilities are fully and unconditionally guaranteed by Mallinckrodt plc, certain of its direct or indirect wholly-owned U.S. subsidiaries and each of its direct or indirect wholly-owned subsidiaries that owns directly or indirectly any such wholly-owned U.S. subsidiary (collectively, "the Guarantors"). The Facilities are secured by a security interest in certain assets of MIFSA, MCB and the Guarantors. The Facilities contain customary affirmative and negative covenants, which include, among other things, restrictions on the Company's ability to declare or pay

101



dividends, create liens, incur additional indebtedness, enter into sale and lease-back transactions, make investments, dispose of assets and merge or consolidate with any other person. In addition, the Revolver contains a financial covenant that may limit the Company's total net debt leverage ratio, which is defined as the ratio of (i) the Company's consolidated debt, less any unrestricted cash and cash equivalents, to (ii) the Company's adjusted consolidated EBITDA, as defined in the credit agreement. The Facilities bear interest at LIBOR plus a margin based on the Company's total net debt leverage ratio, and the Term Loan is subject to a minimum LIBOR level of 0.75%. Interest payment dates are variable based on the LIBOR rate utilized, but the Company generally expects interest to be payable every 90 days. The Term Loan requires quarterly principal amortization payments in an amount equal to 0.25% of the original principal amount of the Term Loan payable on the last day of each calendar quarter, which commenced on June 30, 2014, with the remaining balance payable on the due date, March 19, 2021. The Company incurred an original issue discount of 0.25%, or $3.3 million, associated with the Term Loan. The Revolver contains a $150.0 million letter of credit provision, of which none had been issued as of September 25, 2015. On August 28, 2015, in connection with the Therakos Acquisition, Mallinckrodt Enterprises LLC and Mallinckrodt plc, two wholly owned subsidiaries of Mallinckrodt plc, MIFSA and MCB, entered into a $250.0 million replacement revolving credit facility (the “2015 Replacement Revolving Credit Facility”), which refinanced and replaced in full the existing revolving credit facility, and an additional $250.0 million incremental revolving credit facility (the “2015 Incremental Revolving Credit Facility” and, together with the 2015 Replacement Revolving Credit Facility, the “2015 Revolving Credit Facility”), such that the 2015 Revolving Credit Facility has an aggregate facility size of $500.0 million. Unused commitments on the 2015 Revolving Credit Facility are subject to an annual commitment fee, which was 0.275% as of September 25, 2015, and the fee applied to outstanding letters of credit is based on the interest rate applied to borrowings. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the 2015 Revolving Credit Facility was 2.6%, and outstanding borrowings totaled $500.0 million.
In July 2014, Mallinckrodt Securitization S.À.R.L. ("Mallinckrodt Securitization"), a wholly-owned special purpose subsidiary of the Company, entered into a $160.0 million accounts receivable securitization facility that matures in July 2017 ("the Receivable Securitization"). In January 2015, Mallinckrodt Securitization amended the Receivable Securitization with third-party lenders to increase the borrowing limit from $160.0 million to $250.0 million. The terms of the Receivable Securitization, and the determination of interest rates, were largely unchanged. Mallinckrodt Securitization may, from time to time, obtain up to $250.0 million in third-party borrowings secured by certain receivables, which may be increased to $300.0 million upon approval of the third-party lenders, subject to certain conditions. The Receivable Securitization agreements contain customary representations, warranties and affirmative and negative covenants.The borrowings under the Receivable Securitization are to be repaid as the secured receivables are collected. Loans under the Receivable Securitization will bear interest (including facility fees) at a rate equal to one month LIBOR rate plus a margin of 0.80%. Unused commitments on the Receivables Securitization are subject to an annual commitment fee of 0.35%. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the Receivable Securitization was 0.99% and outstanding borrowings totaled $153.0 million.
In August 2014, MIFSA and MCB issued $900.0 million aggregate principal amount of 5.75% senior unsecured notes due August 1, 2022 ("the 2022 Notes”). The 2022 Notes are guaranteed on an unsecured basis by certain of MIFSA's subsidiaries. The 2022 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2022 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of Mallinckrodt plc and its subsidiaries. MIFSA may redeem some or all of the 2022 Notes prior to August 1, 2017 by paying a make-whole premium. MIFSA may redeem some or all of the 2022 Notes on or after August 1, 2017 at specified redemption prices. In addition, prior to August 1, 2017, MIFSA may redeem up to 40% of the aggregate principal amount of the 2022 Notes with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase the 2022 Notes at a price of (a) 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain asset sales. These obligations are subject to certain qualifications and exceptions. MIFSA pays interest on the 2022 Notes semiannually in arrears on February 1 and August 1 of each year, commencing on February 1, 2015.
In August 2014, MIFSA and MCB entered into a $700.0 million senior secured term loan facility ("the New Term Loan”). The New Term Loan is an incremental tranche under the credit agreement governing our existing Term Loan and Revolver, entered into in March 2014, (collectively, with the New Term Loan, represent "the Senior Secured Credit Facilities"). New Term Loan has substantially similar terms to the Term Loan (other than pricing); including the determination of interest rates and quarterly principal amortization payments equal to 0.25% of the original principal amount of the New Term Loan. The quarterly principal payments commenced on December 31, 2014, with the remaining balance payable on the due date of March 19, 2021. Mallinckrodt plc and its subsidiaries (other than MIFSA, MCB and the subsidiaries of MIFSA that guarantee the Facilities) will not guarantee the New Term Loan, and the New Term Loan will not be secured by the assets of such entities. The August 2014 Term Loan bears interest under substantially similar terms of the March 2014 Term Loan, including the use of LIBOR rates with a minimum floor, except that the margin applied to LIBOR is not dependent upon the Company's total net debt leverage ratio.
On April 15, 2015, MIFSA and MCB issued $700.0 million aggregate principal amount of 4.875% senior unsecured notes due April 15, 2020 ("the 2020 Notes") and $700.0 million aggregate principal amount of 5.50% senior unsecured notes due April 15, 2025 ("the 2025 Notes", and together with the 2020 Notes, the "Ikaria Notes"). The Ikaria Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries that guarantee the obligations under the Facilities, which following the Ikaria Acquisition includes Compound

102



Holdings II, Inc. and its U.S. subsidiaries. The Ikaria Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the Ikaria Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the (i) 2020 Notes prior to April 15, 2017 and (ii) 2025 Notes prior to April 15, 2020, in each case, by paying a “make-whole” premium. The Issuers may redeem some or all of the (i) 2020 Notes on or after April 15, 2017 and (ii) 2025 Notes on or after April 15, 2020, in each case, at specified redemption prices. In addition, prior to (i) April 15, 2017, in the case of the 2020 Notes, and (ii) April 15, 2018, in the case of the 2025 Notes, the Issuers may redeem up to 40% of the aggregate principal amount of the 2020 Notes or 2025 Notes, as the case may be, with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase (a) each series of Notes at a price of 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) the Notes at a price of 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the Ikaria Notes semiannually on April 15th and October 15th of each year, commencing on October 15, 2015.
On September 24, 2015, in connection with the Therakos Acquisition, MIFSA and MCB issued $750.0 million aggregate principal amount of 5.625% senior unsecured notes due October 2023 (the “2023 Notes”). The Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries under the Facilities, which following the Therakos Acquisition includes TGG Medical Solutions, Inc. and its U.S. subsidiaries. The 2023 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2023 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the 2023 Notes on or after October 15, 2018 at specified redemption prices. In addition, prior to October 15, 2018, the Issuers may redeem up to 40% of the aggregate principal amount of the 2023 Notes with the net proceeds of certain equity offerings. The Issuers may also redeem all, but not less than all, of the Notes at any time at a price of 100% of their principal amount, plus accrued and unpaid interest, if any, in the event the Issuers become obligated to pay additional amounts as a result of changes affecting certain withholding tax laws applicable to payments on the Notes. The Issuers are obligated to offer to repurchase the 2023 Notes (a) at a price of 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) the 2023 Notes at a price of 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the 2023 Notes semiannually on April 15th and October 15th of each year, commencing on April 15, 2016.
As of September 25, 2015, the applicable interest rate for the Term Loan and New Term Loan were 3.25% and 3.50%, respectively, and outstanding principal under these agreements totaled approximately $1,978.5 million.
The aggregate amounts of debt, including the capital lease obligation, maturing during the next five fiscal years are as follows:
Fiscal 2016
$
22.3

Fiscal 2017
175.0

Fiscal 2018
321.2

Fiscal 2019
521.2

Fiscal 2020
721.2



13.
Retirement Plans
Defined Benefit Plans
The Company sponsors a number of defined benefit retirement plans covering certain of its U.S. employees and non-U.S. employees. As of September 25, 2015, U.S. plans represented 70.6% of the Company's total pension plan assets and 73.1% of the Company's projected benefit obligation. The Company generally does not provide postretirement benefits other than retirement plan benefits for its employees; however, certain of the Company's U.S. employees participate in postretirement benefit plans that provide medical benefits. These plans are unfunded.

103



The net periodic benefit cost (credit) for the Company's pension and postretirement benefit plans was as follows:
 
Pension Benefits
 
Postretirement Benefits
 
Fiscal Year
 
Fiscal Year
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Service cost
$
4.5

 
$
5.1

 
$
5.0

 
$
0.1

 
$
0.1

 
$
0.1

Interest cost
17.5

 
19.6

 
18.2

 
1.9

 
2.1

 
2.4

Expected return on plan assets
(22.6
)
 
(24.6
)
 
(29.6
)
 
—

 
—

 
—

Amortization of net actuarial loss
9.4

 
8.1

 
12.3

 
—

 
—

 
0.3

Amortization of prior service cost
(0.6
)
 
(0.6
)
 
0.6

 
(4.0
)
 
(9.3
)
 
(9.1
)
Loss on plan settlements
6.0

 
3.8

 
6.8

 
—

 
—

 
—

Net periodic benefit cost (credit)
$
14.2

 
$
11.4

 
$
13.3

 
$
(2.0
)
 
$
(7.1
)
 
$
(6.3
)

The following table represents the changes in benefit obligations, plan assets and the net amounts recognized on the consolidated balance sheets for pension and postretirement benefit plans at the end of fiscal 2015 and 2014:
 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Change in benefit obligation:
 
 
 
 
 
 
 
Projected benefit obligations at beginning of year
$
538.4

 
$
501.7

 
$
52.0

 
$
53.2

Service cost
4.5

 
5.1

 
0.1

 
0.1

Interest cost
17.5

 
19.6

 
1.9

 
2.1

Employee contributions
0.6

 
0.6

 
—

 
—

Actuarial (gain) loss
(4.5
)
 
60.0

 
2.1

 
0.5

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Net transfer in/(out)
0.6

 
—

 
—

 
—

Currency translation
(18.9
)
 
(9.1
)
 
—

 
—

Projected benefit obligations at end of year
$
493.5

 
$
538.4

 
$
52.2

 
$
52.0

 
 
 
 
 
 
 
 
Change in plan assets:
 
 
 
 
 
 
 
Fair value of plan assets at beginning of year
$
473.6

 
$
456.0

 
$
—

 
$
—

Actual return on plan assets
12.5

 
59.7

 
—

 
—

Employer contributions
13.0

 
4.9

 
3.9

 
3.9

Employee contributions
0.6

 
0.6

 
—

 
—

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Currency translation
(17.1
)
 
(8.1
)
 
—

 
—

Fair value of plan assets at end of year
$
437.9

 
$
473.6

 
$
—

 
$
—

Funded status at end of year
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)


104



 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Amounts recognized on the consolidated balance sheet:
 
 
 
 
 
 
 
Non-current assets
$
20.1

 
$
9.8

 
$
—

 
$
—

Current liabilities
(6.6
)
 
(2.7
)
 
(4.6
)
 
(4.8
)
Non-current liabilities
(69.1
)
 
(71.9
)
 
(47.6
)
 
(47.2
)
Net amount recognized on the consolidated balance sheet
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)
 
 
 
 
 
 
 
 
Amounts recognized in accumulated other comprehensive income consist of:
 
 
 
 
 
 
 
Net actuarial loss
$
(104.1
)
 
$
(115.1
)
 
$
(5.1
)
 
$
(2.9
)
Prior service credit
5.5

 
6.9

 
14.9

 
18.8

Net amount recognized in accumulated other comprehensive income
$
(98.6
)
 
$
(108.2
)
 
$
9.8

 
$
15.9


The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit cost (credit) in fiscal 2016 are as follows:
 
Pension Benefits
 
Postretirement Benefits
Amortization of net actuarial loss
$
10.8

 
$
—

Amortization of prior service cost
(0.5
)
 
(2.1
)

The accumulated benefit obligation for all pension plans at the end of fiscal 2015 and 2014 was $489.4 million and $533.6 million, respectively. Additional information related to pension plans is as follows:
 
2015
 
2014
Pension plans with accumulated benefit obligations in excess of plan assets:
 
 
 
Accumulated benefit obligation
$
368.8

 
$
394.7

Fair value of plan assets
294.1

 
321.6


The accumulated benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets do not significantly differ from the amounts in the table above since substantially all of the Company's pension plans are frozen.

Actuarial Assumptions
Weighted-average assumptions used each fiscal year to determine net periodic benefit cost for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.8
%
 
4.2
%
 
3.5
%
 
2.5
%
 
3.5
%
 
4.0
%
Expected return on plan assets
6.0
%
 
6.5
%
 
7.9
%
 
2.9
%
 
3.1
%
 
3.5
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.2
%
 
3.5
%
 
3.7
%

Weighted-average assumptions used each fiscal year to determine benefits obligations for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.9
%
 
3.9
%
 
4.3
%
 
2.5
%
 
2.5
%
 
3.7
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.6
%
 
3.4
%
 
3.5
%

105



For the Company's U.S. plans, the discount rate is based on the market rate for a broad population of Moody's AA-rated corporate bonds over $250.0 million. For the Company's non-U.S. plans, the discount rate is generally determined by reviewing country and region specific government and corporate bond interest rates.
In determining the expected return on pension plan assets, the Company considers the relative weighting of plan assets by class and individual asset class performance expectations as provided by external advisors in reaching conclusions on appropriate assumptions. The investment strategy for the pension plans is to obtain a long-term return on plan assets that is consistent with the level of investment risk that is considered appropriate. Investment risks and returns are reviewed regularly against benchmarks to ensure objectives are being met.
The weighted-average discount rate used to determine net periodic benefit cost and obligations for the Company's postretirement benefit plans are as follows:
 
2015
 
2014
 
2013
Net periodic benefit cost
3.6
%
 
4.0
%
 
3.2
%
Benefit obligations
3.9
%
 
3.7
%
 
4.0
%

Healthcare cost trend assumptions for postretirement benefit plans are as follows:
 
2015
 
2014
Healthcare cost trend rate assumed for next fiscal year
7.1
%
 
7.1
%
Rate to which the cost trend rate is assumed to decline
4.5
%
 
4.5
%
Fiscal year the ultimate trend rate is achieved
2029

 
2029


A one-percentage-point change in assumed healthcare cost trend rates would have the following effects:
 
One-Percentage-Point Increase
 
One-Percentage-Point Decrease
Effect on total of service and interest cost
$
—

 
$
—

Effect on postretirement benefit obligation
0.8

 
(0.7
)

Plan Assets
The Company's U.S. pension plans have a target allocation of 24% equity securities and 76% debt securities. Various asset allocation strategies are in place for non-U.S. pension plans depending upon local law, status, funding level and duration of liabilities, and are 39% equity securities, 55% debt securities and 6% other (primarily cash) for our Japanese pension plan and 10% equity securities, 2% debt securities and 88% other (primarily insurance contracts) for our plan in the Netherlands.
Pension plans have the following weighted-average asset allocations at the end of each fiscal year:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2015
 
2014
Equity securities
27
%
 
28
%
 
6
%
 
8
%
Debt securities
70

 
70

 
1

 
2

Cash and cash equivalents
3

 
1

 
—

 
—

Other
—

 
1

 
93

 
90

Total
100
%
 
100
%
 
100
%
 
100
%


106



The following tables provide a summary of plan assets held by the Company's pension plans that are measured at fair value on a recurring basis at the end of fiscal 2015 and 2014:
 
 
 
Basis of Fair Value Measurement
 
Fiscal 2015
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
15.1

 
$
15.1

 
$
—

 
$
—

U.S. large cap
46.2

 
46.2

 
—

 
—

International
31.0

 
22.7

 
8.3

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
198.4

 
196.9

 
1.5

 
—

High yield bonds
11.3

 
11.3

 
—

 
—

Emerging market funds
7.4

 
7.4

 
—

 
—

Insurance contracts
116.7

 
—

 
—

 
116.7

Other
11.8

 
9.4

 
2.4

 
—

Total
$
437.9

 
$
309.0

 
$
12.2

 
$
116.7


 
 
 
Basis of Fair Value Measurement
 
Fiscal 2014
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
16.6

 
$
16.6

 
$
—

 
$
—

U.S. large cap
50.2

 
50.2

 
—

 
—

International
39.8

 
28.7

 
11.1

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
218.7

 
216.6

 
2.1

 
—

High yield bonds
13.0

 
13.0

 
—

 
—

Emerging market funds
9.5

 
9.5

 
—

 
—

Insurance contracts
119.8

 
—

 
—

 
119.8

Other
6.0

 
2.6

 
3.4

 
—

Total
$
473.6

 
$
337.2

 
$
16.6

 
$
119.8

(1)
Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds.

Equity securities. Equity securities primarily consist of mutual funds with underlying investments in foreign equity and domestic equity markets. The fair value of these investments is based on net asset value of the units held in the respective fund, which are determined by obtaining quoted prices on nationally recognized securities exchanges (level 1) or through net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).
Debt securities. Debt securities are primarily invested in mutual funds with underlying fixed income investments in U.S. government and corporate debt, U.S. dollar denominated foreign government and corporate debt, asset-backed securities, mortgage-backed securities and U.S. agency bonds. The fair value of these investments is based on the net asset value of the units held in the respective fund which are determined by obtaining quoted prices on nationally recognized securities exchanges.
Insurance contracts. Insurance contracts held by the Company are issued primarily by Delta Lloyd, a well-known, highly rated insurance company. The fair value of these insurance contracts is based upon the present value of future cash flows under the terms of the contracts and therefore the fair value of these assets has been classified as level 3 within the fair value hierarchy. Significant assumptions used in determining the fair value of these contracts are the amount and timing of future cash flows and counterparty credit risk. The objective of the insurance contracts is to provide the Company with future cash flows that will match the estimated timing and amount of future pension benefit payments. Delta Lloyd's insurance subsidiaries have a Standard & Poor's credit rating of A.

107



Other. Other includes cash and cash equivalents invested in a money market mutual fund, the fair value of which is determined by obtaining quoted prices on nationally recognized securities exchanges (level 1). In addition, other includes real estate funds, the fair value of which is determined using other inputs, such as net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).
The following table provides a summary of the changes in the fair value measurements that used significant unobservable inputs (level 3) for fiscal 2015 and 2014:
 
Insurance Contracts
Balance at September 27, 2013
$
112.0

Net unrealized gains
15.5

Net purchases, sales and issuances
(0.6
)
Currency translation
(7.1
)
Balance at September 26, 2014
119.8

Net unrealized gains
12.2

Net purchases, sales and issuances
(0.1
)
Currency translation
(15.2
)
Balance at September 25, 2015
$
116.7


Mallinckrodt shares are not a direct investment of the Company's pension funds; however, the pension funds may indirectly include Mallinckrodt shares. The aggregate amount of the Mallinckrodt shares are not material relative to the total pension fund assets.

Contributions
The Company's funding policy is to make contributions in accordance with the laws and customs of the various countries in which the Company operates, as well as to make discretionary voluntary contributions from time to time. In fiscal 2015 and 2014, the Company made $13.0 million and $4.9 million in contributions, respectively, to the Company's pension plans. The Company does not anticipate making material involuntary contributions in fiscal 2016, but may elect to make voluntary contributions to its defined pension plans or its postretirement benefit plans during fiscal 2016.
 
Expected Future Benefit Payments
Benefit payments expected to be paid, reflecting future expected service as appropriate, are as follows:
 
Pension Benefits
 
Postretirement Benefits
Fiscal 2016
$
40.0

 
$
4.6

Fiscal 2017
33.6

 
4.3

Fiscal 2018
33.0

 
4.0

Fiscal 2019
32.6

 
3.8

Fiscal 2020
31.4

 
3.5

Fiscal 2021 - 2025
143.9

 
15.6


Defined Contribution Retirement Plans
The Company maintains one active tax-qualified 401(k) retirement plan and one active non-qualified deferred compensation plan in the U.S. The 401(k) retirement plan provides for an automatic Company contribution of three percent of an eligible employee's pay, with an additional Company matching contribution generally equal to 50% of each employee's elective contribution to the plan up to six percent of the employee's eligible pay. The deferred compensation plan permits eligible employees to defer a portion of their compensation. Total defined contribution expense related to continuing operations was $23.7 million, $20.5 million and $20.3 million for fiscal 2015, 2014 and 2013, respectively.


108



Rabbi Trusts and Other Investments
The Company maintains several rabbi trusts, the assets of which are used to pay retirement benefits. The rabbi trust assets are subject to the claims of the Company's creditors in the event of the Company's insolvency. Plan participants are general creditors of the Company with respect to these benefits. The trusts primarily hold life insurance policies and debt and equity securities, the value of which is included in other assets on the consolidated balance sheets. Note 20 provides additional information regarding the debt and equity securities. The carrying value of the 134 life insurance contracts held by these trusts was $57.9 million and $56.3 million at September 25, 2015 and September 26, 2014, respectively. These contracts had a total death benefit of $147.3 million and $145.7 million at September 25, 2015 and September 26, 2014, respectively. However, there are outstanding loans against the policies amounting to $40.4 million and $38.2 million at September 25, 2015 and September 26, 2014, respectively.
The Company has insurance contracts which serve as collateral for certain of the Company's non-U.S. pension plan benefits, which totaled $9.8 million and $11.0 million at September 25, 2015 and September 26, 2014, respectively. These amounts were also included in other assets on the consolidated balance sheets.


14.
Equity

Preferred Shares
Mallinckrodt is authorized to issue 500,000,000 preferred shares, par value of $0.20 per share, none of which were issued or outstanding at September 25, 2015. Rights as to dividends, return of capital, redemption, conversion, voting and otherwise with respect to these shares may be determined by Mallinckrodt's board of directors on or before the time of issuance. In the event of the liquidation of the Company, the holders of any preferred shares then outstanding would, if issued on such terms that they carry a preferential distribution entitlement on liquidation, be entitled to payment to them of the amount for which the preferred shares were subscribed and any unpaid dividends prior to any payment to the ordinary shareholders.

Share Repurchases
On January 23, 2015, the Company's board of directors authorized a program to purchase up to $300.0 million of the Company's ordinary shares from time to time based on market conditions to allow management to enhance shareholder value. The following table presents the number of shares and dollar amount of repurchases made under the repurchase program by fiscal year and the remaining amount available for repurchase as of September 25, 2015.
 
2015 Share Repurchase Program
 
Number of Shares
 
Amount
Authorized repurchase amount
 
 
$
300.0

Repurchases:
 
 
 
   Fiscal 2015
823,592

 
75.0

Remaining amount available
 
 
$
225.0


The Company also repurchases shares from certain employees in order to satisfy employee tax withholding requirements in connection with the vesting of restricted shares. In addition, the Company repurchases shares to settle certain option exercises. The Company spent $17.2 million and $17.5 million to acquire shares in connection with equity-based awards in fiscal 2015 and 2014, respectively.

15.
Share Plans
Total share-based compensation cost from continuing operations was $116.1 million, $66.8 million and $16.0 million for fiscal 2015, 2014 and 2013, respectively. These amounts are generally included within selling, general and administrative expenses in the consolidated and combined statements of income. In conjunction with the Questcor Acquisition, Questcor equity awards were converted to Mallinckrodt equity awards which resulted in post-combination expense of $90.4 million in fiscal 2015, included in the above total share-based compensation, of which $80.6 million is included within selling, general and administrative expenses and $9.8 million is included within restructuring charges, net. The incremental fair value associated with the conversion of Covidien equity awards into Mallinckrodt equity awards is included in separation costs. The Company recognized a related tax benefit associated with this expense of $41.7 million, $24.1 million and $5.7 million in fiscal 2015, 2014 and 2013, respectively.

109



Incentive Equity Awards Converted from Covidien Awards
Prior to the Separation, all employee incentive equity awards were granted by Covidien. At the time of Separation, the restricted share units and share options granted to Mallinckrodt employees prior to June 28, 2013 were converted into restricted share units and share options, respectively, of Mallinckrodt, and all of the performance share awards granted to Mallinckrodt employees were converted to restricted share units of Mallinckrodt (collectively, "the Conversion"). Mallinckrodt incentive equity awards issued upon completion of the Conversion and the related weighted-average grant date fair value is presented below:
 
Awards
 
Weighted-Average
Grant-Date
Fair Value
Share options
2,399,822

 
$
7.96

Restricted share units
575,213

 
38.97


Share Options. A summary of the status of the Company's share option awards upon completion of the Conversion on June 28, 2013 is presented below:
 
Shares Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
(in years)
 
Aggregate
Intrinsic
Value
Outstanding at June 28, 2013
2,399,822

 
$
35.94

 
8.0
 
$
22.9

Exercisable at June 28, 2013
550,097

 
30.94

 
5.9
 
8.0


The Conversion resulted in a modification of the previously issued share option awards. The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards immediately after the Separation was higher than the awards immediately before, primarily due to the elimination of Covidien's dividend yield assumption and the Company's higher volatility as compared to Covidien. The incremental fair value for vested awards was recognized immediately within separation costs, as the incremental fair value is directly attributable to the Separation, and the incremental fair value for unvested awards will be recognized on a straight-line basis over the remaining vesting period of the applicable awards, also within separation costs.
The weighted-average assumptions used in the Black-Scholes pricing model for determining the fair value of the share option awards immediately before and immediately after the Separation were as follows:
 
Pre- Separation
 
Post- Separation
Expected share price volatility
26
%
 
32
%
Risk-free interest rate
0.99
%
 
0.99
%
Expected annual dividend per share
1.65
%
 
—
%
Expected life of options (in years)
3.8

 
3.8

Fair value per option
$
18.04

 
$
16.51

Share option awards
1,745,258

 
2,399,822


Restricted share units. The Conversion resulted in a modification of the previously issued restricted share unit awards ("RSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The Conversion did not result in incremental fair value.
Performance share units. The Conversion resulted in a modification of the previously issued performance share unit awards ("PSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards was higher after the Conversion as the performance factor utilized to convert the award was higher than what had previously been estimated. The incremental fair value was recognized immediately within separation costs for the service period to date and the remaining incremental fair value will be recognized over the remaining vesting period within separation costs.

110



Stock Compensation Plans
Prior to the Separation, the Company adopted the 2013 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2013 Plan"). The 2013 Plan provides for the award of share options, share appreciation rights, annual performance bonuses, long-term performance awards, restricted units, restricted shares, deferred share units, promissory shares and other share-based awards (collectively, "Awards"). The 2013 Plan provided for a maximum of 5.7 million common shares to be issued as Awards, subject to adjustment as provided under the terms of the 2013 Plan. In fiscal 2015, the Company amended the 2013 Plan and adopted the 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2015 Plan"). The 2015 Plan provides for a maximum of 17.8 million common shares to be issued as Awards (an incremental 12.1 million Awards from the 2013 Plan subject to issuance), subject to adjustment as provided under the terms of the 2015 Plan. As of September 25, 2015, all equity awards held by the Company's employees were either converted from Covidien equity awards at the Separation, converted from Questcor equity awards, or granted under the 2013 Plan or 2015 Plan.
Share options. Share options are granted to purchase the Company's ordinary shares at prices that are equal to the fair market value of the shares on the date the share option is granted. Share options generally vest in equal annual installments over a period of four years and expire ten years after the date of grant. The grant-date fair value of share options, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience.
Share option activity and information is as follows:
 
Share Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
(in years)
 
Aggregate Intrinsic Value
Outstanding at September 27, 2013
2,760,231

 
$
37.30

 
 
 
 
Granted
675,921

 
52.63

 
 
 
 
Converted from Questcor Acquisition
1,292,736

 
25.08

 
 
 
 
Exercised
(878,330
)
 
30.96

 
 
 
 
Expired/Forfeited
(323,769
)
 
41.83

 
 
 
 
Outstanding at September 26, 2014
3,526,789

 
36.84

 
 
 
 
Granted
635,567

 
102.20

 
 
 
 
Exercised
(1,132,778
)
 
29.79

 
 
 
 
Expired/Forfeited
(243,135
)
 
58.00

 
 
 
 
Outstanding at September 25, 2015
2,786,443

 
52.76

 
7.3
 
$
63.2

 
 
 
 
 
 
 
 
Vested and unvested expected to vest as of September 25, 2015
2,649,351

 
50.94

 
7.4
 
59.0

Exercisable at September 25, 2015
1,054,336

 
34.20

 
5.8
 
36.2


As of September 25, 2015, there was $24.8 million of total unrecognized compensation cost related to unvested share option awards, which is expected to be recognized over a weighted-average period of 2.7 years.

111



The grant date fair value of share options has been estimated using the Black-Scholes pricing model. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. The expected volatility assumption is based on the historical and implied volatility of the Company's peer group with similar business models for periods after the Separation, and on Covidien's peer group with similar business models for periods prior to the Separation. The expected life assumption is based on the contractual and vesting term of the share option, employee exercise patterns and employee post-vesting termination behavior. The expected annual dividend per share is based on the Company's current intentions regarding payment of cash dividends, or Covidien's dividend rate on the date of grant. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The weighted-average assumptions used in the Black-Scholes pricing model for share options granted in fiscal 2013 subsequent to the Separation are included within the discussion of modification expense above. The weighted-average assumptions used in the Black-Scholes pricing model for shares granted in fiscal 2015, along with the weighted-average grant-date fair value, were as follows:
 
2015
 
2014
Expected share price volatility
29
%
 
32
%
Risk-free interest rate
1.72
%
 
1.96
%
Expected annual dividend per share
—
%
 
—
%
Expected life of options (in years)
5.3

 
5.5

Fair value per option
$
30.08

 
$
17.38


In fiscal 2013, subsequent to the Separation, the total intrinsic value of share options exercised and the related tax benefit was not significant. In fiscal 2015 and 2014, the total intrinsic value of options exercised was $89.5 million and $34.2 million, respectively, and the related tax benefit was $33.1 million and $12.0 million, respectively.
Restricted share units. Recipients of RSUs have no voting rights and receive dividend equivalent units which vest upon the vesting of the related shares. RSUs generally vest in equal annual installments over a period of four years. Restrictions on RSUs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period. The fair market value of RSUs granted after the Conversion is determined based on the market value of the Company's shares on the date of grant for periods after the Separation.
RSU activity is as follows:
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
724,269

 
$
40.62

Granted
229,281

 
55.40

Converted from Questcor Acquisition
30,747

 
70.88

Vested
(300,237
)
 
34.77

Forfeited
(94,838
)
 
42.48

Non-vested at September 26, 2014
589,222

 
47.88

Granted
273,733

 
105.68

Vested
(219,189
)
 
49.84

Forfeited
(71,272
)
 
68.15

Non-vested at September 25, 2015
572,494

 
73.45


The total fair value of Mallinckrodt restricted share unit awards granted during fiscal 2015 was $28.9 million. The total vest date fair value of Mallinckrodt restricted share units vested during fiscal 2015 was $21.6 million. As of September 25, 2015, there was $30.3 million of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of 2.8 years.
Performance share units. Similar to recipients of RSUs, recipients of PSUs have no voting rights and receive dividend equivalent units. The grant date fair value of PSUs, adjusted for estimated forfeitures, is generally recognized as expense on a straight-line basis from the grant date through the end of the performance period. The vesting of PSUs and related dividend equivalent units is generally based on various performance metrics and relative total shareholder return (total shareholder return for the Company as compared to total shareholder return of the PSU peer group), measured over a three-year performance period. The PSU peer group is comprised of various healthcare companies which attempts to replicate the Company’s mix of businesses.

112



Depending on Mallinckrodt's relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from 0% to 200%, of the award granted.
PSU activity is as follows (1):
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
$
—

 
$
—

Granted
79,230

 
63.40

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(6,490
)
 
62.65

Non-vested at September 26, 2014
72,740

 
63.46

Granted
77,306

 
125.84

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(19,072
)
 
92.05

Non-vested at September 25, 2015
130,974

 
96.05

(1)    The number of shares disclosed within this table are at the target number of 100%.
The Company generally uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards. The assumptions used in the Monte Carlo model for PSUs granted during each year were as follows:
 
2015
 
2014
Expected stock price volatility
27
%
 
28
%
Peer group stock price volatility
32
%
 
33
%
Correlation of returns
14
%
 
17
%


The weighted-average grant-date fair value per share of PSUs granted was $125.84 in fiscal 2015. As of September 25, 2015, there was $8.9 million of unrecognized compensation cost related to PSUs, which is expected to be recognized over a weighted-average period of 1.8 years .

113



Restricted stock awards. Recipients of restricted stock awards ("RSAs") pertain solely to converted awards from the Questcor Acquisition, which were converted at identical terms to their original award. The converted RSAs maintain voting rights and a non-forfeitable right to receive dividends. RSAs are subject to accelerated vesting as prescribed by the terms of the original award based on a change in control, and substantially all of which will vest over a thirteen month period of time from the date of the Questcor Acquisition. Restrictions on RSAs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSAs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period.
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
—

 
$
—

Granted
—

 
—

Converted from Questcor Acquisition
1,829,164

 
70.88

Vested
(390,731
)
 
70.88

Forfeited
(6,402
)
 
70.88

Non-vested at September 26, 2014
1,432,031

 
70.88

Granted
—

 
—

Vested
(1,362,823
)
 
70.88

Forfeited
(34,646
)
 
70.88

Non-vested at September 25, 2015
34,562

 
70.88

The total vest date fair value of Mallinckrodt restricted share awards vested during fiscal 2015 was $127.4 million. As of September 25, 2015, there was $2.3 million of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of 2.5 years .

Employee Stock Purchase Plans
The Company adopted the Mallinckrodt Employee Stock Purchase Plan ("ESPP") effective October 1, 2013. Substantially all full-time employees of the Company's U.S. subsidiaries and employees of certain qualified non-U.S. subsidiaries are eligible to participate in this ESPP. Eligible employees authorize payroll deductions to be made for the purchase of shares. The Company matches a portion of the employee contribution by contributing an additional 15% (25% in fiscal 2014 and fiscal 2015) of the employee's payroll deduction up to a $25,000 per employee contribution. All shares purchased under the ESPP are purchased on the open market by a designated broker.

16.
Accumulated Other Comprehensive Income
The components of accumulated other comprehensive income are as follows:
 
Currency Translation
 
Unrecognized Loss on Derivatives
 
Unrecognized Gain (Loss) on Benefit Plans
 
Accumulated Other Comprehensive Income
Balance at September 28, 2012
$
157.1

 
$
—

 
$
(72.2
)
 
$
84.9

Other comprehensive income (loss), net
1.5

 
(7.3
)
 
29.4

 
23.6

Balance at September 27, 2013
158.6

 
(7.3
)
 
(42.8
)
 
108.5

Other comprehensive income (loss), net
(27.6
)
 
—

 
(17.1
)
 
(44.7
)
Reclassification from other comprehensive income (loss)
—

 
0.5

 
1.4

 
1.9

Balance at September 26, 2014
131.0

 
(6.8
)
 
(58.5
)
 
65.7

Other comprehensive loss before reclassification
(70.8
)
 
—

 
(1.1
)
 
(71.9
)
Reclassification from other comprehensive income (loss)
—

 
0.4

 
6.7

 
7.1

Balance at September 25, 2015
$
60.2

 
$
(6.4
)
 
$
(52.9
)
 
$
0.9



114



The following summarizes reclassifications out of accumulated other comprehensive income for the 2015 and 2014 fiscal years:
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
 
 
September 25, 2015
 
September 26, 2014
 
Line Item in the Condensed Consolidated
Statement of Income
Amortization of unrealized loss on derivatives
$
0.6

 
$
0.6

 
Interest expense
Income tax provision
(0.2
)
 
(0.1
)
 
Provision for income taxes
Net of income taxes
0.4

 
0.5

 
 
 
 
 
 
 
 
Amortization of pension and post-retirement benefit plans:
 
 
 
 
 
Net actuarial loss
9.4

 
8.1

 
(1) 
Prior service credit
(4.6
)
 
(9.9
)
 
(1) 
Plan settlements
6.0

 
3.8

 
(1) 
Total before tax
10.8

 
2.0

 
 
Income tax provision
(4.1
)
 
(0.6
)
 
Provision for income taxes
Net of income taxes
6.7

 
1.4

 
 
 
 
 
 
 
 
Total reclassifications for the period
$
7.1

 
$
1.9

 
 
(1)
These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note 13 for additional details.

17.
Transactions with Former Parent Company
Prior to the completion of the Separation on June 28, 2013, the Company was part of Covidien and, as such, transactions between Covidien and the Company were considered related party transactions. As discussed in Note 1, these intercompany transactions are included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The continuing relationship between Covidien and the Company is primarily governed through agreements entered into as part of the Separation, including a Separation Distribution Agreement, a Tax Matters Agreement and a transition services agreement. These agreements were filed with the SEC as Exhibits 2.1, 10.1 and 10.3, respectively, to the Company's Current Report on Form 8-K filed on July 1, 2013. The following discusses the related party transactions and those agreements.

Sales and Purchases
During fiscal 2015, 2014 and 2013, the Company sold inventory to Covidien in the amount of $35.3 million, $46.0 million and $51.2 million, respectively, which is included in net sales of discontinued operations in the consolidated and combined statements of income. The Company also purchases inventories from Covidien. The Company recognized cost of sales within discontinued operations from these inventory purchases of $17.0 million, $28.9 million and $38.4 million during fiscal 2015, 2014 and 2013, respectively.

Allocated Expenses
As discussed in Note 1, the combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were $39.6 million for fiscal 2013 and were included within selling, general and administrative expenses.




115




Balance Sheet Impacts
Subsequent to the Separation, the Company and Covidien maintain an ongoing relationship in which each party may provide services to the other party, including the distribution of goods. As a result of these relationships, the consolidated balance sheet as of September 25, 2015 includes $6.3 million of amounts due to the Company from Covidien, within prepaid expenses and other current assets, and $3.9 million of amounts the Company owes Covidien, included within accrued and other liabilities.

Separation and Distribution Agreement
On June 28, 2013, the Company entered into a Separation and Distribution Agreement and other agreements with Covidien to effect the Separation and provide a framework for the Company's relationships with Covidien after the Separation. These agreements govern the relationship between Mallinckrodt and Covidien subsequent to the Separation and provide for the assignment to Mallinckrodt of certain of Covidien's assets, liabilities and obligations attributable to periods prior to the Separation.
In general, each party to the Separation and Distribution Agreement assumed liability for all pending, threatened and unasserted legal matters related to its own business or its assumed or retained liabilities and will indemnify the other party for any liability to the extent arising out of, or resulting from, such assumed or retained legal matters.
The Separation and Distribution Agreement provided for the initial cash capitalization of Mallinckrodt in the amount of approximately $168.0 million at June 28, 2013. The Separation and Distribution Agreement also provided for an adjustment payment to compensate either Mallinckrodt or Covidien, as applicable, to the extent that the aggregate of the Company's cash, indebtedness and specified working capital accounts as of June 28, 2013 ("the Distribution Date"), as well as the capital expenditures made with respect to the Company's business during fiscal 2013 through the Distribution Date, deviated from the target. The target was calculated pursuant to a formula set forth in the Separation and Distribution Agreement, which assumed the Distribution Date would be June 28, 2013, that the Pharmaceuticals business was conducted in the ordinary course through that date and that the Company would have approximately $168.0 million of cash upon completion of the distribution. The Separation and Distribution Agreement also provided that an adjustment payment would only be payable if the amount of the adjustment payment exceeded $20.0 million (in which case the entire amount would be paid). Upon final calculation, no adjustment payment was required by either the Company or Covidien.

Tax Matters Agreement
In connection with the Separation, Mallinckrodt entered into the Tax Matters Agreement with Covidien that generally will govern Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including ordinary course of business taxes and taxes, if any, incurred as a result of any failure of the distribution of Mallinckrodt shares to qualify as a tax-free distribution for U.S. federal income tax purposes within the meaning of Section 355 of the U.S. Internal Revenue Code, or other applicable tax law, or any failure of certain internal transactions undertaken in anticipation of the distribution to qualify for tax-free or tax-favored treatment under the applicable tax law. The Company expects, with certain exceptions, to be responsible for the payment of all taxes attributable to Mallinckrodt or its subsidiaries for taxable periods beginning on or after September 29, 2012. For periods prior to September 29, 2012, the Company is subject to a $200.0 million liability limitation, net of any benefits, as prescribed by the Tax Matters Agreement. The Company has made $51.6 million of payments, net of benefits, for periods prior to September 29, 2012. To the extent that the Company's liability for such taxes, net of any tax benefits, does not exceed $200.0 million, it may be responsible for additional taxes attributable to periods prior to September 29, 2012, taxes related to the Separation and a percentage of any taxes arising from the Separation failing to qualify for tax-free or tax-favored treatment through no fault of Covidien or the Company. The Tax Matters Agreement also assigns rights and responsibilities for administrative matters, such as the filing of returns, payment of taxes due, retention of records, tax reporting practices and conduct of audits, examinations or similar proceedings. In addition, the Tax Matters Agreement provides for cooperation and information sharing with respect to tax matters.
The Tax Matters Agreement also contains restrictions on the Company's ability to take actions without Covidien's consent that could cause the Separation or certain internal transactions undertaken in anticipation of the Separation to fail to qualify as tax-free or tax-favored transactions under applicable tax law. These transactions include, but are not limited to, entering into, approving or allowing any transaction that results in a change in ownership of more than 35.0% of Mallinckrodt's shares; any merger, consolidation, scheme of arrangement, liquidation or partial liquidation, or any approval or allowance of such transaction with respect to certain of the Company's subsidiaries; the cessation or transfer of certain business activities; the sale, issuance or other disposition of any equity interest in certain of the Company's subsidiaries; a sale or other disposition of a substantial portion of the Company's assets or a substantial portion of the assets of certain of the Company's subsidiaries; extraordinary distributions by or to certain of the Company's subsidiaries; or engaging in certain internal transactions. These restrictions will all apply for the two-year period after the Separation and in some cases will apply for periods as long as five years following the Separation. Any taxes imposed on the other party attributable to certain post-distribution actions taken by or in respect of the responsible party or its shareholders that result in failure of

116



the Separation or internal transactions to qualify as tax-free or tax-favored transactions are the responsibility of the party at fault, regardless of whether the actions occur more than two years after the distribution, or whether Covidien consents to such actions. Any actions of the Company or its shareholders that directly give rise to additional taxes are not subject to the $200 million threshold noted previously.

Transition Services Agreement
Mallinckrodt and Covidien entered into a transition services agreement in connection with the Separation pursuant to which Mallinckrodt and Covidien will provide each other, on an interim and transitional basis, various services including, but not limited to, treasury administration, information technology services, non-exclusive distribution and importation services for our products in certain countries outside the U.S., regulatory, general administrative services and other support services. The agreed-upon charges for such services are generally intended to allow the servicing party to recover all out-of-pocket costs and expenses, and include a predetermined profit margin. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services are rendered may not be as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.

18.
Guarantees
In disposing of assets or businesses, the Company has historically provided representations, warranties and indemnities to cover various risks and liabilities, including unknown damage to the assets, environmental risks involved in the sale of real estate, liability to investigate and remediate environmental contamination at waste disposal sites and manufacturing facilities, and unidentified tax liabilities related to periods prior to disposition. The Company assesses the probability of potential liabilities related to such representations, warranties and indemnities and adjusts potential liabilities as a result of changes in facts and circumstances. The Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.
In connection with the sale of the Specialty Chemical business (formerly known as Mallinckrodt Baker) in fiscal 2010, the Company agreed to indemnify the purchaser with respect to various matters, including certain environmental, health, safety, tax and other matters. The indemnification obligations relating to certain environmental, health and safety matters have a term of 17 years from the sale, while some of the other indemnification obligations have an indefinite term. The amount of the liability relating to all of these indemnification obligations included in other liabilities on the Company's consolidated balance sheets at September 25, 2015 and September 26, 2014 was $15.7 million and $16.6 million, respectively, of which $13.0 million and $13.9 million, respectively, related to environmental, health and safety matters. The value of the environmental, health and safety indemnity was measured based on the probability-weighted present value of the costs expected to be incurred to address environmental, health and safety claims made under the indemnity. The aggregate fair value of these indemnification obligations did not differ significantly from their aggregate carrying value at September 25, 2015 and September 26, 2014. As of September 25, 2015, the maximum future payments the Company could be required to make under these indemnification obligations was $71.0 million. The Company was required to pay $30.0 million into an escrow account as collateral to the purchaser, of which $19.0 million and $19.4 million remained in other assets on the consolidated balance sheets at September 25, 2015 and September 26, 2014, respectively.
The Company has recorded liabilities for known indemnification obligations included as part of environmental liabilities, which are discussed in Note 19. In addition, the Company is liable for product performance; however the Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.
The Company is required to provide the U.S. Nuclear Regulatory Commission financial assurance demonstrating its ability to fund the decommissioning of its Maryland Heights, Missouri radiopharmaceuticals production facility upon closure, though the Company does not intend to close this facility. The Company has provided this financial assurance in the form of surety bonds totaling $57.2 million. As of September 25, 2015, the Company had various other letters of credit and guarantee and surety bonds totaling $39.4 million.
In April 2015, the Company terminated a letter of credit to guarantee decommissioning costs associated with its Saint Louis, Missouri plant and placed $21.1 million of restricted cash on deposit with a trustee. This restricted cash is included within prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 25, 2015.
In addition, the separation and distribution agreement entered into with Covidien at the Separation provides for cross-indemnities principally designed to place financial responsibility of the obligations and liabilities of the Company's business with the Company

117



and financial responsibility for the obligations and liabilities of Covidien's remaining business with Covidien, among other indemnities.
19.
Commitments and Contingencies
The Company has purchase obligations related to commitments to purchase certain goods and services. At September 25, 2015, such obligations were as follows:
Fiscal 2016
$
125.9

Fiscal 2017
51.4

Fiscal 2018
49.8

Fiscal 2019
7.9

Fiscal 2020
—


The Company is subject to various legal proceedings and claims, including patent infringement claims, product liability matters, environmental matters, employment disputes, contractual disputes and other commercial disputes, including those described below. The Company believes that these legal proceedings and claims likely will be resolved over an extended period of time. Although it is not feasible to predict the outcome of these matters, the Company believes, unless indicated below, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.

Governmental Proceedings
In November 2011 and October 2012, the Company received subpoenas from the U.S. Drug Enforcement Administration requesting production of documents relating to its suspicious order monitoring program. The United States Attorney’s Office (the “USAO”) for the Eastern District of Michigan is investigating the possibility of the Company failing to report suspicious orders of controlled substances during the period 2006-2011 in violation of the Controlled Substances Act and its related regulations. The USAO for the Northern District of New York and Office of Chief of Counsel for the U.S. Drug Enforcement Administration are investigating the possibility of the Company failing to maintain appropriate records and security measures with respect to manufacturing of certain controlled substances at its Hobart facility during the period 2012-2013. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows.
In September 2012, Questcor received a subpoena from the USAO for the Eastern District of Pennsylvania for information relating to its promotional practices. Questcor has also been informed by the USAO for the Eastern District of Pennsylvania that the USAO for the Southern District of New York and the SEC are participating in the investigation to review Questcor's promotional practices and related matters. On March 9, 2015, the Company received a "No Action" letter from the SEC regarding its review of the Company's promotional practices.
In June 2014, Questcor received a subpoena and Civil Investigative Demand ("CID") from the Federal Trade Commission ("FTC") seeking documentary materials and information regarding the FTC's investigation into whether Questcor's acquisition of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen Depot® from Novartis AG and Novartis Pharma AG (collectively, "Novartis") violates antitrust laws. Subsequently, a small number of states commenced similar investigations focused on whether the transaction violates state antitrust laws. The Company is not aware of any existing or pending litigation in connection with these investigations. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows.
In March 2014, the USAO for the Eastern District of Pennsylvania requested the production of documents related to an investigation of the potential promotion of Therakos’ immunotherapy drug/device system UVADEX/UVAR XTS and UVADEX/CELLEX (collectively, the “Therakos System”), for indications not approved by the FDA, including the treatment of patients with graft versus host disease (“GvHD”) and solid organ transplant patients, including pediatric patients. The investigation also includes Therakos’ efforts to secure FDA approval for additional uses of, and alleged quality issues relating to, UVADEX/UVAR. In August 2015, the USAO for the Eastern District of Pennsylvania sent Therakos a subsequent request for documents related to the investigation and we are in the process of responding to that request.


118



In November 2014, the Company received a CID from the Civil Medicaid Fraud Division of the Texas Attorney General's Office. According to the CID, the Attorney General's office is investigating the possibility of false reporting of information by the Company regarding the prices of certain of its drugs used by Texas Medicaid to establish reimbursement rates for pharmacies that dispensed the Company's drugs to Texas Medicaid recipients.
We are in the process of responding to each of the subpoenas and the CIDs and we intend to cooperate fully in each such investigation.
Mallinckrodt Inc. v. U.S. Food and Drug Administration and United States of America. The Company filed a Complaint for Declaratory and Injunctive Relief ("the Complaint") in the U.S. District Court for the District of Maryland Greenbelt Division against the FDA and the United States of America in November 2014 for judicial review of what the Company believes is the FDA's inappropriate and unlawful reclassification of the Company's Methylphenidate HCl Extended-Release tablets USP (CII) ("Methylphenidate ER") in the Orange Book: Approved Drug Products with Therapeutic Equivalence ("Orange Book") on November 13, 2014. In its Complaint, the Company has asked the court to: issue an injunction to (a) set aside the FDA's reclassification of the Company's Methylphenidate ER products from freely substitutable at the pharmacy level (class AB) to presumed to be therapeutically inequivalent (class BX) in the Orange Book and (b) prohibit the FDA from reclassifying the Company's Methylphenidate ER products in the future without following applicable legal requirements; and issue a declaratory judgment that the FDA's action reclassifying the Company's Methylphenidate ER products in the Orange Book is unlawful. The Company concurrently filed a motion with the same court requesting an expedited hearing to issue a temporary restraining order ("TRO") directing the FDA to reinstate the Orange Book AB rating for the Company's Methylphenidate ER products on a temporary basis. The court denied the Company's motion for a TRO. In December 2014, the FDA filed a motion to dismiss the Compliant with the district court. The Company filed its opposition to the motion to dismiss in January 2015, and concurrently filed a motion for summary judgment. On July 29, 2015, the court granted the FDA’s motion to dismiss with respect to three of the five counts in the Complaint and granted summary judgment in favor of the FDA with respect to the two remaining counts.  The Company has appealed the court’s decision to the U.S. Court of Appeals for the Fourth Circuit.

Patent/Antitrust Litigation
Tyco Healthcare Group LP, et al. v. Mutual Pharmaceutical Company, Inc. In March 2007, the Company filed a patent infringement suit in the U.S. District Court for the District of New Jersey against Mutual Pharmaceutical Co., Inc., et al. (collectively, "Mutual") after Mutual submitted an Abbreviated New Drug Application ("ANDA") to the FDA seeking to sell a generic version of the Company's 7.5mg RESTORIL™ sleep aid product. Mutual also filed antitrust and unfair competition counterclaims. The patents at issue have since expired or been found invalid. The trial court issued an opinion and order granting the Company's motion for summary judgment regarding Mutual's antitrust and unfair competition counterclaims. Mutual appealed this decision to the U.S. Court of Appeals for the Federal Circuit and the Federal Circuit issued a split decision, affirming the trial court in part and remanding to the trial court certain counterclaims for further proceedings. The Company filed a motion for summary judgment with the U.S. District Court regarding the remanded issues. In May 2015, the trial court issued an opinion granting-in-part and denying-in-part the Company’s motion for summary judgment.
'222 and '218 Patent Litigation: Exela Pharma Sciences, LLC. In August 2011, Cadence, a subsidiary of the Company, and Pharmatop, the owner of the two U.S. patents licensed exclusively by Cadence, filed suit in the U.S. District Court for the District of Delaware against Exela Pharma Sciences, LLC, Exela PharmaSci, Inc. and Exela Holdings, Inc. (collectively, "Exela"), alleging that Exela infringed U.S. Patent Nos. 6,028,222 ("the '222 patent") and 6,992,218 ("the '218 patent"), by submitting an ANDA to the FDA seeking to sell a generic version of Ofirmev. The filing of the lawsuit triggered a stay of FDA approval of the Exela ANDA until the earlier of the expiration of a 30-month period, the expiration of the '222 and '218 patents, the entry of a settlement order or consent decree stating that the '222 and '218 patents are invalid or not infringed, a decision in the case concerning infringement or validity that is favorable to Exela, or such shorter or longer period as the court may order. After a bench trial, the court ruled in favor of Cadence in November 2013 and found that Exela's ANDA infringed the '222 and '218 patents. Exela appealed the decision and oral arguments in the appeal occurred in November 2014. In March 2015, the Federal Circuit affirmed the district court decision.
'222 and '218 Patent Litigation: InnoPharma Licensing LLC and InnoPharma, Inc. In September 2014, Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against InnoPharma Licensing LLC and InnoPharma, Inc. (collectively "InnoPharma") following receipt of an August 2014 notice from InnoPharma concerning its submission of a New Drug Application (“NDA”), containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev.
'222 and '218 Patent Litigation: Agila Specialties Private Limited, Inc. and Agila Specialties Inc. (a Mylan Inc. Company), (collectively “Agila”).  In December 2014, Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Agila following receipt of a November 2014 notice from Agila concerning its submission of a NDA containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev. 

119



The Company intends to vigorously enforce its intellectual property rights relating to Ofirmev to prevent the marketing of infringing generic or competing products prior to the expiration of the Cadence patents. An adverse outcome in either the Exela or InnoPharma matters ultimately could result in the launch of one or more generic versions of Ofirmev before the expiration of the last of the listed patents on June 6, 2021 (or December 6, 2021 if pediatric exclusivity is granted), which could adversely affect the Company's ability to successfully maximize the value of Ofirmev and have an adverse effect on our financial condition, results of operations and cash flows.
'222 and '218 Patents: Ex Parte Reexamination. In September 2012, Exela filed with the U.S. Patent and Trademark Office ("USPTO") a Request for Ex Parte Reexamination of the '222 patent and the USPTO granted that request. The reexamination process requires the USPTO to consider the scope and validity of the patent based on substantial new questions of patentability raised by a third-party or the USPTO. Cadence and Pharmatop have filed, with the USPTO, a patent owner's statement commenting on the reexamination request, and thereafter the parties made various submissions. In March 2015, the USPTO issued an ex parte reexamination certificate for the '222 patent listing the claims that resulted from the reexamination proceeding.
In addition, in January 2014, an unidentified third-party filed, with the USPTO, a Request for Ex Parte Reexamination of the '218 patent. The reexamination request was granted. In July 2014, the USPTO issued a Non-Final Office Action in the '218 reexamination in which it rejected certain claims. In September 2014, Cadence and Pharmatop filed an Amendment and Response to the Office Action. Cadence and Pharmatop filed a supplemental response in January 2015. In June 2015, the USPTO issued a Final Office Action confirming that effectively all of the original claims were patentable, and Cadence and Pharmatop subsequently filed an Amendment and Response to the Final Office Action. On July 15, 2015, the USPTO confirmed in the reexamination proceeding for the '218 patent that original claims 1-10 and 12-19 as well as amended original dependent claim 11 and six new dependent claims are all patentable. In August 2015, the USPTO issued an ex parte reexamination certificate for the '218 patent listing the claims that resulted from the reexamination proceeding. Because the Company and Pharmatop believe that the scope and validity of the patent claims in the '222 reexamination certificate and the '218 patent reexamination certificate are appropriate and that the USPTO's prior issuances of the patents were correct, the Company, in conjunction with Pharmatop, will vigorously defend these patents.
'218 Patent Litigation: Exela Pharma Sciences, LLC. In April 2012, Exela filed suit against David J. Kappos and the USPTO in the U.S. District Court for the Eastern District of Virginia for declaratory judgment seeking a reversal of the USPTO's decision not to act on a petition by Exela to vacate the USPTO's April 2003 order reviving the international application for the '218 patent. The lawsuit followed the USPTO's rejection of Exela's petition to the USPTO filed in November 2011, which sought to vacate the April 2003 order. The USPTO determined that Exela lacked standing to seek such relief. Exela also seeks declaratory judgment that the USPTO's rules and regulations that allow for revival of abandoned, international patent applications under the "unintentional" standard are invalid, and seeks similar relief in connection with one or more counterclaims it has filed in the Delaware litigation. Cadence intervened in this lawsuit and in December 2012, the district court dismissed the case with prejudice as barred by the applicable statute of limitations. Exela appealed the dismissal to the Court of Appeals for the Federal Circuit and oral arguments were held in February 2014. In March 2015, the Federal Circuit affirmed the district court's dismissal of the Exela complaint.
'222 and '218 Patent Litigation Settlements. Four other similar cases involving generic and/or competing versions of Ofirmev have previously settled. In each settlement, the defendant was granted the non-exclusive right to market a generic intravenous acetaminophen product in the U.S. under its respective ANDA after December 6, 2020, or earlier under certain circumstances. In connection with those settlements, one settling party was granted the exclusive right of first refusal to negotiate an agreement with Cadence to market an authorized generic of Ofirmev in the U.S. in the event that Cadence elects to launch an authorized generic version of the product. If that settling party elects not to exercise its right of first refusal, Cadence has agreed to grant a similar right of first refusal to another settling party. As part of another settlement, Cadence entered into a supply agreement under which an affiliate of one of the settling parties will develop, manufacture and supply commercial quantities of Ofirmev to the Company if certain regulatory approvals are obtained.
Inomax Patents: Inter Partes Review ("IPR") Proceedings. In February 2015 and March 2015, the USPTO issued Notices of Filing Dates Accorded to Petitions for IPR petitions filed by Praxair Distribution, Inc. concerning ten patents covering Inomax. Patent Owner Preliminary responses for all of the IPR petitions were filed in May 2015 and June 2015. On July 29, 2015 the USPTO Patent Trial and Appeal Board ("PTAB") issued rulings denying the institution of four of the five IPR petitions challenging the five patents expiring in 2029.  The PTAB also issued a ruling on July 29, 2015 that instituted the IPR proceeding in the fifth of this group of patents and the PTAB is statutorily required to complete the IPR process on that patent within one year.  On September 22, 2015 the USPTO PTAB issued rulings that instituted the IPR proceedings in each of the second set of five patents that expire in 2031 and the PTAB is statutorily required to complete the IPR process on these five patents within one year.
Inomax Patent Litigation: Praxair Distribution, Inc. and Praxair, Inc. (collectively “Praxair”). In February 2015, INO Therapeutics LLC and Ikaria, Inc., subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Praxair following receipt of a January 2015 notice from Praxair concerning its submission of an ANDA containing a Paragraph IV patent certification with the FDA for a generic version of Inomax.

120



The Company intends to vigorously enforce its intellectual property rights relating to Inomax to prevent the marketing of infringing generic products prior to the expiration of the patents covering Inomax. An adverse outcome in either the IPRs or the Praxair litigation ultimately could result in the launch of a generic version of Inomax before the expiration of the last of the listed patents on January 6, 2031 (July 6, 2031 including pediatric exclusivity), which could adversely affect the Company's ability to successfully maximize the value of Inomax and have an adverse effect on its financial condition, results of operations and cash flows.

Commercial and Securities Litigation
Retrophin Litigation. In January 2014, Retrophin, Inc. ("Retrophin") filed a lawsuit against Questcor in the U.S. District Court for the Central District of California, alleging a variety of federal and state antitrust violations based on Questcor's acquisition from Novartis of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen. In June 2015, the parties entered into a binding settlement agreement, under the terms of which Retrophin agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to Retrophin in the amount of $15.5 million.
Glenridge Litigation. In June 2011, Glenridge Pharmaceuticals LLC (“Glenridge”), filed a lawsuit against Questcor in the Superior Court of California, Santa Clara County, alleging that Questcor had underpaid royalties to Glenridge under a royalty agreement related to net sales of Acthar. In August 2012, Questcor filed a separate lawsuit against the three principals of Glenridge, as well as Glenridge, challenging the enforceability of the royalty agreement. In August 2013, the two lawsuits were consolidated into one case in the Superior Court of California, Santa Clara County. In October 2014, the parties entered into a binding term sheet settling the lawsuit. Under the terms of the settlement, the royalty rate payable by Questcor was reduced, royalties were capped instead of being payable for so long as Acthar was sold and Questcor agreed to pay Glenridge a reduced amount in satisfaction of royalties Questcor had previously accrued but not paid during the course of the lawsuit. In February 2015, the settlement agreement was finalized, with terms consistent with the October 2014 term sheet.
Putative Class Action Securities Litigation. In September 2012, a putative class action lawsuit was filed against Questcor and certain of its officers and directors in the U.S. District Court for the Central District of California, captioned John K. Norton v. Questcor Pharmaceuticals, et al., No. SACvl2-1623 DMG (FMOx). The complaint purports to be brought on behalf of shareholders who purchased Questcor common stock between April 26, 2011 and September 21, 2012. The complaint generally alleges that Questcor and certain of its officers and directors engaged in various acts to artificially inflate the price of Questcor stock and enable insiders to profit through stock sales. The complaint asserts that Questcor and certain of its officers and directors violated sections l0(b) and/or 20(a) of the Securities Exchange Act of 1934, as amended ("the Exchange Act"), by making allegedly false and/or misleading statements concerning the clinical evidence to support the use of Acthar for indications other than infantile spasms, the promotion of the sale and use of Acthar in the treatment of multiple sclerosis and nephrotic syndrome, reimbursement for Acthar from third-party insurers, and Questcor's outlook and potential market growth for Acthar. The complaint seeks damages in an unspecified amount and equitable relief against the defendants. This lawsuit has been consolidated with four subsequently-filed actions asserting similar claims under the caption: In re Questcor Securities Litigation, No. CV 12-01623 DMG (FMOx). In October 2013, the District Court granted in part and denied in part Questcor's motion to dismiss the consolidated amended complaint. In October 2013, Questcor filed an answer to the consolidated amended complaint and fact discovery was concluded in January 2015. In April 2015, the parties executed a long-form settlement agreement, under the terms of which Questcor agreed to pay $38.0 million to resolve the plaintiff claims, inclusive of all fees and costs. Questcor and the individual defendants maintain that the plaintiffs' claims are without merit, and have entered into the settlement to eliminate the uncertainties, burden and expense of further protracted litigation. During fiscal 2015, the Company established a $38.0 million reserve for this settlement, which was subsequently paid to a settlement fund. The court issued its final approval of the settlement on September 18, 2015.
Federal Shareholder Derivative Litigation. On October 4, 2012, another alleged shareholder filed a derivative lawsuit in the United States District Court for the Central District of California captioned Gerald Easton v. Don M Bailey, et al., No. SACV12-01716 DOC (JPRx). The suit asserts claims substantially identical to those asserted in the do Valle derivative action described below against the same defendants. This lawsuit has been consolidated with five subsequently-filed actions asserting similar claims under the caption: In re Questcor Shareholder Derivative Litigation, CV 12- 01716 DMG (FMOx). Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying the federal derivative action until the earlier of: (a) 60 days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) 60 days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In July 2015, the parties stipulated to a dismissal of the derivative case and Questcor agreed to make a one-time cash payment to plaintiffs in the form of a mootness fee.
State Shareholder Derivative Litigation. In October 2012, an alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned Monika do Valle v. Virgil D. Thompson, et al., No. 30-2012-00602258-CU-SL-CXC. The complaint asserted claims for breach of fiduciary duty, abuse of control, mismanagement and waste of corporate assets arising from substantially similar allegations as those contained in the putative securities class action described above, as well as from allegations relating to sales of Questcor common

121



stock by the defendants and repurchases of Questcor common stock. The complaint sought an unspecified sum of damages and equitable relief. On October 24, 2012, another alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned Jones v. Bailey, et al., Case No. 30-2012-00608001-CU-MC-CXC. The suit asserted claims substantially identical to those asserted in the do Valle derivative action. In February 2013, the court issued an order staying the state derivative actions until the putative federal securities class action and federal derivative actions are resolved. In May 2014, the court granted plaintiffs' request for dismissal without prejudice of the Jones action. In November 2014, the do Valle matter was voluntarily dismissed.
Put Options Securities Action. In March 2013, individual traders of put options filed a securities complaint in the United States District Court for the Central District of California captioned David Taban, et al. v. Questcor Pharmaceuticals, Inc., No. SACV13-0425. The complaint generally asserts claims against Questcor and certain of its officers and directors for violations of the Exchange Act and for state law fraud and fraudulent concealment based on allegations similar to those asserted in the putative securities class action described above. The complaint seeks compensatory and punitive damages of an unspecified amount. Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying this action until the earlier of: (a) sixty (60) days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) sixty (60) days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In May 2015, the parties entered into a binding settlement agreement, under the terms of which plaintiffs agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to plaintiffs.
Pricing Litigation
State of Utah v. Apotex Corp., et al. The Company, along with several other pharmaceutical companies, is a defendant in this matter which was filed in May 2008, and is pending in the Third Judicial Circuit of Salt Lake County, Utah. The State of Utah alleges, generally, that the defendants reported false pricing information in connection with certain drugs that are reimbursable under Utah Medicaid, resulting in overpayment by Utah Medicaid for those drugs, and is seeking monetary damages and attorneys' fees. The Company believes that it has meritorious defenses to these claims and is vigorously defending against them.

Environmental Remediation and Litigation Proceedings
The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites, including those described below. The ultimate cost of site cleanup and timing of future cash outlays is difficult to predict, given the uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations and alternative cleanup methods. The Company concluded that, as of September 25, 2015, it was probable that it would incur remedial costs in the range of $39.8 million to $113.1 million. The Company also concluded that, as of September 25, 2015, the best estimate within this range was $76.5 million, of which $3.2 million was included in accrued and other current liabilities and the remainder was included in environmental liabilities on the consolidated balance sheet at September 25, 2015. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Crab Orchard National Wildlife Refuge Superfund Site, near Marion, Illinois. The Company is a successor in interest to International Minerals and Chemicals Corporation ("IMC"). Between 1967 and 1982, IMC leased portions of the Additional and Uncharacterized Sites ("AUS") Operable Unit at the Crab Orchard Superfund Site ("the Site") from the government and manufactured various explosives for use in mining and other operations. In March 2002, the Department of Justice, the U.S. Department of the Interior and the U.S. Environmental Protection Agency ("EPA") (together, "the Government Agencies") issued a special notice letter to General Dynamics Ordnance and Tactical Systems, Inc. ("General Dynamics"), one of the other potentially responsible parties ("PRPs") at the Site, to compel General Dynamics to perform the remedial investigation and feasibility study ("RI/FS") for the AUS Operable Unit. General Dynamics negotiated an Administrative Order on Consent ("AOC") with the Government Agencies to conduct an extensive RI/FS at the Site under the direction of the U.S. Fish and Wildlife Service. General Dynamics asserted in August 2004 that the Company is jointly and severally liable, along with approximately eight other lessees and operators at the AUS Operable Unit, for alleged contamination of soils and groundwater resulting from historic operations, and has threatened to file a contribution claim against the Company and other parties for recovery of its costs incurred in connection with the RI/FS activities being conducted at the AUS Operable Unit. The Company and other PRPs who received demand letters from General Dynamics have explored settlement alternatives, but have not reached settlement to date. General Dynamics has completed the RI and the PRPs have entered into an agreement to enter into non-binding mediation. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.


122



Mallinckrodt Veterinary, Inc., Millsboro, Delaware. The Company previously operated a plant in Millsboro, Delaware ("the Millsboro Site") that manufactured various animal healthcare products. In 2005, the Delaware Department of Natural Resources and Environmental Control found trichloroethylene ("TCE") in the Millsboro public water supply at levels that exceeded the federal drinking water standards. Further investigation to identify the TCE plume in the ground water indicated that the plume has extended to property owned by a third party near the Millsboro Site. The Company, and another former owner, assumed responsibility for the Millsboro Site cleanup under the Alternative Superfund Program administered by the EPA. The Company and another PRP have entered into two AOCs with the EPA to perform investigations to abate, mitigate or eliminate the release or threat of release of hazardous substances at the Millsboro Site and to conduct an Engineering Evaluation/Cost Analysis to characterize the nature and extent of the contamination. The Company, along with the other party, continues to conduct the studies and prepare remediation plans in accordance with the AOCs. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Coldwater Creek, Saint Louis County, Missouri. The Company is named as a defendant in numerous tort complaints filed in and subsequent to February 2012 with numerous plaintiffs pending in the U.S. District Court for the Eastern District of Missouri. These cases allege personal injury for alleged exposure to radiological substances, including in Coldwater Creek in Missouri, and in the air. Plaintiffs allegedly lived and/or worked in various locations in Saint Louis County, Missouri near Coldwater Creek. Radiological residues which may have been present in the creek have previously been remediated by the U.S. Army Corps of Engineers ("USACE"). The USACE continues to study and remediate the creek and surrounding areas. The Company believes that it has meritorious defenses to these complaints and is vigorously defending against them. The Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding the plaintiffs and their medical conditions; and (iii) there are significant factual and scientific issues to be resolved. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Lower Passaic River, New Jersey. The Company and approximately 70 other companies originally comprised the Lower Passaic Cooperating Parties Group ("the CPG") and are parties to a May 2007 AOC with the EPA to perform a RI/FS of the 17-mile stretch known as the Lower Passaic River Study Area ("the River"). The Company's potential liability stems from former operations at Lodi and Belleville, New Jersey. In June 2007, the EPA issued a draft Focused Feasibility Study ("FFS") that considered interim remedial options for the lower 8-miles of the river, in addition to a "no action" option. As an interim step related to the 2007 AOC, the CPG voluntarily entered into an AOC on June 18, 2012 with the EPA for remediation actions focused solely at mile 10.9 of the River. The Company's estimated costs related to the RI/FS and focused remediation at mile 10.9, based on interim allocations, are immaterial and have been accrued.
In April 2014, the EPA issued its revised FFS, with remedial alternatives to address cleanup of the lower 8-mile stretch of the River, which also included a "no action" option. The EPA estimates the cost for the alternatives range from $365.0 million to $3.2 billion. The EPA's preferred approach would involve bank-to-bank dredging of the lower 8-mile stretch of the River and installing an engineered cap at a discounted, estimated cost of $1.7 billion. Based on the issuance of the EPA's revised FFS, the Company recorded a $23.1 million accrual in fiscal 2014 representing the estimate of our allocable share of the joint and several remediation liability resulting from this matter.
In April 2015, the CPG presented a draft of the RI/FS of the River to the EPA. The CPG's RI/FS included alternatives that ranged from "no action," targeted remediation of the entire 17-mile stretch of the River to remedial actions consistent with the EPA's preferred approach for the lower 8-mile stretch of the River and also included remediation alternatives for the upper 9-mile stretch of the River. The discounted cost estimates for the CPG remediation alternatives ranged from $483.4 million to $2.7 billion. The Company recorded an additional charge of $13.3 million in the second quarter of fiscal 2015 based on the Company's estimate of its allocable share of the joint and several remediation liability resulting from this matter.
Despite the issuance of the revised FFS by the EPA and the RI/FS by the CPG, there are many uncertainties associated with the final agreed-upon remediation and the Company's allocable share of the remediation. As of November 20, 2015, the Company withdrew from the CPG, but remains liable for its obligations under the two above-referenced AOCs, as well as potential future liabilities. Given those uncertainties, the amounts accrued may not be indicative of the amounts for which the Company may be ultimately responsible and will be refined as events in the remediation process occur.

Products Liability Litigation
Beginning with lawsuits brought in July 1976, the Company is also named as a defendant in personal injury lawsuits based on alleged exposure to asbestos-containing materials. A majority of the cases involve product liability claims based principally on allegations of past distribution of products containing asbestos. A limited number of the cases allege premises liability based on claims that individuals were exposed to asbestos while on the Company's property. Each case typically names dozens of corporate defendants in addition to the Company. The complaints generally seek monetary damages for personal injury or bodily injury resulting from

123



alleged exposure to products containing asbestos. The Company's involvement in asbestos cases has been limited because it did not mine or produce asbestos. Furthermore, in the Company's experience, a large percentage of these claims have never been substantiated and have been dismissed by the courts. The Company has not suffered an adverse verdict in a trial court proceeding related to asbestos claims and intends to continue to defend these lawsuits. When appropriate, the Company settles claims; however, amounts paid to settle and defend all asbestos claims have been immaterial. As of September 25, 2015, there were approximately 12,750 asbestos-related cases pending against the Company.
The Company estimates pending asbestos claims, claims that were incurred but not reported and related insurance recoveries, which are recorded on a gross basis in the consolidated balance sheets. The Company's estimate of its liability for pending and future claims is based on claims experience over the past five years and covers claims either currently filed or expected to be filed over the next seven years. The Company believes that it has adequate amounts recorded related to these matters. While it is not possible at this time to determine with certainty the ultimate outcome of these asbestos-related proceedings, the Company believes, given the information currently available, that the ultimate resolution of all known and anticipated future claims, after taking into account amounts already accrued, along with recoveries from insurance, will not have a material adverse effect on its financial condition, results of operations and cash flows.

Asset Retirement Obligations
The Company has recorded asset retirement obligations for the estimated future costs primarily associated with legal obligations to decommission facilities within the Nuclear Imaging segment, including the facilities located in Petten, the Netherlands and Maryland Heights, Missouri. Substantially all of these obligations are included in other liabilities on the consolidated balance sheets. The following table provides a summary of the changes in the Company's asset retirement obligations for fiscal 2015 and 2014:
 
2015
 
2014
Balance at beginning of period
$
39.2

 
$
48.9

Additions and adjustments
(1.0
)
 
(11.5
)
Accretion expense
1.8

 
3.1

Payments
—

 
—

Currency translation
(3.1
)
 
(1.3
)
Balance at end of period
$
36.9

 
$
39.2

The Company believes that any potential payment of such estimated amounts will not have a material adverse effect on its financial condition, results of operations and cash flows.

Industrial Revenue Bonds
Through September 25, 2015, the Company exchanged title to $88.0 million of its plant assets in return for an equal amount of Industrial Revenue Bonds ("IRB") issued by Saint Louis County. The Company also simultaneously leased such assets back from Saint Louis County under capital leases expiring through December 2025, the terms of which provide it with the right of offset against the IRBs. The lease also provides an option for the Company to repurchase the assets at the end of the lease for nominal consideration. These transactions collectively result in a ten-year property tax abatement from the date the property is placed in service. Due to the right of offset, the capital lease obligation and IRB asset are recorded net in the consolidated balance sheets. The Company expects that the right of offset will be applied to payments required under these arrangements.

Interest Bearing Deferred Tax Obligation
As part of the integration of Questcor, the Company entered into an internal installment sale transaction related to certain Acthar intangible assets during the fiscal year ended September 25, 2015. The installment sale transaction resulted in a taxable gain. In accordance with Internal Revenue Code Section 453 the gain is considered taxable in the period in which installment payments are received. As of September 25, 2015, the Company had an aggregate $1,447.4 million of interest bearing U.S. deferred tax liabilities associated with outstanding installment notes. The U.S. Internal Revenue Service ("IRS") charges interest based on the deferred tax liability outstanding as of the end of a company's fiscal year, regardless of amounts outstanding during the fiscal year. During the fiscal year ended September 25, 2015 the Company accrued Section 453 interest of $36.5 million which is included within interest expense.


124



Leases
The Company has facility, vehicle and equipment leases that expire at various dates. Rental expense under facility, vehicle and equipment operating leases related to continuing operations was $24.3 million, $15.2 million and $13.7 million for fiscal 2015, 2014 and 2013, respectively. The Company also has facility and equipment commitments under capital leases.
The following is a schedule of minimum lease payments for non-cancelable leases as of September 25, 2015:
 
Operating Leases
 
Capital
Leases
Fiscal 2016
$
21.1

 
$
1.3

Fiscal 2017
17.7

 
0.9

Fiscal 2018
15.0

 
0.1

Fiscal 2019
11.3

 
—

Fiscal 2020
9.3

 
—

Thereafter
20.6

 
—

Total minimum lease payments
$
95.0

 
2.3

Less: interest portion of payments
 
 
—

Present value of minimum lease payments
 
 
$
2.3

Tax Matters
The income tax returns of the Company and its subsidiaries are periodically examined by various tax authorities. The resolution of these matters is subject to the conditions set forth in the Tax Matters Agreement between the Company and Covidien. Covidien has the right to administer, control and settle all U.S. income tax audits for periods prior to the Separation. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that established liabilities are reasonable and that the ultimate resolution of these matters will not have a material adverse effect on its financial condition, results of operations and cash flows.
With respect to certain tax returns filed by predecessor affiliates of the Company and Covidien, the IRS has concluded its field examination for the years 1997 through 2009. The Company considers such uncertain tax positions associated with these years as having been effectively settled. All but one of the matters associated with these audits have been resolved. The unresolved proposed adjustment asserts that substantially all of the predecessor affiliates' intercompany debt originating during the years 1997 through 2000 should not be treated as debt for U.S. federal income tax purposes, and has disallowed interest deductions related to the intercompany debt and certain tax attribute adjustments recognized on the U.S. income tax returns. This matter is subject to the Company's $200.0 million liability limitation for periods prior to September 29, 2012, as prescribed in the Tax Matters Agreement. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that it will not have a material adverse effect on its financial condition, results of operations and cash flows.
Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a $22.5 million benefit, during fiscal 2015, in discontinued operations.

Acquisition-Related Litigation
Several purported class action lawsuits were filed in February 2014 and March 2014 by purported holders of Cadence common stock in connection with the Cadence Acquisition, including in the Delaware Court of Chancery (consolidated under the caption In re Cadence Pharmaceuticals, Inc. Stockholders Litigation), and in California State Court, San Diego County (Denny v. Cadence Pharmaceuticals, Inc., et al., Militello v. Cadence Pharmaceuticals, Inc., et al., and Schuon v. Cadence Pharmaceuticals, Inc., et al.). The actions bring claims against, and generally allege that, the board of directors of Cadence breached their fiduciary duties in connection with the Cadence Acquisition by, among other things, failing to maximize shareholder value, and the Delaware and Schuon actions further allege that Cadence omitted to disclose allegedly material information in its Schedule 14D-9. The lawsuits also allege, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs. On March 7, 2014, following expedited discovery, the parties in the consolidated Delaware action entered into a Memorandum of Understanding ("the MOU"), which sets forth the parties' agreement in principle for a settlement of those actions. The settlement was memorialized in a formal Stipulation and Settlement and Release in March 2015, and includes among other things, a release of all claims relating to the Cadence Acquisition as set forth in the Stipulation. On June 8, 2015, the Delaware Court approved the settlement. There were no substantive proceedings in any of the California actions. On July 29, 2014, the Militello case was voluntarily dismissed without prejudice. On

125



September 8, 2014, the Denny case was voluntarily dismissed without prejudice. On June 23, 2015, the Schuon case was voluntarily dismissed without prejudice.
Since the announcement of the merger with Questcor on April 7, 2014, several putative class actions have been filed by purported holders of Questcor common stock in connection with the Questcor Acquisition (Hansen v. Thompson, et al., Heng v. Questcor Pharmaceuticals, Inc., et al., Buck v. Questcor Pharmaceuticals, Inc., et al., Ellerbeck v. Questcor Pharmaceuticals, Inc., et al., Yokem v. Questcor Pharmaceuticals, Inc., et al., Richter v. Questcor Pharmaceuticals, Inc., et al., Tramantano v. Questcor Pharmaceuticals, Inc., et al., Crippen v. Questcor Pharmaceuticals, Inc., et al., Patel v. Questcor Pharmaceuticals, Inc., et al., and Postow v. Questcor Pharmaceuticals, Inc., et al.). The actions were consolidated on June 3, 2014. The consolidated complaint names as defendants, and generally alleges that, the directors of Questcor breached their fiduciary duties in connection with the acquisition by, among other things, agreeing to sell Questcor for inadequate consideration and pursuant to an inadequate process. The consolidated complaint also alleges that the Questcor directors breached their fiduciary duties by failing to disclose purportedly material information to shareholders in connection with the merger. The consolidated complaint also alleges, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs.
On July 29, 2014, the defendants reached an agreement in principle with the plaintiffs in the consolidated actions, and that agreement is reflected in a MOU. In connection with the settlement contemplated by the MOU, Questcor agreed to make certain additional disclosures related to the proposed transaction with the Company, which are contained in the Company's Current Report on Form 8-K filed with the SEC on July 30, 2014. Additionally, as part of the settlement and pursuant to the MOU, the Company agreed to forbear from exercising certain rights under the merger agreement with Questcor, as follows: the four business day period referenced in Section 5.3(e) of the merger agreement with Questcor was reduced to three business days. Consistent with the terms of the MOU, the parties entered into a formal stipulation of settlement in February 2015 and re-executed the stipulation of settlement on May 7, 2015 (collectively the "Stipulation of Settlement").
The Stipulation of Settlement was subject to customary conditions, including court approval. On May 8, 2015, the California Court denied plaintiffs' Motion for Preliminary Approval of Settlement. On October 23, 2015, the parties submitted a proposed Stipulation and Order re Dismissal With Prejudice dismissing the action with prejudice as to each of the named plaintiffs and without prejudice as to the remainder of the class, and on October 30, 2015 the California Court entered that Order.

Other Matters
The Company is a defendant in a number of other pending legal proceedings relating to present and former operations, acquisitions and dispositions. The Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its financial condition, results of operations and cash flows.

20.
Financial Instruments and Fair Value Measurements
Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes a three-level fair value hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs used in measuring fair value. The levels within the hierarchy are as follows:
Level 1— observable inputs such as quoted prices in active markets for identical assets or liabilities;
Level 2— significant other observable inputs that are observable either directly or indirectly; and
Level 3— significant unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions.


126



The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:
 
September 25,
2015
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
34.6

 
$
24.2

 
$
10.4

 
$
—

 
$
34.6

 
$
24.2

 
$
10.4

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
20.0

 
$
—

 
$
20.0

 
$
—

Contingent consideration and acquired contingent liabilities
174.6

 
—

 
—

 
174.6

Foreign exchange forward and option contracts
3.3

 
3.3

 
—

 
—

 
$
197.9

 
$
3.3

 
$
20.0

 
$
174.6


 
September 26,
2014

Quoted Prices in Active Markets for Identical Assets
(Level 1)

Significant Other Observable Inputs
(Level 2)

Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
35.7

 
$
22.9

 
$
12.8

 
$
—

 
$
35.7

 
$
22.9

 
$
12.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
15.0

 
$
—

 
$
15.0

 
$
—

Contingent consideration and acquired contingent liabilities
202.8

 
—

 
—

 
202.8

Foreign exchange forward and option contracts
0.2

 
0.2

 
—

 
—


$
218.0

 
$
0.2

 
$
15.0

 
$
202.8


Debt and equity securities held in rabbi trust. Debt securities held in the rabbi trust primarily consist of U.S. government and agency securities and corporate bonds. When quoted prices are available in an active market, the investments are classified as level 1. When quoted market prices for a security are not available in an active market, they are classified as level 2. Equity securities held in the rabbi trust primarily consist of U.S. common stocks, which are valued using quoted market prices reported on nationally recognized securities exchanges.
Foreign exchange forward and option contracts. Foreign currency option and forward contracts are used to economically manage the foreign exchange exposures of operations outside the U.S. Quoted prices are available in an active market; as such, these derivatives are classified as level 1.
Deferred compensation liabilities. The Company maintains a non-qualified deferred compensation plan in the U.S., which permits eligible employees of the Company to defer a portion of their compensation. A recordkeeping account is set up for each participant and the participant chooses from a variety of funds for the deemed investment of their accounts. The recordkeeping accounts generally correspond to the funds offered in the Company's U.S. tax-qualified defined contribution retirement plan and the account balance fluctuates with the investment returns on those funds.
Goodwill. The Company performs an annual goodwill impairment assessment using an income approach based on the present value of future cash flows. See further discussion in Notes 2 and 11.
Contingent consideration and acquired contingent liabilities. In October 2012, the Company recorded contingent consideration of $6.9 million upon the acquisition of CNS Therapeutics. This contingent consideration, which could potentially total a maximum of $9.0 million, is primarily based on whether the FDA approves another concentration of Gablofen on or before December 31, 2016. The fair value of the contingent payments was measured based on the probability-weighted present value of the consideration expected to be transferred using a discount rate of 1.0%. At September 25, 2015, the fair value of this contingent consideration was $7.2 million.

127



In August 2014, the Company recorded acquired contingent liabilities of $195.4 million from the Questcor Acquisition. The contingent liabilities relate to Questcor's contingent obligations associated with their acquisition of an exclusive, perpetual and irrevocable license to develop, market, manufacture, distribute, sell and commercialize Synacthen and Synacthen Depot (collectively "Synacthen") from Novartis AG and Novartis Pharma AG (collectively "Novartis") and their acquisition of BioVectra. The fair value of these contingent consideration obligations at September 25, 2015 were $167.4 million.
Under the terms of the license agreement with Novartis, the Company is obligated to make a $25.0 million payment in fiscal 2016, make annual payments of $25.0 million subsequent to fiscal 2016 until such time that the Company obtains FDA approval of Synacthen and make a $25.0 million payment upon obtaining FDA approval of Synacthen. If FDA approval is obtained, the Company will pay an annual royalty to Novartis based on a percentage of net sales of the products in the U.S. market. The Company made its fiscal 2015 required payment of $25.0 million. As of September 25, 2015, the total remaining payments under the license agreement shall not exceed $190.0 million. The terms of the license agreement do allow the Company to terminate the license agreement at our discretion following the fiscal 2018 payment or upon the occurrence of certain events following the fiscal 2016 payment. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of 4.7%. Under the terms of the license agreement, the Company was required to maintain deposits equal to the fiscal 2016 annual $25.0 million payment which is included in prepaid expenses and other current assets and other assets in the consolidated balance sheets.

Based on the terms of the acquisition agreement with the former shareholders of BioVectra, the Company may be obligated to pay additional cash consideration of $50.0 million CAD based on BioVectra's financial results from January 2013 through a portion of fiscal 2016. During fiscal 2015 and 2014, the Company made $5.0 million CAD payments to the former shareholders and may be obligated for an additional $40.0 million CAD to be paid in fiscal 2016. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of 1.3%.
Balance at September 26, 2014
$
202.8

Payments
(29.0
)
Accretion expense
7.5

Effect of currency rate change
(6.7
)
Balance at September 25, 2015
$
174.6


Financial Instruments Not Measured at Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and the majority of other current assets and liabilities approximate fair value because of their short-term nature. The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents (level 1). The fair value of restricted cash is equivalent to its carrying value of $66.3 million and $69.8 million as of September 25, 2015 and September 26, 2014, respectively (level 1), substantially all of which is included in other assets on the consolidated balance sheets. The Company's life insurance contracts are carried at cash surrender value, which is based on the present value of future cash flows under the terms of the contracts (level 3). Significant assumptions used in determining the cash surrender value include the amount and timing of future cash flows, interest rates and mortality charges. The fair value of these contracts approximates the carrying value of $67.7 million and $67.3 million at September 25, 2015 and September 26, 2014, respectively. These contracts are included in other assets on the consolidated and combined balances sheets.
The carrying values of the Company's revolving credit facility and variable rate receivable securitization approximate the fair values due to the short-term nature of these instruments. The carrying values of the 2.85% and 4.00% term loans approximate the fair values of these instruments, as calculated using the discounted exit price for each instrument, and are therefore classified as level 3. Since the quoted market prices for the Company's term loans and 8.00% and 9.50% debentures are not available in an active market, they are classified as level 2 for purposes of developing an estimate of fair value. The Company's 3.50%, 4.75%, 4.875%, 5.50%, 5.625% and 5.75% notes are classified as level 1, as quoted prices are available in an active market for these notes. The following table presents the carrying values and estimated fair values of the Company's long-term debt, excluding capital leases, as of the end of each period:

128




September 25, 2015

September 26, 2014

Carrying
Value

Fair
Value

Carrying
Value

Fair
Value
Variable rate receivable securitization
$
153.0

 
$
153.0

 
$
150.0

 
$
150.0

2.85% term loan due April 2016
—

 
—

 
3.1

 
3.1

3.50% notes due April 2018
300.0

 
294.3

 
300.0

 
290.2

4.875% notes due April 2020
700.0

 
684.1

 
—

 
—

Term loans due March 2021
1,978.5

 
1,966.5

 
1,996.7

 
1,970.4

4.00% term loan due February 2022
7.9

 
7.9

 
10.8

 
10.8

9.50% debentures due May 2022
10.4

 
13.0

 
10.4

 
14.2

5.75% notes due August 2022
900.0

 
876.1

 
900.0

 
907.3

8.00% debentures due March 2023
4.4

 
5.3

 
8.0

 
10.2

4.75% notes due April 2023
600.0

 
539.6

 
600.0

 
563.8

5.625% notes due October 2023
750.0

 
705.2

 
—

 
—

5.50% notes due April 2025
700.0

 
646.0

 
—

 
—

Revolving credit facility
500.0

 
500.0

 
—

 
—


Concentration of Credit and Other Risks
Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of accounts receivable. The Company does not require collateral from customers. A portion of the Company's accounts receivable outside the U.S. includes sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries' national economies.
The following table shows net sales attributable to distributors that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
CuraScript, Inc.
31
%
 
6
%
 
—
%
McKesson Corporation
18
%
 
21
%
 
19
%
Cardinal Health, Inc.
14
%
 
22
%
 
24
%
AmerisourceBergen Corporation
9
%
 
14
%
 
11
%

The following table shows accounts receivable attributable to distributors that accounted for 10% or more of the Company's gross accounts receivable at the end of each period:

September 25,
2015

September 26,
2014
McKesson Corporation
24
%
 
27
%
CuraScript, Inc.
16
%
 
15
%
Cardinal Health, Inc.
13
%
 
18
%
AmerisourceBergen Corporation
12
%
 
14
%

 The following table shows net sales attributable to products that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
Acthar
31
%
 
6
%
 
—
%
Acetaminophen products (API)
6
%
 
9
%
 
13
%
Methylphenidate ER
4
%
 
10
%
 
9
%


129



Molybdenum-99 ("Mo-99") is a key raw material in the Company's Ultra-Technekow DTE technetium generators that are sold by its Nuclear Imaging segment. There are only eight suppliers of this raw material worldwide. The Company has agreements to obtain Mo-99 from three nuclear research reactors and relies predominantly upon two of these reactors for its Mo-99 supply. Accordingly, a disruption in the commercial supply or a significant increase in the cost of this material from these sources could have a material adverse effect on the Company's financial condition, results of operations and cash flows.

21.
Segment and Geographical Data
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:

•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and API consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).

Management measures and evaluates the Company's operating segments based on segment net sales and operating income. Management excludes corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include revenues and expenses associated with sales of products to Covidien, intangible asset amortization, net restructuring and related charges, non-restructuring impairments and separation costs. Although these amounts are excluded from segment operating income, as applicable, they are included in reported consolidated and combined operating income and in the following reconciliations.
Management manages assets on a total company basis, not by operating segment.  The chief operating decision maker does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.  Total assets were approximately $16.4 billion and $12.8 billion at September 25, 2015 and September 26, 2014, respectively.

130



Selected information by business segment is as follows:

Fiscal Year

2015
 
2014
 
2013
Net sales:
 
 
 
 
 
Specialty Brands
1,622.8

 
413.5

 
206.4

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

Nuclear Imaging
423.8

 
431.7

 
437.6

Net sales of operating segments (1)
3,298.2

 
2,044.6

 
1,655.2

Other (2)
48.7

 
37.4

 
57.1

Net sales
3,346.9

 
2,082.0

 
1,712.3

Operating income:
 
 
 
 
 
Specialty Brands
651.3

 
(50.6
)
 
(36.2
)
Specialty Generics
622.0

 
617.4

 
347.9

Nuclear Imaging
66.4

 
(16.7
)
 
24.5

Segment operating income
1,339.7

 
550.1

 
336.2

Unallocated amounts:
 
 
 
 
 
Corporate and allocated expenses (3)          
(286.9
)
 
(228.1
)
 
(134.3
)
Intangible asset amortization
(550.3
)
 
(154.8
)
 
(27.9
)
Restructuring and related charges, net (4)
(40.7
)
 
(81.9
)
 
(26.3
)
Non-restructuring impairments
—

 
(151.6
)
 
—

Separation costs
—

 
(9.6
)
 
(74.2
)
Operating income (loss)
461.8

 
(75.9
)
 
73.5

 
 
 
 
 
 
Depreciation and amortization (5):
 
 
 
 
 
Specialty Brands
559.8

 
152.9

 
24.9

Specialty Generics
81.9

 
77.8

 
72.7

Nuclear Imaging
12.4

 
18.8

 
18.5

Depreciation and amortization
654.1

 
249.5

 
116.1

(1)
Amounts represent sales to external customers. There were no intersegment sales.
(2)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
(3)
Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
(4)
Includes restructuring-related accelerated depreciation.
(5)
Depreciation for certain shared facilities is allocated based on occupancy percentage.


131



Net sales by product family within the Company's segments are as follows:

 
Fiscal Year
 
2015
 
2014
 
2013
Acthar
$
1,037.3

 
$
122.9

 
$
—

Ofirmev
263.0

 
124.4

 
—

Inomax
185.2

 
—

 
—

Exalgo
39.4

 
76.1

 
126.1

Other
97.9

 
90.1

 
80.3

Specialty Brands
1,622.8

 
413.5

 
206.4

 
 
 
 
 
 
Hydrocodone (API) and hydrocodone-containing tablets
167.2

 
99.4

 
140.0

Oxycodone (API) and oxycodone-containing tablets
154.6

 
155.2

 
139.0

Methylphenidate ER
136.5

 
209.6

 
148.3

Other controlled substances
572.2

 
584.5

 
443.3

Other
221.1

 
150.7

 
140.6

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

 
 
 
 
 
 
Nuclear Imaging
423.8

 
431.7

 
437.6

 
 
 
 
 
 
Other (1)
48.7

 
37.4

 
57.1

Net sales
$
3,346.9

 
$
2,082.0

 
$
1,712.3


(1)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.


Selected information by geographic area excluding assets held for sale is as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Net sales (1):
 
 
 
 
 
U.S.
$
2,973.2

 
$
1,780.9

 
$
1,421.6

Europe, Middle East and Africa
236.2

 
250.3

 
250.1

Other
137.5

 
50.8

 
40.6

 
$
3,346.9

 
$
2,082.0

 
$
1,712.3

Long-lived assets (2):
 
 
 
 
 
U.S.
$
905.2

 
$
829.1

 
 
Europe, Middle East and Africa (3)
45.0

 
33.9

 
 
Other
44.5

 
41.0

 
 
 
$
994.7

 
$
904.0

 
 
(1)
Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.
(2)
Long-lived assets are primarily composed of property, plant and equipment.
(3)
Includes long-lived assets located in Ireland of $10.7 million, and $0.4 million at the end of fiscal 2015 and 2014, respectively.




132



22.
Selected Quarterly Financial Data (Unaudited)
 
Fiscal 2015 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
768.2

 
$
819.0

 
$
877.3

 
$
882.4

Gross profit
404.8

 
462.9

 
503.8

 
482.1

Income from continuing operations
87.4

 
75.2

 
55.6

 
90.0

Income (loss) from discontinued operations
5.3

 
23.6

 
2.4

 
(14.8
)
Net income
92.7

 
98.8

 
58.0

 
75.2

 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.75

 
$
0.64

 
$
0.47

 
$
0.77

Diluted earnings per share from continuing operations (1)
0.74

 
0.64

 
0.47

 
0.76

 
 
Fiscal 2014 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
429.5

 
$
448.7

 
$
530.1

 
$
673.7

Gross profit
216.2

 
226.7

 
254.1

 
363.2

Income (loss) from continuing operations
38.5

 
20.2

 
(29.0
)
 
(173.5
)
Income (loss) from discontinued operations
7.1

 
(8.6
)
 
4.9

 
(178.9
)
Net income (loss)
45.6

 
11.6

 
(24.1
)
 
(352.4
)
 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.67

 
$
0.35

 
$
(0.50
)
 
$
(2.04
)
Diluted earnings per share from continuing operations (1)
0.66

 
0.34

 
(0.50
)
 
(2.04
)

(1)
Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.

23.
Condensed Consolidating and Combining Financial Statements

In November 2012, MIFSA was formed as a 100%-owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations.
MIFSA is the borrower under the Notes, which are fully and unconditionally guaranteed by Mallinckrodt plc. The following information provides the composition of the Company's comprehensive income, assets, liabilities, equity and cash flows by relevant group within the Company: Mallinckrodt plc as guarantor of the Notes, MIFSA as issuer of the Notes and the operating companies that represent assets of MIFSA. There are no subsidiary guarantees related to the Notes.
Set forth below are the condensed consolidating balance sheet as of September 25, 2015 and September 26, 2014 and condensed consolidating statements of comprehensive income and cash flows for the three years ended September 25, 2015. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among Mallinckrodt plc, MIFSA and the other subsidiaries. Condensed consolidating and combining financial information for Mallinckrodt plc and MIFSA, on a standalone basis, has been presented using the equity method of accounting for subsidiaries.



133



MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 25, 2015
(in millions)


 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.1

 
$
152.1

 
$
213.7

 
$
—

 
$
365.9

Accounts receivable, net
—

 
—

 
548.5

 
—

 
548.5

Inventories
—

 
—

 
281.8

 
—

 
281.8

Deferred income taxes
—

 
—

 
142.7

 
—

 
142.7

Prepaid expenses and other current assets
1.3

 
0.2

 
205.8

 
—

 
207.3

Current assets held for sale
—

 
—

 
299.9

 
—

 
299.9

Intercompany receivable
39.1

 
128.6

 
9,699.5

 
(9,867.2
)
 
—

Total current assets
40.5

 
280.9

 
11,391.9

 
(9,867.2
)
 
1,846.1

Property, plant and equipment, net
—

 
—

 
991.3

 
—

 
991.3

Goodwill
—

 
—

 
3,649.4

 
—

 
3,649.4

Intangible assets, net
—

 
—

 
9,666.3

 
—

 
9,666.3

Long-term assets held for sale
—

 
—

 
—

 
—

 
—

Investment in subsidiaries
14,797.7

 
18,838.6

 
10,050.0

 
(43,686.3
)
 
—

Intercompany loan receivable
174.4

 
—

 
2,498.2

 
(2,672.6
)
 
—

Other assets
—

 
0.1

 
250.9

 
—

 
251.0

Total Assets
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1

 
 
 
 
 
 
 
 
 
—

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
20.0

 
$
2.3

 
$
—

 
$
22.3

Accounts payable
—

 
0.2

 
132.8

 
—

 
133.0

Accrued payroll and payroll-related costs
0.1

 
—

 
103.6

 
—

 
103.7

Accrued royalties
—

 
—

 
29.3

 
—

 
29.3

Accrued and other current liabilities
1.8

 
77.4

 
489.1

 
—

 
568.3

Current liabilities held for sale
—

 
—

 
72.8

 
—

 
72.8

Intercompany payable
9,699.5

 
—

 
167.7

 
(9,867.2
)
 
—

Total current liabilities
9,701.4

 
97.6

 
997.6

 
(9,867.2
)
 
929.4

Long-term debt
—

 
6,299.4

 
174.9

 
—

 
6,474.3

Pension and postretirement benefits
—

 
—

 
116.7

 
—

 
116.7

Environmental liabilities
—

 
—

 
73.3

 
—

 
73.3

Deferred income taxes
—

 
—

 
3,132.4

 
—

 
3,132.4

Other income tax liabilities
—

 
—

 
121.3

 
—

 
121.3

Long-term liabilities held for sale
—

 
—

 
—

 
—

 
—

Intercompany loans payable
—

 
2,672.6

 
—

 
(2,672.6
)
 
—

Other liabilities
—

 
—

 
245.5

 
—

 
245.5

Total liabilities
9,701.4

 
9,069.6

 
4,861.7

 
(12,539.8
)
 
11,092.9

Shareholders' equity
5,311.2

 
10,050.0

 
33,636.3

 
(43,686.3
)
 
5,311.2

Total Liabilities and Shareholders' Equity
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1


134



MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8

Accounts receivable, net
—

 
—

 
476.6

 
—

 
476.6

Inventories
—

 
—

 
306.4

 
—

 
306.4

Deferred income taxes
—

 
—

 
152.3

 
—

 
152.3

Prepaid expenses and other current assets
0.5

 
10.8

 
215.8

 
—

 
227.1

Current assets held for sale
—

 
—

 
200.8

 
—

 
200.8

Intercompany receivable
13.5

 
—

 
25.7

 
(39.2
)
 
—

Total current assets
14.3

 
29.3

 
2,066.6

 
(39.2
)
 
2,071.0

Property, plant and equipment, net
—

 
—

 
886.8

 
—

 
886.8

Goodwill
—

 
—

 
2,401.9

 
—

 
2,401.9

Intangible assets, net
—

 
—

 
7,082.2

 
—

 
7,082.2

Long-term assets held for sale
—

 
—

 
111.2

 
—

 
111.2

Investment in subsidiaries
586.8

 
10,645.7

 
4,945.1

 
(16,177.6
)
 
—

Intercompany loan receivable
4,385.0

 
—

 
1,941.6

 
(6,326.6
)
 
—

Other assets
—

 
—

 
234.2

 
—

 
234.2

Total Assets
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3

 

 

 

 

 

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
18.2

 
$
3.0

 
$
—

 
$
21.2

Accounts payable
1.2

 
0.2

 
109.3

 
—

 
110.7

Accrued payroll and payroll-related costs
0.1

 
—

 
116.2

 
—

 
116.3

Accrued royalties
—

 
—

 
67.7

 
—

 
67.7

Accrued and other current liabilities
1.1

 
50.9

 
477.9

 
—

 
529.9

Current liabilities held for sale
—

 
—

 
59.0

 
—

 
59.0

Intercompany payable
25.7

 
—

 
13.5

 
(39.2
)
 
—

Total current liabilities
28.1

 
69.3

 
846.6

 
(39.2
)
 
904.8

Long-term debt
—

 
3,693.9

 
180.1

 
—

 
3,874.0

Pension and postretirement benefits
—

 
—

 
116.2

 
—

 
116.2

Environmental liabilities
—

 
—

 
59.2

 
—

 
59.2

Deferred income taxes
—

 
—

 
2,399.6

 
—

 
2,399.6

Other income tax liabilities
—

 
—

 
122.6

 
—

 
122.6

Long-term liabilities held for sale
—

 
—

 
9.7

 
—

 
9.7

Intercompany loans payable
—

 
1,966.6

 
4,360.0

 
(6,326.6
)
 
—

Other liabilities
—

 
—

 
343.2

 
—

 
343.2

Total liabilities
28.1

 
5,729.8

 
8,437.2

 
(6,365.8
)
 
7,829.3

Shareholders' equity
4,958.0

 
4,945.2

 
11,232.4

 
(16,177.6
)
 
4,958.0

Total Liabilities and Shareholders' Equity
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3



135



MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 25, 2015
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
—

 
$
—

 
$
3,346.9

 
$
—

 
$
3,346.9

Cost of sales
—

 
—

 
1,493.3

 
—

 
1,493.3

Gross profit
—

 
—

 
1,853.6

 
—

 
1,853.6

Selling, general and administrative expenses
116.3

 
15.7

 
1,037.8

 
—

 
1,169.8

Research and development expenses
—

 
—

 
185.1

 
—

 
185.1

Restructuring charges, net
9.8

 
—

 
30.6

 
—

 
40.4

Gains on divestiture and license
—

 
—

 
(3.5
)
 
—

 
(3.5
)
Operating income (loss)
(126.1
)
 
(15.7
)
 
603.6

 
—

 
461.8

 
 
 
 
 
 
 
 
 
—

Interest expense
(96.4
)
 
(230.2
)
 
(25.2
)
 
96.2

 
(255.6
)
Interest income
—

 
0.1

 
97.1

 
(96.2
)
 
1.0

Other income (expense), net
216.3

 
—

 
(208.2
)
 
—

 
8.1

Intercompany interest and fees
(14.7
)
 
—

 
14.7

 
—

 
—

Equity in net income of subsidiaries
330.6

 
496.3

 
250.5

 
(1,077.4
)
 
—

Income from continuing operations before income taxes
309.7

 
250.5

 
732.5

 
(1,077.4
)
 
215.3

Benefit from income taxes
(15.9
)
 
—

 
(77.0
)
 
—

 
(92.9
)
Income from continuing operations
325.6

 
250.5

 
809.5

 
(1,077.4
)
 
308.2

Gain (loss) from discontinued operations, net of income taxes
(0.9
)
 
—

 
17.4

 
—

 
16.5

Net income
324.7

 
250.5

 
826.9

 
(1,077.4
)
 
324.7

Other comprehensive loss, net of tax
(64.8
)
 
(64.8
)
 
(69.9
)
 
134.7

 
(64.8
)
Comprehensive income
$
259.9

 
$
185.7

 
$
757.0

 
$
(942.7
)
 
$
259.9


136



MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
2,082.0

 
$
—

 
$
2,082.0

Cost of sales
—

 
—

 
1,021.8

 
—

 
1,021.8

Gross profit
—

 
—

 
1,060.2

 
—

 
1,060.2

Selling, general and administrative expenses
37.7

 
7.3

 
700.0

 
—

 
745.0

Research and development expenses
—

 
—

 
163.5

 
—

 
163.5

Restructuring charges, net
35.3

 
—

 
46.1

 
—

 
81.4

Non-restructuring impairments
—

 
—

 
151.6

 
—

 
151.6

Separation costs
2.5

 
—

 
7.1

 
—

 
9.6

Gains on divestiture and license
—

 
—

 
(15.0
)
 
—

 
(15.0
)
Operating (loss) income
(75.5
)
 
(7.3
)
 
6.9

 
—

 
(75.9
)
 

 

 

 

 

Interest expense
—

 
(86.3
)
 
—

 
3.7

 
(82.6
)
Interest income
—

 
—

 
5.2

 
(3.7
)
 
1.5

Other income (expense), net
30.9

 
—

 
(27.8
)
 
—

 
3.1

Intercompany interest and fees
(9.0
)
 
—

 
9.0

 
—

 
—

Equity in net income of subsidiaries
(264.8
)
 
(171.2
)
 
(300.2
)
 
736.2

 
—

Loss from continuing operations before income taxes
(318.4
)
 
(264.8
)
 
(306.9
)
 
736.2

 
(153.9
)
Benefit from income taxes
—

 
—

 
(10.1
)
 
—

 
(10.1
)
Loss from continuing operations
(318.4
)
 
(264.8
)
 
(296.8
)
 
736.2

 
(143.8
)
Loss from discontinued operations, net of income taxes
(0.9
)
 
—

 
(174.6
)
 
—

 
(175.5
)
Net loss
(319.3
)
 
(264.8
)
 
(471.4
)
 
736.2

 
(319.3
)
Other comprehensive loss, net of tax
(42.8
)
 
(42.8
)
 
(84.1
)
 
126.9

 
(42.8
)
Comprehensive loss
$
(362.1
)
 
$
(307.6
)
 
$
(555.5
)
 
$
863.1

 
$
(362.1
)




137



MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 27, 2013
(in millions)
 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
1,712.3

 
$
—

 
$
1,712.3

Cost of sales
—

 
—

 
890.0

 
—

 
890.0

Gross profit
—

 
—

 
822.3

 
—

 
822.3

Selling, general and administrative expenses
5.2

 
0.1

 
490.6

 
—

 
495.9

Research and development expenses
—

 
—

 
157.9

 
—

 
157.9

Restructuring charges, net
—

 
—

 
23.7

 
—

 
23.7

Separation costs
3.2

 
0.6

 
70.4

 
—

 
74.2

Gains on divestiture and license
—

 
—

 
(2.9
)
 
—

 
(2.9
)
Operating income (loss)
(8.4
)
 
(0.7
)
 
82.6

 
—

 
73.5

 
 
 
 
 
 
 
 
 
 
Interest expense
—

 
(19.6
)
 
0.1

 
—

 
(19.5
)
Interest income
—

 
—

 
0.3

 
—

 
0.3

Other income (expense), net
0.2

 
—

 
1.2

 
—

 
1.4

Intercompany interest and fees
(9.5
)
 
—

 
9.5

 
—

 
—

Equity in net income of subsidiaries
76.4

 
96.7

 
—

 
(173.1
)
 
—

Income from continuing operations before income taxes
58.7

 
76.4

 
93.7

 
(173.1
)
 
55.7

Provision for (benefit from) income taxes
(0.3
)
 
—

 
47.8

 
—

 
47.5

Income from continuing operations
59.0

 
76.4

 
45.9

 
(173.1
)
 
8.2

Gain (loss) from discontinued operations, net of income taxes
(0.2
)
 
—

 
50.8

 
—

 
50.6

Net income
58.8

 
76.4

 
96.7

 
(173.1
)
 
58.8

Other comprehensive income, net of tax
28.4

 
28.4

 
35.7

 
(64.1
)
 
28.4

Comprehensive income
$
87.2

 
$
104.8

 
$
132.4

 
$
(237.2
)
 
$
87.2



138



MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Fiscal year ended September 25, 2015
(in millions)


Mallinckrodt plc

Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
207.0

 
$
(148.2
)
 
$
837.6

 
$
—

 
$
896.4

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(148.0
)
 
—

 
(148.0
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,154.7
)
 
—

 
(2,154.7
)
Intercompany loan investment
(149.4
)
 
—

 
(554.2
)
 
703.6

 
—

Investment in subsidiary
—

 
(3,014.4
)
 
—

 
3,014.4

 
—

Restricted cash
—

 
—

 
3.1

 
—

 
3.1

Other
—

 
—

 
3.0

 
—

 
3.0

Net cash used in investing activities
(149.4
)
 
(3,014.4
)
 
(2,850.8
)
 
3,718.0

 
(2,296.6
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
2,890.0

 
120.0

 
—

 
3,010.0

Repayment of external debt and capital leases
—

 
(258.3
)
 
(1,590.1
)
 
—

 
(1,848.4
)
Excess tax benefit from share-based compensation
—

 
—

 
34.1

 
—

 
34.1

Debt financing costs
—

 
(39.1
)
 
(0.8
)
 
—

 
(39.9
)
Proceeds from exercise of share options
34.4

 
—

 
—

 
—

 
34.4

Intercompany loan borrowings
—

 
703.6

 
—

 
(703.6
)
 
—

Capital contribution
—

 
—

 
3,014.4

 
(3,014.4
)
 
—

Repurchase of shares
(92.2
)
 
—

 
—

 
—

 
(92.2
)
Other
—

 
—

 
(28.1
)
 
—

 
(28.1
)
Net cash provided by financing activities
(57.8
)
 
3,296.2

 
1,549.5

 
(3,718.0
)
 
1,069.9

Effect of currency rate changes on cash
—

 
—

 
(11.6
)
 
—

 
(11.6
)
Net (decrease) increase in cash and cash equivalents
(0.2
)
 
133.6

 
(475.3
)
 
—

 
(341.9
)
Cash and cash equivalents at beginning of period
0.3

 
18.5

 
689.0

 
—

 
707.8

Cash and cash equivalents at end of period
0.1

 
152.1

 
213.7

 
—

 
365.9



139



MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:

 

 

 

 

Net cash provided by (used in) operating activities
$
18.2

 
$
(65.0
)
 
$
420.2

 
$
—

 
$
373.4

Cash Flows From Investing Activities:

 

 

 

 

Capital expenditures
—

 
—

 
(127.8
)
 
—

 
(127.8
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,793.8
)
 
—

 
(2,793.8
)
Intercompany loan investment
(25.0
)
 
(298.1
)
 
(915.8
)
 
1,238.9

 
—

Subsidiary dividend proceeds
—

 
300.5

 
—

 
(300.5
)
 
—

Investment in subsidiary
—

 
(3,735.5
)
 
—

 
3,735.5

 
—

Restricted Cash
—

 
—

 
4.1

 
—

 
4.1

Other
—

 
—

 
26.7

 
—

 
26.7

Net cash used in investing activities
(25.0
)
 
(3,733.1
)
 
(3,806.6
)
—

4,673.9

 
(2,890.8
)
Cash Flows From Financing Activities:

 

 

 

 

Issuance of external debt
—

 
2,893.3

 
149.9

 
—

 
3,043.2

Repayment of external debt and capital leases
—

 
(3.3
)
 
(31.5
)
 
—

 
(34.8
)
Excess tax benefit from share-based compensation
—

 
—

 
8.9

 
—

 
8.9

Debt financing costs
—

 
(70.7
)
 
(1.0
)
 
—

 
(71.7
)
Proceeds from exercise of share options
25.8

 
—

 
—

 
—

 
25.8

Subsidiary dividend payment
—

 
—

 
(300.5
)
 
300.5

 
—

Intercompany loan borrowings
(2.4
)
 
940.8

 
300.5

 
(1,238.9
)
 
—

Capital contribution
—

 
—

 
3,735.5

 
(3,735.5
)
 
—

Repurchase of shares
(17.5
)
 
—

 
—

 
—

 
(17.5
)
Other
—

 
—

 
—

 
—

 
—

Net cash provided by financing activities
5.9

 
3,760.1

—

3,861.8

 
(4,673.9
)
 
2,953.9

Effect of currency rate changes on cash
—

 
—

 
(4.2
)
 
—

 
(4.2
)
Net increase (decrease) in cash and cash equivalents
(0.9
)
 
(38.0
)
 
471.2

 
—

 
432.3

Cash and cash equivalents at beginning of period
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at end of period
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8























140



MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 27, 2013
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
(1.8
)
 
$
(8.4
)
 
$
146.1

 
$
—

 
$
135.9

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(147.9
)
 
—

 
(147.9
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(88.1
)
 
—

 
(88.1
)
Intercompany loan investment
—

 
(2.4
)
 
(409.6
)
 
412.0

 
—

Investment in subsidiary
—

 
(68.0
)
 
—

 
68.0

 
—

Other
—

 
—

 
1.3

 
—

 
1.3

Net cash used in investing activities
—

 
(70.4
)
 
(644.3
)
—

480.0

 
(234.7
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
898.1

 
—

 
—

 
898.1

Repayment of external debt and capital leases
—

 
—

 
(1.3
)
 
—

 
(1.3
)
Excess tax benefit from share-based compensation
—

 
—

 
3.4

 
—

 
3.4

Debt financing costs
—

 
(12.0
)
 
—

 
—

 
(12.0
)
Net transfers to parent
—

 
(1,160.4
)
 
644.5

 
—

 
(515.9
)
Proceeds from exercise of share options
0.6

 
—

 
—

 
—

 
0.6

Intercompany loan borrowings
2.4

 
409.6

 
—

 
(412.0
)
 
—

Capital contribution
—

 
—

 
68.0

 
(68.0
)
 
—

Other
—

 
—

 
0.1

 
—

 
0.1

Net cash provided by financing activities
3.0

 
135.3

—

714.7

 
(480.0
)
 
373.0

Effect of currency rate changes on cash
—

 
—

 
1.3

 
—

 
1.3

Net increase in cash and cash equivalents
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at beginning of period
—

 
—

 
—

 
—

 
—

Cash and cash equivalents at end of period
$
1.2

 
$
56.5

 
$
217.8

 
$
—

 
$
275.5




141



24.
Subsequent Events
Share Repurchase & Debt Reduction Authorization
On November 19, 2015, the Company's board of directors authorized an increase to our existing $300.0 million share repurchase program previously announced in January 2015. The authorization increased our existing repurchase program by $500.0 million from $300.0 million to $800.0 million.


142




Item 9.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
None.

Item 9A.
Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended ("the Exchange Act"), is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act) as of September 25, 2015. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

Management's Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined under Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes those policies and procedures that:

•
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;
•
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and
•
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial reporting as of September 25, 2015. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). Management’s assessment included an evaluation of the design of the Company’s internal control over financial reporting and testing of the operational effectiveness of its internal control over financial reporting. Based on our assessment, we believe that our internal controls over financial reporting were effective as of September 25, 2015.
Management's assessment of internal control over financial reporting, as discussed above, excluded Ikaria, Inc. and Therakos, Inc., both acquired by the Company in fiscal 2015, which represented approximately 6% of our total net sales and approximately 29% of our total assets as of and for the period ended September 25, 2015, respectively. Because management's assessment of internal control over financial reporting included the accounting for goodwill and intangible assets from these acquisitions, the percentage of total assets at September 25, 2015 that was excluded from management's assessment of internal control over financial reporting was approximately 2%.
Our internal control over financial reporting as of September 25, 2015 has been audited by Deloitte & Touche LLP, the independent registered public accounting firm that audited and reported on the consolidated financial statements included in this annual report on Form 10-K. This report is included below.




143



Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 25, 2015 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

144




REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of Mallinckrodt plc:

We have audited the internal control over financial reporting of Mallinckrodt plc and subsidiaries (the "Company") as of September 25, 2015, based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. As described in Management's Report on Internal Control over Financial Reporting, management excluded from its assessment the internal control over financial reporting at Ikaria, Inc. (“Ikaria”) and Therakos, Inc. (“Therakos”), both acquired by the Company in fiscal 2015, which represented approximately 6% of total net sales and approximately 2% of total assets as of and for the period ended September 25, 2015, respectively. Accordingly, our audit did not include the internal control over financial reporting at Ikaria or Therakos. The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's principal executive and principal financial officers, or persons performing similar functions, and effected by the company's board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 25, 2015, based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated and combined financial statements and financial statement schedule as of and for the year ended September 25, 2015 of the Company and our report dated November 24, 2015 expressed an unqualified opinion on those financial statements and financial statement schedule and included an explanatory paragraph regarding the fact that the Company’s combined financial statements for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company’s fiscal 2013 results, may not be indicative of the Company’s future performance had it operated as an independent, publicly-traded company for the entirety of the periods presented.


/s/ DELOITTE & TOUCHE LLP
St. Louis, Missouri
November 24, 2015


145



Item 9B.
Other Information.
At meetings on November 18 - 19, 2015, our Board of Directors (the “Board”) approved, with respect to our President and Chief Executive Officer, and the Human Resources and Compensation Committee (the “Committee”) of our Board approved, with respect to our other named executive officers, certain compensation related actions. With respect to Matthew K. Harbaugh, our Senior Vice President and Chief Financial Officer, the Committee increased his annual base salary, effective December 28, 2015, from $530,000 to $570,000. With respect to Frank Scholz, our Senior Vice President, Global Operations, the Committee increased his annual base salary, effective December 28, 2015, from $430,000 to $460,000.
Also, the Board, with respect to our President and Chief Executive Officer, and the Committee, with respect to our other named executive officers, determined the target grant date dollar value of long-term incentive compensation for the fiscal 2016 annual long-term incentive awards, which will be granted on January 4, 2016 ("the Grant Date"). The table below sets forth the target grant date fair value awarded to each of our named executive officers:
Fiscal 2016 Long-Term Incentive Compensation
Name and Title
Target Grant Date Fair Value
Mark C. Trudeau
$
9,750,000

Chief Executive Officer
 
 
 
Matthew K. Harbaugh
$
2,750,000

Senior Vice President and Chief Financial Officer
 
 
 
Hugh M. O'Neill
$
1,700,000

Senior Vice President, Autoimmune and Rare Diseases
 
 
 
Gary M. Phillips
$
1,550,000

Senior Vice President and Chief Strategy Officer
 
 
Frank Scholz
$
1,500,000

Senior Vice President, Global Operations
 

The dollar value awarded to each named executive officer for fiscal 2016 grants will be allocated between the long-term incentive vehicles as follows:

•
40% of the target grant date fair value will be allocated to performance shares ("PSUs") with performance-based vesting over a three-year vesting period (September 26, 2015 up to and including September 28, 2018) based on total return of shareholders against a defined peer group (weighted 50%) and Net Revenue Compounded Annual Growth Rate. The actual number of PSUs will be determined on the Grant Date by taking the dollar value allocated to PSUs and dividing such amount by the grant date fair value of a PSU using, for 50% of the value, a Monte Carlo simulation model and for the remaining 50% of the value, the closing price of our ordinary shares on the Grant Date. Depending on Mallinckrodt's performance during the performance period, the named executive officer is entitled to receive a number of ordinary shares equal to a percentage, ranging from 0% to 200%, of the award granted.

•
40% of the target grant date fair value will be allocated to stock options vesting ratably over a four-year period on the anniversary of the Grant Date. The actual number of stock options will be determined on the Grant Date by taking the dollar value allocated to stock options and dividing such amount by the grant date fair value of an option using a Black-Scholes valuation model; and

•
20% of the target grant date fair value will be allocated to restricted stock units ("RSUs") vesting ratably over a four-year period on the anniversary of the Grant Date. The actual number of RSUs will be determined on the Grant Date by taking the dollar value allocated to RSUs and dividing such amount by Fair Market Value (as defined in the Mallinckrodt Pharmaceuticals Stock and Incentive Plan) of the Company's ordinary shares on the Grant Date.


146



The performance share, stock option and restricted stock unit awards will be made pursuant to the terms and conditions of the Mallinckrodt Pharmaceuticals Stock and Incentive Plan and pursuant to the terms and conditions of the applicable award agreements.







147



PART III
 
Item 10.
Directors, Executive Officers and Corporate Governance.
Information regarding our directors required under this Item 10. Directors, Executive Officers and Corporate Governance will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.
Information regarding our executive officers required under this Item 10. Directors, Executive Officers and Corporate Governance is included in Item 1. Business of this Annual Report on Form 10-K.
We have adopted the Mallinckrodt Pharmaceuticals Guide to Business Conduct, which meets the requirements of a "code of ethics" as defined in Item 406 of Regulation S-K, as well as the requirements of a code of business conduct and ethics under the listing standards of the New York Stock Exchange. Our Guide to Business Conduct applies to all employees, officers and directors of Mallinckrodt, including, without limitation, our Chief Executive Officer, Chief Financial Officer and other senior financial officers. Our Guide to Business Conduct is posted on our website at www.mallinckrodt.com under the heading "Investor Relations - Corporate Governance." We will also provide a copy of our Guide to Business Conduct to shareholders upon request. We intend to disclose any amendments to our Guide to Business Conduct, as well as any waivers for executive officers or directors, on our website.

Item 11.
Executive Compensation.
Information regarding the compensation of our named executive officers and directors required under this Item 11. Executive Compensation will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.

Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Information regarding individuals or groups which own more than 5% of our ordinary shares, as well as information regarding the security ownership of our executive officers and directors, and other shareholder matters required under this Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.

Item 13.
Certain Relationships and Related Transactions, and Director Independence.
Information regarding transactions with related parties and director independence required under this Item 13. Certain Relationships and Related Transactions, and Director Independence will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.

Item 14.
Principal Accounting Fees and Services.
Information regarding the services provided by and the fees paid to Deloitte and Touche LLP, our independent auditors, required under this Item 14. Principal Accounting Fees and Services will be included in our definitive proxy statement for our annual general meeting of shareholders, which will be filed with the United States Securities and Exchange Commission within 120 days after September 25, 2015.


148



PART IV

Item 15.
Exhibits, Financial Statement Schedules.
Documents filed as part of this report:
1)
Financial Statements. The following are included within Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K.
•
Report of Independent Registered Public Accounting Firm
•
Consolidated Statement of Income for the fiscal year ended September 25, 2015 and the Consolidated and Combined Statements of Income for the fiscal years ended September 26, 2014 and September 27, 2013
•
Consolidated Statement of Comprehensive Income for the fiscal year ended September 25, 2015 and the Consolidated and Combined Statements of Comprehensive Income for the fiscal years ended September 26, 2014 and September 27, 2013
•
Consolidated Balance Sheets as of September 25, 2015 and September 26, 2014
•
Consolidated Statement of Cash Flows for the fiscal year ended September 25, 2015 and the Consolidated and Combined Statements of Cash Flows for the fiscal years ended September 26, 2014 and September 27, 2013
•
Consolidated Statement of Changes in Shareholders' Equity for the period from September 26, 2014 to September 25, 2015 and the Consolidated and Combined Statement of Changes in Shareholders' Equity for the period from September 28, 2012 to September 25, 2015
•
Notes to Consolidated and Combined Financial Statements
2)
Financial Statement Schedules. The financial statement schedule is included below. All other schedules have been omitted because they are not applicable, not required or the information is included in the financial statements or notes thereto.
Schedule II - Valuation and Qualifying Accounts
 
 
 
 
 
 
 
 
 
 
(in millions)
 
 
 
 
 
 
 
 
 
 
Description
 
Balance at Beginning of Period
 
Charged to Income
 
Additions and Other
 
Deductions
 
Balance at End of Period
Allowance for doubtful accounts:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
3.7

 
$
1.9

 
$
—

 
$
(0.9
)
 
$
4.7

Fiscal year ended September 26, 2014
 
3.6

 
0.4

 
—

 
(0.3
)
 
3.7

Fiscal year ended September 27, 2013
 
9.4

 
1.1

 
—

 
(6.9
)
 
3.6

Sales reserve accounts:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
404.9

 
$
2,187.8

 
$
1.3

 
$
(2,194.7
)
 
$
399.3

Fiscal year ended September 26, 2014
 
287.7

 
1,720.9

 
30.6

 
(1,634.3
)
 
404.9

Fiscal year ended September 27, 2013
 
235.0

 
1,171.9

 
—

 
(1,119.2
)
 
287.7

Tax valuation allowance:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
76.9

 
$
155.4

 
$
0.2

 
$
0.5

 
$
233.0

Fiscal year ended September 26, 2014
 
28.3

 
33.9

 
14.7

 
—

 
76.9

Fiscal year ended September 27, 2013
 
15.3

 
10.0

 
3.0

 
—

 
28.3



3)
Exhibits. The exhibits are included in the Exhibit Index that appears at the end of this Annual Report on Form 10-K.




149



SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
MALLINCKRODT PUBLIC LIMITED COMPANY
 
 
 
Date: November 24, 2015
By:
/s/ Matthew K. Harbaugh
 
 
Matthew K. Harbaugh
Senior Vice President and Chief Financial Officer
(principal financial officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
/s/ Mark C. Trudeau
 
President, Chief Executive Officer and Director
 
November 24, 2015
Mark C. Trudeau
 
(principal executive officer)
 
 
 
 
 
 
 
/s/ Matthew K. Harbaugh
 
Senior Vice President and Chief Financial Officer
 
November 24, 2015
Matthew K. Harbaugh
 
(principal financial officer)
 
 
 
 
 
 
 
/s/ Kathleen A. Schaefer
 
Vice President and Corporate Controller
 
November 24, 2015
Kathleen A. Schaefer
 
(principal accounting officer)
 
 
 
 
 
 
 
*
 
Chairman of the Board of Directors
 
November 24, 2015
Melvin D. Booth
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Don M. Bailey
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
David R. Carlucci
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
J. Martin Carroll
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Diane H. Gulyas
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Nancy S. Lurker
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
JoAnn A. Reed
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Angus C. Russell
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Virgil D. Thompson
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Kneeland C. Youngblood, M.D.
 
 
 
 
 
 
 
 
 
*
 
Director
 
November 24, 2015
Joseph A. Zaccagnino
 
 
 
 

* Kenneth L. Wagner, by signing his name hereto, does sign this document on behalf of the above noted individuals, pursuant to powers of attorney duly executed by such individuals which have been filed as an Exhibit to this Annual Report on Form 10-K.
/s/ Kenneth L. Wagner
 
Kenneth L. Wagner, Attorney-in-fact
 

150



EXHIBIT INDEX
Exhibit
Number
 
Exhibit
 
 
 
2.1
 
Separation and Distribution Agreement between Covidien plc and Mallinckrodt plc, dated June 28, 2013 (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed July 1, 2013).
2.2
 
Agreement and Plan of Merger, dated as of February 10, 2014, by and among Mallinckrodt plc, Madison Merger Sub, Inc. and Cadence Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed February 11, 2014).
2.3
 
Agreement and Plan of Merger, dated as of April 5, 2014, by and among Mallinckrodt plc, Quincy merger Sub, Inc. and Questcor Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed April 7, 2014).
2.4
 
Stock Purchase Agreement, dated March 5, 2015, by and among Compound Holdings I, LLC, Compound Holdings II, Inc., Mallinckrodt Enterprises LLC and Mallinckrodt plc (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed March 5, 2015).

2.5
 
Stock Purchase Agreement, dated as of July 27, 2015, by and between Mallinckrodt Group S.à r.l., Mallinckrodt U.S. Holdings Inc., Mallinckrodt Netherlands Holdings B.V., Mallinckrodt Finance GmbH, Ludlow Corporation, Mallinckrodt Holdings GmbH, Mallinckrodt International Finance S.A. and Guerbet S.A. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed July 28, 2015).

2.6
 
Stock Purchase Agreement, dated August 9, 2015, by and among TGG Medical Holdings, LLC, TGG Medical Solutions, Inc., Mallinckrodt Enterprises LLC and Mallinckrodt plc (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed August 10, 2015).

3.1
 
Certificate of Incorporation of Mallinckrodt plc (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed July 1, 2013).
3.2
 
Amended and Restated Memorandum and Articles of Association of Mallinckrodt plc (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed July 1, 2013).
4.1
 
Indenture, dated as of April 11, 2013, by and among Mallinckrodt International Finance S.A., Covidien International Finance S.A. and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed July 1, 2013).
4.2
 
Supplemental Indenture, dated as of June 28, 2013, by and among Mallinckrodt plc, Mallinckrodt International Finance S.A. and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed July 1, 2013).
4.3
 
Indenture, dated as of August 13, 2014, among Mallinckrodt International Finance, S.A., Mallinckrodt CB LLC, the Guarantors party thereto from time to time and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed August 14, 2014).
4.4
 
Indenture, dated as of April 15, 2015, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, the Guarantors party thereto from time to time and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed April 17, 2015).

4.5
 
Indenture, dated as of September 24, 2015, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, the Guarantors party thereto from time to time and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed September 28, 2015).
10.1
 
Tax Matters Agreement between Covidien plc and Mallinckrodt plc, dated June 28, 2013 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.2
 
Employee Matters Agreement between Covidien plc and Mallinckrodt plc, dated June 28, 2013 (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.3
 
Transition Services Agreement between Covidien plc and Mallinckrodt plc, dated June 28, 2013 (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.4
 
Credit Agreement, dated as of March 19, 2014, among Mallinckrodt plc, Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, the lenders party thereto from time to time and Deutsche Bank AG New York Branch, as Administrative Agent (incorporated herein by reference to Exhibit (b)(3) of the Schedule TO/A filed by Mallinckrodt plc and Madison Merger Sub, Inc. on March 19, 2014).
10.5
 
Refinancing Amendment No. 1 and Incremental Assumption Agreement No. 2, dated as of August 28, 2015, among Mallinckrodt plc, Mallinckrodt International Finance, S.A., Mallinckrodt CB LLC, the other subsidiaries of Mallinckrodt plc party thereto, the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 28, 2015).

10.6
 
Note Purchase Agreement, dated as of July 28, 2014, among Mallinckrodt Securitization S.À R.L., the persons from time to time party thereto as purchasers, PNC Bank, National Association, as administrative agent, and Mallinckrodt LLC, as initial servicer (incorporated by reference to Exhibit 10.1 to the Company’s Current Report filed July 30, 2014).

151



10.7
 
First Amendment to the Note Purchase Agreement, dated as of January 20, 2015, among Mallinckrodt Securitization S.À R.L., the persons from time to time party thereto as purchasers, PNC Bank, National Association, as administrative agent, and Mallinckrodt LLC, as initial servicer (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015).

10.8
 
Purchase and Sale Agreement, dated as of July 28, 2014, among the various entities party thereto from time to time as originators, Mallinckrodt LLC, as initial servicer, and Mallinckrodt Securitization S.À R.L., as buyer (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed July 30, 2014).
10.9
 
First Amendment to the Purchase and Sale Agreement, dated as of January 20, 2015, among the various entities party thereto from time to time as originators, Mallinckrodt LLC, as initial servicer, and Mallinckrodt Securitization S.À R.L., as buyer (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015).

10.10
 
Sale Agreement, dated as of July 28, 2014, between Liebel-Flarsheim Company LLC and Mallinckrodt LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed July 30, 2014).
10.11
 
Performance Guaranty, dated as of January 20, 2015, by Mallinckrodt International Finance S.A. in favor of PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015).
10.12
 
Incremental Assumption Agreement No. 1, dated as of August 14, 2014, among Mallinckrodt International Finance, S.A., Mallinckrodt CB LLC, the subsidiaries of MIFSA party thereto and Deutsche Bank AG New York Branch, as administrative agent, as acknowledged by and consented to by Mallinckrodt plc and Mallinckrodt Quincy S.à r.l. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 14, 2014).
10.13
 
Form of Deed of Indemnification by and between Mallinckrodt plc and Directors and Secretary (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.14
 
Form of Indemnification Agreement by and between Mallinckrodt Brand Pharmaceuticals, Inc. and Directors and Secretary (incorporated by reference to Exhibit 10.5 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.15
 
IV APAP Agreement (U.S. and Canada), dated as of February 21, 2006, by and between Cadence Pharmaceuticals, Inc. and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.11 to Amendment No. 2 of Cadence Pharmaceuticals, Inc.'s Registration Statement on Form S-1 filed September 25, 2006).
12.16
 
License Agreement, dated as of December 23, 2002, by and among SCR Pharmatop and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.12 to Amendment No. 2 of Cadence Pharmaceuticals, Inc.'s Registration Statement on Form S-1 filed September 25, 2006).
10.17*
 
Mallinckrodt Pharmaceuticals Severance Plan for U.S. Officers and Executives dated May 1, 2014 (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the year ended September 26, 2014).
10.18*
 
Mallinckrodt Pharmaceuticals Change in Control Severance Plan for Certain U.S. Officers and Executives dated as of May 1, 2014 (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the year ended September 26, 2014).
10.19*
 
Mallinckrodt Pharmaceuticals Stock and Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Amendment No. 3 to Registration Statement on Form 10 filed on May 31, 2013).

10.20*
 
Mallinckrodt plc Stock and Incentive Plan Terms and Conditions of Restricted Unit Award for Chief Executive Officer (incorporated by reference to Exhibit 10.8 to the Company's Current Report on Form 8-K filed July 1, 2013).
10.21*
 
Mallinckrodt plc Stock and Incentive Plan Terms and Conditions of Restricted Unit Award (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed May 8, 2014).
10.22*
 
Mallinckrodt plc Stock and Incentive Plan Terms and Conditions of Option Award (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed May 8, 2014).
10.23*
 
Mallinckrodt plc Stock and Incentive Plan Terms and Conditions of Performance Unit Award FY14-FY16 Performance Cycle (incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed May 8, 2014).
10.24*
 
Mallinckrodt Pharmaceuticals Stock and Incentive Plan (incorporated by reference to Appendix B to the Company’s Proxy Statement filed on January 23, 2015).

10.25*
 
Mallinckrodt plc Stock and Incentive Plan Terms and Conditions of Restricted Unit Award to Non-Employee Directors (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015).

10.26*
 
Letter Agreement dated as of August 27, 2013 by and between Mallinckrodt LLC and Frank Scholz (incorporated by reference to Exhibit 10.20 to the Company’s Annual Report on Form 10-K for the year ended September 26, 2014).
21.1
 
Subsidiaries of Mallinckrodt plc.
23.1
 
Consent of Deloitte & Touche LLP.
24.1
 
Powers of Attorney
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

152



31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32.1
 
Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101
 
The following materials from the Mallinckrodt plc Annual Report on Form 10-K for the fiscal year ended September 25, 2015 formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated and Combined Statements of Income, (ii) the Consolidated and Combined Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated and Combined Statements of Cash Flows, (v) the Consolidated and Combined Statements of Shareholders' Equity and (vi) related notes.

*Compensation plans or arrangements.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.


153
 EX-21.1 2 mnkexhibit21192515.htm EXHIBIT 21.1 Exhibit


Exhibit 21.1

SUBSIDIARIES OF MALLINCKRODT PLC

Name of Subsidiary
 
Jurisdiction of Formation
101610 P.E.I., Inc.
 
Prince Edward Island
Acthar IP
 
Ireland
BioVectra Inc.
 
Prince Edward Island
Cache Holdings Limited
 
Bermuda
Carnforth Limited
 
Bermuda
CNS Therapeutics, Inc.
 
Delaware
Comercializadora Mallinckrodt Chile Limitada
 
Chile
Dritte CORSA Verwaltungsgesellschaft GmbH
 
Germany
DT Merger Sub, Inc.
 
Delaware
Enterprises Holdings, Inc.
 
Delaware
Ikaria Australia Pty Ltd
 
Australia
Ikaria Canada Inc.
 
Canada
Ikaria Japan K.K.
 
Japan
IMC Exploration Company
 
Maryland
INO Therapeutics LLC
 
Delaware
INOmax Manufacturing LLC
 
Delaware
Liebel-Flarsheim Canada Inc.
 
Quebec
Liebel-Flarsheim Company LLC
 
Delaware
Liebel-Flarsheim Sarl
 
Luxembourg
Ludlow Corporation
 
Massachusetts
Mallinckrodt AG
 
Switzerland
Mallinckrodt APAP LLC
 
Delaware
Mallinckrodt ARD Finance, Inc.
 
Delaware
Mallinckrodt ARD Holdings Inc.
 
Delaware
Mallinckrodt ARD Holdings Limited
 
United Kingdom
Mallinckrodt ARD Inc.
 
California
Mallinckrodt ARD IP Limited
 
Ireland
Mallinckrodt Australia Pty Ltd
 
Australia
Mallinckrodt Belgium BVBA
 
Belgium
Mallinckrodt Brand Pharmaceuticals, Inc.
 
Delaware
Mallinckrodt Buckingham
 
Ireland
Mallinckrodt Canada Cooperatie U.A.
 
Netherlands
Mallinckrodt Canada Holdings ULC
 
Alberta
Mallinckrodt Canada ULC
 
Alberta
Mallinckrodt Caribbean, Inc.
 
Delaware
Mallinckrodt Caribbean, Inc. (Puerto Rico Branch)
 
Puerto Rico
Mallinckrodt CB LLC
 
Delaware
Mallinckrodt Chemical Holdings (U.K.) Ltd.
 
United Kingdom
Mallinckrodt Chemical Limited
 
United Kingdom
Mallinckrodt Colombia S A S
 
Colombia
Mallinckrodt Critical Care Finance Inc.
 
Delaware
Mallinckrodt Deutschland GmbH
 
Germany
Mallinckrodt Deutschland Holdings GmbH
 
Germany
Mallinckrodt do Brasil, Ltda.
 
Brazil
Mallinckrodt Enterprises Holdings, Inc.
 
California
Mallinckrodt Enterprises LLC
 
Delaware
Mallinckrodt Enterprises UK Limited
 
United Kingdom
Mallinckrodt Finance GmbH
 
Switzerland




Mallinckrodt France Sarl
 
France
Mallinckrodt Group Sarl
 
Luxembourg
Mallinckrodt Group Sarl, Luxembourg (LU) Schaffhausen Branch
 
Switzerland
Mallinckrodt Holdings GmbH
 
Switzerland
Mallinckrodt Holdings Limited
 
United Kingdom
Mallinckrodt Hong Kong Limited
 
Hong Kong
Mallinckrodt Hong Kong Limited, Taiwan Representative Office
 
Taiwan
Mallinckrodt Hong Kong Limited, Thailand Branch
 
Thailand
Mallinckrodt Hospital Products Inc.
 
Delaware
Mallinckrodt Hospital Products IP Limited
 
Ireland
Mallinckrodt Imaging Sarl
 
France
Mallinckrodt Inc.
 
Delaware
Mallinckrodt International Finance SA
 
Luxembourg
Mallinckrodt International Holdings S.a r.l.
 
Luxembourg
Mallinckrodt IP
 
Ireland
Mallinckrodt Ireland Limited
 
Ireland
Mallinckrodt Italia Spa
 
Milan
Mallinckrodt Japan Co. Ltd
 
Japan
Mallinckrodt Korea Inc.
 
South Korea
Mallinckrodt LLC
 
Delaware
Mallinckrodt Lux IP S.a r.l.
 
Luxembourg
Mallinckrodt Medical Argentina Limited
 
United Kingdom
Mallinckrodt Medical Argentina Limited (Argentina Branch)
 
Argentina
Mallinckrodt Medical B.V.
 
Netherlands
Mallinckrodt Medical Consulting (Shanghai) Co., Ltd.
 
China
Mallinckrodt Medical Consulting (Shanghai) Co., Ltd. Beijing Pharma Information Consulting Branch
 
China
Mallinckrodt Medical Holdings (UK) Limited
 
United Kingdom
Mallinckrodt Medical Imaging - Ireland
 
Ireland
Mallinckrodt Medical S.A. de C.V.
 
Mexico
Mallinckrodt MFC LLC
 
Delaware
Mallinckrodt Nederland B.V.
 
Netherlands
Mallinckrodt Netherlands Holdings B.V. (Finland Branch)
 
Finland
Mallinckrodt Netherlands Holdings B.V. Holland (Denmark Branch)
 
Denmark
Mallinckrodt Netherlands Holdings B.V. Slovakia, organizacná zlozka
 
Slovak Republic
Mallinckrodt Netherlands Holdings B.V., organizacní slozka
 
Czech Republic
Mallinckrodt Netherlands Holdings BV
 
Netherlands
Mallinckrodt Nuclear LLC
 
Delaware
Mallinckrodt Nuclear Medicine LLC
 
Delaware
Mallinckrodt Panama Distribution, S.A.
 
Panama
Mallinckrodt Panama, S.A.
 
Panama
Mallinckrodt Petten Holdings B.V.
 
Netherlands
Mallinckrodt Pharma IP Trading D.A.C.
 
Ireland
Mallinckrodt Pharmaceuticals India Private Limited
 
India
Mallinckrodt Pharmaceuticals Ireland Limited
 
Ireland
Mallinckrodt plc
 
Ireland
Mallinckrodt Proprietary Limited
 
South Africa
Mallinckrodt Quincy S.a r.l.
 
Luxembourg
Mallinckrodt Radioisotopes B.V.
 
Netherlands
Mallinckrodt Radiopharmaceuticals Deutschland GmbH
 
Germany
Mallinckrodt Radiopharmaceuticals Italia SpA
 
Italy
Mallinckrodt Radiopharmaceuticals Spain SL
 
Spain
Mallinckrodt Radiopharmaceuticals Sverige AB
 
Sweden
Mallinckrodt RP Canada Inc.
 
Ontario
Mallinckrodt RP UK Ltd
 
United Kingdom




Mallinckrodt Saglik Anonim Sirketi
 
Turkey
Mallinckrodt Securitization Sarl
 
Luxembourg
Mallinckrodt sp. z o.o.
 
Poland
Mallinckrodt Sp. z o.o., odstepný závod
 
Czech Republic
Mallinckrodt Spain, S.L.
 
Spain
Mallinckrodt Specialty Pharmaceuticals Ireland Limited
 
Ireland
Mallinckrodt Sverige AB
 
Sweden
Mallinckrodt Switzerland Limited
 
Switzerland
Mallinckrodt UK Commercial Ltd
 
United Kingdom
Mallinckrodt UK Finance LLP
 
United Kingdom
Mallinckrodt UK Ltd
 
United Kingdom
Mallinckrodt US Holdings Inc.
 
Nevada
Mallinckrodt US Holdings LLC
 
Delaware
Mallinckrodt US Pool LLC
 
Nevada
Mallinckrodt Veterinary, Inc.
 
Delaware
Mallinckrodt Windsor Ireland Finance
 
Ireland
Mallinckrodt Windsor Sarl
 
Luxembourg
MEH, Inc.
 
Nevada
MHP Finance, Inc.
 
Delaware
MKG Medical UK Ltd
 
United Kingdom
Montjeu Limited
 
Ireland
MUSHI UK Holdings Limited
 
United Kingdom
Phoenixglade Limited
 
Ireland
Questcor International Ltd.
 
Ireland
Representative Office of private limited liability company Mallinckrodt Netherlands Holdings B.V.
 
Russia
Ribogene, Inc.
 
Delaware
Therakos (Belgium) SPRL
 
Belgium
Therakos (Canada) Company
 
Canada
Therakos (France) SAS
 
France
Therakos (Italia) S.r.l
 
Italy
Therakos (UK), Limited Dutch Branch
 
Netherlands
Therakos (UK), Limited, Sucursal en Espana
 
Spain
Therakos (UK), Ltd
 
United Kingdom
Therakos (UK), Ltd Sweden Filial
 
Sweden
Therakos Colombia S.A.S.
 
Colombia
Therakos Germany GmbH
 
Germany
Therakos, Inc.
 
Florida
Viking Project Company, LLC
 
Delaware




Name of Subsidiary
 
Jurisdiction of Formation
Mallinckrodt Switzerland Limited
 
Switzerland
Mallinckrodt Hong Kong Limited, Taiwan Representative Office
 
Taiwan
Mallinckrodt Hong Kong Limited, Thailand Branch
 
Thailand
Mallinckrodt Saglik Anonim Sirketi
 
Turkey
Mallinckrodt ARD Holdings Limited (FKA MIFSA UK Limited)
 
UK
Mallinckrodt Chemical Holdings (UK) Ltd.
 
UK
Mallinckrodt Chemical Limited
 
UK
Mallinckrodt Enterprises UK Limited
 
UK
Mallinckrodt Medical Argentina Ltd.
 
UK
Mallinckrodt Medical Holdings (UK) Limited
 
UK
Mallinckrodt UK Commercial Ltd
 
UK
Mallinckrodt UK Ltd
 
UK
MKG Medical UK Ltd
 
UK
MUSHI UK Holdings Limited
 
UK
BioVectra, Inc. USA
 
North Carolina
Cadence Pharmaceuticals, Inc.
 
Delaware
CNS Therapeutics, Inc.
 
Delaware
Enterpises Holdings, Inc.
 
Delaware
IMC Exploration Company
 
Maryland
Lafayette Pharmaceuticals LLC
 
Delaware
Liebel-Flarsheim Company LLC
 
Delaware
Ludlow Corporation
 
Massachusetts
Mallinckrodt APAP LLC
 
Delaware
Mallinckrodt ARD Holdings Inc.
 
Delaware
Mallinckrodt Brand Pharmaceuticals, Inc. (DE)
 
Delaware
Mallinckrodt Caribbean, Inc.
 
Delaware
Mallinckrodt CB LLC
 
Delaware
Mallinckrodt Enterprises Holdings, Inc.
 
California
Mallinckrodt Enterprises LLC
 
Delaware
Mallinckrodt Inc. (DE)
 
Delaware
Mallinckrodt LLC
 
Delaware
Mallinckrodt MFC LLC
 
Delaware
Mallinckrodt Nuclear LLC
 
Delaware
Mallinckrodt Nuclear Medicine LLC
 
Delaware
Mallinckrodt US Holdings, Inc. (FKA Kendall Holding Corp.)
 
Nevada
Mallinckrodt US Holdings LLC
 
Delaware
Mallinckrodt US Pool LLC
 
Nevada
Mallinckrodt Veterinary, Inc.
 
Delaware
MEH, Inc.
 
Nevada
Questcor Pharmaceuticals Inc.
 
California
Ribogene, Inc.
 
Delaware
Viking Project Company, LLC
 
Delaware



 EX-23.1 3 mnkexhibit23192515.htm EXHIBIT 23.1 Exhibit


Exhibit 23.1




CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-189711, 333-189712, 333-189716, 333-196054 and 333-203912 on Form S-8 of our reports dated November 24, 2015, relating to the consolidated and combined financial statements and financial statement schedule of Mallinckrodt plc (which report expresses an unqualified opinion and includes an explanatory paragraph related to the fact that the Company’s results for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company’s fiscal 2013 results, may not be indicative of the Company’s future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had it operated as an independent, publicly-traded company for the entirety of the periods presented) and the effectiveness of Mallinckrodt plc’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Mallinckrodt plc for the fiscal year ended September 25, 2015.

/s/ DELOITTE & TOUCHE LLP
St. Louis, Missouri
November 24, 2015




EX-24.1 4 mnkexhibit24192515.htm EXHIBIT 24.1 Exhibit


Exhibit 24.1

POWER OF ATTORNEY

We, the undersigned officers and directors of Mallinckrodt plc, hereby severally constitute and appoint Kenneth L. Wagner to sign for us and in our names in the capacities indicated below, any and all amendments to the report on Form 10-K filed herewith, and to file the same, with all exhibits thereto and other documents in connection therewith, in each case, with the Securities and Exchange Commission, and generally to do all such things in our names and on our behalf in our capacities consistent with the provisions of the Securities Act of 1934, as amended, and all requirements of the Securities and Exchange Commission.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Signature
 
Title
 
Date
 
 
 
 
 
/s/ Mark C. Trudeay
 
President, Chief Executive Officer and Director
 
November 24, 2015
Mark C. Trudeau
 
(principal executive officer)
 
 
 
 
 
 
 
/s/ Matthew K. Harbaugh
 
Senior Vice President and Chief Financial Officer
 
November 24, 2015
Matthew K. Harbaugh
 
(principal financial officer)
 
 
 
 
 
 
 
/s/ Kathleen A. Schaefer
 
Vice President Controller
 
November 24, 2015
Kathleen A. Schaefer
 
(principal accounting officer)
 
 
 
 
 
 
 
/s/ Melvin D. Booth
 
Chairman of the Board of Directors
 
November 24, 2015
Melvin D. Booth
 
 
 
 
 
 
 
 
 
/s/ Don M. Bailey
 
Director
 
November 24, 2015
Don M. Bailey
 
 
 
 
 
 
 
 
 
/s/ David R. Carlucci
 
Director
 
November 24, 2015
David R. Carlucci
 
 
 
 
 
 
 
 
 
/s/ J. Martin Carroll
 
Director
 
November 24, 2015
J. Martin Carroll
 
 
 
 
 
 
 
 
 
/s/ Diane H. Gulyas
 
Director
 
November 24, 2015
Diane H. Gulyas
 
 
 
 
 
 
 
 
 
/s/ Nancy S. Lurker
 
Director
 
November 24, 2015
Nancy S. Lurker
 
 
 
 
 
 
 
 
 
/s/ JoAnn A. Reed
 
Director
 
November 24, 2015
JoAnn A. Reed
 
 
 
 
 
 
 
 
 
/s/ Angus C. Russell
 
Director
 
November 24, 2015
Angus C. Russell
 
 
 
 
 
 
 
 
 
/s/ Virgil D. Thompson
 
Director
 
November 24, 2015
Virgil D. Thompson
 
 
 
 
 
 
 
 
 
/s/ Kneeland C. Youngblood
 
Director
 
November 24, 2015
Kneeland C. Youngblood
 
 
 
 
 
 
 
 
 
/s/ Joseph A. Zaccagnino
 
Director
 
November 24, 2015
Joseph A. Zaccagnino
 
 
 
 


 EX-31.1 5 mnkexhibit31192515.htm EXHIBIT 31.1 Exhibit



Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934


I, Mark C. Trudeau, certify that:
 
 
1.
I have reviewed this annual report on Form 10-K of Mallinckrodt plc;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
 
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 24, 2015
 
By:
 /s/    Mark C. Trudeau       
 
 
Mark C. Trudeau
 
 
President and Chief Executive Officer
(principal executive officer)



 EX-31.2 6 mnkexhibit31292515.htm EXHIBIT 31.2 Exhibit



Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934


I, Matthew K. Harbaugh, certify that:
 
 
1.
I have reviewed this annual report on Form 10-K of Mallinckrodt plc;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
 
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 24, 2015
 
By:
/s/    Matthew K. Harbaugh
 
 
Matthew K. Harbaugh
 
 
Senior Vice President and Chief Financial Officer
(principal financial officer)



 EX-32.1 7 mnkexhibit32192515.htm EXHIBIT 32.1 Exhibit



Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


The undersigned officers of Mallinckrodt plc ("the Company") hereby certify to their knowledge that the Company's annual report on Form 10-K for the annual period ended September 25, 2015 ("the Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

By:
/s/    Mark C. Trudeau
Mark C. Trudeau
President and Chief Executive Officer

November 24, 2015

By:
/s/    Matthew K. Harbaugh
Matthew K. Harbaugh
Senior Vice President and Chief Financial Officer

November 24, 2015




 EX-101.INS 8 mnk-20150925.xml XBRL INSTANCE DOCUMENT 0001567892 2014-09-27 2015-09-25 0001567892 2015-11-16 0001567892 2015-03-27 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2015-09-25 0001567892 2015-09-25 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2015-09-25 0001567892 mnk:AccruedAndOtherCurrentLiabilitiesMember 2015-09-25 0001567892 2013-09-28 2014-09-26 0001567892 2012-09-29 2013-09-27 0001567892 2014-09-26 0001567892 2012-09-28 0001567892 2013-09-27 0001567892 us-gaap:AdditionalPaidInCapitalMember 2012-09-29 2013-09-27 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-09-28 2014-09-26 0001567892 us-gaap:AdditionalPaidInCapitalMember 2014-09-26 0001567892 us-gaap:OtherAdditionalCapitalMember 2012-09-29 2013-09-27 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-09-29 2013-09-27 0001567892 mnk:ParentCompanyInvestmentMember 2012-09-29 2013-09-27 0001567892 us-gaap:CommonStockMember 2014-09-27 2015-09-25 0001567892 us-gaap:CommonStockMember 2013-09-28 2014-09-26 0001567892 us-gaap:OtherAdditionalCapitalMember 2012-09-28 0001567892 us-gaap:OtherAdditionalCapitalMember 2013-09-27 0001567892 us-gaap:CommonStockMember 2015-09-25 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-09-28 0001567892 mnk:ParentCompanyInvestmentMember 2014-09-26 0001567892 us-gaap:CommonStockMember 2012-09-28 0001567892 mnk:ParentCompanyInvestmentMember 2012-09-28 0001567892 us-gaap:TreasuryStockMember 2014-09-27 2015-09-25 0001567892 us-gaap:AdditionalPaidInCapitalMember 2014-09-27 2015-09-25 0001567892 us-gaap:CommonStockMember 2014-09-26 0001567892 us-gaap:TreasuryStockMember 2013-09-27 0001567892 us-gaap:TreasuryStockMember 2015-09-25 0001567892 us-gaap:TreasuryStockMember 2012-09-28 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-09-27 2015-09-25 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-09-26 0001567892 us-gaap:AdditionalPaidInCapitalMember 2013-09-28 2014-09-26 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-09-25 0001567892 us-gaap:OtherAdditionalCapitalMember 2014-09-26 0001567892 us-gaap:AdditionalPaidInCapitalMember 2012-09-28 0001567892 mnk:ParentCompanyInvestmentMember 2013-09-27 0001567892 us-gaap:RetainedEarningsMember 2013-09-28 2014-09-26 0001567892 us-gaap:TreasuryStockMember 2014-09-26 0001567892 us-gaap:RetainedEarningsMember 2013-09-27 0001567892 us-gaap:CommonStockMember 2013-09-27 0001567892 us-gaap:RetainedEarningsMember 2012-09-29 2013-09-27 0001567892 us-gaap:TreasuryStockMember 2013-09-28 2014-09-26 0001567892 us-gaap:CommonStockMember 2012-09-29 2013-09-27 0001567892 us-gaap:AdditionalPaidInCapitalMember 2015-09-25 0001567892 us-gaap:OtherAdditionalCapitalMember 2015-09-25 0001567892 us-gaap:RetainedEarningsMember 2014-09-26 0001567892 mnk:ParentCompanyInvestmentMember 2015-09-25 0001567892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-09-27 0001567892 us-gaap:AdditionalPaidInCapitalMember 2013-09-27 0001567892 us-gaap:RetainedEarningsMember 2012-09-28 0001567892 us-gaap:RetainedEarningsMember 2015-09-25 0001567892 2013-06-28 0001567892 us-gaap:SellingGeneralAndAdministrativeExpensesMember mnk:CovidienPlcMember 2012-09-29 2013-09-27 0001567892 us-gaap:TrademarksMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 mnk:CompletedTechnologyMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 mnk:CompletedTechnologyMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:TrademarksMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:CustomerRelationshipsMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 us-gaap:BuildingMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:BuildingMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 mnk:ContrastMediaandDeliverySystemsMember 2014-09-27 2015-09-25 0001567892 mnk:ContrastMediaandDeliverySystemsMember 2012-09-29 2013-09-27 0001567892 mnk:ContrastMediaandDeliverySystemsMember 2013-09-28 2014-09-26 0001567892 mnk:MallinckrodtBakerMember 2012-09-29 2013-09-27 0001567892 mnk:TastemakerMember 2014-09-27 2015-09-25 0001567892 us-gaap:FiniteLivedIntangibleAssetsMember mnk:ContrastMediaandDeliverySystemsMember 2013-09-28 2014-09-26 0001567892 mnk:MallinckrodtBakerMember 2014-09-27 2015-09-25 0001567892 mnk:MallinckrodtBakerMember 2013-09-28 2014-09-26 0001567892 mnk:OxymorphoneERMember 2013-12-01 2013-12-31 0001567892 mnk:ContrastMediaandDeliverySystemsMember 2015-09-25 0001567892 mnk:OxymorphoneERMember 2013-09-28 2014-09-26 0001567892 us-gaap:PropertyPlantAndEquipmentMember mnk:ContrastMediaandDeliverySystemsMember 2013-09-28 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:ContrastMediaandDeliverySystemsMember 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:ContrastMediaandDeliverySystemsMember 2014-09-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-09-27 2015-09-25 0001567892 mnk:CadencePharmaceuticalsInc.Member 2013-09-28 2014-09-26 0001567892 mnk:IkariaMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2013-09-28 2014-09-26 0001567892 mnk:TotalAcquisitionsMember 2014-09-27 2015-09-25 0001567892 mnk:CadencePharmaceuticalsInc.Member 2014-09-27 2015-09-25 0001567892 mnk:IkariaMember 2013-09-28 2014-09-26 0001567892 mnk:TotalAcquisitionsMember 2013-09-28 2014-09-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:CompletedTechnologyMember 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:TrademarksMember 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:TrademarksMember 2014-08-14 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:CustomerRelationshipsMember 2014-08-14 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:CustomerRelationshipsMember 2014-08-14 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:CompletedTechnologyMember 2014-08-14 2014-08-14 0001567892 mnk:TherakosMember 2015-09-25 0001567892 mnk:TherakosMember 2015-09-25 2015-09-25 0001567892 mnk:CnsTherapeuticsIncMember 2012-09-30 2012-10-01 0001567892 mnk:IkariaMember 2015-04-16 2015-04-16 0001567892 mnk:CadencePharmaceuticalsInc.Member 2014-03-18 2014-03-19 0001567892 mnk:CadencePharmaceuticalsInc.Member 2014-03-19 0001567892 mnk:IkariaMember 2015-04-16 0001567892 mnk:CnsTherapeuticsIncMember 2012-10-01 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-08-14 2014-08-14 0001567892 mnk:CadencePharmaceuticalsInc.Member mnk:CompletedTechnologyMember 2014-03-18 2014-03-19 0001567892 mnk:CadencePharmaceuticalsInc.Member mnk:CompletedTechnologyMember 2014-03-19 0001567892 mnk:CnsTherapeuticsIncMember us-gaap:TrademarksMember 2012-10-01 0001567892 mnk:CnsTherapeuticsIncMember mnk:CompletedTechnologyMember 2012-10-01 0001567892 mnk:CnsTherapeuticsIncMember us-gaap:InProcessResearchAndDevelopmentMember 2012-10-01 0001567892 mnk:CnsTherapeuticsIncMember us-gaap:TrademarksMember 2012-09-30 2012-10-01 0001567892 mnk:CnsTherapeuticsIncMember mnk:CompletedTechnologyMember 2012-09-30 2012-10-01 0001567892 mnk:TherakosMember 2013-09-28 2014-09-26 0001567892 mnk:TherakosMember 2014-09-27 2015-09-25 0001567892 mnk:IkariaMember us-gaap:TrademarksMember 2015-04-16 2015-04-16 0001567892 mnk:IkariaMember us-gaap:InProcessResearchAndDevelopmentMember 2015-04-16 0001567892 mnk:IkariaMember us-gaap:TrademarksMember 2015-04-16 0001567892 mnk:IkariaMember mnk:CompletedTechnologyMember 2015-04-16 0001567892 mnk:IkariaMember mnk:CompletedTechnologyMember 2015-04-16 2015-04-16 0001567892 mnk:IkariaMember us-gaap:UnsecuredDebtMember 2015-04-16 2015-04-16 0001567892 us-gaap:LicensingAgreementsMember mnk:ExalgoMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:ExalgoMember 2012-09-29 2013-09-27 0001567892 us-gaap:LicensingAgreementsMember mnk:DepomedMember 2008-09-27 2013-09-27 0001567892 us-gaap:LicensingAgreementsMember mnk:BristolMyersSquibbMember 2014-09-27 2015-09-25 0001567892 mnk:NuvoCaseMember 2013-09-28 2014-09-26 0001567892 mnk:CadencePharmaceuticalsInc.Member mnk:SpecialtyPharmaceuticalsMember 2014-03-18 2014-03-19 0001567892 us-gaap:CostOfSalesMember 2013-09-28 2014-09-26 0001567892 mnk:TherakosMember us-gaap:RevolvingCreditFacilityMember 2015-09-25 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:SecuredDebtMember 2014-03-19 0001567892 mnk:IkariaMember us-gaap:RevolvingCreditFacilityMember 2015-04-16 0001567892 mnk:IkariaMember us-gaap:InProcessResearchAndDevelopmentMember mnk:TerlipressinMember 2015-04-16 2015-04-16 0001567892 mnk:TherakosMember mnk:CompletedTechnologyMember mnk:TherakosImmunotherapyMember 2015-09-25 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:PennsaidMember 2013-09-28 2014-09-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:H.P.ActharGelMember 2014-09-27 2015-06-26 0001567892 us-gaap:LicensingAgreementsMember mnk:ExalgoMember 2008-09-27 2013-09-27 0001567892 us-gaap:RevolvingCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2014-09-27 2015-09-25 0001567892 mnk:CnsTherapeuticsIncMember us-gaap:InProcessResearchAndDevelopmentMember 2012-09-30 2012-10-01 0001567892 mnk:TherakosMember us-gaap:UnsecuredDebtMember 2015-09-25 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:ExalgoMember 2013-09-28 2014-09-26 0001567892 us-gaap:LicensingAgreementsMember mnk:BristolMyersSquibbMember 2013-09-28 2014-09-26 0001567892 us-gaap:CostOfSalesMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:DepomedMember 2013-09-28 2014-09-26 0001567892 us-gaap:LicensingAgreementsMember mnk:PennsaidMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:PennsaidMember 2008-09-27 2013-09-27 0001567892 us-gaap:LicensingAgreementsMember mnk:DepomedMember 2014-09-27 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember mnk:PennsaidMember 2012-09-29 2013-09-27 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-04-04 2014-04-05 0001567892 mnk:IkariaMember mnk:CompletedTechnologyMember mnk:InomaxMember 2015-04-16 2015-04-16 0001567892 us-gaap:RoyaltyAgreementsMember mnk:ExalgoMember 2014-01-01 2014-01-31 0001567892 mnk:CadencePharmaceuticalsInc.Member mnk:SpecialtyPharmaceuticalsMember 2014-03-19 0001567892 mnk:TermLoanDueMarch2021Member mnk:TermLoanMember 2014-09-27 2015-09-25 0001567892 mnk:CadencePharmaceuticalsInc.Member us-gaap:LicensingAgreementsMember mnk:OfirmevMember 2014-09-27 2015-09-25 0001567892 us-gaap:FiniteLivedIntangibleAssetsMember us-gaap:LicensingAgreementsMember mnk:ExalgoMember 2008-09-27 2013-09-27 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2014-08-14 2014-08-14 0001567892 mnk:TherakosMember mnk:CompletedTechnologyMember 2015-09-25 0001567892 mnk:TherakosMember mnk:CompletedTechnologyMember 2015-09-25 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember mnk:NuclearImagingMember 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember mnk:SpecialtyGenericsMember 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember mnk:SpecialtyBrandsMember 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember us-gaap:CorporateMember 2015-09-25 0001567892 us-gaap:OtherRestructuringMember 2014-09-27 2015-09-25 0001567892 us-gaap:OtherRestructuringMember 2012-09-29 2013-09-27 0001567892 mnk:BusinessAcquisitionMember 2012-09-29 2013-09-27 0001567892 mnk:BusinessAcquisitionMember 2013-09-28 2014-09-26 0001567892 mnk:RestructuringFiscal2013PlanMember 2012-09-29 2013-09-27 0001567892 mnk:RestructuringFiscal2013PlanMember 2014-09-27 2015-09-25 0001567892 us-gaap:OtherRestructuringMember 2013-09-28 2014-09-26 0001567892 mnk:BusinessAcquisitionMember 2014-09-27 2015-09-25 0001567892 mnk:RestructuringFiscal2013PlanMember 2013-09-28 2014-09-26 0001567892 us-gaap:MaximumMember mnk:RestructuringFiscal2013PlanMember 2015-09-25 0001567892 mnk:ConsultingCostsMember 2013-09-28 2014-09-26 0001567892 us-gaap:MinimumMember mnk:RestructuringFiscal2013PlanMember 2015-09-25 0001567892 us-gaap:EmployeeSeveranceMember 2013-09-28 2014-09-26 0001567892 us-gaap:EmployeeSeveranceMember 2014-09-27 2015-09-25 0001567892 mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 mnk:NuclearImagingMember 2014-09-27 2015-09-25 0001567892 mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 mnk:NuclearImagingMember 2013-09-28 2014-09-26 0001567892 mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 mnk:NuclearImagingMember 2012-09-29 2013-09-27 0001567892 us-gaap:CorporateMember 2014-09-27 2015-09-25 0001567892 us-gaap:CorporateMember 2012-09-29 2013-09-27 0001567892 mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:CorporateMember 2013-09-28 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember 2014-09-27 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:BusinessAcquisitionMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2014-09-27 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:BusinessAcquisitionMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:BusinessAcquisitionMember 2014-09-27 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2014-09-27 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2013-09-28 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:RestructuringFiscal2013PlanMember 2014-09-27 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2014-09-27 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2013-09-27 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember us-gaap:OtherRestructuringMember 2014-09-27 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember us-gaap:OtherRestructuringMember 2013-09-28 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember 2014-09-27 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember us-gaap:OtherRestructuringMember 2012-09-29 2013-09-27 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:RestructuringFiscal2013PlanMember 2013-09-28 2014-09-26 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember mnk:RestructuringFiscal2013PlanMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2012-09-28 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2012-09-28 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2012-09-28 0001567892 us-gaap:SegmentContinuingOperationsMember 2012-09-28 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember us-gaap:OtherRestructuringMember 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember 2015-09-25 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:BusinessAcquisitionMember 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember mnk:RestructuringFiscal2013PlanMember 2014-09-26 0001567892 mnk:AccruedAndOtherCurrentLiabilitiesMember 2014-09-26 0001567892 mnk:OtherIncomeTaxLiabilitiesMember 2014-09-26 0001567892 mnk:OtherIncomeTaxLiabilitiesMember 2015-09-25 0001567892 2013-09-28 2013-12-31 0001567892 us-gaap:ForeignCountryMember 2015-09-25 0001567892 2012-01-01 2012-09-28 0001567892 us-gaap:InternalRevenueServiceIRSMember 2014-09-27 2015-09-25 0001567892 mnk:IkariaMember 2015-09-25 0001567892 country:IE 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-12-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-09-27 2014-12-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-09-26 0001567892 2014-01-01 2014-09-26 0001567892 mnk:U.S.FederalandStateJursidictionsMember 2014-09-27 2015-09-25 0001567892 us-gaap:DiscontinuedOperationsHeldforsaleMember 2015-09-25 0001567892 mnk:CovidienPlcMember us-gaap:InternalRevenueServiceIRSMember 2013-09-28 2014-09-26 0001567892 mnk:U.S.FederalandStateJursidictionsMember 2015-09-25 0001567892 mnk:CadencePharmaceuticalsInc.Member 2014-09-26 0001567892 mnk:DeferredincometaxliabilitynoncurrentMember 2015-09-25 0001567892 us-gaap:LiabilitiesTotalMember 2014-09-26 0001567892 mnk:DeferredincometaxliabilitynoncurrentMember 2014-09-26 0001567892 us-gaap:LiabilitiesTotalMember 2015-09-25 0001567892 us-gaap:AssetsHeldUnderCapitalLeasesMember 2014-09-26 0001567892 us-gaap:PropertyPlantAndEquipmentMember 2013-09-28 2014-09-26 0001567892 us-gaap:AssetsHeldUnderCapitalLeasesMember 2015-09-25 0001567892 us-gaap:FiniteLivedIntangibleAssetsMember 2013-09-28 2014-09-26 0001567892 us-gaap:LandMember 2014-09-26 0001567892 us-gaap:MachineryAndEquipmentMember 2014-09-26 0001567892 us-gaap:MachineryAndEquipmentMember 2015-09-25 0001567892 us-gaap:BuildingMember 2015-09-25 0001567892 us-gaap:ConstructionInProgressMember 2014-09-26 0001567892 us-gaap:ConstructionInProgressMember 2015-09-25 0001567892 us-gaap:LandMember 2015-09-25 0001567892 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2015-09-25 0001567892 us-gaap:BuildingMember 2014-09-26 0001567892 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2014-09-26 0001567892 mnk:SpecialtyBrandsMember 2015-09-25 0001567892 mnk:SpecialtyGenericsMember 2014-09-26 0001567892 mnk:NuclearImagingMember 2015-09-25 0001567892 mnk:SpecialtyBrandsMember 2014-09-26 0001567892 mnk:SpecialtyGenericsMember 2015-09-25 0001567892 mnk:NuclearImagingMember 2014-09-26 0001567892 mnk:GenericsandAPIMember 2014-09-27 2015-09-25 0001567892 mnk:BrandsMember 2014-09-27 2015-09-25 0001567892 mnk:ContrastMediaandDeliverySystemsMember mnk:GlobalMedicalImagingMember 2014-09-26 0001567892 mnk:GlobalMedicalImagingMember 2014-09-26 0001567892 us-gaap:TrademarksMember 2015-09-25 0001567892 us-gaap:CustomerRelationshipsMember 2015-09-25 0001567892 us-gaap:CustomerRelationshipsMember 2014-09-26 0001567892 us-gaap:TrademarksMember 2014-09-26 0001567892 mnk:CompletedTechnologyMember 2015-09-25 0001567892 us-gaap:OtherIntangibleAssetsMember 2014-09-26 0001567892 mnk:CompletedTechnologyMember 2014-09-26 0001567892 us-gaap:InProcessResearchAndDevelopmentMember 2014-09-26 0001567892 us-gaap:InProcessResearchAndDevelopmentMember 2015-09-25 0001567892 us-gaap:LicensingAgreementsMember 2014-09-26 0001567892 us-gaap:LicensingAgreementsMember 2015-09-25 0001567892 us-gaap:OtherIntangibleAssetsMember 2015-09-25 0001567892 us-gaap:TrademarksMember 2015-09-25 0001567892 us-gaap:TrademarksMember 2014-09-26 0001567892 mnk:TermLoanandNewTermLoanMember us-gaap:SecuredDebtMember 2015-09-25 0001567892 mnk:A2020NotesMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:A2015RevolvingCreditFacilityMember 2015-09-25 0001567892 mnk:NinePointFivePercentDebentureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:A2025NotesMemberMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:SecuredDebtMember 2014-09-26 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:SecuredDebtMember 2015-09-25 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member 2015-09-25 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:EightPercentDebentureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:TermLoanandNewTermLoanMember us-gaap:SecuredDebtMember 2014-09-26 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member 2014-09-26 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:SecuredDebtMember 2014-09-26 0001567892 mnk:A2025NotesMemberMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 us-gaap:CapitalLeaseObligationsMember 2015-09-25 0001567892 mnk:NinePointFivePercentDebentureMember mnk:DebenturesMember 2015-09-25 0001567892 mnk:A2015RevolvingCreditFacilityMember 2014-09-26 0001567892 mnk:EightPercentDebentureMember mnk:DebenturesMember 2015-09-25 0001567892 us-gaap:CapitalLeaseObligationsMember 2014-09-26 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:SecuredDebtMember 2015-09-25 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member us-gaap:SecuredDebtMember 2015-09-25 0001567892 mnk:A2025NotesMemberMember us-gaap:UnsecuredDebtMember 2015-04-15 0001567892 mnk:NewTermLoanMember us-gaap:SecuredDebtMember 2014-09-27 2015-09-25 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:RevolvingCreditFacilityMember 2014-09-27 2015-09-25 0001567892 us-gaap:RevolvingCreditFacilityMember 2014-03-19 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member us-gaap:SecuredDebtMember 2014-07-28 0001567892 mnk:TermLoanDueMarch2021Member 2015-09-25 0001567892 mnk:A2023NotesMember 2015-09-24 2015-09-24 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:SeniorNotesMember 2013-04-30 0001567892 mnk:A2020NotesMember us-gaap:UnsecuredDebtMember 2015-04-15 0001567892 mnk:A2015RevolvingCreditFacilityMember 2015-08-28 0001567892 mnk:NewTermLoanMember us-gaap:SecuredDebtMember 2014-08-14 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member us-gaap:SecuredDebtMember 2014-09-27 2015-09-25 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member us-gaap:SecuredDebtMember 2015-01-20 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:SecuredDebtMember 2014-09-27 2015-09-25 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:SeniorNotesMember 2013-04-30 0001567892 mnk:NewTermLoanMember 2014-08-31 0001567892 mnk:FivePointSevenFivePercentNotesMember mnk:OptionBMember 2014-09-27 2015-09-25 0001567892 mnk:A2023NotesMember us-gaap:UnsecuredDebtMember 2015-09-24 0001567892 mnk:TermLoanDueMarch2021Member 2014-03-18 2014-03-19 0001567892 mnk:A2015IncrementalRevolvingCreditFacilityMember 2015-08-28 0001567892 mnk:UnsecuredNotesMember us-gaap:SeniorNotesMember 2013-04-01 2013-04-30 0001567892 mnk:A2023NotesMember mnk:PriorToOctober152018Member 2015-09-24 2015-09-24 0001567892 mnk:A2015RevolvingCreditFacilityMember 2015-09-25 0001567892 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2015-09-25 0001567892 mnk:A2023NotesMember mnk:OptionBMember 2015-09-24 2015-09-24 0001567892 mnk:FivePointSevenFivePercentNotesMember mnk:PriorToAugust12017Member 2014-09-27 2015-09-25 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:LondonInterbankOfferedRateLIBORMember 2014-03-19 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:SeniorNotesMember 2014-08-31 0001567892 mnk:A2023NotesMember mnk:OptionAMember 2015-09-24 2015-09-24 0001567892 mnk:A2015ReplacementRevolvingCreditFacilityMember 2015-08-28 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:RevolvingCreditFacilityMember 2014-03-18 2014-03-19 0001567892 mnk:FivePointSevenFivePercentNotesMember mnk:OptionAMember 2014-09-27 2015-09-25 0001567892 mnk:TermLoanDueMarch2021Member 2014-03-19 0001567892 mnk:ReceivableSecuritizationMaturityDateofJuly2017Member us-gaap:SecuredDebtMember 2014-03-19 0001567892 mnk:A2025NotesMemberMember mnk:PriorToApril152018Member 2015-04-15 2015-04-15 0001567892 us-gaap:LineOfCreditMember 2015-09-25 0001567892 mnk:A2025NotesMemberMember mnk:OptionBMember 2015-04-15 2015-04-15 0001567892 mnk:A2025NotesMemberMember mnk:OptionAMember 2015-04-15 2015-04-15 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2013-09-28 2014-09-26 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2012-09-29 2013-09-27 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2012-09-29 2013-09-27 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2013-09-28 2014-09-26 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:OtherDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-25 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-26 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:DebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-26 0001567892 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-25 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-25 0001567892 us-gaap:DebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-25 0001567892 us-gaap:OtherDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-25 0001567892 us-gaap:DebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-26 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-25 0001567892 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-26 0001567892 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-25 0001567892 us-gaap:OtherDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-25 0001567892 us-gaap:OtherDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-26 0001567892 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-25 0001567892 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-26 0001567892 us-gaap:DebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-25 0001567892 us-gaap:PensionPlansDefinedBenefitMember 2013-09-27 0001567892 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2013-09-27 0001567892 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 mnk:DefinedContributionPlan401KMember 2014-09-27 2015-09-25 0001567892 us-gaap:DebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 us-gaap:DebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:JP 2014-09-27 2015-09-25 0001567892 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:NL 2014-09-27 2015-09-25 0001567892 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:JP 2014-09-27 2015-09-25 0001567892 us-gaap:MoodysAa1RatingMember 2014-09-27 2015-09-25 0001567892 us-gaap:DebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:NL 2014-09-27 2015-09-25 0001567892 mnk:DefinedContributionPlan401KMember 2013-09-28 2014-09-26 0001567892 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:JP 2014-09-27 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:ForeignPensionPlansDefinedBenefitMember country:NL 2014-09-27 2015-09-25 0001567892 mnk:DefinedContributionPlan401KMember 2012-09-29 2013-09-27 0001567892 us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:InternationalMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member 2014-09-27 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member 2013-09-28 2014-09-26 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member 2013-09-27 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2012-09-29 2013-09-27 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2012-09-29 2013-09-27 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2013-09-28 2014-09-26 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2013-09-28 2014-09-26 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-27 2015-09-25 0001567892 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2013-09-27 0001567892 us-gaap:ForeignPensionPlansDefinedBenefitMember 2013-09-27 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:InternationalMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.LargeCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:U.S.SmallMidCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:InternationalMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:HighYieldBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:PlanAssetInsuranceContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:EmergingMarketFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:A2015ShareRepurchaseProgramMember 2014-09-27 2015-09-25 0001567892 mnk:A2015ShareRepurchaseProgramMember 2015-09-25 0001567892 2015-01-23 0001567892 us-gaap:RestrictedStockUnitsRSUMember 2013-09-27 0001567892 us-gaap:RestrictedStockUnitsRSUMember 2015-09-25 0001567892 us-gaap:RestrictedStockUnitsRSUMember 2014-09-27 2015-09-25 0001567892 us-gaap:RestrictedStockUnitsRSUMember 2013-09-28 2014-09-26 0001567892 us-gaap:RestrictedStockUnitsRSUMember 2014-09-26 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:RestructuringChargesMember 2014-09-27 2015-09-25 0001567892 us-gaap:PerformanceSharesMember 2014-09-27 2015-09-25 0001567892 mnk:A2013MallinckrodtPharmaceuticalsStockandIncentivePlanMember 2015-09-25 0001567892 us-gaap:RestrictedStockMember 2015-09-25 0001567892 us-gaap:MinimumMember 2014-09-27 2015-09-25 0001567892 us-gaap:EmployeeStockOptionMember 2014-09-27 2015-09-25 0001567892 us-gaap:EmployeeStockMember 2014-09-27 2015-09-25 0001567892 us-gaap:RestrictedStockMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-09-27 2015-09-25 0001567892 us-gaap:EmployeeStockMember 2013-09-28 2014-09-26 0001567892 us-gaap:PerformanceSharesMember 2015-09-25 0001567892 us-gaap:MaximumMember 2014-09-27 2015-09-25 0001567892 mnk:A2015MallinckrodtPharmaceuticalsStockandIncentivePlanMember 2015-09-25 0001567892 mnk:A2015MallinckrodtPharmaceuticalsStockandIncentivePlanMember 2014-09-27 2015-09-25 0001567892 us-gaap:EmployeeStockOptionMember 2015-09-25 0001567892 2013-06-28 2013-06-28 0001567892 2013-06-27 0001567892 2013-06-27 2013-06-27 0001567892 2014-06-27 0001567892 us-gaap:RestrictedStockMember 2013-09-28 2014-09-26 0001567892 us-gaap:RestrictedStockMember 2013-09-27 0001567892 us-gaap:RestrictedStockMember 2014-09-26 0001567892 2013-06-26 2013-06-28 0001567892 mnk:CovidienPlcMember 2014-06-27 0001567892 mnk:CovidienPlcMember us-gaap:RestrictedStockUnitsRSUMember 2014-06-27 0001567892 us-gaap:PerformanceSharesMember 2013-09-28 2014-09-26 0001567892 us-gaap:PerformanceSharesMember 2013-09-27 0001567892 us-gaap:PerformanceSharesMember 2014-09-26 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-09-28 2014-09-26 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-09-28 2014-09-26 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2014-09-26 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2013-09-28 2014-09-26 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-09-26 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-09-28 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-09-27 2015-09-25 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2014-09-27 2015-09-25 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2013-09-27 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-09-25 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-09-27 2015-09-25 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-09-29 2013-09-27 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-09-28 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2015-09-25 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2012-09-28 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-09-25 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-09-29 2013-09-27 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-09-27 0001567892 us-gaap:AccumulatedTranslationAdjustmentMember 2012-09-29 2013-09-27 0001567892 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-09-26 0001567892 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-09-27 0001567892 us-gaap:SegmentDiscontinuedOperationsMember mnk:CovidienPlcMember 2014-09-27 2015-09-25 0001567892 us-gaap:OtherCurrentLiabilitiesMember mnk:CovidienPlcMember 2015-09-25 0001567892 mnk:SeparationAgreementwithCovidienMember mnk:CovidienPlcMember 2015-09-25 0001567892 mnk:SeparationAgreementwithCovidienMember mnk:CovidienPlcMember 2014-06-27 0001567892 us-gaap:SegmentDiscontinuedOperationsMember mnk:CovidienPlcMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentDiscontinuedOperationsMember mnk:CovidienPlcMember 2013-09-28 2014-09-26 0001567892 mnk:TaxMattersAgreementMember mnk:CovidienPlcMember 2015-09-25 0001567892 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember mnk:CovidienPlcMember 2015-09-25 0001567892 us-gaap:MinimumMember mnk:TaxMattersAgreementMember mnk:CovidienPlcMember 2014-09-27 2015-09-25 0001567892 mnk:TaxMattersAgreementMember mnk:CovidienPlcMember 2014-09-27 2015-09-25 0001567892 us-gaap:MaximumMember mnk:TaxMattersAgreementMember mnk:CovidienPlcMember 2014-09-27 2015-09-25 0001567892 mnk:EnviornmentalHealthandSafetyMattersMember us-gaap:OtherLiabilitiesMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2014-09-26 0001567892 us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2014-09-27 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2014-09-26 0001567892 mnk:OthersMember 2015-09-25 0001567892 us-gaap:OtherLiabilitiesMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2014-09-26 0001567892 us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2015-09-25 0001567892 us-gaap:SuretyBondMember mnk:MarylandHeightsMissouriMember 2015-09-25 0001567892 us-gaap:OtherAssetsMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2015-09-25 0001567892 mnk:EnviornmentalHealthandSafetyMattersMember us-gaap:OtherLiabilitiesMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2015-09-25 0001567892 us-gaap:OtherLiabilitiesMember us-gaap:IndemnificationGuaranteeMember mnk:MallinckrodtBakerMember 2015-09-25 0001567892 mnk:AsbestosMattersMember 2014-09-27 2015-06-26 0001567892 mnk:QuestcorSecuritiesLitigationMember 2015-06-26 0001567892 mnk:QuestcorShareholderDerivativeLitigationMember 2012-09-26 2012-09-26 0001567892 mnk:DavidTabanetal.v.QuestcorPharmaceuticalsIncMember 2014-09-27 2014-12-26 0001567892 mnk:LowerPassaicRiverNewJerseyMember 2015-09-25 0001567892 mnk:AsbestosMattersMember 2015-09-25 0001567892 mnk:LowerPassaicRiverNewJerseyMember 2014-04-11 0001567892 mnk:LowerPassaicRiverNewJerseyMember 2014-09-27 2015-09-25 0001567892 mnk:GlenridgeLitigationMember 2013-08-01 2013-08-31 0001567892 mnk:QuestcorSecuritiesLitigationMember 2014-09-27 2015-06-26 0001567892 mnk:RetrophinLitigationMember 2014-09-27 2015-09-25 0001567892 mnk:MallinckrodtVeterinaryInc.MillsboroDelawareMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorSecuritiesLitigationMember 2012-09-26 2012-09-26 0001567892 mnk:QuestcorShareholderDerivativeLitigationMember 2014-09-27 2014-12-26 0001567892 mnk:ExelaPharmaSciencesLLC222and218PatentLitigationMember 2014-09-27 2015-09-25 0001567892 mnk:GlenridgeLitigationMember 2013-08-31 0001567892 mnk:ExelaPharmaSciencesLLC222and218PatentLitigationMember 2011-08-01 2011-08-31 0001567892 mnk:GlenridgeLitigationMember 2012-08-01 2012-08-31 0001567892 mnk:FivePointFivePercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-09-25 0001567892 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2014-09-26 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-09-25 0001567892 mnk:EightPercentDebentureMember us-gaap:CarryingReportedAmountFairValueDisclosureMember mnk:DebenturesMember 2015-09-25 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2014-09-26 0001567892 mnk:NinePointFivePercentDebentureMember us-gaap:CarryingReportedAmountFairValueDisclosureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FourPointEightEightPercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FourPointEightEightPercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2014-09-26 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:NinePointFivePercentDebentureMember us-gaap:CarryingReportedAmountFairValueDisclosureMember mnk:DebenturesMember 2015-09-25 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 mnk:TermLoanDueMarch2021Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-09-25 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FivePointFivePercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:A2015RevolvingCreditFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:EightPercentDebentureMember us-gaap:EstimateOfFairValueFairValueDisclosureMember mnk:DebenturesMember 2015-09-25 0001567892 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:EightPercentDebentureMember us-gaap:CarryingReportedAmountFairValueDisclosureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-09-25 0001567892 mnk:FivePointFivePercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FivePointFivePercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 mnk:FourPointEightEightPercentNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:A2015RevolvingCreditFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:NinePointFivePercentDebentureMember us-gaap:EstimateOfFairValueFairValueDisclosureMember mnk:DebenturesMember 2015-09-25 0001567892 mnk:EightPercentDebentureMember us-gaap:EstimateOfFairValueFairValueDisclosureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FourPointEightEightPercentNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2014-09-26 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2014-09-26 0001567892 mnk:NinePointFivePercentDebentureMember us-gaap:EstimateOfFairValueFairValueDisclosureMember mnk:DebenturesMember 2014-09-26 0001567892 mnk:TwoPointEightFivePercentTermLoanMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2014-09-26 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2015-09-25 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:MethylphenidateERHClGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:MethylphenidateERHClGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:AcetaminophenProductsAPIMember 2014-09-27 2015-09-25 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:H.P.ActharGelMember 2012-09-29 2013-09-27 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:H.P.ActharGelMember 2013-09-28 2014-09-26 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:AcetaminophenProductsAPIMember 2012-09-29 2013-09-27 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:AcetaminophenProductsAPIMember 2013-09-28 2014-09-26 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:H.P.ActharGelMember 2014-09-27 2015-09-25 0001567892 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember mnk:MethylphenidateERHClGenericsMember 2012-09-29 2013-09-27 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2014-09-26 0001567892 mnk:McKessonCorporationMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:McKessonCorporationMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:CuraScriptIncMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:CuraScriptIncMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:CardinalHealthInc.Member us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:CardinalHealthInc.Member us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:AmerisourceBergenCorporationMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:AmerisourceBergenCorporationMember us-gaap:AccountsReceivableMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 mnk:EightPercentDebentureMember us-gaap:FairValueInputsLevel2Member mnk:DebenturesMember 2015-09-25 0001567892 mnk:NinePointFivePercentDebentureMember us-gaap:FairValueInputsLevel2Member mnk:DebenturesMember 2015-09-25 0001567892 mnk:Novartis2015and2016Member 2014-09-27 2015-09-25 0001567892 mnk:BioVectraIncMember mnk:QuestcorPharmaceuticalsInc.Member 2015-09-25 0001567892 mnk:CnsTherapeuticsIncMember 2014-09-27 2015-09-25 0001567892 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2014-09-26 0001567892 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 mnk:FourPointSevenFivePercentNoteMember us-gaap:FairValueInputsLevel1Member us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FivePointFivePercentNotesMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-09-25 0001567892 mnk:NovartisSubsequenttoFDAApprovalMember 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2015-09-25 0001567892 mnk:TwoPointEightFivePercentTermLoanMember 2014-09-27 2015-09-25 0001567892 mnk:FivePointSixTwoFivePercentNoteMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:FivePointSevenFivePercentNotesMember us-gaap:SeniorNotesMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:SynacthenMember 2014-09-27 2015-09-25 0001567892 mnk:FourPointEightEightPercentNotesMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member mnk:BioVectraFinancialResultsMember 2014-09-27 2015-09-25 0001567892 mnk:NovartisSubsequentto2016tillFDAApprovalMember 2014-09-27 2015-09-25 0001567892 mnk:CnsTherapeuticsIncMember 2015-09-25 0001567892 mnk:ThreePointFivePercentNoteMember us-gaap:FairValueInputsLevel1Member us-gaap:SeniorNotesMember 2015-09-25 0001567892 mnk:FourPointZeroZeroPercentTermLoanMember 2014-09-27 2015-09-25 0001567892 mnk:QuestcorPharmaceuticalsInc.Member 2014-08-31 0001567892 mnk:BioVectraIncMember mnk:QuestcorPharmaceuticalsInc.Member 2014-09-27 2015-09-25 0001567892 mnk:CardinalHealthInc.Member us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2012-09-29 2013-09-27 0001567892 mnk:CuraScriptIncMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2012-09-29 2013-09-27 0001567892 mnk:AmerisourceBergenCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:AmerisourceBergenCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:CuraScriptIncMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:CardinalHealthInc.Member us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:AmerisourceBergenCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2012-09-29 2013-09-27 0001567892 mnk:CardinalHealthInc.Member us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:McKessonCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2013-09-28 2014-09-26 0001567892 mnk:McKessonCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2012-09-29 2013-09-27 0001567892 mnk:CuraScriptIncMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 mnk:McKessonCorporationMember us-gaap:SalesRevenueGoodsNetMember mnk:DistributorConcentrationRiskMember 2014-09-27 2015-09-25 0001567892 country:IE us-gaap:EMEAMember 2015-09-25 0001567892 us-gaap:IntersegmentEliminationMember 2014-09-27 2015-09-25 0001567892 country:IE us-gaap:EMEAMember 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember 2014-09-27 2015-09-25 0001567892 us-gaap:CorporateNonSegmentMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:GlobalMedicalImagingMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:CorporateNonSegmentMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:GlobalMedicalImagingMember 2012-09-29 2013-09-27 0001567892 us-gaap:CorporateNonSegmentMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:GlobalMedicalImagingMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:SegmentContinuingOperationsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:SegmentContinuingOperationsMember 2013-09-28 2014-09-26 0001567892 country:US 2014-09-27 2015-09-25 0001567892 country:US 2014-09-26 0001567892 mnk:OtherCountriesMember 2013-09-28 2014-09-26 0001567892 country:US 2013-09-28 2014-09-26 0001567892 us-gaap:EMEAMember 2014-09-27 2015-09-25 0001567892 us-gaap:EMEAMember 2013-09-28 2014-09-26 0001567892 mnk:OtherCountriesMember 2014-09-27 2015-09-25 0001567892 mnk:OtherCountriesMember 2014-09-26 0001567892 country:US 2015-09-25 0001567892 us-gaap:EMEAMember 2015-09-25 0001567892 us-gaap:EMEAMember 2012-09-29 2013-09-27 0001567892 mnk:OtherCountriesMember 2012-09-29 2013-09-27 0001567892 us-gaap:EMEAMember 2014-09-26 0001567892 country:US 2012-09-29 2013-09-27 0001567892 mnk:OtherCountriesMember 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:HydrocodoneAPIMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:InomaxMember mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:MethylphenidateERHClGenericsMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:HydrocodoneAPIMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:ExalgoMember mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:OffirmevMember mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:NuclearImagingMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:OffirmevMember mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OffirmevMember mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:H.P.ActharGelMember mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OxycodoneAPIMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:InomaxMember mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OxycodoneAPIMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProductsMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProducts2Member mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:ExalgoMember mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProductsMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherControlledSubstancesMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:NuclearImagingMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProducts2Member mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:OxycodoneAPIMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProducts2Member mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherControlledSubstancesMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherProductsMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:MethylphenidateERHClGenericsMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:H.P.ActharGelMember mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:HydrocodoneAPIMember mnk:SpecialtyGenericsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:NuclearImagingMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:H.P.ActharGelMember mnk:SpecialtyBrandsMember 2014-09-27 2015-09-25 0001567892 us-gaap:OperatingSegmentsMember mnk:OtherControlledSubstancesMember mnk:SpecialtyGenericsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:MethylphenidateERHClGenericsMember mnk:SpecialtyGenericsMember 2013-09-28 2014-09-26 0001567892 us-gaap:OperatingSegmentsMember mnk:InomaxMember mnk:SpecialtyBrandsMember 2012-09-29 2013-09-27 0001567892 us-gaap:OperatingSegmentsMember mnk:ExalgoMember mnk:SpecialtyBrandsMember 2013-09-28 2014-09-26 0001567892 us-gaap:IntersegmentEliminationMember 2013-09-28 2014-09-26 0001567892 us-gaap:IntersegmentEliminationMember 2012-09-29 2013-09-27 0001567892 2014-03-29 2014-06-27 0001567892 2015-03-28 2015-06-26 0001567892 2013-09-28 2013-12-27 0001567892 2015-06-27 2015-09-25 0001567892 2013-12-28 2014-03-28 0001567892 2014-12-27 2015-03-27 0001567892 2014-06-28 2014-09-26 0001567892 2014-09-27 2014-12-26 0001567892 mnk:CovidienPlcMember 2012-11-30 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2015-09-25 0001567892 us-gaap:ConsolidationEliminationsMember 2014-09-27 2015-09-25 0001567892 us-gaap:ParentCompanyMember 2014-09-27 2015-09-25 0001567892 us-gaap:SubsidiaryIssuerMember 2014-09-27 2015-09-25 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2014-09-27 2015-09-25 0001567892 us-gaap:ParentCompanyMember 2015-09-25 0001567892 us-gaap:ParentCompanyMember 2014-09-26 0001567892 us-gaap:SubsidiaryIssuerMember 2015-09-25 0001567892 us-gaap:ConsolidationEliminationsMember 2015-09-25 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2014-09-26 0001567892 us-gaap:ConsolidationEliminationsMember 2014-09-26 0001567892 us-gaap:SubsidiaryIssuerMember 2014-09-26 0001567892 us-gaap:SubsidiaryIssuerMember 2013-09-28 2014-09-26 0001567892 us-gaap:ParentCompanyMember 2013-09-28 2014-09-26 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2013-09-28 2014-09-26 0001567892 us-gaap:ConsolidationEliminationsMember 2013-09-28 2014-09-26 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2013-09-27 0001567892 us-gaap:ConsolidationEliminationsMember 2013-09-27 0001567892 us-gaap:ParentCompanyMember 2013-09-27 0001567892 us-gaap:SubsidiaryIssuerMember 2013-09-27 0001567892 us-gaap:ConsolidationEliminationsMember 2012-09-29 2013-09-27 0001567892 us-gaap:ParentCompanyMember 2012-09-29 2013-09-27 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2012-09-29 2013-09-27 0001567892 us-gaap:SubsidiaryIssuerMember 2012-09-29 2013-09-27 0001567892 us-gaap:ConsolidationEliminationsMember 2012-09-28 0001567892 us-gaap:ParentCompanyMember 2012-09-28 0001567892 us-gaap:NonGuarantorSubsidiariesMember 2012-09-28 0001567892 us-gaap:SubsidiaryIssuerMember 2012-09-28 0001567892 mnk:A2015MallinckrodtPharmaceuticalsStockandIncentivePlanMember 2015-11-19 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2013-09-27 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2014-09-27 2015-09-25 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2012-09-29 2013-09-27 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2013-09-28 2014-09-26 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2014-09-26 0001567892 us-gaap:AllowanceForSalesReturnsMember 2014-09-26 0001567892 us-gaap:AllowanceForSalesReturnsMember 2013-09-28 2014-09-26 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2012-09-28 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2015-09-25 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2013-09-28 2014-09-26 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2012-09-29 2013-09-27 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2014-09-27 2015-09-25 0001567892 us-gaap:AllowanceForSalesReturnsMember 2012-09-29 2013-09-27 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2012-09-28 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2013-09-27 0001567892 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2014-09-26 0001567892 us-gaap:AllowanceForSalesReturnsMember 2013-09-27 0001567892 us-gaap:AllowanceForSalesReturnsMember 2012-09-28 0001567892 us-gaap:AllowanceForSalesReturnsMember 2014-09-27 2015-09-25 0001567892 us-gaap:AllowanceForSalesReturnsMember 2015-09-25 0001567892 us-gaap:AllowanceForDoubtfulAccountsMember 2015-09-25 iso4217:EUR xbrli:shares iso4217:USD xbrli:shares xbrli:pure mnk:pharmacy_indications iso4217:USD xbrli:shares mnk:principal mnk:contract mnk:action mnk:Patents mnk:Defendent mnk:lawsuit mnk:Case mnk:order mnk:supplier iso4217:CAD mnk:reactor false --09-25 FY 2015 2015-09-25 10-K 0001567892 115947044 Yes Large Accelerated Filer 15146400000 Mallinckrodt plc No Yes MNK 7500000 7500000 2300000 25700000 44100000 14.00 30.00 0.897 0.35 0.130 0.145 0.100 0.100 0.160 0.145 0.145 0.170 0.170 95000000 1286000000 5470200000 1176300000 978400000 700000000 900000000 7500000 25000000 25000000 40000000 25000000 90400000 9800000 80600000 42100000 9700000 18000000 274300000 172900000 300000000 1100000000 0 0 0 128800000 0 8000000 134300000 228100000 286900000 0 -39200000 13500000 25700000 0 0 -9867200000 167700000 9699500000 0 0 -39200000 25700000 13500000 0 0 -9867200000 9699500000 39100000 128600000 0.0025 P90D 0.0025 1.01 1.00 1.01 1.00 1.01 1 0 15000000 0 15000000 0 20000000 0 20000000 11000000 9800000 145700000 147300000 38200000 40400000 600000 8700000 14800000 52200000 29500000 23600000 39000000 26300000 29500000 33600000 63400000 90000000 41100000 48500000 1447400000 191300000 187900000 15500000 12200000 0.731 0.706 25000 16000000 18900000 15500000 9500000 47200000 300000 549300000 495800000 413800000 0 204000000 0 0 20000000 0 6700000 168000000 20000000 0 18000000 0.33 0.32 0.17 0.14 2900000 0 2900000 0 0 15000000 0 15000000 0 0 11700000 3500000 0 3500000 0 0 P17Y 0 0 151600000 0 151600000 0 0 -151600000 204000000 0 0 8200000 -143800000 305700000 50600000 -175500000 16400000 78200000 142200000 25300000 54300000 324300000 44000000 596900000 324300000 105400000 31800000 1900000 13900000 128000000 10800000 35000000 14000000 22500000 38700000 62200000 93600000 1515900000 1465300000 1488700000 168000000 0 0 9500000 -9500000 0 0 0 9000000 -9000000 0 0 0 14700000 -14700000 0 0 412000000 -409600000 0 -2400000 0 1238900000 -915800000 -25000000 -298100000 0 703600000 -554200000 -149400000 0 0 -6326600000 4360000000 0 1966600000 0 -2672600000 0 0 2672600000 0 -6326600000 1941600000 4385000000 0 0 -2672600000 2498200000 174400000 0 36500000 300000000 0 P7Y P5Y 2 250000000 25000000 64000000 73000000 120000000 55000000 22000000 65000000 15000000 10000000 10000000 25000000 -2157000000 -2754400000 19 2 4 5 134 2 3 8 40000 40000 0 0 0 0 1.00 1.00 0 0 3800000 6000000 122600000 0 122600000 0 0 121300000 0 121300000 0 0 1.00 0 -300500000 300500000 0 0 P3Y 2 0 P60D P60D P60D P60D 88000000 0 -412000000 0 2400000 409600000 0 -1238900000 300500000 -2400000 940800000 0 -703600000 0 0 703600000 0 -300500000 0 0 300500000 69800000 66300000 -1200000 0 200000 -200000 1500000 0 0 1500000 2300000 0 1300000 1000000 3000000 0 3000000 0 26100000 0 8500000 17600000 57200000 22900000 32900000 1400000 40700000 25300000 15400000 0 9700000 0 6400000 3300000 26400000 0 25300000 1100000 1000000 0 1000000 0 -200000 0 0 -200000 2500000 0 1800000 700000 -600000 0 -600000 0 2600000 38000000 10100000 23700000 43900000 30600000 74200000 0 70400000 3200000 600000 74200000 9600000 0 7100000 2500000 0 9600000 0 0 28900000 0 0 0.00 0.00 70.88 70.88 1829164 30747 8800000 500000000 515900000 515900000 0.125 0.125 214700000 209900000 4800000 0 -1095000000 1095000000 0 1106500000 -1106500000 0.350 200000000 14300000 3100000 P5Y P2Y 26300000 26300000 0 8500000 17800000 6900000 5200000 11200000 3000000 81900000 81900000 56400000 27300000 -1800000 13700000 57000000 9800000 1400000 40700000 40700000 33600000 7400000 -300000 -4600000 36500000 4500000 4300000 85600000 0 0 16400000 0 7900000 0 0 1000000 52400000 2400000 0 5500000 0 109900000 11300000 11900000 0 14400000 13700000 7100000 0 0 800000 44100000 1700000 0 4900000 0 0 0 100000 153700000 0 0 84200000 0 0 35900000 8900000 8600000 1500000 27300000 7400000 100100000 82000000 89200000 9300000 150000000 150000000 153000000 153000000 153000000 0.08 0.12 0.11 110700000 0 109300000 1200000 200000 133000000 0 132800000 0 200000 476600000 0 476600000 0 0 548500000 0 548500000 0 0 76500000 13300000 23100000 3200000 59200000 0 59200000 0 0 73300000 0 73300000 0 0 135700000 141100000 13100000 19800000 122600000 121300000 67700000 0 67700000 0 0 29300000 0 29300000 0 0 782200000 15800000 879300000 14600000 15900000 -108200000 9800000 -98600000 84900000 -72200000 0 157100000 108500000 -42800000 -7300000 158600000 65700000 -58500000 -6800000 131000000 900000 -52900000 -6400000 60200000 P13Y P3Y P8Y P18Y P12Y P13Y P15Y P22Y P15Y 5172400000 5357600000 6500000 6500000 67700000 67700000 117000000 117000000 8900000 8900000 34100000 34100000 16000000 66800000 116100000 3700000 4700000 27900000 27900000 154800000 85900000 0 34900000 120800000 154800000 550300000 162500000 57100000 301400000 521000000 550300000 500000 5700000 100000 0 381200000 11100000 0 48900000 39200000 36900000 3100000 1800000 0 0 -1300000 -3100000 -11500000 -1000000 12787300000 -22543400000 19669600000 4986100000 10675000000 16404100000 -56226100000 38498000000 15012600000 19119600000 2071000000 -39200000 2066600000 14300000 29300000 1846100000 -9867200000 11391900000 40500000 280900000 22900000 12800000 0 35700000 24200000 10400000 0 34600000 312000000 299900000 200800000 0 200800000 0 0 299900000 0 299900000 0 0 57000000 -0.55 3.11 -0.55 3.07 -63100000 359900000 3598100000 3755800000 65100000 17600000 0 47500000 0 0 30900000 0 22500000 53400000 98600000 1329200000 1300000000 5915300000 1253600000 1019700000 1400000000 750000000 2300000000 1300000000 190000000 9000000 0 0 202800000 202800000 50000000 0 0 0 174600000 174600000 6900000 0 0 0 1714100000 129700000 1700300000 8177800000 3039900000 41300000 3600000 43200000 445100000 77300000 7200000 167400000 195400000 22000000 3300000 14700000 87300000 73800000 24700000 4000000 48800000 168900000 32600000 324300000 27100000 292300000 1906800000 623600000 18600000 218300000 1170000000 91900000 1300000000 5601100000 1971000000 73100000 200000 1300000000 5343300000 34300000 5200000 1971000000 1820000000 70000000 81000000 23500000 0 21000000 67900000 26300000 694400000 38000000 371100000 2391300000 1786300000 1019700000 1170000000 91700000 1329200000 5786500000 1253600000 344800000 0 30000000 0 1121000000 600000 0 0 186800000 9100000 17400000 12300000 9500000 1400000 1300000 400000 1000000 2300000 1300000 0 0 100000 900000 0 0 2300000 0 0 0 0 0 275500000 0 217800000 1200000 56500000 707800000 0 689000000 300000 18500000 365900000 0 213700000 100000 152100000 275500000 0 217800000 1200000 56500000 432300000 0 471200000 -900000 -38000000 -341900000 0 -475300000 -200000 133600000 67300000 67700000 23200000 23500000 0.20 0.20 0.20 500000000 500000000 116160353 117513370 57694885 115929588 116283149 87200000 -237200000 132400000 87200000 104800000 -362100000 863100000 -555500000 -362100000 -307600000 259900000 -942700000 757000000 259900000 185700000 0.11 0.24 0.00 0.19 0.13 0.00 0.09 0.14 0.14 0.18 0.22 0.15 0.06 0.27 0.21 0.09 0.06 0.10 0.12 0.09 0.13 0.14 0.16 0.31 0.24 0.18 0.06 0.31 0.04 890000000 0 890000000 0 0 1021800000 0 1021800000 0 0 1493300000 0 1493300000 0 0 49300000 5600000 40900000 10400000 300000 0 12100000 10700000 17900000 -6600000 95100000 14900000 61400000 58800000 95400000 3700000 -6100000 0 0.008 3959600000 0 8000000 900000000 0 600000000 9600000 10400000 150000000 1978500000 300000000 2700000 0 6584200000 700000000 700000000 4400000 900000000 750000000 600000000 6900000 10400000 153000000 1958500000 300000000 0 500000000 600000000 300000000 160000000 1300000000 900000000 700000000 700000000 700000000 750000000 0.08 0.0550 0.05625 0.04875 0.0475 0.095 0.035 0.0475 0.0350 0.0075 0.0575 0.04875 0.0550 0.05625 0.40 1.00 0.40 0.4 3300000 3980800000 6606500000 17500000 56300000 57900000 -18300000 -49700000 -800000 4400000 -500000 -19200000 3000000 -187500000 4400000 -13900000 5400000 -68900000 35600000 -188300000 2584400000 3344000000 -9000000 -107500000 -191600000 2500000 9600000 105700000 427400000 589600000 21400000 23200000 -2233900000 -2987400000 152300000 142700000 13400000 7000000 152300000 0 152300000 0 0 142700000 0 142700000 0 0 126000000 4900000 13500000 91400000 19600000 34600000 32000000 20200000 13100000 93800000 163300000 21700000 28100000 18900000 34500000 33800000 68900000 92500000 76900000 233000000 12000000 33100000 623600000 0 4700000 2177900000 1550700000 620200000 334100000 2399600000 0 2399600000 0 0 3132400000 0 3132400000 0 0 121600000 140100000 17500000 700000 6500000 369000000 533600000 489400000 2900000 115100000 5100000 104100000 18800000 6900000 14900000 5500000 0 59700000 0 12500000 -500000 -60000000 -2100000 4500000 -300000 -12300000 0 -8100000 0 -9400000 -9100000 600000 -9300000 -600000 -4000000 -600000 -52000000 -64800000 -52200000 -55600000 0 9800000 0 20100000 0.037 0.040 0.043 0.025 0.037 0.039 0.025 0.039 0.039 0.035 0.000 0.034 0.000 0.036 0.000 0.040 0.032 0.035 0.035 0.040 0.042 0.025 0.036 0.038 0.035 0.079 0.031 0.065 0.029 0.060 0.037 0.000 0.035 0.000 0.032 0.000 53200000 501700000 52000000 538400000 52200000 493500000 3900000 21900000 3900000 21100000 0 0 0 600000 3900000 4900000 3900000 13000000 0 600000 0 600000 700000 0 800000 0 15600000 143900000 4600000 40000000 3500000 31400000 3800000 32600000 4000000 33000000 4300000 33600000 0 29600000 0 24600000 0 22600000 112000000 0 456000000 9500000 0 0 9500000 13000000 0 0 13000000 28700000 11100000 0 39800000 0 0 119800000 119800000 119800000 50200000 0 0 50200000 16600000 0 0 16600000 216600000 2100000 0 218700000 2600000 3400000 0 6000000 0 473600000 337200000 16600000 119800000 473600000 7400000 0 0 7400000 11300000 0 0 11300000 22700000 8300000 0 31000000 0 0 116700000 116700000 116700000 46200000 0 0 46200000 15100000 0 0 15100000 196900000 1500000 0 198400000 9400000 2400000 0 11800000 0 437900000 309000000 12200000 116700000 437900000 0 -9100000 0 -18900000 -7100000 0 -8100000 -15200000 0 -17100000 -52000000 -64800000 -52200000 -55600000 0 -10800000 -2100000 -500000 0.071 0.071 2400000 18200000 2100000 19600000 1900000 17500000 -6300000 13300000 -7100000 11400000 -2000000 14200000 394700000 368800000 321600000 294100000 -600000 -100000 0 -6800000 0 -3800000 0 -6000000 100000 5000000 100000 5100000 100000 4500000 0 17600000 0 23600000 0 17600000 0 23600000 0.88 0.06 0.55 0.02 0.76 0.39 0.10 0.24 0.045 0.045 0.00 0.01 0.02 0.70 0.08 0.28 0.90 0.01 1 1 0.00 0.03 0.01 0.70 0.06 0.27 0.93 0.00 1 1 2029 2029 20300000 20500000 23700000 0.15 0.25 0.5 88100000 94700000 103900000 139600000 18500000 24900000 72700000 116100000 275900000 18800000 152900000 77800000 249500000 672500000 12400000 559800000 81900000 654100000 70700000 -209500000 4900000 49600000 -174800000 -5900000 22500000 21100000 -34700000 11500000 21100000 -34700000 10800000 68900000 68500000 18000000 22000000 10000000 111200000 0 111200000 0 0 0 0 0 0 0 270000000 346700000 352900000 306400000 114000000 97100000 97500000 30000000 27700000 90200000 86300000 60500000 57100000 8400000 4100000 4700000 50700000 50800000 62400000 60300000 6300000 3900000 1.02 -4.92 2.78 1.02 -4.92 2.75 1300000 0 1300000 0 0 -4200000 0 -4200000 0 0 -11600000 0 -11600000 0 0 0.35 0.35 0.20 0.23 0.21 116300000 0 116200000 100000 0 103700000 0 103600000 100000 0 17500000 17200000 8900000 2300000 P2Y8M P1Y9M P2Y6M P2Y9M 30300000 24800000 5700000 24100000 41700000 0 -16177600000 4945100000 586800000 10645700000 0 -43686300000 10050000000 14797700000 18838600000 19400000 19000000 30000000 3400000 0 3400000 0 0 8900000 0 8900000 0 0 34100000 0 34100000 0 0 0.28 0.27 0.01 0.047 0.013 0.0575 0.04 0.0285 29000000 5000000 202800000 174600000 P25Y P5Y P12Y P30Y P8Y P30Y P13Y 332600000 235600000 600000 87300000 5000000 4100000 882900000 765800000 4400000 99800000 6700000 6200000 693700000 682000000 682600000 682900000 691900000 7144600000 6906000000 33800000 185100000 6700000 13000000 10198000000 9896000000 28100000 185100000 6700000 82100000 7200000 200000 0 0 200000 3300000 0 0 3300000 -12800000 3800000 30700000 10100000 -6300000 -24800000 2401900000 0 2401900000 0 0 3649400000 0 3649400000 0 0 437200000 24500000 318100000 1789400000 792400000 2521400000 119500000 2194900000 207000000 3768900000 119500000 3442400000 207000000 119500000 100200000 219700000 119500000 0 0 119500000 119500000 0 0 100200000 1247500000 17900000 822300000 0 822300000 0 0 216200000 226700000 254100000 363200000 1060200000 0 1060200000 0 0 404800000 462900000 503800000 482100000 1853600000 0 1853600000 0 0 13900000 16600000 13000000 15700000 39400000 71000000 57200000 52400000 65900000 52400000 51400000 8200000 -173100000 45900000 59000000 76400000 38500000 20200000 -29000000 -173500000 -143800000 736200000 -296800000 -318400000 -264800000 87400000 75200000 55600000 90000000 308200000 -1077400000 809500000 325600000 250500000 34700000 -159900000 -107000000 21000000 6000000 322300000 55700000 -173100000 93700000 58700000 76400000 -153900000 736200000 -306900000 -318400000 -264800000 215300000 -1077400000 732500000 309700000 250500000 0.14 0.67 0.35 -0.50 -2.04 -2.22 0.75 0.64 0.47 0.77 2.64 0.14 0.66 0.34 -0.50 -2.04 -2.22 0.74 0.64 0.47 0.76 2.61 50600000 0 50800000 -200000 0 1000000 7100000 -8600000 4900000 -178900000 -175500000 0 -174600000 -900000 0 -700000 5300000 23600000 2400000 -14800000 16500000 0 17400000 -900000 0 -100000 0.88 -2.70 0.14 0.88 -2.70 0.14 0 -173100000 0 76400000 96700000 0 736200000 -300200000 -264800000 -171200000 0 -1077400000 250500000 330600000 496300000 81300000 2009 1996 47500000 0 47800000 -300000 0 -10100000 0 -10100000 0 0 -36200000 -92900000 0 -77000000 -15900000 0 51600000 300000 5100000 60000000 3400000 100000 -2100000 10000000 700000 32100000 3000000 21500000 2500000 4100000 0 3300000 -10600000 -138600000 19500000 -53800000 43100000 15300000 2900000 13800000 16400000 0 41800000 0 1400000 -1000000 3000000 5000000 -1500000 -6800000 2300000 700000 3600000 6300000 800000 8100000 15000000 128000000 123800000 7200000 -32900000 20400000 181200000 51300000 -700000 900000 60700000 -54800000 30200000 -27700000 -56000000 -61300000 -6600000 -149900000 79200000 0 -4100000 0 -4100000 0 0 -3100000 0 -3100000 0 0 270200000 235200000 35000000 351200000 316200000 35000000 7082200000 0 7082200000 0 0 9666300000 0 9666300000 0 0 19500000 0 -100000 0 19600000 82600000 -3700000 0 0 86300000 255600000 -96200000 25200000 96400000 230200000 300000 0 300000 0 0 1500000 -3700000 5200000 0 0 1000000 -96200000 97100000 0 100000 800000 57200000 200500000 64200000 91300000 306400000 0 306400000 0 0 281800000 0 281800000 0 0 57500000 66300000 184700000 124200000 15500000 32100000 0 22900000 12800000 0 35700000 24200000 10400000 0 34600000 7829300000 -6365800000 8437200000 28100000 5729800000 11092900000 -12539800000 4861700000 9701400000 9069600000 12787300000 -22543400000 19669600000 4986100000 10675000000 16404100000 -56226100000 38498000000 15012600000 19119600000 904800000 -39200000 846600000 28100000 69300000 929400000 -9867200000 997600000 9701400000 97600000 200000 15000000 202800000 218000000 3300000 20000000 174600000 197900000 68700000 72800000 59000000 0 59000000 0 0 72800000 0 72800000 0 0 9700000 0 9700000 0 0 0 0 0 0 0 500000000 0 500000000 0 240000000 0.0035 0.00275 0.035 0.0099 0.0350 0.026 0.0325 0.026 250000000 160000000 250000000 250000000 250000000 500000000 38000000 15500000 10800000 10800000 1996700000 1970400000 3100000 3100000 7900000 7900000 1978500000 1966500000 0 0 1978500000 3874000000 0 180100000 0 3693900000 6474300000 0 174900000 0 6299400000 21200000 0 3000000 0 18200000 22300000 0 2300000 0 20000000 721200000 521200000 321200000 175000000 22300000 21200000 1200000 18200000 400000 22300000 1000000 20000000 0 8000000 10200000 0 0 900000000 907300000 0 0 0 0 600000000 563800000 10400000 14200000 300000000 290200000 500000000 500000000 4400000 5300000 700000000 646000000 900000000 876100000 750000000 705200000 700000000 684100000 600000000 539600000 10400000 13000000 300000000 294300000 38000000 4 1700000000 3 70 2 12750 1 113100000 2700000000 3200000000 39800000 483400000 365000000 373000000 -480000000 714700000 3000000 135300000 2953900000 -4673900000 3861800000 5900000 3760100000 1069900000 -3718000000 1549500000 -57800000 3296200000 -234700000 480000000 -644300000 0 -70400000 -2890800000 4673900000 -3806600000 -25000000 -3733100000 -2296600000 3718000000 -2850800000 -149400000 -3014400000 135900000 0 146100000 -1800000 -8400000 373400000 0 420200000 18200000 -65000000 896400000 0 837600000 207000000 -148200000 58800000 -173100000 96700000 58800000 76400000 25300000 33500000 45600000 11600000 -24100000 -352400000 -319300000 736200000 -471400000 -319300000 -264800000 -319300000 92700000 98800000 58000000 75200000 324700000 -1077400000 826900000 324700000 250500000 58800000 -319300000 322100000 904000000 400000 829100000 41000000 33900000 994700000 10700000 905200000 44500000 45000000 73500000 0 82600000 -8400000 -700000 336200000 24500000 -36200000 347900000 -75900000 0 6900000 -75500000 -7300000 -66900000 0 17400000 -49500000 550100000 -16700000 -50600000 617400000 461800000 0 603600000 -126100000 -15700000 -97300000 47100000 223300000 173100000 1339700000 66400000 651300000 622000000 95000000 21100000 9300000 11300000 15000000 17700000 20600000 13700000 15200000 24300000 221300000 187800000 7000000 4800000 227100000 207300000 234200000 0 234200000 0 0 251000000 0 250900000 0 100000 -34200000 -34200000 15700000 15700000 -5600000 -5600000 -7300000 -7300000 500000 500000 400000 400000 1500000 1500000 -27600000 -27600000 -70800000 -70800000 -9900000 -4600000 23600000 29400000 -7300000 1500000 -44700000 -17100000 0 -27600000 -71900000 -1100000 0 -70800000 0 200000 200000 28400000 -64100000 35700000 28400000 28400000 -42800000 126900000 -84100000 -42800000 -42800000 -64800000 134700000 -69900000 -64800000 -64800000 -23900000 7300000 2100000 600000 600000 500000 400000 -100000 -200000 2000000 10800000 8100000 9400000 1400000 6700000 -600000 -4100000 529900000 0 477900000 1100000 50900000 568300000 0 489100000 1800000 77400000 343200000 0 343200000 0 0 245500000 0 245500000 0 0 6200000 23600000 59600000 1400000 0 1200000 200000 0 3100000 0 -27800000 30900000 0 8100000 0 -208200000 216300000 0 2000000 -1300000 0 -1300000 0 0 -26700000 0 -26700000 0 0 -3000000 0 -3000000 0 0 0 17500000 92200000 15100000 0 0 15100000 55000000 13400000 34800000 6800000 44300000 21700000 22500000 100000 515900000 0 -644500000 0 1160400000 0 0 12000000 0 0 0 12000000 71700000 0 1000000 0 70700000 39900000 0 800000 0 39100000 150000000 1200000000 1000000000 88100000 88100000 0 88100000 0 0 2793800000 0 2793800000 0 0 2154700000 0 2154700000 0 0 0 -68000000 0 0 68000000 0 -3735500000 0 0 3735500000 0 -3014400000 0 0 3014400000 147900000 0 147900000 0 0 127800000 0 127800000 0 0 148000000 0 148000000 0 0 4800000 2700000 4600000 6600000 116200000 0 116200000 0 0 47200000 71900000 116700000 0 116700000 0 0 47600000 69100000 0.20 0.20 500000000 500000000 0 0 0 0 0 0 227100000 0 215800000 500000 10800000 207300000 0 205800000 1300000 200000 0 -68000000 68000000 0 0 0 -3735500000 3735500000 0 0 0 -3014400000 3014400000 0 0 898100000 0 0 0 898100000 3043200000 0 149900000 0 2893300000 3010000000 0 120000000 0 2890000000 889300000 100000 0 100000 0 0 0 0 0 0 0 -28100000 0 -28100000 0 0 4000000 600000 0 0 600000 0 25800000 0 0 25800000 0 34400000 0 0 34400000 0 1669000000 16900000 289400000 196200000 47300000 1041600000 94500000 1870600000 14800000 333700000 146900000 49800000 1220000000 120200000 886800000 0 886800000 0 0 991300000 0 991300000 0 0 2300000 P45Y P10Y P20Y P1Y P20Y P1Y P10Y P1Y 150000000 1900000 1400000 500000 0 7100000 6700000 400000 0 38400000 28900000 17000000 39600000 1300000 0 1300000 0 0 34800000 0 31500000 0 3300000 1848400000 0 1590100000 0 258300000 157900000 0 157900000 0 0 163500000 0 163500000 0 0 185100000 0 185100000 0 0 21100000 96900000 67300000 4000000 15600000 10000000 125000000 100000000 23700000 0 23700000 0 0 81400000 0 46100000 35300000 0 40400000 0 30600000 9800000 0 8500000 8900000 0 0 8900000 25500000 0 14900000 10600000 34900000 7900000 26600000 400000 18000000 10000000 8000000 0 2600000 500000 300000 -2400000 0 0 -2400000 -13300000 -1600000 -7600000 -4100000 -10100000 -1500000 -8300000 -300000 -1100000 0 -1000000 -100000 -600000 0 600000 0 -285800000 38900000 51200000 46000000 35300000 24000000 3900000 13200000 22000000 4300000 43900000 3200000 1800000 1712300000 0 1712300000 0 0 57100000 0 1655200000 126100000 0 140000000 0 148300000 0 443300000 80300000 140600000 139000000 437600000 437600000 206400000 1011200000 1421600000 40600000 250100000 429500000 448700000 530100000 673700000 2082000000 0 2082000000 0 0 124400000 0 129200000 253600000 37400000 0 2044600000 76100000 122900000 99400000 0 209600000 124400000 584500000 90100000 150700000 155200000 431700000 431700000 413500000 1199400000 1780900000 50800000 250300000 768200000 819000000 877300000 882400000 3346900000 0 3346900000 0 0 263000000 191900000 1125900000 1580800000 48700000 0 3298200000 39400000 1037300000 167200000 185200000 136500000 263000000 572200000 97900000 221100000 154600000 423800000 423800000 1622800000 1251600000 2973200000 137500000 236200000 495900000 0 490600000 5200000 100000 745000000 0 700000000 37700000 7300000 1169800000 0 1037800000 116300000 15700000 16200000 67700000 117000000 35100000 9800000 P4Y P4Y 6490 6402 94838 19072 34646 71272 62.65 70.88 42.48 92.05 70.88 68.15 79230 0 229281 77306 0 273733 63.40 0.00 55.40 125.84 0.00 105.68 0 0 724269 72740 1432031 589222 130974 34562 572494 0.00 0.00 40.62 38.97 63.46 70.88 47.88 96.05 70.88 73.45 0 390731 300237 0 1362823 219189 127400000 21600000 0.00 70.88 34.77 0.00 70.88 49.84 0 0.0165 0 0 0.32 0.26 0.32 0.29 0.0099 0.0099 0.0196 0.0172 575213 12100000.0 5700000.0 17800000.0 550097 1054336 30.94 34.20 323769 243135 41.83 58.00 675921 635567 1292736 22900000 63200000 2760231 2399822 2399822 3526789 2786443 1745258 37.30 35.94 36.84 52.76 34200000 89500000 59000000 2649351 50.94 30.96 29.79 52.63 102.20 25.08 16.51 17.38 30.08 18.04 P10Y P3Y9M18D P3Y9M18D P5Y6M P5Y4M 8000000 36200000 P5Y11M0D P5Y9M 7.96 P8Y0M0D P7Y4M P7Y5M 0 0 57700000 0 116200000 200000 117500000 1200000 46900000 47800000 42300000 57300000 57700000 400000 1300000 878330 800000 1132778 1200000 3979600000 3968200000 11400000 0 11500000 11500000 0 -100000 100000 0 -300000 300000 600000 600000 25800000 25600000 200000 34400000 34200000 200000 300000000 300000000 800000000 225000000 200000 823592000000 1000000 -17500000 0 0 -17500000 0 -17500000 -92200000 0 0 -92200000 0 75000000 -92200000 1891900000 1807000000 84900000 0 0 0 0 0 1255600000 0 108500000 1102100000 11500000 0 33500000 0 4958000000 -16177600000 11232400000 4958000000 4945200000 0 65700000 5172400000 23200000 0 -285800000 -17500000 5311200000 -43686300000 33636300000 5311200000 10050000000 0 900000 5357600000 23500000 0 38900000 -109700000 8600000 16300000 7200000 230765 1230221 17500000 109700000 103100000 0 0 2500000 13400000 41300000 165500000 100100000 82000000 6500000 4800000 70700000 82000000 89200000 1300000 7900000 80000000 89200000 4300000 33000000 7700000 1600000 6900000 7800000 4700000 -7900000 200000 3500000 3200000 4500000 6600000 30600000 19900000 62100000 45100000 41700000 2400000 7000000 5700000 100000 12000000 1700000 96300000 82000000 87400000 0 125900000 7900000 51400000 49800000 9400000 235000000 15300000 3600000 287700000 28300000 3700000 404900000 76900000 4700000 399300000 233000000 1100000 1171900000 10000000 400000 1720900000 33900000 1900000 2187800000 155400000 0 0 3000000 0 30600000 14700000 0 1300000 200000 6900000 1119200000 0 300000 1634300000 0 900000 2194700000 500000 100000 0 1400000 57800000 64900000 117200000 57700000 64900000 115800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition-Related Costs</font><font style="font-family:inherit;font-size:10pt;"> - Acquisition-related costs incurred in fiscal 2015 and 2014 for each of the fiscal 2015 and 2014 acquisitions discussed above were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquisition-related costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">53.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Results </font><font style="font-family:inherit;font-size:10pt;">- The amount of net sales and earnings included in the Company's results for the periods presented were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,125.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">129.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">263.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,580.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">223.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(97.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(66.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">173.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(49.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of amortization on acquired intangible assets included within operating income (loss) for the periods presented was as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intangible asset amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">301.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">162.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">521.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015 and 2014, the Company recognized </font><font style="font-family:inherit;font-size:10pt;">$44.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$25.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of expense primarily associated with fair value adjustments of acquired inventory. This expense was included within cost of sales.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following reconciles the total consideration to net assets acquired:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="36%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Questcor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cadence</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CNS Therapeutics</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total consideration, net of cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">978.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,176.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,470.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,286.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plus: cash assumed in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">445.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,915.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">98.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: unpaid purchase consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(128.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,786.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Parent Company Investment</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Parent company investment in periods prior to the Separation represents Covidien's historical investment in the Company, the Company's accumulated net earnings after income taxes for periods prior to that date, and the net effect of transactions with and allocations from Covidien.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2011-11 in December 2011, "Disclosures about Offsetting Assets and Liabilities," which was clarified in January 2013 by ASU 2013-01 "Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities." This guidance provides new disclosure requirements about instruments and transactions eligible for offset in the statement of financial position, as well as instruments and transactions subject to an agreement similar to a netting agreement, to enable users of financial statements to understand the effects or potential effects of those arrangements on an entity's financial position. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2013-02, "Reporting Amounts Classified out of Accumulated Other Comprehensive Income," in February 2013. This guidance requires an entity to present, either on the face of the statement of income or separately in the notes to the financial statements, the effects on net income of significant amounts reclassified out of each component of accumulated other comprehensive income, if those amounts are required to be reclassified to net income in their entirety in the same reporting period. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date," in February 2013. This update provides guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date, except for obligations addressed within existing guidance. An entity is required to measure those obligations as the sum of the amount the entity has agreed to pay on the basis of its arrangement among its co-obligors, and any additional amounts it expects to pay on behalf of its co-obligors. The guidance also requires the entity to disclose the nature and amount of those obligations. The guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," in July 2013. This update provides guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, to eliminate diversity in practice in the presentation of unrecognized tax benefits in those instances. This guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity," in April 2014. Under the new guidance, only disposals representing a strategic shift in a company's operations and financial results should be reported as discontinued operations, with expanded disclosures. In addition, disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify as a discontinued operation is required. This guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 with the classification of the CMDS business as held for sale.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2014-09, "Revenue from Contracts with Customers," in May 2014. The issuance of ASU 2014-09 and International Financial Reporting Standards ("IFRS") 15, "Revenue from Contracts with Customers," completes the joint effort by FASB and the International Accounting Standards Board to clarify the principles for recognizing revenue and develop a common revenue standard for U.S. GAAP and IFRS. Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted in the first quarter of fiscal 2018. The Company continues to assess the potential impact of the guidance.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2015-03, "Interest - Imputation of Interest," in April 2015. The issuance of ASU 2015-03 is part of the FASB's initiative to simplify the presentation of debt issuance costs. Under the new guidance, debt issuance costs related to a recognized debt liability must be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amortization of such costs should continue to be calculated using the interest method and be reported as interest expense. The guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 and reclassified debt issuance costs, of </font><font style="font-family:inherit;font-size:10pt;">$103.1 million</font><font style="font-family:inherit;font-size:10pt;"> at September 25, 2015, and expanded disclosure.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2015-11, "Simplifying the Measurement of Inventory," in July 2015. The issuance of ASU 2015-11 is part of the FASB's initiative to more closely align the measurement of inventory between GAAP and IFRS. Under the new guidance, inventory must be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FASB issued ASU 2015-16, "Simplifying the Accounting for Measurement-Period Adjustments," in September 2015. Under the new guidance, the requirement to restate prior period financial statements for measurement period adjustments following a business combination is eliminated. The cumulative impact of a measurement period adjustment (including the impact on prior periods) should be recognized in the reporting period in which the adjustment is identified. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges by segment within continuing operations are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring and related charges, net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: accelerated depreciation</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.5</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortizable:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,896.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">765.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,906.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">235.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">87.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,198.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">882.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">332.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">316.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">235.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">351.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">270.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging (including CMDS)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes are reported in the following consolidated and combined balance sheet captions in the amounts shown:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (current asset)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (non-current liability)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,132.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,399.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,987.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a schedule of minimum lease payments for non-cancelable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: interest portion of payments</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Present value of minimum lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the financial results of the CMDS discontinued operations for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013 as presented in the consolidated statements of operations and comprehensive income:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Major line items constituting income (loss) from discontinued operations </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">495.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">549.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">352.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">346.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">114.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">204.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income (loss) from discontinued operations</font></div><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(209.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income (loss) from discontinued operations net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(174.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, other assets includes </font><font style="font-family:inherit;font-size:10pt;">$52.2 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with current deferred intercompany transactions, and </font><font style="font-family:inherit;font-size:10pt;">$81.3 million</font><font style="font-family:inherit;font-size:10pt;"> of receivables associated with tax payments on account with the taxing authorities. At </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, other assets includes </font><font style="font-family:inherit;font-size:10pt;">$14.8 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> associated with the Questcor acquisition and tax payments of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">78.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">141.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt was comprised of the following at the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital lease obligation and vendor financing agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Variable rate receivable securitization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.50% notes due April 2018</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.88% notes due April 2020</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,958.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,978.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.50% debentures due May 2022</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.75% notes due August 2022</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.00% debentures due March 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.75% notes due April 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.625% notes due October 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">750.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.50% notes due April 2025</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital lease obligation and vendor financing agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,584.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,959.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,606.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,980.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate amounts of debt, including the capital lease obligation, maturing during the next five fiscal years are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">175.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">321.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">521.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">721.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 23, 2015, the Company's board of directors authorized a program to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the Company's ordinary shares from time to time based on market conditions to allow management to enhance shareholder value. The following table presents the number of shares and dollar amount of repurchases made under the repurchase program by fiscal year and the remaining amount available for repurchase as of September 25, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.95817490494296%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015 Share Repurchase Program</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Authorized repurchase amount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchases:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Fiscal 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">823,592</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Remaining amount available</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">225.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The assumptions used in the Monte Carlo model for PSUs granted during each year were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected stock price volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Peer group stock price volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Correlation of returns</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes significant cash and non-cash transactions of the CMDS business that are included within the consolidated statements of cash flows for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-cash impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">204.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the status of the Company's share option awards upon completion of the Conversion on June&#160;28, 2013 is presented below:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br clear="none"/> Average<br clear="none"/> Exercise<br clear="none"/> Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br clear="none"/> Average<br clear="none"/> Remaining<br clear="none"/> Contractual<br clear="none"/> Term<br clear="none"/>(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br clear="none"/> Intrinsic<br clear="none"/> Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at June 28, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercisable at June 28, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">550,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.9</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capitalized software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (non-current liability)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">89.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP"). </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma information has been prepared for comparative purposes only and is not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor is it necessarily an indication of future operating results. In addition, the unaudited pro forma information does not reflect the cost of any integration activities, benefits from any synergies that may be derived from the acquisition or revenue growth that may be anticipated.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="79%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,755.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,598.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">359.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(63.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings (loss) per share from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings (loss) from per share continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.07</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisitions and License Agreements</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Acquisitions</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Therakos, Inc.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 25, 2015, the Company acquired Therakos, Inc. ("Therakos") through the acquisition of all the outstanding common stock of TGG Medical Solutions, Inc., the parent holding company of Therakos, in a transaction valued at approximately </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired ("the Therakos Acquisition"). Consideration for the transaction consisted of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash paid to TGG Medical Solutions, Inc. shareholders and the assumption of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;"> of Therakos third-party debt, which was repaid in conjunction with the Therakos Acquisition. The acquisition and repayment of debt was funded through the issuance of </font><font style="font-family:inherit;font-size:10pt;">$750.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of senior unsecured notes, a </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> borrowing under a revolving credit facility and cash on hand. Therakos' primary immunotherapy products relate to the administering of extracorporeal photopheresis therapies through its UVAR XTS&#174;</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">and Cellex</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;"> Photopheresis Systems, which accelerates the Company's growth in its Specialty Brands segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ikaria, Inc.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 16, 2015, the Company acquired Ikaria, Inc. ("Ikaria") through the acquisition of all the outstanding common stock of Compound Holdings II, Inc., the parent holding company of Ikaria, in a transaction valued at approximately </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired ("the Ikaria Acquisition"). Consideration for the transaction consisted of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash paid to Compound Holdings II, Inc. shareholders and the assumption of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> of Ikaria third-party debt, which was repaid in conjunction with the Ikaria Acquisition. The acquisition and repayment of debt was funded through the issuance of </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of senior unsecured notes, a </font><font style="font-family:inherit;font-size:10pt;">$240.0 million</font><font style="font-family:inherit;font-size:10pt;"> borrowing under the Revolver, which was repaid subsequent to the transaction, and cash on hand. Ikaria's primary product is INOMAX&#174;</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(nitric oxide) for inhalation, a vital treatment option in neonatal critical care. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Questcor Pharmaceuticals</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August&#160;14, 2014, the Company acquired all of the outstanding common stock of Questcor Pharmaceuticals, Inc. ("Questcor"), a biopharmaceutical company, for total consideration of approximately </font><font style="font-family:inherit;font-size:10pt;">$5.9 billion</font><font style="font-family:inherit;font-size:10pt;">, comprised of cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$30.00</font><font style="font-family:inherit;font-size:10pt;"> per share, </font><font style="font-family:inherit;font-size:10pt;">0.897</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares of the Company for each share of Questcor common stock owned and the portion of outstanding equity awards deemed to have been earned as of August 14, 2014 ("the Questcor Acquisition"). The acquisition was funded through the issuance of approximately </font><font style="font-family:inherit;font-size:10pt;">57 million</font><font style="font-family:inherit;font-size:10pt;"> common shares, proceeds from the issuance of </font><font style="font-family:inherit;font-size:10pt;">$900.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal of senior unsecured notes, proceeds from a </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> senior secured term loan facility, </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;"> of cash from a receivable securitization program, as further discussed in Note 12, and cash on hand. H.P. Acthar&#174; Gel (repository corticotropin injection) ("Acthar"), Questcor's primary product, is focused on the treatment of patients with serious, difficult-to-treat autoimmune and rare diseases. Acthar is an injectable drug that is approved by the U.S. Food and Drug Administration ("FDA") for use in </font><font style="font-family:inherit;font-size:10pt;">19</font><font style="font-family:inherit;font-size:10pt;"> indications, including the areas of neurology, rheumatology, nephrology and pulmonology. Questcor also supplies specialty contract manufacturing services to the global pharmaceutical and biotechnology industry through its wholly-owned subsidiary, BioVectra Inc. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cadence Pharmaceuticals</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 19, 2014, the Company acquired all of the outstanding common stock of Cadence Pharmaceuticals, Inc. ("Cadence"), a biopharmaceutical company focused on commercializing products principally for use in the hospital setting, for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$14.00</font><font style="font-family:inherit;font-size:10pt;"> per share in cash, or approximately </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;"> ("the Cadence Acquisition"). The acquisition was primarily funded through a </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;"> senior secured term loan credit facility, as further discussed in Note 12. Cadence's sole product, OFIRMEV&#174; (acetaminophen) injection ("Ofirmev"), is a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The Cadence Acquisition added a growth product to the Specialty Brands product portfolio and provided us the opportunity to expand our reach into the hospital market, in which Cadence had an established presence.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">CNS Therapeutics</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 1, 2012, the Company acquired all the outstanding equity of CNS Therapeutics, Inc. ("CNS Therapeutics"), a specialty pharmaceuticals company focused on developing and commercializing intrathecal products for site-specific administration to the central nervous system to treat neurological disorders and intractable chronic pain, for total consideration, net of cash acquired, of </font><font style="font-family:inherit;font-size:10pt;">$95.0 million</font><font style="font-family:inherit;font-size:10pt;">. The total consideration was comprised of an upfront cash payment of </font><font style="font-family:inherit;font-size:10pt;">$88.1 million</font><font style="font-family:inherit;font-size:10pt;"> (net of cash acquired of </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;">) and the fair value of contingent consideration of </font><font style="font-family:inherit;font-size:10pt;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;">. This contingent consideration, which could potentially total a maximum of </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">, is discussed further in Note 20.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Allocation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following amounts represent the preliminary allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Therakos Acquisition and Ikaria Acquisition and final allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Cadence Acquisition, Questcor Acquisition and CNS Therapeutics acquisition:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="36%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Questcor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cadence</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CNS Therapeutics</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">445.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,170.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,971.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,601.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill (non-tax deductible)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">792.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,789.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">318.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets, current and non-current</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">172.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">274.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,714.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,039.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,177.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,700.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">129.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">168.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unpaid purchase consideration (current)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">128.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">186.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax liabilities, net (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">623.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,906.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">292.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">344.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,121.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">694.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,786.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,391.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">371.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net assets acquired</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,786.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:72px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:48px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">This amount includes </font><font style="font-family:inherit;font-size:8pt;">$22.0 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$73.8 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$87.3 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$14.7 million</font><font style="font-family:inherit;font-size:8pt;"> and </font><font style="font-family:inherit;font-size:8pt;">$3.3 million</font><font style="font-family:inherit;font-size:8pt;"> of accounts receivable for the Therakos Acquisition, Ikaria Acquisition, Questcor Acquisition, Cadence Acquisition, and CNS Therapeutics, respectively, which is also the gross contractual value.</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:72px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following reconciles the total consideration to net assets acquired:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="36%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Questcor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cadence</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CNS Therapeutics</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total consideration, net of cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">978.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,176.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,470.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,286.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plus: cash assumed in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">445.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,915.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">98.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: unpaid purchase consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(128.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,786.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets acquired consist of the following: &#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Therakos</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,170.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15 years</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology intangible asset relates to extracorporeal photopheresis treatment therapies. The fair value of the intangible asset was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of the asset based on market participant expectations of cash flows the asset would generate. The cash flows were discounted commensurate with the level of risk associated with each asset or its projected cash flows. The completed technology intangible asset utilized a discount rate of </font><font style="font-family:inherit;font-size:10pt;">17.0%</font><font style="font-family:inherit;font-size:10pt;">. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Ikaria</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,820.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development - terlipressin</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,971.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology and trademark intangible assets relate to Inomax. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, trademark and in-process research and development ("IPR&amp;D") terlipressin intangibles utilized discount rates of </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">17.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The IPR&amp;D discount rate for terlipressin was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Questcor</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,343.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development - Synacthen</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,601.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology intangible asset relates to Acthar. The trademark and customer relationship intangible assets relate to BioVectra, Inc., a wholly-owned subsidiary of Questcor. The in-process research and development relates to the U.S. development of Synacthen, a synthetic pharmaceutical product. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, customer relationships, trademark and in-process research and development intangibles utilized discount rates of </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">16.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The in-process research and development discount rate was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. The majority of assets acquired are included within the Company's Specialty Brands segment. Assets related to BioVectra, Inc. are included within the Company's Specialty Generics segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Cadence</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8 years</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The completed technology intangible asset relates to Ofirmev, the rights to which have been in-licensed from Bristol-Myers Squibb Company ("BMS"). The fair value of the intangible asset was determined using the income approach. The cash flows were discounted at a </font><font style="font-family:inherit;font-size:10pt;">13.0%</font><font style="font-family:inherit;font-size:10pt;"> rate.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">For more information on the BMS license agreement, refer to "License Agreement" below. The excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">CNS Therapeutics</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The in-process research and development projects primarily relate to certain investigational intrathecal pain products. As of the date of acquisition, these pain products were in various stages of development, with further development, testing, clinical trials and regulatory submission required in order to bring them to market. At the acquisition date, the total cost to complete these products was estimated to be approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">. The Company expects that regulatory approvals will occur between 2016 and 2019. The valuation of the in-process research and development was determined using, among other factors, appraisals primarily based on the discounted cash flow method. The cash flows were discounted at a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">35%</font><font style="font-family:inherit;font-size:10pt;"> rate, which was considered commensurate with the risks and stages of development of the pain products. Future residual cash flows that could be generated from the products were determined based upon management's estimate of future revenue and expected profitability of the products. These projected cash flows were then discounted to their present values taking into account management's estimate of future expenses that would be necessary to bring the products to completion. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Results </font><font style="font-family:inherit;font-size:10pt;">- The amount of net sales and earnings included in the Company's results for the periods presented were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">191.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,125.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">129.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">263.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,580.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">223.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(97.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(66.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">173.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(49.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of amortization on acquired intangible assets included within operating income (loss) for the periods presented was as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intangible asset amortization</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">301.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">162.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">521.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015 and 2014, the Company recognized </font><font style="font-family:inherit;font-size:10pt;">$44.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$25.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of expense primarily associated with fair value adjustments of acquired inventory. This expense was included within cost of sales.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition-Related Costs</font><font style="font-family:inherit;font-size:10pt;"> - Acquisition-related costs incurred in fiscal 2015 and 2014 for each of the fiscal 2015 and 2014 acquisitions discussed above were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquisition-related costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ikaria</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Questcor</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cadence</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">53.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Unaudited Pro Forma Financial Information - </font><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma information presents a summary of the results of operations for the periods indicated as if the Questcor Acquisition and Cadence Acquisition had been completed as of September 29, 2012 and the Ikaria Acquisition and Therakos Acquisition as of September 28, 2013. The pro forma financial information is based on the historical financial information for the Company, Ikaria, Questcor and Cadence, along with certain pro forma adjustments. These pro forma adjustments consist primarily of:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">non-recurring costs related to the step-up in fair value of acquired inventory and transaction costs related to the acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">increased amortization expense related to the intangible assets acquired in the acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">elimination of direct acquisition transaction costs from the period of acquisition;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">increased interest expense to reflect the fixed rate unsecured notes and revolving credit facility (utilizing the interest rate in effect at the date of the acquisition of </font><font style="font-family:inherit;font-size:10pt;">2.6%</font><font style="font-family:inherit;font-size:10pt;">) entered into in connection with the Therakos Acquisition, the fixed rate unsecured notes entered into in connection with the Ikaria Acquisition (assuming no interest related to the revolving credit facility which was paid down subsequent to the Ikaria Acquisition), the fixed-rate senior unsecured notes and variable-rate term loan entered into in connection with the acquisition of Questcor (utilizing the interest rate in effect at the date of acquisition of </font><font style="font-family:inherit;font-size:10pt;">3.50%</font><font style="font-family:inherit;font-size:10pt;">), and the variable-rate term loan and revolving credit facility entered into in connection with the Cadence Acquisition (utilizing the interest rate in effect at the date of acquisition of </font><font style="font-family:inherit;font-size:10pt;">3.50%</font><font style="font-family:inherit;font-size:10pt;">) including interest and amortization of deferred financing costs and original issue discount; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the related income tax effects.</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma information has been prepared for comparative purposes only and is not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor is it necessarily an indication of future operating results. In addition, the unaudited pro forma information does not reflect the cost of any integration activities, benefits from any synergies that may be derived from the acquisition or revenue growth that may be anticipated.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="79%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,755.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,598.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">359.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(63.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings (loss) per share from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings (loss) from per share continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.07</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">License Agreements</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ofirmev</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the Cadence Acquisition, the Company acquired the exclusive development and commercialization rights to Ofirmev in the U.S. and Canada, as well as the rights to the patents and technology, which were originally in-licensed by Cadence from BMS in March 2006. BMS sublicensed these rights to Cadence under a license agreement with SCR Pharmatop S.A. ("Pharmatop"), and the Company has the right to grant sublicenses to third parties. Under this license agreement, the Company may be obligated to make future milestone payments of up to </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon the achievement of certain levels of net sales, of which </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> was paid during fiscal 2015. In addition, the Company is obligated to pay royalties on sales of the product. During fiscal 2015 and 2014, the Company paid royalties of </font><font style="font-family:inherit;font-size:10pt;">$43.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.2 million</font><font style="font-family:inherit;font-size:10pt;"> respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Exalgo</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2009, the Company's Specialty Brands segment acquired the rights to market and distribute the pain management drug EXALGO&#174; (hydromorphone HCl) extended-release tablets (CII) ("Exalgo") in the U.S. Under the license agreement, the Company is obligated to make additional payments of up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$73.0 million</font><font style="font-family:inherit;font-size:10pt;"> based on the successful completion of specified development and regulatory milestones. Through fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$65.0 million</font><font style="font-family:inherit;font-size:10pt;"> of additional payments had been made, with </font><font style="font-family:inherit;font-size:10pt;">$55.0 million</font><font style="font-family:inherit;font-size:10pt;"> being capitalized as an intangible asset. The Company is also required to pay royalties on sales of the product. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Company paid royalties of </font><font style="font-family:inherit;font-size:10pt;">$3.2 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$22.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$24.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2014, the Company purchased certain royalty rights associated with Exalgo for </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">, which have been capitalized as an intangible asset.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Depomed</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2009, the Company's Specialty Brands segment licensed worldwide rights to utilize Depomed, Inc.'s ("Depomed") Acuform gastric retentive drug delivery technology for the exclusive development of four products. Under this license agreement, the Company may be obligated to pay up to </font><font style="font-family:inherit;font-size:10pt;">$64.0 million</font><font style="font-family:inherit;font-size:10pt;"> in development milestone payments. Through fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$22.0 million</font><font style="font-family:inherit;font-size:10pt;"> of these payments have been made by the Company. During fiscal 2014, upon approval by the FDA for XARTEMIS&#8482; XR (oxycodone HCl and acetaminophen) extended release tablets CII ("Xartemis XR"), the Company made a milestone payment of </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;">, which has been capitalized as an intangible asset. </font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pennsaid</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2009, the Company's Specialty Brands segment entered into a licensing agreement which granted it rights to market and distribute Pennsaid and Pennsaid 2%, a formulation of diclofenac sodium topical solution which was approved in February 2014 by the FDA and indicated for the treatment of pain associated with osteoarthritis of the knee. The Company was responsible for future development activities and expenses and were required to make milestone payments of up to </font><font style="font-family:inherit;font-size:10pt;">$120.0 million</font><font style="font-family:inherit;font-size:10pt;"> based upon the successful completion of specified regulatory and sales milestones. Through fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> of these payments were made, all of which were capitalized as an intangible asset. The Company is also required to pay royalties on sales of the products under this agreement. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Company paid royalties of </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of fiscal 2014, the Company reached an agreement in principle with Nuvo to settle various claims associated with our license of Pennsaid obtained from Nuvo. As part of the legal settlement, the Company agreed to return the license to Nuvo, which resulted in the Company recording an impairment of </font><font style="font-family:inherit;font-size:10pt;">$11.1 million</font><font style="font-family:inherit;font-size:10pt;"> during the fourth quarter of fiscal 2014.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of in-process research and development ("IPR&amp;D") is determined using the discounted cash flow method. In determining the fair value of IPR&amp;D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value attributable to IPR&amp;D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Background and Basis of Presentation</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Background</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt plc and its subsidiaries (collectively, "Mallinckrodt" or "the Company"), is a global specialty biopharmaceutical and nuclear imaging business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and nuclear imaging agents. Therapeutic areas of focus include autoimmune and rare disease specialty areas (including neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; and central nervous system drugs. The Company also supports the diagnosis of disease with nuclear medicine imaging agents. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its global contrast media and delivery systems ("CMDS") business to Guerbet S.A. ("Guerbet"), which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior year amounts have been recast to conform to current presentation. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The three reportable segments are further described below:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Specialty Brands</font><font style="font-family:inherit;font-size:10pt;"> produces and markets branded pharmaceuticals and biopharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Specialty Generics</font><font style="font-family:inherit;font-size:10pt;"> produces specialty generic pharmaceuticals and active pharmaceutical ingredients ("API") consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nuclear Imaging</font><font style="font-family:inherit;font-size:10pt;"> manufactures and markets radiopharmaceuticals (nuclear medicine).</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2015, the Board of Directors of Mallinckrodt plc approved the migration of the Company&#8217;s principal executive offices from Ireland to the United Kingdom.&#160;The Company remains incorporated in Ireland and continues to be subject to U.S. Securities and Exchange Commission ("SEC") reporting requirements and the applicable corporate governance rules of the New York Stock Exchange.&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien plc ("Covidien"), which was subsequently acquired by Medtronic plc. On June 28, 2013, Covidien shareholders of record received </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> ordinary share of Mallinckrodt for every </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares of Covidien held as of the record date, June 19, 2013, and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing its legal separation from Covidien ("the Separation"). </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying consolidated and combined financial statements reflect the consolidated financial position of the Company as an independent, publicly-traded company for periods subsequent to June 28, 2013, and as a combined reporting entity of Covidien, including operations relating to Covidien's Pharmaceuticals business, for periods prior to June 28, 2013.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP"). The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ from those estimates. The consolidated and combined financial statements include the accounts of the Company, its wholly-owned subsidiaries and entities in which they own or control more than fifty percent of the voting shares, or have the ability to control through similar rights. The results of entities disposed of are included in the consolidated and combined financial statements up to the date of disposal and, where appropriate, these operations have been reflected as discontinued operations. Divestitures of product lines not representing businesses have been reflected in operating income. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments necessary for a fair presentation have been included in the results reported.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As a result of the Company's classification of the CMDS business as held for sale and the change in reportable segments, certain amounts from prior years have been revised to conform to the current year presentation,.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's combined financial statements for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company's fiscal 2013 results, may not be indicative of its future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had it operated as an independent, publicly-traded company for the entirety of the periods presented, including as a result of changes in the Company's capitalization in connection with the Separation. The combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were </font><font style="font-family:inherit;font-size:10pt;">$39.6 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> and were included within selling, general and administrative expenses. Management considers the bases on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, the Company during the periods presented; however, the allocations may not reflect the expense the Company would have incurred as an independent, publicly-traded company. Actual costs that may have been incurred if the Company had been a standalone company would depend on a number of factors, including organizational structure, what functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. The Company is unable to determine what those costs would have been had the Company been independent during the applicable periods. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services were rendered may not have been as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The combined balance sheets prior to June&#160;28, 2013 included certain assets and liabilities that have historically been recorded at the Covidien corporate level but are specifically identifiable or otherwise allocable to the Company. Covidien's debt and related interest expense were not allocated to the Company since the Company was not the legal obligor of such debt and Covidien's borrowings were not directly attributable to the Company's business. Debt incurred by the Company directly has been included in the combined financial statements. Intercompany transactions between the Company and Covidien, prior to the Separation, have been included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The total net effect of the settlement of these intercompany transactions was reflected in the combined statements of cash flows as a financing activity and in the combined balance sheet as parent company investment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to June 28, 2013, Covidien's investment in the Pharmaceuticals business is shown as parent company investment in the combined financial statements. On June 28, 2013, Covidien completed a distribution of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> ordinary share of Mallinckrodt for every </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares of Covidien. Upon completion of the Separation, the Company had </font><font style="font-family:inherit;font-size:10pt;">57,694,885</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares outstanding at a par value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.20</font><font style="font-family:inherit;font-size:10pt;"> per share. After Separation adjustments were recorded, the remaining parent company investment balance, which included all earnings prior to the Separation, was transferred to contributed surplus. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Irish law, the Company can only pay dividends and repurchase shares out of distributable reserves, as discussed further in the Company's information statement filed with the SEC as Exhibit 99.2 to the Company's Current Report on Form 8-K filed on July 1, 2013. Upon completion of the Separation, the Company did not have any distributable reserves. On July 22, 2013, the Company filed a petition with the High Court of Ireland seeking the court's confirmation of a reduction of the Company's share premium so that it can be treated as distributable for the purposes of Irish law. On September 9, 2013, the High Court of Ireland approved this petition and the High Court's order and minutes were filed with the Registrar of Companies. Upon this filing, the Company's share premium is treated as distributable reserves and the share premium balance was reclassified into additional paid-in capital within the consolidated balance sheet. Net income subsequent to the Separation has been included in retained earnings and is included in distributable reserves.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company reports its results based on a "52-53 week" year ending on the last Friday of September. Fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> each consisted of 52 weeks. Unless otherwise indicated, fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> refer to the Company's fiscal years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. Fiscal 2016 will consist of 53 weeks and will end on September 30, 2016.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the changes in benefit obligations, plan assets and the net amounts recognized on the consolidated balance sheets for pension and postretirement benefit plans at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Change in benefit obligation:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Projected benefit obligations at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">538.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">501.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">53.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employee contributions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Actuarial (gain) loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits and administrative expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(23.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net transfer in/(out) </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(18.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Projected benefit obligations at end of year</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">493.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">538.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Change in plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">456.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Actual return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employer contributions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employee contributions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits and administrative expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets at end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Funded status at end of year</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">19.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has purchase obligations related to commitments to purchase certain goods and services. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, such obligations were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">125.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">51.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various legal proceedings and claims, including patent infringement claims, product liability matters, environmental matters, employment disputes, contractual disputes and other commercial disputes, including those described below. The Company believes that these legal proceedings and claims likely will be resolved over an extended period of time. Although it is not feasible to predict the outcome of these matters, the Company believes, unless indicated below, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Governmental Proceedings</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2011 and October 2012, the Company received subpoenas from the U.S. Drug Enforcement Administration requesting production of documents relating to its suspicious order monitoring program. The United States Attorney&#8217;s Office (the &#8220;USAO&#8221;) for the Eastern District of Michigan is investigating the possibility of the Company failing to report suspicious orders of controlled substances during the period 2006-2011 in violation of the Controlled Substances Act and its related regulations. The USAO for the Northern District of New York and Office of Chief of Counsel for the U.S. Drug Enforcement Administration are investigating the possibility of the Company failing to maintain appropriate records and security measures with respect to manufacturing of certain controlled substances at its Hobart facility during the period 2012-2013. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2012,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">Questcor received a subpoena from the USAO for the Eastern District of Pennsylvania for information relating to its promotional practices. Questcor has also been informed by the USAO for the Eastern District of Pennsylvania that the USAO for the Southern District of New York and the SEC are participating in the investigation to review Questcor's promotional practices and related matters. On March 9, 2015, the Company received a "No Action" letter from the SEC regarding its review of the Company's promotional practices. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014, Questcor received a subpoena and Civil Investigative Demand ("CID") from the Federal Trade Commission ("FTC") seeking documentary materials and information regarding the FTC's investigation into whether Questcor's acquisition of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen Depot&#174; from Novartis AG and Novartis Pharma AG (collectively, "Novartis") violates antitrust laws. Subsequently, a small number of states commenced similar investigations focused on whether the transaction violates state antitrust laws. The Company is not aware of any existing or pending litigation in connection with these investigations. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2014, the USAO for the Eastern District of Pennsylvania requested the production of documents related to an investigation of the potential promotion of Therakos&#8217; immunotherapy drug/device system UVADEX/UVAR XTS and UVADEX/CELLEX (collectively, the &#8220;Therakos System&#8221;), for indications not approved by the FDA, including the treatment of patients with graft versus host disease (&#8220;GvHD&#8221;) and solid organ transplant patients, including pediatric patients. The investigation also includes Therakos&#8217; efforts to secure FDA approval for additional uses of, and alleged quality issues relating to, UVADEX/UVAR. In August 2015, the USAO for the Eastern District of Pennsylvania sent Therakos a subsequent request for documents related to the investigation and we are in the process of responding to that request.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2014, the Company received a CID from the Civil Medicaid Fraud Division of the Texas Attorney General's Office. According to the CID, the Attorney General's office is investigating the possibility of false reporting of information by the Company regarding the prices of certain of its drugs used by Texas Medicaid to establish reimbursement rates for pharmacies that dispensed the Company's drugs to Texas Medicaid recipients. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are in the process of responding to each of the subpoenas and the CIDs and we intend to cooperate fully in each such investigation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mallinckrodt Inc. v. U.S. Food and Drug Administration and United States of America.</font><font style="font-family:inherit;font-size:10pt;"> The Company filed a Complaint for Declaratory and Injunctive Relief ("the Complaint") in the U.S. District Court for the District of Maryland Greenbelt Division against the FDA and the United States of America in November 2014 for judicial review of what the Company believes is the FDA's inappropriate and unlawful reclassification of the Company's Methylphenidate HCl Extended-Release tablets USP (CII) ("Methylphenidate ER") in the Orange Book: Approved Drug Products with Therapeutic Equivalence ("Orange Book") on November 13, 2014. In its Complaint, the Company has asked the court to: issue an injunction to (a) set aside the FDA's reclassification of the Company's Methylphenidate ER products from freely substitutable at the pharmacy level (class AB) to presumed to be therapeutically inequivalent (class BX) in the Orange Book and (b) prohibit the FDA from reclassifying the Company's Methylphenidate ER products in the future without following applicable legal requirements; and issue a declaratory judgment that the FDA's action reclassifying the Company's Methylphenidate ER products in the Orange Book is unlawful. The Company concurrently filed a motion with the same court requesting an expedited hearing to issue a temporary restraining order ("TRO") directing the FDA to reinstate the Orange Book AB rating for the Company's Methylphenidate ER products on a temporary basis. The court denied the Company's motion for a TRO. In December 2014, the FDA filed a motion to dismiss the Compliant with the district court. The Company filed its opposition to the motion to dismiss in January 2015, and concurrently filed a motion for summary judgment. On July 29, 2015, the court granted the FDA&#8217;s motion to dismiss with respect to three of the five counts in the Complaint and granted summary judgment in favor of the FDA with respect to the two remaining counts.&#160; The Company has appealed the court&#8217;s decision to the U.S. Court of Appeals for the Fourth Circuit.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Patent/Antitrust Litigation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Tyco Healthcare Group LP, et al. v. Mutual Pharmaceutical Company, Inc.</font><font style="font-family:inherit;font-size:10pt;"> In March 2007, the Company filed a patent infringement suit in the U.S. District Court for the District of New Jersey against Mutual Pharmaceutical Co., Inc., et al. (collectively, "Mutual") after Mutual submitted an Abbreviated New Drug Application ("ANDA") to the FDA seeking to sell a generic version of the Company's 7.5mg RESTORIL&#8482; sleep aid product. Mutual also filed antitrust and unfair competition counterclaims. The patents at issue have since expired or been found invalid. The trial court issued an opinion and order granting the Company's motion for summary judgment regarding Mutual's antitrust and unfair competition counterclaims. Mutual appealed this decision to the U.S. Court of Appeals for the Federal Circuit and the Federal Circuit issued a split decision, affirming the trial court in part and remanding to the trial court certain counterclaims for further proceedings. The Company filed a motion for summary judgment with the U.S. District Court regarding the remanded issues. In May 2015, the trial court issued an opinion granting-in-part and denying-in-part the Company&#8217;s motion for summary judgment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'222 and '218 Patent Litigation: Exela Pharma Sciences, LLC.</font><font style="font-family:inherit;font-size:10pt;"> In August 2011, Cadence, a subsidiary of the Company, and Pharmatop, the owner of the </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents licensed exclusively by Cadence, filed suit in the U.S. District Court for the District of Delaware against Exela Pharma Sciences, LLC, Exela PharmaSci, Inc. and Exela Holdings, Inc. (collectively, "Exela"), alleging that Exela infringed U.S. Patent Nos. 6,028,222 ("the '222 patent") and 6,992,218 ("the '218 patent"), by submitting an ANDA to the FDA seeking to sell a generic version of Ofirmev. The filing of the lawsuit triggered a stay of FDA approval of the Exela ANDA until the earlier of the expiration of a 30-month period, the expiration of the '222 and '218 patents, the entry of a settlement order or consent decree stating that the '222 and '218 patents are invalid or not infringed, a decision in the case concerning infringement or validity that is favorable to Exela, or such shorter or longer period as the court may order. After a bench trial, the court ruled in favor of Cadence in November 2013 and found that Exela's ANDA infringed the '222 and '218 patents. Exela appealed the decision and oral arguments in the appeal occurred in November 2014. In March 2015, the Federal Circuit affirmed the district court decision.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'222 and '218 Patent Litigation: InnoPharma Licensing LLC and InnoPharma, Inc. </font><font style="font-family:inherit;font-size:10pt;">In September 2014, Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against InnoPharma Licensing LLC and InnoPharma, Inc. (collectively "InnoPharma") following receipt of an August 2014 notice from InnoPharma concerning its submission of a New Drug Application (&#8220;NDA&#8221;), containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'222 and '218 Patent Litigation: Agila Specialties Private Limited, Inc. and Agila Specialties Inc. (a Mylan Inc. Company), (collectively &#8220;Agila&#8221;).</font><font style="font-family:inherit;font-size:10pt;">&#160; In December 2014,&#160;Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Agila following receipt of a November 2014 notice from Agila concerning its submission of a NDA containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev.&#160; </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company intends to vigorously enforce its intellectual property rights relating to Ofirmev to prevent the marketing of infringing generic or competing products prior to the expiration of the Cadence patents. An adverse outcome in either the Exela or InnoPharma matters ultimately could result in the launch of one or more generic versions of Ofirmev before the expiration of the last of the listed patents on June 6, 2021 (or December 6, 2021 if pediatric exclusivity is granted), which could adversely affect the Company's ability to successfully maximize the value of Ofirmev and have an adverse effect on our financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'222 and '218 Patents: Ex Parte Reexamination.</font><font style="font-family:inherit;font-size:10pt;"> In September 2012, Exela filed with the U.S. Patent and Trademark Office ("USPTO") a Request for Ex Parte Reexamination of the '222 patent and the USPTO granted that request. The reexamination process requires the USPTO to consider the scope and validity of the patent based on substantial new questions of patentability raised by a third-party or the USPTO. Cadence and Pharmatop have filed, with the USPTO, a patent owner's statement commenting on the reexamination request, and thereafter the parties made various submissions. In March 2015, the USPTO issued an ex parte reexamination certificate for the '222 patent listing the claims that resulted from the reexamination proceeding.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, in January 2014, an unidentified third-party filed, with the USPTO, a Request for Ex Parte Reexamination of the '218 patent. The reexamination request was granted. In July 2014, the USPTO issued a Non-Final Office Action in the '218 reexamination in which it rejected certain claims. In September 2014, Cadence and Pharmatop filed an Amendment and Response to the Office Action. Cadence and Pharmatop filed a supplemental response in January 2015. In June 2015, the USPTO issued a Final Office Action confirming that effectively all of the original claims were patentable, and Cadence and Pharmatop subsequently filed an Amendment and Response to the Final Office Action. On July 15, 2015, the USPTO confirmed in the reexamination proceeding for the '218 patent that original claims 1-10 and 12-19 as well as amended original dependent claim 11 and six new dependent claims are all patentable. In August 2015, the USPTO issued an ex parte reexamination certificate for the '218 patent listing the claims that resulted from the reexamination proceeding. Because the Company and Pharmatop believe that the scope and validity of the patent claims in the '222 reexamination certificate and the '218 patent reexamination certificate are appropriate and that the USPTO's prior issuances of the patents were correct, the Company, in conjunction with Pharmatop, will vigorously defend these patents. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'218 Patent Litigation: Exela Pharma Sciences, LLC.</font><font style="font-family:inherit;font-size:10pt;"> In April 2012, Exela filed suit against David J. Kappos and the USPTO in the U.S. District Court for the Eastern District of Virginia for declaratory judgment seeking a reversal of the USPTO's decision not to act on a petition by Exela to vacate the USPTO's April 2003 order reviving the international application for the '218 patent. The lawsuit followed the USPTO's rejection of Exela's petition to the USPTO filed in November 2011, which sought to vacate the April 2003 order. The USPTO determined that Exela lacked standing to seek such relief. Exela also seeks declaratory judgment that the USPTO's rules and regulations that allow for revival of abandoned, international patent applications under the "unintentional" standard are invalid, and seeks similar relief in connection with one or more counterclaims it has filed in the Delaware litigation. Cadence intervened in this lawsuit and in December 2012, the district court dismissed the case with prejudice as barred by the applicable statute of limitations. Exela appealed the dismissal to the Court of Appeals for the Federal Circuit and oral arguments were held in February 2014. In March 2015, the Federal Circuit affirmed the district court's dismissal of the Exela complaint.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">'222 and '218 Patent Litigation Settlements. </font><font style="font-family:inherit;font-size:10pt;">Four</font><font style="font-family:inherit;font-size:10pt;"> other similar cases involving generic and/or competing versions of Ofirmev have previously settled. In each settlement, the defendant was granted the non-exclusive right to market a generic intravenous acetaminophen product in the U.S. under its respective ANDA after December 6, 2020, or earlier under certain circumstances. In connection with those settlements, one settling party was granted the exclusive right of first refusal to negotiate an agreement with Cadence to market an authorized generic of Ofirmev in the U.S. in the event that Cadence elects to launch an authorized generic version of the product. If that settling party elects not to exercise its right of first refusal, Cadence has agreed to grant a similar right of first refusal to another settling party. As part of another settlement, Cadence entered into a supply agreement under which an affiliate of one of the settling parties will develop, manufacture and supply commercial quantities of Ofirmev to the Company if certain regulatory approvals are obtained.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inomax Patents: Inter Partes Review ("IPR") Proceedings. </font><font style="font-family:inherit;font-size:10pt;">In February 2015 and March 2015, the USPTO issued Notices of Filing Dates Accorded to Petitions for IPR petitions filed by Praxair Distribution, Inc. concerning ten patents covering Inomax. Patent Owner Preliminary responses for all of the IPR petitions were filed in May 2015 and June 2015. On July 29, 2015 the USPTO Patent Trial and Appeal Board ("PTAB") issued rulings denying the institution of four of the five IPR petitions challenging the five patents expiring in 2029.&#160; The PTAB also issued a ruling on July 29, 2015 that instituted the IPR proceeding in the fifth of this group of patents and the PTAB is statutorily required to complete the IPR process on that patent within one year.&#160; On September 22, 2015 the USPTO PTAB issued rulings that instituted the IPR proceedings in each of the second set of five patents that expire in 2031 and the PTAB is statutorily required to complete the IPR process on these five patents within one year.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inomax Patent Litigation: Praxair Distribution, Inc. and Praxair, Inc. (collectively &#8220;Praxair&#8221;).</font><font style="font-family:inherit;font-size:10pt;"> In February 2015, INO Therapeutics LLC and Ikaria, Inc., subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Praxair following receipt of a January 2015 notice from Praxair concerning its submission of an ANDA containing a Paragraph IV patent certification with the FDA for a generic version of Inomax.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company intends to vigorously enforce its intellectual property rights relating to Inomax to prevent the marketing of infringing generic products prior to the expiration of the patents covering Inomax. An adverse outcome in either the IPRs or the Praxair litigation ultimately could result in the launch of a generic version of Inomax before the expiration of the last of the listed patents on January 6, 2031 (July 6, 2031 including pediatric exclusivity), which could adversely affect the Company's ability to successfully maximize the value of Inomax and have an adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Commercial and Securities Litigation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Retrophin Litigation. </font><font style="font-family:inherit;font-size:10pt;">In January 2014, Retrophin, Inc. ("Retrophin") filed a lawsuit against Questcor in the U.S. District Court for the Central District of California, alleging a variety of federal and state antitrust violations based on Questcor's acquisition from Novartis of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen. In June 2015, the parties entered into a binding settlement agreement, under the terms of which Retrophin agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to Retrophin in the amount of </font><font style="font-family:inherit;font-size:10pt;">$15.5 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Glenridge Litigation. </font><font style="font-family:inherit;font-size:10pt;">In June 2011, Glenridge Pharmaceuticals LLC (&#8220;Glenridge&#8221;), filed a lawsuit against Questcor in the Superior Court of California, Santa Clara County, alleging that Questcor had underpaid royalties to Glenridge under a royalty agreement related to net sales of Acthar. In August 2012, Questcor filed a separate lawsuit against the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> principals of Glenridge, as well as Glenridge, challenging the enforceability of the royalty agreement. In August 2013, the </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> lawsuits were consolidated into </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> case in the Superior Court of California, Santa Clara County. In October 2014, the parties entered into a binding term sheet settling the lawsuit. Under the terms of the settlement, the royalty rate payable by Questcor was reduced, royalties were capped instead of being payable for so long as Acthar was sold and Questcor agreed to pay Glenridge a reduced amount in satisfaction of royalties Questcor had previously accrued but not paid during the course of the lawsuit. In February 2015, the settlement agreement was finalized, with terms consistent with the October 2014 term sheet. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Putative Class Action Securities Litigation.</font><font style="font-family:inherit;font-size:10pt;"> In September 2012, a putative class action lawsuit was filed against Questcor and certain of its officers and directors in the U.S. District Court for the Central District of California, captioned </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">John K. Norton v. Questcor Pharmaceuticals, et al.</font><font style="font-family:inherit;font-size:10pt;">, No. SACvl2-1623 DMG (FMOx). The complaint purports to be brought on behalf of shareholders who purchased Questcor common stock between April 26, 2011 and September 21, 2012. The complaint generally alleges that Questcor and certain of its officers and directors engaged in various acts to artificially inflate the price of Questcor stock and enable insiders to profit through stock sales. The complaint asserts that Questcor and certain of its officers and directors violated sections l0(b) and/or 20(a) of the Securities Exchange Act of 1934, as amended ("the Exchange Act"), by making allegedly false and/or misleading statements concerning the clinical evidence to support the use of Acthar for indications other than infantile spasms, the promotion of the sale and use of Acthar in the treatment of multiple sclerosis and nephrotic syndrome, reimbursement for Acthar from third-party insurers, and Questcor's outlook and potential market growth for Acthar. The complaint seeks damages in an unspecified amount and equitable relief against the defendants. This lawsuit has been consolidated with </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> subsequently-filed actions asserting similar claims under the caption: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Questcor Securities Litigation</font><font style="font-family:inherit;font-size:10pt;">, No. CV 12-01623 DMG (FMOx). In October 2013, the District Court granted in part and denied in part Questcor's motion to dismiss the consolidated amended complaint. In October 2013, Questcor filed an answer to the consolidated amended complaint and fact discovery was concluded in January 2015. In April 2015, the parties executed a long-form settlement agreement, under the terms of which Questcor agreed to pay </font><font style="font-family:inherit;font-size:10pt;">$38.0 million</font><font style="font-family:inherit;font-size:10pt;"> to resolve the plaintiff claims, inclusive of all fees and costs. Questcor and the individual defendants maintain that the plaintiffs' claims are without merit, and have entered into the settlement to eliminate the uncertainties, burden and expense of further protracted litigation. During fiscal 2015, the Company established a </font><font style="font-family:inherit;font-size:10pt;">$38.0 million</font><font style="font-family:inherit;font-size:10pt;"> reserve for this settlement, which was subsequently paid to a settlement fund. The court issued its final approval of the settlement on September 18, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Federal Shareholder Derivative Litigation. </font><font style="font-family:inherit;font-size:10pt;">On October 4, 2012, another alleged shareholder filed a derivative lawsuit in the United States District Court for the Central District of California captioned </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Gerald Easton v. Don M Bailey, et al.</font><font style="font-family:inherit;font-size:10pt;">, No. SACV12-01716 DOC (JPRx). The suit asserts claims substantially identical to those asserted in the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">do Valle</font><font style="font-family:inherit;font-size:10pt;"> derivative action described below against the same defendants. This lawsuit has been consolidated with </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> subsequently-filed actions asserting similar claims under the caption: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Questcor Shareholder Derivative Litigation</font><font style="font-family:inherit;font-size:10pt;">, CV 12- 01716 DMG (FMOx). Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying the federal derivative action until the earlier of: (a) </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In July 2015, the parties stipulated to a dismissal of the derivative case and Questcor agreed to make a one-time cash payment to plaintiffs in the form of a mootness fee.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">State Shareholder Derivative Litigation.</font><font style="font-family:inherit;font-size:10pt;"> In October 2012, an alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Monika do Valle v. Virgil D. Thompson, et al.</font><font style="font-family:inherit;font-size:10pt;">, No. 30-2012-00602258-CU-SL-CXC. The complaint asserted claims for breach of fiduciary duty, abuse of control, mismanagement and waste of corporate assets arising from substantially similar allegations as those contained in the putative securities class action described above, as well as from allegations relating to sales of Questcor common stock by the defendants and repurchases of Questcor common stock. The complaint sought an unspecified sum of damages and equitable relief. On October 24, 2012, another alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Jones v. Bailey, et al.</font><font style="font-family:inherit;font-size:10pt;">, Case No. 30-2012-00608001-CU-MC-CXC. The suit asserted claims substantially identical to those asserted in the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">do Valle</font><font style="font-family:inherit;font-size:10pt;"> derivative action. In February 2013, the court issued an order staying the state derivative actions until the putative federal securities class action and federal derivative actions are resolved. In May 2014, the court granted plaintiffs' request for dismissal without prejudice of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Jones</font><font style="font-family:inherit;font-size:10pt;"> action. In November 2014, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">do Valle </font><font style="font-family:inherit;font-size:10pt;">matter was voluntarily dismissed.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Put Options Securities Action. </font><font style="font-family:inherit;font-size:10pt;">In March 2013, individual traders of put options filed a securities complaint in the United States District Court for the Central District of California captioned </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">David Taban, et al. v. Questcor Pharmaceuticals, Inc., </font><font style="font-family:inherit;font-size:10pt;">No. SACV13-0425. The complaint generally asserts claims against Questcor and certain of its officers and directors for violations of the Exchange Act and for state law fraud and fraudulent concealment based on allegations similar to those asserted in the putative securities class action described above. The complaint seeks compensatory and punitive damages of an unspecified amount. Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying this action until the earlier of: (a) sixty (</font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;">) days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) sixty (</font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;">) days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In May 2015, the parties entered into a binding settlement agreement, under the terms of which plaintiffs agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to plaintiffs.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Pricing Litigation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">State of Utah v. Apotex Corp., et al.</font><font style="font-family:inherit;font-size:10pt;">&#160;The Company, along with several other pharmaceutical companies, is a defendant in this matter which was filed in May 2008, and is pending in the Third Judicial Circuit of Salt Lake County, Utah. The State of Utah alleges, generally, that the defendants reported false pricing information in connection with certain drugs that are reimbursable under Utah Medicaid, resulting in overpayment by Utah Medicaid for those drugs, and is seeking monetary damages and attorneys' fees. The Company believes that it has meritorious defenses to these claims and is vigorously defending against them. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Environmental Remediation and Litigation Proceedings</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites, including those described below. The ultimate cost of site cleanup and timing of future cash outlays is difficult to predict, given the uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations and alternative cleanup methods. The Company concluded that, as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, it was probable that it would incur remedial costs in the range of </font><font style="font-family:inherit;font-size:10pt;">$39.8 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$113.1 million</font><font style="font-family:inherit;font-size:10pt;">. The Company also concluded that, as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the best estimate within this range was </font><font style="font-family:inherit;font-size:10pt;">$76.5 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$3.2 million</font><font style="font-family:inherit;font-size:10pt;"> was included in accrued and other current liabilities and the remainder was included in environmental liabilities on the consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Crab Orchard National Wildlife Refuge Superfund Site, near Marion, Illinois. </font><font style="font-family:inherit;font-size:10pt;">The Company is a successor in interest to International Minerals and Chemicals Corporation ("IMC"). Between 1967 and 1982, IMC leased portions of the Additional and Uncharacterized Sites ("AUS") Operable Unit at the Crab Orchard Superfund Site ("the Site") from the government and manufactured various explosives for use in mining and other operations. In March 2002, the Department of Justice, the U.S. Department of the Interior and the U.S. Environmental Protection Agency ("EPA") (together, "the Government Agencies") issued a special notice letter to General Dynamics Ordnance and Tactical Systems, Inc. ("General Dynamics"), one of the other potentially responsible parties ("PRPs") at the Site, to compel General Dynamics to perform the remedial investigation and feasibility study ("RI/FS") for the AUS Operable Unit. General Dynamics negotiated an Administrative Order on Consent ("AOC") with the Government Agencies to conduct an extensive RI/FS at the Site under the direction of the U.S. Fish and Wildlife Service. General Dynamics asserted in August 2004 that the Company is jointly and severally liable, along with approximately eight other lessees and operators at the AUS Operable Unit, for alleged contamination of soils and groundwater resulting from historic operations, and has threatened to file a contribution claim against the Company and other parties for recovery of its costs incurred in connection with the RI/FS activities being conducted at the AUS Operable Unit. The Company and other PRPs who received demand letters from General Dynamics have explored settlement alternatives, but have not reached settlement to date. General Dynamics has completed the RI and the PRPs have entered into an agreement to enter into non-binding mediation. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mallinckrodt Veterinary, Inc., Millsboro, Delaware. </font><font style="font-family:inherit;font-size:10pt;">The Company previously operated a plant in Millsboro, Delaware ("the Millsboro Site") that manufactured various animal healthcare products. In 2005, the Delaware Department of Natural Resources and Environmental Control found trichloroethylene ("TCE") in the Millsboro public water supply at levels that exceeded the federal drinking water standards. Further investigation to identify the TCE plume in the ground water indicated that the plume has extended to property owned by a third party near the Millsboro Site. The Company, and another former owner, assumed responsibility for the Millsboro Site cleanup under the Alternative Superfund Program administered by the EPA. The Company and another PRP have entered into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> AOCs with the EPA to perform investigations to abate, mitigate or eliminate the release or threat of release of hazardous substances at the Millsboro Site and to conduct an Engineering Evaluation/Cost Analysis to characterize the nature and extent of the contamination. The Company, along with the other party, continues to conduct the studies and prepare remediation plans in accordance with the AOCs. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Coldwater Creek, Saint Louis County, Missouri.</font><font style="font-family:inherit;font-size:10pt;"> The Company is named as a defendant in numerous tort complaints filed in and subsequent to February 2012 with numerous plaintiffs pending in the U.S. District Court for the Eastern District of Missouri. These cases allege personal injury for alleged exposure to radiological substances, including in Coldwater Creek in Missouri, and in the air. Plaintiffs allegedly lived and/or worked in various locations in Saint Louis County, Missouri near Coldwater Creek. Radiological residues which may have been present in the creek have previously been remediated by the U.S. Army Corps of Engineers ("USACE"). The USACE continues to study and remediate the creek and surrounding areas. The Company believes that it has meritorious defenses to these complaints and is vigorously defending against them. The Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding the plaintiffs and their medical conditions; and (iii) there are significant factual and scientific issues to be resolved. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lower Passaic River, New Jersey</font><font style="font-family:inherit;font-size:10pt;">. The Company and approximately </font><font style="font-family:inherit;font-size:10pt;">70</font><font style="font-family:inherit;font-size:10pt;"> other companies originally comprised the Lower Passaic Cooperating Parties Group ("the CPG") and are parties to a May 2007 AOC with the EPA to perform a RI/FS of the 17-mile stretch known as the Lower Passaic River Study Area ("the River"). The Company's potential liability stems from former operations at Lodi and Belleville, New Jersey. In June 2007, the EPA issued a draft Focused Feasibility Study ("FFS") that considered interim remedial options for the lower 8-miles of the river, in addition to a "no action" option. As an interim step related to the 2007 AOC, the CPG voluntarily entered into an AOC on June 18, 2012 with the EPA for remediation actions focused solely at mile 10.9 of the River. The Company's estimated costs related to the RI/FS and focused remediation at mile 10.9, based on interim allocations, are immaterial and have been accrued.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the EPA issued its revised FFS, with remedial alternatives to address cleanup of the lower 8-mile stretch of the River, which also included a "no action" option. The EPA estimates the cost for the alternatives range from </font><font style="font-family:inherit;font-size:10pt;">$365.0 million</font><font style="font-family:inherit;font-size:10pt;"> to $</font><font style="font-family:inherit;font-size:10pt;">3.2 billion</font><font style="font-family:inherit;font-size:10pt;">. The EPA's preferred approach would involve bank-to-bank dredging of the lower 8-mile stretch of the River and installing an engineered cap at a discounted, estimated cost of $</font><font style="font-family:inherit;font-size:10pt;">1.7 billion</font><font style="font-family:inherit;font-size:10pt;">. Based on the issuance of the EPA's revised FFS, the Company recorded a $</font><font style="font-family:inherit;font-size:10pt;">23.1 million</font><font style="font-family:inherit;font-size:10pt;"> accrual in fiscal 2014 representing the estimate of our allocable share of the joint and several remediation liability resulting from this matter.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the CPG presented a draft of the RI/FS of the River to the EPA. The CPG's RI/FS included alternatives that ranged from "no action," targeted remediation of the entire 17-mile stretch of the River to remedial actions consistent with the EPA's preferred approach for the lower 8-mile stretch of the River and also included remediation alternatives for the upper 9-mile stretch of the River. The discounted cost estimates for the CPG remediation alternatives ranged from </font><font style="font-family:inherit;font-size:10pt;">$483.4 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$2.7 billion</font><font style="font-family:inherit;font-size:10pt;">. The Company recorded an additional charge of </font><font style="font-family:inherit;font-size:10pt;">$13.3 million</font><font style="font-family:inherit;font-size:10pt;"> in the second quarter of fiscal 2015 based on the Company's estimate of its allocable share of the joint and several remediation liability resulting from this matter.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Despite the issuance of the revised FFS by the EPA and the RI/FS by the CPG, there are many uncertainties associated with the final agreed-upon remediation and the Company's allocable share of the remediation. As of November 20, 2015, the Company withdrew from the CPG, but remains liable for its obligations under the two above-referenced AOCs, as well as potential future liabilities. Given those uncertainties, the amounts accrued may not be indicative of the amounts for which the Company may be ultimately responsible and will be refined as events in the remediation process occur.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Products Liability Litigation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning with lawsuits brought in July 1976, the Company is also named as a defendant in personal injury lawsuits based on alleged exposure to asbestos-containing materials. A majority of the cases involve product liability claims based principally on allegations of past distribution of products containing asbestos. A limited number of the cases allege premises liability based on claims that individuals were exposed to asbestos while on the Company's property. Each case typically names dozens of corporate defendants in addition to the Company. The complaints generally seek monetary damages for personal injury or bodily injury resulting from alleged exposure to products containing asbestos. The Company's involvement in asbestos cases has been limited because it did not mine or produce asbestos. Furthermore, in the Company's experience, a large percentage of these claims have never been substantiated and have been dismissed by the courts. The Company has not suffered an adverse verdict in a trial court proceeding related to asbestos claims and intends to continue to defend these lawsuits. When appropriate, the Company settles claims; however, amounts paid to settle and defend all asbestos claims have been immaterial. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, there were approximately </font><font style="font-family:inherit;font-size:10pt;">12,750</font><font style="font-family:inherit;font-size:10pt;"> asbestos-related cases pending against the Company.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company estimates pending asbestos claims, claims that were incurred but not reported and related insurance recoveries, which are recorded on a gross basis in the consolidated balance sheets. The Company's estimate of its liability for pending and future claims is based on claims experience over the past </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years and covers claims either currently filed or expected to be filed over the next </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;"> years. The Company believes that it has adequate amounts recorded related to these matters. While it is not possible at this time to determine with certainty the ultimate outcome of these asbestos-related proceedings, the Company believes, given the information currently available, that the ultimate resolution of all known and anticipated future claims, after taking into account amounts already accrued, along with recoveries from insurance, will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Asset Retirement Obligations</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recorded asset retirement obligations for the estimated future costs primarily associated with legal obligations to decommission facilities within the Nuclear Imaging segment, including the facilities located in Petten, the Netherlands and Maryland Heights, Missouri. Substantially all of these obligations are included in other liabilities on the consolidated balance sheets. The following table provides a summary of the changes in the Company's asset retirement obligations for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at beginning of period</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions and adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at end of period</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes that any potential payment of such estimated amounts will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Industrial Revenue Bonds</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through September 25, 2015, the Company exchanged title to </font><font style="font-family:inherit;font-size:10pt;">$88.0 million</font><font style="font-family:inherit;font-size:10pt;"> of its plant assets in return for an equal amount of Industrial Revenue Bonds ("IRB") issued by Saint Louis County. The Company also simultaneously leased such assets back from Saint Louis County under capital leases expiring through December 2025, the terms of which provide it with the right of offset against the IRBs. The lease also provides an option for the Company to repurchase the assets at the end of the lease for nominal consideration. These transactions collectively result in a ten-year property tax abatement from the date the property is placed in service. Due to the right of offset, the capital lease obligation and IRB asset are recorded net in the consolidated balance sheets. The Company expects that the right of offset will be applied to payments required under these arrangements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Bearing Deferred Tax Obligation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the integration of Questcor, the Company entered into an internal installment sale transaction related to certain Acthar intangible assets during the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">. The installment sale transaction resulted in a taxable gain. In accordance with Internal Revenue Code Section 453 the gain is considered taxable in the period in which installment payments are received. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had an aggregate </font><font style="font-family:inherit;font-size:10pt;">$1,447.4 million</font><font style="font-family:inherit;font-size:10pt;"> of interest bearing U.S. deferred tax liabilities associated with outstanding installment notes. The U.S. Internal Revenue Service ("IRS") charges interest based on the deferred tax liability outstanding as of the end of a company's fiscal year, regardless of amounts outstanding during the fiscal year. During the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> the Company accrued Section 453 interest of </font><font style="font-family:inherit;font-size:10pt;">$36.5 million</font><font style="font-family:inherit;font-size:10pt;"> which is included within interest expense.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has facility, vehicle and equipment leases that expire at various dates. Rental expense under facility, vehicle and equipment operating leases related to continuing operations was </font><font style="font-family:inherit;font-size:10pt;">$24.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$13.7 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company also has facility and equipment commitments under capital leases.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a schedule of minimum lease payments for non-cancelable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: interest portion of payments</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Present value of minimum lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Tax Matters</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax returns of the Company and its subsidiaries are periodically examined by various tax authorities. The resolution of these matters is subject to the conditions set forth in the Tax Matters Agreement between the Company and Covidien. Covidien has the right to administer, control and settle all U.S. income tax audits for periods prior to the Separation. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that established liabilities are reasonable and that the ultimate resolution of these matters will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to certain tax returns filed by predecessor affiliates of the Company and Covidien, the IRS has concluded its field examination for the years 1997 through 2009. The Company considers such uncertain tax positions associated with these years as having been effectively settled. All but one of the matters associated with these audits have been resolved. The unresolved proposed adjustment asserts that substantially all of the predecessor affiliates' intercompany debt originating during the years 1997 through 2000 should not be treated as debt for U.S. federal income tax purposes, and has disallowed interest deductions related to the intercompany debt and certain tax attribute adjustments recognized on the U.S. income tax returns. This matter is subject to the Company's </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> liability limitation for periods prior to September 29, 2012, as prescribed in the Tax Matters Agreement. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that it will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a </font><font style="font-family:inherit;font-size:10pt;">$22.5 million</font><font style="font-family:inherit;font-size:10pt;"> benefit, during fiscal 2015, in discontinued operations.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition-Related Litigation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Several purported class action lawsuits were filed in February 2014 and March 2014 by purported holders of Cadence common stock in connection with the Cadence Acquisition, including in the Delaware Court of Chancery (consolidated under the caption </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Cadence Pharmaceuticals, Inc. Stockholders Litigation</font><font style="font-family:inherit;font-size:10pt;">), and in California State Court, San Diego County (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Denny v. Cadence Pharmaceuticals, Inc., et al., Militello v. Cadence Pharmaceuticals, Inc., et al., </font><font style="font-family:inherit;font-size:10pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Schuon v. Cadence Pharmaceuticals, Inc., et al.</font><font style="font-family:inherit;font-size:10pt;">). The actions bring claims against, and generally allege that, the board of directors of Cadence breached their fiduciary duties in connection with the Cadence Acquisition by, among other things, failing to maximize shareholder value, and the Delaware and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Schuon</font><font style="font-family:inherit;font-size:10pt;"> actions further allege that Cadence omitted to disclose allegedly material information in its Schedule 14D-9. The lawsuits also allege, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs. On March 7, 2014, following expedited discovery, the parties in the consolidated Delaware action entered into a Memorandum of Understanding ("the MOU"), which sets forth the parties' agreement in principle for a settlement of those actions. The settlement was memorialized in a formal Stipulation and Settlement and Release in March 2015, and includes among other things, a release of all claims relating to the Cadence Acquisition as set forth in the Stipulation. On June 8, 2015, the Delaware Court approved the settlement. There were no substantive proceedings in any of the California actions. On July 29, 2014, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Militello</font><font style="font-family:inherit;font-size:10pt;"> case was voluntarily dismissed without prejudice. On September 8, 2014, the Denny case was voluntarily dismissed without prejudice. On June 23, 2015, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Schuon </font><font style="font-family:inherit;font-size:10pt;">case was voluntarily dismissed without prejudice.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since the announcement of the merger with Questcor on April 7, 2014, several putative class actions have been filed by purported holders of Questcor common stock in connection with the Questcor Acquisition </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Hansen v. Thompson, et al., Heng v. Questcor Pharmaceuticals, Inc., et al., Buck v. Questcor Pharmaceuticals, Inc., et al., Ellerbeck v. Questcor Pharmaceuticals, Inc., et al., Yokem v. Questcor Pharmaceuticals, Inc., et al., Richter v. Questcor Pharmaceuticals, Inc., et al., Tramantano v. Questcor Pharmaceuticals, Inc., et al., Crippen v. Questcor Pharmaceuticals, Inc., et al., Patel v. Questcor Pharmaceuticals, Inc., et al., </font><font style="font-family:inherit;font-size:10pt;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Postow v. Questcor Pharmaceuticals, Inc., et al.)</font><font style="font-family:inherit;font-size:10pt;">. The actions were consolidated on June 3, 2014. The consolidated complaint names as defendants, and generally alleges that, the directors of Questcor breached their fiduciary duties in connection with the acquisition by, among other things, agreeing to sell Questcor for inadequate consideration and pursuant to an inadequate process. The consolidated complaint also alleges that the Questcor directors breached their fiduciary duties by failing to disclose purportedly material information to shareholders in connection with the merger. The consolidated complaint also alleges, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 29, 2014, the defendants reached an agreement in principle with the plaintiffs in the consolidated actions, and that agreement is reflected in a MOU. In connection with the settlement contemplated by the MOU, Questcor agreed to make certain additional disclosures related to the proposed transaction with the Company, which are contained in the Company's Current Report on Form 8-K filed with the SEC on July 30, 2014. Additionally, as part of the settlement and pursuant to the MOU, the Company agreed to forbear from exercising certain rights under the merger agreement with Questcor, as follows: the four business day period referenced in Section 5.3(e) of the merger agreement with Questcor was reduced to three business days. Consistent with the terms of the MOU, the parties entered into a formal stipulation of settlement in February 2015 and re-executed the stipulation of settlement on May 7, 2015 (collectively the "Stipulation of Settlement").</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Stipulation of Settlement was subject to customary conditions, including court approval. On May 8, 2015, the California Court denied plaintiffs' Motion for Preliminary Approval of Settlement. On October 23, 2015, the parties submitted a proposed Stipulation and Order re Dismissal With Prejudice dismissing the action with prejudice as to each of the named plaintiffs and without prejudice as to the remainder of the class, and on October 30, 2015 the California Court entered that Order. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Matters</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a defendant in a number of other pending legal proceedings relating to present and former operations, acquisitions and dispositions. The Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its financial condition, results of operations and cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various patent, product liability, government investigations, environmental liability and other legal proceedings in the ordinary course of business. The Company records accruals for contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company discounts environmental liabilities using a risk-free rate of return when the obligation is fixed or reasonably determinable. The impact of the discount in the consolidated balance sheets was not material in any period presented. Legal fees, other than those pertaining to environmental and asbestos matters, are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. Assets and liabilities are not netted for financial statement presentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Income</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of accumulated other comprehensive income are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrecognized Loss on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrecognized Gain (Loss) on Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;28, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(72.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income (loss), net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">158.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">108.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income (loss), net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(44.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassification from other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">131.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(58.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss before reclassification</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassification from other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes reclassifications out of accumulated other comprehensive income for the 2015 and 2014 fiscal years:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="60%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount Reclassified from </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount Reclassified from <br clear="none"/>Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line Item in the Condensed Consolidated </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Statement of Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of unrealized loss on derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of pension and post-retirement benefit plans:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net actuarial loss</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total before tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total reclassifications for the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:48px;"><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note</font><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;">13</font><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">for additional details.</font><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.4074074074074%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="3%" rowspan="1" colspan="1"></td><td width="97%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">23.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Consolidating and Combining Financial Statements</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2012, MIFSA was formed as a </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">-owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations. </font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MIFSA is the borrower under the Notes, which are fully and unconditionally guaranteed by Mallinckrodt plc. The following information provides the composition of the Company's comprehensive income, assets, liabilities, equity and cash flows by relevant group within the Company: Mallinckrodt plc as guarantor of the Notes, MIFSA as issuer of the Notes and the operating companies that represent assets of MIFSA. There are no subsidiary guarantees related to the Notes. </font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Set forth below are the condensed consolidating balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> and condensed consolidating statements of comprehensive income and cash flows for the three years ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among Mallinckrodt plc, MIFSA and the other subsidiaries. Condensed consolidating and combining financial information for Mallinckrodt plc and MIFSA, on a standalone basis, has been presented using the equity method of accounting for subsidiaries. </font></div><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING BALANCE SHEET</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="46%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">213.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">365.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">548.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">548.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">205.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">128.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,699.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">280.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,391.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,846.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,649.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,649.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,666.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,666.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14,797.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18,838.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,050.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,686.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,498.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,672.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">251.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,012.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,119.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,498.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(56,226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,404.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities and Shareholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">132.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued payroll and payroll-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">489.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">568.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany payable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,699.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">167.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,701.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">997.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">929.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,299.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,474.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pension and postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,132.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,132.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loans payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,672.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,672.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">245.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">245.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,701.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,069.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,861.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12,539.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,092.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shareholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,050.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33,636.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,686.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Liabilities and Shareholders' Equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,012.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,119.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,498.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(56,226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,404.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING BALANCE SHEET</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September&#160;26, 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">476.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">476.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">227.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">200.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">200.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,066.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,071.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,082.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,082.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">111.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">111.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">586.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,645.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,945.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16,177.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,385.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,941.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,326.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">234.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">234.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,986.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,675.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,669.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22,543.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,787.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities and Shareholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">110.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued payroll and payroll-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">477.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">529.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany payable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">846.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">904.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,693.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">180.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,874.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pension and postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loans payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,966.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,360.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">343.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">343.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,729.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,437.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,365.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,829.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shareholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,958.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,945.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,232.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16,177.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,958.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Liabilities and Shareholders' Equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,986.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,675.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,669.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22,543.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,787.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 25, 2015</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,493.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,493.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,853.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,853.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,037.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,169.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(126.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">603.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">461.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(96.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(230.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(255.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(96.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(208.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">330.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">496.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">309.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">732.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit from income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(77.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">325.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">809.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">826.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(69.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">134.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">259.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">757.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(942.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">259.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 26, 2014</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Combined</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,021.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,021.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,060.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,060.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">745.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">151.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">151.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(86.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(82.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(171.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(318.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(306.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit from income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(318.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(296.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(174.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(471.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(84.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">126.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(362.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(307.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(555.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">863.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(362.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Combined</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">890.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">890.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">822.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">822.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">490.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">495.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for (benefit from) income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">104.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">132.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(237.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 25, 2015</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">837.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">896.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(149.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(554.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">703.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,014.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(149.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,850.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,718.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,296.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,890.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,010.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(258.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,590.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,848.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">703.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(703.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,014.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchase of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(57.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,296.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,549.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,718.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,069.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net (decrease) increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(475.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(341.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">213.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">365.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 26, 2014</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(65.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">420.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">373.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(127.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(127.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,793.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,793.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(298.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(915.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,238.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Subsidiary dividend proceeds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,735.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,735.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Cash</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,733.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,806.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,673.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,890.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,893.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">149.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,043.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(31.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Subsidiary dividend payment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,238.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,735.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,735.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchase of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,760.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,861.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,673.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,953.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net increase (decrease) in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">471.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">432.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">146.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(147.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(147.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(88.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(88.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(409.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">412.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(644.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">480.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(234.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">898.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">898.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net transfers to parent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,160.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">644.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(515.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">409.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(412.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">714.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(480.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">373.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated and combined financial statements include the accounts of the Company, its wholly-owned subsidiaries and entities in which they own or control more than fifty percent of the voting shares, or have the ability to control through similar rights. The results of entities disposed of are included in the consolidated and combined financial statements up to the date of disposal and, where appropriate, these operations have been reflected as discontinued operations. Divestitures of product lines not representing businesses have been reflected in operating income. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments necessary for a fair presentation have been included in the results reported.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt was comprised of the following at the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital lease obligation and vendor financing agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Variable rate receivable securitization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.50% notes due April 2018</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.88% notes due April 2020</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,958.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,978.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.50% debentures due May 2022</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.75% notes due August 2022</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.00% debentures due March 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.75% notes due April 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.625% notes due October 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">750.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.50% notes due April 2025</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital lease obligation and vendor financing agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,584.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,959.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,606.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,980.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">85.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2012, Mallinckrodt International Finance S.A. ("MIFSA") was formed as a 100% owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations. At the time of the Separation, MIFSA became a 100% owned subsidiary of the Company.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2013, MIFSA issued </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.50%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$600.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">4.75%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 2023</font><font style="font-family:inherit;font-size:10pt;"> (collectively, "the Notes"). Mallinckrodt plc has fully and unconditionally guaranteed the Notes on an unsecured and unsubordinated basis. The Notes are subject to an indenture which contains covenants limiting the ability of MIFSA, its restricted subsidiaries (as defined in the Notes) and Mallinckrodt plc, as guarantor, to incur certain liens or enter into sale and lease-back transactions. It also restricts Mallinckrodt plc and MIFSA's ability to merge or consolidate with any other person or sell or convey all or substantially all of their assets to any one person. MIFSA may redeem all of the Notes at any time, and some of the Notes from time to time, at a redemption price equal to the principal amount of the Notes redeemed plus a make-whole premium. MIFSA will pay interest on the Notes semiannually in arrears on April 15 and October 15 of each year, which commenced on October 15, 2013. The net proceeds to MIFSA from the issuance and sale of the Notes was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$889.3 million</font><font style="font-family:inherit;font-size:10pt;">, the majority of which was retained by Covidien per the terms of the Separation and Distribution Agreement. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2014, MIFSA and Mallinckrodt CB LLC ("MCB"), each a wholly-owned subsidiary of the Company, entered into senior secured credit facilities consisting of a </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;"> term loan facility due 2021 ("the Term Loan") and a </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> revolving credit facility due 2019 ("the Revolver") (collectively, "the Facilities"). The Facilities are fully and unconditionally guaranteed by Mallinckrodt plc, certain of its direct or indirect wholly-owned U.S. subsidiaries and each of its direct or indirect wholly-owned subsidiaries that owns directly or indirectly any such wholly-owned U.S. subsidiary (collectively, "the Guarantors"). The Facilities are secured by a security interest in certain assets of MIFSA, MCB and the Guarantors. The Facilities contain customary affirmative and negative covenants, which include, among other things, restrictions on the Company's ability to declare or pay dividends, create liens, incur additional indebtedness, enter into sale and lease-back transactions, make investments, dispose of assets and merge or consolidate with any other person. In addition, the Revolver contains a financial covenant that may limit the Company's total net debt leverage ratio, which is defined as the ratio of (i) the Company's consolidated debt, less any unrestricted cash and cash equivalents, to (ii) the Company's adjusted consolidated EBITDA, as defined in the credit agreement. The Facilities bear interest at LIBOR plus a margin based on the Company's total net debt leverage ratio, and the Term Loan is subject to a minimum LIBOR level of </font><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;">. Interest payment dates are variable based on the LIBOR rate utilized, but the Company generally expects interest to be payable every </font><font style="font-family:inherit;font-size:10pt;">90 days</font><font style="font-family:inherit;font-size:10pt;">. The Term Loan requires quarterly principal amortization payments in an amount equal to </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> of the original principal amount of the Term Loan payable on the last day of each calendar quarter, which commenced on June 30, 2014, with the remaining balance payable on the due date, March 19, 2021. The Company incurred an original issue discount of </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, associated with the Term Loan. The Revolver contains a </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;"> letter of credit provision, of which </font><font style="font-family:inherit;font-size:10pt;">none</font><font style="font-family:inherit;font-size:10pt;"> had been issued as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">. On August 28, 2015, in connection with the Therakos Acquisition, Mallinckrodt Enterprises LLC and Mallinckrodt plc, two wholly owned subsidiaries of Mallinckrodt plc, MIFSA and MCB, entered into a </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> replacement revolving credit facility (the &#8220;2015 Replacement Revolving Credit Facility&#8221;), which refinanced and replaced in full the existing revolving credit facility, and an additional </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> incremental revolving credit facility (the &#8220;2015 Incremental Revolving Credit Facility&#8221; and, together with the 2015 Replacement Revolving Credit Facility, the &#8220;2015 Revolving Credit Facility&#8221;), such that the 2015 Revolving Credit Facility has an aggregate facility size of </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;">. Unused commitments on the 2015 Revolving Credit Facility are subject to an annual commitment fee, which was </font><font style="font-family:inherit;font-size:10pt;">0.275%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, and the fee applied to outstanding letters of credit is based on the interest rate applied to borrowings. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the applicable interest rate on outstanding borrowings under the 2015 Revolving Credit Facility was </font><font style="font-family:inherit;font-size:10pt;">2.6%</font><font style="font-family:inherit;font-size:10pt;">, and outstanding borrowings totaled </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2014, Mallinckrodt Securitization S.&#192;.R.L. ("Mallinckrodt Securitization"), a wholly-owned special purpose subsidiary of the Company, entered into a </font><font style="font-family:inherit;font-size:10pt;">$160.0 million</font><font style="font-family:inherit;font-size:10pt;"> accounts receivable securitization facility that matures in July 2017 ("the Receivable Securitization"). In January 2015, Mallinckrodt Securitization amended the Receivable Securitization with third-party lenders to increase the borrowing limit from </font><font style="font-family:inherit;font-size:10pt;">$160.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;">. The terms of the Receivable Securitization, and the determination of interest rates, were largely unchanged. Mallinckrodt Securitization may, from time to time, obtain up to </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> in third-party borrowings secured by certain receivables, which may be increased to </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon approval of the third-party lenders, subject to certain conditions. The Receivable Securitization agreements contain customary representations, warranties and affirmative and negative covenants.The borrowings under the Receivable Securitization are to be repaid as the secured receivables are collected. Loans under the Receivable Securitization will bear interest (including facility fees) at a rate equal to one month LIBOR rate plus a margin of </font><font style="font-family:inherit;font-size:10pt;">0.80%</font><font style="font-family:inherit;font-size:10pt;">. Unused commitments on the Receivables Securitization are subject to an annual commitment fee of </font><font style="font-family:inherit;font-size:10pt;">0.35%</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the applicable interest rate on outstanding borrowings under the Receivable Securitization was </font><font style="font-family:inherit;font-size:10pt;">0.99%</font><font style="font-family:inherit;font-size:10pt;"> and outstanding borrowings totaled </font><font style="font-family:inherit;font-size:10pt;">$153.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, MIFSA and MCB issued </font><font style="font-family:inherit;font-size:10pt;">$900.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">5.75%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due August&#160;1, 2022 ("the 2022 Notes&#8221;). The 2022 Notes are guaranteed on an unsecured basis by certain of MIFSA's subsidiaries. The 2022 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2022 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of Mallinckrodt plc and its subsidiaries. MIFSA may redeem some or all of the 2022 Notes prior to August&#160;1, 2017 by paying a make-whole premium. MIFSA may redeem some or all of the 2022 Notes on or after August&#160;1, 2017 at specified redemption prices. In addition, prior to August&#160;1, 2017, MIFSA may redeem up to </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2022 Notes with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase the 2022 Notes at a price of (a)&#160;</font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b)&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, in the event of certain asset sales. These obligations are subject to certain qualifications and exceptions. MIFSA pays interest on the 2022 Notes semiannually in arrears on February 1 and August 1 of each year, commencing on February 1, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, MIFSA and MCB&#160;entered into a </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> senior secured term loan facility ("the New Term Loan&#8221;). The New Term Loan is an incremental tranche under the credit agreement governing our existing Term Loan and Revolver, entered into in March 2014, (collectively, with the New Term Loan, represent "the Senior Secured Credit Facilities"). New Term Loan has substantially similar terms to the Term Loan (other than pricing); including the determination of interest rates and quarterly principal amortization payments equal to </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> of the original principal amount of the New Term Loan. The quarterly principal payments commenced on December 31, 2014, with the remaining balance payable on the due date of March 19, 2021. Mallinckrodt plc and its subsidiaries (other than MIFSA, MCB and the subsidiaries of MIFSA that guarantee the Facilities) will not guarantee the New Term Loan, and the New Term Loan will not be secured by the assets of such entities. The August 2014 Term Loan bears interest under substantially similar terms of the March 2014 Term Loan, including the use of LIBOR rates with a minimum floor, except that the margin applied to LIBOR is not dependent upon the Company's total net debt leverage ratio. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 15, 2015, MIFSA and MCB issued </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">4.875%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due April 15, 2020 ("the 2020 Notes") and </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">5.50%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due April 15, 2025 ("the 2025 Notes", and together with the 2020 Notes, the "Ikaria Notes"). The Ikaria Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries that guarantee the obligations under the Facilities, which following the Ikaria Acquisition includes Compound Holdings II, Inc. and its U.S. subsidiaries. The Ikaria Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the Ikaria Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the (i)&#160;2020 Notes prior to April&#160;15, 2017 and (ii)&#160;2025 Notes prior to April&#160;15, 2020, in each case, by paying a &#8220;make-whole&#8221; premium. The Issuers may redeem some or all of the (i)&#160;2020 Notes on or after April&#160;15, 2017 and (ii)&#160;2025 Notes on or after April&#160;15, 2020, in each case, at specified redemption prices. In addition, prior to (i)&#160;April&#160;15, 2017, in the case of the 2020 Notes, and (ii)&#160;April&#160;15, 2018, in the case of the 2025 Notes, the Issuers may redeem up to </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2020 Notes or 2025 Notes, as the case may be, with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase (a)&#160;each series of Notes at a price of </font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b)&#160;the Notes at a price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the Ikaria Notes semiannually on April 15</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;"> and October 15</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;"> of each year, commencing on October 15, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 24, 2015, in connection with the Therakos Acquisition, MIFSA and MCB issued </font><font style="font-family:inherit;font-size:10pt;">$750.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">5.625%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due October 2023 (the &#8220;2023 Notes&#8221;). The Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries under the Facilities, which following the Therakos Acquisition includes TGG Medical Solutions, Inc. and its U.S. subsidiaries. The 2023 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2023 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the 2023 Notes on or after October 15, 2018 at specified redemption prices. In addition, prior to October 15, 2018, the Issuers may redeem up to </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2023 Notes with the net proceeds of certain equity offerings. The Issuers may also redeem all, but not less than all, of the Notes at any time at a price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount, plus accrued and unpaid interest, if any, in the event the Issuers become obligated to pay additional amounts as a result of changes affecting certain withholding tax laws applicable to payments on the Notes. The Issuers are obligated to offer to repurchase the 2023 Notes (a) at a price of </font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b)&#160;the 2023 Notes at a price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the 2023 Notes semiannually on April 15</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th </sup></font><font style="font-family:inherit;font-size:10pt;">and October 15</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;"> of each year, commencing on April 15, 2016.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the applicable interest rate for the Term Loan and New Term Loan were </font><font style="font-family:inherit;font-size:10pt;">3.25%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">3.50%</font><font style="font-family:inherit;font-size:10pt;">, respectively, and outstanding principal under these agreements totaled approximately </font><font style="font-family:inherit;font-size:10pt;">$1,978.5 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate amounts of debt, including the capital lease obligation, maturing during the next five fiscal years are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">175.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">321.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">521.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">721.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">15.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Plans</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation cost from continuing operations was </font><font style="font-family:inherit;font-size:10pt;">$116.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$66.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$16.0 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts are generally included within selling, general and administrative expenses in the consolidated and combined statements of income. In conjunction with the Questcor Acquisition, Questcor equity awards were converted to Mallinckrodt equity awards which resulted in post-combination expense of </font><font style="font-family:inherit;font-size:10pt;">$90.4 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2015, included in the above total share-based compensation, of which </font><font style="font-family:inherit;font-size:10pt;">$80.6 million</font><font style="font-family:inherit;font-size:10pt;"> is included within selling, general and administrative expenses and </font><font style="font-family:inherit;font-size:10pt;">$9.8 million</font><font style="font-family:inherit;font-size:10pt;"> is included within restructuring charges, net. The incremental fair value associated with the conversion of Covidien equity awards into Mallinckrodt equity awards is included in separation costs. The Company recognized a related tax benefit associated with this expense of </font><font style="font-family:inherit;font-size:10pt;">$41.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$24.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Incentive Equity Awards Converted from Covidien Awards</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the Separation, all employee incentive equity awards were granted by Covidien. At the time of Separation, the restricted share units and share options granted to Mallinckrodt employees prior to June 28, 2013 were converted into restricted share units and share options, respectively, of Mallinckrodt, and all of the performance share awards granted to Mallinckrodt employees were converted to restricted share units of Mallinckrodt (collectively, "the Conversion"). Mallinckrodt incentive equity awards issued upon completion of the Conversion and the related weighted-average grant date fair value is presented below:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted share units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">575,213</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share Options.</font><font style="font-family:inherit;font-size:10pt;"> A summary of the status of the Company's share option awards upon completion of the Conversion on June&#160;28, 2013 is presented below:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br clear="none"/> Average<br clear="none"/> Exercise<br clear="none"/> Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br clear="none"/> Average<br clear="none"/> Remaining<br clear="none"/> Contractual<br clear="none"/> Term<br clear="none"/>(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br clear="none"/> Intrinsic<br clear="none"/> Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at June 28, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercisable at June 28, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">550,097</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.9</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Conversion resulted in a modification of the previously issued share option awards. The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards immediately after the Separation was higher than the awards immediately before, primarily due to the elimination of Covidien's dividend yield assumption and the Company's higher volatility as compared to Covidien. The incremental fair value for vested awards was recognized immediately within separation costs, as the incremental fair value is directly attributable to the Separation, and the incremental fair value for unvested awards will be recognized on a straight-line basis over the remaining vesting period of the applicable awards, also within separation costs.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average assumptions used in the Black-Scholes pricing model for determining the fair value of the share option awards immediately before and immediately after the Separation were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pre- Separation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Post- Separation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected share price volatility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.99</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.99</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected annual dividend per share</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.65</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected life of options (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value per option</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share option awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,745,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted share units. </font><font style="font-family:inherit;font-size:10pt;">The Conversion resulted in a modification of the previously issued restricted share unit awards ("RSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The Conversion did not result in incremental fair value. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance share units.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Conversion resulted in a modification of the previously issued performance share unit awards ("PSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards was higher after the Conversion as the performance factor utilized to convert the award was higher than what had previously been estimated. The incremental fair value was recognized immediately within separation costs for the service period to date and the remaining incremental fair value will be recognized over the remaining vesting period within separation costs.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Compensation Plans</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the Separation, the Company adopted the 2013 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2013 Plan"). The 2013 Plan provides for the award of share options, share appreciation rights, annual performance bonuses, long-term performance awards, restricted units, restricted shares, deferred share units, promissory shares and other share-based awards (collectively, "Awards"). The 2013 Plan provided for a maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5.7 million</font><font style="font-family:inherit;font-size:10pt;"> common shares to be issued as Awards, subject to adjustment as provided under the terms of the 2013 Plan. In fiscal 2015, the Company amended the 2013 Plan and adopted the 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2015 Plan"). The 2015 Plan provides for a maximum of </font><font style="font-family:inherit;font-size:10pt;">17.8 million</font><font style="font-family:inherit;font-size:10pt;"> common shares to be issued as Awards (an incremental </font><font style="font-family:inherit;font-size:10pt;">12.1 million</font><font style="font-family:inherit;font-size:10pt;"> Awards from the 2013 Plan subject to issuance), subject to adjustment as provided under the terms of the 2015 Plan. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, all equity awards held by the Company's employees were either converted from Covidien equity awards at the Separation, converted from Questcor equity awards, or granted under the 2013 Plan or 2015 Plan. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share options.</font><font style="font-family:inherit;font-size:10pt;"> Share options are granted to purchase the Company's ordinary shares at prices that are equal to the fair market value of the shares on the date the share option is granted. Share options generally vest in equal annual installments over a period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">four years</font><font style="font-family:inherit;font-size:10pt;"> and expire </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">ten years</font><font style="font-family:inherit;font-size:10pt;"> after the date of grant. The grant-date fair value of share options, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share option activity and information is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Share Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Remaining Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,760,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">675,921</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,292,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(878,330</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired/Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(323,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,526,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">635,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">102.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,132,778</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired/Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(243,135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,786,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested and unvested expected to vest as of September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,649,351</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercisable at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,054,336</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$24.8 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to unvested share option awards, which is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">2.7 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The grant date fair value of share options has been estimated using the Black-Scholes pricing model. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. The expected volatility assumption is based on the historical and implied volatility of the Company's peer group with similar business models for periods after the Separation, and on Covidien's peer group with similar business models for periods prior to the Separation. The expected life assumption is based on the contractual and vesting term of the share option, employee exercise patterns and employee post-vesting termination behavior. The expected annual dividend per share is based on the Company's current intentions regarding payment of cash dividends, or Covidien's dividend rate on the date of grant. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The weighted-average assumptions used in the Black-Scholes pricing model for share options granted in fiscal 2013 subsequent to the Separation are included within the discussion of modification expense above. The weighted-average assumptions used in the Black-Scholes pricing model for shares granted in fiscal 2015, along with the weighted-average grant-date fair value, were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected share price volatility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.72</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.96</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected annual dividend per share</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected life of options (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value per option</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2013, subsequent to the Separation, the total intrinsic value of share options exercised and the related tax benefit was not significant. In fiscal 2015 and 2014, the total intrinsic value of options exercised was </font><font style="font-family:inherit;font-size:10pt;">$89.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$34.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and the related tax benefit was </font><font style="font-family:inherit;font-size:10pt;">$33.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted share units. </font><font style="font-family:inherit;font-size:10pt;">Recipients of RSUs have no voting rights and receive dividend equivalent units which vest upon the vesting of the related shares. RSUs generally vest in equal annual installments over a period of </font><font style="font-family:inherit;font-size:10pt;">four years</font><font style="font-family:inherit;font-size:10pt;">. Restrictions on RSUs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period. The fair market value of RSUs granted after the Conversion is determined based on the market value of the Company's shares on the date of grant for periods after the Separation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSU activity is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">724,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">229,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300,237</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(94,838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">589,222</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">273,733</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(219,189</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">572,494</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total fair value of Mallinckrodt restricted share unit awards granted during fiscal 2015 was </font><font style="font-family:inherit;font-size:10pt;">$28.9 million</font><font style="font-family:inherit;font-size:10pt;">. The total vest date fair value of Mallinckrodt restricted share units vested during fiscal 2015 was </font><font style="font-family:inherit;font-size:10pt;">$21.6 million</font><font style="font-family:inherit;font-size:10pt;">. As of September 25, 2015, there was </font><font style="font-family:inherit;font-size:10pt;">$30.3 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">2.8 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance share units. </font><font style="font-family:inherit;font-size:10pt;">Similar to recipients of RSUs, recipients of PSUs have no voting rights and receive dividend equivalent units. The grant date fair value of PSUs, adjusted for estimated forfeitures, is generally recognized as expense on a straight-line basis from the grant date through the end of the performance period. The vesting of PSUs and related dividend equivalent units is generally based on various performance metrics and relative total shareholder return (total shareholder return for the Company as compared to total shareholder return of the PSU peer group), measured over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance period. The PSU peer group is comprised of various healthcare companies which attempts to replicate the Company&#8217;s mix of businesses. Depending on Mallinckrodt's relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;">, of the award granted.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU activity is as follows </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">79,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance metric adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72,740</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.46</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">125.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance metric adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19,072</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 25, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">130,974</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)&#160;&#160;&#160;&#160;The number of shares disclosed within this table are at the target number of 100%. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards. The assumptions used in the Monte Carlo model for PSUs granted during each year were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected stock price volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Peer group stock price volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Correlation of returns</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant-date fair value per share of PSUs granted was $</font><font style="font-family:inherit;font-size:10pt;">125.84</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2015. As of September 25, 2015, there was </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized compensation cost related to PSUs, which is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">1.8 years</font><font style="font-family:inherit;font-size:10pt;"> .</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted stock awards. </font><font style="font-family:inherit;font-size:10pt;">Recipients of restricted stock awards ("RSAs") pertain solely to converted awards from the Questcor Acquisition, which were converted at identical terms to their original award. The converted RSAs maintain voting rights and a non-forfeitable right to receive dividends. RSAs are subject to accelerated vesting as prescribed by the terms of the original award based on a change in control, and substantially all of which will vest over a thirteen month period of time from the date of the Questcor Acquisition. Restrictions on RSAs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSAs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period. </font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,829,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(390,731</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,432,031</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,362,823</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34,562</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total vest date fair value of Mallinckrodt restricted share awards vested during fiscal 2015 was $</font><font style="font-family:inherit;font-size:10pt;">127.4 million</font><font style="font-family:inherit;font-size:10pt;">. As of September 25, 2015, there was </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">2.5 years</font><font style="font-family:inherit;font-size:10pt;"> .</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Purchase Plans</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted the Mallinckrodt Employee Stock Purchase Plan ("ESPP") effective October 1, 2013. Substantially all full-time employees of the Company's U.S. subsidiaries and employees of certain qualified non-U.S. subsidiaries are eligible to participate in this ESPP. Eligible employees authorize payroll deductions to be made for the purchase of shares. The Company matches a portion of the employee contribution by contributing an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">15%</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">25%</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2014 and fiscal 2015) of the employee's payroll deduction up to a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25,000</font><font style="font-family:inherit;font-size:10pt;"> per employee contribution. All shares purchased under the ESPP are purchased on the open market by a designated broker.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt incentive equity awards issued upon completion of the Conversion and the related weighted-average grant date fair value is presented below:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted share units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">575,213</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discontinued Operations and Divestitures</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Discontinued Operations</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">CMDS:</font><font style="font-family:inherit;font-size:10pt;"> During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet in a transaction valued at approximately </font><font style="font-family:inherit;font-size:10pt;">$270.0 million</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be completed during the first quarter of fiscal 2016. As of September 25, 2015, the CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the sale of the CMDS business, the Company will continue to supply certain products under a supply agreement with Guerbet.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the financial results of the CMDS discontinued operations for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013 as presented in the consolidated statements of operations and comprehensive income:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Major line items constituting income (loss) from discontinued operations </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">495.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">549.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">352.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">346.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">114.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">204.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income (loss) from discontinued operations</font></div><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(209.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income (loss) from discontinued operations net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(174.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal 2014 non-restructuring impairment charge of </font><font style="font-family:inherit;font-size:10pt;">$204.0 million</font><font style="font-family:inherit;font-size:10pt;"> includes charges of </font><font style="font-family:inherit;font-size:10pt;">$51.4 million</font><font style="font-family:inherit;font-size:10pt;"> associated with property, plant and equipment, </font><font style="font-family:inherit;font-size:10pt;">$52.4 million</font><font style="font-family:inherit;font-size:10pt;"> associated with intangible assets and </font><font style="font-family:inherit;font-size:10pt;">$100.2 million</font><font style="font-family:inherit;font-size:10pt;"> associated with goodwill. Further discussion of these impairment charges are included within Notes 10 and 11.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal 2015 income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$10.8 million</font><font style="font-family:inherit;font-size:10pt;"> was impacted by approximately </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense related to taxes paid, or anticipated to be paid, in connection with the disposition. The fiscal 2014 income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$34.7 million</font><font style="font-family:inherit;font-size:10pt;"> was impacted by receiving a tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$36.2 million</font><font style="font-family:inherit;font-size:10pt;"> on impairment of </font><font style="font-family:inherit;font-size:10pt;">$204.0 million</font><font style="font-family:inherit;font-size:10pt;">, by </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense associated with the rate difference between U.S. and non-U.S. jurisdictions, </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit associated with nonrecurring valuation allowances, </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense associated with accrued income tax liabilities and uncertain tax positions, and </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense associated with permanently nondeductible, nontaxable, and other items. The fiscal 2013 income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$21.1 million</font><font style="font-family:inherit;font-size:10pt;"> was impacted by </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit associated with the rate difference between U.S. and non-U.S. jurisdictions and </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit associated with permanently nondeductible, nontaxable, and other items. Fiscal 2015 reflects </font><font style="font-family:inherit;font-size:10pt;">$14.9 million</font><font style="font-family:inherit;font-size:10pt;"> of International current income tax expense, </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;"> of International deferred income tax benefit, and </font><font style="font-family:inherit;font-size:10pt;">none</font><font style="font-family:inherit;font-size:10pt;"> being allocable to the Domestic income tax provision. Fiscal 2014 reflects </font><font style="font-family:inherit;font-size:10pt;">$10.4 million</font><font style="font-family:inherit;font-size:10pt;"> of Domestic current income tax expense, </font><font style="font-family:inherit;font-size:10pt;">$6.6 million</font><font style="font-family:inherit;font-size:10pt;"> of International current income tax benefit, </font><font style="font-family:inherit;font-size:10pt;">$35.6 million</font><font style="font-family:inherit;font-size:10pt;"> of Domestic deferred income tax benefit, and </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> of International deferred income tax benefit. Fiscal 2013 reflects </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> of Domestic current income tax expense, </font><font style="font-family:inherit;font-size:10pt;">$10.7 million</font><font style="font-family:inherit;font-size:10pt;"> of International current income tax expense, </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;"> of Domestic deferred income tax expense, and </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> of International deferred income tax benefit. Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and 2013.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the assets and liabilities of the CMDS business that are classified as held for sale on the consolidated balance sheets as of September 25, 2015 and September 26, 2014:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying amounts of major classes of assets included as part of discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">86.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current and non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total assets classified as held for sale in the balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">312.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying amounts of major classes of liabilities included as part of discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current and non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities classified as held for sale in the balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes significant cash and non-cash transactions of the CMDS business that are included within the consolidated statements of cash flows for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-cash impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">204.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other notes to the consolidated financial statements that were impacted by this discontinued operation have been reclassified accordingly.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mallinckrodt Baker:</font><font style="font-family:inherit;font-size:10pt;"> During fiscal 2010, the Specialty Chemicals business (formerly known as "Mallinckrodt Baker"), which was part of the Company's Specialty Pharmaceuticals segment, was sold because its products and customer bases were not aligned with the Company's long-term strategic objectives. This business met the discontinued operations criteria and, accordingly, was included in discontinued operations for all periods presented. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a </font><font style="font-family:inherit;font-size:10pt;">loss, net of tax,</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, a </font><font style="font-family:inherit;font-size:10pt;">loss</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">gain</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These gains and losses were primarily related to the indemnification obligations to the purchaser, which are discussed in Note 18. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other: </font><font style="font-family:inherit;font-size:10pt;">Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a </font><font style="font-family:inherit;font-size:10pt;">$22.5 million</font><font style="font-family:inherit;font-size:10pt;"> benefit, during fiscal 2015, in discontinued operations within the consolidated and combined statement of income.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">License of Intellectual Property</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was involved in patent disputes with a counterparty relating to certain intellectual property related to extended-release oxymorphone. In December 2013, the counterparty agreed to pay the Company an upfront cash payment of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> and contractually obligated future payments of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> through July 2018, in exchange for the withdrawal of all claims associated with the intellectual property and a license to utilize the Company's intellectual property. The Company has completed the earnings process associated with the agreement and recorded an </font><font style="font-family:inherit;font-size:10pt;">$11.7 million</font><font style="font-family:inherit;font-size:10pt;"> gain, included within gains on divestiture and license, during fiscal </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In periods prior to fiscal 2014, basic earnings (loss) per share was computed by dividing net income by the number of weighted-average shares outstanding during the period. Diluted earnings (loss) per share was computed using the weighted-average shares outstanding and, if dilutive, potential ordinary shares outstanding during the period. Potential ordinary shares represent the incremental ordinary shares issuable for restricted share units and share option exercises. The Company calculated the dilutive effect of outstanding restricted share units and share options on earnings (loss) per share by application of the treasury stock method.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The computations of basic and diluted earnings (loss) per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> ordinary share of Mallinckrodt for every </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares of Covidien. The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.</font><font style="font-family:inherit;font-size:9pt;"> </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (Loss) per Share</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2015 and 2014, basic and diluted earnings (loss) per share were computed using the two-class method. The two-class method is an earnings allocation that determines earnings per share for each class of common stock and participating securities according to dividends declared and participation rights in undistributed earnings. The Company&#8217;s restricted stock awards, issued in conjunction with the Questcor Acquisition in August 2014, are considered participating securities as holders are entitled to receive non-forfeitable dividends during the vesting term. Diluted earnings per share includes securities that could potentially dilute basic earnings per share during a reporting period, for which the Company includes all share-based compensation awards other than participating securities. Dilutive securities, including participating securities, are not included in the computation of loss per share when the Company reports a net loss from continuing operations as the impact would be anti-dilutive.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In periods prior to fiscal 2014, basic earnings (loss) per share was computed by dividing net income by the number of weighted-average shares outstanding during the period. Diluted earnings (loss) per share was computed using the weighted-average shares outstanding and, if dilutive, potential ordinary shares outstanding during the period. Potential ordinary shares represent the incremental ordinary shares issuable for restricted share units and share option exercises. The Company calculated the dilutive effect of outstanding restricted share units and share options on earnings (loss) per share by application of the treasury stock method.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The computations of basic and diluted earnings (loss) per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> ordinary share of Mallinckrodt for every </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares of Covidien. The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Earnings (loss) per share numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations attributable to common shareholders before allocation of earnings to participating securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: earnings allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations attributable to common shareholders, after earnings allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">305.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: earnings from discontinued operations allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations attributable to common shareholders, after allocation of earnings to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders, after allocation of earnings to participating securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">322.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Earnings (loss) per share denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-average shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">115.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Impact of dilutive securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">117.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings (loss) per share attributable to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings (loss) per share attributable to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The computation of diluted earnings per share for fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> excludes approximately </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of equity awards because the effect would have been anti-dilutive. As the Company incurred a net loss in fiscal 2014, there was no allocation of the undistributed loss to participating securities because the effect would have been anti-dilutive to basic and diluted earnings per share.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide a summary of plan assets held by the Company's pension plans that are measured at fair value on a recurring basis at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. small mid cap</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. large cap</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">198.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">196.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High yield bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging market funds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">309.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. small mid cap</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. large cap</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High yield bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging market funds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">337.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds. </font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the carrying values and estimated fair values of the Company's long-term debt, excluding capital leases, as of the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Variable rate receivable securitization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.50% notes due April 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">294.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">290.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.875% notes due April 2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">684.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,978.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,966.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,996.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,970.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.50% debentures due May 2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.75% notes due August 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">876.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">907.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.00% debentures due March 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.75% notes due April 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">539.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">563.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.625% notes due October 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">750.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">705.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.50% notes due April 2025</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">646.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">20.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Instruments and Fair Value Measurements</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes a three-level fair value hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs used in measuring fair value. The levels within the hierarchy are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:108px;text-indent:-60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1&#8212; observable inputs such as quoted prices in active markets for identical assets or liabilities; </font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:108px;text-indent:-60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2&#8212; significant other observable inputs that are observable either directly or indirectly; and </font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:108px;text-indent:-60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3&#8212; significant unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt and equity securities held in rabbi trusts</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration and acquired contingent liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange forward and option contracts</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">197.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6.5pt;"><font style="font-family:inherit;font-size:6.5pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6.5pt;"><font style="font-family:inherit;font-size:6.5pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt and equity securities held in rabbi trusts</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration and acquired contingent liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange forward and option contracts</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt and equity securities held in rabbi trust.</font><font style="font-family:inherit;font-size:10pt;"> Debt securities held in the rabbi trust primarily consist of U.S. government and agency securities and corporate bonds. When quoted prices are available in an active market, the investments are classified as level 1. When quoted market prices for a security are not available in an active market, they are classified as level 2. Equity securities held in the rabbi trust primarily consist of U.S. common stocks, which are valued using quoted market prices reported on nationally recognized securities exchanges. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign exchange forward and option contracts. </font><font style="font-family:inherit;font-size:10pt;">Foreign currency option and forward contracts are used to economically manage the foreign exchange exposures of operations outside the U.S. Quoted prices are available in an active market; as such, these derivatives are classified as level 1.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred compensation liabilities. </font><font style="font-family:inherit;font-size:10pt;">The Company maintains a non-qualified deferred compensation plan in the U.S., which permits eligible employees of the Company to defer a portion of their compensation. A recordkeeping account is set up for each participant and the participant chooses from a variety of funds for the deemed investment of their accounts. The recordkeeping accounts generally correspond to the funds offered in the Company's U.S. tax-qualified defined contribution retirement plan and the account balance fluctuates with the investment returns on those funds. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill. </font><font style="font-family:inherit;font-size:10pt;">The Company performs an annual goodwill impairment assessment using an income approach based on the present value of future cash flows. See further discussion in Notes 2 and 11.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent consideration and acquired contingent liabilities. </font><font style="font-family:inherit;font-size:10pt;">In October 2012, the Company recorded contingent consideration of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;"> upon the acquisition of CNS Therapeutics. This contingent consideration, which could potentially total a maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">, is primarily based on whether the FDA approves another concentration of Gablofen on or before December 31, 2016. The fair value of the contingent payments was measured based on the probability-weighted present value of the consideration expected to be transferred using a discount rate of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.0%</font><font style="font-family:inherit;font-size:10pt;">. At September 25, 2015, the fair value of this contingent consideration was </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the Company recorded acquired contingent liabilities of </font><font style="font-family:inherit;font-size:10pt;">$195.4 million</font><font style="font-family:inherit;font-size:10pt;"> from the Questcor Acquisition. The contingent liabilities relate to Questcor's contingent obligations associated with their acquisition of an exclusive, perpetual and irrevocable license to develop, market, manufacture, distribute, sell and commercialize Synacthen and Synacthen Depot (collectively "Synacthen") from Novartis AG and Novartis Pharma AG (collectively "Novartis") and their acquisition of BioVectra. The fair value of these contingent consideration obligations at September 25, 2015 were </font><font style="font-family:inherit;font-size:10pt;">$167.4 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of the license agreement with Novartis, the Company is obligated to make a </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> payment in fiscal 2016, make annual payments of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> subsequent to fiscal 2016 until such time that the Company obtains FDA approval of Synacthen and make a </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> payment upon obtaining FDA approval of Synacthen. If FDA approval is obtained, the Company will pay an annual royalty to Novartis based on a percentage of net sales of the products in the U.S. market. The Company made its fiscal 2015 required payment of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">. As of September 25, 2015, the total remaining payments under the license agreement shall not exceed </font><font style="font-family:inherit;font-size:10pt;">$190.0 million</font><font style="font-family:inherit;font-size:10pt;">. The terms of the license agreement do allow the Company to terminate the license agreement at our discretion following the fiscal 2018 payment or upon the occurrence of certain events following the fiscal 2016 payment. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of </font><font style="font-family:inherit;font-size:10pt;">4.7%</font><font style="font-family:inherit;font-size:10pt;">. Under the terms of the license agreement, the Company was required to maintain deposits equal to the fiscal 2016 annual </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> payment which is included in prepaid expenses and other current assets and other assets in the consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the terms of the acquisition agreement with the former shareholders of BioVectra, the Company may be obligated to pay additional cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> CAD based on BioVectra's financial results from January 2013 through a portion of fiscal 2016. During fiscal 2015 and 2014, the Company made </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> CAD payments to the former shareholders and may be obligated for an additional </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> CAD to be paid in fiscal 2016. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of </font><font style="font-family:inherit;font-size:10pt;">1.3%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate change</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Instruments Not Measured at Fair Value</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and the majority of other current assets and liabilities approximate fair value because of their short-term nature. The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents (level 1). The fair value of restricted cash is equivalent to its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$66.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$69.8 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively (level 1), substantially all of which is included in other assets on the consolidated balance sheets. The Company's life insurance contracts are carried at cash surrender value, which is based on the present value of future cash flows under the terms of the contracts (level 3). Significant assumptions used in determining the cash surrender value include the amount and timing of future cash flows, interest rates and mortality charges. The fair value of these contracts approximates the carrying value of </font><font style="font-family:inherit;font-size:10pt;">$67.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$67.3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. These contracts are included in other assets on the consolidated and combined balances sheets. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying values of the Company's revolving credit facility and variable rate receivable securitization approximate the fair values due to the short-term nature of these instruments. The carrying values of the </font><font style="font-family:inherit;font-size:10pt;">2.85%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;"> term loans approximate the fair values of these instruments, as calculated using the discounted exit price for each instrument, and are therefore classified as level 3. Since the quoted market prices for the Company's term loans and </font><font style="font-family:inherit;font-size:10pt;">8.00%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">9.50%</font><font style="font-family:inherit;font-size:10pt;"> debentures are not available in an active market, they are classified as level 2 for purposes of developing an estimate of fair value. The Company's </font><font style="font-family:inherit;font-size:10pt;">3.50%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">4.75%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">4.875%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5.50%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5.625%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">5.75%</font><font style="font-family:inherit;font-size:10pt;"> notes are classified as level 1, as quoted prices are available in an active market for these notes. The following table presents the carrying values and estimated fair values of the Company's long-term debt, excluding capital leases, as of the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Variable rate receivable securitization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.85% term loan due April 2016</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.50% notes due April 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">294.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">290.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.875% notes due April 2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">684.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Term loans due March 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,978.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,966.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,996.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,970.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.00% term loan due February 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.50% debentures due May 2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.75% notes due August 2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">876.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">900.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">907.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.00% debentures due March 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.75% notes due April 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">539.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">563.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.625% notes due October 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">750.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">705.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.50% notes due April 2025</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">646.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit and Other Risks</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of accounts receivable. The Company does not require collateral from customers. A portion of the Company's accounts receivable outside the U.S. includes sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries' national economies. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows net sales attributable to distributors that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's total net sales:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">CuraScript, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">McKesson Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cardinal Health, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">AmerisourceBergen Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows accounts receivable attributable to distributors that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's gross accounts receivable at the end of each period: </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">McKesson Corporation</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">CuraScript, Inc.</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cardinal Health, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">AmerisourceBergen Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table shows net sales attributable to products that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's total net sales: </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acthar</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acetaminophen products (API)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Methylphenidate ER</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Molybdenum-99 ("Mo-99") is a key raw material in the Company's Ultra-Technekow DTE technetium generators that are sold by its Nuclear Imaging segment. There are only </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> suppliers of this raw material worldwide. The Company has agreements to obtain Mo-99 from </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> nuclear research reactors and relies predominantly upon </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> of these reactors for its Mo-99 supply. Accordingly, a disruption in the commercial supply or a significant increase in the cost of this material from these sources could have a material adverse effect on the Company's financial condition, results of operations and cash flows.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate change</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets acquired consist of the following: &#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Therakos</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,170.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15 years</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology intangible asset relates to extracorporeal photopheresis treatment therapies. The fair value of the intangible asset was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of the asset based on market participant expectations of cash flows the asset would generate. The cash flows were discounted commensurate with the level of risk associated with each asset or its projected cash flows. The completed technology intangible asset utilized a discount rate of </font><font style="font-family:inherit;font-size:10pt;">17.0%</font><font style="font-family:inherit;font-size:10pt;">. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Ikaria</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,820.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development - terlipressin</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,971.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology and trademark intangible assets relate to Inomax. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, trademark and in-process research and development ("IPR&amp;D") terlipressin intangibles utilized discount rates of </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">17.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The IPR&amp;D discount rate for terlipressin was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Questcor</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,343.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development - Synacthen</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,601.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The completed technology intangible asset relates to Acthar. The trademark and customer relationship intangible assets relate to BioVectra, Inc., a wholly-owned subsidiary of Questcor. The in-process research and development relates to the U.S. development of Synacthen, a synthetic pharmaceutical product. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, customer relationships, trademark and in-process research and development intangibles utilized discount rates of </font><font style="font-family:inherit;font-size:10pt;">14.5%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">16.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The in-process research and development discount rate was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. The majority of assets acquired are included within the Company's Specialty Brands segment. Assets related to BioVectra, Inc. are included within the Company's Specialty Generics segment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Cadence</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8 years</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The completed technology intangible asset relates to Ofirmev, the rights to which have been in-licensed from Bristol-Myers Squibb Company ("BMS"). The fair value of the intangible asset was determined using the income approach. The cash flows were discounted at a </font><font style="font-family:inherit;font-size:10pt;">13.0%</font><font style="font-family:inherit;font-size:10pt;"> rate.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">For more information on the BMS license agreement, refer to "License Agreement" below. The excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">CNS Therapeutics</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademark</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company reports its results based on a "52-53 week" year ending on the last Friday of September. Fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> each consisted of 52 weeks. Unless otherwise indicated, fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> refer to the Company's fiscal years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. Fiscal 2016 will consist of 53 weeks and will end on September 30, 2016.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Currency Translation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company's non-U.S. subsidiaries that transact in a functional currency other than U.S. dollars, assets and liabilities are translated into U.S. dollars using fiscal year-end exchange rates. Revenues and expenses are translated at the average exchange rates in effect during the related month. The net effect of these translation adjustments is shown in the consolidated and combined financial statements as a component of accumulated other comprehensive income. For subsidiaries operating in highly inflationary environments or where the functional currency is different from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date the assets and liabilities were acquired or assumed, while monetary assets and liabilities are translated at fiscal year-end exchange rates. Translation adjustments of these subsidiaries are included in net income. Gains and losses resulting from foreign currency transactions are included in net income. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill and Intangible Assets</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="54%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Impairment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Impairment</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,442.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,194.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,768.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,521.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal year ended September 25, 2015, the gross carrying value of goodwill in the Specialty Brands segment increased by </font><font style="font-family:inherit;font-size:10pt;">$1,247.5 million</font><font style="font-family:inherit;font-size:10pt;">, attributable to </font><font style="font-family:inherit;font-size:10pt;">$792.4 million</font><font style="font-family:inherit;font-size:10pt;"> from the Ikaria Acquisition, </font><font style="font-family:inherit;font-size:10pt;">$437.2 million</font><font style="font-family:inherit;font-size:10pt;"> from the Therakos Acquisition and </font><font style="font-family:inherit;font-size:10pt;">$17.9 million</font><font style="font-family:inherit;font-size:10pt;"> resulting from adjustments to the Questcor Acquisition purchase price allocation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill Impairment Analysis</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has identified the Specialty Brands, Specialty Generics and the Nuclear Imaging businesses as representing both segments and reporting units. For purposes of assessing impairment and the recoverability of goodwill for each reporting unit the Company makes various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a WACC determined from relevant market comparisons, adjusted upward for specific reporting unit risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the reporting unit represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows. The fair values of the reporting units were assessed for reasonableness by aggregating the fair values and comparing this to the Company's market capitalization with a control premium.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's projections in its Specialty Brands reporting unit include long-term revenue and operating income at levels higher than historical levels, which is primarily associated with revenue growth for Acthar, Inomax and Ofirmev. The projections also reflect the potential impacts from the future loss of exclusivity related to Ofirmev. The Company utilized a WACC of </font><font style="font-family:inherit;font-size:10pt;">12.0%</font><font style="font-family:inherit;font-size:10pt;">. These assumptions resulted in a fair value of the Specialty Brands reporting unit in excess of its net book value. Should the Specialty Brands reporting unit fail to experience growth in the aforementioned products, revise its long-term projections for these products downward or market conditions dictate utilization of higher discount rates, the Specialty Brands reporting unit could be subject to impairment in future periods.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's projections in its Specialty Generics and API reporting unit include long-term revenue and operating income at levels lower than historical levels primarily attributable to increased competition. The Company utilized a WACC of </font><font style="font-family:inherit;font-size:10pt;">11.0%</font><font style="font-family:inherit;font-size:10pt;">. These assumptions resulted in a fair value of the Specialty Generics and API reporting unit in excess of its net book value. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2014, the Company recorded goodwill impairment charges related to our former Global Medical Imaging reporting unit (which included the CMDS business that is now included within discontinued operations and the remaining Nuclear Imaging reporting unit). The Company recorded an impairment charge related to goodwill in fiscal 2014 of </font><font style="font-family:inherit;font-size:10pt;">$219.7 million</font><font style="font-family:inherit;font-size:10pt;">, which eliminated all goodwill balances related to the Global Medical Imaging reporting unit. In fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business, therefore the business was deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$100.2 million</font><font style="font-family:inherit;font-size:10pt;"> of the impairment charge to discontinued operations.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortizable:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,896.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">765.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,906.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">235.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">87.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,198.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">882.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,144.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">332.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Amortizable:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">316.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">235.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">351.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">270.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finite-lived intangible asset amortization expense within continuing operations was </font><font style="font-family:inherit;font-size:10pt;">$550.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$154.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$27.9 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">693.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">691.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Other Intangible Assets</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill represents the excess of the purchase price of an acquired entity over the amounts assigned to assets and liabilities assumed in a business combination. The Company tests goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The impairment test is comprised of a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. The Company estimates the fair value of its reporting units through internal analyses and valuation, utilizing an income approach (a level three measurement technique) based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, the Company will perform the second step of the goodwill impairment test to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. The implied fair value of goodwill is determined in the same manner that the amount of goodwill recognized in a business combination is determined, with the Company allocating the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of the value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets acquired in a business combination are recorded at fair value, while intangible assets acquired in other transactions are recorded at cost. Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="85%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">License agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense related to completed technology and certain other intangible assets&#160;is included in cost of sales, while amortization expense related to intangible assets that contribute to the Company's ability to sell, market and distribute products is included in selling, general and administrative expenses. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset, or the asset group they are part of, to its carrying value. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets, or the asset group they are part of, with their carrying value. The fair value of the intangible asset, or the asset group they are part of, is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, or the asset group they are part of, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the fair value of the asset. The Company assesses the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. The Company annually tests the indefinite-lived intangible assets for impairment by comparing the fair value of the assets, estimated using an income approach, with their carrying value and records an impairment when the carrying value exceeds the fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Guarantees</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In disposing of assets or businesses, the Company has historically provided representations, warranties and indemnities to cover various risks and liabilities, including unknown damage to the assets, environmental risks involved in the sale of real estate, liability to investigate and remediate environmental contamination at waste disposal sites and manufacturing facilities, and unidentified tax liabilities related to periods prior to disposition. The Company assesses the probability of potential liabilities related to such representations, warranties and indemnities and adjusts potential liabilities as a result of changes in facts and circumstances. The Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of the Specialty Chemical business (formerly known as Mallinckrodt Baker) in fiscal 2010, the Company agreed to indemnify the purchaser with respect to various matters, including certain environmental, health, safety, tax and other matters. The indemnification obligations relating to certain environmental, health and safety matters have a term of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">17 years</font><font style="font-family:inherit;font-size:10pt;"> from the sale, while some of the other indemnification obligations have an indefinite term. The amount of the liability relating to all of these indemnification obligations included in other liabilities on the Company's consolidated balance sheets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$15.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of which </font><font style="font-family:inherit;font-size:10pt;">$13.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$13.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to environmental, health and safety matters. The value of the environmental, health and safety indemnity was measured based on the probability-weighted present value of the costs expected to be incurred to address environmental, health and safety claims made under the indemnity. The aggregate fair value of these indemnification obligations did not differ significantly from their aggregate carrying value at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the maximum future payments the Company could be required to make under these indemnification obligations was </font><font style="font-family:inherit;font-size:10pt;">$71.0 million</font><font style="font-family:inherit;font-size:10pt;">. The Company was required to pay </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;"> into an escrow account as collateral to the purchaser, of which </font><font style="font-family:inherit;font-size:10pt;">$19.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19.4 million</font><font style="font-family:inherit;font-size:10pt;"> remained in other assets on the consolidated balance sheets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recorded liabilities for known indemnification obligations included as part of environmental liabilities, which are discussed in Note 19. In addition, the Company is liable for product performance; however the Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to provide the U.S. Nuclear Regulatory Commission financial assurance demonstrating its ability to fund the decommissioning of its Maryland Heights, Missouri radiopharmaceuticals production facility upon closure, though the Company does not intend to close this facility. The Company has provided this financial assurance in the form of surety bonds totaling </font><font style="font-family:inherit;font-size:10pt;">$57.2 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had various other letters of credit and guarantee and surety bonds totaling </font><font style="font-family:inherit;font-size:10pt;">$39.4 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the Company terminated a letter of credit to guarantee decommissioning costs associated with its Saint Louis, Missouri plant and placed </font><font style="font-family:inherit;font-size:10pt;">$21.1 million</font><font style="font-family:inherit;font-size:10pt;"> of restricted cash on deposit with a trustee. This restricted cash is included within prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 25, 2015. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the separation and distribution agreement entered into with Covidien at the Separation provides for cross-indemnities principally designed to place financial responsibility of the obligations and liabilities of the Company's business with the Company and financial responsibility for the obligations and liabilities of Covidien's remaining business with Covidien, among other indemnities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2015, the activities of the Company's principal executive offices were relocated from Ireland to the U.K. which resulted in a change in the Company's tax residence to the U.K. Mallinckrodt plc remains incorporated in Ireland. The tax regime applicable to holding companies resident in the U.K. allows Mallinckrodt plc to continue to have flexibility in structuring its subsidiary operations and enhanced global cash management. The Company continues to be subject to taxation in various tax jurisdictions worldwide. As a result of the integration of acquired intellectual property, the Company's income and assets are no longer concentrated in a single tax jurisdiction. Accordingly, in 2015 the Company reports the U.K. tax jurisdiction as its Domestic jurisdiction and the International jurisdiction represents areas outside the U.K. tax jurisdiction. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Domestic and International components of income from continuing operations before income taxes were as follows</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(107.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(159.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">322.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant components of income taxes related to continuing operations are as follows</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(49.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(18.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(187.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income tax (benefit) provision</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(188.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal 2015 International current income tax provision reflects a utilization of </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;"> of net operating losses (primarily in the U.S.) and </font><font style="font-family:inherit;font-size:10pt;">$14.3 million</font><font style="font-family:inherit;font-size:10pt;"> of U.S. credits. The net operating loss utilization is comprised of </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;"> of net operating losses acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to net operating losses carried forward from fiscal 2014. The U.S. credit utilization is comprised of </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;"> of credits acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to credits carried forward or generated during fiscal 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal 2014 Domestic current income tax provision reflects a utilization of </font><font style="font-family:inherit;font-size:10pt;">$221.3 million</font><font style="font-family:inherit;font-size:10pt;"> of net operating losses (primarily in the U.S.) and </font><font style="font-family:inherit;font-size:10pt;">$8.6 million</font><font style="font-family:inherit;font-size:10pt;"> of U.S. credits. The net operating loss utilization is comprised of </font><font style="font-family:inherit;font-size:10pt;">$187.8 million</font><font style="font-family:inherit;font-size:10pt;"> of net operating losses acquired in conjunction with the Cadence Acquisition and the remainder utilization relating to net operating losses carried forward.</font></div><div style="line-height:120%;padding-bottom:17px;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a provincial tax holiday in Canada that expires on April 1, 2017. The tax holiday reduced International tax expense by </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the fiscal years 2015 and 2014, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes at Domestic statutory income tax rate </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(53.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Adjustments to reconcile to income tax provision:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. state income tax provision, net </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate difference between Domestic and International jurisdictions </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) (3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(138.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. manufacturing deduction </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation allowances, nonrecurring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Adjustments to accrued income tax liabilities and uncertain tax positions </font><font style="font-family:inherit;font-size:8pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest and penalties on accrued income tax liabilities and uncertain tax positions </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in partnership</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Credits, principally research and orphan drug </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Impairments, nondeductible</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Permanently nondeductible and nontaxable items </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The statutory tax rate reflects the U.K. statutory tax rate of </font><font style="font-family:inherit;font-size:8pt;">20%</font><font style="font-family:inherit;font-size:8pt;"> for fiscal 2015, and the U.S. federal statutory tax rate of </font><font style="font-family:inherit;font-size:8pt;">35%</font><font style="font-family:inherit;font-size:8pt;"> for fiscal 2014 and 2013.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately </font><font style="font-family:inherit;font-size:8pt;">$2.3 million</font><font style="font-family:inherit;font-size:8pt;"> of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes </font><font style="font-family:inherit;font-size:8pt;">$0.7 million</font><font style="font-family:inherit;font-size:8pt;"> for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately </font><font style="font-family:inherit;font-size:8pt;">$3.6 million</font><font style="font-family:inherit;font-size:8pt;"> of credit related to the period January 1, 2014 through September 26, 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes the impact of nondeductible transaction and separation costs.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The rate difference between Domestic and International jurisdictions changed from </font><font style="font-family:inherit;font-size:10pt;">$10.6 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit to </font><font style="font-family:inherit;font-size:10pt;">$138.6 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit for fiscal 2014 to fiscal 2015, respectively. The rate difference between Domestic and International jurisdictions would have been </font><font style="font-family:inherit;font-size:10pt;">$32.1 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit in fiscal 2014 if the referenced rate would have been the U.K. statutory rate of </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the </font><font style="font-family:inherit;font-size:10pt;">$128.0 million</font><font style="font-family:inherit;font-size:10pt;"> increase to tax benefit, </font><font style="font-family:inherit;font-size:10pt;">$21.5 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit can be attributed to the change in the referenced rate from U.S. to U.K, </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit to the change in operating income, </font><font style="font-family:inherit;font-size:10pt;">$22.5 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense to the change in amortization, </font><font style="font-family:inherit;font-size:10pt;">$31.8 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit to the U.S. state tax benefit associated with the impact of recent acquisitions, integration thereof, and legislative changes, and </font><font style="font-family:inherit;font-size:10pt;">$62.2 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit related to acquisition and other non-acquisition related items.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The rate difference between Domestic and International jurisdictions changed from </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense to </font><font style="font-family:inherit;font-size:10pt;">$10.6 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit for fiscal 2013 to fiscal 2014, respectively. The rate difference between Domestic and International jurisdictions would have been </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense and </font><font style="font-family:inherit;font-size:10pt;">$32.1 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit if the referenced rate would have been the U.K. statutory rate of </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> for fiscal 2013 and 2014 respectively. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions and the benefit of intercompany debt transferred to the Company at Separation, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the </font><font style="font-family:inherit;font-size:10pt;">$13.9 million</font><font style="font-family:inherit;font-size:10pt;"> decrease in tax expense, </font><font style="font-family:inherit;font-size:10pt;">$10.8 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense can be attributed to the change in operating income, </font><font style="font-family:inherit;font-size:10pt;">$14.0 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense to the change in amortization, and </font><font style="font-family:inherit;font-size:10pt;">$38.7 million</font><font style="font-family:inherit;font-size:10pt;"> of tax benefit related to acquisition and other non-acquisition related items.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;">, the amounts of unrecognized tax benefits for which the Company is legally and directly liable and would be required to remit cash if not sustained were </font><font style="font-family:inherit;font-size:10pt;">$89.2 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$82.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$100.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For periods prior to the Separation, the Company's operations had been included in tax returns filed by Covidien or certain of its subsidiaries not included in the Company's historical combined financial statements. As a result, some U.S. uncertain tax positions related to the Company's operations resulted in unrecognized tax benefits that are obligations of entities not included in the combined financial statements for periods prior to June 28, 2013. Because the activities that gave rise to these unrecognized tax benefits relate to the Company's operations, the impact of these items (presented in the table below) were charged to the income tax provision through parent company investment, which was a component of parent company equity in the combined balance sheets.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at beginning of fiscal year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">165.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrecognized tax benefits retained by Covidien</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrecognized tax benefits transferred from Covidien</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions related to current year tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions related to prior period tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reductions related to prior period tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(33.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Lapse of statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at end of fiscal year</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">89.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015, the Company made a payment of </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$7.4 million</font><font style="font-family:inherit;font-size:10pt;"> of tax and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> of interest) to the U.S. Internal Revenue Service ("IRS") in connection with the settlement of certain tax matters for 2008 and 2009. During fiscal 2014, the Company made a payment of </font><font style="font-family:inherit;font-size:10pt;">$35.9 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$27.3 million</font><font style="font-family:inherit;font-size:10pt;"> of tax and </font><font style="font-family:inherit;font-size:10pt;">$8.6 million</font><font style="font-family:inherit;font-size:10pt;"> of interest) to the IRS in connection with the settlement of certain tax matters for 2005 through 2007.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (non-current liability)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">89.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included within total unrecognized tax benefits at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$87.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$82.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$96.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of unrecognized tax benefits, which if favorably settled would benefit the effective tax rate. The remaining unrecognized tax benefits for each period would be offset by the write-off of related deferred and other tax assets, if recognized. During fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;"> of additional interest through tax provision and acquisition accounting and decreased interest </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to cash payments related to settlements as well as reductions related to prior periods. During fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Company accrued additional interest of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total amount of accrued interest related to uncertain tax positions was </font><font style="font-family:inherit;font-size:10pt;">$41.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$45.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$62.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that within the next twelve months, as a result of the resolution of various Domestic and International examinations and appeals and the expiration of various statutes of limitation, that the unrecognized tax benefits could decrease by up to </font><font style="font-family:inherit;font-size:10pt;">$17.5 million</font><font style="font-family:inherit;font-size:10pt;">. Interest and penalties could decrease by up to </font><font style="font-family:inherit;font-size:10pt;">$8.8 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">141.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, other assets includes </font><font style="font-family:inherit;font-size:10pt;">$52.2 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with current deferred intercompany transactions, and </font><font style="font-family:inherit;font-size:10pt;">$81.3 million</font><font style="font-family:inherit;font-size:10pt;"> of receivables associated with tax payments on account with the taxing authorities. At </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, other assets includes </font><font style="font-family:inherit;font-size:10pt;">$14.8 million</font><font style="font-family:inherit;font-size:10pt;"> of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> associated with the Questcor acquisition and tax payments of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">78.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Covidien continues to be examined by various taxing authorities for periods the Company was included within the consolidated results of Covidien. In connection with the Separation, the Company entered into a tax matters agreement ("the Tax Matters Agreement") with Covidien that generally governs Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including, but not limited to, ordinary course of business taxes. For further information on the Tax Matters Agreement, refer to Note 17.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the earliest open year for U.S. federal and state tax jurisdictions is </font><font style="font-family:inherit;font-size:10pt;">1996</font><font style="font-family:inherit;font-size:10pt;">. Additionally, a number of tax periods from </font><font style="font-family:inherit;font-size:10pt;">2009</font><font style="font-family:inherit;font-size:10pt;"> to present are subject to examination by tax authorities in various jurisdictions, including Ireland, Luxembourg, Switzerland, and the U.K.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued liabilities and reserves</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Tax loss and credit carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rebate reserves</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired product</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Federal and state benefit of uncertain tax positions and interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">589.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">427.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(140.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(121.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,550.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,177.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Installment sale</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,465.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(93.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in partnership</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(187.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(191.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,344.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,584.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) before valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,754.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,157.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(233.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(76.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,987.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes are reported in the following consolidated and combined balance sheet captions in the amounts shown:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (current asset)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes (non-current liability)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,132.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,399.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,987.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's current deferred tax asset decreased from </font><font style="font-family:inherit;font-size:10pt;">$152.3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$142.7 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> primarily due to changes in inventory valuation as a result of profits in intercompany inventory, the increase in deferred tax assets from the Ikaria Acquisition, and decreases to operational deferred tax assets due to normal operating activities. Additionally, the Company's non-current deferred tax liability increased from </font><font style="font-family:inherit;font-size:10pt;">$2,399.6 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$3,132.4 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, primarily due to </font><font style="font-family:inherit;font-size:10pt;">$623.6 million</font><font style="font-family:inherit;font-size:10pt;"> related to the Ikaria Acquisition, </font><font style="font-family:inherit;font-size:10pt;">$324.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to the Therakos Acquisition, offset by </font><font style="font-family:inherit;font-size:10pt;">$54.3 million</font><font style="font-family:inherit;font-size:10pt;"> of decreases associated with the amortization of intangibles, </font><font style="font-family:inherit;font-size:10pt;">$105.4 million</font><font style="font-family:inherit;font-size:10pt;"> of decreases associated with the payment of internal installment sale obligations, and approximately </font><font style="font-family:inherit;font-size:10pt;">$44.0 million</font><font style="font-family:inherit;font-size:10pt;"> of decreases related to other impacts of recent acquisitions and integration.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Ikaria Acquisition resulted in a net deferred tax liability increase of </font><font style="font-family:inherit;font-size:10pt;">$596.9 million</font><font style="font-family:inherit;font-size:10pt;">. Significant components of this increase include </font><font style="font-family:inherit;font-size:10pt;">$620.2 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax liabilities associated with intangibles and </font><font style="font-family:inherit;font-size:10pt;">$17.5 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax liability associated with property, plant and equipment, partially offset by </font><font style="font-family:inherit;font-size:10pt;">$21.7 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax assets associated with U.S. tax credits, </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax assets associated with financing repayments and </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax assets associated with U.S. net operating losses.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Therakos Acquisition resulted in a net deferred tax liability increase of </font><font style="font-family:inherit;font-size:10pt;">$324.3 million</font><font style="font-family:inherit;font-size:10pt;">. Significant components of this increase include </font><font style="font-family:inherit;font-size:10pt;">$334.1 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax liabilities associated with intangibles partially offset by </font><font style="font-family:inherit;font-size:10pt;">$13.5 million</font><font style="font-family:inherit;font-size:10pt;"> of deferred tax assets predominately associated with U.S. net operating losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a part of the Questcor integration, the Company entered into an internal installment sale transaction during the three months ended December 26, 2014. The Questcor internal installment sale transaction resulted in a decrease of </font><font style="font-family:inherit;font-size:10pt;">$1,488.7 million</font><font style="font-family:inherit;font-size:10pt;"> to the deferred tax liability associated with the Acthar intangible asset, a </font><font style="font-family:inherit;font-size:10pt;">$1,515.9 million</font><font style="font-family:inherit;font-size:10pt;"> increase to the deferred tax liability associated with an installment sale note receivable, a </font><font style="font-family:inherit;font-size:10pt;">$25.3 million</font><font style="font-family:inherit;font-size:10pt;"> increase to deferred tax charge, and a </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> increase to prepaid taxes.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$126.0 million</font><font style="font-family:inherit;font-size:10pt;"> of net operating loss carryforwards in certain non-U.K. jurisdictions, of which </font><font style="font-family:inherit;font-size:10pt;">$91.4 million</font><font style="font-family:inherit;font-size:10pt;"> have no expiration and the remaining </font><font style="font-family:inherit;font-size:10pt;">$34.6 million</font><font style="font-family:inherit;font-size:10pt;"> will expire in future years through </font><font style="font-family:inherit;font-size:10pt;">2025</font><font style="font-family:inherit;font-size:10pt;">. The Company had </font><font style="font-family:inherit;font-size:10pt;">$19.6 million</font><font style="font-family:inherit;font-size:10pt;"> of U.K. net operating loss carryforwards at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, which have no expiration date.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> the Company also had </font><font style="font-family:inherit;font-size:10pt;">$16.3 million</font><font style="font-family:inherit;font-size:10pt;"> of tax credits available to reduce future income taxes payable, primarily in jurisdictions within the U.S., of which </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> have no expiration and the remainder expire during fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;">2034</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The deferred tax asset valuation allowances of </font><font style="font-family:inherit;font-size:10pt;">$233.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$76.9 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively, relate principally to the uncertainty of the utilization of certain deferred tax assets, primarily International net operating losses and intangible assets. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax residency change impacts the Company&#8217;s analysis of its cumulative unrepatriated earnings. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, the cumulative amount of undistributed earnings of the Company's subsidiaries that may be subject to tax, but are considered to be indefinitely reinvested, was </font><font style="font-family:inherit;font-size:10pt;">$369.0 million</font><font style="font-family:inherit;font-size:10pt;">. It is not practicable to determine the cumulative amount of tax liability that would arise if these indefinitely reinvested earnings were remitted due to a variety of factors including the complexity of the Company's global legal entity structure as well as the timing, extent, and nature of any hypothetical repatriation of unremitted earnings. The net decrease in such undistributed earnings as compared to the period ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;"> was attributable to the impact of the tax residency change and associated jurisdictions that could be remitted in a tax-free manner as well as the removal of the earnings for the entities classified as held for sale. These decreases were partially offset by an increase in unrepatriated earnings associated with income and losses attributed to the current year activity.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has accrued a </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> deferred tax liability associated with approximately </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;"> of unrepatriated earnings that are not indefinitely reinvested on assets from continuing operations. The Company has also accrued a </font><font style="font-family:inherit;font-size:10pt;">$6.5 million</font><font style="font-family:inherit;font-size:10pt;"> deferred tax liability associated with approximately </font><font style="font-family:inherit;font-size:10pt;">$41.3 million</font><font style="font-family:inherit;font-size:10pt;"> of unrepatriated earnings that are not indefinitely reinvested related to assets held for sale.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes for periods prior to the Separation were calculated on a separate tax return basis (inclusive of certain loss benefits), although the Company's operations had historically been included in Covidien's U.S. federal and state tax returns or the tax returns of non-U.S. jurisdictions. Accordingly, the income taxes presented for periods prior to June 28, 2013 do not necessarily reflect the results that would have occurred as an independent, publicly-traded company. With the exception of certain non-U.S. entities, the Company did not maintain taxes payable to or from Covidien and the Company was deemed to settle the annual current tax balances immediately with the legal tax-paying entities in the respective jurisdictions. These settlements were reflected as changes in parent company investment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been reflected in the consolidated and combined financial statements. Deferred tax assets and liabilities are determined based on the differences between the book and tax bases of assets and liabilities and operating loss carryforwards, using tax rates expected to be in effect for the years in which the differences are expected to reverse. A valuation allowance is provided to reduce net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities are also recorded for deferred tax obligations related to installment sale arrangements. The deferral of tax payments to the IRS are subject to interest, which is accrued and included within interest expense.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not expected to be realized on the uncertain tax position, an income tax liability is established. Interest and penalties on income tax obligations, associated with uncertain tax positions, are included in the provision for income taxes.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The calculation of the Company's tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across the Company's global operations. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from current estimates of the tax liabilities. If the Company's estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary. A significant portion of these potential tax liabilities are recorded in other income tax liabilities on the consolidated balance sheets as payment is not expected within one year.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are comprised of the following at the end of each period:&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Raw materials and supplies</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">184.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are recorded at the lower of cost or market value, primarily using the first-in, first-out convention. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete or slow-moving based on changes in customer demand, technology developments or other economic factors.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Defined Benefit Plans</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sponsors a number of defined benefit retirement plans covering certain of its U.S. employees and non-U.S. employees. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, U.S. plans represented </font><font style="font-family:inherit;font-size:10pt;">70.6%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's total pension plan assets and </font><font style="font-family:inherit;font-size:10pt;">73.1%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's projected benefit obligation. The Company generally does not provide postretirement benefits other than retirement plan benefits for its employees; however, certain of the Company's U.S. employees participate in postretirement benefit plans that provide medical benefits. These plans are unfunded.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net periodic benefit cost (credit) for the Company's pension and postretirement benefit plans was as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Service cost</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(24.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of net actuarial loss</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.0</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss on plan settlements</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net periodic benefit cost (credit)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.0</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.1</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.3</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the changes in benefit obligations, plan assets and the net amounts recognized on the consolidated balance sheets for pension and postretirement benefit plans at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Change in benefit obligation:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Projected benefit obligations at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">538.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">501.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">53.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employee contributions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Actuarial (gain) loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits and administrative expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(23.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net transfer in/(out) </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(18.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Projected benefit obligations at end of year</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">493.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">538.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Change in plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">456.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Actual return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employer contributions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Employee contributions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits and administrative expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets at end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Funded status at end of year</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Amounts recognized on the consolidated balance sheet:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(69.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(47.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(47.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net amount recognized on the consolidated balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Amounts recognized in accumulated other comprehensive income consist of:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(104.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(115.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net amount recognized in accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(98.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(108.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit cost (credit) in fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accumulated benefit obligation for all pension plans at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$489.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$533.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Additional information related to pension plans is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Pension plans with accumulated benefit obligations in excess of plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">368.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">394.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">294.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">321.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accumulated benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets do not significantly differ from the amounts in the table above since substantially all of the Company's pension plans are frozen.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Actuarial Assumptions</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average assumptions used each fiscal year to determine net periodic benefit cost for the Company's pension plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate of compensation increase</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average assumptions used each fiscal year to determine benefits obligations for the Company's pension plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate of compensation increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company's U.S. plans, the discount rate is based on the market rate for a broad population of Moody's AA-rated corporate bonds over </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;">. For the Company's non-U.S. plans, the discount rate is generally determined by reviewing country and region specific government and corporate bond interest rates. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining the expected return on pension plan assets, the Company considers the relative weighting of plan assets by class and individual asset class performance expectations as provided by external advisors in reaching conclusions on appropriate assumptions. The investment strategy for the pension plans is to obtain a long-term return on plan assets that is consistent with the level of investment risk that is considered appropriate. Investment risks and returns are reviewed regularly against benchmarks to ensure objectives are being met.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average discount rate used to determine net periodic benefit cost and obligations for the Company's postretirement benefit plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare cost trend assumptions for postretirement benefit plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Healthcare cost trend rate assumed for next fiscal year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate to which the cost trend rate is assumed to decline</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year the ultimate trend rate is achieved</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A one-percentage-point change in assumed healthcare cost trend rates would have the following effects:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-Point Increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-Point Decrease</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect on total of service and interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect on postretirement benefit obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Plan Assets</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's U.S. pension plans have a target allocation of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">24%</font><font style="font-family:inherit;font-size:10pt;"> equity securities and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">76%</font><font style="font-family:inherit;font-size:10pt;"> debt securities. Various asset allocation strategies are in place for non-U.S. pension plans depending upon local law, status, funding level and duration of liabilities, and are </font><font style="font-family:inherit;font-size:10pt;">39%</font><font style="font-family:inherit;font-size:10pt;"> equity securities, </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;"> debt securities and </font><font style="font-family:inherit;font-size:10pt;">6%</font><font style="font-family:inherit;font-size:10pt;"> other (primarily cash) for our Japanese pension plan and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> equity securities, </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;"> debt securities and </font><font style="font-family:inherit;font-size:10pt;">88%</font><font style="font-family:inherit;font-size:10pt;"> other (primarily insurance contracts) for our plan in the Netherlands.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension plans have the following weighted-average asset allocations at the end of each fiscal year:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide a summary of plan assets held by the Company's pension plans that are measured at fair value on a recurring basis at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. small mid cap</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. large cap</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">198.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">196.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High yield bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging market funds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">309.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. small mid cap</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. large cap</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High yield bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging market funds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">337.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds. </font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity securities. </font><font style="font-family:inherit;font-size:10pt;">Equity securities primarily consist of mutual funds with underlying investments in foreign equity and domestic equity markets. The fair value of these investments is based on net asset value of the units held in the respective fund, which are determined by obtaining quoted prices on nationally recognized securities exchanges (level 1) or through net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt securities. </font><font style="font-family:inherit;font-size:10pt;">Debt securities are primarily invested in mutual funds with underlying fixed income investments in U.S. government and corporate debt, U.S. dollar denominated foreign government and corporate debt, asset-backed securities, mortgage-backed securities and U.S. agency bonds. The fair value of these investments is based on the net asset value of the units held in the respective fund which are determined by obtaining quoted prices on nationally recognized securities exchanges.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Insurance contracts. </font><font style="font-family:inherit;font-size:10pt;">Insurance contracts held by the Company are issued primarily by Delta Lloyd, a well-known, highly rated insurance company. The fair value of these insurance contracts is based upon the present value of future cash flows under the terms of the contracts and therefore the fair value of these assets has been classified as level 3 within the fair value hierarchy. Significant assumptions used in determining the fair value of these contracts are the amount and timing of future cash flows and counterparty credit risk. The objective of the insurance contracts is to provide the Company with future cash flows that will match the estimated timing and amount of future pension benefit payments. Delta Lloyd's insurance subsidiaries have a Standard &amp; Poor's credit rating of A.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other. </font><font style="font-family:inherit;font-size:10pt;">Other includes cash and cash equivalents invested in a money market mutual fund, the fair value of which is determined by obtaining quoted prices on nationally recognized securities exchanges (level 1). In addition, other includes real estate funds, the fair value of which is determined using other inputs, such as net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of the changes in the fair value measurements that used significant unobservable inputs (level 3) for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Insurance Contracts</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">112.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net purchases, sales and issuances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September 26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net purchases, sales and issuances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt shares are not a direct investment of the Company's pension funds; however, the pension funds may indirectly include Mallinckrodt shares. The aggregate amount of the Mallinckrodt shares are not material relative to the total pension fund assets.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contributions</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's funding policy is to make contributions in accordance with the laws and customs of the various countries in which the Company operates, as well as to make discretionary voluntary contributions from time to time. In fiscal 2015 and 2014, the Company made </font><font style="font-family:inherit;font-size:10pt;">$13.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> in contributions, respectively, to the Company's pension plans. The Company does not anticipate making material involuntary contributions in fiscal </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, but may elect to make voluntary contributions to its defined pension plans or its postretirement benefit plans during fiscal </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Future Benefit Payments</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit payments expected to be paid, reflecting future expected service as appropriate, are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2021 - 2025</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">143.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Defined Contribution Retirement Plans</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains one active tax-qualified 401(k) retirement plan and one active non-qualified deferred compensation plan in the U.S. The 401(k) retirement plan provides for an automatic Company contribution of three percent of an eligible employee's pay, with an additional Company matching contribution generally equal to </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of each employee's elective contribution to the plan up to six percent of the employee's eligible pay. The deferred compensation plan permits eligible employees to defer a portion of their compensation. Total defined contribution expense related to continuing operations was </font><font style="font-family:inherit;font-size:10pt;">$23.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$20.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$20.3 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rabbi Trusts and Other Investments</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains several rabbi trusts, the assets of which are used to pay retirement benefits. The rabbi trust assets are subject to the claims of the Company's creditors in the event of the Company's insolvency. Plan participants are general creditors of the Company with respect to these benefits. The trusts primarily hold life insurance policies and debt and equity securities, the value of which is included in other assets on the consolidated balance sheets. Note 20 provides additional information regarding the debt and equity securities. The carrying value of the </font><font style="font-family:inherit;font-size:10pt;">134</font><font style="font-family:inherit;font-size:10pt;"> life insurance contracts held by these trusts was </font><font style="font-family:inherit;font-size:10pt;">$57.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$56.3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. These contracts had a total death benefit of </font><font style="font-family:inherit;font-size:10pt;">$147.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$145.7 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. However, there are outstanding loans against the policies amounting to </font><font style="font-family:inherit;font-size:10pt;">$40.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$38.2 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has insurance contracts which serve as collateral for certain of the Company's non-U.S. pension plan benefits, which totaled </font><font style="font-family:inherit;font-size:10pt;">$9.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$11.0 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts were also included in other assets on the consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, Plant and Equipment</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount and accumulated depreciation of property, plant and equipment at the end of each period was as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Buildings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">333.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">289.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capitalized software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,220.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,041.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Construction in process</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">146.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">196.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,870.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,669.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(879.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(782.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts above include property under capital leases of </font><font style="font-family:inherit;font-size:10pt;">$14.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16.9 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively, consisting primarily of buildings. Accumulated amortization of capitalized leased assets was </font><font style="font-family:inherit;font-size:10pt;">$14.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15.8 million</font><font style="font-family:inherit;font-size:10pt;"> at the end of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense, including amounts related to capitalized leased assets, for continuing operations was </font><font style="font-family:inherit;font-size:10pt;">$103.9 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$94.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$88.1 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Long-Lived Asset Impairment Analysis</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2014, the Company recorded long-lived asset impairment charges related to our CMDS asset group. During the fourth quarter of fiscal 2014, the Company received notification that we lost preferred supplier status with a significant group purchasing organization ("GPO") and that a related-party supply contract was terminated by the Company. The Company determined that these events constituted a triggering event with respect to our CMDS asset group assessed the recoverability of the CMDS asset group. The Company determined that the undiscounted cash flows of this asset group were less than its net book value. This would require the Company to record an impairment charge if the fair value of the CMDS asset group was less than its net book value.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determined the fair value of the CMDS asset group using the income approach, a level three measurement technique. For purposes of determining fair value the Company made various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a weighted-average cost of capital ("WACC") determined from relevant market comparisons, adjusted upward for specific risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the asset group represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's projections in the CMDS asset group included long-term net sales and operating income at lower than historical levels. The decrease in net sales and operating income is reflective of the notification of the loss of a significant customer, termination of a supply contract with a related party and increased competition in the marketplace. The Company utilized a WACC of </font><font style="font-family:inherit;font-size:10pt;">8.0%</font><font style="font-family:inherit;font-size:10pt;">, which reflects the lower inherent risk with the decreasing revenue trends. These assumptions resulted in a fair value of the CMDS asset group that was less than its net book value. Therefore, the Company recorded impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$65.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$52.4 million</font><font style="font-family:inherit;font-size:10pt;"> to the property, plant and equipment and long-lived amortizing intangible assets, respectively, included in the CMDS asset group. The Company announced that it had entered into a definitive agreement to sell its CMDS business, therefore the business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$51.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the impairment charge associated with property, plant and equipment to discontinued operations as certain assets are expected to be retained by the Company based upon the terms of the Company's agreement with Guerbet. The Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$52.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the impairment charge associated with intangible assets to discontinued operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost. Major renewals and improvements are capitalized, while routine maintenance and repairs are expensed as incurred. Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capitalized software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The Company capitalizes certain computer software and development costs incurred in connection with developing or obtaining software for internal use. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon retirement or other disposal of property, plant and equipment, the cost and related amount of accumulated depreciation are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds is included in net income.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses the recoverability of assets or asset groups using undiscounted cash flows whenever events or circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If an asset or asset group is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value of the asset or asset group and its fair value.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount and accumulated depreciation of property, plant and equipment at the end of each period was as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Buildings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">333.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">289.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capitalized software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,220.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,041.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Construction in process</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">146.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">196.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,870.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,669.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(879.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(782.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="3%" rowspan="1" colspan="1"></td><td width="97%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">22.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Selected Quarterly Financial Data (Unaudited)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2015 (by quarter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q4</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">768.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">819.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">877.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">882.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">404.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">462.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">503.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">482.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">87.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">98.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings per share from continuing operations</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2014 (by quarter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q3 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q4</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">429.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">448.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">530.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">673.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">226.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">254.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">363.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(178.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(24.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(352.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following summarizes reclassifications out of accumulated other comprehensive income for the 2015 and 2014 fiscal years:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="60%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount Reclassified from </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount Reclassified from <br clear="none"/>Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line Item in the Condensed Consolidated </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Statement of Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of unrealized loss on derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of pension and post-retirement benefit plans:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net actuarial loss</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plan settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total before tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total reclassifications for the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:48px;"><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note</font><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;">13</font><font style="font-family:inherit;font-size:8pt;"> </font><font style="font-family:inherit;font-size:8pt;background-color:#ffffff;">for additional details.</font><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Transactions with Former Parent Company</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the completion of the Separation on June 28, 2013, the Company was part of Covidien and, as such, transactions between Covidien and the Company were considered related party transactions. As discussed in Note 1, these intercompany transactions are included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The continuing relationship between Covidien and the Company is primarily governed through agreements entered into as part of the Separation, including a Separation Distribution Agreement, a Tax Matters Agreement and a transition services agreement. These agreements were filed with the SEC as Exhibits 2.1, 10.1 and 10.3, respectively, to the Company's Current Report on Form 8-K filed on July 1, 2013. The following discusses the related party transactions and those agreements. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sales and Purchases</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Company sold inventory to Covidien in the amount of </font><font style="font-family:inherit;font-size:10pt;">$35.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$46.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$51.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, which is included in net sales of discontinued operations in the consolidated and combined statements of income. The Company also purchases inventories from Covidien. The Company recognized cost of sales within discontinued operations from these inventory purchases of </font><font style="font-family:inherit;font-size:10pt;">$17.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$28.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$38.4 million</font><font style="font-family:inherit;font-size:10pt;"> during fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allocated Expenses</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed in Note 1, the combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were </font><font style="font-family:inherit;font-size:10pt;">$39.6 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> and were included within selling, general and administrative expenses.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Balance Sheet Impacts</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the Separation, the Company and Covidien maintain an ongoing relationship in which each party may provide services to the other party, including the distribution of goods. As a result of these relationships, the consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> includes </font><font style="font-family:inherit;font-size:10pt;">$6.3 million</font><font style="font-family:inherit;font-size:10pt;"> of amounts due to the Company from Covidien, within prepaid expenses and other current assets, and </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> of amounts the Company owes Covidien, included within accrued and other liabilities.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Separation and Distribution Agreement</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 28, 2013, the Company entered into a Separation and Distribution Agreement and other agreements with Covidien to effect the Separation and provide a framework for the Company's relationships with Covidien after the Separation. These agreements govern the relationship between Mallinckrodt and Covidien subsequent to the Separation and provide for the assignment to Mallinckrodt of certain of Covidien's assets, liabilities and obligations attributable to periods prior to the Separation. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, each party to the Separation and Distribution Agreement assumed liability for all pending, threatened and unasserted legal matters related to its own business or its assumed or retained liabilities and will indemnify the other party for any liability to the extent arising out of, or resulting from, such assumed or retained legal matters.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Separation and Distribution Agreement provided for the initial cash capitalization of Mallinckrodt in the amount of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$168.0 million</font><font style="font-family:inherit;font-size:10pt;"> at June 28, 2013. The Separation and Distribution Agreement also provided for an adjustment payment to compensate either Mallinckrodt or Covidien, as applicable, to the extent that the aggregate of the Company's cash, indebtedness and specified working capital accounts as of June 28, 2013 ("the Distribution Date"), as well as the capital expenditures made with respect to the Company's business during fiscal 2013 through the Distribution Date, deviated from the target. The target was calculated pursuant to a formula set forth in the Separation and Distribution Agreement, which assumed the Distribution Date would be June 28, 2013, that the Pharmaceuticals business was conducted in the ordinary course through that date and that the Company would have approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$168.0 million</font><font style="font-family:inherit;font-size:10pt;"> of cash upon completion of the distribution. The Separation and Distribution Agreement also provided that an adjustment payment would only be payable if the amount of the adjustment payment exceeded </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> (in which case the entire amount would be paid). Upon final calculation, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> adjustment payment was required by either the Company or Covidien.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Tax Matters Agreement</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Separation, Mallinckrodt entered into the Tax Matters Agreement with Covidien that generally will govern Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including ordinary course of business taxes and taxes, if any, incurred as a result of any failure of the distribution of Mallinckrodt shares to qualify as a tax-free distribution for U.S. federal income tax purposes within the meaning of Section 355 of the U.S. Internal Revenue Code, or other applicable tax law, or any failure of certain internal transactions undertaken in anticipation of the distribution to qualify for tax-free or tax-favored treatment under the applicable tax law. The Company expects, with certain exceptions, to be responsible for the payment of all taxes attributable to Mallinckrodt or its subsidiaries for taxable periods beginning on or after September 29, 2012. For periods prior to September 29, 2012, the Company is subject to a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> liability limitation, net of any benefits, as prescribed by the Tax Matters Agreement. The Company has made </font><font style="font-family:inherit;font-size:10pt;">$51.6 million</font><font style="font-family:inherit;font-size:10pt;"> of payments, net of benefits, for periods prior to September 29, 2012. To the extent that the Company's liability for such taxes, net of any tax benefits, does not exceed </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">, it may be responsible for additional taxes attributable to periods prior to September 29, 2012, taxes related to the Separation and a percentage of any taxes arising from the Separation failing to qualify for tax-free or tax-favored treatment through no fault of Covidien or the Company. The Tax Matters Agreement also assigns rights and responsibilities for administrative matters, such as the filing of returns, payment of taxes due, retention of records, tax reporting practices and conduct of audits, examinations or similar proceedings. In addition, the Tax Matters Agreement provides for cooperation and information sharing with respect to tax matters.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Tax Matters Agreement also contains restrictions on the Company's ability to take actions without Covidien's consent that could cause the Separation or certain internal transactions undertaken in anticipation of the Separation to fail to qualify as tax-free or tax-favored transactions under applicable tax law. These transactions include, but are not limited to, entering into, approving or allowing any transaction that results in a change in ownership of more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">35.0%</font><font style="font-family:inherit;font-size:10pt;"> of Mallinckrodt's shares; any merger, consolidation, scheme of arrangement, liquidation or partial liquidation, or any approval or allowance of such transaction with respect to certain of the Company's subsidiaries; the cessation or transfer of certain business activities; the sale, issuance or other disposition of any equity interest in certain of the Company's subsidiaries; a sale or other disposition of a substantial portion of the Company's assets or a substantial portion of the assets of certain of the Company's subsidiaries; extraordinary distributions by or to certain of the Company's subsidiaries; or engaging in certain internal transactions. These restrictions will all apply for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;">-year period after the Separation and in some cases will apply for periods as long as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five years</font><font style="font-family:inherit;font-size:10pt;"> following the Separation. Any taxes imposed on the other party attributable to certain post-distribution actions taken by or in respect of the responsible party or its shareholders that result in failure of the Separation or internal transactions to qualify as tax-free or tax-favored transactions are the responsibility of the party at fault, regardless of whether the actions occur more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> years after the distribution, or whether Covidien consents to such actions. Any actions of the Company or its shareholders that directly give rise to additional taxes are not subject to the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$200 million</font><font style="font-family:inherit;font-size:10pt;"> threshold noted previously. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Transition Services Agreement</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt and Covidien entered into a transition services agreement in connection with the Separation pursuant to which Mallinckrodt and Covidien will provide each other, on an interim and transitional basis, various services including, but not limited to, treasury administration, information technology services, non-exclusive distribution and importation services for our products in certain countries outside the U.S., regulatory, general administrative services and other support services. The agreed-upon charges for such services are generally intended to allow the servicing party to recover all out-of-pocket costs and expenses, and include a predetermined profit margin. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services are rendered may not be as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal research and development costs are expensed as incurred. Research and development expenses include salary and benefits, allocated overhead and occupancy costs, clinical trial and related clinical manufacturing costs, contract services and other costs.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upfront and milestone payments made to third parties under license arrangements are expensed as incurred up to the point of regulatory approval of the product. Milestone payments made to third parties upon or subsequent to regulatory approval are capitalized as an intangible asset and amortized to cost of sales over the estimated useful life of the related product.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring and Related Charges</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2013, the Company launched a restructuring program designed to improve its cost structure ("the 2013 Mallinckrodt Program"). The 2013 Mallinckrodt Program includes actions across all segments, as well as within corporate functions. The Company expects to incur charges of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$125.0 million</font><font style="font-family:inherit;font-size:10pt;"> under this program as the specific actions required to execute on these initiatives are identified and approved, most of which are expected to be incurred by the end of fiscal 2016. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to Separation, Covidien initiated restructuring programs, which also applied to its Pharmaceutical business. These programs were substantially completed as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;26, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges by segment within continuing operations are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring and related charges, net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: accelerated depreciation</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.5</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges by program within continuing operations are comprised of the following:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013 Mallinckrodt Program</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisition programs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other programs</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total programs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: non-cash charges, including impairments and accelerated share based compensation expense</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(38.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total charges expected to be settled in cash</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash charges in fiscal 2015 and fiscal 2014 include </font><font style="font-family:inherit;font-size:10pt;">$9.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$35.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accelerated share based compensation expense related to employee terminations, primarily related to our Questcor acquisition, and fiscal 2014 includes </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> of property, plant and equipment asset impairments. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="57%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013 Mallinckrodt Program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquisition Programs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Programs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;28, 2012</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.4</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.0</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(44.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging (including CMDS)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all of the restructuring reserves are included in accrued and other current liabilities on the Company's consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for product sales when title and risk of loss have transferred from the Company to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and any related services, based on contract terms or legal requirements in non-U.S. jurisdictions. The Company sells products through independent channels, including directly to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. Chargebacks and rebates represent credits that are provided to certain distributors and customers for either the difference between the Company's contracted price with a customer and the distributor's invoice price paid to the Company or for contractually agreed volume price discounts. When the Company recognizes net sales, it simultaneously records an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of the Company's products and other competitive factors. The Company adjusts these reserves to reflect differences between estimated activity and actual experience. Such adjustments impact the amount of net sales recognized by the Company in the period of adjustment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes collected from customers relating to product sales and remitted to governmental authorities are accounted for on a net basis. Accordingly, such taxes are excluded from both net sales and expenses.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of accumulated other comprehensive income are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrecognized Loss on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrecognized Gain (Loss) on Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;28, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(72.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income (loss), net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">158.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">108.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income (loss), net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(44.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassification from other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">131.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(58.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss before reclassification</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassification from other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension plans have the following weighted-average asset allocations at the end of each fiscal year:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit cost (credit) in fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Amounts recognized on the consolidated balance sheet:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(69.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(47.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(47.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net amount recognized on the consolidated balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(52.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Amounts recognized in accumulated other comprehensive income consist of:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net actuarial loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(104.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(115.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net amount recognized in accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(98.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(108.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average discount rate used to determine net periodic benefit cost and obligations for the Company's postretirement benefit plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average assumptions used each fiscal year to determine net periodic benefit cost for the Company's pension plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate of compensation increase</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average assumptions used each fiscal year to determine benefits obligations for the Company's pension plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Discount rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate of compensation increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional information related to pension plans is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Pension plans with accumulated benefit obligations in excess of plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">368.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">394.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value of plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">294.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">321.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of the changes in the Company's asset retirement obligations for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at beginning of period</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions and adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at end of period</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of the changes in the fair value measurements that used significant unobservable inputs (level 3) for fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Insurance Contracts</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">112.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net purchases, sales and issuances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September 26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net purchases, sales and issuances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant components of income taxes related to continuing operations are as follows</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(49.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(18.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(187.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income tax (benefit) provision</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(188.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING BALANCE SHEET</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="46%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">213.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">365.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">548.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">548.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">142.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">205.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">128.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,699.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">280.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,391.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,846.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">991.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,649.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,649.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,666.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,666.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14,797.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18,838.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,050.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,686.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,498.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,672.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">251.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,012.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,119.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,498.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(56,226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,404.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities and Shareholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">132.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued payroll and payroll-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">489.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">568.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany payable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,699.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">167.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,701.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">997.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,867.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">929.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,299.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,474.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pension and postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,132.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,132.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loans payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,672.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,672.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">245.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">245.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,701.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,069.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,861.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12,539.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,092.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shareholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,050.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33,636.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,686.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,311.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Liabilities and Shareholders' Equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,012.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,119.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,498.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(56,226.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,404.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING BALANCE SHEET</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September&#160;26, 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">476.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">476.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">227.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">200.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">200.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,066.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,071.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">886.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,082.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,082.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term assets held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">111.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">111.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">586.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,645.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,945.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16,177.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,385.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,941.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,326.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">234.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">234.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,986.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,675.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,669.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22,543.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,787.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities and Shareholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">110.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued payroll and payroll-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">477.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">529.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany payable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">846.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">904.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,693.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">180.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,874.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pension and postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-term liabilities held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loans payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,966.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,360.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">343.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">343.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,729.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,437.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,365.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,829.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shareholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,958.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,945.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,232.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16,177.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,958.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Liabilities and Shareholders' Equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,986.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,675.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19,669.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22,543.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,787.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 25, 2015</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">837.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">896.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(148.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(149.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(554.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">703.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,014.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(149.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,850.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,718.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,296.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,890.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,010.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(258.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,590.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,848.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(39.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">703.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(703.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,014.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,014.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchase of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(28.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(57.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,296.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,549.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,718.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,069.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net (decrease) increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(475.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(341.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">213.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">365.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 26, 2014</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(65.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">420.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">373.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(127.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(127.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,793.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,793.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(298.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(915.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,238.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Subsidiary dividend proceeds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,735.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,735.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Cash</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,733.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,806.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,673.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,890.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,893.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">149.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,043.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(31.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Subsidiary dividend payment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,238.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,735.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,735.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchase of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,760.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,861.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,673.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,953.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net increase (decrease) in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">471.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">432.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">689.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">707.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="0%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Operating Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by (used in) operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">146.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Investing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(147.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(147.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisitions and intangibles, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(88.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(88.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan investment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(409.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">412.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(70.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(644.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">480.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(234.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flows From Financing Activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of external debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">898.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">898.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of external debt and capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Excess tax benefit from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net transfers to parent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,160.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">644.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(515.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from exercise of share options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany loan borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">409.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(412.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital contribution</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(68.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">714.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(480.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">373.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of currency rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and cash equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">217.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 25, 2015</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,493.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,493.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,853.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,853.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,037.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,169.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(126.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">603.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">461.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(96.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(230.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(255.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(96.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(208.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">330.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">496.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">309.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">732.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit from income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(77.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">325.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">809.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">826.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,077.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(69.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">134.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">259.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">757.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(942.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">259.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 26, 2014</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Combined</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,021.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,021.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,060.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,060.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">745.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">151.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">151.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(86.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(82.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(171.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(318.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(306.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefit from income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(318.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(296.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(174.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(264.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(471.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">736.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(84.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">126.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(42.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(362.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(307.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(555.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">863.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(362.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MALLINCKRODT PLC</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2013</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(in millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt plc</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mallinckrodt International Finance S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Combined</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">890.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">890.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">822.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">822.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">490.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">495.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">157.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains on divestiture and license</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intercompany interest and fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity in net income of subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for (benefit from) income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(64.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">104.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">132.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(237.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued liabilities and reserves</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Tax loss and credit carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">163.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">93.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Environmental liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rebate reserves</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired product</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Postretirement benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Federal and state benefit of uncertain tax positions and interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">589.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">427.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(140.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(121.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,550.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,177.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Installment sale</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,465.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(93.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in partnership</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(187.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(191.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3,344.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,584.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) before valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,754.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,157.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(233.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(76.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net deferred tax (liability) </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,987.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the assets and liabilities of the CMDS business that are classified as held for sale on the consolidated balance sheets as of September 25, 2015 and September 26, 2014:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying amounts of major classes of assets included as part of discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">86.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current and non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total assets classified as held for sale in the balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">299.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">312.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying amounts of major classes of liabilities included as part of discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current and non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total liabilities classified as held for sale in the balance sheet</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Earnings (loss) per share numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations attributable to common shareholders before allocation of earnings to participating securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: earnings allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations attributable to common shareholders, after earnings allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">305.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(143.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: earnings from discontinued operations allocated to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations attributable to common shareholders, after allocation of earnings to participating securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(175.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders, after allocation of earnings to participating securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">322.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(319.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Earnings (loss) per share denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-average shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">115.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Impact of dilutive securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">117.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings (loss) per share attributable to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings (loss) per share attributable to common shareholders</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.22</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.92</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A one-percentage-point change in assumed healthcare cost trend rates would have the following effects:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-Point Increase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One-Percentage-Point Decrease</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect on total of service and interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect on postretirement benefit obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes at Domestic statutory income tax rate </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(53.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Adjustments to reconcile to income tax provision:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. state income tax provision, net </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate difference between Domestic and International jurisdictions </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) (3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(138.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S. manufacturing deduction </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation allowances, nonrecurring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Adjustments to accrued income tax liabilities and uncertain tax positions </font><font style="font-family:inherit;font-size:8pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest and penalties on accrued income tax liabilities and uncertain tax positions </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Investment in partnership</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Credits, principally research and orphan drug </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Impairments, nondeductible</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Permanently nondeductible and nontaxable items </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(92.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The statutory tax rate reflects the U.K. statutory tax rate of </font><font style="font-family:inherit;font-size:8pt;">20%</font><font style="font-family:inherit;font-size:8pt;"> for fiscal 2015, and the U.S. federal statutory tax rate of </font><font style="font-family:inherit;font-size:8pt;">35%</font><font style="font-family:inherit;font-size:8pt;"> for fiscal 2014 and 2013.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately </font><font style="font-family:inherit;font-size:8pt;">$2.3 million</font><font style="font-family:inherit;font-size:8pt;"> of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes </font><font style="font-family:inherit;font-size:8pt;">$0.7 million</font><font style="font-family:inherit;font-size:8pt;"> for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately </font><font style="font-family:inherit;font-size:8pt;">$3.6 million</font><font style="font-family:inherit;font-size:8pt;"> of credit related to the period January 1, 2014 through September 26, 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes the impact of nondeductible transaction and separation costs.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by product family within the Company's segments are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.51851851851852%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acthar</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,037.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ofirmev</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">263.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inomax</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exalgo</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">126.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,622.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Hydrocodone (API) and hydrocodone-containing tablets</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">167.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Oxycodone (API) and oxycodone-containing tablets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">154.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">155.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Methylphenidate ER</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">136.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">209.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">148.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other controlled substances</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">572.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">584.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">443.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">221.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,251.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,199.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,011.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">423.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">431.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.</font></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit payments expected to be paid, reflecting future expected service as appropriate, are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2021 - 2025</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">143.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt and equity securities held in rabbi trusts</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration and acquired contingent liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange forward and option contracts</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">197.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">174.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6.5pt;"><font style="font-family:inherit;font-size:6.5pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:6.5pt;"><font style="font-family:inherit;font-size:6.5pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Unobservable Inputs </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt and equity securities held in rabbi trusts</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration and acquired contingent liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange forward and option contracts</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">218.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="85%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">License agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12 years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="54%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 26, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Impairment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Impairment</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,442.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,194.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">207.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,768.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,521.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(119.5</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal year ended September 25, 2015, the gross carrying value of goodwill in the Specialty Brands segment increased by </font><font style="font-family:inherit;font-size:10pt;">$1,247.5 million</font><font style="font-family:inherit;font-size:10pt;">, attributable to </font><font style="font-family:inherit;font-size:10pt;">$792.4 million</font><font style="font-family:inherit;font-size:10pt;"> from the Ikaria Acquisition, </font><font style="font-family:inherit;font-size:10pt;">$437.2 million</font><font style="font-family:inherit;font-size:10pt;"> from the Therakos Acquisition and </font><font style="font-family:inherit;font-size:10pt;">$17.9 million</font><font style="font-family:inherit;font-size:10pt;"> resulting from adjustments to the Questcor Acquisition purchase price allocation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare cost trend assumptions for postretirement benefit plans are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Healthcare cost trend rate assumed for next fiscal year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Rate to which the cost trend rate is assumed to decline</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year the ultimate trend rate is achieved</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Domestic and International components of income from continuing operations before income taxes were as follows</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Domestic </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(107.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(159.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">322.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">215.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are comprised of the following at the end of each period:&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Raw materials and supplies</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">184.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">64.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">281.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">306.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net periodic benefit cost (credit) for the Company's pension and postretirement benefit plans was as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Service cost</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(24.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of net actuarial loss</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.0</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss on plan settlements</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net periodic benefit cost (credit)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.0</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.1</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.3</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2015 (by quarter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q4</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">768.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">819.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">877.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">882.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">404.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">462.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">503.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">482.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">87.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">98.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings per share from continuing operations</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2014 (by quarter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q3 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Q4</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">429.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">448.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">530.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">673.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">216.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">226.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">254.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">363.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(173.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income (loss) from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(178.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(24.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(352.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted earnings per share from continuing operations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following amounts represent the preliminary allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Therakos Acquisition and Ikaria Acquisition and final allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Cadence Acquisition, Questcor Acquisition and CNS Therapeutics acquisition:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td width="36%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Therakos</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Ikaria</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Questcor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cadence</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CNS Therapeutics</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">445.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,170.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,971.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,601.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill (non-tax deductible)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">792.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,789.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">318.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other assets, current and non-current</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">172.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">274.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,714.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,039.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,177.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,700.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">129.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">168.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unpaid purchase consideration (current)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">128.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other liabilities (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">186.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax liabilities, net (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">324.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">623.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,906.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">292.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contingent consideration (non-current)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">344.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,121.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">694.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,786.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,391.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">371.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net assets acquired</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,019.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,253.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,786.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,329.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:72px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:48px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">This amount includes </font><font style="font-family:inherit;font-size:8pt;">$22.0 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$73.8 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$87.3 million</font><font style="font-family:inherit;font-size:8pt;">, </font><font style="font-family:inherit;font-size:8pt;">$14.7 million</font><font style="font-family:inherit;font-size:8pt;"> and </font><font style="font-family:inherit;font-size:8pt;">$3.3 million</font><font style="font-family:inherit;font-size:8pt;"> of accounts receivable for the Therakos Acquisition, Ikaria Acquisition, Questcor Acquisition, Cadence Acquisition, and CNS Therapeutics, respectively, which is also the gross contractual value.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net restructuring and related charges by program within continuing operations are comprised of the following:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013 Mallinckrodt Program</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisition programs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other programs</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total programs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: non-cash charges, including impairments and accelerated share based compensation expense</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(38.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total charges expected to be settled in cash</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="57%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013 Mallinckrodt Program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquisition Programs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Programs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;28, 2012</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.4</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(15.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;27, 2013</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.7</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.4</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(55.0</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;26, 2014</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charges from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.1</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in estimate from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(21.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(44.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassifications </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at September&#160;25, 2015</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected information by geographic area excluding assets held for sale is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,973.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,780.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,421.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe, Middle East and Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">236.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">137.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-lived assets </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">905.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">829.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe, Middle East and Africa </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">994.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">904.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-lived assets are primarily composed of property, plant and equipment.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes long-lived assets located in Ireland of </font><font style="font-family:inherit;font-size:8pt;text-transform:default;">$10.7 million</font><font style="font-family:inherit;font-size:8pt;">, and </font><font style="font-family:inherit;font-size:8pt;text-transform:default;">$0.4 million</font><font style="font-family:inherit;font-size:8pt;"> at the end of fiscal 2015 and 2014, respectively.</font></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected information by business segment is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,622.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,251.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,199.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,011.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">423.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">431.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales of operating segments </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,298.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,044.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,655.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">651.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(50.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(36.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">622.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">617.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">347.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16.7</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Segment operating income</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,339.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">550.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">336.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unallocated amounts:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate and allocated expenses </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(286.9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(228.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(134.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible asset amortization</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(550.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(154.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring and related charges, net </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(40.7</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(81.9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(26.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairments</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(151.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(74.2</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Operating income (loss)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">461.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.9</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Depreciation and amortization </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">559.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation and amortization</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">654.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">249.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amounts represent sales to external customers. There were </font><font style="font-family:inherit;font-size:8pt;">no</font><font style="font-family:inherit;font-size:8pt;"> intersegment sales. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes restructuring-related accelerated depreciation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation for certain shared facilities is allocated based on occupancy percentage.</font></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share option activity and information is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Share Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Remaining Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,760,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">675,921</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.63</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,292,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(878,330</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired/Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(323,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,526,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">635,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">102.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,132,778</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expired/Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(243,135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">58.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Outstanding at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,786,443</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested and unvested expected to vest as of September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,649,351</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercisable at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,054,336</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average assumptions used in the Black-Scholes pricing model for determining the fair value of the share option awards immediately before and immediately after the Separation were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pre- Separation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Post- Separation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected share price volatility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.99</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.99</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected annual dividend per share</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.65</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected life of options (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value per option</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Share option awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,745,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,399,822</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average assumptions used in the Black-Scholes pricing model for shares granted in fiscal 2015, along with the weighted-average grant-date fair value, were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected share price volatility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.72</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.96</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected annual dividend per share</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Expected life of options (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value per option</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The grant-date fair value of RSAs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period. </font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,829,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(390,731</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,432,031</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,362,823</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(34,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34,562</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RSU activity is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">724,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">229,281</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Converted from Questcor Acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(300,237</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(94,838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">589,222</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">273,733</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(219,189</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(71,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">572,494</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at beginning of fiscal year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">165.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrecognized tax benefits retained by Covidien</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(153.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrecognized tax benefits transferred from Covidien</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions related to current year tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions related to prior period tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reductions related to prior period tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(33.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Lapse of statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance at end of fiscal year</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">89.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Statement Schedules.</font><font style="font-family:inherit;font-size:10pt;"> The financial statement schedule is included below. All other schedules have been omitted because they are not applicable, not required or the information is included in the financial statements or notes thereto.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="40%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Schedule II - Valuation and Qualifying Accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at Beginning of Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Charged to Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Additions and Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Deductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at End of Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Allowance for doubtful accounts:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;26, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Sales reserve accounts:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">404.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,187.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,194.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">399.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;26, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">287.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,720.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,634.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">404.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">235.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,171.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,119.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">287.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Tax valuation allowance:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;25, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">155.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">233.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;26, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal year ended September&#160;27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">693.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">691.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#ccecff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">682.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows net sales attributable to distributors that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's total net sales:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">CuraScript, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">McKesson Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cardinal Health, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">AmerisourceBergen Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows accounts receivable attributable to distributors that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's gross accounts receivable at the end of each period: </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;25, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;26, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">McKesson Corporation</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">CuraScript, Inc.</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cardinal Health, Inc.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">AmerisourceBergen Corporation</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table shows net sales attributable to products that accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's total net sales: </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acthar</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acetaminophen products (API)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Methylphenidate ER</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">21.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment and Geographical Data</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior year amounts have been recast to conform to current presentation. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The three reportable segments are further described below:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Specialty Brands</font><font style="font-family:inherit;font-size:10pt;"> produces and markets branded pharmaceuticals and biopharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Specialty Generics</font><font style="font-family:inherit;font-size:10pt;"> produces specialty generic pharmaceuticals and API consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nuclear Imaging</font><font style="font-family:inherit;font-size:10pt;"> manufactures and markets radiopharmaceuticals (nuclear medicine).</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management measures and evaluates the Company's operating segments based on segment net sales and operating income. Management excludes corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include revenues and expenses associated with sales of products to Covidien, intangible asset amortization, net restructuring and related charges, non-restructuring impairments and separation costs. Although these amounts are excluded from segment operating income, as applicable, they are included in reported consolidated and combined operating income and in the following reconciliations. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management manages assets on a total company basis, not by operating segment.&#160; The chief operating decision maker does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.&#160; Total assets were approximately </font><font style="font-family:inherit;font-size:10pt;">$16.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.8 billion</font><font style="font-family:inherit;font-size:10pt;"> at September 25, 2015 and September 26, 2014, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected information by business segment is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net sales:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,622.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,251.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,199.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,011.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">423.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">431.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales of operating segments </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,298.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,044.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,655.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating income:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">651.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(50.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(36.2</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">622.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">617.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">347.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16.7</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Segment operating income</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,339.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">550.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">336.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unallocated amounts:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Corporate and allocated expenses </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(286.9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(228.1</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(134.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible asset amortization</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(550.3</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(154.8</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27.9</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring and related charges, net </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(40.7</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(81.9</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(26.3</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-restructuring impairments</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(151.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Separation costs</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.6</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(74.2</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Operating income (loss)</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">461.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(75.9</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Depreciation and amortization </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">559.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">152.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">81.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation and amortization</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">654.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">249.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amounts represent sales to external customers. There were </font><font style="font-family:inherit;font-size:8pt;">no</font><font style="font-family:inherit;font-size:8pt;"> intersegment sales. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes restructuring-related accelerated depreciation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation for certain shared facilities is allocated based on occupancy percentage.</font></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by product family within the Company's segments are as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.51851851851852%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acthar</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,037.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">122.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ofirmev</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">263.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inomax</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exalgo</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">39.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">126.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Brands</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,622.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">413.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Hydrocodone (API) and hydrocodone-containing tablets</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">167.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Oxycodone (API) and oxycodone-containing tablets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">154.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">155.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Methylphenidate ER</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">136.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">209.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">148.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other controlled substances</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">572.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">584.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">443.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">221.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">150.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Specialty Generics</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,251.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,199.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,011.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nuclear Imaging</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">423.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">431.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">437.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.</font></div></td></tr></table><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selected information by geographic area excluding assets held for sale is as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font><font style="font-family:inherit;font-size:8pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,973.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,780.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,421.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe, Middle East and Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">236.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">250.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">137.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,082.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,712.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-lived assets </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font><font style="font-family:inherit;font-size:8pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">905.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">829.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe, Middle East and Africa </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">994.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">904.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(1)</font><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Long-lived assets are primarily composed of property, plant and equipment.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Includes long-lived assets located in Ireland of </font><font style="font-family:inherit;font-size:8pt;text-transform:default;">$10.7 million</font><font style="font-family:inherit;font-size:8pt;">, and </font><font style="font-family:inherit;font-size:8pt;text-transform:default;">$0.4 million</font><font style="font-family:inherit;font-size:8pt;"> at the end of fiscal 2015 and 2014, respectively.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, the requisite service period (generally the vesting period). For more information about our share-based awards, refer to Note 15.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU activity is as follows </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant-Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 27, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">79,230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance metric adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 26, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">72,740</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.46</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Granted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">125.84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance metric adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Vested</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forfeited</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19,072</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">92.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-vested at September 25, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">130,974</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">96.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)&#160;&#160;&#160;&#160;The number of shares disclosed within this table are at the target number of 100%. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping costs, which are costs incurred to physically move product from the Company's premises to the customer's premises, are classified as selling, general and administrative expenses. Handling costs, which are costs incurred to store, move and prepare product for shipment, are classified as cost of sales. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="96%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for product sales when title and risk of loss have transferred from the Company to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and any related services, based on contract terms or legal requirements in non-U.S. jurisdictions. The Company sells products through independent channels, including directly to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. Chargebacks and rebates represent credits that are provided to certain distributors and customers for either the difference between the Company's contracted price with a customer and the distributor's invoice price paid to the Company or for contractually agreed volume price discounts. When the Company recognizes net sales, it simultaneously records an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of the Company's products and other competitive factors. The Company adjusts these reserves to reflect differences between estimated activity and actual experience. Such adjustments impact the amount of net sales recognized by the Company in the period of adjustment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes collected from customers relating to product sales and remitted to governmental authorities are accounted for on a net basis. Accordingly, such taxes are excluded from both net sales and expenses.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping costs, which are costs incurred to physically move product from the Company's premises to the customer's premises, are classified as selling, general and administrative expenses. Handling costs, which are costs incurred to store, move and prepare product for shipment, are classified as cost of sales. Shipping costs included in selling, general and administrative expenses in continuing operations were </font><font style="font-family:inherit;font-size:10pt;">$42.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$47.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$46.9 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal research and development costs are expensed as incurred. Research and development expenses include salary and benefits, allocated overhead and occupancy costs, clinical trial and related clinical manufacturing costs, contract services and other costs.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upfront and milestone payments made to third parties under license arrangements are expensed as incurred up to the point of regulatory approval of the product. Milestone payments made to third parties upon or subsequent to regulatory approval are capitalized as an intangible asset and amortized to cost of sales over the estimated useful life of the related product.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Currency Translation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company's non-U.S. subsidiaries that transact in a functional currency other than U.S. dollars, assets and liabilities are translated into U.S. dollars using fiscal year-end exchange rates. Revenues and expenses are translated at the average exchange rates in effect during the related month. The net effect of these translation adjustments is shown in the consolidated and combined financial statements as a component of accumulated other comprehensive income. For subsidiaries operating in highly inflationary environments or where the functional currency is different from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date the assets and liabilities were acquired or assumed, while monetary assets and liabilities are translated at fiscal year-end exchange rates. Translation adjustments of these subsidiaries are included in net income. Gains and losses resulting from foreign currency transactions are included in net income. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$30.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> of foreign currency </font><font style="font-family:inherit;font-size:10pt;">gains</font><font style="font-family:inherit;font-size:10pt;">, respectively, were included within net income from continuing operations. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$12.8 million</font><font style="font-family:inherit;font-size:10pt;"> of foreign currency </font><font style="font-family:inherit;font-size:10pt;">losses</font><font style="font-family:inherit;font-size:10pt;"> were included within net income from continuing operations. The Company entered into derivative instruments to mitigate the exposure of movements in certain of these foreign currency transactions and recognized a </font><font style="font-family:inherit;font-size:10pt;">$24.8 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">loss</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2015, a </font><font style="font-family:inherit;font-size:10pt;">$6.3 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">loss</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2014, and a </font><font style="font-family:inherit;font-size:10pt;">$10.1 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">gain</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2013 within net income from continuing operations. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects an estimate of losses inherent in the Company's accounts receivable portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectible. Trade accounts receivable are also presented net of reserves related to chargebacks and non-branded rebates payable to customers for whom we have trade accounts receivable and the right of offset exists. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are recorded at the lower of cost or market value, primarily using the first-in, first-out convention. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete or slow-moving based on changes in customer demand, technology developments or other economic factors.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost. Major renewals and improvements are capitalized, while routine maintenance and repairs are expensed as incurred. Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capitalized software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The Company capitalizes certain computer software and development costs incurred in connection with developing or obtaining software for internal use. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon retirement or other disposal of property, plant and equipment, the cost and related amount of accumulated depreciation are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds is included in net income.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses the recoverability of assets or asset groups using undiscounted cash flows whenever events or circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If an asset or asset group is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value of the asset or asset group and its fair value.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of in-process research and development ("IPR&amp;D") is determined using the discounted cash flow method. In determining the fair value of IPR&amp;D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value attributable to IPR&amp;D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Other Intangible Assets</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill represents the excess of the purchase price of an acquired entity over the amounts assigned to assets and liabilities assumed in a business combination. The Company tests goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The impairment test is comprised of a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. The Company estimates the fair value of its reporting units through internal analyses and valuation, utilizing an income approach (a level three measurement technique) based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, the Company will perform the second step of the goodwill impairment test to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. The implied fair value of goodwill is determined in the same manner that the amount of goodwill recognized in a business combination is determined, with the Company allocating the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of the value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets acquired in a business combination are recorded at fair value, while intangible assets acquired in other transactions are recorded at cost. Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="85%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Completed technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">License agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Trademarks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">to</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense related to completed technology and certain other intangible assets&#160;is included in cost of sales, while amortization expense related to intangible assets that contribute to the Company's ability to sell, market and distribute products is included in selling, general and administrative expenses. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset, or the asset group they are part of, to its carrying value. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets, or the asset group they are part of, with their carrying value. The fair value of the intangible asset, or the asset group they are part of, is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, or the asset group they are part of, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the fair value of the asset. The Company assesses the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. The Company annually tests the indefinite-lived intangible assets for impairment by comparing the fair value of the assets, estimated using an income approach, with their carrying value and records an impairment when the carrying value exceeds the fair value.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various patent, product liability, government investigations, environmental liability and other legal proceedings in the ordinary course of business. The Company records accruals for contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company discounts environmental liabilities using a risk-free rate of return when the obligation is fixed or reasonably determinable. The impact of the discount in the consolidated balance sheets was not material in any period presented. Legal fees, other than those pertaining to environmental and asbestos matters, are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. Assets and liabilities are not netted for financial statement presentation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, the requisite service period (generally the vesting period). For more information about our share-based awards, refer to Note 15.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes for periods prior to the Separation were calculated on a separate tax return basis (inclusive of certain loss benefits), although the Company's operations had historically been included in Covidien's U.S. federal and state tax returns or the tax returns of non-U.S. jurisdictions. Accordingly, the income taxes presented for periods prior to June 28, 2013 do not necessarily reflect the results that would have occurred as an independent, publicly-traded company. With the exception of certain non-U.S. entities, the Company did not maintain taxes payable to or from Covidien and the Company was deemed to settle the annual current tax balances immediately with the legal tax-paying entities in the respective jurisdictions. These settlements were reflected as changes in parent company investment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been reflected in the consolidated and combined financial statements. Deferred tax assets and liabilities are determined based on the differences between the book and tax bases of assets and liabilities and operating loss carryforwards, using tax rates expected to be in effect for the years in which the differences are expected to reverse. A valuation allowance is provided to reduce net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities are also recorded for deferred tax obligations related to installment sale arrangements. The deferral of tax payments to the IRS are subject to interest, which is accrued and included within interest expense.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not expected to be realized on the uncertain tax position, an income tax liability is established. Interest and penalties on income tax obligations, associated with uncertain tax positions, are included in the provision for income taxes.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The calculation of the Company's tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across the Company's global operations. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from current estimates of the tax liabilities. If the Company's estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary. A significant portion of these potential tax liabilities are recorded in other income tax liabilities on the consolidated balance sheets as payment is not expected within one year.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Parent Company Investment</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Parent company investment in periods prior to the Separation represents Covidien's historical investment in the Company, the Company's accumulated net earnings after income taxes for periods prior to that date, and the net effect of transactions with and allocations from Covidien.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Preferred Shares</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mallinckrodt is authorized to issue </font><font style="font-family:inherit;font-size:10pt;">500,000,000</font><font style="font-family:inherit;font-size:10pt;"> preferred shares, par value of </font><font style="font-family:inherit;font-size:10pt;">$0.20</font><font style="font-family:inherit;font-size:10pt;"> per share, </font><font style="font-family:inherit;font-size:10pt;">none</font><font style="font-family:inherit;font-size:10pt;"> of which were issued or outstanding at </font><font style="font-family:inherit;font-size:10pt;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">. Rights as to dividends, return of capital, redemption, conversion, voting and otherwise with respect to these shares may be determined by Mallinckrodt's board of directors on or before the time of issuance. In the event of the liquidation of the Company, the holders of any preferred shares then outstanding would, if issued on such terms that they carry a preferential distribution entitlement on liquidation, be entitled to payment to them of the amount for which the preferred shares were subscribed and any unpaid dividends prior to any payment to the ordinary shareholders.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 23, 2015, the Company's board of directors authorized a program to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the Company's ordinary shares from time to time based on market conditions to allow management to enhance shareholder value. The following table presents the number of shares and dollar amount of repurchases made under the repurchase program by fiscal year and the remaining amount available for repurchase as of September 25, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.95817490494296%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015 Share Repurchase Program</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Authorized repurchase amount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:1px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repurchases:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;Fiscal 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">823,592</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:1px;" rowspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:6px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Remaining amount available</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:left;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:1px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:1px;text-align:right;padding-left:1px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">225.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also repurchases shares from certain employees in order to satisfy employee tax withholding requirements in connection with the vesting of restricted shares. In addition, the Company repurchases shares to settle certain option exercises. The Company spent&#160;</font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> and&#160;</font><font style="font-family:inherit;font-size:10pt;">$17.5 million</font><font style="font-family:inherit;font-size:10pt;">&#160;to acquire shares in connection with equity-based awards in fiscal&#160;2015 and&#160;2014, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90503323836657%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="3%" rowspan="1" colspan="1"></td><td width="97%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">24.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchase &amp; Debt Reduction Authorization</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 19, 2015, the Company's board of directors authorized an increase to our existing </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> share repurchase program previously announced in January 2015. The authorization increased our existing repurchase program by </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> from </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$800.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable and Allowance for Doubtful Accounts</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects an estimate of losses inherent in the Company's accounts receivable portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectible. Trade accounts receivable are also presented net of reserves related to chargebacks and non-branded rebates payable to customers for whom we have trade accounts receivable and the right of offset exists. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;25, 2015</font><font style="font-family:inherit;font-size:10pt;">, such obligations were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="89%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">125.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">51.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fiscal 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ from those estimates. </font></div></div> Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations. Includes restructuring-related accelerated depreciation. For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof. The number of shares disclosed within this table are at the target number of 100%. Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland. Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds. Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013. Includes long-lived assets located in Ireland of $10.7 million, and $0.4 million at the end of fiscal 2015 Includes the impact of nondeductible transaction and separation costs. Depreciation for certain shared facilities is allocated based on occupancy percentage. Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business. Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business. Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K. Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions. These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note 13 for additional details. Amounts represent sales to external customers. There were no intersegment sales. The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014 and 2013. Long-lived assets are primarily composed of property, plant and equipment. During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately $2.3 million of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014. Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation. Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments. EX-101.SCH 9 mnk-20150925.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2121100 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Acquisitions and License Agreements link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Acquisitions and License Agreements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) link:presentationLink link:calculationLink link:definitionLink 2404406 - Disclosure - Acquisitions and License Agreements (Schedule of Financial Results and Acquisition Costs of Acquirees) (Details) link:presentationLink link:calculationLink link:definitionLink 2404408 - Disclosure - Acquisitions and License Agreements (Schedule of Intangible Asset Amortization by Acquiree) (Details) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) link:presentationLink link:calculationLink link:definitionLink 2404407 - Disclosure - Acquisitions and License Agreements (Schedule of Pro Forma Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Acquisitions and License Agreements (Schedule of Reconciliation of Total Consideration) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Acquisitions and License Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Background and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Background and Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Background and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Commitments and Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2425404 - Disclosure - Commitments and Contingencies (Schedule of Asset Retirement Obligations) (Details) link:presentationLink link:calculationLink link:definitionLink 2425405 - Disclosure - Commitments and Contingencies (Schedule of Minimum Lease Payments for Non-cancelable Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - Commitments and Contingencies (Schedule of Purchase Oligations) (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2130100 - Disclosure - Condensed Consolidating and Combining Financial Statements link:presentationLink link:calculationLink link:definitionLink 2430402 - Disclosure - Condensed Consolidating and Combining Financial Statements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2430405 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Cash Flows) (Details) link:presentationLink link:calculationLink link:definitionLink 2430404 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2430403 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating Balance Sheets) (Details) link:presentationLink link:calculationLink link:definitionLink 2330301 - Disclosure - Condensed Consolidating and Combining Financial Statements (Tables) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated and Combined Statement of Changes in Shareholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated and Combined Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated and Combined Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - Consolidated and Combined Statements of Comprehensive Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated and Combined Statements of Income link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated and Combined Statements of Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Debt (Schedule of Long term debt and Capital lease obligation) (Details) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Debt (Schedule of Maturities of Long-term Debt including Capital Lease Obligation) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Discontinued Operations and Divestitures link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Discontinued Operations and Divestitures (Assets and Liabilities Held-for-Sale) (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Discontinued Operations and Divestitures (Income (loss) from Discontinued Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Discontinued Operations and Divestitures (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Discontinued Operations and Divestitures, Significant Cash and Non-Cash Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Discontinued Operations and Divestitures (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Earnings (Loss) per Share link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Earnings (Loss) per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2208201 - Disclosure - Earnings (Loss) per Share (Policies) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Earnings (Loss) per Share Schedule of Earnings per Share Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 2308302 - Disclosure - Earnings (Loss) per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Equity Equity link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Equity Stock Repurchase Program (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - Financial Instruments and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - Financial Instruments and Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2327301 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Goodwill and Intangible Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Goodwill and Intangible Assets (Schedule of Future Amortization Expense, Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Goodwill and Intangible Assets (Schedule Of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Goodwill and Intangible Assets (Schedule Of Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Guarantees link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - Guarantees (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Income Taxes (Schedule of Components of Income from Continuing Operations Before Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2406410 - Disclosure - Income Taxes (Schedule of Deferred Taxes Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2406410 - Disclosure - Income Taxes (Schedule of Deferred Taxes Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2406411 - Disclosure - Income Taxes (Schedule of Deferred Taxes Balance Sheet Location) (Details) link:presentationLink link:calculationLink link:definitionLink 2406409 - Disclosure - Income Taxes (Schedule of Income Tax Receivables and Other Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2406408 - Disclosure - Income Taxes (Schedule of Income Taxes Payable) (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Income Taxes (Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Income Taxes (Schedule of Significant Components of Income Taxes Related to Continuing Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefit Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2406407 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Balance Sheet Location) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Property, Plant and Equipment (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Recently Issued Accounting Standards Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Restructuring and Related Charges link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Restructuring and Related Charges (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Restructuring and Related Charges (Schedule of Net Restructuring and Related Charges) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring and Related Charges by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2405406 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring Charges Incurred Cumulative to Date) (Details) link:presentationLink link:calculationLink link:definitionLink 2405405 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring Reserves by Type of Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Restructuring and Related Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Retirement Plans link:presentationLink link:calculationLink link:definitionLink 2413412 - Disclosure - Retirement Plans (Defined Contribution Plan) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Retirement Plans Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413408 - Disclosure - Retirement Plans (Schedule of Actuarial Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Retirement Plans (Schedule of Amounts Recognized in Balance Sheet) (Details) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - Retirement Plans (Schedule of Amounts to be Amortized From Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Retirement Plans (Schedule of Benefit Obligation, Plan Assets and Funded Status of Plans) (Details) link:presentationLink link:calculationLink link:definitionLink 2413411 - Disclosure - Retirement Plans (Schedule of Expected Benefit Payments) (Details) link:presentationLink link:calculationLink link:definitionLink 2413410 - Disclosure - Retirement Plans (Schedule of Fair Value of Plan Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Retirement Plans (Schedule of Net Periodic Benefit Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Retirement Plans (Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2413409 - Disclosure - Retirement Plans (Schedule of Weighted Average Allocation of Plan Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Retirement Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2432401 - Schedule - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2132100 - Schedule - Schedule II - Valuation and Qualifying Accounts (Notes) link:presentationLink link:calculationLink link:definitionLink 2427405 - Disclosure - (Schedule of Carrying Amount and Fair Value of Long-term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2427403 - Disclosure - (Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 2427404 - Disclosure - (Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration) (Details) link:presentationLink link:calculationLink link:definitionLink 2427406 - Disclosure - (Schedules of Concentration of Risk) (Details) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Segment and Geographical Data link:presentationLink link:calculationLink link:definitionLink 2428404 - Disclosure - Segment and Geographical Data (Schedule of Net Sales and Long-Lived Assets by Geographic Area) (Details) link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - Segment and Geographical Data (Schedule of Net Sales from External Costumers by Product) (Details) link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - Segment and Geographical Data (Schedule of Segment Reporting Information by Business Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - Segment and Geographical Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2129100 - Disclosure - Selected Quarterly Financial Data (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2429402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2329301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Share Plans link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Share Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2415409 - Disclosure - Share Plans (Schedule of Fair Value Assumptions for Performance Share Unit) (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Share Plans (Schedule of Incentive Equity Awards Issued Upon Completion of Conversion) (Details) link:presentationLink link:calculationLink link:definitionLink 2415408 - Disclosure - Share Plans (Schedule of Performance Share Unit Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2415407 - Disclosure - Share Plans (Schedule of Restricted Share Unit Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2415410 - Disclosure - Share Plans (Schedule of Restricted Stock Award Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2415406 - Disclosure - Share Plans (Schedule of Share Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Share Plans (Schedule of Share Option Award Status Upon Completion of the Conversion) (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Share Plans (Schedule of the Valuation Assumptions Used in the Conversion) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Share Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2131100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2431401 - Disclosure - Subsequent Events (Subsequent Events) (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Transactions with Former Parent Company link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Transactions with Former Parent Company (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 mnk-20150925_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 mnk-20150925_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 mnk-20150925_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Inventory, Net [Abstract] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Condensed Consolidating Financial Statements [Abstract] Condensed Consolidating Financial Statements [Abstract] Condensed Financial Statements [Table] Condensed Financial Statements [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Mallinckrodt plc Parent Company [Member] Mallinckrodt International Finance S.A. Subsidiary Issuer [Member] Other Subsidiaries Non-Guarantor Subsidiaries [Member] Eliminations Consolidation, Eliminations [Member] Condensed Consolidating Financial Statements Condensed Financial Statements, Captions [Line Items] Cash Flows From Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash Flows From Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Acquisitions and intangibles, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Intercompany Loan Investment Intercompany Loan Investment Intercompany Loan Investment Subsidiary dividend proceeds Proceeds From Subsidiary Dividends Proceeds From Subsidiary Dividends Investment in subsidiary Payments to Acquire Equity Method Investments Restricted cash Increase (Decrease) in Restricted Cash Other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash Flows From Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Issuance of external debt Proceeds from Issuance of Debt Repayment of capital leases Repayments of Long-term Capital Lease Obligations Excess tax benefit from share-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Debt financing costs Payments of Financing Costs Net transfers to parent Payments of Distributions to Affiliates Proceeds from exercise of share options Proceeds from Stock Options Exercised Subsidiary dividend payment Payment of Subsidiary Dividend Payment of Subsidiary Dividend Intercompany loan borrowings Proceeds From Intercompany Borrowings Proceeds From Intercompany Borrowings Capital contribution Proceeds from Contributed Capital Repurchase of ordinary shares, value Stock Repurchased During Period, Value Other Proceeds from (Payments for) Other Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Effect of currency rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Debt Disclosure [Abstract] Schedule of Long-term Debt including Capital Lease Obligation Schedule of Long-term Debt including Capital Lease Obligation [Table Text Block] [Table Text Block] for Schedule of Long-term Debt including Capital Lease Obligation [Table] Schedule of Maturities of Long-term Debt including Capital Lease Obligation Schedule of Maturities of Long-term Debt including Capital Lease Obligation [Table Text Block] Schedule of Maturities of Long-term Debt including Captial Lease Obligation [Table Text Block] Compensation and Retirement Disclosure [Abstract] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Covidien Covidien Plc [Member] Covidien plc [Member] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Pension Benefits Pension Plan [Member] Postretirement Benefits Other Postretirement Benefit Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Fiscal 2016 Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months Fiscal 2017 Defined Benefit Plan, Expected Future Benefit Payments, Year Two Fiscal 2018 Defined Benefit Plan, Expected Future Benefit Payments, Year Three Fiscal 2019 Defined Benefit Plan, Expected Future Benefit Payments, Year Four Fiscal 2020 Defined Benefit Plan, Expected Future Benefit Payments, Year Five Fiscal 2021-2025 Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter Income Tax Disclosure [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Discontinued Operations, Held-for-sale Discontinued Operations, Held-for-sale [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Parent Company Investment Parent Company Investment [Member] Parent Company Investment [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Internal Revenue Service (IRS) Internal Revenue Service (IRS) [Member] U.S. - Federal and State U.S. Federal and State Jursidictions [Member] IRS, State and Local Jursidictions [Member] IRELAND IRELAND Foreign Tax Authority Foreign Tax Authority [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Ikaria Ikaria [Member] Ikaria [Member] Therakos Therakos [Member] Therakos Cadence Pharmaceuticals, Inc. Cadence Pharmaceuticals, Inc. [Member] Cadence Pharmaceuticals, Inc. [Member] Questcor Pharmaceuticals, Inc. Questcor Pharmaceuticals, Inc. [Member] Questcor Pharmaceuticals, Inc. [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Ofirmev Ofirmev [Member] Ofirmev [Member] Acthar H. P. Acthar Gel [Member] H. P. Acthar Gel Income Taxes [Line Items] Income Taxes [Line Items] [Line Items] for Income Taxes [Table] Operating loss carryforward Operating Loss Carryforwards Tax credit carryforward Tax Credit Carryforward, Amount Tax Credit Carryforward Utilization Tax Credit Carryforward Utilization Tax Credit Carryforward Utilization Income Tax Holiday, Aggregate Dollar Amount Income Tax Holiday, Aggregate Dollar Amount Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Increase (Decrease) Tax Benefit, Jurisdiction Rate Difference Increase (Decrease) Tax Benefit, Jurisdiction Rate Difference Increase (Decrease) Tax Expense (Benefit), Jurisdiction Rate Difference Increase (Decrease) Tax Expense (Benefit), Change in Operating Income Increase (Decrease) Tax Expense (Benefit), Change in Operating Income Increase (Decrease) Tax Expense (Benefit), Change in Operating Income Increase (Decrease) Tax Expense (Benefit) Due to Amortization of Intangible Assets Increase (Decrease) Tax Expense (Benefit) Due to Amortization of Intangible Assets Increase (Decrease) Tax Expense (Benefit) Due to Amortization of Intangible Assets Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions Increase (Decrease) Tax Expense (Benefit), Other Increase (Decrease) Tax Expense (Benefit), Other Increase (Decrease) Tax Expense (Benefit), Other Increase (Decrease) In Prepaid Taxes, Installment Sale Increase (Decrease) In Prepaid Taxes, Installment Sale Increase (Decrease) In Prepaid Taxes, Installment Sale Unrecognized tax benefits that would require cash remittance if not sustained Unrecognized Tax Benefits For Which the Company is Legally and Directly Liable and Would be Required to Remit Cash if Not Sustained Unrecognized Tax Benefits For Which the Company is Legally and Directly Liable and Would be Required to Remit Cash if Not Sustained Advance payment in connection with proposed settlements of certain tax matters Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement Advance payment in connection with proposed settlement of certain tax matters, tax payment Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement, Tax Payment Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement, Tax Payment Advance payment in connection with proposed settlement of certain tax matters, interest payment Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement, Interest Payment Unrecognized Tax Benefits, Cash Advance Paid in Connection with Proposed Settlement, Interest Payment Unrecognized tax benefits, which if favorably settled would benefit the effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Interest expense on unrecognized tax benefits Unrecognized Tax Benefits, Interest on Income Taxes Expense Released tax interest Unrecognized Tax Benefits, Interest on Income Taxes Release Unrecognized Tax Benefits, Interest on Income Taxes Release Tax years that remain subject to examination Income Tax Examination, Year under Examination Interest accrued on unrecognized tax benefits Unrecognized Tax Benefits, Interest on Income Taxes Accrued Decrease in Unrecognized Tax Benefits is Reasonably Possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Income tax penalties and interest accrued that would impact effective tax rate, upper bound of change Significant Change in Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued That Would Impact Effective Tax Rate, Estimated Range of Change, Upper Bound Significant Change in Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued That Would Impact Effective Tax Rate, Estimated Range of Change, Upper Bound Tax payments associated with non-current deferred intercompany transactions Deferred Tax Asset, Intercompany Transaction, Non-current Deferred Tax Asset, Intercompany Transaction, Non-current Income Taxes Receivable Income Taxes Receivable Tax payments associate with current deferred intercompany transactions Deferred Tax Asset, Intercompany Transaction, Current Deferred Tax Asset, Intercompany Transaction, Current Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Deferred income taxes Deferred Tax Assets, Net, Current Deferred income taxes (non-current liability) Deferred Tax Liabilities, Net, Noncurrent Deferred Tax Liabilities, Net Deferred Tax Liabilities, Net Increase (decrease), deferred tax liability Increase (Decrease), Deferred Tax Liability, Net, Noncurrent Increase (Decrease), Deferred Tax Liability, Net, Noncurrent Increase (Decrease), Deferred Tax Liability Due to Amortization of Intangible Assets Increase (Decrease), Deferred Tax Liability Due to Amortization of Intangible Assets Increase (Decrease), Deferred Tax Liability Due to Amortization of Intangible Assets Deferred tax assets, tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Deferred tax assets, valuation allowance Deferred Tax Assets, Valuation Allowance Increase (decrease) deferred tax liability due to installment sale Increase (Decrease) in Deferred Tax Liability, Installment Sales Deferred Tax Liabilities, Installment Sales Increase (Decrease) Deferred Tax Charge, Installment Sale Increase (Decrease) Deferred Tax Charge, Installment Sale Increase (Decrease) Deferred Tax Charge Increase (decrease) deferred tax asset resulting from installment sale transaction Increase (Decrease) Deferred Tax Liability Resulting From Installment Sale Transaction Increase (Decrease) Deferred Tax Liability Resulting From Installment Sale Transaction Deferred tax liabilities, intangible assets Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Assets, Tax Credit Carryforwards, Foreign Deferred Tax Assets, Tax Credit Carryforwards, Foreign Deferred Tax Asset, Financing Payment Deferred Tax Assets, Other Deferred Tax Assets, Operating Loss Carryforwards, Foreign Deferred Tax Assets, Operating Loss Carryforwards, Foreign Increase (Decrease) in Deferred Tax Liability, Intangible Assets Increase (Decrease) in Deferred Tax Liability, Intangible Assets Increase (Decrease) in Deferred Tax Liability, Intangible Assets Increase (Decrease), Deferred Tax Liability, Net Increase (Decrease), Deferred Tax Liability, Net Increase (Decrease), Deferred Tax Liability, Net Operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Operating loss carryforwards, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Tax credit carryforwards, not subject to expiration Tax Credit Carryforwards, Not Subject to Expiration Tax Credit Carryforwards, Not Subject to Expiration Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Deferred Tax Liabilities, Undistributed Foreign Earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Undistributed Earnings Undistributed Earnings of Foreign Subsidiaries Business Combinations [Abstract] Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Reconciliation of Total Consideration Business Combination, Reconciliation of Total Consideration [Table Text Block] Business Combination, Reconciliation of Total Consideration [Table Text Block] Schedule of Earnings by Acquiree Business Combination, Earnings By Acquiree Allocation [Table Text Block] Business Combination, Earnings By Acquiree Allocation [Table Text Block] Schedule of Acquisition Cost Business Combination, Acquisition Cost [Table Text Block] Business Combination, Acquisition Cost [Table Text Block] Business Combination Intangible Asset Amortization By Acquiree [Table Text Block] Business Combination Intangible Asset Amortization By Acquiree [Table Text Block] Business Combination Intangible Asset Amortization By Acquiree [Table Text Block] Schedule of Intangible Assets Acquired Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Purchase Obligations Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block] Schedule of Asset Retirement Obligations Schedule of Change in Asset Retirement Obligation [Table Text Block] Schedule of Minimum Lease Payments for Non-cancelable Leases Schedule of Future Minimum Lease Payments for Operating and Capital Leases [Table Text Block] Schedule of Future Minimum Lease Payments for Operating and Capital Leases [Table Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Recurring Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Debt and equity securities held in rabbi trusts Investments, Fair Value Disclosure Total assets at fair value Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Deferred compensation liabilities Deferred Compensation Liabilities, Fair Value Disclosure This element represents deferred compensation, measured at fair value on a recurring basis Contingent consideration Business Combination, Contingent Consideration, Liability Foreign exchange forward and option contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Total liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Hydrocodone (API) and hydrocodone-containing tablets Methylphenidate ER HCl (Generics) [Member] Methylphenidate ER HCl (Generics) [Member] Oxycodone (API) and oxycodone-containing tablets Oxycodone (API) [Member] Oxycodone (API) [Member] Methylphenidate ER Hydrocodone (API) [Member] Hydrocodone (API) [Member] Other controlled substances Other Controlled Substances [Member] Other Controlled Substances [Member] Other Other Products [Member] Other Products [Member] Exalgo Exalgo [Member] Exalgo [Member] Ofirmev Offirmev [Member] Offirmev [Member] Acthar Inomax Inomax [Member] Inomax [Member] Other Other Products 2 [Member] Other Products 2 [Member] 2013 Mallinckrodt program Restructuring Fiscal 2013 Plan [Member] Restructuring Fiscal 2013 Plan [Member] [Member] Continuing Operations Continuing Operations [Member] Nuclear Imaging Nuclear Imaging [Member] Nuclear Imaging [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Specialty Generics [Member] Specialty Generics [Member] Specialty Generics [Member] Specialty Brands [Member] Specialty Brands [Member] Specialty Brands [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Net sales Sales Revenue, Goods, Net Deferred income taxes (current asset) Other non-current assets Deferred Tax Assets, Net, Noncurrent Accrued and other current liabilities Deferred Tax Liabilities, Net, Current Deferred income taxes (non-current liability) Net deferred tax (liability) Deferred Tax Assets, Net Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Performance Shares Performance Shares [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Expected stock price volatility Fair Value Assumptions, Expected Volatility Rate Peer group stock price volatility Fair Value Assumptions, Peer Expected Volatility Rate Fair Value Assumptions, Peer Expected Volatility Rate Correlation of returns Fair Value Assumptions, Returns Correlation Rate Fair Value Assumptions, Returns Correlation Rate Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Domestic Current Federal Tax Expense (Benefit) International Current Foreign Tax Expense (Benefit) Current income tax provision Current Income Tax Expense (Benefit) Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Domestic Deferred Federal Income Tax Expense (Benefit) International Deferred Foreign Income Tax Expense (Benefit) Deferred income tax (benefit) provision Deferred Income Tax Expense (Benefit) Provision for (benefit from) income taxes Income Tax Expense (Benefit) Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Letter of Credit Letter of Credit [Member] Line of Credit Line of Credit [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Prior To April 15, 2018 Prior To April 15, 2018 [Member] Prior To April 15, 2018 [Member] Revolving Credit Facility Revolving Credit Facility [Member] 2015 Replacement Revolving Credit Facility 2015 Replacement Revolving Credit Facility [Member] 2015 Replacement Revolving Credit Facility 2015 Incremental Revolving Credit Facility 2015 Incremental Revolving Credit Facility [Member] 2015 Incremental Revolving Credit Facility 2015 Revolving Credit Facility 2015 Revolving Credit Facility [Member] 2015 Revolving Credit Facility Debentures Unsecured Debt [Member] Prior To April 15, 2017 Prior To October 15, 2018 [Member] Prior To October 15, 2018 [Member] Senior Notes Senior Notes [Member] Secured Debt Secured Debt [Member] Prior to August 1, 2017 Prior To August 1, 2017 [Member] Prior To August 1, 2017 [Member] Option A Option A [Member] Option A [Member] Option B Option B [Member] Option B [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 3.50% notes due April 2018 Three Point Five Percent Note [Member] Three Point Five Percent Note [Member] 4.75% notes due April 2023 Four Point Seven Five Percent Note [Member] Four Point Seven Five Percent Note [Member] Unsecured Notes [Member] Unsecured Notes [Member] Unsecured Notes [Member] 5.625% notes due October 2023 Five Point Six Two Five Percent Note [Member] Five Point Six Two Five Percent Note [Member] Term Loan Term Loan [Member] Term Loan [Member] Term loan due March 2021 Term Loan Due March 2021 [Member] Term Loan Due March 2021 [Member] Variable rate receivable securitization Receivable Securitization, Maturity Date of July 2017 [Member] Receivable Securitization, Maturity Date of July 2017 [Member] 5.75% notes due August 2022 Five Point Seven Five Percent Notes [Member] Five Point Seven Five Percent Notes [Member] New Term Loan New Term Loan [Member] New Term Loan [Member] Term Loan and New Term Loan Term Loan and New Term Loan [Member] Term Loan and New Term Loan [Member] 2020 Notes 2020 Notes [Member] 2020 Notes [Member] Descriptor of senior notes with 2020 maturity date. 2023 Notes 2023 Notes [Member] 2023 Notes [Member] 2025 Notes 2025 Notes [Member] [Member] 2025 Notes [Member] Descriptor of senior notes with 2025 maturity date. Debt Instrument [Line Items] Debt Instrument [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Aggregate net proceeds Proceeds from Issuance of Long-term Debt Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Frequency of interest payment Debt Instrument, Periodic Payment, Interest, Frequency Debt Instrument, Periodic Payment, Interest, Frequency Debt Instrument, Periodic Payment, Percentage of Principal Debt Instrument, Periodic Payment, Percentage of Principal Debt Instrument, Periodic Payment, Percentage of Principal Debt instrument, unamortized discount Debt Instrument, Unamortized Discount Provision for other credit losses Provision for Other Credit Losses Line Of Credit Facility, Future Contingent Maximum Borrowing Capacity Line Of Credit Facility, Future Contingent Maximum Borrowing Capacity Line Of Credit Facility, Future Contingent Maximum Borrowing Capacity Facility fees for letters of credit Line of Credit Facility, Commitment Fee Percentage Variable interest rate Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Redemption Price, Percentage Debt Instrument, Redemption Price, Percentage Quarterly amortization payments Long-term Loans Payable, Periodic Amortization Payment, Percentage of Original Principal Amount Long-term Loans Payable, Periodic Amortization Payment, Percentage of Original Principal Amount Debt instrument, discount percentage Debt Instrument, Discount Percentage Debt Instrument, Discount Percentage Borrowings, outstanding Long-term Line of Credit Interest rate during period Line of Credit Facility, Interest Rate During Period Variable rate receivable securitization Variable Rate Receivable Securitization Variable Rate Receivable Securitization Repurchase percentage Debt Instrument, Repurchase Percentage Debt Instrument, Repurchase Percentage Long-term Debt Long-term Debt Defined Contribution Plan [Table] Defined Contribution Plan [Table] Defined Contribution Plan Type [Axis] Defined Contribution Plan Type [Axis] Defined Contribution Plan Type [Domain] Defined Contribution Plan Type [Domain] Defined Contribution Plan Name [Axis] Defined Contribution Plan Name [Axis] Defined Contribution Plan Name [Domain] Defined Contribution Plan Name [Domain] Defined Contribution Plan, 401 K [Member] Defined Contribution Plan, 401 K [Member] Defined Contribution Plan, 401 K [Member] Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Defined Contribution Plan, Cost Recognized Defined Contribution Plan, Cost Recognized Deferred tax assets: Deferred Tax Assets, Gross [Abstract] Accrued liabilities and reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Inventories Deferred Tax Assets, Inventory Tax loss and credit carryforwards Environmental liabilities Deferred Tax Assets, Environmental Liabilities Deferred Tax Assets, Environmental Liabilities Rebate reserves Deferred Tax Assets, Reserves and Accruals, Rebate Reserves Deferred Tax Assets, Reserves and Accruals, Rebate Reserves Expired product Deferred Tax Assets, Expired Product Deferred Tax Assets, Expired Product Postretirement benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits Federal and state benefit of uncertain tax positions and interest Deferred Tax Assets, Federal and State Benefit of Uncertain Tax Positions and Interest Deferred Tax Assets, Federal and State Benefit of Uncertain Tax Positions and Interest Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation Other Total deferred tax assets, gross Deferred Tax Assets, Gross Deferred Tax Assets, Goodwill and Intangible Assets Deferred Tax Assets, Goodwill and Intangible Assets Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Property, plant and equipment Intangible assets Installment sale Investment in partnership Deferred Tax Liabilities, Investment in Wholly Owned Subsidiaries Deferred Tax Liabilities, Investment in Wholly Owned Subsidiaries Total deferred tax liabilities, gross Deferred Tax Liabilities, Gross Net deferred tax (liability) before valuation allowances Net Deferred Tax Assets, before Valuation Allowances Net Deferred Tax Assets, before Valuation Allowances Valuation allowances Recently Issued Accounting Pronouncements [Abstract] Recently Issued Accounting Pronouncements [Abstract] Recently Issued Accounting Standards Recently Issued Accounting Standards [Text Block] Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting. Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Intangible Assets Schedule Of Intangible Assets [Table Text Block] Tabular disclosure of intangible assets. Schedule of Future Amortization Expense, Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Asset Retirement Obligation [Roll Forward] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Beginning Balance Asset Retirement Obligation Additions and adjustments Asset Retirement Obligation, Period Increase (Decrease) Accretion expense Asset Retirement Obligation, Accretion Expense Payments Asset Retirement Obligation, Cash Paid to Settle Currency translation Asset Retirement Obligation, Foreign Currency Translation Ending Balance Quarterly Financial Information Disclosure [Abstract] Selected Quarterly Financial Data (Unaudited) Quarterly Financial Information [Text Block] Assets Assets [Abstract] Current Assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net Accounts Receivable, Net, Current Inventories Inventory, Net Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Current assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Intercompany receivable Current Intercompany Receivables Current Intercompany Receivables Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Long-term assets held for sale Disposal Group, Including Discontinued Operation, Assets, Noncurrent Investment in subsidiaries Equity Method Investments Intercompany loan receivable Intercompany Loan Receivables Intercompany Loan Receivables Other assets Other Assets, Noncurrent Total Assets Assets Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Current Liabilities: Liabilities, Current [Abstract] Current maturities of long-term debt Long-term Debt and Capital Lease Obligations, Current Accounts payable Accounts Payable, Current Accrued payroll and payroll-related costs Employee-related Liabilities, Current Accrued royalties Accrued Royalties, Current Accrued and other current liabilities Other Liabilities, Current Current liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Intercompany payable Current Intercompany Payables Current Intercompany Payables Total current liabilities Liabilities, Current Long-term debt Long-term Debt and Capital Lease Obligations Pension and postretirement benefits Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent Environmental liabilities Accrued Environmental Loss Contingencies, Noncurrent Deferred income taxes Other income tax liabilities Other Non Current Income Tax Liabilities Noncurrent income tax liabilities, excluding deferred taxes Long-term liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent Intercompany loans payable Intercompany Loan Payable Intercompany Loan Payable Other liabilities Other Liabilities, Noncurrent Total Liabilities Liabilities Shareholders' equity Stockholders' Equity Attributable to Parent Total Liabilities and Shareholders' Equity Liabilities and Equity Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Ordinary Shares Common Stock [Member] Treasury Shares Treasury Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Retained Earnings Retained Earnings [Member] Contributed Surplus Other Additional Capital [Member] Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance, shares Shares, Outstanding Beginning balance, value Net income (loss) Net Income (Loss) Attributable to Parent Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Change in derivatives, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent Minimum pension liability, net of tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax, Portion Attributable to Parent Net transfers to parent Stockholders' Equity, Net Transfer to Parent Stockholders' Equity, Net Transfer to Parent Separation related adjustments Stockholders' Equity, Separation Related Adjustment Stockholders' Equity, Separation Related Adjustment Transfer of parent company investment to contributed surplus Stockholders' Equity, Transfer of Parent Company Investment to Contributed Surplus Stockholders' Equity, Transfer of Parent Company Investment to Contributed Surplus Transfer of contributed surplus to distributable reserves Stockholders' Equity, Transfer of Contributed Surplus to Distributable Reserves Stockholders' Equity, Transfer of Contributed Surplus to Distributable Reserves Ordinary shares issued in connection with the Questcor acquisition, shares Stock Issued During Period, Shares, Acquisitions Ordinary shares issued in connection with the Questcor acquisition, value Stock Issued During Period, Value, Acquisitions Share options exercised, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share options exercised, value Stock Issued During Period, Value, Stock Options Exercised Vesting of restricted shares, shares Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Vesting of restricted shares, value Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Shares canceled, shares Restricted Stock Award, Shares, Canceled Restricted Stock Award, Shares, Canceled Shares canceled, value Restricted Stock Award, Value, Canceled Restricted Stock Award, Value, Canceled Excess tax benefit from share-based compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Repurchase of ordinary shares, shares Stock Repurchased During Period, Shares Issuance of ordinary shares, shares Stock Issued During Period, Shares, New Issues Issuance of ordinary shares, value Stock Issued During Period, Value, New Issues Ending balance, shares Ending balance, value Inventories Inventory Disclosure [Text Block] Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Specialty Pharmaceuticals Specialty Pharmaceuticals [Member] Specialty Pharmaceuticals [Member] Corporate Corporate Segment [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Total restructuring and related charges Total Restructuring And Related Expense Total restructuring and related expense Less: accelerated depreciation Restructuring and Related Cost, Accelerated Depreciation Restructuring charges, net Restructuring Charges Fiscal 2016 Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months Fiscal 2017 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two Fiscal 2018 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three Fiscal 2019 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four Fiscal 2020 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five Schedule of Long-term Debt including Capital Lease Obligation [Table] Schedule of Long-term Debt including Capital Lease Obligation [Table] Debentures Debentures [Member] Debentures [Member] Capital Lease Obligations Capital Lease Obligations [Member] 8.00% debentures due March 2023 Eight Percent Debenture [Member] Eight Percent Debenture [Member] 2.85% term loan due April 2016 Two Point Eight Five Percent Term Loan [Member] Two Point Eight Five Percent Term Loan [Member] Term loans due March 2021 4.00% term loan due February 2022 Four Point Zero Zero Percent Term Loan [Member] Four Point Zero Zero Percent Term Loan [Member] 9.50% debentures due May 2022 Nine Point Five Percent Debenture [Member] Nine Point Five Percent Debenture [Member] 5.50% notes due April 2025 Schedule of Long-term Debt including Capital Lease Obligation [Line Items] Schedule of Long-term Debt including Capital Lease Obligation [Line Items] [Line Items] for Schedule of Long-term Debt including Capital Lease Obligation [Table] Current maturities of long-term debt: Long-term Debt, Current Maturities [Abstract] Long-term Debt, Current Maturities Long-term Debt, Current Maturities Capital lease obligation and vendor financing agreements Capital Lease Obligations, Current Long-term debt: Long-term Debt, Excluding Current Maturities [Abstract] Long-term Debt, Gross Long-term Debt, Gross Unamortized Debt Issuance Expense and Discount Unamortized Debt Issuance Expense and Discount Unamortized Debt Issuance Expense and Discount Capital Lease Obligations, Noncurrent Capital Lease Obligations, Noncurrent Debt, Long-term and Short-term, Combined Amount Debt, Long-term and Short-term, Combined Amount Change in benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Projected benefit obligations at beginning of year Defined Benefit Plan, Benefit Obligation Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Employee contributions Defined Benefit Plan, Contributions by Plan Participants Actuarial (gain) loss Defined Benefit Plan, Actuarial Gain (Loss) Benefits and administrative expenses paid Defined Benefit Plan, Benefits Paid Plan settlements Defined Benefit Plan, Settlements, Benefit Obligation Net transfer in/(out) Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation Currency translation Defined Benefit Plan, Foreign Currency Exchange Rate Gain (Loss) Projected benefit obligations at end of year Change in plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Fair value of plan assets at beginning of year Defined Benefit Plan, Fair Value of Plan Assets Actual return on plan assets Defined Benefit Plan, Actual Return on Plan Assets Employer contributions Defined Benefit Plan, Contributions by Employer Employee contributions Benefits and administrative expenses paid Plan settlements Defined Benefit Plan, Settlements, Plan Assets Currency translation Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Plan Assets Fair value of plan assets at end of year Funded status at end of year Defined Benefit Plan, Funded Status of Plan Statement of Financial Position [Abstract] Current Assets: Cash and cash equivalents Accounts receivable, less allowance for doubtful accounts of $4.7 and $3.7 Prepaid expenses and other current assets Other Assets, Current Total current assets Property, plant and equipment, net Total Assets Liabilities and Shareholders' Equity Current Liabilities: Accrued payroll and payroll-related costs Accrued and other current liabilities Total current liabilities Long-term debt Pension and postretirement benefits Environmental liabilities Total Liabilities Shareholders' Equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding Preferred Stock, Value, Outstanding Ordinary A shares, €1.00 par value, 40,000 authorized; none issued or outstanding Ordinary A Shares Value Outstanding Ordinary A Shares Value Outstanding Ordinary shares, $0.20 par value, 500,000,000 authorized; 117,513,370 and 116,160,353 issued; 116,283,149 and 115,929,588 outstanding Common Stock, Other Value, Outstanding Ordinary shares held in treasury at cost, 1,230,221 and 230,765 Treasury Stock, Value Additional paid-in capital Additional Paid in Capital Retained earnings (deficit) Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Total Shareholders' Equity Total Liabilities and Shareholders' Equity Property, Plant and Equipment [Abstract] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Income Taxes Income Tax Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Unrecognized Loss on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Unrecognized Gain (Loss) on Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Beginning balance Other comprehensive loss before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from accumulated other comprehensive income Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Ending balance Schedule of Incentive Equity Awards Issued Upon Completion of Conversion Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of Share Option Awards Status Upon Completion of the Conversion Schedule of Status of Share Option Upon Spin Off [Table Text Block] Schedule of Status of Share Option Upon Spin Off [Table Text Block] Schedule of the Valuation Assumptions Used in the Conversion Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share Option Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Share-based Compensation, Performance Shares Award Outstanding Activity Share-based Compensation, Performance Shares Award Outstanding Activity [Table Text Block] Schedule of Share-based Payment Award, Performance Share Awards, Valuation Assumptions Schedule of Share-based Payment Award, Performance Share Awards, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Performance Share Awards, Valuation Assumptions [Table Text Block] Schedule of Restricted Share Unit Activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Restructuring costs incurred cumulative to date Restructuring and Related Cost, Cost Incurred to Date Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Buildings Building [Member] Capitalized Software Software and Software Development Costs [Member] Machinery and Equipment Machinery and Equipment [Member] Construction in Progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Raw materials and supplies Inventory, Raw Materials and Purchased Parts, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business Acquisition [Line Items] Net sales Business Acquisition, Pro Forma Revenue Income (loss) from continuing operations Business Acquisition, Pro Forma Net Income (Loss) Basic earnings (loss) per share from continuing operations Business Acquisition, Pro Forma Earnings Per Share, Basic Diluted earnings (loss) from per share continuing operations Business Acquisition, Pro Forma Earnings Per Share, Diluted Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Level 1 Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Value Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Four Point Eight Eight Percent Notes [Member] Four Point Eight Eight Percent Notes [Member] Four Point Eight Eight Percent Notes [Member] Five Point Five Percent Notes [Member] Five Point Five Percent Notes [Member] Five Point Five Percent Notes [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Loan payable Loans Payable, Fair Value Disclosure Long term debt Long-term Debt, Fair Value Accounting Policies [Abstract] Schedule of Useful Lives for Property, Plant and Equipment Schedule of Useful Lives for Property, Plant and Equipment [Table Text Block] Schedule of Useful Lives for Property, Plant and Equipment [Table Text Block] Schedule of Useful Lives for Finite Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Operating Activities [Axis] Operating Activities [Axis] Operating Activities [Domain] Operating Activities [Domain] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Tax Period [Axis] Tax Period [Axis] Tax Period [Domain] Tax Period [Domain] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic International Income (Loss) from Continuing Operations before Income Taxes, Foreign Income (loss) from continuing operations before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Intangible asset amortization Amortization of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Brands Brands [Member] Brands [Member] Generics and API Generics and API [Member] Generics and API [Member] Global Medical Imaging Global Medical Imaging [Member] Global Medical Imaging [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name Disposal Group Name [Domain] Contrast Media and Delivery Systems Contrast Media and Delivery Systems [Member] Contrast Media and Delivery Systems [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Goodwill, Period Increase (Decrease) Goodwill, Period Increase (Decrease) Weighted Average Cost of Capital, Rate Weighted Average Cost of Capital, Rate Weighted Average Cost of Capital, Rate Goodwill, Impaired, Accumulated Impairment Loss Goodwill, Impaired, Accumulated Impairment Loss Statement of Comprehensive Income [Abstract] Unrecognized loss on derivatives, tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Unrecognized gain (loss) on benefit plans, tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax Schedule of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Schedule of Changes in Benefit Obligations, Plan Assets, and Funded Status of Plans Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Schedule of Amounts Recognized in Balance Sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Schedule of Amounts to be Amortized from Accumulated Other Comprehensive Income Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block] Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block] Schedule of Actuarial Assumptions Schedule of Assumptions Used [Table Text Block] Schedule of Healthcare Cost Trend Rates Schedule of Health Care Cost Trend Rates [Table Text Block] Schedule of Effect of One-Percentage-Point Change in Assumed Healthcare Cost Trend Rates Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Schedule of Weighted Average Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Fair Value of Plan Assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of Changes in Fair Value of Plan Assets Schedule of Changes in Fair Value of Plan Assets [Table Text Block] Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Schedule of Intangible Asset by Major Class [Table] Schedule of Intangible Asset by Major Class [Table] Schedule of Intangible Asset by Major Class Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Completed Technology Completed Technology [Member] Completed Technology Licensing Agreements Licensing Agreements [Member] Customer relationships Customer Relationships [Member] Trademarks Trademarks [Member] Other Other Intangible Assets [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Schedule of Intangible Asset by Major Class [Line Items] Schedule of Intangible Asset by Major Class [Line Items] [Line Items] for Schedule of Intangible Asset by Major Class Amortizable: Finite-Lived Intangible Assets, Gross [Abstract] Finite-lived intangible assets, gross Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Non-Amortizable: Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Indefinite-lived intangible assets, gross Indefinite-Lived Intangible Assets (Excluding Goodwill) Equity [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] 2015 Share Repurchase Program [Member] 2015 Share Repurchase Program [Member] 2015 Share Repurchase Program Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Stockholders' Equity Note Disclosure Stockholders' Equity Note Disclosure [Text Block] Discontinued Operations [Abstract] Discontinued Operations [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Accounts receivable Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Property, plant and equipment, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent Other current and non-current assets Disposal Group, Including Discontinued Operation, Other Assets Total assets classified as held for sale in the balance sheet Disposal Group, Including Discontinued Operation, Assets Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Other current and non-current liabilities Disposal Group, Including Discontinued Operation, Other Liabilities Total liabilities classified as held for sale in the balance sheet Disposal Group, Including Discontinued Operation, Liabilities Schedule of Condensed Consolidating Balance Sheets Condensed Balance Sheet [Table Text Block] Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income Condensed Income Statement [Table Text Block] Schedule of Condensed Consolidating and Combining Statements of Cash Flows Condensed Cash Flow Statement [Table Text Block] Valuation and Qualifying Accounts [Abstract] Schedule II - Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Acquisition programs Business Acquisition [Member] Business Acquisition [Member] Other programs Other Restructuring [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Beginning Balance Restructuring Reserve Charges Restructuring Charges Cash Cash Restructuring Charges Charges, discontinued operations Restructuring Charges Cash, Discontinued Operations Restructuring Charges Cash, Discontinued Operations Changes in estimate from continuing operations Restructuring Reserve, Accrual Adjustment Changes in estimate, discontinued operations Restructuring Reserve, Accrual Adjustment, Discontinued Operations Restructuring Reserve, Accrual Adjustment, Discontinued Operations Cash payments Payments for Restructuring Reclassifications Restructuring Adjustment, Other Restructuring Adjustment, Other Currency translation Restructuring Reserve, Translation Adjustment Ending Balance Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrecognized gain (loss) on derivatives, net of tax (benefit) expense of $0.2, $0.2 and $- Unrecognized gain (loss) on benefit plans, net of tax (benefit) expense of $(2.1), $(7.3) and $23.9 Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amortization of unrealized loss on derivatives Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Income tax provision Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Net of income taxes Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Amortization of pension and post-retirement benefit plans: Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax [Abstract] Net actuarial loss Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax Prior service credit Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax Plan settlements Other Comprehensive Income (Loss) Reclassification Adjustment From AOCI, Pension And Other Postretirement Benefit Plans, For Plan Settlements Gain (Loss) Before Tax Other Comprehensive Income (Loss) Reclassification Adjustment From AOCI, Pension And Other Postretirement Benefit Plans, For Plan Settlements Gain (Loss) Before Tax Total before tax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax Income tax provision Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Tax Net of income taxes Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax Total reclassifications for the period Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent Consideration Contingent Consideration [Member] Contingent Consideration [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Business Combination, Contingent Consideration, Accretion Business Combination, Contingent Consideration, Accretion Business Combination, Contingent Consideration, Accretion Effect of currency rate change Effect of Exchange Rate, Contingent Consideration Effect of Exchange Rate, Contingent Consideration Ending balance Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Basis of Presentation [Table] Schedule of Basis of Presenation [Table] Schedule of Basis of Presenation [Table] Selling, general and administrative Selling, General and Administrative Expenses [Member] Schedule of Basis of Presentation [Line Items] Schedule of Basis of Presenation [Line Items] [Line Items] for Schedule of Basis of Presenation [Table] Allocated expenses Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party Distribution ratio Stockholders Equity Note Spin Conversion Ratio Stockholders Equity Note Spin Conversion Ratio Stock outstanding after distribution (in shares) Common Stock, Shares, Outstanding Ordinary shares, par value (in usd per share) Common Stock, Par or Stated Value Per Share Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Adjustments to reconcile net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Share-based compensation Share-based Compensation Deferred income taxes Deferred Income Taxes and Tax Credits Non-cash impairment charges Asset Impairment Charges Inventory provisions Inventory Write-down Other non-cash items Other Noncash Income (Expense) Changes in assets and liabilities, net of the effects of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Income taxes Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Cash Flows from Investing Activities: Capital expenditures Other Net cash used in investing activities Cash Flows from Financing Activities: Issuance of external debt Repayment of external debt and capital leases Excess tax benefit from share-based compensation Net transfers to parent Proceeds from exercise of share options Repurchase of shares Payments for Repurchase of Common Stock Net cash provided by financing activities Effect of currency rate changes on cash Net (decrease) increase in cash and cash equivalents Supplemental Disclosures of Cash Flow Information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid, Net Cash paid for income taxes, net Income Taxes Paid, Net Income Statement [Abstract] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Cost of sales Cost of Goods Sold Gross profit Gross Profit Selling, general and administrative expenses Selling, General and Administrative Expense Research and development expenses Research and Development Expense Separation costs Separation Costs Costs incurred related to the separation of the Pharmaceuticals segment. Restructuring charges, net Non-restructuring impairment charges Impairment Charges, Not Related to Restructuring Activities Impairment Charges, Not Related to Restructuring Activities Gain on divestiture and license Gain on Divestiture Gain on Divestiture Operating income (loss) Operating Income (Loss) Interest expense Interest Expense Interest income Interest Income, Other Other income, net Other Nonoperating Income (Expense) Income (loss) from continuing operations before income taxes Provision for (benefit from) income taxes Income (loss) from continuing operations Income (Loss) from Continuing Operations Attributable to Parent Income (loss) from discontinued operations, net of tax expense (benefit) of $11.5, $(34.7), and $21.1 Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Net income (loss) Basic earnings per share (Note 8): Earnings Per Share, Basic [Abstract] Income (Loss) from Continuing Operations, Per Basic Share Income (Loss) from Continuing Operations, Per Basic Share Earnings Per Share, Basic Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Net income (in usd per share) Earnings Per Share, Basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Diluted earnings per share (Note 8): Earnings Per Share, Diluted [Abstract] Income (Loss) from Continuing Operations, Per Diluted Share Income (Loss) from Continuing Operations, Per Diluted Share Earnings Per Share, Diluted Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Net income (in usd per share) Earnings Per Share, Diluted Diluted weighted-average shares oustanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Financial Instruments and Fair Value Measurements Fair Value Disclosures [Text Block] Earnings Per Share [Abstract] Income (loss) from continuing operations Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Income (Loss) From Continuing Operations Attributable To Common Stockholders Income (Loss) From Continuing Operations Attributable To Common Stockholders Income (Loss) From Continuing Operations Attributable To Common Stockholders Income (loss) from discontinued operations, net of income taxes Income (Loss) From Discontinued Operations Attributable To Common Stockholders Undistributed Earnings From Discontinued Operations Allocated To Participating Securities Undistributed Earnings From Discontinued Operations Allocated To Participating Securities Net Income (Loss) Available to Common Stockholders, Basic Income (Loss) From Discontinued Operations Attributable To Common Stockholders Income (Loss) From Discontinued Operations Attributable To Common Stockholders Net Income (Loss) Available to Common Stockholders, Basic Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number Diluted Shares Outstanding Adjustment Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic Earnings Per Share, Diluted Earnings (Loss) per Share [Abstract] Earnings (Loss) per Share [Abstract] Earnings (Loss) per Share Earnings Per Share [Text Block] Total Acquisitions [Member] Total Acquisitions [Member] Total Acquisitions Operating Income [Abstract] Operating Income (Loss) [Abstract] Operating income Net Sales [Abstract] Revenue, Net [Abstract] Acquisition Related Costs Business Combination, Acquisition Related Costs U.S. Plans United States Pension Plan of US Entity [Member] Non-U.S. Plans Foreign Pension Plan [Member] Weighted Average-Assumptions Used in Calculating Net Periodic Benefit Cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Weighted-Average Assumptions Used in Calculating Benefit Obligations Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Healthcare Cost Trend Assumptions Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] Healthcare cost trend rate assumed for next fiscal year Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year Rate to which the cost trend rate is assumed to decline Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Fiscal year the ultimate trend rate is achieved Defined Benefit Plan, Year that Rate Reaches Ultimate Trend Rate Effect of One-Percentage Point Change in Assumed Healthcare Cost Trend Rates Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rates [Abstract] One-Percentage-Point Increase, effect on total of service and interest cost Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components One-Percentage-Point Decrease, effect on total of service and interest cost Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components One-Percentage-Point Increase, effect on postretirement benefit obligation Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation One-Percentage-Point Decrease, effect on postretirement obligation Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation Percentage of ownership in MIFSA Ownership Percentage Wholly Owned Subsidiary Ownership Percentage Wholly Owned Subsidiary Schedule of Significant Accounting Policies [Table] Schedule of Significant Accounting Policies [Table] Schedule of Significant Accounting Policies [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Leasehold improvements Leasehold Improvements [Member] Capitalized software Machinery and equipment Schedule of Significant Accounting Policies [Line Items] Schedule of Significant Accounting Policies [Line Items] [Line Items] for Schedule of Significant Accounting Policies [Table] Shipping costs Shipping, Handling and Transportation Costs Foreign currency gain (loss) Foreign Currency Transaction Gain (Loss), before Tax Foreign currency transactions gain (loss), derivative instruments Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Finite-lived intangible assets - useful lives Finite-Lived Intangible Asset, Useful Life Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Condensed Consolidating and Combining Financial Statements Condensed Financial Statements [Text Block] Fiscal 2016 Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months Fiscal 2017 Unrecorded Unconditional Purchase Obligation, Due within Two Years Fiscal 2018 Unrecorded Unconditional Purchase Obligation, Due within Three Years Fiscal 2019 Unrecorded Unconditional Purchase Obligation, Due within Four Years Fiscal 2020 Unrecorded Unconditional Purchase Obligation, Due within Five Years Schedule of Selected Quarterly Financial Data (Unaudited) Schedule of Quarterly Financial Information [Table Text Block] Corporate, Non-Segment Corporate, Non-Segment [Member] Intersegment Eliminations Intersegment Eliminations [Member] Operating income (loss) Corporate and allocated expenses Corporate and Allocated Expenses Corporate and Allocated Expenses Intangible asset amortization Restructuring and related charges, net Non-restructuring impairment Separation costs Assets Restructuring and related costs, accelerated depreciation Tax (benefit) expense on income (loss) from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Provision for income taxes at Domestic statutory income tax rate (1) Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Adjustments to reconcile to income tax provision: Effective Income Tax Rate Reconciliation, Amount [Abstract] Rate difference between non-U.S. and U.S. jurisdictions Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount Valuation allowances, nonrecurring Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Adjustments to accrued income tax liabilities and uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount Interest and penalties on accrued income tax liabilities and uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Investment in partnership Effective Income Tax Rate Reconciliation, Withholding Taxes, Net Effective Income Tax Rate Reconciliation, Withholding Taxes, Net Credits, principally research Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Impairments, nondeductible Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount Permanently nondeductible and nontaxable items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Current State and Local Tax Expense (Benefit) Current State and Local Tax Expense (Benefit) Reconciliation of Unrecognized Tax Benefits [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Balance at beginning of fiscal year Unrecognized Tax Benefits Unrecognized tax benefits retained by Covidien Unrecognized Tax Benefit, Decrease Resulting from Unrecognized Tax Benefits Retained by Former Parent Unrecognized Tax Benefit, Decrease Resulting from Unrecognized Tax Benefits Retained by Former Parent Unrecognized tax benefits transferred from Covidien Unrecognized Tax Benefit, Increase Resulting from Unrecognized Tax Benefits Transferred from Former Parent Unrecognized Tax Benefit, Increase Resulting from Unrecognized Tax Benefits Transferred from Former Parent Additions related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Additions related to prior period tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Reductions related to prior period tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Cash advance paid in connection with proposed settlements Balance at end of fiscal year Accrued and Other Current Liabilities Accrued And Other Current Liabilities [Member] Accrued And Other Current Liabilities [Member] Other Income Tax Liabilities Other Income Tax Liabilities [Member] Other Income Tax Liabilities [Member] Accrued and other current liabilities Accrued Income Taxes, Current Other income tax liabilities Accrued Income Taxes, Noncurrent Total income taxes payable Accrued Income Taxes Fiscal 2016 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Fiscal 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Two Fiscal 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Three Fiscal 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Four Fiscal 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Five Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Abstract] Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Abstract] Accumulated benefit obligation Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Accumulated Benefit Obligation Fair value of plan assets Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Fair Value of Plan Assets Schedule of Share Repurchases under the Repurchase Plan Schedule of Share Repurchases under the Repurchase Plan [Table Text Block] [Table Text Block] for Schedule of Share Repurchases under the Repurchase Plan [Table] Cost of sales Gross profit Selling, general and administrative expenses Research and development expenses Separation costs Interest expense Interest income Other income (expense), net Intercompany interest and fees Intercompany Interest And Fees Intercompany Interest And Fees Equity in net income of subsidiaries Income (Loss) from Equity Method Investments Income Tax Expense (Benefit) Net income (loss) Other comprehensive loss, net of tax Comprehensive income (loss) Restructuring and Related Charges Restructuring and Related Activities Disclosure [Text Block] Net sales Disposal Group, Including Discontinued Operations, Net Sales Disposal Group, Including Discontinued Operations, Net Sales Cost of sales Disposal Group, Including Discontinued Operation, Costs of Goods Sold Selling, general and administrative Disposal Group, Including Discontinued Operation, General and Administrative Expense Restructuring charges, net Disposal Group, Including Discontinued Operation, Restructuring Charges, Net Disposal Group, Including Discontinued Operation, Restructuring Charges, Net Non-restructuring impairment charges Disposal Group, Including Discontinued Operations, Non-Restructuring Impairment Disposal Group, Including Discontinued Operations, Non-Restructuring Impairment Other Disposal Group, Including Discontinued Operation, Other Expense Income (loss) from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Income tax expense (benefit) Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period Income (loss) from discontinued operations net of tax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Accounting Changes [Abstract] Accounting Changes [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Domain] Adjustments for Change in Accounting Principle [Domain] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Unamortized Debt Issuance Expense Unamortized Debt Issuance Expense Income tax receivable Other assets Prepaid expenses and other current assets Deferred Tax Assets, Prepaid And Other Current Assets Deferred Tax Assets, Prepaid And Other Current Assets Total Income Tax Receivable and Other Assets Income Tax Receivable and Other Assets Retirement Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Schedule of Restructuring and Related Charges by Segment Restructuring Charges By Segment [Table Text Block] Amount of restructuring charges incurred during the period by segment. Schedule of Net Restructuring and Related Charges Restructuring and Related Costs [Table Text Block] Schedule of Restructuring Reserves by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring Charges Incurred Cumulative to Date Schedule Of Restructuring Charges Incurred Cumulative To Date [TableText Block] Schedule of total restructuring charges, net, including asset impairments, incurred cumulative to date for restructuring programs. Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract] Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract] Amortization of net actuarial loss Defined Benefit Plan, Future Amortization of Gain (Loss) Amortization of prior service cost Defined Benefit Plan, Future Amortization of Prior Service Cost (Credit) CNS Therapeutics, Inc. CNS Therapeutics, Inc. [Member] CNS Therapeutics, Inc. [Member] Total consideration, net of cash Business Combination Consideration Transferred, Net Of Cash Business Combination Consideration Transferred, Net Of Cash Plus: cash assumed in acquisition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Total consideration Business Combination, Consideration Transferred Less: unpaid purchase consideration Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Unpaid Purchase Consideration Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Unpaid Purchase Consideration Less: contingent consideration Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Weighted-average shares for basic earnings (loss) per share (in shares) Weighted-average shares for diluted earnings (loss) per share (in shares) Antidilutive securities excluded from weighted-average shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract] Cash Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Goodwill (non-tax deductible) Other assets, current and non-current Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets Other Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets Other Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Unpaid purchase consideration (current) Other liabilities (non-current) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Deferred tax liabilities, net (non-current) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Contingent consideration (non-current) Total Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Net assets acquired Earnings (Loss) Per Share Policy Earnings Per Share, Policy [Policy Text Block] Conversion of Covidien Equity Awards Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] Share options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Weighted-average exercise price, outstanding share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average remaining contractual term, outstanding share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Aggregate intrinsic value, outstanding share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share options exerciseable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted-average exercise price, exercisable share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted-average remaining contractual term, exercisable share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value, exercisable share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Income Tax Contingency [Table] Income Tax Contingency [Table] Deferred income tax liability (non-current) Deferred income tax liability (non-current) [Member] Deferred income tax liability (non-current) [Member] Liabilities, Total Liabilities, Total [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Unrecognized tax benefits Oxymorphone ER Oxymorphone ER [Member] Oxymorphone ER [Member] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Property, Plant and Equipment Property, Plant and Equipment [Member] Finite-Lived Intangible Assets Finite-Lived Intangible Assets [Member] Mallinckrodt Baker Mallinckrodt Baker [Member] Mallinckrodt Baker [Member] Tastemaker Tastemaker [Member] Tastemaker Consideration Disposal Group, Including Discontinued Operation, Consideration Impairment of Long-Lived Assets to be Disposed of Impairment of Long-Lived Assets to be Disposed of Goodwill, Impairment Loss Goodwill, Impairment Loss Taxes paid or to be paid in connection with disposition Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Provision for (benefit from) income taxes Valuation allowances, nonrecurring Deferred Other Tax Expense (Benefit) Other Tax Expense (Benefit) Other Tax Expense (Benefit) Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities Provision for Loss (Gain) on Disposal, Net of Tax Discontinued Operation, Provision for Loss (Gain) on Disposal, Net of Tax Proceeds from Sale of Productive Assets Proceeds from Sale of Productive Assets Contractually Obligated Future Proceeds from Sale Of Productive Assets Contractually Obligated Future Proceeds from Sale Of Productive Assets Contractually Obligated Future Proceeds from Sale Of Productive Assets Gain on Divestiture International Deferred Deferred Income Tax Expense (Benefit) Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Distributor Concentration Risk Distributor Concentration Risk [Member] Distributor Concentration Risk [Member] Product Concentration Risk Product Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Net Sales Attributable to Distributors Sales Revenue, Goods, Net [Member] Accounts Receivable Attributable to Distributors Accounts Receivable [Member] Net Sales Attributable to Products Sales Revenue, Product Line [Member] CuraScript, Inc [Member] CuraScript, Inc [Member] CuraScript, Inc [Member] McKesson Corporation [Member] McKesson Corporation [Member] McKesson Corporation [Member] Cardinal Health, Inc. [Member] Cardinal Health, Inc. [Member] Cardinal Health, Inc. [Member] Amerisource Bergen Corporation [Member] Amerisource Bergen Corporation [Member] Amerisource Bergen Corporation [Member] Acetaminophen products (API) Acetaminophen Products (API) [Member] Acetaminophen Products (API) [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration risk, percentage Concentration Risk, Percentage Related Party Transactions [Abstract] Transactions with Former Parent Company Related Party Transactions Disclosure [Text Block] Plant Assets Exchanged for Industrial Revenue Bonds Plant Assets Exchanged for Industrial Revenue Bonds Plant Assets Exchanged for Industrial Revenue Bonds Deferred Tax Liabilities Installment Sales Deferred Tax Liabilities Installment Sales Deferred Tax Liabilities Installment Sales Interest Expense, Installment Sales Interest Expense, Installment Sales Interest Expense, Installment Sales Rent expense Operating Leases, Rent Expense, Net Loss Contingencies [Table] Loss Contingencies [Table] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Indemnification Agreement Indemnification Agreement [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] '222 and '218 Patent Litigation: Exela Pharma Sciences, LLC Exela Pharma Sciences, LLC, '222 and'218 Patent Litigation [Member] Exela Pharma Sciences, LLC, '222 and'218 Patent Litigation [Member] Retrophin Litigation [Member] Retrophin Litigation [Member] Retrophin Litigation Glenridge Litigation Glenridge Litigation [Member] Glenridge Litigation [Member] Questcor Securities Litigation [Member] Questcor Securities Litigation [Member] Questcor Securities Litigation [Member] David Taban, et al. v. Questcor Pharmaceuticals, Inc David Taban, et al. v. Questcor Pharmaceuticals, Inc [Member] David Taban, et al. v. Questcor Pharmaceuticals, Inc [Member] Mallinckrodt Veterinary, Inc., Millsboro, Delaware Mallinckrodt Veterinary, Inc., Millsboro, Delaware [Member] Mallinckrodt Veterinary, Inc., Millsboro, Delaware [Member] Lower Passaic River, New Jersey Lower Passaic River, New Jersey [Member] Lower Passaic River, New Jersey [Member] Questcor Shareholder Derivative Litigation [Member] Questcor Shareholder Derivative Litigation [Member] Questcor Shareholder Derivative Litigation [Member] Accrued and other current liabilities Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Asbestos Matters Asbestos Matters [Member] Asbestos Matters [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Tax Matters Agreement Tax Matters Agreement [Member] Tax Matters Agreement [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Loss Contingency, Claims Settled, Number Loss Contingency, Claims Settled, Number Litigation Settlement, Expense Litigation Settlement, Expense Number of defendants Loss Contingency, Number of Defendants Loss Contingency, Lawsuits, Number Loss Contingency, Lawsuits, Number Loss Contingency, Lawsuits, Number Pending claims Loss Contingency, Pending Claims, Number Filed-actions consolidated into the lawsuit Number of Filed Actions Consolidated Into Lawsuit Number of Filed Actions Consolidated Into Lawsuit Litigation Settlement, Amount Litigation Settlement, Amount Loss Contingency, Accrual, Current Loss Contingency, Accrual, Current Federal derivative action staying period a Period Of Stay, Option 1 Period Of Stay, Option 1 Federal derivative action staying period b Period Of Stay, Option 2 Period Of Stay, Option 2 Remedial cost range, minimum Loss Contingency, Range of Possible Loss, Minimum Remedial cost range, maximum Loss Contingency, Range of Possible Loss, Maximum Environmental liabilities Accrual for Environmental Loss Contingencies Environmental liabilities, current Accrued Environmental Loss Contingencies, Current Number of Administrative Orders of Consent Entered Into Number of Administrative Orders of Consent Entered Into Number of Administrative Orders of Consent Entered Into Remedial cost, estimate Loss Contingency, Estimate of Possible Loss Estimation of liability, historical term Loss Contingency, Estimation of Liability, Historical Terms Loss Contingency, Estimation of Liability, Historical Terms Estimation of liability, expected future term of claims Loss Contingency, Estimation of Liability, Expected Future Terms of Claims Loss Contingency, Estimation of Liability, Expected Future Terms of Claims Tax agreement, tax threshold Tax Agreement, Tax Threshold Tax Agreement, Tax Threshold Net sales Income (loss) from continuing operations Basic earnings (loss) per share from continuing operations (in usd per share) Diluted earnings (loss) per share from continuing operations (in usd per share) Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan, Asset Categories [Axis] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Plan Asset Categories [Domain] U.S. Small Mid Cap U.S. Small Mid Cap [Member] U.S. Small Mid Cap [Member] U.S. Large Cap U.S. Large Cap [Member] U.S. Large Cap [Member] International International [Member] International [Member] Diversified Fixed Income Funds Fixed Income Securities [Member] High Yield Bonds High Yield Bonds [Member] High Yield Bonds [Member] Emerging Market Fund Emerging Market Fund [Member] Emerging Market Fund [Member] Insurance Contract Plan Asset, Insurance Contract [Member] Plan Asset, Insurance Contract [Member] Other Other Assets [Member] Change in Fair Value of Plan Assets [Roll Forward] Net unrealized gains Defined Benefit Plan, Net Unrealized Gains (Loss), Plan Assets Defined Benefit Plan, Net Unrealized Gains (Loss), Plan Assets Net purchases, sales and issuances Defined Benefit Plan, Purchases, Sales, and Settlements Share Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Guarantees [Abstract] Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Type of Obligation [Axis] Type of Obligation [Axis] Type of Obligation [Axis] Type of Obligation [Domain] Type of Obligation [Domain] [Domain] for Type of Obligation [Axis] Enviornmental, Health and Safety Matters Enviornmental, Health and Safety Matters [Member] Enviornmental, Health and Safety Matters [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Maryland Heights, Missouri Maryland Heights, Missouri [Member] Maryland Heights, Missouri [Member] Surety Bond Surety Bond [Member] Others Others [Member] Others [Member] Other Liabilities Other Liabilities [Member] Other Assets Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Guarantor obligations, obligation term Guarantor Obligations, Obligation Term Describe the approximate term of the guarantee or each group of similar guarantees. Guarantors obligation Guarantor Obligations, Current Carrying Value Maximum future payments Guarantor Obligations, Maximum Exposure, Undiscounted Escrow Escrow Deposit Restricted Cash and Cash Equivalents, Current Restricted Cash and Cash Equivalents, Current Less: non-cash charges, including impairments and accelerated share based compensation expense Restructuring and Related Costs, Non-cash Charges, Including Accelerated Depreciation Restructuring and Related Costs, Non-cash Charges, Including Accelerated Depreciation Total charges expected to be settled in cash Restructuring and Related Costs, Total Charges Expected to be Settled in Cash Restructuring and Related Costs, Total Charges Expected to be Settled in Cash Acquisitions [Abstract] Acquisitions [Abstract] Schedule of Intangible Asset Amortization by Acquiree [Table] Schedule of Intangible Asset Amortization by Acquiree [Table] Schedule of Intangible Asset Amortization by Acquiree [Table] Cost of Sales Cost of Sales [Member] Schedule of Intangible Asset Amortization by Acquiree [Line Items] Schedule of Intangible Asset Amortization by Acquiree [Line Items] [Line Items] for Schedule of Intangible Asset Amortization by Acquiree [Table] Amortization Of Inventory Step-Up To Cost Of Sales Amortization Of Inventory Step-Up To Cost Of Sales Amortization Of Inventory Step-Up To Cost Of Sales Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Other current liabilities Other Current Liabilities [Member] Discontinued Operations [Member] Discontinued Operations [Member] Separation and Distribution Agreement Separation Agreement with Covidien [Member] Separation Agreement with Covidien [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Inventory sold Revenue from Related Parties Inventory purchases Related Party Transaction, Purchases from Related Party Due from related parties Due from Related Parties Due to related parties Due to Related Parties, Current Initial cash capitalization Initial Cash Capitalization Initial Cash Capitalization Estimated cash upon completion of distribution Estimated Cash Upon Completion of Distribution Estimated Cash Upon Completion of Distribution Adjustment payment benchmark Estimated Cash Upon Completion of Distribution, Adjustment Payment Benchmark Estimated Cash Upon Completion of Distribution, Adjustment Payment Benchmark Final adjustment payment Estimated Cash Upon Completion of Distribution, Final Adjustment Payment Estimated Cash Upon Completion of Distribution, Final Adjustment Payment Change in ownership percentage Tax Agreement, Change in Ownership Percentage Tax Agreement, Change in Ownership Percentage Restriction period Tax Matters, Restricted Term of Activity Tax Matters, Restricted Term of Activity Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Operating Leases Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating leases, fiscal 2015 Operating Leases, Future Minimum Payments Due, Next Twelve Months Operating leases, fiscal 2016 Operating Leases, Future Minimum Payments, Due in Two Years Operating leases, fiscal 2018 Operating Leases, Future Minimum Payments, Due in Three Years Operating leases, fiscal 2019 Operating Leases, Future Minimum Payments, Due in Four Years Operating leases, fiscal 2020 Operating Leases, Future Minimum Payments, Due in Five Years Operating leases, thereafter Operating Leases, Future Minimum Payments, Due Thereafter Operating leases, total minimum lease payments Operating Leases, Future Minimum Payments Due Capital Leases Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Capital leases, fiscal 2015 Capital Leases, Future Minimum Payments Due, Next Twelve Months Capital leases, fiscal 2016 Capital Leases, Future Minimum Payments Due in Two Years Capital leases, fiscal 2017 Capital Leases, Future Minimum Payments Due in Three Years Capital leases, fiscal 2018 Capital Leases, Future Minimum Payments Due in Four Years Capital leases, fiscal 2019 Capital Leases, Future Minimum Payments Due in Five Years Capital leases, thereafter Capital Leases, Future Minimum Payments Due Thereafter Capital leases, total minimum lease payments Capital Leases, Future Minimum Payments Due Capital leases, interest portion of total minimum lease payments Capital Leases, Future Minimum Payments, Interest Included in Payments Capital leases, present value of minimum lease payments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments Intangible Assets Acquired as Part of Business Combination [Table] Intangible Assets Acquired as Part of Business Combination [Table] Intangible Assets Acquired as Part of Business Combination [Table] Therakos Immunotherapy [Member] Therakos Immunotherapy [Member] Therakos Immunotherapy Terlipressin [Member] Terlipressin [Member] Terlipressin [Member] Intangible Assets Acquired as Part of Business Combination [Line Items] Intangible Assets Acquired as Part of Business Combination [Line Items] [Line Items] for Intangible Assets Acquired as Part of Business Combination Intangible assets acquired, weighted-average useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Indefinite lived intangible assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Amortizable intangible assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Estimated cost to complete in-process research Estimated Cost to Complete In-process Research Estimated Cost to Complete In-process Research Cash flow discount rate Business Combination, Cash Flow Discount Rate Business Combination, Cash Flow Discount Rate Document And Entity Information [Abstract] Document and Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Ordinary Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Public Float Entity Public Float Royalty rights Royalty Agreements [Member] Bristol-Myers Squibb Bristol-Myers Squibb [Member] Bristol-Myers Squibb [Member] Depomed Depomed [Member] Depomed [Member] Pennsaid Pennsaid [Member] Pennsaid [Member] CNS Therapeutics, Inc. Nuvo Nuvo Case [Member] Nuvo Case [Member] Payments to Acquire Businesses, Net of Cash Acquired Business Combination, Consideration Transferred, Other Business Combination, Consideration Transferred, Other Amount of Cash Shareholders Receive, Per Share of Acquiree Amount of Cash Shareholders Receive, Per Share of Acquiree Amount of Cash Shareholders Receive, Per Share of Acquiree Amount of company shares shareholders will receive, per share Amount of Company Shares Shareholders Will Receive, Per Share Amount of Company Shares Shareholders Will Receive, Per Share Issuance of common stock to acquire business Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issuance of senior unsecured notes to acquire business Business Combination, Consideration Transferred, Senior Unsecured Notes Issued to Acquire Business Business Combination, Consideration Transferred, Senior Unsecured Notes Issued to Acquire Business Issuance of senior secured term loan facility to acquire business Business Combination, Consideration Transferred, Senior Secured Term Loan Facility Issued to Acquire Business Business Combination, Consideration Transferred, Senior Secured Term Loan Facility Issued to Acquire Business Cash used to acquire business Payments to Acquire Businesses, Gross Long Term Debt Assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Long Term Debt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Long Term Debt Long term debt Business Combination, Consideration Transferred, Liabilities Incurred Number of indications that are approved for treatment Number Of Indications That Are Approved For Treatment Number Of Indications That Are Approved For Treatment Contingent consideration, potential maximum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Contingent payment, maximum additional amount Milestone Payment, Maximum Amount Maximum amount of milestone payments payable under license agreement. Royalties paid Royalty Expense Milestone Payments Milestone Payments Milestone payment made in connection with a license agreement. Finite-lived intangible assets acquired Finite-lived Intangible Assets Acquired Credit Rating, Moody's [Axis] Credit Rating, Moody's [Axis] External Credit Rating, Moody's [Domain] External Credit Rating, Moody's [Domain] Moody's, Aa1 Rating [Member] Moody's, Aa1 Rating [Member] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Allocation of total pension plan assets Defined Benefit Plan, Percentage of Total Pension Plan Assets Defined Benefit Plan, Percentage of Total Pension Plan Assets Lower Threshold for Discount Rate Basis, Corporate Bonds Lower Threshold for Discount Rate Basis, Corporate Bonds Lower Threshold for Discount Rate Basis, Corporate Bonds Number of Life Insurance Contract Held in Rabbi Trust Number of Life Insurance Contract Held in Rabbi Trust Number of Life Insurance Contract Held in Rabbi Trust Deferred Compensation Plan Assets Deferred Compensation Plan Assets Deferred Compensation Plan Assets, Death Benefit on Insurance Contracts Deferred Compensation Plan Assets, Death Benefit on Insurance Contracts Deferred Compensation Plan Assets, Death Benefit on Insurance Contracts Deferred Compensation Plan Assets, Loans Outstanding Against Insurance Contracts Deferred Compensation Plan Assets, Loans Outstanding Against Insurance Contracts Deferred Compensation Plan Assets, Loans Outstanding Against Insurance Contracts Deferred Compensation Plan Assets, Collateral For Plan Benefits Deferred Compensation Plan Assets, Colleteral For Plan Benefits Deferred Compensation Plan Assets, Colleteral For Plan Benefits Allocation of total projected benefit obligation Defined Benefit Plan, Percentage of Projected Benefit Obligation Defined Benefit Plan, Percentage of Projected Benefit Obligation Background and Basis of Presentation Business Description and Basis of Presentation [Text Block] Schedule of Components of Income from Continuing Operations before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of Significant Components of Income Taxes Related to Continuing Operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Unrecognized Tax Benefit Activity Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Schedule of Unrecongized Tax Benefits Balance Sheet Location Unrecognized Tax Benefits [Table Text Block] Unrecognized Tax Benefits [Table Text Block] Schedule of Income Taxes Payable Schedule of Income Taxes Payable, Balance Sheet Grouping [Table Text Block] Schedule of Income Taxes Payable, Balance Sheet Grouping [Table Text Block] Schedule of Income Tax Receivables and Other Assets Schedule of Income Tax Receivables and Other Assets [Table Text Block] Schedule of Income Tax Receivables and Other Assets [Table Text Block] Schedule of Deferred Taxes Activity Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Taxes Balance Sheet Location Schedule of Deferred Taxes, Balance Sheet Grouping [Table Text Block] Schedule of Deferred Taxes, Balance Sheet Grouping [Table Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Shipping and Handling Costs Shipping and Handling Cost, Policy [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Accounts Receivable and Allowance for Doubtful Accounts Trade and Other Accounts Receivable, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Acquisitions Business Combinations Policy [Policy Text Block] Goodwill and Other Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Contingencies Commitments and Contingencies, Policy [Policy Text Block] Share-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Parent Company Investment Parent Company Investment [Policy Text Block] Parent Company Investment [Policy Text Block] Acquisitions and License Agreements Business Combination Disclosure [Text Block] Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Sales reserve accounts Allowance for Sales Returns [Member] Tax valuation allowance Valuation Allowance of Deferred Tax Assets [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Balance at Beginning of Period Valuation Allowances and Reserves, Balance Charged to Income Valuation Allowances and Reserves, Charged to Cost and Expense Additions and Other Valuation Allowances and Reserves, Charged to Other Accounts Deductions Valuation Allowances and Reserves, Deductions Balance at End of Period Schedule of Earnings (Loss) per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Synacthen [Member] Synacthen [Member] Synacthen [Member] BioVectra Inc [Member] BioVectra Inc [Member] BioVectra Inc [Member] Level 2 Level 3 Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Novartis 2015 and 2016 Novartis 2015 and 2016 [Member] Novartis 2015 and 2016 [Member] Novartis, Subsequent to 2016 till FDA Approval Novartis, Subsequent to 2016 till FDA Approval [Member] Novartis, Subsequent to 2016 till FDA Approval [Member] Novartis, Subsequent to FDA Approval Novartis, Subsequent to FDA Approval [Member] Novartis, Subsequent to FDA Approval [Member] BioVectra Financial Results BioVectra Financial Results [Member] BioVectra Financial Results [Member] Fair value of contingent consideration upon acquisition Maximum contingent payments for acquisition Discount rate Fair Value Inputs, Discount Rate Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Business Combination, Contingent Consideration, Annual Payments Business Combination, Contingent Consideration, Annual Payments Business Combination, Contingent Consideration, Annual Payments Business Combination, Contingent Consideration, Potential Payment Business Combination, Contingent Consideration, Potential Payment Business Combination, Contingent Consideration, Potential Payment Number of Suppliers of Unique Raw Material Number of Suppliers of Unique Raw Material Number of Suppliers of Unique Raw Material Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Restricted cash Restricted Cash, Fair Value Disclosure Restricted Cash, Fair Value Disclosure Cash surrender value of life insurance Cash Surrender Value, Fair Value Disclosure Number of Nuclear Research Reactors Used To Source Raw Material Number of Nuclear Research Reactors Used To Source Raw Material Number of Nuclear Research Reactors Used To Source Raw Material Number of Nuclear Reactors Relied on For Supply of Raw Material Number of Nuclear Reactors Relied on For Supply of Raw Material Number of Nuclear Reactors Relied on For Supply of Raw Material Discontinued Operations and Divestitures Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of Segment Reporting Information by Business Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Net Sales from External Customers by Products Revenue from External Customers by Products and Services [Table Text Block] Schedule of Net Sales and Long-Lived Assets by Geographical Area Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Expected return on plan assets Defined Benefit Plan, Expected Return on Plan Assets Amortization of net actuarial loss Defined Benefit Plan, Amortization of Gains (Losses) Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Loss on plan settlements Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements Net period benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member] 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member] 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Stock Repurchase Program, Increase in Authorized Amount Stock Repurchase Program, Increase in Authorized Amount Stock Repurchase Program, Increase in Authorized Amount Schedule of Income (Loss) from Discontinued Operations Schedule of Income (Loss) from Discontinued Operations [Table Text Block] Schedule of Income (Loss) from Discontinued Operations [Table Text Block] Schedule of Assets and Liabilities Held-For-Sale Disposal Groups, Including Discontinued Operations [Table Text Block] Schedule of Significant Cash and Non-Cash Transactions Schedule of Significant Cash and Non-Cash Transactions [Table Text Block] Schedule of Significant Cash and Non-Cash Transactions [Table Text Block] Consulting costs Consulting Costs [Member] Consulting Costs [Member] Employee terminations Employee Severance [Member] 2013 Mallinckrodt program expected cost range Restructuring and Related Cost, Expected Cost Accelerated share based compensation expense Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost Property, plant and equipment asset impairment Property, Plant and Equipment, Transfers and Changes Restructuring costs Restructuring Costs Basis of Accounting Basis of Accounting, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Consolidation Consolidation, Policy [Policy Text Block] Fiscal Period Fiscal Period, Policy [Policy Text Block] Finite-lived intangible ssets Property Under Capital Lease Assets Held under Capital Leases [Member] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Depreciation Depreciation Impairment of long-lived assets Impairment of Long-Lived Assets Held-for-use Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Carrying Amount and Fair Value of Long-term Debt Fair Value, by Balance Sheet Grouping [Table Text Block] Schedules of Concentration of Risk Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Depreciation Depreciation, Discontinued Operations Depreciation, Discontinued Operations Amortization Amortization, Discontinued Operations Amortization, Discontinued Operations Capital expenditures Capital Expenditure, Discontinued Operations Non-cash impairment charges Preferred shares, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred shares, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Preferred shares, shares issued (in shares) Preferred Stock, Shares Issued Employee Service Share-based Compensation, Cash Flow Effect, Cash Used to Settle Awards Employee Service Share-based Compensation, Cash Flow Effect, Cash Used to Settle Awards Restricted Share Units Restricted Stock Units (RSUs) [Member] Weighted-average grant-date fair value, share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value Non-share option equity awards outstanding Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Weighted-average grant date fair value, restricted share units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Guarantees Guarantees [Text Block] Restructuring Restructuring Charges [Member] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2013 Plan 2013 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member] 2013 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member] Share Options Employee Stock Option [Member] Employee Stock Purchase Plan Employee Stock [Member] Restricted Stock Restricted Stock [Member] Share-based compensation cost Allocated Share-based Compensation Expense Post combination expense Business Combination, Equity Conversion, Post-Combination Expense Business Combination, Equity Conversion, Post-Combination Expense Tax benefit from share-based compensation cost Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Shares authorized under 2013 Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Unrecognized compensation cost, share options Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Weighted-average period to recognize unrecognized compensation cost, share options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of options vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Tax benefit from stock options exercised Deferred Tax Expense from Stock Options Exercised Fair value of restricted share units granted in period Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Granted in Period, Total Fair Value Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Granted in Period, Total Fair Value Fair value of restricted share units vested in period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Unrecognized compensation cost, restricted share units Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Performance period Performance Shares Award, Performance Period Performance Shares Award, Performance Period Percentage of ordinary shares to be awarded Performance Shares, Percentage of Ordinary Shares Awarded Performance Shares, Percentage of Ordinary Shares Awarded Unrecognized compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized ESPP employer match - maximum employee contribution Defined Contribution Plan, Employer Matching Contribution, Amount Defined Contribution Plan, Employer Matching Contribution, Amount Share Option Activity [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Beginning balance Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Converted from Questcor Acquisition Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period Exercised Expired/Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Ending balance Share options vested and unvested expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-average exercise price, granted share options Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average exercise price, converted from Questcor acquisition, share options Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price Weighted-average exercise price, exercised share options Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-average exercise price, expired and forfeited share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted-average exercise price, vested and unvested expected to vest share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average remaining contractual term, vested and unvested expected to vest share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Aggregate intrinsic value, vested and unvested expected to vest share options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Restricted Stock Activity [Roll Forward] Restricted Stock Activity [Roll Forward] Restricted Stock Activity [Roll Forward] Beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Converted from Questcor Acquisition Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Resulting from Business Combination Conversion Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Resulting from Business Combination Conversion Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant date fair value, granted restricted share units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value, converted from Questcor Acquisition Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Resulting From Business Combination Conversion, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Resulting From Business Combination Conversion, Weighted Average Grant Date Fair Value Weighted-average grant date fair value, vested restricted share units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value, forfeited restricted share units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Amounts recognized on the consolidated balance sheet: Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract] Non-current assets Defined Benefit Plan, Assets for Plan Benefits, Noncurrent Current liabilities Pension and Other Postretirement Defined Benefit Plans, Current Liabilities Non-current liabilities Net amount recognized on the consolidated balance sheet Defined Benefit Plan, Amounts Recognized in Balance Sheet Amounts recognized in accumulated other comprehensive income consist of: Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Net actuarial loss Defined Benefit Plan, Accumulated Other Comprehensive Income Net Gains (Losses), after Tax Prior service credit Defined Benefit Plan, Accumulated Other Comprehensive Income Net Prior Service Cost (Credit), after Tax Net amount recognized in accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax Accumulated Other Comprehensive Income Comprehensive Income (Loss) Note [Text Block] Weighted Average Assumptions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Expected share price volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected annual dividend per share Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected life of options (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Fair value per option Share Price Japan JAPAN Netherlands NETHERLANDS Equity Securities Equity Securities [Member] Debt Securities Debt Securities [Member] Cash and cash equivalents Cash and Cash Equivalents [Member] Other Other Debt Obligations [Member] Pension plans, target plan asset allocation Defined Benefit Plan, Target Plan Asset Allocations Pension plans, weighted-average plan asset allocation Defined Benefit Plan, Actual Plan Asset Allocations Debt Debt and Capital Leases Disclosures [Text Block] Schedule of Accumulated Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Segment and Geographical Data Segment Reporting Disclosure [Text Block] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Preferred shares, shares outstanding (in shares) Preferred Stock, Shares Outstanding Ordinary A shares, par value (in eur per share) Ordinary A Shares Par Or Stated Value Per Share Ordinary A Shares Par Or Stated Value Per Share Ordinary A shares, shares authorized (in shares) Ordinary A Shares Authorized Ordinary A Shares Authorized Ordinary A shares, shares issued (in shares) Ordinary A Shares Issued Ordinary A Shares Issued Ordinary A shares, shares outstanding (in shares) Ordinary A Shares Outstanding Ordinary A Shares Outstanding Ordinary shares, shares authorized (in shares) Common Stock, Shares Authorized Ordinary shares, shares issued (in shares) Common Stock, Shares, Issued Ordinary shares, shares outstanding (in shares) Ordinary shares held in treasury (in shares) Treasury Stock, Shares Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill, Gross Goodwill, Gross Goodwill, Impaired, Accumulated Impairment Loss Goodwill, Purchase Accounting Adjustments Goodwill, Purchase Accounting Adjustments Restricted Share Unit Activity [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Net Sales and Long-Lived Assets by Geographic Area [Table] Schedule of Net Sales and Long-Lived Assets by Geographic Area [Table] Schedule of Net Sales and Long-Lived Assets by Geographic Area [Table] United States UNITED STATES EMEA EMEA [Member] Other Countries Other Countries [Member] Asia, Canada, Latin America, etc. Country [Axis] Country [Axis] Country [Axis] Country [Domain] Country [Domain] [Domain] for Country [Axis] Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items] Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items] [Line Items] for Schedule of Net Sales and Long-Lived Assets by Geographic Area [Table] Long-Lived Assets Long-Lived Assets Performance Share Unit Activity [Roll Forward] Performance Share Unit Activity [Roll Forward] Performance Share Unit Activity [Roll Forward] Performance metric adjustment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Metric Adjustment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Metric Adjustment Weighted-average grand date fair value, performance metric adjustment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Metric Adjustment, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Metric Adjustment, Weighted Average Grant Date Fair Value EX-101.PRE 13 mnk-20150925_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 mnk10-k92515_chart.jpg begin 644 mnk10-k92515_chart.jpg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�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end XML 15 R39.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures (Tables)
 12 Months Ended
Sep. 25, 2015
Discontinued Operations [Abstract]  
Schedule of Income (Loss) from Discontinued Operations
The following table summarizes the financial results of the CMDS discontinued operations for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013 as presented in the consolidated statements of operations and comprehensive income:
 
Fiscal Year
Major line items constituting income (loss) from discontinued operations
2015
 
2014
 
2013
Net sales
$
413.8

 
$
495.8

 
$
549.3

Cost of sales
306.4

 
352.9

 
346.7

Selling, general and administrative
97.5

 
97.1

 
114.0

Restructuring charges, net
0.3

 
47.2

 
9.5

Non-restructuring impairment charges
—

 
204.0

 
—

Other
4.7

 
4.1

 
8.4

Income (loss) from discontinued operations

4.9

 
(209.5
)
 
70.7

Income tax expense (benefit)
10.8

 
(34.7
)
 
21.1

 
 
 
 
 
 
Income (loss) from discontinued operations net of tax
$
(5.9
)
 
$
(174.8
)
 
$
49.6
Schedule of Assets and Liabilities Held-For-Sale
The following table summarizes the assets and liabilities of the CMDS business that are classified as held for sale on the consolidated balance sheets as of September 25, 2015 and September 26, 2014:
 
September 25, 2015
 
September 26, 2014
Carrying amounts of major classes of assets included as part of discontinued operations
 
 
 
Accounts receivable
$
68.5

 
$
68.9

Inventories
86.3

 
90.2

Property, plant and equipment, net
60.3

 
62.4

Intangible assets, net
27.7

 
30.0

Other current and non-current assets
57.1

 
60.5

Total assets classified as held for sale in the balance sheet
$
299.9

 
$
312.0

 
 
 
 
Carrying amounts of major classes of liabilities included as part of discontinued operations
 
 
 
Accounts payable
$
22.0

 
$
18.0

Other current and non-current liabilities
50.8

 
50.7

Total liabilities classified as held for sale in the balance sheet
$
72.8

 
$
68.7
Schedule of Significant Cash and Non-Cash Transactions
The following table summarizes significant cash and non-cash transactions of the CMDS business that are included within the consolidated statements of cash flows for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013:
 
Fiscal Year
 
2015
 
2014
 
2013
Depreciation
$
15.5

 
$
18.9

 
$
16.0

Amortization
2.3

 
7.5

 
7.5

Capital expenditures
9.5

 
12.3

 
17.4

Non-cash impairment charges
—

 
204.0

 
—
XML 16 R142.htm IDEA: XBRL DOCUMENT v3.3.0.814
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Allowance for doubtful accounts      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 3.7 $ 3.6 $ 9.4
Charged to Income 1.9 0.4 1.1
Additions and Other 0.0 0.0 0.0
Deductions (0.9) (0.3) (6.9)
Balance at End of Period 4.7 3.7 3.6
Sales reserve accounts      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 404.9 287.7 235.0
Charged to Income 2,187.8 1,720.9 1,171.9
Additions and Other 1.3 30.6 0.0
Deductions (2,194.7) (1,634.3) (1,119.2)
Balance at End of Period 399.3 404.9 287.7
Tax valuation allowance      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 76.9 28.3 15.3
Charged to Income 155.4 33.9 10.0
Additions and Other 0.2 14.7 3.0
Deductions (0.5) 0.0 0.0
Balance at End of Period $ 233.0 $ 76.9 $ 28.3
XML 17 R112.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Incentive Equity Awards Issued Upon Completion of Conversion) (Details) - $ / shares
Sep. 25, 2015
Sep. 26, 2014
Jun. 27, 2014
Sep. 27, 2013
Jun. 27, 2013
Conversion of Covidien Equity Awards          
Share options outstanding 2,786,443 3,526,789 2,399,822 2,760,231 1,745,258
Restricted Share Units          
Conversion of Covidien Equity Awards          
Weighted-average grant date fair value, restricted share units $ 73.45 $ 47.88   $ 40.62  
Covidien          
Conversion of Covidien Equity Awards          
Share options outstanding     2,399,822    
Weighted-average grant-date fair value, share options     $ 7.96    
Covidien | Restricted Share Units          
Conversion of Covidien Equity Awards          
Non-share option equity awards outstanding     575,213    
Weighted-average grant date fair value, restricted share units     $ 38.97    
XML 18 R54.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data (Tables)
 12 Months Ended
Sep. 25, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Business Segment
Selected information by business segment is as follows:

Fiscal Year

2015
 
2014
 
2013
Net sales:
 
 
 
 
 
Specialty Brands
1,622.8

 
413.5

 
206.4

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

Nuclear Imaging
423.8

 
431.7

 
437.6

Net sales of operating segments (1)
3,298.2

 
2,044.6

 
1,655.2

Other (2)
48.7

 
37.4

 
57.1

Net sales
3,346.9

 
2,082.0

 
1,712.3

Operating income:
 
 
 
 
 
Specialty Brands
651.3

 
(50.6
)
 
(36.2
)
Specialty Generics
622.0

 
617.4

 
347.9

Nuclear Imaging
66.4

 
(16.7
)
 
24.5

Segment operating income
1,339.7

 
550.1

 
336.2

Unallocated amounts:
 
 
 
 
 
Corporate and allocated expenses (3)          
(286.9
)
 
(228.1
)
 
(134.3
)
Intangible asset amortization
(550.3
)
 
(154.8
)
 
(27.9
)
Restructuring and related charges, net (4)
(40.7
)
 
(81.9
)
 
(26.3
)
Non-restructuring impairments
—

 
(151.6
)
 
—

Separation costs
—

 
(9.6
)
 
(74.2
)
Operating income (loss)
461.8

 
(75.9
)
 
73.5

 
 
 
 
 
 
Depreciation and amortization (5):
 
 
 
 
 
Specialty Brands
559.8

 
152.9

 
24.9

Specialty Generics
81.9

 
77.8

 
72.7

Nuclear Imaging
12.4

 
18.8

 
18.5

Depreciation and amortization
654.1

 
249.5

 
116.1

(1)
Amounts represent sales to external customers. There were no intersegment sales.
(2)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
(3)
Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
(4)
Includes restructuring-related accelerated depreciation.
(5)
Depreciation for certain shared facilities is allocated based on occupancy percentage.
Schedule of Net Sales from External Customers by Products
Net sales by product family within the Company's segments are as follows:

 
Fiscal Year
 
2015
 
2014
 
2013
Acthar
$
1,037.3

 
$
122.9

 
$
—

Ofirmev
263.0

 
124.4

 
—

Inomax
185.2

 
—

 
—

Exalgo
39.4

 
76.1

 
126.1

Other
97.9

 
90.1

 
80.3

Specialty Brands
1,622.8

 
413.5

 
206.4

 
 
 
 
 
 
Hydrocodone (API) and hydrocodone-containing tablets
167.2

 
99.4

 
140.0

Oxycodone (API) and oxycodone-containing tablets
154.6

 
155.2

 
139.0

Methylphenidate ER
136.5

 
209.6

 
148.3

Other controlled substances
572.2

 
584.5

 
443.3

Other
221.1

 
150.7

 
140.6

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

 
 
 
 
 
 
Nuclear Imaging
423.8

 
431.7

 
437.6

 
 
 
 
 
 
Other (1)
48.7

 
37.4

 
57.1

Net sales
$
3,346.9

 
$
2,082.0

 
$
1,712.3


(1)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
Schedule of Net Sales and Long-Lived Assets by Geographical Area
Selected information by geographic area excluding assets held for sale is as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Net sales (1):
 
 
 
 
 
U.S.
$
2,973.2

 
$
1,780.9

 
$
1,421.6

Europe, Middle East and Africa
236.2

 
250.3

 
250.1

Other
137.5

 
50.8

 
40.6

 
$
3,346.9

 
$
2,082.0

 
$
1,712.3

Long-lived assets (2):
 
 
 
 
 
U.S.
$
905.2

 
$
829.1

 
 
Europe, Middle East and Africa (3)
45.0

 
33.9

 
 
Other
44.5

 
41.0

 
 
 
$
994.7

 
$
904.0

 
 
(1)
Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.
(2)
Long-lived assets are primarily composed of property, plant and equipment.
(3)
Includes long-lived assets located in Ireland of $10.7 million, and $0.4 million at the end of fiscal 2015 and 2014, respectively.
XML 19 R48.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Tables)
 12 Months Ended
Sep. 25, 2015
Compensation and Retirement Disclosure [Abstract]  
Schedule of Net Periodic Benefit Cost
The net periodic benefit cost (credit) for the Company's pension and postretirement benefit plans was as follows:
 
Pension Benefits
 
Postretirement Benefits
 
Fiscal Year
 
Fiscal Year
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Service cost
$
4.5

 
$
5.1

 
$
5.0

 
$
0.1

 
$
0.1

 
$
0.1

Interest cost
17.5

 
19.6

 
18.2

 
1.9

 
2.1

 
2.4

Expected return on plan assets
(22.6
)
 
(24.6
)
 
(29.6
)
 
—

 
—

 
—

Amortization of net actuarial loss
9.4

 
8.1

 
12.3

 
—

 
—

 
0.3

Amortization of prior service cost
(0.6
)
 
(0.6
)
 
0.6

 
(4.0
)
 
(9.3
)
 
(9.1
)
Loss on plan settlements
6.0

 
3.8

 
6.8

 
—

 
—

 
—

Net periodic benefit cost (credit)
$
14.2

 
$
11.4

 
$
13.3

 
$
(2.0
)
 
$
(7.1
)
 
$
(6.3
)
Schedule of Changes in Benefit Obligations, Plan Assets, and Funded Status of Plans
The following table represents the changes in benefit obligations, plan assets and the net amounts recognized on the consolidated balance sheets for pension and postretirement benefit plans at the end of fiscal 2015 and 2014:
 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Change in benefit obligation:
 
 
 
 
 
 
 
Projected benefit obligations at beginning of year
$
538.4

 
$
501.7

 
$
52.0

 
$
53.2

Service cost
4.5

 
5.1

 
0.1

 
0.1

Interest cost
17.5

 
19.6

 
1.9

 
2.1

Employee contributions
0.6

 
0.6

 
—

 
—

Actuarial (gain) loss
(4.5
)
 
60.0

 
2.1

 
0.5

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Net transfer in/(out)
0.6

 
—

 
—

 
—

Currency translation
(18.9
)
 
(9.1
)
 
—

 
—

Projected benefit obligations at end of year
$
493.5

 
$
538.4

 
$
52.2

 
$
52.0

 
 
 
 
 
 
 
 
Change in plan assets:
 
 
 
 
 
 
 
Fair value of plan assets at beginning of year
$
473.6

 
$
456.0

 
$
—

 
$
—

Actual return on plan assets
12.5

 
59.7

 
—

 
—

Employer contributions
13.0

 
4.9

 
3.9

 
3.9

Employee contributions
0.6

 
0.6

 
—

 
—

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Currency translation
(17.1
)
 
(8.1
)
 
—

 
—

Fair value of plan assets at end of year
$
437.9

 
$
473.6

 
$
—

 
$
—

Funded status at end of year
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)
Schedule of Amounts Recognized in Balance Sheet
 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Amounts recognized on the consolidated balance sheet:
 
 
 
 
 
 
 
Non-current assets
$
20.1

 
$
9.8

 
$
—

 
$
—

Current liabilities
(6.6
)
 
(2.7
)
 
(4.6
)
 
(4.8
)
Non-current liabilities
(69.1
)
 
(71.9
)
 
(47.6
)
 
(47.2
)
Net amount recognized on the consolidated balance sheet
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)
 
 
 
 
 
 
 
 
Amounts recognized in accumulated other comprehensive income consist of:
 
 
 
 
 
 
 
Net actuarial loss
$
(104.1
)
 
$
(115.1
)
 
$
(5.1
)
 
$
(2.9
)
Prior service credit
5.5

 
6.9

 
14.9

 
18.8

Net amount recognized in accumulated other comprehensive income
$
(98.6
)
 
$
(108.2
)
 
$
9.8

 
$
15.9
Schedule of Amounts to be Amortized from Accumulated Other Comprehensive Income
The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit cost (credit) in fiscal 2016 are as follows:
 
Pension Benefits
 
Postretirement Benefits
Amortization of net actuarial loss
$
10.8

 
$
—

Amortization of prior service cost
(0.5
)
 
(2.1
)
Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets
Additional information related to pension plans is as follows:
 
2015
 
2014
Pension plans with accumulated benefit obligations in excess of plan assets:
 
 
 
Accumulated benefit obligation
$
368.8

 
$
394.7

Fair value of plan assets
294.1

 
321.6
Schedule of Actuarial Assumptions
The weighted-average discount rate used to determine net periodic benefit cost and obligations for the Company's postretirement benefit plans are as follows:
 
2015
 
2014
 
2013
Net periodic benefit cost
3.6
%
 
4.0
%
 
3.2
%
Benefit obligations
3.9
%
 
3.7
%
 
4.0
%
Weighted-average assumptions used each fiscal year to determine net periodic benefit cost for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.8
%
 
4.2
%
 
3.5
%
 
2.5
%
 
3.5
%
 
4.0
%
Expected return on plan assets
6.0
%
 
6.5
%
 
7.9
%
 
2.9
%
 
3.1
%
 
3.5
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.2
%
 
3.5
%
 
3.7
%

Weighted-average assumptions used each fiscal year to determine benefits obligations for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.9
%
 
3.9
%
 
4.3
%
 
2.5
%
 
2.5
%
 
3.7
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.6
%
 
3.4
%
 
3.5
%
Schedule of Healthcare Cost Trend Rates
Healthcare cost trend assumptions for postretirement benefit plans are as follows:
 
2015
 
2014
Healthcare cost trend rate assumed for next fiscal year
7.1
%
 
7.1
%
Rate to which the cost trend rate is assumed to decline
4.5
%
 
4.5
%
Fiscal year the ultimate trend rate is achieved
2029

 
2029
Schedule of Effect of One-Percentage-Point Change in Assumed Healthcare Cost Trend Rates
A one-percentage-point change in assumed healthcare cost trend rates would have the following effects:
 
One-Percentage-Point Increase
 
One-Percentage-Point Decrease
Effect on total of service and interest cost
$
—

 
$
—

Effect on postretirement benefit obligation
0.8

 
(0.7
)
Schedule of Weighted Average Allocation of Plan Assets
Pension plans have the following weighted-average asset allocations at the end of each fiscal year:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2015
 
2014
Equity securities
27
%
 
28
%
 
6
%
 
8
%
Debt securities
70

 
70

 
1

 
2

Cash and cash equivalents
3

 
1

 
—

 
—

Other
—

 
1

 
93

 
90

Total
100
%
 
100
%
 
100
%
 
100
%
Schedule of Fair Value of Plan Assets
The following tables provide a summary of plan assets held by the Company's pension plans that are measured at fair value on a recurring basis at the end of fiscal 2015 and 2014:
 
 
 
Basis of Fair Value Measurement
 
Fiscal 2015
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
15.1

 
$
15.1

 
$
—

 
$
—

U.S. large cap
46.2

 
46.2

 
—

 
—

International
31.0

 
22.7

 
8.3

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
198.4

 
196.9

 
1.5

 
—

High yield bonds
11.3

 
11.3

 
—

 
—

Emerging market funds
7.4

 
7.4

 
—

 
—

Insurance contracts
116.7

 
—

 
—

 
116.7

Other
11.8

 
9.4

 
2.4

 
—

Total
$
437.9

 
$
309.0

 
$
12.2

 
$
116.7


 
 
 
Basis of Fair Value Measurement
 
Fiscal 2014
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
16.6

 
$
16.6

 
$
—

 
$
—

U.S. large cap
50.2

 
50.2

 
—

 
—

International
39.8

 
28.7

 
11.1

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
218.7

 
216.6

 
2.1

 
—

High yield bonds
13.0

 
13.0

 
—

 
—

Emerging market funds
9.5

 
9.5

 
—

 
—

Insurance contracts
119.8

 
—

 
—

 
119.8

Other
6.0

 
2.6

 
3.4

 
—

Total
$
473.6

 
$
337.2

 
$
16.6

 
$
119.8

(1)
Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds.
Schedule of Changes in Fair Value of Plan Assets
The following table provides a summary of the changes in the fair value measurements that used significant unobservable inputs (level 3) for fiscal 2015 and 2014:
 
Insurance Contracts
Balance at September 27, 2013
$
112.0

Net unrealized gains
15.5

Net purchases, sales and issuances
(0.6
)
Currency translation
(7.1
)
Balance at September 26, 2014
119.8

Net unrealized gains
12.2

Net purchases, sales and issuances
(0.1
)
Currency translation
(15.2
)
Balance at September 25, 2015
$
116.7
Schedule of Expected Benefit Payments
Benefit payments expected to be paid, reflecting future expected service as appropriate, are as follows:
 
Pension Benefits
 
Postretirement Benefits
Fiscal 2016
$
40.0

 
$
4.6

Fiscal 2017
33.6

 
4.3

Fiscal 2018
33.0

 
4.0

Fiscal 2019
32.6

 
3.8

Fiscal 2020
31.4

 
3.5

Fiscal 2021 - 2025
143.9

 
15.6
XML 20 R121.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Equity [Abstract]    
Amortization of unrealized loss on derivatives $ 0.6 $ 0.6
Income tax provision (0.2) (0.1)
Net of income taxes 0.4 0.5
Amortization of pension and post-retirement benefit plans:    
Net actuarial loss [1] 9.4 8.1
Prior service credit [1] (4.6) (9.9)
Plan settlements [1] 6.0 3.8
Total before tax 10.8 2.0
Income tax provision (4.1) (0.6)
Net of income taxes 6.7 1.4
Total reclassifications for the period $ 7.1 $ 1.9
[1] These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note 13 for additional details.
EXCEL 21 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`&.)>$?EB3^P!P,``()0```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W;RTX;,13&\5=!V59D?.8^%6%3NFV1VA=P9QPR8FZR30AO7T\`M8U" M!2V1_IO'R4Y5R/ MWJ>AFZS1C=L8X_MNZ?Q#9]RQ_H^5Y\Y79JWO.O^FQD^_W=*:;K_&;=KIJ=7G M7=C%A<]6BU!UK^IP>.'?)FO[^="FX>:/*^;W__A=#G[$;=]=67W?'C38GNR8 MYN=EK]OAV%'=C_;VQSC>ON=M8N9OU9CF?+)AH?7MD;LD++X.51>%K?^K]_.= M4H_6O*KAO/"$?XJ-MJ;YYFTXW^/_C=\7G&Z.^5SWKU\Z]'W11?NG$R+QICEB MR!P)9(X4,D<&F2.'S%%`YB@A[%````*P(```L```!? M.0Q(OW[ MCMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*> M-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I M//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C M9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P"4$L#!!0````(`&.)>$?A("G7 MX0,``.!3```:````>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%V\UJ(T<` M1>%7,7J`Z;KU7V8\J]G,-LD+"+MMF;$EH>Z0S-M'\2(X0_J2A>%L;&Q!]UV( M#]&J\_FXA-M?YI?]^GPZ+H?G\W+SY^O+<;F]_O]N=UC7\^TT+?>'^76_?#J= MY^/UUG>;W;_7&Z?%\.\[PNT]LO?;K>X/KRC_/\?VY_>GQ\OI^_GNY_?YV/ZW^L MF/ZYP6[:'A2W!T5D4-H>E)!!>7M01@:5[4$%&52W!U5D4-L>U)!!?7M01P:- M[4$#&:1@9`S,)(B=$[&;T3HWB?H68E[6,+HG8S>B=$[&;T3HWB=&[V3T3HS>R>B=&+V3T3LQ>F>C=V;TSD;OS.B=C=Z9T3L;O3/TK-L][&;T MSD;OS.B=C=Z9T3L;O3.C=S9Z9T;O;/3.C-[%Z%T8O8O1NS!Z%Z-W8?0N1N_" MZ%V,W@7ZKM)]6A=&[&+T+HWA=&[V+T+HS>U>A=&;VKT;LR>E>C M=V7TKD;ORNA=C=Z5T;L:O2MTUL0=-F'TKD;ORNA=C=Z5T;L:O2NC=S-Z-T;O M9O1NC-[-Z-T8O9O1NS%Z-Z-W8_1N1N_&Z-V,W@TZ*^@."S)Z-Z-W8_1N1N_& MZ-V-WIW1NQN].Z-W-WIW1N]N].Z,WMWHW1F]N]&[,WIWHW=G].Y&[PZ=]7:' MO1F]N]&[,WH/H_=@]!Y&[\'H/8S>@]%[&+T'H_

@]&[V'T'HS>P^@]&+V' MT7LP>@^C]X!:'1?K4+6.S76@7B>X8"=`Q4YPR4Z`FIW@HIT`53O!93L!ZG:" M"W<"5.X$E^X$J-T)+MX)4+T37+X3H'XGN(`G0*+;`!,K,&V""8EN(TRJPK09 M)M5AVA"3*C%MBDFUF#;&I&I,FV-2/:8-,JDBTR:94),I%V4*JC+ELDQ!7:9< MF"FHS)1+,P6UF7)QIJ`Z4R[/%-1GR@6:@@I-N4134*,I%VD*JC3E,DU!G:9< MJ"FHU)1+-06UFG*QIJ!:4R[7%-1KR@6;@HI-N6134+,I%VT*JC;ELDU!W:9< MN"FHW)1+-P6UFW+QIJ!Z4R[?%-1OR@6<@@I.O4\XE\/^,C_\NEZ>CT_+1\_Y MU\7]I'>>+^N/E_GCM[Q=U8]XY_=ZO=4\O?W\\+?.VU7_7C+]/&7Y\A=02P,$ M%`````@`8XEX1XB35HF[!0``)Q\``!````!D;V-0&ULO5E1 M4]LX$/XKFCS1F6L3)X0"0S,#!'K,T#9'*'T6CI)HL*54DE-RO_Y6\XS94^A\4MK[MSBM-VVZ5SDW'X" M$P5OI]KDW,%/,VOKZ52F8JC3(A?*M;N=SE%;/#NA)F+R<;'MM#4X\Z.<+Q:9 M3+F36@V^R=1HJZ>.73VG(CMKOS8(".AY+-+"2+<:=$J;:E.P&:<\$YJT62_3TC5=I8E._:+;AWOPS[;8([?"/WYI+;F17+D6L_)?^-EME<.6K>$Y M6UAG!K^T>;)S(9P]:V\;PV/5MOHL#P?)83>8P..N:7L[M<$Z;CL3]RWWTF7" M_IB.N''_4RS"I#:1`-];E?EO^F#G:L*NE`-"LAM5C@7+5PW*]NE2*ZLS.0%Z M31@''!#S42KX,7;0U@#3:X`Y;(#I[\=<\(RK5+#Q&U*\QYX=C'@#OXX;8$Y0 MS`5/GV9&%ZI$7'`K+=-3-C+"PC*CF'&1Y]RLO-E8SI0$;G'/B#2%?IQ$,7XR((NU!7BT,58S[QS.FZ&TJ?8V'O`#!"50S`9'AW*)8L[3WX6T\L7P%HBO MK&#G,R-$'O$-_A:I`WD%=SSH3F0AB"!>9H9B;E2J<\'N^;/`%_V*&P7=P0K? M:FL_,'"?!06-=+>$\&@C([VMMZK57VR4^5A[)Z]@IHL\MDA?M9[\D5D63&\4 MQ'@F'S.(@[4QG@[%(][7G7#2B)#V?OC(A,$=$(/R/YPW?OI$#\")(B_*R/]P MN'L#O?&T7.\_TLW9-6@10$$OHZ$I.*"HPV2M0[.">0^[;#W6CY6'[](KNG!0N=M!`NO!T\MI%>_):Q/8$ MI50STJ:B9[0A*6Q]?/U(%8H$CM2A/EXTD3H4&8=4HGZT:(HK41_/8U(O^I_K MYW$?SV.R..GC>4SF_A&>QS0&YP&-Z3;`X#P@=>D(+YYI#,X#&H/S@,;@/*`Q M.`]H3`,]_]Q`SS_C/*`Q.`]H#,X#&H/S@,;@/-C=G[YSXTFZ%!_8P5`XCN_1 MNYAM!0*I[O54U\0$>:B)`:6(''+CF)_*B+0^YO@]^WH5$][4QQSC/(ACAF(J M3'W,,J$^YP]?1]==_6P^#@.VO% MZIC?&V`N&F#.:V.23FPCH,89-1@GMA%0X_QJ@+EN@+EZ)P9$*=R.^=(:%[3- M*8`D\MIH['3Z!!O$HC#IG$,!`)H`U73DC%T].KQ-F?V85R(>O:J+865="-[P/;*"U7HVB?0I!N[3JT)B('A"W"DGDIH^Z54AZ.`]H3/33"H'!]8#$1&[ZWMR]@OI4 MFFK?Q&Z^/*XQ_G'G>^.KKXOMW<_B@_\`4$L#!!0````(`&.)>$>K.&+0/@$` M`&D#```1````9&]C4')O<',O8V]R92YX;6S-DTU/PS`,AO\*ZKU+LS&0HJX' M0)R8A,00B%N6>%M8\Z'$4]=_3Y9U+0,NNW&K:[^/7\=)*1P3UL.SMPX\*@A7 M>UV;P(2;91M$QP@)8@.:AU&L,#&YLEYSC*%?$\?%EJ^!C(OBAFA`+CER<@#F MKB=F52D%$QXX6M_AI>CQ;N?K!)."0`T:#`9"1Y1DU:O9&MN8D@SZJHR.:QYP M;J5:*9!W[5#V.Q4[(W@=CG*0??OT]T\/*4.RKG(?5%_5-,VHF:2Z.#`E[_.G MEW0VN3(!N1$054$Q;!W,LE/GM\G]P^(QJ\8%G>:4YN/K!;UEMR<=ALC-_ M@V'=#?%O'9\,INVBPAHNW&W2R+3<])E`$H+PRJ&RYB)&UL[5I;<]HX%'[OK]!X M9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/`0L MZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#0 M5%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@ M?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSV MQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9>*?IUE!K9';O=05SP6.XYB1'^ MQL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>" M(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RC MEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L&08:7)"82J3E^34@3_BNEVOZ< MTT#PE"\D^DJ1CVFS(Z=T)LWH,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-& M(81IN_`>KR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@ MR.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z& MU3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@* M-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y M/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?! M4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D M8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2 M.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S M&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M#`DL M6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R M0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH`1JV*^NJ]/^26<.[1[\8$@ MF_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS M#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O M#;#"Q([A[8N_`5!+`P04````"`!CB7A'&G191YT"``"!#@``#0```'AL+W-T M>6QE[*[(MIP(].') M=K$W#K)Z+`";P[?ONM$>KR#7#CT;NCHW`0WIU<[GJ.6]<)!$[G8Y'` M:'0&@\.%.V5W1$<=HIZN@V;\')I!^%2=N]+G>Z1__?C94:KW/%KLQ=/%AIOE M[E*-PSU44U+GB':`;3D?8QM'>^0G5Q\ZM+WG4>&A$0[:,YK&I>#^J`ZA,Z1Q M_0#N$=7QEB,75$B@]+.@"1P98MA%3!`EF23&6")&Z-*9;1K[^+1QC'`A;6Z7 M83?/(/29Y"Q+8-C^#D^7>74[F/((I=OE:4,:5T@I+/E47X!V?KNL='%<<.P@ M;=R>Z)E$RVAXMK'`#CIO)F2!Y3IS!%>F-*:X5'J!)+.Y&96H#+I02C`]*0B: M"8ZHD5RM:"=:-L>4WIB7U==R2WM1`A=C[G$(@:%83?5&M%-_#.RF!IMJ3GM3 M]NQ%NF!1KA/HU:BJZ/**DAEGV,$ZTU2T5_ODHP[Y-$8K53`7DCSH>',0^_9?;IA#N8KTYF_M1[BS;J+UJ/;^AY7]%.+_I*9AJSOJ*-#WC= M_R^TJ+]HPS]$"]KF9*,#VNI_UE:0-80JPE<,R'2LUX:;;K4FOO?1FL7"MSW6 MJU"FOP>WLFBQ`I>HH>H+N1?*.A/HYY\,?C1:1]VN)1+HYY]Q01IFOSL"_]&9 M_@902P,$%`````@`8XEX1_O*+M_S"```12L```\```!X;"]W;W)K8F]O:RYX M;6R5FFM3V\@2AO^*RI](U3D'C63=J&6K($`.5=F$$SCLYT$>VU/1Q:L+)/OK MMTC:1GNGNF_5M_\M1V7Q_:]FOPK:Z:_J0[G:V'87-R?-R7 M:U/K_C_MQC3TV;+M:CW0RVYUW"Z7MC07;3G6IAF.HS!,CSM3Z<&V3;^VFWZV MH_6_0NLWG=&+?FW,4%=;6*UM,_O]M_YD:2MS;[J>P('>;#[IVIS.OE6SH-+] M<+FP@UF=$'9+LP6=K>V_9^[#V;! MPBSU6`UW--CG\Y[.5#2/HG3+<%^[M^:I1Z![(]#E8!_-G7XXG86S0(]#>V6K MP707>C`?NG;`U`$H.A04`R@&$#QH:`Y@.8` MFA\*2@"4`"CY">A<5[HI33`]\AX@*4#2@R#!T8T&4`:@[-#+R@&4`R@_%%0` MJ`!0\19TKLNO*YI(S19SKGO;!^TRN.E,3XZBC"':&+Y%W8YUK;OO[NA;NVHL MA3/M+"]+P@\644QLP>POIJ235S0O^GZDBWIF-"MW?6R*H-I*!*,/RZ*=O:!'?ZFT&E%3JM!*DO==?0R+)5-1&N*;HW*Q>,@[.^YS,\0GLCP=X+\X!GCE#1 M2%1TL)V9XKB[!G8N%FX%)]VE4M#?_L$#T5C3@Z9P007"FNRE](HHM"T2;+OKZ-PN*[LY\&2'=7!%B8N(-S0R]NPB%#`2 M!/PP:H(-AJD3H7&1&$+KV@[NOO>[P#?%!=.4W,$('8P$!Z]L0W'4_D?W MALHCL^].:OT5WAI9ON M>)MC5A%(RE*-NAAI2EY?!_\.[G4U3@%X&@==):)0XUC0V)NK8BP*8M0X%C3V MYJHX111J'!\21ZDTH-N.*'0[%MSVCPK+@QCMC@6[O6DOQ@(A1KMCP6YOVIN' M6-2AWW/!;V_:FRM$H=]SP6],>\$1U>^5Z=\A`*V>2T%X_W-S-$2AXW/!<,3M#01+/6FRP0M3=#21(S"GFS%GFR"OB:"K]Y\E>`B M+4%?$RDF^_(5'Q6JFPCJ>C-6PA9J;*4F+]7V9ZP$8W*"ZB:"NMY,D62(0IF3 M0V-R@C$Y0:4306GOJB;!F)R@XHF@N#>\IQB34[0]E0I?+PIM3]'V5+#=CXH0 MA;:GAR[;4K0]1=O30Y=M*6Y*I&A[*A;2/A3:GJ+MJ6"['X6VIVQW0K#=CT+; M4[0]%6SWH]#V%&U/!=O]*+0]1=O30RN0#&W/T/;LT`HD0]LSM#T35X`^%-J> MH>V98+L?A;9G:'LFV.Y'H>T9VIX=NDF1H>T9VI[]9),B./JD.S>?'\V[X.C" M#!J+Y`QMSP3;.>K'\H+BL\O2+:+8;IRX>[$/-85Z1*'MF6#[?A1%?;:IFZ'M MF6#[?M3_F\Z4N$F(MN>"[5Y4CK;G:'O^TWH;4=,GB$+;<\%V+RI'VW.T/1HZ.YX+C7E2!$;U`QPO!<>^*IT#'"W2\$!SWHS"B%^AX M(3CN1Z'C!3I>"([[41C1"W2\$!S?+NG>A%_N08%Z%X+>6PK.D(\M)0BJ_NM@ M81X0A7H7>]>8B/I#NWPS.$G;):)0[^)75IT_+G.Z2D2AZ(58J+]>P.((/R&* MM5<$T?VH<]9?X0T6L7CQP"V6M MJ2'HMAPZ!F/=F="S]R($!Q6REDPH*+\[^G9HRZ]4_6S&KEQK*M8IYJ\ZS=ID MO*P5W7'J\83[RM*C<6]L.T'#,:4EUJ+>V'#V@3W MFL&8\E)ST3X%S;U M;^X9C"DO=21]EZE4P6!L!DA=2=\&HHJPNE&L+ZFDQJ0?IAB,S0"I:^EKWZF( M!?V(=]:E&N='`T^L*1B,S0"IM>G;*541"_JLWZFDAJ7IAZ4, MQF:`U/3TPS(&8S-`ZH7ZMH15E#,8FP%2/U280KH:MY4%59H,QF:`U!%]NP(N M;66WG3]ZA_WJ@LT`J2O*%_DDVG>W'W%6N\W3@/\:A+5%E=07_0'KMUL&4^3O MY)&Q&2!V1CT;Z2J.&8S_NN3`77D5LQG`6J5*ZI7Z86P&L&:I$KNEGDU^Q;JE MBK5+E=0O]6WSJYC-`-8P55+'U`]C,X"U3)74,_7#6`Y@35,E=4V],-8U5:QM MJJ2^Z9L./.4H>(O!V`R0.J>^CKR:LQS`FJAJVT4]WM&FWS4NMD7F)P+WTXE( ML=+]%)3^[&)UXO*E>_U'NZ"SN]]PSH+E6%7OZ;W/S<=6N^_MR,\__OS]'U!+ M`P04````"`!CB7A'-B,'5,%;VUB37C*9>9CDY#S,/-.6MN:H.$#KF;\? M$+5`F%-?JM"U]MH;]P+RCM`/=L.8>Y]UU;"-?^.\70DN@I@&*9!CDV M/O#'B??R>N-R(BCR8.*=RQHWK"2-1_%EXV_!^@"6$M(C?I6X8]J[)Y,_$O(A M!S_.&S^4.>`*G[@,@<3C@?>XJF0DH?QG"/K4E$3]?8S^K2]7I']$#.])];L\ M\YO(-O2],[Z@>\7?2?<=#S4D,N")5*S_]4YWQDD]4GRO1I_J63;]LU/_).E` M;!0X89$+!'['0$F!"!B.T4@+Y)AQH=N@3V.B)R(0XZ M(GZ=0C2F$*D:(XV>O*;'(UT-M[%&3\W\%&*G([+7`HDED&CTI2F0*`&%:-0W M2-)LN8*O95)+)M5D5LXZ=`0(7RMDED*F\X%3PH#,*&)I22QU?N24,"`SVF5E M2:QT?N*4,"#I:PD06AIR1WI&R)PB)F8Y0P78*H9W5\[6&C"JMV`(9A@$0%O' M,'GHKL;`S-A(0&2KZ#Z&T*UB8*(9*K;;@6YF&+O6;#]@!C^"9!5G83RCTX#M M?*!;'[I[S<3,:3;;^$#W-?Q/LQF8.J0G&:G*\T6]J?L$U[D+;KBGXA> MRX9Y1\+%6=T?K!=".!:9A`OQ[6[BTC4-*GSA\C63G:2N(6K`23O>JJ:K7?$/ M4$L#!!0````(`&.)>$>E"R!WF0<``*(H```8````>&PO=V]R:W-H965T&ULC9I?<^(X#,"_"L-[(;;C.&':SEPIVV59EE+@[CG;IBVS0'HD MW>Y]^W/^44DHX'W8%O.S+$N*++FY_$CWO[+7),D[?[:;77;5?7_<.\I_4VV67K=-?9 M)\]7W;_$8*54@93$W^OD(P._=PKE?Z;IK^+#^.FJZQ4Z))OD,2]$Q/;'[V28 M;#:%)+ORO[70SS6+B?#W1OJ7N:UY\+G)X0U!,"QP5,S1O7!<)Z0NBX0%3SD>L" MA<,KMWF.2XB#HX7S(HVKA71=I/&U4,Z+--X6KNX6C;^%L\-%XW'AZG+1^%PX M.UTT7A>N;A>-WP5P?'#ZZ6L<+SU7O63C>4D]WZ]R0YE9;N,\OK[ MUW:%D,C!-ZKQC5]%B()F]?`:0>6^"MF52!C*GL]1(T09TR->-)47$24B3M(8 M,B8(>Y*C)I`*C.H9CII"2BNO)SAJ!BG?#WE9B&[QQ6$A!$2&+7=PS[QL`\]3/8?5CK[ MBII"2FJ?UWZ&*!G0L*RH.:)$P*^X@)0(M>H%K(L1Y@4>+VT%L5"ZQ65`G!Q` M)[,!MPB@-B*(^(!;0LSXFM48,GZD>RZYTA"-#=389S4VV,R\8Y>(LD'"JXPH M;9Q4#HG*(519<]9;A&`9CU47$A$?.*L0^0"$3;NN$=$U@KJRJRPB]`S2DZA6 M%T*AZ/D>^,?Z8P5G2'B4M"LO/*)]4=U_JF]84]?,*5LC1&A!S5WGV!9))_05 M5%]8U?EL,EO43+7*Q5&4YGC:`5A8`EA>:/2(%.M9;4C2#%0RL$"9"F M3FA,CT*N<$,?R()>/))H5MJ.X39AUCQ5=`*<38PG7(E/4@%/$FU MYO=F'/8&C\B+2#H\Q$L\1QRU!,T^(>8;MZ>$GKX"'K^:S>1#@4Y7-A^,$-.6 M#>X093,:&^5C1(7&X7B4:O8 MN!SK[[?T`2MLFIZ(^&QZ(@!H22-@3:/9^GTH(JP=K]P(84=->!,"I))A`V6, MJ):$,"%JF9!/"%/$^3PTP\)"7J\YH@S_8"X09-L=-C*65'O==K8@4WA`L1/7 M6[3TD[#TT\1]]26*]$X^G-6MP`A1O*0[Q$0A#9?Z$@53DK_2F"#J0NF6RYTI MYN11PUK?HR!,'-6N]3T*HORC;%;?HR!*V279'2S)#FP]HSAN12P+K';"T8>: M6=6.AC6S=LD(DI:P$I:P`4GW41TKL,[T>H;LO))TBR4)3M*(2*)M227IBX.D M.R(I\#E)7QTDC>GNV./_FX.D"9)D>PJ/5>J[@Z@I%N71;%%)^N$@:4:V1^]M M*TGW#I+FU.2L\QX<)"V0)'GDO*A^E(@YI>2P%5%+N%2WDG9!$G9!`5FH:&Y+ MM57;2A!;2MPMT4118RLB+73*`+3OD;#O"11O;1]9VX2\M2%U80_.%FOC#LES MN5B1M/N1L/NAWJ_/58EZ%MLG\'TSP@+?I6U&4[1Q:AGDH1UJ4B]L=0*7:ES2 MKD/"CB((.',/I<')*>">N5LLJ27U8DEMJ?>\I#LBJ2WUGIW/&UIEXLS2WUTEY*PEZJ+?7B)HG6%HVU M47/0GGI1I^&6>A7M#13L#0+^FE7ALMFTM+$(U/?\"`F MT_==7M]['H8/+Y3=R.*5##(^%(,'P8POQ&#%C0_EX):3,Y*#+]SXG1Q\Y<;' MQ/;P?[]G)K;3@8LW60,H],YH M*P]>K52WQUCF-3`B?=Y!J[^47#"B]%)46'8"2&$A1G$4!%O,2--Z66IC+R)+ M>:]HT\*+0+)GC(A_)Z!\.'BA-P5>FZI6)H"S%,],=P?TF, MP@I^-S#(Q1R9W*^8N3= MC4UKQ\%]^1J,V#H0C4`T`^'V0R`>@?@.)!\"R0@D3P!VI=A&7(@B62KX@&1' MS.D(]UHNC(EV1M*Z"==?W0JIH[=L%Z;X9GQ&260EIZ7DKL#:?'6'R'O$HP4> MK6UP7BKBS9KD\B#Y]GD2\91$[,J,EV5&G_/)Q+OE,5GR\6.*6U>GD[2N3:&_ M61.=EZ(O<>+OUE27I2H*_>>FX\5?S$!4]JY(E/.^5:[_K[C99VI$*?A%1-:U$5Z[T`;2GI>1<@JO5#,B\HE,I,=WHNW-UR M"\6[Z:68GZOL/U!+`P04````"`!CB7A'&TT5/B0#``"##```&````'AL+W=O M\V*WRHK;GTW;MM9E/R8F5 M18U?&XN>JBIO_M[ADIQG-K*[A;=B?V!BP9U/W5ZW+2IW*)MP$:V.^],RE<_YTDX=3]%((5(Q1U$`M^$ M+"&">L+E!LPN?%M/X0.],<,])(+`A#Q`Q+B31RV($7G2D,B$/&M(;$)>-"0Q M(0L-28VG^NVIK+YWN]:0;$1M@JXV@>R0`'9(-")`V`4(98`0!(@&.XUE_252 MJQS.8+.);`$(F>,\0"1+'2/TJ$&^DYB@)PC=!)'OA";L66>8[B;Q!M655(KC?*3X?E):@TIY(SIYF1@.(&&C5:6"4CB#1M'V=69R&@V MT38.BGC=;3IPFT*WF=%M"KO`?&PKR-R@:-AVRB^D@A`\Q=?]9@._&?";>D:_ M&?02AU?:0:-"WTRM(>6GH%37'2-O8%G\N[]X-KX`EHI1B:+,R8S/K8;=!+%O M?I^L-2Y-_CMI%PP!%6[V[6Q+K0TYU4R^X/O5?GZ^]<40,5B_0Y,%,JPOQ;S= M#AV7\//I,=_C'WFS+VIJO1/&AY=VS-@1PC"WS=O:P>W82\]#8F+6=,//WZP<0)T+))78W5=75CMUYS\6GK`E1X(O15JZ#6JEN M!:$\UH1A&?*.M/I+R07#2H>B@K(3!)\LB5&(HF@!&6[:H,AM[ET4.3\KVK3D M70!Y9@R+[RVAO%\'<3`F/IJJ5B8!BQQ.O%/#2"L;W@)!RG6PB5?[S"`LX$]# M>NGM@?%^X/S3!+]/ZR`R%@@E1V44L%XN9$J/GC_BPPM6(='3J7]!<>S5)R-E``P_.76IK5K M[[Z\1@-MGH`&`IH(\>(A(1D(R960/B2D`R&](T#7BCV(/5:XR`7O@>RPN1WQ M2L.%$='*0%HUX4W%IN#HN=>LSNOF>\UG?6:>150&,]:]3'+<+;GO8]Y04EX_\]`[S(R(BK[ MJB4X\G.KW$V9LM/@V"!SF>_R6SU0W/N_RA1YARORAD75M!(U2[X6;`BY0O!MGVC18B_]02P,$%`````@`8XEX1_?C M]0KB!```=A@``!@```!X;"]W;W)K+U7+Q7FZ[/U:G=E^?9DWU\CC_#`\;>XU<$W_OJTM+ M/L\&^*>Z_C8<_+E]G*<#0W6HGKNABK)_^UYMJL-AJ*D_\[]3I1_G'`K2S[?: M?[]>;H__5+;5IC[\L]]VNYXVG<^VU4OY=NB^UI<_JND:LJ'"Y_K07O_.GM_: MKC[>BLQGQ_+'^+X_7=\OXR]%.A73"^!4`-\+@/UE`3,5,*+`8B2[7M=O95>N MEDU]F;7G.CCS5!)7_.LO=;6C,W57UG;?_M]563+Q?>AGBF"U\B:1E!+ M;&C"?%2RZ,^O0N`-8CS\C!3"W2]O;N7M6-[0\CE'=.-%C)'3B.BRQ&NI#4WE M:9X4]UFL8+&4I>!G*4862\Z2V2+)M-2&IFSNDHAVR01+1EF\RI*1LV`!B4J\ MH2F3NL3>9W&"Q1$6GZHLCIP%+":YRL)2&2;F/DLN6'+*`BI+3MNE'PE&96$I MS!.XSU((EH*RH,I2T+-X+\?NQ,)2:1HS=KU@\91%O>*UIZU?6)>(YLM&&,^; M+Z)=(!4P@X,_:*Q*,V7&\W@/@6YBL:)P,6T#('FHY;QZSZZGS$TSUBM,[G0AI"SGGDGX$O;]T.&06+##!"#CI9*!2]KDV2M9`?:LZ M8<,B`!#%(IT,5,J^T%FH;S%3K;#A(6.C:*25@6I9[X,U4.."LZF5-]J-B`4Q M+_(8(<*[G:<9&*B>(4TCJI!2A9Q5H6L5N#%#]RM+Q?6Y]"H4#`?U3J?2!!.@ M82%(R;P4QI%J!<]P=+D"LVMJ`C,@CX&+Z7&4>L64`>E^12I.]('N8BF7Q[0/ M2KLB,!Q=KTBUF;DBQ,-BZ&/DBE*NB`Q(MRLR5:)M?6C.%'G$ZA*E5#%C0+I5 M,1,WCGY__12+\`_*]2XRHX*^XD6ZF,U-:#P[-GZB<*2=D:UY`S14NP8,AD80 MT[/I5Z01SR8H!8U,T*#/%\CL&DF MS"3W$`SS-43L0IB?MA&89<&I`\#\8LTZ^2P0"8-(NQIF5]`7S\;>!]$C81!I M5<.L"KKF#=M#,*&!)U(QXTXZU7"GZI(WU):?^G$7L+S(Y4G,D)%:-6S1B[I7 M#?5E9K(\45<3&YZ#'&/V68STJF%>1=VKA@K3%*$[DZ8^89'%K!6,]*IA7D5] MC\,PKX9X:,AE,0M-*V5JF4Q1EZE-68^QQTYZ@[&<]5G,?J&4J64R12'3:?O2 M,IEJSX/3#B8/JL^#"[)#?"Y?J[_*YG5_:F=/==?5Q^O.\$M==U5?79KT%[JK MRNW[P:%ZZ8:/^=`"X[;X>-#5Y]LN__N_&E;_`U!+`P04````"`!CB7A'(:@] MTJPWR?BV#.Z'8+: M)H%IFB4MK;MX.1_.O?;+.3_)IN[8:Q^)4]O2_M\S:_AY$8/X[1;Q-_!4@4PC`_&[9F=A[$=:?LWYNS[XN5W$J79@#=M( MG8*JS0=;L:;1F53EOU/2KYHZT-R_9/\^M*OTUU2P%6_^U%MY4+9I'&W9CIX: M^<;//]C4`]$)-[P1PW>T.0G)VTM('+7T<]S6W;`]C[]D8`KS!\`I`%X#(+X9 M@*8`=`U`^GR-QI/IY`D\*[W42E3D2 M0[9^O"'JV@EU]F,)()DG'SK1Q,"!>;:9S,>L;";W,2\V4_B8RF;**Y.H7KP- MP4M#:&P(F@E0>C\!NB3`8P)D)0"V939V.S+=P.!9[F,JDT$&$Q3!C@BV1*!= MI!Q%L%$DG7F9*L0$18@C0BP19!<90U;$*$+2Z>,CJ]MD4"ISI#)+"GNE,K-S MKXR?"$KDCD1N21"O1'Y7PD\$)0I'HK`DG-<3C._Y@47IT)NG5O`DA8!+@BUD1#I5\$W!?Q(V$1 MZ(I8DQ&GWGDR0;<'2A`*R[A#%EA3%@/_54$/#Y4[:%C,';K`FKH8^L7,D0I` M3M14S`-B-IJ!+$4$/2#F#F%@36'LG\*`V-5@@0#V/G*5@Y(2EJ0H'A!S!S&P M)C'V3V)@#EH`40JA]YY7%JBX/"..4V(L<(YTSW[1?E]W(EISJ=9*P\)FQ[ED M*ELZ4UD/:I5\/6C83NK=7)<;UXWC@>3'RS+XNA9?_@=02P,$%`````@`8XEX M1V'!.'R7!0``M!P``!@```!X;"]W;W)KNP/[8WR^>N>[E>K=K[Y^I0MD']4AW[OSS6 MS:'L^I_-TZI]::KRX=3HL%_I,$Q6AW)W7&[6IVO?FLVZ?NWVNV/UK5FTKX=# MV?RWK?;U^\U2+><+WW=/S]UP8;59K\[M'G:'ZMCNZN.BJ1YOEK?JNHA.DI/B MGUWUWEK?%X/YN[K^,?SXZ^%F&0X>JGUUWPTARO[CKW@Q!^LB+]A2M&?NW[XJVO_JV45&\ M7KT-@2:-/FFVH#DK5GUT\19ZB"I!D7YN@V02->1+DF7P= M()H#C#]O(RM`G*+'9$QTE!Q'CSH*C*3*;=45J2P@25;8LC@-TJ\=QRSE&%(V M7P=(6,H)!&`YIV/.B64S,3J()55NJ[2)@TQ2%;9*419XC))AE@U89K>)1\O& MOHTRHF$#:?&1G/Q"H"307]M-F=W4LIN%8@>G]G11F;)ZQ3:,LM#P@1AS+T#F ML8PR9CBS^S<.Q?[-K'N(.>6V@E(5:-&K',=I587,ZU#U+;-*-#N)+KD%">E` MB9,!5"JV^M_M6'''4&EC+4Z(232-89PY)@3*-,FR`F5>DUAI5FB4!MOD$8)X MYE"?XTC.G.RQDA=E#J*K6/'R.N<-,@63T&V;0T'95$C%JK95=B5//OF))]M0 M[QUC%4$9#3Q*NHJY8Z!"Z)ABL7VC,!"'(P?55;\PY*H.,N/5S1Q$"D@4BXS9 M*AL?%/*B,IM.8'I$@8BU`F1)Z-75G$4*8"2/Z5;9$+DRF<:C&9_<->>&!FXD\D9"(Q#Z(NNHH$QH,G*9!V&:!F%F M__-(1/-$@"2)2-KM))IFE8SC'$01%TT[#!!Y;#$TQY:F2TM\GC$V:D0:Y2#1 MB6._"2H;)&[#'%@Z@@Z6R[^&(XK66>+88S!AFH6NF8)"BGP*JN8'&@WL2GSR MYR310)(DD@<,2:+D;2%31227[@)T:98&/D=HSA(-+$ED`FI@B4JCU%&744@N M"+)X7A..XT0#3A(9@AHX\6FUSJX!.@X"8B@K?[=E?L;10))$)J#.H`L=0,Y1 M9A1?V7,A`IGRV",1AQQ(PXI`D@9>1=`-E)4F+A6(.AT%A/7S?T,3^^,1ZTC M?K8BX).1X4IP:E*NYSDHBQQL`957@29.1`(B&G%_LB4X-5&D7)UMZZ+^2"@? MOHD_#_1X6$(K MYQ=QMWIX-\2N;]5U,;Y.^PBS6;^43]7?9?.T.[:+N[KKZL/I-=%C77=5;ZX? MC>7BN2H?SC_VU6,W?#7#^AA?JHT_NOIE?D=X?E&Y^1]02P,$%`````@`8XEX M1^6G5^V*!@``=R0``!@```!X;"]W;W)K37YO=\=RIOI6U6]7RT6Y=-;OL_*>?&>'^J_O!3' M?5;5'X^OB_+]F&?/;:/];B&CR"[VV?8PO;UNO_MQO+TN/JK=]I#_.$[*C_T^ M._Z[S'?%U\U43/LO?FY?WZKFB\7M]>+4[GF[SP_EMCA,COG+S?0/<;4QLH&T MB+^V^5<9O)\TY!^+XE?S8?-\,XT:#ODN?ZJ:+K+ZY3-?Y;M=TU,]\C^^T^\Q MFX;A^[[W=7NY-?W'K,Q7Q>[O[7/U5K.-II/G_"7[V%4_BZ^'W%^#:3I\*G9E M^__DZ:.LBGW?9#K99[^[U^VA??WJ_A)'OAG=0/H&\M1`B,$&RC=0WPWL8`/M M&^BQ#8QO8$X-I!ML8'T#^SU"/-C`^0;N>X3A*L6^0?S=8/@:$M\@.3502;L> MNOEK9_\NJ[+;ZV/Q-2G?L^:>$%CMVBJN>_K+_]O!4NN5Y\ M-AUYC&PQ2X")(PJS@AA!8>X@1E*8%&(4A5E#C*8P]Q!C*,P#Q%@*LX$8=\(L MZMJ2!99]@7578`DZB.$@IBM>ASFTF(A"W-$(EH1")!0@@6;9=K.L@B%JC)@C MF.NX*IYKA[B[B$@O(M87$?<7$0_P@B)'7?4F!,5ZGD3!/W&YT+HOM.H*K<-" M)R-FRJ"9,D$'!JV6N)LH$U`V\9P$K4.04G-#@1Y"D#1S=9FN171M0-#A0=T$2<<$@,S=7)!,6Q%*)$9484)$DE3B<'3TG01L6Q%)) M$)4DI&+IU92$%VR$P;>]7RH#,):.B!"?)GP$M2%G8.E!?B@I])Q<5P\(%R4T M\PW$Z>!^X8D+3!S80*(IC5YZ$"E)L7>E$")$9)D;$^!F",C3QMXC@/DDAJ9] MT7U2`!$1W=$]0,T`C*>,G4H`JTHLO42`^,])4,J">#(:DP%RKLGUM?2@;AQF M0E,6Q)/!SB`,J(RCYF`E@#DXU_K8B,&PK@L+!B-CRU)8?N58S\?"A4R7YWX` MQG/&'B"@"21T@=Q0@<+(!9!C:HB-0(1.(/$H_>H)55Y(8_!J[@L)<&=U]-$+ MH,@!4]11).>D6ZX![CQ!]/?\P(#&:]E%3AO(*8I'3?_)['ST$L#MQF0OB?U) MAO[$I"\)[$2)A`X2ZR$;@9@/)^SW0QT%#IH2>`H M3.1C03P9[!42>@4=M:0"TF+H-+$9@/&$L%](#>YX02J0U$"!U$B)EM@/I`&# M24HVEA+L`Q*7,/("<+6\:%([4&\V'A-*)?86:0%Q155I*4-'B%VL%*DN*X@; M6TML'1):!UFCI0P-H=XNQ70E@6W0T3[%78VY%;&]2&@O9"9=R5!9]=CRX'V$ M3,!0=(Z4":_S?6T`A#:>%(!F(8H_[L!"KL!&P](I4H4*'=.[AY0%\62PABNP M>6!2I`K5V3I:I5(>Q=/!$JXDF$Q+3>:="M59CEPWZNS828&A:/M24'D=]@OK M&?$PGA`6:`4%FCZ-4QIHH95\1@30T67"2JZ@DI/!=:E"[=4)3B?^#@,HJ;#\ M]+4TPR7O5QO83`@G:5M8P^YD?":-/BP"'!T6AR#>J0'$CC)J=;(@GQ45W-Z, MF31L&2JT#"8KJE#FE=2CN&*=5Z'.,Q%0A3(_5>P\1.1QL=RKW2>+Z\N&@8V>EH@[L:D1`U]@T-?8..-AJ<[X^-T1I; M@H:60&<;K7E9ZHL#(/2F,`6@631F2ZBQ6VC@%H*.Q1HJ_.C5@[.Z!EE=D#N: MI;Y\#@0@,W;M6&:!\82Q+&N0Y)GDIQU&CP-P-FOKQ\\DB%/ M]E(6Q)/!RJUAC*>3GPY%640C%X[!PFPB,!9M6P:79FUY<3G]/CS4:' M2]&HYNQ@J<.M`4Z=;:3\\UHS\)C!/[`=@OC'M1!RMAU;!#]^>,]>\S^SX^OV M4$X>BZHJ]NV/'EZ*HLKKKJ)Y/9%O>?9\^K#+7ZKFK6MFN/M=3/>A*M[[G_F< M?FMT^Q]02P,$%`````@`8XEX1[-&Y_6@`0``L0,``!D```!X;"]W;W)K&ULA5/;3JPP%/V5IA]@@6'43!@21V/TX23&AW.>.["! MQEZP+8/G[^T%$(R)+W3OS5IKK]U+,2K]9CH`BSX$E^:(.VO[`R&FZD!0BR4(/E3,*+1F80@NK_)^!J M/.(4SX57UG;6%TA9D(57,P'2,"61AN:([]+#*?>(`/C+8#2K&'GO9Z7>?/)< M'W'B+0"'RGH%ZI8+W`/G7L@U?I\TOUIZXCJ>U1_#M,[]F1JX5_P?JVWGS"88 MU=#0@=M7-3[!-,+>"U:*F_!%U6"L$C,%(T$_XLID6,?XYS:9:#\3LHF0?2.0 MV"C8?*"6EH56(S(]]6>7'AQ<>Q&GC$Q0TW%Z9]2XZJ7,TKP@%R\T82+EM,:D M"X(X]1];9'A+S]8M?J?O9OHN.MQM'.Y_%\AG@3P*Y!N!Z^V($7/:8FZ^-2&K M/16@VW!U#*K4(&WMK"'ZI;)@TZ*^M.-AQ#HY0%9R*Y MVF/4N?>S)!P:Z\,;%^MXI6)B53\_D.65EI]02P,$%`````@`8XEX1T7Q%/^C M`0``L0,``!D```!X;"]W;W)K&ULA5/;;IPP$/T5 MRQ\0`TO2=,4B95-5Z4.E*`_ILQ<&L&(SU#9+^O?Q!0@;1E>S-@7;6#GO&3-6!XN8*!^C=GP:UXM:ENF5FT,#K0%*294ERPQ07 M/2V+4'O498&CE:*'1TW,J!37_XX@<3K0E"Z%)]%VUA=86;"55PL%O1'8$PW- M@=ZE^V/N$0'P+&`RFYAX[R?$%Y_\J@\T\19`0F6]`G?+&>Y!2B_D&O^=-=]; M>N(V7M1_AFF=^Q,W<(_RCZAMY\PFE-30\%':)YP>8![AV@M6*$WXDFHT%M5" MH43QU[B*/JQ3_)/O9MKGA&PF9"OA-@G&8Z-@\P>WO"PT3L0,W)]=NG=P[46< M,C%!3[ M"X??OQ;(%X$\"N3_&S%BCA>8+/G0A&WV5(%NP]4QI,*QMW%+U^IZ.^^R<";O M\+(8>`N_N6Y%;\@)K3O9<`P-H@5G(KFZIJ1S[V=-)#36A]]&ULC5/;;IPP$/T5RQ\0L[#;5BL6*9LJ:AXB17EHG[TP M@!6;(;99TK^O+\"R493T!<\,YYPYXTL^HGXQ+8`E;TIVYD!;:_L]8Z9L07%S M@SUT[D^-6G'K4MTPTVO@52`IR=(D^<84%QTM\E![TD6.@Y6B@R=-S*`4UW^/ M('$\T`V="\^B::TOL")G"Z\2"CHCL",:Z@.]W>R/6X\(@-\"1K.*B?=^0GSQ MR4-UH(FW`!)*ZQ6X6\YP!U)Z(=?X==*\M/3$=3RKWX=IG?L3-W"'\H^H;.O, M)I144/-!VF<XBBZL8_RSRR;:QX1T(J0+ MX4<2C,=&P>9/;GF1:QR)Z;D_N\W>P;47<BS3=Y.SLA29, MI!S7F`N".?4/6Z3TFIZN6WQ-SV9Z%AUF5P[_0V`["VRCP/:S$2/F>(W)WC5A MJSU5H)MP=0PI<>ALW-*ENMS.VS2Y#UOX)'K1G2&G-"ZDPW'4"-:<":2 MFQTEK7L_2R*AMC[\[F(=KU1,+/;S`UE>:?$/4$L#!!0````(`&.)>$&PO=V]R:W-H965TVF0.)TI"E="B^B[:POL+)@*Z\6"GHCL"<: MFB.]3P^GW","X)>`R6QBXKV?$5]]\J,^TL1;``F5]0K<+1=X`"F]D&O\9];\ M:.F)VWA1?PS3.O=G;N`!Y6]1V\Z932BIH>&CM"\X/<$\PMX+5BA-^))J-!;5 M0J%$\;>XBCZL4_R3IS/M:,9$RFF+25<$<^J?MLCH-3W;MOB:OEOHN^AP M=^5P_[5`O@CD42#_WX@1<[K&W/[3A&WV5(%NP]4QI,*QMW%+U^IZ.^^S<"8? M\+(8>`L_N6Y%;\@9K3O9<`P-H@5G(KG94]*Y][,F$AKKPV\NUO%*Q<3BL#R0 M]966[U!+`P04````"`!CB7A'8^-GN*,!``"Q`P``&0```'AL+W=O*VROL M0?L_#1K%G4]-RVQO@->1I"3+L^R&*2XT+8M8>S)E@8.30L.3(790BIN_1Y`X M'NB&SH5GT78N%%A9L(57"P7:"M3$0'.@]YO]<1<0$?!;P&A7,0G>3X@O(?E9 M'V@6+("$R@4%[IU1_CM-[]B5MX0/E'U*[S9C-* M:FCX(-TSCC]@&N$Z"%8H;?R2:K`.U4RA1/&WM`H=US']V=Y,M,\)^43(%\)= M%HVG1M'F=^YX61@UY.+O-WL--$/'*Q$8UDZ;W1JVOGLL\ORW8.0A-F$0Y MKC&;!<&\^J.+S[6F`W"^R2P.Y_(R;,\1+S[4,3 MMMI3!::-5\>2"@?MTI8NU>5VWN?Q3-[A9='S%GYQTPIMR0F=/]EX#`VB`V\B MN[JFI//O9TDD-"Z$MSXVZ4JEQ&$_/Y#EE9;_`%!+`P04````"`!CB7A'VHGD M[Z$!``"Q`P``&0```'AL+W=OP)$W);4]TMZYX<"8K7M0W-[@`-K_:=$H[GQJ.F8'`[R))"59GF6? MF.)"TZJ,M2=3E3@Z*30\&6)'I;CY=0*)TY'NZ%)X%EWO0H%5)5MYC5"@K4!- M#+1'>K\[G(J`B(`?`B:[B4GP?D9\"NL M^=XR$+?QHOXE3NO=G[F%!Y0_1>-Z;S:CI(&6C](]X_05YA%N@V"-TL8OJ4?K M4"T42A1_2ZO0<9W2G^)NIGU,R&="OA+NLF@\-8HV'[GC56EP(G;@X>QV!P\W M0<0K$QO53)K>&[6^>JGR?5:R2Q":,8ERVF)V*X)Y]0];Y/2:GF];_)N^7^C[ MY'!_Y?`_^A>+0)$$BK^-F#"G:\R?+MEF3Q68+EX=2VHSFEI+>OY\UD="Z$'[VL4E7*B4.A^6! MK*^T^@U02P,$%`````@`8XEX1S3Z1;RA`0``L0,``!D```!X;"]W;W)K&ULA5/;;IPP$/T5RQ\0L\"VU8I%RB:JFH=(41[:9R\, M8,5FJ&V6]._K"Q`VBI(7/#.<<^:,+\6$^L5T`):\*MF;(^VL'0Z,F:H#QGC0QHU)<_SN! MQ.E(=W0I/(NVL[[`RH*MO%HHZ(W`GFAHCO1V=SCE'A$`OP5,9A,3[_V,^.*3 MA_I($V\!)%36*W"W7.`.I/1"KO'?6?.MI2=NXT7]9YC6N3]S`WN6]$;5_4$L#!!0````(`&.)>$?7>&]! MH@$``+$#```9````>&PO=V]R:W-H965T+6I;IAIM?`JT!2DJ5)Y6]1V=:932BIH.:#M&\X/L$TPK47+%&:\"7E8"RJ MF4*)XI]Q%5U8Q_@GVTVT[PGI1$@7PFT2C,=&P>8#M[S(-8[$]-R?W6;OX-J+ M.&5B@IJ.TSNCQE7/19K=Y.SLA29,I!S7F,V"8$[]VQ8IO:2GZQ8_T[.9GD6' MV87#W<\"VUE@&P6V_QLQ8HZ7F-M_FK#5GBK03;@ZAI0X=#9NZ5)=;N==&L[D M"U[D/6_@A>M&=(:&ULA5/;;IPP$/T5RQ\0LRQ)DQ6+E$T5M0^5HCRTSUX8 MP(KM(;99TK^O+T!H%34O>&8XY\P97\H)S8OM`1QY4U+;(^V=&PZ,V;H'Q>T5 M#J#]GQ:-XLZGIF-V,,";2%*2Y5EVPQ07FE9EK#V9JL312:'AR1`[*L7-[Q-( MG(YT1Y?"L^AZ%PJL*MG*:X0";05J8J`]TOO=X50$1`3\%##934R"]S/B2TB^ M-T>:!0L@H79!@?OE`@\@91#RC5]GS?>6@;B-%_7'.*UW?^86'E#^$HWKO=F, MD@9:/DKWC-,WF$>X#H(U2AN_I!ZM0[50*%'\+:U"QW5*?_*;F?8Q(9\)^4JX MS:+QU"C:_,H=KTJ#$[$##V>W.WBX"2)>F=BH9M+TWJCUU4MU>U>R2]"9(8EQ MVD)V*X)Y\0\[Y/1O>KZAYY_3]PM]GPSNM_3]W><"Q2)0)('B/Q,FR&D+R8OL MGQYLLZ,*3!$>V MB!!ZH0$``+$#```9````>&PO=V]R:W-H965TE#I2@/[;,7!K!B,]0V2_KW]058-HJ2ON"9X9PS M9WPI)M0OI@.PY%7)WAQH9^VP9\Q4'2AN;G"`WOUI4"MN7:I;9@8-O`XD)5F6 M)'=,<='3L@BU)UT6.%HI>GC2Q(Q*`DBHK%?@;CG#`TCIA5SC M/[/FI:4G;N-%_7N8UKD_<0,/*'^+VG;.;$))#0T?I7W&Z1'F$6Z]8(72A"^I M1F-1+11*%'^-J^C#.L4_>3K3WB=D,R%;"5^38#PV"C:_<Q"D3$]1TG-X9-:YZ+K,\+=C9"\V82#EN,1<$<^KOMLCH-3W;MOB].$;?94@6[#U3&DPK&W<4O7ZGH[[[-P M)A=X60R\A9]Z(!``"Q`P``&0```'AL+W=O6B? MO3"`%=M#;;.D?U]?@+!5U+S@F>&<,V=\*2+X@O M(?G>G&@6+("$V@4%[I4OT;C> MF\TH::#EHW3/.'V#>81#$*Q1VO@E]6@=JH5"B>*O:14ZKE/Z<]C/M/<)^4S( M5\+G+!I/C:+-+]SQJC0X$3OP<':[HX>;(.*5B8UJ)DWOC5I?O59Y493L&H1F M3**_=T6.;VEY]L6']/W"WV?'.YO'!X^%B@6@2()%/\;,6'.MYC[ M?YJPS9XJ,%V\.I;4.&J7MG2MKK?S(8]G\@:ORH%W\(.;3FA++NC\R<9C:!$= M>!/9W8&2WK^?-9'0NA!^\K%)5RHE#H?E@:ROM/H+4$L#!!0````(`&.)>$&PO=V]R:W-H965TY/W,`]RM^BLJTSFU!20 MP;47<BS3;Y>SLA29,I!S7F,V"8$[]RQ8IO:2GZQ;?T[ZI`-^'J&%+BT-FXI4MUN9UW M:3B33WB1][R!GUPWHC/DA-:=;#B&&M&",Y%<75/2NO>S)!)JZ\.=BW6\4C&Q MV,\/9'FEQ5]02P,$%`````@`8XEX1\MI;*RA`0``L0,``!D```!X;"]W;W)K M&ULC5/+;MLP$/P5@A\0RK*=%H8L($Y1)(<`00[M MF996$A&2JY*4E?Y]^9`4.0C:7L3=U+V!GO0_D^#1G'G4],RVQO@=20IR?(LNV6*"TW+(M:>35G@X*30\&R('93B MYO<))(Y'NJ%SX46TG0L%5A9LX=5"@;8"-3'0'.G=YG#:!40$_!`PVE5,@O,ZIC_[;*)]3L@G M0KX0OD8"2XVBS6_<\;(P.!+;\W!VFX.'FR#BE8F-:B9-[XU:7[V4^3XKV"4( M39A$.:TQFP7!O/JG+7)Z3<_7+?Y-W\[T;7*XO7+X'_UWL\`N">S^-F+"G*XQ M'UVRU9XJ,&V\.I94.&B7MG2I+K?S+H]G\@XOBYZW\,1-*[0E9W3^9.,Q-(@. MO(GL9D])Y]_/DDAH7`B_^-BD*Y42A_W\0)976OX!4$L#!!0````(`&.)>$=% MKX]AI`$``+$#```9````>&PO=V]R:W-H965TVF*BYZ61:@]Z[+`T4K1P[,F9E2*Z[\7D#B=Z8$NA1?1=M876%FPE5<+!;T1 MV!,-S9D^'DZ7W","X)>`R6QBXKU?$5]]\J,^T\1;``F5]0K<+3=X`BF]D&O\ M9]9\;^F)VWA1_Q:F=>ZOW,`3RM^BMITSFU!20\-':5]P^@[S"$;EM\3L\6 M>A8=9CN'^><"^2*01X%\)W#V$`*S9#;;.D?Q]?@+!5U+S@F>&<,V=\R4?4KZ8%L.1-R:D^ZR'&P4G3PI(D9 ME.+Z[PDDCD>ZH7/A632M]056Y&SA54)!9P1V1$-]I'>;PRGSB`!X$3":54R\ M]S/BJT\>JR--O`604%JOP-UR@7N0T@NYQG\FS8^6GKB.9_6?85KG_LP-W*/\ M+2K;.K,))174?)#V&<<'F$;8><$2I0E?4@[&HIHIE"C^%E?1A76,?_;91/N< MD$Z$="'<)L%X;!1L_N"6%[G&D9B>^[/;'!Q<>Q&G3$Q0TW%Z9]2XZJ5(=_N< M7;S0A(F4TQJS61#,J7_:(J77]'3=XFOZ=J9OH\/ME@F7!U#2APZ&[=TJ2ZW\RX-9_(!+_*>-_"+ZT9TAIS1NI,- MQU`C6G`FDIL=):U[/TLBH;8^W+M8QRL5$XO]_$"65UJ\`U!+`P04````"`!C MB7A'5D&K8Z0!``"Q`P``&0```'AL+W=O.O>G1JVX=:ENF.DU\"J0 ME&1IDEPRQ45'BSS4GG21XV"EZ.!)$S,HQ?6_(T@<#W1#Y\*S:%KK"ZS(V<*K MA(+.".R(AOI`;S;[8^81`?!'P&A6,?'>3X@O/GFL#C3Q%D!":;T"=\L9;D%* M+^0:OTZ:[RT]<1W/ZO=A6N?^Q`W81MAYP1*E M"5]2#L:BFBF4*/X65]&%=8Q_MK\FVM>$="*D"^$Z"<9CHV#SCEM>Y!I'8GKN MSVZS=W#M19PR,4%-Q^F=4>.JYV)S?96SLQ>:,)%R_(!9$,RI?]DBI1_IZ8J> M_DS?SO1M=+A=TW?9SP+9+)!%@>R[$2/FN,:DE\FG)FRUIPIT$ZZ.(24.G8U; MNE27VWF3AC-YAQ=YSQOXS74C.D-.:-W)AF.H$2TX$\G%CI+6O9\ED5!;'UZY M6,&ULC5/;;IPP$/T5RQ\0LRQ)JQ6+E$U5 MM0^5HCRTSUX8P(KMH;99TK^O+\"R5=3V!<\,YYPYXTLYH7FU/8`C;TIJ>Z2] M<\.!,5OWH+B]PP&T_].B4=SYU'3,#@9X$TE*LCS+'ICB0M.JC+5G4Y4X.BDT M/!MB1Z6X^74"B=.1[NA2>!%=[T*!525;>8U0H*U`30RT1_JX.YR*@(B`[P(F MNXE)\'Y&?`W)U^9(LV`!)-0N*'"_7.`)I`Q"OO'/6?/:,A"W\:+^.4[KW9^Y MA2>4/T3C>F\VHZ2!EH_2O>#T!>81[H-@C=+&+ZE'ZU`M%$H4?TNKT'&=TI\B MFVGO$_*9D*^$CY'`4J-H\Q-WO"H-3L0./)S=[N#A)HAX96*CFDG3>Z/65R]5 M_K`KV24(S9A$.6TQ5P3SZN^VR.DM/=^V^#=]O]#WR>'^QN%_"!2+0)$$BK^- MF#"G6\S^CR9LLZ<*3!>OCB4UCMJE+5VKZ^U\S..97.%5.?`.OG'3"6W)&9T_ MV7@,+:(#;R*[NZ>D]^]G322T+H0??&S2E4J)PV%Y(.LKK7X#4$L#!!0````( M`&.)>$?`D3_UH@$``+$#```9````>&PO=V]R:W-H965T6U[D&D=B M>N[/;G-P<.U%G#(Q04W'Z9U1XZJ7(MUG.;MXH0D3*:\P:>N6Y$9\@9K3O9<`PUH@5G(KG94=*Z][,D$FKKPQ\N MUO%*Q<1B/S^0Y946?P%02P,$%`````@`8XEX1[$'<2&C`0``L0,``!D```!X M;"]W;W)K&ULA5/+;MLP$/P5@A\0RK*=I(8L($Y1 MM(<"00[MF996$A&2JY*4E?Y]^9`4.0B:B[B[FIF=Y:,8T;S8#L"15R6U/=+. MN?[`F*TZ4-S>8`_:_VG0*.Y\:EIF>P.\CB0E69YEMTQQH6E9Q-J3*0L\;Q.TPC[(-@A=+&+ZD&ZU#-%$H4?TVKT'$=TY]] M/M$^)N03(5\(]UDTGAI%FU^YXV5A<"2VY^'L-@)S^G:F;Y/#[97#^\\%=K/`+@GL M_C=BPIRN,5_>-6&K/55@VGAU+*EPT"YMZ5)=;N=#/$3V!B^+GK?PDYM6:$O. MZ/S)QF-H$!UX$]G-GI+.OY\ED="X$-[YV*0KE1*'_?Q`EE=:_@-02P,$%``` M``@`8XEX1YL1-*2A`0``L0,``!D```!X;"]W;W)K&ULC5/+;MLP$/P5@A\0RK*=%(8L($X1)(<"00[MF996$A&2JY*4E?Y]^9`4 MN0C:7L3=U+V!GO0_D^#1G'G4],R MVQO@=20IR?(LNV6*"TW+(M9>3%G@X*30\&*('93BYM<))(Y'NJ%SX56TG0L% M5A9LX=5"@;8"-3'0'.G]YG#:!40$?!%D8 M'(GM>3B[S<'#31#QRL1&-9.F]T:MKU[*_"XKV"4(39A$.:TQFP7!O/JG+7)Z M3<_7+?Y-W\[T;7*XO7+X'_UWL\`N">S^-F+"G*XQ?[IDJSU58-IX=2RI<-`N M;>E276[G?1[/Y`->%CUOX1LWK="6G-'YDXW'T"`Z\":RFSTEG7\_2R*A<2&\ M\[%)5RHE#OOY@2ROM/P-4$L#!!0````(`&.)>$=CZ2<5H0$``+$#```9```` M>&PO=V]R:W-H965TVF0.)TI#NZ%%Y$VUE?8&7!5EXM%/1&8$\T-$?ZL#N<L$)IPI=4H[&H%@HEBK_%5?1AG>*? M+)EIGQ/2F9"NA/M`8+%1L/F-6UX6&B=B!N[/;G=P<.U%G#(Q04W'Z9U1XZJ7 M,KW+"G;Q0C,F4DY;S&Y%,*?^:8N47M/3;8NOZ=E"SZ+#[,IA_K5`O@CD42#_ MWX@1<[K&[/]IPC9[JD"WX>H84N'8V[BE:W6]G0]I.),/>%D,O(6?7+>B-^2, MUIUL.(8&T8(SD=SL*>G<^UD3"8WUX9V+=;Q2,;$X+`]D?:7E.U!+`P04```` M"`!CB7A'.`',KJ(!``"Q`P``&0```'AL+W=O M`Z\"24F6)LDM4UQTM,A#[5D7.0Y6B@Z>-3ES_.8'$\4@W="Z\B*:UOL"* MG"V\2BCHC,".:*B/]'YS.&4>$0"O`D:SBHGW?D9\]\G/ZD@3;P$DE-8K<+=< MX`&D]$*N\>])\[.E)Z[C6?TQ3.O(?<15=6,?X9Y=-M*\)Z41(%\)=$HS'1L'F#VYYD6L< MB>FY/[O-P<&U%W'*Q`0U':=W1HVK7HIT?YNSBQ>:,)%R6F,V"X(Y]2];I/2: MGJY;?$_?SO1M=+B]\@5]<-Z(SY(S6G6PXAAK1@C.1W.PH:=W[61()M?7A MWL4Z7JF86.SG![*\TN(O4$L#!!0````(`&.)>$>9@+;2I`$``+$#```9```` M>&PO=V]R:W-H965T6C&-$\VP[`D195^8XD+3LHBU1U,6.#@I M-#P:8@>EN/E[!HGCB6[H7'@2;>="@94%6WBU4*"M0$T,-"=ZOSF>=P$1`;\$ MC'85D^#]@O@S^K4/X6M>N\V8R2&AH^2/>$XW>81M@'P0JEC5]2#=:AFBF4*/Z25J'C.J8_ M^[N)]C$AGPCY0CADT7AJ%&U^Y8Z7A<&1V)Z'L]L6B?O3"`%9NAMEG2OZ\O M0-@H:E[PS'#.F3.^%!.:9]L!./*B56^/M'-N.#!FJPZTL#P*%TY'NZ%)XDFWG M0H&5!5MYM=306XD],=`6@;B-%_5O<5KO_BPL/*#Z+6O7>;,9)34T8E3N":?O M,(]P&P0K5#9^235:AWJA4*+%2UIE']%?9MK[!#X3^$JXRZ+QU"C:_"J< M*`N#$[&#"&>W.WBX"2)>F=BH9M+TWJCUU4O)[WC!+D%HQB3*:8O9K0CFU=]M MP>DUG6];?$S?+_1]'4LJ M''N7MG2MKK?SGL867Q2!:^"E,*WM+SNC\R<9C:!`=>!/9S2TEG7\_:Z*@ M<2'\[&.3KE1*'`[+`UE?:?D/4$L#!!0````(`&.)>$?W-E7NI`$``+$#```9 M````>&PO=V]R:W-H965T._5*R_9@/K--`"6O$NA MS)DVUG8GQDS1@.3F#CM0[D^%6G+K4ETSTVG@92!)P=(D.3#)6T7S+-1>=)YA M;T6KX$43TTO)];\+"!S.=$.GPFM;-]876)ZQF5>V$I1I41$-U9D^;$Z7G4<$ MP.\6!K.(B?=^17SSR<_R3!-O`004UBMPM]S@$83P0J[QWU'SHZ4G+N-)_2E, MZ]Q?N8%'%'_:TC;.;$))"17OA7W%X1G&$?9>L$!API<4O;$H)PHEDK_'M55A M'>*?_6&D?4U(1T(Z$XY),!X;!9L_N.5YIG$@IN/^[#8G!]=>Q"D3$]1TG-X9 M-:YZR]/C/F,W+S1B(N6RQ&QF!'/J7[9(Z9J>+EM\3]].]&UTN%TY/'POL)L$ M=E%@MQ*X7X\8,9`V_ MN*Y;9<@5K3O9<`P5H@5G(KG;4]*X]S,G`BKKPWL7ZWBE8F*QFQ[(_$KS_U!+ M`P04````"`!CB7A'0)E:ER%9L4C95%7[4"G*0_OLA>&BV)C:9DG_ MOKX``82T><&>\;G,&-M)+^2[J@`T^N"L46=<:=V>"%%9!9RJ!]%"8U8*(3G5 M)I0E4:T$FCL29R0*@B/AM&YPFKCHXI_+?!9CHSSC$8^*M M+BMM$R1-R,3+:PZ-JD6#)!1G_!R>+K%%.,#O&GHUFR-;^U6(=QO\S,\XL"4` M@TQ;!6J&&[P`8U;(&/\=-#\M+7$^']6_NVY-]5>JX$6P/W6N*U-L@%$.!>V8 M?A/]#QA:.%C!3##EOBCKE!9\I&#$Z8%*I.]I='C4T)N5FC`>,IEC@DG!#'J MFQ817M*CN<5]^FZD[WR%NSD]/-P7V(\">R^PGPL\!:RQ'RAR&42+P2.FR9+3+PR(;,CR$&6[J8IE(FN MT?X$3MGI,C]'[@A_PM.DI27\HK*L&X6N0IN+X$YM(80&4T3P8/:S,L_-%#`H MM)W&9B[]#?2!%NWXGDR/6OH?4$L#!!0````(`&.)>$?R:)8`8@(``.H(```9 M````>&PO=V]R:W-H965TN&M+RBK8!(Y=] M^`R[`VP41"-^5Z3GDW&@@C]2^JXF/\_[,%8QD)J>U@KP1.MN?X- M3C\P^KP M8"?A3(E(Y8!K-69V+P/EH&V61W8PQ21Q/&^R=DS6E@!X36S,@E>1.B:I M)9!X36S,:MYDXYAL+(&UU\3&I/,FF6.260(;KXF-R>9-MH[)UA+P'[R%@04' M#['CHDI_E,C\+A8F@05%!.#:6)6Z\F>8!4I@08H!%/,@>T(,L@<7T2 M2\*?9PYH0:*!6_U@E3;X4\T!+<@U<"\`L*H;OL@#"X26I)M[!\"TP%'RQ?E8 MMP!:DF_N-0#3&HV_HQT+_N$ M%WF'K^079M>JY<&1"MD1=?NZ4"J(C")^DF^UE!\>XZ0F%Z&&&SEFIA6;B:#= M\&4Q?MX4_P%02P,$%`````@`8XEX1WN)50.E`0``L0,``!D```!X;"]W;W)K M&ULA5/;;IPP$/T5RQ\0L\!VJQ6+E$T5I0^5HCRT MSUX8P(K-4-LLZ=_7%R!L%"DO>&8XY\P97XH)]:OI`"QY4[(W)]I9.QP9,U4' MBIL['*!W?QK4BEN7ZI:900.O`TE)EB;)-Z:XZ&E9A-JS+@L!%M9WV!E05;>;50T!N!/='0G.C][GC./2(`?@N8S"8FWOL% M\=4G/^L33;P%D%!9K\#=&P4;/[@EI>%QHF8@?NSVQT=7'L1ITQ,4--Q>F?4N.JUS-*L8%H84N'8V[BE:W6]G?=I.)-W>%D,O(5?7+>B-^2"UIUL M.(8&T8(SD=SM*>G<^UD3"8WUX<'%.EZIF%@ROM+R/U!+`P04````"`!C MB7A'DLPCYK,!```6!```&0```'AL+W=OXQUV0(G^D9V(.Q)+14GQH:JP;I30"I/ MX@RG<;S#G%`1%;G/O:@BE[UA5,"+0KKGG*BO(S`Y'*(DFA*OM&F-2^`BQS.O MHAR$IE(@!?4A>DCVQZU#>,`;A4$O]LAY/TGYX8*_U2&*G05@4!JG0.QRAD=@ MS`G9PO]'S9^2CKC<3^I/OEOK_D0T/$KV3BO36K-QA"JH2<_,JQR>86S!.RPE MT_Z+REX;R2=*A#CY#"L5?AW"R2X>:9<)Z4A(9\*=)^!0R-O\0PPI+NCI M=7HVT;/@,%O2D_OK`IM)8!,$-JL6;]P0``!D```!X;"]W;W)K&ULC53+;J,P M%/T5RQ]0$Q-H%1&DIM5H9C%2U<7,VH'+0[4Q8YO0^?OZ$0A$D=(-MB_G=<4U MV2C5AVX`#/H4O--[W!C3[PC110."Z0?90V??5%()9NQ1U43W"ECI28(3&D4I M$:SM<)[YVIO*,SD8WG;PII`>A&#J_P&X'/=X@Z?">ULWQA5(GI&95[8".MW* M#BFH]OAYLSND#N$!?UH8]6*/7/:CE!_N\*O<6TB<8"&Y]D]4 M#-I(,5$P$NPSK&WGUS&\22;:;0(]$^A,>(I\\&#D8[XRP_),R1'IGKEOM]E9 MN'(B5AEIKZ9"]S:HMM53'L>;C)RTFER7V`["6R#P';5(EVW&#"'-2:^;Y)U-DS7F&YVD5R;I2B"] M:;+&/%Z9D,5T"%"UOP0:%7+H3!B.N3K?LV?JI^L"S[.>U?";J;KM-#I*8V?4 M#U0EI0$;(GJPK3;V3S`?.%3&;1_M7H7+$0Y&]M-5G_\W^1=02P,$%`````@` M8XEX1U>\+7SW`0``$P8``!D```!X;"]W;W)K&UL MC57;;J,P$/T5BP^HN>1"(H+4=%5U'U:J^K#[["23@&ICUC:A^_?K"U",D,@+ MMH=S&6>82=9R\2D+`(6^&*WD(2B4JO<8RW,!C,@G7D.EWURY8$3IH[AA60L@ M%TMB%,=AN,&,E%609S;V+O*,-XJ6%;P+)!O&B/AW!,K;0Q`%?>"CO!7*!'"> MX8%W*1E4LN05$G`]!,_1_AB%!F(1OTMHY6B/3/(GSC_-X>?E$(0F!Z!P5D:" MZ.4.+T"I4=+.?SO1;T]#'.][]5=[79W^B4AXX?1/>5&%SC8,T`6NI*'J@[=O MT-UA;03/G$K[1.=&*LYZ2H`8^7)K6=FU=6_2L*/-$^*.$$\(V!G9-'\01?), M\!;)FICB17L-%T9$*R-IU82[O4Y4ZN@]3Y(TPWN`R3,3U.EP56O<#*":R\*^[\*SK,T<.LPF63]<1D[0E$LR8^ MYH&?8C,QV7@"R:R)CUDMFVPG)EM/8#UKXF,VRR;IQ"3U!+:S)C[F@<+O)B8[ M3V"^\!YF_4#AHW#B8EI_)#%?^@EH6GL\:EH&XF9GDT1GWE3*]>P0'>;?9S6YP2\B;F4ET8DK/3ILGU\Y5Z"S")_T%UCH"3T<*%R5V6[U7KB9Y0Z* MU_T('OX'\O]02P,$%`````@`8XEX1X?29&7.`0``X`0``!D```!X;"]W;W)K M&ULC53+;J,P%/T5BP^H"03H1`2IZ:AJ%R-57736 M#EP>JHVI;4+G[^L'4(B0,AML7\[K@NUTX.)#U@`*?3':RJ-7*]4=,)9Y#8S( M.]Y!J]^47#"B]%)46'8"2&%)C.+`]V/,2--Z66IKKR)+>:]HT\*K0+)GC(A_ M)Z!\.'H[;RJ\-56M3`%G*9YY1<.@E0UOD8#RZ#WL#J?$("S@O8%!+N;(9#]S M_F$6+\71\TT$H)`KHT#T<(%'H-0(:>//4?/'TA"7\TG]R7:KTY^)A$=._S:% MJG58WT,%E*2GZHT/SS"V$!G!G%-IGRCOI>)LHGB(D2\W-JT=!_FAXLZ,%M>CC10Y];Y7;@7)T/\X/=\_@'GJ4=J>`/$5732G3F2A\$NVM+SA7H M$/Z=_IZUOF[F!852F6FBY\*=0+=0O)OND_E2R[X!4$L#!!0````(`&.)>$?Q M.8>)$@(``.,&```9````>&PO=V]R:W-H965T0/*+XD<1(YEIJNJN[#2E4?=I^),XFM@O$"B;M_OUQBUR!+R8N!\;D, M&AB*GHM/60,H],5H*W=1K52WQ5A6-3`BGW@'K?YSXH(1I9?BC&4G@!PMB5&< MQO$*,]*T45G8V+LH"WY1M&GA72!Y88R(?WN@O-]%230$/IISK4P`EP4>><>& M02L;WB(!IUWTG&SW26H@%O&[@5Y.YL@D?^#\TRQ^'G=1;'(`"I4R$D0/5W@! M2HV2=OY[$_WV-,3I?%!_M=O5Z1^(A!=._S1'5>MLXP@=X40N5'WP_@UN>U@: MP8I3:;^HNDC%V4")$"-?;FQ:._;NSSJ^T>8)Z8V0!@3LC&R:/X@B92%XCV1' M3/&2K88+(Z*5D;1JPNU>)RIU]%IFJ[3`5R-TPSC*?HI)1@36ZK,6:>33TPD] MO4_/!GKF,LRF]&QQ7V`Q""RL[YOD@4GN"6QF33Q,'M\W60E/%=*_\#4$L#!!0````(`&.)>$?% M)_6&PO=V]R:W-H965T97(3M";;3L'^_OB1IND+B)9Z9G'/F MC"_YB/K#M`"6?$FAS(&VUO9[QDS9@N3F!GM0[D^-6G+K4MTPTVO@52!)P=(D MN6.2=XH6>:B]Z2+'P8I.P9LF9I"2Z[]'$#@>Z(;.A?>N::TOL")G"Z_J)"C3 MH2(:Z@-]V.R/6X\(@-\=C&85$^_]A/CADY?J0!-O`024UBMPMYSA$83P0J[Q MYZ1Y:>F)ZWA6?PK3.O8O;GF1:QR)Z;D_N\W> MP;47<BVRWR=G9"TV82#FN,1<$<^K?MDCI-3U=T=.?Z=E, MSZ+#;$W/[G\6V,X"VRBPO1HQO1XQ8H[7F.R_)FRUIQ)T$ZZ.(24.RL8M7:K+ M[7Q(PYE\P9>N6XZ9<@)K3O9<`PUH@5G(KFYI:1U[V=)!-36A_&ULA5/;;IPP$/T5RQ\0L\!NTQ6+E$U5M0^5 MHCRTSUX8P(K-4-LLZ=_7%R!L%"DO>&8XY\P97XH)]8OI`"QY5;(W)]I9.QP9 M,U4'BIL['*!W?QK4BEN7ZI:900.O`TE)EB;)@2DN>EH6H?:DRP)'*T4/3YJ8 M42FN_YU!XG2B.[H4GD7;65]@9<%67BT4]$9@3S0T)_JP.YYSCPB`WP(FLXF) M]WY!?/')S_I$$V\!)%36*W"W7.$1I/1"KO'?6?.MI2=NXT7]>YC6N;]P`X\H M_XC:=LYL0DD-#1^E?<;I!\PC[+U@A=*$+ZE&8U$M%$H4?XVKZ,,ZQ3_I8:9] M3$AG0KH2[I-@/#8*-K]QR\M"XT3,P/W9[8X.KKV(4R8FJ.DXO3-J7/5:9O=Y MP:Y>:,9$RGF+V:T(YM0_;)'26WJZH:>?T[.%GD6'V9:>??U<(%\$\BB0WXRX MOQTQ8LZWF,.[)FRSIPIT&ZZ.(16.O8U;NE;7V_F0AC-Y@Y?%P%OXQ74K>D,N M:-W)AF-H$"TX$\G=GI+.O9\UD=!8'WYQL8Y7*B86A^6!K*^T_`]02P,$%``` M``@`8XEX1US7MG&F`0``L0,``!D```!X;"]W;W)K&ULC5/;;J,P$/T5RQ]0$T+;;$20FE;5[L-*51]VGQT8P*K-4-N$[M^O+T!) M5:E]P3/#.6?.^)*/J%],"V#)FY*=.=#6VG[/F"E;4-Q<80^=^U.C5MRZ5#?, M]!IX%4A*LC1);ICBHJ-%'FI/NLAQL%)T\*2)&93B^M\1)(X'NJ%SX5DTK?4% M5N1LX55"06<$=D1#?:!WF_TQ\X@`^"-@-*N8>.\GQ!>?_*H.-/$60$)IO0)W MRQGN04HOY!J_3IKO+3UQ'<_JCV%:Y_[$#=RC_"LJVSJS"245U'R0]AG'GS"- M<.T%2Y0F?$DY&(MJIE"B^%M<11?6,?[)THGV.2&=".E"V"7!>&P4;#YPRXM< MXTA,S_W9;?8.KKV(4R8FJ.DXO3-J7/5<;'>W.3M[H0D3*<X47>\P9^<]V(SI`36G>RX1AJ1`O.1')U34GKWL^2 M2*BM#V]=K..5BHG%?GX@RRLM_@-02P,$%`````@`8XEX1Z`/'FB_`0``>P0` M`!D```!X;"]W;W)K&ULC53+;IPP%/T5BP^(>;<9 M,4B95%6[J!1ET:X]<`$K-J:V&=*_KQ]`8#329(/MRWE=<4TQ"?FF.@"-WCGK MU3'HM!X.&*NJ`T[4@QB@-V\:(3G1YBA;K`8)I'8DSG`WB12(V<$_GO!$Q,QR`*EL(K;3MM"[@L\,JK*8=>4=$C"(H.I]PB M'.`WA4EM]LAF/POQ9@\_ZV,0V@C`H-)6@9CE`L_`F!4RQG]GS0]+2]SN%_7O MKEN3_DP4/`OVA]:Z,V'#`-70D)'I5S']@+F%S`I6@BGW1-6HM.`+)4")@3X\W]/@^/5GHB4^8;.EI=E\@ M7012+Y#N6HSV+7K,:8_Y1,KLRB3;"20W3?:8]+Y)?F62[P2RFR9[3'YE@C?3 MP4&V[A(H5(FQUWXXUNIZSYYB-UT?\+(82`N_B&QIK]!9:#.C;J`:(328$.&# M:;4S?X+UP*#1=OO%[*6_'/Z@Q;!<]?5_4_X'4$L#!!0````(`&.)>$=+MF:D MM0$``!8$```9````>&PO=V]R:W-H965TSCESAK') M!Z7?30M@T8?@TIQP:VUW),24+0AJ'E0'TKVIE1;4NJUNB.DTT"J0!"=IDCP2 M09G$11YRK[K(56\YD_"JD>F%H/K?&;@:3GB#I\0;:UKK$Z3(R><1`?";P6`6,?+>+TJ]^\W/ZH03;P$XE-8K4+=%V2<\.]P6R22"+`MFJQ<.ZQ8@YKS%/]XOLOA39+02R)+E99(WY^B7)8G`" M=!/.IT&EZJ6-$=M^-$>-P(` M`!L(```9````>&PO=V]R:W-H965TU4MT.`%G5A&'YQ#O2ZB]G+AA6>BDN0':"X),E,0I0EJT`PTV; MEH7=>Q5EP:^*-BUY%8F\,H;%OP.AO-^G,!TVWII+K)L( MGE9)Z8X(^W\ M]R[ZZ6F(T_F@_MT>5X=_Q)*\%X'TB.VR2!W<: M+HR(5DZD51/N]#I0J7=OY2)#!;@9H3O&40Y3#!P10*M'+5#JT]&$CA[3\X&> MNPCS*7TYPW\Q""RL'INL`I.5)[". MFOB8S6.3=6"R]@2V41,/`[/')IO`9.,)P*B)CYE1.=O`9.L)Q!/O8V8D'F:! MB[GZ$XEXZ@/0C-Q#&/IX5Q7&LQ^`9J0?HM`'>1+Q`O!!:$8%P#STR3V)>`T$ MH!E%`,/K#[V[C>)E$(#FU$'X`D#O>J,OZL`'A74`)H\W(^)B>Y1,*GYME7N[ MQ]VQ#SXC^_A_PLNBPQ?R"XM+T\KDR)5N(?:]/W.NB(XB>])1U+I3CPM*SLI, MUWHN7.]R"\6[H16/_P?*_U!+`P04````"`!CB7A'\):^ZZ8!``"Q`P``&0`` M`'AL+W=O&\9,V8+BY@I[Z-R?&K7BUJ6Z8:;7P*M`4I*E27+-%!<=+?)0>]9%CH.5 MHH-G3U1_"M,[] MB1NX1_E75+9U9A-**JCY(.T+CH\PC;#S@B5*$[ZD'(Q%-5,H4?PCKJ(+ZQC_ M[*XGVO>$="*D"^$V"<9CHV#S-[>\R#6.Q/3%V3=]E/PMDLT`6 M!;*+$6\O1XR8XR7FUW]-V&I/%>@F7!U#2APZ&[=TJ2ZW\RX-9_(%+_*>-_"' MZT9TAIS0NI,-QU`C6G`FDJL=):U[/TLBH;8^O'&QCE8D;H)\LS&WD6>\4[1NH%W@63'&!'_CD!Y?PBB8`A\ MU)=*F0#.,SSRRII!(VO>(`'G0_`<[8]1:"`6\;N&7D[VR"1_XOS3''Z6AR`T M.0"%0AD)HI*,M$^(;(9X1L#.R M:?X@BN29X#V2+3'-B_8:+HR(5D;2J@E7O4Y4ZN@U3Y,PPUR'(U,UEY M`LFBB8])[YNL9R9K3V"U:.)CUO=--C.3C2>P633Q,0_T9#LSV7H"NT43#Y.& M]TUV,Y.=)[#<>!_S0..C<.9BKOY$8KGU,]"\]WAR:1F(BYU-$A6\:Y2[LV-T MG'_/L;WTW_`\:\D%?A%QJ1N)3ESIT6'O^9ES!3J+\$E_@96>T..!PEF9[4;O MA9M9[J!X.XS@\3^0_P=02P,$%`````@`8XEX1Z7&@$&S`0``%@0``!D```!X M;"]W;W)K&ULA53;;J,P$/T5BP^H"8&T&Q&DIE75 M/JQ4]:'[[,``5GVAM@G=OZ\O0*&*E!?L&9]SYHS&)A^D^M`M@$%?G`E]B%IC MNCW&NFR!$WTC.Q#VI):*$V-#U6#=*2"5)W&&DSC>84ZHB(K,"K@ M52'=&\DG2H0X^0HK%7X=PLEN M.](N$Y*1D,R$N]@;#X6\S4=B2)$K.2#=$3>[S=["E1.QRDA[-16ZMT:US9Z+ M-,UR?'9"(R90CDO,9D9@JWZQ1!*MZET@G032()"N M6MRM6PR8XQIS>[U(]JM(MA*XNUADC?GSJPA>#(Z#:OS]U*B4O3!A;G-V?@+W MB1_\#[S(.]+`7Z(:*C0Z26.OCY]U+:4!:R*^L2Y:^TCG@$%MW/;6[E6XMR$P MLIM>X?PK*+X!4$L#!!0````(`&.)>$&PO=V]R M:W-H965T9J[W*/!.#9FT'KQ*I@7,J M_QZ!B?&`0SP7WMJZT;9`\HPLO++ET*E6=$A"=<`/X?Z86H0#O+V>PG M(3[MX:4\X,!&``:%M@K4+&=X!,:LD#'^FC1_+"UQO9_5GURW)OV)*G@4[*,M M=6/"!AB54-&!Z3Z)B4%KPF8(1I]]^;3NWCOY-&DZTZX1H M(D0+X3YPP;V1B_F;:IIG4HQ(]=1^NW!OX-**&&6DG)KTW9N@RE3/>9P$&3E; MH0GC*<WM\6B&>!V`O$FQ;#;8L> M<]QB_B-E(C==/_`\ZVD-?ZBLVTZAD]!F1MU`54)H,"&".]-J8_X$RX%!I>WV ME]E+?SG\08M^ONK+_R;_!U!+`P04````"`!CB7A'@:Y)'BM*+%L!)+*=H MW<";0+)CC(A_9Z"\/WD[;TR\UV6E3`*G"9YX>@5(CI(T_!\UO2T.^\?X&AA<@(9IQ*^T19)Q5G(\5#C'RYM6[L MVKLW]_Y`VR8$`R%8$;`SLF4^$4721/`>R9:8?[<[:K@P(EH92:LF7/>Z4*FS MUS2,X@1?C="`<93S'+.;$%BK;UH$WI(>S.C!;?I^I.]=A?LY/?Z!?S@*A$X@ M7+1XOVS18"$0 M;IHL,='*!,^.(`-1VDF3*.-=H]P)G++3,#\$]@A_P].D)27\)J*L&XDN7.E! ML*>VX%R!+L*_T]^STM?-M*%0*!/&.A9N`MU&\7:\3Z9++?T/4$L#!!0````( M`&.)>$<.V+XWP`$``'L$```9````>&PO=V]R:W-H965T."?JWQ&8'`]1$DV%=]IVQA5P6>"9 M5U,.0E,ID(+F$#TE^V/N$![PA\*H%WODLI^D_'"'7_4ABET$8%`9IT#L//B^:WI2,N]Y/ZJ^_6IC\1#<^2_:6UZ6S8.$(U-&1@YEV./^'2PM8) M5I)I_XNJ01O))TJ$./D**Q5^'<.3?*+=)J070CH3'F,?/!CYF"_$D+)0X+,3NF`"Y;C$)#,"6_6;%FFTIJ<+ M>GJ?OIGHFY!PLZ3OLOL"V220!8%LU>)NW6+`'->8Q_LFVRN3[4K@QTV3%687 MWS?)KTSRE4!RTV2-N7[?>#$='%3K+X%&E1R$"<,Q5^=[]I3ZZ?J&ET5/6OA- M5$N%1B=I[(SZ@6JD-&!#Q`^VU8#@\:X[<[N5;@E`0``L0,``!D```!X;"]W;W)K&ULA5/;;J,P$/T5RQ]0$T*:*B)(35=5^U"IZL/NLP,#6+49:IO0 M_?OU!2A95>H+GAG..7/&EWQ$_6Y:`$L^E>S,D;;6]@?&3-F"XN8&>^CS\COOODN3K2Q%L` M":7U"MPM%W@`*;V0:_PQ:7ZU],1U/*L_AFF=^S,W\(#RCZALZ\PFE%10\T': M-QR?8!IAYP5+E"9\23D8BVJF4*+X9UQ%%]8Q_MG=3;3O">E$2!?"71*,QT;! MYB]N>9%K'(GIN3^[S<'!M1=QRL0$-1VG=T:-JUZ*;+_-V<4+39A(.:TQFP7! MG/JW+5)Z34]7]/1G^G:F;Z/#[9J^W_\LD,T"613(KD;,KD>,F-,U9O=?$[;: M4P6Z"5?'D!*'SL8M7:K+[;Q/PYE\P8N\YPV\<-V(SI`S6G>RX1AJ1`O.1'*S MHZ1U[V=))-36AWL7ZWBE8F*QGQ_(\DJ+?U!+`P04````"`!CB7A'Q=T?:;X! M``![!```&0```'AL+W=O+$V%`U6'<*2.5)G.$TCC/,"151 MD?O.95E(/05`JDH#Y% MS\GQG#F$!_RB,.C%'KG:+U*^N^!'=8IB5P(P*(U3(':YP@LPYH2L\9]1\]/2 M$9?[2?V;[]96?R$:7B3[32O3VF+C"%50DYZ9-SE\A[&%G1,L)=/^B&\DG M2H0X^0@K%7X=PIM#/-+N$]*1D-X0<##R97XEAA2YD@/2'7'_+CE:N'(B5AEI MKZ9"][90;;/78KO//Z9N)O@D5;I;T M0_Q88#L);(/`=M7B?MUBP)S7F,-CD]V-R6XE\.6NR0KS/YUD-R;92B"Y:[+& MW'YOO)@.#JKQAT"C4O;"A.&8L_,Y>T[]='W"B[PC#?PDJJ%"HXLT=D;]0-52 M&K!%Q$^VU=;>!'/`H#9NN[=[%0Y'"(SLIJ,^WS?%/U!+`P04````"`!CB7A' M\2=WPK5L*T6X\CY]*3!!?T18W\DU!&4%"+MG%XRW#Z*Q) MI/:`[R<>057CYIG>>V%Y1J^BKAK\PAQ^)02QO\^XIMW6#=QAX[6ZE$)M>'GF MC;QS17##*]HX#!=;]RG8'*!":,"O"G=\,G>4]R.E;VKQX[QU?64!U_@DE`*2 MPPWO<%TK(1GX3Z_Y$5(1I_-!_9O.5KH_(HYWM/Y=G44IS?JN<\8%NM;BE7;? M<9]"K`1/M.;ZZ9RN7%`R4%R'H'._,F]7O:,@'T!#`20/`I(>P)X4@( M/X\0]83H44+<$^(9P3.YZ\KMD4!YQFCG\!:IXQ1L))PI$:GL<*W&S`>1M>-R M]Y9':9AY-R748X#&/$\QP8CPI/IB".#:=&"%B)9"[&Q,O(39VYAD"7.P,>NO MS8:#V=#4([0$TJ\%HD$@,@*1)0!MET&?K@$U&N2O`A`OP@[W87?MQ#,[\=0. M].TXAK*+)V&"(`%I&$1P";FWD3$$,)[4:((\3)'Q.H&RE@^X3V;N$\M]8$>" MQGUB%0DL8?8/8`[W,'?-KF=FUY;9!P32V=E+__?LP9D#:#F8_9RVZX)^(7:J&.T@5&#IPE_)!$IY>XV+&A="3=QCLR_P=02P,$%`````@` M8XEX1ZC!6SFN`P``"10``!D```!X;"]W;W)K&UL ME5A-;YM`$/TKB'L-.[N`'3F68EM5>Z@4Y=">B;VV48!U81VG_[[`V@XSI\'9&.S^;ZJ4^:&V]MR(OZWO_8.WQ+@CJS4$7:3TQ1UTV_^Q,5:2V MN:SV07VL=+KM@HH\@#",@R+-2G\Q[^X]5HNY.=D\*_5CY=6GHDBK/TN=F_.] M+_SKC:=L?[#MC6`Q#VYQVZS099V9TJOT[MY_$'?KJ(-TB)^9/M>]N-;5.DS>%5KW2>MYF:RK\O2=]KMH']\VOVKYW MW3])<@D;#H!+`-P"1/QA@+P$R/<`]6&`N@0H$A`X*=V#6*24BG4R*=T><)U#6!NWQ0*$&,2<9.J<.4#@,3 M.01:(5`RF0Z!U@@43QB"(\(W0GP37&7J^$:]*C*<#()6"$3I.LRZC_DBH(?Z M+]^8\(T1W\&GLHS[94`-/[L50L7#;V'=!XEPPOBL$T(X0809;VA*/LGIV$]R M1AC,>@FB,,0Z'6:),0R9(B15VL6SEP(8*011*L18J0(H"V"()2#)J"-I'8E2 M*$8*1=6JT6JI>47$48M!G#K4=")&*6)&BH2J34:KG5(64XY:#$H8=:A?!#8# M8Y&"D*B%<*Q:$(0%",1B-J@6@T3(J$,=`\@,@M.X:=.$T5T3:-L$Q5&+0(*Q MQ`!U#"`S"(;U(:9JX]%J:4^`A*,V&:V6.@:0&01CE8(953L;JU;2SB!#AEH, MXJB5U#$2FX%#%8A:":/5TLX@)6.5PB#!6%`E=8S$9F`L=#*B:J/1:FEGD#%' M+0()QH(JJ6,D-@-GLJ=SE!P]2$G:&21GE,(@CEI%':.0&8"QK"LZ2ZG1LY2B MG4$!P[<8!(SVH:AC%#(#,*ROZ"RE1L]2BG8&%7'4(A`PVH>BCE'(#,!8DQ6= MI=3H64K1SJ"F'+6X?7`^0^H8AV[G:?:VYA3:=UFQNWN;7?K`=H-%W)_*>[6;H_J/$?SA"59B@$``#L#```9````>&PO=V]R:W-H965T(''[ M]LO!=I,JTMX89IC_FY^#JP'-N^T`'/E04MLM[9SK-XS90P>*VP7VH/U*BT9Q MYT-S9+8WP)LH4I(56;9BB@M-ZRKFGDU=X'9$'M2BIO/'4@``I`\@W_CLROUH&X>5\HO^*N_7N]]S"`\HWT;C.F\TH::#E)^E> M.7'$[6H9HDE"C^D4:AXSBDE?5ZE-T6%*.@F`5%,IX:19N/ MW/&Z,C@0V_-P=_G&EYL`\61B(\VDW7NCUF?/];)85>P<0&--DNRN:]9S#?/\ MFTV*J4F9FA17@!__!Y03X"X!RBO`_;7+57*9:G2LR;-RD7]KPRX.IN='>.+F M*+0E>W3^C..!M(@./"M;+"GI_$N>`PFM"].UGYMTN2EPV$]/=?Y?ZG]02P,$ M%`````@`8XEX1P86[L3;`@``4@H``!D```!X;"]W;W)K&ULC99=0\O1X%3G-GPQ@^4"N^S:WN^\@]"'!_#D&\.M",\8$?:RR<[ M-G1$R.:P#_EQH&0[BKHV1``D84>:WB^+L>]Y*`MV$FW3T^?!XZ>N(\._-6W9 M>>5#?^EX:?8'H3K"L@@ONFW3T9XWK/<&NEOY3_"QAD@A(_&GH6>NW7O*_"MC M;ZKQ:[OR@?)`6[H1*@21EP]:T;95D>3([W/0KS&54+]?HO\8IROMOQ).*];^ M;;;B(-T"W]O2'3FUXH6=?])Y#E@%W+"6C__>YL0%ZQ:)[W7D<[HV_7@]3T\R M,,O<`C0+T$4`DV\%T2R(O@3QMX)X%L26()RF,B:B)H*4Q<#.'C\2]7G`1XD/ M*HB,[/$QVC#E5Z:"R]Z/$D>@"#]4H)E!([/6&7@A0AG=.03R33G2Y,@U0*43 M$78AM8'DMTU$BXEHFF=DS/..6<1+@*GY%&L!8BM/R331">DG!$9!YJ(J@\JQ MFZIU"L=Y$-UVC"W'6'<,S5&RR3'61HE`$L0NJC(HC(+<1=4&%2=!>MMQ8CE. MC)>$G)83;9@\#;#3L06!7/^9"CRYUQ40QK>]IY;W5,]VXK2>:F,`[8WJSG4F M3@-G#FH=RK447#6;668SW6SJ2L@ZT\VZB$HG$(B=:75'N>HSMWSF^LZ#W5G- M]8P%J3.K)N-<"[7.9,$=7P`$EEMUS&C?K_,%KV=H\>)<2Y4!/2"0N[_SVN!2 M<,^:@]!V;1X!SBU@/4/S^@#VIK78UJF'Z,K;J`T,P>".W1@BVS4R7&/GACQ# MLQ]L)WO>D$T*IO&5+=G@Y):<6+9#[>3MZ+`?2QCN;=BI%].I>.F]E$E/8Y5D M]:]5^32>Z%]ARN)(]O0W&?9-S[U7)F1=,![B.\8$E?9`()?<019XET9+=T+= MIFHM3B7/U!#LN%1PES*R_`]02P,$%`````@`8XEX1];/=W-A`@``%@@``!D` M``!X;"]W;W)K&ULC9;;CILP$(9?!?$`8',F(D@; MJJJ]J+3:B_;:29R`%C"UG;!]^_I`LL9RF^0B8.>??SZ/K7&JF=!WUF+,O8^A M']G6;SF?-F'(#BT>$`O(A$?QRXG0`7$QI.>0312CHPH:^C`"(`L'U(U^7:FY M5UI7Y,+[;L2OU&.784#TSP[W9-[ZT+]-O'7GELN)L*[">]RQ&_#(.C)Z%)^V M_@O<-%!)E.)GAV=FO'L2?D_(NQQ\/VY](!EPCP]<6B#QN.(&][UT$IE_+Z:? M.66@^7YS_ZJ6*_#WB.&&]+^Z(V\%+?"](SZA2\_?R/P-+VM(I>&!]$Q]>X<+ MXV2XA?C>@#[TLQO5<]:_%&`)42*V-B]EJG<5:%5VFT:"*EV9F:R*5H3$60F5Z&UHQ*DQ5!ZA(UEJ@$QN<)KL3B M2@RNHEQG+#168F0LLB!VB1I35((@>DR26B2I05(F3I+47#OX!\E*%`7)8Y+, M(LE,DLQ)DAE)HCRP]C/5)*8H!H\YHR-$QH= M?$)G_`/1$<92Q]Z-`(``+\&```9````>&PO=V]R:W-H M965T,'>+^TC35I;28S#Y.99]K2 M:@Z(`[2>^?L!40N&GLZ+P':MM==&W!0]H1^LAI`[GQBU;.O6G'<;WV>G&F+` M/-+!5KRY$(H!%TMZ]5E'(3@/)(S\*`@R'X.F=(M)OW="=`N_-M>8RX)>%/_/.#88M:TCK4'C9NKMP<\@E8@#\:F#/M+DC MO1\)^9"+'^>M&T@+$,$3EPI`#'=8082DD$C\9]1\I)1$?3ZI?QNJ%>Z/@,&* MH-_-F=?";.`Z9W@!-\3?2?\=CB6D4O!$$!N>SNG&.,$3Q74P^%1CTPYCK]ZL M@I%F)T0C(9H)8?8E(1X)\8.0?$E(1D*R(/BJE&$C#H"#LJ"D=U@'Y.D(-P). MI8A0=MB@1M7^BJU@(GHOTR0J_+L4&C'1@-GKF'!&^$+=FB)R37JDT:T)*AT1 MIS;(P8"L7YN()Q.QJC/6ZXS_HXID$E#+76)L5&R:S%2E"M.JC4J]U`:J#-#* M6YN@7)5K@++7;M.%V]1PFY@Y5LIMJN6(O-B&J71,OBQ(80[/,$_-9@NSF7Z^ MTK75;*8E6=N-5#HF?%+1P0#E7O+:;KZPFQMV`]OWV^=:%BNBTA%1D%A/@5U% M&?6U_QQ#>AT:)G-.Y-9R]0_.T;DG[R+9)Q;QO>C5JK4^9,JB`U?X$]!KTS+G M2+CH0D/+N!#"H;`6>.*KU^(VF1<(7KBI\-,233.,ZU#?3^^^O/ M(`G9;'@@B7.TJZ.5M&<=+]ZR_$^Q29)R\C?=[8OSZ:8L#_/9K'C<)&E3VKG'[+L3_WA=GT^]6H?DEWR6-9#Q-7+:W*9[';U2-7,_W:# MOL]9&\+W_>C7#=W*_8>X2"ZSW3_;=;FIO/6FDW7R%+_LRE_9VTW2<3#U@(_9 MKFC^3QY?BC)+>Y/I)(W_MJ_;??/ZUGX3>)T9;R`[`^EJH#H#=30X.L8;Z,Y` MNQJ8SL"\&^A1`]L96%<#OS/P70V"SB!P-0@[@]#5H%[S=N4\9Y/C8@MGDWZY MQ?MZ"SMNTB^X4,ZS]$LN-#&9M>G;)/]57,;+19Z]38I#7+<$,:_Q>3U.-?BD M:`;,VZ*J\K^HKKXNC3:+V6L]4H>1#>828RR'N8(8)3G(/82((V)6>[M"D-!A_52_?JI--0773[ED@.Y':#]^U7!A2#3\EFH+V3<0CT-$$"&, ML%[]QR%7_%C#[AKBKH&$25!;R`6"D$0R+2,#O`AER+C;`B,(%)X8!*X@\$S[ M!B.'^5G"SP+G?<4Z;Z%/P@P[#X%G2OO#WD.D%,+5>9\X[Z/(!^SJ0(P5+$$? M$K1ZF"`"JF"8'P(:Y6P MU7D5PHP1FHMHB_P&D9);HA9WC7!JN#%\AT"Z0@!W@UWT`ZYX6^@MA.IAW`\T M9##LXQT$^L,K=A^B!![)`4+&#$-7*#X><7(X"X1'TJ#6:R`/^`KL0%URCA!` MP"[;>?\1DK;<$?\%]1\I)R/9)H-!_![08;I-P`PO9X20PA_>+E8828MZA*6D M+)$P,XIG*1U82I1B`=V9$$^,#>4(40C5VIFGHCR1@*$<>I[*@:?"/`.NA?0\ M$=:R+:3GB8=5[GE+=9;0B"DO73!H@"F44&,L(4Y[8R01,G3>'@459P*K,^LR MQE$`=8I60`7D)FD%U2$""1'CIY*DP!$;3IQQY(A?=#^0>#_@XP5[LK+NZTB;LD3]U@ZL#NR, MTOF\(VE?E+CEL3FZDK!#N8L'21N41`V*/WY$TJ#ZE^B<,7)<1<#1M4;G`N?:4K0A*ZSUV88<*:SU1\**D,99 M]"G:9!5NLFPWNU>P=?+Q5+B[#D=^A9"4XHCGM`TKU(:MUQJ9[<-==52@UN76OC:4M3F=-=4@&E6)SY;U MI8;2POVXH6DY:51.ON`G@^44N$]&JTEC<<%.%FDD!(2S$-!MW36F[6SUA4]^ MJ:!U9E"=\;'^#F)XOQYNR\F#UE99FGS@^Q3EI5)%0/O2U5.FR1>'S_LDJ>R?NO7 MQ=\^L]!^*+-#_PC&\3F0Y?]02P,$%`````@`8XEX1Z$:KU[(!P``BS$``!D` M``!X;"]W;W)K&ULG5OM5B(Y$'T5C@\`J7QGCGK. M@NN,L_/AH.[^9K15S@#M`HZS;[\TG=94$9KJ\8<*WDJE4KFWBJ0]?BF7/U:/ M1;'N_9K/%JN3H\?U^NG=8+"Z?2SFDU6_?"H6F[_1N M:S2?#:00=C"?3!='I\?;]RZ7I\?E\WHV7127R][J>3Z?+/\;%K/RY>0(CIHW MQM.'QW7UQN#T>/!J=S>=%XO5M%STEL7]R=$?\.X&A*DP6\C?T^)EE?S>JV;_ MO2Q_5"\N[DZ.1#6)8E;]^>17_7.ZV/Y\J?_B133+&\AH(%\-)+0:J&B@N`8Z&NA7`^5:#4PT,&\> MVF.PT<"^>6B?DHL&CAN#CP:>:Q"B0>`:5#FO,R?8)J_)!K9)DVY@YQN:A`,[ MX]"D'#3;I$DZ&+9)DW:P;),F\?"6>:7;39K4`SOWT"0?V-F73?8E._NRR;ZD MV1_4&K%5F+/)>G)ZO"Q?>JNG226\\*["+ZMQ-H/W5ML!E[5R;41FM7GWYZEQ MZGCPLQHI8N06,T08Z7*8$1Y'YS!G&&-RF#\QQN8PYQB3G<][C/$YS`>,"3G, M!2/VCPCC10[S%\9`#O,)8V0.\QECLOGZ@C'97'S%F&PN+C$FFXMO&)-=GS%C M#:\8<5VG&)V/ZV8?9K`A0YX1LF&$JADAT4P\8P35C*#K$10:@>PK6Z])C5EL M,1*,[KL<[`K!7%!]GX-=IS#O^R*D7XP(-(E`IZLHZSH%@0.9+.K^#!N289-D&(S(S69L$D:T)W/P;>L55\.GB8%D5^UW$XB; M@$+EC`""Q%IUDAV#!2#3`"3'0>98.XR@[/XPL7H>A(SW0%HF*^EDD6('E7,S MC*"8'"58GJBP`U+VH'.[8`BI&(.`D`A'BR\JP:"1+Y./"FF!X$5%I0`,\F3S MGA#5Q9YT,T#CO:"6*5-%`"P)K`6FF@#=10&H*H`_S),1^*X[G*H"A,,[?!1! ML7CP%E8*XDF*PSM\%$%QUTFC^I;CBXJ,A,,[?"0!^>)%115"RL,[?"210@#/ M$U4(F2H$[9QB+R"10`38TPL@&&LR5$(DEA#.#I>&L$2:SBR1E*W2'F;)601U M"-=1-ZYM[]KHQJ6]7P##ZIXD);[$Q`_YD#Q2.HX?RGR9,M]2187XH5FFU!=] MSQ)$1;FO!/(%N5UYIE+N&R>V7QQOE/T*D+?\IE`I^P//$26_DLA15CS/5$I^ MQW.T\[%/M>E9$Q$BOV$YHKQ6&D6D0YG#NJ@, M$F!IJ##&-AOC-A^Y)&=&5)2418MH.&/0%D)U;R$451+%:"'.5=<60E$A4:%- M''UTD^H(*.;2:BHD6K0D.VXJG>J(M"J;:8T;#=WGG.=HJC0:*PVG5]'T4$AW M/Q725!^T:LMT79_>ZU0?TF."%D<[IS>H[M,#*!\=X0.Z]3 M\@;?-YW=4B)KVZ:&+KI-NPN6&]I=:(?<<"JL]G07^>Z[B!)9XX[`Y]CU32,B M<^(UE,0&=P.L,8#$:Z!SO(:6;X/*-^PYJ4K+M^1HN:'L-`KY@6R),BD[M=I3 MH!`*%$M$#26Q044>6&/0YMUT;]X-I9=!]()L^S0V*;V`4Z`,Y9=!_`*.TAO* M+].=7X;RRP3.?DOYY3B?("SEEQ6,_6;3`JCRQZM7""3S1[`8PUE<2\NHA;:- M4.OLC4T;=LLAHJ6$MYCPK#$4V0A6==X(EA+0:L9&L.C"@;6NM&Q:EKAO#P<\,BC MXVC-.I+RE#L><4=R&A6O:<2Z>\2TQGE4XV3V,]K0I_7+T+/.&G3!`8WW@EJF M3&GH$0U9GRD\+87^-^Z==RZ>_>&E&_FT%$K-"IC2T&,:V`=*GN`Y2XM`BE,6PLYS&X@\BB.T(':?W/B- M1S?$SK,;@D,@@E*ZQ[WSP(3`UYU9I3QO4-T> M!!$[STP(?-B9O0`\;U!-$2>N!LFSND^3A^+S9/DP7:QZW\OUNIQO']&]+\MU ML1E*]#$<=#IAPRP8``,,G```9````>&PO=V]R:W-H965TZ9A)+47GA.O=&']&-@%0)SS`2"OWYK]]_:IKKO)C^UFU]Y,G[KN^6H^;^^>ZFW5 MSIKG>M?_YZ'9;ZNN_[I_G+?/^[JZ/U3:;N:Z*/Q\6ZUWT]OKPV]?]K?7S4NW M6>_J+_M)^[+=5OM_/]6;YNUFJJ:G'[ZN'Y^ZX8?Y[?7\7.]^O:UW[;K93?;U MP\WT-W6U2F8HWW=/?6N+Z>2^?JA>-MW7 MYNWW>NR#&P+>-9OV\'=R]])VS?9493K95C^.[^O=X?WM^)]8C-7X"GJLH,\5 ME/UE!3-6,-(*=JQ@I17<6,%)*_BQ@I=6"&.%0"K,CZ-[N#:?JZZZO=XW;Y/V MN1IFK+KJB^^'('WD27N(MC]>\O[JM/VOK[?>^.OYZQ!H+*,/93[E9317HL0H M@2OS.2]C'%=D@6$B5V:)91)79@5E;'$N,^\'A!T5?1H5IIGEBGW.BVE;J%GZN#F6-,=FS7%)T!]'!L3E`6+\ M.(`G+?`P(`9[ZHX#XO.>ZH]S!-+(<.E5BZ21$0*0RQ&/C8Q9(ZV:F8^S))(E M01;'9DGY4)B9^SB+*DB:P8>S/)X=\K'0,9%20:`5I6@B]:O)/G9H+#2.FPDS MP?55FF9"708^D\XSZ9E@'B@J7X7ZC7RB7)DJ*"M*1:6I+*1*?"H+)C`+@D2. M)LHU[%W!SP>7)9),!JIS!4)WBN].KO1BY@5Y`LT#8G<_F70AM]A^W`1J5=04 M%+B"XZU+Q0O'C9J"`E=PO/>HW!:,M3.!$6OJ"QI\P?'^HW-?\,EF;/IY)FH, M&HS!$0<:*:AS8U"%2I+)K:DSZ-P97)*$.&O^Q/Q<\R+&::IEC5HV7(=+G6LY M&-$UI#C6H&4)ZC05JD8BLQ.NU+E00Y#H1U.E:L0R.]]*G2M5>U$B*E2-^&:! M5^I>*4QESFWH:(W('J>>*7)19\D M"P5#^6V0W_RL,SF_?;]RE(P;M0:##&>)5QI_X;A17S!(<,MGR7U!*2T9..H+ M!@'.&Y`!7PA19$&&.H-!BK/$*TWN#$H[T46RU!IL;@TN"2ABSYH?*6)SS8N( M9ZF6+6J9)=["YEJ.(HI82F>+*W+!/+#O-L%(9Y9X"YL+U5HGD:JE4K6(9W;& M+2Q(-G@K5 M([-9#BX]G*(9R7&=ISKUR&S'3>NEA_-M27^H1CURG=WW+7VN464*@8`\E:E' MK+.^L_2Y3(V*$K[Z=Z?EB/+`=\F#EPK24)EZQ#A+O*5'C!>%Q!$\E:E'C+/$ M6WHX7!=AR%.*>UR"LYN^I4^7>6F@>@]XB*;8+*&X,`N%=T!X\Q,NY/#624LN M3Z">$!#>+.>605_8'VH(`<'-^5(>1YQV*%]X0BY3C$3G^ MDZD']\F#Q,,3]8F$*#=LH@3WPR0[\41](B',6?BMTH4^D:A/)`0Y[T8)#M<% M'$C4&!*2G`7?*AFT(RJ<>?:HTG/U6/]9[1_7NW;RK>FZ9GMX1.FA:;JZCU7, M^J8_U=7]^$>X?LVNK0,``,82```9````>&PO=V]R:W-H965T_4NM]D,WZHNL?S4FIUOM5%E7SN#JU[?DA")J7DRJSQM=G576?''5= M9FUW6;\&S;E6V6%(*HN`A6$4E%E>K3;KX=ZW>K/6;VV15^I;[35O99G5_SZI M0E\>5["ZWOB>OY[:_D:P60>WO$->JJK)=>75ZOBX^@H/>SZ$#!%_Y^K2&.=> M/_AGK7_T%W\>'E=A/P95J)>V+Y%UAW>5JJ+H*W7*/Z>B_VOVB>;YM?I^F&XW M_.>L4:DN_LD/[:D;;;CR#NJ8O17M=WWY0TUS$'W!%UTTPW_OY:UI=7E-67EE M]FL\YM5PO(R?Q.&4=C^!30GLE@#\PP2<$M`U@4\)W#5!3`G"-2&:$B*2$(S- M&EJ]S=ILLZ[UQ6O.66]`>.C"Z[Y(5]EKAFKUN()=LYON[OLF$G(=O/>%IA@V MQ#R9,>Q>1#JK@G>K;.SG\7P\!83=+.].V5VG3(?I\R,`B(! M>P&\%L"Q`)H%XMA>@),1\%G322O&E*27/OE$MR`D0OU3U5@7EQ)`?`ZPU.A`60-FMWHZ!4T3!AFYV!"0 M2J'=[ND4-$I)Z21$Z05N=WP*)K_`!/J1@Q0E&(3=]"F(998$2C!$=M^G$"U4 MH?R"M%L_!?F9ME&.(9ZMD(MQ$^K]9*GW&260A7;O;Z>@<<*"R]!G#E)`I<#N M_>T4-#WKN?`=MC[VV^;)[.;?,A/H;HL5+IPQ"C3#C\Q_E3*!_@(L]EV6BB+- MN)V`+>/+"&"49B;L!&R92;.0<>0+!RF*-)LA';J4D(0`)A<30#ED\4<$R/$[ M'XMGR,<.P#.ZJ[+$[O\=,_=5CBZ@(64:0[O]=V@R#<@2)RG*-(+]V;]#6.9) MI#PCLSM_AVRA"D49T>[\'>)GVD91QAG*H8.;4!#GHUCJ?*3\861W_A[-+35Q M8!3IGHK2[OL]FGNJTX:*%&2,[;;?HPER$OLB,?\<5"G5F-@)V&.RS)N<(LW# MCPB8YL9-I+]$OL-T.`6:@QV"/3>!3N"WK_Z!\?/^G+VJO[+Z-:\:[UFWK2Z' MG_5'K5O5U0K]KD4GE1UN%X4ZMOVI['LWOF89+UI]OKXUNKVZVOP'4$L#!!0` M```(`&.)>$>D[\U^'`4``/D?```9````>&PO=V]R:W-H965TM+6?VL#]XWBU]%?JH?EH>F.7]+DOKUX(NL7I5G M?VK_\U961=:T7ZOWI#Y7/MOW1D6>",9,4F3'TW*S[G_[7FW6Y4>3'T_^>[6H M/XHBJ_Y]]'EY>5CRY?6''\?W0]/]D&S6R9?=_ECX4WTL3XO*OSTL?^/?=DYU MDE[QU]%?ZM'G17?Q+V7YL_ORQ_YAR;IK\+E_;3H76?OVZ;<^SSM/;>1_@M/_ M8W:&X\]7[[L^W?;R7[+:;\O\[^.^.;17RY:+O7_+/O+F1WGYW8<<=.?PM=%W7NKAA%LBUVW MOWYNC!'KY+-S%#2BUSR.-9.*+?`B[93F"6K2\`X6N0(T=:`/3'$P>!\VIUW#&TY6=CZ-1 M'`U*A>+H(8X>Q^&64$^#HAA0#C7OP*)ZVMAZ.G0%[EX][9"GB\XS15%2<)D: M1ADTCU!CYH-PAJ)TJ^%H>A)&G7-43\YC"\HQ(US,3]%M$(6:"BU7E(0E#B7G M9^DVB$*HU!*HY9@Z#K`S=CJ0B@^$L>.`.^,(+@P>0A,]A!9?A;V7K@WIVE&Z MCI(L9H\#^$Q*<)'B9-/89`6F1K!Y.+=(1)BL@N,XG%#4(`ISR`E*C[II4@!` MRG(E<)L2T7U*8&2$HI05B"C$"$R,T)2RCEL5J2*X4PE`E173Z4`1I6P8/6'! M&DY8`(3#@^>B!P_W*Y'.K^%/030455MG5GH^E,3X279O#7=#J"`*H0SC*\K> M"Q,H`8&6L-V0`M56BMC:2MRT)&#+ZLG:RG'3$MRM*)$P@E+-S]DG)"*L;!(C M*`&"EK#OD+AIR>BF)3$YTLXO.$]09`EX2=RUI+NWX%S';[QGU%))T@!B#&5* M&<`T=M%1F$$%&+2$1JSPQE%%;QP5[EM*$`80B#0CS#6%`522,(!J#*!>"4*< MFULU"GY0Y`BM26'\%,"/LA-3&#\5C9_"^"D*?D"D&>52,7Z*@I\:XR<5!3Z% MX5,4^*"(,GP:PZ!-H^'S8.S,^+8MY90#-X,)-.(>%BX$$C!0 MRD8OPG)J,(P&P.@(>V*C<)%5=)$Q00;N(/5T[N"\T5%.C,S-@2/@S.FIR;L+ MHFL@0AC,HK'S*\\.BAPE' M/4$)*-HQBE:N6#I^$:)B+BW@TA&F@\7'*3;Z.,7B7F8)QRD[*'*4;#&)]NYQ MRK7&8Q(991-@,8@6@)@2^H.].?N//ORWF!_KYCE]A"+*4Q^+6YD%D*6$@CG< MREQT*W.8'\?GL]TB$24.)L8!8E**"TR,BR;&86(<8?>WA:*;L4U&3T3/V;O_ M,ZO>CZ=Z\5(V35GT3T+?RK+QK2NV:J$X^&S_]27W;TWWL:.E&IY,#U^:\GQ] MT/[UM'_S'U!+`P04````"`!CB7A'0'F3"TL$```H%0``&0```'AL+W=OS^K MY:(\-MF^D#\KKS[F>5K]>R>S\G0[([/QQJ_]=M=T-X+E(CCSUOM<%O6^++Q* M;FYG7\C\E48=I$?\M9>G6OOM=>+?RO)W=_&TOIV%G0:9R573A4C;KW=Y+[.L MB]2._(\*^C%F1]1_C]$?^NFV\M_26MZ7V=_[=;-KU88S;RTWZ3%K?I6G1ZGF M$'`(L"9O/J0=L5*YAV^ZN*TP;VZ#U@-=F^=6;=WWYQ=)80;*G8ZA8(,\ZQ!R1@2M`KL,F)E#@,:WCG"O(RBU0;[J$.M,OAE! MK)`'`Q+;(-\-"+-!'@T(MT&>#(BPKNJGJ_+RN=I7`Y(XY(:.N::AAD=@A M0C1&B(8(D1$!K1@;YCI@BB%YC/C"AGK143<\]I-0^Q`;Y56G<.J[Z(_1"L2& M?NX0@:$58+HU0YO..Z;I%`+\R(:Z-U"<^Z@2^%`)!HHDMDC?=`QGP@<;ZD%' ML7;YN`WU74?%-/2MF7C445$D[+&>#!0D/G*U&.RBHRB-F(\F&0]^T6$0"NL< M7W40X02T1;V<88XRS`V/")OH%ZXO9NR'B?YQ&%.@,84V9NSDRP0Y.YE*=9P/Z)Y)R`7[&3"G M"5$LAG[NJV<%4M407A)#IXK!?9Q$AN&$2PS<2TD\W7*XFQ+F8CFC]H'B5JEJ MDIC5K[7=*X(XGA2?;CMP]P=P!P\![H=7^3_&^;5@MCPAB[]#AS M11Y^6`,ZV8F`RQRB*TY4:0?]L0K8A?E%A@TCI^*"&,N)'6RH0-=L:$#:2F7C!`M M"@TGUR8E2`144_P(0.GG&P/5]W82 MB_#"^Y.!@Y@Z%0'%#8)&U\RG7NBH7OSM2+CV`^VD(I?5MC^`J[U5>2R:X27T M?/=\R/<%NI,.=/^.S)^(Y?XSF;\.1W@?X9>+0[J5/])JNR]J[ZULFC+OST(V M9=G(5G;HMU6QD^GZ?)')3=/]Y%VY#`=YPT53'L9SR?/AZ/(_4$L#!!0````( M`&.)>$&PO=V]R:W-H965TO$1+@B^"6;YU:B&[C>?Q8(P*Y2SO4RC=GR@@4,F25QSN& MX$F3"/9"WT\]`IO6*7*=>V=%3B\"-RUZ9X!?"('LWQYAVF^=P!D3'TU5"Y7P MBMR;>*>&H)8WM`4,G;?.+MB4F4)HP.\&]=S:`^7]0.FG"GZ>MHZO+"",CD(I M0+E<48DP5D*R\-]!\U92$>W]J/ZJNY7N#Y"CDN(_S4G4TJSO@!,ZPPL6'[1_ M0T,+B1(\4LSU$QPO7%`R4AQ`X)=9FU:OO7FS\@?:,B$<".%$"-)O"=%`B&Z$ M6'=JG.F^?D`!BYS1'O`.JH\=;"2<*1&I#+A68^:X9&=<9J]%YONY=U5"`R;4 MF+V-"2:$)]472X3.G!Y:]'"I0&DCHN1QA6BL8,)=9/&3U>JQ0#P*Q$8@M@3B MNT-(31<&TAJ/69*XJR58.8,EZY7[Q($E=VX2NYUTT4TR+^.N%\W8J)L9+ M>NLEF7OQLT4OVP(MG MW2&"6*5G"P='>FF%^;^G[#2^=J&Z@W?YO1QK9@K=9(J\@Q7Z!5G5M!PB_]02P,$%`````@` M8XEX1VN/JD.O`@``*`H``!D```!X;"]W;W)K&UL ME5;;;J,P%/P5Q`>`;3"7BB"UB5:[#RM5?=A]=A,G006$>D&O)# M+$ZL(__=`6W99A3"\3CPU MAZ/4$W%=Q2-OUW2T%PWK`T[WJ_`>WFU@J2$&\:>A%^'O!KMPJ! M]D!;NI5:@JC+&UW3MM5*ZLVO@^C'.S71O;^J_S#E*OO/1-`U:_\V.WE4;D$8 M[.B>G%OYQ"X_Z5`#UH);U@KS'VS/0K+N2@F#CKS;:].;Z\4^*@@8!& M`LR^)"0#(?D@I%\2TH&0>H38EF*"V!!)ZHJS2R!.1'\>\$[!N191RH$P:MSF MJZ(0:O:MSD%2Q6]::,`@@WEP,7!$Q$I]]A4HG-*10T=S+UB[B`3/03832/F] MB>1J(K%U)I,ZT^\%TJN`'=ZG$P'/9&8KM9C>8#`&43*'6KLHB-.HF$-M7!3* MHP4E8\\Q=AQGY0*!S,LLNS6SW'.0?Y49MIGE;F8(3C&%3X"2/!8%" MY`4"TGDODN MLB6I9&Y/9"B:A:TGL`)')7!^"]9RZ+$?*Q*Y(50(``/X'```9````>&PO M=V]R:W-H965T943N=]J$S M9\Y#^QPU"G.`T"3*Z=\W%\20L15]`!+V6GNM+3L[[RG[X"4APOMLZI:O_5*( M;A6&_%"2!O.`=J25;TZ4-5C()3N'O&,$'S6HJ4,$0!(VN&K](M=[;ZS(Z474 M54O>F,*_.I5`;89&'(^Y8-:3E%6T]1DYK?P-7.YBH M$!WQLR(]MYX])7Y/Z8=:?#^N?:`TD)H\S)CM:_JJ,HI5K@>T=RPI=:O-/^&QD\Q(KP0&NNK][AP@5M;A#? M:_"GN5>MOO?F308&V&,`&@!H!)A*_!,0#8#H#EAHIT:9]O4%"USDC/8>[[#Z MM^%*AC-%(ID]KMF8*9=TQN7NM4A!EH=7133$(!VSM6/@&!%*]H1[1;-D>KV%9PV5C*#(G;=QB^[35P5D\:!ZFF%.?+&W7&D;9`ZEIW]K1IU^KB^TQ1YA\_D!V;GJN7>G@IYZ.L3 M^D2I(%(="&052CF,QT5-3D(]INK3-./)+`3M;M-V'/G%7U!+`P04````"`!C MB7A'37`5_-8"```<"P``&0```'AL+W=OP$;,+`B2!NBJCU46NVA/7L3)T$+.+6=9/OO:_.UML4F)(>` MS'@\O_Q*V3L_$B*2"N?["EKL)!#=O#Y MB1&\ZTA-[<,@0'Z#J]8M\F[NA14Y/8NZ:LD+<_BY:3#[MR8UO:Y?L$H/\"3A3`61D1W>16.] MO](*+F`KDF'&AW.+5#JB#">@VP,2'9? M1#B*"/M]AOH^@P4!HC%`/WR.#*,R4R3J=]ICV@X3!5XR!RIU4`J\+-!^8(ZQ MT1D0>>%]\;$E/M;%P\!<)>W%Q]HJWP)M%0U46J!X#K0Q0-!#]_4B2R_2]$9H M5BXRO8YFY2+3Z^B&UX-VG0%#[15^J3VQM">&UPN^E]1*U?315,TL!=FM5!WL MR[1]ALA^D7%OGPZ*DUF_#(@'[XL%@:56%6?-L"4A@.48`(]:!J"M`BXP;0`- M23>?_:4!RKPTN)]T!@6`13:&]@:,"@<7%`D0V39&#]MH%QH0+['1*!"1-_N! MEP8*A'8U':W34TH%D=KDL>(Z1]FJ3H.:[(6Z351=ZINW?B#H:>Q% MIX:X^`]02P,$%`````@`8XEX1SH-@+6Q`@``S0D``!D```!X;"]W;W)K&ULE5;+;J,P%/T5Q'[`#YX506H2C686(U5=S*S=Q$E0 M`6>PDW3^?OP@U+9HDV81L#GG^-S+Y=K5A0VO_$"I"-ZZMN>+\"#$\2&.^>9` M.\(C=J2]?+)C0T>$'`[[F!\'2K::U+4Q`B"+.]+T85WIN:>AKMA)M$U/GX:` MG[J.#/^6M&6710C#Z\1SLS\(-1'753SQMDU'>]ZP/ACH;A$^PHGU]6*>%&"DS1/02$`3`6:?$O!(P.^$Y%-",A(2CQ";4'0BUD20NAK8)>!' MHLH#/DCXH$2DRYSE%:Q6>19?+<_2BF#\*LY@\AW@>[(V@@:"PU_4&@.*LW\[)JO9^V@P!V.L>_8Z6/X'HG$ MSUORY;SY[02F=S1#Z+0!X)?2V`U=%(R*V0[HH&`>^5]8;&UZ'1WV^O3`@PT[ M]<)L2-/L=$)Y1&K3].:7ZN2B-]-WF;HZDCW]189]T_/@A0FY)>O]<\>8H-(> MB*2]@SQ;38.6[H2ZS=5[-Z<-,Q#L>#T\32>X^C]02P,$%`````@`8XEX1R1? M[_G]!0``]"$``!D```!X;"]W;W)K&ULE5I-<^(X M$/TK%/VCULU=0<=L^>Q$FH`9S%SF3VWZ^-;:+7T\(BAP#F MJ?7TX?=:;=;OU>E[_5*6S>SG87^L[^=X?R6.^JX^Q4/MW/?U-WN4TZR!GQ M]ZY\KYWWLX[\MZKZWGWX\_%^'G<WNJF.HQ-YK-#\;-_W1W/K^_]-\MX:"8WT$,#'=K`#`W,I8%*KC:@H0%] M-*"K#>S0P+(&BW[LYYG+BJ;8K$_5^ZQ^+;K]I.Y:^*D+TD:>U>=HIWY!VKFK MVZL_-JE1Z\6/+M"`T6?,UL5\(!9M=+$+/7 M3RJ.E$@8428R(F-`Z8BF&2\9XR4P%B=ONW1[(>)<^L`9H*RX5CE@E`V9XA4C MO`+"2^RFQWQV,98DMMN5RT2R#^\?!D6Z.BBWMS.X"N5! M]E&2\US@B\8ABD@.H+#C)W%/(*P[+`-"\+H#W5QW(*Z9A)HIFRFQHH)\<`>4 M^J5D,R0A=&.*25PO"?52/H*2*V*M,,O^#RCSRQ%T7&RL1`?H(7$])-1#V4X) MQ&X9F=C]DWT*VZ2>(RG)2NOGSS64L,XA.RMA0=E3NLD09HA[Z\CYQL2:N(P2 M%E9D7P60QU<)"L]RDH,8)5>YV[OE5WN1*NM^.ZRZP5OFFIM=^<'](O/KK>K%^+Y_*OXO2\.]:S;U735(?S M4_.GJFK*=D1QU,[&2UD\7C[LRZ>F>YMVT]3_**'_T%2OXV\L+C_TV/P/4$L# M!!0````(`&.)>$>FAK-T#@(``/$&```9````>&PO=V]R:W-H965TGXWJ^%Z'=AR$\U;A$/:(\[^::B MK$5"#MDEY#W#Z*R;6A+"*$K#%C6=7Q9Z[I65!;T*TG3XE7G\VK:(_3U@0H>] M#_QIXJVYU$)-A&41SGWGIL4=;VCG,5SM_2]@=P")*M$5OQH\<.O94^&/E+ZK MP8_SWH]4!DSP22@))&\W_(()44K2^<\H^M]3-=K/D_HWC2OC'Q''+Y3\;LZB MEFDCWSOC"EV)>*/#=SPRZ(0G2KB^>JAF4R]E;F26@"&]* M:*PQ+0>[)H'97!-*_4]-X&2R,2;0-HGR98'-)!`;@A4Z=!.DCZ,1`IQ9TO&R1.1;9'21<%M@ZD-MG M(7,G0?X(FX=Z1" M;HQZ%ZLH%5@J18%4JN7Y,P\(KH1ZS-1B,3NR&0C:3P?,?,J5_P!02P,$%``` M``@`8XEX1S!0AD2R!P``P2P``!D```!X;"]W;W)K&ULG9I-<]LV$(;_BD;W4L0WX)$]4UO2M(?.9')HSHQ-VYI(HBO26JOF$-O2`GCQ\3X+D)B_5?L?]7-9-I-?V\VNOIX^-\W+U6Q6WS^7VZ+. MJI=RUW[S6.VW1=/^N7^:U2_[LG@X%-IN9CK/_6Q;K'?3F_GALR_[FWGUVFS6 MN_++?E*_;K?%_M_;OJ]UD7SY> M3W]75ZODNY!#Q-_K\JT&OT\Z\=^KZD?WQY\/U].\TU!NRONFJZ)H?_PL[\K- MIJNI;?F?H=+W-KN"\/=C[:M#=UOYWXNZO*LVW]8/S7.K-I].'LK'XG73?*W> M_BB'/KBNPOMJ4Q_^G]R_UDVU/1:93K;%K_[G>G?X^=9_$_.A&%]`#P6TM(`9 M"IA3@9,POH`="MCW`O[3`FXHX-X+V$\+^*&`)P5F_6`=AGI1-,7-?%^]3>J7 MHEN`ZJH-WW>5M#5/ZD-M^WX&V\&NVT]_W@1GYK.?745#C#[$W,$8H[F0!0Q1 MIXA9*X!5H:>X!0U;L&P+,(35L$25."YDA4+2>9WFJ-/THV70:-GS%=AC!;:O MP*(*B,C0][2/V?4Q.**O=`DCM%:9.2_$$2$."?&XF=@+<:`9Y3/#!2UA4,S\ M>26>*/%(26"5>*C$2OH;2"L!M1+95@)HQ66*[2Z,R25"(A$2D9"$&^EC;E&, MSUFQ$0CY31DX]%`O#LMI5*]Q!:.,I%>)]"H!QDW9K!""_82BN%>(]X%'J((PCR&S.?BG^`Z$3SH0AP[`F.0E M.%4T2RB4`@*;BQ8*8MME@5<,@]@UNT(A.I-X@_)?):27'9B%@MQ.F-")Y`$P; M;XB27".2!Y;2"PTI';-X\9Q09&N$[,`C6T,8NS%X:8QL"4LUA;9&T`X\M+5% M@^`3^L=K@T5RR;Y74\QKA/G`8UZC_;5HJZ\IP#4$>.)9J/$66X_9!(6U,R?1 M0^&L,9SYA*(A18TRD$M($8S3)B717%#>:L3;F',H76C(22O`I*:8U`B3D<>Z MAIATHM..H60TB(Q\HEH82#/ES<@)#X4E([&AH=`S"'K1L.-K%)K*$34P*/@L M70@L0S%I$"8CSV.#-K/6N[&QTGBL'$^2<744IP;A-/(0-PB4SN4C[D5Q6H4@ M.2$8BE2#D!IYPAN+!BP?.4[CL/94*#"OH2`U"*219[R!(-7YR`8518%G7>-B M*&P-VBU'GNH&8M1(MA&&0M0@B,;$.PI!U$MFFY+1(#*.9`\#R9A+3AF&HM$@ M-"8>C0:=_(UDJVHI&BU$HTL"K?9$L^$QH,5/324J*'4LH@Y]$CATUT*:B/8_ MEO+#XD>6O%DMY$+(!,O>?GBPB:"0^(1CH=N]-A*W6^IVB]W.+T@+?>S:0YA@ MZ5MJ9>L%[+4>]2D7C1XULPT"I%IH9MF9P%(W6^QF_L1DT7E02>QLJ9UM$C#9 M$CL+..BHG1W:Z20^?3MTNI,L!D=W,$XA;$BD:H(-IR_%AJ-V=D:P^)U!24RT M@W34T,X*%K]#3[N,%)WU,\.^3F-=,G_C\&C?G;0SSZ7 MB(UTL<2+%POUH$OG<\S2(0_&(,DRGIK08Q/R_/+HN)$[2?;VU(8>VU`BEMK0 M7VQ#3VWHD0T3^Y;NSJ-=N00ZGIK0XZQ*-I/#GM6CK"IX'>*I`SU.J:P#[SQR MH%-.U*,/;_NP!]FS_YV''M1.8D%/+>BA!6.>\U.$4JJ-H@?DGB95'U%3`@;Z M1-=DNG1-!NK!D",5_`XL0`]&R0P&ZL"@4#O\%B*@4[K$Z8'ND(-&[5AN`A#VI%48^"%Y$]/I`]$@T4O]%[#_!6HOTNDR\^+Y,I!DP6LFXH@LQN4@K-6!$!I3< M*HB>=M=?W%UJFHA,H]CK#XN(LI:63.Z'6RC(-(I/%A&>`Y,:>S\ZWBK=D,;T MV=H]MHJN@%C)VDW4C0GM1ZU`:Z+/>-+%SW@2=5!"&\V11V<)9C`OR6")9K"$ M=Z/LJ\M%@KM1*WJ1E'HS'DKU#74??%Z$VBI!6SF2!(;K3@E;3Z*,9K4$K2^>MTU_?VYTZ>G>[2WNKMX23Y?J*N58CYO MA^]JF2SS33L"[3>._<:WWQPND,[>1=W,7XJG\J]B_[3>U9/O5=-4V\.-SL>J M:LJVKWG6#NES63R<_MB4CTWW:[>%V/&'X=&OYYC]02P,$%``` M``@`8XEX1_,PC39;`@``>@<``!D```!X;"]W;W)K&ULC57+CILP%/T5Q+XQ&`Q,1)`FCZI=5!K-HK-V$B>@`4QM)TS_OGX08A`E MV6#[,X*,F526`GA>!"A>UFZ4Z]L:RE%Y$6=3DC3G\4E68_5V3DK8KUW=O@??B MG`L5`%D*>MZQJ$C-"UH[C)Q6[JN_W"4*H0&_"])R:^ZHW/>4?JK%S^/*]50* MI"0'H12P'*YD0\I2"9D0\N/XBARF:SG.D=R MPI=2O-/V!^DL("5XH"773^=PX8)6-XKK5/C+C$6MQ]:\2;R.-DV`'0$^2P@Z M0M`3_&B6$':$\$X(9PFH(Z`1`1CONG);+'"6,MHZO,'J<_*7$LZ4B%1VN%9C MYD!D[;B,7K/$1RFX*J$.`S5F8V/\'@&D^N06T!W2H46'4QML;40PF<-N`'EY MG$1P2R(P/H.!S^BQ0'@3"(U`:`D@-$K28-8#3#B$Q*88!E)KR#??BX>@R-1C M"$(OBY$B?FP*C4RA@2DX:0K-F$J,*60G`N$B&*+,WEL;%4TA=C8" M/O&E12,[D9UJ,.DFFG%CRKJ)!EF@L9ONC*+A&07_.2,;AM`S9Q1K4YJD3:GU M+"$952&9L=A5P89$X[\)6#=(1=A9W]W<.=!++R;?@3 M\==XN8TGXNMDN=5M!MRWS=(&G\DOS,Y%S9T]%?(^U)?7B5)!I!=O(:N0RT;8 M+TIR$FH:J_*8WF`6@C:W3M>WV^P?4$L#!!0````(`&.)>$=S(E@-Z0(``%D+ M```9````>&PO=V]R:W-H965T0)9!##_?WR^8\NK:,`(@"SO4 M]'Y=R;'GH:[(E;5-CY\'CUZ[#@W_GG!+;FL?^O>!7\WIS,1`6%?AY#LT'>YI M0WIOP,>U_Q6N=C`6$JGXW>`;U>X]D?P+(:_BX<=A[0.1`V[QGHD0B%_>\`:W MK8C$9_X[!OV84QCU^WOT;Q*7I_^"*-Z0]D]S8&>>+?"]`SZB:\M^D=MW/#*D M(N">M%3^>_LK9:2[6WRO0^_JVO3R>E-O"C#:W(9H-$1+#?%HB"<#S!X:DM&0 M?!B2AX9T-*26(53LLG);Q%!=#>3FT0L2^PFNN'P007ADC\IH@UH07CO*1]_J M`N95^"8"C9I(:C:Z!DZ*D$=W3A'YICW2[)%K@JVNB%.79&=(RODDXGL2L>*, M# M.OFR>;[,Y$N`]H-./MV1%D'AY--%&0R2>;[!^0"%5:!BP98NY@M4 M:"1?@!MW:XCX?LV=13%4L%BRJTL+JERPJ\MYJ-+,)`]2)Y8I*X/(B:6KDB5+ M#8%%)3YYVF)#)Y8A^H1KU$Q@A7T&C6"F+BN""`*G;&?($GUK?(ZI/HK2I3#%P&-+;%SZAUIOT.'A)+LRZNW)M6?JBS>-3IW?4R1Z"VM\(SI"QSC'6FVAR\$SXV]D M$QE^3%U7%W3"/]%P:GKJO1#&NQW9FAP)89@#@8`7X\S[W.FAQ4&ULC9A-,%',_^^Q4@'+6F332'L2T]W7J;EM0=%I>J_M7LI6R]WV5Q M;.YG^[8]S8.@V>YEF3=^=9)'-?-6U67>JI_U>]"<:IGO>J.R"&@8BJ#,#\?9 MC_%Y[S;DL\_J_E2RJR_V,S,:!'X?W?=L-!,M%<+7;'4IY M;`[5T:OEV_WL+S)_H:)#>N+G05X:X[O7B7^MJE_=C^?=_2SL-,A";MO.1:X^ M/N2#+(K.DUKY7^WT<\W.T/P^>E_WX2KYKWDC'ZKBG\.NW2NUX8?7G1OEVVMZ?_6P<=4> M:]3HQS*A=!%\=)XT0WOFP608BCQ"-PQCUB9#KD2@5.)2Z0S*H(9]Q&-4A\FP M"$.>*)#*4:DF@P:\^7JA#""I0\!L#)@-N6&&@SCB#A[XZ($/'CB(U9(Y,&O( M"(S9F(Q(4":[Q=Q6&UEJ(Z`DQE9916`30$0,`0W(L4S#I*."%/$C+)T9 MH%RR0(@=%BA&C.-A$8>P",@#Q:,RH;O83]%L`8K[L4M75QET)6PM0^N7FZZFDB+W1$04.Y9@F\B_N6="A!. M[.#';80[FM!K]P0$%GST&:\`E##T"*X)*.;"YWA<@/JC+QCS!:C(J?X188=F MM@8D$G@JA'G/X^=9@'L5%VPRQ*UFI#)WB36D4XT)[H1!8@Z^FB[F@&*N=6/ MH3WIK8:PNH$O_N2R6P0:@N.'/@G`))PZ:*-VS:93Y7AOZ9KO&UU/K:Z*%Z'K^\"5[1[C6*- M/Y+Y$T'&UV3^@H[3^3?,SX;.G['QC,Y?L'%U6N>9.K%_SJCS-L]HB,X0-8.I M4EM:S6#KJ#VH9A@ZP]4,1VJJJ5*INAK[;-7N:[ZX]"OK7=U[BK<<-[T.%'6YW&U[K7=\O+_P%0 M2P,$%`````@`8XEX1VQ18*+"`@``.PH``!D```!X;"]W;W)K&ULC9;+CML@%$!_Q?*^MO';(\=2'*MJ%Y5&LVC73$(2:VR3`DFF M?U\>C@<0D\PF-N3<>P^$`/45DS=Z1(AY[^,PT95_9.ST%(9T>T0CI`$^H8E_ ML\=DA(PWR2&D)X+@3@:-0QA'41Z.L)_\II9]SZ2I\9D-_82>B4?/XPC)OQ8- M^+KR@7_K>.D/1R8ZPJ8.E[A=/Z*)]GCR"-JO_#5XZD`L$$G\[M&5:N^>D'_% M^$TT?NY6?B0_22?5_5- M&@@@TU-\-6C)RB6!WCB M.!%)>&:/RFQ$S2^?"LI[+TV9YG5X$8EF)I9,JS-@(4*>W5DB]LWP6`N/704V M.I%D+J0SD.JQ1'*32-0X$V.,$Z2V!:JY3(T%I2A9JI(J9%&,--5=#U1$0 M10%P49U!Y5F0/?;-+-_,\*W,,IGRS;0RD8O8W"%*I:H3WT"6!%^8V]QRS777 MS&G2Y@]=[Q"SJTZ4:1`_-BTLT\(P!:XJ;:%528/,Q6QT)@EBIZW)?&$)E)9L M:<@ZB[2EOM*JH'+:ZE`2!;E35X=RC?E4M[)T*T,W<>I6^FHKM+6F+P0#2IR) M.H-)@^2Q+H@L7W&J:,*I4WB&%N/2.<$FE;M_ALZDP%?F&`!;VMCP,^?J;&=H M*>2>9HMR+V(3TO>[SYUCVSDVG'/7EMG.T/SGKNS_5#$[&Y1SB^X,QMRCE7.H M';$C(@=Y5Z'>%I\GIHZ_I7>Y#ZWE=V M)SW@$I^XE$!B=\<[7)9225SY;R_Z=4U)U(\']>]=7&'_B!C>D?)/<>:Y<.O9 MUAE?T*WD[Z3]@?L,G<,3*5FWM4XWQDDU4&RK0I]J7]3=OE5G$J^G31-@3X`/ M`@B>$OR>X"\E!#TA6$H(>T)H$%R5O6MNCSC*4DI:BS5(/D]@+>!4B@AEBW5J M5-T0T1T3L_/4O4NA'@,[S%;'P"G$3D?XX11D/X*LIB"'D1<8/#"NR#$9 M!@YA?!4&CL(D\P+^(!`H`7\D8+B,5!L*4RO,RC$*B54A(Q"O$!HU!J^6FMD.(B>U9JH6B,]J.-/878Z)EI216P8 MB4=5@'F!Q*@B>;6*E>%@]:P*1=FN](?'FVQ"A\2>$\\;`9[A1'Y%M3+@`@E@ MM`'`JW4`:+J`"YZ-'M3'=29!NQ$H<):8,5]_,'K_(W^!1&!6$KQ<26BZ"!=\ MA7K0S&=HC#)OL:LM%0VZXE^(7HN:64?"Q:K3+1$70C@62IXCE'+QO_$8E/C" MY6$L4Z@56`TX:88?BL=?3?8?4$L#!!0````(`&.)>$?!K"XN]0$``,\%```9 M````>&PO=V]R:W-H965TN0D"6[`#XPC"I-Z@@(?#\!'6I[M\CUV@LK ML0^W7$A(X'%[KSPFM[:81:`$4.[KRJ[7#/6]H[#-<']PGN MRTPA-.!'BT=NS1WE_43IFRJ^50?75Q8PP6>A%)`<;KC$A"@A^>'W2?//)Q71 MGL_JS[I;Z?Z$."XI^=E6HI%F?=>I<(VN1+S2\2N>6HB5X)D2KI_.^PEG2D0J.URK,1.7[(S+U5N1)E$.;DIHP@0:<[0QP1:BM!%A?(<`:6#313"[ M,.538+N`R6.!FDQ,&P;3:PR,H`>W4.4"%<;>[K&9:&4F6ICQ M'PO$JSCBS\:1K!PDE@#T5W&D)H[$;C3STBU0N0"%5F1_M;);6=DMPO@/@705 M1OK9,+*5@\P.`V[N^C&S^PR@%V[^&TM4X*W-`.OL#>B"OR-V:7ONG*B0QUB? MN9I2@:66[\E-;N3M>B\(KH6:[N2XSEJ0-&Y(Z/,.@W+1>,*!V*,Y:C`-)8 M$J,X#L,<,](/057:W(NH2GY1M!_@12!Y88R(7\]`^70(HF!)O/;G3ID$KDJ\ M\IJ>P2![/B`![2%XBO9U9A`6\+V'27I[9+P?.7\SP=?F$(3&`E`X*:-`]'*% M&B@U0KKPSUGS3TE#]/>+^F?;K79_)!)J3G_TC>JTV3!`#;3D0M4KG[[`W()U M>.)4VB!=O@6H? M%*6[XF,GZ9V3U'<2W1;)G)/4*_(8WD(*Y\.'Y,GN/R:2W?G(/!]1$6Z.)+OI M]F\S\5$/A0=R7K!WX$9RAF]$G/M!HB-7^NS:@]9RKD!+A3NMU>DK90THM,IL M'\QHW%_F`L7'Y]O6V?HN[;]["W9[Q03(JOI;ZTJ'K8(!_,.;[ZZH:(MG,/^:@?W(.#?'U-?K[L;L6_Z'H]-Y4W\I#?[*T\28XZ&/Q7/5? MS.6#GOL@AH"/INK&W^#QN>M-?6VR">KBYW0NF_%\F?Y1\=S,WX#-#=BM`23_ M;,#G!MQI$$UD8[_>%7VQV[;F$G3G8GC;<&?E[1#$1@ZZ,5H[#9?M66>?ONQ4 M*K?1RQ!HUK!1DV,-\RGV6,'%31)9`"\%NU),MV\9H5"O!^#7`,D4@),`&85, MIVY,FF;49"P4/M$>BU(59C$ZX'6NQ.%*,)>#I2:L!&5D/&0^T9Z(($Q>)Q$. MB<`D,O:B")0%4AYR+PM693Q<\;92AR5%+`!^EI0.2^I%(:(L7%%YTD&19%C` MBR)1ED2YA3.C$!&$*VI%.2B*H'CK(%>XPZG[@L2$@D4\>QTD;2A_[X5(. MHS9ML*:;WIRO^\7;IG7W&U!+`P04````"`!CB7A'1Z6SM@P"``#E!0``&0`` M`'AL+W=OP#$N28M%@'K2:=6KHRW6*HAOP'1@*4!9CC+DU+.M&PSN/D>O!?HGV5 M:841_&C(()R^I]E/C+WKP;?+P0\U`J'D++4#5LV#5(12;:02_QH]_Z;4@6Y_ MC/YB)K!1OZWH5<\9W*-S9\)6,)B38\,RK,USO?A63M%.)[ M+?ZP;=.9=K`K>3B&;0?`,0#.`5'\SP`T!J!5`+!DIJ[/6.*RX&SP1(_U84=[ M)>?:1#E[PKAQNUVJ,J%F'V6>QP5X:*-1`XWFZ&K@EJ)R%2B9)4`!;%+`B<(. M7Z";`<7/#=!D$%L#M"@C64*FM@RKZ8PFBF&0;:FJA2J!`7H.$Z]@X@5,NDR3 M6)C82;,"R2V(JXA0\!^;DJPX$H?)@%@"``#(!P``&0```'AL+W=O M51K-H MUT[B!#2`J>V$Z=O7%V!LY$S2+`(VYQQ__D'^\P'A=U)!2*V/MNG(QJXH[=>N M2XX5;`%Q4`\[]N2,<`LH&^*+2WH,P4F8VL8-/"]Q6U!W=I&+N5=;9W@&5P;^H:&[W#<0LP#CZ@AXM\Z7@E%[62QK19\ MR&O=B>L@GZ31:#,;@M$0S(;`^](0CH;P64,T&J)G#?%HB&>#+_;@RKV+RNT` M!46.T6"1'O#/R5\S.>8A+-DB(@W+%\)J1]CLK2;/7-4_`AA-L*.L1*@%!F#X.B*:`2`9$ M2D"TW(D_ED2*.B'R'#^(C;+]?=E=G'B!$VL%"?1U,DD3*\OX?NQD)E6IJI+( M67G*SSJ%SA[39POZ3*./C?39G1*I[*HF=E(CK9ZS_*9=Y?QJ M(;Z(SD&L([IV5)XM\^SB=[S&=,D??@`G\"?*D[8AT09:>K M.`K/"%'(X!B/;56LK&UL MI5G;KRTB9[FU@ MG.7!0/OTF3/=TTU+&KUG^8]BFR3EX&>Z/Q17PVU9'D/3+)ZV21H71G9,#M5_ MGK,\C-4[HWN65Y9AKO#L/QJ+$M\_$H>RWWNT.RS`?%:YK& M^:])LL_>KX9LV!E6NY=M61O,\Z%\'M3B'[/L1_WE=G,UM&H-R3YY*FN*N'I[2ZZ3_;YFJE;^1Y+^7K-V5#]W M[--FNY7\Q[A(KK/]W[M-N:W46L/!)GF.7_?E*GN?)7(/;DWXE.V+YN_@Z;4H ML[1S&0[2^&?[OCLT[^_M?WQ+NM$.7#IP70=;.MB]@W,6[TB\T^/9>0=7.KB: M"W@2[^DN(*2#T%S`EWA?=X%`.@2:"]3Y;K-FZ2[!^D0SW46Z3#.NO4B7:Z:; M;-9EFVFGFW7Y9KH)9UW&F7;*69=SIIMTUF6=*6GWSKMT>6>!KB[>99[CS)MM MH3=MXB8NX_$HS]X'Q3&NFR<+:WQ>\U3D@Z(AS-OV4W6*HK*^C?W`&YEO-9/$ M\`8S43$VIR`K%<)ZA%DIH&7P(5R"*_[D"CD8G);!41A< M%##1'H`6C/*X4ST^,6$; M+K6+.8#Q@*):J!ANT0J7*LCV\6HM:`5`ED]3K:%TQS9\"A:!F!@L`"^-G+LH MYRXX-6A-O]V`JX8";])MY:L8BT)$-.*T4@\I]8#2@%3J@5"[AJ!0:^]"J%M8 MY/W/4`NT`:&6ETL6ST1`:?0AN!$@(0Y980!CTV4X4T&N89,U!24)WR#K9:[" M'!JS`%0^K6FI@H3!R#RK&.;A(RG3C(2[-"P",;`44:'"9A337P_-IT;+)2I`L M?;2O6@-8%Y57V=^ M"V7H@8LK#)V)@'&\!0ZZKDWO@:M[P`=&GFT`(DLD@A!#9T!E-A9LZPBV0=`% M_DGN@FY_/.@V#+K6N<%S&%,',0_%*I##O@-B)=`O7$K M@I;INP;3$H><3-Z#!M,*,/'_)"^0)8'"R3D%BY`LYNB4`1Y-F3J;>F@A9DG9 M[JF55-@:P"K=@H1%B,W7*E\\J#)/1[<'PBW\$[K!K%JU()HN`CAF6%Q'.!Y0 MF3JA>A[==P2L3(_N.T*C[PBMOG.9:8J83O6=RTPSO#N2Z5:#Z0XPG>D[EZGF MD.IDW[G,M$#;P[=6NKYSF6F)0TX>@X>S3'TEP*L9CYVH!'&^\_25(/Z@]>"! MGJD3/6ZJO7!?K_7X>JW'_X/6@\=[%IS1W37Z`'8>ET*M`8IH/%VC#S[>=W@[ MX#=NC>K&<,$'S]:.D MS[R^AXOL$Q8^,,*^8F%$V2<\O*9X;GCXA;)/>?B5LL]X>$O9[WCXC;+/>7A/ MV1<\_$[9ESQ\H.Q5PL*(6^3.^B=NYN^8CD?'^"6YC_.7W:$8/&9EF:7-G>WG M+"N3*E-53QL.MDF\Z;_LD^>R_BCJJX?V,5G[I&ULC93-CILP%(5?!?$`&`PX)")(,U15NZ@TFD6[=H():`RFMA.F;U__`#6( M=KJ)?SCGW.]"['QD_$TTA$COO:.]./N-E,,)`'%M2(=%P`;2JR M&JDW0)&#Q5>U'>E%RWJ/D_KL/T6G$FF%$7QOR2B]4 MOK+Q"YE:2'7@E5%A?KWK74C6S1;?Z_"['=O>C*-]DJ#)MF^`DP$NABCYIR&> M#/'&`"R9Z>L3EKC(.1L],6#]L:.3DG,=HI(]8=*X?5VJ,Z%V'\4QA#EXZ*!) M`XWFV=7L*DI7$:>+!"B`70HX4]CE$W0KQ,>/`^(Y(+$!\:J->`V);!M6TQL- M0L&NJ'1%Z2'XCUZ2#4JR0DG653*+DCA5(I@$<$]5KE19$AP^ADDW,.D*)MV% M29TRQVC[7B865X12#?,EMMRD MQ6]02P,$%`````@`9(EX1PCK)GSM`@``LPL``!D```!X;"]W;W)K&ULE5;!CILP$/T5Q`<`-F!@19`V1%5[J+3JH3VSB9.@!9S: MSF;[][6QP]H6FQ`.P7;>S+PW>$937@A]8T>,N??1=P-;^4?.3T]AR+9'W#W:'@^L)8-'\7[E/X.G#8PE9$3\;O&% M&6M/DG\EY$UN?NQ6?B0YX`YON731B-<[KG'724\B\E_M]#.F-#375^_?1KF" M_FO#<$VZ/^V.'P7;R/=V>-^<._Z+7+YCK2&5#K>D8^.OMSTS3OJKB>_US8=Z MM\/XOJA_\DB;S1M`;0`G`X!N&L3:(/XT2&X:)-H@<0Q")65,Q*;A3552/C=ZHRJ](!1.G[U41H3)\EXXT!HZ8M8D!$R(4WF=#0-\V MAX8YG`M0FX@XG8-L+$AQGT1\)1$KG;&E,[OO(+DZ4-OGQ'*0VR214JHP@TI4 MGD6!D\],R;5@""U0DSID4HM,84?)%9G4B))G11#/H6H3E>4P@/?)((<,,LBD MR6R8-3(E1W%0S.6O-E%%$F1SH(T)RO,@*LSG/OO,89^9J021'5)A:ANSH`1R M)TAN.5B0X\*YOL6CUQ=$#@79`[^^P/HS:9#^3DDP>\UK&X6"!5D'P*4#;EUA M74\:--%!LU?81J4&Z:_I0)>.U:22!9\8N!T&/-QB@-MC@-5DP'S%`K-]H#0H M(N-90MQM)L#J)B!9X`*YVM'#VMTZ!-D2[9FA/87!$JYN+0*[&-,%+MQJ!`^7 M(W3+$9KEF*)L5BXT"RT%2^1"M]"@56@`+7`!';D0/BPW=EG$M^3JOJ)!7W[= MT!AM>DP/XXS(O"TY#UR-'=/I-(<^0SD:.>=K,9^J:?+3356>F@/^V=!#.S#O ME7`Q>(U3TIX0C@6]*!!U&ULE991DYL@%(7_BN-[%=`(["29V;73:1\ZL[,/[3.;D,19E53(9OOO M"V*R0$UB7J*8XX5]%'4[=R$>^4VC^DJ5SM>,-D(O:\U?]L M1- MB^,BAO'IPDNUW2ES(5W.TW/=NFIX*RO11AW?+.)'^%`B8"2]XE?%C](YCPS\ MJQ!O9O!CO8B!8>`U7RECP?3AG9>\KHV3OO.?P?3SGJ;0/3^Y?^O;U?BO3/)2 MU+^KM=II6A!':[YAAUJ]B.-W/O0P,X8K4_$,9)[9IXV?-#RSIAHYTCV M;IV-2WLV3JT%CBM)59+.S)-4`HQ3H1&&'C\BE`/BV M078RR*U!YAD0'[*P;5A-VVL@P2`I?!FVO7BRHJ"W8?(`)OA%%Z`<56$%`FYS5($+(47S81LZ%X*I!# M9SF^#!3.9NA-9S1A$D(:QD+OC06!@`*!"9^?030TG!<)'9.5OHP6_ZWXJ?.! MW[,M_\FZ;=7*Z%4HO5?H/^P;(1379B#1CV2G]W#G0+R'U!+`P04````"`!DB7A'&"7OA@@#``"W#```&0```'AL+W=O7WG;JF&MJ'@;=&RW"!_QPQ.D M&M(C?E?L+*S[0"?_POFK?OBQ781(Y\!JMI%:HE27-U:PNM9**O+?0?0CIB;: M]Q?U;[U=E?Y+*5C!ZS_55AY4MB@,MFQ7GFKYBY^_L\%#H@4WO!;];[`Y"CWA!P7OM(A2#D2OUID7HN9.J-&W90YT'K]IH0$#/69E M8_`5$2OUR1`0CNE@T6$J0&$C2#(%68\@^13DR8:D)+N=*+DD2LQ<$#M1FMP6 MH!*W7F!)F-S&239F:V M&9Q'DV^Y^!SU:3*YDTQN)S.]EG(K"DEI'M&IE`L;!A1AGX6"D9..WG2MR9EY M2&!GL6%\[VK#X&8!M]?!:@P"'[?$C6/O!3E!'A+4=4OO=INX620^;D<@XK'L ML5O$>%3%!#PD,M=M=K=;M_JP1_D5V*XL4)7EL<]CM[3PJ+8(N2T!R/$+Z%Z_ M@)TL`'OX'4##3H)0Y/%RP*T:L`LBR3VF#-RS$>X^',$]'<'G>(31^9A%>(S* MAEFQ41[%">ZY!W.I/IH3T36[:9`'*1'*?_O@*$(U3`\L5\^.WNTZ[> MHEV=6?/&#Y0*YZ,J:W[O'H0XWOD^WQQHE7./'6DM_]FQILJ%?&SV/C\V--]V M1E7I0Q!$?I47M;M>=>]>FO6*G419U/2E1>[PXF>Q/XCV MA;]>^1>[;5'1FA>L=AJZNWZQ%0?)-G"= M+=WEIU+\9.=O5*TA;!UN6,F[7V=SXH)5@XGK5/E'?RWJ[GKN_TD"939M`,H` M+@8H6C3`R@!_&I!%`Z(,B*U!J`Q"P\#OU]YE+LM%OEXU[.SP8][N)W0GX4WK M1'IV>.>MZ0LB<\?EV_=UBLG*?V\=*0QTF$<=@RX(7WJ?#`'NV!PT)2,\+H#,C@@O0.B.X!HS#+JT]%CZCZ; M0&+/(DYHQ`GU.$8RDCY,J(7!$4D],L4FTV%``N2EU]E$!IMHE+9HDDZDTXFC M1(NCP3(=!B$@C?4LG=B@$X^*$$_2B;4X7Q!*OK9`"J1(1`N:.43D9X0"EQ&;+(&120DM5"A4EI(4*IB#9 M#&2>")A$8%0?L'!AM@UT<]]`9N-`9*E"0SKTU@'!9,ZR6=`\&;.[H-"F-N'U MVDQ#YHF8C06-.XM-;6*S-O'-M3$%C)+K#253(-4JI"P\F\RG9JATM!FQQ<C"F^^@"[!Y0J9&`2Q:N@+-]W3UQ5O"S5/")B5=\V%J M46P@9J7(S94RE0I+!X%(':YT%<8IV'Q2P50B1*/EVIP"327"S4H$4XF0+"QW MV`:Z$`F./8NN`:8.(1TMU^8H:>H0WZQ#;.H0HZO5?<8C?<5):E->;`H,CP1F MGL#5P17#*-1_GWU?FSPJVNR[F8\[&W:J13]X7-Y>YLJ';JST/^'KU3'?TQ]Y MLR]J[KPR(>>?;EC9,2:HI!%X<@T'.?E>'DJZ$^UMW"ZNGP7[!\&.PVA[F:_7 M_P!02P,$%`````@`9(EX1X7:R.Y)`P``:0\``!D```!X;"]W;W)K&ULE5?+2=SIM(O.9+)HU\26;2:` M7"!Q^O=%/%SI%K#LA4'XW,.Y3UFKBZS>ZI,0C?-9Y&6]=D]-_(LRO:7@ZR*M&F7U=&OSY5(]YU1D?M`2.07:5:ZFU7W[+G:K.1[DV>E>*Z< M^KTHTNK/D\CE9>U2=WSPDAU/C7K@;U;^U6Z?%:*L,UDZE3BLW4?ZL&6@(!WB M9R8NM7;O*/&O4KZIQ??]VB5*@\C%KE$4:7OY$%N1YXJI??/O@?3?.Y6A?C^R M?^W<;>6_IK78ROQ7MF].K5KB.GMQ2-_SYD5>OHG!AU`1[F1>=]_.[KUN9#&: MN$Z1?O;7K.RNE_X73@:S:0,8#.!J0(-%`S88,&3@]\HZO[ZD3;I95?+BU.=4 M99L^M/!*D;3,3MVQ57VX6L_J]NG')F%\Y7\HH@$#'>9)Q\`48JLC6'B%^*V` M214PJNB7CV"H2&X3L)$@Z`F83A`04V3JPFT]W`.7C*%VNHHQL!&3(AB&QIBX#9!A+R)#`(VZ4VDZPRI M!Y/>Z"B(B6\.1(`7)4CC"/AR)$8XIR'8&,BN#$J1# MS2A-B`T%1;&@]-Y@4,`JP*(Z!M#@+(UFRL.``0MMZH/B24#-46#1,#3`80GN M'4!)-%HJ!BA)BXQ%N81I93"2JMV<=@$VOPWBG@9BD:ZR,6A4;>QJLK^)-@O&GD>#[;7T_7F+U!+ M`P04````"`!DB7A'GSRK'LT!``#?!```&0```'AL+W=OL+4$"1,AM\^\_YC@$[[X5\5S6`1A^H8U%IW!XS5I09.U49TT)J52DA. MM1G**U:=!%HZ$6>8A&&".6W:H,C=W*LL&NNM;83N,CQI"L;#JUJ1(LD5,?@R_9P2FV%*_C50*]F?62SGX5XMX,?Y3$( M;01@<-'6@9KF#B_`F#4RX#^#YW^D%<[[H_LWMUN3_DP5O`CVNREU;<*&`2JA MHC>FWT3_'88MQ-;P(IAR3W2Y*2WX*`D0IQ^^;5K7]GXE"P?98P$9!&02$!_< M@US,KU33(I>B1ZJC]MMM#Z9<6A/CC)1SDW[W)J@RL_=B'V4YOENCH<9+3O.: MF*13#3;^#R%DA.P\A,P,2!0_-]A-*0>'G7-HO4.X398Y$Y]S7I3L=YM/)(W6 MH&@)2I>@S(.B!6B[V3\'Q6M0O`1E#T'SHB0CGP$E:U"R!.T?@I(5*'D.2M>@ M=`$BX1*4>E"Z!*TP>/;S=O0*/ZF\-JU"9Z'-.7`_;26$!N,4;LS+J)U,=UKQ#U!+`P04````"`!DB7A'_?L9&8@&``!5+``` M&0```'AL+W=OM%S[8*!3).8$YO2\^^/'1OPOE9@!1>0F%%-NN%$L(M-L5J.S\YVC_[MCLYJAZ:]6I;?MO-ZH?-IMC]=UJNJ\?CN9P_ M/?B^NKUKN@>+DZ/%<[GKU:;6ZO&HZ&T7[YW>Y+-?KSE1;];^#U9=*NX+CST_6+_;^ MMNW_6=3ELEK_L[IN[MKFBOGLNKPI'M;-]^KQ73W43;5Y M*C*?;8H__=_5=O_WL?^/%T.Q=`$U%%#/!:1YM8`>"FAN`3,4,-P"=BA@N07< M4,"]%+"O%O!#`<^M(0P%`K=`'`I$;H%NS/N1$^PBSX,MH9_5]T:$G/W;Z76>G-3ZK]P9W?>RV85:W3W^?1!./%K\[2X-&[36G1&-% M2K.D&IG2G(TU3B?K.J=V5$IS,=8D%9^H%9W2?*8:D])<4HU-:;Y0KT)*\Y7: M<<^:13M$Z7%23^-D^G%2Q()G6-!/%G1O01,+@6'!0!L,L0#CUVO.B,8)1BT6 M:K'$`D22[R.@UVSW&JU%]\.HR4%-CM2DDOY0C6;4XJ$63RR89"U48QFU!*@E M$`N<"(L0'S$[/J2`1G33V`L+RB3';A#U@V?%\,.I3F)U!"O'@4(J\%JJ?+#J'?;Y[B-&$K*&*O)%MVV^6XC/I*RD9P/3JG(LQQ&@B3!PTN. MC8`.AWR'([8CONWPDHJ\XLSUR)$2Q`9GUE$2'%8RVV$U23H$#I_D^6P0]8&M M+#^P%7*D2(KRG&E0&73;Y+N-&4@1.+RC;MO![7$.DCEN(T>*(N)3874!(I9? MR)'R9'H^4!$5L2K"9*0(;#YR;&`Z4OGY2"-'6KP=OY^T>&?\:LQ'FB`76#8P M'^G\?*21(ZU?<]L.;NOWNHWY2--\Q%E[:,Q'.C\?:>1(.\YHNW>N/C32I$E6 M"IRLI#$KZ?RLI#$KZ3$H!U8?RT&4O_HPR)0A3(7DJGD)(DX",TB3H309C@VD MR>339)`FPUC=G1JRNLN@R4PV6>;M_CT%$2=3&LQRAB`7.-@:A_WK\OL7.3*> M$;^#Z!WQB[G)!$[\4A%G9V&02T,26.#TC170OU9D]Z]%CBS=):67Z53$6K5: M7"U:`EO@9'V+AQ0V_Y3"(D%V#,>A7>@@Z@.*=4PQ.:<@_$26#>3'YO-CD1_+ MX.?)SWZ,!X(M+%(\FH*B'(0U(A,5H4J3E`'3+)!,N@AHK8F3LH* M."\$18VDEX>!3`Q6LXJ(J(9 M`3K.9BMBFHWY:38B3I&L1-.[RPLJ8NTN(W(4*4>2U6W(4[`I'JGI#* M.#L/*?`TI7N2[_GD;;/PG&"G,J[G"%;WA%3&NL0@\&59]R3;\^GU#2E8X2Y% MON>)RQL`#:_-D_L;[[G`,;W!0:YP'-@>GU%5VV1.UI73^QN2HJ5X'3BYPO&> M.QS32QR2+M8.W-F1XWT[V]6VGOVLFJ;:''=7#6^JJBE; M2^)#V^B[LKA^_K(N;YKN8[$>Z=HJ&'P4``#P?```9````>&PO=V]R:W-H965T$VJ"ICP9B)J^)TWNYWMWO?FOVN?NO*T]E^:S;M6U45 MS3^/MJRO#UN^G6]\/[T>N^%&O-_%'^,.I\J>VU-]WC3VY6'[E7_)$S9`;H@_ M3_;:.M\W`_FGNOXQ7/Q^>-BR@8,M[7,W3%'T'^\VMV4YS-0_^>]ITO^>.0QT MO\^S_WI;;D__J6AM7I=_G0[=L6?+MIN#?2G>RNY[??W-3FO0PX3/==G>_F^> MW]JNKN8AVTU5_!P_3^?;YW7\)673,/\`,0T0'P.X6AP@IP$2#8A'9K=U_5)T MQ7[7U-=->RD&;_,O/;P9)NEGWK2WV9K17/W*VO[N^YXSP7?Q^S#3!!(WT*,+ M$CY$[B*D_H#$/0,O#3'3&"^_"DA#W)]!SC.H<08)9Y"0IAD7,H+.XT)$Y`7E M`,0C`A>%N"C(1<''I",7Y3R&8RHC)H<8=9^)1G;5D`G!,P:MQ<`9C'>FXJ%1'.G/_[C-+$;,4,DOA M,_7(+'69>5FY"$;Q>89X9)"'=^V/F>LQPTRDO60RX+&41>E]/IPA0H.:.HP8 M84VJ=S`7F(1;W\N2A"36Y2$L?*$<@1F"#!8M+RD[F$FP'[Z;*`8@3 MN&#!XJYB91EE.5AI^'JIX5AK^++8S`X",L*8WR0A4)@-5AI.DAH.M";R@G(` M$I2@YEA=>`I<1/%RAEV4K7:1P+$L&,5%$VJ2EX"+@J`P&X[9<(J+)M3XH"3R MRRX"$?1?8'T14%\D9442^4C(]3["T2P4R4=N<9&0S*_Q@S3)_-J-$+?4"3\) M*X,P8/=3K))@RR;K+8N#4*0DR[HI/`OM_A`HS`8G>I&1S._F<*XB;S6:0Y2A M2)3$VB"A-DB"1DFKL_S$D>S).5Y:0("!6QB5MH$9WE)RO(R@1J6^

P'"B]?K=A M.5"&M-O<2!I_\K-VJW\3."`#(-)IG<8M@EYN$6;KZKMJ%X"$F6"5 MT5!E)&4U6!OT>FW06!LT21NT&_.?BO;9)BZ(<#*GL2;H94V8O9/=]XX?$CYE MQFI@D!H0,JO!:F#65PH&JX%9KA3F\VX0ZBS04X5183ZX6C"D:L'$"0[EA"U:)1FMDBPT#R,D#T!&)K'SGO-2O-H_ MBN;U=&XW3W77U=7M_>9+77>VGXA%O<./MCA\7)3VI1N^)L-.&%_NCA==?9G? M57^\,-__"U!+`P04````"`!DB7A'+20)8LX!``#?!```&0```'AL+W=O3BJEG3PJM$ZLHY ME7^/P$1_"*)@G'AK+K6V$[C(\517-AQ:U8@62:@.P;=H?\RLP@E^-]"K61_9 M["(HY.,3.H?4.890NLUURLB4G\9RY*,J2QYCD'I,L,;LE9ND2 M]+0*FHN2KX&R>U"V`)%P=8/FHFP%A&<_;T MX<9\GMK<-M.`0:5M-[.[Y`^@'VC1C=?)=*<5_P!02P,$%`````@`9(EX1\;] M@K17`@``PP<``!D```!X;"]W;W)K&ULE57;;ILP M&'X5Q`.`,>>(("5,57K%=NTD3D`%S&PG=&\_'X!@A)HT%X#-=_H=_#OK M"?U@)<;<^FSJEFWMDO-NX[KL6.(&,8=TN!5OSH0VB(LAO;BLHQB=%*FI70A` MY#:H:NT\4W-O-,_(E==5B]^HQ:Y-@^B_/:Y)O[4]>YQXKRXEEQ-NGKD3[U0U MN&45:2V*SUM[YVT*SY<0A?A=X9[-GBT9_D#(AQS\/&UM(#/@&A^YE$#B=L,% MKFNI))S_#J)W3TFHC(G96^Z!`&3N32H-(*A`>P,T M(5PAO^H!;9,.30]OS:.8@\+$?^SBCRYZN/--%_A8(1@5`JT0F`J^F3/4Q6A0 MJT%^\-@E7+B$IDM@ND3:)9RYA+&3KH$*`Q0Y3ZQ9M,@2F5E"TR;16:)YQ4'L M^&NHPD2%3OPX3;Q($YMIHM4T\4KA?.0-K(G?7,!M.+.DN8=237ENN6.,'G#2 MC4?F=&[G_P%02P,$%`````@`9(EX1]"/]DA[`P``\0\``!D```!X;"]W;W)K M&ULE9=-26`Z[:$SF1[: M,[%EFPD@%W"<_OLBD!WM5AB20VSPL[NOUO(K=G41S6M[Y+RSWJNR;M?VL>M. M#Z[;;H^\REM'G'C=?[(7395W_65S<-M3P_/=$%25+O6\T*WRHK8WJ^'><[-9 MB7-7%C5_;JSV7%5Y\_>)E^*RMHE]O?&S.!P[>-T6HK8:OE_; MC^0AHTPB`_&KX)=6>V])\2]"O,J+[[NU[4D-O.3;3J;(^Y0E?LF M,RF(#M`3@&Z$VZ/OIPH70^`[MF M\,<,#&;PYS,$2$,`,S"XT'#LU@C5`\21(>7 M0)D.>4O:2SPD6!J_KCB!=0)E;YY6R*P7(+YC7'D&\VC0M&""!4,_#CVC12A* M?97,H6;-@"+FG9-!RE^R+0C%JBE4O>",(#=_5NY*_$_;*V%8![3H$/6%J>XA M:DDE[.0$6GG(S)40M<"&"?9A`HTX7/(SB'!OH\_W%EL505YE/KQ(#'ZS1B-* MET#9)#0M&=L507YE/L.(;C/$2"4GG MD6P"F1:+S8JBA\?(+);,B[V#J-Y"9(E+4>Q2%+H4/KZNYMB'ZD$=12,T8Y@0``(H;```:````>&PO=V]R M:W-H965TGR+&48(UF+U8: MS<7N-8E);`T8+Y!X]NV70]OI*G>%UM[$AOQ5_?>!K\OT^MRTO[I]6?;>[[HZ M=@^K?=^?[H.@>]F7=='YS:D\#O]Y;=JZZ(?+]BWH3FU9[*:@N@H@#..@+@[' MU68]W?O1;M;->U\=CN6/UNO>Z[IH_WTJJ^;\L!*KRXV?A[=]/]X(-NO@&K<[ MU.6Q.S1'KRU?'U:/XGZKXE$R*?XZE.?.^.Z-YI^;YM=X\J_]FZ#]&8\*6INNFO]_+>]4U]"5EY=?%[_CPM.Q;@\Q/T@;\JG0Y0T0\1#A#ACL:SZ,UBXZ3*)*I MKVRJ'*E"X2?+;F+B)L8C0MI)9S>QT8[R(YLF-S61+[`FF:;'-M$6B5+?8;&DQ'"*#">AU7!J-!/:K>28YF*Z8H#I>=B)!8&3EL>@&K%ZW29D#0%:4'YD;F``4AJ"/,OT3: M'0G4E&2F"LN&%>@P6P*H(\".[(^E5C%+1\\7%CEXH%07$M M,*^3Q-YY!.SD9JE>E@:212Y^*)(%9G*2VOT@E`(W%Z8JRIS&F!)7$.1FMHX_ M"9.GPOJXYTBCG+A"H2LR%_Z+S&$#8$5\_46Y"T[`>4FK M?\TG0"2T/J@YUDB7\A0H+0'3DJG^`5>?S&IW$&U9$6^9,A4P4YD?`6#B4G#/ M@RD"SC(6J67+DH)7AE]N`WK.I4E4JR1G)+P3"EQ)@&M_+J58'I<< MI+"5I,BU;T@2850R<\FK>#\W+P^$HC<,X(/=3+R(URW6..%57F&O M-PQ)BF.'34=21$M2T";V&4B79\`NX9U0\DI2S:9V)]FR$[N$?P5'@:H(4.UE MFC)IR7&#%?%N*%25<,&[$HOCPDAX)Q2HR@FHR@FHO(KW0X&JG("JEH'*2'@G M%*A*.6!,+?.4D?!&*$\5KD-I07]QL@S4KR3Z;2LCXJ M:@^55GMHSVSB)&@!I]C9;/]];2!9VS6)PR%@\L[PSF`_,HL3[=_8GA#N?;1- MQY;^GO/#0Q"P]9ZT%4/T0#KQSY;V;<7%L-\%[-"3:C,$M4V`PS`-VJKN_-5B MN/?K)=^H_P4.)(2@;%KYJN`U];T.VU;'A+_3TG4PU)#+A MFC9L^/761\9I>P[QO;;Z&,]U-YQ/XS]Y.(79`_`4@"\!$%\-B*:`R`@(1F=# M75\K7JT6/3UY[%#)MPT/0M[+)"*SQX9L_=@N41D3=]]7$.9X$;S+3),(#Z(G M5615E*HB2BZ20#BPVL!G&^/P$>LVHML9HG.&>,P0Z1EBW68Z%C**ND'T!2!% MF4U6_B?#M_W$AI]8\Y,X9$B,GB1W]R0U/*1ZAD0O-A][DBK%XA"!352JH@+E MH7K`;6.982Q3C*5Q8?65J2\A1:G5ER;"RNN"A06ZF%U MIH5D@(H[6U88/@O=I[4=3X7ZT"29:9JF2F.4WW8#H3$Y)2%5/PZ=!S!*`@,^ MN;6F275>C6$\,T4-'23(HQSM@$;RGE M1.0*D9A3>_&]$<7O6``^P$``+,%```:````>&PO=V]R:W-H965T,OH@*0Z)621ER<2LKV[+HBJX!BL6,M-.I+P3C%4AUYZ8J6`\X- MB!(W\+S(I;ANG#0Q=T\\35@G2=W`$T>BHQ3SOU<@K+\XOC->/-=E)?6%FR;N MA,MK"HVH68,X%!?GP3]??4^'F(A?-?1BMD?:_(VQ%WWXD5\<3WL``IG4%%@M M=W@$0C234OXSD+YI:N!\/[)_,^DJ^SZ(?&;]=QAR M"#5AQH@PORCKA&1TA#B(XE>[UHU9>_LE]@;8^X!@``03(+#&K9"Q^15+G":< M]4BT6#^>?U;A7),H9B0,&[?9*Z-"W=Y3WSOYB7O73$.0Q5P705.$J^C?U0B< M)3R8P,AR6:7Z"(5QY")<>CLM"1393&]0, M0;MX6R9:R41+F7@I$UN9:";SQ=N%VS+'E)JTN(2?F)=U(]"-2=7:I@\+QB0H&^HE'52I"3H="!12;X^Z&G:F MV(-D[3@BISF=_@-02P,$%`````@`9(EX1^6X1./>`0``$P4``!H```!X;"]W M;W)K<*$C0J'&#+D2^LO$[GB*D6O#$B#"_X'01DM&9X@&*/NS:]68= M[9,\F&C;A&@B1`LA3+XDQ!,AOB%`Z\SD^H8D*@O.1B`&I/_L<*_@7(LH92", M&K?C4LF$.KV68;"+"WC52A,H,J`G%Q1M(2H7$:<+!"H'FS:BV88M'R.W0QK> M%XAG@<0*Q.LUY_:CM85DPWP% M+?=@^1=02P,$%`````@`9(EX1S;)98V3`P``=1(``!H```!X;"]W;W)K[%)I.YV+UF MM"H9H"[4)5^\]>U&4FV\OZX#6GFF>[/J@L/"`D],HLK]SULF][KM=+<99% M7O'GVFG.99G5_S:\$)>52]UKPTM^.,JNP5LOO5O<+B]YU>2B^)WS2S,Z=SKQKT*\=1<_=RN7=!IXP;>R2Y&UAW>>\*+H,K65_PY)/VMV M@>/S:_;O?7=;^:]9PQ-1_,EW\MBJ):ZSX_OL7,@7 M&RG*:XCKE-F'.N95?[RH?^9D"#,'P!``MP`:?AG`A@#V&>!_&>`/`3X*\%17 M^H%(,YFME[6X.,TIZY8'7;1XW25I,SM-GZU6X]L.1=.VOJ\IB:.E]]YE&B#H MH8T&W0BO36^L`:X>#J-P,!5(Q@0+3$BJ(?%]$>PJ@JF.,KVC\_L9_&L&=?GD MZQEB76:D^JJ@JH?(_1H!JA&,:U!"]!J!JA$\5B-$-4*]!M5KS%6-<%QC9C%: M$:H2Z570O(>J2C2J\HW,HOMEYJC,7)N4T&)UQFAAQ+I0=C\#)4A$YR_C'+[> M67^XBQ`5F*@$4Z&)2C4J9+Z%:(I%Z[=^8"RTT2E*(K-H1,W-HA%E<1=3P*I! MRT&)6?68BD-F%FT!I9/0M&3L/)3IDBW6*,7>0WVK%:93%,S]MJ%23-GT'+L9 M#:PF*["9+`LHG82F)6-SI)H[$M_"DFB$)SQZW%*PK]&YU83K%#52B4:-S4(; M.Y0JL!`=8]&QE:7HCDN-5((IH_&D&F7E@X#-&XC-(L64T>$2F++EL6:(UA^P;] MW3$,+7($>,J#AUT%L+M!:#7EH=7@A5.&H0U>.'7?3*O&?@K1XXL=^RE8^2FB M)AZ@F(K-/7_<4`&_FX)N@@#W8,M_FT]2T'OS>R73K`N.Z MV6#*_)"8IJ;U8!MDNBD!>M`,WUP#I3Y5@$!LHI)I2NGQ1A_G):\/_2Y'XVS% MN9+JN_G6>MM)>>HW4E#[ABY2M1_RF6:]/&4'_BNK#WG5.*]"2E'VW_E[(21O MY9%9*_/(L]WMHN![V9U&G7ZU*Z(NI#A=-WEN.TWK_U!+`P04````"`!DB7A' M^^SV&J(#``"U%```&@```'AL+W=O&ULE5C; M;IM`%/P5Q`<4]H8A\?K#W>!4&].>@BK;^8HRZ;7W:F*E+;#*M] M4!\KG6Z[H"(/>!A&09%FI;]:=L^>JM72G&R>E?JI\NI34:35WT>=F_.]S_SK M@^=L?[#M@V"U#&YQVZS099V9TJOT[MY_8'=KQ5M(A_B5Z7,]N/=:\B_&O+:# M']M[/VPYZ%QO;)LB;2YO>JWSO,W4S/SGDO1CSC9P>'_-_JTKMZ'_DM9Z;?+? MV=8>&K:A[VWU+CWE]MF@1X=T`T1-.E'Y^"^&\X'X7QL@O40 M(=3G,XCK#+*O0@P)AA&!H[QFZ(AR"DD4XAEE/ M82:91,`D/(@U/$1U1$F`E]QP1%?T")Q>@+F$9-\Y'(1[HY M8D(.A6]`S7\#Z$`6D70!HXZBUH"2!#NS!?)9N#D("R2+49=XOBYH5T;RJX-* MHG&_0BJ*+!P-RQW#AI+PR7$T+)]O6(Z&Y9PBBX.::AZ3H&DV:&KN&E$2EF6. M[93/[Z<<&RHG=51`A>.+BX-*&&43@Y[FX$-*2=A7^?S&RK&S\I@D2SQE#T<6 M0!&Z'D=/B9TF72=H0CKJ,1]IYR_[Y38HV1$JGB(BF+"1RW1/A*,05CT)6XHY?P-I<3F M(Q-2PX5U?R]HL+&HDC_W`%*X4<=#$Z)"EWMN].SVMN8 M4VG[0Z+;T]L)W4-W0!=\P%?+8[K7/]-JGY6U]V*L-45WL+0SQNJ&1OBE^:8/ M.MW>!KG>V?9VT=Q7_:E:/[#F>#TDO)U4KOX!4$L#!!0````(`&2)>$=7]6NW MK0@``$\_```:````>&PO=V]R:W-H965T[VZ*]W*W/>1_'A>G]_U^ M<_SO2[XK/FZ7M.P>_+5]>2WK!^N[F_6EW=-VGQ].V^*P..;/M\O/].F!M*YM MSB9_;_./4^_W18W^:U%\JS_\_G2[S&H0^2Y_+.L^-M6/[_E]OMO5755#_]OV M^G/0NF'_]Z[W7\_SK?!_W9SR^V+WS_:I?*W@9LO%4_Z\>=^5?Q4?O^7M),X( M'XO=Z?S_XO']5!;[KLERL=_\:'YN#^>?'\U?7-8V&VX@V@8";2#;!O+2@,QD M`]4V4#\;J//2-%,Y+\3#IMS?K\CTNYF_;WNJ3429Z/[P.ABL:ZZ'QQ#+,/FHM=<#`WPT+>0>GX$V8W0 M?/PLPUGX^1Y4UX-L>E!!#R:;[T$S#+K?0V9M.%'3+$5C=&B'\2NVWK99CM!* MS&,Q#(L)9T/A**[!8OJCB)48,GH(C/0*\(UE6&R(97"8>]L;YI=L-0CX@1F9 M>2R.87$]+%;Z02BN/THUY>%U":SL"H@*S[#XX'UQV2`8'[P)9F4'P?C1MVH4 M#64,3ITC^WZ20!_$@H@H.8I("3G<"SQ]D("?TDX.L5@;(5,33`]E))^AVJ'[L MRVS$!?8*/#Q%D`N7#\AXY+D+?+(+!(]'D2$N:*W:T#?(2R>(CT1(&+16,W01 M6F%X>`80(EP]I`_)/"!DN@=X,`H%>4"E)U_!:P>A(1=HB`W$>)$QCHAG`,%* M"`OT8;D3;+H3>#@*!SG!I;]VG(\%1,@BX%H]4JF$5A`>R1.`9(0,>%%R0I;I MA"QY.$J(D*5(GW%4Q4-\+"7B@=`*P\,3@&1L#&PK)&=CF<[&DL>BG&;CEB)E MGXV183@32XB)I1T`BJ:0YN5T1E:=-5 MG(#5-`%WP]#LPH^8C"/AL:Y"ZK7`MD9QZE7IU*MXY"F(>E6?>G6&E'N*,Z^" MF%?U*569D>(GL`+Q\%A7(>]:I`_.NRJ==Q4/007QKG+I,^:\JR#>51[R@$_& MHWG0ZY!W+;`1UIQW=3KO:AZ+>IIWVZR@15K(:TZZ>IITNV'D;/(9,1E'PH-> MAW1K@K0;.'P`Q%S9.)#6G=(8[@M&[3:=WQ:';3 MM-ZN7F`ULGHN"Y8%.M5QG/O=-/=W<`B`$QQV>S/RS5!@AJ+FJFEB>?YP$.EB0].Y1&LO#;QT)F\#T[;:24' M%S^T0M#P[./#^L0!1P2>UR<^O3[Q/(P]=$3@3>I\>>'AIPN/;O4MM/HV%0U/ M&IX5%,`Y@><%A4\O*"B+M2K0P7QG!D<[9;Q8J)\`M7EG-I5ZQFPFT$3:F(Q5 M`8C&).-E0/TDW0>15"6;K@0N*Z-29\U9OGX"^4`#/ABVF4`326,R1N%`:5ZM M3N2#=!*O9AYA@(UF+5&BA;"W1KX+PCV1JH6PL4::.>"*Q`1%$N8+HU!YP;4"QVB!1IU^@*\1I%ZC7"Y&MTC7Z- M(@$;80HV`B5LW`Y$%>4"IF+SB"`TDK'1%3HVBH1L-*-DN[RIB?MIBH1L-*-D MNXPTOUT>LYG06$>Y@.G8/"(LCX1L=(62C2(I&\UHV;J5D8DG^A1)V6A&RW89 M:?Y0?\QF`DV4"YB2S2.Z\DC*1E=HV2@2L]&,FNVBNC=79(!(TT8SHK;+:!;+ M2\P.1!7E`B9P\TC5%2GJ M"XO`#`(4I0,F=_-0+Q%=7R%XHTCQ1ICDC0+-F\`NF41DC8G>*-"S^;$-1&`% M(HJ2`I.]>613'>G>Z`KA&T7*-\*D;Q1HW^0*2:F1]HTP\1L%NC8QZ@F?C"A2 MOQ&3OWDDP47Z-[I"`$>1`HXP"1RE:N`H$L'1C`K.=B--T'5[=W/,9@)-DPO. M;5HT]9.91E%0!](W_@U)^RT*,7V_V\#X_OIRO89\6C\7[H;P]7YJ] M/+W<]?XBZMO'[/E]?0=\X'D]N4_W]0SCO]7PZK^=[V6O?PY_=_.V>$<\*Y:A4P(``(<(```:````>&PO=V]R M:W-H965T@`J:V$[JWGXV!V20J]"9@\YWO=PX^CLDZRMYX08AP/NJJX3NW$*+= M^CX_%J3&W*,M:>23,V4U%G+(+CYO&<&G/JBN?!@$L5_CLG'SK)][87E&KZ(J M&_+"''ZM:\S^[DE%NYT+W''BM;P40DWX>>9/<:>R)@TO:>,P=&Z@<2$6.0EE@>;F1)U)5RDF2WP?3_TP5:-Z/ M[L]]N3+]`^;DB59_RI,H9+:!ZYS(&5\K\4J['V2H(5*&1UKQ_MRZ:^=?I(&0]CC`#@$P"D`ZL0UJ$_S.Q8XSQCM'-YBM7A@*^5,F4AG MA_=N3%,Z);4YJE\2Q5Z:VJZV\@@7-/[EFI%KX"[K0RB-=UOJ9"7KB#=;680K^E_ M2X6\:`4IF?=E\ND.B`>0N:-!=-$?7 MY7[JZ0$``"8%```:````>&PO=V]R:W-H965TZ"==`GWNIKI6T"YQD>>&7- M@*M:<"3AL@OVZ^TIM0@'^%-#JT9[9+V?A7BWP:]R%X36`E`HM%4@9KG#$2BU M0J;P1Z?Y*&F)XWVO_L-U:]R?B8*CH'_K4E?&;!B@$B[D1O6;:']"UX)S6`BJ MW"\J;DH+UE,"Q,BG7VONUM9_^19VM&5"U!&B@;#>?$F(.T+\("1?$I*.D,P( MV+?B!G$BFN29%"U2#;&G8[TU<&E%C#)23DWZ^9I1*).]Y^LHC#)\MTH=*'*@ MPP0T(+"17ZP1!5-Z-*(O%CB.$7&Z!#E-(-^?FXA[$[%O-)XV&C]72'H%'^Z3 MJ4(RM>E!AQDH?5XFG95)IPJ;:9F-+^-!W(\T7KTL@8X34+A*ET"G&6@^%SPZ M3@SDU=U+A0IQX]K_TT-VN/K[R!['6?Y@G@1_@Q\R>=:0*_PF\EISAT`8R<-\[66^\3A="`7R7I^&0-E/<#I9]J\^.T<5QE@53D M*)0"EI<;R4E5*2&9^$^O>4^IB-/UH/ZJJY7N#YB3G%:_RY,HI%G7`2=RQM=* M?-#NC?0EA$KP2"NN_\'QR@6M!XH#:OQEKF6CKYVYD[@];9F`>@(:"5[TE.#W M!/].")X2@IX06`1H2M&-V&.!LY31#O`6J[?#6TLX4R)2&7"MQDQ_92NXC-XR M#[EQ"F]*J0AC_8\$VI M_ESAY7N%8%`PVVTP5?#]N<_0%&LPC<:$;O];0N;/D0]-A9:I<%:69^5Z,:[" M22YWA98P^2/,0R>1Y22:M2=8;$\T3;+8EF7$0Q.Q92*>M\.;YXC-RQ1/NY$,IY*$Q;BIR M%FH9JZ=EYJC9"-H.I\)X-&7_`%!+`P04````"`!DB7A'LV#\9ST"```F!P`` M&@```'AL+W=O&ULE55);Z,P%/XK%O<)V.P1 M0\1GI.&LE>>$2+`>UE4 M?&-E0M1KV^:GC)28KVA-*OGD0EF)A5RRJ\UK1O!9D\K"1HX3V"7.*RM-]-XS M2Q-Z$T5>D6<&^*TL,?NW(P5M-A:TNHV7_)H)M6&GB=WSSGE)*I[3"C!RV5A; MN#Y`#=&(/SEI^.`>J/!'2E_5XM=Y8SDJ`RG(22@)+"]WLB=%H92D\ULK^O!4 MQ.%]I_ZDRY7QCYB3/2W^YF>1R;2.!<[D@F^%>*'-3]+6X"O!$RVX_@6G&Q>T M["@6*/&[N>:5OC;F2>2TM'D":@FH)\#@4X+;$MP'P?N4X+4$;T*P32FZ$08_7W@&L)9TI$*@.NU9CIKVP%E[OW%"+H)O9=*;4@I$&[$:A'V%)^ MU@-98SH:T-&L M$$[:'GZ[[=$D0_2%MN^B[[8]GKC$H[8'8Q/?F,0#DPBY?HR6?:`S,5+3Z.,7 MW);3@HQ5^(47!^'49O)I^_,^<."#T-3('DR3DK"K'LLG4G\TIO\!4$L#!!0````(`&2)>$?,@R!6400``+H7```: M````>&PO=V]R:W-H965T#_SK*B?9X>F.3WY?KTYF#RM/Y4G4[2_[,HJ3YOVLMK[]:DRZ;8WRC,? M@B#T\_18S!;S_M[7:C$OSTUV+,S7RJO/>9Y6OY8F*R_/,S&[WOAVW!^:[H:_ MF/LWN^TQ-T5]+`NO,KOGV8MX6NNPD_2*_X[F4EO?O2[YU[+\WEW\LWV>!5T. M)C.;IG.1MA]O9F6RK//41OXQ.GV/V1G:WZ_>/_?EMNF_IK59E=G_QVUS:+,- M9M[6[-)SUGPK+U_,6(/N'&[*K.[_>YMSW93YU63FY>G/X?-8])^7X9?TFYZB*=67G5. M6L]>W7NKAO%MAZ)N[[XM!(AP[K]UGD81]*(E$MT4?NO>&0-FV!PLND`YJZ4JS8@$-!)@'Z$[ MDJW2@O'XA*2!\"(%D7-2C:HK?#%SL@BZG@F\H$'L+HNH&!-&T+5'X,5',XD]9^*$.6<@(-$` M@RNE56.TL6Y82E70N2BNJXN1#Z05"KWOC`VA+H'F/@#9ZP)!S]GD0T4<037\$%%]@ MX4M4BE,QQ1(.,$57*L[3E/:.'KCKE:1<2LRE4@P?M*O*Z5U5TJXJ M,7!*.WN"M+>X[#3BU84)15PBE9V(Q01=ZNF:"-4&#H5 MN:,)-(T%-QK%4Z&=;!(S7-`^J/[B=?N/]VT"TYT7;ANF)."BJRA-BM#$:#V* MTJ2FTZ0H32IZ6/7U4=LTQ0%WAZ4H3@KCI#D^*$YJ.DZ:XJ0#SK/6-DX)ER9- M:=*8)LW8=FL@16N87C1M3AI#HMWOZTB5A(PNJ"E)&I.D.3XT+5A/+YAN[W3( M*IBH:%_SK1/.W%3[_JBX]C;EN6B&P\?;W=MQ]`MT)Z3D_E(\K8=#Y7!3.Q`'DVYO%YG9-=W7J&-S.%H>+IKR M=#TIOQW7+WX#4$L#!!0````(`&2)>$>H9HBN@0(``"`)```:````>&PO=V]R M:W-H965TTDF=G&9G8?=J;3 MA]UGFI#$J4I62-/]^P4AJ3!T:U]4\)QS[SW(Q<6%#R_BR)B,WKJV%\OX*.7I M+DW%]L@Z*A)^8KUZL^=#1Z4:#H=4G`9&=R.I:U.8923M:-/'J\4X]SBL%OPL MVZ9GCT,DSEU'A[_WK.6790SBZ\13*OL?4 MQ.GS57TSEJO2?Z:"K7G[N]G)H\HVBZ,=V]-S*Y_XY3NS-6`MN.6M&*_1]BPD M[ZZ4..KHF[DW_7B_F#=E9FEA`K0$>",8)SXD($M`1S"=@2\%P"L03B M$5)CUFAU325=+09^B<2)Z@\0W"GXH$64P0)[OT:3#GZ/W+[*5K]`U!+`P04````"`!DB7A' M&5/BD;$"``"M"0``&@```'AL+W=O&ULC9;+ M;J,P&(5?!?$`8(PO4"61IKET9C%2U<5T[21.@@HX@YVF\_9C`TELRVVS"9=\ MY_CX]P]F M.\ZVO:BI4P@`21M6M?%LTM][[F83<5)UU?+G+I*GIF'=OT=>B_,TSN++C9=J M?U#F1CJ;I%?=MFIX*RO11AW?3>,?V<-3!@S2$W\J?I;6>63"KX5X,Q>_MM,8 MF`R\YAME+)@^O/,YKVOCI$?^.YK>QC1"^_SBONJGJ^.OF>1S4;]66W70:4$< M;?F.G6KU(LX_^3@';`PWHI;];[0Y226:BR2.&O8Q'*NV/YZ'?PHPRL(".`K@ M59`57PKR49#?!/1+`1H%Z"9`7PKP*,#W"L@H(/<*Z"B@GB`=JMNOS8(I-IMT MXAS)(S,=FSUHO#,FVCF2O5LW++E>':GOOL\R2-`D?3=.(P1[Z-&&BC(+,7.; M@2%B81,Y#B%+!R$A9.4@90AY$;SZI+DBP*O!2E7RH"G0=Z/<.^<4!#0ZY MZU"X0?%0LP%JAYK1@B"4A[B%S>48$EJ4(6[I^.5E64`8XE;NN`3`/`MQ3S:7 M483M>7Q:">15`KD=YBU\.50"62-AF%`2HA8VE9.D0"%JZ5`X*8/4RJ%HDG\_ M,>Q-#+L3\R(/T*,-88!#S-PSNJ/;B!>%N`Y>MY%A&&+-F.0)#$%+&X(P*;_/ M0KTLU,T2[-0YM3L+8)3[3_O8T3:',0#E'<4IO$"%$XB"8`,6=CL@OSAC9SD0 ML#OKTS"E%Z9TPV3!IO$@&.P:#[JC@3/@A3%;M>V!@GTS4M?'SHM#QU>W3?FO MB=3:E(YLSW^S;E^U,EH+I?>W?C/:":&X-@*)7OJ#_G:Z7M1\I\PI-3TQ?$T, M%TH<+Q]'UR^TV7]02P,$%`````@`9(EX1VE3;WV+`@``M`D``!H```!X;"]W M;W)K;*^C1F4*Q"51NV^_"4%*,K'U1DCXSOG_$T`RN_+V71P9D\%'735B'AZE M/$VC2&R/K*9BPD^L45?VO*VI5,/V$(E3R^BN$]55!`$@44W+)ES,NKF7=C'C M9UF5#7MI`W&N:]K^>V(5O\[#.+Q-O):'H]03T6(6#;I=6;-&E+P)6K:?AS_B MZ7.FB0[X4[*K&)T'NO<-Y^]Z\&LW#X%N@55L*[4#58<+6[*JTD:J\-_>\[.D M%H[/;^[K+JWJ?D,%6_+JK=S)HVH6A,&.[>FYDJ_\^I/U$;`VW/)*=+_!]BPD MKV^2,*CIASF637>\FBL9Z&5^`>P%03T'RI2#M!:DCB,SJ=O>FH)(N9BV_!N)$]0,;3Q7>:A/E'(C.K36W7-T= MH68OBQBF>!9=M%,/P0YZ&D-9'ON8I6V$B0\JQA#T$:LQ@;S=K"W$6^?90O(! MB=2">%<%WE8%F56!]JJ0[QW0S2$Q#LAV2.TV#?3D0)D/6CI0[H,*&\J`#UK= M+7*D2NPRL3>5!0&`O*D>@0JG'/2F,5O>8NY&($XG8G1!O)`?R/J/+1Z#"@;P/\LJ!'G@M4R=5:CGDSE.>FX8- MU!@HFX#$1Q5C"H$)R'S4RO)*)\A+K2V*3'#\?;+,29;9_YY.'6R2958W";[# M%6-.O>8D29"/6XTYA"%)L]S'K2T_E.<9A#[NV:Y+`$3N2D2CC].)'MAOVA[* M1@0;+M5WKOLH[3F73+F!B7(]JBW4,*C87NK35)&ULC5=-;]LX$/TK@N^5^$TI<`QL[03;PP)%#]VS$M.Q4$GT2DK< M_OL5)=KA#.A$%^O#;V;>(X>/XOILNU_]T9@A^=W4;7^_.@[#Z2[+^N>C:4P_C8O63]J3/E?@IJZHP1HK*FK-K59CV]^]YMUO9UJ*O6?.^2 M_K5IRN[/5U/;\_V*KBXO?E0OQ\&]R#;K[!JWKQK3]I5MD\X<[E=_T;M')AQD M0ORLS+D/[A-'_LG:7^[AV_Y^11P'4YOGP:4HQ\N;V9JZ=IG&RO_YI.\U76!X M?\G^.,D=Z3^5O=G:^M]J/QQ'MF25[,VA?*V''_;\M_$:I$OX;.M^^DV>7_O! M-I>05=*4O^=KU4[7\_Q/3GQ8/(#Y`'8-H/F'`=P'\/<`_6&`\`'B/4!\&"!] M@%P:H'R`0@'9/%C34._*H=RL.WM.^E/I&I#>C?#.)1DS)_V4K9MG-F"LAHHV]RS]H[)N,"L2H@(RB2V-;A(R4*+ABB3*2B6LQ6_H#VV4%:DN;G`*<9RDQ0*SI=AMJ8*< MXAL-#6U4YO%^"S&"IOF2Z[L6]E`*3523^&H#[BAP M,UY648[F8@DA;*$4>JA"ZUKX+[<0)?$("<\:I5K@:`S;+"-P+J)TMABUI!+% ME>`GJZ91X1C%XGP0:D$7,NS##/DP:GCE*X66J#CNC!GU`%",I4N^;[%Q,F2< M\>V>`3]<4@>;(8-?G5K$=8=>.&XL2+?VND,4=LLL.-&KG>[Y9#D_#/9T.2A?3^N;_P%02P,$ M%`````@`9(EX1T%I?(OL`P``H!$``!H```!X;"]W;W)K[#2D?G8?>9)DZ"#I/P-L+G6S<_V9$SG_2J+JGWV3UUW?@K#=G>5O-^.][\UV4U^Z(J_,]\9K M+V69-?^^FJ*^/OO;P[+_PIS?!!LB( M^"LWU]8Z]P;R[W7]<[CX8__LLX&#*'#I*8H!D]]Y']FIY\Q!T/[ M_.;]MS'=GOY[UIJT+O[.]]VI9\M\;V\.V:7H?M37W\V<0S0XW-5%._[W=I>V MJ\N;B>^5V:_IF%?C\3K]HMELYC:`V0#N!EQ]:2!F`_%I(+\TD+.!)`;AE,I8 MB+>LR[:;IKYZ[3D;VH,_]?!F<-)[]MK16S/5MR]%V]_]V'+!DDWX,7B:03"" M7A'HC@A[]\X8X&-SL,S!%2"U$2)R0=X0)'E,0MQ(3)T2@QX1-C/I$S4&P%$BR6\>,XFL31>"6Y,V]MQ?D&/.$ZJCPR%Q8L3B+`J6=P!0!HRB0*SA)RHE(8K002MK59':9 MEF-1[>01CJ46\K=U42:!=M8"EQCSUNRQ:7`IAPZG**@"OX M`)4V(-+F'GO`G&%L)@N092:<,N&8B7O@S:BY,AH2KE9L5J#*!X"7TCWUP-:J M;UPHT.`>^!@I$A:+-<^&5->`Z)I[](%`P:22RDT*X91D*YH>J*R!Q,OBGGT@ MD8)$RCV-$8SV]3*GB&Q$(/*W8O8!E2O`SWL+LP_4HEK;$O4(%L^/[>I_[A&J M8A#CQ!=V:_QXM[HARTSH4R,0+5R8=J`7"[,+<.>TC%M^ M@:*Z*1CFY)YV@JUJGR]@$Z/0>H\M37,__H\`+#>S"Y M_\J?TNG3P:>;[>:<'$>PD!?U#0,``%8, M```:````>&PO=V]R:W-H965T1%^=&_9*+M_Q MD$,B`FY)0^6OMSU31MJKQ??:ZE-=ZTY>+ZHG#P>;VP`'`YQKB`9#-!I`^M`0 M#X;X9H@?&I+!D%B&0.4N9ZZL6+4N>G+QZ*D2ZPDLN;P707ADC\IHO7HA?.XH M;_U8@PCD1?`A(@TB*$4;0S0J`A[>.0;T33O4[-`U0*DKHL0E>38D:!HBND)$ M*M'(3'1&A/@:(5818CT"1)&)J41/NBB)38D*NU&23DHRF,6A2U7JJG`:-K%@ M$Q,V=L(FT[")#IM%8>J$-50(1C.`4PLX-=X/#)W`Z31PZIPW'=:MN`N:6:"9 MN9"`$S2;!LTF0=V*NZ"Y!9J;H-`)FD^#YAK&%X#"##II#5D:HQG$R")&YJ+- MG<1HFAAI*"`*4>:4E>CNAWB7&(1661%[D3[+T8P8P$H;&/45)LBD14,1!AHN M2A=AXI*5ABR-%K'UQ6:JG!JR.8E#&QJ:B5M3+.9%4D/]7Q]PH0F[/C+)L;X"[R!LE_[@/`W@A`8I)D[L6E M5W`$[RXN79;"19K,(%*57MH4D6AX;+%K+GA43X>Z`,S"#*&%%F@'HQ;W!WDD MI=Z6G#NF-ONQ=3SV/D%QL++:-V!9`D<[3XQWI(X>SL9[Y`DZN`V]+D[5`?^L M^D/=4>^-,'[4D^>R/2$,\Y3"!9^.(S_DCP\-WC-QFXEY4L=>]<#(Z7J*'_]* MK/\!4$L#!!0````(`&2)>$=9@%H&[@$``%T%```:````>&PO=V]R:W-H965T M3!JY1J][XO+Q4P(E]X M"XW^!-(=HP1\?<$ ME/<'+_3&Q'M=5LHD_#SS)]ZU9M#(FC=(P.W@'<-]D1J$!?RJH9>S/3+>SYQ_ MF.#']>`%Q@)0N"BC0/1RAP(H-4*Z\)]!\U'2$.?[4?V;[5:[/Q,)!:>_ZZNJ MM-G`0U>XD8ZJ=]Y_AZ&%Q`A>.)7V%UTZJ3@;*1YBY-.M=6/7WGUY#0;:-@$/ M!#P1PO2_A&@@1`]";#MUSFQ?7XDB>29XCV1+S)\=[C5<&!&MC*15$^ZX=&=2 M9^]Y&.$H\^]&:0!A"SHM0!/"U_*;-;"WI.,9'6\5*.:(*'E>(1HKN/`8S0WB M+G7I*5EV3I)=GTL@#AW>NFEY52 M^MQ+NO*2+A5VFUY6H&TOY&3=EI8ARQN?:K M_$E/$O?P'S)YUI(2?A)1UHU$9Z[TH[(OX,:Y`FTN>-$G5>E9-P44;LIL=WHO MW/-W@>+M.,RFB9K_`U!+`P04````"`!DB7A'+.(W/,`"``!2"@``&@```'AL M+W=O&ULC99+CYLP$,>_"N+>!3]X100I(:K: M0Z75'MJS-W$2M(!3[&RVW[XV)@1;)LDE8.<_,[_Q8YC\PKH/?J14>%]-W?*E M?Q3BM`@"OCW2AO`7=J*M_&?/NH8(.>P.`3]UE.QZHZ8.8!C&04.JUB_R?NZU M*W)V%G75TM?.X^>F(=V_-:W99>D#_SKQ5AV.0DT$11Z,=KNJH2VO6.MU=+_T M5V"Q`9&2](K?%;WPR;NGX-\9^U"#G[NE'RH&6M.M4"Z(?'S2DM:U\B0C_QV< MWF(JP^G[U?OW/EV)_TXX+5G]I]J)HZ0-?6]']^1PWYTL^J[9\7_4\:#F9N`S@8P-$`Q'<-T&"`;@;XK@$>#+!E$.A4 M^H78$$&*O&,7CY^(.AY@(>6=[SWUNGUE4O!Y>QG`1#,\N!3>1I$L!>M M#=&H"*1[9PSHF^9P8@Y=`>:KI-)I&\`Q3"%SDTJ#2'*P@0]<:I3"RDUD:`3 M*34BX1C'3B!#%N,0/L;)+)S,W(O4B9--XB`1)DDYA%#U@75.U0'P?-+LQ\++LZ`FS&BIVQU@#?WX21:5XWSV1721"9 M3(G[^$3/'9]YF28*)E_>AG:'OH7AWI:=6Z$_BN/LV":MH/IR6_-KL"AULW-S M4^0GH6NZ],R'[@OXCOF=,4,D7ODB^HVSPQD%-]T*])NHXZ99'#P0[ M73NXL8TL_@-02P,$%`````@`9(EX1W"6`::5`P``:!```!H```!X;"]W;W)K MR> M:>(DJ("SF#3=?[\&3&I[,7%[:,!Y,WX>SQO-9'TE[1L]8=Q9'W75T(U]ZKKS M@^O2W0G7!77(&3?LFP-IZZ)CK^W1I><6%_O!J*Y<\+S(K8NRL;?K8>VYW:[) MI:O*!C^W%KW4=='^?<(5N6YL9$\++^7QU/4+[G;MWNSV98T;6I+&:O%A8S^B MAQS"'C(@?I7X2H5GJR?_2LA;__)CO[&]G@.N\*[K713LXQUGN*IZ3VSG/]SI MYYZ]H?@\>?\V')?1?RTHSDCUN]QW)\;6LZT]/A27JGLAU^^8GV%@N",5'?Y; MNPOM2#V9V%9=?(R?93-\7L=O$H^;S1L`-X";`8H6#7QNX'\:!(L&`3<(%`-W M/,H0B+SHBNVZ)5>+GHL^/=`#@[>]$^;9HH.W=HPO"P5EJ^];Y/MH[;[WGC@( M!M"3!+HA7.9^=@^P97,0S&%N@TQ$^.$<))<@Z7T2_D3"'P_JRP>%^QZ"R-81U`R@*'3B.5`F@I"7..$<*A=12>"DGO!G<`NA0C^4`Z#0 M3T;ZH;#G*D:Z30633#()`O7((RH74>`[T7W^D<(_DOD'L_PC89O8F2B=CP#!ZDBGO3+XD&> MPJ&OP0OR"7FE\<33JN6(ATT&A8F036+@%)B8#GK:2*6-3&3#49-N/&`F2ZZUAW)#U?M3BB9%$J4X@3J9[/@C(%9)(TJ+[-R200,F*C=K@0+FJ'=^@@-:PAJ+T9[]$5F*Y)EV%2DHS$76$>JW%['`9; M:NW(I>G&4>FV>AN>'Z&?YY3U)S94CR/PIYOM^EP<\<^B/98-M5Y)QZ;%8;0[ M$-)AQH\5(=LZL;'_]E+A0]<_QGV5'0?A\:4CYVFNO_VXL/T'4$L#!!0````( M`&2)>$=1%7U7V@(``.$*```:````>&PO=V]R:W-H965TP'S3420=HFJ]E!IM8?V[$VEJ%(=D>T0!)@$]H9%_V>!H@9$31W.O%TWH)%T>/0FM%_[3V"U`3F'",3O#EV(]NYQ\6\8O_/%S]W: MC[@&U*,MY2X@>WR@%O4]]\0B_U5.;S$Y47^_>O\NTF7RWR!!+>[_=#MZ9&HC MW]NA/3SW]!5??B"50\8=;G%/Q*^W/1.*ARO%]P;X*9_=*)X7^:6,%,U-B!4A M7DI(%"&9";)T=PFI(J0W0BI*(U,1A=A`"IMZPA>/G"`_'F#%X!-WPCQ[1'B; M9'U9*0BS?C0@28HZ_.">%"@6H-8`S8B0N7?&B'V3'FOTV!5@HR.2['&$Y!HA MD5DD>H0L?>P@O3J0RZ?4+$-IJLQE'A(T"E`4Y"[,YA[FKI+,4I*92BHS2BF5 M9%J4;U$0NT`;"[1@XW)+2VYH22.GEMS(.'5*,3$+-KBP-K@PE2S(I;1R*74/ M46GML`0]ZZ#,F4I;:JE4=]+5,>62PE>6V,H46SG%5H_%5OH12.TCJ]0:H"JH M'LL%D:67-UA-<)$X!1LH6W&F6DVDJ7'K-2!)4"[0"VR]9MM+G1>H5:A19164 M+L4;`Q4O$!/;8N(E5UZAYKT$[MK$YJ5?T(!`8NM)EEQ[A5(;%11N.3H(!`L: M,[`[,S!;G_GHSK$YK M%RK4_M0'-!W$=$2\+3Z/5/Z9S=9Y`GN.^5!@V5L^F3GL++%5*P[:*SLCP_R_9'=Q"B#W[5 M5=,]AH>^/\ZBJ-L<1%UT#_(H&O5D)]NZZ-5MNX^Z8RN*[4BJJPCBF$=U43;A M8CZ.?6T7!GX5NX/_3`0+>;1E;PT]DMJ9\@(R(_TIQ[HSK8)C\BY0_AIM_MX]A/,Q!5&+3#R$*]?$J MEJ*JADA*^:<.^J8Y$,WK2_3UF*Z:_DO1B:6LOI?;_J!F&X?!5NR*4]5_D^?/ M0N?`AH`;677C_V!SZGI97RAA4!>_IL^R&3_/TY,4-,U-`$V`*R&+;Q*H)M`K M@?";A$03DC="1*Q.9I,P&OIL?0_DQNT+IQQ$XJC&_N\8IFD-J1\A< MZ:Y3(UW"L]@SWPQI9;866G9LTLK^3BM'6KFEQ9RO<9T;6A#[2I$8:0TMUQ0C MKL26&C6I^<@0+&-W%P8>,0`M&`)WKQA"\3QL9S/J3I9WO\NL26)[4G&W0DC ME$>G(MB0!#DR^S@&Q"ACB._.&+"+@/AD;*%83#V$``O95F.Y1PR\A\+]FRA@ M_T!BQ>#.5K@$TT'*TXZ]C^EO%];FQ^-WD2NP70F>K@3L2K!=R=W]5:/TSI&Z MYJ7W>0L)F>L;P24#$TFSQ#<#;'8L=3V_$\<2X?C9JRYM0S:8I=3VW7HKM@(T]-/YTEKJ/7D_K3>)Y%XTLR6Q''N$IKMJ+,\43-3#T93Z[1F_1B M?BSVXDO1[LNF"UYDKPZ;X\EP)V4O5$+Q@UIK!U%LKS>5V/7#93HLPNFD/MWT M\GCYX>'ZZ\?B-U!+`P04````"`!DB7A'QOL#I;<"``#I"@``&@```'AL+W=O M&ULE5;;CILP%/P5Q`<`-A?#BB#MIJK:ATJK M?6B?G<1)T`).;6>S_?OZ%A9;*"$O`9LY<\[8GOC4%\K>^9$0$7SVWE9 M=.U`7EG`SWV/V;\7TM'+*@3A=>*M/1R%FHB;.A[C=FU/!M[2(6!DOPJ?P=,: M9@JB$;];?YMD.^GDQ7\K$ALT'0!L`QP!0W`Q(;4#Z%:"7+C:5:5W?L,!-S>@E MX">L=AL\23A3))(YX)J-F>62RKB<_6A`6J`Z_E!,%@0UZ,4!C8A8TL_F@*$; M#B?A<"[!>HI(\_L9TFL&,WQ.717E?8;LRI`9ALQEJ-PR"R/$@`8C!$0+EB+W MTN1.&I3<9R@\J<7#4I%7`W)K`*[4TDA%$ZEI%67WTY1>FM)-`^\S5)[4ZF&I M(/&*4$:^(=;NJT49M3F*%M0*@)_)=1)*%W!`3S"`CRM._3I<+Z#,59Q9Q1YJ M@>>`;QF0W5Q;9#--38,66`;XG@&>:0HW3V[SY-,3N\!8H/#SN-9":`$'\G<0 M/;Z#OG&`YYQRUJ`69?2"/$)S)WOMHHJH6%!/Y=?C^A!5"VZ`Q%L7F#R\+M!W M&`1+SH%%6<75W-JM/" M=/:L>)C(W^=XTEGTA!UTQ\6#+3T/PC06X^S8U3U#W9E\P9OZA`_D%V:'=N#! MA@K9W^AF9$^I(+*,))(;>91]YSCHR%ZH5Z1VV'1B9B#HZ=I8CMUM\Q]02P,$ M%`````@`9(EX1TH/K]OJ!```JAP``!H```!X;"]W;W)KCP#&P<9I#C06*7G2OE5B.C4J65U+B M[MNO3K:'S-2@E8OX1/*?`S]2<.1?FKVJ1I/?F=9[OJ=KJIZ_U-$%2OFS1/ MJB_%/MTUOZR+,D_JYF/Y%E3[,DU6G5.>!3(,39`GV]UT/NN^^U[.9\5[G6UW MZ?=R4KWG>5+^=Y=FQ>%V*J;'+WYLWS9U^T4PGP4GO]4V3W?5MMA-RG1]._U+ MW"P-M":=Q<]M>JB<]Y-V\"]%\:O]\+RZG8;M&-(L?:W;$$GS\I$NTBQK(S7* M_PY!SYJMH_O^&/VAFVXS_)>D2A=%]L]V56^:T8;3R2I=)^]9_:,X/*7#'+H1 MOA99U?V?O+Y7=9$?7::3//G=OVYWW>NA_\7HP7*0X44'-3BHLP-< M=-"#@SX[J(L.,#C`V4%<=#"#@SDYB,N3C@:'B*M@!P=[ M]SL7LEU.FRV(2]!G29=C]TF=S&=E<9A4^Z0E3]RT]F4;IPD^J;J`99^[39I5 MS;]TOU^R6=$-)81@1UC*#[ M"`H/PN*11OVR]$:[SLC:L/MC:&FBI;%6C+6@U]*.EM`ZTEPU(&J`U.+0JP:. MFC+`U3)$RV`MX=4RCI;4"FLYR_WL&@J0?S3\A@Q5Q!U]1+(HPJ.7C!"6+(#% M(91W`:R[V+'E#C+^'DD!%7# M12$&3A!:%82\?D,%+0P"5P;P;ZEP2T.?JN4B*A>Q$GHP6I8Z>B:I::P"GLII8>:+RPJ+HJM1G$5A%=6GPO) MQLKP^HV5%"Y)X++>A1ZLAHG+"#BSEI)J$09)L^NM'I$5A(JC1$&5"%1-6\51 MB5@)CA1E5")&0TYQDA11.0)121&5!L]&>E-8NH@JRB;=4?)5N\^/H*-KT5(AUP$N*YNA0(I7`.IRBKVB[4R/:G?IT M'4SXB+P9I=QV)X#=YQ4E26DLQ[ITIRBI$2@IBI(B*'FORN\50HFC0R%2&"+_ MA=1"1=>F+FUNRC**_$*A[L;1H2@JC*+@!-&TK>D1;4U3B#2&2$C?C.^TN!)6 M35N:EEA'^1!Y'*R&3+GB9I$2J3&10OOEU$BY3S>GF$C!:6Z:$JE'$*DID1H3 M*<@I1&_U0*TXEU6:0JD)E-8O%8V0HEQJBX/$G"`Q7=_X^O4%VMP`-S?YAY.! M\,I*!)1+()>;G.8&M+G!B.8&%"7`*$G_^02X*$6L(Q<*$9";.&^)6()[QG,\ M=6'I?3KC(;QYKX>6@$YYKKE+!X2W)XI MKKDS!`HI8$@EI],#A11&0&HHI";D-#7C0LJIV(9":@2GV%(K3@4TM'\:R2FV MU(HE18$W+O!@..W>:+*-1H_81@JH`300\"7PDW'YE-)[51TX3S+VR5OZ=U*^ M;7?5Y*6HZR+O'F"LBZ).FWCAER;>)DU6IP]9NJ[;MU&;-OVCM/Y#7>R/3P9/ MCR?G_P-02P,$%`````@`9(EX1R=Q%]C/`0``V@0``!H```!X;"]W;W)K`JW&(LXPB:(,<]IV05F,$0Q,$\\=9>&FTG<%G@I:YJ.72J%1V24!^"+_'^F%O%*/C5PJ"\/K+9 M3T*\V\&/ZA!$-@(P.&OK0$US@Q=@S!H9\)_)\S_2%OK]V?W;N%J3_D05O`CV MNZUT8\)&`:J@IE>FW\3P':8EI-;P+)@:G^A\55KPN21`G'ZXMNW&=G!OMM%4 M]KB`3`5D*2`NN`.-,;]23U"R!N5KT-:!?%$:A\ES3GK/2=><[4..+TIVX2;9+G.RG]02P,$%`````@`9(EX1U42 MB^]``@``]@8``!H```!X;"]W;W)K93?S@G'//O7:N MBPGA-])`2*WWOAO(WFXH'7>N2^H&]H`X:(0#^W)!N`>4+?'5)2.&X"Q(?><& MGI>X/6@'NRS$W@LN"W2C73O`%VR16]\#_/<(.S3M;=]>-E[;:T/YAEL6[LH[ MMST<2(L&"\/+WC[XNRKG"`'XU<*)*'.+>S\A],87/\Y[V^,68`=KRA4`&^ZP M@EW'A5C@/[/F(R0GJO-%_9O(EKD_`0(KU/UNS[1A9CW;.L,+N'7T%4W?X9Q" MS`5KU!'Q:]4W0E&_4&RK!^]R;`1/%>(%H5(*D2*0AI&NLM$ MYB$Q@W29.X$)5*F@*'/RYU;BC9583R;5P\322ZR$^>+KD$PZT2&^\XFZ)ALK MB6XE,\4Y)DH"0``&@```'AL+W=O&ULE9;= MCMHP$(5?)W'APYLX,B:CCZ[MQ3(^2GEZ2E.Q/;*.BH2?6*]^V?.AHU(-AT,J M3@.CNS&I:U.,4)%VM.GCU6*<>QE6"WZ6;=.SER$2YZZCP]\U:_EE&4-\G7AM M#D>I)]+5(KWE[9J.]:+A?32P_3+^`D]KJ'7(&/&K81=AW4>Z^`WG;WKP8[>, MD:Z!M6PKM015EW?VS-I6*RGRGTGT/U,GVO=7]6]CNZK\#17LF;>_FYT\JFI1 M'.W8GIY;^T/0O)NVM*''7TPUR;?KQ>S"\5FM+""7A* MP+<$;`HWH+',KU32U6+@ETB%+A@Q91RI$8U0;3O2I4J-GW%9`,+=)W MK30%F9RU'93C\A:3*D"0@J^4S%"P2X'["ME5@1B%S%7`;IV%J=,$]6,0AF0& MAG@8XF(R%U,9#+$P4"8SGD?N87(70UQ,;C"YCYC M2@]3NI@BB"DM3)UDR/[,6*;*8U8NLPPR*_MM0$EQ'U-[F-K%5,%EJNW69BP3 M(,\<^K_#QM0S-,"K%%P?$Q1\(E/4M-IS%ANP#W*M3"`,PA8()7,Z\@T/KN,) M#H,R!S3C50+?\N!ZGF3!50;;]&@&QK<\N)XG8<]#_B#&-SVXKB=Y&%,\B/%- M#Z[K2=CU8-L>SWK??*>#:W52AONI'NS'=SJX5B=5<'^!^M-^4FOK/=$#^TF' M0].+:,.EVL7'+7?/N61*"B6J\J,Z+-T&+=M+?5OJELSQP0PD/UU/0[H? M4$L#!!0````(`&2)>$>)M_[GD@4``/TA```:````>&PO=V]R:W-H965T4<55LPL+#5J7RL'E60(`KML5* M`K)_O[IAU"5Y/?M]V!^KR_E373]?+)?5 MW5-^R*I%\9P?F_\\%.4AJYN?Y>.R>B[S[+XS.NR7,DGL\I#MCO/UJKOVK5RO MBI=ZOSOFW\I9]7(X9.5_FWQ?O%W.Q?S]PO?=XU/=7EBN5\N3W?WND!^K77&< ME?G#Y?R+N+CU':1#_+/+WZK1]UE+_F=1_&I_W-Y?SI.60[[/[^IVB*SY>,VW M^7[?CM3,_.\PZ,>'X^_OHUYV[#?V?695OB_V/W7W]U+!-YK/[_"%[V=?? MB[>;?/#!M`/>%?NJ^SN[>ZGJXO!N,I\=LM_]Y^[8?;[U__')8!8VD(.!/!DH M>]9`#0;JPT">-="#@3X9"'?6P`P&YF0@Q5D#.QA8KH$;#!S7P`\&_L,'?=8@ M'0Q2F&'9W[_N[E]E=;9>E<7;K'K.6DV(BP9>MH,T(\^J;K2R3ZKF_E?-U=>U MT#I=+5_;D0:0[$`;`CHAELWPP3GDG)I+,H=)0G-L`21"H"L`R1#HZQADO`IA MKF&@(.@O`.D0Z&8,2L.,;@DCYS^/H'J/H.KODJ),S.=7>X\0-J@K\*YZ%RM8SD$!K]U=/]1;4)*C>K@K=7F*G^HI[$6%`V ML8PA'+KKIKOKD0;5@X7UVO9K\8#JW;4+ANP$JD:`;$PHKK=BK!O&-!)E(XEL M1`+^Z*&X4I1.0JAM'!7G(Y`/E:"UH?AN!E3OMELP3&CENW",KZFL)2,X+%&>$*(F$%X61>BIF73LX\A\8V:G>KL%"KL193+\-A(2`1S):K M*"B^`4-1:RI$QUB@-';!>GH7K+&Z:LD(BJ9J=<%51N",@JSAU$J6I:.!VC6=;8+.OIS;+&4J<])PM\Q%^2!#%0 MG`SJ5!-UI0QUF01B8I+),3%8YHQ@Y``%I8PEWZ`"#5"`AC:MG"-*BPJTTQ5H48&6H<`-@%0P(Z.@.!F4J069,CIGBS*U MTV5J4::6(U,`!7=M5U%0G`S*U-)VU3/JM46=VNDZM:A3ZSA!H:!P$Q,%QU%'=8CZ$(-`W/A!AV$(WOWQJ(,VK-Y&)AJ?X7".*!T*T8$077"BK1N? M`7,BA_724;%ZACH\UDL_O5YZ5)@?*\R*\`&_'Y_(_G'`OQP]+S[DY6/WMD$U MNRM>CG7_*/=T]?1&PY?NJ3QHY>\S_SLK'W;&:_2SJNCAT MCYX?BJ+.&W+)HLGCISR[/_W8YP]U^[5-\+)_.Z'_41?/[R];G-[X6/\/4$L# M!!0````(`&2)>$?27K[B@P,``/<2```:````>&PO=V]R:W-H965T(DJ(`SH$WW M[\>'R>PS#.8F!/+Z\/A@/0&V-UZ]U1?&&NNSR,MZ9U^:YOK@NO7APHJT=OB5 ME>TO)UX5:=/N5F>WOE8L/?:#BMP%SPO=(LU*>[_MCSU7^RU_;_*L9,^55;\7 M15K]>6(YO^UL8H\'7K+SI>D.N/NM>Q]WS`I6UADOK8J==O8C>4AHV$7ZQ,^, MW6KIN]7!OW+^UNU\/^YLKV-@.3LT78FTW7RPA.5Y5ZD]\V]1]-\YNX'R]['Z MUWZZ+?YK6K.$Y[^R8W-I:3W;.K)3^IXW+_SVC8DY!%W!`\_K_M,ZO-<-+\8A MME6DG\,V*_OM;?AEXXEATP-`#(#[`.+/#J!B`$4#W(&LG]>7M$GWVXK?K/J: M=E>;/+3QJBO25K;JOEHUM*N=6=T>_=@3?Q-OW8^ND@A!'WJ20S"52.0$#>X1 MMR68Q(`18]A]!`4C]I8KT+&"/U2@:@6B8H;#1(90.6#Z3C@52I10X$3++#YB M\546U++-P.+/L@RAQ%_-$J#.!BH+7:X0HMF$:@5?!0V&V802*'A3D42.$(,U M$B&.2.((-$V-Y'-$NJY&"BPXFV68#8+9J$T))FDV\M5SZ"2+G/$<6":)$4FL MDDS.^"F6^Q)'3CQYA>04$(.N$`_!=.*4:0P6+"%HQ1*R6@8$,`?,ZD!T1:3$ MA'UG:C4`01Q`3-0@4L*8GN-/MD5-&?V1`%85@(D:`(QX8#T/Q3VF MJ]4`^`8(?!,U@'QWH[EI4#(F=PV`-06!@1Q@V5*:B!X$6PK"63F,),N:TD3T M)%A3$,V*822)#"Y/M/;R8$D!DI3!OQG$>,G&J[5`\9T+]6:U('HB4G-71Q/1 MDV!!43(KA)&$+)-,1_0D^*F,PFH5T/^>RZB)"BA=GLUT1$^"I43].1$(SU+% M-]HG"*JJR\BT%)N)!B9"H,MJTD3T)%A--)P5POCT',[W9GQ^#A=ZXTJO**[I MF?U(JW-6UM8K;QI>]*\F3IPWK"WF.>W4+BP]WG=R=FJZKU$W]^&]S+#3\.OX MFNG^KFO_%U!+`P04````"`!DB7A'GH.2E/@!``!3!0``&@```'AL+W=OBB>0@@-16Q&B$XSB+&.GZH"KMVJNH2GY2M.OA52!Y M8HR(OSN@?-P&JV!:>.N:5IF%J"JC65=W#'K9\1X).&Z#Q]5F5Y@*6_"K@U%Z MS\ADWW/^;B8_ZFT0FPA`X:",`]'#&9Z`4F.DP7\NGI]((_2?)_<7NUN=?D\D M/''ZNZM5J\/&`:KA2$Y4O?'Q.URVD!K#`Z?2_J+#22K.)DF`&/EP8]?;<71O MBO@BNRW`%P&>!=@%=R`;\YDH4I6"CT@.Q/1NM='EPIAH9R2MFW"[UT&E7CU7 MJS2.R^ALG"Y%3K-;%,T5D;:_R<#!4HX]>8KS^P;KR6#M0JZ7(;\0(9D<$N>0 M^`[X8;W<9N9RNJ+>%N$8A\5]3GK%27U.@A^6G-1Q4H_SS:OY+R6[HF3+_P,O M*86C9!XE#]/[E/R*DB\IZYN4W-]+%GZAN<45IEBVIKC9FL+#K/(DS*XXD??5 M,Q"-/=P2'?BI5^ZCGU?G^^,1VU/S65Z5`VG@)Q%-UTNTYTJ?/7M0CIPKT#'B M4+>NU3?$```:````>&PO=V]R:W-H965TG)KF^A1%]>O)%ED=EE=[:?]S+*LB:]K+ZBVJ MKY7-#OV@(H]X'.NHR,Z7S6[;W_M>[;;E>Y.?+_9[%=3O19%5_WZU>7E[WK#- M=./'^>W4=#>BW3;Z'']J;M(/TB+_.]E8[WX,N^9>R M_-E=_'%XWL1=#C:WKTT7(FL_/NS>YGD7J?WE?\:@__]F-]#]/D7_K2^W3?\E MJ^V^S/\^'YI3FVV\"0[VF+WGS8_R]KL=:U!=P-M[W93%-&03%-FO MX?-\Z3]OPW^2>!PV/X"/`_CG`"97!XAQ@$`#HB&SOJYO69/MME5Y"^IKUCUM M]M3"JRY(&SFH^VC50%=;6=W>_=@Q%YY&@/!*81_HX M0HJX2+VY8#%*HEL/5MA(QC:)W0>?FB14LYP@7*I#PA-F#.<$6Y<1YAGCB!K& M_;D1.`]!XD8X-9LPG2?&!;$X3`CIX"YF$M)"F'),85J4/RT:Y^&VH.9LGA4- M"Y;SM"RBEM/![.FYK"I MF2#$8(@2SKPIX7?:Q]D2*4N@Y61P+W,HIXQB<`PFQ?B3@K60)Q12$J=>O43*$F@Y&=S) M'.HJ(Q0D8D2*B+U)$5@'!2.0,H)&^5D@!8`(E`C"Z5``A;?4D M;E()-9(33*K$)E7ZFU2)I4VFJYR,+E6Z!I2E6B]L]Q#.D`R\P@VMH%1R@EM5 MV*TJ?[>JL,8I3N%&N4YT:;L'0+3MGL)-K:!<<@JUV*\J?[^J[E[94/RJM M&DNB7K6M$S&N(TV,#F=A>P!+8Q,2UDN-FUI#?>6$!4K?O8GU-Z\:ZZ)>-:\3 M,<"\BC34\\0`F!:455?CQM909#G!Y6KLE.".-E!9!<$4&FQR MC;_)-5@0S>K+V(D2U\"2=G_F[M`$BJ8@K,8&&UCC;V`-ECJS^I95C_6ZOM3$ M*D1'>^-I%H!A4B+GM/&:O=D_L^KM?*F#E[)IRJ(_93R696/;0''8\GRRV>'S M(K?'IOO:/>%J.&(=+IKR.IT8?QY;[_X#4$L#!!0````(`&2)>$>_?:]D40,` M`,(0```:````>&PO=V]R:W-H965T^MF]F M9]&^R0/G*OBHJT;.PX-2Q\Z']VHJV9TLUV'\ECR]FV#ZJK M",=Q&M6L;,+%K.][;AHO#:\5+N#ZKKB!:S MZ!:W+6O>R%(T0%5U3'KD/Q?2SS&[0//]ROZMGZZ6_\HD7XGJ=[E5!ZTV#H,MW[%3 MI5[$^3N_S*%7N!&5['^#S4DJ45]#PJ!F'\.S;/KG>?@GCR]A[@!\"<"W`)1^ M&4`N`>0S@'X90"\!%`1$PU1Z(]9,L<6L%>=`'EFW/-"CAK<=B68.9,_6#OYJ M*Z3N?5^@A)!9]-XQ74"X!RTMT`T1:7KG&#BTP[$1CET#K$P$25R0M04I[HL@ M5Q%#\XG8$Z7W&>B5@0P,U&9([C,D0$-B,Z3V1`?0$H`R%VAE@5#L!*U-4)&2 M^WI3H#>UI>3W&3+@63;9LQQHR'T\`Z#"Z9D)RE+LM,PFHO%]O0706]@,'NF" M8F!:MUU-=`TA(`,A']]L%,&YTSC`1=W6V2A-YJ$:0]78'LECS2("W2/3W:-0 M!_5RST91ZG:/>GB\ME`%\5DV<'=!]LY!?2:>0O/2Z>9E4$?F99Z)2C,G:&53 M86,S')<#-Q`$>0)ACL$!EGMX2W& MP!>,I_L"#V9,O'PQ46D^8@L9.P?&Y<#4QR"I/0X]G$!;DNFVP+,7IUZVF*@" MNP\^F\K<@<;EP*3&=E)3'VMS:$L^W19XO.+"RQ8+-7(_6@$N]_Z]ME#FRAN_ M>L+4)W;J)Q[7"H*`>01--H_`XY5@'_,@RFV>C1J[@EHHKSLH^>_B;B=UXG$T M$GAU)]/O[@0>K\3K]FZC$$KA=!W:%XT[(137\N(' M+>_`V?;6J/A.=:^9?F^'$GMH*'&\?C&X?;98_`-02P,$%`````@`9(EX1X"X M2N3]!@``C"<``!H```!X;"]W;W)KVE;64IKNWZ]D40X!@S+K/,2V M>`""`'@(09J_5KN?]5-9-I/?F_6VOIH^-?72K%?;\MMN4K]L-L7N MO_?ENGJ]FHKI<.'[ZO&IZ2[,%O/90>Y^M2FW]:K:3G;EP]7TG;A1`X&,8+*">@W@34 MJ(!V`CI6P#@!$RM@G8"-%9_*%HBL5\5[U.ZN>BV]_BLL/O.CVM\DF]5[CK=TB;S'5[ M]==":`WSV:].E0/!'G3M@R0+N4%Z#HA9:P)O!TSQ%.#)LS-\\!%2O6D5VY/6[M$D#PB-G*(3?_SG<0Y M(B-4J$&%ZE4H/S(I-M/T&=!#MGM(ED&B.-0'A+(V(8E@^T1`*)%SFC[Z&&NR M!#C4)Q]EK$PLA_KLH[1,$\&AOO@HI3)>UU>$@CS1'.K&1TFI3))SCKCU89!F M[!J7/DA8`4E,A#6)L/8C3(S)>INUOS(CDHQ#W?JH"ZN3//7^!">R]$7:&.D( M\PTQWWCFVU2S]AO?,JU3FGQN`0@FM.+7N40PL$G,SK3$:HMWIF+-MOY$*J5I MYZQ&J$S$N!V)@(E*FXRL(,,K(([7_0HR;Z*4M=Y'""T2P^E9\GK"QN;$V-S/ M<=[4_*2I/N(BIY8ZUR*051XYA:T5*3&WJUU\YQJ6=QW*^3FN)2[WC$MUY M$.-$GM,^@',AQJ61IX>DG"W%2&*[DEZBPA%X,L8@84-F(VY7<7=]DE*QA(BT M1J!`6DN?8*-N^FZ1B+6!FUN,`N\8&%DF)6Z)B=O$E)J2$K<\@[@E)6X90=P2 M$3+(`$5@F!3\";DD,!M5JTO*VS*"MR7B[?:`B,@!W.(PH3483',Q?1E)*5S& M4+B,H'")N/FHOS@L#:&R4'H35-3**(%+0N!1!$8)7)Y!X(H2N!HC<.=BA4MD MP]_Z*Y^6CUNA@HG^=#K4OE\_%([Q+CPLU+C(OL7BI*\(I4YH'@ M2!0@)!SB&\?*K\7S_0BW.P,J!HQF9YZ M"IUZ`8/U:8-1UR34\<2HR):GH@>>,GB[QQ"SHMT5=49W15%V5]D(IP[.&VEL MN[[4:<@R`!FQE?90E'^(6!GC>4U;*/J,%HJF;*U'&[F.#Q"('O;N\9A&Y;@. MM+1O$0Q4X&';$L%$6^_$'$6Z)^J]7+^X[L()&^`#]J4B;'5(J:TI-6 M(TX=)L(49F**>GWTG-`GE4Q)?B;>^(;,K=X_YMJ7IR5[UL&_<8Z7#Y\$K6 M>^A>,B'7K\7E5\%R(;D;K93>>S;NQG.9\5K_5VL\M^EI/J-<_3\K^K;%L< M+J=T.@S\VKRLZW8@GL_B(V^UR;-=M2EVDS)[OIQ^HQ=+85I(A_A[DQTJY_ND M=?ZQ*'ZW%_>KRREI?$NLW.0K<&G8EMU_R=/KU5=Y`-E M.LG3/_WG9M=]'OI?#+$T/X%9`@LE<$O@1\+1,3]!6()X)XB3!&D),I2@+$&% M$K0EZ%""L0032D@L(0DEM&O>KQP)IAP7^WVUJ3I-&9:;LN"[#`M..:+$?2QV MD7R3UNE\5A:'2;5/V^>;7K3XLK73&)]4G<&R?T*:8*Z:T;X<9%<.Z#_.5"A`]Q"XQX(=\!1/H@ M=P"B?)![`-$^R`.`&*^JGZJR^-S;)8`D`6O#A[7I+[]Q$".2!Y@0@PG1FQ#N MRA#HINHCH(?L.H@Q+!(^U`U`:1VA0-!](``437R6;EV,5B9B/M1W%Z4TC[0/ M=>>B)"<1]:'N7900QF_K`:!8$DD?ZH>+XERH*/$)L7!AC!CO')A-::_2_$;X8S M$"-0P9!E8!0IR.C7%60,>\(^5]!B[)SER!:Q0#")-QQI*SD`"ZKE&$X^#%9S M6H88$5@_<89^N&)@,D`_"1YB/;(3`UB[D1#GC_JU!)9%R(;*S)5B,F)#&3N"V1)S1E@A<#XA3;*">\1_T8ND;;V9\ ML6AF_?&7QN?FE^ZE5/SNTGRV3U^R95J^;';5Y+&HZR+O3M:?BZ+.FJF2J`FK M=9:NCA?;[+ENO^HV_/LW2?U%7>R'%V/'MW/S_P%02P,$%`````@`9(EX1P`G M;\Y7!```SQ0``!H```!X;"]W;W)K[O].6-Y=2YRKV2'A\E?<+9%I$%:XL>9W2KEM]-`F2F.B1D!H;S2*$!L2FLGIT)'M(Y!'%0GL,:-J,<2\F)$-VU"M'"@P2TM@6PTC"$Y=8A,; M"XM=JB;6LAB8;@NI)U4JA#:AE2I$^=:R4FNGZ5[O3[<9GFXX0!`8$6I..6J( M(A<1:)0@A+]?@Q"9GJ#[5:@Q`V4H&5F'.!PH0QT+@-GJ91G^#W.*,C;7AD<+ ML5N=2E$,;#UG*2'9P*T5O=(8C,T=%LA`W5?:#"N-K-Y\.D.BKYZZB`1FC05_ M4&-FNX6A2T.0E.P]P&S^79!5"ICGB:X87:0V@U(C2XO,I1G/`:=,43/(]`^" M;#9=&#MLY-AA(ZL-#N+(/*ITP5,QOD&-HZX\A&@4`4Y/$V0V2P1&RT>>-"75 M'<1,MR/Y/T"CK">ZM9/29DAI9&&B@;=&8F'-P!T;LU^CL5XLTZPQ,(B!BW-F M\T1J6S2?A=U$>H.-G:)@]BFD]BE*L'TFO9G%R)C)5_XA9ZP\MN^C*F]77/-: M'%#ZT?Z=UR-J_F$;XTLX>X&6\36<;6WC2S1[LNFLT>S5-LZ3/ML@FQ)/&[]C ML^%QYG>P]0[A=\2;@H]E+^:7Y,A>D_)XSBOOK:CK(FO?#1R*HF8\G&#*7[O5A_PYS\1]02P,$%`````@`9(EX1S`?AT,R M!0``?AD``!H```!X;"]W;W)K\^%7NTK2R?F>'8WDSV%75*7:<\GF79DEIYZ?T6/_G)2^RI*K?%J]. M>2K29-L&90>'NBYWLF1_'(R&;=NR&`WSM^JP/Z;+PBK?LBPI_MRFA_Q\,R"# MKF&U?]U538,S&CJ7N.T^2X_E/C]:1?IR,_A*X@VA#=(2_^S36TWR3WG^ MJWESO[T9N$T.Z2%]KAJ)I'YZ3^_2PZ%1JGO^3XK^[;,)A*\[]4D[W#K]IZ1, M[_+#O_MMM:NS=0?6-GU)W@[5*C]/4SD&U@@^YX>R_6L]OY55GG4A`RM+?HOG M_;%]/HO_A*X,PP.H#*"F`9X,\"X!_J>\+WG_PI//`Y@,8(8=<,ESTPX"&1`8 M=A!*/C3M()(!D6$'C=_"-=>T"W(QFIAVTCE-J'$GG=?$U&S2N4V,[2:=W\34 M<-(Y3HPM)YWGQ-1TTKE.@.W\\Y#.=Q*9YD4[YZGNO",6>KM-C),J&0V+_&R5 MIZ39/$G<\$6C4XM;92M8B.VGWBG*NO5]1%CD#9WW1DI"M(5N(>11#%DI.A?" MJ5/`\Z`#M0L*XM$>QI#PT#PG$/$Q8JJ(H,A,01B&S!6$8\A"00(,62I(B,[J MU5E97\]VHR"1@3=>YXTG:L2#602!@8+?*?A"P8?&N&J67!2`0(XM$H;4]C%J MK%!!8&MU$(@Z4"@284I3R`0\M"E&S2#%`\\.,&H.*>:Y-L&H!:1\/\2UE@I% M(YMAU`I2GN=S.\(F8@TQZH;H&#<0(@&A8%+['6::PPPZK/43"H<9'%GM,,&H M,:28Z]DA1DT4+4[UX0MJJE"NCVO-(.5Q3Z\$0D$S;!1S!:-H<2VXLK;P#)<0\D*]-VFT`KD? MMB+ILYJZW[,R-LJ!YKG`?2!FIJ>&9C2'W8WZ7M"M-3\5,( M,?T(D$:K*04AOD/,(>;CS$*1"O&;`!4GU M.QMJSH;062B'GZY"<:Y_1^`?6/J?Q`]:^H/%/K'U)XT>LO3:L'A@Z,D*[7QJ< MOW,Z&IZ2U_0A*5[WQ])ZRJLJS]H;O9<\K]+:J7J)#:Q=FFPO;P[I2]6\#)IO M..+G`?&FRD_=KQV7GUQ&_P-02P,$%`````@`9(EX1W@!;U22`0``?P,``!H` M``!X;"]W;W)KV&,7.H07%SARTT;J="K;AUJ3XRTVK@92`IR;(D63+%14.+/-3>=)'C MR4K1P)LFYJ04U_]V(+';TI0.A7=QK*TOL")G(Z\4"AHCL"$:JBU]2#>[N4<$ MP(>`SDQBXKWO$3]]\EIN:>(M@(2#]0K<+6=X!"F]D&O\U6O^;^F)TWA0?P[3 M.O=[;N`1Y5]1VMJ932@IH>(G:=^Q>X%^A(47/*`TX4L.)V-1#11*%/^.JVC" MVL6=^Z2GW29D/2$;"6DX"18;!9M/W/(BU]@1TW)_=^G&P;47<BW2Q7N;L[)5Z4.3LKD"K$<1\*\RL/\TN%]>6H$;2;@M:K:Y]L&ULG9U+<]M($H3_ MBD)W4ZA&/]`.VQ$KR1N[AXV8F,/NF;9I6S&2Z!7I\>R_7U`DZ,[J3J!D'\:/ M29#)!O!U=:&3>O-C^_3'[NMFL[_XZ^'^EB]_WA8?WTO^O-_?;'VTNYG/[A][LO7_>'?[AZ]^;J?-RGNX?- MX^YN^WCQM/G\]O)O\OJ]Y.Z@>9;\^V[S8U?\^>+@_L-V^\?A+__\]/:R.YC8 MW&\^[@^OL1Y_^W-SL[F_/[S4^-;_/;WJSS<]'%C^>7KUOS]_WM'_A_5N<[.] M_\_=I_W7T6YW>?%I\WG]_7[_^_;'/S:G#Q$.+_AQ>[][_N_%Q^^[_?9A.N3R MXF']U_'WN\?GWW\<_\_0G0YK'^!.![CS`>)G#^A/!_36`_SI`&\]()P.".J` MJ^-G?QZYV_5^_>[-T_;'Q>[;^G!!R>M1_G1XD?&5+W;/K_9T/"'CV.W&?_WS MG<2N>W/UY^&53B+W++HN1:ZEN"D5?6A);D&26Y+WI61P_JRY&C](\].XZ=/T MQT_CRA>(R\?WT_'^>'Q?'I_08SR.Q5'R>/P8,:QR2W53JE*75D-+=5NJ7`HK M-7#I."JEJEO^3%Y])E^>X>#Q+8;CA_+%6P0_:"-'U4VI\BFN#`,@GEH`RBA^[DI53U75P9+I:HO,3"2^Z:7F+Q+N+=*C6]@"JX5;_L)2DOJ?0B M32^I')?QDNJ;7D#ETDJ6O0S*RU!Z<4TO0_DN.>N;X.0%5%U7G$GJ)2LO&?&D M1N9XS'5NWB"%XJ:MH"ZD4S8.,\[/,6F._/5)<[H,!A]73;=7T?0,ZYSLIKB[N M2)-<2I3GV'94DC7'&%?CM7S^U3:'8!_2U>'Y53V9*B8B8 MO&@B2\!;S+7=A,5[C$BX$\UCB>BD;SN)RT[:$NY$TU@`QT/;!Y`V-)E]@Z+> MF\Z0YK$`D-N3II2LE>@[K^DS.0*A2T.R3%=RYO*IT!(`9ZCIXB?:D MYP"6CC`,5:;[P&FD.JB$R6W@2EA*3]R`2+JB:N!V-%&=`SOM*<>5J!Q%I#Y! MF43+&7<:J*X'0^TYQT%%F]GI*E4QF<9'(]1!6=NUIQP'=6TX*9';2^_(%00ZUX\K M%TN30+.Y!S9+>^;J`;J.E=]*YDR&JK8%L%G:G> M(X="V]E,J7NZT8B$.]%X[@'/TIY/>^@]^*HA,PT3-!]\;[JL-:)[0+2TY],> M6@LC'!Q9:H,P#3#UQ/H2PZ&'=0>J&;%H6]IK^/=#?D5&W%M,HM!;3O9X!^G(&,!1#_DSL4S7N2V);^IY>0]9# MZ[4]2_L2GAT9$B5JWF>W("*7SWM\)<-GTICV@&G=^3RQQ[M%]A`)-Z+Q[*&M MG-L^9N@\^7AI([CJ!$/;H?DFUWZ9Q43"?6@6^Y+%I-OI`UPB[CAC@O-YL5]`S+?#X9;.E3/W@"[[:YF6.[S$@GWH9$;`+GD(2`^ M4^O$MT,`/+:62AEV!9XT2-RX@MWO8=$`&&9$JC(FY&,S-B@[<]B<1E:!()-Z*A M&;&UVVY=1N@+D(?@2F09%4W.B&W=]E02EXM3(N%&-"ZCPF5[:19+#N:8,RDZ M0.>"I<4<-2\C=G3;BZ)8TC"G3DCG"71N,)VK:L,"M`QTZW(Z5\O%*I%P([I8 MC8C+]HHFIF4C;0DWHJ$;`;JZ53D9688ND7`C&KH1"E3B8[E`)1*^C403-V'O MMCT+I>4*E4BX$4W;!+0E+2IT4PE,2Z0<-#D'("?I%@[+Y"02;D23U8;EENH M1,)]:&(.BIAD6*").L*Y6=[?@,SB1M-R@!5]>YDWE`QT0\?VC(+,]!AKT*`< M8/L6N9.7JU,BX3ZJC;300VT7'L-R<4HDW(=&]@#%:7N)-RP7IT3"]_)JQ&;H MGK:[A7F9L$3"?6C"9A5Z:'<+,SRD&H:^NGU.ERP*N^A-R\VL>9M5H=JN#_,R M<8F$.]'$S4#<]@Z9C,1M;W7.+ZQ4L\9M!MRV6X49.JA9)!/,H;"+R=!$S6?P MG@JHC$T!RX?2M,RXC"=[VH&#[0X=:,;ZR="BRYJ5&9?RY%8`$I+IE8JX&0W, MC#U4<@2%%Q\NUA[0/R6V`L(^YMUU152"A M0\2V5T"3:OXFW/8I-JWLP+:3U>$I49X#7I-DZJ>3,O)7:=%8.P6-UQ/,>S(+00$VL> MH5!R-`4OI9$9PY8LB=>(@=1$,V.F(K7@'EH682LAG+M8E7;G,2J%(8T+1TN, MK4Z-B=I(0*8SP59"%TA`"W0^CRL#2P"HSHM!8(RU(T6LE;!2VDIAJ:-C.CMF M&O,S8J2^+#U)J0-;D-@B74G!-)94<9GSZ)2ZV(XIW^I7JS+>I\8DZDPW M2\5:2("Q#+=`M(NGN%%GS'&+5,R%"!C)O#'F2CSICGEBI2)I`I(UD! M@;083W4KG2W7+56N3"!81OJ7`IDQUP4V3JB38$OKUG%=Z.VV%WT"L3&>\E8Z M6\Y;JGR9.(5>-E(8VJ4[`%!HVP(@5N,5L&S*7!H@%ACX%7^3""`QH+@F"RS M)<'A&',4O,JC"0326!@<@F:DV`"--0Y>Q=$$\V@T$(Y1,UX"@>ZY!+)\X4$5 M2I->5=7D5H3$F?-Y(-TJ%$KV8KH3JW2:8#R-K*$Q=Q;8PP^E,^;%JWR:0$!- M7[_3"83D63_XMO<;U!V6'Z;0G/P,J4UU'J;4+*U3J0)E@HDR-DE`7*Q*C4]U M'J@LDWN5*A.,E9'VJ4!@[)!.9$,-NL[6UZF298+1,GJG0/>XZ]G22F703)E2 MJ:)E@MDRLKU/(.5%`^0HLR7(IZTQ? M?U-__PWN0",+-0B:T8PYRFPA.)6><59B'T%O5C)TNL&`LK\.OE==5 M!$YT!LYR^_P,K4U%.J363,W8*FW\UICE^.>6O0O&>:F<]4 M@1A":VQ[J`3#Q/(O;%GDH;<&]/,>*E0 M"]$WW6H]>S$\!20:[J6*O@EDW\A.48G+N]V89L9+Q=*H6$K*"$BVO%O)O9H/L5@Q5>(2A'-I6*(2C'-#->JO(9LG)D8ZE` M!(YY>>$^9*E"<@(I.;*Y5*(!]D0SXZ7^`DGH0).)QQ"08YH9+Q6CHTIKD-80 M1.!>C47F0`L8E(XW7DJF4J%*S4E4-3*[W4HBOYK;HH#*V#O;$KJ*T0GFZ,@W M;QJ"=$S#O511.H$L'?O>30C*O0K1N>I[?Z=!0JES8:S>+17HSVS=5*1AN,[4 M2:UR<8+!.+(-50S!.*:9,5/1%;-Q[)F#(1S'-#-F*KQB/HY]#VTR\)5H9LQ4 M?,5L'-O1F`R`)9H9,Q5@,1;'UM;)0%BBF3%3?TDO=I3)U),,93#1S)BID)H4 M4LF*.@$HC14,'F2L8*K@GB3L+).>*03IS`[S+SBL(GB"&3P2)X3#-CIH(U)O*8%P.KB6;&2\5J".31 M;:B&2![3S)BI6(VI/-88)7$[-/-25E>9/(%0'M^&"H&[V2(/E>8BKXKGR8#] M8S*_&A)Z3#-CIOYR==S'3+@-&;Q7XD*?V4/<0=7"T;9)JTKMR:`V8I`.*,3R MYE<0*+6O(*HDGT"4K^J!GGY4CN3EXOCT\W*4M%T<7Q4_VNC;^LOF7^NG+W>/ MNXL/V_U^^_#V\".-/F^W^\WX@MUJM/YUL_YT_LO]YO/^\,=#%?1T_(E1Q[_L MM]_>GGX"UOG'<+W[/U!+`P04````"`!DB7A'+[0J4@<.``#^7```&@```'AL M+W=O&ULI9S);P]]G'[YOM^F$HTXU%SEU]L_>UJ%>9.AN;9J_9>AP;4F1R^-8/(SDE\OM\N;J:?WC;/-M MN7_!]8L]_[2O9U?YV>90X=/Q#=D-YLWNT[]O=-#JZO+O?54]9`[0;0E9PR%S MJ.=$7.Y,X.TPY_@5IBC/?L/+DK"60UZ5B..(UU`)B[P!Q'/(6T`"A[P#)'+( M>T`2VZJ3K;*8MK8#)#?TC1WZYOCC;[;L6Y]30Q5NJ,(=JW!ESY!!%HXCX(@\ M'I"4S,QQU$N@8IR1@1"/`P$HG;F:7I=,#&EF..I-285H9Y&CWI:4MVJF.>I= M23F7^+K>`V7RS'/4O*2L=6&6N898E)A1B7W&KH1TU*9H5+F'/>EA7_8P>?YT MM-F7W^.RI9UWQ!:`*:-GY-WP1ZM++&758'(@)H?29,/905W!T!X[4J^!4HZOZTU)V6#IX#U2;TO*>,=;_PXH$^BP/%+O@=*! M_\9Y2>GD[2RP70R8"HJOK2NQ9-K&922=',M.9@?@\:W') MN.QG+=-M(A:GTF+'6IRPF?F.70"U&R2\R4#YV&1R)B;GTF3/M=X\%U^C6'-+ M(O,#I\O0!\6PD6W5BAB[=^E^6LM^S[QGAM>0BE%O,5!)SYPJ_K!]TD$14^I) MY0DT?8+2VW*1;>^>J34X(-IKVN;]1"O45+'74'O!,6-GM'G/'+_E8C18^W<0 M*CV.G:OG/3-,Z2.E&MJYQ"[B;E9H&"=EF5@V1^49J->E M2[?+LX-@KATTEO?"E(W<3@I]+O_P#P%E=&Y["NI9Z-*U\)H?[>`T\`\`B#`9 M`J2:!$=3MT*7?L4NIN*=(0WB)LS@`%D>Z@#2Q515L9FJI(YHL^%;.6O3M+632"<@%6NI..I2'3VQ]]H=L#M7OL6)3)42XW"GG#LTP$E/)TIA?$BFX9); M9B%#-=>4FNM9I;PUI5)F=KY]"8PTV[X":J<8K'_\&J@4&_R/-U#D0D=!:-\B M9]@A]`X@(WCQ[X&RB9]YYTBI43P^=#G:[X1@J\.FF>G,JU5E`%`GQI1.C.?5 M]-:@?R*$;R\!&Z4ZAC$`D!!*O09*F!/>$+-BXN>$M\`Y'GJ'E27>KO=`1?[- MG`.T"RK9H;&@UGM!O+$I5&%8I9NIWV=*O\^3[NM35<96W\[8=W))\36]`B8G M.ESZ5!52AD\.==`G3$KBP07BA%X@Y(\U*D(]+3;Z:H?ZP M*?WA)+Q8I1]K?.9?Y05@%S8(":X.N)W0M,3=AOK%IO2+F[R-DY?:)Z(->*EM MF6A#G4<#^176Z9N;:==Q&ND$I&(K=1T-)%;XT,=4,BN#K9-()R"510+J"EI( MJ_`!A%63MDXCG8!4;*7.G(4$"I\5M)`=V8D3[VX#9B,_LW5`^:;WQU('Q$(6 MQ?$-;*8;>!+I!*1B*U51"]D37M9M.8L;0=,!LFT-1V=Z"ZM/O$+9NU]"6[KEM2>=["TLK;+9O8?USOX7.SA960]@,^-R&Z=$UB70"4K&5 M9BLL)/7YW)PMLPP7V@0AQ8*BE&*`C)@;H@#4&Z(XJI2N54@C0'23SQ0`=L$J`#EQC@.ZI:GI43=4R'?F3 MAO4QN@<-:XO1/944#Z$.'Z/[Z5!G&ND$I&(KU0T/H0[O%WD[;>LDT@E(Q5:J M%1XB(3Y&]Q4)&&R=1#H!J=@ZVE`&80^OQQ[6=+TP:P$UVC+8OT$`E2M)%9.I M/GB(H?@(W4_'4--()R`56ZDJ>(BA^-T6OK*8.S0;($TI=T\G>@\9.79I;>ZG M,W+32"<@%5OIW.XA(\=[WOZY\4N@,W&`7!H?C(?I7-HTT@E(Q58:M`3(I?'! M>,"017I1$9/>5*14D]</:D^`B$2PNQ06XY6P M-@Q8)5\`W*_D"P)5K4#"$U[NP[1N32.=@%2LI;H5('O'!]PAMS5Y;FSR_'\V M>:2R&&$?$9VU^Q:/T[HXC70"4C&6ZF*$#4-\V!UU4XM'W=;BP/U2BU.9C"2W MQ\?@$91-C,$1$V-PP!IC\$AE,I8R*<3@$78X),DK`>S"JBCL31AA:$G:RM M)Y'BZ,@'A#9"W\.A#_DP$G+R:23@VHXC1:HH$>(@/OD?$XY9Z80-B>I)@C!+.&JCR"0AG+4!3#YL M`UCC:9M$I25!R,5K1@(M$-*&"*GG"T:B@I$@<\?[&0F6@J25(*"!5(,+O#89G*-]'9/4$"CG<*$BRP2"=AD!).PB#4=A(FT:@H M02*.#_!3&G\G/S<^RE3$,L1'@M&@3U;8)+8`;&>T-+,`E]O$(E.%RR0D MXN/^#+%.Y#4%(?'\"F`N-L45F6I82`GY.>]9F`#'K6E@G0:GQD'B(E M/O$V0+7,6P/324S-X-$)>04ADG!H6%7.R)\,GF0ZB:D9/#HBKR!P$L[?JND] M#PU,)S$U@T?GXQ4$3<(17#6]\:&!Z22F9O#H,+R"V(N7[0&J&SR]%B4Q-8-' MY]X5!%["A0AJ>JE)8FK&C`ZU*\@&\HOT`U1OO>G=#1)3,WATHEU!%I#WT`?H M.5\T.HRN(&W'+]8/4+UEIA>")*9F\.@\NH)L'9NPG0]0W>#IO=P24[OM9*0^ M<&.+=(\%W*R2A0N*%HB-[O,:K-;/EB#FDA8(<(1;(#3NP);-QA!'M/O92C2^ MK$63`$<03]V@1=-,)S$UDT=:!)>UR-=7Z`8UFF8ZB:F9/%(CN)M%C-HUN4)% M12FX03):821UM,9HFS)4>GPM"][+(MGOF^WWC?;[7[-_I&CTGA;!(]`-FC;- M=!)3,WFD:7!-BQ#$:QV;FSPV-GG\M28?225HJX.?NPWF[7#]?[VXH_K]?;U>YIU6SW?G]=+3^=?KA??=[N_[O?]?!TO)W[ M^,-V_>VZOVW\=.7YS?\`4$L#!!0````(`&2)>$?.,MDA%`T``&=;```:```` M>&PO=V]R:W-H965TW?]M-N]?;RYV7YY6JX6V]GZ;?FZ_Y^OZ\UJL=O_NOEV MLWW;+!>/[P>M7FZ<,=W-:O'\>GU_^_[:;YO[V_7WW?[,=B0W?` MO$/^\[S\N1W]?'5@_WF]_N/PR[\>[Z[-@<3R9?EE=SC'8O_/C^5\^?)R.-7^ MK?\\G?77FQX.'/\\G/T?[]>[Y_]YL5W.UR__?7[WIFNNKQ^77Q?>7W>_K MG_]8`_'>!_'1`F#PBG`P(YX.9X*>\#41:[Q?WM9OWS:ONV.-P?]N,> MOCF<9'_FJ^W[V3;'\=T/Q7;_ZH][V]GN]N;'X4PGD'L'/0#HC+C9GYY]#W>- MA[O1X8Y[@_D8X2,'*0#IVR3\0,(?+]3CA:;V&<)PAN.OGP*>(2/-[GBM1]#K M.RCWW2QPJ/D8Y9/G466,LC[.%%<=R55'Y*PX0T>NNAN?(?9(-!XONAL1_6`# M&9E\O&8$N31C886<*VFN.A'.":[:<._SD,;OXVP,L\321ESJO<`;<#G/3#_^ MT[Z&3*XAPS4XPPY\'KTIBY@W$85'B#Q[PK-'GI9ET5_V'M:0-SD4\/&[.'8T M3JBIX6A#B@"1R5I*EM14]O8[@4XE8,:"Y@`*%#3PM1?R=92O@T>\X\?6C?GR M;,<0U_'/4P&4G7D%84\)8RUW_`![>'#=OA9W/&T$YMX(3S@!^G'%D,F?5>14 MD2W*B-,,0*0#@&4]\)]8'']BQK)E<$Y0P<_8X2R`RWV>*?H`2[7$=GCM@?_D M4`)RR%0?!^X`W'\>PN>&YU/=R<]V+$&^.IY'5B/47G6\YSA5*/K MERE3`;&H(.S3^&`S#&'/TYDC+%GZ;`^E"*5A3.;&H)YF_M7D]@4(_`1G& M>`SY$*VJP7)4FAQ*$SM^#\[@G<'?SX!R4;B=`65&14WF3!7*H4*YR`ZANU!8 M'!46Y_!M>&5QKOEAMB%%@,ADJ:@X(BKL'?[@?)ML$U($B$R63D7<6$2UR($6 M);Y+%,E%L0:8>&D%8,JQ]E25_%B5%*VU/^O- M8/&@WF@\'D]EP!.?B&]`_+B`"_5W#B";A:<+4/ON-"M(TSF%)]:4QAZC%=QC M!>>-'C]1FD_5NPTI`D3F2FNWQWD$[XWXKLVU"2D"1.9*Z[7'F0,UU`"1"9""V3`9IWP:X)?.\.1)J0(D!DKG0&$,@,@+WW@]/=^X@3 M[OUPX3P@T'6"0.8!BG8G5"L%6(]Y?R:$]D?4A!0!(G.E=3^@ET0]F8%LN_"W M(46`R&1IX0]8^(5[OUWXVY`B0&2NM/`'+/S\?#+PI1JX-B%%@,A<:<$/6/#9 MIJ>$"^M]H/4^8+WGK9(P+M2B50(HT2H!E,HJB;3L1[+RP%LE\<*B'FE1C\21 MX>_L.%&R3P,#D`^.'[X"**>Q%R,M[9&4=O[^CFUSIPTI`D0F2[OZ."[JDE\2 MH1,7_1*$Z?R22!4B@D(((A[;"M&&%`$BEW#&%\H/)$*3T07AW=$(HH%OWA#0+SS!"#5"'=4 M=CJ4':.P,KJSIIPZV8ZL0VO.0:M\1RP5]JE^Z$@'7WD=I^<)<1W[.10$98TX M=;2)[XB+H]GW0DMTAR5:V/G2+M%M2!$@,E=:HCMLXGE#I&OW\&U($2`RUVI# M$5D$%LA.E-YA0Q&LZ[J^6D\8;BC$J6XH6J4[XN+PU:7MC-*U!1XMK1\P7 M?M+2=?V;-B`3N>^[Y\D!17E!KP"EWMB0J%@D='V%G2X*E5A>ST!4AKB(^W'D7 MJD:BJI%0-82GI*T:;4@1(#)7JAH)58.?P27<$-0+31S"]K<^OYLED1VK"M;5 M1E24#6'G*%FL[8Q&HA+5C82ZP?>?=U72A3*0J0QD M8M[PVQ(RKG%Z8;$<8'V0=@D"+)A>XSIEJ@F9:`)OKN2VR=^&%`$BDZ5SA`S[ M^ZFY,G!M&T$"1"9"Q2.#>`BJG]L[>-J0(D!DKE0P,@B&8*KD<87WARVL_,0? M<:D39J\%<(=$@4*B,U6-C'80;Z[DMFJT(46`R%RI:F0T@GAS)<,F'U\]_P-? M%!?AZ1^#8J>9`&0J&AD=(;Z5R.#B9-K3#S=&DNC`,%^X?)"KK`+Z0;R_DL'J MB4X09X0)%U8`I1QG*D(91<@H9CS]66%./6]/5H45'DM/BWU/?!K>8^G'93K[ M)*@4P((3K,(",!LZ3=/;TX:_)^:0PF7I:4\6@(4K07\_"IL%YXCKK;0T MASAEG]33^MX3+TE('UWHT?>T(O?$_>$UKV^OY;8A18#(9&DQ[G$>P'<6_;A^ M2O$C``55B:C285!CA9:LAR5?G@JL]TK9HAZ-=TW0P]11,S)I8,=O0`T/;([" M?&!.D#X;(8A4"+(+07<%U/<_O'*I$6--E0HS6-V%D)&!.!=?/.8$%:IMU'$8 M@0NG`-94V3!#]N\(&2.#(A![:<6'(+T5.A)Z1MUG1U7E\,J$)W-F#PV_F#0" MF!@UPI.ILD:F2J095!$A;62@ZE>/3!QX`TR(/9H+)P?65'$T@_(AQ,?,6#X. M3Z6BV;2F2I`9%!&^TQE04R*BP!0),T&XRH\9LA#!3S$&V-F:5JUZ6%,%OPSQ MA(00ZQ3R=`SY/)"X"53*$"%.R/\A1I5HK;/(&$86C!P+V>']-*`7 M)NP(]+FS4J@5@,GJPLBVTAN,(PMQH@%UMJBE*#7BI$`1PG1*66>@,00M>#O6 MXCPC16')!8$A57M1SMS'.&>3)K!AZR0T1J&IR7-^]$!ZLA#.!112PI)QX3S( MUC%HS$$+3H^%]+*SGE]@F2-.N+Q"SZ8<\4K.2![:*.;*]E<\>>BM23Y98_C8 M*C-L26A82!E9UUZA5F"*A)E@7,TI2&18X_78*A!L,1$LN#U6D0A68(J$F2!< M57>2"N;WJEA%*EB!*1)F@G!5SR$9++HY%D*_\IH7XO;\JDG$F?H8&%31_RI$ M;#%%+.VRL9@CUG:<50+8.N(>">*'H=V)WHVF>\7>S6%9UY"O*C'F@(6]-M8I MIA,"9H),55LQWRM^A4Q[\5F!*1)F@G`UV7!DLB$0AGE$XIWY.<)"EZ3T-P%F M#75/5QRL)S,.U3?H5*V_QWHN]!]>T?JW,47"3!"NI(.$>X66)B[0V#XPT37 M@<"IM@.1NKZCRB%;&D063!S($$]MPJ3(B58`D:I>H(HF6\@FBSZ.(IPL82;( M5,JBRB=;14!9@2D29H)PI2P84J8.SIFPPX]4:@80-]4-$*2J'0B5RF!>6=B. M,Z"FAUNA,@)F@G"E,AB.IK[-F;!"913Q:`DS0;A2&4Q(2U:-(B&MP!0),T&X M4BM,25.3)@V$)Y0H#82;F")ACH1O1M]&O%INOKU_K?/VZLOZ^^ON^$7!YU?/ MWQW]R1V^S9B\_G#X3NGW;SG^=9K[V[?%M^6_%YMOSZ_;J\_KW6Z]NCM\L?'7 M]7JWW)/;Z]GUU=-R\7C^Y67Y=7?X\;`?>7/\&NCC+[OUV]WI:ZW/WZU]_W]0 M2P,$%`````@`9(EX1UY>A4'%`0``XP0``!H```!X;"]W;W)KV$ M[NWK`Z3`HC6[P?[-=_J-<=$+^:8:`(W>.6O5)FBT[M88JT,#G*@[T4%KWM1" M(C6N]PB'."50J\F@^6EIB=/YJ/[#=6O2[XF"G6"_:*4;$S8,4`4U M.3'](OI'&%I86<,H]T>&DM.`C)4"B25E(T2/5$?NQH[6!2RMBE)%R:M)OE^E,F=5S&67Q?8'/ M5FD`Q0ZT78"^70/M9J`X_%3")L;5+/&8Q9U#I0$M[@DBY.\)/((VT5V@MMCK8[A[40&HQ2>&?VI3$WSJ5@4&L[S&ULE5=-:'M:WZZKI M5NZQ[T\/GM=MCZ0NN@4]D8;]LJ=M7?1LV!Z\[M228C<8U96'?#_RZJ)LW/5R MF'MJUTMZ[JNR(4^MTYWKNFC_;4A%+RL7W&GBN3P<>S[AK9?>U6Y7UJ3I2MHX M+=FOW$=XR!'FD`'QNR273GIW./D72E_YX.=NY?J<`ZG(MNUI.)Z]3%^_@LF^%Y&7])?&%F-D#"`%T-(+II@(4!_C`(;AH$ MPB#0#+QQ*T,@\J(OULN67ISN5/#T@`<&;[D3YMGI!F_M&%\6BH[-OJTAPFCI MO7%/`H0&T$8!71$>VLXAM8?"(`K=(!OESJ@'0>Z&:QB[@)E`B<'\Q\:@6&DEB/ MGDA-%28M.4];ETG`-E4O4&(A8(2,>9PI.(C13"KG*@YBL$E4"'3NP4T-F+@' MBM08RR930-C7)7:*=_`U+0#]0(#01@U`EO)O"-*Y"E.!/'%G5$$#`J0+9$%? M/R$@LM$&D+4=I^EHM\&\$0J&FET'P+R!08QGH*B+)3 MG5G4'0*=--@HA4!-%Q=DIBR#X%-E3I1EE$V8]>,$(1NE0/(!P.X$H8E,IJ#, MEYP9R#Q?_1Q!^*8TQ(*OAV^R< M+3TW_=B_7&>O'>TCXDV6-K]AG>[8EWZX62]/Q8'\*MI#V73."^U9"S?T6WM* M>\+HL>_B.D?6BU\'%=GW_#7FX1^[TW'0T]/4;%\[_O5_4$L#!!0````(`&2) M>$=OT\)2]X0!`-%&!@`4````>&PO#R_'PY*__JBG^^J^V?_VR6NS6>;E- MKLIE\D.Y+;9/R>N2!RVJ,KE(?OGP,CD[/4].DZ),WA2K%7S=_-6OMW_]5[_& M(7B8P3!Y4Y7;^P;&6.;+\.KFV9;9XOM_QF^*0^_S^\*?`*&>)NM\_;DL-MR\:FNEMMDLUITC'(- M2ZBS%4R]S#\GO\V?PN<^UMFR*.^2#T_KFVK5FN7M;\.OKG=UC?MZ530+&/CO M\ZQ&P"8OLVUKD1<7_?G%L`4;6=NK8I77R36\=U?5K87]E-5W>7*U6.3P%#RS MY.<[X?SQ:=.:?]"_:*W?OO`NKXMJV;EV@Q?_QW_[;WO/5\/A%7S9PK_P29DW M^NRKOP^_N8)7E_SZ*KL+?[W-5DUKY3_7<*)9_91\N,_JO$E^WFV;;5;B,7>< MQ._SU>KB4UD]ELF'/&NJ$J#]NFEV;7#_?=Y:LXSQNVH%5QBGI7-J/?:VZD)1 M0:CW^::JMX2+VVS;AHT\_FYWLRH6`(TJV[9P$ZY_M2J6A"ZPX^2Z6M\4N!L< M,DYDB;\*"RY;HHB=YMBX<\R3\#!VG:X[[/&[AGBWMZ9YD_Y*MJ M0Y>CZP786U8SQ5W`@F,#;NO=8KNK$?$6]TATX.S+O+7LMU5Y47M/%^M-5M0T MO;S8`@-PN`2F7L*>&L#>79W3R@&!<;6MB[M!2D=#,X*>K0",Y^%CK\MMCBLQ MF^[\G4=IS;*]![++OT5W^EI/GMS6U1I@!Y>OW.'2*EXDW(GD)@=^EIO%;K// M;0C\PZ#%W][5U4/1X(G`V\G9#6`!8`G-<[YWK&/7=<1[2R#%_"K0!O#'L@*IV>C<6]ZGM)IG@X'O4'LWNP]Q>^S!L@88',)JX>[ M`F="5"@Y>UMM\V1V_J)K'S^Y?5R[_?^L=@$L)N'QB06T#F78%CK,.O!5>BGE M$?;M"Y![URS=TEM[_'U>W-TC+;YZ@,4!.W^[6]_`TP#(-F_JF/!EL=KA$'\Y M2)D9HK"*`49>Z%KIH^SZ(I-="W>I=F:K!#K^M@6SE[!RH!6+I,YO5_D"&-8O MO=_VD!?=LOR`/(41[Y?>AUYRFR\M%6V0R_F/CND']WG4"R?\NUU6`\%8/3$A M+LL=/`GPV^RV08T^D\\<++.GI*RVL+=6N1-D]4%3+6MMC`+OB%+V[!4E*U1$6CP>3QSD&X> M<8+DL=C>P[[@/PU(U+1$EA>0O+X"J3I!6:^UMV<*!&?O,A1%[G.`?[8Z/U;# MD+?MD'N$^X]`6!Q!,20&]E`<3:2^=(_P-1SB/4R('+8E`NW=H=M:UT#=6V9^ ML_!>\G:KJ6YR#YPB?TD?,`0M_O#5/Z+]/XB^?,9'C:9I65Q\QU-NP-SI&K3'NC<^$I MH]Z\A3QT::JO@F?W:]\4K[[P)GE`Q56USBVRIV><1!0B:IO?9_#<`JXRVBF: M8U=M-)BKIH&W6MSH.FM88%W@'_F?=K";50QY0=EEZ@?[R>&AFQ5059"N@0*O M5M4CK0QEIF6UN]G>[H#FFQ<0B4`@8=09]:9M"O4`$U9UT9:J7N:W>H?4OUA:,9LF$D24S6>T^2[0\*_)?;Y:TA90:XBC]_[Q0'@$0KA]2NE$M[0. MA"AI`5%I]L>J6C["P46DY*R\*P#&,E7T[9^J\NX"F-CZJ!TPJ8NOG'=WM1=* M/Q793;$JMG!,;2R29]89JA_X")[ZRJYOF=^T5F\1:I,](39%?J^1N<#/=;5B M&4+^!EUG15D7_:"Z9W2+N0 MK^#V8;LU4*V:V9W0CX@QXJ&HJQ*?@17LF5EK6\0!CEKET1#@X?>,R2#ZJ?L! MDFGOJQ50V>:[Y`>X2]NG%O+!_1_`4FN!$:#QB3`!!#]NXU1UFYU96?Y\__]OP:]OC?/^)M,\>QM#`;3 M=#(8I:-IG_!D,+A,!Y?]=#09R=2_H>^&LU$Z&,_EF4DZ'\[3R6SVC$7Q@:.P M6^=9LX/OLRW=PC09I,-1/QT.!S0\_CV];-F7KI;+`L4D%*J!9E_`2(ML4P`: MM(T?VXP8NM6MSI:`[0L03R+W>;?>,47H%D#BR!?#L(-H2CL\YLU]_#N40O;+ MN-H1`(B7_%H.9.^#(B"`2^6B0$-SU10'?`U7 M!^2*_RLY/4P*[.V)6`1PA,Z]MH>2&^`NWCY-N?-U(05?\JJZIOO>CY`J'PKY MKO:AL._,(Z,]"Q#=[Q^&1/>[SP7%5Z-#:Z0O`\*7@^";`*!-OO>\>[2.A9K# M*[BKQ^LD[@TR)CC;\M4"5*FXC'GE%.MD6Z$:4@$I`0D9%4K27C9HO%W"^FZ> MC$D"ALRZAWR9`Y<`9+?WI+I#CYF"V!; M3(@C`(]I?-TF^:AN1JN/F6F/.K!#>(/P:P[AS37+%ZP>+LG/$=$('!P(=H55 MP!SL:,D$L;IM7R5?3;$@I02>Z]SRKB%M%OYGEG[\=H5[[M\NND:)::*E\S,( M["AKQ12+]Z`U/QG&[#TI]@`&VPH(1<2O^AG-I:0S:!\)DY(C+LE+G.;6[B>J MQR',R+(&W)"N_(8$IHC6O:N-S_L-IM5+EKGRZ)9K*IF5^<^C]!Q)G%C M%-ER4.(KQ%5XZ"E'?:+DZ0@V1BMT-#0FV:N'CV1RI#5T\N,/483[:-AR_&>E M/;U#[>EUF5P?T)Z,BR@"%:!7-^Q;VM6;53NF@?43,J%FY9,0VW7D!FK]B]E5 MS.P:OO6]Q<4;5HR<3+5-6-/@@('A$6^R3'?HQ=?F0IV]5)<,CK9:?`K/^Q_> MH]'I554_9O6RI9LPMN#+'8;[\(4W15FL=^MD(^8^&C MT$JZH7QV"SF[PIX=TM&%.OLF?O9ZK,CC.,H2(R+P:Q0,8'U-7C]T6'`,#;;4 M>2DGMH]Y57')]UFO1"?Y@:7F3JSK"#8)7PM0KN.M4``7B1\I>E66P"3P<-&! M2*+9W^W@F!9`U91@UK7Q;S%R%#Z=1Q9?Q^]$C@'XUTX(VG]H^]^)KLKGUT^SQ:?[FI0$)BI M8G@$6-X9B.E>78;CHY96OC.H)<< MM2/U4!CERHH#K*S9W33%LLC0HY6<+8"/X&U\R%=`[$_T6R=H$3[!ZRE,]N0\ MA7N<9,G=JH+S2)H-JJS@_B4$#1%]GY>XV6Y#N@Y_J3T9)M%0"E*;JO=,D<32E6LU[N2X\]JI#ZP+&+4;DG\\AF_ MA#.4^:ZN5M4=`+6^SW<@4LJG,M_<\R_L--FMUE5)G\]_D]!$9"3.-OQ[F8-` MA2(KP&93`+M%?7R!7BS:I`:1,EO7NCG=L M9:9LU52`#AL,!FF(#@-:W)658);9)5%I`\%UOBQ`O1$A#V#VR?6;EQ].SM4=KI(?=WE]`^+AA]Y5#YZ0CT@E'N^+ MQ3W2"C1K$/>$QV]RDOA6.7Y>'H4NEW)0,+>;&89=XF[,H)Z7CY;/HQJJ#`>Z M6[%%B8*@[$`2G"7'G2%EBP<.Q58!;!LFS\L$0+6&N7`(TO%Q\A\9LF_PLF`* M@=P5.74#'SL$2,,9[N>M7#)YO@?$O8!]/>%W)KSK/H/SE+<6>&HL,J/:2G^* M1W>CV`(O?WL/.!"]90B'6\0]`/\R;X"ZW*`Q`:CSXXODS__TS^U;P,157$V& M8-_@;^@2#W`]2I^!6/DCVZMDQW;4]8Y_BXY,9HX\Y`D`/;@)!6WO[.3JW6M` M78`24#8CV<&*@.C"A*FA:1@@M"FJ8HD"VY/XOOAV()-<$N?0]T5^#S3XI`?%^!/HC; M>UD`>@!5([1ORP(;M!D)C5L7=[459A25^?,__4\\#7BQV)"%,E_L:'/5[6V! M!\163M3]2KJ+^.XO0'%@W-_"_I;5VJ>S=8YY2\1:JQK0D.X,D$HS!'$ON7V- M7&Z`^1_16`6?*&;S`RRB=F[.'SXS"\$YUJ!CD%AW\N&':SCOVF9%U#F9107; MA4``#%8`6;P)=CG)'4"E+DECJW>KO#$@>9L_)G]?U9]8&[?3]MJ@?34FH?14`BT"?"ZQ%NU6O22GV%I*..(<6*4NN$;97!BG0AVMQ2[.Y)) M>,U77EHXA[O,B:%0@&^HZWB[(7*>6.C>%QL1=4(A!`+<(1N+?)-NVIWZ7)..E)'D"9./E:Y$&0\(H2O[*/?-9V' MFGK+VQ"'#%?&=.>9L'6<545L,]59`@/(:N-\H1.LET0E2#@6IS_N0>@ED@Y) MTJ%[M\@W0@N(2.*8(#!=7;U#5,&U\I0>&7[F\MFT@G(`@IW6A1,8XM<@NP%A MW4B!Z^Q3GJ"A`U03(:99T^S68E@AN3)C1P%?0SS7W(29DWNNPYFWM,9U8Y\# MP*A(QN`%>XN#*836/.3$#2A:44(H>^AAVBG)#L/DE\4M6@1%!$-2:C?W1=A@ M]+^MW%BS(G6E4J(-CT`:X0I5CZ6("%:YIC7C+2C8B.4?YWNH"+>,80A>)%REI;&=UAI.*TP-J*O=W7W2@%P* M6)O42'(%"$H6MBN#\T+60V)#QDE)N'.+K<\$W&YC9`%\0Q1)F(`U=>1-F)5` M$@A<%B+K\#"R/D<2M)!+!(_E\XZP?M"B7)88[4V4?T`SH!B405'G(A%K0T0> MGPDSSX)\,D`Y5)I0P3)$4BQ2@K_(6+)%N'JE&_#U]$U)J0$QR)VEW'QW2U., M78;%`Q5$5$?)GA1N%6E@\D*89&?);5;4GNBOUA(>JT$%<^U@BTC)^>L`TX$< M+U9P?0L0_'Q1T=.)LJ9#&5M8AT1$_TB315ZC0\A>?+K$&ZO[^*?T@.;>0.NA M.43S(6U)PR#UI%#E$`OMO(\(2BG< MKBV=)Y(2MJ2X_%^GN-CT`N.*@Z7Q)B@1`L17'-054=CFB_M23)+W.T`>!&JU MJTFY!3"L=Z5<=?B<@S!6YC>D600AY%+L60:W;U18#N^(L",B-6NPCL0*& M46YU2".Q5GRH-YDU2*).F^P:S`Q\1+V[0`P#HL31/_986=% MK`8`D6?+!8LWM>CS:W)Y&QG"$"@W+.W@=#3O78(>3:YV.F=]F1$B]%AX_YMG MI'.CIFG%-[)DD#HF6^*@#2M?.`"[B^I!N:92!0`UGS2`J&UO#(:=Y/4#*?H6 M1Q'WY-::P!JK!MX\^39*9>%KW>C?@)+[B`HAOZ)OB:%X>EWF-NGA%2$"N.Y( MI3N>^%@1DF)[F+3AS!Z[Y$$+7XU"@L<`32C$,5NA_KOP5L7SXY%D26GS=M'4 M4]6-IP4I5Q/1&DZ11US&%3DJ0?B#495T12E67\@^4PYS0YM4LEF1*-R!FL489:`2!>LFK"L.NS1..?*?!&34*/"Q=.EBBM,)J/4KA MENP13,4?N[2X[X03.$&^8"@CW^2L[+5IM]E!QC*AS2?@)%V8``,"2`/33[B[ MYDSU+'`'DL=-OGU$F'FF"XX;,KP#8`(J\PY$_]43BUR2_(ESLI,+$*D0W89T M4;(/PQDR80?>MM`4A7#%+I!0L<;CPMMAKJLB-,#IL@?@2IP?)NC`PL->*"=Q]0@W_=)<<8Z%G['EK(*B.Y=13`GY+'SJK7<5'5-5[EQDS*'1XO)5D7O M^`OXSIF"0/'#@2VI!@SR.)`9S3I:VJKM'GD/S>M*W_-4/',-?:><=PL-"H6$ MJELCVR]]6C'"<'_K`..0:7+APXW8;M%70<(F!4ORN6R+=>YN3R9R,'E'&1^% M"%`R$<9\Y39(%-_B8=?.)D%QGUW0X7&5.NWMKO'B\Y6"0;)]*X#5,"-_$._" MXIN=,67&B];6XA0RJA`TF:G3I@RLK[E'SK%OTB,1;(_5W;E*,Q<&(8+9M[6X M]Y)?-I6=4"GWW>QUF4RFZ>5\G,YFD_;0*OD#C8@JK46J`_1=7@L(8K=(G54P MH39P"+-A%$V5<$_LMQ/Z-EI('-'FHJ%!Q55#Z;JA$4]!),H0P$8JQNNZ``Q> M98]!:$.&]8LPH(",DR@GF/B!VL5].9")H2P2M)@:T]>N0&I;*J\6Y2R2 M`>*M1./@??YPCQL8<_LS M,6A9+)W4P%_$=BX7!"8:#LT%T`E(5YGJK\8TH_VW1N.T;6CZ=Q6:%NI?L23VJ\A[IP6)%7#;LER9O''3HAB;I*Z2D8DPE)Y M(8F$8)/_9$AS$#VCBAE.IA23(U+>VSUC4D9HFXK(*VS!9;NH0W(3N`F#J2\O MU=#J:XE>AFX)33?,7%$# M!-*W0T+1W)MR(C:"S%KG01%:(]((,31F4H2Y+G M3'-#X]5%5RM'I^DQ.;KDR:H]3KNW%XZCX-#@1'HP3,JJC!<[`O-BKB/IS'\$ M1;.!^R$N*'T2:-@S@4QD76*'G+9SH.&ZS%>>-P%(@C/MYO*^("*U6&A1-='`RX*+_S.48MJ<"35+47A=;B_IIM5H& MP;I+;RN@_Q.EQ@$HT_0F6WPRDM`->9^M=RY98-B4L<@Q?["V1ZMV>_LD+X4% M!\F]!0E(Y((DKW".?""BLC'[IV//Q>PA#GV'5(9;J3E97ZCP:7Z'TKU"XW7- M.IB,O^-``#13+).':K5;FY?)J;DC=>#W]X%*J:YT::J)HM<9?;O`+[(RKW;- MZDDD9+)^.NF93]H1`N,/7TK"+QU#:LX@M9<%L&-7E[I0$9..I9&+&F/'=WG! M=%1N`KY51!*)87$C4>6\`F.(B$A"0%'0M:/"EC`_ M,9%<`$/XW:72$3H^.^%+O"ZV8BCB^#G)LI3J`QSD4=LP"K%.L'4\W[)+ID2(@#$&CR)N1UZJ>49W%2+9K@ MG^7^L5LY8NUXX^".T;K9H$OQ3&X/Z)^WK+J]LH4N4-P+P.;)O,_9@SAA(]5P MV8DV'O9&UHF6PN=I;V8_4WFV\65O;K_QRWJVA-)05GROZQ^_5/6/R] M-EL%,F$/TYB/7!/R'$1O3\>+34%H;Z($E//0KVVG"V\84Y"Z'$XR=30=I":L M!+0J;G,7Q,KG9/=CBW-^5,4Y7XF1P%$6*VQZ<64D&QF#*[GTK'?+UG2#H2N1 M@C(_B#'MC,.K1$^F5Z)Z:8^W>QT+VPL'%*FW*_/IC MX);$_*R\.0:&%&C#7+AEIV[RKFJGSFS[95%M)LH5T$N,X-E1=;UZ=*K>\>G8 M,A"/[N[)37?+:T;RD+L*>:2(<,0<>;0BQXSI,")C*.Z$),4]E!(F`>1R:C-P M'`+(&=42Q6?/R)V.6"(HSH^.,SXNN_U,['E5LZA(,?.Y#` M8HD?IQD$/9;65-1+?J2,!5I1U7!\#5IJZ"(@K+%^,^CM[C@\1\B^D27S2_,P M85YCY'ZC?F_J<[^18H>4IAC,?$=+]?E>&H\\<>O84PP^LD1DJZ>#X8&%"*2^ M9F8M8WMI;:Z@`:FL]JDDF?8S8PFP/[(-7?]1XW"=)6W)1TDZZ M<"X9-'-RA`V:"YA,D4NRHG\E>`M])G5Q1[E84JWUJ:58X\EA*IM$7)*EIF$O M26<=FEYBZT6]M_6BZ$F_CM]+4\?//HY=?E0$>*W>]M('I4Y&5AZJ."R19`?* M!]H2]IE3%XVACCCD/1/\EA@<.B?*<6R=EE745,;D([%/(-4U:H[%524%@3K;49J?'>T#JQ]R:4;M6 M9-(=V"][BWM&03/_7#0<=&`+3GM_9\H3:G@SG(BI@M)0T*)<1:G(NJD!;R@` MF$4W&Q1S492I_(6N1R`G.(_+=+7F)\[$)'D)Y'O*6+*>W$(MCOU;&.A#)>"4 M^:[:XLBD1^=4EBM-JAN0O/(M!;`TL`403!ZXQH.QQ;JH7FL$6N9KBIA706I* MU6I[U,PO4J`8M/?MV8IRJT4 M`)U?R2%]HD)OL#X9'DJA$Y:4_8YPQD;=1;0<\E`[_$*U'S'[8D5[S0$KEB^2 M[W<%)34VR:"/-V<\$;_03UAB@'B"!\(!/C3LRT/72DUKJMOM(X**'AF81]YD M"V"4N2C7#A;^0!X;M(,V5BI84.\.M'B:6>*V`!<XH1M)0MI2WP92YX:@JZ"%7`1;982,T"LDC M:I22$^5RU"HI+9]@<92-T61WI;&]YUZB`S(@C)W!`!HA+8NB!B!(]K?UBXHF M'J6.F40'!G/KC`Z[7&1AK[M?0><[U73A<"^NW&G"8>2(E9!*^.6J>V(5AC^A M7=ED9<5=(NT=."P(UD,$#_,A,-N('D?&KFI47JU-[7PI@Y=Y%2QC0:!!1P&G M+K:40=8=';.`MPOMW'"K:@R;-(EH:AE!A.F]BI!O3*0&A^BPEP:57JXJ*?;V MS@7#AKPHS="BY(G4+N"XR_K("W6;(LZ[=WP\<0N=);GZT.<$+\>T*[=KTK5X MC\'FK9'+7X:YQV[^+P+?"H@FF*2=8MR&G/LC,)\"*C$A?L>MDI MG79Z%+TMAXA8*:.G[[;1":RSD]?OWO_W;+WYS=(0A\,\DI*=(FY(+$RFSV`VXM*X"I-=+W:HL60))AP_`Q`R9^\!!< MU>-`P:T+V,):@LT`XXGWLE./G8^[QG$@AU@`W6))22)!$MR"LAJ`%+/$Y/'- M!Q"XL>R2G9;&M4M7)N.B5GS3/(\Q1D:`)=G*L%,^*;;&29E>XHZ4#R<(SIY; MXQHRNH>)/2-]VYX>J>ZD-#]BB`!&76$LB!P3[]/+P3&KHL<4X[.@<3OP>!S+ M;2U$#B.\+38IR*G099]Z(T;';/=2\BB_6%%*4M28#Z1NV^:2&&RSTOA"4]@8 M7.1A-_`V]G?MC':4-QE;#R^F:(3O>&Y1$P1]8!?.)5%Q*I*6ND6G1SQ#/AUU M39#$$>S7;O$96V"5F8B[*"^]Q#0.HI5RS575,X@;^;B'0L)NV6R$#8M@93B* MJ3%A^)/-SVN:XJ[D5749E46.(/>)#>YF)T`6D1!RE/L-^PJQ9[FOBA>%W"F+ M-44T4<;_;6U+LX",K&4V%C`IO`7NF\B\ZH$M-2EE#*T+D[R?;!^K"\#N#?,/ MF%>N'27"T`^V&@1[,W!T57$B*@.ZDAZ[LMA:+W=+%FAR?B"PWMH2$^V77-DW M-;H-EA(-*8/_/)G&65:*2266@SW]QCAJMIV<91+T(:9"SN(4T`$MQL;IYYX, M:0O-V=4);W`4SEZ9B+0?[(.PF-083T[V.25ADN2I,2M$(KOD@Q+@6XP+#Q\M MWKRK(!A$/8C&0J-^\:D\9P;&#SDX^'%5^,)69-O?J2M"RC!NWX>61>7(<&XI MGL`B-LXF6Z/Q!+3MVO$?M^\[1T^L*M1YN?T95.IP(!;')9_6:2.965FO=0?% MH5^S+;VA=8"(@H#6G]CE4]FGA@3NH5]73J`WA40Z=["7A!;\.;:I8A]Z.&F_ MU3+NB`VT+)[Z'K%);8^R@3X>E@%#AYP>D@UZ[=41/C#O\RQ=;`_T:FI91NS, M9_NM84J=.F!7\Q$JI@X2M MA+&I(5_0E6`I2-E>)V17LU8\$P-BTC";9(8/C*SA#!*T+1BR^/.!*`DHQS[BXN\M)1"&3%L46H2[VB+X98JG*4J\9 M`27-[I$`&^XY45MVL<^N!F]4:#O,5=X)C6*+"F@KD_7U8&@/+"0UE"CD)W&F MC/9L2D41"S@^TK&P-.`D44C`>,)O*;32[39N%[$V^&,V9J!1U%%FV1X]/(8C MYRE\72`N.UF`JFF+AINI6DC&)<4O7-:_E!G3:/@=I[77L&QR#G5PERM<%IJ= M#]R9;VM@[K(H>[NAQM\KH\<K+=1%Q+2KI;P>!\_9R-N M^ZOJ2>]ZH)640J$A4C2ZMJBUVF1;+AMB"XC91A@NM%G"&C#:1.KC1%N:/BE? M..>2B'.#_&"F\I=)GL5\1*[_Z;+;]7HM/+`]++H=37:!VQZ7Q*&K`C/=L&6% M'+%J33J_3:JF"!K+%9141E4BQAZFOR*;N-"Q?PK'Y-,GH]'%+14@#FU5=UAMP3#"^Y9&]G!;,#&EBS`;5$T+4JAY9,MTV&"!7K) M3W1RMU1:13E4V=F]81E#0N-],!!C;FXP;!6#55'@DC#PN)/WM2VA)+>X\&,3 M'%=:K+)B[619H9J>%17KMO6.#[1U&(*5=E( M9UN>B!TX'"5(=C;LG,.%$+FEC@XG\PP#=W`JVPMR(H0$#W&`!T*$%'T"`:K. M)W5\N*MIB[A$QMH)%A,1;KL<1Z);KD7+YJ&"U$YMUS6 M(ELM3#@MF33Y=V[]+-2"#9O<9J&12GA&SJUE0U!TL5F M7/E_KDO"=X%$')L:1LW_3(G.8DV]#;98(<6J'LR3X;D+F-]6+"Y<-4'EG6DG M>S:Z*(HM5*&*E:H@ICVU25Z:;KJXWCWQSX%@S`<@O15,!AV,@#R/3!,+MAZ( M@.F\G.U2IRU6>3`8_OA5*R.>1U)C27'X_4U5?>(3I].30@E[Z@:[6'JZ_B05 MWG)7-!>5A/>1+-!!-PH7R&Y`RB8'+[M8+]4P;S,&9E?6:)V_)7S M))J./.;+"/R*VS2,NVI'4*8BWQ'!7A6?)H516FF"O=[J<2?`>6(+LE58"S%ZK@FK\H3$N4G#2-8/C&13?(13 MO'[_P=C=C+QNZE:I5B,D&`OZAE'G89FK0)!U`:;&<7P(RADOU%1*)6A2MX)& M"D70&>:?L[7G3=(=24F%>_+'X3J$>2XJ&LY_P?-?X/P7'*/@TO_1N]%P]%RC M&6C&[Z^HK^_6"(2F#JVK-CWI_\KLCTR!'(4@3M4=1Z4!8=AI+R?VG2%B3]$0 ME9"B+04>`BDB0/`."Y:Q@UMGQZ]*?SP/%*E2&34R/HD1`VY%`;+\4HITY1+X M!J<+?+_@ZG7J=86<:04HBG&X;7"-/+5`^56 M9Y3NR+DR`<;5<2$'$R5RK5Q*FR,O]@]*Z-]Z_[+U3ZDWU-M MMB=C./2HD+`$S"5%=M]+.CO)FE_BY=T.*34JK$&I$2K+HETM[MKT%0A;1$B*IU6'*%N95OIH&+$Z2!UTJO>QYDX2[]XM1;*6P5S,*>&O&&ONU17W-SO42W'42XZ9F@BS:],8?80[)YV=O+KZ\#V%S'6/ M]LN&C`%G)U(@O83%:5>J?*=F#N\([L?8G MU3_C1'7O60`'-U6P;.L@4OENGA*8G?Z^Z`^2DVMZ\LE6QET`,<>3_8(5]$X` M7N@^V17_AME6AP;40A5-.(E0,/+DPU-,EZ,;Y]W>RZ78K> MBU/;.X>2$9%FV[*PIAD&U=TM9?_VYY3-=R1J8]&;QE^&R@.&YRCMG2H+7 MK@B%%$0\KG@L`M[,G!7O2534S'(I+MD"^O0\!!3*"VF M+8EQ:F7!7U9;5P$DACJICRU>4B?*58IQ&EG!JX,G()$";L].1$\YHJ12HDCF M[K`3SM6,\)5:8V%#[4V_!AV7X\))F/O\1\?@,6#PSTKC?>^GA?\M%;?@,G8/ M9#+\R2HP5YH4("A^;XT-'ZG\[I5GOW>S`(L#+O8YM^E_[@J]1.;>>0UVS+`L M';?'8@Y"Z92I%RPG40FJGY.OYGN;_J/==".;5JZP<-/.PL(UAWVG1W>1==233P_+NE.S6UN7 MIU&NSYMMJF6&5D6)>#8GD\`E&]\UR?/N^N1 MNI/?]JZ3)!R36"C@@T@E M^/9/%*Q);9SPXS45PO/>2'Z@%&&^YUP6]X@[;IC:`<>;;&JG-Z7-58^\*4J> M[C:ZXJ:LJ(5J&SY`>R+K-.])OR!ISRR`F31$K)<,(A9[Y6"5*-PM?R.G5&RO26N8>-"0;4+Q"@3NQ+DK&1>@F[F&S\X MNHE+6K@N+Z*+5SE;)3"B"=2V?_,?=(4;ZWS[DG9R73@_)YR70I=LI^""9V++N+:5(`E_I6.RB)0X M&M/)6STD89Z4AA/6ZPP([H(YH\#9R>M7[[%#.I:`.7HY)GJ5N3`+4'"B6'4= M-'S:KM$S_<7LL6%@4"Q;`P2';4?26PJH85K)MD!>IY(NX)OL5_]C(\/0V M^7:IK2C!!W;<30.2T80]ZPRB4A'5[A M#8K;\1PE4.>VI<'@S=&Y:L-D@2E] M/BAW"AX:G]MTW_@SMC;?L?,B%IQ-SB-'2_+"&26TG6MX8S!/0\6'LHYI`G'R M*VG>1A[?_-M,>!GG5*X1HP'V^="W8IC*(4='?)3/,_6X389=S:4%"M MHB"3]29+;=5[#"/E0ATW6UU]^>-]$/!?2?Z3__3)V"=EUQJ,(6J3XTNF@/U)%S^"M\H,P9=)2DB[:M/^ZX2VO2/N$KD3B>=&:&XPF)RY+SWYW=%K$W`RY%L MU+UHKHO-0XA6@:*Z5?E6_.PDJDHP]-O(MR:!R\5[2H:)Z0)W.$XY9=^EBM3= MH)ZW8#&9+X^7WI]:L3EU!GQJ"_SMR?^TU;>0:;;!DB\DVWC#6ABG9#)OU=L`B4&K>*'#.K0U^P%;:C+,G9)2 M*7EHD?[7QJO0E;E?57?MS8]]K]MI.NX=L`NH7NI=#Z*B]L+4!SW('?P@T*QD MYZX$%TA6:ZZK?&:)Y*;@X3@GGN3,D7735Q7AEQ]W>7V3BS%!2[9$YXA84N[) M9Q-^<3J<]GM]57'DX+@KK<*FQ<2*P;V(P<(O4&R#O^^7F=WI.1P!W<#.3M$G9<9 M[N?M;K'"QD7R/+8S"#LOT1YCVG\D55Z+7LT.]2X;=VS3);DF>69^=[A#\I#@ MB*35N5ZRW(^>6O'8G((.@,LR.XQ-EI(-$%`1(':2>T[K>V3\-I,AY@ M#6/X=SZA?R?C>6]$O1ELYFTRZE_VQLEH,NS-D]'XLC<%8!Q.>9U/>Q/\SR`9 M#,9PJ=_GIG$Q%:ZE>"U`*92+^C#E>-H;)G-XY6U57M3>LRK93%Y+_OQ/_R_L M!8?%O]@//8:%C6&Z&2SV]?'`&<.NSH9]G/H\F6*)9YQ?E:*X#\`$1+C M&2"N&8,4(S(PPT#7@#'B8Y=,^?*VH\J'XW>!Q8/0UNX]:N<%DN#0E?=OI.(!P M0[B3P41FZ>%$,`;L!BA M"2`K.6(.MB'F%+A(U"(`WLSH;U7"&YE!B!FC+O0F&M6%&:>ZI/T!$'_%61J8 MM.#?-=>7PD3W6;16Y]/!V)_9M]N;>.8V_+#CC2)YK3=MLD7[4J8&&J8Q?:L9 M^$MX`[CY0K]L(]GU3L9Z)WU_/7:0O9NX!*;RG.W;/9R.)OZK=KZ#6P^IQ-&0 MTUL?J:UWK63OS@3V&W_TOMM+VFU,X!9 M.I(?_:X&B;2O&!TE7N\KDA3J)K::N-^FRE>4CHL*CVIEH45- M_:?)<#Z'C9TFHP%RM:-`ZV?4?`%\3?XIS(Z3GB:#V<&-ZTDG*-1-\/;S[O5O M7P""Z9"T(SCAZ:&;I",.;/,+6B9^\"*C]]^L4+X]H%ZJJCY_*8W75T\#K=*K MB'^**>@3/C9$G<$EG)Y7-PH[RZ&&B/^78O),1I=BYT*%;(!/#:9P)]X:`!Y4 M!J\PRY+PQ(O_]2`7CR.G7&SJD*,D)++G=(2!Z/1=C50NC1P[$Z"JO/A45\MM M\GWV*:]?M)OX]-FT\@$;>V2K[5-R?9^OT:ZC3$EGZ)?-T2W$?3X`=4_:@Y^< MIRI903M*7(23F^8=MYO-=UN>S%F/L!EB1=;>1;:C'A)!-TY;[8QS@@EN&#Y# MWA8M,KIY,3GI`AWB*MJHHMP`4U57F\[6^=9H0U%2L:@+BN1*J`=%IE/W'[-6 M&_!.RU#&!1\E.\?6&(FT@FJW,]3F,)<>)C4>G:[/3C;=5RB5I^2'J?Z!VA#= M24.DTX&G?;6*^F,`1-@.BX["]1G1:ND]UQA:ERK,1\42F%`#*?!:ZY:6HI@S M0+G(Q*S'!/D%L+=HPI4/(9MX+1T,2,&B(RC#5:6MI;`CPQ:6H#H!'+[`1T71/Y"]*?Q7E!(1:+4(H4C"U!\**$$8<\H#+MY:R;Y=`4Y)9:/^8H"SV3L6GI:T"IT0"@"_@.>YTDU>]#6 M*/Y0YXR-3!\/-:L?2>X[4I*=].TD;J5R3D^U(47ZOJ@^U((`N:T=85/N\=V9 M>M>4XS7^\ED:+42#X%K6V:-$0JYT/7HR_[% MN<]TZ6[R;IN,25,X/UJ*T-XD'[%!P!@,%-E$&IBV!":FC!0";/UGHMTL6%UK M781QTO(">FTT."^/X7%E*VN&KWQO>-BU<]?N<_]-@F8=\5D2.ZSW,("YSCY5 M0%A>EPN@R&6WC\L@J2G(&KQZ=F*^.#FW6$;'H,J\"RY1`,)N2Y&(IA$=_`HR MP>(3/O/QQQ^M;^J#Y)S+/*DAAWBN6"E!WC>MY-RJCO<;#D!.O+%L4E@O2]]F MLV0)XWRT%$C=K$QCI#]*OU)WR6(@D=`K M=>Z9M,6R](RBB7#XVQUI%AIA=.S.Z72BC>;9'2#TG41)8!2LEV@$XA=*$CO` M_`7%TY`,3PT<)WT]S$U5UZR`&?=BG2/K(%SBG(;;;.&8HFZKV+-;_L[V#2G6 MZUU):D.V>7*2+G,-6\5-/%QV-HG$`"^=G?#'KR<.E,N` MW9/^II(69*]?'T<;S(*>$5%P+&7@H;\U71AVTH5N('P!64`;OR(+LI>O(`IM M:'Q+DH!>R)NO)0C#\3Z"@'.^)Y+@]!BU[Z85]J#.-(V0#`;(=XVE&*8>*5S6 MUV]_?G/U![C19V6QK5&K_0PX5R`H MH%$:]%IB%HL,HRO_;@>B"Y"8EJZ.=WAWA_&'V+V6>]A&+[$J.[7O4G9-9&^_ M>0!-#!D<'Q`K_:"YIBG?$K*Z^;'^;;1%#[B[G`O=.8.@WWH?>S#W^ZBP\R5) MDWYO-I^Z6$CZUEG6!!:X(LK2II^]W?I@>"QS5W!3%4O1@)/BE%*MTL4).6L0 MRK9L7,385?^0A-K8^0-Z$]ZQ(VZ3#].)DXK-U@@DJ>OC9V.(O#LY[Q]BTWNN MHS\V7,ZI-YJ\9EXB&]"J`C'>\&ATU4P"WSH;-'D\96ZG00IK1X29[^IL3>4H M;OT@`FVK&,;N]-_TWJ'D#@[MJ8#5"\HUDF`6I9[^X24\Z)NY<9DV;.[J-7E43" MO\1'KU3\#JSW[.35RZL3)F)D`2R3P3R1,M@LP_J!HQF&&^/&RGQ74]'_-*GO M\QT@IGPJ\\U][=H!;'8KP$_ZK.@<94)3K!B*3HT5:(RZC/U&=M@3BW4WG8-$ MT9P<%Q?0)@KW+RK5CP`V`M>R?O*$LT=@NJNG"R8#MB$]K/S[HOH=P+7.F!A> M9U3Z+T:3WU#SM\'\6Y#DCFDL19;?#Q!DC80+VR^I)GSBN\+YJ MV#PO-6KV$GCTM6L";<0>CH/I5MJ8*IH-'T$4G8$S((^9/W`GZ0FTA(,$Q)[Z M=V0:S]T]__G5Z_=O?O@=\G\`_A8+#*(@#Y3"$@W8W\]4SOD!#ZN@3"N@*W4! MCZ/V@:C]D)=8[QS-_*I:G3>B%4!5+VYTOQ4KKI%0T5%0>)$87X,'S0,4MOM` MAF(TF;%I;LD**B M&(')F(E#5<7\[EJC$Y$P5N,=:S[5!G_'!CE/4NV-@D!V5)=\<<_!RA[:/ MU(6DF[5BC#/WE"\4#@#D&UV\_L)JXH>M$=_OGQ;9"L\J`+O=PS^4.;[;( M#'BG@W'=90Y^X%OMZ-\FH#61VZWZ'(MMUKOLA&6PL@6;Z?CBD^<3.PZXKO(^ M'S#^LQS?7@$-KQ\031M24.E7XE&&Z!/E@?N#ECK17@HFW)Q[`K>TA$D80SL( M25Q/8S?*?**D!"GA&2%%CUG8B6V/978V4[Z9LZB.2+*GBD`Y=U'@7@%R6_Y_ M&Z&-ERH,2=Q=7<\;E87[6NJ6[5*;!=`:*"G7/#F=>UXB<5@R`3,DS1"R81_X M/B[Y=[3D*UM0+O!KNX)'I@L;B<2U^![J)U6+SO"R2%<4W1;WV#["ALC%#%.< MG=523FU5@M5??ED14I=&Y7DV\(1T1#&R%VZ+LB4[C)FD]?HUHB7&;0./.TVF M4_IG/)X`!L._H]X0`S4`46UR73(<]2;)$$-1+J>`@,.!.,K;+;8&Z8#R+P;I M?(I/3=++/EH6!NF(Q/GY`-ZW32+/,*@!G6DN.N\<5H!QW-,YQK$,TNELCI'C M`[Q?PS$L@P,X3%1+5R`'IFB/ASCQ%&,&A],QA@&@#V1N`SK"4X/)!AC]/4K[ M(PQ7F<%>IKT9?M]'H^E@B.]>1T)%AA@Z.QH"S`84P3.>P6OHK/FE)%.![7?I M7^@S6>TY`1/_/QCBF^83;U5/=*;V>`Z*ZR5L!_8XNU1O=95[9I+HCS`:CBED M"(\;CJR/XPSG:/`:8NS/=1$Q0'%F\H!`G_:$?6 MF*MR.1_+^2/:#=/1'-%U-$5D&N$YOLVWK1,\A1+W''T_B"1$0L589./=3X=#CQR>3DX.ISG%C(U3HCZ71,XFZ7C:IY,&/)A=4OP7\?UWJUWS M0CBS:A:K2"[11:**3!.)(B(F119B\\@3EW>VF! MN3MG3`+*7.X6"\.Z=75)*R#>X'7NZ.XK!VG)'@QCJ>*7P)?FRU['F M?J>.=9C^@Q_O=9:>IW@''8O9Q]*(9WZ//\4:3ZQGY=AF;-*B(M)OO=T"RUXK ME49@&]2R/<56]&+MP96TCBZ&5V";+4AS00H'08V[-&7C,AL4Z#4WMUL@2="T M-S>5S>V#%/6C>^FA\$_]B[:Y;K"!'7AA"FH9'KK<28'BV:K:A'Q)`W%=Y^KX MLY6`@:7)>[3]TF$)@VFO_RN0@[_7;2B<8TN+F@;(4K#3-E`-6U$_4.UK[#1B M5E'&FJC9J\!IA$Q%3"Z208&@!S:^NK[!.C2/5?T)J#_F@)M0#=%N"$F15EUX,43)25RN!)!.(]C!#6+; MX*HM*77%EL8"!.->Q"^B#[.A3Q],^]&$Z,;0-!=]75Z8B!`$/UG35#$DNO\7 M:,99%7@^<)&3&4HF&"!JUL.!PT:*[<16*70@RVBCB7/^OBXK4+>.I3;F,AY! M;PY>XVQK&^%Y%ZCYBU[PV"&F"E9\K0X?U-G)ZW?O_WNVWOSF)7J-]:$YH#6. M2@1;1"(!6L.O0$@S_U)N'Q&.2#1D8F<+J`T):WIVY@>T4`0R%6WG]LJ<)<92C*>^ZLH%IX&+OKJY=7 M8K;/5BY*"NW_<+3M>"EM[7'60RI:(?3IOTCMOR=2Z]0%)K:_S[%K=;Z\N)(F M@<^@OI-T-!Z1#MVBOA.0&0>C_9V?1Z1_/X]"?W@J`:QHLQZ"YCZ*T&=C7?@B M29&=7F+_\^A2M`WW7NING3LF!B7K<@1IS[%4*3H"&&K9UO6F?\<$*`,MLOD^ ME?`GIH$%#AU[C_]S\Z%XH_4OX4_/94)]9CS\+[&BRRY6=,ST/I/Z+Y[T[XTG M_>LQFX_DVOMC50LR?$O&.#^2IBX%-WYOL8^0:N+-T_HU_H`@+ZYLEX#2=XN8P= MU;R=VG`I1[6N)66J>"%TEV)&RK3A?,M-S;SZ4YS265KYA;A>TV)[Q+!L`(C^ M93$=<&U:VSG"DSCJY=\O6Y,I3)RF[,= M$':T;851+RVO,\;YAL(F#*TSV[0[S!I5+9(KS(2Q-K.6V]QFDYERRURJV6[' M\'GI3$JMB6U&&]94,ZF0O,GX9D2L'7XPCI:,)D5`<,&XM]ITU51!\NP=#&+`.-`)%?L3Z+INTE M-4G6-E]J6R[%%HW%5]5^\U&[U=&7NH2ZP)^@[^*MF=@5&K?%]6#@VV*KA$P] MFTDXC$!9FA""(@I8L_-3Q*/4AG?VL'U2HD-KV7V3>XZ'7H7 MS$'(W9I_>[1?5Z_G3$>>&EUCQ93`$H1#-Y$P^'(Y/^;6<[FZ-L[3\XN+Z5ZVH#8W6ER-N82 M;CX$_>K1I3NXMG02'F/5L>0]L,T:#[2A$\Y?303$8%W5UC!L/@()49%8*-NY-6L?QD)7)/32)2_>BZ)R366-+[S?C!+# M)8]AT)W4WHE"R.4)&&=>["'%J76@578#8G#[>G6OQIV_];M2M9.)8(!@Q0C+ MEGD8@1_&7#>#\8&"3Z;L$![1];M$W_FXN* M=X``20@K:8B%Q55;E26IVZ8X=OM'&P?@[G!U^P)PZ9^EX*2IIM?J'X`KQ68: M%[L-W21/W6W?;E=0W&;,10;4M^HWM`JXK9A1D"]]LADKMQ@U?JJ5=,Q@ZBB( MS"K]#+0DWEZV$\)8!_,UD'#E84\!KA).M;V$P&`;/9(G@YP:42ZZB-KA0J&O#5L'?Y*^":7JWGCKJ4L9N2'MK&,0-';N89Q??@ M]LI*[>"]A//>*+30842=6)^T&46'+/E MX!3L/?^RR8?<2(\[?<@\HQLN-068J@*X@MJR<$ MUM(MR@ZHBSN*#::>`59#X5XY>&$9F1BW=%D_[@P;!M`=XHZVZ/8&DTUI49QH MR'5Q'G*K4W!3-C*6L2YBU)F"NMARJM5#OI^Y60+U18B`0EG M,E%T;'$H*THC*_QU<'D>U19,-#(G'\NZ@MYM./XA4-FN:YHH&EF/R_YO\SN) MED,Z_"#1L+:A("<(PI/.#D@:XCK#K9HW0ZX;K9HW0RG\6+04M-'2H9X$YM-,$HY;-+5%[.T0E2+)R")Z^[+*H] M`V&X]X`4H'YO@@K0RV*U0XB'H]$8;LB.9?7Z4SM2I`:)6,_1#N<5%XM%L6IU MPS)C\>"L=E3V7-M)PI05/G1GH3=3"SNW)6>OLS);9EX_/,A*4R>W[#?O^S15\!=["MLGG,+,.^;4A4M M&SS3TP_7[R75;UMMD@^]*TP+LE^<*'JNR^K8O>),<%70KV?7(OLOZJ6I/^4: MFE#AJ)8S0`\O%\&5)B*SY:?<4(`U!A%OL<:M+E8$4B$\ARJDLSB228JO'[HJ M;4*:*^@%>-!X)@_2,_EX_++;CJNW=-T(!5+M0+Q]8.6FNGK*5ESCM)0[[=N\ MHG7@XOHTK4@-B`6?1BK?A]3JP4@5V_9]QC]\SE9W&&F&.#7WQMYC1/+OE<,X M"3(E:RNFO7V,V-"_]Y-R[F:YMS@$D"P^&$$RU5XZ@UE37%O8T+7&*W^Y6RNQ' M=@/.;LN7+9*C+-X6GXGEW$LG$[TBUP2>L%E M+SD^5K*W?26FW=%&M8G^2C3>7\XP@LX:=],@RX*-1GZI>!^_`;'_-BM-&_3P M\H@_<6D)`D_]9%`ZM"[);4&YZG3JK2OTXQX#Y)?YID(IZ+F7SQ+\QZI>+1^+ MI;Z"IE::#,ZN\^^P*ZE\`Q?F:K%#62BYRQJJ&U+GE.?W(,G[2U!0'W*T;3OW MGC$5Q'DH2F>8"^ML]E]'[1&]Y-)=^LTEO&G;C*#K`H75><(Z^>*_LS?)'"-> M)5.[0!8?_SAS>L/?_Y__CGYP_ODK/K\M*B6 M0NFD+J67P&UH7Q+2/B!]<))_P%9#:P#M']Z?G(?07%*[Z1`RG"0?ZW)DU89C M4/9=7I8-WM'GXJRGU!E1A`*,G#!"RR%1`A_<'N0K=C'XO?TP_!4&LP7I[*!' MK*K;O,P625,MBQVZ0C=D&6ND-IK2W6W1"D"W5_E-;:F'/E<.-3#V1%>AR:NT M4;1[CX"2D5=P?O=83,12S$]EGOM4EXL&-1NTEAD?D<@_'BNQRHEUJ9'\A1]( MO-14FWC<7NEI,.RW>)P5HH[@&!"*B(36+GJJ_925C?(7HU"C&/V0EV.B^OR-&TNX6J? M`K/:U:4GXL&W.*0+Y7%A/J'OB8HU$X[X#6<&NEW)D;U.QZVBG7ZS*3PXZR7B MHN''OW#E+G9W!4]0`@].V4;/D0_:5;8K&1,2O]V3U#@">M-P<6VTQZV)-E+P M+!E,S`NYU%(A=/<*A+_C84R86N<#+I76%*K/%I1:BE=>^$CCZ=O628>9>Y1P M(07EFHY0DXI]<5YOJH%7,HJ)H*=#NCMO`"+JKRM=(>O5%"7_G"^023'MI+(V MIE6L])&R_2A9`A"FDR9KL4.Y(MA!%T+K3Q1VE)=+'S$!+6QI;%T6^QKS!PN* M,J2U<$A<^\1=_4>DDQG51.+3!R#Z58%LX73E]*$AF#:C\7N;F1H2>[QFI@.` MZ4T;(K7U88PUVV<8&D%U M%3C+U]7H1"53-4,XZW/(0I_B$\Z&M)`][?!.<7STXLX&],\0UWST:9B[:=2U/["O&W3]YYL@B9`PU6'`M*"!J_(5'&8B^S0"29>*T%6L$: MS]JOKI,.1*)ZRMEA9,I8I_'6`BAO.&=U6,L@LH^&2[,J47-O^T$)H%%'>;"E MD13P(>[->K-_?S"&H7Y`5/&)HR?8QL!!E;.H;B*5E1-/1.J<8A@H;2NUGLY4 M"?Z@/9,:';WQ("PIQU4@T04=(!43"[RB7CN9%WONJ[Z<[\SMXNMH/S*>?R_M MB;N:685_$\<^J8++36W(Q@BC1EBVYTC`#^BPCKX'^0Q$[2A'07Y(=;'H-FP MI`^>PS-A?S8E^@E;HW_&`I414?UG'X&P"3F%*1_FI'4*V*]U)O/0B5_R1S+* M=AW&V8#6).E3BR>.#A';ACPB*^%-B6LO=GI&S!IB;SXLR]2W07Z' M#V^`O>GL21`_/.KP3`4?/K_^LX]N9ECSA-&=/_%NGW]T?<(`=8DNV^)'H77X^3O_>R5 M.E@A\3DTN`GOYA#W#1!\T*9!8Y&N,=JW'6=:9"M1`P5#J-8W1PKR6F!2K*?% M=E.G]2QV;-E[(,6?XC@"5M3->T)U("+SH[TY(N4/L!%D2[IWBT?V=XZESD9* MQI?#FJ/D_R'&[26\(@9I+\2;R@UQZR)W?K$&=*V$QCU=$%OF"XDB^(AMA+M_ M2U["U5I5#>K\W::):2_1PZ'!^$WVI*K^*\NE\>:K+$Q3_)G5:`Y&N:6"NV+5 MI&I[QJ#T&A&@M.=/W2O;MJ`LD5XUK?AUC+JAE`CRE^M1/"S:K-!7LJ;^+ABO M(\=,@\L2)#66?"TF=*,K$D]:VC9=%[G>"S\M[1(:EJ5U,@JMST?HF%#-M8W2-'750DZ[3 M$G_JDIT0`'XK7NNK(L-?)@>C,A5MO(T?S1GI\1,Z'4SR8KFT,9C4%8XZO^$] MJ4HN(VKQ`#T/J[RURAXU@K3]W`H)EO=MB%@'MG%'%8Y!H<7P@.VIZO]H@H*] MYJS>(RH144I;[[:((MU3\DG9":E4I=]P%GL^E,;4+^#:PW%O\EM.Y30A:>;: M.=))7.=%JQFC60-VE^]/B0/BGQ1TA']2OW!_<:,ABC=8;8TR"ECR!V652J+1 MRR-Y>3*1^GM_D7ZURC[:2S[H;IHQZ#%0?$7JH/DI#C0I#OE"0Z_/]37[I-2, MY_#)!]I\0F4J*1L&M9=V1V';TQF?!5$;"\1=HM!M2CUZ\YWU23+E=):IG!K+ M7?[$\.U4E(0YZ1UC-:2>_TS$B7.U$GA99#FJ>,F",9_MV7QH_A+)[I23#?YE MSOMCD'5QL&&SVY1=4R:^=U=X=^H[M:C^H(U>E+:)9\ZNH>)8SB5P9^S;*FAW M'"\KAHCVF-XJBJ`<\>E867&ZEJ0CV(_LTJ(*=2-[1(NY7H;NEQ>=UIHLVK[^W>I8S,PW(LA]A?>F)DEW$M5JV3*6/"8CWSCO3W&C\*[ MX7#@X\WS,6_FMSW_>L1#NO$-4"]:\/V;XEZ[@V#&4.?\&3R$>Q*H"6P=Y-(>:II0"Y]TFF"8%"2U@U.6Z*J2+[0EO[>WP#&ZM@89M%W@9W6U3SA>:S(=H5B$_.Q'[%M@*T6]&J M_*XD2]LFP:Y&+%ULT/B=S94G#0/%?W3^5*5+NSH;T@O(@]%H%0#+**$*#%XA M9MB/+=_#0*I,RB+M0PQ@;,I!*]AKG5T!J.\B,+YR*K2*GDU)IF"9$VL]V!B' MK-X"1:827=S&6TQ4UTSB4J\QB5=%`&-4LY(#Y<[&YVB=&K"):,86/I*9M.$" MP*MROD-CGJ5OBQP*Y\@,CG6/IIC.[$64(",MO- M1V0&(G$;1;P]U^>`I/71N^_V.EE>8W60R$.8U=7_%0&S<.:8W4,%T'=#L\?HB@.HU][.7K$1J]XE[P7!^YWV/YC0Y3WV/,*LK;H/@^-[@)&,L1L\4QKQ(=3DD@C`U M_8MA)5C:ATPIG&!$09P">!,C*RU&5`-H-;T*T&@W.VR)6Z%13A(7@YD2TS^G M[>#!P"9KC+&]D4<#<4`00<@>F>M*@$/U M=@T#3?W"!LW:4H:T/Z]N1;3[6F&#C:.B>YV2H*$C,M4&*$AJ-.M^(*3A\()W M]A'!]&M7'Z8AGHZ&2GP.UA>8`PICB)?9):,1+-\$M__PB?%=8\N^+NWO] M$F%F8&]TSA3W+OHG`DS'8_(-Z'L7U`;`UO'3N^E-1MYS>3#NM3FR,GUDI_Y M\IQB#PJ=J<%CBX/`W#Q,X!FHP)3@7BZRDE)@9:&.?_D;#2\J42S:/3P.-S2E MX*3^'O+ECQE"G].,6JM4Q13\]S7X<.Z!;^F(S*T8A/XUY`0^VXU>G`@_2.4> MB%#R8);:\`^GET/?/*97H(A4V'.9G8X8\:9_L?GK*`3_13A1T!4G.(F]C,KG M0R.?#\4-)-^<#PWZ;4PTZ^;"$\5@)50@)1K1 MXAB&1AS!$R/\:S#NICH'^!<3I9E2FK\QC[@*@_]-C%,:"U7#82/QAQ)$(NTB M,8.M5+7EU'+9ZL-72-\US$S%E".IA,)5F.##2MHS8@*=*?>H$SOJ?%U(,\_B MEHJ(-+M&K#RD9I[.YG[*\JR5LHPY)UVQTUQ+V57YDSP.WT(4AD`HR[I-`_?* M-5)`"B9.`3B*56"0PC(Q8D`CSRXH;QA?'-JMI8C<"D'<&7?$J/HW*"1HS76R'>S=#.-4ZH[_%5NFN M9MOW^2+#AM9!M!.MY@YY-WK'9'M-OF?]KG1Q%R#20%24E".V&KM*D;(U)G94 M8OM<3",4C:>JFD4D;[$(:2#\+1# MD?8*KD_=V-()UI23V;TB3RU/E`K*O`&!NJ2F""[9BNS"IPG=<(S-[)/#:7") MX="_[#G/B%58A6R/*`2C^WTM09",W!ID-@82="5%(OPX%?$IT\K]"X>)3-RW M^?C;E0-L11\V><:#M!YL,2D^(@V7N MXKA_RC:<:,IR+_V)Q?5,4[LSB=\=#'G8?A@:[:?.$4R(>M.!\G%V&7V#C'NO ML;-B^F<8C3`.62ES`5_%-#AX[BF)HFM@L5XN&?4AKZG_T-G)Z_;RRP8&]CB;^9H?3MKH6BRAH[19V\]5[ MF5@B!1^FO>XK%+O[*;$(#O!SM-+1G^Y(6DQ!%[=VJ<02^+%Z+%_$))V(G'-U M5'PO$!<*#;NT78T[_*,S5#NGZ/J(1&<%78'MBT_GE!0PIMIB,^[K25?A=5AK MFJ+TNCE6/(;]>?*="%/Z]D2%J?FEUU>WE8>VAP%(UTT@`-E#50-_>;))=$;V M$[/-O7;<&+W&Q%1@V`E7Z-LG@E*%7Z%^5K)TB@Q.\5@#R[Z`[]C-KW7>,6Q=8)?O&EA`:3!6C[76%G'2^/E.Z MN4UJ8"(*F(M"J4YBZ3I5G?OB2HHB>@!04CZM;\9Y&F8]O6_->N;$&`885K67 M^0PH`'$P'%+Z\6`\8+%XA!3GJH,U\,1^47R8=!(Q5EN"$=K+-4];.K:G+'#* M6=U@E82<:K%X97-\"+06%#&,=*[G^+6(V646!&ZZSN_MP;V9'15V8A,\0"1Y MM[W'CEU4A?$JF@[8"?W!N&V8^M>$?J8@0A3Z4EO78^Z36'8XTR`/?+<8)G+9 M.=)SMG7E4KNX.#^KX2QPNANJK6C2-M$6_+C/5UQ3"LL0'7N+?]9'B`T:N)4] MGN#QD)XC/"^YFO]@S$-,9YBF:U3,,!.("3TKLRK])\`\SV"B67"LZP(;!13- M4Q6(S3JHM-_^,"J?UP<5R+3VX.H?<0T;3')[([^YGF3G/(<%!-MQ*+(;C8AW MV(X,"+'Y_3N&LL[AXDXIPJ:EO!ES;JKRI4,;M:6*>S+Z>[/)^1O)PE)'2A)*<,!((2$;-*K1)W><1V`II^E)%FKI%8:2:NKVM,/]Q MNM?:2V)`5J\*DK<`-5D#M^UPVGD<[;RR`FT/\TO@S%=6B$/!/TO*'2S%':5JBL\MR\M6@Q0-(!T^2GW6?8-T`93N(# M'-H_YC7_X,(B?]OKT-%$!.,BTOD:LPWAR&+Q2DKIK%Q;1G3\**ZL!"?V!!J[ M)DL>1GQOMWST,Z"V$OUO:2&E^R@54IK.B-;$%A92?K29I=6QY#@B]U)/ROM\ M8>67,#[8YM*>)G-N<$)Y1Z^E100^-D2#UQ"#9A&A*8T!WY0H.DP->)*\`,"S M2RK\@+&W/Y0/15V5B/.P(3WO$./QAAAG_CZ_X=A96<08JTZ0*/0#)0HL;5=I M*B@SF@/E?=>1DCW"24=HH'O5NA/*V;A/^+1"Y\BN\`-69;F(5&49()B&7%@\ M[&\QZ*,4-\?F2D0;AM3?#[7RR0R_'0^GO>"<%'Q>8'#RGGHK9X.Q*6,P9!M? M>P5G@W0R,647TL&4H[Q?EP".U8I&0;:)CXTO)YQO-A_)6%U1X)37QI;%.1=@ M.!NEH_%8"C"DD]F82CB\W8?XDC<9#3V&,::3L13^2`<33HZ,!>3#[\8,.F5K MY]Y)3W&\.9E)Y`.^CJ_I,Y"$\B-UC(QKHD>L\OL5CF??8M\DY;0Q08C`RQ5O2T7Q.2/6%I_/1\U*T M!$Q+WY0Y12(S)SK>.E[?@]1>`E[\.7,VS@\N40T+5T_#==)1".U;!KAQGSRM M!&+[:FK<2=;QW=Z@:F[3SK]+/8L2R9S6ZP54,#::[*1$B66E?./.!1?*"K[# M**K&:#+VI(($^$@,,AP^%(-!^X\E;1_,Z>501WH'[JX8X$Y'PW'![!],^1<*X_XH0O*N).3455!T$6AH-VSD=#GP[2NPFA_-P MB"?\OC!I6J=DBWKF,#IVQQDSYF"T!W$$FH6[E/V2_WD!&=O:+J_F[O0:45 M@WC"M=AM0I#+D?D8+N;P'/[96W,SI4BGXYFV+@JE/O(2XJ-7BRV(].JX&/:H M#]R91ACJ:C.F&QN;QY..Y$Z#=ZQ./KVXC]2DP3 M729DC0$8!A4VHQY>'BK($&A\Z(\6A0JE`E+5`Y7?AF>>S@>*QU%L;EEI+X>? MIHXSGH[&.D<)FP-S#CE.+,7>.;';N;6'DZ"/-F[T=#`/\_5_&[M-P?:ZA`_5 MS,+?PI*WXUK!O,"[MLAP/8<@P/6;$R<9><$F]V742]+%[!@B"FU%D. MD9+H<]$81L:ZC['KYX`8/WG?_J?N,-L]=1PZP9R.[IR=.B;W&3;FLFE:81VT`2J1G`VO%WI M.EVHIFJM4FE>I*;N(^=7Z&(SL#1@,XWE33EQ``P6=N7H?H[GH^15=$2/+N<* M9XUG&>W)&ZS[YDJ;V7[PW7OR.8OJJ)Y1)&1AXQ;C*W)0D!IPZV++-55H`1E9 M97-&) M+F%Y)4(S*#(S"'AO!8[&KX-45S.R@$]]Z2@7+EI:]D8B#HQV<4O"5%:6Y*#R M^^7E:VJ9(W/;W=F&0R9&UU2TS*EZ?.`A^TAXXU0\0I!HND"I!>..&QN1?VV% M.4/GVN'X.K#2A*5&BLD8$Y6?EWZL]!5(-"-?K>[8CHU_YCCG^.5BKZ)C\#%`/AJ=[=KMG)(`5_MWFA#%4#)YUP+;5OE-I>N(.&TO`!8 MWN8%4V@%#J>=(GK3WW`@O7;G570 MV4W:E6!C@S:P?TN7JXF/P<0U8FF=+NC)1A%([DOM<^UZ,55THI7C`7?%LF52 MD=1UNL_#!D)<_)-M-O3TGBJ:F5O8\B M!Q`*W#PQPAB15QB7A)QN-8H"._TOL(W7F$$T_:O MQE&@8^8CKWAQFQC8I`X]7;S"<>M\U_FBK:[J'!/BQ`V?1+J0FG&RP#RHLI3?<%WM@,Q7R[LGUKP!5B1/YV"`E-+$EG^ MW=06)Z5`%?)8=V]-UM1]_B1MPQV6ZS;Q!*@?.N\IW"+D3U7]XOB6\:'":.0Z M'-!(,Q+YH$1&BODQLGK5+1)ADZ(9A1F>#<:F3B-^P0V60FDT7^X=;2B-7?#_ MWW*#J03A/7,YHSZ7K):-X;8BJ^KLFW%)5?FF$ZZ6B/&I`5#VOG[<$C':9@_$ M.@<_'F9?@!14Y-#?^5LGSS@POO MU^^/$'DNA,D.!A,LSXWNQPEF0KZV]IAE6^2E$H]X7'ATQ\UB*-M@@)61S3RS MY/L#LN4Q5__H:W8*M_-R3$$PO>&0X`D[&#\'Z^AY>'W:IQ*EL]F7H04M93JC M].2]ET.L/CY!OOSU$!O]V(#)I0^3CU[#)5AMY&QPF(Y@0)VU81:*[>944J>7RZ.)!Q1=U>A8D%AG)=C8KEN_8#GLP%E,8WZP&3"G;O@U'QFV'4\[!EX=C3V3^3#Q`85,ZXB M/$J^WQ74X@9CEK&.P7`VQVYMJD=W4]UN'Q&/!A2X-,>HYC>P%!".I6VX6_`@ M'5)MYD':'V,X\#70//+)B!7.XL$8_:B#^25B0SJ;HL0P2"_)=V7;I,:!=C:; M,GL_F\Z&U-)B;X2RZ94ZGW,B]FR&-:T_JDA82?J1J!MS(*(72+/R9,5^"@K[ M&(>=-0??S"E,1DFV%3HW+B5[R"E1RQL+F#"*3[=67TE5),E5RC@[[#)8^43O MQ<.VF'F[WDYG,\6:#G&W M<#,_5>7=Q4_P80E,!OU/KBQXH1JUYS&VYCRQXV*5*/%8'X) MK)O,@U5]EY4&Y\Y.?GSW\\FY!&6@A\?LZP+YYQ//P.VH:C*KHI55^L3FMB.V M+-XWPEG_Q=*:J8#K8E6-+;=)VQ9;8J59`LS[[BXG<-'OK6RK&(3I[Z;)33C) M`A/"C-/+V#E:IW)@A2Q,4&(G6LXQ7?Z66@F9,#^]`#(,4*DW,J2CT1")U4U5 M?:*@E%QJ^[%X(46MO-.6?@CUDARE(9*9P,)H8+:$+XR-[)Z33;?'%?%G_"V:G&EB0Y<<`BKX#,DVYZ#1NR M,)G$+S)X;DPE@KN,W5>F!>72A*ZX`TL3^V5LCHLT6GAT(YMOPA/6P;\4TQ/,/4SDY^?W5]#==7 MG:1UO,=>U`M\%S8':&6*SD@`&;'O%J4U7-K-'-[LE<;IXFK[X^S;`V MHW8K*&NFZ4G*-8HHBDW*Q9$VQM-+I:L6UFN$K_T.GX!]YJDX?;`Y%?ASG6^M M"='$NW5M;1_:F.)OX6VTAE5B5#@R77?TL0NBAZ4"SF.*>G/[);9 M$H>]F:00-L%Z7OR*O MI^.1[MQHG_T82Z(R"6N.;S#M(PD>W\S\UF6=P5RBBU+H_$+[,-45B&GN82@D MM7%F(A!K#&D/`0TPQ9)MCQJSL1S^AX"FG8T&V*[;8 M?3A23&KNY21V8136W1U>A6T,>:70`J(&_5I84N5`:##(V#E5_9^,U9(*>Z/G MZV*W/J"\X9);E#T`LC%<.U7.:!.=BARI;+:A0%2AL[4VO=K[@9!D)A*J-TBQZ*(O20R-"0,TR3P6(^2:&VV0')--JY*T M-]4>C0WK"W,#J.?J68=/`]>6-S;=*%2X/MR3,>^8L6#V%9[U-[LT^XP@1W6I4+:& MPV@Z^'HT/0R)`PA[E,/#B:,''1U8F0Q`^".G;[W)EP1!(T@%JSL3*F3T?:OL MN^IGI-*C9_^Q59>N4T]M9?:&\IR_C/.6?LF[CMK-<4V?5L+D45`,SC"HA_XO:1U!@>7?D'D$"\8/#]L&]FC^ MS_#\=U=UV"U]$%"40B8ZCVVA7(OX7*:_V-K M.J/L#_KI8#ZC-<3/M"Q,0 MX?6L7B([J=C<-AK@ZG#_0V=QF`PH`G&#^UQ(*ZTC(C/ND)%$YHF M]:UQ?6+Q9"_G(XI8,M\!8LRQ^(7[9I9<$CZX;^;TS:7[9MBG;_JA\>YE?M.* M5<+OCC3]8>-E>AK_8_)YOC;>JXM,O#/E"I)?2CDKF.>ED?_PO&D=KS$;!R76 M:VPI_*6O74N.[AI3M3GZCM*^C-"&_=E>),/>;/(KT@WA)^SU#G+0%4#`GAZ; M!/F_?6LD_&A>X!)D;^CZP2D-$MM>?H`1X-0!OM?OAU.\RF]JZLX,[PPQ^I)? MD3>N=>"0*GY%>P51<^DJ>N*Y&*;:4+\('HBCAOG2NP)G`*7A4)X9FME^"D#R M.S36(;)+.WA;@]G$,!$"#)64: M_]%9,NKSF%/Y"PV+0$5FL<>'V/V"'C<`V']&@W0^H0*=2+/APQ0_3'B&0V>% MX5HX.A9AX7]Q"P`Y@/"NSLUDY;P+YC?R)L?$S M6E-K!MG-B-@3]0$2+!J',Q@HC9)+&G6*;$O^FL."+H?>\S\OMA7=6WQCRD<[ MD@/C'<0/;3AQIS"W3[_/'ZH5V:NDSNIMMF#KXX0>'LNS&/[_%7C?ERAYC??^ M70>)8$*MD@9]ZE\$.(!G.$/A@)^GIU!RN.Q?4@59?A*M]/-9G_NDX-,@$;^M M'H2X]0?#U$\4\RNGO*+U@E;5N^HE9R=O7K_Z<(7EI8E?U&LC@`[PC)DMV2H? M3UY^5T>_')?\U$MH<$KMIM1C`KHIDD4&.8Z9167JL4Q=&SPJ:&4^I;2`;69R MA3-7XMSIMEXE$M_1EI+.BMEK_S][;Y?<1I:E"6[%3::8(,V<2/R#B*PI,XI2 M*)@EA9BB(KK:QN;!"3A)#X%PECM`B?64#[V$>1FSZI=>P"QB9B>YDCF_]YY[ MW1T$)45695<_2"0!]_M_S__Y#B^H38E> MXREBJUMW+%D2&P88YRC)*W3)1@MUS)B]..''2A`/7,1XNIE>@.&`>XW9- M4^-PN28!X\(=3VB<[^T>C<.U/%@`6_8^;4(R1Q3N^AGHF\%IO%LMR&-QM=7J MAZ"PJ6V&PW6J)9&DH\ML\3&J`'"V45LD#[)N M+C^-!J>#/F@%Q"D3T#:N\X3#5A6.5W'7-/$1+D9=4M%&TI;YX?M<;F75>56+ MRKB>J;EU+HTIF4#H(-A9(*'VBLM.;N@EO(2,=T,5'(-'V+I:,$:3/,@AG*"O M<((T^]B"S-ZV<^_;Y.&@-7*%_B7R-QU]`E*6>YLW#YX,&W?90^)+^)@#`(MU M6V3K]996!,ST7*I/2(F:K:!%)73H^G@?J$H<0_88(]`_>Z?(IZZ@E>"<9 MJ$'0@TF))?G8ICL[!'\BC"I(H'F.!]^X/*@1ZIN&YB`A;TI60IF`2_.X*'8*R7J.(MVEQ@8YPQ%D&%Q4)F,-\2?%`(@L@/I0* M0;*"UB3XM&L3FT^E<,!8`2U:@&KH%2-?G;Y(8S]90U"A"'*Z M;-U"RP'.Z:]_^3=:B/?F%6]W.>57A-`\_/4O__W0!)RS>6*IP67X_I(=Z*L5 MVWL_BSC6.0B!=%Y;9A5-QH(O[3F9,_/*KLDPEM2FO,Z)/;F-WG]%F'WY1=RY M<"3YN(RMW6\P:J+5^]U4:X2T15_N)+`08!GCK;CZ@3NZ>G][]-74OED#,DTE M5WEN"[?#74?JWGFQ/-^`%VVTF$6'1CIT)=)'H4/;6 M7X06\XO>__>7WOO>&S($=C^'.E:L7G%,AD9Z[JUN(?D-RR9RX-?"9+<B9(!F. M&=!=$QE3:ND$"X'ARB&-$J1,JT9WCL7?#`T&M;YY?SQK*6V]PF"`%4J<'$:_ M[.U<#Q"/TS8+2WE)RHL4JXU);+`VYN0:K4K5)U-K5`F"0$G[:",J81.<=4JP MH-A:@^+;LB&I)43:I0\(4UFA:Y^-8;^IKKFX4"T'\RFK4-E3O?=Q=:[WP1X1 M2R=V#*G*70H*52<0Q4.7-JC=2K`9I/SB/K\A#]0^G7"T3J`$'/AT>'S.9EG78@\EP/R/2''Y/PKYC M+8F]S>??[472V949D/0`\S40W)SG8/X$X_[D4>,^]T?X=\.A4%CZE4R%*'SP MO?&?T6X88U)LLR<#O;WU:BV)H.1;V^TRY`NBK-KQ]7*[^^DM^V2%NM*`-&V/.0LM]^6:NJTRLI@L3QRE+4"[8I;T0!'9)W#>]^"/B1[Z03'C" M4M0HV,4B7^6^-/DF6@@*V<;7&+8G`Q&GK.LC[<;`Z^YN5VI/&0M.FX;`J:6; M>'<:]GJVQE?6;F\&[5`V[9$"I@T'`11'\ISNL*SOW0V[)1AS+>H)%D52'(@T MA@Z!.C(==0PW;8Z'V=ZX[S3TW5D+8@BX5(D55PN'*XU1)8KA M+!YID8&OI/HM<`3-*HJ/#])H]H*@;2H[3`;]@8Z^J)JC9F)M"AMNU\1ME#(2 M9BY)>1$NJ+M)#."/GTBR@-Q`;.S@\E`6H15X?,<<4#";K MWV&&]1A;B`7O6<`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`<$H:M$QHX^[(IV?1-[3 M+Z7O=O4NP>BZ_3+'7M:]2@T/$8F'72: MC\BBAE]RWDV,Y!A[]OP6.GI?Y]:;K/Z^N+*J9`"&@0!!7O'6L2T,((T*#7=D MK:62>AJ6K5OGGS?)%3JD#9`;'X3N%&)*VK09Q%@NIQ]D$(\HG]-F$$_"3S!) M$C^)$G>2O)38V!=[ MOL.PVHHJ,+IZ#L MLLRU1#=FA"`0$NR#7Q97+MT8;:-5\\_@U<2?;D7^F-R4GW+R!W16<8N6UM<^ M(2S?]N'(0I+`I`._%4%51Z/TDA_EVHA7>+.7)O6&!,%BX=HEF.H#]GT<.E)C MEEAV!'=AY]#B(AGG\N(+7:OS\&WWN5RX_XIQ'/;WJ&Y;].=%7MTC7Z+Q/T_& ME'\ZH9I4#/K0I]_]_RX@F]X8(##C`/-9*>T<$W`1G`)3FE\I3@$,=ENMD^@X M'@P19^`0?H[EYYQ^:OXN_CN)X$>(L2TV6U025XRK-:=$Y0&B8_D,;(2!B-]E MP;*VTSWH<\_\`_\_&/>PQM&!%.N80\.'R1O"[Y+1P]@W*R'K"/.!\!Q8G,,. M^^?'#\ASS+9&.(P!`VX.1E3HXV!(_<,O,^H:?IG24/#<&06,T^1#I#J#D]J\ MQ77:H`4J]/IR%XOR>DT8!Z66+C3Y!>K5J6_R7&[LWF=ZCR(=3SCHP0F6WTY9 M(FN=^P]8;*63OM'H+O/K8KV6W"_"Z8/C/SJFK9GT$0S@.>;I]^ECV+?@UN"= MP1O3EW^=-T0NQRLA62P\2G9<3>>OW_-8!2?NH!]<`_T[Y/-^,"9 M33S@E.AS1=KD'PY`&CH,!D]H$JPYZ+O_EN=^PC4ZB#XV`?=ZYRM(>C&8$#"9T/B0.(ZEF.?!A,LJ\6](0[^*G)Q\`4W\@4"4%/-$9OT<<5F0 M=7+U*C]'18E9%9RB1_[MJ7!".#R'>-.G_`.G:-L.W^&+=#"3/1[/Y+49+O"*S;`FIKM2['_:*&_^;$NR8`*RAZZG1U@<0'D MT@8@2I:&JQIPC*T&<^0"X;MGUQ0+LX?<&0!:31O*W=YW8@_!"U%*W)G>3]B: M\.$>B#QCY]ZD^B1AH+71ZC)[B1*4W#ZFDG!AM8?1R)02B\&]3FS"*\*$\"@, M=F$XD"(4TSWM.`\>XS"+G3.M0SS+@&N=[%ZCY\EH>LR5!JFN6#?Y'<[Q(J&R M/MUG\7'!KCH;L\*?F>8N-;)[DJ!)DAYI2J6@>EF0X<\!&NAE$IL72\!"QS1U,*_80?/_BF73O:QU8@!+&W5O+9HI!;&3SM:!T[[BPW?JA M'YL]7:3JLJGB9[4>\)^[M;N7%N.6=)7O$M0[OD/+%OP_I/_Y=U1]OGM,:YO2 M0U-Z`=DW-C&G)@:NH?<2Y+6P!AR7)X/DXKO@_Y$9$.(]???5"^]M#^;\_7NM M.2_/G%9XY-9\:*;[]`6;TO]CMVP_-N;FK49L%0W0CAN9@5W&>@TY=$8)PI%'D);F@8OC_O.4B-*UJ(2PM MR3.<&78CH+K(Q+FFF6@7]C9AB@1"N[)/=$V0#*A9L/&>OQ+0*A+->$R^<(U8 ML&A9\L^$_@4O+^^+6FH:5#G5/,6E6A/XN(!$D"$:F#19F?W=8ON6QVM(2+'( MKQ_*_Z9U*3P4O+2DRV(R>BPB; MY[5:!?;/=YK/"VWD-1QFC'/-4*&NR4JQN&&04X0L7Y-!N22O".P;OWZ9X_K= M:KV>1GVZ\-QN)8%M'R9`;H3=!&JG426B5Q$9ZC9",?E@.BBA?#T_T9,1[^G^CHII1X M!59PPJ:*VK4FB"BX16/A?T1)+4_!R-F5U):(6J%J&#E*G,,Y_W>">7!'L.0+ MC(R_AE_+@O&8Q1RA/=]T3K6V1;DW@<2:DR>F:IHAB#O;;J7^S87B,ZHE8`POY,30RFE%/,G@)B0I/. M0+*KKE';""J>#\??J2,^@O6;3;^+X?YZA"0JE6+"IH2>*>P/VX@6S/,\4PJ& MQ2'.!$N.(<[8U`J=VZG8)]($?0.`'L9YRWS29#)I M3(9>04F1`NBQ;"C`;,J_I3!PI+3(N!1\.Z@W]K5L+TGQ#EM=%4@820& MI`4*:]\S=:0H>!2_O,JH'N!Y+/3M+:/);Z\:)VB(U&V( M4C&21/SY,EJ4&4*\)H-DF)QVX?0D(_A>#6",Q$W(J\E\A,@QC/$YZ",);?[? M8MAW?)T*0][>2K*]Y:2$$QW"2#?D62YM7+GJM$M<3:O3K2FV`8U*G+6!29M[ M6>I?T*/P/:F;OU)K;TT)W!_-:W_>EBA$G5.L#YZ3$ZZ>^98D3F899U34:L': M%_F&WM!5&APF%Z9^)B_MNTLD6:3^G:WOMO[I8?CT+^NRZ\G1H1Z%"[?1$48QVO6-Q4T7G[`=0 M&^`6",C_5?&9+%-D^T'R`D.'Q4`0]S$5H)\G`^!6V,Y/<(>2AX+.`\G@!$4< MX!&_0G0M$F)8RN<&9]#43&!K><"-2P[-3(T=F__B78`.CLGW-@R0;[U5=]2? MD]5\,!0W%[Z[_\$9_]T?G"D9M>5'Y\&9(!@^_==Q<-"Z.#R&M1N@+?]+3\YP M@$T,:31#::=YE5G,,CT_2V9%[C#PKR2Y-+$[107J-,A#!UZ%TPS##28U,FL\TGB0A2 MZ]`0>D3H\5Z3L;1\9`KMF*'>;LF5Q%,@98A"B%8/7,C'`>>19;>L@&.ZB$02 M-&#^-=P`_8SWJ5%:3$QA=1XV:8P`/F0L*,G#!3#+&-G2- ME96PPP4%G>!^5^5ER48,&JN[\'+2E]DFT\Z'A[WXTC4^D-HN7F+"96;OPLXM M#@YRM-]TT#KM&!P11L\L07X`=06(8:F%>/2L//)ZQSG?=5NZ[L!33YP+/_B" M4_?['KI>&T5K_;!-#F/%@I,!_(&`9U[F*SA3;U;EPY)@EO+5ZNCCF@#1L2(9 MCBOC(^/[,3'9[6O;'));8Y>1J;G0[N5F^4D?IQZDEOI6)6#$U$=J&X]*IUG- M`'JF;A$5]28>JH5@R$D'>G@\B`ER'1M33> M.Z`F9CB%2-`KE:"OJ)A&JV+I2>RINT@O)"PAV]CPV!ECH9.`B($(:.U$5-V, MRQ&2?1>UM@G;025S`'<@6PD/4XCT6@,`V^-<.,RE?11:8(B%U/8QH/ZSWQ@& MG6,83"C6H'T0&BFL2E:0\57?9)5()^ACS122VUC9.]VD=-I-(*ZU_[,TEP`56AY5&O= M7;DJ8)V93A-.=1AVQ7$A9;6D)?=^BDQY!.6(.5:IQ:G9)U7PU?&&:"7^7'%$ MLE]1!*`L6!F`5!!&`@8W\;Y<05..P(%K069SYT*@;')BPK'L&.6420+)U7A>.KZV7*_WR2)XPGV/<)Z/,V%9X&\P2"HP9!ZD>Q_AAGSP_ M-K=CQ*K[<9#>,<(89G1$^P\'R1'G>@_&Z$@:8"B9IE[8V]E,T/@0'-E"$CP1 M8C!CH6N3?3Z2/"5H;-P?''P\;&06D&_-OX.V??\.G(J<$*D#A[LU9+,%`7[I M:-XQ3G*60W=;S!=%1=RX@OTDB494.>6/+H3F8KKHJN#J?IK$@!71]!P;/7&&!)IQD1C9STWXN\$GA^UHE!>?&^91U\=F.EJ11VXJ,'(;+ M"[5C3>]0(MK4S>G6[(3#.)\LH>*O+ONUJ(*&>JY2%A^A8/!:<=&$:NTH$CD< M!25LGP_[)@.+".+05I&,I97':D2^SRXOB^1#M:U%:V(Q^TGO"9X'&!S MU,"&&I"$-H]3/?41YL(^F&]\0TY:)PP[P_$O5667$;YP$[T5\""38V MSS!\KL`8TGL46MCWXA-QUM*AG$[38MB(%F:G=91AU7DT&5X1HU)CLFD"-]KJ M7\34U4A!_BU*86RZOYAEQ]*[J\6,Z4:T;[KVCR9$]"CM$0CHY-\>6O72]W_M%@TK:3?#!1)B#NC^!W*#FAQEQ6 MW8EQK9YL=YW49.M`:.=QC5PLX?XM#X7&;G*59\R6_YJ+%J=YBJ6=?W1\V9TD M>K$I%Q^1E.15_;U:[>DJ^QS3^)WS2IG=!>LJ@?Z"7M3MYJ:L2`MT-0DG_7[: MYW]HD9,&6-E)D6;Z&_Z\WT,Z@O!O^'7*92D']R6[?+.!*Z&FO M1=[<,$#1\84CX0_:81:^' MQA;@,R'P,X7B4+*]KO5:BC`P!*1`Y#TPB:8$?VPRIQ!DU.6,A(+P?YQF@ZV8 MH::X0O*U,G2M4P^-WSI,"]:7\=I[I;(Q!SH9:-Q;0->"'L#UAB@?R&V\1]F0 M3'[39<*%%F%&U*@L6X^/.M:U4#L&8N@XI/V1(NB$E*AE>\W=P"4KKZOLEB:N MZ`X",A\BP#=H7#C*%JW8>QK$(.9QX&GBJ$C!5^OL.M?9Y^L;(31NXGPINZQG M)OO2IXJK_8+<<^28\<:.RBP?Z>/>\&[P+715X+K84#=-VO1(FVK2OL^*%0T) MSX=IJ*O`1H_I0KREF(5''?_L)B,$CK-\DA._=[87_O*Y%$PV1^2'(!3D&$[) M9#Y,"$+@??Q0)NJX**;:M1DDR'W3)BJD6(27>>?]^)&@/J%M;^"64# MH*VXN(.9%3R(2\^,XH(G>D'3T'Y:)L(BYA%?C.P37,W(SF)-1P$C;W!-.CFM ML`T&FJ&\2@(0A_>BH%&=])3/EHS&65!VP#E,E`B)H8!$R]HT$JB>G&=!QZ-; M&42+Z2PN%74*W8PTT&%5W[;KJ/C_>4?.96X@[/9AI(C<04*?UGL_,SX_[ M)O_+JGM?L@-T.*SHW-(@D8KM0L!8@`Y4URCLK368W`)I&Q=+6\$S+XKQM9(B MK.%B4YK@CLV(5-S:%VO%VQ(1'N,_R[QM!6BGZG'-819UL)GC061J&9O+QNJG M>2"B1(]=K;,UVJ9P2T1H/^$YGKJ#29??K91\?:Z2#RZJ+?"-X5N.112N\9:C M?TWP>D$QW$;Y<-NR!#`$3$-B''!V_'4I M.`+IQ"H/-09WR[RTQ2>_$:U,./*47E MMD8FSL>I9=U"8DJA/%1_(7"#-B)7W#&]150BQ@D359C\Q>9C1EL,R5A'J%!; MJVVODU"$P4@*V+1S1*DQQB)6J1#5'&N?^2('2B*_KYW^*5&G/K3'739_$F44 M]R4Z?;G.8&U6L32D=PILPTJ_ M(AXVF(S,<\=PM^MHP`(<$*(W9)3*@A?GB%*8.'J?\B]#%5$5%TX%<^?!8^1Q M-REK6!U+T)'ZUA:;A:V_6&6+CT<7"P3BKK4:DSBD]%M,G'M?U!^/KJH\AAK$"F#PM?QP[4G- M,GW_QBZMH\.]"-,WTE@5! M,!LLW?;[BCE.L2#T[1:L*62%*W;^[[UBG:T:+N+?MJ)5W9`BKS*T#KJ*W>+# M12'1-]S@3I_0!(M^)K-X%'?JXB9W,H>GLP*7HJMA&D)5T:A.44T-"UU7URU$ M_5':W4F79U-(73M0K M8.3UU:(FT`#^_+OAQ$%DT1DQ=7+]#-@\$IR>R=>>GDE\>B8MIR=8K<',&&'V6:[D(*IA-A@: MNX0\XX!G_'3-(JLKZO#KEGXB2[\#_97,$H$&VY[[&6G8>;%A,*EV8TC8HB1] M6@(1O=AN"4S14:QT:%)0_DH"G'Q:03PUQ4< MC2U1NR)@?YFQW>VA7["9..:$J8^E\6MD_2?\&&'"Z$!XU]P0G=ONIJA!)*#L M3AQ85>3D^PU%622SF@QG@VPB=*[`'M(TQ(C1(.=LT^;WWEFE<>FXS80:;D1R M;[XXP^BT=5TLQ*3SKM-%/W,VC=FTGPY'F&4\FO5&?38.P4I,9Y-T/AP@MN5T M%%LWV^SV(-@/Y]#>:)J@&^W8S6Z9'!S/CM/1"''[T`0R14T##M_R#[(=^,AH M.(*Q(*S>>-`['NT8NP9]C-()_#X[GB>C:>]X[$<^FJ23Z2P9](<8SV"&,4@' M(QCA#$$%A_/>;-XVD.%X!(\A9MP$=)G^CH$HM80FCZ?I>#S"Q9I-DQEAZDX1 MX^17T:D)3E\4;!N;2_>XRUT*#4_'\W0$BM2$+$>8-SW!_.;(VM3RZB#M3\:P MYM-D-,95F*#>AHGBNU'LJURB%<>&N2'M(F<'9AFXB]OT>IE`2#?9%HW:7-8H M3#D62[.F[N_I&6:U,^4R)*IA%XU)E$\2\U>?,V8>L2#TDE_8O9!1RU*WGFP+ MXLBM([<^!_?[,K'.9A%'K]0YUTZ7YCASA2?E%B@P2#G[59S8:&@7ZU-30HQ=ZC,C2MNIF4)UA;P]N7M'W7KCM$RT$6 MBAT+L3#T$L>E?(#D]!9C3^I],.H/3^ZR#:;$"[O4K\F-:)M3F^-E?I.!-EA% M(^VVO<1C-B&P`KB*QITUGQD?O:EA,Q0\5=_8L"I8N#:SIY:7[^#M58A)RG5E/;T222L="$4MFY[H"O]^(PI=@ MN"8@R5CF&+0G=++2J*&!;:W>T<"^HD(-.8M_CPEUS&2"LGN)<63JPFWW(,7" M7-HT6!H$F\8" M=SX.E1.VH@=>=:%C3PVPAY]))NJL_MFQ\3`C^=Q M>@'*`1THM.FC@WT^&L4^=,I_[$*U[3+HOL\7Q5VAX2%H?.4\X'6I@9Z5A(P2 MFMXB1TW=G0Z?W2O>1Q8D2(AR:>H&JQ,KD0J4>GHCT`)+F#+RF4>4;JPD]]=UPHU+&-ZC?5:7E&A1:V&URB3 MN@4!-%"2([]PWWM&T>0+W6/M>I1L^$X'4[GG.HV'3I= M9#B`6SV:)45?FX_1X MA`K->-@;'W>/5+6FR3&,:#A,QC/LP(US!MK7:`0ZTZ0W]?T.!_-T<$Q*V1Q5 M+-/O#-2]&68'3X][@TEWOZI>3&;#=(PZS*@WGG!F31E9I^/0BYVN&SUPC83) MB6@PQR;GI&[[I6GVYGGP,3Z-5M7@LTK9'-^OH"36OM%[YCT,Z8 M].%&D!^_6O,Z=O2OTQ-UH37C,=(F)OII]-GY5S*"1S3`\Z?02\\;GD@YG>G6 MC$.A@XBXKYT?W'H*+'TUO(N6A"?/>]W-!8-!.^JJF>&VK]L<#XAIMP@#&27X M7-(S#CJ_B2!CXQB)SO=D^C`WHQL>IAXJ4`X?9ZT>4?AYUUJ%C3!4[RU(IC3] M*S?]`/441XOI5I+0"/H=B-^UE'G$R(1-8/G]ZU_^;]!1B\_8GNJL#,*DV)RP MSE%FB5M6.VY3#Z\YG93Q$/DZ!"Y-NJ@F24/O@:T0%YNFG&?:HQ&'3H:,5Y)^\D4+1OSD`M5ITRI1EPJE$?#6G`.\\;Q]CZ M/13Q31B7*POC^=44N`\:(*=##'EXE$T"MYJ-N>^I']`L'?6GR6`X06;XM2," MWMHG#CH'27H/#CH`T6`^&R?S*3Z.NX#7H)$`LN1`>*NH(M@$VPJK7!5NP;OU MKV-YT*ZB>]N:,Y62MR4L1'*:5:M2]%',7ZD5JY@""LI+(]5*%D3;Z5]4!<$Q M&.4#HQ7HE,;D.PANZU*;FX-#.G5NQ5.YB*[FYWY*+WD/FTJO`W$]]V2HXUG2 MC4<(PW]:5DPBF-TK8O@`0?4',T%FW4]E-]JR,@R=)XD6>E!#^\">!:G*H8)*IAX9$F"S2A!E"H+(Q_95#M,W<5PN'[]%^,E(Q!,I MA0OPX9>6'S@38(];B[+M737NW!M",PZ5E80]<>L&?N)PU%ZNR`RTN)0A9OM! M:R4462R,.R'!VS'X`B:?HP5]C15_ MOS'#;;);5W=M+U_?,6BV@^DX5E3GH+Z.$%&*/P\9<'_HOGB4`0_2\6B8]J$M M?B$>I?8X2$?3(8QFU-;G:)Q.Q]/'.U46"\]/0'OGI[]6911J\HC."$1Z9G*/ M]J3.P[]#I7'B:+FK.,AQ.>@&22%?V MFX\_7*<&M;K:KE9'1']\4$O#(L6@RQ;'T'J'Z(6HJ'EN*B^'+U:YQZ:A%.R@ MD#");3@/6*\F@HU+9T9_$)!@!+M8;A`?7-ID88H/=_"C@PFWR4'"18S#T0/SJHR-^"P!>*G,1U)S,ZPP`^C M&,`VMHX*[LYJI6*P3MA&".%J,F*N^U),B^5=[A*V+S&I?IFC;9XC0ZKR8UXU MX]$\P,<.\;FP'OF>\VD'!.1L%\+0GLP,;OW!3(LW'B/FV[ON MZ1Y@A;]#2E0DH/F#&14A'A+@.V*%[09E'$RP3**\=#`>4O%(+)@XV;?3@Z$O M0>HJC8['5%0$Y$R!E14/'W'''9O'#4MA:%#?$$,?YO\(I"-!]A],:>P'DV.N MNCMQ`/AA3U0140*HJWA\!\C&W&2":IU?-Y=Q@GB/N#J/(4-.^X2I#M,9N^J= M<_JM+V4K/;@!IXK!&:T;4ZD1(.,)UT:)7HCS:3`-L,(AI__[E5!Y9\\[T/E^ MRT*T[/,;E/C.X%-57D'J6J)D2#AU/KGZ0O.I.9H_6NJM:MG;.Y6@'+86&M6XZF4Y(8E*T%Y@]515% MEV;[BG`Y6$%L?>**X&W!V\]]-@^W+W)&PM+SA*DG7E6Q\M3Y_J5M'9L)@A9< MXO[MW783U%=M+=8%\E&>,QX1$%:*??;L?9F#?+-J(B(14\H6)L@)1/%;&.EY M1N$L(FO$KRD\PSG!7@>-[$!EF/62/?L+TQ&:&:4FSB/.*`VCT5'R1B$MR(3/ M$$(:OD"(GI3AT`!K M";80W/9P$!VG@-$:KD#!7R_PDAG-K5E@L/BXS0/H!^UFRZRJ7:>1$ZB0CW>Q<'-S! MBT-"K#T*+RV0THDVB[;Z#T`9WE)L6.V_$%,-39I59*%/M1^3P^7P@Z1UOBI6 MN8%Y@:%XV]=\FU(+=Z+JD.@R( MM84I,";UUN%P.'RCYZ.)48C3Y/EX&L,-3P8[PE]:D1B1.#)D-@%)U7)D=D:U]))!X6*^@8L-K6I$0&+Z[O M'1<3:&L_P,^PMF"%(_0FBQ;+QF,@&B=<:PU&]DIQ37;0MT?H56OT:`0,(`CA M+BC/U'JSD(97@E`3`N/K!AA:P;C0&,*%6>=L$O'X+;[)JO\ M&I'O;/[`)E_0V'\F9[FU$*9PF[P^6";F^W:Q4;3,BJJSO,Z0B2X83F M1P?NZ+`W6K!JE"ZYP0I@HNY12%Y49;[4HEH"[;ZMT>#S">'LV!)^5:"U.O6$ MC8-#41GW;<>-R4E%'XV,)D47[I)KG2+L(,D^XC!6AY`"';EF:0;/1W,3CQ%B M*(T\F_L:.)Z>4X$N$"4R.8,E0@3-BT?C"=WM7R\]87-N`$QB6E^7#?;HP-W) M@\4$&?$.M>"'8SH*JD>K1<]93B>QJP%2]'59+EG.R#0#N=2J)G8,==JD>`%4 M9G<^@RMN\7P:VB]U`PV<@ZY/0`)3W2,0?`E:,(!%$K%8>)\62F:"%7JSM+_@ M6'_*Z\95]Z<"Y.]J*\2=.S(5-GM!L#`\T2X]$'1AMWP92BQ[-NG'8\4*O'+N M5*&+E@NI1N(NJ6*NYN-5E=WFG\KJ8TM%X.``1,UW9FJ'H@[+:EZ@B"6^P+P; MW(K=H=EF#B[#MT;CG>9A!`T;^VP($J+'Q>PJKZVI31S#;#R:LW#F(-)3>V/; M9]&UP1(HKP/CHMAHL)8@E)3"9>`>KG/--,+)D`>'6`P:=TE:-4R(H(X^K7TJ MAA0GT-X(T!&7R?2L2T+>/"3DM^OBZB&F,X)-_V`&[!(`J/8VB.Y'VP%5*:<\OX0#1@2&)@LO>(Y4$ND%@<[R25,.$>3(Q@U`"(NHJN-?W5?#O_O,AS[`%+-/A)'3AA M;*$9XRCV5JY%MT1XL1?Q!V;SDL;&0C6-+55U2H#?P( M[4[=3+@5;"FB!LKCR0!K)=_XH)O(3K'6TD&7UPBSFU[?$CY'%@K'))]FQ4I` M9]NDZK824S`^]@T_<(-86892IH*7D?B3T_@*SEY%62G>,+T%!;/VRC[V#"K1 M6F*'+V2[1Y.)CHM:DAJ_J^0]0IAO\2`M\]1K50:>"WNA:O/"S,TT=6T+;2VP M")&W=9-]9#.-J\'4<=OM6A!GUJ70W[/[DNR/*.#<G.;HPTM)!RM4(L" MZL":X3(K6H&&,,5:3\C^VT@O6JD\Q9AP89SFVE0'`G+TTY>,6_B MM96J(D^[9J[F<0EM"+ES]#Y4#WG[.ZSBR*%9':O#C(Z(RO-B!C86D?)]]4KL M\XKGXR-G4WM7>4&6F,T*7W/N-#^+OH>:5AI#_=$SB:G4Z%IB&SV9;$DHHL4% M9H$G(_^<:7XW:4B:P`XR!YX4:*,-A;U]*0(DH47I3+(-#!'D$H4F\%H)%YH- M-)\=2XZF7RKO5$7QD>%EL0H:HA589QJJ9X9[H[W'7;D%23:+;"MRCW6A55_- M($QK:"Z%(QRQS.[C&_?3Q23J/'Q8K#ULULVD!*0U[9)UQ`+9*46'3X(W5QFX,. M4J7&!$='KU[AWR5C.#T_##/[)*!Z*6&PVU><4)"-J&D\;$%!`J0A@H] M0L3[&2_*Y:!CK/)^0\RHF^[&;9AS'"MG+I:4%:IVO^!+K.TY.N![5>9D6"M) MU52.MWK"9F#4\OHZN^93O?O6ZJ4)R`G)^2@>X25[<++3YE/I4[J ME]04M)"Q+!LTY7)[:X+8HS@X9`L<1&J*HD0VMQ/'&(O;N]+&^!D;55!4\S&T@.*C`Q5AY"(MA//+Z"#F90S M"EBNBWC7Y6`NGPK.R(HL@AB]GSNE4]LK%Z`,&8J%V]U`$#,K2-1%&W(BA+`3 MKDM"_-T%.B`ATK[">GV=:^J`D*]9E:QSQL6+A3,A[%$E0I3W?$63&U@HJO&W MEAK?BO$I`2=,"B[4T>(9;[L]+IA8604.N12ET7IQOF(!W2C$#%6EN,HBS8GIVN7:HT=@?R] MVM:G,PD6[HC)D)(ZAY%9;,N8+(F-Q+9R]JL%TR-'X4E8/QLD7 M"I]^8SSFYO:.HBGT*ZTM#1NW/&++%E?:\)J';R4JP;(17$LM"$7LC1YFB!_Q M$J#<>L_^4IS&47EU=%H6[:3 MSU"91%5.,O;8$%GGQD7.L%GJ2'!^:A(R7'RUWV##E7P]T*7921G?11KU,J\?AP4"K:,N>UHC[QG#=.%EN(*8F*W5(TDE+- MA,TC4>$Q0,J`ZB7>I4N.]T8ZS@F;M837$)G;[9:_A,4P9R1N5F?PWN^+YCGN)>?!LK8(7*WM>GO)Y MV,VSZN'/5@_^4(&^QT4A-&[B$\G'SK@HGBSZF_PJ]U1_C0D?@F/Q8\8+9@V* MV_7'-9[_97:+FKGLB7H3\_5]495K`7SEQJCX^+VWO;.\B4HJ.CHHL"4-G6<% MH>D5UVJ'QZA9@HR.VB>MSP&2961#WN2RDA@T`W2:)W.;K;>(?2W>D6SA9L8. M1(W@R!D*R'H`C9FB8=PPPG(4XX0;IO%D48KP7;F1XH4=W="]>XNB^R+.EKG,5T5.$38H<*S%H>@YG,0@8&*1 MEI?SKIFB2M#921G32#576^'T0.21!K`[Q1>KSY:(HZ/1ETA.D.;Z4"A78#!U MNJ8/I-$@/7*_7&$62:_+)Z#GD#@".O:R%6S0*2B5E-3JU+(#X@=(%/GD9U$A MTA<@*5>'8>I//PIZ(:;)1]NZD95O5`T%4^^C,PKY&^@LN_8NI`+\`&IQ=I5C M]`N>8\_,`T.*#L)AXQMW`U-]-J'M[(D=HM29<[C+5BKJX$`1*YVICE5:8`^P M]*0*:?(M#7+7N+CI-3USA#41P!.K!!0/&+AMSLN[L"V6*1JQY]5:D4 M!Y,[V),`$LN0QR--J-2Z1F%W+`1&69G.6<4:4(57]M%Q23'VJ#:H&ZV*NIV% M'1XY0EK98EEP.;G*!,7]:HL!!45"W8M21^']$X+9[)'Y,;+O\>"N5_UY+"AW`!@M,J-@6G^_R\ M7:S0Z/?>*=?X*E:P*"3L@0>!<2T4D8=L[R"(JZG"Z'*W>M^I;`=[0.830/T`G@?IR`N-]6K,.H MF9GT:#J$I?/]Q7LJUHRHL"=N\P5&1"=ORFUA=QCS!'D.\-N"7+8#@T\:XL#0 M@<8\A9QT$X4JWE2(WD&Y&$7=>+ZEJNK>,<N=0G^:,>+G\N.KF7+?;EH.HG5"#;OHF M?'R:ZB,V0KZS*W4Z/-*7<61ZB.JP2Q,M>8O^AD`$IR#OV&9!Y&WCD^9.*=_F M.H>!-JT@.Q].3/7J3AM)\OEV]4-]!RO_OS\C<;"ZSY_](S*MW6TWB).#@HC5 MG%P*8/G6;$D4U7XH48!)AK.$GK1*`^*Z#X2B&&_+5VJ?"F+5W'PV2R:8.>L_ M."8D4O/!',N3^K^'?4I2CQB7,?@K8>1(8N/(9^9'?U>+!Z_=02%]@/Q'8VWX:Y',B0ECY2 M!^N>MILKG&`!+^R:/TSH8ZZ!?)Z#%BHW1:PZ_0=(8`C=A8I=PT8(`8Y!U M7H&2XR!.D!=('D*YW2R\QEN;>(]V^6F[)J\47,B"S9\TT;]/N>HU!4?*X3@W M>W"&HNB]7*/^@%,^%;NF&>TE`&"$O757YNO,F!9(*'M9;:^35[@N"SZZ)X%? MAB0Z+9'C!21,ZBH76R8!UF;`$6[U7;%@X:)"30BH98%F5V[CNLK$"/'+NG`( M!C50"'AFG3.FYKNK*TS=/\!Q_O4O__;+QT-PC75I0>RX\[=:U<^%9.%BRM%!M/:<4)Y;SK":Z"6X&?,6X\7H*?\T_) M?\4$'3H5O(;(W&Z*_(JYW!;$C95K9*\CP`GB7[:>/E\-(T=`6N`;1<%6PB'@ M(A)AE(2]AF$OM$2;2(CV_4"I=SSYJ%)*W![CT MQRK/E@^:JI:*#>-O84\VS)^(E`.-'7,"9,6"^Q5#>A1O;U_%!0]J'@."K_PRWYR-:GC<5M5?#:!1R-W9>6GL+\ M_BHW>%\2@<.'Q-U$]C1B^`&TH+/XOF.>`52T,U"^0P//NY M1"(%C3Y3U]`OS_Q"P/%] M"4([?'7P[/3LY;-#/[8?)3;^0X662V-O.'CVXX=3>++.<[HPRL\P;$IO@CJ. M[)'2:5+C'TZ_KZ,=8:U*HEG,IF0&'-$0,0EY)=IR#_+*72HH8ZDA?)ATI+H< M_%Y3_A-C"(C@ASAO%P]K>!K3JU\"%]O\O_\/KP*("WB.@,>\II?YE]T?#8%:<08(EGW3`(SE0=)ZEOT%QBP8>;J-,0U:N`:&ALL%\KY MBZW8MFTPD8TE=&.@-ALCB41Y)."(K.B"H///A8"F5YH1F:#BYS:LS=E51S>M M_E]H/F!>(5IN'&E&[?OGUY.6K?_X#_'B?_/.'"YJM?';Z MZLV;5_\/_WX\B3.X/?1^I1;!'<0(?`1'P0H3(Y:_`$,XO7]3R])WB81#0U3<'E0M*9KR<8U;2_0 MA2GJ`('.]5OUG]I5)A[K4OWMJL)9`K&68_Y0,*19^:CC**%BRW@D')(`U">_ MAM6@Z,?-@Y8=,S)`:O>$#97;:R0CGO$][;R1O\WM5V;3T.4H4ENM1Z_)RAEN M0J1M/<$+B;-DH]92A!D)$Z4N>K%*..[DX<`:/6-D)OH6U6VT6?Y895M,HQ38 M,KD('_+/F=?,DM<$;UE6?E@Y]L']M[Q4LD*RCWIV!6*AZ7=4%( M\DA.D+44FT;-D+$M.'6],#+C;+WH)?<]U@M_+$N&"R`%,58*D9P%^CN,\02D M$9AHR)(93RJCOU=DK,>5?(D@=Q5[@;"ML_5O%#=XCT5M5ZBN<@ZX>^O9H2X5 M*ZUZ*4&EK3;NS@;V`'4`O:Y`G@=6NO'G.[O&Y)>-$DZWGEU38A>@N634XV]` M]<3FK/+NIS@#VIG6BEI[(YG1*L0<4@72#&Q7$Z:S(46_!3'I874'DAXY#)*? M3E?)*S&X'<'J$1FGR'4X]+]@&RM4($'4(2`=0,?Q\Z2DQ>'8L&4M'P*MMCXU9+(7E.=1]Y\\<]M MNT"GXN#R$`=&0&_NL-(`W1Q=Z8S]9J=^18YLT#PNGRUA\J'8`BP^7>)@?V2% MB'<#G73N#L-5N+X-,BYY*T2$_\K1VF4I:G=70D(#`J>7AY7JB/1F8MAN]6`9 MTV;&Y3B7=/EO/\.SCNG&#C5$/:) ME',J%2BE3^PT3EXDXM=N@NGL6A$D7F8\%(:OB(DXJR6\U.!'L@HD/R4P7+J' M0()CH8%.5[AR'+2)6K-K4X>H0%]B>PQR!*JP?-GYVDAIIH_1.9+1=P:@RDB1U"231, M12C)2,!+"A_[#:8$,V:\%Y*[:L80P$W-LY6E ME30;N)7,XZ0Q8I?,)9&?T4L>4O9'_.(&I,%JL2U@[<[)F_6'$Z=CO_&:\H>' M19G\Y,MEO::"-F_.TP1I\(HDA[=;\E*%X"(Z[)0%#*/H]6?+L4/<&#X`:H$CG0<,.YX%@"5>ICMG@7K/>Y/8Z>?_J MXL.[]V=O_OK?_D=2K_+\+D$14PB%VPE2MF19W::RP$%!>H02M.&+22.-X+-ZD0,R0Q0(X8@DDP*]L&@>[287I5;,IIW4J M[^!DBQ#)1)2N3),U[+CF1NCGF7Y?/WF"ND3^(A5/OC]B7Y0+Y`3)^'.=?`+: M<[%QG:`]YJI`8Y%J[&:]UARO)@']V=KJ6?;!(*-)9\=PAEMR$H7IZ&W"^:Z% M=H2^[=*%JA@R.BO61FSMPM`?[F3DBEGRW\X+OL90I MMO+]<'`LU,W0M!]`<`:E7&VA%Z#:K2D9ZPF3(UNH4K_N MZ:;!=_"54&N<#G_S4[FB(R1?Q`22'B*(+C3%\)'(M$>EY$L>NFS$SR6&V>L05JFL[GPQ0W4)^`7_6)%)=*R+#(ITRC@!N)Z`0WF%M9@2;H3@$1 M3Z>=9,FH?V1+7:4M#[G%<>=93I`\O-[P:H]@[\R/_.'&#@,[:D_RYWKUI,S$,AH;JV8[R'GJ:[%-*@(@O0\ MIU!7&GELS`ZAE5QH:H,'$4O13@/IW(UA#\IXMEZ70BC>$(7"_01"(?8:_=(+ M=8&/=^S(90/7*SD[3T,>:_1Y^BTY')IGHG8$&&18SQ M?J")DS1TT[.]$(P!I6Y(NJ[MLN)?__)O/Z.&@@X`@6OA?-=S4+J!4][=)&>_ MJJ2,,H"W=SB630H=:7TB!F'"1`O->_0PG%P7<)PUZPOW[)P*B.3P%&5W&V[1 M?);7-DO>HD&._Y*]AKF%:PZSIO=QWFUJZG^(0\4S;#\0D9W0G@A^[;'#`%OV M>V^W%0'9;$S6ZOOBNJP(R@"8"<4#T0CQ"=JA+7O$L$+F@WJN;9"%M"]FL'LV M!^7BT/9F?"2>^)Z+D5Y@D8 M+SHBV'%`>5`86X"/NW0NG2->0+\P]HT,N@#^_%:^\X$,ON?+/4%;9C#$[6 M9_>!E"7;D#J`Q-Q:FR;(H\.55MB&N8!UHVZ<-.7`6F@$+EO0(@NM@>1@:MQ(>@'U=3H.'P)::`/F3V^DWI9#.M#WM2_,(+$A M&X$ZW#261%8KU16M<@\@0[%1"O7K0$@<*:U;!25>3J]VYI^IG;A?3UP]WJ/= MX)7$DY!@R[)#3!PRQ:3%A[E;H1VSS%..$JQ-QO2NFZF#^+76DY:T MK0M<:6_Y@=-C:R?YU&M?95E.&N5'Z-7%H/ZP%:: ME3G*-#Q:1=>9-U?)G3Z>>3S%P=&@3X,;#(\&YA%&W&D]]G<3%[5?Y1!B%C M<5<3:%OWQ)2?V8GM>+K*D]BW;8)A85F_5]E.@?KJ<'2U%A>KT*$6^`=2B=9S M3F"B@L;8QG7$O1B[S*_RM2(3.5'Q2VV!FM<8"1>D4JAJ\#*[+Y;)GWK)/V7H M\8JD@3T4C[:PHU\+1&62$.=6MZN:N#`*#B4Q;XS2-7?6![3A4-C?AIV)SCH. MO)^G15E0"_5::@,Z_?Y(C$KHZ[C7XRUP=!*:E1E%MN5B,-=1LQKK4?DRZ(T9 M@C`M-;^XH:IMGA95G(Q19HP*P#6F&VVB.<5ST00+;,Z`8AD#YBI;8%P"BE-+ M9TO,/RKV#(:L.*,/NESPR_H1%[F;ZW;E`K1=S@<_QNA?5Z6L-F]K=@G/@B:R M3*-E5PG4KWYMT!J>@4RQ%M#;;/6,YY)52VOD2R4K`P>O$;L\N[9`6:L-A=Z' M8D,^2KIR:0Y>`1%+1I)$^>0-=>[[#@1]&P=2*?T38@/2-8)3A^BFMW>Y%]@ M+B4<-%08LD5.>%@EQEJX;$U+I/GV<$Z#*T5`5F#612+=O$_&:S7U\\M.H@WA MHEI!EC!3TU2D3>F&T0<>]B^>>#QIPF%#8+8JO]K*&5WGU^5&^+%)!>>\9KF! M9K'6OGS\TIMI_+;9%9+?U=P#-$L;S-%F1(8EL9^TMQNYN9T#^^R*FXNF+ZT* M%\L_8P)$S8:J]OE[A8&B)ARR%*TA"OE*YCI7+UO+D0]&0G`+BB@2/"+GU:U# MB.Y)2L6#V04^)@(\LJ8+O2JDR@Y16(G^M+T7BH=KTD977&T)#W%YFWWVYADJ(,&J9XU%)#`J\N#9 MV3D&&IY'F.B6U$W$GKM#7_^YW&A<[X_LG7O)>:,+@8:!B9R+?,#T%[IU$H.R MHDNL]IM]QL``6S-&K-?&-+M!@B#R*"'^X8<\76=`>D=NW7/DC[<,N*PZ8NUJ M<,GFA6,Q55T+[R&G-7"*9#..R:R)#.`#9V*@S9T=1R]*Y.<'S\X_G+S`V$Y> M.I`O*'E8/.DBKW%@H]R\*R+L)L`I'/#B!IVZZVN/_'COQ74R<$J*&M#`.0M3 M.`0)]5:$O4`8D5(WZ]\JCABT65YL;ES)S30%(SI3EA6WJNZB% MI9=4"MABTTB%H3SLJ19^`E1%PVVA)CC1@V]X4[#E;]\=G5+D+; M776TEU)L*]$CL]AL*Z#(&U[OT>`;39O`6VU7C=D'MSW0G';<*=)5^>M6)]M? M__)O\K5S^024`5[Z^9V-.JZ]^^XC%H#7N*V_E?-'Y]KA_K&FH<#[H^_M]O]( M],+7>X!:V*N2K]_)_2/'XXG>GWT=/IW$^%''#YST6NW8N@DF`7!OW\^.-?TJ M?X\<&)(@X38?$''4O]J2JXS+Y_?T\\C4=KMYOC+I[]2+)PP-1W``>(.-"O(^ MW\"Q0UKTQFB.9['5W#VF=.:9^P3=]V+3=5JE7&>7;KP'73C%&!L8JJ4/IXBV M7\)]SDSD4T8^B5R2F41C(ZDL2F%U^!"U]]IT9`V'V;R_4B4O' MS-3#]!UJL(TO#P_BUL2`F+T&6:^MFJ)R58,*MV?P`%A:<#8S2VD@_.>,(Q8WI@QG08*J7?X8=2R&U50YM-\ M&HNAPJ:R$(>D,95HK%)5&>,P963.Y&Q0V.ATH^Q#=J0OW!OJV<#SC/>Z200' MS.AO3NG;>(-I+_FE>:F$8*38/%+.Q1O6[K2*WPJJ,4:BV-T7%+$,/6'+]/>]2[",F/MG_HJ<[9? M/ZS@8!NCD5;>UGH3=-P-X(NOY!@L8E/0#-?0VDDR9G)((YWOE5:>'/.U4Q;8 MQ6CVV^PEJ(W;#:-5G'+&V$(,;"T\KS6B(4ONM`7.')-5TOOUR5E<&[2%2'V8 M#LOIN!7S9,Y>*JOZ6[!!.#HX+AC'G\J;=?)//4(K0B0'@[8244V7=Y'"P[WD MXN3T?C4\&DR'H^3EV]?)P8]OWWT^U$0GS;:A,I>2,'X)1[MB6S_Z,G(@%81Y M%!2#^713FMH3;BS(!#%<8E,N/KK*#^(C8(C:01(AUPYDUQ%- MWG\?J/02&P@TOB$3$\L[:SZF-LH1N)A'U,Y2RUSY.[#J\]2#^V$ M#]E@/AJGUA',\>#V,0D(OV6`"T$%0/\W991+?R!DK("HD=2BX2AU8/TAARWH M7Y@;E","IEA(M<8+/K!EHB*4+\9H*$7_H*S5*Y3XT,=PE]6W$J\=8$L0Z4%\ M?54"":(7U_D=["5FYM8/ZR6T3W4.;2X[CE(' MS+YG'UD"1P/DQ$IJ/!@I%-2JE6:D>FP,,19?5^4G('R^X?CLB">,RE]PE3N, M;O&5P87TTQG%JFQT3,7G9"4&9_JO!9)5R1Z:=2D!*>#?1([)K&7C((Z$/FKM M*SK7=`[4G<'^*R^V"C%#VR:,RA_^=E6%J=?IKQB[T&]0KU`8$#DD(K)JVK?I M/Y+4J1^9K6G/T@P60N^*\?DTQA'+;KA)]:?.[&^1H>70H(V8VZNE9++_%[EKA1HO;'086J!0P(`U(*`.MUQ]2AXSO/K^JJ_MZ$IFHZ-H`,2 M]T::=R`G1E(*.D'8_BQ,8+M6Q"$"-(>[O\PYYT"`B4DG]9EA!"V:+P.O[$NI M^^+K^81YF@XJ@[8I7%9!GA5I` MO@/U]$_G[U6<8M5,&+P<1A,XBB(&12(NU-V-3DI^WOOVEV7R*ZZ*G;Y(IQ'R M;$#3*1W_BP@[U6#[?0C[8V<#%I4)?"(+:BA\6#?-8,?*$6U->F]06"?FUY[) M6(G?)C69+$J*RL'$-.>FD>/>W)2VO+0?"%!CV@=>_6"+-8:SH`*S.])%@Y"/ MG?I*2O`6S?Z6()JM$#YMPYG+C^2G[M=5<841`H0^)!&TT-;!XE!,MLARS`1; MM<`#;XO%9[10;MNSAPWFLFMT071MQ`UKD/.V'K&L&=!A]I8L%5]H'?,?K[MEP7'S-/^(`"4Y@>D&XD8\`H:[RH`1T>]8\(=K;?G_:' MP\GQT>DO1Q=OCD[_^;1=X_,M*?817(&(L*/EXN24#X*6H#(*)FZ*& M%#RJ_$D[9-3?A:-CA\K^$&D($DRGJG[WJPUEA2T(D8H"-`=;4!VF354) M!(;AUTH,_X'/_9_@_QI/>T/2.$7R$Q_SXWY_@,?\[:D_YD;B\"?\&XH<#=O> M:%^&R>Z91H.UX9?ND"MS[3KLI!1U,6`M[\FX^18H8=P&5V/UA0!;T'$#51V\ MFT1VE_?++$P+6*!;2LZ'(_G\'G@^PN%B$($+K"0;9O+NCJ=@5.`3W[Z+XAFE M5A_:8*85(ZG#$B;EG0W+R8)5=+?Q=Q&<.4+[`P;16N2:;L,DAQ.:1!<- MQ]:@?>4@SLX3A3GVCZ4.>>W`N.6,?4!3-*A!@JFI\>TPCXMLM4G>X**H.((S MXRF$DQ6G2^K)L<'#-N(A(\MB`A:Y!>YD$2W&;$NZ@U)M@7>E_`SBXFQA)VF0 MCPD-1F%?-19&YHKV4=U,$%R#1X6;4<$>[,2ME>;W@.":$T:]E44SP=H%X0`M ME+MJ^XA5A0R,)7N5:%EJC@O84!2@\FKH)C1>ZD^K4*0 M.9JVE(T=9!%6O78)O1OE"4VL9"PFN-[>)5V%69/*#$/S_'''+$A]L7^M)(>F MCK9??=F-@@S`Q:V$N0FZ)A>6VVY62((16JQ`/H^Q9;[4D85V#RRW$;06551R M(KN+ZI3^4[$^PR2AW8W'%3)HGD`.&SE&C)PM*43W?CJW.:S$,CI)WIR/1RGM MK$P'JH`XH[E2[2IW9^\31:E1!5K=GY44]]/T41)M,"9GA'6\C*W^^6`P,C7\ MHOKA&&C\A`%B5Y

.IHFV5:%Q"=M%62-2*!L MGXTM`!C4&!>G`4,]+D7NMNUTUBE]O`!K1_W5W[>,P1Y5NKZDD`%;^R.9:;62 MXJ_JK?F"R@9_NX)>IU5V"3HU2.[`XW[6?+W_4JQ`&+O"-/VK[;7HYU38]*+` M*+TUUDM]B\008QH1[*8LHDM9,/(\!7-R#!E1`3S:%))KTP/?%L04I0:@U&VO M22XH*T6H/'M[^NP0TXXY"F(PG\XX&7M^/(1!O#U-"&`:/<%5H)><>&1^1@?' MR:)KB=-]<$8U(F#^*Q0;3F:ZU:"J]T-]9L7(I1*JN%+#&9S_O<_;6L,[$Y-J$SP M/7Y,:U\8YR`]%[)*X(<;D3!.L!PC2.W/7ITC0NC!IKRF'X22`" M/L$#824);4D#SJ5$#T;ZL2"4O'Q89[<8//^N6JXS!0OX0#5XT"%&U28B@1SV5V^V2URX]V=_^/'BF2\2!R]9H\N,8ZQ$0S(_3WB-1-V MWAJ+MA%V'IS>=U@TR(5ZM>R*P+50)J%60B0?,@W/+H51*00\VBNSC,"/M0AP MMHY.7'!!S9:)6'W=A3KVQYZ(&H+Q6UDPK:40HVV)T3"[59T6O)6.XUK]E?`CK>[1@"G*>Y=QRNK4$,HB)1H44 M#\S74C5(]QAS6YA/<\RDG`<\9!TK%$DS;DAX@2AJS=7Q6'*E*ZW83&O3.`T< M-8"$KZ*@*Z_0>F&/8@.$]2$/).]"^#1*`;"L+22^@O^U]R2B"G!)!ZO^*J4F*C&D'?PD#J M2U`'4Y<7%9Y<$Y8K-4@(SGLE)H*6]X6SNV^4Q].JMC+T;`W;N4*[@<25,PC35=\.E(ESV'NK`$(.'#>(]=L5X.">7\+H3KLG!@DGU-$FES MOV)S$JJ5XOFB*HH5PW^E5.`>P0HZJG2'K3IUU#/*$Z.L>@GQG,O*PG5@_IT; MA`<0IYK$50<'E*HMPNI3F0"C-Z7&H1$KG$0U[/`*7V8HV]RRJ8-0,<*HK$KJ MLM!$D5E1;+M^>`6C^%?8;D$Q,\5,6U:%R&P@9+S"E(B8?X6#>P/IVBI M.`&:](`!HOB*DAN*0>Q9VRY5Z04B M<<>&,V^A01)1B^Y<5DN24%T7N!G_'S'-!1TZ;\IM M43N#[%O01("8%LURC!E>]ZQA+%X#&4"K(NQ7M?%^(F,O9A`#5U(-%L6Z=(>\ MMZX98X6/[,I/!5L*IE+G`G#"PBM2@)I47*Q$5#T$4X6]P6%F1=5+SHV?P86UK[BV&X>U?RJKCZ$!=55J M.#I\N&O?F+#_PQ\V__@/?ZB+?_P'_+?YQQ_=J3D#J;D2P!H\5:K@<$51*8(2 MGG_&@`K*C*";R39(JEHO(K4S)U`$/GL@*3:&2H9*:"J5/KRB7#DUQ,'Z;2ER MAKB:.+1%;J'8>%?!E]+IJ5\Q/ZC'P?;DFA4,>C^IZVW!%-''W=;$F.'4''$5 M*O/T30%WN5K'2[;CY,9?30CD+[ M0%J:&X'`>['(X^RJ9F",$E=+"GW]0_*&YC#XZU_^KY9Q$<06//TOVY(\N%S? MCU@%R0&\V*RV^;@1"6XRZPKLYX_2TQ![JHOK-:70KU6K;?;MG#SF*TDM9YU] M11"I*%_Q7UPBBWL9Q;VT+62A*)C8*)U?&.IFE3/0\ZCH#L\YC;0A9$=OQJ)+49M$:)H=)I+-!N9:1R.^FVYA02 MMER%3G8Z'52H2@4:Q.2#GBBWW">_W6[/69V^L3'N*! M'*-#D)/\^-_1;KWS"W_&"R]/#\.G?[%;%#XY.I2.?@"%XM)DK#S88`)%\@+= M_K)(*,N[3IXGHW%O"C^&X]X0?@SZO3'\P/.QXZLW?KFQ2R`^E:1=4`P%.;G- MCD`3_5[?-6O^."6I[%HB02@!S)O2*,>\$KN,/&6;'].4X=/G4CY:;-.9C^SW@. M)KT93GE(\Q\,>\?^''1]]>1S,)B8>1/]_R$#L5W8/(/FXYJDUR=REX`&7$R)F0L4'>-,F9 M/QH]>PF"-&DEH!>$K(FXF^H#DO$6\"IUUZ(6*=)-)=$K$O-42W')0=B!RA7< M#P.]R`"9J5)EZ$>[?NCL;]BCHI[MZ[W_4MH0VUKY%O9)O&$I8E/KI%QH!D*5 MBN>*_`N+$F[GOW(.J8Y,SQU!$S[A*/K'68-;/.@C$E!';_J3BT,GB0?-EO!Q M>2OU/#G(FBTY\0!4'X@5+%`\7<%26JT_/^WT_#')6"A*Q>7JHTMW'J1'*4>H MO&G6&DJ::)^ERMK4Z+*U(=3@K\@=+$,@R+ MV.)TC)MTU4M.Z#Q4RX]Y?D=BM*C+G&V6;._H;K!\X65P9Z"VGRUNRI(` MVRC^/,!MV2(PDJJ*2S1<+\VE]6.3WFL%4V\966T"1`G9F&H\:WHE]U2"QE[Y M0#\/VT.'9)-]#K>`=)S`QU'E&ZG4RINAT]75T0"!J]46T9PVN;%PF7E!,]MJ M+3$&&`]#P^LEK\MRB6:'R.++-K&:DT;7&.I[+0\F!3R"*(,B1=8UXQW6HOF` M+HP&&/(RX5:YR%3:(\PCA*<=')$-JA'3Q$6>NTQ&3#W=UEJ+ZN<29\?`IH-! M[ZLX7TLFBSVUO-_AVV$?&,TR!::NX2+;.YFCA??!<.6?+P*@,TF'ZVHWA'ZR MSMA-B3;LC!4_SEUX/C.(UQL_K]=` MI,JK?$T5/RJ%P7*HJ".&29@V-%IC9I2I24A<34$P3J>(C@2&$Y&*?/2)O)%$ M-:-SHG$Q?OTQ[W4A,6)8DUDT^N=?*:WG=_"R8\?!PUH4](I<+6=7A1E+_"&U76 M<0OJ?`?IL(O>&M%%8#W/!].9.02="$&ZU!$$L,XB/(6(,L;=!V')SX<30THT MDA5HKL\6GZ;R,/,#=[7QN`9OA_9=TX#$U9/IA\WZ<1P#@]#6C0*,X0G8.6:B MP]P.4H'.E@B+./B6EH:3W\(U([:'4`.>&RH*$TS0G2>?@X'W`DEJQE&/`=*6 MT+R@%#K)`GP[8G%MF8NIWR7M^SA1G7)C!PC%N#5*4E"R2HFEE45R>^E]0(&(,AMLYHA? MGV._+)5GRE)\<C49W5B@68=X,4RIZKO-2KQ'BW?+IML1`17]#QW=`=Z4I?[ADF'5TLL\)+!$-WP4 M)4FZ34ER8F_2Z$%K4IL1#U M>3Z)1N8.M6Y\RQ(QE8X6@RP;:[L8S\?QM/EPTU$(F<_?ZQ4<]$9X!5_(@0S9 M/<.0C9UY[%P'>S!$R?X0<="%W"G,RZPW25Z)%_C*&SJH.S%1'$Q[,WBWO4N5 M,-0RV^Z7`TU+G7'D`C`^.A(VLZJBI#GU9.-0,HEKI%^0;L!*YE3OP*G+[)R3 MB$3]4+$'5;&]S7XK*T%^[*0`0$BA;<:\^GT][(W6KL]OG4IGUT9G!$:'QZ.U)3 MI@/$&U#%67C#FCAW!K M3X*B,:8^-:$BXQ.1?KAH&<6`87#2M1HANY0D64I_C07PK.5DS8"TA2=K9L]: M*ZG;ZUBYP)!@:Y]TA$1QO20;GIRG.CA0X8QB4RD5R-**.PO,)$/?ZX*#Z;!Q M-&,R.@7''RDQ=<;S?Q7SER&((8.LD^76E05LT$._*X7G!3M'#DQK\AV-;=SK M][]C8-15B5%?NP;1UH\0JM5"@'&8HY*15G@J1>.XL`]G"_9M2(PB0[97;+5J M,YN/\+80]B.TWNF$"7?&S@PZ.:;IXF_SW@1^6^:7,`#R"WP3CPV-@`!#!.A$ MC"AB9'4);G@EHQ`-/^81#2U%-6#"/X_YEXE\,>E-A[)_$WIF31;63G=#VHS8 M>-2QH6M9Y]QZ:]2"$L.VBR_0+#+C92+K9# M7_2N?E^GQ&)K6KC[X M*X)/:[+5<``'9SX[!L$5?DZG_'..0BI^CI$1$?&@UTU+0%OS6BW9_V)\;%/ M.C9S.-&-&4_A?WW\?2=7F?`PZ']]^C1V!YSR2W@+.=SB?5%_K(WF8*@XF_2L MVP)DM-^BHA421NQ[806"NZF@\78G=(L:$4KPRS*O)>N%S!8)FG4Q$A/&2*+U M`O:[!%D=*\M'WDA;4*/93].]*Y)!+88]+#WF(@V..,Z^K!19&/XPB0TUI^4A ML516 M,(`3K&4F&UO`!DK7^`^8-8>6@/^*`:U$C8G^DL'C%(3RBT55W&TDT7$T2+Y+ MIO`/3_-WR=O%/V$:[3I(B06R]UTRQ`<'<_COE)+RH8.?:)ND(>@!'AKB?_C; M"0(L<';)BQRDVK!%;(9>&&"KW2O6=KJ^Z=I=5V7=U_"YD=:T+2"LRG.': MQ>L_P+6'+>I4NX1/D8Z1/+J?4)'J"\/O2U7#Y=PN;>W1_-Y%+M3[1KK&4T*"D2`\;<1LY0)0",54'!K_FR1$\"Y6\P1?Q4 M>H7#O4-QQ=`A=\,Y73VI.PAS18P9LN95VSM%CF&%S]EZ)`^,P[6,\@V1&%%M%\%%X.=>EB;5!)6&.7_^.I'^$>?WD22!RF?\';2X^]SDLJ3D81F"^S M3=;U\'N*[,+3L2/^?X!1'3L:5Y,T,R\LU/DO6RPW686VZPBOFLV=2RGDBL,0 M.?K:G26UL>!K%YQ-#[SP195A:`[9!=R'K[D,6)UZU;MEZ7B$HC>8.$'K2,<;,H%HE1 MW(+\7G+1XXJ?OGUYX49.H`3;O+K,-\;<%=G+?6KQOCFJAR3J>*J"VA@,&\L$JCL[,3<9"W%AG#@<"0&5RA=(9RF9<9 M/I/0MEN"Z^#"K4*,I!^`G_V/YBEFAJ:F/HG9OL3OT"P0G55\YK(HHX__&+7L MKH)KNW;?N9J"+2T#1U4-00R4EY*A!9(TYB$N2/PH[XJR6,)']<,:)HJU-`14 MEPM(^DRNL'BT\36R20,Z01D:%XYS0G`:,9LTX2WA&E'^6#R-`^5K,MS\$!.V M'+K$",)IH&&6"-;RX+/J#YDQ-D&?;#0ACJ1QT3N(=57SW5PR]TC M<=X?TUVX>OZ-@$28F^%M1Q2Q4J#2IF;B0C0X-I=394QGJ7(N["B>RH6`>-&T MA$V\+_!`D1T=^!GGOE+V6(9F=#$'I;1_Y)#!,,]*86X4*$WL[*FLH7W,QVO6 M`@Y"%=PX=)HJ7IRL$&;V^D;D$9>>NO=J<_D>!TMFC)O6@.Z"P+NMYHUM-/F2 M06G6MJMHEAV*HQ-#):VSZ84MW6$-#H:R4RR_PH<0NE`NJXTZ['0S3\4V=>E$'F8([ M-*R?O1[68$2#=#K$H8\'HQZ^@Q-KX2F#=#@9]*;PFLH/A83(^ MA@9'&,HWF?4&IM%1.AIC"#&\>CQ$`V(Z@ZT8,8B,N04M4Y_"C$;)P:0//1XF M!Z,I]'C8-GE4GYKPMLS%M2[R?R<&JK&LX&-,!C/Y@-J$!S/`0O\Q!=EL8 MG,UHXH=)RV&83-"]/IA@CAELX+SM'-`L9S-X;C:$><>'`,X=7(QC;.;XT6%, M)VCV'X[G:,H?H,D<+\+)K1J<5.MRIE&$H:@H^LD;8-F&0`1J7;(36:F#5*O# MN_,^=YXAKVB1,'ZD.TNO*G&GF!Q%8R=YPP\G@,$109\$#:\A2^%4C'R_+IGS M,]A+,S),HK@K9T"R"D*/#OB9VH@S`T'F8WE$(1;"I!%(I`F&HS.&;($/ M]#(*`VD5!GMTX-UH@M/MEA$8$5!O!O=9FNWOT:D+#@2J6SIL"OM:JD2CXF7]=T57NY[8&KD+AJB2P<_ETK9@V/K>7GU.5M=E\D(^0@YBP9#_)^) M/>6_SI$T'B-]VHM?_?2PK,I%N40[IJRWB3R$L MR7*Y8G@65MZO<)F3(8D10V+I0Q(L>$L'(XQUG*"OET[-[EU\@XY_`4Z1A/&A M&=^<_*?/D^/A'#IX9$1(N\<8]CH:06\\FC$=ZP'U.9^/*:E[WA_#W[@.?E6( M+HDK@JDSJ`A%4`J>8J\%P\7'(&PHIH^/$JH$K*6:@Y8R'+^+ MA0&>X3=890]7H+DN;/CR_M5;C#%9BEY*.&&I8+MIHO8=:Q8!2ULUVE62#S1; M1L"93'T3LL41.L_[)JTE=$JU!R4'6D;3$BU7X,]L1(1)>=FHNXSRCT@M$T#^"ZBOWS,/GS(/GS,/GS*/GS."!@ ML^DQG]_!G([@\8P9V?$Q"FZOR>4GE7_'?92)QU/D<),^D4MX:(!;A[(G.\); MR=(QTLX97A3@"].$LCO.`HF57FXWD]84!P'D>9H,2:%@R?QG4EJIC3D*GG.4 M,2<8+D$=O0!E?(%5-M8$'W^G@>2[AHD7#M$%9A/Z,1W3C_&,/YS!GJWH[CV] M57A]S"U2>_#GU&S5>+^M&@]1+H:?Q(^>)Y,1TK3GR10(Y"ST!FC@FC<3LG6HL M>"X&2-0/AF-6V483W.[#K]K)*>_=")?MH-^;X$3@-Z#PV/+7[.=TBNV.7:O: M)G[K;RJ'>5/."M+#[48=9NPCN,O8,>)"+21_NHI$CRM?^PD'%):Z&P+O/ M?KPXX6(DF(`B+IP!AFM)_`W*IL6R$`0D-;1VH?QZ1;XG;9.3'>/R)'IH>W9C+!K1C`2J35C@%,L88Y986.V*G`0/YOB;.6"3EV55 ME5CZV4>44S*]#3>ZVJ[D*FS7SI5,([^&\XPERW**#`CDV[O5(@X/LI*H8%%I M`>M;RJ)H#;K"+ZO\1F"UO5D918O4IGNDBAT3>K-Q9(B\>8^""\*DWK4HD#\T M!H^G1J97.AE;EH97$*LWX":$WSI/H]]*5T8G5@C4%'W%+=KPB75I3ZE;YSHQ M!5!*G0A&?7/! M^;2+5I>[E`H)Y?_/WILVMXUD:X-_A5&A>B\5`>D2&P%X8B9"EN4J=7M12Z[N M#QTW)BB1DME%D1HN=FGB_O@WSY9Y$DB`H.RJVSW3'VR!))#(]>SG.>AS-0.M M;QB[+63]43O0K]-T[JY!Y^XLG;M7\9/NQ,`T-3>I>1!?&Y%#@X"$%Z`.L#?# M>I.=2]L%T/.!H?HO*I(2>[&J]_[]V;MWEQ_._WS]\#FY\O+CZU9AQ#$3`1]HT$T1B;]X5? MVH(X@2'-I^;0D!IVH]?5VR/GVJG$F&'G[`\79*_SUCPH$#]BC*U.\&\2IRB\ M,8C7&$RT9Z$T-C`GV[#<#,0Q=W6YA/SB%?;50FR5,0-NT97%[^%3LYW\INZ. M,Y"9W=55[S19<`^`7)@8Q9??AP'-Y_YMOAG`=K*JS'C=U:4^/"J@,*W0`@:B M8Q6-*Y![AU54HG6*S./DC:KUS:CS1FI%*T$<1VD%IFGU7!R5&1C5KKK447_F MJRIF*#JZ$E0;%P8?C;.*#7MR77?\Z7^7#H.G3I>, M:EM4D-$4EU&9PBS&HVB$\=[#S/2R)(\$M:)6`&/DU3)`)B<-+8DR=$8-DVA< M)-9)\5&G+L$7L-G!UL*+G(-=@Y:*3PZ6BORLCCH88H*:,'\% M'\[JJ:4T9+!T"MI=G(*Q]XQ+.IG[P)Z)?>5K:_,N9W5*`J^\*9`;V M,1GA<*O0KFYGR]G]?*N((?HHW=5%:R$M.QD"4(D7W:0VC6!W9-XUG1MW>_`E M<2*TAZ[<^/>OED\H:D?H;XE1F'/U16M;'!%H]$8CGAF5A., MZT.C8^58K>T8B/2H`G.2?XY9K,BC%$WUEG:EAG2E0+HT$9.[J`>]",3+:=#W M$F%$$OZ7$6'0MU6B^6E<5@HOM!B!ZW>O!),58]YB=!628%+T6[FK/1),GLCI MP*O^$@P("9CIE<16A$G`5-5/A!F-K-PSJE-"S3M3.2``U#HT.[Y3=(F!:"%% M3\R!@2F21\SG`MCH`5)+:!CM%Z2CUH8X@I&L/L@3KA#FJ%_I&`E&*8 M504.O[B4J4NCL@`7WZ%22J*N]DLI><4/X$4W.4V,NE0QB9;KGE**"`]T=8B4 M4O'DP]\]4@IE^((8D8Y1CPD=Z%#_TBSE6:"KIJ2"ZYE'10)"B1$!4A`ZH?UQ MCE)*$95(F(-"BJ$*Z'0B2I6`2).DY*=R)$MN.DA&>2&]Z2VBW'PZ^W3Q_N+# MI\''M^:G]U?7%S^;^R[_>C$PSW]\?R$>*DP4:+6H_4^(,-HK1K2._G=^?/_S MN11AQF?LSC72GLCQ(%S_"=$ M03049SK'HE2VH)-@MLF;AN3L4Y=MP8;#F.7D(0[P>#"VJBS%(5J&C164&6YJ M6(UQYPZ3=(34X[?20IW#'IBC&V@70<"E32M&O);CFDJ MDEC,+<-D5%H*7Z+O6E$="SB#L-XS#$7)<$@XXQE3*_C'IQ1*$SE?)NPPO8%3 MG/NL&G,`BCDL9OE1#QCUY:CR7Y_B_,(NZ^,@IN6!FIE>%T>VAQA= M3.8$\Q[E-DZ3S,Y!F8S1N>PZ@3]*2)GV($"7[$N!HPW''.=K_U;XO+#]^!'O_A*B5G5K318A=) MY7]NH\6C)+9DD:Y;:/%H+%4AY/H@6IR""`J,LK#@%`7&9!U`A<>IM7+!50<5 M3G.F/&AX1JH#1I']L>"DV,;"=?"J$1*><#<*;AL$@_X4'@MH''O7CL;SZ16" M6N3(`X8%VES&+)!+A'F#NN./RLH,%LUAF;22=!12@>ZG>&YB\[(N@IZ*@1G" M\TO[COWDO+(C%M6@-S$?)D(BXB(FC@68-@D&V(MD_@YV[('D?)@:W8U8H;P! M[!^5;7@(.#WPL9VJNS4=(2O6U_OZ%'A_4HU)\N7W9RE^="V]E)X/"1O2?J!= M!20$MAMTI:+\"]N5K(BQ<]P5N:$?<<\2;H3_EA1:%!/#X&_/&XT`"4_'"1O_ MS&J0%`]6P9QZ?#0HQRG*YO;&/X+&%Q'%ROZST'B)D:U_#M/XLA*"2U=!^EXF M8M:CJX-H>XZVC=B(7%;HK8!"'4#:%3$ M;5A"ZD>E$W=XZ+)5#N=33-E'I6CE&+47)M`Q91.)40(^YQT$>L0+,[(1^&'J M;-FS_9OU(,RB;8@#J3=A+D"1J,2#@V&*0@)?)E_G$%Y)K2+?DA;S'!WEJR^4 ML`G6C.&M(LG'#;(G["\3C2\K<#'V]0KM5=B#+*>X2>K!=Y&M1?W)Q8Z-N7Y* MMLXADM;-JAL_?!\BO!)4I4AO`IL1_\,Z92!(0Q/X38LT719A?(4E_OPCDC'N*QG\X) MC\")(%FIY$K^H,J*V+`I]C:XG4IHPE+$Q%'`")**"DL%[<>F%T#5)3*OKJRB M;1@W94P6UC;1XH1X9I-'9'0I^[A\@NOK&G:QM3.*:=?FF;A?1O:O73U!SYW; M&5;K9?NN^F'&7>*1A0XV`R:N4EYQ)&^65%DJC,B-&=?';'0*\&&JA MJ2@%8)]04HO.773S*=$@>(&5_.[M<%6N+`81(4,4%0&^`A9JB#@4FF!A=O8; M`"\1H#=%?Z\8XCB515>OS@+;CJ)@,80<6:[=9$.ZI+?+L?&J<-F6>:%K.\_, M_,X(+A/5NPW::H2*VU/"W_E;;\CYS_HZ2$#\WQ*TM)FEQ-3-1TO%.RS".E1Y`U]"QX71&(%?''MQ5!\XX,30(NQF#MI!;ICM, M,TK`;O=L3\#-\C!?+AGCA4/F@7&CLYM]&1],G9X=NMA"2CQ_`%W"\EWI?&RHE"!HT7%;L;I==YC9>)ZL<4GY7E<$BTC-#V>"].";MS=J6 M#7/,N+`WN--.W_E[5O_KSRF!KIMNC)5_GR`X9+-"&$^%9KR#.65F>3U?LJI& MS-%CF-U\$L%(4N+;62':>9:BQ>90'@F/YYC%'XMRFZ`Y[P`>V2.P[/=CEG^X M+>T/8I;#&.G,D=B#S/1F%$9`\QJGL%F_CZ)7*,,N?_@6;EDJ896O._DD&\50 M.\I&9,S*XH1%MFX^-W9**E["A4\);/#M:=J3=PD%Q@Z-L\S9?TH,64E2TEN_ M![LJ432PS`$_'!2NT+%Z/WV&.9;*5X2Q.EG; M5890"9K8,0(FD%+/ONR^K$V,PO)OA(&H'1P*]A9M+"*_JN>=K`EWE-YB_LX2 M+C%B,)%^/`9!9*P_L82(CI'L0_8E0# ML#-'W!WK;X8N-2`=7`71BR^AI.3V9Q]GIH'D_1G-I*>1_31Z?_@\Z#MK07WZJ-*0HXK75#3Y;'>KJ#(/!1LP31@A*?F1C"6TBT>9`_O MUE#2ABC4$=7>L%54L8-KUT&S\Q[6DT?(\/LR7^TV"XWD:W:"J@*84T[NQ.N] MO'CJOS;P!K.UCW*O,WAB:QTT_3\JO6^:T!QWG\U4+F:#R\O!"=8_<8AB?\&R MY\]$3CGX=8AYK@V0COT/MJ_^@5VH/QY(1A](DU(805=;X%LV\E9=A@QS=@%M M[Q:V",*K?MZ$HP$E?<8J-I$%\B,H[-+/ MK`,6+G$BLG,IW?>L2+F8)"5^/@HNP"A&=-!"9N\:\+@/'14DQ1!J4EP2[8U1 MH`<;?95Q"!3$$J?]1IB4F+08%0E,#D;/&ENOX29ICK"7$*I160DB MYH0*?,LG(]U\<5M0UKGWV`L*-`6D,\*)2?!_9$28`]ASQ%`;"8/#);P0&^XU M2@SU0P.]N!B@N3JE>3VY^Q5P"[CB),"I8"+!E<+R'@ROC')R-P_02'O_F^N'_^M19Q2Y(,1RQ4M@H!+0UA8([:]$H&-P6 MSR75L71YYT]K0YWF3["O.60`^-G='4R?)5C8YO"'G\[.KGXX/AW4Q_P+28\7 M7!JL3KS;!TS]]@"X#IP#`A$!:@N>;QP<]%(H\D;C3DN5=2EA1M.C:S12]0V2 M"J$S%BF9:S!"RGZP]FF$;F4&J$(@!EOXMJU8*N,6U%ZQH7J?`1AK*(JQW2DD M?4"UF0\5A.S@FLNDP%Y6R_J/+]A_7I%*84)U[!1(R?CZV6S'YSH: MC,P"0JXA8.6245"0UYJ[@2]V5%S`V_A%(F4#B%Q0B%0FY[9A;7@K/5T;1?L&EW3X(G,N7: M@?0""M.,"9S3VN=F32X=O M320.$4M<*8S0FZ`,9P-S'@2JGO`>KDU5N('.LMNB-!D\Q5!RD*G:34<1E35I:K./CXQ2 MI:OX.DX^$+;?(0!<$_$VRNO=ZF$Y#]':P"VU'8+?_[\H:]*M6(:4CRR%"7Z% MPACF0'.U%2S7A_F.&SY>NBRZK8DBK^!5N]T]0YUL(KM<*!Z+-6T^2Z+L=`;H MDFO[B$!'&^()A`FFGOFGT&+IY^VS]P!29:C-1S>1PJ!IOFL:BU'=W7%!&]TF M(<0]6UPF$";F6#'$'B&I'"RUFJ'^]@/2!Q0)K-P`%1I0L/G'SDR>V?%,*?5* M0)6=C:H3P7Q#0="AL6@Y6WB5R"T0&<*.;B?SA51-<4P/@($PEY.1N%DBH!=X MA><,^T2=8['04[$)-@Z]0#+OM+?FJTX'YXP:;=NR)<#A#4:BA&P$`K M'C2`*N.MD96E[-N=_P$;XLH*[Z1E,B:\7=%\3T#:WOR,) M&1""IT;L6.P>Y6&ICVRFYV^?_?[I(VT+P(!P!"*(X0"3Y8PL28(Y"]5[+1>C ME7:$P-7@O7/+$,D:1/:PF-VQ6R]U:C^1CJG5Y*6,RI.$:7*U$?L".E5($A0@ M,\BD1GXSBQ'I@L!4DWP+E[!'.&,7BF0L;F)DD85JO':/5X>'$-[9Z( MN/ZQH3-F?R_$H-;`L'.[6N&U/S[-ME1'ZYY*S_DGG69[8\O3H9;"9PRE'K4# M'3R9&R-;GAG#DB1U-TU@^81X:B680`8+JQE.NW#%@>R&F0H=/;?AP)J`@D1J M6ST%-7VVP7JK)*CYY5:);"( M(P9:K7@?ENRA8-IF'9M;LSBU@DA6W6DP9\.1G@2][6?S'\2Y8^A\/WVSX_F! M_0W=+AJ,D?PPAK+OD(_"M'U^WG"5N4N-J2]0P$&A/MI"?"]INX,9[V2%T0K=6,`60]N$^P`R)5,`&V_^?9A&$7 M;-$$GN0[,^-(";=4&U(7.)&?7/DQM3I6.!'!I5Y3PHCC3V8K,6")44\-B0%\ M0795@MH_9;#Q^1J"2M9X*@E/5+(A)NLU>+!?6=H"*"Q&>(DS M5K9T5-G(/6!_7LSO;8%962<93\-*(J[`3R`_+T+&DC"!"3T(R,`UHF#%3L\0 M@E*2J,AHLC/L='G'H1/6/;EB>6CBV_FB5BO3FO4`6SMAY1L("9Q2J6PG,R3" MY`)%=^@&3E6PKIK?.`/(3Z"2]L.LU@8,B2NGJJ*3LA:/9K]_)GX,W&!F_;+$ MC;=J0CT6NL'JP\L7FF$0J!C!<)=L23)\;?>XHSXYN:&>?'&*J^HC!BMCB!&4 M'CXO@$_?4Y^!S*@Z,JB2D(D'G4&!98;BFBQM*,8"I,G=1"7FS,P9%6#]W',# M\!JMV>QDU\BM#EL9T#"%RQENEPJ:W3FW%YI19VB\,O1A<'B_]NW!3RV;P.X2 MW[!8L]*YA*A33B;#'JW0PD56&#P(,->0XF34?[<M-O)\E=/'[USU9*?)D^@BL/Z/'-!3&>\ M=;S(@_'=HFD`(%=X,\X?B=S/(8V)]"R@]/,'K/+)`$S/#47JGD&'\;BS9KY! MXM4>/M&@S];=>:T*JB_KKL*[.50/FB.I#TY*TX MM5IT0"P2>P\U;J3'I+__N@3JO%V;GB]01VKLL\F7R7R![Y]AF"RH2@%T/)S' MKVO03D#?NR?KE_+MV#YOG*<>X--1#P(1XG3/(DT6FU5SI:P>J'#`[VJF#R## M4G57S"`"Q82U@+5%X^MGTSV-^& M]9HA&,[WA:#5Q>S'05O@11![PW3VB#Z$[>SN\Q+J$3]KG0`I$&U#*&2Z>C0; M6&P#]0EV:()7%DWP0M`$N[$&R;:V%3X'LPZ54O]A7FY.Y^RKU%">/X(TK(1V M)1$+6S4GR?`IJ*8+CA:*IR7E`^`PNA2C1N&XSB)#%M)0"9P+834@9F&6-T4S M418%K-%<^Y"5Y6CKU24(2.=?0!%VVPVT7-CX)PL<*\*EOQJ\WLVQ!,1F$(_@ M8&4Y^QC>0305=*O=BL[K=?8:KPEEAN>3^Y^VQ>R$JAFPN_ M(8\AVT8W7OW`'50=L6\)Z[!6#0O4P>"[YU1]>74K5>-LD_=8X8*593.-H#6N MP$%G\?#LUK:NQ7V%I2*6H3G1W-8C=*YO)1U/O<*4L.L"!=B5UM;Z*!._NHOG MDV?R-5L+N*;IM[;]+F=2C9?(BQ!-F]53"[W2DIIG^@-NN6&2!=02-!AV&CN/ M_XH!,*FHA6A.1N]FJZ\DN%*5!>!/,]!'9U^$TMS-UV82I$J?^-A8\PL22Y`3 M\)7^NVT]FUO57>!PE^V/S('<0DP+5?@F^!R@*\K^J$R.N+\LQ`X\;;8)F#M6 M7<;XY@C<+JCU!PF>F1=TQ^+M`4'/A<9W_68+GJ+Q'KV\7E#]>J;,.CR`&G2K MTV0:>@JI-5[1N+FVP+L!;(3!BE-?=Q'$1>3.ZQ?).()"M;WAIW-B?Q0OTDBXX+I MI`JPM(L,L^UAIQG;UX,0;YE)P!`77'TWC-;)&OYP>76-@=MO?CA&ZX53(1Q; M#U%*YNZG4%C*&U6C'_8-?GEV=/U/T3E$A6*(Z[$<%^'0)G/#_S9<'PP*WDJM M'"-0^GYKG":Z<=^\JML-L;=^2CO7N,JHZ7$2%'B>R$,&\<3"K-S&,K,[GV+I M,\=&<+^825N`D9J%*X_%?C&B^FJG=ABV:[NNK*+SM6*Q.R01K[&1I12H:&5V-ZF9V[I^^]0;=G3(/#V=W9O=NIUQ M_<[^L,52!;UGQW M:`/=/PIG=>>Z1UI`9^L`[#-@Z4'K.PHGM?':(1XP!%5MF_6?O>DQ!) MG,4P#G-D6<)6-VP1(8OKR\TEEG*P_;HZ,0?DB5B0>:_D0E6SVT MKJ*%@Q(G1=B1>#[?6O=K0YS8S.@&?^)<>'#SH;F-!E2MVZ`@UL ME$:VQXKG;Z@(%_.)XDJL499BD,S8/L^?-BI<1.:)%5@J9U-';[&52#(]M4W+.IX@`,9T)!)* M5.JUYD%,:K`S&9847]BM/\IH*D:"EM7J-&,_LIE' MAT"YI+.ZD7O/F?F^YNPV^[4W&JRQOA`]II>"N*DOP0';?O\VZ]CU[#"QH=NJ M"U\_A]=9Q&V_5Z'Z\91(",']G3]ZLP>14;M;5+3-[K-&HLD6_3PN]XMW0*3" M?06KY4%P<6?!PDG/RHE/^17L=D$/G21M01@PF"X-"5M3DJC(376G,<\=U+H" MAZA$W+OAX43.\5B9-]V2(0<]QJI/MORR]:[)EN?C>@>()6@G,EJD:<.I>U._ M1S:8OV7\&.!(.P5M5"?WH+8U3&.\^*O;!4\H>F+FOY&11W5#9'MW$CA`G/>I M-IJTN5M5Q M/:%D*!J[/8"33E3E848FA^4]G,9IT.AJ>\.!T+2S@*E2=.NIF']"(6PPR\O9 M5JQI(0@*G6L8"&H'B*#7J-6?*XB@OO>UI8UMQ9,+UAPC;JZ>9S,7 MV3`[M`9^G<`IA(<$2AP\_20?>[:'![.8VQ-T==1I*FP=:@CV,:LLL`YJ.>MI M8&R.8F5@Z?J,CSF'#N<0R5`:`\`-`N^.>'>0#=<]P.\;.M4'M4P&IZ)?CRG` M\Y&0SAV2Q^06XEX`M$4C.]%0(Y<-"=@I@#70C-%!=D(9&I<:91S#,?#50-OF M*YM4J=#Q,>#R;K*XD_!4M,/2[U1MCFD.66.'*()CT"KX.EBSP.1`B78_AG!W MLUQ@N_(E?B_->*J"OB"LHYXH>PXK,I\MS7,867P_FUHQ'T^!ZMQ&Q"OOJ_O6 M5#PODX1$`#5M+EHK.(%_VAD%-BDYAW2ZXL-*ZIWB^<3C.,BC"^T6_U-=`52?]EF+XM@!ROIY;Z-;3J? M,O$&\0:H/0W6192M..%?9MZ2-6NF@T1P4&LIZ=[$I=1,HX2@7'PY$1#.(\*,Y-,RT`YT1CR!W9*UBD=:[99JY[@^'N M#2[OWVME-O0H;"C=#+Z_7:U^I17'U=O0(#I0)EQL.AY_E$/-_##98LL/G$>T M>=L9XT`1&Q@N4TI&#B]O5W=51`!I`_(6U^`/.`O!Q[`T9_-"*7@0W?S3P/S- M[Z-Z7%DS@#1B*1'I]V+^ZPR)_&2)IPI7>8-U,=;:`AIZ&]IF&XY%;UWKBXE1 MI%8F(5>]NMV)@9[P`US6](40JR8+/W^'/;+8#&?CF)9LZ@USBLOK&['TB=0O M94,D)6S.XC5O7TO#X;`C1*-?\Z0F#KOX6O%V[YOE"75TQ3Y4G,U;Z.$&R)JL MX>RWR:/GO](PBJ@T/OOM8-N/LQDKA?#^$WK_";S_A`(K7&(]^%,V%!VXT0QT M0L\OL$3-5L1*;%V&A>/)1S_*^-#X2*$3[`G>4=2=(0P[[9H%+#@D]AC"L6)2 MM,7`2D.*<")HA'.2U&NGSK:_6OKM>5,1*255;\9G-IN84S$W&@%*WZJ"C%E= MKC>\\AY7FS-J6+["/6"1OXZ;\>05?=$\FY985B&8O%L_5I"@O?B"6,(B2%4`<%F]3N2%;F%L_UW"!A MY\YQR9-:FTIK)W.CTED#]8G'4-H-[TC?F&;[3S8G3A>%O!R"C0,9`QWURD_/ M4A4-$;NBT%=IIL23(\V;H79TPGE%'CF$E+X%?N/2%O6(_"E66]\6CY;CK?UQ M2DU1-@C%MJW)JZD=8OEQ0RLM"@WPP8W"%D&7ECT&&VW4#O$7.V;E)FBG MMG(=_5/'&V-&X62]1,/4Y'X[\TE2F_9EUG2*T$LB7="P$6JT'5JF_LR5?08?>>Z5XW096`>'\I.A@#6_"L"W@`1_@=P7>_BLY;)?/Z]:'W2` M**R_4E!'X,XY`%B#('N/ED%;/8+&2;$FJ%0KD&:+WERSIRHYAP1T&J':OWI` M/5^&5*5])6Z?ZPP8>=`:?5#/@#UP]ZL-]_S$3'.WY=,"LA5N/'(K[EMV"H;: M.-KKMEI@Q7K8!V`?>>X:UV!C+]S[,/?Z36;@7KN1IU<[]SF;=!T6-KQG.:N] MJ_$J1']!-*89988UNV8I#D=R-E;>IY1-4Q;;0$!9ARW)M@]AG!)X!=E?ZPWW MW%HB`JU96X(C]%&@B;_LS":\6X5L:ZX)>Y.*_Q?#T!R/']LM^4&T4LX\Q*'& M!)@3=(=3M*'%,\L4\YX0L"GBM'*VL%'&/##TYFY69V/M@')JQT-'&MO<[6^R M)EOLM1KT6J0/.$$_H"Z$A\L&_NZV"Y1/)KT3$+DF<[-HQZ:-7\AG^0Y7!3K8F7Y7;^G?J6[?)]7MH!5Z M2Z%'[]"OL#?>]M_Q2_^T\4N-TZ0113\ZSP!B]VA0T3X'F]T>++_B#+2T'\*G M5>P3!:4-4AWK\')V6(7ABL3^_9N;-F142_]ZP58>@EHYT1Z*D!%9@[_?ZRZQ M=;D!/&+!MA%3E%*(<9M3_C02*X3^6]:+'7=5OB4\3H+7AG[KZM59G")..=2% MAK]0T+!>KQJJKT/=6BBWG&9C+.J\/^2K@FI2YK]X$,<9ULQLK1P-V.T9U+*% M8HH?5LN3M7>O"K;@QPC;>Y1Y=6H`+QQJKI58DK+WY&18.FU$!9>Q7)ASW5G3 MAM0U/@9X\1*+EP&8>P(0\@>\2Q4$AN+I#'B/1>"I1I&9_7'7\5*>ZG?*&/#S M;#$]>;M:GP!^_0L.5E=X,)\N&PYKD_A]Y+#/LP79P]&^W<\ZL;H/G,#Z:>-# M^"IT:^"LGDL4CH+;?L2#A/WUG"E6>D-+"89^M2Y="+,"2G1QI2ZSE!J6H1R; M+5T!!GXG<@!M_S'L_W%"E53K<==P0P+X_"G@VG.U:;8'"CB%_4S#RN'0C0%Z M_],*0SGHZZ[UF@L,B%HB`.ZO*@3U3['03Z^I]2V[+YA?\8.:MR=8_@PKJW8/ M7+\4:P+G<(YI]/JW%TQ!D2!=-"M<=!U,+11;K!\@9?CAD[(E'7@\M2W18NC@ MV. Z3J/JYU=]`>;J6"9'\O!NISNQJ3\F1\*"N!!RTNJ M@!A65,",XJ@HH4Q.&D,MO02JS!$5%M;41HV'L6D(*CW'!8B,29%1_6C3`TN5 MZZMF7A:#\)9&(ZQ)7IJQ0`4=\_T(RT\G\.QY@-XG((JEB9FS&-EP5IK'X/3^ MLD2\")NN*8GD7."%>^OJ[L5)J2J]TE#UBX9JC,=8*P_JJ<>&U;NGVF('B(_[ M+:1)AGP?EMLLV0C:22H@40DP\'-78:36KDX*)9#4XQU#M,LPUF,[;Y) MI9A]DSW*41E7&:\_;+LD2BO8KFD!FPGKI7Z8;1LK>`2US^.*ZCI%20[#,OH$ M-H*D.TJ3"O=W!05X89-\^@PA"X\<]C=%MRXB%04H5)A$1&%J$B(OFL[ MV?6SS(7)OOVT=6TAZW.\?1:9HZ%"NN)\UVQX.2'\P@"N.2HXTF;=/NZL\F+! ML=9IZ[T1BPHAD&YXJW+]7WJ'DQ5YYYD!5ZZ8G-V'0/=`RXYQ+F17)F,L'9ID MO,_RGY>K_8P&&,ZQ-"3:XXS(Z3S$_WLB<6L;B"2Z;HO['7(R/L$R>HB>H5N\L"7 M0)W;;3;BA&@N6GMOW"):.H(Z7\Z3RQ.>CKABG9ULK"!,@CY--7+O@DY`BHLZ M-H>]4;A-5*)SE=!;-V3[6L5K=R0&?T>I?O!I]MMV\-K(J+\V*F#Z)\)+U%QY MZ=&-O,^::E:OO&1M2^UG9;+Q9KTN'/J]"1R?/+"I4R,]&O$OP_+8--/Q&-:G MS/&HY2A3F'V=P/EY0\:ZT);QXY]5\,U1!C*?Q[O->2T4=_>9)@3SLD7.H5C6 M(]DT*(P/(ZR6@*7K4Y)!;`33I+D8/B1^M^V[#B@B.ES/N(W6S'%5_LAS(*ZOUTPIB&@=/GU?;U1/` MTD*2`L0&<($3E`+FMI3KWOQ1CG$/H$PUL_:L**4BD"VF!EE`.`:Y@:0;5C"I M!S9:F_.A$?;^;OXT64HDE0MM\""=[!`P($Y`G20TTD$(`JW4Z;\`XHQI5-N9 MCM#GBB@(E%3?[$BM+0`?!'4XV"0-$])_;0G$!`AZ#27*=,$0V=&/@]/!:QW' M[I7#L.8%F>3(YDD0YD,("NX0T#>2&XB'"9B#;($:;`\\^HBXQ%]7ZU\-\830 M<S9+."#KND(VAV8RW8N$M,9XFBR-7`(A-XY M+1O)..:'J-`^,RU0@'!#1?8:-HT6^YV;^AL`:)XLML^#UX!4##5&'BBY0G29 M%]"',O'I@W@Z;G2TO!Z$0LR\VHB\P?7YBCMBQ+)*@1QDLZ+K*`1#UYNV; M,U?S1*8:4\?-TC;1)AQJOZIT!966OKIB+/\FM?\ZI-:9B(C8_DUB5,\X1O4` MZIM':88Z9=F@OKG19>.T.]@#2X3'AU'HF^>EF5:(@$]B*,/=I,]B47Z1I'AF MVIZL.0?(HTO!R)M.ZOYZOOJK.<3K203N]U.SB5IJ$#_KT$-.N^\Q&:K;L/A4 M44?]#AX_F2UXN=FWYM+L8ZG4B/8N(@)TCO__S8?"L54OX4^',J$1,1[ZBZQH MW,:*^KS>9U+_YDG_:CSI?X[9P,,8+>&CSG\7QG.FZ>,T0"`/:OTG4%C!6F_; MMUZ.%R@1Y'LLO\7&\!'1/;YP_A>6O:=5U,/8)U\=C_.37:\@L6IR\?X;J M+#=FHF]OK1EJ^,/K]S<_'']W>T0?NCPQ_!NH$)D%@E@4?+I,'UW1/PDQ4%@4 M/S3B#WXPDV'>2]WX]\'[_E)>PZGU':0]]`Q8FN#V2@\0XF)P437E-O2- M=)DNK]8KV(:/$_,6NP>[_8:[Y60WG7.AQ0$^Y&U@B]3$-4BG#/GT2&D47V9V MB7Y!JSTNK,3P8=XQQ3I``N-A?'5++=:$4M`>^'?!-<%,JCXK%_!"(`78> M4CK@$N0;+(JF^T'8("KWB;4;9ZOG?B'2O>3)3J.\*L,AL1STARE4;M72'((]AF/8_L<@5W0F M)G8T!%$S,3K71J]Z^NA\A>\Q]UK#;^YR4G7O$;#;^B\5/X M&L1`:X['3A0A*>]!N-!X$<$UDO1*^D(W=!9 MBA[2?1O$WQS74HO0+.ZGYZ<9)5XVG?][(H8I'D:JU=M<8_L:*7D8H95D.Y%" M?`R6(R*=5244O!P(-E*1SM74_AI$PSJ";2&.7"_@(//!DI=2FY5+?]<4TEHN M"*:!4C:G:J41]_RJ8_OJO7HEFXUVI_U(R_Z:@\$-.U3ARY3YF["[7/ZGR&3X M7RAX![N"N;%1"V9WQ_Y#;4'RRSHU.]YJXXH@O/-8_K0VTM8+ MVPQ(I\?R!R-;+6J1"X'*Z53QW^N9Q.`+B@($`KJ[B1+3G_#L2_95G'%<2`Q' M+H'X\!X3GV)$*OP')#R':-=>,Y]`(!B^#6)A81T.G/MA@>3$#`W_9#PK*1+! M@Y>`J2:O0D&+F3=6`?*42GX/KOB8/N8YDKCP8@QC[!.O!Y-"[*57+IGA??@6 M[@D-BH6YT.I)1H"9PO$`XIE'-L1D_^*9/92YE4#VT&OQ)/25UF]T\-*5PJER MVN[TB49[^-*-<`>H0S1NKEN2L$@2T^+RS&89OKMEW5*[$M@P?0PO6K`/X163 M7"N@;1CM,\(_1/0PJAM>?NV;`-:U'J(%`E(=.6.LQY!^D2CSGC5`9H;T3 M";6/.@1FD=52XK3X<<;7L4=2Y2;?SJ"&^T"_IU>,%8A.;\PCFRT#D5PNN7@; M85IYW9BK;H0I`W?#0QNJ14#BZ7C5R&Z2/D#VYZC`DPJ7J`[#)2:8^IU+$R## M$/Z,<7&4'\YS#K"WK[&%Q'\Y_?-I+?R3//0MT*XUP8WR=.1S M&L"):,N)"RTP[8]KM[^#B]UK8?6[@JM(B^,+GGNUX?#B<1;**[V*(TKD&:$0 MB#G4_N)5.>;#8"PR2'OLSM$&2XNI5P&;RR%R?`Q"BN24>.\;CCAC&(*)"]X] MQ*?\%YMO"Q:J*I33,M6D?K]+<78],0\S[\/4&A(D.&FY2FSZ,G&G(PK*_9_? M=\VD"&^_`7L#4S-F5UTCR)UIW?P&A)0&'M*XUGZK@MAJA^KM,\8LVMCWK.4] M=9=9&Y`B5CP/;M&Y'^I;VYQ7[2V:3MG>NIZI+8"=A/5#!1:M:7G*^RR&F/4S M%4^[7;G4$4(C;6[E5[2\LJ3-&S@O:GPL^0ZPD<`2A.L2**C10;Q]C,=A`A(1 M[MB2)6^22Q4]Q9C5R$-'+S>"U[DG8L M0*#/13%"D#C`\9W:$GP`C+8%SZY"68,KJ0+])T-&(.*!,,42<,9#H,?G2+_> MC1W=Q+\)^NE1XJ_I@)[A@1A\A6L MF7-)PM/[QN5BCE0RAI]]TGQK:CO4>.-I(#LDXJ"C[SCY67#R\];)!_/TRR8_ M"TW^6#H!Q*;EM/FD2CFY2?9Q&'-H##U%9O2V3A;"3%5A:A^E0.IX:$K.:F-Y M]<=S-3%4ET*@\.V16_L,>G,PASX5`N%ON?UCR]S0FKD_FOK5H1JT%Q5H_VQU MWVDD^&6I4I5`/GS-O3ACX_I+D';$+E\W7EN1<*??JK&+$:S,%>A$WM\0_Y0- MY]8LS$HVNBL`4/DM9R$ MOH\/"[++I61D&Y)=[D;5PA@6(M54SNS[;O)$1;*(A\\(,.=QOK5F/&H6X7:L MV4^MZ6PYK:]F"6H=+B@NY_X-O7RH;^B-?<4-HMZ\8P2.>ENM*QS:FA'C60/L MY,PF`+OCT8X-!:786=7A^`P*L-E\7GU=]L6!.E.5$,C:&`(+,GL?%?>Q!;=H MD9E+$',1'2R@.]?`(1Q._S&:N#.,C2@I'1M6J@>`'JFJ5X2%U&)>\^K&:%MC MFW"O392V&H149(NH%--W6ZX-K=?I]UZO"FF,V@1`^OXD>=J>FM-76[ MSZR?H+!K&*A3H\/,$)U`BJX&YK31H5()>OOZT[\O)'H*0@4$(U M:FVFB0[DDII!;OKN08(?M[9TR+#.5#%QS/0GU8WH_DSA35GV:2N+"GZJA[?6 MERYHR"',.2<@$%C!_C-=P7R."1H@SJB)HCQ-N@B!I?-$BKMD/M_@#%/4J&\T M5#R!,_+)1,@<'=,K-%MO`"GTFZY`4:I7EK;6C4#6J78TJ)(PD&$"`E8"EA&@ MB%A?"C-V2%7R2DT9,1+C$L#`KU)NJ\W4AVX$DF0KB@\8IA&`2U%\0)27&488 M?.C:^.PN"]J73!M%GG%<2A3GY!,+65W-[R)V%PX@I_6E1]!>51;8-'Z`QZMN M_)7:X>\G'NLUG6T.$7\GNMK<`<+5P53!EUD]*GG,M!$1A?+$&D@#`*.P-AA1 MTD]H&Q)8KH>/UDMX-ELL3B56*4JK"C?I]UGMCO(L/?S5K4^'V,._2S3\NT3# M[U"BH6;YN6@-FU_N'L%YN%J_ZA^8/]E2Y1(I20II@2O>6U">`!*JF)S[B)UV M'L&`(H`I:-S?@(-!U+AT5*(49OB9>!CA"XKQ=<66!WTA&%7_#`8%@'0(3'8_0G%3GY^4864^Y-\NFS]'O M?EB_;%MB5HL20F=.*NA*?CI(> M)[>%+; M,C0P!_NI(N_0(@@A:-A2=M6!;$'(9%F6!078\J#T># MJB)G0PF0T?7UL[C<[#:M(0GVV2_21-!$Y<+440BN[1'SM,VOUHF#+S-"_83[ MT):+$-0`-9TNRN>PFT,9B%&6)6C9HY#T)(JKS$+!!H*=$XRWI=@EN:K'/L<8 M[C:D/\?UCQ)ZFT;%F-)^[$_P_CRA]$#[Y1M73U*;^-I+*&R;A]F"$[@\>%K* MMD3U`9:B1!7.K.B1.188JN2@->L^D"O]TT0!>T=K=<<:=S: M06]_K\/HX10<>+O"&6@I:V;H7E16A-I=C"E/?(QP]R/,D(18$P:Q,$2YA#CI M"I.%\1+!WELPKM``"R9#M/X"_58UT4J0XY&V@ZTPL][",:89T[]']>P!`Y1UXS$R"QF[H.,8K"L8%WPZ M&M5?\79VN\:8/?-,8I,`8WY"5FV!J^82QW"L1LJ?HO4/<>]A75QYG]AF@F:J MCH;SI9I9PDP=E##D;>]J4_)7X*EP'CA(V+I_1>7G0PC!52/0\\72:@>XWB MJ,K1HY=A"1HHZY"#^S;KL59C3NT%@S_]A2&8F3,SC-6"7N1&[76 M&\/NP;`0NKNB00#?X$NP.Y78I\8;>#0ILAD,5.-=E-7?(+-D%$5LE6JPT55E M.C1.O/L_WFU7>&[AB8*6-N4%HQ&$%RW)W2I4]N[KV9?5`M'DV#%[/[DCU+D< M;Y94Z5Q5QWK!OA^Q!4KO>_^L&\Z>8RQ?/,(`.[,'8`W+W);X_8?#-9!F;HL4"I;0==U6%5I#B%9R]B$NA7CU]"L8![ ML.1YM=-:(%>8&"+QT,P.3*(CC]FE2%;0C^]$HQ+ M!%\UO[,QL&W`%*#J/LG-XGI'+*,A[4U7QD"E0;5G]$H33]C=NLWABA^T@8RU M``'[O<8YZ<8\\0!OC"X`F@;V_P@#3@'D)L;_1V2Y\_ZW.3GX1`P*5PP'`/D4 M(ID`?(`Y0!KB<%,Y_X/\A>_O9]E%A'`+X/VWO-RH`%N1[ MD,MU>2Q4M?=O$(SOP3`?4J01)0$-IIPG6W#R#>4,=286.[N'[%Q'"39D66,A MF8+5WNY(*[=@='A.^D1ZUU#PE,7%1J#H-^OEECR?)57JD&)5$FHK&*`=U52Q M"GK?4^0+F<$B+P<<+>_,\!5->WCL&.+"<*>!F6F$KG/,>IY27:A\%&.,0DXQ M[#D$*'GG%$XIG-$1_VL]DWP<+P3?!DMO@46$C>QC_&>/FSU:PX?)?'E,)VR8 MH85G3-(3O#!W,X.6`K\JLHU5P\BU81)SCF%,P36I_G-5/U+#).54QL*C!G"D M),;>S/E_#E<[KE"G#UX+?`(?S2HE6O-[KVGJSG<`(+?RO MY[[XPU>[91V))G).I=S;.7;SRR21\3D;#P*:S)C)L=2Q'N9D M%Z>KT9YB5TSQKAW%`W*M8ZYZF>R^C62=O8#NOJ)"LGYTU!&HIR`0D(O#S6.H M>N5PS/R=PO4R00>":?S04N%X.*;#.BQX'V6,+80UU+E>'-GM#AE,WZ4,S126 MW7,F0HX%"U2X5Z6,J*!;36+!U-I,V'O,J%%8+)TO*`7WRA=82.L!]0:=.G", M8W#;AZ>B?V\AY[>4*8DQ9N78KJSI7`/Y)+2OR;QU9JTJ://6%M6/-K;)=8#< MP7L,=_("#!9#WXVUX@YTON0BCWM$,P^78=S09'J?P!["*T(-R0GJ)[`R MC&/<36](\\&`-KT*`?D0AGMA(925K-A(_^#TL\G"`W;5R60\,R2!M6(X7'FW M40ZLZF.(&P/RE(-YUCSVK/-)T+G')3FP*_1ZMS*+I,+:O!!QW%VU4!80:U0_ MA>!;<`M_K0>P^+#ZNPW-F87;[MB9&'JJ9B.@7':*PK4-7%,`VY458)(_(I[2 MCYB$^*/=/[HWP-I_1$`+N;<1NS-Q4T4#;Z0"])R)=K4Z/%3,M*6S`)Q&?>Q6 MBM]X:P4J'HPMP7'FYO\$_Z=K&O,>97>,-XWQ@0(G+.%IBVU#UYSP[87ABX<3 M*<2/WO^IZA!-_[=.O,TUV+/;_I`YI^FI<(93.^>)&N[A$S;&_S.9MJZ#_O-L MLMA^OH/1@1UH\&D-(B&\LG'DD7>5DW-765LW!%W$-*+:N:/_+^&ND#`[P4C`=9:P:(?,U"Q MDPK_ZXPQM]'B'Y>SDZO9^@ZR:1[,Y6H.B%I6KSKCSAVP*F?F#,Y.GER;3]CF MG6U3!ORY=88W&FK==V)1G+M9J6#'+V43!G]],^-?9?A++DD-6=/,[KUT';;- M.3';/=BRJQ0+!`&#`#2[5D)(Q\`B^WNAI1UR@<_.`U/5X(2<'&9?4+?6U(E4 M;YK"5Q<4G*_#IX%<)$#%@0+`7S2DJSL*18],H,J'53B98]'0.@;_W?ZN4$F^:O().TSW1[$43/3;:04*%1M0FR& MY[JT@[YKW[7=(.PH#2;=8%9$E974RI`Y$_/:TN[W&6_VAOZ>7 MX"Y^JQ[[RVX%V_(*PF%0$#PC>)3W6+"42.OE%"!U[D@H0]OR.RST%!][`'VT M9A]O8>;0G'FY?-JYNQ/_[E^6J[8[TV/98S=V!PD.V"-@3#_.8?L\D0(5NS_N M!./-"X#0Q!LS")3`_US,N@>,B$Y1T*!+-G/7-O`KPS\QS>5^#AQA_IM+0+K? M0<@4X#=!]$>&\8"`#4P9!3^;PSEXGN-^6,&-Z/OT'*`7CU!OP2PQ%XFE!B'_ MJ&`_&748JFTM[]B8-`%`J#@>*ZL4?:)5B"&L%&SWB>=J'*!K\KV7C@!Z?0.I[''-&Q$MV#E3+*\S_T)N$ MVVGNG)1'LWU*-R[_3E%$'?C2L/K9E"S8VS]0M%/;JSQ?P`M8B-VNT[O=OGO-L7 MLMMK^66:";A5/[>KW@V'#HL)YCG06`%"B".GP56!^+XYZ;(<00G@_Q/!M9AS M3(_%I@Y;F(L>L-ZTH<)]`%K5KP]Q:Q_B'"UP^Y"JD2!VRM:BD8K2?L68"?6' MY'>+J5`+6@/#?B0@?QC02H%Y]C8KLVYTSE_T(AYV!1*/3\D>#WX&^]C+RAI8)5!2@9L/X` MS&:('BXT8B!^9K.\3=8AFL/%ZAK$2[F=ESL\#*`M48,[YX0 M1E`W3%O7IGR[A20;<4,9Q31K`EM4C&^^D2V'=F6S%U_)F!HU\'Z"%DX`05\S M:)K"%1N`,+4_*A-$93FMQH3./[]S97MV2Z!\>9%'B6%U:7E:=5)W:OXCE:+A MGG%`1V"V_4EI6DIJ`H%?IK"6Q,]CDI78OP28[KZ<.0S-T.3RYO_(\V4G65V= MV0"VCRH)U/!'OW4]U6E^6F5%U8> MH6Y0?LN7%8@]&,:9H'$63-K7\\VO)_?KVJGWX79>969Y`3C3PYB%8U2%9A,G=28W<1M6 M[5NW^+2`GV.@>[W631OM^RP;(/R`^-^V;.9`C]";79RFC:S$=JK:`H?E+[N` MG9+!UOE%:^Y/W7*`AS!=FI&YHOF[8^&B+,'4862ZF@='(2\AG&<)2?#$C6H4 M,Z!<)5$Q'D5)"F8JHT&G(^)K9N+'AB=51CC.C1B=,C7;BN\]F,061TEEVDNQ M9I69>1G=%-)*RRA-(<0"J.Q8<+#^\^UJ?3_#^J'#-(&D0X1FCT_+M*/OHI(9 M6<=<%V4%M1K+S/4\S:-\7`SBD5',1KH;,:#N1$4!\1])=5I4H8XD&8#S(%(# MQ,YW=$34,M-D.8ZR+(7)*J#Z$R)O@J?NKV:>&$9HAQ!4LZFG:'U!H,H6(=(T M/,ZJ*#5$)T?F!(:W'`QD-886>#2.1GEFYGP,X&%F%B`]S4Q3$QA.`>*<*X]: M!('1N*\I5(F$5*!VWH2TG):PT?KJYA=WZ!Z/1Z,?]Y324?N/316TS0(;D"7>*"Q] M]8ND^_2YG0F_-T1V!AFBBY5BO6;7.L;+*1#HJPJC&898Z'9U]VN`A5KWU-7, M3-?#>F44\Y9[D=.FX!`_7ZTE693T70@\@*1_X+5%M\])J1\TH;\L]X!^!P4' M;.KF#`R>N#?9&>W"M^YI0T*Z$8/OV@BUR4:G7TX&$%$*I_T$7<_D3<(2[BBZ MLHF)PD).OS=]:%('&XG:B]V5217%XPS0D\M2#N4PK4:&"8*EC[[WZ<4HL3_L MI1=QE!EV-3)MT0/U7LH;XR@=)Z8W:>B=:6:8R'C_2X4BF/OS<<)W7[=2[.]. MK(LDBY)Q198_TP$9;&(F.2EC*/UE:&>?A3$DKF1T;`SPJ]*$EAY!=S0@$E<^S>FQB*')EZ=Q#UJ=&_Z1@11@^$?>T.9[15WV,NN\/(#3AXOM&:!9MQ=;^_@G91_W M`-HE,^<-%'^?$+J>=\-/@,7'`(;.\LR6K9XSM:]"+@!Y.N?NL)!8XA)"=#^V M#Y=0C`@Y!;RQPP*3CA+TBH)Q>T]QV!RB=OFAH=FQ6&-Z5%J8][TO'28NZMX& MUV>$9%FOOTFGK&/Q&).)LJ]RS!R&T.T]OA3T:]N2K24EFN362^R_"4-FV4C1 MJ+XY+$:N7FSL!8]_VU@RQ%&`V=GGDAF/".]O+,B2HS]-&WM/S3$KTG^^]TZF>K\1B[49T6`!X^_,]X99`7K@TWRJ#VQ3D MBBD"(]E,`#"/<@G5>_5J+^9:N?063%NFBK8<#:CV.?QO=B$*J!V@:RV!BT#"CQ(/6`(2[&#$Q=)/X6R,XMF(5]S3A[G M#!<$JTQ50R%FH"]"W96XC%2L?]^*#E!>RHL!;N@VOH<65-;*<\[FL$C:,8M@ M:-HI6^@G$@P9Z11%,&90Y79W#.N;HA^UU:IR.[.E`JF M9)"@Z,K[4):=PXN2$N4Q%48$1.J9!U\3H]DZMA[^/7ETJ=0P3X.5=USOQA2) M5757$7@_7\X?=X\,0F#[`#.$Z5W0/'D;\8X]RS7')5+-/W+S!$?PI)M?^LWC M'9MV(]HKJ;AK7D-=\0$4ZH$'"==3:6`5&"(TJF'SQ#EBF,3>'K=1='JC5_P= MX(C-R+>22+(ED;66$1]!U5R(?4H9O,]:V16F\I/>`E?D97.Z>FO+IM'ZLKPE M@`S3GTM$%W3$*!Q\UX\L^2%,9RXW_)W*_GLO`:=H&+BV(:88_M?CM+<$P*(A M084NJ)>.T"-_DG#$L\XGPJ#`P7:T0^BQIAAJ*(YN;V=&XJRV^#6 M20D_+&$X`X=MU/'3.UT-P@+F>WDW%+\W90!91K`S8Z"& M[5U>^:0B4TG.],EHY3,S:9!N1HD"7/J#DK#(Y^.B%`&T(561LE"[B<-7T?+/ M/:6F?='U_WO[($?,@H2`Y>)$90:W_G3P/HASM0_4AV_:!X8LJUA3^G38/@`A M7\?@'F'`+*&G)*ZGV/1A9;U;HS_5B,_UB!O1?9T*./?)<6U`81D%A0P`E7#Y M.GV)P99B+?!X M/P8;9-BF]AH.1G9:MD","1#;N,P4CG\G$AN"KYF_XS']K5!7--^/>N&Q`=F& M?ZB\XG\]$-DHXAVO@,?MQV0K"ZC_3M?5"&QW?5#9LQ M:.E]H-F*4:X(V%YLMG$V5G'^^\#9Z'^^N^WD;YBL0<3?VA)`""KI583V,WB/ M00OGB.L:].\4($O@"PB,)1&/RNZQSRHVXS5_'L&(T3CTE)YG&W_5A:]E=*[) MS=UZ_K0%E-*[TT$:<]X9!;2\O_NSD=XQ1(^2!M"%!,Z_!&Z,(9S&'&X(N5UP MOB,WA)Z]!/Q_"5R=/1I2LED9/7_V>K8VG,!K$9HA5R"TVCYC/`L;32B^Z]P1 MPG#X-2^"OP].(,X(^E$;\Q_#W,=Y^[2",Q47H'M&XT2F]"7[CPN]_;Y[S\B0 MGR?K^HX[NYMM)T;U6SU]GBU=1X9G5Y?'>!ON%9B%][/MY^<%W(8VT\'%]0"W MT(AN:IQ;>9+ M`'[@.YM=6)!K?>X_=RO/6:CP3A!"9OX'!PPP9!A'#Z],,>&I]V&,J@T/28@+YY;(/5K5^ MF`ZF*2!;0;4_(V/@6W]9NA)`C`_SRIY4BE]U-UA\JF$*P"DE%ZM.DI*M8"D5 MMJ[7&/2!HH?P?G2TQ3FA!H'SC)Q+5'J!PD%T^6$C%!L:LF%?6P:^-:Y86#*H M$19])!"DM=?,W)8#V+!#*X^MJT[%U-XA0C'>0>")PR+#9:FOI[BTLC'8"H=% MCATH8!._T64?<.[\@6,X5GTSY#GBEZ.#*P$_9V`?X"@+*,=30.)JH_X`9'XB M@E%<[NW&.`"2NN">5F/75L>8?ID"=TI;O!+6V]7H;0Y)8XKFW*-NCLO MRF_FU3-5Y0YQCQE1D#?T5.H7J`2A!ITZQ0UO>^/M;CN-A@D:ZKUN%!\YQ5WG M;0C@DM)MC$2;BH@)"OQ<%P6SN4BKN[N=Z:#141T(1&<5!2"3-[B!T/MX(5M( ML/DWP%BNF'W6&W(TUMPD55WO#=LU:VE#Y;QD"B'I+5"Y'?S]"!A*2L&E,5M5 M$)3@'HC&%R,EH5Z2"*+SY7+U"'ZY4HOX%[]-%@\KL.YG`]1*XF1L2PB@%:L" MDEL"W>O%!W]^GJY7=ZOI:CECV0(VT6?W[0F<``YC1KD(\GS'D*U+3!(3_3[^ M]MQH8R7?!5O(D06@Q]9'GYDN3@\^J]*OOH= M3/04@`7FW1Q`9M@L>OOLBY]GZ]FDKZ#X8!^$@SA1]AP-E>'*/!PN1G)(,Z9] MPZI514I&P:@H1V01C3*L='RQ@QI+1L.93Z?F71<3!O\ZNX=5'"0H_20HB20H M#S&60@JVN1QL%AG%)W1M$IR^!4Z?16)6_:O0#G`T*!-`8-S3(V`Y&=@VL0`M M]2;+J,8UO+-"T#5H%')R81[T[X5MH>)%#J%+^&4Y);[?G!=.=X%0&K.C,1R`"UIT MUA.K<>)%HUWA5(8E<`^@S:,8R(JJ700EA4:J6M%^:!7(TMY`J+%YV^*Y>:3D M"/QE-UD;$F`&Y9Q\I+(9T=IL?G//<4_U[8`6^X5EZRS6H3F?_P^U?#SX2SSX M2S+X2SKX2^811*A/A1LV)L"0LBBX!!D(F%3KQZP7A&-D(Y#=LS%PS'R$Y!=K MZ'"<2D=%0ZRV7,#)0/C0:N2B6_I4,P0#'E6%1\6'L4]=0<,*!.0*9&'(-*$7 MU6I8JIJ][=V$$P8^!ZQX.**JE&8+%?1ET:P#V;M5\WA&+6)[(\ANT6@KO98J MPY+SYB_R-\!2)A39<0&`;MY2)50Z*`$=,4'A/\4TFMXU*-,2&;YY1%P:PQCU MG>-#%@ZX[Y#043.,(2I*6XZ]IEG!OHB!B@.@/:J6:4Z%O;]E)<>T=BF6L!R= MYB-!B!U!R]^RGF/`>$XSVZJT";^ZXTRUJ3%13P4\"6T$310)F1'?H=3;B"`3L$AVFL\5F M]I44.96`O;O\'/QX>;B#5S=?'QW^>;LT^6' MGP:OS]Z=?3B_&-S\?''QR<@_+:$ND!3(?,/L34^.>UK<^5_X@$$T<-//T[-3 MYN@W1C*>3^<3+`EZL9AC*6#53^DPU?IT5[:\ MI_4,0M(BJZ!R73>S;6IM1F,L8*NOG:^W<_[TOTO,L.02D:C9V?UKI*2B@@BN MN(1D#R#:HVB$+K!A9GI9DDW.(FG)"J#;4"T#.+%I:)"+42*?B<9%8LUT=':X MRQ1*'J/8SHNY4183PJVJHAAK.)B34.(;1AA2/HX2U-.QA`BD M$8F#5`=0P:K=J#+(_R&X'+(3O<"+/A7.ZL$WR:G+JL1J/O:@/DV><8)HR*"3 M2W1%C.@\$%D`7-;8D)=SC4C>GL'78+K M\$+N:YY7+PH(#)0@WF5EQ2_,QZ4ZM?KF\-8K9(1XX6T;F0TYJCB*,>R_SD.K MWUE%Q0C":2NP$53XOWJVPGP1O_8:-F@V"MD?"BF-979+`<;NJUKX>#-Z7!%# MB^!'5Q>>E5!WTTZ&!$3A13>IA?SJQ%((NJ9SXVX/OB1.;(DZO'+CW[]:/J&H M'7%__\J)1@M[Z'B'^I9D.2\T77$1L="*1J,Q'/',K":8@89Q$N6(V`?U>*-1 M!8J*?XXY'"N/4C0J6=J5&M*5`NG21$SNHA[T(A`OIT'?2X21T)=_&1$F)6`0 MS``J*Q6?5HS`^;%7@LF*,6\QN@I),%A^75WMD6!R*89%5_TE&$S=PO2-V(HP M"2A!_428TH_44J"1+?&N>THM<2SE,^FJ0W+)L;_FQ(\SF+8L MJK(<'6'C*"Y<)E^GU))%:9E+E5#3`.JKXRA-QNUR"TX$8$>HJYK<8OI2CDF6 M-]TK*-HQKK#4_!CU54/8LI3SXF*`R0"Y^`\266(R$*4ZA!CFNB&RQ!S&"?4: M^?R@4>X%(DL\MLLZ5J)(4V1!6]!59"`?$$(Q"REXFH#/T%UD0/,1>!$46 M/)PDMX&.T7I*O5!:\*J/8?9`G7`'M4++6T!*,05/X`7W>04D9R81,MU3RE%A`>Z.D1*D7)>\'>/E$)!CR!&I%BD+7B@ M0_U+LY1G@:Z:D@JN9QX5"0@E1@1`;%UH'ZN<'QMJ5R)A#@HI&9;''3&E2D"D M25*R@#J2)3<=)*.\C-Z\Q&SC6X64+0B?V9^8VULJNOET]NGB_<6'3X./;\U/ M[Z^N+WXV]UW^]6)@GO_X_L*KP#"C"H[_'(8?;>(E\DK_.R^4_QDK-P"D##YC M#TL$)?92[]HS";L;R]PJA'Q],X-Q/42#!W##$#88D8T@OWB)0"NP$MNP]#(M4R<*:9T9R71%TP/XNI0DL M#;V^'%7^ZU.<7P+!V._MH.6IIUP/1[:'L>#]`_ZA]H&D26;GH$S&Z"EQG<`? MVP`=[$N!B4I)/O>7]>.QO/I%8):Y%0'D,!?QJP#2%AG@[KCC\JP#4;489FT MDG24BX'NIWAN8@LI$R;HJ=BT(2:VM._83\XK.V+11GH3\V$B)"(N8N)8D%F$ MF%JI*`,(#W0@.1^F<=#2DRU'VA7`0FAPL]IS'70;5>R(L;.<5?DAG[$G3&*[-^2 M_.0Q,0S^]KS1")#P=)Q(<=1T5$BUTCRG'A\-RG&*ZH"]\8^@\8+$],]"XR7" MJ_XY3./+2@@N707I>YF()9&N#J+M.9I38B-R6:&W`@IU`&G/Q;Y!5QVDW5FJ M6"[$BP:-3K%/XP%F!1*W80FI'Y5.W.&ARU8YG$\QA?R78@C`$)0P@8XIA%_L M(/`Y[R#0(UZ8D0U/#5-GRY[MWZP'819M0]?IZ468"U`D*G$:8\+^,M'XL@(78U^OT$2&/V)%((OL@CO0EL1OP/4_%!D(8F\)L6:;KD M*DIHN#L:D&\.+"MI(?AV130NQM=_)D')V\_/@[;N/?[OYYS6? MN#$/WL(.!?)"U+L@8#E(7Z:$ZJIDG:Q4`BQ_4&B<&ZEIR9X4=R1P6!:DP9': M"$+["TMN[<>FAV/NO";FU975Z(V$0/E0A36"M#A8GMFV$AFES3XNG^!:(>9B M?ZT-5)+58DWPY@4H`,2)"`3P=BXOPT#,C0?)&ZH!#WB5\I+S MY**\TM)O5&;$$;G8.)`E3:XI;)'QGST$$#N?$NF"%PA02:8^X)N;4L+I++HZM598-O=KM9KS`&F-[M--J1+>KL< M&\PU@6AW;U"\T+6=IPH%.>QM,`H)N["GA+_SM]Z0LQOU=9"`N`G4VS`O>+\E M:-(S2XF)=T/9@,>HZ\.<=@."H$CEG99A'"N%@ZZA8\,IU\0]=@6S.M_,F+B]V1>[+<=CLD:`O'C!*=#K"L%^./OP[J4W<)^^#;6 M552I:])][&9="0UT".G=2,*JF-QLX#@K61.Z<2S+E4X1PH;;;31BH7U(ER)] M=S.^(LWMO?*IQOC.]5$6:IPU&%\BTC]>]&1],G;$SN;X^:@<.3=F%D&:0(4, ML2+:_KVX'[B:@/560I+1&_H"[I<2[TMCY:TAR\F+N9XL._QMYWD%9Y;'3@0K M8ORJ+\]+)-['KB)\$=QL/"MVM\LN')/V9FW+ MACEF7-@;W&FG[_P]J__UYY1`UZ%8C8I=H`1[V:P0HE2AO?!@3IE97L^7K!,2 M<_089C>?1*B!E/AV5H@9($O1-'0HCX3'<\REC46+3M!N>`"/[!$T]_LQRS_< M:/<',8/W\(M2R6L\G4GGV3K&VI' MV8BL9AE6!M[/Y\9.2<5+N/`I@0TL/DU[\BZAP-BA<98Y0U.)X3A)2GKK]V!7 M)8H&ECG@I\,9%2V=$YGI\N6:F<2F8F1J&X_"%3I6[Z?/,,>8O'L/"`N`E#19 MVU6&F`R:V#'F%9-2ST[SOJQ-K,_RSZ*WMW$HV%NTL8C\JIYWLB;<47J+^3M+ MN,2(4_K[\1@JJBZ.RP+C'H:TLXY1!AX=S%OJ6[R?RO4RTA]B(B&F>Q#_B%$- MP,X<<7>L8QNZU`3!O/L5JBHM*;+R-147NA>`9(:Z>4-@[$`[_U,DB/D22R,9 M&G8$U^^98S13JY].+6_YY>;-8'C4S!+$>]C2Z%Y!_X=O9LUNW\U_VBU/;1G3 MO2TK$VUX(OYN*RIL_JO^]!N!@H,;T;;=:!_K5JUTK3P$N9[J)X>"XV)F^[\' MX8Y^],M.1T`8&((9'M]M5,G(QF2?PZF:SY:F]1X^JP8P?A,^ZK\'1XV1.FAI M#;#+8<4P\BO#^@FQW^ZMDP%OCST;2F?9[VF\:[UN/L^?GBPA;F!\,\JM)1L/ MSIVQ]UX/.40]&*F2&6:(%CN\L40,JS.0*F8;T]=F%\TR;6<,H#"OQ^&;Z32L M^7X'4:M?FELH3JA&2<.9P#CH_RUUDDW;GV9WGY>KQ>JA4?XLW]?(._02(B,7 MV)/&W>6^1CZM)],9U$]OCB+=]^SKW7P!1ZUQRY[$"#MW]XTC$(_VCAI8!L3F M0K2,X6+A<_G]Q]-IM]_>R/I%E#_+<#UC=I M6V#;2I\%3MLFS+;2OL+NGM:5S/9WLM=Z)'N[V6M%[-T]5^1Z=H?H`%(27M&Q M&^`36#SYPV3-,02:%^]EN\Q26]CNA]E7CVJN5TMS?2<^QS5#;!,$N[K-"$5S MLW4ZJ>LO2T:I,R-"P=<*[Q?$-P+LTWF'/SH7,\S=&Q=[8!A&`*2BY>%CC[M0 M?>#-=O`>"GA3PS,@CF:%;IXW,(R^/(B[8#VTD0]B0$!`KI;-&RH-BMTWPJSY M^+3:F.]_@G*6FX@1<6!RVV:ADY$=SL7[XWRT/`F:D(V09I6HL;\.0!-Q'OF7 M[XN6DAD_SQ;3D_O5^@1PLEZR(UIZ$+F6,3VEY]8))#TVQ#L__]#T"LNY>*E_ M#>!G3!)AUJ^JA4T:,%T$'G7+^W4#^_6P#J@LF'`O=)K,MW:E[_)'GBQH52:( M7\4/G[1(]CM1!8W+V%AVA=GY\BUNV6$*T"H(TD7=)N,"<5LZSF,$'UITGK5G7L/AER<0UZMU_&(5(< MYF(Y04^*W!HQANG+B4HPL*C>'$8I09U,-\_--RH;9^>/-ENN.=><1:?FXT+( MY^L6\OG&W&FZ=!>`Z=FW8P./M-?!D#Q?PX=L;#>&T#9.-T9F8;XT%)-;#6YG M]`D14Y?+&1XO@C6<(H^;A][G*E,#-.E7!)9$8#I;.2A,CWI-VJ5U`[S1;@#) M'GW73KL\N_;KR:^SAFC^:0*3&_K%#[;#\.,A[*QCVEK$[B.IV_>IR>6<-G)E MM9$+D1A16#]XS=5B2ED0#QJ2UH\ZA]A]+?HE/:3RO/GY%W7JXV_/AA`^?084 MPHOKP"PHLR7P:[+`(&0LD).S(.\[YVHS.[."SU+^SO3Y[0ZC50.M?NS1JH4I M!!X%60]D1_2IH=+TPJ)KYXO.K;_+S``[ZRQ, M;_UF(+A4E@?57T-C=H_-^;C\%4H2U;^U)=NO:!UG.ZQU1IIBDZ10*2B9>IT8 M#O*643*,,'4%OECR_=S+ZLS`=-MZ*%VSX@QBZK/1+T"`D+6\Q8$LMIFNM0_/ MM/MHUF:#9O'`E/9J9#-;0J'>W1)K.,VF7)JGQPH%6I$V7#DD6ZZG1X-M&];, MB^F3^0TJ6))YJ+FUIC/H2J\%/_]P@TB2DR>\KVU;$"+Z?P\.VTT?=A@-@&*S MI1VN\N/D"0UHI,5MC8"U90FE%\E9`^[VXN3],VR=&S.;M[<];8AJ;MFE&\E< MZJK!DZ#.<&VQ14!<;7`?QH8'^U['*O3LJ&'&9KI!OA%ZV="."%Z^7W-&IS1J MP+3GW5>SI1%'YGUOWROA'=15FN7GP7K^\%D]?:#;8M+".=ZX.F#_/6AC&4AT M+8Q*9Q-ARNO*=9U3N:ZW-2H9/3)JPRG"LL=T(>.-FZ8XH:*%2+C=&ZR"(CQK.6(IZ=)?DC? M\:=WYJ=F0WES$EPQ@QIIV$+'$%3T0&* M0Z?&T"GW=XKY_:0XL!<]+-&+T#7V:.",&"W3$&%I:#`(2F4+JJG%I^/O9[<; M5"(;8J^%01N"$10,WT[_:TCAU]:HV^1@1CAK'DX"M`N=6I\NADTB`KG68JKM M-!*W$=H`4E;3N8-F'QM6ZA>6'?+;&Y/3A%L:JLX&M!XVFM5`I+AL5->CK45O M.Y^BZ0F636W8M2=A>1YTH#WS>S`):):^I>YX&LX+3GE`X_'B$1O"Q6*W><51 M4#1Z:'WBAM/@QEB+?=>U6<*/W/74_`Z>RJ:,(Q3D!?/7WABX.JXF:YS)$%WK M5+-%S.CIHF]0"KOQHL'7&8ABL^G)Y(MI\V'6&=70XD47QP4:^WM+:R30@&2S M/,$4C`V6N@HFM[<^VVOXPSPW%+?,[>QCO"=D8OZVVOL"BH/-QL?)]J MUV>K9EI'[%W,HJF.HLN[2MQ"L MPX5Z6T+C>K;9+3AH0=MASS$X7)GJ-B]@4"Z)@MV.[4)N':LC)-=0G;'V-G3_ MKQG[]3P46\D0N7K69"6^>6JOUBNL<#+1Y7+;YNY0ATJM7`W[H/M4EFG(MO7R M--J?[1KLU=8W2T$#'9P``4JRZ5ZPYU[TGDYYJ+/\;%/P)T`?W*MMH@R^_N.] MA1-_'MQL9T\GOSP9P9H@@3ZVM-`L:6LW.B'N[`O1Z)X\OWGL";T#2X!U.V>Z MPEEYXAQT6X,;&<*Y>C8+`;8SR=!J[C-7E)2V9R#Q91:.[L/$,C^5;`W5!3%. MDF)8^S\"[[BSK',-$20'O:_%!&^&;&AQ:T1X#6%I_RW![>$K=OMN-V>$ZS^_ M6+];-UY2J\(<5L':*M"V6\:X_FD;)0_4`VV[M58/M+E07,_Z&Z-K>1UXP M[S2!:&@`#<-B<LIZ6+M M?$N+1:KMUV\Z&DP`\3Q\>GYB#*7-2P[%N>.H'ULY:O#M@[]?`\*]$2Z^3M;3 MQJ9];;.Y.!2X\>;P<3OG3#33YQGK!`?($:C#/K4XFJYG$GW9XH\[]Q)6%L$# M?D&92BV#ZA<;VS(54=^@X\`<]7XVM'4Y=FGO/FAY]F6#]L]'WRXTGGK9R[OX M8:]^=#7PLBZI# M#C>\-=]$M.06HWOMT(Q]OGO<+2B)PW3IC6G'IU_M4WR`T$A9Q7-YYYWWSFF` M:;J(U&^57KV6NF15IVPBB.F=>>?S/9'5!G+)F!]?O>S$T3:PH):0MT M_GO\7]'?D\;D?9_8ZJO9^BZ@!R1QR-*2!"UJH4A;>`%'YD:#/YD=N9G.*3C2 M&W:3C[0UUHCWU<.JVS=>W.C@S0[/AZ<@AMP%?=X@:][^ID\KS_CQ#7,1C&3[ M!0*IQ6NJ(`LXBN?K:K<`)8!BF5!$-:1POMUB+-3\'JO/;G8;<_B734-S:^,1 MEQ0W#=Q/OACY_';Q;.5/>J=`)V"M;KN-H9&0--^`@C5KLFM[>Y,H(J8#W20P MKJUOF'!T^"%OD+4AVY%Z2)T!0X@A!&^R62UQ.JX,N9L'$GY44I49*H+!6$+ZO\WVFK@20 M0H;0.<[]FJ:67]ZJESLQ>;0Q`N+L?QX,KV?W9LS'@[/I/W:,=$)!W[@/\3-V MPK2!L4R[[>?5.A"P$JYZ-`QE03UWI"!8)*+(#5<[LP/.O,;1CUP))ABY&^Q+ M:9;G5I<`@FV8S_9[^$LSH:/'G+1,"8;JF'%!W(]I#M!`^JI`]>MR:ZAEWFS07I4K_>%,K_:9K:';,=P4=>S+S.C MVAHFLOXR-R+2\/+ZIIE',_V"\I/@3052XHPV1ZE6&\N-\'S=&8H#68BP=H^3 MK7EKTQ#QHM9;&B=J_Q2F3]_Y35:`:7E=]R2C<8+0:AJ$XO3FU"BF;V=3F_*. MV?@A>HM>:A*=C*0[(>PS1V>M*'&`GFJ&UHM67UY?O#O[\*;^M=816H60KMK$7C`Z(Y8BY)<"X!#C-^.00#HJU->T:/19%U/2.E`>RT%F8HL(-``7#U M)QIFEY;,.]E@-DTT)'AL,#%!4F=Q7_@INO]06FG3XN-;0WS,_L>GU5+.K"Z- M$+2?&14`"S;H!K_)A=_D,'N\IFT#\?+D0X,2BDV6KNTJ/,"7V-Y)='[5\KVN M&?HD";5M?+C12$!D=\@4[>VUSU,S[-*[UQ`3(#@[]!^C=0/V&AQHFPS\@BFJ M.E/V*>>P#`=0]S<,F:X+W71#J#W4;B(*QF[Y"=">UF3>9H_CQKY.K1(F)@SC M`$L5)0YMN&L>!6L'S:W2V!(X^*FU.1E5?OMU9B@2J''(/V#%\,(C"@U#7/)? MT=_3;S#$O:%X<;C\RVZR(#0,R3]>+07C\KG5$I@UXV+\N1'S0$O571@G`/LX M!BVY^6&I1TK>.&,$D-CO^`Z-0VK8P'9IA(7/\Z<&84`)'?#M"',(\[O;8N+^ MGC>)H/.S1G[B=N/A<>/AOQ>-KX10H:1!H38KX)>]D`D^&6;F]K_=^.O9_<+L M(V)VO_SOXJZMJ9$<6?^5>I@3TQMA/-B&IGDY$327'F:@8:%[-C8VSD-AEZ'. M&)>WRJ9A8W[\46;J6DJI+C9Q7B:F<2DEI:14*B]?#G\?_R\\6W.Z MHB$S@W(=J)W8Q'-YIOGVD\-Z^P-L#M>\=PTRV_VBWC?V62$GK"VA;'RBQY\F M4$!%(@D/S&%[3I>;>:H<%C-U.+SF4+U3MDY^9!@-)938"6&^S8NZQ_XQ88^A,!F:9=8TP^7Y= M9(^Y]-TF/](*86YAIP]H,"EH9661DJ@RUL*9W!>_B=4`J$:9EC,4KR&A*TZ? M!G;WAC.8__F*+EAQ%G\"I&S%!E#1:$BET1U@V!*D/2X\=.#S7@_T)L-_5\#!AU8S&ZW6B!^3U"..IK<@A MK[PM;UAH@,B2M5 MA]J=FT=.>]<)][3IX'@Q\`/JS<"34*!QE;V,RN2,S[+HSGV/IR'T2; MWRE9W+.],;/[05'I2@)0X^V$_PMH\.M`IKA9.XEP'%FU[ANTJN'UP37>,XO* M4OYTUMGTK0$;L:6/2:$6P;U!@2!*`XG@&-&'UK`BWW*/)F.)CR;+.697#$)K MORS.+[?I&]@%>P.] M@M0FJBOK*CZ&LYBA$0DAQUOXA.ZR!U)D>7KG<$MG6(D'I(OWCSUTS+T MD6)F:6.!=X?C0N4WCV\X%[OYL63`SU@'@,X-EFIF!\^;M1S>DD6#N?U]%G>4 M,1-UW&7L;"$VUFGRP?@[52U2SOI6I\-AO77IJ_>AVIE\#[B"'33.0*9S,VJG M=K-]N-*I)(328\9I4E1:8?VV`,V/?2)!IEJ@Z==__$<]V50.'/3NAX;$&0OT M/D0V.9%D#4#-/75P8S`W!HE,K.DRN%D@%Z?5\$[$E8\$0*U'^""2L-DKZNQ2 MW?,2<545IC#A\-:P=[W^ROQ,24J$'4H3:YW\Y&^UAH0HW;V!EPKGAP4\S')^ MIK"`4#DA>3H'@P_!8&NV#FAV`:D@*5V$C?(G:^H?LYDQV0<1J+`P@T2T:D$[ MA-?:@SK(/K>'DQ>Q5$AAS5((LH!RF7J55+@3CVEX5)8Y0)K@%;M9K1:,POB/ MHOP3C7:4(NG[CY9Y)79G\B@N1A^=*`IRN57L:9QT[\2IP.TH5"J*J\5X"I,< M`Z9>R$!5H<9V;(X77#*(1Y=XC\!18">PS7.("RD>2T88Q)5CMJ1!2SXU MX);%CKO!";HE@P83-A)N0Z<#HZNL16J`3:;$N/I?H7*6?U1U;AR*C]M+KQ4; MH/UE43R(`PUG`&PD@;PY_JM^.+X-:VM.R:B-4??E`^-^@[_/#L(8+(A8-MAY,?)/O]J M0S0W^:3S6B+F\G@_@@.G`)G]E^+"H!I[VR(`R\>RZ5+C_T6%P`4D-*#E%9%+ MXU%GQ_O)+'WCE\7&&]Q816P41E"]T=\WXJV2E8LWYX@%I' MT(Z"--NU=)!6!3OV^17$.`HKRX5+`SH8?F(F5>\@L%4/AQ^94U)O'-A?AQSN M%[]1CZ*C0+$%+S=VU>X)>AI;"C*(/RI!K&%+43]P&!H:'@P%GYB&8T_FXY<- MU+YK/&WZ2Q"@1Z=,`G+@2I9::"!^6!_JYE$H83!6+ZKMD!^K`8WM<`9KS?X` MQ">XO64KRWA:M[,ZT=@H)0%"WM2B1B-$`QO;U;$[`\G_C3U`*,' M9'_XR=^F^\/CXS"];A.NL2UZ:WAW`[VR\JG*A['O!GI"R\BN-FL,/5)9I]@8 ML-3)6B'O\P<8$J=HTXWT`>ZP*V_HMCOIUDH(8?4""=_KHWWVB6?U&!8T[D>;NPZG=I^3`%=X%QJAV@6-FK1O6\UW8<-QAYW: MI<$MD(#^8<]@857>`65:TWUZ;RYW$P^TX_]:$PE8>+P1XW1>LN4,`_AT&>W@ M^^BJV\#8-W=C]4?IG^!5:L=`J>KYD#<"X)MY;&,:C1D=9H0\B4'@/P<2?C6; M!6)L:S=41&>I7V6@85AGZ&:Z+C"?A)]KIT#I/6$ MCVUORZK;=7D`8JG6Z47V4&)8&2ZA=X4ZJ'U\__.A#N`W7A'U5VGL@J6/\\Y[GL5FT==F@"76@"& M^]DW\F5EK^*'!91IB;W!C6?V*I]#6'RU*?'0JP)="`@#\[I+'Q[RY%L)M\U? M263DY'H_M7&P8&!-`1:A!N"@2==/>I+%DAEE'[)7>)XL3W1R`G6_JW4;^E]5 M/@+RO$?OIX!6LL;X&`C3QM\^!P)IKHMB]O:S:'22CL"%!&,-*?=7Q0^HN_%=A<3OPSJ*Q MH*D%!6Q6D>%B,ID:1A6.VH2ED8&?*MP*,1<_D`'",U*&=[%T[\L1KC$F2:$R M19AQM,_5)&&)E<7_$I=U8)B6S![5R7#$/.U90=AQ,ZN-9:Z%@7U64>Y>;"!$ MG'*O\*I!.GTT2PV%X\^9"RH+,JCR@J2Y.%N-$HH"&R(=6#>&WJL?'K$$)K=E M=1RN7ZM:X;WPQ9IN6^Q8%6TM&//+AV+C;]-&5LB88XX)AN?6MO7]-5"VY465 M;;&^;,5H9.&BG;B0BU+&%R4ZGLALY5:M:*O&OXT?#%*[*[NBB^"A$Z;7SV>F MBFDKJI17@X4C$-<+E]DN,>TMUM=VQ:V_-H;S?25T8JPDT&%`+2:%A3:,-T_: MCX5"4&9/($5?=*(2%LS`2!%_GHTWR:U[<[#V2GZ2K0?8;]<0G.F)?E1B');M MWY3A\4Z'%%C5P2OGZP8:1J4^@'G[`:C(KJ^@1^4 M*`P4;Y;9GF7^O"URR,'7%XJL5"5>2>EB_31-2QGT]:T$J0OZMF]Q#%.1V1)JQB9=R#-C9J'^XQLN]:##J*`UBG6X_#V MK,V0?*](])VFB^E&`F($GS/>$8E5G9EP5OV#X=C_(UOYY2/GNSH:'C/^4IF* MZ&!-YW(M0LS84T&)3J`1:SD:+)*_X1CZ61XQ/V1 M>8E,A@?^'_GS:[$JTH"JP6`#?$^K2EOP]%["!1+)@SOB)HCK*VXO0F_&#\N/BUPN`=5]]_&46 ML@?`)5`Q!;',Y8`)*E-6!)A7+10U_?<&O/(F)KVARS6@5ZW;=33F-S-;_F;, MAOHZ0T6[97B@1ZSD.&*C*ARZ"#J.V6'P/Q`L+2Y;[C'&XL:R[BV'/HMJZAK) MVBR$UZ*!'VQ`ID>D]>2]ENRTCED>';.+X%'\+5V)7=6"%9/C3O0:&'7(5I\* M4NO/,7&5"I8ML*Y$GP5WVS?,JJ&U;\>M$_C$GLBXD'/+NVZGH#/V]K\@"`&#IN3:C3PMA$<+_>/XL;1>P*=%IW^_I=6<5VMS/^-5+? MCJE7<&VW8JC^\OV9:7>U6T:&*/=FHH.YT_K#=V5AO:>=<3!&N#<#SR#_HB*L ML(O\%1-=T)H$)MFP5&QL^:XL;NQZ9SSOU%/O1?A5/!>2?^;@M0XX-L/?OBNC MF?ZKZ_;LR-=#ASAC;@OX6\K9)/8U__IA9]SB"'9BD"UYYRAYI>=ICI+7^)](L_@&AL1- M^98\@"P9).!!>00[ZD,Z_1-!I$UR_U2'D7 MCLK0+@J9LM/:8:2A`\>C/2YJS^]?>45.+5\M_N8^]X*?#9*#_5'RNREYF?TS4D"3\Z[N:!BF<&ON(7GLD@D/<4G"<:3HVOV!L/V0)V4]:7 MTMPF?)K;*50E0[21=5/\VVVI0K6H_P%@FTI'%"!];*J9`17Q$_R0OA4C?DO5 MOP8*(?P_P>!5'9BA0I00BF./BDC:86,#,L9<0-%[A6:T]-#1I;!N@F8ASMJ0TO@`K6U&A+14FTK0>/-FP MI,2MJ1$!X*1[S&'-W"/VK^?WM[=)YER20D(\R_ROC`NQ9^:T2>MM!B MQ3D4VR#`B]#6^!CH#1%S.;9)5*[42-L-PLX$&Z#$=^I>W@H2S^DTVZ"^7,G% MHGQ]4#-`M4;M)7@=;"N#!Q;,F`)5!;A\FINY2;Q%+##D`5)-HE6;[S.8[N,@ M>03`#XEK6(N#A&>%6*0I1'2[#`'L@6E#M=*NK0-5V-ULO:*ZQ05 ME0+'?%X$ZJR/^0QPY\:M(73*)9?Z!RDGF%(DENW[2G!98D-(U[!0)_&)4L_6 M,IJAIP$BL-T1#Y%@R!%Q6=?$&0T_&W7S%28OH/&F0&E*`-%S+3?;BK<0K##? MRY[72_3*T3/_*VEWNX!'S::(OC_!LI06,,*5X&:P%0&I+'@)&TGH2G@LB4O!01X<=FU$S:,8LS&FHS9L(2[O/IS;UYF#7GO MH^'1F`DN.?[H*V=J!NER"5MDE@M!EBVMQ[A/YJ.?-XGW M%IS4-D\R^L0BSQPVG-G#!F7,TK!A3C2PGD*U`8VZJ[ADB3TDE*@7!J!Z!SJL?#`/7(A<[_`K'I#].A)8W2C,U5.PFR"O4YD&EM&JI=+U M_1VX=;8>:B;!S6%EYVJG;$FSS6;9X56Y?7=*XSCL?D5NWWE0JK$Z:D"\A6_* M.)4&.?8':R8+2I0=G'CY*#$(+)5T^*R?Q'-9RX.OA60V(PU0MB9GL%Q6Y%<' MH1!XP2C9T.XETY9J2%9$1'Y;TG([[G:\1DBTHQOKHR*=*'JG%<)@77#%-,U M*M,R7MLT'PD5U;.6!)?%.C*VN@X.8)ZK30L55L?1*-:DCM]F8A:/9;%9M6PP M80.23XN2*K[2RYHR4WT#)1N_WDI"X]CH0<]O8>_CME*;*+?;NFT3^MPTL:Y9 MB#T2[AJS"[%4.`P'G##Q2=XPN9E8\$76]2BS*?@\,3B`S_`V^:GR0R5^^Z6` M.H9K!4UPEI7Y"QI"XX;N+U#V1698&N"'``A!C^6]JW,#K"3ON^XU.`R11%=N57LBB9-@U!8#5@6M*C6>TQ:'F:\>%G'5']&[BW1%_^[M^EJ M]?H8$0\H4FUSHG698Q!%LIZ>MI_`SYNU`[BQ4@E\-NS%,+G/,D1O2D83'%]J M7`,S6F7OIO@&8`2IK*J&&:_B7#X#[DZ*F>2P:=+E6U6"R;2/S0K]4+9Y=F9U MZ6T_?;?K2O1B):9/`";MZ=,Y\#_U6D0F#T+RFFK4AR<+'VF8M`&>J+6"PO%H MZVR)XHD+K:PWWK,^[OM+J57LF675LM0X9.0&TX5)7E+ M*H9GYE>=`>)M`UT41H&"1$9W6V:`&&+P0V!?2ZD0A6V`8J-X?:FBAU"2F$/8 M,WW=.&0CH!&RD&D#Y2^;%%]'66.T20->/M$I2B>%/B81+$U)YVGA_YR;/"V- M/LAJ$C["E-Q?<\)##2%A7Z?E&R17);_B$T#TS M/,6?TS\QFA$@ZI^7^O8([V;#H<+&%;3@$L$JXBFV1X$HDFI:%C^V&Z'>39$Z MC7K45213O6>W/)0:2^Q\^9(7Y9+0H`<2IX"0%M,YK)<2)EM.%\H>Y;*Z.6Y( M75@S#YT0[]%A%3P;T\WH"1<+P'ZR2']4FWQ]RB2]V]^-=27RV%>C6W'8F2W/ MP?8!O-L20H.AZZ*<^0''!.XO@?8#Z@#5GY&!Q>>O4[R.*&MH!`Q;\)"IGWSCZI M'@3+BDKUX3_>ZR22I94J'39Q$'R)'2KHL1H!=MIVZL4 MWHA_">@0.(J`X=?WC+SD92'%A%ML,@#>^O-X/,:3_O-X]"FATR/VX%IAF8&+ M8I'*0);D7NP)2`T=)%=7IQ[?Z.A!EGTFCL#B3=R74B#6VVH#JTFD;C/IBWP!-C[Y#'*@L/*EK%0N M>Q1]\_(ZP#@^@->?(];!A6LKH,R)<`^`IA)\C3,,P>1G&HZB\:9] M+N<""&IO)D@U2>LM/_(E25H3?(A>X']D4-P/(K`%A.IQ#KQUYC@5VJ[[^HK!8K(M^3X0T)ED`J MDF@9C]ILS@9UP[&ZJX#1&ZT\MDX7Z=`-7N2)E3]BJ?-]+$IA/Q?O/'H*)GZ7SMGV/F6[3@295+ MXL^'7GT.>';PUQ9L#G_J,3G\Z5'[3[W5"'_JK47]TS!SO2][L%:U-56PP)1K M8^7VH[>"2FU">.A(_G9D+JCF`%0/GL0=AZ-F&WXP.HM\8+@UL$&'[A2:YAU"C)M<3 M"Z44X"N1?T"P[I8([O=R\GC-?U_F_Q:+!&6"KV698'%S*_Z$B7S=3!>0L7"G M2OS=$2ME^.*W(KDOQ(7J40YPG",LZ=UEBYSF#P#H.'BL!->2E`#/>APNIU"#,*72=K M*%!X<7:2G*S`B^/K\*'6L39=)W!;P&,I-W-@MZ86!U-#:&H3(MM_&@[(4`9# MB\#*OMPC3?DI61C#E'4]I[I'\OA@;(B*VK+/D03@='BB?O<>\`<<2&`\YT+L MP,]Y\8=X89=I8N2B.!Z;A;]!1CP&8I?2'_BU/_!W+.0AOI!9Z%$JT9(>81K' M'`IAZP)JFBY3ZJ1E*;4P"6=Z%T*L27C7>T@ML0/YMO[5LYP:#KFR@VWZ"E9\T,0EKCG43.B*-1Z#U9_@C/;S+^P\V) MX53H!5W)/-!`!1H:LT4]/O#=PIUL!6W2&\:D'N1CG1JT;"$3*Q__,'2DPWLQ MU$+\U*`NQ-%'+-'0_!B0I]]GD2PT`CI)-_8/I&V,&T MDZ,KIV\:B=-?>U=Z=;SZ5%EQ+K/8,CC5+*`RWF:%&1=&U<.*MRC!Q>NZV3OO MW:/=U#^LERE4:2XQSR/=MAZCU["S/NE1V*;:6XQ4QZ)S'K'>I7F;*'4HO-E$ MJGW9WSBO.JFL'4FWTER[T>Q6Z3Q.JU,-1W/>P[]T/JA.T[8'T6G4^1`ZK?L? MP#"9CH?/(=3[X,6H=#AT,3+M#UR8-UL=M@C97@6?Z#BROEW@(KOUY*3X?1")%)RQ:_NXF>3W]72APB)Q`T'LQ/^F(!3@?L4G< M.UR'%$%'%C+<3*K&H3&.V?3SW8WFY#D3:T96Z\]9*=3<5JSKQR.A,.NB::I6 M^XYV[7OTW6DSO3*'V[=V_K)KS^S/=U?WV9E,2UFA1"?.'1\SSV9O^Z!"4.F,B,!+LCR M$1]8T/)+!BB`JR>T0YREZ[0&?"`_ON_++'ZS'> M1V-HML9S@NFH*'+Q+A9;2SSGEW[Q0(B$*)V6^?-*W,R<_X8/_8WT6U00(Y9. MI]D"7O7B3[-L56;3G"_&I2,%)!,B@17J"]"W5D!P`>'?)1;?")V:AM9?`%HK MGW9L_V51/(C-8R[UGFQ?_^I?D_\9_.N`40$4S"T& MU33F.&!\;27WT?DB?Y:VEDABGO+54T$-<65-C%+507^;3C>K M%.P[1N5A<,SDZ"L[C/7T^NQ^3VU$'.M49DZM[0PK(9?6UOR=*#B9NX*%5TWR M"J'3I5!G];%`Y"/R'NO4'S*V0X1B2H[#4H-+B3$E#U)&>/.XI#2SRL%U,P%2 M9/E6')PZ**V9$T%KY;'``00]6HH`Q$@@""#DQ<^5FAG,0V[J\,`<.:&9&SK> M?A)T>TEKI#\FVIRKW0@POQO8C2!MY4700\BR)UD%"02.<)^[!I(7MA4ZKV]> MIX7ZV_MT>9VMG]X6H!A@R&UR?K>+><@-*>[Y8K&`?/3-`V#,3+.=<$FBE&]+ MY_PU73P6S82:;IHY7*`O6],AO6EK,I?+XCE]W7Y6[9C<0*67%$"G'QCFK_*7 M;*9<1`]O%H7DI,S2/@K75AU&-3*/0/T#`'3(")*006ZX/C_A_@;94G?G5R=? M/?^K2BO?`&P.4[$L4Q<\X5>06IU)F.%'O-WTU8L1]E;]1/@W>.C$`LL[B8(*M$`RH@29>$NG;P?51BI-4E_+*<>9<$\FR!/%,^44*1>T[+ M7%RSF)N-8YS#LT5L17!-KS"?23EA5[#!PM?8PNM"*1YBF\AQ`?F?1OO#H^29 M]LT`J?^T/SQ0?U$((++$>23V]%[A#-0>3"Z6V9^ MJ+<%^0[A7XR7K&6RW]?B99A,]BE#KVWG7'?>B]9%O]6IW;!.EQ?WWG'>9J*. M5S-`QW$P]JL1:"G.I39K^)\!^!&*==#NQS_*4DT$.0?0\Q*A:WP;]1_2QC-3S-QU;_W3)=M`B"E<,33[*0W+V/3#OV"GOO3>#2L5ICFYU` MD!`#)'K&!_E@^1MK;W`63(><(QY>QO"-0FI$UX"R(3L`C*;H%L.O(!]3)LDE M'R3,BR<)0M@V.'2\]GP`DO_7]5+E./H<9M,XN0#Q;/0X"7?$!1:!TH"('!\V M!"'[-\*)`3P4H0Z9YV.J:33U2]*BH5]GGV!@@A$RWM%6N^'-PFH5S[(L\].6 M`Z**<0&[@Y;K&1_T7:;01R`VQ^&M.CKFR^+4.X@7+0E69[F4A>8QB*RIS(T^;)>78@X&%QD. MF-#$%OF<(H&4V;Y[GMQ"[`^\%<"X-2LV#^OY9@$&$23HW2[%2Z8VGH72K(C0 MHP-R'\J7K*E8KKK9A0YJT&\)YH\!>3DUUI]+%E++S=MCZYB=96!LX55-/99S MTH7Y4=#+JJ0)!KD$$?E MB3^P!P,``()0```3``````````````"``0````!;0V]N=&5N=%]4>7!E&UL4$L!`A0#%`````@`8XEX1TAU!>[%````*P(```L``````````````(`! M.`,``%]R96QS+RYR96QS4$L!`A0#%`````@`8XEX1^$@*=?A`P``X%,``!H` M`````````````(`!)@0``'AL+U]R96QS+W=O&PO=&AE;64O=&AE M;64Q+GAM;%!+`0(4`Q0````(`&.)>$<:=%E'G0(``($.```-```````````` M``"``=85``!X;"]S='EL97,N>&UL4$L!`A0#%`````@`8XEX1_O*+M_S"``` M12L```\``````````````(`!GA@``'AL+W=O$&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`8XEX1]XY&)_=`0``N@0``!@``````````````(`!7RP``'AL M+W=O$<;314^)`,` M`(,,```8``````````````"``7(N``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`8XEX1_?C M]0KB!```=A@``!@``````````````(`!^#,``'AL+W=O$&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`8XEX1^6G5^V*!@``=R0``!@````` M`````````(`!WD$``'AL+W=O$>S1N?UH`$``+$#```9``````````````"``9Y(``!X;"]W;W)K M&UL4$L!`A0#%`````@`8XEX1T7Q%/^C`0``L0,` M`!D``````````````(`!=4H``'AL+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`8XEX1V/C9[BC`0``L0,``!D````````````` M`(`!_T\``'AL+W=O&PO=V]R:W-H965T M$&UL4$L!`A0# M%`````@`8XEX1]=X;T&B`0``L0,``!D``````````````(`!B54``'AL+W=O M&PO=V]R:W-H965T$>VB!!ZH0$``+$#```9``````````````"``3U9 M``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1XY, M&'NB`0``L0,``!D``````````````(`!%5L``'AL+W=O&PO=V]R:W-H965T$?+:6RLH0$``+$#```9``````````````"``<=>``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1T6OCV&D`0``L0,``!D` M`````````````(`!GV```'AL+W=O&PO M=V]R:W-H965T$=60:MCI`$` M`+$#```9``````````````"``51D``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1W2L*:RA`0``L0,``!D``````````````(`! M+V8``'AL+W=O&PO=V]R:W-H965T$>Q!W$AHP$``+$#```9```````` M``````"``>!I``!X;"]W;W)K&UL4$L!`A0#%``` M``@`8XEX1YL1-*2A`0``L0,``!D``````````````(`!NFL``'AL+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`8XEX1YF`MM*D M`0``L0,``!D``````````````(`!0W$``'AL+W=O&PO=V]R:W-H965T$?W-E7NI`$``+$#```9``````````````"``?=T``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1T"96I7,`0``X`0``!D````` M`````````(`!TG8``'AL+W=O```>&PO=V]R M:W-H965T$=[B54#I0$``+$# M```9``````````````"``6Y[``!X;"]W;W)K&UL M4$L!`A0#%`````@`8XEX1Y+,(^:S`0``%@0``!D``````````````(`!2GT` M`'AL+W=O[X!``![!```&0``````````````@`$T?P``>&PO=V]R:W-H965T$=7O"U\]P$``!,&```9```````````` M``"``2F!``!X;"]W;W)K&UL4$L!`A0#%`````@` M8XEX1X?29&7.`0``X`0``!D``````````````(`!5X,``'AL+W=O&PO=V]R:W-H965T$?%)_6&UL4$L!`A0#%`````@`8XEX1^U(75^F`0`` ML0,``!D``````````````(`!@8D``'AL+W=OV<:8!``"Q`P``&0``````````````@`%> MBP``>&PO=V]R:W-H965T$>@ M#QYHOP$``'L$```9``````````````"``3N-``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1TNV9J2U`0``%@0``!D````````` M`````(`!,8\``'AL+W=O&PO=V]R:W-H M965T$?PEK[KI@$``+$#```9 M``````````````"``8N3``!X;"]W;W)K&UL4$L! M`A0#%`````@`8XEX1\6#N?_U`0``$P8``!D``````````````(`!:)4``'AL M+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`8XEX M1X&N21W,`0``X`0``!D``````````````(`!=)L``'AL+W=O&PO=V]R:W-H965T$?3O$57I0$``+$#```9``````````````"``6Z?``!X;"]W;W)K M&UL4$L!`A0#%`````@`8XEX1\7='VF^`0``>P0` M`!D``````````````(`!2J$``'AL+W=O&PO=V]R:W-H965T$>HP5LY MK@,```D4```9``````````````"``;FE``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1_.$)5F*`0``.P,``!D````````````` M`(`!GJD``'AL+W=O&PO=V]R:W-H965T M$?6SW=S80(``!8(```9```` M``````````"``7&N``!X;"]W;W)K&UL4$L!`A0# M%`````@`8XEX1QE+'WHT`@``OP8``!D``````````````(`!";$``'AL+W=O M&PO=V]R:W-H965T$>A&J]>R`<``(LQ```9``````````````"``;&Y M``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1QT. MF'#+!@``PR<``!D``````````````(`!L,$``'AL+W=O&PO=V]R:W-H965T$>D[\U^'`4``/D?```9``````````````"``9;,``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1T!YDPM+!```*!4``!D` M`````````````(`!Z=$``'AL+W=O%-71$"``#J!0``&0``````````````@`%KU@``>&PO M=V]R:W-H965T$=KCZI#KP(` M`"@*```9``````````````"``;/8``!X;"]W;W)K&UL4$L!`A0#%`````@`8XEX1\K$KDA5`@``_@<``!D``````````````(`! MF=L``'AL+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%``` M``@`8XEX1R1?[_G]!0``]"$``!D``````````````(`!&N0``'AL+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`8XEX1_,PC39; M`@``>@<``!D``````````````(`!?/0``'AL+W=OD"``!9"P``&0`````````````` M@`$.]P``>&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`8XEX1VQ18*+"`@``.PH``!D````` M`````````(`!#O\``'AL+W=O&PO=V]R M:W-H965T$?!K"XN]0$``,\% M```9``````````````"``90$`0!X;"]W;W)K&UL M4$L!`A0#%`````@`8XEX1_G/[OS3`0``Q`0``!D``````````````(`!P`8! M`'AL+W=O&PO=V]R:W-H965T$='I;.V#`(``.4%```9```````````` M``"``7L,`0!X;"]W;W)K&UL4$L!`A0#%`````@` M8XEX1Z'GR8!8`@``R`<``!D``````````````(`!O@X!`'AL+W=O&PO=V]R:W-H965T$=*DQ_A[@$``%4%```9``````````````"``?`6`0!X;"]W M;W)K&UL4$L!`A0#%`````@`9(EX1PCK)GSM`@`` MLPL``!D``````````````(`!%1D!`'AL+W=O&PO=V]R:W-H965T$<8 M)>^&"`,``+<,```9``````````````"``10?`0!X;"]W;W)K&UL4$L!`A0#%`````@`9(EX1R:Q&PO=V]R:W-H M965T$>?/*L>S0$``-\$```9 M``````````````"``6HI`0!X;"]W;W)K&UL4$L! M`A0#%`````@`9(EX1_W[&1F(!@``52P``!D``````````````(`!;BL!`'AL M+W=O&PO=V]R:W-H965T$&UL4$L!`A0#%`````@`9(EX M1\;]@K17`@``PP<``!D``````````````(`!B#D!`'AL+W=O&PO=V]R:W-H965T$=12,T8Y@0``(H;```:``````````````"``<@_`0!X;"]W;W)K M$?I2Y:I!0,``&$- M```:``````````````"``>9$`0!X;"]W;W)K$<7O6``^P$``+,%```:``````````````"``2-( M`0!X;"]W;W)K$?E MN$3CW@$``!,%```:``````````````"``59*`0!X;"]W;W)K$$?[[/8:H@,``+44```:``````````````"``3=0`0!X;"]W;W)K M$=7]6NWK0@``$\_ M```:``````````````"``1%4`0!X;"]W;W)K$<\*Y:A4P(``(<(```:``````````````"``?9< M`0!X;"]W;W)K$?7 MY7[JZ0$``"8%```:``````````````"``8%?`0!X;"]W;W)K$?Q[(S>+@(``*8&```:```````` M``````"``:)A`0!X;"]W;W)K$>S8/QG/0(``"8'```:``````````````"``0AD`0!X;"]W;W)K M$?,@R!6400``+H7 M```:``````````````"``7UF`0!X;"]W;W)K$>H9HBN@0(``"`)```:``````````````"``09K M`0!X;"]W;W)K$<9 M4^*1L0(``*T)```:``````````````"``;]M`0!X;"]W;W)K$=I4V]]BP(``+0)```:```````` M``````"``:AP`0!X;"]W;W)K$>(X**.I`,``+D/```:``````````````"``6MS`0!X;"]W;W)K M$=!:7R+[`,``*`1 M```:``````````````"``4=W`0!X;"]W;W)K$>PD!?U#0,``%8,```:``````````````"``6M[ M`0!X;"]W;W)K$=9 M@%H&[@$``%T%```:``````````````"``;!^`0!X;"]W;W)K$$=PE@&FE0,``&@0```:``````````````"``$=1%7U7V@(``.$* M```:``````````````"``9N'`0!X;"]W;W)K$=!`UQKI`,```D1```:``````````````"``:V* M`0!X;"]W;W)K$?& M^P.EMP(``.D*```:``````````````"``8F.`0!X;"]W;W)K$=*#Z_;Z@0``*H<```:```````` M``````"``7B1`0!X;"]W;W)K$$=5$HOO0`(``/8& M```:``````````````"``:&8`0!X;"]W;W)K$=N0(``)X)```:``````````````"``1F; M`0!X;"]W;W)K$>) MM_[GD@4``/TA```:``````````````"``$?27K[B@P,``/<2```:```````` M``````"``92C`0!X;"]W;W)K$>>@Y*4^`$``%,%```:``````````````"``4^G`0!X;"]W;W)K M$ M```:``````````````"``7^I`0!X;"]W;W)K$>_?:]D40,``,(0```:``````````````"``<*N M`0!X;"]W;W)K$>` MN$KD_08``(PG```:``````````````"``4NR`0!X;"]W;W)K$=JO7UA.P4``*D;```:```````` M``````"``8"Y`0!X;"]W;W)K$<`)V_.5P0``,\4```:``````````````"``?.^`0!X;"]W;W)K M$$=X`6]4D@$``'\#```:``````````````"``>S( M`0!X;"]W;W)K$<' M;U2N80\``))K```:``````````````"``;;*`0!X;"]W;W)K$$?.,MDA%`T``&=;```:``````````````"``8[H`0!X;"]W;W)K M$=>7H5!Q0$``.,$ M```:``````````````"``=KU`0!X;"]W;W)K$?R2#ITC0,``/T/```:``````````````"``=?W M`0!X;"]W;W)K$=O MT\)2]X0!`-%&!@`4``````````````"``9S[`0!X;"]S:&%R9613=')I;F=S :+GAM;%!+!08`````EP"7`+XI``#%@`,````` ` end XML 22 R70.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Intangible Asset Amortization by Acquiree) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Intangible asset amortization $ 550.3 $ 154.8 $ 27.9
Total Acquisitions [Member]      
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Intangible asset amortization 521.0 120.8  
Ikaria      
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Intangible asset amortization 57.1 0.0  
Questcor Pharmaceuticals, Inc.      
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Intangible asset amortization 301.4 34.9  
Cadence Pharmaceuticals, Inc.      
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Intangible asset amortization 162.5 85.9  
Cost of Sales      
Schedule of Intangible Asset Amortization by Acquiree [Line Items]      
Amortization Of Inventory Step-Up To Cost Of Sales $ 44.1 $ 25.7  
XML 23 R124.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Narrative) (Details)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 26, 2012
action
Aug. 31, 2013
lawsuit
Case
Aug. 31, 2012
principal
Aug. 31, 2011
Patents
Dec. 26, 2014
Jun. 26, 2015
USD ($)
Sep. 25, 2015
USD ($)
Defendent
Case
order
Sep. 26, 2014
USD ($)
Sep. 27, 2013
USD ($)
Apr. 11, 2014
USD ($)
Commitments and Contingencies Disclosure [Abstract]                    
Plant Assets Exchanged for Industrial Revenue Bonds             $ 88,000,000      
Deferred Tax Liabilities Installment Sales             1,447,400,000      
Interest Expense, Installment Sales             36,500,000      
Rent expense             24,300,000 $ 15,200,000 $ 13,700,000  
Loss Contingencies [Line Items]                    
Remedial cost range, minimum             39,800,000      
Remedial cost range, maximum             113,100,000      
Environmental liabilities             76,500,000      
Tax Matters Agreement | Covidien                    
Loss Contingencies [Line Items]                    
Tax agreement, tax threshold             200,000,000      
Lower Passaic River, New Jersey                    
Loss Contingencies [Line Items]                    
Remedial cost range, minimum             483,400,000      
Remedial cost range, maximum             2,700,000,000      
Environmental liabilities             $ 13,300,000      
Asbestos Matters                    
Loss Contingencies [Line Items]                    
Pending claims | Case             12,750      
Estimation of liability, historical term           5 years        
Estimation of liability, expected future term of claims           7 years        
Accrued and other current liabilities                    
Loss Contingencies [Line Items]                    
Environmental liabilities, current             $ 3,200,000      
'222 and '218 Patent Litigation: Exela Pharma Sciences, LLC                    
Loss Contingencies [Line Items]                    
Patents allegedly infringed | Patents       2            
Loss Contingency, Claims Settled, Number | Case             4      
Retrophin Litigation [Member]                    
Loss Contingencies [Line Items]                    
Litigation Settlement, Expense             $ 15,500,000      
Glenridge Litigation                    
Loss Contingencies [Line Items]                    
Number of defendants | principal     3              
Loss Contingency, Lawsuits, Number | lawsuit   2                
Pending claims | Case   1                
Questcor Securities Litigation [Member]                    
Loss Contingencies [Line Items]                    
Filed-actions consolidated into the lawsuit | action 4                  
Litigation Settlement, Amount           $ 38,000,000        
Loss Contingency, Accrual, Current           $ 38,000,000        
David Taban, et al. v. Questcor Pharmaceuticals, Inc                    
Loss Contingencies [Line Items]                    
Federal derivative action staying period a         60 days          
Federal derivative action staying period b         60 days          
Mallinckrodt Veterinary, Inc., Millsboro, Delaware                    
Loss Contingencies [Line Items]                    
Number of Administrative Orders of Consent Entered Into | order             2      
Lower Passaic River, New Jersey                    
Loss Contingencies [Line Items]                    
Number of defendants | Defendent             70      
Remedial cost range, minimum                   $ 365,000,000
Remedial cost range, maximum                   3,200,000,000
Environmental liabilities                   23,100,000
Remedial cost, estimate                   $ 1,700,000,000
Questcor Shareholder Derivative Litigation [Member]                    
Loss Contingencies [Line Items]                    
Filed-actions consolidated into the lawsuit | action 5                  
Federal derivative action staying period a         60 days          
Federal derivative action staying period b         60 days          
Tastemaker                    
Loss Contingencies [Line Items]                    
Provision for Loss (Gain) on Disposal, Net of Tax             $ 22,500,000      
XML 24 R55.htm IDEA: XBRL DOCUMENT v3.3.0.814
Selected Quarterly Financial Data (Unaudited) (Tables)
 12 Months Ended
Sep. 25, 2015
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Selected Quarterly Financial Data (Unaudited)
 
Fiscal 2015 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
768.2

 
$
819.0

 
$
877.3

 
$
882.4

Gross profit
404.8

 
462.9

 
503.8

 
482.1

Income from continuing operations
87.4

 
75.2

 
55.6

 
90.0

Income (loss) from discontinued operations
5.3

 
23.6

 
2.4

 
(14.8
)
Net income
92.7

 
98.8

 
58.0

 
75.2

 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.75

 
$
0.64

 
$
0.47

 
$
0.77

Diluted earnings per share from continuing operations (1)
0.74

 
0.64

 
0.47

 
0.76

 
 
Fiscal 2014 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
429.5

 
$
448.7

 
$
530.1

 
$
673.7

Gross profit
216.2

 
226.7

 
254.1

 
363.2

Income (loss) from continuing operations
38.5

 
20.2

 
(29.0
)
 
(173.5
)
Income (loss) from discontinued operations
7.1

 
(8.6
)
 
4.9

 
(178.9
)
Net income (loss)
45.6

 
11.6

 
(24.1
)
 
(352.4
)
 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.67

 
$
0.35

 
$
(0.50
)
 
$
(2.04
)
Diluted earnings per share from continuing operations (1)
0.66

 
0.34

 
(0.50
)
 
(2.04
)


(1)
Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.
XML 25 R78.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Significant Components of Income Taxes Related to Continuing Operations) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Current:      
Domestic [1] $ 0.3 $ 40.9 $ 49.3
International [1] 95.1 17.9 12.1
Current income tax provision [1] 95.4 58.8 61.4
Deferred:      
Domestic [1] (0.8) (49.7) (18.3)
International [1] (187.5) (19.2) 4.4
Deferred income tax (benefit) provision [1] (188.3) (68.9) (13.9)
Provision for (benefit from) income taxes [1] $ (92.9) $ (10.1) $ 47.5
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
XML 26 R104.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Actuarial Assumptions) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Effect of One-Percentage Point Change in Assumed Healthcare Cost Trend Rates      
One-Percentage-Point Increase, effect on total of service and interest cost $ 0.0    
One-Percentage-Point Decrease, effect on total of service and interest cost 0.0    
One-Percentage-Point Increase, effect on postretirement benefit obligation 0.8    
One-Percentage-Point Decrease, effect on postretirement obligation $ (0.7)    
U.S. Plans      
Weighted Average-Assumptions Used in Calculating Net Periodic Benefit Cost      
Discount rate 3.80% 4.20% 3.50%
Expected return on plan assets 6.00% 6.50% 7.90%
Rate of compensation increase 0.00% 0.00% 0.00%
Weighted-Average Assumptions Used in Calculating Benefit Obligations      
Discount rate 3.90% 3.90% 4.30%
Rate of compensation increase 0.00% 0.00% 0.00%
Non-U.S. Plans      
Weighted Average-Assumptions Used in Calculating Net Periodic Benefit Cost      
Discount rate 2.50% 3.50% 4.00%
Expected return on plan assets 2.90% 3.10% 3.50%
Rate of compensation increase 3.20% 3.50% 3.70%
Weighted-Average Assumptions Used in Calculating Benefit Obligations      
Discount rate 2.50% 2.50% 3.70%
Rate of compensation increase 3.60% 3.40% 3.50%
Postretirement Benefits      
Weighted Average-Assumptions Used in Calculating Net Periodic Benefit Cost      
Discount rate 3.60% 4.00% 3.20%
Weighted-Average Assumptions Used in Calculating Benefit Obligations      
Discount rate 3.90% 3.70% 4.00%
Healthcare Cost Trend Assumptions      
Healthcare cost trend rate assumed for next fiscal year 7.10% 7.10%  
Rate to which the cost trend rate is assumed to decline 4.50% 4.50%  
Fiscal year the ultimate trend rate is achieved 2029 2029  
XML 27 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Sep. 25, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill by segment were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated Impairment
 
Gross
Carrying
Amount
 
Accumulated Impairment
Specialty Brands
$
3,442.4

 
$
—

 
$
2,194.9

 
$
—

Specialty Generics
207.0

 
—

 
207.0

 
—

Nuclear Imaging
119.5

 
(119.5
)
 
119.5

 
(119.5
)
Total
$
3,768.9

 
$
(119.5
)
 
$
2,521.4

 
$
(119.5
)

During the fiscal year ended September 25, 2015, the gross carrying value of goodwill in the Specialty Brands segment increased by $1,247.5 million, attributable to $792.4 million from the Ikaria Acquisition, $437.2 million from the Therakos Acquisition and $17.9 million resulting from adjustments to the Questcor Acquisition purchase price allocation.
Schedule of Intangible Assets
The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Amortizable:
 
 
 
 
 
 
 
Completed technology
$
9,896.0

 
$
765.8

 
$
6,906.0

 
$
235.6

Licenses
185.1

 
99.8

 
185.1

 
87.3

Customer relationships
28.1

 
4.4

 
33.8

 
0.6

Trademarks
82.1

 
6.2

 
13.0

 
4.1

Other
6.7

 
6.7

 
6.7

 
5.0

Total
$
10,198.0

 
$
882.9

 
$
7,144.6

 
$
332.6

Non-Amortizable:
 
 
 
 
 
 
 
Trademarks
$
35.0

 
 
 
$
35.0

 
 
In-process research and development
316.2

 
 
 
235.2

 
 
Total
$
351.2

 
 
 
$
270.2

 
 
Schedule of Future Amortization Expense, Intangible Assets
The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:
 
 
Fiscal 2016
$
693.7

Fiscal 2017
691.9

Fiscal 2018
682.9

Fiscal 2019
682.6

Fiscal 2020
682.0
XML 28 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
Subsequent Events
 12 Months Ended
Sep. 25, 2015
Subsequent Events [Abstract]  
Subsequent Events
24.
Subsequent Events
Share Repurchase & Debt Reduction Authorization
On November 19, 2015, the Company's board of directors authorized an increase to our existing $300.0 million share repurchase program previously announced in January 2015. The authorization increased our existing repurchase program by $500.0 million from $300.0 million to $800.0 million.
XML 29 R79.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 26, 2014
Sep. 28, 2012
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Taxes [Line Items]            
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent       20.00% 35.00% 35.00%
Provision for income taxes at Domestic statutory income tax rate (1) [1]       $ 43.1 $ (53.8) $ 19.5
Adjustments to reconcile to income tax provision:            
Rate difference between non-U.S. and U.S. jurisdictions [2],[3]       (138.6) (10.6) 3.3
Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount [4]       0.0 (4.1) (2.5)
Valuation allowances, nonrecurring       (2.1) 0.1 3.4
Adjustments to accrued income tax liabilities and uncertain tax positions [2]       (6.8) (1.5) 5.0
Interest and penalties on accrued income tax liabilities and uncertain tax positions [2]       0.2 (7.9) 4.7
Investment in partnership       0.0 20.0 0.0
Credits, principally research $ (0.7) $ (3.6) $ (2.3) (8.1) [5] (0.8) [5] (6.3) [5]
Impairments, nondeductible       0.0 41.8 0.0
Permanently nondeductible and nontaxable items [6]       16.4 13.8 15.3
Other       3.0 (1.0) 1.4
Provision for (benefit from) income taxes [7]       (92.9) (10.1) 47.5
Current State and Local Tax Expense (Benefit) [4]       $ 0.0 $ (6.1) $ 3.7
[1] The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014 and 2013.
[2] Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
[3] Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
[4] For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.
[5] During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately $2.3 million of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014.
[6] Includes the impact of nondeductible transaction and separation costs.
[7] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
XML 30 R118.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Fair Value Assumptions for Performance Share Unit) (Details) - Performance Shares
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected stock price volatility 27.00% 28.00%
Peer group stock price volatility 32.00% 33.00%
Correlation of returns 14.00% 17.00%
XML 31 R127.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Schedule of Minimum Lease Payments for Non-cancelable Leases) (Details)
$ in Millions
Sep. 25, 2015
USD ($)
Operating Leases  
Operating leases, fiscal 2015 $ 21.1
Operating leases, fiscal 2016 17.7
Operating leases, fiscal 2018 15.0
Operating leases, fiscal 2019 11.3
Operating leases, fiscal 2020 9.3
Operating leases, thereafter 20.6
Operating leases, total minimum lease payments 95.0
Capital Leases  
Capital leases, fiscal 2015 1.3
Capital leases, fiscal 2016 0.9
Capital leases, fiscal 2017 0.1
Capital leases, fiscal 2018 0.0
Capital leases, fiscal 2019 0.0
Capital leases, thereafter 0.0
Capital leases, total minimum lease payments 2.3
Capital leases, interest portion of total minimum lease payments 0.0
Capital leases, present value of minimum lease payments $ 2.3
XML 32 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 33 R133.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data (Schedule of Segment Reporting Information by Business Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Segment Reporting Information [Line Items]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Operating income (loss)                 461.8 (75.9) 73.5
Intangible asset amortization                 (550.3) (154.8) (27.9)
Restructuring and related charges, net                 (40.7) (81.9) (26.3)
Non-restructuring impairment                 0.0 151.6 0.0
Separation costs                 0.0 (9.6) (74.2)
Assets $ 16,404.1       $ 12,787.3       16,404.1 12,787.3  
Depreciation and amortization                 672.5 275.9 139.6
Restructuring and related costs, accelerated depreciation                 0.3 0.5 2.6
Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Restructuring and related charges, net                 (36.5) (57.0) (5.2)
Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Restructuring and related charges, net                 (4.5) (9.8) (11.2)
Operating Segments                      
Segment Reporting Information [Line Items]                      
Net sales [1]                 3,298.2 2,044.6 1,655.2
Operating income (loss)                 1,339.7 550.1 336.2
Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,622.8 413.5 206.4
Operating income (loss)                 651.3 (50.6) (36.2)
Depreciation and amortization [2]                 559.8 152.9 24.9
Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,251.6 1,199.4 1,011.2
Operating income (loss)                 622.0 617.4 347.9
Depreciation and amortization [2]                 81.9 77.8 72.7
Operating Segments | Global Medical Imaging                      
Segment Reporting Information [Line Items]                      
Net sales                 423.8 431.7 437.6
Operating income (loss)                 66.4 (16.7) 24.5
Depreciation and amortization [2]                 12.4 18.8 18.5
Corporate, Non-Segment                      
Segment Reporting Information [Line Items]                      
Net sales [3],[4]                 48.7 37.4 57.1
Corporate and allocated expenses [5]                 (286.9) (228.1) (134.3)
Intangible asset amortization                 (550.3) (154.8) (27.9)
Restructuring and related charges, net [6]                 (40.7) (81.9) (26.3)
Non-restructuring impairment                 0.0 (151.6) 0.0
Separation costs                 0.0 (9.6) (74.2)
Intersegment Eliminations                      
Segment Reporting Information [Line Items]                      
Net sales                 0.0 0.0 0.0
Continuing Operations                      
Segment Reporting Information [Line Items]                      
Depreciation and amortization [2]                 $ 654.1 $ 249.5 $ 116.1
[1] Amounts represent sales to external customers. There were no intersegment sales.
[2] Depreciation for certain shared facilities is allocated based on occupancy percentage.
[3] Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
[4] Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
[5] Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
[6] Includes restructuring-related accelerated depreciation.
XML 34 R73.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Schedule of Net Restructuring and Related Charges) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges $ 40.7 $ 81.9 $ 26.3
Less: non-cash charges, including impairments and accelerated share based compensation expense (10.1) (38.0) (2.6)
Total charges expected to be settled in cash 30.6 43.9 23.7
2013 Mallinckrodt program      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges 7.4 27.3 8.5
Acquisition programs      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges 33.6 56.4 0.0
Other programs      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges $ (0.3) $ (1.8) $ 17.8
XML 35 R89.htm IDEA: XBRL DOCUMENT v3.3.0.814
Property, Plant and Equipment (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 1,870.6 $ 1,669.0  
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 879.3 782.2  
Depreciation 103.9 $ 94.7 $ 88.1
Weighted Average Cost of Capital, Rate   8.00%  
Property Under Capital Lease      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 14.8 $ 16.9  
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $ 14.6 15.8  
Property, Plant and Equipment      
Property, Plant and Equipment [Line Items]      
Impairment of long-lived assets   65.9  
Finite-lived intangible ssets      
Property, Plant and Equipment [Line Items]      
Impairment of long-lived assets   52.4  
Contrast Media and Delivery Systems | Property, Plant and Equipment      
Property, Plant and Equipment [Line Items]      
Impairment of Long-Lived Assets to be Disposed of   51.4  
Contrast Media and Delivery Systems | Finite-lived intangible ssets      
Property, Plant and Equipment [Line Items]      
Impairment of Long-Lived Assets to be Disposed of   $ 52.4  
XML 36 R57.htm IDEA: XBRL DOCUMENT v3.3.0.814
Background and Basis of Presentation (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Sep. 27, 2013
USD ($)
Sep. 25, 2015
$ / shares
shares
Sep. 26, 2014
$ / shares
shares
Jun. 28, 2013
$ / shares
shares
Schedule of Basis of Presentation [Line Items]        
Distribution ratio   0.125   0.125
Stock outstanding after distribution (in shares) | shares   116,283,149 115,929,588 57,694,885
Ordinary shares, par value (in usd per share)   $ 0.20 $ 0.20 $ 0.20
Covidien | Selling, general and administrative        
Schedule of Basis of Presentation [Line Items]        
Allocated expenses | $ $ 39.6      
XML 37 R109.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Jan. 23, 2015
Class of Stock [Line Items]      
Preferred shares, shares authorized (in shares) 500,000,000 500,000,000  
Preferred shares, par value (in usd per share) $ 0.20 $ 0.20  
Preferred shares, shares issued (in shares) 0 0  
Stock Repurchase Program, Authorized Amount     $ 300.0
Employee Service Share-based Compensation, Cash Flow Effect, Cash Used to Settle Awards $ 17.2 $ 17.5  
XML 38 R134.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data (Schedule of Net Sales from External Costumers by Product) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Segment Reporting Information [Line Items]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Operating Segments                      
Segment Reporting Information [Line Items]                      
Net sales [1]                 3,298.2 2,044.6 1,655.2
Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,251.6 1,199.4 1,011.2
Operating Segments | Nuclear Imaging                      
Segment Reporting Information [Line Items]                      
Net sales                 423.8 431.7 437.6
Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,622.8 413.5 206.4
Hydrocodone (API) and hydrocodone-containing tablets | Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 136.5 209.6 148.3
Oxycodone (API) and oxycodone-containing tablets | Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 154.6 155.2 139.0
Methylphenidate ER | Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 167.2 99.4 140.0
Other controlled substances | Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 572.2 584.5 443.3
Other | Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 221.1 150.7 140.6
Exalgo | Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 39.4 76.1 126.1
Ofirmev | Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 263.0 124.4 0.0
Acthar | Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,037.3 122.9 0.0
Inomax | Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 185.2 0.0 0.0
Other | Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 $ 97.9 $ 90.1 $ 80.3
[1] Amounts represent sales to external customers. There were no intersegment sales.
XML 39 R76.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 26, 2014
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Taxes [Line Items]        
Operating loss carryforward   $ 7.0 $ 221.3  
Tax credit carryforward   16.3 8.6  
Tax Credit Carryforward Utilization   14.3    
Income Tax Holiday, Aggregate Dollar Amount   5.1 0.3  
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount [1],[2]   (138.6) (10.6) $ 3.3
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount   21.5 $ 32.1 $ 10.0
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent     21.00% 23.00%
Increase (Decrease) Tax Benefit, Jurisdiction Rate Difference   128.0 $ 13.9  
Increase (Decrease) Tax Expense (Benefit), Change in Operating Income   35.0 10.8  
Increase (Decrease) Tax Expense (Benefit) Due to Amortization of Intangible Assets   22.5 14.0  
Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions   31.8    
Increase (Decrease) Tax Expense (Benefit), Other   62.2 38.7  
Unrecognized tax benefits that would require cash remittance if not sustained   89.2 82.0 $ 100.1
Unrecognized tax benefits, which if favorably settled would benefit the effective tax rate   87.4 82.0 96.3
Interest expense on unrecognized tax benefits   5.7 7.0 2.4
Released tax interest   9.3    
Interest accrued on unrecognized tax benefits   41.7 45.1 $ 62.1
Decrease in Unrecognized Tax Benefits is Reasonably Possible   17.5    
Income tax penalties and interest accrued that would impact effective tax rate, upper bound of change   8.8    
Tax payments associated with non-current deferred intercompany transactions   52.2 14.8  
Tax payments associate with current deferred intercompany transactions   8.7 0.6  
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority   81.3    
Deferred income taxes   142.7 152.3  
Deferred income taxes (non-current liability)   3,132.4 2,399.6  
Increase (decrease), deferred tax liability   44.0    
Increase (Decrease), Deferred Tax Liability Due to Amortization of Intangible Assets   54.3    
Deferred tax assets, tax credit carryforwards   163.3 93.8  
Deferred tax assets, valuation allowance   233.0 76.9  
Increase (decrease) deferred tax liability due to installment sale   1,465.3 93.6  
Deferred tax liabilities, intangible assets   1,550.7 2,177.9  
Deferred Tax Liabilities, Property, Plant and Equipment   140.1 121.6  
Deferred Tax Asset, Financing Payment   20.2 32.0  
Tax credit carryforwards, not subject to expiration   3.1    
Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries   369.0    
Deferred Tax Liabilities, Undistributed Foreign Earnings   0.7    
Undistributed Earnings   13.4    
Ikaria        
Income Taxes [Line Items]        
Operating loss carryforward   4.8    
Tax credit carryforward   7.2    
Deferred Tax Liabilities, Net   623.6    
Increase (decrease), deferred tax liability   596.9    
Deferred tax liabilities, intangible assets   620.2    
Deferred Tax Liabilities, Property, Plant and Equipment   17.5    
Deferred Tax Assets, Tax Credit Carryforwards, Foreign   21.7    
Deferred Tax Asset, Financing Payment   13.1    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign   4.9    
Therakos        
Income Taxes [Line Items]        
Increase (decrease), deferred tax liability   324.3    
Deferred tax liabilities, intangible assets   334.1    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign   13.5    
Increase (Decrease), Deferred Tax Liability, Net   324.3    
Cadence Pharmaceuticals, Inc.        
Income Taxes [Line Items]        
Operating loss carryforward     187.8  
Increase (decrease) deferred tax asset resulting from installment sale transaction   105.4    
Questcor Pharmaceuticals, Inc.        
Income Taxes [Line Items]        
Increase (Decrease) In Prepaid Taxes, Installment Sale $ 1.9      
Income Taxes Receivable     60.0  
Increase (decrease) deferred tax liability due to installment sale 1,515.9      
Increase (Decrease) Deferred Tax Charge, Installment Sale 25.3      
Increase (Decrease) in Deferred Tax Liability, Intangible Assets $ 1,488.7      
Internal Revenue Service (IRS)        
Income Taxes [Line Items]        
Advance payment in connection with proposed settlements of certain tax matters   8.9    
Advance payment in connection with proposed settlement of certain tax matters, tax payment   7.4    
Advance payment in connection with proposed settlement of certain tax matters, interest payment   $ 1.5    
Internal Revenue Service (IRS) | Covidien        
Income Taxes [Line Items]        
Advance payment in connection with proposed settlements of certain tax matters     35.9  
Advance payment in connection with proposed settlement of certain tax matters, tax payment     27.3  
Advance payment in connection with proposed settlement of certain tax matters, interest payment     $ 8.6  
U.S. - Federal and State        
Income Taxes [Line Items]        
Tax years that remain subject to examination   1996    
Operating loss carryforwards, subject to expiration   $ 19.6    
IRELAND        
Income Taxes [Line Items]        
Tax years that remain subject to examination   2009    
Foreign Tax Authority        
Income Taxes [Line Items]        
Operating loss carryforwards   $ 126.0    
Operating loss carryforwards, not subject to expiration   91.4    
Operating loss carryforwards, subject to expiration   34.6    
Discontinued Operations, Held-for-sale        
Income Taxes [Line Items]        
Deferred Tax Liabilities, Undistributed Foreign Earnings   6.5    
Undistributed Earnings   $ 41.3    
[1] Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
[2] Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
XML 40 R86.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (Loss) per Share (Details)
shares in Millions
 12 Months Ended
Sep. 25, 2015
shares
Sep. 26, 2014
shares
Sep. 27, 2013
shares
Jun. 28, 2013
Earnings (Loss) per Share [Abstract]        
Distribution ratio 0.125     0.125
Weighted-average shares for basic earnings (loss) per share (in shares) 115.8 64.9 57.7  
Weighted Average Number of Shares Outstanding, Diluted 1.4 0.0 0.1  
Weighted-average shares for diluted earnings (loss) per share (in shares) 117.2 64.9 57.8  
Antidilutive securities excluded from weighted-average shares (in shares) 0.1 5.7 0.5  
XML 41 R81.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Unrecognized Tax Benefits Balance Sheet Location) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Sep. 28, 2012
Income Tax Contingency [Line Items]        
Unrecognized tax benefits $ 89.2 $ 82.0 $ 100.1 $ 165.5
Accrued and Other Current Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 1.3 6.5    
Other Income Tax Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 80.0 70.7    
Deferred income tax liability (non-current)        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 7.9 4.8    
Liabilities, Total        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits $ 89.2 $ 82.0    
XML 42 R87.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (Loss) per Share Schedule of Earnings per Share Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Earnings Per Share [Abstract]                      
Income (loss) from continuing operations $ 90.0 $ 55.6 $ 75.2 $ 87.4 $ (173.5) $ (29.0) $ 20.2 $ 38.5 $ 308.2 $ (143.8) $ 8.2
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic                 2.5 0.0 0.0
Income (Loss) From Continuing Operations Attributable To Common Stockholders                 305.7 (143.8) 8.2
Income (loss) from discontinued operations, net of income taxes $ (14.8) $ 2.4 $ 23.6 $ 5.3 $ (178.9) $ 4.9 $ (8.6) $ 7.1 16.5 (175.5) 50.6
Income (Loss) From Discontinued Operations Attributable To Common Stockholders                 0.1 0.0 0.0
Net Income (Loss) Available to Common Stockholders, Basic                 16.4 (175.5) 50.6
Net Income (Loss) Available to Common Stockholders, Basic                 $ 322.1 $ (319.3) $ 58.8
Weighted Average Number of Shares Outstanding, Basic                 115.8 64.9 57.7
Weighted Average Number of Shares Outstanding, Diluted                 1.4 0.0 0.1
Weighted Average Number of Shares Outstanding, Diluted                 117.2 64.9 57.8
Income (Loss) from Continuing Operations, Per Basic Share $ 0.77 [1] $ 0.47 [1] $ 0.64 [1] $ 0.75 [1] $ (2.04) [1] $ (0.50) [1] $ 0.35 [1] $ 0.67 [1] $ 2.64 $ (2.22) $ 0.14
Earnings Per Share, Basic                 0.14 (2.70) 0.88
Earnings Per Share, Basic                 2.78 (4.92) 1.02
Income (Loss) from Continuing Operations, Per Diluted Share $ 0.76 [1] $ 0.47 [1] $ 0.64 [1] $ 0.74 [1] $ (2.04) [1] $ (0.50) [1] $ 0.34 [1] $ 0.66 [1] 2.61 (2.22) 0.14
Earnings Per Share, Diluted                 0.14 (2.70) 0.88
Earnings Per Share, Diluted                 $ 2.75 $ (4.92) $ 1.02
[1] Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.
XML 43 R77.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Components of Income from Continuing Operations Before Income Taxes) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Operating Loss Carryforwards [Line Items]      
Domestic [1] $ (107.0) $ (159.9) $ 34.7
International [1] 322.3 6.0 21.0
Income (loss) from continuing operations before income taxes [1] $ 215.3 $ (153.9) $ 55.7
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
XML 44 R71.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Restructuring Cost and Reserve [Line Items]    
Property, plant and equipment asset impairment   $ 2.3
Employee terminations    
Restructuring Cost and Reserve [Line Items]    
Accelerated share based compensation expense $ 9.8 35.1
2013 Mallinckrodt program | Minimum    
Restructuring Cost and Reserve [Line Items]    
2013 Mallinckrodt program expected cost range 100.0  
2013 Mallinckrodt program | Maximum    
Restructuring Cost and Reserve [Line Items]    
2013 Mallinckrodt program expected cost range $ 125.0  
Consulting costs    
Restructuring Cost and Reserve [Line Items]    
Restructuring costs   $ 8.5
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accumulated Other Comprehensive Income
 12 Months Ended
Sep. 25, 2015
Equity [Abstract]  
Accumulated Other Comprehensive Income
16.
Accumulated Other Comprehensive Income
The components of accumulated other comprehensive income are as follows:
 
Currency Translation
 
Unrecognized Loss on Derivatives
 
Unrecognized Gain (Loss) on Benefit Plans
 
Accumulated Other Comprehensive Income
Balance at September 28, 2012
$
157.1

 
$
—

 
$
(72.2
)
 
$
84.9

Other comprehensive income (loss), net
1.5

 
(7.3
)
 
29.4

 
23.6

Balance at September 27, 2013
158.6

 
(7.3
)
 
(42.8
)
 
108.5

Other comprehensive income (loss), net
(27.6
)
 
—

 
(17.1
)
 
(44.7
)
Reclassification from other comprehensive income (loss)
—

 
0.5

 
1.4

 
1.9

Balance at September 26, 2014
131.0

 
(6.8
)
 
(58.5
)
 
65.7

Other comprehensive loss before reclassification
(70.8
)
 
—

 
(1.1
)
 
(71.9
)
Reclassification from other comprehensive income (loss)
—

 
0.4

 
6.7

 
7.1

Balance at September 25, 2015
$
60.2

 
$
(6.4
)
 
$
(52.9
)
 
$
0.9



The following summarizes reclassifications out of accumulated other comprehensive income for the 2015 and 2014 fiscal years:
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
 
 
September 25, 2015
 
September 26, 2014
 
Line Item in the Condensed Consolidated
Statement of Income
Amortization of unrealized loss on derivatives
$
0.6

 
$
0.6

 
Interest expense
Income tax provision
(0.2
)
 
(0.1
)
 
Provision for income taxes
Net of income taxes
0.4

 
0.5

 
 
 
 
 
 
 
 
Amortization of pension and post-retirement benefit plans:
 
 
 
 
 
Net actuarial loss
9.4

 
8.1

 
(1) 
Prior service credit
(4.6
)
 
(9.9
)
 
(1) 
Plan settlements
6.0

 
3.8

 
(1) 
Total before tax
10.8

 
2.0

 
 
Income tax provision
(4.1
)
 
(0.6
)
 
Provision for income taxes
Net of income taxes
6.7

 
1.4

 
 
 
 
 
 
 
 
Total reclassifications for the period
$
7.1

 
$
1.9

 
 
(1)

These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note 13 for additional details.
XML 46 R141.htm IDEA: XBRL DOCUMENT v3.3.0.814
Subsequent Events (Subsequent Events) (Details) - USD ($)
$ in Millions
Nov. 19, 2015
Jan. 23, 2015
Subsequent Event [Line Items]    
Stock Repurchase Program, Authorized Amount   $ 300.0
2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member]    
Subsequent Event [Line Items]    
Stock Repurchase Program, Authorized Amount $ 800.0  
Stock Repurchase Program, Increase in Authorized Amount $ 500.0  
XML 47 R50.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Tables)
 12 Months Ended
Sep. 25, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Incentive Equity Awards Issued Upon Completion of Conversion
Mallinckrodt incentive equity awards issued upon completion of the Conversion and the related weighted-average grant date fair value is presented below:
 
Awards
 
Weighted-Average
Grant-Date
Fair Value
Share options
2,399,822

 
$
7.96

Restricted share units
575,213

 
38.97
Schedule of Share Option Awards Status Upon Completion of the Conversion
A summary of the status of the Company's share option awards upon completion of the Conversion on June 28, 2013 is presented below:
 
Shares Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
(in years)
 
Aggregate
Intrinsic
Value
Outstanding at June 28, 2013
2,399,822

 
$
35.94

 
8.0
 
$
22.9

Exercisable at June 28, 2013
550,097

 
30.94

 
5.9
 
8.0
Schedule of the Valuation Assumptions Used in the Conversion
The weighted-average assumptions used in the Black-Scholes pricing model for determining the fair value of the share option awards immediately before and immediately after the Separation were as follows:
 
Pre- Separation
 
Post- Separation
Expected share price volatility
26
%
 
32
%
Risk-free interest rate
0.99
%
 
0.99
%
Expected annual dividend per share
1.65
%
 
—
%
Expected life of options (in years)
3.8

 
3.8

Fair value per option
$
18.04

 
$
16.51

Share option awards
1,745,258

 
2,399,822

The weighted-average assumptions used in the Black-Scholes pricing model for shares granted in fiscal 2015, along with the weighted-average grant-date fair value, were as follows:
 
2015
 
2014
Expected share price volatility
29
%
 
32
%
Risk-free interest rate
1.72
%
 
1.96
%
Expected annual dividend per share
—
%
 
—
%
Expected life of options (in years)
5.3

 
5.5

Fair value per option
$
30.08

 
$
17.38
Schedule of Share Option Activity
Share option activity and information is as follows:
 
Share Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
(in years)
 
Aggregate Intrinsic Value
Outstanding at September 27, 2013
2,760,231

 
$
37.30

 
 
 
 
Granted
675,921

 
52.63

 
 
 
 
Converted from Questcor Acquisition
1,292,736

 
25.08

 
 
 
 
Exercised
(878,330
)
 
30.96

 
 
 
 
Expired/Forfeited
(323,769
)
 
41.83

 
 
 
 
Outstanding at September 26, 2014
3,526,789

 
36.84

 
 
 
 
Granted
635,567

 
102.20

 
 
 
 
Exercised
(1,132,778
)
 
29.79

 
 
 
 
Expired/Forfeited
(243,135
)
 
58.00

 
 
 
 
Outstanding at September 25, 2015
2,786,443

 
52.76

 
7.3
 
$
63.2

 
 
 
 
 
 
 
 
Vested and unvested expected to vest as of September 25, 2015
2,649,351

 
50.94

 
7.4
 
59.0

Exercisable at September 25, 2015
1,054,336

 
34.20

 
5.8
 
36.2
Share-based Compensation, Performance Shares Award Outstanding Activity
PSU activity is as follows (1):
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
$
—

 
$
—

Granted
79,230

 
63.40

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(6,490
)
 
62.65

Non-vested at September 26, 2014
72,740

 
63.46

Granted
77,306

 
125.84

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(19,072
)
 
92.05

Non-vested at September 25, 2015
130,974

 
96.05

(1)    The number of shares disclosed within this table are at the target number of 100%.
Schedule of Share-based Payment Award, Performance Share Awards, Valuation Assumptions
The assumptions used in the Monte Carlo model for PSUs granted during each year were as follows:
 
2015
 
2014
Expected stock price volatility
27
%
 
28
%
Peer group stock price volatility
32
%
 
33
%
Correlation of returns
14
%
 
17
%
Schedule of Restricted Share Unit Activity
The grant-date fair value of RSAs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period.
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
—

 
$
—

Granted
—

 
—

Converted from Questcor Acquisition
1,829,164

 
70.88

Vested
(390,731
)
 
70.88

Forfeited
(6,402
)
 
70.88

Non-vested at September 26, 2014
1,432,031

 
70.88

Granted
—

 
—

Vested
(1,362,823
)
 
70.88

Forfeited
(34,646
)
 
70.88

Non-vested at September 25, 2015
34,562

 
70.88

RSU activity is as follows:
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
724,269

 
$
40.62

Granted
229,281

 
55.40

Converted from Questcor Acquisition
30,747

 
70.88

Vested
(300,237
)
 
34.77

Forfeited
(94,838
)
 
42.48

Non-vested at September 26, 2014
589,222

 
47.88

Granted
273,733

 
105.68

Vested
(219,189
)
 
49.84

Forfeited
(71,272
)
 
68.15

Non-vested at September 25, 2015
572,494

 
73.45
XML 48 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Tables)
 12 Months Ended
Sep. 25, 2015
Income Tax Disclosure [Abstract]  
Schedule of Components of Income from Continuing Operations before Income Taxes
The Domestic and International components of income from continuing operations before income taxes were as follows(1):
 
2015
 
2014
 
2013
Domestic
$
(107.0
)
 
$
(159.9
)
 
$
34.7

International
322.3

 
6.0

 
21.0

Total
$
215.3

 
$
(153.9
)
 
$
55.7


(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.

Schedule of Significant Components of Income Taxes Related to Continuing Operations
Significant components of income taxes related to continuing operations are as follows(1):
 
2015
 
2014
 
2013
Current:
 
 
 
 
 
Domestic 
$
0.3

 
$
40.9

 
$
49.3

International 
95.1

 
17.9

 
12.1

Current income tax provision
95.4

 
58.8

 
61.4

Deferred:
 
 
 
 
 
Domestic 
$
(0.8
)
 
$
(49.7
)
 
$
(18.3
)
International 
(187.5
)
 
(19.2
)
 
4.4

Deferred income tax (benefit) provision
(188.3
)
 
(68.9
)
 
(13.9
)
 
$
(92.9
)
 
$
(10.1
)
 
$
47.5


(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision
The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:
 
2015
 
2014
 
2013
Provision for income taxes at Domestic statutory income tax rate (1)
$
43.1

 
$
(53.8
)
 
$
19.5

   Adjustments to reconcile to income tax provision:
 
 
 
 
 
U.S. state income tax provision, net (6)
—

 
(6.1
)
 
3.7

Rate difference between Domestic and International jurisdictions (2) (3)
(138.6
)
 
(10.6
)
 
3.3

U.S. manufacturing deduction (6)
—

 
(4.1
)
 
(2.5
)
Valuation allowances, nonrecurring
(2.1
)
 
0.1

 
3.4

Adjustments to accrued income tax liabilities and uncertain tax positions (3)
(6.8
)
 
(1.5
)
 
5.0

Interest and penalties on accrued income tax liabilities and uncertain tax positions (3)
0.2

 
(7.9
)
 
4.7

Investment in partnership
—

 
20.0

 
—

Credits, principally research and orphan drug (4)
(8.1
)
 
(0.8
)
 
(6.3
)
Impairments, nondeductible
—

 
41.8

 
—

Permanently nondeductible and nontaxable items (5)
16.4

 
13.8

 
15.3

Other
3.0

 
(1.0
)
 
1.4

Provision for income taxes
$
(92.9
)
 
$
(10.1
)
 
$
47.5

(1)
The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014 and 2013.
(2)
Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
(3)
Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
(4)
During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately $2.3 million of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014.
(5)
Includes the impact of nondeductible transaction and separation costs.
(6)
For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.
Schedule of Unrecognized Tax Benefit Activity
The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:
 
2015
 
2014
 
2013
Balance at beginning of fiscal year
$
82.0

 
$
100.1

 
$
165.5

Unrecognized tax benefits retained by Covidien
—

 
—

 
(153.7
)
Unrecognized tax benefits transferred from Covidien
—

 
—

 
84.2

Additions related to current year tax positions
4.5

 
3.2

 
3.5

Additions related to prior period tax positions
19.9

 
30.6

 
6.6

Reductions related to prior period tax positions
(7.7
)
 
(33.0
)
 
(4.3
)
Settlements
(7.8
)
 
(6.9
)
 
(1.6
)
Lapse of statute of limitations
(1.7
)
 
(12.0
)
 
(0.1
)
Balance at end of fiscal year
89.2

 
82.0

 
100.1
Schedule of Unrecongized Tax Benefits Balance Sheet Location
Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:
 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
1.3

 
$
6.5

Other income tax liabilities
80.0

 
70.7

Deferred income taxes (non-current liability)
7.9

 
4.8

 
$
89.2

 
$
82.0
Schedule of Income Taxes Payable
Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown.
 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
19.8

 
$
13.1

Other income tax liabilities
121.3

 
122.6

 
$
141.1

 
$
135.7
Schedule of Income Tax Receivables and Other Assets
At September 25, 2015, other assets includes $52.2 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes $8.7 million of tax payments associated with current deferred intercompany transactions, and $81.3 million of receivables associated with tax payments on account with the taxing authorities. At September 26, 2014, other assets includes $14.8 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of $60.0 million associated with the Questcor acquisition and tax payments of $0.6 million associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.
 
September 25, 2015
 
September 26, 2014
Other assets
$
52.2

 
$
14.8

Prepaid expenses and other current assets
90.0

 
63.4

 
$
142.2

 
$
78.2
Schedule of Deferred Taxes Activity
The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:
 
September 25, 2015
 
September 26, 2014
Deferred tax assets:
 
 
 
Accrued liabilities and reserves
$
92.5

 
$
68.9

Inventories
23.2

 
21.4

Tax loss and credit carryforwards
163.3

 
93.8

Environmental liabilities
23.6

 
29.5

Rebate reserves
48.5

 
41.1

Expired product
26.3

 
39.0

Postretirement benefits
33.8

 
34.5

Federal and state benefit of uncertain tax positions and interest
33.6

 
29.5

Share-based compensation
18.9

 
28.1

Intangible assets
105.7

 
9.6

Other
20.2

 
32.0

 
589.6

 
427.4

Deferred tax liabilities:
 
 
 
Property, plant and equipment
(140.1
)
 
(121.6
)
Intangible assets
(1,550.7
)
 
(2,177.9
)
Installment sale
(1,465.3
)
 
(93.6
)
Investment in partnership
(187.9
)
 
(191.3
)
 
(3,344.0
)
 
(2,584.4
)
Net deferred tax (liability) before valuation allowances
(2,754.4
)
 
(2,157.0
)
Valuation allowances
(233.0
)
 
(76.9
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)
Schedule of Deferred Taxes Balance Sheet Location
Deferred taxes are reported in the following consolidated and combined balance sheet captions in the amounts shown:
 
September 25, 2015
 
September 26, 2014
Deferred income taxes (current asset)
$
142.7

 
$
152.3

Other non-current assets
7.0

 
13.4

Accrued and other current liabilities
(4.7
)
 
—

Deferred income taxes (non-current liability)
(3,132.4
)
 
(2,399.6
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)
XML 49 R75.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Schedule of Restructuring Charges Incurred Cumulative to Date) (Details) - 2013 Mallinckrodt program
$ in Millions
Sep. 25, 2015
USD ($)
Restructuring Cost and Reserve [Line Items]  
Restructuring costs incurred cumulative to date $ 96.9
Specialty Brands [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring costs incurred cumulative to date 4.0
Specialty Generics [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring costs incurred cumulative to date 15.6
Nuclear Imaging  
Restructuring Cost and Reserve [Line Items]  
Restructuring costs incurred cumulative to date 67.3
Corporate  
Restructuring Cost and Reserve [Line Items]  
Restructuring costs incurred cumulative to date $ 10.0
XML 50 R97.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt (Schedule of Maturities of Long-term Debt including Capital Lease Obligation) (Details)
$ in Millions
Sep. 25, 2015
USD ($)
Debt Disclosure [Abstract]  
Fiscal 2016 $ 22.3
Fiscal 2017 175.0
Fiscal 2018 321.2
Fiscal 2019 521.2
Fiscal 2020 $ 721.2
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (Loss) per Share (Policies)
 12 Months Ended
Sep. 25, 2015
Earnings (Loss) per Share [Abstract]  
Earnings (Loss) Per Share Policy
In periods prior to fiscal 2014, basic earnings (loss) per share was computed by dividing net income by the number of weighted-average shares outstanding during the period. Diluted earnings (loss) per share was computed using the weighted-average shares outstanding and, if dilutive, potential ordinary shares outstanding during the period. Potential ordinary shares represent the incremental ordinary shares issuable for restricted share units and share option exercises. The Company calculated the dilutive effect of outstanding restricted share units and share options on earnings (loss) per share by application of the treasury stock method.
The computations of basic and diluted earnings (loss) per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien. The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.
XML 52 R52.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Tables)
 12 Months Ended
Sep. 25, 2015
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligations
At September 25, 2015, such obligations were as follows:
Fiscal 2016
$
125.9

Fiscal 2017
51.4

Fiscal 2018
49.8

Fiscal 2019
7.9

Fiscal 2020
—
Schedule of Asset Retirement Obligations
The following table provides a summary of the changes in the Company's asset retirement obligations for fiscal 2015 and 2014:
 
2015
 
2014
Balance at beginning of period
$
39.2

 
$
48.9

Additions and adjustments
(1.0
)
 
(11.5
)
Accretion expense
1.8

 
3.1

Payments
—

 
—

Currency translation
(3.1
)
 
(1.3
)
Balance at end of period
$
36.9

 
$
39.2
Schedule of Minimum Lease Payments for Non-cancelable Leases
The following is a schedule of minimum lease payments for non-cancelable leases as of September 25, 2015:
 
Operating Leases
 
Capital
Leases
Fiscal 2016
$
21.1

 
$
1.3

Fiscal 2017
17.7

 
0.9

Fiscal 2018
15.0

 
0.1

Fiscal 2019
11.3

 
—

Fiscal 2020
9.3

 
—

Thereafter
20.6

 
—

Total minimum lease payments
$
95.0

 
2.3

Less: interest portion of payments
 
 
—

Present value of minimum lease payments
 
 
$
2.3
XML 53 R67.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Apr. 16, 2015
Aug. 14, 2014
Mar. 19, 2014
Oct. 01, 2012
Therakos          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired $ 1,019.7        
Intangible assets 1,170.0        
Therakos | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired $ 1,170.0        
Intangible assets acquired, weighted-average useful life 15 years        
Ikaria          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired   $ 1,253.6      
Intangible assets   1,971.0      
Amortizable intangible assets acquired   1,971.0      
Ikaria | In-process research and development          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Amortizable intangible assets acquired   $ 81.0      
Ikaria | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life   15 years      
Amortizable intangible assets acquired   $ 1,820.0      
Ikaria | Trademarks          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life   22 years      
Amortizable intangible assets acquired   $ 70.0      
Cash flow discount rate   14.50%      
Questcor Pharmaceuticals, Inc.          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired     $ 5,786.5    
Intangible assets     5,601.1    
Questcor Pharmaceuticals, Inc. | In-process research and development          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Indefinite lived intangible assets acquired     $ 218.3    
Cash flow discount rate     16.00%    
Questcor Pharmaceuticals, Inc. | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life     18 years    
Amortizable intangible assets acquired     $ 5,343.3    
Cash flow discount rate     14.50%    
Questcor Pharmaceuticals, Inc. | Trademarks          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life     13 years    
Amortizable intangible assets acquired     $ 5.2    
Cash flow discount rate     10.00%    
Questcor Pharmaceuticals, Inc. | Customer relationships          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life     12 years    
Amortizable intangible assets acquired     $ 34.3    
Cash flow discount rate     10.00%    
Cadence Pharmaceuticals, Inc.          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired       $ 1,329.2  
Intangible assets       $ 1,300.0  
Cash flow discount rate       13.00%  
Cadence Pharmaceuticals, Inc. | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life       8 years  
Amortizable intangible assets acquired       $ 1,300.0  
CNS Therapeutics, Inc.          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Net assets acquired         $ 91.7
Intangible assets         91.9
CNS Therapeutics, Inc. | In-process research and development          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Indefinite lived intangible assets acquired         18.6
Estimated cost to complete in-process research         $ 18.0
Cash flow discount rate         35.00%
CNS Therapeutics, Inc. | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life         13 years
Amortizable intangible assets acquired         $ 73.1
CNS Therapeutics, Inc. | Trademarks          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Intangible assets acquired, weighted-average useful life         3 years
Amortizable intangible assets acquired         $ 0.2
Therakos Immunotherapy [Member] | Therakos | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Cash flow discount rate 17.00%        
Inomax | Ikaria | Completed Technology          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Cash flow discount rate   14.50%      
Terlipressin [Member] | Ikaria | In-process research and development          
Intangible Assets Acquired as Part of Business Combination [Line Items]          
Cash flow discount rate   17.00%      
XML 54 R111.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Narrative) (Details) - USD ($)
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation cost $ 116,100,000 $ 66,800,000 $ 16,000,000
Tax benefit from share-based compensation cost 41,700,000 24,100,000 $ 5,700,000
Intrinsic value of options vested 89,500,000 34,200,000  
Tax benefit from stock options exercised $ 33,100,000 $ 12,000,000  
Performance period 3 years    
Share Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 4 years    
Expiration period 10 years    
Unrecognized compensation cost, share options $ 24,800,000    
Weighted-average period to recognize unrecognized compensation cost, share options 2 years 8 months    
Restricted Share Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 4 years    
Weighted-average period to recognize unrecognized compensation cost, share options 2 years 9 months    
Fair value of restricted share units granted in period $ 28,900,000    
Fair value of restricted share units vested in period 21,600,000    
Unrecognized compensation cost, restricted share units $ 30,300,000    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Employer matching contribution, percent of match 25.00% 15.00%  
ESPP employer match - maximum employee contribution $ 25,000    
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average period to recognize unrecognized compensation cost, share options 1 year 9 months    
Unrecognized compensation cost $ 8,900,000    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average period to recognize unrecognized compensation cost, share options 2 years 6 months    
Fair value of restricted share units vested in period $ 127,400,000    
Unrecognized compensation cost $ 2,300,000    
2013 Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares authorized under 2013 Plan 5,700,000.0    
2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares authorized under 2013 Plan 17,800,000.0    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12,100,000.0    
Questcor Pharmaceuticals, Inc.      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Post combination expense $ 90,400,000    
Selling, general and administrative | Questcor Pharmaceuticals, Inc.      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Post combination expense 80,600,000    
Restructuring | Questcor Pharmaceuticals, Inc.      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Post combination expense $ 9,800,000    
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of ordinary shares to be awarded 0.00%    
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of ordinary shares to be awarded 200.00%    
XML 55 R61.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures (Assets and Liabilities Held-for-Sale) (Details) - Contrast Media and Delivery Systems - Discontinued Operations, Held-for-sale - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Accounts receivable $ 68.5 $ 68.9
Inventories 86.3 90.2
Property, plant and equipment, net 60.3 62.4
Intangible assets, net 27.7 30.0
Other current and non-current assets 57.1 60.5
Total assets classified as held for sale in the balance sheet 299.9 312.0
Accounts payable 22.0 18.0
Other current and non-current liabilities 50.8 50.7
Total liabilities classified as held for sale in the balance sheet $ 72.8 $ 68.7
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt (Tables)
 12 Months Ended
Sep. 25, 2015
Debt Disclosure [Abstract]  
Schedule of Long-term Debt including Capital Lease Obligation
Debt was comprised of the following at the end of each period:
 
September 25, 2015
 
September 26, 2014
 
Principal
 
Unamortized Discount and Debt Issuance Costs
 
Principal
 
Unamortized Discount and Debt Issuance Costs
Current maturities of long-term debt:
 
 
 
 
 
 
 
2.85% term loan due April 2016
$
—

 
$
—

 
$
0.4

 
$
—

Term loans due March 2021
20.0

 
—

 
18.2

 
—

4.00% term loan due February 2022
1.0

 
—

 
1.2

 
—

Capital lease obligation and vendor financing agreements
1.3

 
—

 
1.4

 
—

Total current debt
22.3

 
—

 
21.2

 
—

Long-term debt:
 
 
 
 
 
 
 
Variable rate receivable securitization
153.0

 
0.8

 
150.0

 
1.0

2.85% term loan due April 2016
—

 
—

 
2.7

 
—

3.50% notes due April 2018
300.0

 
1.7

 
300.0

 
2.4

4.88% notes due April 2020
700.0

 
11.3

 
—

 
—

Term loans due March 2021
1,958.5

 
44.1

 
1,978.5

 
52.4

4.00% term loan due February 2022
6.9

 
—

 
9.6

 
—

9.50% debentures due May 2022
10.4

 
—

 
10.4

 
—

5.75% notes due August 2022
900.0

 
14.4

 
900.0

 
16.4

8.00% debentures due March 2023
4.4

 
—

 
8.0

 
—

4.75% notes due April 2023
600.0

 
7.1

 
600.0

 
7.9

5.625% notes due October 2023
750.0

 
13.7

 
—

 
—

5.50% notes due April 2025
700.0

 
11.9

 
—

 
—

Revolving credit facility
500.0

 
4.9

 
—

 
5.5

Capital lease obligation and vendor financing agreements
1.0

 
—

 
0.4

 
—

Total long-term debt
6,584.2

 
109.9

 
3,959.6

 
85.6

Total debt
$
6,606.5

 
$
109.9

 
$
3,980.8

 
$
85.6
Schedule of Maturities of Long-term Debt including Capital Lease Obligation
The aggregate amounts of debt, including the capital lease obligation, maturing during the next five fiscal years are as follows:
Fiscal 2016
$
22.3

Fiscal 2017
175.0

Fiscal 2018
321.2

Fiscal 2019
521.2

Fiscal 2020
721.2
XML 57 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statement of Changes in Shareholders' Equity Statement - USD ($)
$ in Millions
Total
Ordinary Shares
Treasury Shares
Additional Paid-In Capital
Retained Earnings
Contributed Surplus
Parent Company Investment
Accumulated Other Comprehensive Income
Beginning balance, shares at Sep. 28, 2012   0 0          
Beginning balance, value at Sep. 28, 2012 $ 1,891.9 $ 0.0 $ 0.0 $ 0.0 $ 0.0 $ 0.0 $ 1,807.0 $ 84.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 58.8       33.5   25.3  
Currency translation adjustments 1.5             1.5
Change in derivatives, net of tax (7.3)             (7.3)
Minimum pension liability, net of tax 34.2             34.2
Net transfers to parent (515.9)           (515.9)  
Separation related adjustments (214.7)           (209.9) (4.8)
Transfer of parent company investment to contributed surplus 0.0         1,106.5 (1,106.5)  
Transfer of contributed surplus to distributable reserves 0.0     1,095.0   (1,095.0)    
Share options exercised, value 0.6     0.6        
Share-based compensation 6.5     6.5        
Issuance of ordinary shares, shares   57,700,000            
Issuance of ordinary shares, value 0.0 $ (11.5)       (11.5)    
Ending balance, shares at Sep. 27, 2013   57,700,000 0          
Ending balance, value at Sep. 27, 2013 1,255.6 $ 11.5 $ 0.0 1,102.1 33.5 0.0 0.0 108.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (319.3)       (319.3)      
Currency translation adjustments (27.6)             (27.6)
Change in derivatives, net of tax 0.5             0.5
Minimum pension liability, net of tax (15.7)             (15.7)
Ordinary shares issued in connection with the Questcor acquisition, shares   57,300,000            
Ordinary shares issued in connection with the Questcor acquisition, value $ 3,979.6 $ 11.4   3,968.2        
Share options exercised, shares 878,330 800,000            
Share options exercised, value $ 25.8 $ 0.2   25.6        
Vesting of restricted shares, shares   400,000            
Vesting of restricted shares, value 0.0 $ 0.1   (0.1)        
Excess tax benefit from share-based compensation 8.9     8.9        
Share-based compensation 67.7     67.7        
Repurchase of ordinary shares, shares     200,000          
Repurchase of ordinary shares, value (17.5)   $ (17.5)          
Ending balance, shares at Sep. 26, 2014   116,200,000 200,000          
Ending balance, value at Sep. 26, 2014 4,958.0 $ 23.2 $ (17.5) 5,172.4 (285.8) 0.0 0.0 65.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 324.7              
Currency translation adjustments (70.8)             (70.8)
Change in derivatives, net of tax 0.4             0.4
Minimum pension liability, net of tax $ 5.6             5.6
Share options exercised, shares 1,132,778 1,200,000            
Share options exercised, value $ 34.4 $ 0.2   34.2        
Vesting of restricted shares, shares   1,300,000            
Vesting of restricted shares, value 0.0 $ 0.3   (0.3)        
Shares canceled, shares   (1,200,000)            
Shares canceled, value 0.0 $ (0.2)   0.2        
Excess tax benefit from share-based compensation 34.1     34.1        
Share-based compensation 117.0     117.0        
Repurchase of ordinary shares, shares     1,000,000          
Repurchase of ordinary shares, value (92.2)   $ (92.2)          
Ending balance, shares at Sep. 25, 2015   117,500,000 1,200,000          
Ending balance, value at Sep. 25, 2015 $ 5,311.2 $ 23.5 $ (109.7) $ 5,357.6 $ 38.9 $ 0.0 $ 0.0 $ 0.9
XML 58 R139.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Condensed Consolidating Financial Statements                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Cost of sales                 1,493.3 1,021.8 890.0
Gross profit 482.1 503.8 462.9 404.8 363.2 254.1 226.7 216.2 1,853.6 1,060.2 822.3
Selling, general and administrative expenses                 1,169.8 745.0 495.9
Research and development expenses                 185.1 163.5 157.9
Separation costs                 0.0 9.6 74.2
Restructuring charges, net                 40.4 81.4 23.7
Non-restructuring impairment charges                 0.0 151.6 0.0
Gain on divestiture and license                 (3.5) (15.0) (2.9)
Operating income (loss)                 461.8 (75.9) 73.5
Interest expense                 (255.6) (82.6) (19.5)
Interest income                 1.0 1.5 0.3
Other income (expense), net                 8.1 3.1 1.4
Intercompany interest and fees                 0.0 0.0 0.0
Equity in net income of subsidiaries                 0.0 0.0 0.0
Income (loss) from continuing operations before income taxes [1]                 215.3 (153.9) 55.7
Income Tax Expense (Benefit) [1]                 (92.9) (10.1) 47.5
Income (loss) from continuing operations 90.0 55.6 75.2 87.4 (173.5) (29.0) 20.2 38.5 308.2 (143.8) 8.2
Income (loss) from discontinued operations, net of income taxes (14.8) 2.4 23.6 5.3 (178.9) 4.9 (8.6) 7.1 16.5 (175.5) 50.6
Net income (loss) $ 75.2 $ 58.0 $ 98.8 $ 92.7 $ (352.4) $ (24.1) $ 11.6 $ 45.6 324.7 (319.3) 58.8
Other comprehensive loss, net of tax                 (64.8) (42.8) 28.4
Comprehensive income (loss)                 259.9 (362.1) 87.2
Mallinckrodt plc                      
Condensed Consolidating Financial Statements                      
Net sales                 0.0 0.0 0.0
Cost of sales                 0.0 0.0 0.0
Gross profit                 0.0 0.0 0.0
Selling, general and administrative expenses                 116.3 37.7 5.2
Research and development expenses                 0.0 0.0 0.0
Separation costs                   2.5 3.2
Restructuring charges, net                 9.8 35.3 0.0
Non-restructuring impairment charges                   0.0  
Gain on divestiture and license                 0.0 0.0 0.0
Operating income (loss)                 (126.1) (75.5) (8.4)
Interest expense                 (96.4) 0.0 0.0
Interest income                 0.0 0.0 0.0
Other income (expense), net                 216.3 30.9 0.2
Intercompany interest and fees                 (14.7) (9.0) (9.5)
Equity in net income of subsidiaries                 330.6 (264.8) 76.4
Income (loss) from continuing operations before income taxes                 309.7 (318.4) 58.7
Income Tax Expense (Benefit)                 (15.9) 0.0 (0.3)
Income (loss) from continuing operations                 325.6 (318.4) 59.0
Income (loss) from discontinued operations, net of income taxes                 (0.9) (0.9) (0.2)
Net income (loss)                 324.7 (319.3) 58.8
Other comprehensive loss, net of tax                 (64.8) (42.8) 28.4
Comprehensive income (loss)                 259.9 (362.1) 87.2
Mallinckrodt International Finance S.A.                      
Condensed Consolidating Financial Statements                      
Net sales                 0.0 0.0 0.0
Cost of sales                 0.0 0.0 0.0
Gross profit                 0.0 0.0 0.0
Selling, general and administrative expenses                 15.7 7.3 0.1
Research and development expenses                 0.0 0.0 0.0
Separation costs                   0.0 0.6
Restructuring charges, net                 0.0 0.0 0.0
Non-restructuring impairment charges                   0.0  
Gain on divestiture and license                 0.0 0.0 0.0
Operating income (loss)                 (15.7) (7.3) (0.7)
Interest expense                 (230.2) (86.3) (19.6)
Interest income                 0.1 0.0 0.0
Other income (expense), net                 0.0 0.0 0.0
Intercompany interest and fees                 0.0 0.0 0.0
Equity in net income of subsidiaries                 496.3 (171.2) 96.7
Income (loss) from continuing operations before income taxes                 250.5 (264.8) 76.4
Income Tax Expense (Benefit)                 0.0 0.0 0.0
Income (loss) from continuing operations                 250.5 (264.8) 76.4
Income (loss) from discontinued operations, net of income taxes                 0.0 0.0 0.0
Net income (loss)                 250.5 (264.8) 76.4
Other comprehensive loss, net of tax                 (64.8) (42.8) 28.4
Comprehensive income (loss)                 185.7 (307.6) 104.8
Other Subsidiaries                      
Condensed Consolidating Financial Statements                      
Net sales                 3,346.9 2,082.0 1,712.3
Cost of sales                 1,493.3 1,021.8 890.0
Gross profit                 1,853.6 1,060.2 822.3
Selling, general and administrative expenses                 1,037.8 700.0 490.6
Research and development expenses                 185.1 163.5 157.9
Separation costs                   7.1 70.4
Restructuring charges, net                 30.6 46.1 23.7
Non-restructuring impairment charges                   151.6  
Gain on divestiture and license                 (3.5) (15.0) (2.9)
Operating income (loss)                 603.6 6.9 82.6
Interest expense                 (25.2) 0.0 0.1
Interest income                 97.1 5.2 0.3
Other income (expense), net                 (208.2) (27.8) 1.2
Intercompany interest and fees                 14.7 9.0 9.5
Equity in net income of subsidiaries                 250.5 (300.2) 0.0
Income (loss) from continuing operations before income taxes                 732.5 (306.9) 93.7
Income Tax Expense (Benefit)                 (77.0) (10.1) 47.8
Income (loss) from continuing operations                 809.5 (296.8) 45.9
Income (loss) from discontinued operations, net of income taxes                 17.4 (174.6) 50.8
Net income (loss)                 826.9 (471.4) 96.7
Other comprehensive loss, net of tax                 (69.9) (84.1) 35.7
Comprehensive income (loss)                 757.0 (555.5) 132.4
Eliminations                      
Condensed Consolidating Financial Statements                      
Net sales                 0.0 0.0 0.0
Cost of sales                 0.0 0.0 0.0
Gross profit                 0.0 0.0 0.0
Selling, general and administrative expenses                 0.0 0.0 0.0
Research and development expenses                 0.0 0.0 0.0
Separation costs                   0.0 0.0
Restructuring charges, net                 0.0 0.0 0.0
Non-restructuring impairment charges                   0.0  
Gain on divestiture and license                 0.0 0.0 0.0
Operating income (loss)                 0.0 0.0 0.0
Interest expense                 96.2 3.7 0.0
Interest income                 (96.2) (3.7) 0.0
Other income (expense), net                 0.0 0.0 0.0
Intercompany interest and fees                 0.0 0.0 0.0
Equity in net income of subsidiaries                 (1,077.4) 736.2 (173.1)
Income (loss) from continuing operations before income taxes                 (1,077.4) 736.2 (173.1)
Income Tax Expense (Benefit)                 0.0 0.0 0.0
Income (loss) from continuing operations                 (1,077.4) 736.2 (173.1)
Income (loss) from discontinued operations, net of income taxes                 0.0 0.0 0.0
Net income (loss)                 (1,077.4) 736.2 (173.1)
Other comprehensive loss, net of tax                 134.7 126.9 (64.1)
Comprehensive income (loss)                 $ (942.7) $ 863.1 $ (237.2)
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
XML 59 R116.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Restricted Share Unit Activity) (Details) - $ / shares
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Restricted Share Units      
Restricted Share Unit Activity [Roll Forward]      
Beginning balance 589,222 724,269  
Granted 273,733 229,281  
Converted from Questcor Acquisition   30,747  
Vested (219,189) (300,237)  
Forfeited (71,272) (94,838)  
Ending balance 572,494 589,222  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average grant date fair value, restricted share units $ 73.45 $ 47.88 $ 40.62
Weighted-average grant date fair value, granted restricted share units 105.68 55.40  
Weighted-average grant date fair value, converted from Questcor Acquisition   70.88  
Weighted-average grant date fair value, vested restricted share units 49.84 34.77  
Weighted-average grant date fair value, forfeited restricted share units $ 68.15 $ 42.48  
Restricted Stock      
Restricted Share Unit Activity [Roll Forward]      
Beginning balance 1,432,031 0  
Granted 0 0  
Converted from Questcor Acquisition   1,829,164  
Vested (1,362,823) (390,731)  
Forfeited (34,646) (6,402)  
Ending balance 34,562 1,432,031  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average grant date fair value, restricted share units $ 70.88 $ 70.88 $ 0.00
Weighted-average grant date fair value, granted restricted share units 0.00 0.00  
Weighted-average grant date fair value, converted from Questcor Acquisition   70.88  
Weighted-average grant date fair value, vested restricted share units 70.88 70.88  
Weighted-average grant date fair value, forfeited restricted share units $ 70.88 $ 70.88  
XML 60 R62.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures, Significant Cash and Non-Cash Transactions (Details) - Contrast Media and Delivery Systems - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Depreciation $ 15.5 $ 18.9 $ 16.0
Amortization 2.3 7.5 7.5
Capital expenditures 9.5 12.3 17.4
Non-cash impairment charges $ 0.0 $ 204.0 $ 0.0
XML 61 R128.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Instruments and Fair Value Measurements (Narrative) (Details)
CAD in Millions, $ in Millions
 12 Months Ended
Sep. 25, 2015
USD ($)
supplier
reactor
Sep. 25, 2015
CAD
supplier
reactor
Sep. 25, 2015
CAD
Sep. 26, 2014
USD ($)
Aug. 31, 2014
USD ($)
Aug. 14, 2014
USD ($)
Apr. 30, 2013
Oct. 01, 2012
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Number of Suppliers of Unique Raw Material | supplier 8 8            
Number of Nuclear Research Reactors Used To Source Raw Material | reactor 3 3            
Number of Nuclear Reactors Relied on For Supply of Raw Material | reactor 2 2            
Novartis 2015 and 2016                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Business Combination, Contingent Consideration, Annual Payments $ 25.0              
Novartis, Subsequent to 2016 till FDA Approval                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Business Combination, Contingent Consideration, Annual Payments 25.0              
Novartis, Subsequent to FDA Approval                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Business Combination, Contingent Consideration, Potential Payment $ 25.0              
CNS Therapeutics, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value of contingent consideration upon acquisition               $ 6.9
Maximum contingent payments for acquisition               $ 9.0
Discount rate 1.00% 1.00%            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability $ 7.2              
Questcor Pharmaceuticals, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value of contingent consideration upon acquisition           $ 0.0    
Maximum contingent payments for acquisition $ 190.0              
Discount rate 4.70% 4.70%            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability $ 167.4       $ 195.4      
Questcor Pharmaceuticals, Inc. | BioVectra Financial Results                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Discount rate 1.30% 1.30%            
2.85% term loan due April 2016                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Discount rate 2.85% 2.85%            
4.00% term loan due February 2022                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Discount rate 4.00% 4.00%            
Debentures | 8.00% debentures due March 2023 | Level 2                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 8.00%   8.00%          
Debentures | 9.50% debentures due May 2022 | Level 2                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 9.50%   9.50%          
Senior Notes | 3.50% notes due April 2018                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate             3.50%  
Senior Notes | 3.50% notes due April 2018 | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 3.50%   3.50%          
Senior Notes | 4.75% notes due April 2023                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate             4.75%  
Senior Notes | 4.75% notes due April 2023 | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 4.75%   4.75%          
Senior Notes | 5.75% notes due August 2022                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Discount rate 5.75% 5.75%            
Stated interest rate         5.75%      
Debentures | Four Point Eight Eight Percent Notes [Member] | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 4.875%   4.875%          
Debentures | Five Point Five Percent Notes [Member] | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 5.50%   5.50%          
Debentures | 5.625% notes due October 2023 | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Stated interest rate 5.625%   5.625%          
Carrying Value | Level 1                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Restricted cash $ 66.3     $ 69.8        
Carrying Value | Level 3                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Cash surrender value of life insurance 67.7     $ 67.3        
BioVectra Inc [Member] | Questcor Pharmaceuticals, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value of contingent consideration upon acquisition | CAD     CAD 50.0          
Business Combination, Contingent Consideration, Potential Payment | CAD     CAD 40.0          
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | CAD   CAD 5.0            
Synacthen [Member] | Questcor Pharmaceuticals, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Milestone Payments $ 25.0              
XML 62 R136.htm IDEA: XBRL DOCUMENT v3.3.0.814
Selected Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Quarterly Financial Information Disclosure [Abstract]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Gross profit 482.1 503.8 462.9 404.8 363.2 254.1 226.7 216.2 1,853.6 1,060.2 822.3
Income (loss) from continuing operations 90.0 55.6 75.2 87.4 (173.5) (29.0) 20.2 38.5 308.2 (143.8) 8.2
Income (loss) from discontinued operations, net of income taxes (14.8) 2.4 23.6 5.3 (178.9) 4.9 (8.6) 7.1 16.5 (175.5) 50.6
Net income (loss) $ 75.2 $ 58.0 $ 98.8 $ 92.7 $ (352.4) $ (24.1) $ 11.6 $ 45.6 $ 324.7 $ (319.3) $ 58.8
Basic earnings (loss) per share from continuing operations (in usd per share) $ 0.77 [1] $ 0.47 [1] $ 0.64 [1] $ 0.75 [1] $ (2.04) [1] $ (0.50) [1] $ 0.35 [1] $ 0.67 [1] $ 2.64 $ (2.22) $ 0.14
Diluted earnings (loss) per share from continuing operations (in usd per share) $ 0.76 [1] $ 0.47 [1] $ 0.64 [1] $ 0.74 [1] $ (2.04) [1] $ (0.50) [1] $ 0.34 [1] $ 0.66 [1] $ 2.61 $ (2.22) $ 0.14
[1] Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (Loss) per Share (Tables)
 12 Months Ended
Sep. 25, 2015
Earnings (Loss) per Share [Abstract]  
Schedule of Earnings (Loss) per Share
The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.
 
2015
 
2014
 
2013
Earnings (loss) per share numerator:
 
 
 
 
 
Income (loss) from continuing operations attributable to common shareholders before allocation of earnings to participating securities
$
308.2

 
$
(143.8
)
 
$
8.2

Less: earnings allocated to participating securities
2.5

 
—

 
—

Income (loss) from continuing operations attributable to common shareholders, after earnings allocated to participating securities
305.7

 
(143.8
)
 
8.2

 
 
 
 
 
 
Income (loss) from discontinued operations
16.5

 
(175.5
)
 
50.6

Less: earnings from discontinued operations allocated to participating securities
0.1

 
—

 
—

Income (loss) from discontinued operations attributable to common shareholders, after allocation of earnings to participating securities
16.4

 
(175.5
)
 
50.6

Net income (loss) attributable to common shareholders, after allocation of earnings to participating securities
$
322.1

 
$
(319.3
)
 
$
58.8

Earnings (loss) per share denominator:
 
 
 
 
 
Weighted-average shares outstanding - basic
115.8

 
64.9

 
57.7

Impact of dilutive securities
1.4

 
—

 
0.1

Weighted-average shares outstanding - diluted
117.2

 
64.9

 
57.8

Basic earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.64

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.78

 
$
(4.92
)
 
$
1.02

Diluted earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.61

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.75

 
$
(4.92
)
 
$
1.02
XML 64 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Instruments and Fair Value Measurements
 12 Months Ended
Sep. 25, 2015
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurements
20.
Financial Instruments and Fair Value Measurements
Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes a three-level fair value hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs used in measuring fair value. The levels within the hierarchy are as follows:
Level 1— observable inputs such as quoted prices in active markets for identical assets or liabilities;
Level 2— significant other observable inputs that are observable either directly or indirectly; and
Level 3— significant unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions.

The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:
 
September 25,
2015
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
34.6

 
$
24.2

 
$
10.4

 
$
—

 
$
34.6

 
$
24.2

 
$
10.4

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
20.0

 
$
—

 
$
20.0

 
$
—

Contingent consideration and acquired contingent liabilities
174.6

 
—

 
—

 
174.6

Foreign exchange forward and option contracts
3.3

 
3.3

 
—

 
—

 
$
197.9

 
$
3.3

 
$
20.0

 
$
174.6


 
September 26,
2014

Quoted Prices in Active Markets for Identical Assets
(Level 1)

Significant Other Observable Inputs
(Level 2)

Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
35.7

 
$
22.9

 
$
12.8

 
$
—

 
$
35.7

 
$
22.9

 
$
12.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
15.0

 
$
—

 
$
15.0

 
$
—

Contingent consideration and acquired contingent liabilities
202.8

 
—

 
—

 
202.8

Foreign exchange forward and option contracts
0.2

 
0.2

 
—

 
—


$
218.0

 
$
0.2

 
$
15.0

 
$
202.8


Debt and equity securities held in rabbi trust. Debt securities held in the rabbi trust primarily consist of U.S. government and agency securities and corporate bonds. When quoted prices are available in an active market, the investments are classified as level 1. When quoted market prices for a security are not available in an active market, they are classified as level 2. Equity securities held in the rabbi trust primarily consist of U.S. common stocks, which are valued using quoted market prices reported on nationally recognized securities exchanges.
Foreign exchange forward and option contracts. Foreign currency option and forward contracts are used to economically manage the foreign exchange exposures of operations outside the U.S. Quoted prices are available in an active market; as such, these derivatives are classified as level 1.
Deferred compensation liabilities. The Company maintains a non-qualified deferred compensation plan in the U.S., which permits eligible employees of the Company to defer a portion of their compensation. A recordkeeping account is set up for each participant and the participant chooses from a variety of funds for the deemed investment of their accounts. The recordkeeping accounts generally correspond to the funds offered in the Company's U.S. tax-qualified defined contribution retirement plan and the account balance fluctuates with the investment returns on those funds.
Goodwill. The Company performs an annual goodwill impairment assessment using an income approach based on the present value of future cash flows. See further discussion in Notes 2 and 11.
Contingent consideration and acquired contingent liabilities. In October 2012, the Company recorded contingent consideration of $6.9 million upon the acquisition of CNS Therapeutics. This contingent consideration, which could potentially total a maximum of $9.0 million, is primarily based on whether the FDA approves another concentration of Gablofen on or before December 31, 2016. The fair value of the contingent payments was measured based on the probability-weighted present value of the consideration expected to be transferred using a discount rate of 1.0%. At September 25, 2015, the fair value of this contingent consideration was $7.2 million.
In August 2014, the Company recorded acquired contingent liabilities of $195.4 million from the Questcor Acquisition. The contingent liabilities relate to Questcor's contingent obligations associated with their acquisition of an exclusive, perpetual and irrevocable license to develop, market, manufacture, distribute, sell and commercialize Synacthen and Synacthen Depot (collectively "Synacthen") from Novartis AG and Novartis Pharma AG (collectively "Novartis") and their acquisition of BioVectra. The fair value of these contingent consideration obligations at September 25, 2015 were $167.4 million.
Under the terms of the license agreement with Novartis, the Company is obligated to make a $25.0 million payment in fiscal 2016, make annual payments of $25.0 million subsequent to fiscal 2016 until such time that the Company obtains FDA approval of Synacthen and make a $25.0 million payment upon obtaining FDA approval of Synacthen. If FDA approval is obtained, the Company will pay an annual royalty to Novartis based on a percentage of net sales of the products in the U.S. market. The Company made its fiscal 2015 required payment of $25.0 million. As of September 25, 2015, the total remaining payments under the license agreement shall not exceed $190.0 million. The terms of the license agreement do allow the Company to terminate the license agreement at our discretion following the fiscal 2018 payment or upon the occurrence of certain events following the fiscal 2016 payment. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of 4.7%. Under the terms of the license agreement, the Company was required to maintain deposits equal to the fiscal 2016 annual $25.0 million payment which is included in prepaid expenses and other current assets and other assets in the consolidated balance sheets.

Based on the terms of the acquisition agreement with the former shareholders of BioVectra, the Company may be obligated to pay additional cash consideration of $50.0 million CAD based on BioVectra's financial results from January 2013 through a portion of fiscal 2016. During fiscal 2015 and 2014, the Company made $5.0 million CAD payments to the former shareholders and may be obligated for an additional $40.0 million CAD to be paid in fiscal 2016. The Company measured the fair value of the contingent payments based on a probability-weighted present value of the consideration expected to be transferred using a discount rate of 1.3%.
Balance at September 26, 2014
$
202.8

Payments
(29.0
)
Accretion expense
7.5

Effect of currency rate change
(6.7
)
Balance at September 25, 2015
$
174.6



Financial Instruments Not Measured at Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and the majority of other current assets and liabilities approximate fair value because of their short-term nature. The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents (level 1). The fair value of restricted cash is equivalent to its carrying value of $66.3 million and $69.8 million as of September 25, 2015 and September 26, 2014, respectively (level 1), substantially all of which is included in other assets on the consolidated balance sheets. The Company's life insurance contracts are carried at cash surrender value, which is based on the present value of future cash flows under the terms of the contracts (level 3). Significant assumptions used in determining the cash surrender value include the amount and timing of future cash flows, interest rates and mortality charges. The fair value of these contracts approximates the carrying value of $67.7 million and $67.3 million at September 25, 2015 and September 26, 2014, respectively. These contracts are included in other assets on the consolidated and combined balances sheets.
The carrying values of the Company's revolving credit facility and variable rate receivable securitization approximate the fair values due to the short-term nature of these instruments. The carrying values of the 2.85% and 4.00% term loans approximate the fair values of these instruments, as calculated using the discounted exit price for each instrument, and are therefore classified as level 3. Since the quoted market prices for the Company's term loans and 8.00% and 9.50% debentures are not available in an active market, they are classified as level 2 for purposes of developing an estimate of fair value. The Company's 3.50%, 4.75%, 4.875%, 5.50%, 5.625% and 5.75% notes are classified as level 1, as quoted prices are available in an active market for these notes. The following table presents the carrying values and estimated fair values of the Company's long-term debt, excluding capital leases, as of the end of each period:

September 25, 2015

September 26, 2014

Carrying
Value

Fair
Value

Carrying
Value

Fair
Value
Variable rate receivable securitization
$
153.0

 
$
153.0

 
$
150.0

 
$
150.0

2.85% term loan due April 2016
—

 
—

 
3.1

 
3.1

3.50% notes due April 2018
300.0

 
294.3

 
300.0

 
290.2

4.875% notes due April 2020
700.0

 
684.1

 
—

 
—

Term loans due March 2021
1,978.5

 
1,966.5

 
1,996.7

 
1,970.4

4.00% term loan due February 2022
7.9

 
7.9

 
10.8

 
10.8

9.50% debentures due May 2022
10.4

 
13.0

 
10.4

 
14.2

5.75% notes due August 2022
900.0

 
876.1

 
900.0

 
907.3

8.00% debentures due March 2023
4.4

 
5.3

 
8.0

 
10.2

4.75% notes due April 2023
600.0

 
539.6

 
600.0

 
563.8

5.625% notes due October 2023
750.0

 
705.2

 
—

 
—

5.50% notes due April 2025
700.0

 
646.0

 
—

 
—

Revolving credit facility
500.0

 
500.0

 
—

 
—



Concentration of Credit and Other Risks
Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of accounts receivable. The Company does not require collateral from customers. A portion of the Company's accounts receivable outside the U.S. includes sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries' national economies.
The following table shows net sales attributable to distributors that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
CuraScript, Inc.
31
%
 
6
%
 
—
%
McKesson Corporation
18
%
 
21
%
 
19
%
Cardinal Health, Inc.
14
%
 
22
%
 
24
%
AmerisourceBergen Corporation
9
%
 
14
%
 
11
%

The following table shows accounts receivable attributable to distributors that accounted for 10% or more of the Company's gross accounts receivable at the end of each period:

September 25,
2015

September 26,
2014
McKesson Corporation
24
%
 
27
%
CuraScript, Inc.
16
%
 
15
%
Cardinal Health, Inc.
13
%
 
18
%
AmerisourceBergen Corporation
12
%
 
14
%

 The following table shows net sales attributable to products that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
Acthar
31
%
 
6
%
 
—
%
Acetaminophen products (API)
6
%
 
9
%
 
13
%
Methylphenidate ER
4
%
 
10
%
 
9
%


Molybdenum-99 ("Mo-99") is a key raw material in the Company's Ultra-Technekow DTE technetium generators that are sold by its Nuclear Imaging segment. There are only eight suppliers of this raw material worldwide. The Company has agreements to obtain Mo-99 from three nuclear research reactors and relies predominantly upon two of these reactors for its Mo-99 supply. Accordingly, a disruption in the commercial supply or a significant increase in the cost of this material from these sources could have a material adverse effect on the Company's financial condition, results of operations and cash flows.
XML 65 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies
 12 Months Ended
Sep. 25, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
19.
Commitments and Contingencies
The Company has purchase obligations related to commitments to purchase certain goods and services. At September 25, 2015, such obligations were as follows:
Fiscal 2016
$
125.9

Fiscal 2017
51.4

Fiscal 2018
49.8

Fiscal 2019
7.9

Fiscal 2020
—



The Company is subject to various legal proceedings and claims, including patent infringement claims, product liability matters, environmental matters, employment disputes, contractual disputes and other commercial disputes, including those described below. The Company believes that these legal proceedings and claims likely will be resolved over an extended period of time. Although it is not feasible to predict the outcome of these matters, the Company believes, unless indicated below, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.

Governmental Proceedings
In November 2011 and October 2012, the Company received subpoenas from the U.S. Drug Enforcement Administration requesting production of documents relating to its suspicious order monitoring program. The United States Attorney’s Office (the “USAO”) for the Eastern District of Michigan is investigating the possibility of the Company failing to report suspicious orders of controlled substances during the period 2006-2011 in violation of the Controlled Substances Act and its related regulations. The USAO for the Northern District of New York and Office of Chief of Counsel for the U.S. Drug Enforcement Administration are investigating the possibility of the Company failing to maintain appropriate records and security measures with respect to manufacturing of certain controlled substances at its Hobart facility during the period 2012-2013. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows.
In September 2012, Questcor received a subpoena from the USAO for the Eastern District of Pennsylvania for information relating to its promotional practices. Questcor has also been informed by the USAO for the Eastern District of Pennsylvania that the USAO for the Southern District of New York and the SEC are participating in the investigation to review Questcor's promotional practices and related matters. On March 9, 2015, the Company received a "No Action" letter from the SEC regarding its review of the Company's promotional practices.
In June 2014, Questcor received a subpoena and Civil Investigative Demand ("CID") from the Federal Trade Commission ("FTC") seeking documentary materials and information regarding the FTC's investigation into whether Questcor's acquisition of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen Depot® from Novartis AG and Novartis Pharma AG (collectively, "Novartis") violates antitrust laws. Subsequently, a small number of states commenced similar investigations focused on whether the transaction violates state antitrust laws. The Company is not aware of any existing or pending litigation in connection with these investigations. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution, after taking into account amounts already accrued, could have a material adverse effect on its financial condition, results of operations and cash flows.
In March 2014, the USAO for the Eastern District of Pennsylvania requested the production of documents related to an investigation of the potential promotion of Therakos’ immunotherapy drug/device system UVADEX/UVAR XTS and UVADEX/CELLEX (collectively, the “Therakos System”), for indications not approved by the FDA, including the treatment of patients with graft versus host disease (“GvHD”) and solid organ transplant patients, including pediatric patients. The investigation also includes Therakos’ efforts to secure FDA approval for additional uses of, and alleged quality issues relating to, UVADEX/UVAR. In August 2015, the USAO for the Eastern District of Pennsylvania sent Therakos a subsequent request for documents related to the investigation and we are in the process of responding to that request.

In November 2014, the Company received a CID from the Civil Medicaid Fraud Division of the Texas Attorney General's Office. According to the CID, the Attorney General's office is investigating the possibility of false reporting of information by the Company regarding the prices of certain of its drugs used by Texas Medicaid to establish reimbursement rates for pharmacies that dispensed the Company's drugs to Texas Medicaid recipients.
We are in the process of responding to each of the subpoenas and the CIDs and we intend to cooperate fully in each such investigation.
Mallinckrodt Inc. v. U.S. Food and Drug Administration and United States of America. The Company filed a Complaint for Declaratory and Injunctive Relief ("the Complaint") in the U.S. District Court for the District of Maryland Greenbelt Division against the FDA and the United States of America in November 2014 for judicial review of what the Company believes is the FDA's inappropriate and unlawful reclassification of the Company's Methylphenidate HCl Extended-Release tablets USP (CII) ("Methylphenidate ER") in the Orange Book: Approved Drug Products with Therapeutic Equivalence ("Orange Book") on November 13, 2014. In its Complaint, the Company has asked the court to: issue an injunction to (a) set aside the FDA's reclassification of the Company's Methylphenidate ER products from freely substitutable at the pharmacy level (class AB) to presumed to be therapeutically inequivalent (class BX) in the Orange Book and (b) prohibit the FDA from reclassifying the Company's Methylphenidate ER products in the future without following applicable legal requirements; and issue a declaratory judgment that the FDA's action reclassifying the Company's Methylphenidate ER products in the Orange Book is unlawful. The Company concurrently filed a motion with the same court requesting an expedited hearing to issue a temporary restraining order ("TRO") directing the FDA to reinstate the Orange Book AB rating for the Company's Methylphenidate ER products on a temporary basis. The court denied the Company's motion for a TRO. In December 2014, the FDA filed a motion to dismiss the Compliant with the district court. The Company filed its opposition to the motion to dismiss in January 2015, and concurrently filed a motion for summary judgment. On July 29, 2015, the court granted the FDA’s motion to dismiss with respect to three of the five counts in the Complaint and granted summary judgment in favor of the FDA with respect to the two remaining counts.  The Company has appealed the court’s decision to the U.S. Court of Appeals for the Fourth Circuit.

Patent/Antitrust Litigation
Tyco Healthcare Group LP, et al. v. Mutual Pharmaceutical Company, Inc. In March 2007, the Company filed a patent infringement suit in the U.S. District Court for the District of New Jersey against Mutual Pharmaceutical Co., Inc., et al. (collectively, "Mutual") after Mutual submitted an Abbreviated New Drug Application ("ANDA") to the FDA seeking to sell a generic version of the Company's 7.5mg RESTORIL™ sleep aid product. Mutual also filed antitrust and unfair competition counterclaims. The patents at issue have since expired or been found invalid. The trial court issued an opinion and order granting the Company's motion for summary judgment regarding Mutual's antitrust and unfair competition counterclaims. Mutual appealed this decision to the U.S. Court of Appeals for the Federal Circuit and the Federal Circuit issued a split decision, affirming the trial court in part and remanding to the trial court certain counterclaims for further proceedings. The Company filed a motion for summary judgment with the U.S. District Court regarding the remanded issues. In May 2015, the trial court issued an opinion granting-in-part and denying-in-part the Company’s motion for summary judgment.
'222 and '218 Patent Litigation: Exela Pharma Sciences, LLC. In August 2011, Cadence, a subsidiary of the Company, and Pharmatop, the owner of the two U.S. patents licensed exclusively by Cadence, filed suit in the U.S. District Court for the District of Delaware against Exela Pharma Sciences, LLC, Exela PharmaSci, Inc. and Exela Holdings, Inc. (collectively, "Exela"), alleging that Exela infringed U.S. Patent Nos. 6,028,222 ("the '222 patent") and 6,992,218 ("the '218 patent"), by submitting an ANDA to the FDA seeking to sell a generic version of Ofirmev. The filing of the lawsuit triggered a stay of FDA approval of the Exela ANDA until the earlier of the expiration of a 30-month period, the expiration of the '222 and '218 patents, the entry of a settlement order or consent decree stating that the '222 and '218 patents are invalid or not infringed, a decision in the case concerning infringement or validity that is favorable to Exela, or such shorter or longer period as the court may order. After a bench trial, the court ruled in favor of Cadence in November 2013 and found that Exela's ANDA infringed the '222 and '218 patents. Exela appealed the decision and oral arguments in the appeal occurred in November 2014. In March 2015, the Federal Circuit affirmed the district court decision.
'222 and '218 Patent Litigation: InnoPharma Licensing LLC and InnoPharma, Inc. In September 2014, Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against InnoPharma Licensing LLC and InnoPharma, Inc. (collectively "InnoPharma") following receipt of an August 2014 notice from InnoPharma concerning its submission of a New Drug Application (“NDA”), containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev.
'222 and '218 Patent Litigation: Agila Specialties Private Limited, Inc. and Agila Specialties Inc. (a Mylan Inc. Company), (collectively “Agila”).  In December 2014, Cadence and Mallinckrodt IP, subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Agila following receipt of a November 2014 notice from Agila concerning its submission of a NDA containing a Paragraph IV patent certification with the FDA for a competing version of Ofirmev. 
The Company intends to vigorously enforce its intellectual property rights relating to Ofirmev to prevent the marketing of infringing generic or competing products prior to the expiration of the Cadence patents. An adverse outcome in either the Exela or InnoPharma matters ultimately could result in the launch of one or more generic versions of Ofirmev before the expiration of the last of the listed patents on June 6, 2021 (or December 6, 2021 if pediatric exclusivity is granted), which could adversely affect the Company's ability to successfully maximize the value of Ofirmev and have an adverse effect on our financial condition, results of operations and cash flows.
'222 and '218 Patents: Ex Parte Reexamination. In September 2012, Exela filed with the U.S. Patent and Trademark Office ("USPTO") a Request for Ex Parte Reexamination of the '222 patent and the USPTO granted that request. The reexamination process requires the USPTO to consider the scope and validity of the patent based on substantial new questions of patentability raised by a third-party or the USPTO. Cadence and Pharmatop have filed, with the USPTO, a patent owner's statement commenting on the reexamination request, and thereafter the parties made various submissions. In March 2015, the USPTO issued an ex parte reexamination certificate for the '222 patent listing the claims that resulted from the reexamination proceeding.
In addition, in January 2014, an unidentified third-party filed, with the USPTO, a Request for Ex Parte Reexamination of the '218 patent. The reexamination request was granted. In July 2014, the USPTO issued a Non-Final Office Action in the '218 reexamination in which it rejected certain claims. In September 2014, Cadence and Pharmatop filed an Amendment and Response to the Office Action. Cadence and Pharmatop filed a supplemental response in January 2015. In June 2015, the USPTO issued a Final Office Action confirming that effectively all of the original claims were patentable, and Cadence and Pharmatop subsequently filed an Amendment and Response to the Final Office Action. On July 15, 2015, the USPTO confirmed in the reexamination proceeding for the '218 patent that original claims 1-10 and 12-19 as well as amended original dependent claim 11 and six new dependent claims are all patentable. In August 2015, the USPTO issued an ex parte reexamination certificate for the '218 patent listing the claims that resulted from the reexamination proceeding. Because the Company and Pharmatop believe that the scope and validity of the patent claims in the '222 reexamination certificate and the '218 patent reexamination certificate are appropriate and that the USPTO's prior issuances of the patents were correct, the Company, in conjunction with Pharmatop, will vigorously defend these patents.
'218 Patent Litigation: Exela Pharma Sciences, LLC. In April 2012, Exela filed suit against David J. Kappos and the USPTO in the U.S. District Court for the Eastern District of Virginia for declaratory judgment seeking a reversal of the USPTO's decision not to act on a petition by Exela to vacate the USPTO's April 2003 order reviving the international application for the '218 patent. The lawsuit followed the USPTO's rejection of Exela's petition to the USPTO filed in November 2011, which sought to vacate the April 2003 order. The USPTO determined that Exela lacked standing to seek such relief. Exela also seeks declaratory judgment that the USPTO's rules and regulations that allow for revival of abandoned, international patent applications under the "unintentional" standard are invalid, and seeks similar relief in connection with one or more counterclaims it has filed in the Delaware litigation. Cadence intervened in this lawsuit and in December 2012, the district court dismissed the case with prejudice as barred by the applicable statute of limitations. Exela appealed the dismissal to the Court of Appeals for the Federal Circuit and oral arguments were held in February 2014. In March 2015, the Federal Circuit affirmed the district court's dismissal of the Exela complaint.
'222 and '218 Patent Litigation Settlements. Four other similar cases involving generic and/or competing versions of Ofirmev have previously settled. In each settlement, the defendant was granted the non-exclusive right to market a generic intravenous acetaminophen product in the U.S. under its respective ANDA after December 6, 2020, or earlier under certain circumstances. In connection with those settlements, one settling party was granted the exclusive right of first refusal to negotiate an agreement with Cadence to market an authorized generic of Ofirmev in the U.S. in the event that Cadence elects to launch an authorized generic version of the product. If that settling party elects not to exercise its right of first refusal, Cadence has agreed to grant a similar right of first refusal to another settling party. As part of another settlement, Cadence entered into a supply agreement under which an affiliate of one of the settling parties will develop, manufacture and supply commercial quantities of Ofirmev to the Company if certain regulatory approvals are obtained.
Inomax Patents: Inter Partes Review ("IPR") Proceedings. In February 2015 and March 2015, the USPTO issued Notices of Filing Dates Accorded to Petitions for IPR petitions filed by Praxair Distribution, Inc. concerning ten patents covering Inomax. Patent Owner Preliminary responses for all of the IPR petitions were filed in May 2015 and June 2015. On July 29, 2015 the USPTO Patent Trial and Appeal Board ("PTAB") issued rulings denying the institution of four of the five IPR petitions challenging the five patents expiring in 2029.  The PTAB also issued a ruling on July 29, 2015 that instituted the IPR proceeding in the fifth of this group of patents and the PTAB is statutorily required to complete the IPR process on that patent within one year.  On September 22, 2015 the USPTO PTAB issued rulings that instituted the IPR proceedings in each of the second set of five patents that expire in 2031 and the PTAB is statutorily required to complete the IPR process on these five patents within one year.
Inomax Patent Litigation: Praxair Distribution, Inc. and Praxair, Inc. (collectively “Praxair”). In February 2015, INO Therapeutics LLC and Ikaria, Inc., subsidiaries of the Company, filed suit in the U.S. District Court for the District of Delaware against Praxair following receipt of a January 2015 notice from Praxair concerning its submission of an ANDA containing a Paragraph IV patent certification with the FDA for a generic version of Inomax.
The Company intends to vigorously enforce its intellectual property rights relating to Inomax to prevent the marketing of infringing generic products prior to the expiration of the patents covering Inomax. An adverse outcome in either the IPRs or the Praxair litigation ultimately could result in the launch of a generic version of Inomax before the expiration of the last of the listed patents on January 6, 2031 (July 6, 2031 including pediatric exclusivity), which could adversely affect the Company's ability to successfully maximize the value of Inomax and have an adverse effect on its financial condition, results of operations and cash flows.

Commercial and Securities Litigation
Retrophin Litigation. In January 2014, Retrophin, Inc. ("Retrophin") filed a lawsuit against Questcor in the U.S. District Court for the Central District of California, alleging a variety of federal and state antitrust violations based on Questcor's acquisition from Novartis of certain rights to develop, market, manufacture, distribute, sell and commercialize Synacthen. In June 2015, the parties entered into a binding settlement agreement, under the terms of which Retrophin agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to Retrophin in the amount of $15.5 million.
Glenridge Litigation. In June 2011, Glenridge Pharmaceuticals LLC (“Glenridge”), filed a lawsuit against Questcor in the Superior Court of California, Santa Clara County, alleging that Questcor had underpaid royalties to Glenridge under a royalty agreement related to net sales of Acthar. In August 2012, Questcor filed a separate lawsuit against the three principals of Glenridge, as well as Glenridge, challenging the enforceability of the royalty agreement. In August 2013, the two lawsuits were consolidated into one case in the Superior Court of California, Santa Clara County. In October 2014, the parties entered into a binding term sheet settling the lawsuit. Under the terms of the settlement, the royalty rate payable by Questcor was reduced, royalties were capped instead of being payable for so long as Acthar was sold and Questcor agreed to pay Glenridge a reduced amount in satisfaction of royalties Questcor had previously accrued but not paid during the course of the lawsuit. In February 2015, the settlement agreement was finalized, with terms consistent with the October 2014 term sheet.
Putative Class Action Securities Litigation. In September 2012, a putative class action lawsuit was filed against Questcor and certain of its officers and directors in the U.S. District Court for the Central District of California, captioned John K. Norton v. Questcor Pharmaceuticals, et al., No. SACvl2-1623 DMG (FMOx). The complaint purports to be brought on behalf of shareholders who purchased Questcor common stock between April 26, 2011 and September 21, 2012. The complaint generally alleges that Questcor and certain of its officers and directors engaged in various acts to artificially inflate the price of Questcor stock and enable insiders to profit through stock sales. The complaint asserts that Questcor and certain of its officers and directors violated sections l0(b) and/or 20(a) of the Securities Exchange Act of 1934, as amended ("the Exchange Act"), by making allegedly false and/or misleading statements concerning the clinical evidence to support the use of Acthar for indications other than infantile spasms, the promotion of the sale and use of Acthar in the treatment of multiple sclerosis and nephrotic syndrome, reimbursement for Acthar from third-party insurers, and Questcor's outlook and potential market growth for Acthar. The complaint seeks damages in an unspecified amount and equitable relief against the defendants. This lawsuit has been consolidated with four subsequently-filed actions asserting similar claims under the caption: In re Questcor Securities Litigation, No. CV 12-01623 DMG (FMOx). In October 2013, the District Court granted in part and denied in part Questcor's motion to dismiss the consolidated amended complaint. In October 2013, Questcor filed an answer to the consolidated amended complaint and fact discovery was concluded in January 2015. In April 2015, the parties executed a long-form settlement agreement, under the terms of which Questcor agreed to pay $38.0 million to resolve the plaintiff claims, inclusive of all fees and costs. Questcor and the individual defendants maintain that the plaintiffs' claims are without merit, and have entered into the settlement to eliminate the uncertainties, burden and expense of further protracted litigation. During fiscal 2015, the Company established a $38.0 million reserve for this settlement, which was subsequently paid to a settlement fund. The court issued its final approval of the settlement on September 18, 2015.
Federal Shareholder Derivative Litigation. On October 4, 2012, another alleged shareholder filed a derivative lawsuit in the United States District Court for the Central District of California captioned Gerald Easton v. Don M Bailey, et al., No. SACV12-01716 DOC (JPRx). The suit asserts claims substantially identical to those asserted in the do Valle derivative action described below against the same defendants. This lawsuit has been consolidated with five subsequently-filed actions asserting similar claims under the caption: In re Questcor Shareholder Derivative Litigation, CV 12- 01716 DMG (FMOx). Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying the federal derivative action until the earlier of: (a) 60 days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) 60 days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In July 2015, the parties stipulated to a dismissal of the derivative case and Questcor agreed to make a one-time cash payment to plaintiffs in the form of a mootness fee.
State Shareholder Derivative Litigation. In October 2012, an alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned Monika do Valle v. Virgil D. Thompson, et al., No. 30-2012-00602258-CU-SL-CXC. The complaint asserted claims for breach of fiduciary duty, abuse of control, mismanagement and waste of corporate assets arising from substantially similar allegations as those contained in the putative securities class action described above, as well as from allegations relating to sales of Questcor common stock by the defendants and repurchases of Questcor common stock. The complaint sought an unspecified sum of damages and equitable relief. On October 24, 2012, another alleged shareholder filed a derivative lawsuit purportedly on behalf of Questcor against certain of its officers and directors in the Superior Court of the State of California, Orange County, captioned Jones v. Bailey, et al., Case No. 30-2012-00608001-CU-MC-CXC. The suit asserted claims substantially identical to those asserted in the do Valle derivative action. In February 2013, the court issued an order staying the state derivative actions until the putative federal securities class action and federal derivative actions are resolved. In May 2014, the court granted plaintiffs' request for dismissal without prejudice of the Jones action. In November 2014, the do Valle matter was voluntarily dismissed.
Put Options Securities Action. In March 2013, individual traders of put options filed a securities complaint in the United States District Court for the Central District of California captioned David Taban, et al. v. Questcor Pharmaceuticals, Inc., No. SACV13-0425. The complaint generally asserts claims against Questcor and certain of its officers and directors for violations of the Exchange Act and for state law fraud and fraudulent concealment based on allegations similar to those asserted in the putative securities class action described above. The complaint seeks compensatory and punitive damages of an unspecified amount. Following the resolution of the motion to dismiss in the consolidated putative securities class action, the court issued an order staying this action until the earlier of: (a) sixty (60) days after the resolution of any motion for summary judgment filed in the putative class action lawsuit, (b) sixty (60) days after the deadline to file a motion for summary judgment in the putative class action lawsuit, if none is filed, or (c) the execution of any settlement agreement (including any partial settlement agreement) to resolve the putative class action lawsuit. In May 2015, the parties entered into a binding settlement agreement, under the terms of which plaintiffs agreed to dismiss the litigation with prejudice and Questcor agreed to make a one-time cash payment to plaintiffs.
Pricing Litigation
State of Utah v. Apotex Corp., et al. The Company, along with several other pharmaceutical companies, is a defendant in this matter which was filed in May 2008, and is pending in the Third Judicial Circuit of Salt Lake County, Utah. The State of Utah alleges, generally, that the defendants reported false pricing information in connection with certain drugs that are reimbursable under Utah Medicaid, resulting in overpayment by Utah Medicaid for those drugs, and is seeking monetary damages and attorneys' fees. The Company believes that it has meritorious defenses to these claims and is vigorously defending against them.

Environmental Remediation and Litigation Proceedings
The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites, including those described below. The ultimate cost of site cleanup and timing of future cash outlays is difficult to predict, given the uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations and alternative cleanup methods. The Company concluded that, as of September 25, 2015, it was probable that it would incur remedial costs in the range of $39.8 million to $113.1 million. The Company also concluded that, as of September 25, 2015, the best estimate within this range was $76.5 million, of which $3.2 million was included in accrued and other current liabilities and the remainder was included in environmental liabilities on the consolidated balance sheet at September 25, 2015. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Crab Orchard National Wildlife Refuge Superfund Site, near Marion, Illinois. The Company is a successor in interest to International Minerals and Chemicals Corporation ("IMC"). Between 1967 and 1982, IMC leased portions of the Additional and Uncharacterized Sites ("AUS") Operable Unit at the Crab Orchard Superfund Site ("the Site") from the government and manufactured various explosives for use in mining and other operations. In March 2002, the Department of Justice, the U.S. Department of the Interior and the U.S. Environmental Protection Agency ("EPA") (together, "the Government Agencies") issued a special notice letter to General Dynamics Ordnance and Tactical Systems, Inc. ("General Dynamics"), one of the other potentially responsible parties ("PRPs") at the Site, to compel General Dynamics to perform the remedial investigation and feasibility study ("RI/FS") for the AUS Operable Unit. General Dynamics negotiated an Administrative Order on Consent ("AOC") with the Government Agencies to conduct an extensive RI/FS at the Site under the direction of the U.S. Fish and Wildlife Service. General Dynamics asserted in August 2004 that the Company is jointly and severally liable, along with approximately eight other lessees and operators at the AUS Operable Unit, for alleged contamination of soils and groundwater resulting from historic operations, and has threatened to file a contribution claim against the Company and other parties for recovery of its costs incurred in connection with the RI/FS activities being conducted at the AUS Operable Unit. The Company and other PRPs who received demand letters from General Dynamics have explored settlement alternatives, but have not reached settlement to date. General Dynamics has completed the RI and the PRPs have entered into an agreement to enter into non-binding mediation. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.

Mallinckrodt Veterinary, Inc., Millsboro, Delaware. The Company previously operated a plant in Millsboro, Delaware ("the Millsboro Site") that manufactured various animal healthcare products. In 2005, the Delaware Department of Natural Resources and Environmental Control found trichloroethylene ("TCE") in the Millsboro public water supply at levels that exceeded the federal drinking water standards. Further investigation to identify the TCE plume in the ground water indicated that the plume has extended to property owned by a third party near the Millsboro Site. The Company, and another former owner, assumed responsibility for the Millsboro Site cleanup under the Alternative Superfund Program administered by the EPA. The Company and another PRP have entered into two AOCs with the EPA to perform investigations to abate, mitigate or eliminate the release or threat of release of hazardous substances at the Millsboro Site and to conduct an Engineering Evaluation/Cost Analysis to characterize the nature and extent of the contamination. The Company, along with the other party, continues to conduct the studies and prepare remediation plans in accordance with the AOCs. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that the ultimate resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Coldwater Creek, Saint Louis County, Missouri. The Company is named as a defendant in numerous tort complaints filed in and subsequent to February 2012 with numerous plaintiffs pending in the U.S. District Court for the Eastern District of Missouri. These cases allege personal injury for alleged exposure to radiological substances, including in Coldwater Creek in Missouri, and in the air. Plaintiffs allegedly lived and/or worked in various locations in Saint Louis County, Missouri near Coldwater Creek. Radiological residues which may have been present in the creek have previously been remediated by the U.S. Army Corps of Engineers ("USACE"). The USACE continues to study and remediate the creek and surrounding areas. The Company believes that it has meritorious defenses to these complaints and is vigorously defending against them. The Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding the plaintiffs and their medical conditions; and (iii) there are significant factual and scientific issues to be resolved. While it is not possible at this time to determine with certainty the ultimate outcome of this case, the Company believes, given the information currently available, that the final resolution of all known claims, after taking into account amounts already accrued, will not have a material adverse effect on its financial condition, results of operations and cash flows.
Lower Passaic River, New Jersey. The Company and approximately 70 other companies originally comprised the Lower Passaic Cooperating Parties Group ("the CPG") and are parties to a May 2007 AOC with the EPA to perform a RI/FS of the 17-mile stretch known as the Lower Passaic River Study Area ("the River"). The Company's potential liability stems from former operations at Lodi and Belleville, New Jersey. In June 2007, the EPA issued a draft Focused Feasibility Study ("FFS") that considered interim remedial options for the lower 8-miles of the river, in addition to a "no action" option. As an interim step related to the 2007 AOC, the CPG voluntarily entered into an AOC on June 18, 2012 with the EPA for remediation actions focused solely at mile 10.9 of the River. The Company's estimated costs related to the RI/FS and focused remediation at mile 10.9, based on interim allocations, are immaterial and have been accrued.
In April 2014, the EPA issued its revised FFS, with remedial alternatives to address cleanup of the lower 8-mile stretch of the River, which also included a "no action" option. The EPA estimates the cost for the alternatives range from $365.0 million to $3.2 billion. The EPA's preferred approach would involve bank-to-bank dredging of the lower 8-mile stretch of the River and installing an engineered cap at a discounted, estimated cost of $1.7 billion. Based on the issuance of the EPA's revised FFS, the Company recorded a $23.1 million accrual in fiscal 2014 representing the estimate of our allocable share of the joint and several remediation liability resulting from this matter.
In April 2015, the CPG presented a draft of the RI/FS of the River to the EPA. The CPG's RI/FS included alternatives that ranged from "no action," targeted remediation of the entire 17-mile stretch of the River to remedial actions consistent with the EPA's preferred approach for the lower 8-mile stretch of the River and also included remediation alternatives for the upper 9-mile stretch of the River. The discounted cost estimates for the CPG remediation alternatives ranged from $483.4 million to $2.7 billion. The Company recorded an additional charge of $13.3 million in the second quarter of fiscal 2015 based on the Company's estimate of its allocable share of the joint and several remediation liability resulting from this matter.
Despite the issuance of the revised FFS by the EPA and the RI/FS by the CPG, there are many uncertainties associated with the final agreed-upon remediation and the Company's allocable share of the remediation. As of November 20, 2015, the Company withdrew from the CPG, but remains liable for its obligations under the two above-referenced AOCs, as well as potential future liabilities. Given those uncertainties, the amounts accrued may not be indicative of the amounts for which the Company may be ultimately responsible and will be refined as events in the remediation process occur.

Products Liability Litigation
Beginning with lawsuits brought in July 1976, the Company is also named as a defendant in personal injury lawsuits based on alleged exposure to asbestos-containing materials. A majority of the cases involve product liability claims based principally on allegations of past distribution of products containing asbestos. A limited number of the cases allege premises liability based on claims that individuals were exposed to asbestos while on the Company's property. Each case typically names dozens of corporate defendants in addition to the Company. The complaints generally seek monetary damages for personal injury or bodily injury resulting from alleged exposure to products containing asbestos. The Company's involvement in asbestos cases has been limited because it did not mine or produce asbestos. Furthermore, in the Company's experience, a large percentage of these claims have never been substantiated and have been dismissed by the courts. The Company has not suffered an adverse verdict in a trial court proceeding related to asbestos claims and intends to continue to defend these lawsuits. When appropriate, the Company settles claims; however, amounts paid to settle and defend all asbestos claims have been immaterial. As of September 25, 2015, there were approximately 12,750 asbestos-related cases pending against the Company.
The Company estimates pending asbestos claims, claims that were incurred but not reported and related insurance recoveries, which are recorded on a gross basis in the consolidated balance sheets. The Company's estimate of its liability for pending and future claims is based on claims experience over the past five years and covers claims either currently filed or expected to be filed over the next seven years. The Company believes that it has adequate amounts recorded related to these matters. While it is not possible at this time to determine with certainty the ultimate outcome of these asbestos-related proceedings, the Company believes, given the information currently available, that the ultimate resolution of all known and anticipated future claims, after taking into account amounts already accrued, along with recoveries from insurance, will not have a material adverse effect on its financial condition, results of operations and cash flows.

Asset Retirement Obligations
The Company has recorded asset retirement obligations for the estimated future costs primarily associated with legal obligations to decommission facilities within the Nuclear Imaging segment, including the facilities located in Petten, the Netherlands and Maryland Heights, Missouri. Substantially all of these obligations are included in other liabilities on the consolidated balance sheets. The following table provides a summary of the changes in the Company's asset retirement obligations for fiscal 2015 and 2014:
 
2015
 
2014
Balance at beginning of period
$
39.2

 
$
48.9

Additions and adjustments
(1.0
)
 
(11.5
)
Accretion expense
1.8

 
3.1

Payments
—

 
—

Currency translation
(3.1
)
 
(1.3
)
Balance at end of period
$
36.9

 
$
39.2


The Company believes that any potential payment of such estimated amounts will not have a material adverse effect on its financial condition, results of operations and cash flows.

Industrial Revenue Bonds
Through September 25, 2015, the Company exchanged title to $88.0 million of its plant assets in return for an equal amount of Industrial Revenue Bonds ("IRB") issued by Saint Louis County. The Company also simultaneously leased such assets back from Saint Louis County under capital leases expiring through December 2025, the terms of which provide it with the right of offset against the IRBs. The lease also provides an option for the Company to repurchase the assets at the end of the lease for nominal consideration. These transactions collectively result in a ten-year property tax abatement from the date the property is placed in service. Due to the right of offset, the capital lease obligation and IRB asset are recorded net in the consolidated balance sheets. The Company expects that the right of offset will be applied to payments required under these arrangements.

Interest Bearing Deferred Tax Obligation
As part of the integration of Questcor, the Company entered into an internal installment sale transaction related to certain Acthar intangible assets during the fiscal year ended September 25, 2015. The installment sale transaction resulted in a taxable gain. In accordance with Internal Revenue Code Section 453 the gain is considered taxable in the period in which installment payments are received. As of September 25, 2015, the Company had an aggregate $1,447.4 million of interest bearing U.S. deferred tax liabilities associated with outstanding installment notes. The U.S. Internal Revenue Service ("IRS") charges interest based on the deferred tax liability outstanding as of the end of a company's fiscal year, regardless of amounts outstanding during the fiscal year. During the fiscal year ended September 25, 2015 the Company accrued Section 453 interest of $36.5 million which is included within interest expense.

Leases
The Company has facility, vehicle and equipment leases that expire at various dates. Rental expense under facility, vehicle and equipment operating leases related to continuing operations was $24.3 million, $15.2 million and $13.7 million for fiscal 2015, 2014 and 2013, respectively. The Company also has facility and equipment commitments under capital leases.
The following is a schedule of minimum lease payments for non-cancelable leases as of September 25, 2015:
 
Operating Leases
 
Capital
Leases
Fiscal 2016
$
21.1

 
$
1.3

Fiscal 2017
17.7

 
0.9

Fiscal 2018
15.0

 
0.1

Fiscal 2019
11.3

 
—

Fiscal 2020
9.3

 
—

Thereafter
20.6

 
—

Total minimum lease payments
$
95.0

 
2.3

Less: interest portion of payments
 
 
—

Present value of minimum lease payments
 
 
$
2.3


Tax Matters
The income tax returns of the Company and its subsidiaries are periodically examined by various tax authorities. The resolution of these matters is subject to the conditions set forth in the Tax Matters Agreement between the Company and Covidien. Covidien has the right to administer, control and settle all U.S. income tax audits for periods prior to the Separation. While it is not possible at this time to determine with certainty the ultimate outcome of these matters, the Company believes, given the information currently available, that established liabilities are reasonable and that the ultimate resolution of these matters will not have a material adverse effect on its financial condition, results of operations and cash flows.
With respect to certain tax returns filed by predecessor affiliates of the Company and Covidien, the IRS has concluded its field examination for the years 1997 through 2009. The Company considers such uncertain tax positions associated with these years as having been effectively settled. All but one of the matters associated with these audits have been resolved. The unresolved proposed adjustment asserts that substantially all of the predecessor affiliates' intercompany debt originating during the years 1997 through 2000 should not be treated as debt for U.S. federal income tax purposes, and has disallowed interest deductions related to the intercompany debt and certain tax attribute adjustments recognized on the U.S. income tax returns. This matter is subject to the Company's $200.0 million liability limitation for periods prior to September 29, 2012, as prescribed in the Tax Matters Agreement. While it is not possible at this time to determine with certainty the ultimate outcome of this matter, the Company believes, given the information currently available, that it will not have a material adverse effect on its financial condition, results of operations and cash flows.
Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a $22.5 million benefit, during fiscal 2015, in discontinued operations.

Acquisition-Related Litigation
Several purported class action lawsuits were filed in February 2014 and March 2014 by purported holders of Cadence common stock in connection with the Cadence Acquisition, including in the Delaware Court of Chancery (consolidated under the caption In re Cadence Pharmaceuticals, Inc. Stockholders Litigation), and in California State Court, San Diego County (Denny v. Cadence Pharmaceuticals, Inc., et al., Militello v. Cadence Pharmaceuticals, Inc., et al., and Schuon v. Cadence Pharmaceuticals, Inc., et al.). The actions bring claims against, and generally allege that, the board of directors of Cadence breached their fiduciary duties in connection with the Cadence Acquisition by, among other things, failing to maximize shareholder value, and the Delaware and Schuon actions further allege that Cadence omitted to disclose allegedly material information in its Schedule 14D-9. The lawsuits also allege, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs. On March 7, 2014, following expedited discovery, the parties in the consolidated Delaware action entered into a Memorandum of Understanding ("the MOU"), which sets forth the parties' agreement in principle for a settlement of those actions. The settlement was memorialized in a formal Stipulation and Settlement and Release in March 2015, and includes among other things, a release of all claims relating to the Cadence Acquisition as set forth in the Stipulation. On June 8, 2015, the Delaware Court approved the settlement. There were no substantive proceedings in any of the California actions. On July 29, 2014, the Militello case was voluntarily dismissed without prejudice. On September 8, 2014, the Denny case was voluntarily dismissed without prejudice. On June 23, 2015, the Schuon case was voluntarily dismissed without prejudice.
Since the announcement of the merger with Questcor on April 7, 2014, several putative class actions have been filed by purported holders of Questcor common stock in connection with the Questcor Acquisition (Hansen v. Thompson, et al., Heng v. Questcor Pharmaceuticals, Inc., et al., Buck v. Questcor Pharmaceuticals, Inc., et al., Ellerbeck v. Questcor Pharmaceuticals, Inc., et al., Yokem v. Questcor Pharmaceuticals, Inc., et al., Richter v. Questcor Pharmaceuticals, Inc., et al., Tramantano v. Questcor Pharmaceuticals, Inc., et al., Crippen v. Questcor Pharmaceuticals, Inc., et al., Patel v. Questcor Pharmaceuticals, Inc., et al., and Postow v. Questcor Pharmaceuticals, Inc., et al.). The actions were consolidated on June 3, 2014. The consolidated complaint names as defendants, and generally alleges that, the directors of Questcor breached their fiduciary duties in connection with the acquisition by, among other things, agreeing to sell Questcor for inadequate consideration and pursuant to an inadequate process. The consolidated complaint also alleges that the Questcor directors breached their fiduciary duties by failing to disclose purportedly material information to shareholders in connection with the merger. The consolidated complaint also alleges, among other things, that the Company aided and abetted the purported breaches of fiduciary duty. The lawsuits seek various forms of relief, including but not limited to, rescission of the transaction, damages and attorneys' fees and costs.
On July 29, 2014, the defendants reached an agreement in principle with the plaintiffs in the consolidated actions, and that agreement is reflected in a MOU. In connection with the settlement contemplated by the MOU, Questcor agreed to make certain additional disclosures related to the proposed transaction with the Company, which are contained in the Company's Current Report on Form 8-K filed with the SEC on July 30, 2014. Additionally, as part of the settlement and pursuant to the MOU, the Company agreed to forbear from exercising certain rights under the merger agreement with Questcor, as follows: the four business day period referenced in Section 5.3(e) of the merger agreement with Questcor was reduced to three business days. Consistent with the terms of the MOU, the parties entered into a formal stipulation of settlement in February 2015 and re-executed the stipulation of settlement on May 7, 2015 (collectively the "Stipulation of Settlement").
The Stipulation of Settlement was subject to customary conditions, including court approval. On May 8, 2015, the California Court denied plaintiffs' Motion for Preliminary Approval of Settlement. On October 23, 2015, the parties submitted a proposed Stipulation and Order re Dismissal With Prejudice dismissing the action with prejudice as to each of the named plaintiffs and without prejudice as to the remainder of the class, and on October 30, 2015 the California Court entered that Order.

Other Matters
The Company is a defendant in a number of other pending legal proceedings relating to present and former operations, acquisitions and dispositions. The Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its financial condition, results of operations and cash flows.
XML 66 R100.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Benefit Obligation, Plan Assets and Funded Status of Plans) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Pension Benefits      
Change in benefit obligation:      
Projected benefit obligations at beginning of year $ 538.4 $ 501.7  
Service cost 4.5 5.1 $ 5.0
Interest cost 17.5 19.6 18.2
Employee contributions 0.6 0.6  
Actuarial (gain) loss (4.5) 60.0  
Benefits and administrative expenses paid (21.1) (21.9)  
Plan settlements (23.6) (17.6)  
Net transfer in/(out) 0.6 0.0  
Currency translation (18.9) (9.1)  
Projected benefit obligations at end of year 493.5 538.4 501.7
Change in plan assets:      
Fair value of plan assets at beginning of year 473.6 456.0  
Actual return on plan assets 12.5 59.7  
Employer contributions 13.0 4.9  
Employee contributions 0.6 0.6  
Benefits and administrative expenses paid (21.1) (21.9)  
Plan settlements (23.6) (17.6)  
Currency translation (17.1) (8.1)  
Fair value of plan assets at end of year 437.9 473.6 456.0
Funded status at end of year (55.6) (64.8)  
Postretirement Benefits      
Change in benefit obligation:      
Projected benefit obligations at beginning of year 52.0 53.2  
Service cost 0.1 0.1 0.1
Interest cost 1.9 2.1 2.4
Employee contributions 0.0 0.0  
Actuarial (gain) loss 2.1 0.5  
Benefits and administrative expenses paid (3.9) (3.9)  
Plan settlements 0.0 0.0  
Net transfer in/(out) 0.0 0.0  
Currency translation 0.0 0.0  
Projected benefit obligations at end of year 52.2 52.0 53.2
Change in plan assets:      
Fair value of plan assets at beginning of year 0.0 0.0  
Actual return on plan assets 0.0 0.0  
Employer contributions 3.9 3.9  
Employee contributions 0.0 0.0  
Benefits and administrative expenses paid (3.9) (3.9)  
Plan settlements 0.0 0.0  
Currency translation 0.0 0.0  
Fair value of plan assets at end of year 0.0 0.0 $ 0.0
Funded status at end of year $ (52.2) $ (52.0)  
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements (Tables)
 12 Months Ended
Sep. 25, 2015
Condensed Consolidating Financial Statements [Abstract]  
Schedule of Condensed Consolidating Balance Sheets
MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 25, 2015
(in millions)


 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.1

 
$
152.1

 
$
213.7

 
$
—

 
$
365.9

Accounts receivable, net
—

 
—

 
548.5

 
—

 
548.5

Inventories
—

 
—

 
281.8

 
—

 
281.8

Deferred income taxes
—

 
—

 
142.7

 
—

 
142.7

Prepaid expenses and other current assets
1.3

 
0.2

 
205.8

 
—

 
207.3

Current assets held for sale
—

 
—

 
299.9

 
—

 
299.9

Intercompany receivable
39.1

 
128.6

 
9,699.5

 
(9,867.2
)
 
—

Total current assets
40.5

 
280.9

 
11,391.9

 
(9,867.2
)
 
1,846.1

Property, plant and equipment, net
—

 
—

 
991.3

 
—

 
991.3

Goodwill
—

 
—

 
3,649.4

 
—

 
3,649.4

Intangible assets, net
—

 
—

 
9,666.3

 
—

 
9,666.3

Long-term assets held for sale
—

 
—

 
—

 
—

 
—

Investment in subsidiaries
14,797.7

 
18,838.6

 
10,050.0

 
(43,686.3
)
 
—

Intercompany loan receivable
174.4

 
—

 
2,498.2

 
(2,672.6
)
 
—

Other assets
—

 
0.1

 
250.9

 
—

 
251.0

Total Assets
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1

 
 
 
 
 
 
 
 
 
—

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
20.0

 
$
2.3

 
$
—

 
$
22.3

Accounts payable
—

 
0.2

 
132.8

 
—

 
133.0

Accrued payroll and payroll-related costs
0.1

 
—

 
103.6

 
—

 
103.7

Accrued royalties
—

 
—

 
29.3

 
—

 
29.3

Accrued and other current liabilities
1.8

 
77.4

 
489.1

 
—

 
568.3

Current liabilities held for sale
—

 
—

 
72.8

 
—

 
72.8

Intercompany payable
9,699.5

 
—

 
167.7

 
(9,867.2
)
 
—

Total current liabilities
9,701.4

 
97.6

 
997.6

 
(9,867.2
)
 
929.4

Long-term debt
—

 
6,299.4

 
174.9

 
—

 
6,474.3

Pension and postretirement benefits
—

 
—

 
116.7

 
—

 
116.7

Environmental liabilities
—

 
—

 
73.3

 
—

 
73.3

Deferred income taxes
—

 
—

 
3,132.4

 
—

 
3,132.4

Other income tax liabilities
—

 
—

 
121.3

 
—

 
121.3

Long-term liabilities held for sale
—

 
—

 
—

 
—

 
—

Intercompany loans payable
—

 
2,672.6

 
—

 
(2,672.6
)
 
—

Other liabilities
—

 
—

 
245.5

 
—

 
245.5

Total liabilities
9,701.4

 
9,069.6

 
4,861.7

 
(12,539.8
)
 
11,092.9

Shareholders' equity
5,311.2

 
10,050.0

 
33,636.3

 
(43,686.3
)
 
5,311.2

Total Liabilities and Shareholders' Equity
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1

MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8

Accounts receivable, net
—

 
—

 
476.6

 
—

 
476.6

Inventories
—

 
—

 
306.4

 
—

 
306.4

Deferred income taxes
—

 
—

 
152.3

 
—

 
152.3

Prepaid expenses and other current assets
0.5

 
10.8

 
215.8

 
—

 
227.1

Current assets held for sale
—

 
—

 
200.8

 
—

 
200.8

Intercompany receivable
13.5

 
—

 
25.7

 
(39.2
)
 
—

Total current assets
14.3

 
29.3

 
2,066.6

 
(39.2
)
 
2,071.0

Property, plant and equipment, net
—

 
—

 
886.8

 
—

 
886.8

Goodwill
—

 
—

 
2,401.9

 
—

 
2,401.9

Intangible assets, net
—

 
—

 
7,082.2

 
—

 
7,082.2

Long-term assets held for sale
—

 
—

 
111.2

 
—

 
111.2

Investment in subsidiaries
586.8

 
10,645.7

 
4,945.1

 
(16,177.6
)
 
—

Intercompany loan receivable
4,385.0

 
—

 
1,941.6

 
(6,326.6
)
 
—

Other assets
—

 
—

 
234.2

 
—

 
234.2

Total Assets
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3

 

 

 

 

 

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
18.2

 
$
3.0

 
$
—

 
$
21.2

Accounts payable
1.2

 
0.2

 
109.3

 
—

 
110.7

Accrued payroll and payroll-related costs
0.1

 
—

 
116.2

 
—

 
116.3

Accrued royalties
—

 
—

 
67.7

 
—

 
67.7

Accrued and other current liabilities
1.1

 
50.9

 
477.9

 
—

 
529.9

Current liabilities held for sale
—

 
—

 
59.0

 
—

 
59.0

Intercompany payable
25.7

 
—

 
13.5

 
(39.2
)
 
—

Total current liabilities
28.1

 
69.3

 
846.6

 
(39.2
)
 
904.8

Long-term debt
—

 
3,693.9

 
180.1

 
—

 
3,874.0

Pension and postretirement benefits
—

 
—

 
116.2

 
—

 
116.2

Environmental liabilities
—

 
—

 
59.2

 
—

 
59.2

Deferred income taxes
—

 
—

 
2,399.6

 
—

 
2,399.6

Other income tax liabilities
—

 
—

 
122.6

 
—

 
122.6

Long-term liabilities held for sale
—

 
—

 
9.7

 
—

 
9.7

Intercompany loans payable
—

 
1,966.6

 
4,360.0

 
(6,326.6
)
 
—

Other liabilities
—

 
—

 
343.2

 
—

 
343.2

Total liabilities
28.1

 
5,729.8

 
8,437.2

 
(6,365.8
)
 
7,829.3

Shareholders' equity
4,958.0

 
4,945.2

 
11,232.4

 
(16,177.6
)
 
4,958.0

Total Liabilities and Shareholders' Equity
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3
Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income
MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 25, 2015
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
—

 
$
—

 
$
3,346.9

 
$
—

 
$
3,346.9

Cost of sales
—

 
—

 
1,493.3

 
—

 
1,493.3

Gross profit
—

 
—

 
1,853.6

 
—

 
1,853.6

Selling, general and administrative expenses
116.3

 
15.7

 
1,037.8

 
—

 
1,169.8

Research and development expenses
—

 
—

 
185.1

 
—

 
185.1

Restructuring charges, net
9.8

 
—

 
30.6

 
—

 
40.4

Gains on divestiture and license
—

 
—

 
(3.5
)
 
—

 
(3.5
)
Operating income (loss)
(126.1
)
 
(15.7
)
 
603.6

 
—

 
461.8

 
 
 
 
 
 
 
 
 
—

Interest expense
(96.4
)
 
(230.2
)
 
(25.2
)
 
96.2

 
(255.6
)
Interest income
—

 
0.1

 
97.1

 
(96.2
)
 
1.0

Other income (expense), net
216.3

 
—

 
(208.2
)
 
—

 
8.1

Intercompany interest and fees
(14.7
)
 
—

 
14.7

 
—

 
—

Equity in net income of subsidiaries
330.6

 
496.3

 
250.5

 
(1,077.4
)
 
—

Income from continuing operations before income taxes
309.7

 
250.5

 
732.5

 
(1,077.4
)
 
215.3

Benefit from income taxes
(15.9
)
 
—

 
(77.0
)
 
—

 
(92.9
)
Income from continuing operations
325.6

 
250.5

 
809.5

 
(1,077.4
)
 
308.2

Gain (loss) from discontinued operations, net of income taxes
(0.9
)
 
—

 
17.4

 
—

 
16.5

Net income
324.7

 
250.5

 
826.9

 
(1,077.4
)
 
324.7

Other comprehensive loss, net of tax
(64.8
)
 
(64.8
)
 
(69.9
)
 
134.7

 
(64.8
)
Comprehensive income
$
259.9

 
$
185.7

 
$
757.0

 
$
(942.7
)
 
$
259.9

MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
2,082.0

 
$
—

 
$
2,082.0

Cost of sales
—

 
—

 
1,021.8

 
—

 
1,021.8

Gross profit
—

 
—

 
1,060.2

 
—

 
1,060.2

Selling, general and administrative expenses
37.7

 
7.3

 
700.0

 
—

 
745.0

Research and development expenses
—

 
—

 
163.5

 
—

 
163.5

Restructuring charges, net
35.3

 
—

 
46.1

 
—

 
81.4

Non-restructuring impairments
—

 
—

 
151.6

 
—

 
151.6

Separation costs
2.5

 
—

 
7.1

 
—

 
9.6

Gains on divestiture and license
—

 
—

 
(15.0
)
 
—

 
(15.0
)
Operating (loss) income
(75.5
)
 
(7.3
)
 
6.9

 
—

 
(75.9
)
 

 

 

 

 

Interest expense
—

 
(86.3
)
 
—

 
3.7

 
(82.6
)
Interest income
—

 
—

 
5.2

 
(3.7
)
 
1.5

Other income (expense), net
30.9

 
—

 
(27.8
)
 
—

 
3.1

Intercompany interest and fees
(9.0
)
 
—

 
9.0

 
—

 
—

Equity in net income of subsidiaries
(264.8
)
 
(171.2
)
 
(300.2
)
 
736.2

 
—

Loss from continuing operations before income taxes
(318.4
)
 
(264.8
)
 
(306.9
)
 
736.2

 
(153.9
)
Benefit from income taxes
—

 
—

 
(10.1
)
 
—

 
(10.1
)
Loss from continuing operations
(318.4
)
 
(264.8
)
 
(296.8
)
 
736.2

 
(143.8
)
Loss from discontinued operations, net of income taxes
(0.9
)
 
—

 
(174.6
)
 
—

 
(175.5
)
Net loss
(319.3
)
 
(264.8
)
 
(471.4
)
 
736.2

 
(319.3
)
Other comprehensive loss, net of tax
(42.8
)
 
(42.8
)
 
(84.1
)
 
126.9

 
(42.8
)
Comprehensive loss
$
(362.1
)
 
$
(307.6
)
 
$
(555.5
)
 
$
863.1

 
$
(362.1
)




MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 27, 2013
(in millions)
 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
1,712.3

 
$
—

 
$
1,712.3

Cost of sales
—

 
—

 
890.0

 
—

 
890.0

Gross profit
—

 
—

 
822.3

 
—

 
822.3

Selling, general and administrative expenses
5.2

 
0.1

 
490.6

 
—

 
495.9

Research and development expenses
—

 
—

 
157.9

 
—

 
157.9

Restructuring charges, net
—

 
—

 
23.7

 
—

 
23.7

Separation costs
3.2

 
0.6

 
70.4

 
—

 
74.2

Gains on divestiture and license
—

 
—

 
(2.9
)
 
—

 
(2.9
)
Operating income (loss)
(8.4
)
 
(0.7
)
 
82.6

 
—

 
73.5

 
 
 
 
 
 
 
 
 
 
Interest expense
—

 
(19.6
)
 
0.1

 
—

 
(19.5
)
Interest income
—

 
—

 
0.3

 
—

 
0.3

Other income (expense), net
0.2

 
—

 
1.2

 
—

 
1.4

Intercompany interest and fees
(9.5
)
 
—

 
9.5

 
—

 
—

Equity in net income of subsidiaries
76.4

 
96.7

 
—

 
(173.1
)
 
—

Income from continuing operations before income taxes
58.7

 
76.4

 
93.7

 
(173.1
)
 
55.7

Provision for (benefit from) income taxes
(0.3
)
 
—

 
47.8

 
—

 
47.5

Income from continuing operations
59.0

 
76.4

 
45.9

 
(173.1
)
 
8.2

Gain (loss) from discontinued operations, net of income taxes
(0.2
)
 
—

 
50.8

 
—

 
50.6

Net income
58.8

 
76.4

 
96.7

 
(173.1
)
 
58.8

Other comprehensive income, net of tax
28.4

 
28.4

 
35.7

 
(64.1
)
 
28.4

Comprehensive income
$
87.2

 
$
104.8

 
$
132.4

 
$
(237.2
)
 
$
87.2
Schedule of Condensed Consolidating and Combining Statements of Cash Flows
MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Fiscal year ended September 25, 2015
(in millions)


Mallinckrodt plc

Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
207.0

 
$
(148.2
)
 
$
837.6

 
$
—

 
$
896.4

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(148.0
)
 
—

 
(148.0
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,154.7
)
 
—

 
(2,154.7
)
Intercompany loan investment
(149.4
)
 
—

 
(554.2
)
 
703.6

 
—

Investment in subsidiary
—

 
(3,014.4
)
 
—

 
3,014.4

 
—

Restricted cash
—

 
—

 
3.1

 
—

 
3.1

Other
—

 
—

 
3.0

 
—

 
3.0

Net cash used in investing activities
(149.4
)
 
(3,014.4
)
 
(2,850.8
)
 
3,718.0

 
(2,296.6
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
2,890.0

 
120.0

 
—

 
3,010.0

Repayment of external debt and capital leases
—

 
(258.3
)
 
(1,590.1
)
 
—

 
(1,848.4
)
Excess tax benefit from share-based compensation
—

 
—

 
34.1

 
—

 
34.1

Debt financing costs
—

 
(39.1
)
 
(0.8
)
 
—

 
(39.9
)
Proceeds from exercise of share options
34.4

 
—

 
—

 
—

 
34.4

Intercompany loan borrowings
—

 
703.6

 
—

 
(703.6
)
 
—

Capital contribution
—

 
—

 
3,014.4

 
(3,014.4
)
 
—

Repurchase of shares
(92.2
)
 
—

 
—

 
—

 
(92.2
)
Other
—

 
—

 
(28.1
)
 
—

 
(28.1
)
Net cash provided by financing activities
(57.8
)
 
3,296.2

 
1,549.5

 
(3,718.0
)
 
1,069.9

Effect of currency rate changes on cash
—

 
—

 
(11.6
)
 
—

 
(11.6
)
Net (decrease) increase in cash and cash equivalents
(0.2
)
 
133.6

 
(475.3
)
 
—

 
(341.9
)
Cash and cash equivalents at beginning of period
0.3

 
18.5

 
689.0

 
—

 
707.8

Cash and cash equivalents at end of period
0.1

 
152.1

 
213.7

 
—

 
365.9


MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:

 

 

 

 

Net cash provided by (used in) operating activities
$
18.2

 
$
(65.0
)
 
$
420.2

 
$
—

 
$
373.4

Cash Flows From Investing Activities:

 

 

 

 

Capital expenditures
—

 
—

 
(127.8
)
 
—

 
(127.8
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,793.8
)
 
—

 
(2,793.8
)
Intercompany loan investment
(25.0
)
 
(298.1
)
 
(915.8
)
 
1,238.9

 
—

Subsidiary dividend proceeds
—

 
300.5

 
—

 
(300.5
)
 
—

Investment in subsidiary
—

 
(3,735.5
)
 
—

 
3,735.5

 
—

Restricted Cash
—

 
—

 
4.1

 
—

 
4.1

Other
—

 
—

 
26.7

 
—

 
26.7

Net cash used in investing activities
(25.0
)
 
(3,733.1
)
 
(3,806.6
)
—

4,673.9

 
(2,890.8
)
Cash Flows From Financing Activities:

 

 

 

 

Issuance of external debt
—

 
2,893.3

 
149.9

 
—

 
3,043.2

Repayment of external debt and capital leases
—

 
(3.3
)
 
(31.5
)
 
—

 
(34.8
)
Excess tax benefit from share-based compensation
—

 
—

 
8.9

 
—

 
8.9

Debt financing costs
—

 
(70.7
)
 
(1.0
)
 
—

 
(71.7
)
Proceeds from exercise of share options
25.8

 
—

 
—

 
—

 
25.8

Subsidiary dividend payment
—

 
—

 
(300.5
)
 
300.5

 
—

Intercompany loan borrowings
(2.4
)
 
940.8

 
300.5

 
(1,238.9
)
 
—

Capital contribution
—

 
—

 
3,735.5

 
(3,735.5
)
 
—

Repurchase of shares
(17.5
)
 
—

 
—

 
—

 
(17.5
)
Other
—

 
—

 
—

 
—

 
—

Net cash provided by financing activities
5.9

 
3,760.1

—

3,861.8

 
(4,673.9
)
 
2,953.9

Effect of currency rate changes on cash
—

 
—

 
(4.2
)
 
—

 
(4.2
)
Net increase (decrease) in cash and cash equivalents
(0.9
)
 
(38.0
)
 
471.2

 
—

 
432.3

Cash and cash equivalents at beginning of period
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at end of period
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8























MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 27, 2013
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
(1.8
)
 
$
(8.4
)
 
$
146.1

 
$
—

 
$
135.9

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(147.9
)
 
—

 
(147.9
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(88.1
)
 
—

 
(88.1
)
Intercompany loan investment
—

 
(2.4
)
 
(409.6
)
 
412.0

 
—

Investment in subsidiary
—

 
(68.0
)
 
—

 
68.0

 
—

Other
—

 
—

 
1.3

 
—

 
1.3

Net cash used in investing activities
—

 
(70.4
)
 
(644.3
)
—

480.0

 
(234.7
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
898.1

 
—

 
—

 
898.1

Repayment of external debt and capital leases
—

 
—

 
(1.3
)
 
—

 
(1.3
)
Excess tax benefit from share-based compensation
—

 
—

 
3.4

 
—

 
3.4

Debt financing costs
—

 
(12.0
)
 
—

 
—

 
(12.0
)
Net transfers to parent
—

 
(1,160.4
)
 
644.5

 
—

 
(515.9
)
Proceeds from exercise of share options
0.6

 
—

 
—

 
—

 
0.6

Intercompany loan borrowings
2.4

 
409.6

 
—

 
(412.0
)
 
—

Capital contribution
—

 
—

 
68.0

 
(68.0
)
 
—

Other
—

 
—

 
0.1

 
—

 
0.1

Net cash provided by financing activities
3.0

 
135.3

—

714.7

 
(480.0
)
 
373.0

Effect of currency rate changes on cash
—

 
—

 
1.3

 
—

 
1.3

Net increase in cash and cash equivalents
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at beginning of period
—

 
—

 
—

 
—

 
—

Cash and cash equivalents at end of period
$
1.2

 
$
56.5

 
$
217.8

 
$
—

 
$
275.5
XML 68 R44.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories (Tables)
 12 Months Ended
Sep. 25, 2015
Inventory, Net [Abstract]  
Schedule of Inventories
Inventories are comprised of the following at the end of each period: 
 
September 25,
2015
 
September 26,
2014
Raw materials and supplies
$
66.3

 
$
57.5

Work in process
124.2

 
184.7

Finished goods
91.3

 
64.2

Inventories
$
281.8

 
$
306.4
XML 69 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data
 12 Months Ended
Sep. 25, 2015
Segment Reporting [Abstract]  
Segment and Geographical Data
21.
Segment and Geographical Data
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet, which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:

•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and API consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).

Management measures and evaluates the Company's operating segments based on segment net sales and operating income. Management excludes corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include revenues and expenses associated with sales of products to Covidien, intangible asset amortization, net restructuring and related charges, non-restructuring impairments and separation costs. Although these amounts are excluded from segment operating income, as applicable, they are included in reported consolidated and combined operating income and in the following reconciliations.
Management manages assets on a total company basis, not by operating segment.  The chief operating decision maker does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.  Total assets were approximately $16.4 billion and $12.8 billion at September 25, 2015 and September 26, 2014, respectively.
Selected information by business segment is as follows:

Fiscal Year

2015
 
2014
 
2013
Net sales:
 
 
 
 
 
Specialty Brands
1,622.8

 
413.5

 
206.4

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

Nuclear Imaging
423.8

 
431.7

 
437.6

Net sales of operating segments (1)
3,298.2

 
2,044.6

 
1,655.2

Other (2)
48.7

 
37.4

 
57.1

Net sales
3,346.9

 
2,082.0

 
1,712.3

Operating income:
 
 
 
 
 
Specialty Brands
651.3

 
(50.6
)
 
(36.2
)
Specialty Generics
622.0

 
617.4

 
347.9

Nuclear Imaging
66.4

 
(16.7
)
 
24.5

Segment operating income
1,339.7

 
550.1

 
336.2

Unallocated amounts:
 
 
 
 
 
Corporate and allocated expenses (3)          
(286.9
)
 
(228.1
)
 
(134.3
)
Intangible asset amortization
(550.3
)
 
(154.8
)
 
(27.9
)
Restructuring and related charges, net (4)
(40.7
)
 
(81.9
)
 
(26.3
)
Non-restructuring impairments
—

 
(151.6
)
 
—

Separation costs
—

 
(9.6
)
 
(74.2
)
Operating income (loss)
461.8

 
(75.9
)
 
73.5

 
 
 
 
 
 
Depreciation and amortization (5):
 
 
 
 
 
Specialty Brands
559.8

 
152.9

 
24.9

Specialty Generics
81.9

 
77.8

 
72.7

Nuclear Imaging
12.4

 
18.8

 
18.5

Depreciation and amortization
654.1

 
249.5

 
116.1

(1)
Amounts represent sales to external customers. There were no intersegment sales.
(2)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
(3)
Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
(4)
Includes restructuring-related accelerated depreciation.
(5)
Depreciation for certain shared facilities is allocated based on occupancy percentage.

Net sales by product family within the Company's segments are as follows:

 
Fiscal Year
 
2015
 
2014
 
2013
Acthar
$
1,037.3

 
$
122.9

 
$
—

Ofirmev
263.0

 
124.4

 
—

Inomax
185.2

 
—

 
—

Exalgo
39.4

 
76.1

 
126.1

Other
97.9

 
90.1

 
80.3

Specialty Brands
1,622.8

 
413.5

 
206.4

 
 
 
 
 
 
Hydrocodone (API) and hydrocodone-containing tablets
167.2

 
99.4

 
140.0

Oxycodone (API) and oxycodone-containing tablets
154.6

 
155.2

 
139.0

Methylphenidate ER
136.5

 
209.6

 
148.3

Other controlled substances
572.2

 
584.5

 
443.3

Other
221.1

 
150.7

 
140.6

Specialty Generics
1,251.6

 
1,199.4

 
1,011.2

 
 
 
 
 
 
Nuclear Imaging
423.8

 
431.7

 
437.6

 
 
 
 
 
 
Other (1)
48.7

 
37.4

 
57.1

Net sales
$
3,346.9

 
$
2,082.0

 
$
1,712.3


(1)
Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.


Selected information by geographic area excluding assets held for sale is as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Net sales (1):
 
 
 
 
 
U.S.
$
2,973.2

 
$
1,780.9

 
$
1,421.6

Europe, Middle East and Africa
236.2

 
250.3

 
250.1

Other
137.5

 
50.8

 
40.6

 
$
3,346.9

 
$
2,082.0

 
$
1,712.3

Long-lived assets (2):
 
 
 
 
 
U.S.
$
905.2

 
$
829.1

 
 
Europe, Middle East and Africa (3)
45.0

 
33.9

 
 
Other
44.5

 
41.0

 
 
 
$
994.7

 
$
904.0

 
 
(1)
Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.
(2)
Long-lived assets are primarily composed of property, plant and equipment.
(3)
Includes long-lived assets located in Ireland of $10.7 million, and $0.4 million at the end of fiscal 2015 and 2014, respectively.
XML 70 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814
Selected Quarterly Financial Data (Unaudited)
 12 Months Ended
Sep. 25, 2015
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Financial Data (Unaudited)
22.
Selected Quarterly Financial Data (Unaudited)
 
Fiscal 2015 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
768.2

 
$
819.0

 
$
877.3

 
$
882.4

Gross profit
404.8

 
462.9

 
503.8

 
482.1

Income from continuing operations
87.4

 
75.2

 
55.6

 
90.0

Income (loss) from discontinued operations
5.3

 
23.6

 
2.4

 
(14.8
)
Net income
92.7

 
98.8

 
58.0

 
75.2

 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.75

 
$
0.64

 
$
0.47

 
$
0.77

Diluted earnings per share from continuing operations (1)
0.74

 
0.64

 
0.47

 
0.76

 
 
Fiscal 2014 (by quarter)
 
Q1
 
Q2
 
Q3
 
Q4
Net sales
$
429.5

 
$
448.7

 
$
530.1

 
$
673.7

Gross profit
216.2

 
226.7

 
254.1

 
363.2

Income (loss) from continuing operations
38.5

 
20.2

 
(29.0
)
 
(173.5
)
Income (loss) from discontinued operations
7.1

 
(8.6
)
 
4.9

 
(178.9
)
Net income (loss)
45.6

 
11.6

 
(24.1
)
 
(352.4
)
 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations (1)
$
0.67

 
$
0.35

 
$
(0.50
)
 
$
(2.04
)
Diluted earnings per share from continuing operations (1)
0.66

 
0.34

 
(0.50
)
 
(2.04
)


(1)
Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.
XML 71 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Cash Flows from Operating Activities:      
Net income (loss) $ 324.7 $ (319.3) $ 58.8
Adjustments to reconcile net cash provided by operating activities:      
Depreciation and amortization 672.5 275.9 139.6
Share-based compensation 117.0 67.7 16.2
Deferred income taxes (191.6) (107.5) (9.0)
Non-cash impairment charges 0.0 381.2 0.0
Inventory provisions 0.0 32.1 15.5
Other non-cash items (59.6) (23.6) (6.2)
Changes in assets and liabilities, net of the effects of acquisitions:      
Accounts receivable, net 0.7 (51.3) (181.2)
Inventories 61.3 56.0 27.7
Accounts payable 20.4 (32.9) 7.2
Income taxes 30.2 (54.8) 60.7
Other (79.2) 149.9 6.6
Net cash provided by operating activities 896.4 373.4 135.9
Cash Flows from Investing Activities:      
Capital expenditures (148.0) (127.8) (147.9)
Acquisitions and intangibles, net of cash acquired (2,154.7) (2,793.8) (88.1)
Restricted cash 3.1 4.1 0.0
Other 3.0 26.7 1.3
Net cash used in investing activities (2,296.6) (2,890.8) (234.7)
Cash Flows from Financing Activities:      
Issuance of external debt 3,010.0 3,043.2 898.1
Repayment of external debt and capital leases (1,848.4) (34.8) (1.3)
Excess tax benefit from share-based compensation 34.1 8.9 3.4
Debt financing costs (39.9) (71.7) (12.0)
Net transfers to parent 0.0 0.0 (515.9)
Proceeds from exercise of share options 34.4 25.8 0.6
Repurchase of shares (92.2) (17.5) 0.0
Other (28.1) 0.0 0.1
Net cash provided by financing activities 1,069.9 2,953.9 373.0
Effect of currency rate changes on cash (11.6) (4.2) 1.3
Net (decrease) increase in cash and cash equivalents (341.9) 432.3 275.5
Cash and cash equivalents at beginning of period 707.8 275.5 0.0
Cash and cash equivalents at end of period 365.9 707.8 275.5
Supplemental Disclosures of Cash Flow Information:      
Cash paid for interest 200.5 57.2 0.8
Cash paid for income taxes, net $ 123.8 $ 128.0 $ 15.0
XML 72 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements
 12 Months Ended
Sep. 25, 2015
Condensed Consolidating Financial Statements [Abstract]  
Condensed Consolidating and Combining Financial Statements
23.
Condensed Consolidating and Combining Financial Statements

In November 2012, MIFSA was formed as a 100%-owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations.
MIFSA is the borrower under the Notes, which are fully and unconditionally guaranteed by Mallinckrodt plc. The following information provides the composition of the Company's comprehensive income, assets, liabilities, equity and cash flows by relevant group within the Company: Mallinckrodt plc as guarantor of the Notes, MIFSA as issuer of the Notes and the operating companies that represent assets of MIFSA. There are no subsidiary guarantees related to the Notes.
Set forth below are the condensed consolidating balance sheet as of September 25, 2015 and September 26, 2014 and condensed consolidating statements of comprehensive income and cash flows for the three years ended September 25, 2015. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among Mallinckrodt plc, MIFSA and the other subsidiaries. Condensed consolidating and combining financial information for Mallinckrodt plc and MIFSA, on a standalone basis, has been presented using the equity method of accounting for subsidiaries.


MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 25, 2015
(in millions)


 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.1

 
$
152.1

 
$
213.7

 
$
—

 
$
365.9

Accounts receivable, net
—

 
—

 
548.5

 
—

 
548.5

Inventories
—

 
—

 
281.8

 
—

 
281.8

Deferred income taxes
—

 
—

 
142.7

 
—

 
142.7

Prepaid expenses and other current assets
1.3

 
0.2

 
205.8

 
—

 
207.3

Current assets held for sale
—

 
—

 
299.9

 
—

 
299.9

Intercompany receivable
39.1

 
128.6

 
9,699.5

 
(9,867.2
)
 
—

Total current assets
40.5

 
280.9

 
11,391.9

 
(9,867.2
)
 
1,846.1

Property, plant and equipment, net
—

 
—

 
991.3

 
—

 
991.3

Goodwill
—

 
—

 
3,649.4

 
—

 
3,649.4

Intangible assets, net
—

 
—

 
9,666.3

 
—

 
9,666.3

Long-term assets held for sale
—

 
—

 
—

 
—

 
—

Investment in subsidiaries
14,797.7

 
18,838.6

 
10,050.0

 
(43,686.3
)
 
—

Intercompany loan receivable
174.4

 
—

 
2,498.2

 
(2,672.6
)
 
—

Other assets
—

 
0.1

 
250.9

 
—

 
251.0

Total Assets
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1

 
 
 
 
 
 
 
 
 
—

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
20.0

 
$
2.3

 
$
—

 
$
22.3

Accounts payable
—

 
0.2

 
132.8

 
—

 
133.0

Accrued payroll and payroll-related costs
0.1

 
—

 
103.6

 
—

 
103.7

Accrued royalties
—

 
—

 
29.3

 
—

 
29.3

Accrued and other current liabilities
1.8

 
77.4

 
489.1

 
—

 
568.3

Current liabilities held for sale
—

 
—

 
72.8

 
—

 
72.8

Intercompany payable
9,699.5

 
—

 
167.7

 
(9,867.2
)
 
—

Total current liabilities
9,701.4

 
97.6

 
997.6

 
(9,867.2
)
 
929.4

Long-term debt
—

 
6,299.4

 
174.9

 
—

 
6,474.3

Pension and postretirement benefits
—

 
—

 
116.7

 
—

 
116.7

Environmental liabilities
—

 
—

 
73.3

 
—

 
73.3

Deferred income taxes
—

 
—

 
3,132.4

 
—

 
3,132.4

Other income tax liabilities
—

 
—

 
121.3

 
—

 
121.3

Long-term liabilities held for sale
—

 
—

 
—

 
—

 
—

Intercompany loans payable
—

 
2,672.6

 
—

 
(2,672.6
)
 
—

Other liabilities
—

 
—

 
245.5

 
—

 
245.5

Total liabilities
9,701.4

 
9,069.6

 
4,861.7

 
(12,539.8
)
 
11,092.9

Shareholders' equity
5,311.2

 
10,050.0

 
33,636.3

 
(43,686.3
)
 
5,311.2

Total Liabilities and Shareholders' Equity
$
15,012.6

 
$
19,119.6

 
$
38,498.0

 
$
(56,226.1
)
 
$
16,404.1

MALLINCKRODT PLC
CONDENSED CONSOLIDATING BALANCE SHEET
As of September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8

Accounts receivable, net
—

 
—

 
476.6

 
—

 
476.6

Inventories
—

 
—

 
306.4

 
—

 
306.4

Deferred income taxes
—

 
—

 
152.3

 
—

 
152.3

Prepaid expenses and other current assets
0.5

 
10.8

 
215.8

 
—

 
227.1

Current assets held for sale
—

 
—

 
200.8

 
—

 
200.8

Intercompany receivable
13.5

 
—

 
25.7

 
(39.2
)
 
—

Total current assets
14.3

 
29.3

 
2,066.6

 
(39.2
)
 
2,071.0

Property, plant and equipment, net
—

 
—

 
886.8

 
—

 
886.8

Goodwill
—

 
—

 
2,401.9

 
—

 
2,401.9

Intangible assets, net
—

 
—

 
7,082.2

 
—

 
7,082.2

Long-term assets held for sale
—

 
—

 
111.2

 
—

 
111.2

Investment in subsidiaries
586.8

 
10,645.7

 
4,945.1

 
(16,177.6
)
 
—

Intercompany loan receivable
4,385.0

 
—

 
1,941.6

 
(6,326.6
)
 
—

Other assets
—

 
—

 
234.2

 
—

 
234.2

Total Assets
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3

 

 

 

 

 

Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
Current maturities of long-term debt
$
—

 
$
18.2

 
$
3.0

 
$
—

 
$
21.2

Accounts payable
1.2

 
0.2

 
109.3

 
—

 
110.7

Accrued payroll and payroll-related costs
0.1

 
—

 
116.2

 
—

 
116.3

Accrued royalties
—

 
—

 
67.7

 
—

 
67.7

Accrued and other current liabilities
1.1

 
50.9

 
477.9

 
—

 
529.9

Current liabilities held for sale
—

 
—

 
59.0

 
—

 
59.0

Intercompany payable
25.7

 
—

 
13.5

 
(39.2
)
 
—

Total current liabilities
28.1

 
69.3

 
846.6

 
(39.2
)
 
904.8

Long-term debt
—

 
3,693.9

 
180.1

 
—

 
3,874.0

Pension and postretirement benefits
—

 
—

 
116.2

 
—

 
116.2

Environmental liabilities
—

 
—

 
59.2

 
—

 
59.2

Deferred income taxes
—

 
—

 
2,399.6

 
—

 
2,399.6

Other income tax liabilities
—

 
—

 
122.6

 
—

 
122.6

Long-term liabilities held for sale
—

 
—

 
9.7

 
—

 
9.7

Intercompany loans payable
—

 
1,966.6

 
4,360.0

 
(6,326.6
)
 
—

Other liabilities
—

 
—

 
343.2

 
—

 
343.2

Total liabilities
28.1

 
5,729.8

 
8,437.2

 
(6,365.8
)
 
7,829.3

Shareholders' equity
4,958.0

 
4,945.2

 
11,232.4

 
(16,177.6
)
 
4,958.0

Total Liabilities and Shareholders' Equity
$
4,986.1

 
$
10,675.0

 
$
19,669.6

 
$
(22,543.4
)
 
$
12,787.3



MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 25, 2015
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
—

 
$
—

 
$
3,346.9

 
$
—

 
$
3,346.9

Cost of sales
—

 
—

 
1,493.3

 
—

 
1,493.3

Gross profit
—

 
—

 
1,853.6

 
—

 
1,853.6

Selling, general and administrative expenses
116.3

 
15.7

 
1,037.8

 
—

 
1,169.8

Research and development expenses
—

 
—

 
185.1

 
—

 
185.1

Restructuring charges, net
9.8

 
—

 
30.6

 
—

 
40.4

Gains on divestiture and license
—

 
—

 
(3.5
)
 
—

 
(3.5
)
Operating income (loss)
(126.1
)
 
(15.7
)
 
603.6

 
—

 
461.8

 
 
 
 
 
 
 
 
 
—

Interest expense
(96.4
)
 
(230.2
)
 
(25.2
)
 
96.2

 
(255.6
)
Interest income
—

 
0.1

 
97.1

 
(96.2
)
 
1.0

Other income (expense), net
216.3

 
—

 
(208.2
)
 
—

 
8.1

Intercompany interest and fees
(14.7
)
 
—

 
14.7

 
—

 
—

Equity in net income of subsidiaries
330.6

 
496.3

 
250.5

 
(1,077.4
)
 
—

Income from continuing operations before income taxes
309.7

 
250.5

 
732.5

 
(1,077.4
)
 
215.3

Benefit from income taxes
(15.9
)
 
—

 
(77.0
)
 
—

 
(92.9
)
Income from continuing operations
325.6

 
250.5

 
809.5

 
(1,077.4
)
 
308.2

Gain (loss) from discontinued operations, net of income taxes
(0.9
)
 
—

 
17.4

 
—

 
16.5

Net income
324.7

 
250.5

 
826.9

 
(1,077.4
)
 
324.7

Other comprehensive loss, net of tax
(64.8
)
 
(64.8
)
 
(69.9
)
 
134.7

 
(64.8
)
Comprehensive income
$
259.9

 
$
185.7

 
$
757.0

 
$
(942.7
)
 
$
259.9

MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
2,082.0

 
$
—

 
$
2,082.0

Cost of sales
—

 
—

 
1,021.8

 
—

 
1,021.8

Gross profit
—

 
—

 
1,060.2

 
—

 
1,060.2

Selling, general and administrative expenses
37.7

 
7.3

 
700.0

 
—

 
745.0

Research and development expenses
—

 
—

 
163.5

 
—

 
163.5

Restructuring charges, net
35.3

 
—

 
46.1

 
—

 
81.4

Non-restructuring impairments
—

 
—

 
151.6

 
—

 
151.6

Separation costs
2.5

 
—

 
7.1

 
—

 
9.6

Gains on divestiture and license
—

 
—

 
(15.0
)
 
—

 
(15.0
)
Operating (loss) income
(75.5
)
 
(7.3
)
 
6.9

 
—

 
(75.9
)
 

 

 

 

 

Interest expense
—

 
(86.3
)
 
—

 
3.7

 
(82.6
)
Interest income
—

 
—

 
5.2

 
(3.7
)
 
1.5

Other income (expense), net
30.9

 
—

 
(27.8
)
 
—

 
3.1

Intercompany interest and fees
(9.0
)
 
—

 
9.0

 
—

 
—

Equity in net income of subsidiaries
(264.8
)
 
(171.2
)
 
(300.2
)
 
736.2

 
—

Loss from continuing operations before income taxes
(318.4
)
 
(264.8
)
 
(306.9
)
 
736.2

 
(153.9
)
Benefit from income taxes
—

 
—

 
(10.1
)
 
—

 
(10.1
)
Loss from continuing operations
(318.4
)
 
(264.8
)
 
(296.8
)
 
736.2

 
(143.8
)
Loss from discontinued operations, net of income taxes
(0.9
)
 
—

 
(174.6
)
 
—

 
(175.5
)
Net loss
(319.3
)
 
(264.8
)
 
(471.4
)
 
736.2

 
(319.3
)
Other comprehensive loss, net of tax
(42.8
)
 
(42.8
)
 
(84.1
)
 
126.9

 
(42.8
)
Comprehensive loss
$
(362.1
)
 
$
(307.6
)
 
$
(555.5
)
 
$
863.1

 
$
(362.1
)




MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF COMPREHENSIVE INCOME
Fiscal year ended September 27, 2013
(in millions)
 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Combined
Net sales
$
—

 
$
—

 
$
1,712.3

 
$
—

 
$
1,712.3

Cost of sales
—

 
—

 
890.0

 
—

 
890.0

Gross profit
—

 
—

 
822.3

 
—

 
822.3

Selling, general and administrative expenses
5.2

 
0.1

 
490.6

 
—

 
495.9

Research and development expenses
—

 
—

 
157.9

 
—

 
157.9

Restructuring charges, net
—

 
—

 
23.7

 
—

 
23.7

Separation costs
3.2

 
0.6

 
70.4

 
—

 
74.2

Gains on divestiture and license
—

 
—

 
(2.9
)
 
—

 
(2.9
)
Operating income (loss)
(8.4
)
 
(0.7
)
 
82.6

 
—

 
73.5

 
 
 
 
 
 
 
 
 
 
Interest expense
—

 
(19.6
)
 
0.1

 
—

 
(19.5
)
Interest income
—

 
—

 
0.3

 
—

 
0.3

Other income (expense), net
0.2

 
—

 
1.2

 
—

 
1.4

Intercompany interest and fees
(9.5
)
 
—

 
9.5

 
—

 
—

Equity in net income of subsidiaries
76.4

 
96.7

 
—

 
(173.1
)
 
—

Income from continuing operations before income taxes
58.7

 
76.4

 
93.7

 
(173.1
)
 
55.7

Provision for (benefit from) income taxes
(0.3
)
 
—

 
47.8

 
—

 
47.5

Income from continuing operations
59.0

 
76.4

 
45.9

 
(173.1
)
 
8.2

Gain (loss) from discontinued operations, net of income taxes
(0.2
)
 
—

 
50.8

 
—

 
50.6

Net income
58.8

 
76.4

 
96.7

 
(173.1
)
 
58.8

Other comprehensive income, net of tax
28.4

 
28.4

 
35.7

 
(64.1
)
 
28.4

Comprehensive income
$
87.2

 
$
104.8

 
$
132.4

 
$
(237.2
)
 
$
87.2


MALLINCKRODT PLC
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Fiscal year ended September 25, 2015
(in millions)


Mallinckrodt plc

Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
207.0

 
$
(148.2
)
 
$
837.6

 
$
—

 
$
896.4

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(148.0
)
 
—

 
(148.0
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,154.7
)
 
—

 
(2,154.7
)
Intercompany loan investment
(149.4
)
 
—

 
(554.2
)
 
703.6

 
—

Investment in subsidiary
—

 
(3,014.4
)
 
—

 
3,014.4

 
—

Restricted cash
—

 
—

 
3.1

 
—

 
3.1

Other
—

 
—

 
3.0

 
—

 
3.0

Net cash used in investing activities
(149.4
)
 
(3,014.4
)
 
(2,850.8
)
 
3,718.0

 
(2,296.6
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
2,890.0

 
120.0

 
—

 
3,010.0

Repayment of external debt and capital leases
—

 
(258.3
)
 
(1,590.1
)
 
—

 
(1,848.4
)
Excess tax benefit from share-based compensation
—

 
—

 
34.1

 
—

 
34.1

Debt financing costs
—

 
(39.1
)
 
(0.8
)
 
—

 
(39.9
)
Proceeds from exercise of share options
34.4

 
—

 
—

 
—

 
34.4

Intercompany loan borrowings
—

 
703.6

 
—

 
(703.6
)
 
—

Capital contribution
—

 
—

 
3,014.4

 
(3,014.4
)
 
—

Repurchase of shares
(92.2
)
 
—

 
—

 
—

 
(92.2
)
Other
—

 
—

 
(28.1
)
 
—

 
(28.1
)
Net cash provided by financing activities
(57.8
)
 
3,296.2

 
1,549.5

 
(3,718.0
)
 
1,069.9

Effect of currency rate changes on cash
—

 
—

 
(11.6
)
 
—

 
(11.6
)
Net (decrease) increase in cash and cash equivalents
(0.2
)
 
133.6

 
(475.3
)
 
—

 
(341.9
)
Cash and cash equivalents at beginning of period
0.3

 
18.5

 
689.0

 
—

 
707.8

Cash and cash equivalents at end of period
0.1

 
152.1

 
213.7

 
—

 
365.9


MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 26, 2014
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:

 

 

 

 

Net cash provided by (used in) operating activities
$
18.2

 
$
(65.0
)
 
$
420.2

 
$
—

 
$
373.4

Cash Flows From Investing Activities:

 

 

 

 

Capital expenditures
—

 
—

 
(127.8
)
 
—

 
(127.8
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(2,793.8
)
 
—

 
(2,793.8
)
Intercompany loan investment
(25.0
)
 
(298.1
)
 
(915.8
)
 
1,238.9

 
—

Subsidiary dividend proceeds
—

 
300.5

 
—

 
(300.5
)
 
—

Investment in subsidiary
—

 
(3,735.5
)
 
—

 
3,735.5

 
—

Restricted Cash
—

 
—

 
4.1

 
—

 
4.1

Other
—

 
—

 
26.7

 
—

 
26.7

Net cash used in investing activities
(25.0
)
 
(3,733.1
)
 
(3,806.6
)
—

4,673.9

 
(2,890.8
)
Cash Flows From Financing Activities:

 

 

 

 

Issuance of external debt
—

 
2,893.3

 
149.9

 
—

 
3,043.2

Repayment of external debt and capital leases
—

 
(3.3
)
 
(31.5
)
 
—

 
(34.8
)
Excess tax benefit from share-based compensation
—

 
—

 
8.9

 
—

 
8.9

Debt financing costs
—

 
(70.7
)
 
(1.0
)
 
—

 
(71.7
)
Proceeds from exercise of share options
25.8

 
—

 
—

 
—

 
25.8

Subsidiary dividend payment
—

 
—

 
(300.5
)
 
300.5

 
—

Intercompany loan borrowings
(2.4
)
 
940.8

 
300.5

 
(1,238.9
)
 
—

Capital contribution
—

 
—

 
3,735.5

 
(3,735.5
)
 
—

Repurchase of shares
(17.5
)
 
—

 
—

 
—

 
(17.5
)
Other
—

 
—

 
—

 
—

 
—

Net cash provided by financing activities
5.9

 
3,760.1

—

3,861.8

 
(4,673.9
)
 
2,953.9

Effect of currency rate changes on cash
—

 
—

 
(4.2
)
 
—

 
(4.2
)
Net increase (decrease) in cash and cash equivalents
(0.9
)
 
(38.0
)
 
471.2

 
—

 
432.3

Cash and cash equivalents at beginning of period
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at end of period
$
0.3

 
$
18.5

 
$
689.0

 
$
—

 
$
707.8























MALLINCKRODT PLC
CONDENSED COMBINING STATEMENT OF CASH FLOWS
Fiscal year ended September 27, 2013
(in millions)

 
Mallinckrodt plc
 
Mallinckrodt International Finance S.A.
 
Other Subsidiaries
 
Eliminations
 
Consolidated
Cash Flows From Operating Activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
(1.8
)
 
$
(8.4
)
 
$
146.1

 
$
—

 
$
135.9

Cash Flows From Investing Activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
—

 
(147.9
)
 
—

 
(147.9
)
Acquisitions and intangibles, net of cash acquired
—

 
—

 
(88.1
)
 
—

 
(88.1
)
Intercompany loan investment
—

 
(2.4
)
 
(409.6
)
 
412.0

 
—

Investment in subsidiary
—

 
(68.0
)
 
—

 
68.0

 
—

Other
—

 
—

 
1.3

 
—

 
1.3

Net cash used in investing activities
—

 
(70.4
)
 
(644.3
)
—

480.0

 
(234.7
)
Cash Flows From Financing Activities:
 
 
 
 
 
 
 
 
 
Issuance of external debt
—

 
898.1

 
—

 
—

 
898.1

Repayment of external debt and capital leases
—

 
—

 
(1.3
)
 
—

 
(1.3
)
Excess tax benefit from share-based compensation
—

 
—

 
3.4

 
—

 
3.4

Debt financing costs
—

 
(12.0
)
 
—

 
—

 
(12.0
)
Net transfers to parent
—

 
(1,160.4
)
 
644.5

 
—

 
(515.9
)
Proceeds from exercise of share options
0.6

 
—

 
—

 
—

 
0.6

Intercompany loan borrowings
2.4

 
409.6

 
—

 
(412.0
)
 
—

Capital contribution
—

 
—

 
68.0

 
(68.0
)
 
—

Other
—

 
—

 
0.1

 
—

 
0.1

Net cash provided by financing activities
3.0

 
135.3

—

714.7

 
(480.0
)
 
373.0

Effect of currency rate changes on cash
—

 
—

 
1.3

 
—

 
1.3

Net increase in cash and cash equivalents
1.2

 
56.5

 
217.8

 
—

 
275.5

Cash and cash equivalents at beginning of period
—

 
—

 
—

 
—

 
—

Cash and cash equivalents at end of period
$
1.2

 
$
56.5

 
$
217.8

 
$
—

 
$
275.5
XML 73 R83.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Income Tax Receivables and Other Assets) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Income Tax Disclosure [Abstract]    
Other assets $ 52.2 $ 14.8
Prepaid expenses and other current assets 90.0 63.4
Total $ 142.2 $ 78.2
XML 74 R114.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of the Valuation Assumptions Used in the Conversion) (Details) - $ / shares
 12 Months Ended
Jun. 28, 2013
Jun. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Jun. 27, 2014
Sep. 27, 2013
Weighted Average Assumptions            
Expected share price volatility 32.00% 26.00% 29.00% 32.00%    
Risk-free interest rate 0.99% 0.99% 1.72% 1.96%    
Expected annual dividend per share 0.00% 1.65% 0.00% 0.00%    
Expected life of options (in years) 3 years 9 months 18 days 3 years 9 months 18 days 5 years 4 months 5 years 6 months    
Fair value per option   $ 18.04 $ 30.08 $ 17.38 $ 16.51  
Share options outstanding   1,745,258 2,786,443 3,526,789 2,399,822 2,760,231
XML 75 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Tables)
 12 Months Ended
Sep. 25, 2015
Business Combinations [Abstract]  
Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed
The following amounts represent the preliminary allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Therakos Acquisition and Ikaria Acquisition and final allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Cadence Acquisition, Questcor Acquisition and CNS Therapeutics acquisition:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Cash
$
41.3

 
$
77.3

 
$
445.1

 
$
43.2

 
$
3.6

Inventory
23.5

 
26.3

 
67.9

 
21.0

 
—

Intangible assets
1,170.0

 
1,971.0

 
5,601.1

 
1,300.0

 
91.9

Goodwill (non-tax deductible)
437.2

 
792.4

 
1,789.4

 
318.1

 
24.5

Other assets, current and non-current (1)
42.1

 
172.9

 
274.3

 
18.0

 
9.7

Total assets acquired
1,714.1

 
3,039.9

 
8,177.8

 
1,700.3

 
129.7

Current liabilities
24.7

 
32.6

 
168.9

 
48.8

 
4.0

Unpaid purchase consideration (current)
—

 
—

 
128.8

 
—

 
—

Other liabilities (non-current)
0.6

 
9.1

 
186.8

 
—

 
—

Deferred tax liabilities, net (non-current)
324.3

 
623.6

 
1,906.8

 
292.3

 
27.1

Contingent consideration (non-current)
—

 
—

 
—

 
—

 
6.9

Total debt
344.8

 
1,121.0

 
—

 
30.0

 
—

Total liabilities assumed
694.4

 
1,786.3

 
2,391.3

 
371.1

 
38.0

Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7



(1)
This amount includes $22.0 million, $73.8 million, $87.3 million, $14.7 million and $3.3 million of accounts receivable for the Therakos Acquisition, Ikaria Acquisition, Questcor Acquisition, Cadence Acquisition, and CNS Therapeutics, respectively, which is also the gross contractual value.
Schedule of Reconciliation of Total Consideration
The following reconciles the total consideration to net assets acquired:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Total consideration, net of cash
$
978.4

 
$
1,176.3

 
$
5,470.2

 
$
1,286.0

 
$
95.0

Plus: cash assumed in acquisition
41.3

 
77.3

 
445.1

 
43.2

 
3.6

Total consideration
1,019.7

 
1,253.6

 
5,915.3

 
1,329.2

 
98.6

Less: unpaid purchase consideration
—

 
—

 
(128.8
)
 
—

 
—

Less: contingent consideration
—

 
—

 
—

 
—

 
(6.9
)
Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7
Schedule of Earnings by Acquiree
Financial Results - The amount of net sales and earnings included in the Company's results for the periods presented were as follows:
Net sales
2015
 
2014
Ikaria
$
191.9

 
$
—

Questcor
1,125.9

 
129.2

Cadence
263.0

 
124.4

 
$
1,580.8

 
$
253.6

Operating income (loss)


 
 
Ikaria
$
47.1

 
$
—

Questcor
223.3

 
17.4

Cadence
(97.3
)
 
(66.9
)
 
$
173.1

 
$
(49.5
)
Schedule of Acquisition Cost
Acquisition-Related Costs - Acquisition-related costs incurred in fiscal 2015 and 2014 for each of the fiscal 2015 and 2014 acquisitions discussed above were as follows:
Acquisition-related costs
2015
 
2014
Therakos
$
22.5

 
$
—

Ikaria
30.9

 
—

Questcor
—

 
47.5

Cadence
—

 
17.6

 
$
53.4

 
$
65.1
Business Combination Intangible Asset Amortization By Acquiree [Table Text Block]
The amount of amortization on acquired intangible assets included within operating income (loss) for the periods presented was as follows:
Intangible asset amortization
2015
 
2014
Ikaria
$
57.1

 
$
—

Questcor
301.4

 
34.9

Cadence
162.5

 
85.9

 
$
521.0

 
$
120.8

During fiscal 2015 and 2014, the Company recognized $44.1 million and $25.7 million, respectively, of expense primarily associated with fair value adjustments of acquired inventory. This expense was included within cost of sales.
Schedule of Intangible Assets Acquired
Intangible assets acquired consist of the following:  
Therakos
Amount
 
Amortization Period
Completed technology
$
1,170.0

 
15 years
The completed technology intangible asset relates to extracorporeal photopheresis treatment therapies. The fair value of the intangible asset was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of the asset based on market participant expectations of cash flows the asset would generate. The cash flows were discounted commensurate with the level of risk associated with each asset or its projected cash flows. The completed technology intangible asset utilized a discount rate of 17.0%. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.
Ikaria
Amount
 
Amortization Period
Completed technology
$
1,820.0

 
15 years
Trademark
70.0

 
22 years
In-process research and development - terlipressin
81.0

 
Non-Amortizable
 
$
1,971.0

 
 
The completed technology and trademark intangible assets relate to Inomax. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, trademark and in-process research and development ("IPR&D") terlipressin intangibles utilized discount rates of 14.5%, 14.5%, and 17.0%, respectively. The IPR&D discount rate for terlipressin was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

Questcor
Amount
 
Weighted-Average Amortization Period
Completed technology
$
5,343.3

 
18 years
Trademark
5.2

 
13 years
Customer relationships
34.3

 
12 years
In-process research and development - Synacthen
218.3

 
Non-Amortizable
 
$
5,601.1

 
 
The completed technology intangible asset relates to Acthar. The trademark and customer relationship intangible assets relate to BioVectra, Inc., a wholly-owned subsidiary of Questcor. The in-process research and development relates to the U.S. development of Synacthen, a synthetic pharmaceutical product. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, customer relationships, trademark and in-process research and development intangibles utilized discount rates of 14.5%, 10.0%, 10.0% and 16.0%, respectively. The in-process research and development discount rate was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. The majority of assets acquired are included within the Company's Specialty Brands segment. Assets related to BioVectra, Inc. are included within the Company's Specialty Generics segment.

Cadence
Amount
 
Amortization Period
Completed technology
$
1,300.0

 
8 years
The completed technology intangible asset relates to Ofirmev, the rights to which have been in-licensed from Bristol-Myers Squibb Company ("BMS"). The fair value of the intangible asset was determined using the income approach. The cash flows were discounted at a 13.0% rate. For more information on the BMS license agreement, refer to "License Agreement" below. The excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.


CNS Therapeutics
Amount
 
Weighted-Average Amortization Period
Completed technology
$
73.1

 
13 years
Trademark
0.2

 
3 years
In-process research and development
18.6

 
Non-Amortizable
 
$
91.9

 
 
Schedule of Pro Forma Information
The following unaudited pro forma information has been prepared for comparative purposes only and is not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor is it necessarily an indication of future operating results. In addition, the unaudited pro forma information does not reflect the cost of any integration activities, benefits from any synergies that may be derived from the acquisition or revenue growth that may be anticipated.
 
2015
 
2014
Net sales
$
3,755.8

 
$
3,598.1

Income (loss) from continuing operations
359.9

 
(63.1
)
 
 
 
 
Basic earnings (loss) per share from continuing operations
$
3.11

 
$
(0.55
)
Diluted earnings (loss) from per share continuing operations
3.07

 
(0.55
)
XML 76 R53.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Instruments and Fair Value Measurements (Tables)
 12 Months Ended
Sep. 25, 2015
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis
The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:
 
September 25,
2015
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
34.6

 
$
24.2

 
$
10.4

 
$
—

 
$
34.6

 
$
24.2

 
$
10.4

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
20.0

 
$
—

 
$
20.0

 
$
—

Contingent consideration and acquired contingent liabilities
174.6

 
—

 
—

 
174.6

Foreign exchange forward and option contracts
3.3

 
3.3

 
—

 
—

 
$
197.9

 
$
3.3

 
$
20.0

 
$
174.6


 
September 26,
2014

Quoted Prices in Active Markets for Identical Assets
(Level 1)

Significant Other Observable Inputs
(Level 2)

Significant Unobservable Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Debt and equity securities held in rabbi trusts
$
35.7

 
$
22.9

 
$
12.8

 
$
—

 
$
35.7

 
$
22.9

 
$
12.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation liabilities
$
15.0

 
$
—

 
$
15.0

 
$
—

Contingent consideration and acquired contingent liabilities
202.8

 
—

 
—

 
202.8

Foreign exchange forward and option contracts
0.2

 
0.2

 
—

 
—


$
218.0

 
$
0.2

 
$
15.0

 
$
202.8
Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration
Balance at September 26, 2014
$
202.8

Payments
(29.0
)
Accretion expense
7.5

Effect of currency rate change
(6.7
)
Balance at September 25, 2015
$
174.6
Schedule of Carrying Amount and Fair Value of Long-term Debt
The following table presents the carrying values and estimated fair values of the Company's long-term debt, excluding capital leases, as of the end of each period:

September 25, 2015

September 26, 2014

Carrying
Value

Fair
Value

Carrying
Value

Fair
Value
Variable rate receivable securitization
$
153.0

 
$
153.0

 
$
150.0

 
$
150.0

2.85% term loan due April 2016
—

 
—

 
3.1

 
3.1

3.50% notes due April 2018
300.0

 
294.3

 
300.0

 
290.2

4.875% notes due April 2020
700.0

 
684.1

 
—

 
—

Term loans due March 2021
1,978.5

 
1,966.5

 
1,996.7

 
1,970.4

4.00% term loan due February 2022
7.9

 
7.9

 
10.8

 
10.8

9.50% debentures due May 2022
10.4

 
13.0

 
10.4

 
14.2

5.75% notes due August 2022
900.0

 
876.1

 
900.0

 
907.3

8.00% debentures due March 2023
4.4

 
5.3

 
8.0

 
10.2

4.75% notes due April 2023
600.0

 
539.6

 
600.0

 
563.8

5.625% notes due October 2023
750.0

 
705.2

 
—

 
—

5.50% notes due April 2025
700.0

 
646.0

 
—

 
—

Revolving credit facility
500.0

 
500.0

 
—

 
—
Schedules of Concentration of Risk
The following table shows net sales attributable to distributors that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
CuraScript, Inc.
31
%
 
6
%
 
—
%
McKesson Corporation
18
%
 
21
%
 
19
%
Cardinal Health, Inc.
14
%
 
22
%
 
24
%
AmerisourceBergen Corporation
9
%
 
14
%
 
11
%

The following table shows accounts receivable attributable to distributors that accounted for 10% or more of the Company's gross accounts receivable at the end of each period:

September 25,
2015

September 26,
2014
McKesson Corporation
24
%
 
27
%
CuraScript, Inc.
16
%
 
15
%
Cardinal Health, Inc.
13
%
 
18
%
AmerisourceBergen Corporation
12
%
 
14
%

 The following table shows net sales attributable to products that accounted for 10% or more of the Company's total net sales:

Fiscal Year

2015
 
2014
 
2013
Acthar
31
%
 
6
%
 
—
%
Acetaminophen products (API)
6
%
 
9
%
 
13
%
Methylphenidate ER
4
%
 
10
%
 
9
%
XML 77 R72.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Schedule of Restructuring and Related Charges by Segment) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges $ 40.7 $ 81.9 $ 26.3
Less: accelerated depreciation (0.3) (0.5) (2.6)
Restructuring charges, net 40.4 81.4 23.7
Specialty Brands [Member]      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges 36.5 57.0 5.2
Specialty Generics [Member]      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges 4.5 9.8 11.2
Nuclear Imaging      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges (4.6) 13.7 6.9
Corporate      
Restructuring Cost and Reserve [Line Items]      
Total restructuring and related charges $ 4.3 $ 1.4 $ 3.0
XML 78 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Cost of sales                 1,493.3 1,021.8 890.0
Gross profit 482.1 503.8 462.9 404.8 363.2 254.1 226.7 216.2 1,853.6 1,060.2 822.3
Selling, general and administrative expenses                 1,169.8 745.0 495.9
Research and development expenses                 185.1 163.5 157.9
Separation costs                 0.0 9.6 74.2
Restructuring charges, net                 40.4 81.4 23.7
Non-restructuring impairment charges                 0.0 151.6 0.0
Gain on divestiture and license                 (3.5) (15.0) (2.9)
Operating income (loss)                 461.8 (75.9) 73.5
Interest expense                 (255.6) (82.6) (19.5)
Interest income                 1.0 1.5 0.3
Other income, net                 8.1 3.1 1.4
Income (loss) from continuing operations before income taxes [1]                 215.3 (153.9) 55.7
Provision for (benefit from) income taxes [1]                 (92.9) (10.1) 47.5
Income (loss) from continuing operations 90.0 55.6 75.2 87.4 (173.5) (29.0) 20.2 38.5 308.2 (143.8) 8.2
Income (loss) from discontinued operations, net of tax expense (benefit) of $11.5, $(34.7), and $21.1 (14.8) 2.4 23.6 5.3 (178.9) 4.9 (8.6) 7.1 16.5 (175.5) 50.6
Net income (loss) $ 75.2 $ 58.0 $ 98.8 $ 92.7 $ (352.4) $ (24.1) $ 11.6 $ 45.6 $ 324.7 $ (319.3) $ 58.8
Basic earnings per share (Note 8):                      
Income (Loss) from Continuing Operations, Per Basic Share $ 0.77 [2] $ 0.47 [2] $ 0.64 [2] $ 0.75 [2] $ (2.04) [2] $ (0.50) [2] $ 0.35 [2] $ 0.67 [2] $ 2.64 $ (2.22) $ 0.14
Earnings Per Share, Basic                 0.14 (2.70) 0.88
Net income (in usd per share)                 $ 2.78 $ (4.92) $ 1.02
Weighted Average Number of Shares Outstanding, Basic                 115.8 64.9 57.7
Diluted earnings per share (Note 8):                      
Income (Loss) from Continuing Operations, Per Diluted Share $ 0.76 [2] $ 0.47 [2] $ 0.64 [2] $ 0.74 [2] $ (2.04) [2] $ (0.50) [2] $ 0.34 [2] $ 0.66 [2] $ 2.61 $ (2.22) $ 0.14
Earnings Per Share, Diluted                 0.14 (2.70) 0.88
Net income (in usd per share)                 $ 2.75 $ (4.92) $ 1.02
Diluted weighted-average shares oustanding (in shares)                 117.2 64.9 57.8
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
[2] Quarterly and annual computations are prepared independently. Therefore, the sum of each quarter may not necessarily total the fiscal period amounts noted elsewhere within this Annual Report on Form 10-K.
XML 79 R45.htm IDEA: XBRL DOCUMENT v3.3.0.814
Property, Plant and Equipment (Tables)
 12 Months Ended
Sep. 25, 2015
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
The gross carrying amount and accumulated depreciation of property, plant and equipment at the end of each period was as follows:
 
September 25, 2015
 
September 26, 2014
Land
$
49.8

 
$
47.3

Buildings
333.7

 
289.4

Capitalized software
120.2

 
94.5

Machinery and equipment
1,220.0

 
1,041.6

Construction in process
146.9

 
196.2

 
1,870.6

 
1,669.0

Less: accumulated depreciation
(879.3
)
 
(782.2
)
Property, plant and equipment, net
$
991.3

 
$
886.8
XML 80 R96.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt (Schedule of Long term debt and Capital lease obligation) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Current maturities of long-term debt:    
Long-term Debt, Current Maturities $ 22.3 $ 21.2
Capital lease obligation and vendor financing agreements 1.3 1.4
Long-term debt:    
Long-term Debt, Gross 6,584.2 3,959.6
Unamortized Debt Issuance Expense and Discount 109.9 85.6
Capital Lease Obligations, Noncurrent 1.0 0.4
Debt, Long-term and Short-term, Combined Amount 6,606.5 3,980.8
Variable rate receivable securitization    
Long-term debt:    
Long-term Debt, Gross 153.0 150.0
Unamortized Debt Issuance Expense and Discount 0.8 1.0
Senior Notes | 3.50% notes due April 2018    
Long-term debt:    
Long-term Debt, Gross 300.0 300.0
Unamortized Debt Issuance Expense and Discount 1.7 2.4
Senior Notes | 4.75% notes due April 2023    
Long-term debt:    
Long-term Debt, Gross 600.0 600.0
Unamortized Debt Issuance Expense and Discount 7.1 7.9
Senior Notes | 2020 Notes    
Long-term debt:    
Long-term Debt, Gross 700.0  
Unamortized Debt Issuance Expense and Discount 11.3  
Senior Notes | 5.75% notes due August 2022    
Long-term debt:    
Long-term Debt, Gross 900.0 900.0
Unamortized Debt Issuance Expense and Discount 14.4 16.4
Senior Notes | 5.625% notes due October 2023    
Long-term debt:    
Long-term Debt, Gross 750.0 0.0
Unamortized Debt Issuance Expense and Discount 13.7 0.0
Senior Notes | 5.50% notes due April 2025    
Long-term debt:    
Long-term Debt, Gross 700.0 0.0
Unamortized Debt Issuance Expense and Discount 11.9 0.0
Secured Debt | 2.85% term loan due April 2016    
Current maturities of long-term debt:    
Long-term Debt, Current Maturities 0.0 0.4
Long-term debt:    
Long-term Debt, Gross 0.0 2.7
Unamortized Debt Issuance Expense and Discount 0.0 0.0
Secured Debt | Term loans due March 2021    
Current maturities of long-term debt:    
Long-term Debt, Current Maturities 20.0 18.2
Long-term debt:    
Long-term Debt, Gross 1,958.5 1,978.5
Unamortized Debt Issuance Expense and Discount 44.1 52.4
Secured Debt | 4.00% term loan due February 2022    
Current maturities of long-term debt:    
Long-term Debt, Current Maturities 1.0 1.2
Long-term debt:    
Long-term Debt, Gross 6.9 9.6
Unamortized Debt Issuance Expense and Discount 0.0 0.0
Debentures | 8.00% debentures due March 2023    
Long-term debt:    
Long-term Debt, Gross 4.4 8.0
Unamortized Debt Issuance Expense and Discount 0.0 0.0
Debentures | 9.50% debentures due May 2022    
Long-term debt:    
Long-term Debt, Gross 10.4 10.4
Unamortized Debt Issuance Expense and Discount 0.0 0.0
2015 Revolving Credit Facility    
Long-term debt:    
Long-term Debt, Gross 500.0 0.0
Unamortized Debt Issuance Expense and Discount 4.9 5.5
Capital Lease Obligations    
Long-term debt:    
Unamortized Debt Issuance Expense and Discount $ 0.0 $ 0.0
XML 81 R135.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data (Schedule of Net Sales and Long-Lived Assets by Geographic Area) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Long-Lived Assets 994.7       904.0       994.7 904.0  
United States                      
Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items]                      
Net sales [1]                 2,973.2 1,780.9 1,421.6
Long-Lived Assets 905.2 [2]       829.1       905.2 [2] 829.1  
EMEA                      
Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items]                      
Net sales [1]                 236.2 250.3 250.1
Long-Lived Assets [2],[3] 45.0       33.9       45.0 33.9  
EMEA | IRELAND                      
Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items]                      
Long-Lived Assets 10.7       0.4       10.7 0.4  
Other Countries                      
Schedule of Net Sales and Long-Lived Assets by Geographic Area [Line Items]                      
Net sales [1]                 137.5 50.8 $ 40.6
Long-Lived Assets $ 44.5       $ 41.0       $ 44.5 $ 41.0  
[1] Net sales are attributed to regions based on the location of the entity that records the transaction, none of which relate to the country of Ireland.
[2] Long-lived assets are primarily composed of property, plant and equipment.
[3] Includes long-lived assets located in Ireland of $10.7 million, and $0.4 million at the end of fiscal 2015
XML 82 R113.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Share Option Award Status Upon Completion of the Conversion) (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Jun. 28, 2013
Sep. 25, 2015
Sep. 26, 2014
Jun. 27, 2014
Sep. 27, 2013
Jun. 27, 2013
Conversion of Covidien Equity Awards            
Share options outstanding   2,786,443 3,526,789 2,399,822 2,760,231 1,745,258
Weighted-average exercise price, outstanding share options   $ 52.76 $ 36.84 $ 35.94 $ 37.30  
Weighted-average remaining contractual term, outstanding share options 8 years 7 years 4 months        
Aggregate intrinsic value, outstanding share options   $ 63.2   $ 22.9    
Share options exerciseable   1,054,336   550,097    
Weighted-average exercise price, exercisable share options   $ 34.20   $ 30.94    
Weighted-average remaining contractual term, exercisable share options 5 years 11 months 5 years 9 months        
Aggregate intrinsic value, exercisable share options   $ 36.2   $ 8.0    
XML 83 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Current Assets:    
Cash and cash equivalents $ 365.9 $ 707.8
Accounts receivable, less allowance for doubtful accounts of $4.7 and $3.7 548.5 476.6
Inventories 281.8 306.4
Deferred income taxes 142.7 152.3
Prepaid expenses and other current assets 207.3 227.1
Current assets held for sale 299.9 200.8
Total current assets 1,846.1 2,071.0
Property, plant and equipment, net 991.3 886.8
Goodwill 3,649.4 2,401.9
Intangible assets, net 9,666.3 7,082.2
Long-term assets held for sale 0.0 111.2
Other assets 251.0 234.2
Total Assets 16,404.1 12,787.3
Current Liabilities:    
Current maturities of long-term debt 22.3 21.2
Accounts payable 133.0 110.7
Accrued payroll and payroll-related costs 103.7 116.3
Accrued royalties 29.3 67.7
Accrued and other current liabilities 568.3 529.9
Current liabilities held for sale 72.8 59.0
Total current liabilities 929.4 904.8
Long-term debt 6,474.3 3,874.0
Pension and postretirement benefits 116.7 116.2
Environmental liabilities 73.3 59.2
Deferred income taxes 3,132.4 2,399.6
Other income tax liabilities 121.3 122.6
Long-term liabilities held for sale 0.0 9.7
Other liabilities 245.5 343.2
Total Liabilities 11,092.9 7,829.3
Shareholders' Equity:    
Preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding 0.0 0.0
Ordinary A shares, €1.00 par value, 40,000 authorized; none issued or outstanding 0.0 0.0
Ordinary shares, $0.20 par value, 500,000,000 authorized; 117,513,370 and 116,160,353 issued; 116,283,149 and 115,929,588 outstanding 23.5 23.2
Ordinary shares held in treasury at cost, 1,230,221 and 230,765 (109.7) (17.5)
Additional paid-in capital 5,357.6 5,172.4
Retained earnings (deficit) 38.9 (285.8)
Accumulated other comprehensive income 0.9 65.7
Total Shareholders' Equity 5,311.2 4,958.0
Total Liabilities and Shareholders' Equity $ 16,404.1 $ 12,787.3
XML 84 R94.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets (Schedule of Future Amortization Expense, Intangible Assets) (Details)
$ in Millions
Sep. 25, 2015
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Fiscal 2016 $ 693.7
Fiscal 2017 691.9
Fiscal 2018 682.9
Fiscal 2019 682.6
Fiscal 2020 $ 682.0
ZIP 85 0001567892-15-000047-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001567892-15-000047-xbrl.zip M4$L#!!0````(`"Z)>$<[0&I\WK,%`"LY>@`0`!P`;6YK+3(P,34P.3(U+GAM M;%54"0`#%^!45A?@5%9U>`L``00E#@``!#D!``#L?=F2VTBRY?.,V?R#1L^3 M*F+A)NNN:R`655:GE*EDJOK6?2F+!"))7($`"TM*O%\_$0`7D`1(D(DE`O"V M[FJ5"(((CW/VY_[SO?"A]_X==DW/LMW9/]]_F]XH M4_7V]OU__/I__O<__N_-S7].'N_>:9X9+;`;OE-]C$)LO?MAA_-W_[9P\/W= MB^\MWOW;\[_;K^CF9OVMY4?A98`D2^R-^GV9_&?T+#V/A[(U>!Y;+](8X?_W M\Z,@C4>B9;V,Y7Y/%GO6N#<8B2\"&B%+'([-E^1N/Y]]Q_Y(__F./+@;?#2] MR`W]U3_?S\-P^?&77^A''P)L?IAYK[^L/_Q%[`G234^XD83WFZ]%OD_&F?>] M]:?TB_+^%RUL9W^'?)!Q.?YISK.OIY_0+_3WOV"[KS@(L[^2?)8Q&COP9%$8 M;K_UX\>/#_$W/7]&+N])OZROV'S!L=WO)ZZF'S^C`&\N7QQF.QO_F"BVPSR!Y$_!']@K`_!M=SW6B1_5!6Z/\2KI;X%W+1#;D* M^[:Y_=[Y+^U_P<S7#N-?R&?;RZE M'U@'K-C:,_EP[](P\])^ M`X]0Z6;#E@_D0=ZO/Z7S\,_W@;U8.F1(O\2W29R=Z;DA_AF^L\E#&QK][E?Y MSRZ/80%.]_=?[7WMD+/W!<#06 M__'+X9>37_GEZ&?6O[(DS/*LO1\FAO!#C02&7Q-W.+X1AYL;[#Y+?P.[UN;Z M?GQ]?_>#UO;JS=_M?G+S-VL+Y=CLEMQV\%5@UEX)=,)D],1'"(/M7=>?O&7T MQFV,&)&/X?>D%%A*'+[\U]JG_J7A%]O%U@2[Y`_A@X/<0+,#T_&"R,=!QJ?* M3SO8?OL!NU0H)5_;N_8S7CQCOTXK;_F&9U2-)7^7_*5%?OSGTK'-S7.]L^Q% M\NC_?+\>R\>K+/'^U\W7SYGB'[]D/LGZT7\Y?O8WH";M,LI$#2>DJ6KX)9'F M/IQC_\$+B*((;1_3"=^[4[=Y=(5UVD"M+3HFR*'":3K'.+SS3!02X\;P(4KI M+\4T_0A;BFO%9E+CO"R\L]&S[=BAC0/^X)(WWO>_D@%_+#A@KA%`-:S,D8:5 M8AN,"FO81/,.=C_X=@T;VTSBR&9B;(-Q89M)^WE"*3:[37#&K,%2-#N`3&F. M5N1C^.(^PTH;OL3'\`_`7YJ331S&-M).0T(I&A'TOR/R?*JW6'HN^==]M:98 MEDUC$G(>D&W=NBI:VB%R^`NT)X>[TU\GQUMMG&7.8^XB\Z6@,0R'\_IE+SB6]?T%KB]`"HZ]AK!Q()D68=?<#^LNI^*]%V,/Y<)UH@_C`5?[@$$RTX/2!:;Z$?('=U&Z^WT^M;!QY::SHYU@Z"I7^- MYR%_O?#<:>B9WUL'DLUE1V.L$1P,+"!?GQ8!.+J1YH@7ISF@<>M/XH3\LK;\LIZE5?#[#/G] MJOA=?)Z!WTWPNXIYO[H:].1C%$3^JMTDSQAE!RM"5P$$EC>;6=UB`337+8B# M:N!1'5Y>$X+0T9T*$,QU=ZI`,->=R@"@Z-=XT:\EP@^0U#B2:NB0O*[=&K+( M1K)(5OH-+E>.JF'YYT0#6D5E:1V:GF`3ZKTU[VB]?208% M4,^,5[5V?+GBAQGG/?9+G)R-/*BBN?N@_I6$[RTB]EY$L.4%IF\]FWW"+O:1 MH[B68BULUPY"GUS[BO6?2X*PS0G]*9[$BH$(R7#UY",W0":][4M&[L/CLD?HTY8<<>GB\QXDF87/%GQ64AT_]$T=*P*F+'_P2"3%.([,D5$ M[Q`2SNQG!RM!@$-BQ<_HOSU?=5!PN**`++Q`_OX:M$<8L[+QX(XP3ATQ?R4<\Q!,VYZ[G>+,58#GE M)W.L`X!N%:#);P"@*P-TVKH`Z&N$QIUM4D.[,V7FXUA\%E`P'WR.W"5?T+;ZAXEITD6%)ASM9/:V6^^"<1#:QE3MK+XH+6&.' MI'US`&19A.S4>PE_(!^3RS9_U/`K=KSX"ZH7M-DG7X3FPI8"H+,(],_(G-LN M]E?IZP#::UCEV@;`S"*82_':O)89^//:4'>X%NAW&`5X[CG6[6+I>Z]MKPA? M!.T3M@$PLPCFXNEA)_!;7WH(D*U9-7<"OPVI9@!SS6*B$RE@0V("4L`3WEX0>3C8+(B_[+T`N1\\KUH&9!;.!&-JO0:\G.V M&V'KGCQ!V$ M\^EF?(`SP+D0G%EIG)/.S*#VM7\02%[$@6VBXE&,HD,"NPM"2G*OT8X"$W/?Y@C?X%,'(4$ M$@XUZ`?^$)XST&3JSXX4RL>G@*(B,ETEURC&]T(<14'XB%7ZY@QZW[X'LF^?E''&#DFW.%]@!L3_L$GES;PG'1=.RX4F@^ M>(X.C.5Z$!TZ&QTZH8*@7M?)>AUKRN>H,_WD>L8<^^B[US8WO#^LVGQ;!=W- MZU7L:<'E*9C.4NE\,*%-+%`G9V,)]V8H%.MC<(/87,O8,U._W#(PY`VP1EC$ M!U!)O<*P$&^$7FK/+D%G#")$[V<^+TK)=5^X'X4&=\V,\#TMZ^K/D$ M&=BX#$Q-\H&H8[.0U9KI9FG+`P-%GM+%'U0\JY$)'2AXMD[@`A>`"\R(^#)$ M'S0TEJ8@JUZB;:PSMP(YVRA\.^*/6<(P&WZ8!R!#"QD+X&Y)YUA%A0@0'KSB MF@/AP>)R*DB5[J">E?()`]"_>`L\]!B5"@$&-KQ??(`.0*#L(FK3YZ"\L9\( MA-Z;%I];+.X8Z)1Z8R\$9.V-@[XEF7I%?2'@MSF`,`=^NWU([49FW3A%\CO/G8787VCX.7Q:+?&>6/CF$O1%/K;HIP#FLS^8 M9AK>.DML`78KP/[>\:N#_R]T86>O@+P,R)K)KX=A)[S>87]8$H$[_,S M(+\.Y.?9O8-RYZ`CX8ZD7+/XT"H5!3N@?HE>/?H7_,'S>$`)!/9'U*T^A.IV MM>W>\+B^VS2QV:[D-EUBTT9.N#JX&7_(8F(#STF#)X]RVN+UNKRF][!EN;R# M=Y/>>1GOL%6](+Q_F2('0=)(EY[CSD M:A'^3/LOQ)XH7`+/*<^+!LP_.%(.*I''OID_O8+H"=Y3[%4NI/Q]/=K57EMYRV6WZS3P%ZKI_@=K&( M7"^,MU>U+2A5(]UKZA4JAY7YLUPO/9L^"SF[2E+[ZL@#=MT`V;`:6`OZ]ZW= ML>K/6D86W9A7_,46N>#^[8E^W%O4$%:SS, MM7=`9U/;.YM8;>[(*)L6JCEUK&R554E]>PVI#64LUIHW2C])!7;=%EK7A[.R MBE&$@1-72JDR=7:S31-+N8UOMX'*"^CT3NAT9JHNS8,=FK`[VX3-"@F.=B)` M1V*S'8D,)'B,>$?8D=7^'5GL^D%8I<=6=B/09SU[\CM"3>2 M-M"=1<>K3IS.L5)KEQM)S!!2[1U%P@Q%8ID@K^[]Q7#J"9QZLC=?E6[$+MC> M^I93`=+?Y0^BK!T'D/[MSM8^+GCM56&_VT`!Y?[%]A?XE3]2,.&W>2SB[,UX MMXA[?HEJ@AQ$@#.=8YS=IG)"'#=/9EXSCCRK[_ARUNQ=9G1W=T:M6XJ4:"84 M.^FL^$97V#["U,[8UNPC(6%P="-<5)].7\_*V8#P9J)6G3=29HF@@I,#V3I? M!R#;"L@RMU?JT"V3B!7Z1/)%/I&5#T0B;Z&Y]XEA!R3F4H%%K[FXE/LE,AT2 M&&\7:$9NQA_",ZV4`.NLF6JLWV:9F6>7W!!:MV7P3]@E3VQRN.+`"6!S+`V8 M!<1U<;ZO\5$3'[D6>*C*/53:SH#7B_"ZVW[I+SV?7`EHK0"MNRV@>U;F&JL9 MBZ#9<-U\>D]/(-V[I#58VWR<-\1N+;-E[0T`:#0/#0:ZZ(M#(S[)XKAXU1I< MQ"=&Y(VO@Z"0`13L@(*5_?.%/06DZ]WU'(5$*("D&9"P(D<+A1>0HUT,,H7] M!R@/\!<05!@(*BQXCJ-2+7)G^X?I?D8_[46T."C'=@5)&W/L0LZ>/\^#EI:'*#R`GI$'*X+G7RF,6DDRACA."8#AV3[8)C2CNFM#W` M,97OF/8&3)FIN!9MQ_9?]X&I+Y:.M\)XBE^Q3W>$<`BOTT/=@2YGK!US5N?R M+P`+(V!A)2\[`$L'FG'8;(1A$AP2@(,]<#"Z3-#^QG@FF]*9]!O7!Q5^N]!9 M[0!G$B`R^`[6?`#!`(+%V!QD6BM`7;.%C< M0L&D&+W(9P`PNN,QKI>BH#8Z(4#@96PG!57K2K>ZBJ<\)OQSY#N[I8B0%7 MJE"(`1`#VJ&D3YXE56$`:-^.`5ZB0#?V%ERI:\"Q@V/OO+H!<<^A6V=(W+.@ M:QK,;;OG_9O&/OC].K/:5D*8O84Z5KQH0R("O&A7O2@KP&\\A>QF?82=5)*E MPXQ8D18-:NINTH&%J`!$**U[`-I/FFX_867EO4%=#9X4/"D;.OLV\:3``F!! M(\N/!\Z]'6J2FFPPL@8DEE9862A!-A4XS6X\"Z[\*I>1UV)&`$H M=BF<0\(/"7^;`GSCM:_NKG&PP0<&5CJ8K((U?NX"D`)(P5*DH`):A%20!_W- MNTI*R7]Q/QR4E@HVM9L<2GD=*>754,YHPAMW5YFP@&5V6I*J\,L-K[(`K#L* M:R:E=B7]IH!@+OLT&W**D'EU+O-BTA4VI7,A5^M>KE95O:$2#`,.N<1"$SV1 MX,^ZZ<^J:)]H:CLC9=@C) M,8?A.6^\R=P7''!W$!";X=8UO05^0C];//-G!LK]C/=AQAF=\0K4=]*&+DSQ M,J2A*_0T;-(_U#EYUR^47-JS+-T(XHTDE+Y0DJ;,%B=*%,X]GXQH3_$9GH_M MF:MZD1OZ*_Z8DCV\G2[+&A_O!!&_RK\CMR>$'N&)..*#&^)-3R#_+G-)$C\=:OS-(MYO%Z/YN.MWDGJ"H6H^S7" M06AZ_L,<^0MDXBBT3>0$Q*8?6L;GLR.M,5$DP;V"G=QDSK^F2`[3SL"TO\DY M'`"EDK.H`"4,H*3:*M)Z:SM)F>@?DJ2)_(&/M$F^,&VJZ3#`'`5%6?/MP_2# M@2WLTQJ6-0W)S_\>^8%MV2:G"^-Y"HLRI]AH&7:R=21/FATLO0`YGWPO6JH. M"@(R.:GJ[86;YGG"SIFA,W9T9`VIV/J0$0O;?]WA&7+T^+FVWD/U7@EWL/O@ MF`)DCHQ2UF(R/S4A%HX#*5A:AR#81!"L^=BX4WF#BHCI M3=S^M.'<0'G.&BY;>];P"_9];-DQ2T+TTUFORJY+ M^7DXV%R06I!_\D+DM&G>-U=DCY%[OA?N+@*^,\'W1OT^\+U5?OW!]\@]PA5M MEZ5MOCH1/$OZY)/5TVJYWR>M!`$.X^3\FTMDKXJ6-C'*'48!C]UF!4:^0\+Y MH7/-_HQS4`UD^W\@)\*353SXN(JS!X=<`_*'A=S![A!P9K0=+PJ`&^'-C51< MZ2SN1@S;M4-\9[]BZ]8ESS"SGQV<&(H_-!1P)&?'VT%7,LN?D3FW7>RO^!89%TW[B3%SCX-KA0/@H!D<5)6'7HN#26238?-X M[L5%4[\_3.YG^UKOKWINLL&76/+6)=^<^3C@4!I>-/>G!MU9_P](:`H)K$4` MT/U=F.6I]Q+^0#XFEVW^J.%7['C+Y-")@,<*P44@*&P![C%RK3H`+]M$\^LO`"^=\Y MC+L7CGE7$C\<-/>Y5AH))[J%`N&#HJ7:)_+%S MCPL9<,$U+NK0"M?@@N>H<148&HL8=6B'2Q"0I%6+I8-#;#UA<^YZCC?C\$#T MBV"0I#(YH^Y\E%B_9X'[G5C7.(838^?>1UR+"_`1S?F(.K!P;:X9-R.;)$NG M;P9#OCE7:$%HVXK$'SZN3D`+68)[S)11GP#,L(D95K7(G6U2B[LS9>;CN#38 M%262._)6^1'`!%^88+7B"3E+LSD+J[B`RA;O""@C4^$9!?RMBM6A&S3\'-[& M^V+IXV[+%$_87]QYR$6N]07_V/S;06/(G>?.0O(1O78 M*DD=XY19RNK6R+)J^CWA!V;EWB\50*,B]L3>%R_$AZU)9Q#HVIZ?^EH;$'AH MBKI0=V!*[E$G%_"!9K^D*5NY%DA`[4]7VVR>@((!80R75%YQ":V7]&S@^/AVZ']/W$S[V<4 MTG];T>UMWLOOD;,B]QNV!WC7C)M[/!2(J887^3$CI_1-C5#OV$=-`>N`WJO, M5\7VCJUO_R2!`\!Y`,X"YFD[.AOTG+&$@UB];]+C@.)I M0/&PL,(#=2FH2S&IR:^I*'<8KZ47X`&]6>A-P"LI2]]VA'Z5M=5O;M!&G#99 M7,%0?K9G:T"'^FYZ@2CR%< M@MK6%$W.=10?&Z@>*#=8K6$-UDER+9)I$,8=0R>S&-G/L*4;85RV`I2_RD1) MBR/(82"'J1[!PQMQU,BZ?&Z8:0/8K@RBC.>G:Y5U7F31/$QJ6;O$X9AJE"+) M5,H72A&Y;"DB?17CTH34@Q9_:/%_DW.2:,%"ZC5;/+O\L-46E\WJ/VZU906S MM>Z9:N>7U*'[HHG3+4$*9 M`,H$;2F&]K^*OR-7/)M_`.8!\V\7#,*-6&J&4N,J52MAVO3*%#C@"TI`L.\* M]EW56?I),C%)N#@3:P.D+DNI2L]M)*&A,/GVXSKH7>Z75.Q,V@.'YH_IH$^Q M9];NA4JZ4#;'/OKN!=0VERZ9=;X@77BMK2T%Z?2275FKM4?=0[`:7^-J_*%; MDFZ$46&W=-!=5*);*KQ$<>N:?OS>:.1T9;6BZ)!Y7KC0+DKDMEX1CD"C*,DR M1RM3MCWG%2=M/:&P\SI(\LIP7E_-&H/8NL5 M4_07\^W9K::I"T[):E$_P`D<,M0-4/G.T_T![@7&.QP2XMR_))=<$E);`Y)C MZ^P"799YZ@FQK45GA<&S==6S^N-E4Y4R%D)DW<7>M391HED4A$*[SLEEH^Z; M9^'NE8#?7GW;?O,/Y-NT0>.1/->^EO!-*A"KG9X,G4'2])IQ0]U8 M+8K&S0O")B-T:U+Q-D"1@6,I*DM>B\TO[`R"G4'L(5BK_.#/=.D[^97V-3G4 M??)GNMA]:--Z<^#T609%(FSZ^DH:'4YZRCO;Q?NKNSPA\+1;.AX;_\O&5?NE M5JX@-^&,&EQ';MH#U8G4%N6FS2*UD7IQTT@UDDKA04'EA<0-:X)=\H?PP4%N MH-F!Z7@!?4U,QJ=[\?0^G&/_P2.SBT,[Z5[?N]/>UWG$[A7&V47D*ZQ3(R"E M.&A?5.%+O]6E-/&V_[9A0&-GT%CQ&X,RJ\<`K\[`B[5:AL6#<_']LQM-R1SS7P0 M;K/L7%:A^HU$*3A/W/.E_T:^J"B8*ZY%_T__.[)?D4-&!I2I@C*G3`VLJ6O] MO&1M\LVU0VQ-0S+G0=IL]R_?IGH\VO9A_2)(76<@[OUR>0CKA/ODVDNQJH4K ME,%=='L%0CS#@KBC?OBM^I@JM7`%+*J31=DV!QXUJ9A/\PA`#PAKVE-#T:_+ M\H:UG(!5EE1='^^B=V]!N;RC,8?A#!MB#L0<1G+HM[($48TF MP4[Z%N^D/SCJ@T'4P,$SIX#$W,$S%6.KT&EMT!3$8FAG.H]D,;@S>7Y=-OE4 MWT,\;<'*:]=D1`W`@'>/!9T,Z!L1C8J?! M[JU:=,+I['S"WLQ'R[EM(B>^H^E%Q-VN_OK]`6C)=VGQ@J?-AN1RI?-I_N6L][9G.H-@C_I<[(#[?:X40]3NXL`C1OVPGD+Q]\!&%MCO[ M['G6:I^,Z[]"POH*[E+;[/'M4)DY0(!%ZS/!#DA"R`1!$%[ST@4HV#-;L&?A M%0K=+"%T((>`$@)D#Q42GT:/[6>W+IEVY)HX=JO(/"0D:_1OL5RD,>[*@6S_#^1$>++ZC!'E/QVHX>._(^R:JWU_OKDV M=67P2(6*SV51JL#84TZOP.!KZ]MD;0\3]2W?/DP_W"%_AE6T/`CL*4-O__@; MF47DF_/5'7[%3C;.;MUE%`;Q!4+^+3N'VXMUQ?'4E!6;B\UL!HN.I[:"1P)6 MOYG5A5,%X'@W<@=@?,L9_YL]F_]I8\>:>*YU6`\L@>4BL/QZEF=-#DO,%H'9 M[#+[EMS+=Q'-@9%3/K$E(/;UQ,Z8&Y9X+0&OV>5UG1H=2-X1C0Z,9Y3QF^_$ M^\KC"RH0Z9"*EW%$9'IV6.(VY-^,<]NP?V+KUC6]!A$;D6B%AFZ$TK M4GD3Q!+#0;TRS'#:6C1=(,?Y;%LG&[^`BT6ZM(Y,":AG$?5UQ#60K2V/:Z!< M&69XX;@&LK7%H1(T:QNY77$?%#0XMK;U-7U0P$@&FY:`"ZS'.%"O M[8UQH%T9YG4=E2<0L"VO/(&*;0G#@8X,T1&PS_@9$K"BTMHS)&`MA6%6U[D_ M#;0K7Z4>T+!M9'S59TA`)&_Q&1(0R_G:K0*U8*B_`.(9[P.%M(QU M00@Y61M97;0K#$C(2`L78+Z*?BD(/^#SN<4_PUTBP*MN=(D`WQGE>QV=_]!L MS+YLA,YG%IFMD?OVO\I_/FE<;.23.L!'GO;;%5DA>#,%",S]4".6VI%@N+WI M]K/T-[!K;:[OQ]?W=S]H;:]N+!P"8X`QO`<-&8(&4(!A"NP%#2DFP:APT#@@ M36E!HP]!`QC#*F-20>-`-)560Y``_X!_#O`O[2<9I8DFZ9QH"C0[,!V/EAJ" MC$_W@>OYV)ZY#XG!DV_O?:4-("Y@D!1TBEFD1N$AQD`:%Q8>!\`K17B4#KQO MKAUB:QJ2)PO2MKY_^3;58Q-U'(?7&:B#L#Q;>018=@F6+-3V"M4V($RW*TRS M4!\H'7C@#WGWAZS`LM0P#?Z0?7_(0B`^7R\"9]AR9UAQ1:9WN3"+,?9WL$+)U$PRNJ: M=W,!Q;NQFPOXSBC?X2W"['(+O+6Y!_MY'AE9\'";&[S>=! M0O3N,K9VQ"WV\!M("(K1`34LUYG@EIR>^M,4#_N+J]!I[:7UZ!2&>9U MG?U<4&CJ2#\7U)P897S-G1]`^&YT?@#?&>=[I>^]!9:W^;VWP&W&N0UG\O/! M%DJ+P'_G.$?W@7=W((JO`NZ+7B'Q*VM%(*LK8VLAK=GED5" M>'LF`YE+YV`*R.!'XT!ZW%J-`YDZ7Y4JZ-V$?DEN\<_S:@TC)P68AB-MMX_:5'15`2?;:'X`)M56I0<"VM_`-^K6-S"ZXEP]8R,;& M.T`\\[$,$K86QS+(USK,;.B1:C&SH4N*869?LS,=*,G@-G+@`A>G_(*&;?DI MOZ!C^>J7`>D):H];_+-\#A%$.KX$)$2\MC'^H@XYX"0K[6R`>BXR.1".+<_D M0,DRRO!:.K]!OG(0*D&SLLAM+>'VGT_:EA'3.?+Q(UY&9(Y0@!]\;^:CQ39> M*_0;V=?PQY;\L2:Q[^Q@JYU\,L%^J!'2TNF7X^D?;F^Z_2S]#>Q:F^L/X++Y MI-10`%AA!BO5.HIDXL6I5N>,O6'\PHTHE2Z"I!3RE1_(MYY62[RG)AYQ$/JV M&6)K&GKF]V^N3<+%]!M_8-\;WBX>GAQ?;?B6]CUA)2(7YK>Y^:U)Z,`4USS% MS,D9"@H90,$.*!+//BH,B@1$@](UK@R1@(E(<#"_546"2138+@X"Q?P[L@.; M;E_8YC!?(V()T_,?B+)?(!-'H6TB)[AUS0\'9:?U7KZ0()`._,XST?9.>[") MS#"B]0-U3H^2"?C#3(Z]DCSHK,'*JN2.3\L96<>`<)CIT.KP%[3`>U4;Z3-R'-LUO_N>%1XP.0X(R*5[EZD% M7C&]`W\@28][5\&YU/YV?;M1<1AW78 M[5!V4[@WEHZY\\)Q75\L'6^%<8SR^R652OQ-?@Z'<\<&8"@`AG;"````T1Q` M4'N%8XJI?IY]PB[VD:.XEF(M2'@FLX*H9-9_+LE,\IA4^?SW:A"M:^C!?];$_&FQY+QSQXH0)FOZL%S"L'WC;Z`RB8!P7SC@7J M:#75T:IU#]0["%^EWR-7'#';OGHHDP>7R.2#Z\L@0]+O&AMMR*S1]GM"!R7W MA&H;$S!L@0S8%/>A!]>7V#TE,6NP_>:BLB%S=4=A:R)(T_575BH,%^\5``0P MO3?@XHY0F$]6.T"W<=W%XB#TXO_G2A@."GNW"H3A)L+_96'[KSL\0XX>#V.; M:*O>JVW9V'UP3'XX0`;S\6`P2?9\-)HZD5^Z/+EX[MK>!5_2O)?N99OKMV]. M$L.2"\AB0$$;I3',*4?R.,MA;_M-]+\C\GRJMUAZ+OG7_4-^%-.,%I%#+K6^ MX/`3LMT[+P@,WUMH.+!G+OW@WO\:(<=^6='M."B8&X[WXS=L<;D-ZJ15=A@I MPRP="Q5E0/#X)*1`L?X["D)ZDRZ`K8`!.@:KPVAU,::>?&)$)^FXZQ263@R\ M\[$.0%$W*-KG6$`O\:27*G9*%$TBH*F#:!+W?5EE1SR"EN9:2[/0+%<&K$`Y M-:J<6(#185$8,,0\AFH^B1'43U?43UT'7`.@V@PHYD)HK:LZZ>U-/@,0T2`BF/01$$48BB)5 M95!OE:^007&;0;$B==]4)`0GQ9"3JJ)H6(:3`FW3Z&H$*X[F37TC?;C8B9R&_'%QZ^7_<1Q_9](-YT M%3MZ9,:735;I3_C>O;G!4\'#,<\:[R2F+GB>XK9O9+,I;CV'?]L,/YQB@=AO,)RR7`*60Z0'69AP<`J@'5[3D2(Z-R!!(<)'@3$IR% M"EC&ACB@`]"A"3JPLK'O$B7_A'Y^1F&(_6`;N#N,_K,Z)]=<'<%[S7GHV7K* M@T^$IVUM7A"CN%:Z6J`$`0Z[[,W/%U>*&Q`0WLRK+L&57^?*W_+630@9+2[: M9U$0J`60[QCD3[]N"JA16M0I_.8KH&"+*;CIU(HYLUIB[^7^V;%G:(],NOMJ M>[Y+AXR%J/9T'Y"JVXIR_U/PI0F3R0HQW3T.F\`L*(W_? M.]RZ%EZXA"G);VR_=W"_@_I1^O'BUWI:\7M(D4-K1XX7D%\A/T?^9>D%R/GD M>]&2OH/4B2S;G677E[;&2K\B:H*^8Y\?=Q$S-`,$"54*HZ`L+A=<@Z]L\?T< M"'?/<1J%93U//2!.)CL'Q5SW'&;(#?`S3CBL,/_/'CI-*='Q_4ZPW7^'O)$-L$+"1IX M_D8]/[`;LK-6LJN.+I;"[)J2OPA7$\^U#OBTG8M/V)OY:#DG`'!2%/!79(JL MW[`]FQ/1;P>!%_EVFXEP:*FRH)]KZ`U:3UBZ59B%^@"GP03J`Q#'2O8)L&0) M_@66+,'7=<'7@9/BV4F!=P#O4%W7OI1N:*`'_ZBQ'6;8-6V\G=_[E]U?[[H: ME>`9!Z$7[`5#GBA5?+P)##('S/:B^Z":S7B[`PCN",T2;Z"B8+>D]C4BEC(] M?XK-R(^]T>Y"#H%R-,@$$.='6:>+&)1<4M>2@ZJG>!F*`_KGPI-.W\(]]QP+ M^QKYS5=RY2MN]?P7&7"-CD+<7U\YZRC$"G;M)O%%V(LOV;#1T*MM/:%GY&*2 M:7UX_;`QZP,QZP*9.`IIR9*&Z_9`Y^)!,QQGY!N"H(HW?5^H3>Z\']A_0$&` M;/.1D-'_@G_\3F(V7G$(H0MERKFQJ.;GE`8$?'UDE`F(C)K6E"?:*X^P5SUJG@\><2A[RWGMMM&7.0. MCFTXU'&&0`XG/2?Q`LG=>.I:6/7))2[4T511*XE"J,' M\BCT-0/M@\]5`V<81A4$J5O(DAO.DO=?7Y3.>?PEO@L/Z(#W&+!(%KMP;/= M,/X#]DWRX1T$>_OYE^XWM M'W;=?`,G%E/5S6O.^>*&/BZUP/JWR3"*&NO/0 MX6M_JB!F*_A5R(S\THSQE?ZC^--UG/*-D`;]X=,/+^:Q3K+0EQ%OD_?^OR(EYX?8DM9>!'1F]?)\;C9 M=_-`'/;>Y?'BA,%K)\.%$U:M#(\;G0\FG'L&7I(13^V?Q&D>I&@V-=N<(1=@Z$:R:!'^C'QS+O9$H1Y>MH%>^=;CFE0MP?:V;#'%K]@M)_B4 M7Y.=8M?V_%2YL@W$*&!Z?M.CTF+.T=1W@I5;29(!C6N72BK1A.UD9@'S;1BN#+*S,0VX&N1GD M9HRLF&VA$:_DI)=SF$O.VEJP+S(#W0Z9+%3L6\=1Z#7EFJ#LQ<\VLK.A-0VK;1;I?H2U[G:4-UE=ZV8A[L!.!]CIT'Y//O=QYHXO9K*?5LJK M,V;GEQ8MT%4-5B1@=0U6U]A,=UK9=]_15\A"$-^ MFPI!';:7EU`2YYJ:3(G$]K*S2+\O*$50BEVK'D*/>PL6@9BLB3.ALTK<:P]M M03QOM&-S_$RJ9C94O..RTO M3K:U^8JEPT[9"8^M[+BZYNSU%J^`P=I3"74&Z%*"5@BV7'=[,YL"O(2SXCLL MGYA*8EIY(E139\7#^C7/"V3LQ<:.5N$KVEW0GY`^0/;56'@%;`21FU%3AS MNVF?RM21OJ!?&J@%U=?W",D^OTV/D.\SDE=48R2+Q\ZQ0\G6=T!" M]S$#'&2I?0:XU[0^+7N7'!ROQ>M&.2:SQDZ>K`7O:8*B#L.ADH7,L47[RB%B M0L1L1<1LV5NZ(9.$:@YDE,R<"]O6'EK.#H5ELI.W96^C!T4(;^ULC2JLHHZB M)9'HSR=MQQG/I?/NHY!8Y=$.OD]6$^R:\P7RO^_S`#DX>*1PB?"#[UF1&=X1 M'7-`I8S;'3%J_>VC2P]NM;[LWI]B_]4V=Y+P,P[G*VPK$?)`D#BOLXCH%J:$BKZH49^F1)5 MBHDZVMYT^UGZ&]BU-MI*^U0OC;K\9\]`7:!N)_-C_J,NR.@NLY@9&0VQ&`@-A&X1H5F) MT/P7ND!<=X[%S8IK*&G!XA,PN86+3RR([,-6KDD4$&0$@6+^'=F!3>=G2Y^O M$0Y"T_,?B"-<(!-'H6TB)[AUS0_YW5QW-GJ.3Q50'10$VWL1!(2V.R-&(W\* M"#,2+!3J"C-\_'=$D+[:^3'^*/WCDSD>#X[%14T-IU/)/) MLYR(80JG&$KIDG[Z*D%L?V*GIU+DNMX!YX= MA+[]'(6>GY.:\4!,8NF/!Y9>9WUYIJXP]\U)Q?.FJI8L/-YV=W:J.Q9@4\M, M0%6@*E"5BP6D/*JJD8^FIF\O0R*U@*35D#3#R$!/B*0%(BG0$^C917JR$CW/ MT1/YENTBYS>,G'">43<"CI;%T1Q+`U&!J$5D+A`5B-IIHG(B>)4%N6G@1;Z) M)]B?8:@A54_9\S8'\D*4+1!E@;Q`7B`OBY'WL"LBM?J\_>-O!*/(-^>K._R* MG>Q6A%MW&85!?(%0J+6AJR\@/&'5C&7]8[-6VV;`T3L1&SR/\<)WR5Q+)/'@ MEITZ][?>-\A@7Y3;S4/D,K- MNH^-4I:+JK!+FD.W=0IAJAL\S0FYE[$9@NU,\`"L0K.=-\`..JB2:Q<2U"ZJ M4&L2U"YJKUU`)8]5-D`ECYD*PY5O5BF+4/`RE7I>IL(*5;OT_I2B#*00R'C= MXHDWT-;"OK:^=_:TN3O+O2;?,UL'^R`W8E4-0FY4/QLN*WI/H^<@WGT?AIZA M*RXR=R3 MFJZA=93AD==%)[=5(Y M0:58E6S;\6;8+G)-&SF/.(BW/%W#%27E(FAZ93'V%E0Q3[-?9RY;`XM0A44I4\;N[.ZM5WM01=4]S;9 MS']AWZ/_:^UR3+&1=BL(KYO\E6@F";!>R^AZ+<')Z$82JG(0L`/M&"&P`XUI MMY5^T6/U9P^FWTOXR?.LX`L.S]^K2Z&P*QDM'6\E088"R*90XIR M$F.AZ`1%)R`K*_'T3-$)!#$(8B`PQR4IB+80;8&LK$CC^MY.#FSEZ/WD0%UD/P:'?8G[,U\M)S3SNL]-NJ?=84?RL1A;#?D][^NQ_SQ M5B\+C[DFVY%B9[-JD=?(*Y\"S[&MF&"WQ`[[Y[7>DF_[Z^'HCKVPW91SX@$_ M*:>3,<[=#)\<:`?=C0SNIE/NIHJWD*3J-@7=S?TR/IG`G4V3(7&XD_FN9&LAQ0SM5SNT<;"VU<%^]_CODJ,M(G+Y^GO$_ORAIN#@TQO`SXR^ M8S$KM:13T-=L\3>X@.[B$<)GRS?'3Q^YJLQ-V<]VV9O') M\9[I83D6#?"W"S0C-VL?PJZ)9]6HKEQ8^'J M$W;)\YH!.FQB$"21G;"1G MK`3VQCP?!/8V!W96O%\INK7KX`3-!]#HE->HNY@#%CR844O-K;"#;ZRK;Z2%6C+X"O; MX2M9";YY+;9'W?J;UOYO4RXQ[5FP>7_YV8DJI.L@:7@=]>6%(`*_;-.V%0SB?&^X8W!7'7$B_B/T` M`_`&H`LZXAF*BWW``W^)P.$+J4'R\7;@1O$9A+#-QXR>6M*"2>U4M;XP#"#V M=@$2Q;48N`4^]-=%)`<)UB8B%Q-MX-A;(>#>V$+RX'M69(;W_A3[K[:Y.[3T MMY7E>Z9G>2Y6'FYABUKMK2=9,Y/`.FMJROI5+C;&L>!HR]_WF4O%6]=;H)_0 M^\4,`=,3T@3Q.KX;OR;:?<;A?.4LY]BE]\;ZXV^JL^_R(!XR0O[S8_@*_`O&8 M(=[^E`#U.*?>>2I]B4P'(Q_VW%>&["P+=Q#8-655$%,@IK`24UC)HFI:>0/J M`?58H1XK*VUUU1(_/'Q0S'"._$_8`?XQP[^,>>D0"5F)?W65,WZNH)S/(@N/ M)Z93Q?R.98#0=<(8_3K:=<)*]*NK\`+1CTWZ=3SZL4+#ND0H;1U??PK=7DSQ M\'AF.D7$CLG0O>D608ZRR4,19&F[%R6@M8LQ^G6TM:MC"Q(@0UGE7]=E*"OQ MK\Y\D![/['N.@ZUI]$RW\YH82,D<*?-GJ5,$;6>>")V8G>_$[&+D@0((H\&F MNP405N)+75V9L"['*`V[O2['2D&D+AI"-&24AMV.AJS0L,ZZ))1#>.`DE$.8 MRAJ;B)-`2M9(V>&%`U8B94U$A%/$..$EG"+699K"SC\V6=GMG7^LD+"FI0XX MRH]='G;]*+]V+G?`U&RIO4] MJ%IRPE&H6G9YE0_.:&&,CAT]HZ5CT1$VPS)&NXYNAF4EVEU&NUOR;7]M`-VQ M%[8;7]@^.IP<:`=AL'U13/^;%9/[99 M<7?4CVU61=02N+'9I2YYUN`&:)$;FR6XN4@JI+E<(L[X ML9F\S[4B.),J2GXYLAGE9O.2M,]1#+ATC3#!9:DVNXU5O/#%>Z5Z<2O5'[%# M[FP]D`=:/9%4.$`F5;#!9)7^9%L'4;U7V[*Q^^"8_*GYXF--:@1'@ZU6T=LN M7:,+$STO"#=2;VN']2=OXLQMH@'^LK#]UQV>(4>/'VHOCY= M,R3#1[Z-.:IWD=%]/!C=+ET[/;S:9O=`K90RNZDVG%,3O)?0IC+6MLSPF?%U ML"VD`"B(VR/C4[W%$KFKE@`A8TPP^5F3O_6#J]L@B+#?DOG/'A9``*)^K5&? M.4@448$0#]C7>[=)U0#FL<9Y/*ADU):508CFB97G9A-2,+[G]YS7!37%LR\^ M-[O`WG;/+\1:7F8SU;T&$UI_?8.5SK0"$(`\J,.3#W(,(`$:KJ%%,!9`D30^ M0,[6?,YVT'5X$)(7V1GU&CF.[ MYG??L\*'.?(7R,11:)O(">([(]>Z=4TZW%?\X"`.C^[(,4&RL^\--J@-.WVZ M!U`8E^X):!5N@Y,_D!/%8D1Q'.]'?$"HXEJ/.,#^*PZVL,F__/Y%PR_8]['U MA'XJ08!#CN+!!BK%K+!S*A>8@?LJW\'1WA<"9GN5X?F:%SV'+Y&CF*87N5W` MR?G1UY@.LK#Y).,D*?!`7'L@YBH.&6?:`<3:`S%6&DKDZT44Q,0F8V)-+>8E M8&.*'!P\XC#R>2J%EH&+XY%SC8FWAR2`11.P8#+PB)"]MT78U%#U[0-:6HB6 MJLZ/*B](@:YMM-;#0K!Z>ZT'`,4,H%BI[+RM&@TAC:V0UL+Z-&1JC6=J+/BJ M-V9J$/D8*1%6E9>]80T>L,$(-JK:)?6&\C$('+8$3@V+#25Y$M`J#2PV5.5! M2E(>@(D&,%&%XBBWCPM@T4A:PT)^_,8E!4!1P\ZERB-/(9WA.YTI"1N1:R?` MT+\]_O6@/_X5S)&/@[U)M.Q78O>]!Z%?^Q(MZ#N(O;WW_=H?%Q@%D8]_M0-/ M%H7A1W+CS<]O/MHS1L:M4C^B8=>+=^#E_%HOTVUC*(S>\9XQ>?2MUW37B(G?S(V5UPQ`]1_^,@, M"*>R^_M%5??U[DSG2CI$)T@D6U@N&@V;MU^'[$+WM9XOM$V9$;WPCJ M8#P:#0U=5L8]8SP:#'5='(BJ.IDH_;[4>__K"W+H!!_=?/N3:N33S=*&'9C( M^1,C7T]2D0*_+HY4<3#6>YJJ#W15[4NCOI3\NJ))ACI^_^O-1K6<^J7MHVB> M&2VV5SS$5P$%`-)[_\*K`#ZM#41J- MY<%D)"D3S1`$M3_:($!3Y.%^?I'[2X?/X2T6GAMO.(V52'`?A51Z6[:[3]#U MQM_W[RQLV@O".O)77XSTO,B]_G"@J,)(DO3Q2-6TH;@VC-$?]\DWJ2N([[71 MAX+0'\O#GBSO/>^))SI\^(1QCWCI^2'Y>!JBL!B;1'ULD&?3-6V@]OHC>:P, MU\\Z[HNB_O[7/ZF\.?=+!X]CV`[V58*MF><7F='16))ZXY$T4!5I/!B/QQ-C M8S$RPQIATQWR9_@=2Z.)$E1>_WUWZ7_+W8-U)S&6<00E^0!W*/_B?];*G? M/WBR1SRS@Y`>=_`%+8K03E44132DD:R/AY/^T!`,?8M^8Z`0]*?W4[];.F;Z M0?9_[N!9_O`BZVDK,"BKA"21(FNB3VM7Y/'V#_3D(TJSZ6KQ[#D%'F#2&XS$B3XR#/*YUA^KLK1&L#J<3/K$$)^_ MK'WAWJWC'XQWPB\HG_XGSJ$T$BC(+]INA*W[)<4[3:R.G^*@1>;6-;T%IH3$ MU-=.D$,K&M,YQJ'B6HIEV?0^R*&W=SPJ3X+)BOS+T@N0\\GWHF5`;N%$].FR M'R'U^F'J2H/P,[9L1#R2AAW[%?NKZ2H@/[XI&.612A'&LB(1BO3ER6@\'`Y5 M;2`.Q?&0X$B2)Y-#4@W[:T(5,]2;;"KS:E-BR^%8E$>2JO:("Y)5HQ_;=$*, MJQE'CJI.F_9YM>E@H$HT9"L]K=^?&+(FRM2FO4E?48?2X-"FHO1VF]Z_W+KT MG`P2PZ8A7GY;/GFJ%X3W+W&Y^E*\WGE)5>;@H*_M_F2F!`Y1/3LW^S8PF):B!J*(6G26->,GC89CF@D7T=PHD]'!_YK M5RX4Y`\I*U]FLE*-+2O13)`+&?MKA(/0]/Q<:^<9:=@GZ;=(!'M?4'3%$/N] MP5IE:((^T.0\(TF],HV4G+:6I"3I6_S;=IR#V^S9*7%7HK+T;:=?OJ&DM$@F M.;%,DBI![(U)'B/+)`/;H$DD?Y.1@O4^$"ER8*,+1KHUTV8\Y,O/ZQ,&J:V) M]O\1AP%RY\?#_#X1<\*]&0K%V.H&3W,21I:Q1:@]#EA*<]P7FPP1WY%GM&Z) MYG9G]K.#DYZKR>HS^F_/5QT4!'L.\=9]\#V3_"I=*D.^.5=HS'S%CK>D)#^- M3J4W&9/$NZ?IZI`6B51#W8AP@^1VHY31-ZL7O0]2/[%Y0;.]VL4\^,DD M-U0-?:#(DDS$F#C6!6V3%I$(HF5:0I!Z=9NB3)^UO8MQ`>X2C;98.IBD]$_8 MG+N>X\U6IZTKD"R3A%Q:`Y2&X]%0'0X&&YR1?**7;5VY=J`U;MVMS(F"D&@A M_Q$[B?*ZA^#-=VA6CQ?( M_W[&L.I$-(:2(&GB6!;&@PGQ$-+&L#U%G;3:L+6%)6FO3&[T)T-UH!N]@4&R M8WDTWH8E92R)V18?U&SQ_E=[=F<&^9T5F>.]/L?]J MF[O#*V]=;X%^GC:\J(XFDC86^P-9T2=:;S+I:SI)D8V!W!<,06+#3]=M^$L= M1F](!,-DJ(U$HS>1Q\01ZWUB14&42/JICW+@RZ,5*_4.YR']A'W'7A*E3Q[[ M])2,AA-C."`0%@U9D$5-D0R%3HD\$?2Q8@C94S*LW:/(4ZW0;,2YQ'_WAZ)2_200(65; MZV(>8;,;)#M;ON#P/DZO*TGQ$)+RX=/7 M-'$XGM`D7I3[_;ZNCR5=GXB#`='Q(_4(/L)P(#%FE>NB0JY)9'E(-'6OWQ-5 MK4]()$_$(36)I&F*/A:/%O/&PY'<@$6FV+4]$G?,B&X^Q/[BSD,N&8#MV&%R M)KT5>NN:Y^:V37%/&>K"6--ZO?%`ER>Z(HC*MGQ$I+-\M);7ZUWIHZZQRO76 M_^8&R2]]\4(<,&9T>309RVI/584A,?^(_&&P3I'U),T\?T#V=7R$HJEB#;I]LM\&1U9Z/G&#F'NC#S0?/O\SEIGHQ[YOSX MW0'F_DLRMM>FKJ0K&)'ODQ\Z,]%Z;S0FSFJD$@&@]\T"H>V-F)S+G+9+7WOHDOWBOR0SN@WT>N1;O8SE%"'?0- M59H8&K&8*LJ]R:;54AU/1OKH>/GW/"/.#Y^U>8!%ZU&BA[3B&IBC+I4^N M<,[8T#!H`Y+1'VK*0-('BJ;VM:T-Q\,C'=68#1\\VBYO;^^1U2>7_>H::JR) M[?V!S=!'QVM1U;CKOJ:(>D\3""Y').GN#XVA.A`F?5T0#)**I[$9-X3+!;QU M$;-49MFW@[,X*$<:;0M2-5DBX-0,VJ2V`>5$T/9RYS>!\A+CZ00=M.?5?<5^ M$'\W"-,?_UQB$C&K#6KY,8/$!EDP!CU-[X]Z\D20Y'5W@JI*_?%QUW4;/-(;N9'9AC1&*W.:4/ON=QB9.A&;SCJ]57R)Y*-&J*^;>M4C;Y^ M9/816/W`ZE-,FX%GG[!+..G$_74+VXU[@.G[E-8/?&XB#(&(85D<#0?$QTPF MNB"/1QO\TVZHPXD8]095SP21>][,M?\'6[?KO<-H6YYC26TH>BC#30G.I%8QWG;L(46KJ=X*BK: M4!WK`V.DBH9*Q-=@LDF1C9ZB'V5.PNB,;.#4UK74(R:&I$BB-%)IW^EX,#3( MOVR,+0C"45U-',IG*HU<6KN**JX\4E2E+P\FXXDVF6B2I@Q'AC'IC41=D,31 M45^W0'N^^31MZF_N/'=&2WP:?CZ3@EP9^$;IY0/5&!KR4*-P)>%NU#-&NBZJ MP[[>E^AZPJ&)I;/5M+)-T)BYRT1UVN2J1#)B=:`/Y8D\&0[4X5B=&(:BR0/: M?3$1CMDDZ*JF"R/A*,'IW"34HA4-49!ZAJA)8UF0 M^\0=#31MT_NA#,2LKH8SE9)6SD856K)OC"1YTI?IDA(A`8FI(R7N"!AJXZ'> M.RI1-61R=7U^3X0<9W7_[-@SNHG>B,+(QW'W'+:"%]];T$UH]R_K/BW[=?WS M&6NR@H;-GG`C[9Q[;G/7_<_5PO.7<\_%^N,9<_8DA2AQ45!UN2]-AIIFR,8Z MZQF,-".CT)3"\=L&F;*5O_3H(0/(M>C!<":]RZ90=G87-K6_Y]A6;/];NLOT M8,OA^N9?/'>]=>Y(GAR-->. M6:YXS$-!H/N71T3&JI(VU(:2/M[`0,MP:*(X$JH>\_$B8KEC5L6),!8$8SR6 MAG3CL2I+RF;,/44XTN\D41U?/N;D^(Y;,C;?3+:W/:`5=33!L5@FLYR_(D(F MA@:;B=SOC]4!+09M*L)TX\C1NN;F*?-__^IGS%R4S)PFW;$7:V][3MD/)X8X MZ?=&HB8,>S(9DMQ;;X!11[V!?%3KNI'&Z?:WVL=)8/8I0O1@#\^GBX*V99/H M=;:P3_)%7>D3BDF:(=%]>@-]LQ(XFBC"L7*0^DV.\@'Y\1IC?)MS?E-4A;$X M,8:R(HO:<""K\F8&-5DWCF9P?_-Z[4/;3EK2=^6?*WOW>T9/F4PD51N0T1C# MP4C:\&_T'/;*O42YT9ZI9Z1!,' M32-Q5]EZQ,'D"&SG544=H[W2:RB$2`I12X*H]`U5':JZ/MQ,J4%\Y,4!N(ZQ M7N(Z=&DHZ\/11.@;NBP:RD`8;`Z'&VF]049F]O_9N[;E-HXD^R_S/AN5=:^7 MB:CKC#=L+]>R=V(?,61+@D4!#!"4K?WZS6R@08#50*-!@"(5\^"P98)0YB#9\Q8B6Z(I^, M%%(J7[JZWBR$K9Z<+K[2BU@0P0NS$1UQP@2Y!)63[^C_@H!8V9,O_+WZX<2WT"#JW[.'$?X9F_O^KH\(M->KM^TJTDJZVXJ^MG0'D$?93$Z"CPEX@L2V4+'JYU%D/T] MS/OVR#%8[('QE^9N_7JPY[#L]%.J(>`\;@[5MC6M`#@&O?:AX*Y]?SG,,A64 M5Y*99)C`?$W&Y'Q@,A>G!!$EY![,X#\8]"'6)_9;0"@,4>G97&*Q2AEB+T9' M&5<(&2XP\8C]"+&704AN7:$?`$=L@?.,C;-[W/!D<699+`&C=H^N$[`:M5<2S%W,[MO2VS!?TOT,S:]Y/ MGS)R//5TB5@?FYOUA^GW[K=&?_3\=!?(^:*9?IA=K48`KWY[YU>&RH200@YP=4O1I``SW$1>6"B5P&\(;9S7M&*5!S M)=@7PS,UD^7']>_,9YA9/BQH]$Q7-SRR9$%*9:-'MX$!IDD13^-`3J].J$*\DD]I:G?'(\-RI5D/M)T$:\=(2TW7]]J0\_V%" M,[2?JVQ;,IH(&UQ40=-=*IJ!3MG%Q@H/:YTXS]#"X-?)G^U7;#\.MF1KJ\'"ZZ?#D<7-H+1B7CN4#SU" M2%12SQ,KPGC<^]4%BNZ1\[AUG4V<0XJ+PAI3=`Y>ZU(L$*G_AKW#Z\I0V3XS M=1EY?I[/KD_14*2L7D8KO7<97;+'G'XMDDRFI^-)]GF9HQ=W3K$.:LI*!RX4 M*(!'3(&PHB.\R4'(2BS%^ZS,\\6ZS[,OT\5\1E'IY'8K.!RG)2,E>D(=L[)> M,*EDTEUU>;))U//#=FHWCE[4.<0X6,=LB:Z>`>I$!Y`,4MG4,2L3Z_10'#(( MIXCQYQUU?ZT[ED;J(&5<9+9&:Q&8U9)W6RJFK'U5*"Y<7WR[9RFG+_F@HW&, MR#AY1N.;7*#1QAN\`S-U)XSNBS)&+[DTU#:'+NFFI53J0I'WOZ'_62S1'^$G MK^:K)L%[_%17I##2MW@5=^9=$UW8@6?7'340L[ESB'-`="*I4\73P(GVQ0P&$CCO!5G65' ME'M6<6C4P^)+0ZHDHM4'7.8OS;]0\]T/QJG(A1!8H(H)#X[2@34-BH!B+NG3 MT]D_/\ZIT_B/67.S7=,ZMO-!8&#!C<*E!IUD%%W17,Q&Q)I3WL$>=S=NE9>0 M\Y#V&+<9BL;<`XJB<-QQLSECUM8ANS7NW'(^N?CZN5G^-ELTDUOJNO\[99P_ MSN_O'[/2P<;G^BO#U\VOKV?14Z-^5S&Q^5F5V.Z_=7_F1?ZATFJTWJC*7-ZN'K+U!7,[06&!SS8%TL):#Q[QKFNC M^:7TL%LS.O^]N5YN?K[F4QAD57K>Y?-O-')H%RMD2OT328V`?=`>A\^1`/\Z1[>S)>.!6.Q5 M@LNHVW\ M:[/X:;*\_D@DPUL_7\WT'30D_H_)XJ8JZ5Y_8DA.2"*C$VB">=*E MY"*LBE:%8J"FA=[!_-E`7E0G;]6Z.`9,N.!*YEZKR+(6J=6)QCA"U1F@W&E< M?>5*>:O6"0HO'@P$KRT+3AJI'"G%O65K)3%>-,+* MZ"*1:!*;%D@NF4TBYE"7*ROI3M3#!KPS(_]6;5+2$K,6!I&)6#1H@XD,(:^4 MLTGZJJY#.F5?%_)OU?"PY'T.$:B0D4)X[:(AY%FRLH127TV#^#;(/S%>/WR^ MFTP7]2"GMVQ_DG,<8_G,K,E>'&MO%7;Y$)4 M'+0LQ=T^?'C_);^'OSYP41O M/[N.\"X*QPMC&IR)X+N9M%'Y5,\Q7$M[XO+.+YX\+%[F$C_E:7)@2E5#J6Y((IZ&-+\$YXM7YJ#,8GM8\+[CSBS=_G/Z\_3F8? M&OKM..^=&/COH;5['#0P;XQ"!Z`2)](Q8G)8EW`F7P\>UZ;:GD?A_ZBS^R6N M8]GLKZ+[';K$U].^6ON1JLEANER!N8'[7 MW$W6`TP_+)H6DS]P)\7YE^G-M'D*]YYO0P>P_9,M':Z^Y>IV:)8$*)95-!F] MKOC>G]C=YZ,X7B-EBM%']86'W^U>KS9VJ1J`V'"0.MAB1K,!X.R6>+2^/<]?Q$,(>'/C9 M"5T9ANM6+`9C]&/0+ M#62KN=Q<,F$VB'D\2H/98$2EJ:IFXD55-(8SU6B6 MI.9.^V2=E44Z834D#-L#)D-Z'[W+I448R8JJ1)`,E:%E23*SU6`?2#08.D59 M][F<0XJ!>Q`P//M@4T[".:++P_.\CD*L%?4USRX9S!E6=I%3+"$FI:(+RB3@ M)C*5N[!6<%;/B'XA<4X\Q2:BE0454!SE#/?*;GC5!E@!&O5ET7I\!#4=FC%Q)AY#$6/%FB'M4.E%`2_W&\:XA1WN]+FLXAQ5EG MKW$+QC(CJ6-0&.IUWXQ@8.@=JJ=0`'.N?35P;YDMGET=%1JDB.&0@\=[2Q%< MKGL8U7D7=A&CA*)X`5H5X""`)9\[4^NS$.(BUO\(<4XU2L[R[$I!-\$`_Z(2 M>=>YC">CKNUY416-L4DJ)PTQ2N82S95%.QL[08)*=1C[0B*,M$G:):X]8HQQ MD0E)!]VED($%Q?8-0S@@1;7*1 M;&7PI\FM[?3V?4G-+/X]WQZA/]QVV`8K8#VB)0L M,/1KMKN^,05/^5_^=@7F?]YO8C M,K>48[#>.:;0#[,@77+F\>J)[]ORIZSM(H)=;B8CN*BC*-X'80,$P:/NM*J$ M-?L"QU>`S.![9S#2%[ZB$$-CI^/CL$E6*L%`P7;_]:L1\"*>.>GLI>.>"=2V M`8RO0\#XIX0LC=BW`<38\2Y6F)$B"`T-DQZWM'$A)]?RBO[[:<_/FZK,TZ.B404>7(12: MA%%,$9Y[#.R5J0_HD^JY5X#\0%;,*.?RED5N4W3.*JG7MR>!%Z%?L06Z]"AM MRJ1ECAQMM#3,EJCM(P6[-?M*\YZ'3'LNJ-6Z+.:?5^4U#_C1K7V]7+V#T]"J M]HGV,\I#':54-]4LQL?MN)%3"IY*@8(*G`K739'"@L[,Q%Q=G^U0$CY_O1<5 M?2!^=9AD:<>C2YXR=90\:13=."U5";RZI_XKR)WJ\5'WV/-S[WM#'$H))/7V.RY85EFU^]YA#.;K M"0N*Z;W2G[;D"\L_L/FM22$[&4,V.F6,Q"'*=O-;F@?)Z[G38'9:2M\``@,' MP!A+5Z8V>96`A>1!^_8`&'3SO&:T!"TO*S_5Q&XF$D[67%:GD(7E:)(VN(MU MEL$R:6T,W:TPS_5,<=-CU`\LYCG+/D3N(Y/R5H.`2%='UN,)[5@&\9CVI(>2 MG[SN13.Y;U+3_7M#"[1RVD_HG/JV%OSWN0J*#]ROL,2D2DR5PC#XU!$-L.'@ MLRDJYNHMA2NQ"\ MU4S]JCGZFG-#[F948]=W?LF.TNX/GR:+Z63H@!L,06G^MXN83=J`1UPC%)AT M<"-4/;57.>W>(!9'[G2C?<90A-JAP#H>`I,=?V)$;U8_T)ZTTT]$`S.WAUMJ M=B!O_\1R;I5//PNG.+EI9M?-"8["&(E9C-11EQQ2%HY;AFB&4C``R'4DPY0< MB=R1\N_%=#T0`K^2:DAG]QV[*IKD7^=;8(QW&YHG%]$SO MFYH]YI"9.2C@7ECPPVLH__-A,;V_F5YWY:-I^A[W&^W\4Y(8%U7A64N=.)>! M*0`3)3BO2P\/,HA#@AVSQ#/+-]1KYS.*8FDOXYXV(FB1P`2K0(*-K"(X!FX/ M.1O,^71&BXB!@L!"M'-8`1+0R?0_8(-*_[">J:-&2-ANZAG MRS"@)0"&2:(\-TUA=O#9-<'[H`$D!Y MH@Y"XBX+@G%9G:+HG<4]J]U)'.A/8X:@]B:$:4B%X[73(42ML1K5-2>N0%44P@-HC*4 M4J;A4-IV)Z1DM\RX47NS2#U!/&QF7\!+AL6-0D0(GK@!TV4%A%-$4^*-$Z"U M>CL(L]>8'0=V35<`9##"]M(?GR#J[DOV&3MC)!:LZM2S*"=VZS4:5] M0KHMY`./NN-W*F=-?:M!164RAQM?Y^:$8L9@X;`P"ZO,O,[<[RB^=&=BC`"5@G8ZE2 M'@Z-,(&G,O69B[R[2J0?,?NI9-4N$@5^<)2&1299]+E]EG.TBL_/"/%$2Y%R MRC%ZB%&C$^`8P?8R*UXJ4;O+I,^S],PUIMS99%FD@0?J`B')E8F;<+!TJNZR M-V='U]%29&^]XXKG*+B-)`?%2Y<[=U[M8A5[=F2'4@$\,9>53<*J+.':E;'M MIA&2[1I-WI.8O5@*!59"IJRC)"TL`@W$_4&YE%$*7#,!K^7+8")Q&OIDIU#C^$\S9:Y<".4<-X!H,&&T\G MGP1G-!XCY:8$3Q"R%T-!@K,L8)$I24GC@#4D
?;5=XFFX%Q(#>)3?N?<1@I6GN" MCS.P(2DSB%6J=7[?,#>6Q65-6"&!74,%/1\N-?5D%O#YJSR]2M[RA,MFY/5X M8>^:&&OUIKGVN;D^WO+F92(*]4K*=WN+?+6G1,JFSNWT2O?H3=[Y09Q M?N4Z#5V/XJ&JIT7%\]9'WLZ1!]0XL6E&KYV&AJJB5+A<)X"$&;/GLF:R464I M%<,$!IW\H0M=:$5%@Z20U^=<:+"\>%+SR\P07]Z2P)!H4S`K<](VDU:=50:F M%*L+IV3NY2F9C(DXJ<6)]),*9Q_6LD+E(122?X'(G?A)B:_S/O+T-HO`4F@( MC25JINQXG+!L[3HC;2V%:K5)$B524^9'RKY1)(@ MW\5C&A/S,%'].)#;,=Q')/:T?*+/@OQN_T'PDGMBXD2)S6FI4GORN"F95BD' M2IO@K3H@RJM-(\N('.8&*\NC+!W433P:7>AF;*:9A1QH->*0SY;=\TY1_I1J M)UM6%>R4W4+29R\^+%.FR6B($,*TU8DL6BJU`S43)AN-VE))I&KV6#F#4N(O M?QF>=8_+/;XOZR656_2EG(HF66FF19G(F6^2[1,6ESZ`S6<6^521%'^9R?TI M\Q[2$XK),JLR.:EYFS%=)KP*G,>IN+Y'G%04EZH(9:JI0Q'8 M'"#-10Z"6]/3%)?R-XCEAA0;Z32B3'*JMD-QI,26/!6G5:&2IHG4"E4<0[*/ MN'4L&HKEA)JPMC2E5!YV&/,)R_`1.:EEWH3S,/60ELHVQ5YRB#`]GJM&K9P_ M1=A5*C1/34WJ=,'R7)/;.-$,U#4^D*OGWR=79"JML[!&88X\RKG):*F.$+-D M9RRMU6J3V7[)BLFSU/VI](Q*5Y?/\G@)T9RM&LM M0R$R2Y#64"D[6:4@)U$DKZ0#U%7F6.7D3LKF!`UI?_..-+4ZK*C901E43ZK` M'!$7RDE([C*3U.UGJ+9>NGI3X^,%RTU[P&2#"([K%.RT;,=PT6#+JHX_$@_* MZB$4$NB3A%D^0V@G1X13ML_,,]D72YIRC!1=H4\]HE!I([$[[IW4>-0")<<5 MW7P8U1;CI.6(JWUZ3C&G14XTA.0PYL='N2QD4ZZH24P5H>#OU#Z++&KL2Y:1 MO)^^-S>6L1\$4A*%V4N5T<;QQH5CUD5[/7%\N\8E/SC5-,6:N-G3TL3LY<#0 M$R8\%T'(14L*`9)$BA23^`M").&E13G[>#SC:8C2XD,*R#5D2[9`679:OWH<3Y,G29HII[X^ M$DW((2B;8T*>1[=1R=P(IZRMGZ+4FJAX8@L_.P]B9N?JM#&,[?MF;-\_6B/B M<6.QI!*)1R>=X[-1Y_2TG&*ARY,DJXT]#BE<2&@P$K)R*+M:Q;_TNH->2?FZ M25M[\L8F;*)E2U0(LFN+4PGZ3B[J(6WP1\6!EK'I\:]$77%07YB!)W7WHWIN M1;:&W-^11VUYGRF8NW%C#W6J/@_7@4/:RS7O%PYODA/M>WQD4F[KL8N3G)`, M1%K++.-*O<64,WG8SP]DL$QO&L4A.U7)4:.E"&;>"TUE-8$'*Z&'OKI44U>[;&N9)[N\N5FM)!Z M%ZI1:<:1T[SAO749Y3C+3W7U1'(YHDZ833_9\LEN^I4]SM79'!5G>XHB7!/H,1(DBYJ.LGAK8LQI>U3O M>*4G7_.M^AS[K9/V8,COC13V>`O68=?X+"*]"[J0P5+DT]5^0B!T/=A4Y$E[ M-"Q<]`@/USWI:B\RQCZHH,7_T/2:J6N*J=FJDH*J"Z`VY]+BFJ9Q<#1X>S0D ME(L?!VI'5BA[1^]HN'Q8]T-`,)$[:*G@Z1H?]K;+Z`9#+K%J?-TV6;AH9W). M2V72'`TD'\FF5J[,Q4V#36D?C\X>=Z=]';[9X:A+XJQ`<%K;DJ&I&4!3L2? M%'Y*B>JP*_^H-R0S6WW8ZZB:)G4WE+:W\AZO>+E^*CT^,-I_^+L_75Z=7)[4M?EF1 MC7LA0_V\`<%_Y$C;?(LW=0=#M5<@_31]"-$6,O],IG2-3>]'(3>`$Y-$H++4 MS#FG2LB*QVEOM"0E.CM!GL6^V,!6^0R^F]0!DCLHOORO3A_B,$_@W,KSZS,S MXO..#TMY21-=/D;G_/F!X3YHX)[)5V[0.[5JP*@)1Y<)=>U^3FLWO M53[*%]6/E/=Q/IA.\`\.CQ*RR9\^EYN=])H/W#C*OB&71Z^.W^IK2F>)&#IF4*C,G\M53!*% M_&QE.L;<-0O;SS*UE+E:)YUQM/?62ZHL/QT@29(5O3`))!&JHD!$^BAN.@)^ M:5K;6NK#26/M_UT;T^788T\7E4*UYFJJ-?>/7UBN^6BX9;WF_K9UGG?\OEW? MA_G58YSUGM]F]6Q4K>T2:G.O5:,G)U>YE`5GP+R;.C;)TG+=OO7J7A2)G0[W MY.!I6FD!JRG1G_\TI(EA)!IQ&UJN%+6K*YE;LD)J;MZGVY'K]-%*YE^U4:2- MXZ?=J74*!X')P&1+3%:TMC?E-4BY%S+@\!48<)F6^BW24%YZ1:WX=:4/]JJ" M<'W:@4GWATF776YHZY;P8=U8K6;R$*S67E9;6ZIM91>.TY9$;W5PT[*$F$Q> M@3$?CU"^E*S+!5(OTD(9R]'VIV.NV_+N#NGOWN"20`)``DP+Y*@$%WN28#!``$ M``3`G@B`87<``5!"`*%&<:SJ`'*CRB;*&IW;Q+$&NXQC;;"!63:J1MW2-L8? M)4E;T-8@8-5.#^\=L(ZZ?0`+P`*PR@96#\`"L``L`*MQCE>;_*OKI"QY50Y6 MP\#3/RG/D6H+2.J'A^8JF:;!X:Q[##@`#H"#@D/W#&@`&H`&>=N@/$>C+6C` M1LYCS'*5-*M,6Q-P;BC\^*?\^-),K];[\0V"6'/5$X`%8`%8`-:CP%)4.AWT M!]7S%P`&@`%@`!BV>)YC&MD^/.#BW(>WIN.],5P_K,3Q:AB8#DO,F5M>^\:D M(+]!I`^1OF=XY+B'0QN``^"`P#?0`#0LA=.0,5.&SU$C3[\Z:S,IN2R;@ICV MS/%D0UQN%&:(G]P9182R^2S"`$]X+H/^#G(\X=/4"I/-U6=M@EUI^3^`'6`' MV*T%NR%0!]0!=4!=(U&W]_M/W+;4"$44N;+K#K:>V)(#M`\@JA]>FJNA MFH:5_@FP`JP`*Z^3']26D#Q0`50`%:4X)S6*$U2G;C^+R(@"TPLG(C`<[Z^' M?AR]66YCCX@!CE4@Z[N>:JHMP$+6-P`&@`%@`!@`!H#M"\#V?M_H(@X"X5D/ MR@US93,Q1#-^.^R?EK7FR@`J@TF*H($@.5``50$6U_LEZ M#FV_X9[+L^V0A6>7W0AY[`>V"!+J].<_C=!W'=OXEY[\MQ7P'ETM_3*^=?E- M]5B#TCJK/4?89UGZ*0)70,?2.TN=#4OL+;4M,7?`<:\O4A%3W=X"@7"$<-R] M<"RUHSV$(X0CA".$8VN$XZ"\3K^0C9"-D(V0C2V2C:55U(-L+#U.^?IR<2KD M8_HG])Q7EY'IT(<5A/>7Z;8^7S:-D&`Z,!V8KL:T`M.!Z"XAD3XJHO*?S"=P+@SW5AP5F'.HN- M.V0=G75/@"P@"\AJ@($(@`%@`!@`UOIS'-5Y8%>SN>L_""(A_18XXUB6DZD" M9@U#4W^(C0T$-%&S+-GH*Z\\+-``-#0<#26VL04:@`:@H6UHP);/,PZ'J-[A M:(M?CQ9H")C52CT!6``6@`5@(1(-@`%@`%@S`+;W6SWO5=N`T#`]VS#MF>,Y M8128D7,G#/%S+KQ0A,;<=&R$-'X['/31Y.D639X0_EL/*^@="*P`*VM@I<18 M.:`"J``J@,I+_)L:114J[)S&AXI"$46NF`D/)XN>-N9*+.GQ+%':C,<&0:^Y M.JTUL.N?`':`'6"W6]@ACHZ-*@`,`*L5P/9^H^HB#@+A60]&%)A>Z,H.UY6` MK((^7*]L0Y:V9[4N;?;9E(1"VU^LG0)J@!J@UE`3\AD*M<62!*J`*J"J%O[9 M>@Y]O^&>VY,]`X1GUZ%;0,7Q@]J4#GU)L^.:U!0=#4_*RP%H?=P(@=GMS0!( MF3V6,F5V,8&4@92!E(&4P4X89`UD#60-9$U#9,W>[[I_H+45/%\SBJN*UQ1# MA,/Y3\/VX[$K7A1%7;_S?`N$T[H$W#&]2M]?/3HJT2=;EV@;[;`V@.VP_;HC M>PIR#7)M/;EV/.J>0JY!KD&NU9G!(-[8*@=W(")CZZ3L/XCL1YKWK6S_^[?_] MW__SK^F+_-G,B61!`;KU@B9'"R,\RQ'AI1-:KA_&07:K+'=-'[Z)R>\''RX' MO?[1?X[^Y_OE@>'8](5I16^/+D:#R^'I8/!A\&'T_J1__O[H:G`\N+AX?W%\ M,>SW#_YM8<'RU/_NS$1H?!;WQC=_9CXN?W.WNXXGWDZ%Y+7^H/=+@=E.B;/6 M#=?FGEF0F[WD&0Z1U5.?\R_U_&!FNH77]OF:],&2!0Q+N*Z^YO>#WH'\3&QL M)9\WI\:]8T=3^I/FK-%#R'#->2C>)7\L33X;5#XZG$\?79'+N49\68[E]X/1 M+\]"M2AI]'UGQQO=N%F4FU:D!%.B7UJ(^T6FA/QXKSAO[+NV>E#_K/MB\;X' M9,H).UD^LB#N*I/N+Q%6><$S&-$%95JDWZ>"2#"CQ7DPIF9HS./`HO\*P\^4 MC!$(UR3U8T0^K61&/OJ87FX1(YF.9]SZOJT(&XK@SK%$V#7.(V.)L!N.5>_4 M:5M`4L06EA_(`;[C/3(UG1LQC\1L+(+,TAX<=0Q64B\=@GQ^QPAC:UH@SKT( MA$&4FY"\)99_]R0/06E5H[1&+U1:IV=;:JW^MMIN)^]#):U']XC)L#5=%@RE M;.6R$))14P)QLP35M+8![UNZ.RL+/7$-DSY;S)#O/> ME20:G96X`P^%M#<*:1,KIJT*J<3CF'N-D/W21X--=M#V3A\A6?]%H'L\DKRS M@=4V3-VNV>2#[DYHA/&8]WF8[+N.^DTW<"(W9IP/08-3?96%I-EX<\->^$ M8?*`:'I$)=.F>=,(22PR%]&EW!IMXGBF)Y>%%M!V^!$=?AP].N19^40\<`J-C/;)O^0=S=X+8KQDPFKE:UY[Q MF2;$.W7LD?0E#WZQ(E]_,2CB+!"6IC)GO.9$?Z&?`8LD&NDGQYHZMR3>'!8S M=SR;6SU@NF/NAR3'E)A7,BLEWH0DC)Y7(.9^$"U-30H$*>=]UU54#B.2'C0= M.P[25RAI.NCUCM_*-7,\X\[Q557;[*7I4VZRIYS3%'B%G2C;3`[$;:SN#34= MB1HI!3[3.*>+).`=Q?_Q@Q^*6Q1-Z>N+J2,F\@\R%$/AI@]9BS7,0&Q-SYGI M>'+;VYP32\Q)'$N9;1%5DTUP$O52]9*>B4G\DAB/IBR'YUKCSTPOGK!ZE73F M==`[Z:O7@U0$$_%O_MBDA:0;U1!7+5-_P,LT[!K_-75(P64Z3\V-OI+ZAKYD M[8D3F#YXH MC8@?0;E*:08RJ*W\=&UFTP!O\])I%+ MA!MUC".:UQGZT?"[5+,^*?#@XOKRX,W&4D_"%+N1*3O@6E+`LX< MDORTX(<''[Y?T)6A$%*<)E:0&3RDK(AW^_^#5<8"0IEN^G0GJ& M.5XRK3]C)W020R%1<3(`%2K->O4Y.FQU\? M3M+]R>XL#A2T!WWNU M"%/R7\FPS?6<=L^$TEQ/>F@J#97=H(+DT4J"H$^7.BIVI)0$_T3H",P??IAS MR@QG-HL]&<,RYV1`DY?P5Y)"[%*$#S24F?'W?YQ?7OWW7^D_WXS__GXCETI_ M=W'U\>/5?R^*C`7O+GDIR29^7M[1ZV@K0P:+)!](P+(3<9?9"A\NSXNA-)8( MPI39M[(J+=TK"2,11@[I)#*8'I90Y7.\V2I]?"#@*FYP<6L3T5R5[BJLA[1]U$TFL5=0GP)"')V6_])'D M;#4%3.7!,4=K+4_"D8'3D:,E$2MNB4I_QJ;T?4BG$?/D[;1.?NVZI"R-\_B6 M965FG&S&GR%3/%U/J9&UW$]85SYK):LNFUL\B7NA'<^$XRT.'])[V37TE7R6 M-YOI*QHJ'-H5NE\(7(T>-77)%,L,,66T?>+PLDE(^Q"8L4W<=N>$.=GU7?PT ML_B1\8?PV'C[-8D>=O^(F7X5'U@D630BN0L>&=!`BKU^U M-,KFF+<"YX%T"W)&'=]-"&"!&AK2JJ$'J+FE!*#QTY!(4SLA!T..JR0(?7;99I9HN!06.0XFX?Q!#NG:^V?L2=/#^,8&\H2TC/#*+%+4NYZ MC#+\[H*@E&_\)QD1TB[.7/O[Q%!?V@YD9T*]3?J9^1`KOSWVR/,AYF6^_Z/=\9Y8KI)#OJJ#%AMF$F[82[(];",*_*#R;YA M9Y`>GWL$/=?/4:P_E)&4D31>6)RFRUI4.#+8%/[0,M&22QOY[Y1-I*QDQ28J MRG-HLL]/EF;HV")'W/4M,=/U5LR$>(;DB`Q5.U&LS@[II=62_,%PVY:;W;Z19.88Q%R1]^$G$ER1BY'35KC6;:TZ@&K3_IH(H M:C7()\XP3%"XE0HO]5354FAW_X6CS9.%<)1@I1@G(.3:'5)DI)`E;$'WD<[//C^[0OQ MNTU$LE*;A-=)QB%9S/"L%J=Q_IYM`[X\D5WK482%5VX\8^)][;.H69'Z<99L M"DT%Z888-%R)0Q+!BX:?Y*XBY3CVX80<:4N?Z3KL3J4DM1.9*P?072'\&?'^ MG,PT)WDDW[?\`EKM?S>]F.>E7!L5&'M\67E"A+:9F>-`&;_]]Y@N'A3BMXH\ MY%9ZB6-.LRUL:RX/:'%W*YJ26$BDR825E:7B*YI/,QW'(T_>M3A"OGIBWOE! M\B0F^_*KB&?NF8-FFMW4J[K94=`"I:7HG,^%Z>:E9V%^A%>E_?3CI2)5^I,U MG;PY3-GQ`_\P)5L_L&('WEH]TRB^RH2IOYZGX=./:1"T<0OVB)W[_<'RC;\1 M:T93B]V'/P(_GAL?OW8,UORN-'L_Q3*?2T6_+:UM$VATI'5G@-R-TA9@;[.EJ79)WF_I)<_)Z&LW2EE!TAIOVS=/*&I;ZMI29_Z0HO?)Y,W0N***'T);S],'-X;26*Z.7IY6P^YEV#$^?KPH3XIG$?1^Q[@P;7Y'1X?"'=MARA=EES)&U:`B MWMKEW_Q[3Z167"EC(Y.OG#E*3D]$']%>A1K%3\N-0ZD7.(Z93ER!:!LU=4EK M)7=F$R7U^.IU"K_13TIM2<*J7_Y&A@TC7/^PJ,?D10=O.FK/1"'63-Z8*%Q; M#5WSU6>?('S;'Y`KZ,[FBPZ32VE)[ MBZP+-]:$7UA,BCLEOB8JZT[S#N]Z,_&)K+>W(E!B-C(E$Q9VDO3U:LIR%"0P M'5=^23:NZV3\*'5;&O\PC6'O[8PX9:I3ZCHK+DJ)D\)3>SFO+DSA)I!G:3V.]-U^C1)R<)BZ;:LY,[A^E2=E2402DSS9B6K,]# M3J$(/+7?G3.T?-GED@`L=^:EQE>NEJF3XB7A.H84L!P?GOI!I$;O^O20(,DW M-,.!9=HUS:4&99"UX=+M4!7GW,HBEOYOS[S3$%@.(0TD(96YD3$P& M@%S3C)1'+=1*$>^+F8ZC5(G) MEQ;W!KYV,K7FJ+!V0;&5*/PW(T5!OAL'V>^<]95&).4NY#Q2J3\YQ3UB6<&; M@C(>FGMS7CC(S/=QDB@F1==J]R:75/`YBPNI[`;.7=9!&-)>9F"2D3>?&M?_ M2)P]-E^S:'-J;'K!"'^P-4,YO'9)8-W/!FR81L^+7P+GC".=' M9\:QUYQ!L'RM8AG3^,2[.NJ39F%:HB(KY193/B>_G.78D+DHW%(H-?NM%IA4 ME%R-IX5-K3R@U&W/88DXO&IT9)1N'%"6CT?*'6NYO7_GW/J!'X?$KD(=YY`4 MYBLD)\A,TZSO`>V(_A38H_Z08[(#%HEVW"A(]3V^/<2W,%DYQ'WG)WHB374QDG],R<7-8)UFD.H_N@TQ!5 M+F'"Z*X9>RH#P/<$/V+F$S\3#/K&H=J85H!(OG0FN2RQQ']2B5I)A)_DS_W4H3&KZ6C*<`:GRJ,L1H22 MXZOL*\06YT"HG(69^9.DX/^J>:2]VI,YL@A1Z9K>BC1-D@;[E*:Y@0(*.9[` M8BGBS`+QDY[K/9((LFTL8>',B>9])<&+D2>M$WF(,HF=P9J>ICOX^\W7[[R3 M:-)`LRR\U:,O>&OS[+'R5?RYPUSCY")-1YOKBM0 MAQ;QD'Q-ZF0EB:IJ!&-3IWWK(UXR==4C>TOMM&K8JHL3&`2FH[.J^("($]@R M1,8.5S:2;L&Z38,P"A"2T)TWY!79U MTKOT-U6(5*\N@YP>G6;HK5AB&3MM'M03=R=)G^TL[!*/>)6,V'/XS40\%0-/ MN>A1YM@$8JG7O0H_2<;LO9GJ`\D#:@LZET&>9P&RN[RW'QQ.!M;P5^>($ATH MWUE\C^-I)>/P@JL*^EG<7&\'/.,79LA)ME,XPR30;N@2E5G[+V^9"*7BN? M#"5YMX:'K&:5:,-$L_Z!]UEN:HIZ'B+D\!-8?_ ME/O4S!>GV'_;[\G!]0=O^V<(MVQZ)8@WX[VPS#@4A9W9XCKKA+PL+/FL5M-C2:%) M`OGQB25*.#^Q)ZX.A+&8"9@[)4ED_34QSIF\ZM!T872:QRT_X/2CPI9T1Y^# M2E/FI!3,;6'(&APY/\06$Z&&'^9L_<:IC$>MPU?<;J(U=%>8A]+!3QSU2_/. ML8U_[QK_87*RU((]MT888-7!CW\X`8%?'P1>F;&7[%WPN27V*[)=AH0!T[`R M!^?EZ;)(Y:&EN])DO:EIR:(_5I+PECP@F7YOJ'<+.-?@+L$ZN[R!`H?:RDZC MDHP']2GP5H_5`/G=/^;::YV(`*9[9Q&\SG5@7\,G\FN3.<:N^DQ MYK0`A;K,9-)($DIJJV4UQW0M^=5V9X'LB0^149_S+!/+_X`,+$^>1>.+#]1< MS,#.[]YT=(D('GQR,%3-;M5YS+QO7]SU=R*9S)8NC0QP)4&M[)!G-[>U0C?? M"2^YG!SSA#_4F=]"?$[78EG^C_S%(^\F M3350P4M5'(9CD[G-<8=KL1%RV81SWG-:[2VO]90X4J449)XL/USN MERKW?"%TUY/;O,FFN+HY]9<8`3-=A4;.0KIOY-H,"F!Y(&"0\HR[JS#JZN?NY"WEV;B74_4XQ:FKY^JS0+QDPL8A"J. MO7K^F3LJ\Y5Y\O*DA*0ANY")WGB4>J:G6;XPDJYQ'JI4,[E+F+M$\VM*!]85 M4E'PLY3+^I!;!<4F2OTSB2:W?G*Q_+SCXN1J2RCM+H]+Z5P0Y9_Y8_Z=8-H6:7SM^3/S9Q:] MO>854_&9D!QP>=#J\.#Z*Y]=^II/"BQM9SVO2(_TWMT3\;S/?I0<&OV@DGHN M5>DT>;Y5\?=7;7TJ[4Z#3^W1Q-`AH^)K8/[D=,_+I#Z(#'?)C<[<-ES$TE&[ M?A97T>,O%=&(!EI[?9&):5_9_&*_4QU@UBT/#U^_E[/G:FB$?VJZR'J3,DM3^@ MSEQI033AS8W\F8OBB*TI9X-YM\G=\I*$0'([2!<*(I5PMGAZ@@>CC_2Q6R2LU7.))JF-4!N9;YZ&O;.W#KY;B?4QB,)8O1_JF,%0Q:S-*3'96''Q0F5;G@;1=?HI?"N'`P?):J2$45N+Y M>8;I\=I4&O*.DSR*)T5V;@%4L$YF6:LU&/9+(@#'*`JO6J)#&P5B(7+QA,"0 M,2_U\\IDFUR&A+ZL_!P)PU@4IC24SU_R)TC#+#GHATD2(SG(L*O2(Y+ZGTR-TGNC+$R16F&=:XC>.R:M,B=!(V3`C8MTDB$>5[K/)$"2[ MPF0_,^&<7+6JM?,AGF"$%^5`:"Z7;A/)YT.I^))/JXKEY-(@JLQ]T%-[.O5A M'RM4M?U8XT7F*/%ZW:BRLZP+VG>^\9N(2*2QY?(Q%]LLS9DI;I6G+TN,@H/T M&\ZYU1NY:?14:\FTBN,:ZO:"#PG0NN75[@7-EG[W6+^G1S=,F3TA=,T>'9F4 MSO)"1<"T*'.8Y9<\4HRQ6!RQXM*,JW:RDW#`0IAA[*C(?^[41!IRZ.3"[+Q[ M$*HR(BQ2,];((B7YP_@Y';(8K*9AIZN6W3PS?W`Y`Y(7;V5A0RD(YZ;JD4"_ M9R],3@O(^H$\HE+X\2_D/!X9=)F["L#;/+$]VY-_D!,;./:M*,B!TL2`YM-^ MQ\A>5#Q(K&SQ0G6]Y,J%8G]KBHF;6!ZF";(MCKP@N"&$F\8%[W')2N?1P^*Y MKEP-8EN!9"X+8?D/.B.<.#:;C$*1J7_.Q_1RU>L\0+"UGM'+/<4ODR-7( M]9L8K:6-6-L8X52(7%P_RC;7N\;?EQ53&OS.[0,ES"$A0MI$;HF.'S(<\2X) MO3^V>-LY@Z]:%MX=M67`29BRNHX\"^W+TWG,N0JS\HFTFO9CBH[N MSHD&,WE[HL^(S"$)V'!BIGD"V;`*8B>W'Z9KYQID':A:P2R,-\T%)G+ MI8FX'`,ITC"_!60J5X;MC#1I45)>IN&&:;A/Y>;EUCNWEMTFEN]_1"=^C2-5 M$OQ"E=BR]'[L"G>@Q)#58CZW:OPOW4YYM(#;)KD]I11SIW;XVIW.E5AT./B?EJ6Y@!_]9-6BHNHG2O^[Y\-1YU\LJLZOY^_ M3!_@GZGRZ+K<,N?XRCJQ^GWD4[FD?Z23EIP3"`O;;C(IU?%DR1W2">D^/>_M M^KJF1ZSDOU92BT6Q?1T0E'4,)^S@O:,HXAS?J#EBL`G;2%O],2I49@5*=!?T\Z*GOP(N_H!#=S9M[*=!65P<\I'2J! M7VMIR:/DW*OBBSJ5+&]ZIPDHDCMS:5^<7"#K^12,/JDY2Y%(D]+R=_)9YV^U M$M%X4`B3')FD]Z@$N2Q>H"7^NZH$_C4G'F3H7B\.M[V(O_@')['WED1\T;C5 MOL:"DDRRY%N(CS]0%4" M@I-I:1!R5T$E%+'4X5+S]LJS$VDJ\6+(Z2>M3J0< MDW"7W4%3Z9(U1DOS;]-WA;_F3TLD]52Y:K`^/R9W+@H>V(+]SYE3*DU#Z^S8 M2]J+.)R(3J*:&%E)PY^R9+B,F&9UL60_4WIX/C?6N%2.R21MD[[0QB@M6"XY MIJXK3,O+J;W:!.9<@9SOJ7A6NH+YLSMS79*]4*1F0CR?+Y.JDQZ2S2-WJ<). MOL!-WB7HGZHLBN;M'#TBXY.DX)O,*C8NA:S+P,`I/1CY)1.BHT[B8>F,O:07 M1LY"3X-P=C:F1,TG/E.A:/=6SE/UOM,?3&1;'M%0KM,E_>>38;PW:7X/':,2 MA^D?4IV>](^-RR\7QN&_?_V6>$PJC*EM>"W`.K(\?IUG;@O3 M9OW/G,/S>J9,Z9JS=B9\P$(VP]''V^EAA]8;G?S#;D".UBLCS8=95@]?(WT( M+@F\XMHW2V;V4Z,K''U?\%#"R)G'6<^SY0-&.8:7NR%;[F)GMGF:D=M,?AOI\QOY6+ENQ9!L/%=N_GWR/><'T4*;-FP`RI.Y9)"RC4%.6<@*HG0C M<-A[*UMG]WK'O<'@Z/3MQ=_?WGQ\>_'?%ZL#NAR?R(HOCX,DS7M"/K$ER^+: ML=RI'^N0I.[KW>$(ZLST3%V(4W9HXN/(ZAI>;IG50R^1-3\=61E0!AR+9F=B MDTB.2G+V0FV`ZDS:%?KA$96;L_7,L7]7W`67;\^_)Y]+FF8)/+(E\+`0@=1G M<).MA,=O70J&JAV*A1`HZ09^0A(C714*E94F4B2^U)?:/TC^.ST\9"`F+EBI MX+M@!;:(P-->K\\(_'21(3#GB67@VQ-7;&EW?+BNC:R2!)<>&.9,Y%0V)/;T M8S)"AF$?L[E57$_;/W:^'/QH55^9?%RPT$LSM762$&&6K%=2_?"GV+R<] M87HR:'#T1+Y!,;SW@N04)GLN#3NM!Y';BU?ES`,MF,FJ(/.*V\+* M[_FOV%6E]SQ+F.ZL4"TP;X,E]M^CFFY3DV_UYK,LA>"%60/*>4Q\QX]-3"YU M@&MY6[I>T2(G?#XV%#H_HP?CL$Z!DC>[C1$U@0)[&BMB8ZJR`Q2Y2-".3E!D M;ZS.DJC,<)#?+/>8(P4KR_BW[NA5ZH;^/3*GK+_/.9?I)]D:P;Q;JC^8GJ MLA$@MH[E&DAODK=E&0)U2F62%8S2.PT]>JENHQ2`&=;E;,*CSZ5!+N] M.*MZY=TY@>_ILK??2"7Q*>DDKI`K(Y8K5M,X`;I\:C\I,U;,1R;#5-O.]"N7 M_+[-2,$FR`+H=MM3FG-O*IADW4G38'^*S^*JF`$D+,C=NR:#Q MEC.U%AH)BI^13LU5]JVN:Z+?W]'99C1)>FZ4M>G*M=\F*VFILJ.4.ZXNW'B7 M36',G\V5*8N;NH%Q>9N(YN7SEY)2< MK%8J;5G=O9U\+76HU!%9#2S5W=S6$=G\W:-_YJRIR^;ZZHSA7X8.BSMI.U,7THG4Y8MT)6%"R9QI'8A4TV7E)]12B<4 MB1HMIOXFIFE>D^5-<+U@'$&\,QU7%EG/_+<6W7F7`[BTE\J_=@.0':N'&XL(5'EC@'[E6U,.Y*YCME5;9= ML!'-I,R/J@H@[1V6QK)84[[\]"='.HYJK2[(NU$5"2YTYH`C.Y!??[HX>,,U M_M5QO/[9\8GJ?'!V.J"9?+HPR!KBF#)[F?E(];EN'J(KC/S=8XIQTKRJ?LID M";G#^=]O#MX87YAQ&(.\$V%HKB]0NDA0?>2,_^0:*DF/@EMV.+TT&2)79L1. MS67Q<^[Z?#Y!A=AC=0)\IFN%I1(T8^5"6>>>+F5]R>4)TH-@_QZ'7*>LDSM. M6OB=OY:T=W+''N1U14^&W)5(>^'GY-9;#S3/JZ_<`?XP\F\%#ZQCR)G_DXV=2-TVH>L%RZ5T2-\DQ'X4<7SF2*PG? M2>JARF09F6"4;P`4^HX62ES'T[/O62GE`DL2[J2H.:ICY8":G/WA^`\?TY35 MZ;/(OLR:TA4;=3.6?!9ZOG.)YF?-MZJ`+Y.G? M+*"?N;7RU),V!-@BD&EHQ:O9)B*RKF"WJ1FFI4-M/?6LYB@/>OE(5J$2MPQ, M\#++G[B6>;+]D,8GJK7-]>Z2VLP<_!9"\0TVXU6 M2V)=WZF[NM"4/NCCI47SA@2"[K.GQ!<-A\@KX)B4@HW27YELVS$2N-PP9RLMJ,QD0.XP!2J_LC89/MYIG8[9&>?XIGF0$C73%7!98-(UEQ* MOIP0/?Z7&$_WTM1].1*+9&%]I"HO&+)77+Y,J**\5UP]5@[LKQ<<]S\GO??` MU3#XEIS7)Y_LF6F+AF*XOF`'+O)99H3F_`UF5-4IWO'BHJFM\E5C.PE\D;B: MJPW,;+^#A56HXV=^8$LO*'T%+T;E%H<*%95IU\W)!=NX/ MKB+'V7`?_=@)T_W]3^2TDW9R2CHIM!`,(ON<%?-2`H-'PIEWNHEW@RC+U,OE M,*@>*LF)5N;Q?-+X0/%Y^IAO!40J'[*REGD:5A*$-*CO?/ M.'@H^)'DW_A<.D?F0YFVX[O^K0QF9-(MOXOIL!]?6!]EMZBW=Y(V9CQ,TPFZ MQM=<7E-:S\B5/IBN9W3O!S^*6[.NG]0AHB^?6GRE;A?&TS6^Y:=!T'%L%G-J M;V)F/B@@RL/1$[X]!167[YQAVJ79_,$'W0F_6_ MT87ZRF1`/&?E=FO'7A&46^\D]6NX+4=>$Q3WOO-Y=\KQ=@+I/%MY"4ROYE_I M]>K]@>J'&I*(E-T0.-'35%7_Y/_KWL M,16&)G'7-UI+,H0^BWOCWYE<#U7LK+,_4`AAEO*2DY+.L>N=VR3M,&TAK9J8 MS0,GZ919I-R%KWF%6/6KCEC^(?L?*7_[XNL?!V_4W(,L%B\S?'6:X@D;NX\Z M'J:.8FHKO7_R=B9KZ$6!B$@-*>"8X8J1R34U;J1Z.">XZ`')KQ-]DK6IR$K: M)1O/+"W%3,FY7<$01%GH?RU>)[)YUT=NDVB1T0THT/ MOA4S;3_D-A%N]";"![F%(,6'K`=K)\XCK>,LVY%(#]MHU>!*0IQ*4J4[8H'B M<;:M]-Z86H8#S]=9V@?Z0;*UGNFE[R$Z%'*X^&G)PFGI^/6/PN&JQ4@KK["O MB:'+*0V*2ZZBW+E,.BN9DJ(.24RA0AQR_?N][EDR,;FBB^N9*%5=]VMQ^#HT M+D^PJ!<47IY[2R<[M)+0@]OL6FG0G_7K+).W2?TO:>UH^=P\J9D<]DI+SXV6 M^%=UY;R3Q'E`X]+SQHCXK3091$?_\M'*HV.^>E$S%]XEXD:8D84M&@I(#=Y*\!9CE MK5'>%PP4'LJ9WJ#L[$(E`J7+G*M,..)S`RJZG MBB!RMSB_5UP0W)GN7MBOS<6[6B",CS*MJZF8LR<2X.3-)H4BK?NR2/77/XBY MU(699"W(;;8\I)2T%1TSJ=LY(`\EN)4[KODET&_DE0V6[;7%\63J0NO[567O M'Y4QJ^R=QP5(48,4]'U^SLE#XSD9>\;9XP]51,R$CI(TF>Y)3R[3,CWZMCQQ MR]%!H]-A=U33[.5!Z=+S^TIIF-FX[.).F4]+[&@T[`[+I:\.F^FFJG_&W/DX M4#5XTEJNF1D:K31TD]00R,WB?9-EV:.*,FH?R`4=W(A MJQDS7/$P"/F=ON5D]2&S@(\Z3/HVGOM>41+H%^6Z):Y>O=Q-TCGCW>6L'$=G M1;%?'@'96?=9=J*<`.?8J`SL4*=8J9KU'/89N^G^7NYX[;VO#M6_E>*72^#; MJ4%]DY?_D*$E^BR[I/FQ9 M<5/YO^V'\;XFO5P_IC*LP<>6Y7WON2.:3`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`DMAU MMHV6`%#NII,9.5,[_8M!+W;>W,*CI##B\H5?1/YFN0>O$AZ_\O$S73[QLSRG2GK75I#[1#X0?S+^)E%FLLL?%)!F)^!2J'+"A7H0X>;%"C0^B#+V5-EO;D!E6,+=6I:E?M+ MG%599S-<=FR>738=,WZI+K-\UP_>_4M/_E,LRLNHI-D[1K[>,2S+ZI:KM<-1 MCTH9];N=2[[<,Y-'\/7O>LDSM"3AS_F7>JR:W<)K^WQ-^F#%DI9P77W-[P>] M`_DYG)M6\GD%?;X[',G@Q*=O_LST%D=^[]C1E/ZD.8]E,=.WM$JN.0_%N^2/ MID#UY MY=.R&_M;WG>VX_?M^K[=S.^Q5=4\><=-KDCV:48:^U'DSWXK@&1`#)]'0/ZS MNK[P52"1P]\\.\P<+-FV9"/OW=2Q"8KE&F!IR.-)P5,D=CK@%9U2Z;ML]- MWFE.-MQX54DR9='O659\@H[E MD4OR;I7T&IYU!V5IF%+8IW;U@[L.SV(:@!=PKN MU";1]2%0M_-0XJN9D3M)'^*3L*4G#A5SWX;SGX;MQYR@_9+D-_U0F?N]E$VW MCQOVZQ+Y]6E:?0K2<8F[^L_1M32BU=E_J)\XK)T!`A$($5@C$5AF%B9$8-%, M_*L\7[;J^IT-K!&'=(NU`F2SL[2ZVEQ%\V6;RMB:YH[G)L?>FW]^_=79MP:# M5Q_Y\J>/JU][=ARJ"D+?N(!%+(SWM(Z-/:HN"YP9:7T?(RGK4RP](7ZJT]&V M$3F1ZJ&R-.%MWO^7T].RJW?KTBZJ,:$\NBV/=`D$5X,+G1GAV?2$:E"C.V9+`:*'Q*$,50IC^8&Z M&*1ESID5U=VRXHPCNZ]%>M$NA974HQSH]>(*)%**J/HY^K`[5R])ZV,&JHLO M"9K)A,^UY^L5T5SUL7G5,T[.)3LQ[^FR[UF=73UG659X'G/G[E#5_=2SU+5' MM+L>I0_F!WC^3);J3-HL9&W@^!DA;#V3P)ZKY]T& M:;WR_XQIXH2/!2VST,-$=O]0M1-E(P*)Z=!T"^(A7[I)UUPRSBT"CFPM33RO MBC4I>63'6H**I&B'%!^J26HI^J?J2GE*3CQ#$):0NJD?2T1998+%O.R/L]C\ M\CJA M=1M7H3!7UD>5E[R]Y9YLI%O*L8;ZG='HI.Q2\FP0):)FK$6-[`!H)_*&E6:^ MMLYBA2$_CF378D=6_LI6E9P>H167?.`2)]THO2JM*&ZKI.K"A[GQY"NLKQS/ M0^'M9MI;29L4INZ?Q75Z*P9NI@S7R43DHS;97%@FVZY-E# MQ[@3Q(6Z`"];U7,I][1#IEN^S[GK"OV5](!EZYZDXC?5;EXSJ;;%GWMRUME/ MOR-OW/BRZC#_F(L1W=-XRX'P8%1RDXW.SFJ+_:5_U!V4W$1IAZ71N+_)2;G# M;W)9NMWQ36DUZ79=26\YHV8[0G.OCB2RLB*,E1>&"Y)*EI=41XA7AJL:6FVU M6#+2D64BK:FP8U>6[)TYGC.+9SK^DWHU*ISEO;78JY*%=Q/Y;9;BX:S+&54; MEBB]B-*+M2E-B-*+2'!91>Q7JW6W!BU7T&^YL%U&B=+KV'U)_8LU_#7D58'M MRF&["V4:KFL]['1LFP$!Q1T?R^3ZD#;./'Y-J?(HK7>0_/7Z&8;K,MQ3!*R` M3F6?*1GT=W"2:R^R!1LDNFJG\2&[(+LV)]0NCL/MA>AJB'^\"XOK9!L_I655 M%?HGW4W(\.34VP*1^J&A=DJ\K7#HE7>TL"UH@._^O";9I*;@WI4RZ!^55RBX M]:7A&@2LYBJEMB"KAYJ+\'LVUU:;F#AM-?3Z)084V@*1^J&AN2JF87!`<47X M/]MKE,$F]OW>66EG.PA=MP5L#<)5M[2TH[8@I'Y@:+"FJ2!ILV4*YQD*M055%7I1_:9K))_/?ZT^(U4-FY50 MH1*)5VN73VQY9M99F=M[6Q-S+W*WX!W#.U[?MD?8:8=><=.-D(\B#-]E16+F M?I`4'=O"%%G[4-=N#FW53A;!O]S/<`MVV>`?;LXU7TDB<^V0.].-GRBG485\ MWJ5!V03!5!MB-4VB(SB!X$33G2#$)M94X`UOH%$25=5'OOSI$I!`ZD(YG^3,A2]"JE@%IQ=FT,IIGRPX#83P.'=LQ`UDR-T@*(#/>7*[@3N_S M5,N`I#*D+$X?1U,_D'5V5<$ULHE\-TY\5%6L?::HR/7'Z"W_Y.XANBI]VC.$ M?A$1%QZ+IDD!YAS]C?/;0*@:^&,1W0OA+4WA@JOZ.\+KIG_)>C5W@:")JL*_.:*9L>WHBFB*'J$QI_\$R01NQ-Q,2OW_ MU]1Q97,"FB_HRQ2,9BZ>:DV4O'N'7N-%T<;\+UPN0B6+*K;D1+:-Z9CBSFUM&E/D,6 M!TXXI54ME$N6-:W-T/=D33$F4%JW/QW<4\O<_`XRE<+ROWC-=:7"?)7W/$8G MQ$D2:_-`V,(28Q7HGAA.T[NO7%C>1_(JDN-ZQ(+5Q;8]DLM+[@ MFM"AT3\[.TG[<0QZO;-B$<6D6'JH6G_$7G[HQ.T:R8OUMA5WJ#?0D(@KB/;$ MN,2MBA-4)PR%0BZCSKT@8N:/A/E3UEK]:`U2R6[RL9([94EV'G[L)9]EOPR? M:W2;]C_C4-9[E+7T@Z0Y!4O!R)2]DA@R-!(]@M4+\:N*S.FBW03L,0V;Y(TD M;[$H]VH*]XQPZL>T*(R7,1>^%ZH;4Z@>QNLC9=)$<$\1-R^;YG'`DR'H\_KS M:MM.:'*Q1]5T0$4,:>UCW7@D5WTW:6)0'+K$5VY-B>J!0TLA$%AKEZ8EDI?=H2XZ,[(H4EPM M*8Q<6Z(S6<9RT.&%)M8*+:*S:G'PJ.JK5L&DZU26>G$B*(*G.>?K:D.BN`"Z M79$MIYP4O]=MGWA@,\^9D(VF;U3/2EH7!;JE@$:T*VZY@C<)-Z[83=+EJQ,$::J$="\/34P*0'Y;AEDF;]C&+B$`6U5IFD!\>..BPY2/KKHNHLF5.P-!0=;79 M3&^_:<7\D3XVN4O2#<&1_&+.GOR331-B[Q[0&!.'DDP?C))@*F/;`.G3YL2]5@GDLBX,&D*EI"%N^G18>1;/_AAA`!/ MMP9)>\0EU^9(WM%].!S9`T9>=4F+<,_.SX4?JTY/%U,N@$T#.RQT.LL$F&6J M!G(OQ?>U;7N.&))W1Y@G^V6(Y)+V3;0=*H8]R0%KITQ*V?M/H[K(@4E\(C$7[7?9H:'8.[U;GT MWT\LV079PAO<4PK-RJB<_P@-;JQI3,RV[H3*80&ERI/6A6.I>`C4#BENW6I1 M,R23M;D5\$\)@\'BY)SY5;'1!(!;ELJZ">LYKT:>0H#55DQBS9>?(OC)GYJU0 M7@;Y1"3WQ`.Y^A.AO[/\D#M\')+15KREIFJN( M:N[%O^8,;1H#^:;DG)DSX.QV.RF__%_B-DF-WPC'<5AX0UN^1Z08N8F MN/XF=UT$SGRN:+GN+5])';N;W%"6ZU`1.QE?R6+Q[]>?T9M2)E3T':1J+-@[ MOA;52E*/U.6%*WAWPI4-Y3USIOI/<5M5SR8V"%<['F'.\R@X'.G,M_0XS#4\ M#6E;:3,D)+V:O93-*\R?TY%,Y7Z:J,U M@ZJ1<)WL,KW2_TA91+&!,YFL=I*T..EDB0FY!_*+)BXQ7>*-D$J%VW,B#8N9F&?J!^-0X??L?VMA)GWMS=:%$+"W, ML)?(V/-TQ.Z#VG[,];4/BUY:7B:E)"D`+Z4*@86[<1N3P)^1]RL"PH*,%6E" MR22<,!<[U99>MG@%FT^.3+G3X3O5O)K<+\(=/92;8-OF0]*A/>`^V^SL26(E M?:&/NL-#\6;!K'SD9=+J#GB?/%DRNJSPKI#3BDABAU%Z\](&5DJDO4M.)$J#U^N\^N](.VD8\X9NVZ:7(%WWIP4[PW M<\D/WC34F?A>=.&+LY++FDLYL&(R@F9,W2SM+"_4K9R#3S:0BN\\%*,!.8]= MQ0-H7@XGEJ1"ZU?CDY^F`'P-]*XCO?1E&[%NN MOV_Y19IBC4^,3328[(F;&BK*:/!B&8[BE!,Y6?(>I8!0"13Y<%X^[#C7QX&8 MSUG6\Q/23?A.WGU0&"(\ICESQ80)VQR07/#(*_-D0,E@CEW M9-]*=T@Z'#JU@O3>+1DD,NOC59-QDK__]:]Q^/;6-.?O+K+.R^>>?2$3&,BG MLTCR7:86U7=BA_>N;_WXM__W?__/OZYQZU>R%ZV']#9EX/V,OHG)[P%][^+B_'8Q/.Y?'9\.!X/C`7WU_F(PZ)\? M_-L"3^>Y[9DNNJO.#-0=YP5RM@+G.5,@D),:RI-!0]`-;60-L;*A=C,3.+,H`E8\4 MJI0O'I;$!ZTUAF:RN'*#%.2'D20Q\KS42!P:B)7Z*LEX5GJ)8]/EW`TCG`K>!F-+ MD`5J+G0A]V&T"Z%%-\_XHUPY]LH[:=3!]/1.V%PY,UK@%\D@_?IP3,3SPRQ5 MGYTYEN)>J))ZDU5@IY0$FQPC+S7QFE/T&^<^LZ84P'J[/BN1(21WZ%HF*G\F^FZD'XZ. M+B^''ZXN1Q>]_L7YAXO+DQ.E'\[?]P=7@]KJA]PS"^='V[96 M/ZZP1SJM2`E'F/NEG:=_N5FR9(3TCY\1$&L<$]T#,IU;5CR+E>I0_EE!X!E* MXJU+R;5.C#;&`.2-!7+"/>6VF#E**?5N%2BE#['())PL`+ESWQTRFV!U_$*A M?33<4FKWMY7V.W[?KN_#_.HQSGK/KR&5S&M7BF7]XC\5%&_>O`903II;,EJ_ MJLS'9@0\?=3`49N>U@.G`'FA^_P1&=1U`^N5PWI_]W)!EX]^&'*$_))NOY.9 MAZ55@@8;@@W79<,_.*/BD)GQ#7/C>W4PU/CJDG`$/X(?=\"/E84'U^OI')SOH:;P7!?D:)-9JIY$AO""\ M-B?4+OL10H1!A$&$0825+,(.3P;=TJS\9XF50>V5R%8)_^Y9.]U^]Z@T2.Y)&]WZ MX:QV]L&^HNGPI*I>)X^39B,#OA[2NS0;'5#;6Z@-SKHC:"YH+L"I'#@-N\>` M4VWZ93;(^$W(6N4 M9XVE91>#)^J#*;\',89ZG+G:%\.O1EALKI9K"\!Z".$!6`!6%=GOY>40`E@` M%H"5`JOZDUYM`=;>;SH]DRUXK-K9U24,LOX!PQU#;MCO]DH#W3ZDB&1S)\4S1B6V"'C6J$_0&P2G,:=U`Y M'&H-J`/J"M;D+K;;]@%V#=F**X\R-VH`&[35OF!![)G,"*2IG'<*[&9S];$W(N]^P8)SMH9'1"/$(^OE&M;41GW;8B)_$&(3HA. MB,YFB,ZC08G;?I"=D)V0G?5F2^7`FN?$A\_3M6S[8AZ]FI#EY\=CT0^RP_1L M>0SLE3-)WY<_ZUGA_,3+?PXCY? MDSY8HL.PA.OJ:WX_Z!W(SP1]*_F\8G&^.S.B]F=Q;WSS9^:25J?EN'4\-4@S MCOSD"V5"R&_N'3N:TM5$&"V42."XYCP4[Y(_EG@J&W=^YR(35+V56TUK;'[( MP?Q^<-S[Y5D96!33^L;^EO>=[?A]N[ZO,?,[WNC&AN3LU<[T3H<[?(5.=\_0 M\FD;9TE`O\`:E)_NE80>^ZZMGG,^(W,M,K+L2%)4,C-R77VSV]'FU*DZI7=1 M4*?74IV69>\".NM#9]^@L@O5R\L=9"^!/<&> M9;+GY@7W:D#R1K-OP^BW4P[]Z'AD)!*3&HXGPX$7/@?80C(GZ2])"FE;UM(U MNXEH;#-Z#8<]-[-TD1O\V.8-N2`T]_]5!Q:)KK$7"'K1_Q(3R((T]"T!QKFC M"^Y$^%I:MK^3S<85+UTD?&'@_4+POSX;DEON-_;+W&]\FI9J"[)"8O9VT/!] M+[8<&R0DFV6)0`1"!$($0@3NL0BL$>&J,["OV2T2862(GW/VM%H67*V2<#)Q M)3)_&O/`OW/"JNI@5A`2>,T"1I6=D7N<-&TN8U0_R-5.R.\QU,JKT`>H`6J- MHT]U3/,U4?DR<]5);8'U8Y`5QGS[#2?N9R%CZ-M0=1]K0I98B`LECNOC\]5. MN.\AL-"+%\!"%*J>A&M(!&J1:/J(T-&\W)-9;4ANKC.IP%7@*G`52%5[4C5$ M+>XN98RWM?A//E4\]\/H;2`B)U"9>F/AB8D3&7/7])XY8=PH&0>TUIP^X!_P M#^A3)Q58(S^[VLBZ:46Q&3BF*S.H2XW_S6CU75$>*?MKB*Y73F,[0_`=H:Y: M!-_W$'RG.VA!"/`!?$TA7'6&`]\6QO-'*$$3^FVI[%;VE*-YI!*2^BK7AAZ$ MV,:6:2>.'QBA".X<2QA6(&PG*E6)O(!FKYGI-BKO,`$RV>!`MADJ9^650P54 M`)7ZT0=&T+X:J5]=TR/C*(ID:8S'Q`WE8IRY.=EF%^B1H"!2[@@N\KD`8ENC#` M$7`$^B#PM)TDJDLMF+;XT(>CW56N*+?993WX$?TLZV1S[0UJRRSI!]0"M0B; MM:AT33$-M.$TW%&%FH8I@./N25E(A,^]-Q*YK6CHEW,ZD0ISDT)T@;&EJP*$\K(!_>7F].-OEU- MT'(X_VG8?CQVQ8L*B+]F5+4AM@DMD251 M+[E9+^<,TA'2\96D8[^\,XV0CI".>[[U6"_"Y9R;OT8F(7'E];F_Y46&)5Q7 MD^'W@]Z!_$QSMI+/>MQY8IXFCIR>QW=G)D+CL[@WOODST_O->(P0JYRN>\>. MIN].UJ)]D4W6OW@SOX^FN`D7/'%V@N5N@2U'3+HM!?@RXT_DO]\*QS->@C`^ M"?*BF9=N`FPAC\LDZO>I"(5A6E8\BUW94-TG9YA&X<_F@9ARO=0[D6QN\Y`W\9J&-9A*$\O%0FN;\ MW46>LU2V++/"=P+6>]>W?OS;__N__^=?LXL]FUM1VA\[T M#F(JCW'Y34Q^/_AP.>CUC_YS]#_?+P\,QZ8O3"MZ>S8X/3_MG9X.3WO#7N_T MP]GPM#\X'EQ*_8 M<.R[MCZA,UR65(T)]U=*F53&&?27=!5)A7JWLD@Y":PG5;5$'(Q*WHRY]LAFN1.S,9E'I&,&'>/3]8>;<^/>E)L(,UI` M^LM\B1&0O:S?Z_U2RH/>^O<>C2R,QZ%C.V;PP*;9A7]''X3'EALI3T]8TFB[ M=Z*IM.1NQ-P,I"'7U9-T>&93XEGF13;T3._!$"&OH!-.Z061;]";.H;M!/0T MEU[#":7)IXX<0&1Z$7$P_4C_P^/@=_ED(RJ&3\?HD(+1OUZH5W7X^4X8QH+L MGC$105@QS9@O9)C0C_047@0C"H09QCQ-]5R"5'=Y26K)8"FE>>*D+TD^$:N1 M-2C4#A6;26''N)\ZUE0:X)-8TI(($),=Y26F(7UW&]/ZD5%$"S-^,#[1=V2L M_PA\F_L;6%V#S'[B69<\>R:\XS'IE.$N#RW9(DPM>C]T$HL^MR"_ABM=A`Y! M(!01C=)US+'CRB7J&.+/V(G42"TSG!H<4@AY9(%PQ1T-U&"S=RX94#L3^CWO ME@;/(-/3(Q;3H]*D412D"R2K%']5C%)@.,7'CIRL&=%@:#XA]X)0D^#;Y1,E MO8C>3'//SV,II7/(4Y'^$_%B^LZF<-X-N6K$`H3^L:"ED1-5ZY^H)JN@FL:F M2\I(&(1\KB(N*56*M"+!$TD)FP6'!D<=%K?+[?>V>;YD@LI&>BQ'NISJN?5( M'Z-_F)H`3/F5OOH"UI)=[F@:D._]0,H[-(3'SGLCUJUK7+G.C$P@M6>?0ZK] MSSB,%"D(>4)?Q62X$\D/)%(*NH5IXQ!J@T21:7[6,H(0'9J6>M-81/>"%"7[ MWC.?2+\HCE*ADT@7&3[)OZYK7#RRC&J)$PMODEIX>7G,"[9@TS+\F-/CHG? M5QQ],T385G9I%1Y[+0:?&ZS%JQ]4Z]Q].O_X\?KSQ7]\^W+YW?CZ\:(IX[[X M\OGRZO/-U:5!?]U\^7A]>?[]^O,?QOOSC^>?+ZZ,F[]=77VOWV3D?><-TKKU M(Z'ZR)>_;^&;(RQ>>[B-"Y[.S.#6\=0@S3CR MDR]4U$I^H^*K'!XH+Z3:>V%,=72\95"UO^5]ISM^WZ[OP_SJ,4[,[S7GU]`C M7J4JSTI/X#Q766,W)W2>TN M,&ZZYPW>(04W-H@;O\@8Y4TNR@?&`^/M@/'R07RP'%AN!RR7Y=2(M0]WXA#M MVN0]ESOEE?#J#NG9!)#7AECME8[@.'`<.`XGO(;WE7!` MTM-`?/3CSG2?/3U<,38K;F==GW)L+ZBV5I.":KT2RTVBB3D"2I`QD#%+Y9>. M!I`RD#*0,I`R538)[P_+ZTH&*0,I`RD#*;-\FV28TT%_4#W4(&L@:R!K]E?6 M#(^/2BQWWW8I@U[%YZK.#Q=0LH1SQU4,.ERG>0,6RA=B+5WTO&*+U@K4=EMP M@\TYH`*H`"J`"GW;T>BTNUP9"W@`'O83#]`20`50`2U1E0^^'XE:U]Z=X)KF MFY7C6!L]I<90VZ5L6A_Y0GQ]!^H)``/``#``[/D\E--^]Q30`K0`+>@N``P` M:Q#`H+LJCW:T*JAQ*28B"&2/:-F6*C)_5A/>:!B.$#)'R!PA``>&HX':`F@`JB`EJC*`=^/=(.O@9B;CFV(GW/N3:QZ'ZONQ98N MTFAN7=Q]7\)A_>X0P;"J"0"EM7_`ZG4'`!:`!6"5OH'3.\(&#J`%:#4B+@&` M`6``6*:[3N!O51O[:%6(XZ(0QS"FPK6-B1\8H>D*1`P11]]^GM`^0`50`53L M#2H&9V?E59H"'H"'AN,!6@*H`"J@):KRP_Z]:7Y[5,>@U.VCTW8],=P=G5!H&ME$/U6:Q%8&MB&0KXK2'K0C@ M`7A(HH_]SO"L#T@`$H!$18$%Q`<`EQ;#I=\Y'1V7M[G<%@5287I'P[,[O@;^ MG&;_T#'FKLFNNF<;XL_8F<_(<:^L[R2"9YN3IBU8;!#LFJNV`#``#``#P)[/ MJCA#>21`"]""[@+``+!F`0RZJ_(82)M"'7_XOGWON"["A#@9N?T\H6B`"J`" MJ-@;5`P[QZ.S[@B(`"*`".@)H`*H@)ZHV.VN49BKTL(2IG?KC%VA#P@@W0`1 M9424FZBJ`#``#``#P-8IXG!\C$T;@`O@@O8"P`"P1@$,V@LI!QLQS$>?QRV" M&=I;()2.4#I"Z4`%4`%4`!5`!5`!5``50`50T02GO$9AL"H3$NY$&''A`\/Q MC#`>AX[MF($C*BE=V):@6'_4.3D[Z9X@*E8U`:"O]A!=IYW389D]*8`NH`OH M2M#5Z_2.>MT>T`5T`5VEUVX<#3O'I[O8,%WFE$TIT_RJCH`>H(=4(&0KO"3^ MD>OTZ?JF5W&[SX9AJG\RPO$FQ-@18T>,':@`*A[K:=(9G9V65Z\>B``B&HZ( MPT'G^&107@@;SC[@TF*XP*Q"ZL+&3/,EHI\J[+.(N-C^QL4:!+#F*JFV`*Q7 M7O,A``O``K#2N,)1B;U2`2U`"]""40B``6`[T5U]Y-A5&^4HE> MR`&-?==6S_GN1Z9KG&\:WGB:C_S`%D%"CN'\IV'[,1>C_)>>_+<5R/1#^8H^ M/3'T7<=.'_CJQ)6W_67G!-PQO4K/^SCJ]/HE[E\\2[<=,-'K2SGL<$!\07SM M0GR==?K],X@OB"^(+XBOQHFOX:E,J"K/?83X@OB"^(+XVE'RV]%Q9S`X+G%7 M=%W";90>UP#60^X<9!MD6YUD6_^X,^J-=BC:]L(T:WJ28^V$73K/`<>`X!XUZ)X_8E;0IYB?OG/>TPJ>JC8XX=UXD< M$1JF9QLW4S,04_I9!.&OQM6?L1,]0"%`(=26<.`X<*I/SN=SW%9^;5)L-[[^ M=B,"334R"2!K&B-K!FBZ!B$#(0,A4ZF0V4'G.<@8R!C(F/V5,7":(&L@:R!K M=F+/P*!97\B\/"&CZ:'A<\NB]8U"8VX^H(5G5=JZ+7C!'MW>HJ*'=H5``]"0 M5#49#KJGP`/P`#S`9@(J@(I'M,2PO!W,MN`!>5I/.>-!+&SVQ0/?=>6!:_WW MVT"X9B08*R&Z=Z*Y((+LC5%:;0$6=K$`,`"L2G.Q-RRQ`P>@!6@!6M!=`!@` MMAO==0)H51D#:66H(_`?3)=/I"%6U@75RTAT!64`6D%4VLD:G9\B7`[0`K4;$)``P``P`2VX[.CY%K8-J`Q^M MBF]<+$\ZMO$O/?FO-3&R ML\[QV5GWJ+0HV;9D:PMT$:#>18!Z3\!9Q0X1``J``J!E)?0=GY1XJA70!#0! MS9*@>7C6.25TEE:4^,5TRQAM4\*]FK/U!L@%=DUZ_O`SZMH`&NQ+[BXB3\BKM`0Z`0]/A`#P`#\!#9<$%Q`@` MEQ;#Y6QP!N^B%)>\1H&TZD3*1Y_'+8*988MQ5$DH#:&RO3WGU""(-5=!M05@ MQYW!68FZ"^`"N`"N-'OB9-0]`[0`+4`+AB$`!H`U"&#'G1%I+U27J#3:T::@ MQE?AA8[OJ9Z=?A@%(G(",>-DA+'PQ,2IIFMGPV"%,Y*(GR-^#E0`%4#%L^&# M_G%YAR^`!^"AX7B`E@`J@`IHB:J\\1K%OZISTZ^\.R?P/?;+31=]+1!M1K2Y MP;H*``/``#``[/DJ9$/LY0!90!94%P`&@#4*8%!=50<^VA3?N!03$03"-AS/ M\F?"B,R?*(%0C9IJ"V;J!X_F*AV@`J@`*AJ.BF&G/QS@0"L0`41`3P`50`7T M1.4^>(U"7M4YYU\B^BGGF2/_`#%FQ)@;K+``,``,``/`GL]2'?2QBP-H`5K0 M70`8`-8H@$%W51[]:%.0(ZONF(MN&%/AVL;$#XS0K*:A9\-`A8@Z(NJ(J`,5 M0`50`50`%4`%4`%4`!5`1;T\\QI%PJISV:\]\M$;@N98JJRT`&W2.3P;E]:4#N``N@`O:"P`#P'8`L,-=J:]E1MF4 M,,UO+@GD`7E0;4A;V)YIU-F,J@]D^($M@H0<_?E/(_1=QS;^I2?_`6C/4J@M M>*L?M!JLMX`JH`JH`JJ>#":.CKI'P!/P!#Q!2P%50%4M404M5;/$CEYCHQKR MT[V0`QK[KJV>\]W?1=^+9QBOU$"C?AE?\0R+[Q;*9YV37K^\ZC!;TW1]^C18 M!&!_H`:Z=D]@W3L^*W%7#[`&K`'K5X?UJ'-ZW"^OD1Q@#5@#UJ\/Z\/^H',T M/.N>OCJPM\K2V8$T0`H/0-\RT/?[G=[9H'OVZIC?"V6^]YE#-U,S$%/?I:4. M?S7$G[$3/52![8:%LH\ZPWZ_.R@+A&V!2_V0T5QMUS!$]'N=WE&OVP,D``E` M0MXV'':.A\?EE9<#)`")AD/B<$28."T1$S@?!+RT&"_P,Y`44TI2S,=,P[U4A3_96>4?9;'=QR/+]W+/.KT M^F6>.]Z:H'L1_L2VQO8F"40D1.2KB,BS3K]?61(71"1$)$0D1&2C1>3PM#,Z M.RUOKP(B$B(2(A(BLD4B\O#HN#,8''?[]:$HD@LA/R$_(3\;(3_[QYU1;U0' M\;D7)F9N0^BOD:SMONKZW-^Y>;F.)]Y.U;9)?]#[Y;?<1"W!U>/+FNKJ#9I/ MYQ\_7G^^^(]O7RZ_&U\_7CPYYQJ-^^++Y\NKSS=7EP;]=?/EX_7E^??KSW\8 M[\\_GG^^N#)N_G9U];U^DY'WG8>&/S%NQ#P2L[$(,M4R..X8@U[_Z9/-K[<( M\O)W3D0OL+2AYG@&W>8ZOA<^;5&\'K6W0G9=7/L7QR$Y1G_.O M\?Q@9KH%;=3G:]('2REC6,)U]36_'_0.Y&<2H5;R>06AOCLS$1J?Q;WQS9^9 M2R;2S`QN'4\-THPC/_E"V6/RFWO'CJ9T-1%""W<2W*XY#\6[Y(_?%H5U-N[\ M?GF6-M%;F>2PQI:[',SO!Z/^+\_JDJ*ZTS=N>]_9CM^'^6%^F-^NY]>0\S>U ME)T1],LE:\JP?@6]'QMRURG+1P'9@NW793C8E M\\R(K';3-3XXGNE9PKCIGG?!C>#&'7"CJ@A_$X]#QW;,8+-::6`\,-ZVC'?E M.C-'23ZP'%AN%RQW0:S&`XRZH_%?W`1WSO3)1/\ M53?@*NXZ7Y^C,"\XZ5*3PRR]\NKU5;SJKW\2!0&E&NE_R)C&R)C^:8F]02%D M(&0@9"!D%F\[/CTKL>H+I`RD#*0,I,S2;9)A3@?]0?50@ZR!K(&LV5]9<]([ M*;'_8]NES,MS+YH>"CZW+%K?*#0"80GGCHL8=`Q/1!NP4%8TH%V]%BI0VVW! M#?;F@`J@`J@`*O1MHY/C\BJL`P_`0\/Q`"T!5``5T!)5^>#[D:=U[=T)+_(W MK,:Q-GI*C:&V2]FT/O*%^/H.U!,`!H`!8`#8\PV(>L?=ITM,`UJ`%J`%W06` M`6#U`AAT5^71CE8%-2[%1`2!L`W'L_R9,"+S9S7AC8;A""%SA,P1,@#\H[@`@_`0\/Q`"T!5``5T!)5.>#[D6[P-1!ST[$-\7,NO%"$LD2, M+QN#6+I&H[EU;?=]"8?U4+:@--V$.#.`E6FS'@ZV`5E`5OG(&O2/`"U`"]!J M1&`"``/``+!4=PU.NGU`J\K@1ZMB'!>%0(8Q%:YM3/S`"$U7(&2(0/KV\X3V M`2J`"J!B;U`QZ)48D0,>@(>&XP%:`J@`*J`EJO+#]R,)X=J+1&#Y,WKW0ZXH M824Q,#^P19`0I3__:82^Z]C&O_3DO];$R/K#$G,2MJ596Z"+Z/0NHM-[@LPJ MMH<`4``4`"W+>CWJG@"90":063=D'@[/NH-7A^8REVU*M5=SM-X`MH`M+-X6 MZ-679W4,>LT.&GWW(]/=P2&5AH&M/\+Y+VQ%8"LB<>;.``?``7!(X-#I':,> M.1`!1%024T!H`%AI,59(>YSTRVN>W1;M46%F1\,3.[X&_IQF_]`QYJ[)7KIG M&^+/V)G/R&>OK.!=CIZ3&J3`!:@!9T M%P`&@#4*8-!=E<=`VA3J^,/W[7O'=1$FQ*'([><)10-4`!5`Q=Z@8M`9]?K= M,R`"B``BH">`"J`">J)BM[M&8:Y*:TJ8WJTS=H4^&X!T`T24$5%NHJH"P``P M``P`>Q9@)YW>Z:#$$^(`%\`%<$%[`6``&+17W<"U]RD''WT>MPAFZ&R!4#I" MZ0BE`Q5`!5"Q'2KZ_7YYMA?P`#PT'`_0$D`%4`$M494C7J/05Y5)"'%X1AB/0\=VS,`1E50J;$L@[`@G;TK41C4"6G/55%N@U>]UCD=EUK<'NH`N MH$O?-NJ<$;C0FAS@`KC*+]38/^[T3T[**UZ*!@^`'J"'U)\:!47:%?O(-?5T M?=.KN+-GPS`UZ@Q/CU!+%;%UQ-:QXP14`!6/1>PZ9Z,^.C8`$4!$$@@X[@P' M)38Q@;L/N+08+C"KD+BP,=-\B>BG"ILJ(C*VOY&Q!@&LN4H*``/``#``[/G" M6L,1SIP"6H`6=!<`!H`U"F#0795'.XH?X^*S$PR007Q!?$%\07SO*@1L,.D>C87>T<\)ME"77`-9#"AUD M&V1;G61;?]`Y.3WI#F&:O7KT'[MM:^RV#7>YV_8,$7!^\!][>"^IKLB.TQ0^NB88\=U(D>$ANG9QLW4#,24?A9!^*MQ]6?L M1`\MY-W:@;XVQ(*T!,>!X\!QX+CZ$`XDWQ*S>V9&<:!B^?[$ M<-/N[;881Z\)TXI/OM-6A8;/+8O6 M-PJ-N?F`QI@J[%`>@-J"$^S-[2T:>D`#T``T)+JA=U9>71#@`7AH.!XJB&P` M%4!%PU'1[_>Z)\!#";[V?N1GD1,>Q,)F'SSP75<>M-9_OPV$:T:"L1*B$^;3 MCDIYG0S:'O="<'T'2JLMP,+N%0`&@%5J+AYCSP;0`K2@NP`P`*Q1`&/=55ZA M[+9#"_D&2:@C\!],ET^B(5R((/KV\X3*`2J`"J!B;U!Q?(*=)<`!<("2`"J` M"BB):EWO_4H_X+0#/Z++#$L7C'&S.HT(@CUU8@"I!Y43`/IJ_X!UU.N>`5E` M%I!5-K)&)R>`%J`%:#4B)@&``6``6&H5#LZ@NZH-?+0JOG&Q',TPIL*UC8D? M&*&)H@?5**VV``B!=*`"J``J@(K$_CHKKV8FX``X-!P.4!)`!5`!)5&1*[X? M.0C77B0"RY_1NQ^JK$4X]@-;!`E%^O.?1NB[CFW\2T_^:TV,;'!47@K0UC1K M"VX1G=Y%='I/D%G%]A``"H`"H&5E\PV[1T`FD`EDU@V9A\.S$@NEO)1H&9=M M2K57\[+>`+:`+2S>%NC5EV=U#'K-CAA]]R/3W=5)E88A;G!:WHF4MB`&>Q%[ M"X=C%.T''`"'Y+;3T7'W&'@`'H"'\L,*B`X`*RW&REEOU#V%[BC!&:]1"*TZ MD?+1YW&+8&;88AQ5$D1#D&QOCS8U"&+-55!M`=BPZ/B>:M/IAU$@(B<0 M,TY#&`M/3)QJ&G4V#%8X%HGX.>+G0`50`53LM`,F\``\-!P/T!)`!5`!+5&5 M-UZC^%=U;OJ5=^<$OL=^N>FBE06BS8@V-UA7`6``&``&@*U3>*R\,^)`%I`% M9$%U`6``&%17K9"U]VD(EV(B@D#8AN-9_DP8D?D3Q0^J45-MP4S]X-%@,S\Y0#`&(`"*@)X`*H`)ZHG(?O$8AK^J<\R\1_93SS)%_@!@S M8LP-5E@`&``&@`%@SV>I#@;E&8J`%J`%:$%W`6``&'17S:"U]QD(677'7'3# MF`K7-B9^8(1F-3T\&P8J1-0144=$':@`*H"*9\MKE]>U&6@`&AJ.!N@(H`*H M@(Y`'L+6S'+MD7]N^3-Z]X/A^J87&G/SP1Q7XYFW)0Z&0#,"S;5456T!6+]S M=EQB$SJ`"^`"N)+;1IWA<0\%K0$N@*N"9I''G>%@%ZIKF5$V)4SS&TD">4`> MG#*D*&S/-.H<1L6'+P"DMN"E?M!HKMX!*H`*H*+AJ!B.AJBY#3P`#]`20`50 M`2U1L>^]9K"FUUBO7'ZZ%W)`8]^UU7.^^[OHT>`'M@@2^O3G/XW0=QW;^)>> M_%=NH$R_C*]8?M-K5C(Y+;%1][8$79\X#<8_@MN["&X#T]%O1YV3P5GW%+`& MK`'K]L#ZM#,:GI18$1RP!JP!ZU>'-6>0'!_50%UOE6&R`V&`]!-@OF68/^F< MDH4^?'7([X4JW_NDEYNI&8BI[])2A[\:XL_8B1X0I?YMU#D[.BTO+[HM<*D? M,IJK[)J'B-$1=FZ`""`B.9C6[PR&@^X(D``D``D5K^@?=_HG)^4=><')%N"E MQ7B!FX%TF%+283[FBFJ:GFT4W?JK3=WZ#2)*P_E/P_;CL2O2X-!6T;A7#$.] M%,5_V1EEG^7Q'4?C*Y"'I\=5)1UM0L^]"'YB3V-[BP02$A+R58(.O<[QR5&) M%3L@(B$B(2(A(ELD(L\ZQ\U>+__CVY?*[\?7C15/&??'E\^75 MYYNK2X/^NOGR\?KR_/OUYS^,F^_GWZ\^77W^;GSY0#]]^OKMZF]TW?4_K@R: MYI=/5_6;H+SO@Q.2"#(>B(T,X=G"-I8&NLUC;\0\$K.Q"(S!4<<8]/I'I3QV M>7"O3D7UD2]_YT3T`DN;U8YGT&VNXWOAT_;?7LJ0W%,*IA=OR?ZR`ED\[@DOZO/3LM4\F64N>]2/P[@?'` M>-LRWI7KS!PE^(,(BP/1-AP\YP=-P]@_B" M^(+X@OAJFOB"!081!A$&$=9@$08+[+6K1K4DVJ_W3L+(\"<;!_C7KJY6Q7Y4 MNQIT/D>AMF`-^5?UZ8H`U`%UR*W8ZZA@!10%3+$04]!50!5=!3 MM4!4A2F._>9&/>2GI1S'/P(_#(UYX$^XPT;<$AMDAVH?(` M,``,``/`GCH&KKW/[[@17)7BMF/<"D\$ MIBL[?9GVS/&<,`K,R+D3AO@Y%UY83?I'T_#5/RXOT-@6$-4/+\U51$W#PU'W M!'``'``';7[UAB?=4R`"B``BJO+X@0J@HN&HZ'?ZQV?0$Z5XXS6*?U7GIG\3 M(='4FDKWW!9WPO7G,T&/J=(W;TM0#%%G1)UKJ;4`,``,``/`GK<73X^Z?4`+ MT`*TH+L`,`"L00"#[JH\!-*R2$<4Q%84!S0ZPYJ:P:T(.X8G*CEWT3`L(6:X M\3RA)MPUYY^9^``^#0<#A`20`50,7B;:->=P0XE.!ZURC4 M59U/_H?I>*'A>P:]C=QSAYQS(3,17,?B[(-*PE_/5.%H2WCL%4H"M3Z(5AF! MH!$!8`"X!@`&0`'0=0%Z..P>O3HREYEL4Z*]FO7W!J@%:J%6H58!4``4:G7G M:O7E*2&M*\?Y92ZX-H5W:SB>Y<^$<>CZ8;B)H=+6P.YA?W!<7KK5/L`+NR![ M#)82RU<`*\!*B[%RW"NQKMB^.%3`0VOQ@+P2H`*H6,HK.>XC1;U\!W[/03*L M`"3/T*H)]`'_@'_`/^`?\$\]Z0/^`?_`28#K7+6K4*-M^^IBU-=>)`(1IA7O MJL!1:[;FSX[+.]ZQUWOO#8)><]57:V`W&/:Z`^`.N`/N=HN[(\`.L`/L=@L[ M,C*K1UU;'#L@"\C:1*$=[:")WSYHM(;LO>X@;J(RI1%^1/AQ^WE"&;46%;WR M3@T`#4!#P]%P=@(X``Z`0VY#J31??Q_<#F!E;['2[_:@.4IPPFL4$:M.H'R) MZ*?T$+-.;7A36;G[M@3(!OWC[K#R^%A;X-<@I#572[4%6E74W0'``#``+-W< MZ9TB70'I"L`=%!L4&P#6&H"=HLU?M1&1-@4^9%J"Y<_HW0^&D^0H<$^!B1`A MPHB_'?9'J$U5IC$(E=1:K""C!Z@`*I8VHDI4((`#X-!P.$!)`!5`!5!1K8]> MHXA8=3[9U9^Q$[';SGD*2?:"/S'">!PZMF,&3C4N_+ZT5AB6V<,974_0#?#U MU>*^0'=T5F9F$J#;&&T+:-8=FH.C7@TZ%@&:@":@N;39U>F=G)18LPS]Q(!< M(+>9\:.]5ZU-;?BW/`1YA>,1=*-W;^4WI7">_+34%/!:Q:$F@3^C@7N1X\4T M&L-7O0)]+S3&8N('(@E81>9/9)IPM*EWAHU";(E@2Z0*/Q%X`!X:CH>3X0!X M`!Z`AXJ"%8@Y`"XMALN@?U3>CEA;U`=R2QYCE_?"$Q,G4FY\U9[ZOD3IN-'Y MV:O'YZ#HD&R"X#N"[[76S`U2P@!HW0%Z2'YB:=7@H'A5Z%0#= MG@W@S^Y$KS8U%Z444LE/F^>9(.C[VW!08@.C?5&!T'2MQ0-R2H`'X"%7*ZYW M!CP`#\`#XD$GE>2=MBVT\`6)654\LL10!D M`5G8V'U%U8;,"P`4JF]=U7=<8HVLMB-KG[NXR$]+N1&?TWJPKZ$%MR&M?B9? ML?S`5\V@*+%\_[,Z<&TB-!BM+R52.<`MC=0-UI5[!./=%IT$C+'M!R0^DG(R M.-YASC"0""0"B?6H]KK5!N(.$%R;W44`%4"%#UK;B%&-`K35";,O$?UD<$?@ M0$R%%SIWPN",G30G)S)_(G#[A%(]'G5/*X_<(A>G5G!LL!H%[``[P`ZPVQ9V M9\@\!>P`N]W"KC\LTR%L>WH`H`5HP9#<$W#&]RL^$*--D?XYH>Q%-?A5L[E-*$R0?)%\)7M/I M457;:)!\=3'G(+L@NUHHNTZ.*JM@#=D%V079!=E5897@T6"'AA?2#"'8(-@@ MV!!*:Z!1EMLT^&MDTO177I_[.SW+Y7?CZ\>+)^=?7YYNK2N/CRZ?WUY^O/?Q@W MW\^_7WVZ^OS=^/*!O_[Z[>IO=,WU/ZX,FN*73U?UFYR\[X,3$K*,!V(_0WBV ML(VE@6[SV!LQC\1L+`)C<-PQ!KW^\J&);1Z[/+A7IZ+ZR)>_:3#[%(5[TU.?\:SP_F)EN01_V^9KT MP5(&&I9P77W-[P>]`_F9!+R5?%Y!J._.3(3&9W%O?/-GYI+)-3.#6\=3@S3C MR$^^4/:=_.;>L:,I74V$T*J'U(IKSD/Q+OGCMT55DHT[O^.;)1'T5N[LK[%I M+`?S^\&H_\NSFJZH<_6-V]YWMN/W87Z8'^:WZ_DU)%6E=FYT.MSA*YS6>X:6 M3SL^2_J\]&2?3R992Y[U(_#MR)B[%J(W8+M=L]TUO\V31;7)*?K@>*9G">.F M>]X%-X(;=\"-ZC3I33P.'=LQ`V>C,NY@/##>MHQWY3HSQ]NX#R!8#BRW+SKLQ89>@P1:[;0M M1!A$&$081!A$&$387HFP0:=W.B@QWQWB"^(+X@OB"Q881!A$&$081!@LL-=) M:J]S>E%UL+OP0UD[>-,8_JM6`]^O]HMMP5K]8%4[BP"H`JJ`*J"JI*HZG=Z@ M7V+)1"`*B-IO1$%/`55`%?14+1!5899BO[E1#?EI*4WQC\`/0V,>^!,GJ@21 M+:FQO][@#@`K@`+F@O``P`:Q#`H+V0 MO[$1P]P(+BIQVS%NA2<"TS5,SS9,>^9X3A@%9L3MC,3/N?#":M([&H:OX4EY MY8[;@J'ZP:6Y>JAA<#CI#H$&H`%H4&CH]@(>&XZ$";Q^H`"H:CHJ3 MT1&T1"E^>(TB7]4YZ-]$2#2UIM(QM\6=9:ZBP` M#``#P`"PYS=TCH?=(T`+T`*TH+L`,`"L00"#[JH\!-*R2$<4Q%84!S0ZPYJ: MP:T(.X8G*CEQT3`L#8^PU;KI/*%S6@L';"T!%4#%XFVCXVX?<``<``>' MMP4-R#9XC%G^,!TO-,@+I[>),'*B.!"R\('K6%SLH)*0US/M/MH2$JLBYKPM MZ=J"Y`:!MKD*#P`%0`%0`/35`7K8+[%RUXN)EG'9IE1[-?/N#6`+V$*O0J\" MH``H].KN]>K+$SU:U]GSRUQPYH=W:QRZ?AB^,1S/\F>51)J:!LN3H_)R0/8! M7=CEV&.LE%>>!5`!5%H,E>/N65E%-#06C0@:02H`"I6N1ZE:8E]L*>: MGE)27V0-=WEBZADB[I3W$"(&]X'[P'TU(2*X#]P'[@/W@?MJSGU-=T6JH^RU M%PFNI9>T[JO"T6]+3@`JI$#NUS*2UA:`'9X>E[=EN==)-8`=8`>]!KT&@-4! M8,/N"8`%8`%8Y1N,@QV4U-L'@W'OR^VE@1#D6B,-"&E`2`,"*H`*H&)-5!QU M!T`#T``T*+>D1(=_'YP/0&5OH=)'2>]27/$:A<6J$RA?(OI).^C&H-,Q M/!$A2O9$^+E7WL$%Q)_K`[3F*JFV(`L[IP`8`%:E)S4XZ9[NC+/VV<<"[``[ MZ#7H-0!L-QE!I76I:3VPD)K`J0F6/Z-W/QA.DJ?`+0@F0J`O(%F)9^75:H0M MB'A[BZ&"]`6@`JA8O*U$_0$T``T-1P-T!%`!5``5U7KH-8J'5>>27?T9.Q$[ M[9RCD&0N^!,CC,>A8SMFX%3CP.]-FX;!\:C$#2+T::@@#@F="-PNX;9_TB\O M91RX!6Z!V]UDMO=ZP"UP"]PV"[/%-&K#5XT&?2\TQF+B!R()447F3V262'NW?]H=E;T[L,]F M*U1@>\%2:C`68`%8V@R68:_$KH,`"\#28K"4&KYHBY,#/.PM'@[[1T,HCTV4 M!U)4'B/A>^&)B1.IV$#5[C^">@CJ(>I>8T4(@`*@`"@`^NH`/>SW2CPCC403 MP!:PA5Z%7@5`]QN@T*NU#CGM=1(*(KM(.,&V(+9!D'`"L``LI8/E[!A@`5@` M%B2<(.$$>-@P:C`:0GE4[OW7*))7'0FS((#MA#H.(.Q<&$`V=.$J*95GH[0E MIK>+!B_[`-H&X;.YJJ\MJ$.1?&QE`6#5%@D:=8^AV*#8@#LH-B@V`*PE`"/% M=E1>W]N]5FS[W!Q&?EK*L?@L(L/UPUD MW$9879]T]0=R_3#;8#VY3S#=:05HP!0P!4RW@>GHI%]>7B-@"I@"IG7/>WGV M=$#U@*M_8`A(!!+A?KZZPD2ZSF,D_!+13P:W'P[$5'BA<_S1L/QZ[8D>QTE=CQK_LG(`[ MIE?Y<>;C054%H9Z@VMX&FNLG[VIG8D"P0;"5TF#GI,330Q!L$&P0;!!L-1!L M1T=EGAZ!8(-@@V"#8'M]P79Z/-RA)XKL0\@NR"[(+H31:L1WV^PE_#4RB32K MKM^9Q,W1QG4\\7:J`OW]0>^7WW+$LH07B>#U%02&V[KAKMY?^G3^\>/UYXO_ M^/;E\KOQ]>-%4\9]\>7SY=7GFZM+X^++I_?7GZ\__V'"`6,H1G"]M8&N@VC[T1\TC, MQB+(C)[!2<<8]/K+AP:V>?[R*%^=G.HC7_[.B>@%EE:]CF?0;2Z7CGQ:?Y0S MZMQ3"M9?CU2L?(I#J^RIS_G7>'XP,]V"HN[S->F#I1XS+.&Z^IK?#WH'\C/I M8BOYO()>WYV9"(W/XM[XYL_,)9MZ9@:WCJ<&:<:1GWRAC`?YS;UC1U.ZF@BA MK02R`%QS'HIWR1^_+6K];-SYS?PL/Z2W,FECC7P`.9C?#T;]7YXU2HHVE;YQ MV_O.=OP^S`_SP_QV/;^&9"'5+DZ2#G?X"J#&'7"C.BA\$X]# MQW;,P-FH9C\8#XRW+>-=N<[,\39N(0F6`\MMRW(7_FSL>,)>EYPH+[%1_=+0 M=%]7>SQ*^@;LH96W=_L<_S5\SW:7=D/2JQT"/$%\07Q!?$%"PPB#"(,(@PB#!;8#L570]*+JH/=A1_*LM"; MQO!?M0I\R[IM/D.AMF"M?K"JG44`5`%50!505=()_;->MP<\`4_`$[044`54 MU1)5T%*[BENL%XOM-S>B(3\MI2C^$?AA:,P#?^)$E>"Q):73=[DWTA8<8OMC M%PH/``/``#``[%E3"BTG<=HQ; MX8G`=`W3LPW3GCF>$T:!&7&'*O%S+KRPFK2.AJ'KJ#LH"UMM@5#]T-)<)=0P M-/3*JWT,-``-#4?#Z*Q77N*G#U@0J@HN&H&)T=E=>SO2UX0*&D MQ]CEFPB)IM94^N6VN!.N/Y\)>DR53GE;8F$(-B/87$N=!8`!8``8`/;\(=VC MD_*L14`+T`*TH+L`,``,NJMFT-K[3(1O(HR"V(KB@$9G6%,SN!5AQ_!$)8()6P_*."+0^Z-4@<#57,[4%6"5F5P-8`!:`E=QVTNN.@"P@ M"\AJ0.P!``/``+!4=8W@;54;WVA3&.,/T_%"P_<,>IL((R>*`R$/5KB.Q8[^#(7G/'AW1J.9_DS81RZ?AAN8BOL73#R\'0' M^VC[@%-L`6`+8'W4]`J<%432`6N`E>!J\!5 MM2=50TSXZB+@UUXD`A&F-?.K<(X;Y@.C*$J#A7!])&_+4''8/RMO5P-;AL!* MB[&"WH]``]``>PJH`"J>LJ=*VVK;!WL*%>B>]>%5-G(5X&K+_C822)!`4DOM M!8`!8``8`+9&;&$(8`%8`!8T%P`&@#4(8-!.YFJ%L?.@)H`!J@(X`*H.)1'5%:4::V MH`%I!D^F&9`_3N]^(,]'M05UV-#! MA@X`5B'`=J'5`"P`:^^`!`_&$ZGG'H^F'X1@4];"?4<0]A MY\(>LG4)EPNI.BND86`[++&7"3090OLMA@IJV`,50,52S+Q77M8%X``X-!P. M4!)`!5"Q0DD<`PXEN.XU"I3M,*GAI?UAH%I8!J8;ERBR4M) MNM'VW0Y$06WV]H!X(![>=K.T^-XGR'R)Z">#^P8'8BJ\T+E+2L*F*3&1^1,Q MZM\&I^C&C2T;;-D`#H`#X+!XV[#$NG2``^#0<#@<'H_*BU@@;QA8:3%68$F5 MY);7*/ZVP^27BQ6N>S6QH^'\IV'[\=@5+ZJN\YH!I]*I_Y>=D?I9[MYQ%+Y$ M,;B:M*Q$%;9!DK9U9`@$*`5I/`=KOC:K:1H($A02%!(4$;;L$ M'0ZJ2I&%!(4$A02%!&VY!#T<#&OAQK

7$UP9'-"'E;=QZ%O$70M/D&:VZ/ MZJ^12719>7WN[]R\7,<3;Z=J\?J#WB^_Y29J"2\2P>M/]56&NYJK/YU__'C] M^>(_OGVY_&Y\_7C1E'%??/E\>?7YYNK2H+]NOGR\OCS_?OWY#^/F^_GWJT]7 MG[\;7SX8%^^>+UEE9>_9S3RG8.CW2 MJO(I#G&1IS[G7^/YPD#Y9BUK"$Z^IK?C_H'&J091W[RA3)7Y3?WCAU-Z6HBA-9NI+E<5:9%?:]OW/:^LQV_#_/# M_#"_7<]O[\]$O=0SR`OYX2OT+WN&KD_3\VES-K%S(%-S[.C>H,[DT\#AW; M,0-GH\KS8#PPWK:,=^4Z,\?;N/$C6`XLMRW+71"K\1S-2-CKDA2G0=8GKQE. MC0\$AM#XP.U.OJ@.)]ZM<6Y%SIT3D7)Y5PDK5TON%U5JJ9V`:`KCUHYP8$>P M8XT(!W8$.]:(<&!'L&.-"`=V+)VJ+]^:Z3?7XY&W<:\'BYV<>>#?.9R,,GXP M#N.0_G"\-TE'1_)WS-3?*0WK%7CK]2!J10F9CY.H?(J47I6C=]+M[8HL;4F) M1&P0$@829DV2'/9'9;:R7I,N**(%\0/Q`_'SV^GPI+RF>S!P(&$@82!ABK>5 MW^L6<@9R!G(&_%);F^A?:G9AS+1%#_)P+SW:B.-@H124K']&N M-B@51`O;XJO7#QWU$BE`!5`!5.P1*F3J3&G9>4B-`5A:#!:H$*`"J(`*>:D* MP8[A8R0\M_Z,G="1930,T^.3*)'IW3IC5X0=PQ.1X4_4H163KPS6KWRP"0!+ M)76[]-6CI-D7158CaPP%@`!@`!H`];UL..OVC4?=D9\S59K,3R`/RH-J@ MV@"P.@`,JNVU(RIM"IS(RLN6/Z-W/QBN;WJ&(W.K9X)HAQCE87]T5M[)AGU` M5/W`TUR5U3"P8)L+J``JEE3($5EKI149@0H!6%H,EI/>L+R2&%`>P$/#\0"3 M"LD06_CTB0=/SKP1)DUM'A!50]@:8>N&*:RV`.QPV.GU1R56"=GGL#60!^1! MM4&U`6!U`-BN-!O`!7#M';B@O784&FE3!.2;"*/`L2)ART,?""0BD+C]/*%U M@`J@`JC8&U0,NWV@`6@`&J`C@`J@`CH""0DO8Y8O$?V$(!>"7(@B-TPK`6`` M&``&@*UA#Y;7JAG``K``+&@N``P`@^:J$[!>GEC0;W@HX[.(5!W).!1<95*7 M2Z"A&F;:BJX2N%703U,_DZ]XILWB;B%9;M6%=2FW4<+X^J1K?C8YM")@NA*F M92>^`J@`*H!:2]Q1`!5`!U!H#==@YZ9?8$^$YTNT`-1HHS2J"2S4*Y59"0OGI7L@!C7W75L^YX`C4!Q(AH?$A\&?&!\.`\>53;B]/RY_ M'88Q^0^"FR322T3@F:YABS$Z`$0X_H7(&HY_+=TVZ)R>]*A4)/5&.!UZC0%"5E>SFYH,LY;_HFQNFQ]7MYDY$7Q#A MPXKRSEMRS`/GJ'".JI8:K"T`.QPGZ!GU>NG5;0JE7/VT1!@:D?G3&`M/3)S(F'#R=#@U M`_%V;/*!?LN?S847FI'C>PA7(HB__3RAKX`*H`*HV!M4#$64^AKXM-IVJ#(:Q$\16$XHZSG( M[`;#GW-&0R7!DX:!;EABP?)]T5I03JV%`[:I@`J@`J@`*H`*H`*H`"K@4+P< M#DAI>+34HA>1;^[/Z-T/ANN;GC'V`QH8C16I#0A&(QC=-&W5%H"=](8E]CH! MM``M0`NZ"P`#P':PD;H;Y;4/.ZG`'7`'Q5:WT$B;(B`7NF2E13\%SCA&J04$ MUU\V3Z@>H`*H`"KV!A5<11R[3D`$$)&E4I<+";CZ@$N+X0*S"JD+V[2BB`-K M:N;.%2!EX2F==#;H#BJ/BT%3U0I^S55A;8$=@M+8;07``#``#``#P``P``P` M@V=6D6>V]]D,7R+ZJ1*L^8$M@H0$_?E/(_1=QS;^I2?_-0UR5>BT9RBT+ZH- M&@RH`JJ`*J"J+/-P<%IBE='4F`?^G6,+VQ@_Y)IVF%;DW#F1TX!<$P!"S7@V6_LA>J=.^3:*XF$V%%?*K(BH-`>-:# M$9B1,*RIZ=V*T/`]&6%J2N"WKJ!]A;V6O)M)[T2:T:T!0]-3YZH MB]G_L[-R_7\<3;J8I0]0>]7W[+3=027B2"UY_JJPQW=>CNT_G'C]>?+_[C MVY?+[\;7CQ=-&??%E\^75Y]OKBZ-BR^?WE]_OO[\AW'S_?S[U:>KS]^-+Q^, MB_.;OQD?/G[YKYOZ34G>]\$)22X8#\0X'",5MK$TT&T>>R/FD9B-16`,CCO& MH-4@GKND>Z5 M3W&(%SWU.?\:SP]FIEO0X'V^)GVP%-2&)5Q77_/[0>]`?B8M9"6?5Q#JNS,3 MH?%9W!O?_)FY9!G-S.#6\=0@S3CRDR^4&2:_N7?L:$I7$R&T?B3=YYKS4+Q+ M_OAM4=]EX\YO[F1&T6"EK;'&_I`_;S?P:DN)>7^]Z^`K9ZL_0\FEO<,E^*#U=X)-)UIEG_0A\.S+FKE66 M5PVV`]NMRW;7_#;/C,A+("?L@^Q`)(R;[GFWBA#:;J@);FP0-\I>X,9-/`X= MVS&#BEI>@?'`>`N,=^4Z,T=)ODU8#IH7++(;EW16+L2S=&D(+[:E;58J\L1W`? MN`_<5T/NJPWAH'GWC?M>OEO2R@;OAW%(?SC>&\-/79.M6KWOW+&N!U'_LFL2 ME4^1"NJ\E%=O&F61$,6#@(&`R=]V>'Q48I?A*CI5U(-U-JD"C&TK2!](GW5( M,AJ4V4]C?^P;2!A(&$B86AQ6;;6<@1\%.0,YL]:YV9-A=_D(&B1,^7'D&FUM MO&+RR[5W)T(DO[S$,JA8/=:(3VNG-\%]NW0"D7X`[@/W@?M:Q'VU(1PT[[YQ M7T.."E='P`MSSH5(#/%S+CS;B>*@/H>ZVE46KRU^?OW045^Y#%3L$2JPC[>? MJ#CL#TIL18*T&H"EQ6"!"H%A!51`A;Q*&^L:Q9*J(^&Y]6?LA(ZLE2$;7#E> M9'JWSM@581Q%Y.O#-8O;["/G>>K2#EZC#3[HLAJ!,/F:C@`;*\! MAAT[`&Q-VW+0.3D;EF==/DN7-IN=0!Z0!]4&VQ$`JP/`H-I>.Z+2IL")+*]L M^3-Z]X/A^J9G.#(O>R:(=HA1'@Y*/%R^#X"J'W::J[$:AY6ST_*:8.\)6+`E MO*=@.>L?8?,+8`%8UJDAUAD,3\MKZKHO80/86JU%!#**D"2Q,=.D/6P>#'J? M0P"UN?HG3=2NY/A#6R)N"&DCI%U+I=46@`U[O>X1H%5W#MDG#ZDMT(+N`L`` ML"H#>;M17GL2X:L-UF`SUAQW4&PH_+!%MD.2VV`XGA&F\1!$%!%1W'Z>4#^M M1<7AL',R/"K/OML3,PX;M?L)%R@1H`*H6`IOEZM#6H0(F%7[B0CH":0O;,PT MW\AU#QPK$K;!M>01'$-P#!D+#=-3`-A>`PS;J@#8>@`;E7>2",`"L&I&.&BN MI@&L-J"":5AS@$%S51SL:%-,XTM$/R$@B(#@]O.$C@$J]A(5V$[=3U0,CKLG M@`/@`#A`2&@9[&+=]M(QF&M=A% MK([GJE8_T#+@I2HT\K['6L!+X"7P$G0<>*E9O(2Z!H\6)0S#F&QV8?@3@UXB M`L]T#5N,*^F_V)93-HCG(F)6SXA92P#&,:]A=PAPU9U'VF20[PNX^J.S$K>) M`"U`JUZ$@V'8-(#5!E0P#&L.L&&G-QIV!P!7E8&/-L4WOHFY^2![+BP&.`S3 M(P"9B+XB^835G+!H&,!SH0T!Z!_JH8:@X+#$8L54>33V$*;HP`"K/0Z6/ MCB7`"K`"8PO&%E"QE089E9?NO`\:!-D-CY'PZJ;CDY(9)>A3;\L,(F0V5**FV0*9^Z&BNRFD8 M*@Y/>N75*MZ'8#NV:_<7*_WR"@4#*H!*BZ$"8PO&%E"Q;&SU86QMHD&0V?`8 M";\&/DW*#E4^@_@I`LL)914'F=M@^'/.9ZBF:T1+@FJ#HQ*K*K8]JM8@T#57 MG;4%6=@/PH8K``:``6``&`"V1P"K#:A@(M8<8'"^-D#6WJ8<*+1,!%%DSOP?C_[)U;<]NXDL>?=ZOV.Z`\)[6> M*D4CZN[,F5/ER/;9U.8RFWAW:Q\A$K)PAB(T(&G'Y]-O`Y)\B6^23$H`^<]# M2I))$&CVK[O1N,6*)VRL-%6,ZHKI"<\>_-CLEIXAJTD`YPN%_GJRJE!WU"WR MK-6J)Z8QI@JT]M.;`EI`RS'![75E4J/=V<4B<<2+B!=!'B8*83K#:Y1FM#QU M(J0_:3G.R]IZ$BQ5!1GWZ/#7]8"*"E&!H=EZ4M%I##H]#,Z""!!Q,[.G6"30 MU4=856%<$%9A+L,VITGF.ISR.SLM8`[#LWGIP0Z&?."IG,+/7Q=6%>R0E,9X M*P`#8``,@`&P&@'F#%0($1T'##VSO>Y16:6DR)>,_E0*:TI'0J]$$,R_LU3% M,F(_M>P_WY`KPZ>](*&ZN#9X,%`%JC!8#*I`%:@"5:"J@E0A`@15H,J7F1Z! MYUF-SR)C(4^G;*Z5V7$R8N/K.Z=J\C"3ES*3'LS_6"JSN>(%3=XMM[T=K%=< MO^T>4XS$OV^)?U>1[#0&_58S`);>8;FET'R(Q6HP;@LK=-\*#?O!#G;AJ8L5 MPK0;!`=%3!GH-OJ#CJN;C.P`9DSV!K.>,=MN'/5V@6PM7&GM9_J<3B8BS,S2 MIS#76B3A-=,\$RR<\N1"I$PE-F7F2\[:56CWD-"N!;_NH>JQ]P2/X'&'75/T M0,'C;4>TV=X5B.B+`E)`"J?IDM-$$`L>X31==IK80><1$=IO5\)6:*SBZ':> ME4Q"+16'SZF7Y;3+_B2;3X(/[,Y26/19*Y/^5JGYRW7!VAV;L"8A#& M/0]<%>HZPV8+V.VXOXGY"BX(;H_8=0=!@5$M)IH!+;<$5['\30T`(9)'!9$U6 MD+J'H+^>S3-:>GV/"\E&#PL\H0'FL:@.!V9&P#S"/.[? M//:'1P5.N81]A'V$?81]K(Y]+'T!)JPD.MFPDK"27EO)0:O`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`VVPK@C&!( MV9E6,_9E+C3QG5RPXS"3ES(CY_*N%%4N5]RO.D'%.0/AB^(Z)SBH8W6VV:U5 M;`EUA#I"';U41V=4$,ZZ]NKX^B&8P-\>C[W-'`UGMSF;:W4IS0R:\34[S%/Z M().?F;KI[_";_DYAK)>]L7G5E@X^+:+B)5+XX5U!64L`"SH:TPW-*>SD//A+ M&!\8GY7Q&3:[,#XXKQ[&!\9G]UL,=OO-8%=BJP,#AW8T>3;3XDER*MP&2;BH66[NBF;*\N+P>_(C/S58F3'R?BR226:[=60B&,V-=[*N[ M1X=;)@54U)0*C,75DXK#H#LH+N6+J3&`I<*PP(4@L`(5<"&O=2$8,7Q*A,?A MG[E,I=U?@_'$+%')>'(AQ[%(&RP1&5.3Q6H6;J[4ZV^)L+>$<+7\U9.BJ8LC MW7T(=O`P&?>N+ M2K=UU.P#%L`"6%[4D6[0;K809R'.`@_H?930<7N/$M7I]Q< M(Z&&C#4RUIXYK*H`=M@?%A?9U3ICC9%88`>_AAE&`,P%P';BUBI$EC,T(6)T MG"RXKATE1:J4^[`G^R)QB,3A]NV$KP$5M:0"@Z[UI")H=D`#:``-\!&(G$`% M?,3>)R!4YLS0Y3&ARR4%LTB,2]EQ$`MB:IV/]84VMVQ7'0$;'NUB5]T*H85!<*`%WP7` M`!@`\Q,P9Z!"<.@X8`@.-T&KSB./]K:O8LZO[1Z,/Z8X[+F4(9_+C'X@^:;E M+(7P#"\LNT,:VM%A'E#A*!48W*LG%8<%KD;=:HZ8&R$&#E0`*G`@"*M`!1R( M@_.('E2?"T^^A2%.6\>]L+!(QD1F;F'G%Z91K\7;,S?X'YG!%D:0\DRI! MA@TI;*2P/?-N`*S6@&$0%H"M!UBGP,TY`!;`8,5`@-'0<,GFM] ML&H_M^'$S&*8W*R<#E6:80I#*4ZJ*LBX1X>_+L.ZXATSQ))T*G+%-LSK5(L!<#$M)(2/OFQ:H" MV&'0(!'M("M=!]>'L5:0M_Z)]MUNLP>GYKJ&`"W_T$+4B*@1@)49-?:"7O,( M,2/VCG^]I'[7BMYVE"X6=(CO0H$D%(JAZ4H'^1#&]<8=28R4>)9%DU#-7,WKV M-8L53]A8::H8U;64OGE54F5MK/@IS!5UWK\%#$CN(-CUOR18 MJ@HR[M'AK^L!%16B`N.O]:2B/RRNMP,<@(/G.!P6R0,Z^0BH*LP*`BI,5MA8 M:;YD]*=2$F%*1T*O1!#,O[-4Q3)B/[7L/R3*2A!=57#UB$Q_O1L`!:`8P@6@ M>P>T5>`IY@`38`),>$Z7`74&2H2VG@,*S^G2Y(W`\U20V70SY.F4S;6ZE)&( MV/CZSJ$:/,SDI*NQ>CZXI;L+BVDWT&#V,68"CQVX+.KWB M3L4&246,:*TO&P\Z(Q5ZZ[6T#X.@VQS`/CBD*77*`E6)I,/NL+7G>38[X`^3 M<(#9?CN&`W0-,7&G&%TZG4Q$F)G-/\-<:Y&$UTSS3+!PRI,+D3*5V&2.]^E5 M5UEV:7"D%J;`(^K]];9`&VB[W2W%K`6@_8J4"OJPF!C%DVCQ0?R9RTL>BR1S M9C+47C%M%X5I58!RCQU_7:%G-/3ZQ1U66B$<,.^@GCBT@T%S"![``WC`/$8$ M3:#B<2\QZ"%J*J17[E#V;8?=]=%3W7/&,S86%S))S!HF-6%S*E-%WJ?LJN7! M:K_ZT".J_?6)`'!ST50(,(Q'`S``!L``&`#S$S!GH$*(",`J!Q@F06R451'T M^S;YE`T2`9WY=Q:I?!R+FTQ`N=.;]K::ZR\[%^".Y>7PG),715:+*6#N&3KG MH@A8+E@NM^8'P71M&N#7-,,`TP73Y=A<+M@NV"[8+M@NCS-BL&#H.,*"P8)Y M.$<2MNN'E/\O&:?F/WK](Y__^DN>OKW@?/YNI!*R,:F(SA8[I?/X6\8S,3-I M\G-J^OM8A7_\[=_^]5_^>N<.*TV>297\3I_"ZYL+29:)$=A7,?GMX.RDW0IZ M_]7]O_.3`R8C^H&'V=N35M`9#4Y'[_MG_?>]]\>#HT&OW6^/1N^/3WOT[>!O M/[R`N\(\ES.1LL_BBGU5,_ZT:;QS>RP3\7:Z&!H(VJTW]W`:$CL_OF#[71JI MD+GJT@5%OO'SJ3`R6@I01(OA"34;4RVCU6[U/*9B5R_!+..,\TBPC&[E8:AR M\Z.:V.\C-2/-O6XP2;]=354<7[]55Z:H-!^G,I)<2Q*8>0B597>_-ZM!KZ8R MG)H"KAE=S92V[TVKF,V4-D_B"=5EDEV;X9&0[EP][U)E9AYJ.N5:I`USXY1? M+JLVEK&D.S)U4U@VU2J_F+)4DERX9M:BI$UFA$#WY_&B(32FMC>7-]F)O!0I-2?7PK:-RH[R,&-&"U.6 MJ(S*F=/?3)M)D.,\-7](Q>-/HG8O"Z=K21IJ)IKL.([I"&,I8C67B?F-JDY\\0LKR@;C],Q$Z1F) M3@NS89^I$(_^D:?90M:)H`JD7%^S"2D%9Q,N-5LV=/&4V[K\^%I7JD"249IJ MV'S>_#UFPIXT2/[I2;M_VAT%)Z?!RHIU3SIG>[=B:Y1Y+S!KKY#%V__WF,#<\U- MP=;_L%#$\?*:WPY:!_8[.==P]7US:5S)*)O21VKSTJ>3OX[Y/!7O5A\>-/ZV M4G<'PN\F*A[)(:PQE&[K\MM!]\V+`<3]4&9YWU%_HQLW&]"G-U)`7R4H;#3_ M5;[R\?'\H/V":5@C?JR!F(R9*RV"=#:R,JUF5^2;C5O4Y9><$.EV.'@_XK#7'O:$M+'&QYWW#'S]OU?55OWV8. MV+_V[>;]>3+3T+D\ZDUU!Z]ZS)F9W\2<>NECH6_EV.XUF.EI M(6\/?=N)OO6MOG6WB)1A]+91PLZ.E3#8:OK`(X4\U-1[50GN=60*5]W?M4Q" M.>R6JY/_G?"9(GG]DSK9)H%JQB1L]MEVPC^D:6X2TFRD MTHTVF(3:>J.VFPTZP\Y"86%GW;"SV)7IJ0DJ(WL06<9F/,OU8D1:35BL3&N$ MGK&(A/Y\HGA;[<=^`E@GOEM["XV#QD'CH''0N'IHG"?9R_*"NW9SV'O#;!P7 M*YZP*!?L>*YE;)+`_7WV^=R03V'3V7$:TV%Z0Q69_0:;&](R;?1;9I4@BI5?[59HM MJ2ZT6.Q76>7,P.L=4P?Y`*3&D M%O<`\]=_N022FSX,1($H7XEZ_2&O!4[/`T@`R5>0X)J\ZF(YE-HH;VSL(S;3 MV[7M^:[?WDVNVB;YX)=1FY%1 MB(4;\6)AAQHO!-A"KA"Y0H=RA1[TL8+B0D`0`V+@9<`,F`$S#Q(-.%NJB.Z. M0TF&,CU-[&Z:]/F=D*]6`P'1;JNRB!H0`VHV82:'D;'BNGS.)2-J,IQGS5,4?2;1TA-(#_H@,NKX1`9 M\H.`T"T(:^@!CYJ;K`T'?(`/\,$#^M9;K%*G\,@N'8O$6"19KL5JG*R\#F$% MP0M:2,,@HU![U[:\GRBSS- M,$Y61)\3B\F0)W3$Z]5PI"SH%A=!@C[0!^<'YP?\@)\7^`5].+]R>X=5Z@0. M[93)!Z-CRU5DFRS)+RW9_T!8SPNHZ/U*"XPEJT*->X!XZ)HP]`5R0$Y]_,@0 M.R."!M``'X$1J^U#\1]&K%:['Y;23ZG*@0M]Y..0CW/+6;F=CRNV-S0H;JL, MP`?X'((/?@UH`:TJHC7`.O]RNVM5ZI7UFOWVO6[9ES!38Z$Q@+2$J8=#49#Z MC@["T@XPXRR):#"E`!*GRA`F-(3_=6'C])N+W)UJSU2P@@UX9< MFUO.JDYC2$&`A!SHJR1]U8LA`1@``V``#$-*6RO-5W&IXDNJ&0NUB&3&)CR4 MLIX+]IVYQW2<0`V(\]R#(FX,*4/'(P`!H**`? MXE#OO[P.RHC/9<9C1I)-!5-C>@;/I$H83R)V*9)(:3:1"4]"TXGA%UJ(F4BR M%)F"9Y+<&&%""LXE!U:G$2:DZ0!AM2'T5%!>R5,4R8C^U[+^]KL!M](;=YB:[ MQ3^/W=K-]!@]]RCSUX55B:6@=53@'#^0!)+J2E*G<=0K\IA>L`26ZLK2L`>0 M:CUD=K\&Q>:<%UVN#3M:ZZC84AH=TK)(Y>-8W*C95FP^]79VH-"O%?%?=B;9 M%W6X$.NWOB"+[^OV6_WBI@AL+\]:F%&/+*9S@0HL)"QD53(8L(^PC["/L(]5 ML(^=QM&PU1SN7YZPD+"0L)"PD,Y9R!*RC3"/+^8I?\DXR>71Z^]\OM.N6";B M[5186Q>T6V_NJ=_P_L15VW#[729DVQ[D$/=QDAP>?/IQ].S[XF5WQE$V4GHF( MT2?.`G/$H[I*Z'N:CU,92:ZOF9JPD;JD+R)A,B%53A(1VC4,5S*;LFQ*Y8HY MU_9A368+9]*4-U5Q9-=FJQDI_S43J=$@F4[I`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`MAGD=2L3&X02'=98NYCS.31PVXW^(MU<4C9D; MQ4SFLU7EK\C@L3FU0)IW1:(W"GM;4$H7\R3)K53HU7)-T9*V6KT@,>C99JT. M0F14(EMBE039)5K/OV3"9`4J:-*!RB15$[,C$L2#R"1O[R0F0`6?8(+&RF[ MSN<"[$\;;UQ>VU!6A>9\3\`:!SXX5K:BM1Z>)@[\C":'LF`5$9&9[1E5%0TUESO_P@QBUFFXXK4`@J%!,/"W-<.!`;:"*8"[7+51%I3L' M@32)U!D&X.) M`*:T2<>_3Y<1%?V7W#=*_^ZDY@&2Z]HQ48/`$ZATM4>;]6[S[/A[\W,SKX[Q MI8IQ=WQ"[N9P!MH#OI=;'&NECV2$PF7[*)XVTNP?B<[?1K,$*D`6GGC<&L_:6V.YA5B1#?XX#Y=.I$\PY#E0]P$.+&S^DEE&B MA&"5W,A&]3KW$;+*+@AGP$MP26)UH"V2J,!8+.2-#5`)+LX5B(IJ$^2E`P+/ MAD<`0Z+AH:R?1FP2H<2,0S`H&"=@>GE"RL8^IE%#J6^X]@'&J'I#8-!$+GRI ME&!,2GS`[H80F%M>.CBM?1+`+&U+GC2F@-$GU-3\A2:/LC=7Z!2J/#U4Y2KH MX@IX'H>6)F)K9Z:`.>*J6:4.1E#%J+RYDB M@OH#;"7G`>BJB`4T?N6L/9G;?P`3X9W95[Q[^^'+W8TR<5\*4B7>'- M"1@\2V8'*OWTX>VOGY8F6'`/3P);7UM!>Q$N048JJ)&(60\!A*SGS*-Y_$Z\ MWS7A9,8%R:8\R*8.2R)]`#Q(189DU]+C`008QI?S--(3"I"3P9)QX7EV@X%1 MDR4@NQ<>T`N%L_BV$.@[I.L`U)D(?)MZ--+UR0Q5QBT8^]-ZGY;#Z/(EM[H! M\B\,GX')'\!$8&(Y@S\(G7]K0R\FHU3&N9[%RNO0J$`.;<3&9WO<4(:37K"$_92LU\[],O`H=53-CGG$PY01N^NAX/Y?&N!A-WV80/T5?-[H M'C0\ZXST@QO;-J^`F0+^U9?LQ@*Q*V.;*&?8OT-U`L)*@DQ&!W-S7"Q\]&.K M>G4W*-Z@6K\EX\?>OEUQ0$OMABU<;BD[Z!F7[!52-^FZT($EAE4`V"YO779O MOM6WOD^Z-R6 MS,`K@:(4#')/,G_(W+H+F9$L:"K?"^4FI.#8?>F6 M.U48'EWQ30@=G, MH]A4B$8F=&C*X#"V@50A#;)TNH"HC"\6X-?KI(4HQ)T"E=>@M;K,J'7PRW+N M2^J'*`\F\YB)'P3^(P8?FNRF2F11VTLX#TL9ROD)XA9+AC[+28*S;L2G/W4`R1'$2I[+Q_O^)P)"*P_U9P^ESG,L3N\"?FS&O MCSL_-#\U?U()3MNOQVV!U1V!A5!!KD44J*C:KCL$QOR-@?G<`TNYG;A]9`GG M04%5YNF6*LTXI(?;RRJ.D-!]F(;2TT>LDE+%$?^'@QX*GF(C^[FEXJ"E['A[ M?.M3$]O#">SK!?CT3PP]?!2S>J(>CDPS59D56%V#<'3XQEP?WPL5HK37CWKVPF\^RR)P#RC;L MB?L3%?B/%F6FHXX5+QDWHRR/))L@2FND>!0;6)R+EP`;>-K-V:3#[=4Y-)-&>;.%CVQ-ZP_0->('`WE[J/DE*TFRALHS0PI$'%B&]W,GW#,->1_C5[N]1*5FY#<5 M7ND]+)1XJ?0&\Q03=53*")I@:>P7,U7F0+!9-H:>WXTP%Y0<&ZWALRF$]E>'?[G=-Z_3*VOU)W'8UT>?V MK:G,2O,A>1 M"RHV>7`F6\7B&/='XR5]S'W`XV1$G`MF53B^+6,2^);:#\3]1$S0\/1KLF]9 MRL/ER,%A<]%TD'A!G'0`;IQPX[*4Q,+*$@+?KVZS.&A-4.Q6X$MYG;PF)L;+ MS]6Y(=D4E4W;%>I]F)&47YWU/%B=Y1ID\V$SHP9HP&]`SHU,!FXGL,2"/Z&\ M?2YU=>?WZ;Q?/L4-N&VO!#JI*,#44>9;/O56KJ3+O#2!QOH(#?HM/5,E(S&E MGI=9*[1,]P5R^;H8_XRQ@ID+*H5U"B]6T4U$Q`>4VX%&;GP&3AQ-Q>OP#S"D MHP`\Q-BUSS(YFK8Z!1I3A/CK9RJ5#Z%#N]4V2E`G6">D-KLM*XC2$@#E-R3V M4X,Y*"B>&KH.+P9KAJS:=U;?P)L#WTU$%S[LU<0\3Z`I34UD=R%_A'@W$JN0C7PS1*+V!G5T`7YDTDB2G=H4J9\)C'^O9@$ M*A[65L^.K9GV2F)\G)^BDH>S]VAKO8[&VY)%"PFB#LU;.S^H1"4_"I:[W,NG(HV3A)B5 M*+63SYQ?R>Q-!7INE(UE8$7G_G[6I/@?GB9NT^:H:Z0#)>1#' M&>-"EN4-KY*,7*[5+DSP]0]L&?'8(>2HR+![SESET^1R%-?,MFGVZ81S27%W MX(FKZO%N^_#$.&TFYE/C=C(;<\N](0E\+75&B1)ET*8N!02V96%E&:KJS0%(*5ZGR9X1N!EGC91VB#E3@WMY^`0K^@2 MJ=D1YT$0Z<3O950O-LN66LP'A#`1KJ!/&&7G-TDH!#9ATZK66>&/+%DJ720^.K#5\SG7Q93*ST&>M_Z4UM=00R3;;%$P@O7$<+D>5R?Y,:H6D$H#8^8?]MVYE(MF' M#PU,KFNF6FVM@&O+7"\W8I4G1;$QJXS6RH<>G@\7O7(R+O22ES.A'L1%)M+3 M3P)'Z'\[*W?W=[J[TU*N;5S&($4C%_C*)%(N8V#9A,TT'';\+',1LD,F^N(# MUN=Z6,0M-X,M0TT#!A:7(A/#2N73^E0V/VFT[4G]K*3;0/JJ1_M2O@ARLXUW MN14Q=*9"XR0!P5S,3[&0%(E?L"E&2&'!];"@`A.U@]K'MCR,<-%J!X2SM18X#FI-W>\@9SK M$E+ON3X7Z5WI?E+52"]XSFFR">OT#JNP*M#5-I_:=Q(/;V`LA/B,BY>P(';1 MVE`\!%]NV=HWX[?M[IAM8INE:_;E'_]@/PL;(<\^^VX4)P#NXILM)WGAGEF6 M$*7TRS(#S/H8*U)T=*`WL?J8VAKT73/;]TB1N$E;TN],-V/`\+'JRZ'"^>KK M;7W0*FI_-@XU0+,<-1&68O&LPX-=9#*UJ/IMZYLSAP5R#77*^DN[,1Z.FGVJ:X;[ MON1,]L3:4^X<-K?+9WI8?.%@VH7J#)A1E0U=KHN7V?H?;=-_"]D4B]NFCD2O M^$DEH:!65><\H&LMWQ1&MFU4RCPS=^!/*WE&3&K\G'VIYP=S[N9>V\9KT@>K MTTC`2G#=^)H?KUI7ZK-<<"OYO&%]OH`;(I6@^00>^-HQ2H^.'<[>H%65G/"" M*7-\(<6;Y(^UR2\'E3W+.3WUI;?Q9.X=3H-68_GQ:C3^[L7S9/)'WL0WM@^\ M[S3OJ]L9V$M&.O:`H_<:P6BG/`O8/, MUIW!8Y2&9T15M]-N=D@ED4K:%U7[G`U?5Y74-PF>B\;(9:FDSCYVS,6II"&I MI,/@MMO1O\G??_L^DM?WG"_>W(E)>./9MSJ0^1/&,>4=\*KK2VPW^`5F_];U MK:]__Z___(^_I3>E%_PZQ9T]X4D5]OPD7-R>OO5E*#_/>"#>8H^TC_'N=OHL MM24+'SZ)Z8]7[^]P.^.WWK^^W%TQQX8ON!5>=\;O;_O#;O=]^UVWVQF.;^]& MH\Z@4<8[7J1V]M.#N\WUD/M+NSUHM@T?:F)F9(-!:X8AYY.G!77%: MMS[NQ_'4,;T`[D9RB>[F:F.'`QD&NH(?TV3I+ECSRPI4Y14:<) M!W'N9"X??N7B^"@3S"?49Y\S?$TC=;T&\O% M2U+")_Z#B%M&;)/EIL\]^LNHU1P8GJ8\CBW-R=6Q:9&_86KJ,,7(BO-*K!GV M[98-S-L$I'R9B5S/HBEW`O;`W4AL/*I+PT'&%0'IL<5Y+*CN1,]@)3M&1?KT M>&,T`[#Q8"[W,Q"6?^_!/&V5L>OJ3&;^C4U@J:9.N&&@\`;C:.NUF\-2V@V= MGF&#QB!_]PW3+".ACGW>KL>"E\BPV&/();(]]AAU(>;)L\Y6$;&L/^+E M;S"6YEA;_,]0E M"J*A2LC$?.'Z3T(IKI@B&RRW>U7(J.H8$Y(TV8VNVU'U2J`9LD_6[='25 M><,BSXEK/_1G7Q;XE=H%$C[&L>]S%3<]4M[3*VC8,+I-H@(H<(UW\L)'_6 M4@T;ZQ/TU8WF]"!Y%/K)%SKZIKXI("X\/#(N/!P>FO3:.G%V[JGO*W$V\.DW M<;$5ZQ0EP;*!E6!;]#R#+VI7+L,DN6BU M62>>Q9J)$B0;;R_ON,%_<4LSTUHJV=ND3;4*;:JUNT?NJO6[M*MVSETU`_<1 M06F;DK8IB]SU4/I=LD3#DW-$^Y6GW*_<9CZSS$;FQM_??1.!YY1%>!1.N"C`=F6L03&Q(.I1T MJ%$GH-/#XD<0^I[ICT8:=D.9S83OZ MU-:)F/K8QFIFVY7#9=GL"SJ%^X]/Z(&=KN:\P#H MR^Q()'V[A.O,D^:GF6Z1?Y4,.,"!);39DR-<&QLX1O.89'$_IV66>CR*!]^% M)[FJ1Y3,4-'/=/=ZIIDEMAM^$%(UD(V;A,%C,JTEL[-*>X+F&U.J0^/#[>]P M<&+PR!")&H:!,XETSOBF/F;Q/)\9;N2M#-AQ72!X=M!(,(;]21%`UP@F-N$2 MQH':+>Z+%6>^J-GCOPM@?]].^6%YB+-^#;98D_XV$E3T;&UDC+7.8$NNDRR2 MRR:W;UUN?;W^;,U\5_=Q4\>,`_R%J];%%H"7N29JN!%DFPHK#L2Q[L16\#&_ M5%%AHJ)B=+8V9:5.JZ>R`?)WGO5W3IW+;XZRSU)GVY@VSY'H%&XS4$PN,(<:=<.Y-T[?J&A64SX0MW6;@[6S_?:%ZN[TFUG$.][DO'S M1-S0#]0H#Y M'=2]HZ[&:[F3IT)^._GM<6J?Z?Z1=<%$?0X:HLK6(TX> MVGQ>7Y.MS>\0XADHI`TVC2\IIGMU]>GS[_+J]1E+:S/3LQV;>7X83Q,GN;FJ M$RP>O%8X_SGC(9MS.$F\BA,>P''D. MP[>?K=O>OTI;U>BJ*EP1/&"=1%SP#*.UD9]#W_JJ6%EX4D_PH\M?.-FFC))-RS%8LV!3>7ZF!0'C-OB;,5S5.7<_ MF87T-?#MD'P'U`V4]8^V^SA++HG;B>Y$4\)OK(YE%,,_] MG%3]9_2MDN6--0T,7]EB*H(@;S)@\P=_#O+0#Y[B"]7T_7"6I*A=3[A<]C%X MA076PD+*N$\-=G6COMY*#UO1`P0R_^;,HSG2XUCI'P>'X@Q]Q6$V@%PO_ANT M]9(&1T,&SW$W;>(P6C&5@.\F(M$D(.=NXJ60T>0/H`_^SNT_(AFB M;,(+4HI$@`?-([B>Z=&.*>V:#+B/31T)+(G?]EC_E]61Q^QN8W>CBZHC(L#DZ_=*Q5SQO^YF92Z?9-CN7>+13P.T*#V18#R>' M$N+U<0S93QCR1IJ';D9KQ3IY4F-V*^:0B@\HS-(?3:UX+`6:GVU#:7^O+;7 MO$B'J`U*&,+,D>"3HCFB!A:`>+2J&&C9L+N%%K*2 MUNCL>\I@3[!,_:`JT`^*3MBN>&N31.L"O!< M>B!Q?.YP>EPV'8M-QV*?CPO34ZZSIUFGIU;OXB2<=/QT9#:)[?,=88G/P2[).2J=QG#0:G2ZE`=?2BZIF88PKD$+YK;S5^3L MRE3EES3=8;-;_'&W)&5(RIR3<,;Z<1)5Z\*.N[M%96'-TE.U(L'\X@R+?^B$ MBG.:7B4Q*P;#?F/<,>:^7(K]0'*YMM6'_4YS8"SF07BX&#P0?8@^)[%S3Q/> M+Q=]*'R_35W=;LD7O[%T!J?!\\7J&,!O-SKC3F/8+?XTH4LQ!4J$NG+)L$OL M`]WI-UO&6ML0M`A:1#@B7$D(5Y;`]`58\G4RV).$4XH^AS^\&@U'C:ZY?>WU M-2^.%H;9@C(I*33]8@Y(JSDVYJA>BM%,>"#Z$'TH-%TJ@[9$?E6A9S8Y@;"_ MCWL!F+-XZQB(?M7M=!O#@;&S1^MX7)HQ&[E$\"N7,+O$&'6OW1P57^1R*>8V M08L(1X0K"^$H1DTQZ@-4XO::T(&J"35V2-DA1#-6(U)DI*[1!U(-1^;,^0(F M73G;@@1Z?4/;@^;(F%0A/%P,'H@^1!\*;9?)#BZ1.U:9`L(Z!K0'W7ZC/QA2 M8*V,/%)7*7XI,>MVJ]/L4#L0PA;%7HEP=2,5!62L#N-X6C0Z/7,%7>]1$G*TJ:H3IVCY/U. M<,]FD?>@/XAO"V'A'Z'/\"O&)?.GE0VRE\1WZS0&O7&CVS=WR/U+ MQ*J+AU<^/)8NQ%/;4'FK.::&)H2'LX<\2QPJ/VL;L9KQ36WEZ+AI+(.P+F*T MZH'CPFM`.1J3)?;='W5\( M6F=W1TI$N"(MT&;Q)]@2IUV@$!^82XFIO0S/N#S?AVC>;[K^9`/+$,UU/'&= M;`MU6M_EF&X$'+9*5?79\0!SP*0]T_M(M9K-C=J]61O[GH^*`1$[$OI'O/F- MYP=S[NIO'O6!8^,OH;-4NLS-?N$[^ M9D0"7'@+K,^]I[_")`6P*2KBA1Z7=(#:/&`3I(J04@]*LJD?Q*PK&9^&@2O[Q*^1PG:EXCA`6,$G`K3"**8%8 M5HLL@GE"@RQ?-)@`6OE/`M^AF[*Q!0_A6$B9OP! MQKXR4NYY.`B`C@.\;^,\XS>OCGFY)E84!,A$CA?"/XIG`G$/D@??N>!/BL-@ M%A:7L_3)()6`Y48V MW(A3C=]LPP,B*?$2&#N\T9D"^-0M.%L/N(A/0!$T60$SVC(5T.W<]>%RM23A MIM>J^ZY71"4H-53C'.'H@ILEWQ2A"RR!/+95^&>>FO.-6LE38@V"G[.OC:V@ M[(O;>$WZ8&6!@S1VW?B:'Z]:5^HSN!=6\GF#VOGBS('2OXA']LD'^;XZ\CD/ M[AU/#Y)'H9]\H5U<]-P;YS^4**-\D?:]IR.>[L;DGJ#(TV M.H$[[+>HL?QX-1Q^]Z*;E??EXAO;!]XW/O'[3GW?:>97D0RZ\@9J7LS=S&WJ MK!=$[TO+]D$IG!L>LBY!\^;X[KB[VH5/9X*;/YD*NE:#Q;3*'J!>-R/,<+`\>3CK6M6BLIQM%=,_'&M$2/?V,3 MX8FI$ZK20\^'4<-L504&EI"PW*#ZZ@&8.?C"^]??;*ZP<31N]LT6-N*DS(P- M&W08'5LC*7%S'H3[U'AQ`0U-H]MLEY7$[4ZS52")JU>[J3_BY6\<@*-CQ>DR M0@(L,[FID>=@0:01FGT2EK-P8":J4OO3Y]^Q)/1!@/Q@#[XJZE,&A:[Z"X0E M@+;+'5*L]`11@8)-#2HN!%:=>U4Y'')X4AT8UQDF#*^+MIKZG??`^0%WW2=] MK^/%M7+QEBP()2"(.]?CU)7$A@N'IWX4F*P<9LFR*?$)I%#S5.5-FC2Z1@O( M$3J!*I)M,%OP<(9EBS9V0,M5J"8%E[H6<&/%6K*`(%OL/R)5K(W%<PG#%3G_!HV1 M:P=:/A\=6*NV-EZ+]5FI)5/1$6*V\Q4'5H#9_B]I9'"C&QGL:@6<=)#_4*;J M'1IH:J_MGVC/'1`]HWW+W&V_^-YUW)$IVR:9=8:JEY6Y$[//4_5TQJ;VG5ZC M,RB^:)%.&B\75$NG^8Q;!N=DQ?-OTNW*<1477[U6=%"*^*^(?%@>X? M.G)W3IE5$E1U.N-&9V3L^+2Z(*1\8"B=%J]MDFV_V:-C?P-"Z=077!8(^0SD<^T([ML3589J&25G;N7%[(K7H%-W?YHW.ATS&WK7L+N;?GP55VU537M M-#08T:L+'LC5.E&:0QT=KW:-P<&0NU7+0V*9'Y1CM0YU5!PW:C8^[, M'MJ!J@;JJJNSZN(T#49-;`\.1O5&?23-)0;*FIQL4P.8/-GFO>^Q',).QYZ5FB@.Z] MGQVXA`>XZ,%:(]_&RGRRW^^>36A5^7"8'TO`;@ULGG!YTVJGW@\-Q(YMXU%XC:S'.1 MJEH,*`Z8^2YX+-CX-PH\]FKK+TC!3--;)`]*#KA.H7SK??'T86XP+/@:(QN+ MUPT8%Y=1L)0(1C@0:"_6V[D=\J1KE!Y;%RT_&UP-I$6@.M+#A)-UF`GNAC,+ M<:9HY3DB:4K-0U`@"UA)!98%(%3S3DK@_Y<<<#G\08(:^(;/G402>$]*;%1] M)X`W;<4Y7D[A_E4NUSD[_EC3;N9%@,H2G\F:*3M%B7,O=$)7+W0"3,Z\2&E` M;,L?P$!X\)3T0=;=LN%BU1<;N_J!B`P1-496J;5^=N5!FA&&:D;M MM`R-J)%?@T3)5DX/::VSM56T&:KC?1)@N-G9A"G_L$:/Y6.&BU#OG;3UU@`\ M:*-3HNU-1E MF^*9S\8SJ?$Q==DF9J,NV\\.DKIL5[K+]D&;P=3.M_[M?-.81,?87O%E-_6M MD%@KG95`(HQ$&(FPLXNPBGC492K8K6URT+C1Z5(;9G+X*5LN3@OO4EMR\N]W M9I>/:]OV<0(#GL=;!)SJ4GYQ2J.N+C"L$.*JJZ\(8)<+L(MWC/;N#%%7,[`` M]-0%).7#0W65#:&B+J@@%\ED&XB+L]9>#1J]L;&X`W6!J`;HJJNXZH*[0:U=5:55-.W69O0(X6 M.5J[L4N!60UU,?>&PT:W90Q2M;?W*@2KZBJENF"KW>D;;`];>VQ=O"]U\M2) MBN&)@NWD$Y%/1*@@SZC$:0UU,=XH6XB\HU*J)P+8Y0+LXEVD0E,G*@:@5^UQ MHV7NH`S*A"`WJ<9H&7>:+6KZ30[2CNRR-:]A_T,M=K?L7CR8P23ERYH1T>ZV M&N/A"4^[N.C*]PJ!O;JJLBXNVWA@4(=>DK.V_42-$_2^/=[/>)V!Q[-_85OI M94?EN)&R[4C+];&K]*,3SAR/P?])ICNQ8E=IT*_8)#CDP;T(,[=CJ]0-3=TK MT2WX2Z;)^++'>22!'#C7G^$6N(`'KL_FOBU4G^FDM;ON;AWX$SYQ7.PVC*3D MH2.G3\Z&WM<6C`'&P55S=/P1:!ZYJAW[6C?Y^-0.W?^;2QG-%WAB@L21V4PM MS:;!8=MTU==]Y;0/P:V9.J&`/>*Q$_#QY!,T M_4KIQ5>A0V)G>#+2[;5?4H$NG.MGOY2!Z6JF60BM.;2."*U%H[4B[D:1V=7I M46?%*MNC@[KG`V*7L@D,*D#2<_4%BO%S*NH,%/+_MI'PU@_T.9>^.F14'S=J M[!BFXO8=SX>\O5I*G-!6+`<_D?-V;J562\R5-)I2,[!V0J/+<+ M:XXXQH=6Z+9]M4:+F_B/R5%Z7!^EI[?HKUKXZ'ER?X`_#3! MU([T*?&)\VOKKX]"QY>:6=3F2&5XK-ND!]&B>H=_ZX]X^1LGA/=9^DF?A,0" M_>7639)98X1.GY)3[*7V"C:^B[VZ^O3Y1EZ]QC4/.4!&^JYPGY!7+-]#!8S9 MR_I:=5P]9O?\%L'3+#]@-]:?D2,=Y,*$X5063^;6D#E(3U3C+!3!7.*CX2$@ M5GQ0U(X'WZOG`T!1&"UOQ8&Q.8Q)C>O!5^E(2K=+E:?$&0C7ZZFNYE'Y->I' M?#[PN'`>!`-FP+F!AZ?1)\?-IMPS'L"&')FS;@'\'$0DEX8^&Y##13>*$.0E(Y*X(+_ MPR?%U`(AH5Z=8#&<.3!YX;$Y/&&606+HS,5R!91LCL>S:35@OO&"J]0L&)V: MO\KV8=$"/NN4)?06G4!@.][->=KFSR@O+&=\L:&E#=&A\9?H+-/.4!T:/SIF8T. MC:=#XRL7J*W^H?$7EWESRB8<5$]9+KB63OL9MP[H,'0Z#)U$1VI.C]F\; M7M5P?I57?<:@R[;=.DJ&`: M+#5A)<_II&KFHK5)B:RW"!?ZT1)#W7TM.C$ M,MJ%*J5FJHM+10`CQXKVH@X.!+8;W4&G,>I0;S+:C2(/B3PD\I!H-^KT"1&] MQJ`W.!F)+EDUE0AUU=59=?&=:#N*O"83VU'[GV^[RRY+3)$-QZ_6=;\*]&!_ M8"XMX\53;&DWBWPU\M4NUE4/9+'.=Y3#6T`]YW*UO0^^[G[D+0[:^!KX= MYMHMJI:I<0O%6%W&9Y]FVI,:[:$Z;/:,MA]MGK!U:J?9-=XZ52_<[@U4O:5A ML[:0D>>$:>?;9MRR$FXO0Z/53K-_V8U6SR-X#`U>?\3+DRZQZINU_E#OXEZ< M[+-JY/HQ"JP9EX)]=/D+QSZ4=LFR1UUSVU\H$.$QTEF9^MR\V:NK=Y\_?KQZ MS<##!!!B\]=?K=!'6=76_9V:[/-:']9IY+K7JK-JTN`T[?(:#^>ODOW>_-Q4 M/5P=V^&!(W3WV=P-5MP\]\\(*#9U8/0H0C;<"`)$`$T=-+M!2BPXFA;.`K5) MDBVV:ON8NM,(O7CY"GS&1OE>@Q9!G\#X7JLQ(E# M!+&SH9C-!OD9*`']!D$<*[?^>JO\@X3;JU.-N&-JQ+E^YCW%A!D#XO7JZ@'G MKO$)BQ:J[_')ENLO8"C`%68(@`WH-_(FV"\X7;^Y@35Q? M1H'X=7J;L3(^:?OB%HP%J9I>OL5Q?.1/V'Q9?@$2OG5!KOW]O_[S/_ZVZ5G+ M>[)/O0D"[#FMGO'V:>VY-VAVIL]61(,/G\3TQZOW=\@VO_7^]>7NBCDV?,&M M\+I]T^^_[X_>#_IOW_4&PV%OW+WK##JWMV]O;MX-;T97?U]1)-G5>Z'I\";7 MJ%QZ**=OX`]L7`Z:1/P982_LV(9WI(R0NQ;*<@1^%%GAJ7LT2/P&$8I?)9;E MYG,6UGP)1W<@%^IHA8G`R$`16GVMD26UM*:6UB6ZCUI:UR)&>(%=AI72I9;6 M!3`;M;2N>DOK4@ZOZ#;;P%UE2K18-7%R(VAW5@R\:_6-N5V8S_H(L86*6Y@2 MDA?7=+O3Z(['C5&G^*)]VA6F-*G36B_4,F[CE%7$E`V!_V&QUS1Y_4!5'DDIN+_U0L1ZP[:HZ-G51>%SSLE".V^ZZ8 M@9VLU5VRA2^Y^P\P`1;R@V>Y$7(4OA+FYGB1L']="+TW*9<#V6=;K'?7Z_3? MO7\W;@W>O>W?O6W?MM_I;;&W_5&G/SS[MEAMMG$*V*/I'+E'TSMT!V-0X%:$ M&3NN;:R8X/C4I[6P7.^%K?<=!/$%4"DKYMA2SJG=YSM''6NMSEPN3-A7*'5N M"ZV>)4T9DQ76YZN>=/OSW>?U7(%#+`9VIS.4,7UAZD=!.,/8Y9-*. M&MED.>`Y#[QP2V7OX"KWR!93!_PO3*S@]X%0&A^SDB3H M#H;)M3@--HDD4%NJS+9_1"*8",S(P!/2P4R07*? M3*4B#UO-EM%DY$9\[/MZLG"<2++,#5>4=P(9;B;\X(6<[!4BP@MMI'3RNIEP M]?'L8#:)-%$%UH5[EJ..A9>1&\;)D'!S^B"51)5FIW#,'K2SH/(34,6YAKE1 MS.#Z"1YN+UQG[N@DJ_1(^W^X_@3>_+.P47ZS#W-^CW20XEZ?3J\IESXB$![' M^?P2*;,VN9YREDLP&TRT%7]&,:YQ<16;)1E269[(RX]'P!I+F$G)A&BQ`#PG M^;6`<2,%15\@9N`'HDIP//@LBLQX>]$/JHTO=9Z4N/:Q_M:@7\M4L[JG MTM5]?I0J>&2HN-T^0_I6J9*UWFO-^R_0O`>XXV7FND)VU#<3\6?^!Q@RJ&#! M6Q1SJ4P-#'*HLB1M/[!7KB_E:^U=;+.'#N%ARD!<6P^3K3Y(7!*K/<]J9SWD M@%CMDEAMY[P(ZG>XM464"%7LYZS)-I1/>`'YA+UVMUE\[[J+2"BLD.0JG4HE MX47"ZP#A->Z3\"+A1<*+A%?UA%>_-VX:2R&_;.%UR<%>G<&$K?2P7]6>/F-M MT]%;@Z:QB%==4%(^0)1.D]<6#_U.>H,FE2N9L*)*Y!<69UY] M%MC?[K[![H4G`NZJ_#MNSQW/D2%NBS_LW`'E$L]'&0^;Y@ZUJ/OQ*!4"7'75 M58V0U29D$;((6::1U6[WFNO]EPE:%(#;>)MJE1)9H2Y"LV8\N!>RP3P1DK?U M0\M:ZX+&BL$O.HJK;H`K-.BL`%!BZ!%NJL4 M`+OXN-RO>,YN(:@Z;\V]\:"$N72(ERA3%VR5#T85UE%U0Y.Y75E"$Z'ILM$T M,I?*?2EH*C*"V*JL1:@^K74L^+!SYYMGJ7\2<]:`E+TXO[%G+O.]]OXB!60H M(+,SL%YU6@8W[UZDRI)-]B7+V:(/KPEWA#OS1\"U#`9KZJ[1+CX"&INW(?^F M>N=[$DS=B?#$U`GW$4]U33]IM\QU$*D+9LH'C^HJG8K!X577X$X`66Z$E1IC MI=,V%^:OB^JHB+FUBI'XQ`D\^*(\<'FINVP!9*L8J8BKB*N(JXBK2D\JVH\K M8C\.RRO5"5[\F[%X6&Z#N+OXQFP_PE.FCMD[IW:.NU"V[OT>7_4-;D0>3Q_+=Q'$FZX_V<`R1#O@N.>ST_7`X9_HH'%](JDZW=M[N2D!1BG6)GO(N_^B M"HP97.1P%67*J(720EO%$%Z&9"B@VM.A@/1,)^^E&.QW[Q0_BEW5(D:+>; M=1`2_>1\W6P:EC&880Z3V05^Y%(MEX5+/'EB?`%`^^;,8"73<96Q7]F9>.\.G,KB]DXQ:YL("SA/*#2X@5-86!:^L#29$1)B35K`PEL MB(H%8V55HB/;!_`1>'\Z%8'P+`&L$3X*X;'?FY^;2CBCX:,^_`%FC[0=!1MI M2NMVFOU"IIQP^.J4838`ABA0%MP#=R.UR<2XZ_J/'.9O;&*MYOBD:\DM*\"- MLXR@R`A0&'!TH*! M`>8Y6E@-_`AW(1TB["B#BU)ND7*:4V,58Z?G,(:17@5^V!D'2Z*3Q^;_YO$T,O MF7"9GJ^R[J;"3H_^H'Q%M%`X4UW!OQT65&`T/M@3$9S><\@.ND M,C(R`>ZL&ZK#Q.SVY[O/;!))F)7$ZWFH@L26"[8"CR$V@SKO% M>!#>:8'UC[N*RIZ>F M".+'^VJYC?Q6?D1V7YX-7X>9&UL9KT@?K5;*$Z\;7_'C5 MNE*?)3B2R><-C/#%`2BS7\0C^^2#X[(Z\?3@^11Z"=?Z'P.]#R7IV"\$F%=7^Q!6&(\ M8CP#C!=;)+L2EHX.V9G(MSP(GE08;`Y3#Y6%..=_^($V-K5)&ANK:8X"QUWD M0.TZ'M(D\%`(G'"!JB`[2D.L^@I=XKC*V9;%)6/?6)86D3I;1&6VGM$2*@=1 MC&6H%S=CTZGD@Q$=UD:F_OD;*I``.)\`,%;#7![[!P-SYV+7OYUHA8)5.#U\JH&AXZYPZGJ`@=RB+8[1"MEOH5IE;I8<)TAG75!OE&9%%1= MD-5MT4'UY!OMRBWJ'.TTP3XIOTL_*V5&YN`/_2$="4#>$7E'RV`![1>?SCMJ M5U?)J$]K*7I?_!`K?W0.WG,E((XN`A)_A% M]&8DY[BH?%N2CR0?"XI1M#L&@Q0D'VL0XMARQ,]@<>XC?BIS&E(I2$5<15Q% M51IEJ'#+]F`X`-TO)X MK$D9`AQ\Y,\DW&@3O$J*Y9RD&_ M9>Z@R+H`J'Q8*9TRKC$=,APN M?1&[S!0PH"P<$H_5$H^#D<$:/!*/.YJFU3U`FLY,V&\V+YR9(&$48&];V)+" MXG*V#`#AAS#@GN3QV6?/GZ&P>M#NVJ$)ZG@-;':AGJ0>CPI0*@,_7)Z+]P1D METS@`64;SE1H;#A08?6Y_0L47J'11>(Z.@_B&3:DHT>(U4[' M:L8:6A&K$:L]SVH[MQ*D--=MT;D[L0@$GB*^Z3S/,F2?752LN.:AX';?7$./ MRX[T5DAVE4ZIDNPBV76`[#)X=@7)+I)=)+M(=IU,=@U.4"]P$;*K(N'9`LLB MYSY,\=_[^HMU39#NT'$&%-:CN8V M>@@/A(>*XX&TQ"[V%94*;Y_-C>LR7_5/\_Q02!;ZZW6O4\?CGN5PEV4J8%79 M[*/`NEFPWRR\;O($WSIR2TML-N,/@DV$\%@@LEUR+,L/D`#N4[-R--0?\?(W M&-UT+/VDG[D+0[2^!KX=LK?\JPC62WD/62UV%P4PS:30N--JMQIJO3XO,,?9 M#9_8[4S,$=5R6>'\:NJ#>1VX3^RKYS]ZV)?H:GV$5Z\;[''F6#/VF&EOKNJE M?5AA[^FO,O.:CV"IS[DEHE"_3(I[Y(N&NAE8![A!6#R2P![88AA>$UGP!]8Y M6Y$$00,<-^'88UWQ$#`?4\L5EU^OO-?U<6U%,`>"`3>)>\=B_N0/887.@Y!- M]@79+IWO7(3J_BVMV9D%Y`42O1I';CC;7T$5GP#!1E\X_@V3E!( M+`BPFRM+9&39-]8W'?*@AK'QK#OZ!_$S\H.I(:U']0XC48;U4%)AU@](*3/# M='VI#S57V.+?&F;("`\S\J"_M)IM!E>YFY)?#J.F0<*5CE9#T[3RC#':/7?, MC,HN]0RR3*)?%H&#_4)<1+2KC)K8T$&; M8*[[AR@CQ9^`%HJ%?'S)(@JL&:BJ(-&/V"P$%4,$SU=:XASI-@0TO<07<"?/L-##VR9GE*PBCF8*\K%L>');TI MGQ1I3>NSOW0ZS;Y15`-=/#%U@(+VJJW;;SQGDFWKVJ-,3G\^<;QL"Q]<#S#T MP`XMSNDXNSM<@L&O"QCUS5JQZT^.)3P0W[`L'\".=EV0ZQ$L^\<`ESA\JIQD M5?=EY8-V+1Y\]T$KC05P(CP1V'D1H>>MW!X08W@HBPA0(L3*"D$`8BR11DZ6 M/(N8/%FU!A-2O:>NX3O!D:;?GN9^L)@!TS2!NNQ.6'&?*3":&S%B,F]5,DH] M:L&?J7"+.0DDE( M<[,8F9Y%.`O\Z'[&_B>""<"JC90D%-]`_WGW(NT_ABQD!_P1&`-5(OBGELL= M4#Z@P7RL@$*K8L$`]'E M`3.K<("%COJF82T59%Y?>::LT+9ALUU9G(VU[G':#O517X%1$*J$-VV6:MJN MZK=R.>;/*\7D[[]]'\GK>\X7;^Y`BOF2N_\`/EW(#XH6,+F[C*[^-575^"T8 MYT"0+R"KWKJ^]?7O__6?__&WY&'O8C[Y*(+/,S"V/X(NMY[2:Q6>X<,G,?WQ MZOT=&@:_]?[UY>Z*.39\`4"_?M]^VWKW;GCS[N;ML->_Z8\&[UJ=0>?V]NW; M=_UW@W=7?U]1&UFZO-!A;E,@O%Q:!T3\,BX5&]]+*ZK74!:NM83C*_247N,] M8`JC<_,80S>*H[HP4P>GHP(7VFK2P5[!O$AI$A`W6J6#VN$/L-#W0C\+(!"% M8'5YZOZ8Y97)JT;89'>.JUZSXV@PQJ-IQG!^WWAB(./H7BU4K4/)KPY6.E)'J>X@"&[X(`T<%SO4\(\^)(Z3Z ML[]0)K_X)@++D3K,N12OL)I6%.M\%>O4,V1B.@6QC`N2G=".+U,":_M*P)KS MQ<)-_1+MTH0!6!D1SC)$=,Y%.`."5==@T[S&TY:A&BU(*OM%7@6-%LUC'W`% M'QO8#-E@#:G_$WF"=4:Z`ZAB?O$G:MG8ZUT^<(V!IRP7U<^^"58K]UQ`Q7PN M;-2]8%%DNJOJL#GPRB1*UOA8A1+G;\6%DFKY;%3KBL)OT)71M(<_#$6LX]X+6%6//+!S>WG` MO_KD"HXR(W+3!X#2!9K)F">2=VYZ6FK*K09[\H_X+0*99/G!LX](+[JQ_HP< MZ2P?YH``0VD,X%#!#7WC?<"]V`U*_*4U`H!`M12)I(8%`*`=HTU9OR!<]8YH M(FK50R6;,_)^ M&5K2LA:X\-[1HL5540X^\5'7)1H2A3:8Z$&*=GWS`@M=EV)<"R+\\TGS0D9^ MK$OSW9EWG/+NGC;E"V;@LR;C/L;BV]ONW=O^[7!P]^ZF_ZX[&MR]O='&XFW_ MKC5^?W9C<8=GYO)6+JDY\[&]F7N'MN@=U+'7;I%!P+60W^@%)[/,&6XG)=2[ MU-S\*34WE93;E7X[Y4+M:I\7EQ%N/,9]:J\[H[\3S9UZV[OY#TKQ;G!VPT?_ M6N5,)>Z5LO56OP7S#0-EZ>/!ZO5C7TV9>+;`O2A,DMEF@0ANS?019FH#S)_/ MX5[MU^$$U#Z5Y2QT4%J"'17H4\_2)!JTO%2X0'A@CMF8Z!7$FS"9F^&A"G<8 M2$1S)O$X,K3)>;MIGN/P!YGS9?7(E.W72(Q7>"0H_3\B3YWZ\+PMB1??1/>1 M#./%XH'>/H()X+BW3UBR&0`4S%EUB]IN=+7A&0A+H`&.9U``3:?"T?HT0Y9E M>$'%!O%O6)@-P9#EZL26IY,Z&_=-W8T@Y:ZXCIPI/ZA6-37!M.\/0O*W4BR>*1%I^F810U7"V MW*C7!S=B7S"T$5=96,WBC=9E7@_.'+T<#&FIJZ>!/V=QM%*YS,NM12ZURZ$2 M'=FC(O@$H[FA%"LD&*%%"ND6"'%"BE62+%"BA56(E:XH\\7M^C? M60E4+IXVY\&]X^E!\BCTDR]T3$-]HT-NXUYSU.XM_]NAT]'*?PH8S8].1ZMP MJ2V=Z$+G5!&KG9'5Z)PJ8C4ZIZHJ[9#>;8T3>=$<(]'^AAIR$PQ[0N)6`>FE M(59]121Q''$<<=RY"%<1QW95T^9'T%L)R5VW.[G`WK':^(/>N(QU\7-;PZ'> M_U`1/HPDQRD3J+F3!(&)F/JXW[/,QO"GR["N*K/;O-U]3@.^'%:1L1.0BINQ MZ9Y>W=:HV3$U[1+DM!V>VD4NZEGI0Q+@3!+@5;O7;8Y,SWO)YI59^]<5PC2I3,`")BKMYEOGDT`)8`20`F@Y07H\='_]ODMXDJ%_QN,3T,15,#B MKIAXZ+;ZS>&I!$-=\$^1LG+C*7ZFJB%XG@FK')/>E7)[Q:QW)QT%M`FF]82I MP=CPBZ9R\7`[O[JL>F!Y%;5QQ=IX8;84^J+2M\I$P]+0C?B0^+`,=",^O%P^ MK+JR/N4N\(8(UY:#50HQR6L2H6X/#&[NUCWT7"$D5MC9K0FR7K6'_1-@BY(C M"7>$N\QM_59S0!JM2(.SWG;E2G;A4P+U M:Y3(9RA!*;-P-P>Z57_C_9?E(4*Q`5\6&WT/ MUN\"$]M^A`,^3`U3IU-4\'X#T2Y"L%(0DF07R:Y3>(?= M]KBY<^=O8U0C+Y`$&PDV$FP%.L&CHBI=+]4FJUMFOCE>VW[L`PA4?^YX=/!# M*71'>7BQ=(0CCB..(XXK/^$H6WGMMO_;X5SX:WVH]R'L^=*64]6R--I]"@PR9#<^WXZ@*'N@4^BC3&/LP7W`IQJ]YV MW"AT'@1ES^YFEU'R++G=95)<=0%6$44K!#`"&`&L@,KEN@.K#N$[E2]ZZO"= MLB:%70@.SYM2<.KPW["H[K*7NB]>/OA66"=>$A9-AAX)B@1%@N(Q84_*%CN_ MI5LBO[*X;+&WN!.]K&1:RQG;H3CJ$+Q3F@4E]E!B3YD)5QIB$<==`L?5(19U MIB,#S^F/E,.(,5:/4MR,S9\!/C"V15L7*[]\XJ)<,I8$0(T$P*M.LV,L=K[. MY959>BIV)>E`TF'#-CB9!S4/`I[8]Z##G,Z*PMIGHU0(B:53W!>'++!^AZV3 M<=8EF\4$.X)=1J&-S.U,UUVAU2&D;3B]\J#FF^3`7J`#"_J="L,I@D41K$L5 M`*]ZS3'%MRF^3=*!I,/Z;>UFRYAPJ(MY4+?XMCENN=/U6I3F6FD!72)6+1WA MB..(XXCCRD^X.L0$*PHS172G.E-%=R8$\:WQ[V MR8&E"!9%L"Y4`%":*\6W23J0=*`TUP/\C>^5/;WQ^LS?F7FYCB>N9ZK'_YMV MI_7=#ZL359\=#V"\YA2<:>8OCKZHT7Z9"713%N"T8`0\/44KFT>[3*"=^@&; M.A*XCJU-YY"W=UKM=YP$)E6L]^V9!-A\4@*%@+@Q70*5[)'/W)M-N,/`GX5'DPN=*Z3,_2:C-U( M=?4MB`?N/6&L(PH"$`R<>2)D&/*`[Q)Y@-!IX/4@)AZY9)[/N.OZ5BI6\%&1 M9SM2QTC@.>H)H<\6'#69LX!+O?O,V7U[CQD?I@Y=5NNT78XUG]="\=]_^SZ2 MU_><+]Z\BY_P402?\?XO()'?PMR^_OV__O,__I9<]9X[P3^Y&XD;*44H?Q9< M1D"N7[U/.*,`'H!MN&5ZLTJ`A`^?Q/3'J_=W*`M_Z_WKR]T5G\W>'_3&H_>OAN,A^_>=?J=0>?V]NW-[7#DFA1UT]0')GI$OE!6`"QBX#\XM@`FE-%\SH,GY*V% MRX$5%-G93`"#3)ZRK/M77'M/(B/BE-D43TF\1#$BL!:\TI`:C*/%<2=^14Y;6+[>CWZ#UH-A36E$A.TQ:C/Z],W! MUM-+'+P#*G+.5"MY1LSU^#G[4L\/YMS-O;:-UZ0/UM%A2[AN?,V/5ZTK]1E, M=2OYO#^>'QT[G,&?,.?XM`=8)96@LC']I=,3O^_4]]'\RC'.4B`C,A3/7I41L_$]^U]7.4JX-V,GI%3+E%+/:( MYO#R`\*`),F*D&1%,.+^DNZDK/D^#5@8VY0GCB..>X;C?HM\#$1]#!Q+J)C9 MC8K3L9]Y\!5#%AA6_X#>)%*+Z?`1>_63>!`N:].>*3'I*9CT,[S&F0(IX%&_ M8AR7_3J1(GA0X8H/WB(*GT]>.]>X8YQT"">$DU/CY'?/KQ)&NCMCI&[E949H MJVY[IW?5/J>[5,^'ILO93N6H,Y%+)ZVJPI2E(QRQ([%CB0A'[$CL6"+"$3N6 ML#%:N^+FX^_-STTFY]QUV1R6T>*+<[JMY:#)):9\]YO4\8SB,F??@"4!0`*` M!``)`!(`IQ8`>OE'G7;'V/J3'"`Y0'*`Y$!=Y$"!FU"U"".X/+@7>X80+J[+ M4V_0-%9<7?LN3Q0N-A`N)F01L@A9A*Q2V80$,`(8`8P`=LX.H%5WNCY@FJ:G M:MRY6P2\*H:B;KMIK&UU75!"L,T$!HN$PT MT#;/.;9Y*NYPW(E)F.F'5\5*HVKE)U>(ZTI'..(XXCCBN$H0KC3$(HZ[!(ZC MR/&=`Y.4SM01-ILZW^#_XX.CIL`A\IAVK+F1R6BQA:A`LQ_66J,NG])?A.HA MK^)N,_"@/?W:NOIM[?&H28&!\$!XT'AHTLE^A`9"`T6Y MBW""+J.8X;]A/.S)4>=V^.`/%0&DNF2NM=OFME5KG[)&H2[*"25D$;((676S M"@E@!#`"&`&,RAD.YYIWB*(CQPY`V?"BD1R$]0@.A@=!` M`6Y"!:&"4%'";9^*NQ\?/!D%W+,$C,`+`VZ]<';.A?OX[?;`7'EI[;W["B&L MNEJJ+M"B\!D!C`!&`".`$<"J"3`R#@OWR>KD>JGC?0O!4P''P9XW)6AD#%4O MD*8NX"H?CBJLGNH%I[&YK21"$Z'IPM'4(301F@A-)0Y17`BJ:(MK&U-]\<.] M&@7OP4Y=8"?;CR:N.`IQ6Y=A]T.'JW]8U(N4?9%9GZ-P`80T?I)'=VBNJ/]P M:IZ`Y\XO+2LD&$MGG)!\)/EX#OG8;8W-=;HG^4CRD>0CR<<:R<=VQ^!)<"0> M23R2>"3Q6"/Q:#0[@^3CCL'([T,.=-EX?>;OS+S6&J1F^6\$S):9N"7P,+#S M3_W`X3^[;IEGYH1>*WF&XX$\UY^S+_7\8,[=W&O;>$WZ8+4@S!*N&U_SXU7K M2GT&;K.2SQO(]L69"\E^$8_LDS_G:ZKDT;'#&?P)_>Q%3>=C'-[8/O&]\XO>=^CZ:7SG&6>[Y M522WKW2V<3KX8)QW"">'DU#CYW?.KA)'NSABA=-:M#2/_C)SPB7VF`VE+$WDH$=^5CG#$ M<<1QQ'&5(%QIB$4<=PD<1[V_?V]^;C(YYZ[+YN"S6'QQ3A>R'#0QEO!4W(R- M9R8-F@-3LZY+!A'%2$@`D``@`4`"@`1`_04`M>XF.4!R@.0`R8%S;`C5(HS@ M\N!>[!E"N+@.K?V6P1+)NC=HI8BP@8@P(8N01<@B9)7*)B2`$<`(8`0P.K?Y M<*[Y@"F3'@\=W]NKN^3.\*H8BKIC+!PZ(W/-1@@.!(>*PZ'= M;K8)#@0'@@/M\Q3@693(GR_.X[@3$[B%RGY.*8!*0ZS*2F[B..(XXK@R$ZXT MQ"*.NP2.H]#QG0.3E,[4$3:;.M_@_QW/\N>"38%#)%LCY"$.!MPFH\46H@+- M?ECK4[I\2G\1JH>\BEN_P(/V]&OKZK=UVA36HS@&Q3&6>*#*%<(#X2'%`T6Y M"0V$!HIR4S7#P5SSWS`>]N0(UV83'_RA(H!4E]2U=M?@B7AUSUFC4!#ZFJ7BJ&A0X4]A`9"0WQ;M]DC-!`:"`VTPU.`-U$B[[TX-^.+'^[5 M*/=YBOF!+8)DVMW%-V;[T<05[/]KJ?\<1+FMRQ"_#6]MPZND[SIV^J9R4-?8 M84DO4O9%9GV.P@40TK1PZPV[YDS?PZEY`IX[O[2LD&`LG7%!\I'DXUE[0 MX%$_)!])/I)\)/E8'_EHLB42B4<2CR0>23S623P:34X@^;AC,/+[D`-=-EZ? M^5M=Q"SANC%W_7C5NE*?@0)6\CF>198A1\!]V5E]<>9"LE_$(_ODS[GW`]LV MO4U!TD?'#F=O>J-=1&R>67:_>+\X+4QQ'YYXIK\WMQC>($ M;EX>PM"`>X.%'_!0)!=S*46X?B7CGJV?#@_RK/C9S?5NOX=B^6_?1_+ZGO/% MF_?<"?[)W4CWW,6*C,\S(<)_@!!=P)WI3:I.`SY\$M,?K][?=5KM_F^]?WVYNV*.#5]P M*[R^?7LWN+EKC_MWK=;;<7_8:=^..H/.[>W;VYO>V]'=U=]7..(Y";*-99]C MJ%4)M2]9%("2\3+)PAF>U!\$3_O:` MY-8,(F3HS(&9@$UA'9)?@"_QAEM_#FAZ^JMDKH^S$L&2@L1]I^"^@>*^G=,(?[>JFG'1TRDUXXC,C;(D9_3IV(N]=$]5!%"UTL](RI"4(2E#4H:D M#$F9(Z1,BZ0,21F2,B1E2,J41,I4;]/8,'0ZS5'_.Z8R-UV?>\R.!+M9!(Z+ M>^_[E(V]W%IF#M+1%7M3K[U#"'/#+6L0R[VWG7XH9-Y/V:=\>VJHNF"D?/*JK=2J&A\&H1R$]P@/A@39!"16$"D(%;?^88IHO29*: M=D-^YH$U0S=D'W/CXIS]=F,\'#6-M7"JO;M?(:155UO5"%R#`8&+P$7@*@1< MXT%S2.`B3(.+!$SIA^VPHUC6J,6R. M*9I!,3Z*\1$:"`V$AKS!U3)WR!C!@>!`<*@='&CG9QNWC%7ACRTFP@NC0"3[ M/\4Y'K5Q\\G'IP!:J?14;9!%'0,)680LTEF$+$)659#5H[J?8KVQ.CE=_>9* MV4]T'\F0]GIBEY3J?BB@1P&]]+;1<$!U/X0'P@/I!\(#X6$#'H;F6N74!0^T MX[/5G%#I9FL[/G'%SSZ,='%>?H_"9Q0^*Y.FJ@NP^M3KC8!%P"H@=D!;J00L M`E8A6ZFTX5.H,U8GGZNWNN&3]'DKQ-VJ&)0&%,^C>![%\Y;.4'?"#]0'@@/&3TPZ!+%3Y&7(P2>?1%)IL-.CGGXUEZJLZ;A? MBIZ52U/5!EJM/H7/"%H$K4KT_R6`$<`(8`0PV@`ZP@G;?+YJ9Y\.MW4-:-!! M/Q3@HP!?)N#=&Q`>"`^$A^(L+D(%H8)045=4T&;0-J;Y)!Y\]P%&QJQ`V$[( MIMQR7"=\(H__&>>-#LRF8%JY=!5!BZ!%T")H49R:`$8`(X!5!6`9S^S[D$]< ML?'Z#7__[?M(7M]SOGCSGCO!/[D;B;=/;[G+/4M\G@D1_@/(M@#F^`*S?^OZ MUM>__]=__L??UFZZ[*^;8 M\`6WPNOQ^YO![?NWO9MA^_U-]Z;?'7;&G4'G]O;M[8;C@?30 MG[,O]?Q@SMW<:]MX3?I@M7K,$JX;7_/C5>M*?0;6M)+/^U/CT;'#&?P).!U+0X2[[X,DPB.:` M9\FX9S.4>DR)/?:SX"CTU&^%">MC!%A6&'5Z<(%)M:4(\:`(X4AFBRF,SF9< MLG`FF/CFA&P1.):`CSQDCW[DVFPB6"`LX3S`A=/`GZM+)0>9YT^!N'"S%"'S M`[;@CLU"GX4!]^14!(PSU^$3%55KL$ABL`TNCN:+T/$]J=\QY\%7N'W!D5D= M8"18,?W>2,(8/34>=6?F3>ECF^P+#&:ZG-1]Y-BH"9F0N%".G(&(Y?"J0`A@ M^P?A9J^>.2+`?C\PO,>98\U@--^<.5!,TP-'`'/T)U($#TK*.]XBBEEJ[GCK MET;>^L7PDXT3F2O&PZDL1Z#'K\8%TW;"&5R'CTL'QG@@<'FF(/$!=&^>Y=AC MN"XG&MJMT8I6O!ZT#'/B3VHQVAG;<0.A902+`M/_,_)#H*+B38G$!%,$&#+F M'B1/`"8*#!0%GN83F6441\@?6-UHU\G23L)HG"E,'Y[F`PL%&ZBI`(<,E?E) M..IBVP&,A^X3$@V&'7_Z07%ZW>C6W4:W3>@%7M.B`GX@O MFX<\D2&!^#-R@E@NW/ISD&E/*!9M?+F_8`ZRYJ.7%87/:_?2*I.#?*#2SD9I M$B5F448K-2]!XO@/(%A`A6/7W9=BUUK`QI1H+[XQZ;O@__U_+?6? M(FCY?'C!`E4D`C-1[#IJ:BX,20Q)#/,.1OVBO^ MF'K%-]HK_CGC%7](O>(;;:7N:D:>=":OXFC`:T(.(><4HCSCO?VJ`B"_+CW_ M#\KS+S-..H03PLFI6*/WE^:!J9S6FJKXID/C: MRG@^6'4H_DY(]"H(KM(0J[X2GSB..(XXCCB...XR.&X_2W`.0W;%)=E\ZK8[ M,0G59B=N=(=/3.(6IM[RG`E7Y;H$?#)Q6!A$_VJ',WQ6(,J7L2`-43`)V>N;Z6)`!(`)``J)@`:+?,G1%*`H`$``F`B@D` M:LMC*,Q`T:[C()/?M^TNOC';CW`3\YB-VZVK$;]-93VO;1'73!B]2-D7>?8Y M"A=`R#*'.0XGY@E8[OPRD\0CB4<2C]42CR:#0"0>23R2>"3Q6"/Q:#)$1N*1 MQ".)1Q*/-1*/1;25(REI+BYIIJ-497*?U*>U?/>?E@T?"DEZO\0L/-HF(_XA M_B'^(?XI+7V(?XR948FY7QX/]-SIY5,18+X5N6Q'WLT($:%!\[>WR,A$RMA0P=?4"RAF0-R1HR:$C(D)`A(5-Y(4,& M3=';9A?:->`6OH*WP:/QE"GIV"+0D1WL),`MU3/?5@=0Q5<=%O%)2;#U\#53 MM42GQ65[2!7U%*@OXC#":N*!JLL(%80*0@6A@E!!MM-)6`K5\971WHI1R;@UE[MSW;&WTN=J.MRL'2WV346A#B4 M9'7!.P5$3Z`8"7B7%_TC8!&P*+Q.`".`$<"J"3`Z++$RA;%4_[I.P(J7N;;' MP^:X&#=W4X'K)=2QDNPBV46RJV)Q`I)<)+E(;OS+Q#8UH=/+92:< MB1+'S&;;(#+/S`FNUDIR!G[.OM3S@SEWM*_49 MF,]*/F\@VQ=G+B3[13RR3_Z>!GER^D>)/\L3;YY:"R M<=,E#@8;(^$[A%[58'Z\ZG>_>Q%B>;#'-[8/O&]\XO>=^CZ:7SG&6>[YT89( MT8?.OI"-50`MG[=(+%!%(C!CI*E/:XT"/XM%*.83$2PIVQDTV#9]W6FUC?4& M/G]^YI)`@V;_,,JNW'BDITJTW9!:[$9*_')7^_*D,WGUDW@0+FN_)B01DLXA\^$USA1(`8_Z-83[ MV*\3*8('Y<%\\!;1"^GA9\9-IY:X.7^T@5"S,VI^]_Q5Q)1:U71WA@S5WY@C MOK9!"NF_?4JB5\'%*PVQZNL;$\<1QQ''$<<1QUT&QU'[J)VZ@D]"55\M_HR< M\(E)846!:@[%9L*U,4P5\,G$86$0R;VJKHV3N69I%<7-V'@V:K\Y-"7F:Q1K M*%EDIES"EP1`C01`IV.NDH8$``D`$@`5$P#M3G-$`H`$``F`"Q4`U`#14)B! MHEW'08;.Q3Y;F4?=S\4V&>:@`[&/(Q^)1Q*/)!Y+)1Y-!H%(/))X)/%(XK%& MXM%DB(S$(XE'$H\D'FLD'HOH'TI2TEQ<$A/A+RCW27U:RW?_:7DT7B%)[Y>8 MA4?;9,0_Q#_$/\0_I:4/\8\Q,ZJ(KO\5-;'B]/*I"/0!Q/.%\*0^FOBP(XB- M9Y/0\>F5R3]I]PVV%:W[N1,4'RM1RAH)FU1P8S@>C4<8H.D^PBV56]R`))+I)<)+E(KN.)ZYGN)-3NM+[+L=DHB6.5:>+'##X; ME.OTS,7D]$>\_(T3PONLI'W`/J?3-=>F?0A-F7KIAC>%,Y%]&UL$SIP'\#B= M`P_?^%/V>_-SD]VCZO'FF/BN$N+OA6?E!H_?6GZP\`,>"C;Q/5LVV?_-A,?^ MC/Q0V/AL"Z\+!.,/W''5.=T.YM<_4#QA/!OBDGN'YX0ZO?MKZODZ3O=NZ:+N3TO+G M<]^#-?2MK[+!'F>.-5/O?.!N!.^+)+#KYDD%`NB+7\/]GBI/X"Z\(1"6?^_! MFMO9D27I/[`.=0'/7IE-&Z9]"'B2=P)=`\7T\7OPEJ=8PD+$3H,U@5 MSY^CAH(UFG,/0*/89+HZ"_%MX4)?(I"+$11-RG6^6T_*/V` MO"LC:Z886PH&>L]YX'C%\V*G%$(=\@>6YA5=P#Y?9\4+X']`7Y(UW M_6<$XU$$MC>.9N'"HL7B`Y M#2]$X8`/U5Y537:C!$5@?Q5B@2*&6Y8?P70=8!*0,=%""4W!\?4<32L' M7J#E/;XP^YTU\WV)4C;PY_#B!Y!T`N0BO'@:@>17#\)[;"'FPLY(\^78XK?# M(B#]-HY,,E`S@`9725$@GESXGH*6@I%ZDS^%N8M4!,=4^:O4@`GYM_P2`,O& M<'4FD2)6($(G$&IL:C&2Z2;4F7#XUH+7N9$51J#<)'MTPMF*EL+'1`%B%L=``LP/#S*428)X'ZP7VAGX=<^`2)]"&AP26D^I/ MK2,5=(#'8;$6B\!'QIUPJ=6CXEC@&+Q:*5;-G+!((/:XG#'THV%]V&>!:Q7` M]0&S'6E%(!%]A/_6J%_@1(WFFU.XV<0-.B M(#^$_$!A)8\=1IPI$7M]:@5L?*]ZP1MT.V)??M`<,WB0"U^;L<6C1?X"1 MY$_!6\"/`9L(M,+`,;+$'-FPVVX@*PZT-IJ"R%E*#7Q)9AD6_$G[)8]@,\T% M1\O-7A4\_D1CYBENR:NLMA5I%#\WP]A@"`HKU-;C!.R^@'LRMAIBB:=$E-)+ MRL\ZX=JVFZWOC*PIR-R;$,3N(M2D[_05Z?M:"JR2_AD(J`4P,J2_#)L=HWQ; M/661R.6;Z![=5UB0WA:Q_(**,,&3>E':XWZS9U;X*GL59_5;!(8;3(C=+*6P MQOZ6607"1<`!,)-;_YKC3'\":Q3[;6"H^);#$JU MIMLO_@.Z`)+=_$/=GW[^../!G./7*X](KH`GQ&;U.AW>.OX_X8Z`;Q&]4CQC M"&2)ODFFL$=P#DRQXV!HF!TK*B5^A^=JU1L*M-IC598P*K\/A/:G%/,G/)"7 M)L`U\>)I;3?G7^%.0RO5Z1LV0Q*=CU[!%!0PP!2-A48\;.VRI':!,0%H?AXR MFDCQ9X13`:)GIL+`I'!<%2QBH3/'F!,`*KMB_D3'-9;F%MP*4\W+E(JLHS+" M]8S0K-HZIR;[,,W_JA@7[Q-VGJ.5MPK/SSBQ@?_$W5"%:%)9F=J)'&4^VJ@8 M%H1W>@*FP]UE@`=>:$<84\R$AV+)KT7E,N9D"X;!HN5Z]D%?Q5HZF7)YN;+) M;M2DMYF$VJ$)Q#Q>K11H42J(UF6/G($SI$+^H&4%T,&43=(R/OLO+TM2VV

>NPBDSCYC)`;9781M8"@>;@`V)?]JB68D:1>(JMH$.IQHT-]&[794XI['8445V&PK1]:YKI2\W"Q.CUU`]TJ MX&+ZW#0_$?YO03ZIT/'J2>ELM4R=A.JAD9AGZN0<2\-EKZMP;:7*V&&1\\VY M7CZFO\5-OQ,D(K?UF`47`T(./Q4NP(+EE<-\8-#/;7_L&W*K;+`+DV^8-IBV M8DR;F$[EE!,#T_;FX.Z7F'+1;/S^TL]+M^^Y/OLP9E)T5K/Q\XKL^EQ0^M4] MR'[^ZR])].&!TNG'.WO,G,1C7T>S.@#W],>YW$UT[CM?%N4`[H5P[OD#77B! M_[UM='L&K?F5>O6N.KWFSS$V2JQ\.8H%'`&2[V"$AH-HK3R01'[+P8)>/Y MFC&Q9GIEVP?>U8/_M__KX!X-TYB-*N;GXP3AB#!]8Y?1$66)`([1F'@N^YE( M%/NCP!=7LE&.2=9]KS$^9O0]CQ^M8^=EW[['Z7'X03;"W]F0F/V=QX^PM M.<3S9N=\.C/.Q#&SH<[\>']M92_]D?K90^(T">9?9$9??/-,W63,SF:2FUEW M9KD]',;DX_S#AOXNGWLU*UY8_.Y6\B-'7BV>Y=-9I_/A75^R[@IG%YH'7M0 MN8+BE:MXLXBD4-*X0A,XA:1FVX7D@NVHC+#T-;J@<.DYG( MB#B$/@F^ZH214#6$(HUE+F[$LGGB=A=:^$*H?_IM2,$`G,X`0$]&2+ER:@O? MI,!/@H@65.JJ2+8V@#D5W6ZLCK;J0+=JH' M$W6=CV)P:!LP7UQB=J3P>F]QM%&B]Q`DV)O7X.U:`D*S)2!KJSZD!3>%K*(\ M8?/;RLQ[ORO9=]5>\7675J]7XJ++>C=`)TNIDK$&-K@PW./+9[\7?2'0_QA&YQC%UV,T&U$L3WO!AM;-#CLX* M[5:G=W5MF?WKV]MV\\KL=3H]JVWU^]?]UN"Z-="_LX++)4>?"&*`($ZRZ)D0 M3)BZ3[^/6<3-Y'PYQ#&/SI]QY,Y:*#R3B$7G<9QF43M&[/6EWN(&3/8,KC'O M3LJ^Z0=/U*7$WW:W9YJ,Q27W),29ZEQLN<5O*8D3AZ<%.VZQ..G*^4]*8[J\ M&?79`0\)$\>B.H+.&TY,PC3)SA*% M$D*M$9FI/6+8RL8O$J01`PX;$E?L;$MG\4#\R2X0^X>3>J)Q!3-\[#)^^PE) MQH'+;."C:(^1)EP?V1"&+#"Y0%FFQH_#,`K"B+*KV6#Y+_&+PR":/YBL-"9`Z83 MRC61H'&@<:!Q2JWP.+VG77\"^Q4E=RDJ9>1YXVSZ8NZ+1U$P0;-)#K[^;;EL M#>$DB>@PS1@^SB0'DTDPH[K'+$0B48R&9!0P/XX]+W`6].Z"UF47\;5QU*$A M^R>[>TR<--JW_K+8(C/U9UW5J>5N&EUYN\SK,I%9/?M4+:,.%D`C"W!NVDUY M%62;:J[,N_\!S`.8!S`/KRZ#\$![6G%S$8`\]?D_$LM0>+3!><*P3IR@4``,S7EPDI=BW3DJ=_`%``*``4`%I9 M@![/_I]F3:JZ]/\%PJ.$1`I$W(J9AZ;1*FHAD;XK@H`IJS:>\B]+4YF3SBNY MO3AK!1:1`J$-,%6%&WXW5*[9`EHEB>4W=M?NA:?>75OA\JTJR;`R<@,]!#VL M@MQ`#^NKAZH[ZS)G@;2!5V?7JA MZ0151X`J0!6@"E!5.JU9TUJ^-P/2_-5\A2[FKUW6:;8;TG8KTS[K!#ZG`NY7 MJI"K6DTDF80]5J10#0B(!\2K0_\>*E"H+,R70!OZ!^]?2,+[)*P$\%6)T?=0 M?5G=DZKOT4E?PV1919'WVYHAU<&P`@D)M@ML5QG98=/L-7+O_"U- M:I`%@F$#PP:&K<`DN%MF_]XZQ&2Z5>;+T[6WVSXP@QI,J`^-'RKA.ZJCBY43 M'&@<:!QH7/4%!]7*&Y?]>];U]A*ST>-'DKG>>+6=+;I$0]YH^A#U?&_*2;4J M#;,E+S#6);2M'H"J974TQD/;;O0`#@`'@$-&FW3D;<>G"QQT(SZ*#,8^3T+L M)'RJWJ5>FM`G`M6S^>(R*)Z%M+M*CDL78!6Q:`4`!@`#@!6P0WM" MM=CI(]T*Y97%58M=\YGHY4JFC9JQ'(NC#L$[E%E`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`P82SIDQN;-:.^?.Z!/)UI$\X!=^[1UQ`M^A'A5^8>_I,:-G#UJ# MYE5O8#<'S8'5M%MV-CW6OVY=#[IZ3X\]C`F*U@3(?&WR3(B/!DS$,0/'O+0R MP2]LK#@14V!Q@I,T":*IF"$3_`G_NA],F-)/OX]1&`5/-.;W&P71^BW8=UMW M'$"4W3Z>S:[!G-I)YM1,Z]A)M5;);&8'PG')\BJ55UHT68KMF8KN'1 M!"0FH&KEJ)JT);^@:J!JNU6M62AAF6\BQE25-RLG=0$0!-8/=1<"P@6&KI&$S>PUI7%>]@S)% MF.CB,+=BM;9\NG+_2..$%_W$?..6^=RDV,5E)45>3"_NGB8\D/8IA];1WS5H MYCI!?T!_0'^JU*JC2ERR/`_YK\9]0S##9*O+NT`^22K$#[97WVKNSX^D?U:)97J./7#H: MD8CX#MFL+^?%XY]Y68LOZL"QA_Y((QJ[U,G*PJL3Z5H_H/-FX=&N8N@_-YO= M1ELV35!GYPH^5&.P&(`5P`I@)5=8F;L0M2[KFX$D72=))]A/1]A)6+SH/R*7 MN*F(&2L4,@(Y"N0HD*-*NTU=`'9N`SD*Y"B@KF346254SM4!=:HPI\6)ZO^Q MEV9[=&"^10;V'1)?(!8U1,1)(QX"0];(\2;-R]4!5D"PU!8JACRDU"6A`C1H MBX9F0]H6"[J@`>A&?MG;+!*_WZL%"]AQHI2XJX6;'L5#ZM&$\K7_OHM2%K=% M":9^5M89Q%3*//?NQSR`S7SSAF@+SUG\M+@V"6&[JDM$-8M<@88!U*U,O`,- M`Z@#U)6+NE;#*%RO:AULJQI3B\L^SSLN\:@X)#[V1(S,^(LRF?_B62,+._O M'N(H\4D4CVD(F1I47T+UI6*N2A>`609P(8`L0!:XKBH`K'YD8S\B+DWB"Q1& MU'=HB#UOBB(2,P$Z8\$H!E$XQCYRH_2Q0BRB#2SB*]ZD"P6>P)L`;Y*O)ZJT M4A.`"D!%9ZBTY:TVKP-4@']\FW^AP`'@(/J<&C!OI7`%N96EZ\)^Q=D5[OV M98"Z*:`M*N2/=`'6N5D"LNHP%P:H`]3E#P_E<0?:NS-52,+B;-"W>=-'-`JB ME>70)):F1%G3[9DLFN$+@M7<0MLK M;E!`[:`635[L`'8-[)JP:V+73VS6[(W''N_=D5H("52H= M_3'AI1I;SU_Y+$Y"#O&\F0Y].C/.Q#&3@#,_GHUB5>VZ3,=61_5`)R1&7\@S MN@LFV/\)O36\;6GR,W63\4>[F\S8=Y M5#APO"OCE35'#;`X,_HP)NP*G*1)$$W%UFD1[\\;D9%''+Z%,?O_OQK_;&P[ M*1A)J4IB`Y1Q&\&(C&C,Q(XLPVQ=B#JJ[/GO&VA$F$%B_RIN',U6$>.PQ3#8 MAV;C:+L$]D=!^V-I;7\^^XZ7NB0S-'3"U##A>)SOY;CH9(.>MC2[$5#)VS<< MX%-+^#2UAL]MYB>F+((5/H)/"61X6F(IJQ^.B,=@P8"4!(CX2;9Q:D0XRHB+ MAE/4#YZH2XG/-\ER`M\G6>O49YJ,!3CO28@C@2Q`4BV19&N-I$'6,W@9>#4O MEL'CW7Q?D&S7$.211QI[F3MZQC%B3T5X!?]%!A?,@14%#'_TB2`R&I'LDSN+ M-O^!_12S"-2\X#]D-=!5C.+4&5^L_OP2RC@,H^"%3MC5WE1*J/J=U6@B=I+' M!B`E9N4N.Q.-L#/,HC`SP\47LDL"]_6(V;^B('T<$@S:W2Q%BPOA"9%3$:C(U5,/%Y9D5INX@/=;@N0WA^;O1P:PG$<.%0X4_%D:P2E\Y^4SOMM\(>A M[&$>9]:"+V<@P>AX>S$__^/PX[TS9H+UR-?1S3RJ^2Q&\H!?[MBC MWA&6QSK4H^))'OC-'ICN7'N!\^&4__35UV)Q:L3<25=^2) M^"FYC8+)S8L0L]=/XX3]4!1?3[]%`7^[\97OWI/HB;)7M/@5GDAS=;TCHT]G MMP.N5+_9OS\,SA!UV1=,02[;M_VN:?3M*[,WL*^-&\.^:5EMJ]^_[@]N[9NK MLU]>X6&7Z7O+\NV"TZIIY?;A-;S$,66^P9\9$)E3<%\(NP1[7*NG*,PDB;+K MA)Y1H4"H'S`WY4^_9Y$I>X7>W#/_D$XY%//S* M/=<:VL->`XO+A[MTUG;^K!G`#&[T#ST.J/L'X0!*CG` MXZOFZUEVM7Q<\[VU*&OE,)L%+_L*T\RQ)&7+)2LFSR$\'ES_X77??42L+(Z> M,X\P##QW;2KB=^;;#HCU0#,/TDRO^9_-Y5L;SA^5'BRNK\"Y27>6$T._+V(-)^E;E"EJER M_A3L%=BKH^V5)7-A.5@KL%9@KSSJ@IGJP:-R[KS.F#$M&S:A!\P`9DX;NNF"'*#LE]7R MP02_%($H:>)2`&IFM]6P(#\"3JPP@ M@"]CQX*C%CZ?.$2_:EM7H2H/M.^*M17N5ZJ%88?\)>%V[S#:;175# M`K0"6@&MK3MZ^Q/=\4L1/*W9^RX$U%2A2H:D*LC.!`$T$3 MJR$XT,0Z:^*)F"ZYR[$ES[7^?>I&@1.X+/Y!YU??/O\@MA\?+[^]Y!MP8^I3 MWOB*[TV<%$*':OY)D//7",?&I:*9\55W^@"G^HA15TGI2%F M+*,G+Q,#S`!F:H`9T^[*6TJA"V:`7-RYT;(X"SR-,).DP3C!ON@V9U'&B M;74L(#*`R*B2OZL5_+JVQ.4.`#^`'\!O#_C9=A.6].K&(ZJX@TSE^I073YM8 MIL2]+-Z1GRX(K![8%/9S]<.4E\>:%U3++0_R;LIL1]E76OG5`(@0JGJW6"7].4.)<+\`/X`?SV M@E\']M\`Q@8RH$K*"O0*]`KT"O1*"5FISMC("ZJR=9X;]91*@#]`'Z-L#?:T.-&[6C2TJ<*:2L"NPM]?N)GO4\37#%^0&Z=`C M!R^\L?:JUSN^,TF!T/RN="&?7J;%1QL73;O=Z$DS>>^)MA9UC]4S@94+/L`* M@A6LCA6T+HRN)7&C8K""8`7!"H(55,L*FA<=TY*XS1)8P?4<^4?14F?K^2N? M5\:U,?6QJHS=+8@[^<#%")%#/&_VJ)_.C#-QS%Z?,S]^I>Y\-`M-GCW9`YV0 M&'TAS^@NF&#_)_36(VXC'IZIFXP_VMT\[F%=H?.?O!_WP8:XCT+OF//B:%TW M_%QTQ\!^/GMV#.3Y1-U1`RR.H[DC841BXB3HB+ MJ)^0R`DF['FG*(FP'V,GH8$?HV2,$Q3-[X!^Q1Y[M2VWC6O9Y^ZJ\P\HUZ0F766K1>J>DZ1*DJT>UZ1S M=9]3_0A1D(4)13(@:RUL;.S+K:O^SP\] MSWX@]%8P-E4WN>?!1-Z8$6K]"+F09[OCZ%B]$QF&OI2-[U<.)IA=B:2^ADBB M8RZ'XLP4[.C,,O_[[>^A?W%+J??FFS5AH]!FG\97\D,$#__F(W;MC%TQC3[% M5W;'G)`-A#N]^BF_KT/M?BB__Y0)O_?P67["T`K\KC/ZQL0=MYA_(\?DQ2ZI+CSELS(//]$%]3O]&R?SQVD@KY,%7-GYW-K@TJT;C M2_WOF\LSPD?R!ZE7%XW!H-9IM*YZS=Z@US!:W4&W:S;-?K_7[3=K/?/L_;.O MMXT7-\GWD%DDU8\_DQ[Q9N(C;"96$KADR.3O?'0N(3>VY:\*/^,P"`5[.LV/ M/Q>A/J&>)UQ/<`GB\PDJHX7'^HH MA;67'FM4%RD]T9R:0%?B6=*HRC'/+#')V3;U?/9F_L?*X-=/NX]U[:@[LRR%8]">HJR*(T"XLK23;'RU'!!X@J@:FO&U>U&II_ M8JV<0I!\,>%01UM/K-V3SR1)ZDCM#)U,\TO2G6+27W:6!6T%`E9Q)Z6R(*L. M8&'=DWRV2I+64E9#KV9BW8-U#]8];8+45S:R[2+EE"&S*,!I2+?U$[9%W?9U%NT@=.A]SF`6?^GXSZH6"C M3\Y79H5"2)WJ49\GSS^J=UNU0>>JTQG4NT:_WFE4._4X_ZC?K59;)<\_NIFP M68Z02BZ*/K=//.'>\1$CE/CA=$K%PSPESY6#:/11"'5&Q'[Z+'&* MH$H^FLX^$)''8_DER9WZE,1UY&W%_).1H?IFZA1U>R;O)9_$J#4AGGQE=X2\ MI6/D+1G-`Q.7&K52)O:4/7$)XROV^`JRYLNO=8L,H)4,H&_,"]ATR`0Q&^=D MDVVI#"LLMZ"0&2CDE]!5>>^?A2I20+A#NE;`[QCYDXKORB`=NX)<*Q,M*FP1 M+QU6:_-O,",S'^$)B MYY%Q8@(GP$G6./G+<9]C)->326UGD"2NV)6GO=BMM14-\YFOYB+Z)47AQU;& M=F?5OOC+4.A%(*[<"*N\C`^-@\9!XZ!QT+C3T+ADEN"L4O0)V7S199=L&$2; MG>Q'R(,'XJLMS'C+<\)L5325"#H<*'IB;;%8(YUV:2==BP1/:;@0`1+:O1+JD#X$XI]BHY6XMT7ZG"D M$O1^BE%XV":#_D!_H#_0G]S*!_JCS8R:F_OY68$>.[Q\S(2JEF6Y4X\Y/@U4 MM^>%PEJZ%EA:5Z9E6WP>L+;,R?+1S*+7:UE6?O"/Y2AD#213&)))PT<%K@'7 M@&O`-3!H0#(@&9`,#)J<M&J1BUD!+42E3_;&7\O M5:(N3Y?3FC8GQ+XB*PO>X1#-8&($\$[/^P=@`5APKP-@`!@`5DR`H5EB81)C MD?^Z*L""I[D:G5:ED\XR=UV"ZRGDL8*[P%W@KH+Y"2C"PL`7 M0Q/,^E)DPI$D<S/_8V7P3R^UZ#=]PD%SK2=\!]=K]#+OSAJU5R]";!GLLPN-/:_K9/R\K*_# M^/+QGOD>'S9$TFXZ^T(T5@JRW&Z16'(J8D*/D18=K10*_,:\@$V'3#Q)UFR> MDTWSM5DUM-4&/GY\YI.`FI7&?I)]=N&!*U5HZF9-_1*Z`1N1SX);TE[B#NE: M`;]CY$\JOK/`5]&NY%K9;DI:I.O[ZL==[S1J MH]+21?,E\C7DS#.3+_(%`92(`$Q37R8-"``$``(H&`$89J4-`@`!@`!.E`!0 M`%&3FP'>KL,@@[[81TOS*'M?;)UN#C3$/DQ\H$?0(^@Q5_2HTPD$>@0]@AY! MCR6B1YTN,M`CZ!'T"'HL$3VF43\4+*G/+ZD"X4\H]BDZ6HEW__#4&B^5H/=3 MC,+#-AGT!_H#_8'^Y%8^T!]M9E0:5?\+:F+-PLO'3,0-B*<><_RX-?%^+8BU M1Y.@?7IAXD^,AL:RHF7O.P'_6(Y"UD`RA2$9]+@!UX!KP#4P:$`R(!F03.%) M!@9-VMMF)UHUH"]_DD^3MU8-V7T^8B+V[*A*`M3Z$?+8Y_-XUGX>GT<1O-1E M\^!1;`7&`N,!>8JX#AUZ`N4!>H"]15P``(<-)?U`Y9W/JWZXP6:B+]R:@?"C;ZY'Q57>*$'&6/^MR_42*[ MDJU:ZS?'6G=/.T<,@W7O1=FG7-KLLG\1$:R8_<\V!"QI&` M2>BS<6@36PK:)U0PXH=#G_T(Y:O8#X1.74D#_V$C$6Y/H)9_>Z_%Q3P_Q:!`PX:C[#^5;C[F\ MJ7"GZBR?+=]R>]FN-&"[<,^E&;KZS(6MCAG57/HF/)LM;\.+F"W_-1,)%_RC'/R%T2MTT]G[V9_[$R^*>76MQ2>"3\ M^MH]HATV):)W>7?6;KQZ<2I9GM1F%]8SOJZ5Z+JB=P9)S^CKNU//9@K;`;,F MCASG[8,VD^84!-@HM[0LR9A,:)17X)9;8)K5RVR0!VE2[ASONA?3E4E@'[A4 M66F,T%O!V%1J[^&%K4HH)6W+5I!3#N6B65EJU0PXZ"38_$;0$9M2\5T;*9V$ MV(Q:N<658Q[+I\"*2'!E$EA_K1>IN'-G03:H()^Q MZT[!AIV&/UQW=,]M.\F.0JU7KYI7MZ:<]_YL;R`= M]_O,3GGN3"^-0UY:YK?B7%'SV1O-`IWUC7R>ZL>=UG8R? ME_5U[8*\)[[?,<=7D%5`[FRWQ]=MO=#DXJ7B`NG&866W9(^.5EI@?6->P*9# M)IZ$;#;.B;*9BFLH0QD7[G"8,JZYWZI^+KW5LK&:GL(2LQGI:;UD_I3\*N]+ M[8+28-(79'EL^OQ#N/[V5?.QWJP_6]#E\N6ZT2(3$PPPFH6R658X#>THM/!Z MZE$NE"L#R@?EPP2!"0(8/7F,'C9!(`YETZ[2-X]9G-K!`^D)ZHR.UOLQ6@2G MWAM^^TIYM>B-MG5R=-G1VZ`D\S0<),LXPRY%8=;.ZW6SLK-C86^PGT2R78&H M,'>SMG:KYIBJ>'R*VU7C"IXQG&49/5`8*`R6'"RYG%IRYKG1J59#`.&UO2.S6GPU8'=:8X; MA*57J+7S5K.M,0@+/6S@,`<+@@6+Q8*:#,:DDMW9,"R1_FISZ(!$0:(@T1R1 MJ'G>,`V-F9DP)<&"8$&P8+%8$*9D_DS)3'O*IEH=?*_I)+>CN0Q5W]JXH2GW MI?)'E>X)DX\;D85BDK.BI^?1F;>J:M-33?0[U2%WJ23ZK&KZ\PHGCW72N6,) M1GWYB.$#61'-Q?,#^U`:7\T!CKZO]`/HDYW2DW4D+Z$S`\L5RP-R0N%-9&*3SS!+4:H M;;M6U+NE4DSZR)P,-;U\?*A.?\,#>7LK_F6E]M7VZ6VTN6O'2M>-#=TY_H=) M?ISTJ6!]UP]NA"3>KS1@R9N`5YMFK5:M55LMPZBWZ_UZLW<9M^SH]FI=XZK< M+3MB,5JJ=[8EY4@")4C5>CN<>E%KI*COMB?_2["`BZ@GY6/W;,^F3MP(U-E^]&'2ETX3BT"4N-*B'-T]BRDLMW954Y\@46G0>Z,*Y5 MQD4H9]*J&)G)+E%`9`%JYKS*I=:5;,H!7`'7C.%:D(5(>I)2WB#E4KR?<&L2 M]R)]-A=S_W$ZEN>-F*6\`\.<&D6373K\M[*B%Z.0)?L28U(.O$D94X M;FO;IOANF]T;=LJO' MOS&X;`YZQF7#-.M&IQEOG/<&U7ZK6>Z-\QLY2\^%&`7<7"O?O!/%I,B97(K9 MDSJCPEK4SCU;VEE?T;Q] MU=H/O0W@E)+\YXJ8GV[3\H)9G&@_C M=XH2;X#Q'7%\!?%^YLZF?7Q=M/-$&`94K0AA&%`UJ-IAJE:#__90U\CC2O"8 MJ$7KIA-HW?3:T%GF_^3B)U"3]=B><3`;F&T#LS4Z&;34!+.!V5GQT$0+ M0*`!:)A'K!F``YSXV79#V+4$*%:+J157+?ERTC0:^FS>_:5Y$@O.`A%C[JP* M\"/X\4@;";4LV\)@IP'D"?($>9:"/!L-C7L5L"UW7(EO3A'+[,4.2;%9HIMZ MV]-;E/ZWIT0KP<8VLP*?_%7YWXJJECTKGQ67V%9I6']5OE7(F$GMD3^K'_P@ M2IY>/+4>_WPCCF!*Q[ZH1#RK\3YA?7+ MKCDP:IU^LUWK7?4:W<[58%:8MVLT+R_+G5\X%Q]G<85=E5`HN*K\[H[CJO-1 M5J!*(Z1!](,J%"#_CU%K0CQY7W?T9D?+8T\AK`0G%SR_;DK%+7?BEZ1AX,Y_ MB"W*Z)<44O#:1RO=F^L,+F2H8:MJG;"1R[$YE^.Q[5+L^3<;`>K[GAUC5$4^L2XBN])ZK0E.#4]N/U4NAYMK0Z M#V:&F:CWD:B6ZC!)!9O7!G5[.IP,K7J8>N^Y9E/CGF;9BPO!L:[;L0ZR`EDE M<)*W]!7^+#U9[66@G9H=]F]7?%=.:D^X%O.3&%]EC=TTS'K%U`6RLF`)RW`- M>#B`8E["0^)YJ:Z518RVQDRSLF`&#H)#5&K`'>Y/V"CJ49S*O/22.RR]4KK9 M3F@=(ZVHW00R*PNHL0+.8(;,#)D%F%J;&JW1DT/ORW M+R]P?.XZ4:"*)\\5+.""3>5+/M["LZGCDWOJ+[1.2:6Y",*?=80_F_4#XY_- MK..1$?^'_(,#G>>&<80P[UP%=7^>&6,S0_AP+R6T++F6 M%5^+ELWXI,H$'@./':B!L^;;?S,J0&$E4;#=W6`%U#YP'C+T=*LADD&A:MFI M&KH;0M7RUMT0J@95PP0*52N$JF$"A:KE;0)%9X%-(4#?F+CC%HO"&PX&[I[A MT)%7Y*1+O!Z8HY[,K72\"J[U#'+33R+*K$#4E;LY%=0%ZDHNJ$;%`'6!ND!= MH*[B49>V3G.@+E`7J`O4E15U56%U@;I`7:`N4!>H"]0%Z@)U@;J*0UT%B89- M#W+7:A.8^4'2[<74*F4FW,767CE68W7FLH`D?WC(W31>6CAT*DW``7``'&(X MM%%6''``'.9PJ'2`!J`!:(C#7?4MRH$&H*'P:-"69E`6-"#&?9.R7/WTF!6P M$1$L"(5#7"H[[-$M6%V+T]?DL80KTU3PPI]5Z$\Z4U2J1Q-M7[3Q4(Y M`F)Q)['RP*X.V`%V@%W6L-/ACP;L`#O`+H%6Q5)JFX:I;>5?^C9%`!@`!H`! M8``8`%9,@)U\;%QWZLHA_H<&JE"U.XZZCE`K"*G@U":VJ[G5>C']_!WX^9.. M$Q-0:='0QAXPT``TS..#3'U=RP$'P*'@<$AA$0)4`!5`!5`!5)0,%5583EK\ M43GR`F?GJ/($=P7Q]RL<>W*^X==5Q!0@IJ`H\QA0!]0!=4#=OF:EMG3NTN]_ M`E@`UN[365U##5=,9T`=4)<$=1T-;A*@#J@#ZI*A[O`H!Z`.$7;__.#Z_F.R MK\^"P&93YJ23\5LPD#7U]00XE049YJ+2HJ%6:0,-0`/0,)L;@`:@`6A``!%0 M`50`%4`%4`%4'(@*A-=M4IJ/+"">_$]WQ"TR9`X;\[A?`GEM"3;BP>%N]KDW M-.ZY,9-)S?M)1FXXM-ECWXU]Q(J.,+M(MNPM8XRZOM+E^POS))K*%(@TA1T-?'0/0(^@1]`AZ+!,]UO3EHX$>08^@1]!CB>CQM:DQ^OM@828* MF2N`GB**%=29,Y4$=6JCSI;&8&)0)Z@3U)EOE01U:J/.IL;L)U"GABR.WP,J M9;;V_#5_O_T]]"]N*?7>?+,F;!3:[-/X(PMZ\0YSW_4#_T;=[T:.L6>[UO?W M__CUE[>KUWP)J0B8L!\&W*&.Q:E][8Q=,8WJP2S?04K342+[RL;OS@:79M5H M?*G_?7-Y1OA(_D"MX*+3:G9ZW:M:O]9H='J#7KMS:9A-L]_O]:\:E[W!V?MG MGV!1GC=\RGSRD=V3K^Z4;N;FA7?6J+UZ$7[+ MM#*[T-CSND[&S\OZ.HPO'^^9[_$5)!,P=Z;WT^LV-@4JKMUU6#4Z4@YDM.3, MPX0>\R0ZNH\GKZ%KC^+[#+@O!TW4E$Y>#Q_(C]@J*%LR:GY5L'8$#7Q!EL?6 MR2_:JN%#T:!HVQ1-6VPC%`V*MDW1M(5!0-&@:-L4;>=PQ/]G[VR?$\>5?_]Z MMVK_!U7J;/URJPCC)S!D9Z8JD,G6U-VSE6MZ1N;-QX;>-&1B.V33T1Z_J;IIGHKW MVQV)VRNP_DT/RZ6<0X7Q@O':7E`=NRNOV!2,%XP7C!>,5V7&R_'4<)L-0;KNO/61UP$H_GN6A2B+F M)$JH?*4I#VVGV04/X`$\%(>U+-24!@_@X=$_\%!$VFHM4WC`U/I+ZO(Y#I(1 M(\,T&15[2L)XPF^3)&.6%MM.Y+;P*$.R!V2MXU<0]9O"H$:XZ>NL3"'+;U6P M#`-D@:S:D=5JH74PR`)9\LGJ6A6LOC&%K-I/\\P"K^,HR;+_-8V_!F$V"\'8 MH.0(3#.T6O*6AI@"D'JLZ.N!-*/!<>4-X8`#<-`=!WE).-``&C2GX=B6N%YF M]9UO^_!:E?W"W-#*MLNP"%,0]K\2]CM-'V$_$FKJ>"QCR.K(\V0@"V2!K,=\ M6@>I:I`%LK!P`9-`VU,U+W+L\_.H0]A;M9=*D)MNLH)>0:^@5]`K760%O8)> M29>5[OEN>6/U'LW"@/"Q:\SO)B-CEI+LCJ9;[8;8X;+BL&PR?D'@7&Z_K;32 M>#I+:YP_>^_']G2J@Y]29E2[RXLM.6`QHIR%(A4KK*;?0IR*#)!^8Q@8&8V, M3!O[XV!D8&1@9,HT,A[67\#(P,C`R)0:+L'(E)IATCF1=!Y&DYP-MDLE$65R M2;MGD$Q=1,UQQYZ""CR@82,$7FC8`.KH7N M:IH;:FB(&JJE:>BSCC[KAQ:@$E/F.C3,\YQNL_SUQ[5HF*>1Y5+.H<)XP7CM M8+R\3@4EGV"\8+Q@O&"\9)?^<2UY_<%@O&"\8+Q@O*HR7FW?Q] MJBKJ=EM>Y3)3(%&/!^46AYZ"L-'L##[#"W[6*\)"6H M4"A-4FF[/[1;WQ:Y3@5SQJ:@J!%U^OHL4\AR+%0M!UD@JX1V;$ZW@E8;JUJR MK534[],&[(#=%ET0?;>"P6(=N*O]1!$ZM6\A+!])0B0)D22- ME:%7!Y<5]`IZ!;V"7FDA*]TSYO+&J3LT@C>A>Y=T.M#0L+3(K(263FAHB+20 MAD,7&!F-C(R+#7LP,C`R,#(EIN&M9@L[K##[!0L$"W2H^?>FA7G`<#RI,, M.L<;MG#;:K;1#+4"]VC8\,%<'%QTC@<.P*&$6+4.`T*P4E]69$95=6!E(7AZ ME].;B*W[?64.;T$V*X'$HNP[7-#/A;>DJ5YG::7$ON+/]WBC5V'(Y:1/]D]N4Q&-/Z-O"3O=>'O?3C([Z;R>%,U ME]G8_,?;1>#\$;>!Y)6(4KR?90/EBW$!OYMD)[>4CD^O@CLVF$3LR_!14!=A3.,@I-'GF#_YJ)#2M3C+-7])O2@) MOGW\Y>>?WJ^>X9(%R6W,I3_X+.07#D,V.,LREF=GP3^3D(OW+![\$=*;,`KS MD&7\WR8C-E@^=Y'*X1\NV?##T<6Y8]FMK][?U^=')!SP+VB0G_2]BT_NI_ZY MW>E:Y^=]KV6YYT[;Z?=[9Q>?6HY]]'%='NH%R_*28=G'+A>?PT*)IGS*'/Q< M"ZU*(CZT$MFNN49Q_4U9QB]8:!W_.PI'_#VF7.WY3X/B)0K5+722ABGY3J,) MFW\3SMY78;YI\OC=]$6APL&*'?$JZYXH@L+"XE#OK\ MC=-`5[X>\ON*RK^M/N5'!VSQ\@WR=<*R/."_>'Y3_3^OI@\R9A-NV6;7F?[@ MM#0'OH'R+1E[:WZ.F7*)SXL7C06OT=)E;6O1/VSEH+?`9NIR;8L_\ZPK$'<` M$1UG['3^Q\K#K_?A3\-T:^V@>@,?7-S,AR.W_>N6[G]VH+WK<5;5%\0#X@'Q M@`=X0$TFX-1-PKRUZ6#F16:26&TOMZTL[9TV):PYR8(7"[@+9NGRK=BR@O#B MT_W4K=\DT>!Q\%>,M9`7A$HJHI+343X4$@JIB$+.8SRH)%12$96S,]DN(N>EM^Y>P-QEJ/5 MDA97;ZJ@KPFY&EE.EPV4*$S/;KJR'%2]6\9C?\CN?ATV$#;P<#;0]V$#80/K M8P-AYK8R\Z3;0C``_@81[=^)TNB``1(&*^!MKNR$NE@0?P MH#D/CH=US/M%XNHEON1IQY><_]-L<4&#!),T%87:1=EQ$8_//J^(=8<+BTJ,U,LBT9&1%\/7!Q'I,0!-H`DU97K,C<;4'R`29(%/6:I&F#S`/F<(R?#')==';\EDWOD,` MNXN<-Z^]6;$[;?BV5V&&""5(,1T#%E^8VVQ8;K?"E!!8!(M@<3V+G8;M^\T. M6`2+8/'P8U3+JC`?"Q;!(EA\@46GRC1/'4C4?;52I3F@_FP)4Q32FS`*\Y"I M7S1%590=3R+)Z#FC!ZT:>]DZ,.DZ%=3X!I-@$DQN/N1M=RK8!@\H`26@W'Q9 M>T=BMA?\9CR5SV>I,$=S1B_M3@+N2K0/$QB M-.Q3"3U\79@I8773F`%@`JXQ"#>T* MIFB!%M"J'5HEQ&,`#(`!,`"&10LR]>B<#5F:L@$1K6\6\AX-$K.\_.2'9M2Y MCL2J>Z9@I1Y!^KHGS7AH.ZZ\K!]X``^:\V`WNI;$G`*(`!&:$^%T'8R8P`-X MF//@HSF4E+AML2L#8``,@`$P``;` M`!@``V``S%#`VA74*S(%+"Q;6#ULVFEEP&Y6>P,K6B[WD*L6/*^Z.O&F4*<> M8!I[+;-XLANV8U?7XP]$@2C#B2HCW@)5H*K>5+D6G!1P`DYP4H>F"BL\MLYM M+-:@H%DV&1VFDZPQ"<>NU_2JPM;XE*1&Z)KK/DU!TV[XG7:%S?,`)^`$G!O" MZ33IE/;6*)0[89EE]:T>XUH:]&B23W[J-RH!5805E`E*^BT));3@16$%805 MA!74S`JVBMF@%JP@K""L(*Q@3:V@W7"=;M.!%805--P*PM#M9.@TLF5=N\+4 MGBFV:F'*XUU.^1.N^WUE-[8@M"B,VU-EE0#;_\7;S9OP1MZ%G11&6W\_2:_-'']C8E[5Y\OJW, MP\H#EKCD^R[,"!TE$WYD&`?19,`5:^6!=_%9CM.T"/]5%":QC!,VY-R6[S8[ M"MY6QV^Z5^$T'@@Z=YT>NQ?FON0'K14GP[>,O/__T?MVYLSR=\$=)N>7F MI[ED$?9X;/'`_,,E&WXXNCAW++OUU?O[^OR(A`/^!9?$B??)=WL= MN]7I=_J]7K?K.3W/:3M]_J%GM?J=HX_/3.UK7O4EI[KIF*2S9DQ2?`YC(,D'=%HZ;*VM3@JV&I8MH7"3`=:ML6?>18]<+D.\P#(+6[:)U[@&4;E66 MFT\A'%I'Q9!55D*R:ME!2>NCI-+VJT-)H:1E*>G&6T.W<_/SJ3)U]ER]/M/H M/`M_3VRY,QU"TN3?-.(A=?`M308Y^<\T>["WC9A)>A>!OOAV*EA.H,YL[ELJ M^IH`2Y"3[)ULOL2Z*0?4E\-/Z6)_:4GK4F"Z8+K6.TU?8N4*V"[8+M@NV*Z* M;%='XAZ(6INNG>+.NH67"ZLAYM/2V2X)E!?+?^PAUT-6\9"X'],4GC`S4UL< M6FUYN0#@`!PTQZ&$@N"F4(%D_SZ*]27G_U3J.*PN9=B.+0D9(%DR>U+%;85V ML'!]_UT72!"!VNUW^TCH5PAJ02VHK9!:VZ^NRRA*GJJ9M92G3=,N.,A%/A[F M6?*VT9M""9(OM<6A8\MK(0\<@(/F.#@2.RB9@@.2D/MHU!\LRTX)E_I)0+.[ M^;[EQJP^!;\/$H[&-$Q'3.S4%UN<*9=4)#8N,R[C.[%Q^8:*30'U'"T]8&6RD]88`ML`6V56+K2%@#!FJ-37E6 M.RJ?ID7G183$8#H0P^T\(3>,9"S/(_Y)%!/B8_9RM%9"W=>RUF`KNU9]SX*O MNJQ9=RVT+T%&K^(!"TP73)>$V357WG0"3!=,%TP73%=54S\N6F>6-G'TZCN==G-GNQ87W MJ34ORGMN66VSB_)>+U;-)=-:L]ED-*(I_UU6A,N$BEK/8?Y0U)I>KN";3F6? M-?A!-UE.XSRD4?1`^']$3=YI;>AYB5\>C+/1.$H>F`C).6A4%)P6,V0W+&;# M,.>G$35_BU*^[$?`QL7,&#_/BH+N\JC_ZC1;$BIR/YU0Y!.&T[J.HBK9XG-R MM+9Q%RZ/_[_(K<3#*N-5F& MLL8'*6OH/0/^C?V_JW M6)#D/]MO`E!-G%!-C&Y8^Z:K3:8@,R/YMF7="K"#N&`#_`!OC6'=246KC`= M/LREK0T18Q$BAC%A61Z.:,XPKZ;@L-04!I'R!#D@!^2`',GD'#L2$I'/Q+-Q MJ>P2AC@EBDI:$7P@!^2`W.$KV-=X?F]]\(:Y/EU&I\8G79#Q1,83$`)"0&@2 MA,=64UH)%WD=FPP=$X->T`MZ=:47LXYK`E=1*WY,'XK&Q\@V86H$4R.J^$&0 M`W)`#LB9#A3MEH0M2)CB`'-@#LSI%H35=5KQD@41S;)PR$52S!ONTU1KZ6:R MR?@%D7/)_;;2B>KI+*UQ/H-C^LKYB;8"-JWP;Q!MJB,N99=Q5N7(3>R MNZ1P.@'RY87;I!;PFQO.$A^QM-E_RBZ=(V MV_3KG(&S/7G5B^LR8(9G+!>9S8M=J\=3>5DDLVM_@SFXJ=?!K^1*V4]:%/LS>O1$;5EB[QT`6G9:\:N2F((>D*)#!]DB0`W*D M1UWHSP9B0,P6PS.)[=),00;3:-N%2@?N5U&GS,:QC*:]6->,O*0R/K56]-J@ M%_2"7DWI]>25`0&]H!?T5NM[9;1%!;Z85)0>*6."<<]!=4<6U\`726,@APE* M3+>`G+(*_>_?'AS."L@!N2V:0DHK!0/D]@CO:CM#6G9OC5JE<5Q/7KB'-`ZR ML(?WN;7"UW;EM6@&OL`7^%:*;QO.%_2"7DWI;;6:%O!5.48V/!2N=R,3$TV* M+6]1!0P'\ME`#I.OF'P%.64Y*VG#7S@K(`?D-IE\Q?A0A<"RMI.ODS1EB@AH0W8=H7- ME]AQ!:R!-;#V,FN6Q`8K8`VL@;57&OE)[+]>"]@P1;O-%&VUC3C+2)J]Q>\* MK/*D9[?0:0SS*$IX1\/(DMFY"&2!+)!5YA(!``;`,`FX!82>C%)D=:$/DWAO MQ&U5U+#=(U-UR`!-PF)8[-."RS*#!NQ>!!6@`E2`"DWFK12/8C"ZDA.KU'CR MZ5#M*PU+ZAUW*DB7;[VH>%OC7IZF8;F_$J[0-.IL"=7-01VH`W7;4&?!UX$Z MY:FKX:S6L2USYRKVMI40:M8UHL04V2ON5-HF-7A-Y$0-1@4S!:`"5(`*4('Y M,V6&7BC0B0FXG<.ETKHCFI9S=&0T,D72$4E'I/JWPLZN8)T\L`-VP$YV`4I0 M!^HPPR8[8O0\>3T=,,-61BQI>,A8TRZ">J9FCUUY*[3AKY&O-1@5S&*`"E`! M*D`%YO:4&7IA;@]S>[M*M?3F>_,<5E6=>PX=2TE<)UE=5QX#@S`D34$M&N(I M//(%H``4@`)00P&MX[2CQ(6JF'4L(\HU/)A]HV==J^A9M_\"S;5-4UWN0`;) MY"9BCQYD%\2E]=XXK!K_JW(A'UZFI=O7CKQIVC?%6HL>,$C.PP+"`FID`6T+ M)A`F$"80)K"V)K#T3!@L(2PA+"$LH?*6T$8\+-D$+N04W^64/_ZZWU=V8\4= MD(!%T4R)/AQ91\5G+MY@_OF9+HH7U)FKV>S.KL,1R\B?[)Y<)B,:_T9>NL5U MB=3[<)#?G7J=36SWLL)M_N/MV1`B4EJVR)QYS#R;GFRL6W^FN M"K,7UV(SR%Y2*G-OS#AEF:BE0/([1M)G6V5(,B1C%F?B3QH/2,)_E))QDN4I MR\.4B2H,Y(;%;!CFL\Y._'1Y.@GR2;;LYI M2C,0[]]-LI-;2L>G5\$=&TPB]F5XN7AWE].;ZSUB)/CV M\9>??WJ_[OCO+)ZP[((_ZJ)FB;CS_<,F&'XXNSL64P%?O[^OS(Q(.^!O^.XK;.CC\_4YS5S\Y)^OZ9]B^;, M6S-6*3Z',1\5SJ"5Z4:N6,2"G`U(&`^3=#35RIL')#V.ST517;5!2=5Z>/7A3ODHVSYN>8B4]\ M7KQH+!XY6KJL;2V:Q:W\TA:*,?4TML6?>3;:X"8KHN.,G<[_6'GX]:[KR=0Y M:Z>,-W`]Q1$Y:U0L98?[>CT3 ML"MC%>J##L9)&6&9:]6A<=`X:-RA!*=)+%[>+-)?S:N-IVW*D(L:4MA_8<4S M$;CJP'-V7M@GKLJV4P80,,L@%VP^]8S2YL`&P`;$!M;8#G MV/**#9EB`W1/)Y;'R*=)FHQ9@_R[6$I,/M$L+]:%G0U3+I%=(M:Z=#IPW+:\ M`3?JBJ@#FW+NN7YHM2P)K0J`%M`"6FO0*K]!CREHU3ZA_$7L,RB#)\VPL5U? M7A-'4^A0#P1]_8MF/'`OT@$.P`$X%(=Y$@M\FX*#[CDWY>#98CVIA$(+XJL7 MWT8%&]^52?Z_707@+9U]3<(E"%*V<7,;KM>6-Z^XNSQK46X!%A(6$A92+POI M-*R.4V7=&5A(6$A82%A(;2RDW?!M1^*<'BRD`=,6\M1+5/LYB42YGWG5F151 M[7!6<=C^F^4RE;RR19W`9(^X M0Y'0HFNUL`X7R1,=?3VLC#96IN-TL6X25D:E$3-*/]0YY?7ZQBV%\E_NZ_FO M&BX6:\F;*JR+PX!?,!8'UT7-`N"`Q.+!1T,*#K+@M$NUVOZ5BT3>YH1G_(HF+SN-1\M1Q7'QF<1[F#_Q/FHNNY-SY M3#N4YRF-,QJ(GS:(,/#B@/N[,+CC/XMHSL05Q`^#9!+GZ8/XY\_B7^+!_IW% M0:N&M#JKM!H$VNH6-`'<.`U'-.6'\AL=C9."LR'_-AGS!WMHD#'G8;INA_TS M"<I'!1PR0= MG0[8D$ZB>7QK6TV?\(,C[KOVO$YQPD8!<)EW;#4]F3=,^$!@YMP+80^G;:]% MV^'B4413V`9WX]F8<0?_G44/^QNEU_3NN0UZKH=+J!4619YF[A:ISOY^_VZ2 MG=Q2.CZ]"N[88!*Q+\-+]IW%$Y9=I,GHTX^,O/__T?O4R5^Q6>(M+-DZX M$8AO/\=";XJA6^]A]H^/Y^"&(!9"O63##T<7Y^)%?_7^OCX_(N&`?\&'<2=N MO]OS7>?]XZ^OCL+;[F*%[R$YLJ06>-$A2? MPYC'EC-S*S/"O&(15_7""CV*D=P\D)M)QN\SRT@VE2@)N5_/N!^,>*B;O;X1 M>Y^'W4"`2U!8\W/,!"0^+UXT%@\5+5W6MA9=UE9CABU>_7048%O\F6>)*^Z3 M(CK.V.G\CY6'7S^L>/1EW;6IB`U&!<6]?#AJMW[=5`UJ%HUJK9QQ3CL>-A8K(]30CO5$:MTM;;NT]`:*:!R M@H/&0>.@<>H+KO:Q[=68!2&-\@?22VD\R/9&=524=-@_47+('F/]SF+^HT#:**N\W>6'''XY M+5M>1T)L-E<',;T M\OM#9/6;Y[C(O"'3@$S#G`?7EE=9!#R`!^UY\.6E!DSAH<3,FZW[".MQ!WDR M)&+?*A7;C>8;8E3JM&CO6FF^NC!+AW(V;L/I=BJ(P5#(!MD/8+E-DWG/JR"I M#RR!);#<9JE3JXH&A+7`ZE^]J)(WK`\+I35AU; M<[%'-@HXO12,^A*GVH$3<*HW3BU?8A?;FN"$59EOIH;+(6]=\>NZA9=NP_7: M\AHD[B[@6L2?&E&MLTL%V$4ZM^-4V38`8`-L@%U%0MBWG>;&A4L`-A;`[JAN MQ:>5\BY?'I=HA'&0C%@I55[D2'!!0]7D`^V"=D&[%)0>,EQ5 MUW8Q<>]6NV5+'/::OG-+([S4,E9U1.NX94E8^;>I@)ZTI#P)2;;3^S?/`7;` M;@4[MRUA91^PJW>:YME`4G8!&XWY$D4"I5G"K$:P:F7:ZLCF<=V6\(&(UD" M-#EG`6R!K32MZ;E?Z!EVSEU@B M`0.6UAW6:EG2-Q."))!4/Y)<*?/,=2()2="7=.FOF$91$M"<#0@=\8?-T>?U MX,NS%=(\Y00'C8/&0>/4%QR2+OTD'2:9:Q7*2:N#3^'\W#)):E8R:N`S@6LR;2*,3Z M'$6B=Z.BZF1AO5*:9^AL#3Q+WN+U.D"/?$U]6>G8F`@`*V!E MHU%F&ZE-I#;E[").XI-T::09CL8T3(MNQPCUWEHAT'%L9W^3A"J`R*4`L-4< MIHTR@,AA@CLX-M4=&[*55VQ,TV(^G-]")F_H")!,K.J$Y$5MJ3CNRAO48>P& M5$Q&Q??D%62N`RNZ[Y.5)[+G;;'(<91DV?Y&!WWP7A"XU[8E++A:6_((7?"0 MSJ@HG0&L5UQP2^*"KKW%NY7SKL`6*#,*!O)`7I).^FY9M0OAR*6G30]"]'P= MI,_/-@\9!X]07G":1>14= M3'LI'V%@/9.H@-Z5-\5E2@I+/2;4,B0&\V"W'/1K!`_@87:8XP$'TY(X.K:( M-W%3AI3=\779C:$17WHY)Q/)\GV)Z_9`%L@"67.R'(FM!TTGJ_8)MY+:V6O, MC^W(ZTIO"B;J$:&7G]$9APZRS\`!.#SA(&V9LBDX(-OVDK:\NF)*6A"#O03/ M#FNW/.E-H[&9`+D);!$Z\$Q7%WN$@#6P-@MKVV[#6U<_5'^74RZ7M;]?^+OX M$0E8%,VTZ\.1=51\YA((YI]G3[&HD-Y\)\?LJ:[#$7"8C&O]&7GJ\ M=2'$?3C([TZ]SB:685E9-O_Q=E$,?\1M=.*570J"@V6TA>CV`>K8WG^#M]A: ML=<#EA=4G8TXO7E&4A%<94P<3R.N6WE"^#59&M.(!).,\\_2K$FN^8D8N1?_ M69'*#E>/$QEG(6',[S1CMZ/'^V^NWMZV$`-6#6%UC(;U<@YI1NY"SF0J;IOT M_WU^=3+OJU.@$"0C?K\/)$]IG-%`Y$3C,LFRYI@L8XLND:S^#D.HLF`*Q,=C,*8TSBK',M^C%F_C M`=?0-*>A*"<[$M\6OV@0%G\/TR06!'%\Q>\2SDPZ+3I+XB2?=<<:""]K*5U>/>A:ZNOQZ.4H#S,C00+_>[`P+0!/4TL66D:SL#3O M-4S21Z^2<2_!`1ARO8S"/.3J%G*W$T5)4(!Q0S/^7WY,$@03_B3!`^'>(Q!> MYY;M3\IKPG@.QG/A++W_0LWEB6NWK,[L[_?O)MG)+:7CTZO@C@TF$?LRO)IZ M6C[X%M.-\>WGF+^$4?$Z>@^S?[SF#]CC@O_V\9>??WJ_YASB5?7$"^DO#`6N M+IB9,X_7++AAZ.+<\>R6U^]OZ_/CT@XX%_P ML?V)[SM>J]]WVEVO=^9_^M3I68[3=OK]WKGM7EQTCCX^>UNO6:F7C-2F+[NS MYF47GT,>2\0SUF7F\`K!\F'1=%)X)L-B3!4^O::"BXRSP]FXSUZO+K'CDPJL M6+J)_)9TWYJ?928?\7GQLK%XA&CIPK:U:"ZW\E=;O/D1'X"&\?0FZ21/YE], M9Q6*;Z9.RK:X8&;I7FXR(SK.V.G\CQ5=6._UGDRMNW:+^09>J[B9#T;L0-O:]4!-CNMJU.EE53>6,USR)]-)34Y\Y M&W?L/7*&SJWHG`N=>ZYS_Z?X@@U.SKA(>/Q!/OW@L4B8,?*?-`P8M+#D!1.' MT[S-)_@/H(67;,0C:9%/[?,#4AY`3&A$KEDZVC1(J/3^CWG4_\#C6@E=,``, MS/;;"G=V>YNR6YHS\IGC$<99&)#_TFBRL<'&NU(553U''SL$@5U51>JIHD\\L;6/R> M4AZQ#@XY]%)D6-'V6XVN(RU\J2<6XUZ7VUY(/T_4ONJI_$XNG%^MLT&9&O$Y;E09*2,[$3*@NEU*0Q.(%O M-YRNT_#=-E)K*FJ)J3:^T@9*!QQ,.ZVFA9+00`OY50C.-,&IDIBNP4C>I`'[ M?,$ILL_Y;\<=O]-PY'>1I$,62EQO86(B^MAUW(;?+K\S(<;(2N&GEC&K M8X[:LYN=\C>YU&6X#;0@.`A.%<$A1XT<]0XN\>4]H>UB3ZBT7HJ["$V']@=N MH\5%Y7?D#>?KT,A`/<34LDLFI[;;S0XZM(('I&XA'R4'R!@'ZQ>.:;.!T,2$ M=MMM-5IM'XDU%77$5"M>EYRU;3E-!^5`P!9RKQ"<:8)#TAI)ZQU\(A96+W8+ M;=BNT_!]:9NOL&P$^1*#\\].M^E+FZRIR[`9/$`^D`_RSTH-:16*K+"T6HW! ML..Y?#C!,$QRRU,A2[^`27UI: M_21*IU6LL98W7%UJ%^6.?Y!!,A'=>O?I%Z7#(FRGX7?:#<^3M[GK+4EBE3:R M.B9GR5M.TT1:X1$+\IC1O`[U19GI>U;YF^N1@VV[3@>.0$`LI')+? M3;NVVCX_S\%-QV%RK?N'YTH)41G!&:&)FB6*E!*B,H+361,A1`A1#2'")B*1 MOF=$\5^6B:XW-!Z02?Q]^H']&+-`_)$G1'Q%:$:2H;9)=D5B-Z?1]KH-MR6O MR?U;PC(EPE./1^52/,:FRJUF%P5-P,/!4YX*I\H/6D;,,+TQUHYVF])6$)IB M1G5/')>^!Y2*P:0BJVM,7%%O-ZR6UW`E=LW<68JF,*T1OOKZ/E/6U;L>JK\` MK8.'(PH)KLP1:+/\#K;0M!H:\;:\)3'&V_"%D.==+H;W:W^_YN_W[R;9R2VE MX].KX(X-)A'[,KRZHRGKT8P-^LEHS.*,YF$27^5)\.W+6/R9G05Y^#W,'Z[% MI:ZY7'H1_\>/O_S\T_O73O=W.A75Q[GI. MV^GW>_W^A6-].OKX['TNOIOK<,0R\B>[)Y?)B+Z,^\+A41BSD_F$EV/]NH13 MA[/S7%^*SV',K0G'SY,\0W9]Q\A]<3-L<$(Y!?26AWA/XB03+G\2QB3G/^Q% MG(<3_H:2B#_U.`T#L=UBE`Q81(9)2@8L9^DHC,6WXO=#&J;D.W])3$P7B6\R M\4Y)4IR;4/$^,Q*.1FP0TIQ%#^2&\?.P8O9I\6LZY"+SXF7C)!W1:.G"MOC-XXD+ M%DG`HFCVFP]'UE'QF1N:8/YY>X4[EPY'O__JFP5VVZK,#[1V/ MZU9\O:J/J^;Y-)E+5W?(]N8JCJ7TSNK6J&UE:>^TF&/-258MZ-*MV$M.;(\! M7_%IZKZX3*+!]#S_2=G)@J.0-1B$9D(S]]7,),MW44W,3+Q2L6>Z-&DZLA1C M4D:^)Q$7;\0##>4#Y-(5X1W!L:^+H0"Z4L488(!E5REJ:L<9A*J>/8SC9BJC#P M4\-%(+;;VIE&X;"8K$]FT__'84P>&$VS;2I9FSIX=>4M63-E`9%ZD.CKG4"# M[C0@6GM)62Z>EH*)^&SJ7F0%%[O$7E*6=AXVMMB_WMVFP5DEH5CY\6RG:4G; M&VO\TF"-S)9R+A_6"M9J;VO5;DHL#6.ZM:I]!'^UNK(>,M3HZ]^T0Z4KK99`'5!!Y(<=7X=:N[+<@BF+;M2#1$,OIRL-TF9G3:$!P1\V MD&%+AJHC:]=J6N4W+3'%EFEDMI1S^;!6L%9[)][]I@MKM?F>9.=2Y;E:2@"\.(B9_'@V3=_Q6'^0ON=#7KDN-VSUEFWUW/L"[?M=#^= MG9]W9CURSL]\SS*_1\[:K0B&"%"]]F=S:4;4-EJWIC@@;*]G_FFRC/IILH-QTZ M5'J3OQ>CJW,QNBKR?&)TO/%B#N1,7XH`_TSBD^^L&)?27+0=RMGHA@\I';\A M=MQ*FXLZT(KKP_4NKK+^:@4KJ@\??6N$JW+>3_KHX)"J>/@DX:8:!Q,&$Z9A MI%@>>K]/JWHS62M-/8O'T8BXE34;DZX2' MLT&2DK/@GTF8A3+[.Y?7'.1PGLAN=)QNPVZC[+&26E)7SV5*'Q[?:G:PQ`(1 MTH;J\M\B%XL`Z;=CMVLU?%=:>>NMMR&IHQ/;;(M1#!1]_4^=W4RMO8E"H[<2 MMTI,5YW)\S0F1D;'[89G*5I$20TUDN:9%().7Y>%D`DAD[(CP0,L86D72UBD MY;5,7:EB-SS7:5CR0JU:S.6J1YB^CJO._LD4'A!K5;3HP<1(J\J51J8`IQ%; M^GHF4T(J`(;`"G-1.R<"[8;;=AH=1]IV".3\$"$A0D*$I-,H#K-1!UX0X37: MGK0ZZ9B.TH,Z?7V6*;$3IJ,0-H;JVU7ZN_9,R[>K_9%[BZO_B)T5A]0E*JC M&1DF$6)# M;59.:SSY[SC=AM.1MD/'%$+4@T$Y+V[JM$6KU?0L\(!P=3-U09&X_>;%]65U1*OV01%VY3PNB+:LAN-*\TI8^(R`R>"`R?6:OC16 M:NU-%!J]84_.85U0UVMT*NB@#->D%'7Z^BQ38B;/:7J(F1`S;:@N*!&W9[*] MTVTXCNP]-V;/WJK'E[YN2S?OY&-+#4(M%(B3)R+'=QN^6_ZB4E-@TX@K?;V2 M*<&4;;6:;413B*8P`[5E^L^QNPV[(VVM/M)\"(M,#HNZS8ZT5$NMO8E"PS?, M0!W6!?EVP_'1I`@S4)KX+%."IG:G*;&6%V(F)8:"E<]`/;&&\G"RYJI\I^%U MY74S1WTX)5'5UP-JYNA\M^E)LTJF\+!S?;CW[R;9R2VEX].KX(X-)A'[,BQJ M]MS0C`WZR6C,XHR*[4B7W%ND8<`]QE6>!-_.XL&S;_Z*PSP[F]5CNQ8W<>?WJ]>Z*\X94%R&W-9#*[ICQZ+V9"?XS*)(AYLW=-TL'P:_H)B M\18NV?##T<6Y<$]?O;^OSX](..!?T"`_\<]V7VG=][_Y+8^V;[KM)U^ MO]>[Z/7Z[M''9V]U\0UI7Q'O^H[-2N#Q6R#3TG'99#2B*?]=1G+^SX\%\U(6 M4>'^\Z3X7KQJ&C_\3T8F"V^%G^,'N9F]EP9A/X)H(AZ/A*),#G__J+1WB$I[ MMK-GJ;UVR\@*=J97Z#/]^30)R]0=ZZ$HW$J]-9E!+%0-JO:ZJAUTZ2Y4K4ZJ MMO'J,TSIO91+Z-&(Q@$3*=`;=AO&L0AMDB$9AAD7"'G@T?@A>4:!NAH4J.LX M36EU@^I=GTXCDZ:+5;S?)7S-3" M>.V?M[4UCR3_>FG2C*0LIV',O[UY(/WD>S@(V3:E'4V=QI\:^HYC.](LO2DT M(34(*D`%J``5\TT%_Y^]<^MM&TGV^/,NL-^A8>QB/8"B$:E[Y@+85CPG.)O) MC)VSP#RVR99$A"(U;#*)Y].?ZJ8DZV9;EZ;$RS\/@23STBS6K[NZNJK::C?K MJ*NX1^I`AB[_\EIJ<<0#.111-*_*G:6Y5I:\@PQ&K-)G'\#7F]BK+K,?J MU[/?T[TL2,*?`'_"'GM3UCL@"V2!+.,UK@`6''4[:\N=BSCVQ40$,;Q[+QMR MV`46-;@+,IR5AKK."7SJH`[4@;J5[)`3N`6K0!UNK5ZSUQU8=O.V>].]Z=_,]EU[=VO;-YGONV;HI:=?U>%OO9A$ MXZ17NO4"FE5X-(VXCWFLXP_87*"ROJ$,AV@:TYNW+>XC%_>1L_LP3S(O4!NP MJ6*2@CK@.KOR?1;&=-'%49*-^1=!?Q'.N#'9Y(H?9Y>V0\$BP(8\:G M4WH\I2\U_3T2?R:>*GT41GI#."\8JAW3E)ZLW-D+])^WM%2J4^E2Z4YSD8C# M31LZ\@MY%H-;%V6B_/P M?/EH)YX/6P<>8:OV#[-:^G.C96.+J+E]PMZ_9V_8PNAC/'#9D]G'YG:?J0D! MYJ.[;UR6@:R*(!_H#_0'^@/]@?[D4S[0'^@/]"BU\R$?Z`_T!_H#_8'^Y%,^T!_HSVEG':NQ/9M!.B69E6Q?/AD(Z43> M5"V9`-+30WH&W7M9WS;"3HQKW%+JPK48>4&@EN?"(?M-%ZN#$D()3Z"$-V,> MC=)2B>\#)YP(Z!WT[@1Z=^7.2[NK^(2/*H`0F@?-.X'F#19U8J%P4+C3VGGO MTA35_2P\)/_N/JKX!(46]C",=&9*/$Q\QF.@-R[_@4%3S]JG^DBK))%QV+Z:QF#R(Z$F<=KO& M5%XY7#"GZ>@.D4\^U.F?ID5@_HG-;Y)KK.9J6>IJ@'_P7QG^+7/;"H!_\`_^ M"\9_^OI[MF4;>__H!]`/H!\H6#]PV3!G"&PJ>6'>/)(&T3F@"&`V``#(`M^;>:)U.L*CN^0!VHRR*ZI/3#&:+Y=G,<=;7CR%AGCFZIM#N_ M]LW-5LO2R8"&RM)@F=N8#32`AH+3@+@G4`$J-KPD'40!F72&`)72HF)PC;DL M`P>*Q^QJ^U4(R%%]$6@9LQ9.B3D&B.['1J79\'E1EC0.&@<-`X:!XW+ MC^"@<8<(#JO,J!F3PX[N:.`#U`97L`NV;UNO4>^@#T M`>@#*MH'6.8"ZL$_^`?_!>/_DHR`OL'*$(@700>!#J)$'42SWX>)8,3_BKHQ MJ!N3Y]"]LJ0KVKTN$A:-#=9`"V@]>0MJ7=M@B4G`!;@`U\+2;J#@&<@"61DX MN:Q:I]E"Z1B4C@%YIR7/:)!)Z0$S..Z:"]3]VLUUOF-*3LG0SX*&R M/%@UJXO-PD`$B$`)&5`!*E[PF%A6OVZ;5I4J.T:`2VEQ,;KD7);A`X5D=BXD M\XE_8U^XG_#8"P/&?6*6!XY`)9E3]DG(0$;..S0NSX++C;"@<=`X:!PT#AJ7 M'\%!XPX1'):<44DFAQW=T?X?I(B=SOO5-5AOO"S.+W0`Z``JTP%8[38V:4(/ M@!Z@LCU`P]Q2,?@'_^"_B&\556)0)2;/D7EE MR4RT>R?(!RY+3P:R0-;N=2R:2/D%62`K`S^[P4*M(`MD@:P,LP`!&``#8%G$ MB)2>+`3EH0Y,SONE@G4_5AM%S($#<)CCT,!J#7``#G./)6@`#:`A.U\(J``5 M!:?"Y'IQ67!8\E-\'_,'7VP]?LOG'[]/Y)L1Y].W]\Y8N(DO/@[_.Z]_OM7CA,F02P'GG3\4":1^$0"N?9#Y_//__C[WWY^U[MO4Q%(\4DU?G%A>B.!$ON= M&/YT<3M0>7^_M_[X-+A@GDL_<"=^UU[C\2CYY$R'9K^(KNPLG_'EFET[WO4"\&:=E8RR[\:\56'I$ MQKJ:Z.]>0%T"P=6B`TSJS:>Q8$+&WH3'PF5\-(K$B#XROB19)E+1,OKH+=X# MX_I%L/!K0&<^/+*8+G433DC_'VMTBN,GZK'86/@N&X81DYQ.VCB_QCRI;^"H M!L0A>U!_H1-4Y1SY0>OIF[+3Q>]_K]>[1=7^]C9B=:!YYWF?L?[^SL*QZ+?C*R=+7ENNN"6UT,6M'+W$2WOZIW M+\C1G+C2>4*&\NKTFXC:R;8'*V='M8_29#;KWH#-!&`MPX"AHGV&EH!36DN@ MEP5@QJRI(I#7LQ'5@Z%M?_+V49I*#VT$F+'Y2J4YJM8DU]YG/1M#VS/D&0L* MJ-+0=NQ"D(D%G*TK0_+C\"8,'!'$D3[SX_#.DY^O']7_:DTGC/99`'K7N6ZU M[$&S3_,TNS6X[=]V.K,%H"OK7=,J_P)0NMBB%FO210HY)E5F@8CUFHUD/(XC M[R%)_QB'S/5D^D,821:/>#5W;LV$SLAKZ7_KXKG#"]&6_53H] MCWW[U[&WTM=AU&921,'"X?(JUK_IX<*8>N&%)+`<=8[EJ/Z1RU&=]J'+0XT3 MKV,=?!X:BOG9^FE'1D- M+7UFMO@?),O*.`C.;XCN-9W)0`4W)3N[BQY+-VZ1*XU%??,SI7A"#]?UT%C) M)^@A]/`(/=PYXG>_H7M"JN&+//LD5^,A[+5YXQO]BSG#\R:)^+T3>=.XQMX' M3OUH^K,0\.Z*>[XRC$WK9*+;:R??+&1G>/*SZ11"V8L3%7RM*JW'K^P!5L`* M6`N7%0ELLS"GJV8U?W#^5T@9!NPFC*:S=2Y3JGFT^_6,FQ'M$]:WDQ#VPK!@ MI,&!4EE0;&.318`"4$H,RE[AJI4'!:[0HURA/**[<9_]C^!^/,ZQ/S0OD9NY/!1:&P:3V5*#FS/Y7(PGN4X7R55&R+8]R-HU]IS4SYE0 M=VY=SE,N,C1Y)TWNO*C).T_EBUZ>R9P.9QF@:;06D['0X9?[C,R+-N5QC>2$ M\LVZ3\;"YKE=7/G,NC@W]<=7U\YW0D9!J"](^1)SDLDJ;?F0(;Q`O!K8@>%0 M9W>QYD!8."P'@,,V57*[5E;! MK2CRH3]8GSZWE[V,S.5T0PD@!^3*BESNMX4H&'R%=^L<;UF*F`X*PNE8!$^+ M0)=7O[W_SI2&%9BW\^4.Y$=%$(E1DD@,E"@$)^#DK)R8"[6O`BAP"#Y;ZT'$ MXT=?V6R>RV/!WMUAUO2\M')8IR$_J@1'Q;G'LS(B9S7`')@#??_P^D6]&G$_?WCMCX2:^D!^'-V&@%MG34.>/PSM/?KY^5/_?W M`Q4\]'OKCT^#"^:Y]`-=_,V@TVIV^S>#EF5UFU>=FW==NV%W[)N;ZYM!QWIW M=?'SFO"7)?E*4/"V=X<0:8,ATO:1(=*M`\-R^YT,XW+IC1@8F/;-8\LH)E)_ MW8QWL8XO1V!&3#D)'=TNIED/QWC@LE]$.(KX=*PDP`8\YIGUU+E-W1DDD:CA?)F/V9\"@6D4I@&:;!RJJ'KRUGLS!GS(.1<)FGBWJKH2)-]$E%*].D M'B&5F-5I]U/A>-R/']EU1&*76O9//_XB`FJ>(]E#(DDV4JHY+&,?7N_,?Y_:A1!][QJQ>/O6#M[-_&G#IV1R0:$CEO2#V[Y)V3O>PPB>+Q M3F^;!P$99(X6+8_II;,Q=YF.WU,Z$-#;YLP50R_P8N^+8'P4":$9H[](&N*T MGMQ\&-POY*W^\DLBH@<1U]A7XF_,/,G$-Q*\?H4A>Z#1DN[O"_7=W4E).S/U M6+D17=95K9E?="S\-+-,96%IM4BO&O!`O7/2.IGXU%R=O^4]:0CCD5A2,M)/ MK@KY*UO("Q+Z)9R*U-3:UHHQ'?\@1,"$[TWH7CJ]+0HG^N:_^.$#W?F#<'4_ M]'["1^II9[HVE\_B$I$(N'J>7Q,=#S\__N7./[:4H\)ERV=J-*Y88*4])T5T@G M\A[HO3\(-=4MYO.J\_9.Y-C+=EY_O)=L:?9<$[<9E*FEW=W)MEDUM3*T:?>Q MLC8T8>WI5^R^5F]Y]G*XXZ1GVYWC/2?*+#WJ4;.T,/7A;[V8+N_,3,PUZV/C M^0^1YRQ"1J2VS(1'GP5U$0_J!M0I3-<,%77,@Q>N_;SSFWC6O@6+8+&@+,Z- M?L,TRL4-1ND-MK)X]=M[9<-(FK(HVXZL2Z+3#T?4GAJ;*,M/UQ8,IU[HN?23 M?`QHV*<+:&];%/H^02Z3!QF3G2KH`+X2/:=N$6H[@3O:!J>;D''N*3/B!_57 M@%\U\)_AH<)=P=J$R4P_0"J<#`FZ)%H;F2/N;HR_[#*8M6&&O/AN9Y_=LV1F MX0<_F6V?VYG*!Q[P4>K%F`@N%Z]7?.%^0O-WN5;>93;]?YJWDVW&I?(+!/-? MEDO@!.[2&5[@A!-19TOW%-\SECQNBS-@-,[::DFRD<4BTGJ!*3+ZB_J7JHM M=(4O(DCF+VDN*BYE2*.S5:O4S2+AZQLXQ/I(#UN[1KVB4UG5)OISH'[<%[U.?/)*0\ M=3,O@VHLO7>5`*Q;KII$UW@@`#?54O]UYAA]JNQ$.A(&CN=[^BED4?TORY3K MCS)]\5)ARVT!=,:>&"X=YI*=*-4KG_#/ MRJ$3TLW4M2(Q2GP>^8]*ASVRB[3/5:N?IYU>J:)LNZ5Z-S5=,4O5IA[YCZN. MVZ5;J->^XT57GD,+8":2KX*TB50L"K]Y=+Z@%AL90_]I=>HMLH=]?ULQSX-& M9:6SAMIFUWN&VQ:SQ:9D3.VJISSNZ0+%T\\=_7.KIOH;Y10GF]Y_+*B+]U[X MJ5M_3?,6WO&Y-GMZW2?M9&1V'DXL_F_,;5`?#0U%?;2]^C?41T-]M/(I(.H( MH3H:2E:A.AI4K?RJANIHYL7ZZZ*^=R9Z>D*9%@'PW`BKO#TC-`X:!XT[E^`J M/[=]-92N@H4\:AW;KA^_^=Y,6W*0J&/*BY$S*O+5E928B);5K!MST8`'\%!P M'NQ&IV[,CU06'N#$>-W&>C9$&J4NELPONVW5CZ_.^9J&E86[`B%6K`&JG'!9 M_;ZYL0MP`2[`]017P[+JQ^\"7A6X*N]\>RUAIGHSJY;=A.<-G@9X&N8\-*UZ M%SR`!_`PXZ%KSC50%AXR]+Q91;>P%AFAX7!;"NF&B`^XASI-)M-GQ*URN%]( M2F]/8WV12RO=DXD@FC6[WSO!'"P+6>2N8X'W MHPC>CR)@:=<:K=8)G/K`$E@"RWU"G=IMC)9Y<6<6W=K^J"MDY<>FMK.QJ;/. M$3WC]+IGSMOTFIC*@CV\4<#IN8Z5;GI9;/6;'7JQ^]=MI79?01RZ\?O9`^P$0![2'F7CVO%D3.I\F)&@DL:ND6QBU4& M(7\ZESOY0+N@7="N'$H/'JY3UW8I8^Y6IVT9-'O+GKE5(+SRU5E5$:W+=L-` MY-^N`GK2DNPD9+B?_@[8`3OSV#4[!B+[@%VUW31KAJ3I`C8%YDL5"32V`E(5 MPQ`#47EYL`Q&NX$'\%!P'IJMKKG0E[+P`&?=B6O!O!;G6,:93\=@=6EU#"08F1)@F7T6P!;8&M,ZNV6N_'OE!U2D"=_/MJ,.UX*] MSCEI+$9P9K/9-YZ@6^X02SA@P-*VT]KMAO%D0I`$DJI'4M/(.G.52((3]#E= M^K^`^W[H\%BXC$_H86/L\WKV\.P<:5[N!`>-@\9!X_(O.#A=;L)H&D8TLC(> MT."Z&&;%MZD(I,A3*>3FRV7;#FG7D\)D]^F,\X2<3`4N[9Z)3#R5,HSEU+$RM5$TOB+ MQUX8F-*Q,L8!7*I5$V,4(CXG)[/W4@URI>3.:K<,;(L([L`=N-MKBF8BA0/8 MP?\:_W`G9!PE3IQ$*N!-^6`CX6L/K#/FT4C(&@O(%,V/%[:5R>891>X-6@US MP>M5@![^FNJRTK.P$`!6P,I.5F8'KDVX-LUD$8?!FVC%TO0F4^Y%>K=C3/5> MBQ#HV99]?)>$*H#PI0"P31^FA3*`\&&".PQL>1_8X*V\%U,>Z?5P:H(T9SH" MI#)6=8+SHK)47/;-&76PW8!*F5'IMLP59*X"*T7/DS4GLO5ML=BE'TIY?*># M??">$7BK8QD(N-I:\@B[X,&=<2)W!K#>&(+;!@.ZCA;O7H/W"?J"W%C!0![( M&]+);C.KVH48R(V[3<]"]#P.LDO7.3O=.Y=WR$!N19,5]`IZ!;V"7A5"5G!F M36??-C9]'XAII#88T\N-NCK-4C[NL1D1VV^IKG-\BD3;9*&:[0U%^;MS=_@Y M8C!W@H/&0>.@R`+ M9(&L.5FVP:T'RTY6Y1UN&6UG7V!^+-O.;1B.9`+X)I`B=>:6KCQPA8`VL MRX6U974P6I_>5/\^YB27K<ZI,W$9+]*KZRNW#"@Q_8>8559=C]XOUD,/>(^ M.O%"EH+B8!5M);IC@+JTCD_P5JD51SU@=I.JJPG1&TL6JXHHX#YS$DG\BTC6V2>ZD&!?U7\;4CG@[D%HXBK,"ZBE4HPFB_;7-YNW+\2` MM8"PVJ6&]6X.J61CCYB,5+/9S8?!_9OYOCH:!2><4'L?61SQ0')'^4>(Z#&/ MES#_P'UJN?,Y"MV8GC"(O2"A%\'"M.J2.H.&=1$Q'K`P&(7J;S*93OU'QD>1 M$)JUKUX\I@L+QIT_$R^BH\.A_J[:Q!X22;*1L@X6J\ABL]0LO@\SKL1CE.$TS?44"?7:7 ME@4PTE22A7:I65A9]QJ&T6)4D31*$`!#TDO?BSU2-X^&'=\/'0W&`Y?T/YT3 M.DY"3^(\,AH]'#7JC,3QI+PDC'4PUH6S\OZUFIL3UT%>G6,>1G_WR%8.9KIL MTD?UJYC/R!_H]9&Q3GTA2\_3UC>IP:J%,+<+&.D&XY(4AA3BJWRYI,*NC]_; M\OAG]\AET?BE:Z[H:F-^C=G[5M^7;QJ$T83[*[>U&LO=VU[CRTOCR5K+TQ&C MWZNW_Y^]+VV.%,L._?PWHB6,=E3R^NJK9C/KU`F:3$ M-`DY0)9*_O7OG+L`F4)")*24I+`]GI+$A7///?L]BV36_R=_RR.Q(,V2<%M$ M/_)_/$!%NT*JI:#<6OW]#(5"0/OIG2Y_VU.7L872L>O$E_[@O,%);G`B>"/4%YG2,YI1M"QIB#PT@Z+\P!`9RPXA/SWH:A3$!8;K M_@:Z[0CC:Z;,8RA3>6'";,?E\V]#6Y#[D&A/2*.R*(V6%/+2N)N)].T0Z6A% M)3.1SD1Z*B)]]GSKJ>=\CYB.L"QOGV\>C5T:@3;B*%6:3]N>+2&P42-@WXR% MOTX2>ZYY/@A=-$7NA/B2%J)BC#"-_JW4^4Y(,IV=/IWEU2ROAA=5C]BT;996 ML[2:I=4LK4Z&K_\[SV*_U$XJXQ')K^LXWT1?C@E,/-H3>X"8&G:W<'*6DG7E M2AR+F2Z%9\Z//>N;@`X>GJV7_%9B>SKS0, MB98QIX#-D8IS4FQOBOO$$9NLSMPW<]_,?3VXSQ3G8HU+"Q`^F<`KR:/23SVV MU\G#=-5G:._S^?$$'0\&%3^^MH^XT&5YQ"FE'>A]$_W'SX^+)ZP_9W[=6Z9* MRJG&@\S<.G/KS*WC%@2(^G@7?3.W7D#X]I"W>5-$8SMN?\H3-Q5Y081.#8EG M@[B9$F=*/`_$S93XEBGQE2)=XY9CCWS7^N_WJSQ;9BNP?X3O[-\^?$_&3=S6 MOWV/HU_".`6(!-*;N#Q)..P"H]"2;HQ7L7$I9O/LY,X\\]2]Z9R/.K/,S#*] MU(PJSKT>+BTZ<\+DNJ_W#\R]C/_NA8R]MY2+(&GJE7YR7_E2^'9"+#I=)?BV MV&\NFY_9;V:_UV(_Q1K/.+UX]IM(*MYXY/%S5-[>)]O;*(U781D)_L?9Z7LF M7^GC9=]<"ON<'Z=,5TE=(,_(HC6>)S;SS,PS;X!G)-48V6]FOYG] M>K"?JBIS2>^EQ1&GV$'F[.:4GSYL(DLC]K+HP-^E<.#Y,=N$]=S;XSE)$Z^, MF>=FGIMY[D7S*,=+U'HC/'=IH=`]"$[65>8O40H/+5^EK\RH7N.42^*EA:Q) M+\?QC^+]353+3T@D7*[2GEF_8GUIS$*CF?5GUI]9?RJL+TK2B!>I,^M//PY] MOAT+^K1].`'>IH:KF:YFNIKI:J:K2>#JTD)GX]EHO^R(Q2%\V(0W`-])[.6W ME#LA*R/V5;[TW(D)<>"$W=6WQ'Z*-.)=[LQ^,_O-[->+_8RY_\8WF1^#@N\MLELS@[K[+!>I,,Z`>X#?W6\S*29 M^V;NF[FO!_=IQCRX^=*B12>\J8Q@19CTZF[2(X]/V7X55MGN.HF.+KR1>^7K M#9],0]GI\(/#OC8Y:"LQ0\'RDH M+T13'K%1\2P%9RDX2\%9"DY+"DH+0Y)';+,T2\%]'_D',E*G]?G&OQO[>G#U MT21&LX7C7GWC9(?",DH2!NI/[\1WY&;J!!^B>Z$ MC]DF3/]->`S$ML##7;PJ;W]4S>>HAWV"?O[#_6(?L,4^!/W$G1=RZ[[@1]0- M87M^>S:$Y?&B;M`&3Q>C^1AM\ZB(TK(0;N.BS'($6W!_]CZ]SZ,D+*.5$*=E ME"^S#;F_CI1#F42A$7Y?)#L$4PJ*(D+>B9`5".B?Q4"$NX/?P8P+6 M=O'C**CHH^]:;"HB*T7^#H8^_+GYT12WG.Q]5A*;XK67?GM*GQU`3C66),*> MF54$\C,)MT7T(__'@\VWJ\!:[LJM5RW/4&$$F)_>Z=JW/;4G6R@=N^] M]+IY?V-\;R*73F<7:ZC!E3KR_,9N_O:<:]^&<%M&:(Z-8P&2G^ZH<+_.DA5] M3Q`7:`/^#33V$5;63'7'4%U7#K,N5ZC/%S10W M4]RDZO`N*>WX]ZM/S[X>.@5>S@,+PW-`#E`P_HYIRL9X6Y87EJ&,U[WT4G(L MSH_WSTM@SC+@@F2`M#!,<;R,_5D&S#)@E@&3DP&J/.+LDDN1`5,/)YZ.1_Q= MGFVCA?`SR7H6_+`HA3!="?8:T^&.\5@?+1H^!5I[!+A'-[D5?9Z[/@>#7C(8 M]&982Q/GH?' M"-/5+Q/C!]`BHTV.F-EA9H>)L\.8$\(OA1VF'G,[.^;ID4\Z5D^(5QQ2>3;! M_^YN!5TT^Q(=(DXHW%Z\$]B;'HTZ2\A90LX21D M).2+=Q![TQ)R(M<6XY'77S,$//X2K7C7F0>H.N*MN&QXL9P\C6*YMU@OEGII^9?LZI7NV,W)O++60[<6;+^3@F`_R.,W$M+%&;\W#GX,D4=?TL M928C94S9FO,F9RES3A;SW/KA+8>\GB[<.J/XEW*Z$XEGIEO!C2WD06Z"R[9MDURZX7 MR4!17[+X9Y9=L^R:`Z#/-N:?-UQ]GD_^Z"WOI.:3'RNL+G7(>3T^*LPC(2S+ M/+[>X1CG,A/RZ(9,)K\."_A%EI)9XTFVI+.=V>SQ*"WC\I[/.U^"\BG([QO3 MT!<""GA<<'<;+V\%.CT=OX`/+K-=6N;W^.$@4\)L7BEC@FP`(8`4^X$V6LZ]AK'#I.MX%#8!:CQ M8AN!@O\2)??#A1)__D\_[(KW-V&X_?%3=(/R[F.TS8",TQL/H$BR8I='GP$7 M#M#%'W_^YW_Z/W^JGK\%B>J@K>*"+(W`^D#CX]&;)JF:_N.[YB*Y:F! M%,NPO2>6*\W*?R]8'9I42+Q M1YMMDMU'D5!$^9=X"7^%!R,BH4`D15^7MV%Z$X'JRX7P+D3S%Q>!M@:K.$Z+ M,M\A%1]8T3?`R.7[%9K!ZS#.A2]ALHNH20U&`'O1E?`9K6H"2%S4\,%;0+*3 M]X"9$&%5MY<$&\)7DVPOR3[*TB,MZ M`?O>=S=1&N5ADMR3Y[Y$!3(H^^OW5T(`[]ID.7X`I15U&,+K;`<8W>5"06B( M(H1N%:7)&O>4";]D\#U)ZY`H#Z5%?^Y_AO3X+:"P$=Q?=V51@B"$ M/=LH`.&H/Z,LJ^32,^2*9'FN[JFF8=JV9HF!Y7D^E2NN)SNZ_^IRY:1\]]NG MWX60H0Z)-"R`_I($3),A>G(?KJ-3TXW1YQC7@#W=F^'(\WHPF_M1*M@S2D7^ M%G;*^'/SLRE2?K+W84ELVK&]'(D>]`LNT4V<4B##79GQ7]!H(_D-]1XD$1## M`MY@RR;AMHA^Y/]X0-'M[DAE`YNM(!,$EI_>&<:W/1T9ME`ZYO[A*7$YP'M]PD@N!COL,['-Q-9-;/]#?A&M MWMN`DO`F>JZ%\:)`_H4X/!XZ/`$Z//^-#L\108.Y7&'_^B9+WZ/WA8Y4*7R* MMF6TN08_2C86&*49K:'>J-T+WE2.RX4W;J32W)0EN8\X/PYE8FUL[,2 M9A$VB[!9A+VZ")N(1WTZUB/&;K0ZQK^YL.)]PUK(RMS-8G;XYVX6=)FN7*DS M/\S^_3/)I7'_*&RB,H^70KCZ^ZXH\4[Y%.QT*<74+VG470H;3HCCIJNO9@9[ MNPSVYAVC_R:AZMD,/`7W7`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`V9C<"QM0<-CO?+5;EL(ZSS:$ M+5BO]W\MX$_1)BZPUSL;0[0K0(Y&>>-/"_J5)"R*>!V3B11"$26(T(7`.J`3 M-(>K39S&19F'V&%V?*6L?1IM]F$=#A=0]P)M;P3N,`[2SOVA6V/C]&7*-U%PD3BQL+D;'^HBKE:IL,3[VXCL,3C,J&Z.X^+/Y!FP%`OA-OP"QN'N(Z(LC^T M1K@)^$Z$G;;+&VH_56$L['R^T.K1<`I+0O4M<5NLVW.9^1P M7M_O+5@(L(?#,3+@3="/[[WZ%HR+$+S)HK*5^#N)[4-0E)`177Q"SJ(>=H/: M/P\[0-XJ)H,CR02<&DUH M>Q7\XX4`H(##>W,K(!6`Q86D(.`PFS1*`(28C!1#%EW!AY9E5XU/@6A*6)BZ+UY0LR`2@N=V0W MCWSJ2G!!KH:`A.I=:-T5P%9D1?7U:+6WE=NLV"([X@MNT=W#&`#]2`[_+@G! M;A%4Q`L07HQ0XD0A9E;B*"!B>B[9]_?VB>^IT8$D'X'#R0AF%:^!F"/,K;R. MRKLH2@_,:W[N$1JR.#D(O54AK*F*XC=J?O-?D1*^9&3.$%FS#>,5ISE.!``' MPL+?OR/&?GB31_"E+UFRV_#%Z"BCD`;T_,_M/GQ-GD[Y`%0X*_A7O-DEX,5& MV:Y([JN!IF':R!VE)UU+`AQ^M"'TOZR/8<'/8%%Q"U#'+F=4D!%,4MD!A[!K MD'O!SJ:@)`-'57^`LA61">#U`\I0&Q-_(X_Q,!:-9]<[^!P*'J"XHOF'Z@@` MV;"=#*1)`MM!GB'>"%)+?7H41LJ]Y`PKFEC092AH@+Z3^'_WYL(V/2U.U=7& M<=AE!'R!WM(:OI/E!ZQ.L4T&<1418;?\2\1X;)T`"S0HL*A(L-YC-5N(B"A" M)@TT70F?=NB'54<*A`??7=+02;A!LL%]5+31G+W%!"F'-$Z;$A06U6]]VL(Z M7^47?HV0@1/$,U=7M20@PA[%*ITGUE""5/)LXI+-#[Y!_9(B)M!/WI6W0*]E MS$<-4Q,*WX^:"!B,H!LH/`9:0`,K1Q0D]PNAP,,J"52$';Z269$,,+`K;QL' M140L][^GB?^C(J43LA+G"-4#SJ*_B=(?KC%`$.8'(0(KX2?GPT31B#0VMM=%]$_=E50Y.$G MB!48DC@5\9Y#$DP!F&`7, MUA'?!R<<*+V`QJD8X@HJ\)`ZOXZ0.FI0, MA\1+`BYI+@2.0!'*+-E[(*?W$0F&L/GN.48C4?:3R.5^I.3PY2R)**0#)0_> M0:;&K]Y!R:%%_A`R$;\;?P'&]S>Y2'D_#FPQ, M$:7@8"@ZVUP#.:Q@@RDH&50H10E_99*PP-@R'`SP#Y5W(6BCS8["5`<=\^@6 M-HSN(\A*<*;IJ/J]XV,.)&PKQBCKS6V"0;XUA1F5891^B4&,TP_#ZKM;]#,1 MZ+9CCHLJ5-GP\E&!U@\M""4!YJ*2:-MG$0`[(SP2W&]U1O7I9!25B$-ZG.WO M)6YRN"3W,2O<$#RWVT0K$@P`"=T?KBX:_/P($514LG<@^/YF<`#)BI_>7\*8 M1=3QJHT$:HM=0DZ/X'J=Y2`^TOHX.%]6P?7'WNQ1TN[Kà$;S]OJY3!T@ MC>/%]7!`GPRT*.*5\8I!BJ=A&SM^`O3^@$!'>?,-LL4)_-L%%185S[`4U)IO MV&5!UA*..Q5+C>7'CT,CDCP9(J$2&JS4P8K("KSH!4QB;KG(*^+5VI58ZM`'Q3ZM[OG`DBI#5L2EB MM-,?.WR*"FXQ&N+TD4/N9XTW=4%]X+'$D'@EG2'R4"^=`'E*3XDS3?_SXB,% M84$CDN0?/O@C7\($9?DTCZNIUJI[T$)8XN8P?XZ M!J2\B7+B[6[#+:;MH3=V+VS"_`\,F]$DBF9\%)-Z*J>Z)&F$MYA)1EW/>$.C M>?#?"Y:2A8&\^"9.23`6X[#E_8.<*U2@>111YYYE\14D5$'W0QQT_$=4G]H< M?CL'IK(YA7R,EA$0JHT;#BJ.!OX(:IQT/\90T$MGF`6J>_4O"9;'1">_[H-[\F;\?&] M5-:[6Y"&=U&5F_T81"Q)E50J(""P9[RNB+[&>`LU&Q)G*?,^L+S6KJJ,LSV@ MQ@8(4]`TY#KF"\Q-BWKI+5G.S0'0O+L($XY!!.7P$78E0$+3<5X@P`OVKVQ' MLGSQ.V`3[SOA.28D4PX&K9[G]_@2\F[\9MP`;DVN1#)PK>,RVC2SR[,2WTSR MW**O2V(L9-=%ED0H&G.A@"V\!V<=WUS7"I`@,77=>8[R*@+ILEH(9;2\3;,D MN[EO7E@34X1*,$!1FFU`]O%\XFD>_:7SYF\Y.F+E_4+X+0G953B:^A/.QZBW MM*VV%/$MT5*.DM^,(,->"3^'?P>Z!9L@N@-]1Q;$&[PP;]SK-R[-^44,Z&_P M9L$*!R\:V(M8)#1HM0WC_*F$#P_K0,"+(#469<'<%+^;* MG!8L"+1FA;(W6"8L6Q-XOE&H0*1/A@8),GO+!?X7S&.M)14F>.+)OD_(7B.0 M+ZL?7YS\Y]+>G]ZI`TM[S7XENL-K@H]==\I2XO/K_'.Z-E_.+DX0L&<7P\Y8 M@V72R\WE?!5T+^$:UZ&QRS2;72YA)BEYN9!= MXXOQA^J5>#T1\Q+771%-]9;]=[S\R*.2=3FK;RI7<;'-"EI^^>0]S()50A7E M7NULW9^H6>.T:E[QD)N@)-[$:5AU\*DJ@%A/I,>6LC2(@\)VIMIGO%>RRI,]BG8M3G>V&/Q'"F2 M(@ETK'B*EE?!OM$(WO*B/3"'6;>RB"7286M^VE8PPMI7+-JCJY=Q#B>'G;:7 MY*I\%2]I(CS+#7AX88]I3N23^]\FJ8%I5F*7P0I<3-#Y\/B2&*_\=RG)OX%E MV#0+B\86S;Y9C11ZPLKD&<(!L!IH&^O!LZ>:R#W<04VZ!_"0FU/`RQH^01^? M*"&]N$9YX6M_&\L+"](1=*(Y.?:&9H>1GH1(V&%C2RQUC;=%8/2]7^->U#66 M#RHH:<%EG0D#J^-F8\&:O@N>`[1B288-,/:S>$I,S>,P4:FTW>7+V[#@'1*Q M4I3DYO!>=X\"#!O"K,`R7L?D^OJP?G\O9YE_9?5H@PH*:+TIDE;TY/M1=E38 M69$VF]CO$1:W51'5NR8U172/!YNO6@KL@\'56/W]=-4"3A,S-UFVNHN39**B MY_->2FKWX=5-18N#E@P-3(9%);=K^JQH-D[?L[01-`W^3G)GB0(CZ9BHD_(H M7-XB>GG:%\EU74=A$5.52@^<9KK=L\18DIW+$E!)-LECB^N*L.KSF%=;V:(M MC2PF?+@'?%;C_M$3_N[=A]\^$K<`_^.]^YY4L=?IR'6R3IO9PG)VP)!(]X_C M`2Q[7UGLE1Q@FA&(!-(/89.ALT!L9Y;"6=P+D6=%KUOV"E)!4)TBJ44@=R!TV1(;_)JVO MV3'1??*.K00M'"KR6,-HK5!3[V#//J6W'9?!A6%).Q[SU/0]-F@<>5DC?%_1 M(SNV-=5916M@M3)ZCV?^4&TQ(BK*AZ8Y-K-/FH1./D%9B36%N(;5<-K`U\2S M?93/*)MU`Q,7S$39:P1+&GET[Z+N%40ZQ^[G#+(R"600=`Y:>P81-^=@O]46 M>VR!5B$0.X"E7IY]W=-S;?:_,+N&(/Q7(@D_U!BPB2$T37ZL=G9HRE36<(NU MS#QI;OBAM8I*@YN1(?,/L-#O)J44\5C#%&;ND]9`UZA,\:NTP4W88LA'&%/C M5N8AYS9:\(!KGI>W`KC8>4GK`]"*:G9C(5W_@76P/);V[<+F-NL])YU&%$@' M>!#2$86E\0""PZ4#/D";7@OE709$%6VIQ03?948^5AL(Y`^LY3_OU(-OKX5' MN],/YX-\3B(D<5EUPGU@LA<1?>"@F0!C_*)E44P*?0[>7LT38-''$/[??<%Z M)57.QH*U.X])"V->;\RW+7P7LK[HK&02+(P="P$2!1X#WK_?<_5XO5,-'3,H M:K58B:N6\,[!/@@5DV#;7F!DW[PBE+2E<]RH_82:>44/BB&_HKC#P\<&#'17 M!_W2&P]B[1L/$M)3Z?,%2A_LX."/2;SO7K1L^U\;+$("S;C]?6Q5I-SRNAJ4 M/4N7E>P5X0;3[M.4IL,?]HF_J>5)%?MZE+GWO\"J<)MGP[S7=I/YP6FCF$FJ M5GZ/2!SRU[`D*YJN>HL?CW4#;M]"Q:X0W"<13:7+#R");,BT#*&0NG M2R(692Y8&0F3I.@Z8SEVG@B;HH"[)(2YK5&DZ>I. M#'7A_<*/M_%J%3T(U(R45C[CYU+QTT56\)B MM.T3[Z7.FLP>7`#4Q'R0XK\WQXE?0X0=4#R\IF`)4RD;A'[0H!9;:;(D+AQ3 M&B7)HNJ0NS=`O9Y%'1\_<'2J!2ED"GJ(P]AN;B*2-$"J"LC<-DRIN\/FG^22 MN]&_KWDUBQ?33^7#%#@;FU[XLPO^)TH;8$6&-2=L7$!];T-R%.J,?YKH7S43 MQ0ED`,B"WPT>WO"V7Y-C;[(\"DO>S0P?>02PQ<'=;BLFX'WL!IS,`Z]WVYY0 M7/53>\[&.#;@)6W7UP_??G@,S_Q.O)\9U9[-4"&T\5E8B-V?:TRVYVX<"=9+ M59+P1,U'3NM*V,\HWR_NV;!$X>80NJI7[(/2GPZF&;?(Y[&JGOWMI.F.W+S2 MW*)G9;L5AX?0@_"[">T)NJ\&<^0KFN=8@T#:#[<@A*?`[$-U]IEY;Z(4R,UP M)@/HV>5D^_,V60D'U^VN20HI"*,J;SLL20$G'XW.\U;NP<)`GDQ9KAWVZL=) M-NA*+IJ3Y<*D7M/HTYU$-S@*@-93POX+GJ$$S!&3Z72@T?*","#/$3EL[LL8 M:;G,=]A]E&1'-,^$W8-L=28)LNN$(914*\9?:?IR M`PR>?$7E(L]NK(84UEGR;:,(K\.$]%TM;B,BN\."2%O<%AERB]DYL"?LR9ZM MZD;F5\)?R%/G^#!56\^.K8T@KM=(&E!-`P3I5,?<1#0G-%VC M:%ZUUD%4T-!N_(RRT,:BTV:O6%)QZX1!Q'(:E3Q/O&4*),B',9%_]@A-S5GG.VE!]\`.Y?O2?'4";^`,!,D[>RY M_;D,\X%:Q9_#KU.UC=@.2MP!;35.SAE-B3C+N6KY%('?0$^:C`Y?K3*F&S';FHY]:%;\5C()Y7U&K=@1&U3.[?D\DH*^KF81[___!(#7!VG^F(8O)Q*JT)"3.D4XPV1EE@(4-: M+PX'/3R<([5@GB31\$G\1T3,@#`EHH"<Z21A1E:H08*C]_OO(>_>1!&+?>+WW]/OO\?O MOZGM'&X6!.-LURZEW*=.KI-E%Q@1H2>:S@``EB*`[C&D,XD!65._/TOWW[:%B MT8C%-EGHGMT/`"_'Q2V-*S""1&H%D@03BY26[2UOL-3BP15/.P0LF-&TO&A- M),BA@L^K:9I'$^8$3CJ-8ZZ-TT,)!I9"EF!5TPI/$CVV/20VC95PNTWPBH`; M9.06]RLS1F_8%PM:.K8!B.J396?L7-O;K0 MER'U`)75+5:]J^:JCOT75'E8ZM+FC?10W^)6[3)5, M:M:O-F(&C9!PPT*J[J,>!NO`N@&5F5=NR3V:'%C6B?,IL=,A*0'-&L/9Z[AD MFRJO]MS(07@@M)@\Z@K:AD5U`H>BDRG?+*66U41%S:6'%7^C+A6W*SY4+M4T MC^NWQSQ$XCYVA$\:+2P:`8O&@-C]US6DX.)`)#9;@J+)#\23DBNF<%U&^RKX ML<`.B`/DN$7EN)/W4(\%&;U96LRF3Z^J>G?\Y9[[_S3W\7__Z8==\?XF#+<_ M?JK%"YM="^#_!E(`;[4^PPDZ\*$__OS/__1__E0M*>$W:-B!Z/1)&!8CBEY< M+,$[`Q>U6D6NR."'C]'ZIW>!)XN2]E_JWSY[[X1X!;^`3;W7`EL274_3%#6P M9<<15R54E]]^<#*FS21T?);%ORW=ES:8ZRNN,2EDCD=Z'!;?'O/]*^(B,18P@H%]@.PS3T#L5$F5']X&V%L-? MK:+-EKJ)9%AP7I!_?\E*FL7#TA+N8K1R49ZSJ"G34Q@F):1'#-#K_>C:O=!D M+=`_UUF8DV9"JQBL/=*!".W#'!:N,]9KAC=#PT,(R93R#U2GL51&;OJ"*%^U MN5E4YS&!ST,#AXR"SZ1[ITLL>-+.AI]^*A0[C+?!=HK*#KZGX3ST8<@KF3U; MY9^2=%>,,R>L)7C:!!5[:?,_TPLX[@@19&ZJI"H:9:!CS'G0[\$>"*UBYXTE M?)K%F'"SNY1TL*T.OE;?!!5[GZRS2LA+&=K._K+M3=C`1*<*'R/>I6RBZO77 M5/B/,-TAC2U["8/-X1C>,LVFL0RCHI31/%*%."YI"US MX5B-W83(LUGZ8MH+#Q:IB&-Q%GX"B]95YO MQ;L\D9AF$E?==&BCE[U6>.D.E1")Z5"(2"(]=F?)&WE!>4U^\/$52:IFR0;U MGZH#(MGA52^Z1L(L3Z=E+ZXO$=8DTJ7*E(@6O&DT@D5ISX;.J?7!L> M(*2;.*5``D-E_!>T%(C\AG;JL?0K2S,E0[5$U5)E2Q^O;X\QL&^/T:\?3KU0 M$H]=.)%UUHM\;R(5H6=7QU>!J[][&E>,T1@FI.U7@80UA7\1R?\Z! M(NTI[-&)]Y?*2GI&B.NL*WG/ES25F32/(4TZK^8T`I1C?JP>&<]`>0?Y/HU^ M8HGN`:6/A7R*Z]H=;7HKO4[@6=+X%9J33$%6G`VRIB9DGV3O8[CX462?DIE' MDZ0TWC,6_CH)[PD\CH6ABO:MZ=-&5/OI=MI' MZL]93H]4OE2TV,\))JRLM`L M>;8USI%&+E47#(V,CBH"AT6A6EP!=50I9V@C>@+'XO52N'?V%)[E*3R6.S#[ M#;/?<`Y1M'TYIH`<6V4[3.@8/Q\GRR;1P M"V)'P]I$5/'<7/@%=_-BE>FL44"=S-A,P^1%R[Q/$JFC)61/FI"$95RL[^LN M2EB0B+GPF'$9DYI*TE*)M@<@'9'3-%JRUWC&8_48RKN1Q$V;#='4" M(+51@:P!Q(1<.E>3'TO+N=.N7WN-K?`QFB';J/[`_*B][<-OU$6C/TURW[M0 M[KE5;_NUS*`U-VE6,36D\Y^A+.9P1/IN_-[2E+2!XF M6JH=8N*;1%^QK MG9#6\1DV=B&=.*K2+2S"H55%8?/T*QRL]C'07APT#EZT\?%"W("S/;71"MW, MT6'K;9@^9F+N&:)DFJ"=KG[%VF/6Z:'X2/KLHM`E'1_NGV&46I)L>(IA289N MFYZM^Z9N,J/4TQ7CS35LX*@4:ER2(CV[Z@^(]7A>MKLN<>H%?WR:(IX0$?8\ MH5O.&UO.HT8'5NQ@PN9K[*%AQ='`7T']ZHZ'>"-+TG.UV8,*FT$2/_&6]K?: M;]5"N[,\@!1[**V!VK-F83UK@$2[Y<*;&ZU@L,U1'M.NC.@]8K.4&F+:U>6/ M-+N#-^0DS+>J/UO/('C8X_&JHH5#/-X!^DLLIE^O:0^I1HEJHQU@-08&-`NX M)>C7TN;\3QX2B=H\."G\.?^RW_.>]N3"*T.Z$>Q4>YW#OTC&]C5I'=;H0[MD M8_X*5F0/TO\NHMU(R\P](?][ MREM^_9Y6MUZW'445/<31+#BQ;E&7+L'65"G_7<%1+?W7A M?]HY<,/;E;!;=Q;J)]"N\,3(H?R(E/(R'4T6M!-'LYDKZ7T1%JS"O2.'=(X: M55$C213'BQ.I`^-$YLM4,$^B8OJ,,K5.-_*SSH+47S-0=>+$HM>_,W\N39U_ M0J@D:U?6R?%Q!G'*5T@H.\-0[W@"QNA!-"?-#NO1BF%LYM&D*W4LWGG3+/+& ME+-Y"MXY7;G"RS*5:EWUP<^LD&:%1)BJCQ5SJ0K)&,^6>],<\K;T44O[X5D? M'=0=FK(D/YOF9K74-XOC8;A[4/!Z/PP.3Z_]:KY)=UQ;-EQ7LCU74M3`$P-) M4E6#QK4]45)M^[+CVI]I*^1J.@)KM-IO6AS+UL1AI&3*,69K_L6V?^.IO,5! MH]5-^$?4F$%#!S87.]HYFW6'#ND0!-89-DN MGQHPU_*)@MZ+?8G2'7N(C:8ADRA+G)S(QT1BHVXZ98?UH"4C9JO-=5QCM7#" M'OT2T@:*^>/'=9:5:59&?X4?A*_D5WF&)WU;EML??_CA[N[NZNMUGEQE^Y/P.DH8-W6M^7_)=;(/#YEED>7OA!^Z`;)UUU`L MPY,4"QA6\BR0T_3EON,$[0!UK!D&4*!9FFKX3J";01#8KLI?[LBB+]NM`'6L M&0B0K2J*YAM`76N&`:1(@:H'CFDZGFHKBNXY`4._&?B&U0I0QYIA`*F^8XJ6%AB2 M[_JV:[F!)!J6;7E&X'IJ*U%WK1D&D*[HAN\[HBTZAJPXBN@I;+>*(OI>*T`= M:P8"9(NR[_F.X9F&9BFRY7!Z\&71"]H!>GK-,(`L/W`T5]9UV)QI6Y+BLJMP M)[!,HY7MN]8,`\A194L"X6%CAI;IRI;J*8%L>YX<.(HFM0+4L6880)[A@NAP M7:`*Q52!FU6^6\7SY?8CZU@S""!9M%77]#0YD#W7`]$BR:XL6Y8K^J(H6FX; M0%UKA@$D69JF.H$!4LX0%=!2JHJN-0,!LDU'=\'VDR1;=T2@`@-E"LA<%^BD M50YUK1D($,@VVW4UP_%E`VQ`.>"[5520N^T`/;UF&$"ZH6N:"$K1LD3;!O1+ MC(5='5R(5EW6M6880(;M:9ZDZKZN!ZXE>XKG<8Z1-+E5EW6M&0:0J2FR;[J2 M:OM@'&N*;3E,R`$.[%;SHVO-,("`+71-\4VP2CW=<%UTC67+%@,1C"VS_<@Z MU@P#R`6*"'17%Y7`4QQ0";[%=JM+KMX.4,>:H0`!!WLB6,6F%.BJ;<(1H!JP M-=,5]59'L6O-,(`\33%UV41WQ@@\V1$=KKD--W#;V;YCS3"`0&4;G@:\(4FR MYFBR)]O$^G,MD#">T@I0QYI!`*FB*@6>YKI>H%N:[H.+S'PL%\Q"I16@KC5# M`0(YZYB*ZH"T\QU03MP+U73);]5E76N&`:3X(J@DT]3!KG$M<+9T'GP"C\)O M)>JN-<,`TL#Q-"0_L"U+-]0`I*]<[=9JUV5=:X8!9$@6Q@L"$+&VK$J*+O$Z M=\WR]/8CZU@S#"!7=DU3]E5-%RW/4*P`'':0*:JONG;0KER[U@P#R`,G1M,\ M,"`"%[[D>Q)YN28IEN18K>&8KC7#``H4WPNPX`NL',,+X"A\3J"FU*[+NM8, M`@@,8@ML"4?RM$`!BE15G;C%MJ3;GMP>'^I:,PP@#<2;"YZPXANV`ZSL2WRW MOJTKK7Y9UYIA`#F@*!W/$0U-!?=8!G%G8PF'ZNF:XXNM;E#7FF$`^;8(`M?R M;`4D;Z`Y3F5L28$CM1KY76N&`014("J:Z`+C2#;X,8;,W6(MD-N)NFO-((!` MDCB6!#+$M<&/<2W+D1#])IA?MB\IK1CJ6C,,(+"K@&E,S0(G%!QD*]`JV\:2 MO%8:ZEHS$*!`M!7+<6W)='S?EDW%X3Z6JP>M;-^U9AA`*JCMP/%L,U`4U7`" MS50K^]AJOUKH6C,0(-G7%-TT14]W)1W$K^9R`C5%J96HN]8,`\C0)=%1'0=L M4<5U5#<(U,J4`'.K%:".-<,`,C7)UTQ;UQT?7FZ#;R/QT`K8%^U:80#YM@KR5C0D.;!$0[=,KXK*VY;<#E#' MFD$`&9+D!AKX6+KK*IX!YE;MA7JZW!I!ZUHS#"#9\55P[K1`=15%LC37XN:H MKNM*JQSJ6C,,(,7#FQW?4`Q1=WTYD*O=:IYAM=K476N&`N1;`9@."D@W,&S4 MP)>YU!7U=N7:M6880)KI@:VGZ:HB@C<3:)JFD[LOW]7`JFCUR[K6#`-(UPS1 M\D59U0S=E$3-;=S!&U9K!*UKS3"`+##+1=%Q'-O0+%UQP('@\4+P:5I-V*XU MPP`"L29IBB3AWCPL.39(),-674N1C%;5T;5F($#@QOBJ`RY-8-J>C=3;&!T155FW?0X_/Q3IM"]P'RU#:`^==:P8!9(I`!+(#/HUK MZY)AFJ;%K#_7T4VE-=C0M6880*YFR;[A2BY>6(#`$S6+$RC\7^N1=:T9!I!O M@PUA63*(%3.0#B=@]]@@7T./"(KHLBM/]]3VKFL M:\TP@!1/,D!)2ZKCBH$5>#)\`IPK1P._QG-;E6O7FF$`J8HE>ZIH*JYMB@HH M:UGE4M<+VEWIKC4#`?(]"82):02>!GZQ*ND\@"F#H&E5KEUKA@&D^4"7@:%[ M"FS9E3V)WWW9KF,Z[0!UK!D&$"!?5U5),TU04:H-PE:IT*_KK;JL:\U`@"S1 M#A15=RU7-501_"PNY&Q/$]N)NF/-,(`P(F\IH@2[#6S1%$V#HQ^(1&\'J&/- M,(`"RS9M%^PLT=1\"0QDB0<.5,EJ-S^ZU@P"R%9\3PMR9(.B`$D+BB M&@3<"_4E3VK'4,>:80#I@>9)LF(%*C"RZ2@NSW2Q;4:@0#Y@>9(MB^B^^`YABZ*3*9HHME^7]:U9AA` M($5\H`)3<@S5LE6Y4I3@VVAVZUU'UYJ!`)FB89N:+3JNJ2BJA_?+S+8)%+G5 MA.U:,Q`@W]5]SS!`[,,;%05\&ZZY;LTP@"RP%TP))(ML&K[B6:Y3 MA><"WVIG^XXUPP!R9!<(00,ORY2!771-Y)F_CFA:[4?6L6880*X(AKIDR*KD M`8^H'AP%O[>01:7]R#K6#`3(\\!*!R5D@GZRP2&6^(6NXH'WUP[0TVN&`>0I MCJK*O@16%MZE@L?.=VM(BM*U`M2Q9AA`ANKKIN&HFN^ZKF*KBAQP#T)TC59[J&O-0(`,Q=0T<*UT,=!$ M,(FU2NIB5G([0$^O&0:0&:B&)IF6Z*IN8-@!G`#)4@A4+0"#JQ6@CC7#`+)E M6;(EW9#L`)PJ5Y$]L?*QQ/;+EZXUPP!R'QABJMJ`B=SV\;PW-9\ZJXU@P!R1<^&PYSP'CGM@VX%NT`=:P9!I`J2J+J^H[I2[+D2&"]%JFKWJZJ5BN4;$P_'>KZNA: M,PP@L&<\S#\.5!:80#Y8!F[5B#YHBXJ#AR#R[.E7,40),JS2VY?ON1 M=:P9")".]:&J`::6$BBV$I!:,=OS`EOW@M9[^ZXU`P'R,8$LT'Q+]'S;4.6` MIP#ZEFFT&OE=:X8!I*N.&'AN(%D@?$TP04U>>*3IMM6.H8XUPP`R5=B>I$N@ MF_#2PM""JII.D?16U=&U9AA`EN;XX+W8C@YR%^2^Z\C5;JWVH&?7FH$`V7K@ MRZ:ON)JB.B9X?CJI8@$WV3&U5INZ:\U`@%S%LP+'L$DFLH%A5(Y^RVN_Z^A: M,PP@0+ML*D80!)KE:X%H!#XI,PYTR?"==AKJ6#,0($R5D!V,]5BNZQMFU1!" M4Y3VU-.N-<,`JKNBYHNJ MY/@RIB(KP,'*8Y*Z8\TP@'S#4#4P;#S-E(/`4FQ;)"41(BH%J=T>ZE@S""!P M9FS544'T`UDHX)NCC*':M&0:0Y3FVHX!M#"QL M^.""5GFMGFFV-P#H6C,,(%M2/&PF8OF8?"P:LL$C&28H\78,=:P9"!"XZ9;D M!)H&\@X;"DA5%8MJ>*V.8M>:80!YMF0KEBUYH"UMR?1`/W$UX,KM!6]=:P8" M%.BV!+:68GA2(*FFY8I\I7UYIA``6*(_FJ;ON*!AX6H-ZO#/;`M=LQ MU+%F$$`!)B2:MNK:LJEI\&)#XGZZ8TKM]E#7FF$`@6;451%(08.W87.J@-0; MRB[8IF"CM@+4L6880*KLBB)H2K!+0K>D&%`^FV`M2Q9AA`NNZKE@$; M=0';CBF#>N+WI_8C;E#7FF$`69[D@DS!N"%H;1O<&B[D=,MH;_?3M6880."H M^Z9K`:H!_[)NBGZ5QZ%K[3T;NM8\$R#>6]'.EW1./6G(2I>%^;*CSR)[XHF?-P3"\KX%_[IFB8H*A#DI`19?";4$[@/0J M.^S3:W&:.^S3O+&Y0Q&TI8P2QC0E0Q)-=";H0D\Q/:?EBN?5=MBC&^0DS[!7 M>\E)GF&O?I7-'7H:V)/P%/:\D@Q=U&0>WO;``9=:3/'7VF&?!IC-'*T=]FDBVMRA!LH3_%EP]]&!!7FC\L/W5,4TSDA;].E* M.DD^[-7F=&^'ON4XX`&X&!KUL,;",Y'694ER9+,M7OM:.^S3-W62DJ97(];F M#L&S%6U'PPY8L"E9!6-/Y#N4C;9(SFOML$]GUVGNL$^KV'UMX<`"`YP1PW-D M<"T]?I$#LE1I"S&_U@[[])[=MTMUS[0"U5!4R_5-'$)=V:6*?TX[[-/,=I+Z ML%=WW$GZA[W:[4Y26_3JWSO1'?9H"#Q);=&KP_`D^;!7R^+F#DW#4'5)!'6A M.Q)8J*+/\YD\U7#:^M2^U@[[]$">YAGV::H\S3/LTZ5YDMY3K[;/S1TZ"J9B M@'4*8C>P31O[V<$.95_5@<"]EIRPU]OA\_M(3])JZ]68NKE#-/7@X!7#\CT# M)(OE^&ZE\37QR(BP?$X[M`,P:U1+%4&RJ#X6_7N5I#';R@)>ZPS[]/*>I-76 MJSGX)+5%KV[CT]QAG_;ED[1I>O5#;^XP`"]$=0-+5CQ%]!734GBO5T\%IZ0E MB_RU=MBGP?J>3:."[Z&9X#Z!"12H&O;:Y#NT7/E\[@][=6R?I,;OU0)^FCOL MTU-^DI*F5Y/Z26K\7EWOIWF&?=KH3](_[-67?Y+W%KT:_4]RA[TF!TR22O4^ MHP@FF1/5:[;!)&5IKV$)T^3#/M,7]JPVWPT4TP'Y9,)Z1;%TWJ;84VRW+37[ MM7;89YS#)#W@7O,A)FFU]1HX,PV>F M2:5]IME,,HK1:SS.)/5AKWD[DY0TO0;X3#(+NM=$H$E*FEXCAB9IT_2:633- M,^PS!&F:.^PS56F2<9I>8YJF>89]YC[MZ4-3QEXSMNB+NJH'EFU@%QI=MN$5 MKFNT],9XI2C&T3N/0.)\.'O>:?35(? M]AJH-DE]V&M"VR1E::^1;Q/=88\9XUE&Z248Q>4^ZF*6GZC,W;JR$U M?<4`WH/UGDEWSH>4I@^JKO*)X3Z*ZB*`8<*;B4 M$DBLH*4AZ6O9-,?NT+%`"`<*WCRZIF6:>%^%.]0U3]'U<^+#/J,+)UGIW&L6 MXB3O\8_?X53N\7N-CYRF3=-G'N4T-7Z?`9>3]`][33M6J\QII/,-NDU%W6:DJ;/H-5):OQ>DULG66_1:Q3L M)+.@>\V6G:35UFM8[20E3:_IMY.\>SIZA].ATCX#@Z>I+?I,()YD-/'H'4XF MFMAK:/,D8]Z]ID!/4EOT&BL]24G3:T[U)'W\7H.OIWF&?29I3_(.N-=H[FE* MFCZSOB?I'_8:'C[)2%2O:>33I-(^X\VGN<,^\]*GN<,^`]@GNL,>$]VG*6GZ MC(B?9*9"KYGS$]UACR'VD_2`/1=.R@/3V0:7W@(8%:/J[@D'^\2LH,G8-![. ML)(\57=%S1=5R?%E[/6E@+)0GK)I)E,EZ_G@!6G@''J:*2.PMBV2WIUKOJT&HFN(*JA"SP""Y=,? M),_R+Z#WI:\;V!]?@2TZFJ\&NF/R^T-5\>4+B'G[I#>$IMF2JHFZ+]EJ8V:7 M>0G5>;[AR[ZDB4Z`XX_PND7E]X: M3TRTFLX9VI+BX61'R\?N7J(A5U/-P1I[HM?79.9;^+;K8=?G0--`^>.8+JGJ MT(J*[@+.T+,E6[%LR0/SVY9,#^Q3;K6Y\A/]O*>C#\$RLR4P3Q3#DP))-2U7 MY!I?UY[H.#"9FQD_4(#0P/?Q%0VD(P#I5Y&HP+4O0)8&V-C$M%77EDU-@]T9 M$K^W`)OE"?]P,E%],*_!ZA*!!378$@[I#DC7>=E5'0QM3-_RQOQ)4033V[-< ML&$,T^83/,#)`!DT?6T1Z+JO6@8#7V&[6J7Q=3B5QV]FIL.'GJ;[IFL!10*9RKHI^E7]H:Z]S-PU]E027D?) MD532@0V*B@,L4*CRJ,AV^1)_NTD`AO3FIW=1^O[W3^_^_#':PE^CM"R$\C82 M\FB9A$41K^-E6,99*F1K81NE!?XS3%="!@_EPC8KRCPJXSS:P$KA.DJC=0QO M0)S#*^"/NV6YR^/T!G^*\B\1O#W;>]'!*[+K)+XA7RRN_O3#'N9Z(+-'6Z^3 M(/-#NDQV*]CL'@[>YU$2EM%*")?+*(ER\N\5XGT9DRT/V'&/(-1)=AQDN;". MBV68"+(H:0OA]ZM/5T)1PAZ%.%UFFT@HPZ^<0I":OE'T*U78Q$D".U\06B!K M-F&Z0T:F9+.*5H`^));#Y=J5SE<+=U$>"?"1ZS@%E-[%Y2TE8OSZ*EZOX<_I M$H[C.BKOHB@5/("G*.,E^>J'M(SRE!P`0/]W^&ZQBI>4!(6@VI.*^Z"GVKTW MM=Z:`&R4X0%SR-:-5X;+?^SB(B8?(\#$`,Q-3ED.62S*UL=319^@STFHXC,< M0KK;7(.H`*P4MR$\"P=2+).L8.B(<9\QB(7P.HD$>$`(2W)X99C?1&5CN22* MWP[`10^7YB2X^`4V4X0)((!NLLSCZQT2!0C$/+HA%'`=(EKHT0M)5HM>_!G$ M8US>PS\!02`R0$U245WF85J$A&`70IJE$2ZXNXV7MP(5./@%?'"9[=(RO\<_ M?\"_I*LAZ'R^=W$2='KQERA'_00(6\=?HQ5GQ?4N!<0L`9UQ09B1<.OG/`J+ M'6S^.H,_+X1-EI<5('9?M%?;7D=@J<&O\1=<'.Z+ MMW35^%DY'C5]DF%/J]&3#!1Y`L2WHF114#XE],?9BJ@`2;PR]M7;-V)3*Y2, MJCZ,>*6"GQ1%N+-YL02;AWD`D,2V.$KXAK2C=1-N0Z;LEF((#V*>/ MLWP:]FF84QTKC[L_>ILH31W,E!;,.N[YND47`UQ]X@_`SH M`@'_1YZM2A3N99SNT#[,MA&EGD(`N0^&0@AH3&\R_%NQVVZ3>Q#.>42=B\HP M)&973LT*_!EA$JYW!9B/Q0`*[--X8,;X&!COXYB?!./_M0MS0"AN&H19F*8[ M0#BB=UY"@8`='X,`481[#I\JLA*_@"J8WX$CB##Z_00NOP.?A6U%21'?X@3T[ MVZ8@`J6`!81"!SRW#=C6[_]SP"GT**AZ2(@M>;1+<9DOE0.+?X27`FD)B1@ MYOH2(X>Z$A6%$Q4/O@VE0<`@]X-1G5\)GZ)(^`6Q(BD$T>%J%3/$KB(XG60( M2GMJ2?!ZE\?.!M4F\0;J@@(EQ+C<0V_1BV*B( M>!$]>O,+B@8;T+2TMNK?.YM-8JT5?%Z$ILAN9KO9F:DX""E0U`OF!8;R)@GK MX6\^8)P!]#.*<90H1B?J"2_O:/IP2HYX61/&CNI&)-S*TW*7X+C,CM(X7M'$ M);$LO86S!`LP=P5_49@NV,M3T2BV;AZC")_00D?)I M5&3$%?DI^,-6\$=/P1L_1_N/(\^@7=`?C,MP>EH9ZL*X'&`C6R;I]CE'3P8M7VF]25RE--!ZUUPQRS*IB-!YN$W&S_ M'"Y8?W4+IZ9(.S$3:"4!C:45+K`\Z].^U90^<7D%4$L#!!0````(`"Z)>$?V M+,+>6#\``$*T`@`4`!P`;6YK+3(P,34P.3(U7V-A;"YX;6Q55`D``Q?@5%87 MX%16=7@+``$$)0X```0Y`0``[%U9<]PXDG[?B/T/6LTS6B3!LZ.]$Y)ESRA" MMK6RO#W[Q,!%%<,L4L-#Q_SZ3;!.2:4B2((LVIX76U4%Y/$AD4@DKC_^^CA/ MCNY%7L19^N[8_,TX/A(IRWB_);EMR>68>"3=:TW2\A/ M:%4,R:^0:2%L_O98\.,CT"\M%.@O2_[^*+]X5OX!UZ7-(`A.ZE_718MX5T$@ M:Y[\X]/EUUI%%*=%25(FC@&#HZ,_\BP1UR(ZDO]_N[YX1F!.$J#/ON<9+W]C MV?Q$%CHY98!WE4BHOY0SD;_/YG>YF(FTB._%!3367`HO!?M]EHOHW?$\_0XP MF(X16(X$X2\M*)1/=^+=<1'/[Q+X[F1`F24\O$K$ETBA\+DH29P4_?7LP_40 MV%P+EI"BB*-XT5.*+U5Y*,1TR3(>CC>$)D(#!L_I:)/_GU5WN1#2O3:+K59])&D_DSP'J[A7-KQNY$;29F/T'TF<_R])*OCS@L-/8/W2 M&$Z+0I1%3287O"9!:)P`15'`;S!`/:VDU`U1%Z:'1F9M M\@.#\1:?T?6_RK./63XG%VDD_Y,U=*O>S&)TK2'HR*#W)G$MS9?H)BM)\AZJ MQ5SD@X#0FN-(F"@&,VV(:)+\C+#OMWE6I7+X.2-%7$A3$@4P;-%"+:F,)/OG MK&P$O16-D>2^RI*8Q;U%?TE&D_008\_CLK9(X`N=JXS36Y$J"*Q0BA$%.EOQ"D_AV,<'KK5X')F-J_BE.XWDUOQ2D$%?DJ2X- M`^!G"`MERB:1SK+^42<2G9F.BGM>B[S%=RS4IJ@%\U#ZM7:QVKD<4B]-]VDN?JF%I0F MQ>QCDCTH=]0)R/9#XMPUUSHQ*:>,_1E)Y%#X=29@_GU`=/?)<4C\%$>OWI3U MZ;@4H$Y0+O@+ON8*\,\(C*S%1?IU1L!LLP2FVL4'F,J63^M2S>IJ9#*2YMN^ ML:=^NTB-J$7K1SK@8\5)L-TDSCMLRS MH:>%\#OK#2U?5Z2;B6B2_%S0IO%CNXA&KBVG,?NJ:)1J$_A<9NGMCS'E8:45`*%%\7 MU"5!7+`Z:5()_N5NN7@B4RGG8-Q%&0-8S<*UH3&FW,O%P6?K[7\7"?^8Y5]) MHMK=]7,:$X/%D'B9%<7'/)OOKJ(1B`[LQD2CK:OO0W-,O;[&MVF]Z2LMY0P# M?JUSU<7L)B=I09CN9N[";TP\U)QJ>TJZ=%CNSP5>'T"`\FEK-;]):(6JFJ3\ M0'*9@BAD;[X2>3TE;Y!N7Y4!I5*S;(6:`\JHN-JK4G5`*3>!TNK7U2]RY9G5 MG2.I2M4M/3I9#*BUDKMHKJA+PCK?I0CPKK):Y5C\JR3&\Z):I?A:9NS[M;A; M+DM>Y=EM3N9M,%*BH%5F-:O:4523%.O<\45:E'FU6B1=;U+]!%.<*E=:HNQ" MZ@!:M`SO=)`^@)9*=M6=H":-_I9E_"%.$F#Z7L:4I=:`TO`Y; M&ZPK&5NFM;7^>8^*R*J11[3=(CJG5@(UZ\+93G#%I&>?;4F=ZA M]'E/$F;I5NH9T=$TVUY87!TRU]5J"K2'U'/]Y;5@(KZO1QP8BNJCJVU&9#W$ M1]%4%%?D2 MDSS@EL'KE$]78*;UNMP_J_A.83ML8[VAY6LY!VI-9VCYGYV*WEVDIV;M.0RM MLY+%*];6)*L,1-,R>;HHBDKP4\:RJCZ&!1%,RDG.FZ15KC^6O"W[16=ZVO21 M&7XF][75AP>68='[&_HJ;M6=]K!,#XG,\E>(+BN9TGB_N/L*;/DF.X?:`\+3CO,A,8(/(K^7 M[7<#4LA<93&DW2BP&P4-I>&_#0EM4J^N#9`Q1[.`.TL/(\LY3"+3^HA=F<>T MJJ_,@.]5C:4#K6'T:#T\*M4>1M;M.QS+BN0Q2>J+SNY:)(7ZD!Q1'Y^_I0P,H]-5.A M.;1>,'>X$GF<\9@M`6X34_4A.K1F]<<_XW*VY3A>]2`(>C\\,E$4&IM5&^.A M$?I3Q+:[V7N3D5IPFR3+/KA&,+CR&T5LQB-Y31Y-<*W`N8MGY:S#`??]/ M19(X>I*Q^R*7I(A\1VHCZZ)R6U\G6IKUD'WC)4= M+CD=@I5F%.K[+E*9T\Z7HEW'Q?=VZBG1T"7W(H$'MO0W(0]UW,WD]03GI"1- MPC96'%S"9Y&2/"I<=PEP`I&+3G+VM*EUF@NBV!)#\CP`+G+B]^&Q%'DJ MK_HMRFHN1I?1Y'LOR6DHK'\'.CT*VHC"N[JG%U(3:N M)HH&U(&6+CWJ4\`*B?77!;5+T#(-W5Q1NX0[XLVM3/''++\2>>V]ZH0JU/J6 MQJJN4BN3`36_J&,O`'MQOO3T0>Y#6&Q0^'8GG]20/)=Q9Y8N7Q?KCH$.=@.B ML:LMVFW/[$EU0-WJQ;Y8>B:-JJD3'47:[-BJMJC51'5"W^KLOM;/HKU(S ML9$TD5@NEAV&<#(].0V(P29+M1D"OA5RW4Z'WAVH:]=5+41ZH[@N:2I:B']6 M,-!\N%>XL^"MX@-)\_*S8GNWHZ)-]OF6R04[^<:6R!?WGS"TG:STH M[M2)D835&PBS]!(*+8M*X174:_TDKG@LA=SX,!K[_B_5'E!DO4_%CJ[(+B^@ M6X@VK[>.RWM_+QQ7EL&>/UVK42L!:B09>^:_EJ+7KX5'I*#UV]Y5@6X)N3N1 MCNU$)&6Q^J9V=<@PE^^._V7Y=;C*7K^O+Q2O0=K:>==.C\]B?7@K(50D[XY! MYG`@3J$O?(M$KH4<;C#D$]M&AH$YXK;C>-0.A/#E.B-,_>>"`LG9J[Y8-\#RK7I\LBQQ4L@(25)$<2GFJ_I1GLTG9&G9!)L' M`/RAC'YYJZY,I]Z39'NX&;@#O&8<.I[KTX`Q9`AN(Q9$'B(BX,@Q;1:1R#`, MR_M5.D,7`QRP/VAIK1^M;ZS.8ZI)OYV;^B^?7`=;]EO$I$PA<#*%^;^`Z[&9!;2+&#;>$' M"`>4(-NP'11A&R/J$,?Q#2:H:78S0>=7,L%I-=&/%C!L?3-2:+#U35:ET3_7Q+METH@#N M8X'0),*.$X;C"K![UX9>&6`LFWD% M5[IO/;D=H=`GAAM8U$:,.@8RA:#(E!_EO-L(`M\VZ:37<09I^6QD2,>8.BHJ M<9'>/&3_)TB^;U+8FE9H,]\,#$`B`FB0;T8PIW`H0Z9O1:;)3A8*L$,XBSBU73SE!85) M65L?6*=E;#!1T6=L*V(AL_W(Q40@81LR.\X$&:.I)<.IF5L M/6"=D+'=S$0N2%3N7,?J3"MTH9M1AP8HHJZ#`D\(Y!.'(DMXOL%,S_T_NXI(D>[18YI^66[D_B_+%[WM,KS]Q0,VW'.%S1`EU$+>% MA[`54`AW36[XCF-YO-$6#X7<_M2%4OT01[YM^%P@'-AR7=TBR+'@+]?P+=L# M?Q69HEM?'&>:/K8)9..`/(VNJ907:D,F-*G%3>Q[R.>6CR#>,I"(#(Y,UR'" MIZ9A!QVW:$W%W%JW=Q>+Z@[G9`Q+*1_4DE)(+1)QSQ,HL@-`@4+(%3E6A`P; M"S?`%L9&QR!VG&S01,RK%Z)3LC"5/%!K6J%I<]/C'D.^9T"0Y3L^XA#4`S"V M:1J$"`]WW.@W3A9H.E;6!],)V9E*_JIRVI$/!V+>99R#=D`Z&2-3RO>TI!2RB!I>1%R$N64ASX@(\IE+D&E'!HNP+P)O MTMF>B9A8+T2G86$7*4@OBO(B94G%Y:$0+3F>M\F&GNVZV!8N)[+D:?F,DL.-R M,Z;D6V1)S.N\!23?E&1GT3)-CKPG@K^&ZYA)&E^]Q[ M/\*A!9MWOXS#&*@$1."US>[R[MIY;;( M+Y%\:6,/&F]7"OV(<$]@!SF!ZT%$:6$(,$2$/.9[E'H,$S.8!+LAC\OGPF1'J:]7/2/U*#6_@^&JUF`'GGLL ML!?=,.!44,.P(7XD,(>F9H`8=J!UJ,-H9!@F%AUS$^.D60]HDF,#/X:17JT[ MV5KF^K3=ON'TC2HA=9DC./6A![(`.1%,G@W#"I#`+C5LCFT<=30M^Z=W=QI! M'<5LM@;_^@[VQ9W>Q8='D;.XV+QGTA".[:P;1B;UG8B8*/!@9NMXC"$'FSZ* MJ,]YX+F"^I/>-3>1J$P7N!TN?G@6',ID!EMAX'4 M8):1!=[4@N@2_*JQ/.OOV`$).M[@-$[J\P#6,1BR8_N:]:OM\MZT.AA4=#2O M*X9>8)J6#[&BRV`L#@*/HLBV!>+""(3M4FYW36-Z/ZL=#8;L&'94NT.85BQ3 MD?R\DD]2+IXVKA.]>TRIL6YHB,@'9QJ!1Q44^NX;GTC3;LI74M*H8&I85(+QG",,7(H\1"GA"/F>X;%+`O& M]XZ1=O"S&]OP4'<)EQ:"9)%\.R3F,8^IJXA:-?=Q\9/.Q'3#^JXT_?SN%@,PQ*!F^PTBNJ[2?:[G>;: M8<"%1Q@,WA[S;&0X'&2P84"W(X(MS!WF=YW4F^9/:TS#`CR&8;T!FKRBM2@' M6)I2)!R:.`@$\R+$I3MV;9,A;C`#6=P.'-=CEFA.J0_;%:%Q%_$Z)G8];$][V\^4#$XOT!U"SNT4T&5&EBB\X9[V5P@Y=D5D^#:R`X,A M,X!QS,,X6N:-`A=3W''N>]`UI2$-0SNB!_$ZBZ>"/XEREO&-]"HA9Q.)T#4= MV\6>`Q&7AY'I1Q!TNQ"%&<)RS,`&O\L:[WZ:XF+20;R-/I#'-#/Y`O?6;+V> MHN^`3\':%"F%1A2Y`$6``N[*XW\<(X-8A M7D_J51:A=M0*#4\>=3$XXA:Q$"6<@Q*&4^<"O,C%S#<[GK<]Z`K4T..=?EC' M\$87*8$)N`AZ:"H$#(MQ8ULJI+8QW:=?9S"I6%S#T6Z*,J)]]>?QHBR M)(OB93@#TMFM2E4L"<``'QJ-[D9?:)&T;ND=LU8'GH=16AL;U8]"::-OPXFV MS0>+?XU;C05[>G2FQJN4G"!)9Z!DQ\$+>U=;2"6;XT#K9IN4$9=..>/CWT@M M'%$4?0[/:'ETIC@(.3(PQ7!"(7B0%CD:&U4V`\/\VWA"7SKM3;T;3=..WB]B MUS7YM'57@=.:(W"C)&@4G$`S2`JYI(/G;`A#J:R-/>M'H;)QL/\1K10_A7F- M#WW_"7%]UI#KP\KH/:RJIM`R96B;41<#*+('EHH&6[B4(N>8V%X59?*U[$\H M^;1QQS-J1O.GH8F)&:.)GITLD#E:A;GDP@<>^S;!SX-W:3D!-"TX_5T<;`VR MK@=R>SCL`;1PS#@=+QIC#A*L1P/).H+!9@&)1X^*"X)VH/S;G$P&;>_WU#(Q M>"T(Z45*RYN:YB9\K8E0]E/,]@Z=$"GD7$@"KS?/D5\1T2^(\*B>XGA[U].\Q)*A8MZ$0(,IDM6(*0 M)&=3,#HAY-`J&VW,+2-3QA2`-6(4JQO,[Y9?P_PPTGBF1^>B9(YY"UCHEBXY M,+`Q&O`J.Z]X"#@TTTH;*\KXK&(DF)H998_B$,_TZ%AVC/D:?5QD@*@%:3JA M]!D=;92D011QX#M2&PO&V#)J M;R M*6!\F"Y'L3U9H^UB5EY*'\!'J2"9R"$C9KIL-0;+BPU#_1>:ZRNG63RF@JN) M>W#U:2+P%[F_/=\NK]>K;U6=7V*9+3!O,C35<)[K!Z#]L5RDO7?1*.-W-L18 M'$M`Q[:`JQX;!H4#(73TFJL8W$`?T>8*T$FD=BXT&VI'KQ9?9JOEHBZ(#M'R M^OIQ'?1#:.[(D3K&%2^)(6U&D>",1HB>3J91UK$:D9SD0--M"!NWU=#A=LG9]$)\X??#.HBH\>03A21W1-4^8=9E#9*IF6S4QN8'"]"ZB\S2?X*F2BHG6.XE&(?9)J_5 M&#QE/&S.8:P]B#\\WZFSI68%+!F4T70="I]`ZA!!&).-]8:KH36LVR2;&NO< MCPI1$_7D^AIW^B#>-NBPE,15+E!Z'W!,#C"C)Z$8&;.\)KK8>\2G7,$!CTX/ MVW728\!H!%A$"5HS"*IY4 M9.6BG9Q.V,DG98>FP:NEP\H[3$@SI\NW1IX>[+:RK5NG,EW;VA0(FI9+5WD` MIIF#H@O74@:D/U^R,7@\RA@9IC;N]U]JIK[55YKI#@)XV*PC@$CM2P211%+[ MLN>`)4KP/HA2>!$J7;1)=KP-/Q&6QC:QVW4?=.!W].IRB"&7X,`2Q4(0Q-2B M40ZR4=%AB`GUP(1I;6RFXVW_N"@U>?-9X>+=DP9CSJF0:N=PC.R:\KP0;O@&;>D:8(-M8!' M%*4Z5-"_BM(U;6CB0VWO;>RQ(TH8+4$TN:M;9Q-RZX("H8B82[`. MI`F/2: MFUQRG8&N3I++:B%Z$V*M#QB$+)FN5#>0W;34,4XBC_&@&>&5?;_:L*-'5TVJ M0G$%*DI>T['[U#XX@T38X@ MD?@3UE25DE9<2HG5V_^2G2Q&.,1C`7.)V3$^/&('W^6[N)OLJ=/:S`;SM\E@ M_C:%-^7G3R22X?6OB[YB\:?EG,CC^I9S?FMUSAE>WQ9!>#U?_GF>S"#;GT=O MJ]!]GVOVZ%?I[<-TI>@W\48OKI:K]>S?_>]W/AGO[]Y9)Z-728,Q*I`$FFHH)I?@ MDM`N)2]5M)=LO#TC"4V$;PO*ZD6EGT(O[5W5U]!]M+2]0Y=5\CYJ#TG1ZI(* M"23S!5C,N61:N`H#H]//6A^I!?6,AFA+GY4'>0:)T.G_/],O9SO-._NZ=E+8 M$*V58+RKZ]0,2#H@!JR8*"RK&MEVR6;ELW*@T;%MYLWPZ]7G,%M5!8D4N-7' MG5D+MW?H.#0NVE MRV]X;O*[[0N5.W20+I80760.E%8X%O-.=^&IX.YS-2Y<8;9WRJ/'#@KMH"&:M9=*4@5D'8 M@"PQDTK/C6?!UA"F2W[[.3=53H=S$S]?TH<221.O_DJ]_]6[L,8WB^V8[G+^ M/6*83DF7>&0DGA3-0)>:X]"$`LZFP!VS@8>!48=M7HJ:4=S$J$[OB;C7H>YI M#?#SN-8]G4G5%,:YMH-QPS8"(6\,S52.1DO?#*%;O7'^._ M+DHCGMFQ]NH']#_JQ?T\<+J?]IL;_[7S6WHS#14.\D\.I$3DS%RL$B*B'/2$!W4I%66""0R MX]30T(DVG+,I+1YX#BYEI\YY:EZ2O/F%5DDZ\?_LG]2D6'J M>^'43W:<:XNQEE!6J"`)5B![%\%E6[S)0JL\T`U%MK%&7R;=-]^5BU28;U?S M"=0 M(7!@7AD0*L44(['#_0G%)WM&VU-&GM:R64:_I-VO:<>-U0E+,-3*[Q8+'143 M-&B6(A0OK-91(NIXR8+L*/O]]*ULRRTY9 M!EY[`5J7`(1.`1>$D*&8E(:&$[01%:>GMJGQ;"+EW3TJ'V22W-*Z8QBXUO46 M-S6'!@H._?&BGWC)SH9@]L;;3K.V7U8TO[>K)4DG.];TH%47T`KF-:V@)A<3 MNF8&B9F3*EJ*,$'8%"[;5'#J_GR?K.LD;)H$X(5Y=;_Y@G0(:^*HZ]TN+-N: M=RD894(D<+CV8&V-ZV&A0+$,,296A!UH!&VSZX-WZ?M(NG'`:;'M/R^OB>D!#GIB`V;+`&Y5H560X?E]"2+4ZJ"8^WVZ<`T M.=]8-:&/OY"2N0KS&A2F'#9`)XFP)1<.D,7Z5$QJ:#;) M0)&9A\15"FF@QV0CLAB;]4^&6PNJ>8?72-^IK_0OB9_-EWT.T?W$LK-?9X), MD>E`JD)B($4QD*O1(M2W)%TS$N+I0=H_$HV,#=>`Y&KO\7/89(,F?O9<0K7O M6G71^Y2SCV"+3_!V1B)_G^$G1P'G$9'>KVZ2>N;5?6`W1OI MO*UYYQ%##B)#3#Y!*2D0VZ(?'?IL;-:*FX$^%/K'VO:141IP;G\)L\5R\7+6 M.Y32]Y\K.OBD79>-X<:5!$H&!")&!3GC)LN?9;1<>=$I\\<\NF.@,V#SGL2[ M_[%*W/K+E/9:@A MM%%4\9@TT`C!OW?RKG,]%YST/M!EIAW)6+6F*-+*1:TG&0)=URX2``Q-UD/# MO%I%>0W=QZ.?`0:`U=[NOVWB/V%9KO!!L-GOQ/-7L_77/A4NG6^2OA^/#O>3[I$<774Z%>TYW6S5I"9=K$$"I57V%-SXZ7R[;UM>$UL;`[=*>2!_[ MF[S#S]4-9?'Q%758?QWIP73G-SJ71%0E<;!>)M",!9!96K!TXFS2S"`.C(!M ME@]RDKNY+:9-(KB^>VC^*5S/T@X:V]J^X\J5J!TC-9O.<>^KI5V@,R MXNYR$H*7QLF'T=818W9,1:>,,.`,=X"12RA>%R#DLL7L4;*!"P5@29?]6$+[!1:1H2=`'4Q51#VP%+1 M8`N74N0<$QOX]M?F*AIWLY9C`M7$C>`8PMZ"3F9%*A]"3;%2<^,)21PN9#!& M%V>M3,Q<=&G.2;=_%+Q:4,';U2;/AT6M%K>#(G9W[(06 MC%1M`4;9")*1L"H5$,,BY$#MT(=6,4!Y4#J;*X"FQB\X[-#)]3(!7"PKY4/.)W*R^ MWE/U#IIXVKAC41!EUW=UG6G\)!FHP(CX4PC1&=+-#!M&!8W57C"_&V8Y5\7F_QK.W;_F1Z=Y]HE1_AP[CPQ/%.S$2C>)VXV08A/3(5-3-6O<0X:IT^8;^;XIORV7'S\@*NK^ML^H5M__?Q6T\:]B?/9 MQ_XCS6?U>ZCN6E55?SS#;V7-SSK/Z2O5;KS_'\T_@MA`Q_?*!:>4? M.,^OEZL:1]5B-PZ9YB&F_$N9:U-&<,B$WL\^+F8D:H3%>I/S\8]EG_WQ0;ZC MBT&OP<%-T[E0ZRYA(CR*@)!8[UU?R]<7;TJF/]J!SP!M#+V3 M[O^R+;(M5+FM:W@.K?OD1\?2V_X1.^T"MTIGR%%$D*5XX$QE4%$20$9EF0:& M+K4Q(9^=\B;!>&+];]M%])84PC2;]J+?]MU[_62KOTDOC/0(-Y"'MLUO>O'G MUB+18GG]AQX_4T_WG=[H\@X_WZS2)U(HWZZ6'U?AJMDRI]^W37V`,/]U48.A M>J\?(M?787;[\O1[_PR!CV(DSCV/EJK0,?.:?K=J0HH_9_-Y'\1`//KCC+YX MJVR?Z;,M]V+'-.X9\.N;JO"]N*J^T?_N/[3QW_^^RZ5,^*[1I._H8Y#0ATO9B]> MTC^NUSN-*2>,VJ%+7I;L('HM@960ZKM;33T2N+,Z%*8&OGY?2ECHF>CJ]/C2 M$_;H0D.H-^4+QB7ES:"="4Q:JQCX&FGCHHRU`C*'PB-'Z]S_LW==S6[DQOH7 M=15R>%38=:G*7LE:;>WC%*+$,D6>RZ#U\:^_C2%Y@@[C<`9#R7Z11(I('QJ- M[D8'F\^_W;K1ME]ODW>]*>3&@CNCYY^SR> M=_-$RT8[9"F(.TCBU/7X&`OYN);,BFZ[N;` M3:?SOXJOQ:&<-1?UT;!)02)<;5*M\*`9ZUIRH\[%UNO6S>NA M6./J>;&`-CGG)>>@;5#R>"I/G`"2F`)<$:XS!0_!4*-B-(3%CJ[!P]+(P/LX M'PB\44@#_['[;FNN*>D3%]_:B)Q7(2S6;GH1Z9S582."E<@#&3"=**(N-1#/ M#=ZP4O)@0U;LIE-:]['II^AH*"1'H;,B7LUP_XY%N!UNU,@LLB#4@5>!@)'. M@'0EM:LK]7-MU"'==-K_&O1R#5IC\9XW^'FR>N,6BWODS7^Y1;R4V>SIH>&2 M)IM+FDB>.+!8\M!0$E":%C%9%`TDZ_@L7:=V=27NT@]T'3(UOIC,+[-OD\5\ M5K0O-ST>!GU1^\;+3%UQOF=16KS8;8+(6=YF%!3*!W5]2MT?@Q*&!JX/.MA= M<.[Q@ON8O%L]W'SG$L3)CAHJF"2EGIVB#CDC7I0@-=DND"9J,NNH`-6):QF: M,H9`L!=6\>^["7[^L)C'==BGW)_1JA&&!26$A5"@LM0'L,GK[=0C@M0UZ+%. M2,K@;.%:N&Y$EREO4OCW9I-FNZ*`RP_SY6J15I.-^\#NV^NTG(N&:FCB0H1D M@3G<)$E=`)EU*0KM`@TF&9(Z2BCZ1R/`&\*X#_[T:XJE-(6;;;+Y;&3&!O:VN>,O7^^F\_OT[+\'X8W[!FJ,5"0G(T!H)4$)I<&'@-OKDDT< M==G4U>AH?S0RO1F$QS%:GW:Y.\N4?;B;1G*=A$(0)$JV@,L7>$,X#3K:;+S( MB$?7TJ7DIR&V?@$AKUCS1J>J,A*1(BE=!3/,8(3-H+6S+%$G5==+4H# M9^\>YU6L)PPKLXTGDT4=^`[EO_M22;Z-,?V_]>3N1#C5A3TU223&7-;E^<9# M,2M$QAVC=I[5*Q#S/1._+U$T M;CHMIZ0MJ'O`W-"MLT8R2S@EN-"2!Y]DAL>`X_6_J>_EK'"Y(P.K^^#6&PU5 MQ?(ZL]63I3[Z0$YF?WZ93Z?W[_\J::G7?CF)$[B6=FG".HI&]%#MFX$%\QR0<'I;%"G M808O?4)`";ST4\HFNXYFHTI%=89P:!P6P%MS/GZ#HWU71;)"V-.S&3U-A_;W M0E\G,V#]SS6Z\IK?K!>+L[6W(QV44A:6$>%+Q(D!9CT#(;T#:KFBQGH4_3I> M7#^N!_7@$(YR63V?_&_S6;B6AA[[:*((3'.'*S&9Z4)RG%CF;I2AF[ M*Y%,+]"-1R:7\IF]39O(+2%>HQSG7`(3R@N-X[8D,%?9T""CZEB77/RLQ'(5 M>F,(Q0]??DPA3;ZUB1M>S3;9A<]))7&IN>G[P=RSL0Y;EHZW:RC/-IA@P'G# M`.4``2%+T:JN.DO#%!FI,-.>N1\YDWM^W7BD_1!"!L5\AD2EA6!2!&6(],D) M:?5-QI$/L'.'JKU>A58/GENM/P_.Y<[-[I]D4CW*ACOUTQA&M%!,`_(FI#5> M(H[[NHC\9(1HE% MV)RS&G+D'&2TNV=787!5':_L88WI=16]`52J$\MU\S]*TCC5K;`ZH6,H` M4G`/VJ(2PCU58',TPHL0E;CIY"J#D\156(W!FO'^PBFC1MAV^HQ5OUH5!_%U MB;3]Z%8)+Z#B&;Z8?YLL1S;W/TQRZQ6\=0,^1U=YWJ+Q)H9,+05B>`3#3`3M M;2Z54YE5UAN;3Z84'UX7>[)#!Q;R:K5UZW_8LL?VN'=G:G%7C],4ONIV8>L2OIY(CF-P;"-2Z;[5781I24JBRXJ=-+ MSN=9[1OF`O.F<%-I=$E3;R`JA?_*5OI(:/:^H\90,[=7O]0U%'+U].!G; M/&'/Z/[M)*->5%Q"CI9^[-AC(P++(:@`QDL*IA0^10V-%SLK-=Y&$]U-.W95 MY%L#8#DBK;U-)?*WA+K]<^VFDSQYB`8NV[AQO#CN17]=QTW*-",L#+AEJ#P$ MF\#DG''Z3"BI(Q54W_3#1472&P[3$2GPS1S:[S';N^\X8C8CQ)"SGA M11&=-2`5C2AH4"D8Q5V+'7E@G4P1%0EQ6%A')$;\8I/*\W.:E3HGIR+*+NFF MP5M`ANQH26"+RK#U')Q+M)1Y,5P1R[GK*+[5R491D<#Z`K`&*?TQ6^#F9#E*SCPU.=K!-#$%I=/#L\0/V"(F2YPM,SR?+YL?ASLOI2*A3CN=B8V_;Z M=E[16R-%=(266`06."Z5H8YD#-FF@-$J,-,Q`5^=[!%]DDY='$>^]=H<<6TV M*)S(EVY7WO,^&BZ3-X%O1!+Z M;5[LWD43\=.T*PCT]*9#80H#=&>/T06L-<ZG%VX%;?]]`(1;3(#H]/^\#J3`)C'0%%'!.<$JY) M5P^"']=@/QQX8[P?/RW2_J(P5OO;CPD'1)UCOJ]&R/]>D:N\RUV^U.,-&RX8 M%]XYB+0,FE$W9,$2L"%DPYDP+MC_MG?>WB&K^'"[?7/N0"&'6C;>IYQ1P0=' MA<+A488WSF?((D2KF92:=\RW48=$^MS._932(W0U267S_M>%5`ZT;*A/VG%' M(?AB+,@Y0:920XI>4M3YE%,=HP;JB`D52*4_Z$9)2'8VJ9QHV1@ON(XL@O)X M(&C6%%R)YE>1%Q<'KO3IX)F?S06D?\QJTLB6"W8GE>,=-,01:S,)>#@415`% MJF->H39O8P[!>>78CY5T[)K=/4`YO4-8E8"^IOG1_?4/MTJ+B9N6M^4/ZT7XXI8I?G"+57DJ+#$(!XO>7-%;$Q05N>0_ MT!IGZ'3)`>Q9,:41E(QYL:7L&J2B2_3F:3 M)5ZC)97IY41RN'4C62(N^02.\`S$^@B>N.+K("+*,D'YT-&T5!'F9%KMJH/^YA;EX>7;B?CK82?Q*-H>_,F88MAA\(Z*9<>:-:40 MJ3:NQ)?*#-D5?Q;E*&I"3!'KE)9RI`>B@],^54O[>,-&24LS$02(05ZB+"[6 M244@:**Y$EJZV+%\0!WAJ[_MG`^,6Z58\O77=?N.^S;=H3ZZB\>XFZ9V>V;Q MU=?Y8C7Y3_M]EUH"?0W1>",9>[H=5G.OP%7Q+`S%;3^W?+Y3J5$J+S=>NW__O*S>+3.L^C#%[SPD>) M;[58A]5Z@3/`3=@Z?KSYXA:?A]Z#8R/?#@:/D@\>Y>,_[3&3W:?YRDT/C';8 M8?#,EDUDE":2&&25(OZ!7,FE0#9I_)57+)Q.2'[6,I[-PSWB-5^NVK0;;OEE MB]V[69BNBS@=7V-T`CF#?4NE(Y5EE(L01^4:VWM0V\#B3? M9!J$039]?B,0=XA).3;?%J?M;`LN`?]C-??I][1:31-._0VNI@.IG=5O$W4F MSB4.T>(?5C,+)B>S7;XE/NJ;M%.-26%#(3NP<'/NG7+\=Z_O?T^?N^O6/\G- MTH\Z]&SB6T/7^7=-AUZ:7)9O.05?$E0I8C*H'`)0'3FUDC.5;C(7VY#'O0Z. M-=3K9ROX3EX^13C;GSZ,4)2!Y_.U&&Z6'Q\>F=6YUB\OZ:IA)W&LI M(",.H"S10*RU0)*TSO!H;-?:*-6<6H>DA)=>BH/C6T-._("2T,9.WT8+?L!+ M<_'`4EXN@^+QJX-=WWD0?I$7)&HCB!D*)=M!$>6!92V^]MRQ>[YP_75@/JI?]24<=G0U`-E#JCV._QH"=F@#&$3E+AG;GY^E(W3*U] M@5[Y?7M39&'^]6Z1OI05[S+?E-P0WZWR&"`;6;,@&/7``-3H)(1$6?L\CII!-L-0'J-!:XKK^Y"1)7FZGC55ZEQ7%\>QRE ML5HGGE4`:[R%Z%-"MILTJ$`$4TQ%23MZ%M`Z#..FB.VTC%9QHRK%*W5:X8?% M9+[X/2V^34(J=I)-GJ0!:?_X@(WUAAC./#@B$B1M)?A2A%L[E4C`[=?DI#/; MR$4@?KI3T/N6#6[K/&X)^31_G;:^2"G^BEMX!@QC&G"V&_;>3R>?W"@*1E$IW6?+D MJ,_D=`K.:JMWDT5)W)LVM&^V#TBHBF*5J@\PL@\ZE?@//7C%B M?9(=$["-9D\9G(+Z0'&LRV_GE+);CKMO4X&->;'M/9!C3J@(.PFEG3@)6YA. MOQW6Y@/[YW@1,]C?1<-24%*QMOX[`<:5@&CPU`0E"'12*M/1&^!LO9;[JX@LOT=-LQK38)BX$GV)9S4@#5)@J!,&Y]L\%TEJ3K5 MG6Z"W'K#=AS*>WP7WCZ(E M`,H+!MH*XWFP5(:.IC#U4W.[P>`=R\31?BP%8YX8]%^8;);O4((HZ69NQ>CP M9TMA*;[ZEA;N$=EG<0O)L\5K:;Q4WUQ?M-=%[[7E-A[>=. MY;?YJ@XF[_,;MUBT0[>/5N6AY]%:]O?Y[/.GM/CZ-OD:GNU[+78/#U!/?''^ MD=QRC=?6J]7C#PN;62^*3_QKMYR,^C:U=WM9!FF\S+A8SXTA]HT5F?+ MG.:H8D0*S`F.0S)=Z@@9ECF37)TLKCI]G)/GJI>0:LAOSTYM)>1R/&&#;4DZRP#"&\"^/8] M1`0"P7F9*2Z6L(MS1NX-#]TEARUO]6FVW'*V"Q?5K:,F*\-5E@1XB!E(X@)L MX'8;Q4LX+KNC>EWG'/2YA_/*2-8X'*_72Q25ETMG)OO+^/,7;IK-(LY6*N`(33@9$#=$G4Z,$9ZQ3G) MTG=,8%\GV^2`A%8)SX&5Y:6FSG M^7&R_%>-"6PR6*!"\[=@T1,@QB:$%H.9H+O302W!= M5@8L].A4AV)Q*[9@H^.M(]B1:AGRK,CWL0N?3 M(VA!?<*B2I1[@1''T@;DYV0FT_@R'^)<,&B"8O`$">WS0D@1,,L!N^>@;`^: M`@:V&("]C8#$HE3(Y=&)>94#;#TI[2H;?9!44F)Q*I`#`%!+`P04````"``N MB7A'M':')`&UL550)``,7 MX%16%^!45G5X"P`!!"4.```$.0$``.Q=6W/;.I)^WZK]#U[/LV/>P$OJ9*=( M@CS'54[LL9T]\\:B)5CBA")U>''L^?4+4"(EV9((D@!$9_\NAS/IFC17B=3L*BZGE>%,O/EY<_?_[\]/*8Q9_2;':I M2))ZV5`=;$'^NJB;79"O+F3E0I4_O>33\S.L7Y)3\%^W_$Q^G18-P79C<+GZ ML6E*:'=8_U2KMK)E69?5KTW3/-K7$#.5+__Y]?J^0N,B2O(B3";H',-U=O9; MEL;H#CV=D?^_WUWM,%B$,>8_^9&ET^+3)%U?2,KK!=%T1/(MCG>8:>OIPODA\8,1E(E@((7G_KP*%X7:(OYWFT6,;X MNTN.,A-XIF6,;IXH&D-4A%&<#]=S2*^GP.8.3>(PSZ.G:/50Y3=E<2K$6,DB M#L>'\#%&###8Y<-,_K_**(\J).UD>AU-<)?(GF4(D9&X76PZ>HR"LV&9I6+,+'*,8<48Y_ MPW/IE`T0'"01CV&4X!DP"N,[E)=Q05IO$;MI7N1D'*DT0#ESW(;T+ARKJP1' M"[.H-JR]2+,B^GK3Z:F1:5R>,QB'^A&N_VV6^FFV"*^2)_(? MH6"M>GL7PK7&04>*G]XXJJ2Y>7I(BS!V,5DT11D7$#KW*`@3RF"F"Q-&DCOA MY,G/CKL)4)DVGN#A5XDB,M;Q[C M:+9*\`:KUZ,3D9I_C9)H42ZN49BCV_"U:HTGP&\X+"0EFY@,EM6/+)'HW:E( M9&[+;#+',MSP\(56YOPUI9I,J>F9R9M,R71-NLKQP#L-28=5UXM'[#7)K,EE M[O'P3%4F&,3SE'IU'F,9]G%*O3>/23OYA@JW#O.Y'Z<_J1_4$SB5+5Z;5NWJ,NQ$D.;;8^-`_?:Q$JA%YT7)84Q/JMDM M=I^DF.-D9A+&7-3 MV^:/[28,>^V8QAPC82C5)O"Y3I/9`\H6Y%OB^.$R*L*XJC]L:C3TL@]CS$7# MKV%19M5RZ*Y0^'F.2[(GBIW.;+IBB`)5H/B^(2L)HGQ2%4U*-+U9KA=/2"D% M8N?.BPB#U2Y<%QXBY5XO#NZLM_^!XJF?9O=A3/NXL^]))`:K*?$ZS7,_2Q?[ M21@"T:,[D6AT'>J'\!2IUWTT2ZI-7TE!,@S\:U6KSN)]7#$9<%[98>EEUPU)IJN&@G9"5A M5>^B!'A?6Z9RK/ZE$F.W*5,I[HMT\N,.+=?+DK=9.LO"11>,J#@PE9G.J_8T M921%4SN^2O(B*^M%TF:3ZE>,>"]0FTI/*K_@P9:?1[ MFDY_1G&,.WV[7;-%=`I*_C)V=*4>G/CKL+7!NB3![/:F8>]E25:>WI(,UG9X MGR)QJ1LQ5/L`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`E]ZJ`AWWI=T2. M/BSGY!`_#(NP3=A60NX2[D1*Y$!M]4C@0>`:IS+3U4/BO&ZH[`R%E);@V><) M<"&)G_=2H"PA%^+F1;E`&1;S%G,L)[1C,*_^!.*Q;G.'EB0C3F9;IR2=5Z?, MHP2'DIT*Z9Q[Y8X-53A'2\Y,VKA*57',DF$?BE^;4RNDR^])6$XC_'.KT)VX MB)6=UKGZ,!.K":4#]>#%2H_JK"Q%8?U]0^82="Q#MQ,REW!/O+E5*?;3[!9E MU>A5%50QU?Z$.E` M3L.DBC)+ALNZP82IJQ?EB@1:/*.LK MYSX>+(6<8U[9I'Q$%PTD/44]PFFOP%.RV[!ZG=HU;K-N262B&!PZOW89O12( M;!L2U?OPER$W$E?R8HGC=++/,)51GL+\L;),F5_,PG!Y20:^2Q07>?U--11> M2/+Z1=]_6W\=4(A'+D[#(*&K`BT:(>/P$<5?SK%005]6@:0:OFU#5=6`Z^NN M!'3?]U3=L#1+-4W'W06DVE"19K4%3XU(-5$/1Z-B$UC0,!4'V+HI:8H$9*@! MI4'",F$;$AMOMK/)69I-4?;E7*ZIUL]ZIZF)O)E>E'E381*G M.,W\LU<(*=Z=K;L-?E1@W1\+ME^C8,W>4+G`5 MS0>:;EO05SS7LB1'-VMP7-,`@MSJR,S0V\TZ6C_E!UOE4YS=XXV8<"=FV>,6 M>]L'JND#Q82::^M0LAU95BRMULO1;2/8&[=Q)[IV!DKY0?2K^.%XBW M_HX>XS:^>*-OC8=5`ANOBJ73?Y5Y]?[$KSNIP?%`Y`B#P'0\P[`-35$5V91L M%U@2;#27=$^46^Q+>-[[Q$#K'8XXV$$DV#F^H>)WC$%SA3_*HUE2S:+99FMI M_1JK/]!T1G8DTKM.;_:![UH^4&W'TGQ3=QQ'!;;4H*;H:B_'4CZ<8XD"4+#; MK<\,UH=6R/)(O[&)@A'.*"3@:9KINYJO:$"#OMV$>XXA]TN3U`_G2NRA$N(T M-^Z57:Q.EI+@_2%=E5[Q@W'S1&Y\2^/83S.R]GG,8^BY!``:B@,-57%=R==5 MW_5DMPD-+*"-:TH3EU]S@U#PV',,IEJ9X16:FE,@*WB65PU=AHIM&9Z&I_\- M%K+>6JX2[$X\K-RO4M,301'>=$SLU>6H=V@2AWE>+=A52T<4GC6`:V#)$I1D MSX?`UO`0;@,?-$&F(=G2N,(E$5XF#DT1'O=65LHCWRZYLB19'S>E<$&6W02J M;!`@@2IYLF[9DBIOGEL(O'XC'[>X2X1/GA#>+2?][7)W&4OPTM:[Q^ZF+!@L M>`E:HMNWTX*Q##@!R*/Z[637T82\1<&>96C?"U>$=GU\GX.@IMJB_?"Y\[KUE]MRXI= M606VI.F>ZGD.\'79=65@6^H:$==0/6<,2XML3/IVC8#ZGF?HDFU@6$S=;^=AM@@GJ"S(2=[#2S7M1`$P31.JFF'@Y`)+;2BN;M5"J[8I M;,&7+GOK"7C*"0X1#^CJ/?;UZ_Y:INGWC0,`3-\P-4T'V)44X'L0:+5&NBSU MJW-W+QF-C)=X#_@6XA2Y;;0^1!*0Q24+*KYDXY%%U?#C(C6/C.H:VGBG MZ2&F.FKUP>C\:CXPNLE[#*8?/'F3JZVNTS`Y.EGO-@J@+ZN2(>-$5M(L7;-] M6?'60D$5.OW*_=PFY^'8IHR0$%.J?T[C9[(M(T/3J/!#U_S M0#4=K(>.-L(<9JL7J@]#YE>P_NNAZ#&87;^[O24YN5R7[)1_; MMZ+N:1U8GFIH#K!DW\0AJ*][EB[7.GEXA"Q[9UR6WT5*1^Q6]N,3ICP[.$1LSZ!OU3_JYM@*%P%<_P%<.S-9QUND"O MHU_HN+!?.L8MB&=LZJ%P""J2&%@I4[7C;21VV@P M#B*>/9_@BJJKE:^2(DQF$Q-VJWYDC6N#%>4>_#`3DA1,GTE M^P\WYVW:RY'[*0()`M>6%4,!FN6:T`:.VDR-*K#ZW7@`/KI?L$%+A"=LO]GX M>OU&R)9BR"&2`*JFIT#H:I*MZ1KT?-5H%FP\2^M7E.[N"^.L?#!"[50^T9IO M'B8*9$/1%-6V%=NQ/5UW[E?_1:(%!H@)]`-R MA'\M:-XZ,1RD"7!>;=G`LG55@Y*BJ89O-/JIFJN/-TX89J[]MF<&T*_G"*,+ M$$9B?Q9['^)HF>%Q+6K=__"F8>!ZP)5?1FJ,L_)'F5XM%F:3DRI]P>7SM[@A%8#I`EGS+EPS%-#T32IK4 MB*NHJMS+?-RJ]8P?-F:X]##C58(%?SEJM^TF@0F!*7DX;-=5Q?$U&6<(3>SN M*>[(ZN9L#34`B!Z6<;(H+]+XZRO*\GL8!SMPL0S/Y[$3D.0Z&$<[R6,9^E1VVPW"8"GN[KBJ8XL.8ZMX^?1LKVF,CV&:`4#TL`Q$RW2!ID=-L],F<%45C\"N)EDF`'A0QD]OHY-C MJOVV*IL?PS9#D.AAG%N4)'D8';?.;J-`-219,AQ3,67+4A595IPF;<`99#_S M6!_#/(.@$+(0\K[HU[96NI\BL'%FZ&FZIJBZ9:J*#16M&1@@:4H(]IA?AS78@A0>P0*K M7]]'1E3-+LS<6(5\GDTU&SM=(%GB,YLB)ILF^:DJOYFN_7J_,>,/U^U0)N M!5,^MF2-4I_S*^$4)1/4U;YM9`'.XF3#]["PND9>)66J8%K0]($FJKUD*E%3HU()ZGMEO_9=; M"9:3-=F`(^8$PAKPP>>L.W+"(8-N:0!/2%`WH$KNVX6;J_?=GI=>=2]FC3.- MY@OF"!RKXXG8'MP"QP>N8P)7\:&LZI(EJNLS-^MV\C"&J_^]Q M!)O1)?0?V=%.X6`B3NM)'K`,VY,M25-U8*H2L)L80;6DD=VHS]6RO4[L=<-/ MA-^LWI`5);,.9_8.T@26[9BN:D*95-HL1;&`45]E[+F6UJ_ZQ*VR(=(_6&$F MQB>*:%8=07##O/72V'>-<6!I*CC)=RTR#CLX%=3`QLL=I=\HT7VM<9S1\V"\ MQ'L`W96A!TC^E[TK76X;Q];OT@\P@WV9NO,#ZTRJTG$J<=_YR6+;M*W;LNB2 M9"<]3W]!2:2=Q%H(+@*=[DI74C87X#L?P(.S9E7NDK*!TEXA*!TA4CIBZ@.2KTS.F^-`\DIGRF(OK/9[,/C4UF]\Z"Q[-N+,L0AQ]+Y\"?L;T`Q M2FJ3D@.6)>8_ZHYMV1,28WI\37G_^VRQG7:Y6`>E(J@3X5^K64`[WS:1S'_? MU"X]P0?5_[G1 M02_+G4FYGE:Q;2$>UL'=[C?7!SC4YC&9=UI[2418/9J8,"X-&A2@%G$!T&.Z M/;N39T"\SK<(HMMLZ<3 M&Y?8.Z:K=:C-IS_0$B-13_P)*'C&-=+A-$TQ9LP`:1IU``H5%W$QIAMW5.JT MQ2M"-57WY>-B76XVO,]W^;*X*^=A)*M/Q54Q>RH^%LO-3\N;VN.Y1WMM_9RL M+ M=1%FM%Z]6ZT>PW=Q6?U=F?`^/%9(7]QL9[S];;N8V8@79-@&U+"F.."&*3*8 M^<:,P(F/TX('RV$:]%,T*I(QF9^G?S(_%XM9N6PZQWPHU_4PU]^K^GNVKF%> MEJ&P87,@J(+`&T:P$Z[1_\(A-,[R-EA:5N^;6Q*HCD&]74.3NF]&W;MF8`ZV M>VLFJM.(H%5PF?66"A7PJV%3!,35@AXL">W\9!P4WC.;F?ZU+%_EX:FW9MY! MZK54!C`G'::$V48OK5)CXVR18!)L&@BD?C:JH"N6MXO9?XOK=]=A<+.;6=[X MU&OCEEIG M360S,9C&<6P:!N\T,4[,0O5B4N\68;,^;"[O]N!,&(EAV-(#3EH"XQGGSU89 MRB+9."T+^J@0CN-F7Q07-]N.@P==Z\^799P3QIGPV'ME+,$*H3JGT5GC(V,Y MIV4*[P!(E"M]>P!]M[B>;:NSKB[O\K5:%NKA85D^%=>^7%XNBWQ=?8_WNMK; M/"0#@C'DC<#6&@0`E(RP9F,$D27PX32LUH/#-<;2_K;Q?-#>BZVM[<`RWW=+ MA@WU%BM#'9`&8^(<;38N0R-KX,-IV*U[!B>M4`VU#%^LVVU$Z*?J7QLEBN.4%V4**L8`QHY;1*W&&+)GFYJ-I=DTC.%)0#JV MRM'8%':FUT_YNK"/RS#9C\5R5A[29ML\)G-$!>W>*"@]#D`0YIHZF`YA'->] M%$[+[CT@8&/0YG,^+U:?BJ=B\5C\JRROJY"5`_1X[?+,,$PPEX91)!R"5%K7 MS,I`%]D=5NL^C\T/UV6`",]$./4:[R443BOW'/E,2&24 MY71,EET1&6,E;ENSS%]+.JM-J(="WTZY/>.:.0C"M"W3TGDGPQ&X*%H=\9:_?D#DKH3.>N,H*A@55BM69 MA5X:$UEG:EIFPEZ@>2'T__G[,RIA=']L?_CMSW;W?@/.ER]?_G:?S\,OKOY8 MEM?KOX53XM\WZ+S,,]PX3JI$T>(Y3?0Y,]&'26S.E1"C[0`:EE M#NFAPU/;=%0$!4(<(\\,#6<(B()&LD,$61&KC+=>ZH'AD0O\9)%^?YH:%JG- MTJ^F>[W^Q]6\7!77__QEO7PLGG]8AA/\U[6;;U;K/W]9%;=;%\!D:@8[4%6+ M$MQ9KA1U'@&I:D"X=&,E9PZ;KGVRU$^L&=P.M#,%P/98#Q8(R)G23-KPC328 M$HY=/5\I/$DWB[NS!%L7AHW#ZNUS9'QN1-8,/A\U.AL.8FH&AP^LD$I;#`U@ MWG!@1+,W2LE3:Y7:'\C[:P:W@R1"3FUK!AOL%+0<>`TL=ZXR#J.&D@;%Q?Z< ML69PC(PZ`!(AH>%J!B/H%:!0&\HU]SPHO@K7JJY7-,Z@>L::P3&R[!NE"`$/ M53.8*8JU<=`1Q#C0Q%1UYW<#MU#&!2:?L69PC'A[!BE&NCW5#/8*81-F#1UU M8:N!2#C7#)3#N)R%,]8,CI)F/^"<*?`F.F+95#&CB_7VRFT&9'7G*6?L(5^? M*6408T1:2CSGC%@!F[53E:1+7E_K;O5)$.>$V5U%&7R9S>>OQ^6'YWTH%Y4= M*X@U#/FVCDE1OZ_6R_SJ4)#'>0:4$6TA,4H+91E'U@/J8"T9JD"D2_IG6`'C M(I_PFGA]*ZCJ[RRNJVSDIWR^Q^\^SHLS*[A7GB@I*=!($QX.H3724KE$=_E4 MZ3CD]Z.K[*:V2MXMGL+UY;)E=;GN[\N\88@!%0Z"(B"I.#.T/O03(EABW>5_ MXC41*[+I+85OPTHV5;(T*]HDYH9`RTS8;@(@,4!S>/382(D2B? M.?'_!='WF.<&>ELF-/<,&&8]19)4_AXN:YB`C:Q(,KAU+W$RIB.PJ:D3VTM& MTAFVEV204>P8-(YZ2K0,\,)&06/,QM5T'CSC+_$ED(R\IK8"=L;8%[\8U]K^ MXA:(H0Q099R52`);VW\)#^!'K8S!4Q9_PI71679GUG]^6SSDL^N/C\NK MNWQ5?)-B/((^=.#M&5>:41[0H]8@H3U3O(Z$(M+AL1IAOJTED*X`I_:UJ`3S MP]K?=XX8=P"9`MHP++'!@BNG*!2RV8$0BCSG#IX=F_C225J&4UL]MM@6RKK, MO[[XY3,<(ZVA8\/(2&"&@[(J]NL])IP+\\+>12*[S@R>@/P3+J6>19E6I9ZA MFBHYI1"Q@BC-"7;.8>B:3491'DGOOSR]8TED:MO^J]^[(P57SS*.3'NA'5=& M<8NY@=6)[ED.(+)CU/`%+Z>[,I*1Y=36U/CVJI?&#B4E=\Q*S)BGPA$!<42HVYI$"%+[;P`-18AO]9W`KXRZN< M@K12J;X19KZXFN7S3\7J,2RFP9II))&T%ICM7/0*\.EH$XS79]M+$63J\$1([E.D,3(J5SG\Y>'@L,">_WJ M3'AM/6*6(2FL]$X3!>IA8H?CSD9GK+<1);E>L!E#O;UXV#A/*UMCU?;D?1F@ M.%XUX,!=6=A,!/,&`1?(&KX5+/Q?SU$H&/=)/5-QBT@#2W_PG(D"[42?53H! M(%(A`0GT$#GE<3TGPD1B&G$OTCDN\9:HC"'IEXU+/A2GE`?9%:,P MLG7I4`+O+)M3.OZT@^1,[M\7E/]4S/-U<;UQ=+7S[.YY2*89P%Y(JC5&"`IB MJ$6-1NHC5;WSM">(W04&0RL1I^EWR>SJOERN9__=S'/G,J@TY2A?Z:MGD/K- MY:$W_]Z\^9!;M,OC,BT-#%L#X,(%74`9RD3EX3:658)31_-FAICL/@]H[*,R M[R@5UACN)9,,8Q'^WDT24XK/Z@$=1WKEJ`@FZQG=:JV?UV&SJM[WOMRVZSWB M'3UP5Z:5@P)IA2`01`.#]*:Z[P:8J@YL2A[2X:5?#@7<&%K%GM$>]7X=O"^S MSFBFD>0:6F.%P4BZ>IZ0<9RN=[07Z9W&B$Y8O5UN).<538\2XU.A4G(O;C8G MI;UVX[W79M;",!F&`0CG,H%)`*;^8F.G]&BM)TX[2O0DF[)?5,X5#A$70X4- MP,X1:X7P3@!L`FBUC@8\]B.9D-+4$/H!;?KQ,0A+*:&2E=Z.)/;2$=DH\H;P M=+6$SA)L'2@3A]7;YTARVD)ZU$C$=>PM`D`(*[5VEG,MA8'U,"72Z;L.8V$_ MP77<#IL1PN`HU,(B[8S'0"H>!H-]/2!G(I7T,X9.Q0BK`R!)A<$IRZSSX90" M"0E#%UC`9WN94G%EF<\8)Q4CR[Y12B@,3F+$!:5.&D\1HAB@9V9RS>/\-&<, MIHH1;\\@14CWY3FAICOER7-Z\XS8\Y M[W7JCB/)/5^F+YN5@^A7WAB+WVMT=M#!UB-\SJ$[$;Z.JH!6[O/6$UGY>`Y2N=;:;N%Z7?6\`O3TB)&>"343^W>VNNQ2A=_?WCXMRO>GQ^N=) M>5:OW)%9PHRC5D$A&4;A^+/MZ;OYND(<6ZYM*#M!#["_DFS5'9<8V^LB#/SK M8=OKBTLR8ZNBAIP`*C%#51UHVWREK)!QWO+!;*_]"JH#$#$+K%C.9P_+H"K, M%H?7U0\79I8YJGB57FD!9=AJ@VJ3O2<@TITQF%6UY^74%8YI!3-`[:12P!BA M<64@\M*J>FY21M82&C"8873]N!_@IN^L5EXP!#54WELJ0<#2UF9%;X`BZ:K, MG278VFL=A]7;YTARVG1ZU.A-L6Y3LT!I+R&Q$'.`'342$5N[I;RU(K$8QAY! MWE^SH!TD(T0M<*"U\QXQ13!&#&'C&DKZ,-BT-.=A9-0!D*2B%H@GO`J7,M@K M%?01$5[=#)T1DY9^/8PL^T8IH:@%8C2RPCIL&(%`"4(D:O8.[287M1`CWIY! MBI'N8K79TQ\V+Z]>?5BJ>R[/"-GT$)=*"X00T8:Y.KC1,W4\H3*ULC!1TNP' MG#$T7%^!7;R?/?W8SUK_^6O^?^72S/.`S^'C.0N6\MHUK M+T`Z5@Q:ND?HX<`\,Z&>Q_XAOS]^@&KYI(P:JXS&W&ELKW79S*, MCRJ-,.<(&DP%(\^0")-8,9S!!%'VC]48^\3E,BC5]_GRC^-YJM]?FC%FJ57, M;1)SPB=<"E1'_'F(56+U8H>6?$\PC9*=_+A:E_?% M:(D-$0H:(NM#@'<,W M9KS$]/I28H41XE`;+)W!%A"E=V9^"8RPHVUHQY/C1LVK20/NJ5'W>Q%=5&'& MEW?YHNX+.A*QCXXCPT@@3[B!(H#.K;8F;%2U')P":=@YW@3M^Q;&**G(NPD= ML"K\IYC=WJW#G)^*97Y;_+8J;A[G[VYP4.>$]X#A6@:;V'P[R1+;E/44QO.=33'8_ZS1LSRJ542$&N)"!,6X^)J+%E`L=MX[W'";T1 MFL?"'N%]=:OU[+YNAE"56MDZ#'\XT>YQQIYZ>R8D\BR@JQUD3`L<]":.`JJ?%RL/X6![N'"B7=G+!`:`TP4 M(UH1PY0G.DPCZ#(<<8;C>@CR-T&%82#,TZAP$^CLR^5]_FYQ4_VUJCH$-(,`$9X`X9+KDV"$,GPL:-(3MJEAIFIFU;S!^8?>MN M]DO>=<)*ASCVE,' MN112&^%K0*CQ8Q7+.\D7/[S43TS<;0?:]),RK=0$(RNH)(`;S0VKVG=MEZ?4 M;(*)NR=+L'5V9AQ6;Y\CR7F_TZ-&$I18U1KDKN5C.U)\?W?&""`0:17V6RV! MFQH=B?5*_Y).?D6DFJYJSFD"KN-`,AM51 MS]]!.59#E%1IT@6L,Y&E'KK+EXO9XG;UL5A^OLN7AM-UQ(3;9M>;1O9OSV+F M`4*`_3][5];<-HZM_U$7]N41:R:WTK&KDYEY9#$6;:M:%C.4Y+3__0"R*+L3 MBZ(@;O+<2E8*BV=X]005H>M8:2]NCR/66L*GNP6 M24>.5X!A@0;3>+PC)M-2%$4O=I=#H#$`2*-1?J3N`#*$: M.*.,"C_)`;6P7CH7,NV*N3V:&%-IZ\: MI3M8!L+LT@+JXQ;#%RX\\I@OHB.VA8'0G?"<`\WAFWGB_OPJ;_MOAZIT\G'W6-LV5>6`.(D\A0ZH0( M---[#R"W,*UJR9!:?U\G7I>P79KJ-VRQ$J:UT`9(`(*!A;7@WNP*OTB":&)= MTLYSWRY&N3L=TE&C.[:WEH<"-NI5G;,`G=_\>5>5FV6$*P91K6*N5;$*/WY& MR,B;VLI+I_?M[Y2[WVG5*KS5V,PQ!RP15%E/L;&880V0)L8I!9BR1Q74L[?1 MU/S[Z+B,>0^=M)8S2IG`01A36R]?R<&\#`>[?'=,A+(_;"8;KK$MH5K,8@;H MT]96R&]VH0JOOSD2P=%^DHP`8RGB)N`&-'$*"(YKV+1(O"_JL<=WAXQ0#@3: M$.K+ZR4>O:'_]>%,QY*&4#CAB'1"PO""^GI'!!D_W;"-/LC6P!EGX?4>.&%R MP1G39(#S[Z7*Q_EL7BRO%TNM[N( M<[`MNX-AB%?S.9/E2]";MTK%IXC\\7#,AE&95-([#7RL`P$YQ3@H5/L].CVY M#L3]2>_N4!J1$UI49VX8EQ$>L')4"F*58!*H6`EDMT_!+)^N$.^$>NTXXBRL MWB]O3$ZL3X\EAF>%+T7TR-Q]*)9%E2_4G/V2(](C:T%?!**6ZY+1]0 M?JU*_WN^OG\]X^FNAXY^.(,.8(RP-2HH"5Q1R\D>:4?%1.)L^O.%31+F!.OF MR[J\^?.^7`3\5S&.8OWTN5P77[[/X]W18_@PNO`C5H=\I6W'9S+8$8A(ZQGC M"'D$P1YA2`2<2$!TS][3GM`:XB0SY<-#8.RX@VT&[NIJLUZM\^4L\'G#.=0T M++,<:DV\4,H9X[7U2*AZEU`E)D'V4C6ZWU.D0Y`&9H5P3%U56Z$_^U>^V!1U M?G8[CC@T.K-::D6=85H"Y*",A6OJ/3.!TK3D7LHM#\88'6'5ZR7IL3O*>-J- M>4=Z72[F-_->EQ`I-E]OKX3#&O8!&./]ZN>\>E8ZQJPI$*O&_&U53=?(QP=E M3&!E@JJ/6"R(#Q65L5VB0-1(J-#Q]H\#[?)8U8"W!V0"$N/#!H4F`%'-N>'B M>7?<,Z^'ZG#;6!N@"^*4/:`QV0OEG^QCG2_RY4WQY;XHUEO[8+8E6+Z(%8## MNC?AV-)/X7^^EZM\\2$<:M]C'L=B$W6";97@"-2FF%U]WT5U'6^2.<0",B\H M<102@@@,DDD:RFU-+N`&LPQ/JDYP+NF@?00BN%)>VC5!C%QQHP%DYEK MHAT)5`O'#K:48ZHPP18#0>N%(8'3"V.J&['AF9&:N>`)A@:#30/+P9Q]6X)T6E*5T_Q M!STI71UC-!9'/"_XJ(@Y-C1SV'EK?'B-".,0("6PW^V6*B\F'$C8'2%;<$@' MF+UW3IFF(G$V*L/3^6OXW:."X-"0C%,6;YJ!QK'%&-5!00;U[AAU M:+JJPCFD:J3ZV>B\-QZ8G!(P!=*?[0=P?Q6+_+GFUI=P<"UOBM6G3P8AE"]G M"(KK?!TCZ?;+:W06),V5(2B!9]P2([#D6&"C]ELDGJ7ES?QKLKO]_-E2[H??#[#BD/GD-5.4\H-8DZ9O79";5I#I-ZJ#75*VZY`2:#? MAT6QK.:SNZ(E_0X^GP6MDGKK."%2$$A`6#7<+54QQB<2'=4+_;H")8%^=:'+ M+\7-IMH6)&A)R.,#,\PH@LH`8*`(%DF05;*&0C.HTBC:6X&<3BG:.3H)I+7Y MXWP6C(-\6:SSQ6^/OQTN:MI(Z9/GR0A@)FR+8D`(Q=8YK6V]-202"=];>9I. M"=\W6`E\\/NK&*I_%>NBFB_SZFE;['2^6*R^E55I@V[P(Z\.^U&2YHE^"$F9 M$EXZH8WDGLK]UC!*+%/46XV83OF@;[`2^.!3^:.HKO/5*I_?_#%_+*K/Q8__ M*ZI5\=1(]F/#,A@8V$.&`0[X."$IPJA>N)4P+7JU\];GO5"Y8VS.D=\Q./8Y MUMX&9GO*LK;S)%IPYA`"$O&G=<22:A>^-0EZFGB(LC=)U!#N%!>1RS4 M&6O'NO(<&))!C'707[B$TE`+K>:V=@9K+Q(;69^NW(WI.NT(F[$H?[RERL%! MF?,TGFDL_"'>4AE>);Q77H,&,UTGZOE$:\$%9Z'T'OEA<@[5*;'!V4J`NKFI M-MO"@E?K^Z(RFZK:.O/V108;Q7_+T1GF5FE%!%8TUL=P6MKZGEEKQB>2!-LE M/6<3<-HS))@>6&.*R05))X)?3>T\4)HM-5%OH@9".O=`'< M^V22R6D0$^>-R;J+D!0\1K9388%3%@A*6;UP8L7$8JTZ(<$I'J/3X$E1%E?? MBM6Z7/V>K]?AAYM5P[>>S6+0`2%..VH,\B)(0TQV2S1,VC0*]G?3VC$%N\!D MB"/Z0*V6M!J^VV.,,V:`4)H0$'1:2JV4=<1)^$/3/'^GN_/'U.RZ@V=$%CBI M/NLOXS)*A>-,`H`DW]-O?2>H#)R/UM#\DE*P'7(<=-UP M\@@CB1-820[K'3G'W<5I`6>1[7CE]C2\W@,G7(K,'YD!SI;[Z:7[B0364@Z5 MAQH8(YWPLEX:!6;ZI?M;8]M8NO\T&$9PLSX'Z:_48E'<%;/%T\?E;16_FGW> M',E_/&VB#-JP(.&-$4$N$HL]@/N:5N&;B3%$[\6Y.L9K!,XQBWS^L/I2K->+ MT[GEC<$99)9+&S1I0)6#"'+DZQVCH!F#*?L`^^"0\S$:-H?N>:71HME59VYB MA\.C,LD`)-!#3C24,)R>RK!ZCP3B-#.@OZR-'OB@,W#&N+?;,NK5K2UNB^4L M;^X6?W1LQ@GC6BNLE0<20,`QW#E,)*=KY>,*$W4[_O+YNB.JEU#,X;&6&RK:C]+ MIY.UQ%\'9PXH&H67DI)R0KWDC-8[5N&0&^@.:#*O^/D8);SCS[]3WOIY4#;4 ML_$:6UZ7B_DLFD8?E^MRQZD'WO@39LBDPX"3`(^R&CHF*72HWH[`;FKY'=V^ M__T!-9:^IQ[*S;*I4_CA09D0,8 M$C8CR()M"&N^,'E5/86/MF7U=W&L[65"PR09A)I+I3ESV`$J+%2D!C7FP:0I M"O*2N*,OK!)DQ'51SV7=?YT]3V""@_(@C>>S(R0TA!(G0GR"V.NB/4U M`IHE9O!"<`&T[`:13@B&6A,,92C(&R14;&/IJ`8&.@/JY855)]9*O02773>( MC'`>_Y&'OZ]NK\.G\V^+(G[[>Z#!P^:A_7%\>(X,&B\"7L0I3S34Q%).]Y:F M5XF%#B_81=<95A/AE?RO\WGE>8Y8@P#&:V\M(=9:8Z!I??/!`9&)P=<7Y<;K M":LA>&6G9_BR54NHU::+WY!J8%5VDZ1$61D5&@%DY8;'/1=5M^T<29% M6E\[>$D^OIZ@&HQ1BEGSNH^;!*=,DRD3KS^(@,)HASEV$M0WZ!QSEBB&+L%] M.`!<9_B._MZB\RKBNBICYDIL'^:6ZZ)Z=FX<<2"UG2:+EC%U7"$)I/(""2IJ MYPCWS*659X.7X#D<`*X1-!*W6L\?\O5/0K*]-O+V^,P0B[$)-K$SCDN/@N)> M2U?A>6H_I4OP-O:)T_GW2+ME!%S+VSKK^>D?@9/+*M:S^EI4;S:W2YPI"V:V MQ$HD)Z"9[&81#KB2'BQ??-NICY34RRVBXLG&[;NY$S MF*-AUDQZ;(/$Q,Y!9!1&%*(Z$%LXBA,=59?@=!P>O;12LM<@AY)A3M2XM@$_4(M&E^",[@F4(+>'-=D?75?DXCZ&Y MP6B*T'P(&%XMZX9)GXOUU6W85H/N<,:LF7?14.><`>(8YUAA7_MV!`6)X0OH M$CRCPZ/WBL.Z;[?5]NWY56'C.:&P#VW)7Y9X,[E M^*G(5\5U_K1].I#@VSV-)50=C4CM!XN7]ZEI-\VI/%7F-;[9XH6PZ%6C[5]MM#9X,"@STWFA-)")(` MQ/IJ-6R8^T0S[&1F.RD;M!>V2$\1/0W"2T@,E$B:H#L2`Q@.&BNSFM)Z1UQ- MN2EC'V0[GB&8AM=[X(3A.:"[%-$!&>!L=TQZBJCQ4@F@*0\V'U7.:&'4_@`D M:F*=D\[!MC%%]#08VK^:J^+FM[OR,=C,\_A6DOB/2#[RZF4,'V6?BKM\X8(Y M=%!XO_%4YBF#%BD/(<%`,$R1M+7B%/Y+\Z:?'@DT&>E\/D;=4_9Y*0*>%2OUS!-IB=5G5`OVD[/"/`2$.\@D&,0(*4 M`9#7&W'63ZQ8:;_NE!Z!Z_G>(,&!^H;Z<7#XRZCP=+ZZ]XORQQ$G^7MTO"J+ M"-+*!H82EL<^A5QA&4NB>B<<.>IP?"^.5P%L;.6''66`$V>!%7L;8 M:1B-K\]#J91"EE-KN=`&,T-$O5YG*+@,'/L M.H_1\$'#^IXO#_<;:'@ZP]@BIJ#A2+"8^^>MH_6>O%$3T=S325%V#<$E6=F2 M(Z``5A0["[D41((]2I3PM)(4G:"LWJFE+TFIXU89ZXS>G:(Q!-U?F<;ETBWF#T$UW-H0 M1PE_9&0&A+1*0!VSMRD'Q@B]A]!"-Y&28IU1OELX!GGEBW7T>6S#26?%3#_] M4\W39F%IT^62<\(M\0YQP11@A`&[1YI0A(+ M'TS#0Y=J=_<.X[08ZSD^=!,^VT[_:ZEN_K.95T783G@1UD_7BZ#SJ>7,A4^_/S1GX;>?)"-4 M>@2]U,HPHS2UVN(:`<<3B_0.?61U0N)?K.:>,!R%B_1F%=ZOU:I8;=-W(HB[ M;][*MTN9)M.,:0``HIA"$OX58-\#S;Q-$WZ]'4EC"40-^SMIBAF M*Q\V_^(9LO.XX>7L4*+UD5&9`]&C`)!Q$`>CU0(+3;WLL.JT"/[>ZOH,1.9N M01M%*$0)MG[ZO5C?E[,7+FVRC]I.D3"4""`0H\!*Z5^.,0'38IUZJ^PS MIC#H!L$A^.?C\J:*V:>V>/[[X_*/L-IJ'BL(1/@:^.;8T`Q8QYSTP'D`PE]8 M:EOK_!XSD.;%[:T"T(#\TC%R0YXSOJQ>'Y)7Z_NB>@.B%L=-RYDR*&3`-UB+ MC,:XM8"PE346AL&T"D&]%0@:X=3I!\AI.5RZ(EX MFA;>F[$UJLNO.Q@'D9>O3N1XB1]K?<3&0-\:77S_)>_*FM3(E?5?TKX\:IWC M"-^QK^UW!6ZJ;>YI4QU`^]C__DI`E7L#"E5)#7-F(F8)EX3RRY24F[?W^TOYP^[Y=?DO5N>+& M6:0*H4D1?%2^YHB8G#%+(-9#;#05`"J.!#04H-Z-"5QF-:1_@-R4`[&&(+E? M-\UZ_67V2S?+R*'-UF'Q?;9J]&R;N?`C-:3;KOX5[(Z(UJAY`_`:`4#BOP#A M49.`A,*>%U#G.0AJNPY+"%M-6&M:@Q]N^_6:=CW(R_1\2*`Z;:'4O0%HOJV! MZW>G-`/`1^/W*AR116ZV:1"K*P\V%3M>?'W8'IQ?6G5[N[A;1!UQF&@<'!VL MY<1@8I6&6GGA`;$]S0KJ/$6YMN^QK)1,!5YM]?CSIKWY]ZZ+R]K]:E8WB_7Q M!\Q38T.T)K$'EDC%K"%46^]U1Z]A)J]X16W'8VEE>0KH%A2K/O5:N#>,;'3C3 M(WE9;T/3O$X.G#A`)6S*[XSGLJ?Q;P<)Z)!B!&6VS/DG^'2K`EO%S7M[V]QL M/MRZ7_$P7GYK/J7&0,MM;.ER&RF2`HU^SNY.1'B=,TU(/>LY2[H`5)3&PUTB MWZL"2.<%CQ?SQ]5YDBP(8)5TS5<7NKO3G\$N$J];)3"#$)BHR[0;Q]G M>)Y+IYCS[BT%9QQRCR3FVFNPM3_N5\WW5$GE9Q/W4?OCO[`-!D.$00J8``H) M"P$0WN)HI&&EJ4;R9,Q:(2N^>C4V)943EEHF->3Q+^6UZG!`BM;J3#!A-;;! MG!U1C>T\U&;77(T-<6T8)!YJ`[0S1$4UOXT\C(;K M'J7*>>FX/;PRR!(C#86:6>R[]<9M`Z^C&MM@U`_5]6ZB2HJHHAU-E/M:-5'/+>,SF!5#JK&=!4&5)Y6)JK$) M`AD4R4?GA`?>80Q=1YF3]%*KL>4R=Q(4JCBL"U5CB_:DP@@*`IR`S&N('@%G M1-[Q7+X:6RZ_)T6CBE^F6#4V)"16"'%DG<)`8ZEQKTLJ"O-\,>6KL>5R?EHX MJASIL[MF_:GYV2P?FK_:=IZ*3QP[T%_Y/"@H.$!*.DX@!C321CJJ6/RS"TLM MJ60[CP>JSLY?;S[<;A?X^?4NZP>^#$)K9#U37$LJK7)15^FT$V8%RE/0+J36 M5"[3QV%4@]]_K=KU^N.JO5T[Z$4V[UM\.Q^I5R1H][201,$1Q"0 MDBH#4+P<*8.,@XYR!VF>5G'OR%O.'FBLB4B&6$5W]N[F>[>)5#"5>O M?!7B-<:90U%']802H)EPO>;B?69ER0MY4SV7D>/QJ;2A-ZN'F\TV^M)\GZV^ M'8U;?.WS0*RTT?+1'`!-K2&<^\XSR:+UDI=95RPYHMKV'0M4QJY]]^-^ME@E M4O8_^7>[V?>LW;1/EG0T2C5WJB"9!%&VD:72&(=?N[A?_2YP[!3S#'DD7!1B;Q4W?[18FI=X72SM MH3Q_QR)4XX3OZV3O(E;>1YODR`'_RM*:VQTQH"A*)BHCN:!%>91;VOW&4W'J@J1WU: MU]_MLGUZ-IW>_,<'!F^42S5$A?$42T,8[T-]&*$V4R2NW+LW*68YNOZC'-Q. M/-5R[IO#*OWA$8$81;5!\10SPGG/F*6H6RX%-N^M'5ZIFVY:L.H<^YT2DO+@ MSJ_-/&A\L-A`K;B(9HF`'@-O6.]U0H9DG@-7[J@K`5U]D7DM44TWM^UJ'^C^ M9?:K6?]/M'96D;Q'^V%:P2NZBH"XMYX@(7VZJI7PJG>_<"E19G_D*W5/7CX# MZFV"2-7^VM[733LIL"]&!.4YX@X)(1`U,E(F>]P@I-]0PHQWL#V0&,QLAHRMW\8Z!J)J[ MYY6DU+3<3GP_)G&-7'DBQ;LT@E/^H/R9@P?2Z6@C"V(1M1X&=.7.Y^D` MN[Y0&-M]0`BQ&5@#!GM4$GU;="H:/5 ML^TQY%P!QRV.VXQR,!S`OO/A-L^T':>6*HLE0RUM/$,KT$ MY;/M![-B0+;]>1!<4[8]UX1I0*!0#GN(,,.F1PG$S9!G>ETLC`B,;!9EA"4$OR4*JO*2;\MGVN?R>%(WKSK87A@()E<(B]1776&@!.EH- MS7P'+Y]MG\OY:>&HP7JU7C>;(9U`GWX8B+T*9 M5@XF!*9.+,G/U$!K]?MX.9W'GP5),">4,2$,UBF\/-J=_44(8%X9G6*Q^-.R M=P00-=AIF]LF$CI/82-;N@=MYB.C@J%&6&ZLX\P@*S#@J3S[WBS1*B\+JUA4 M_K3,G@Z7*MZU57,_6\SW@8[Q+MH^]S]!Y)BW[?3H@*#!&#O&I2%$,)'DOZ-9 M0G-AG0ZFE87I\:FGVF\[IMZWZ]G=7ZOVX?[=\N;N81YUDE?CS@;<_=F3!J:L M93Z>F`YRI9FQ#/YQ;H',OMG%XM\GU@QJP9:1RK7_H<3,];GJ0G%PM&GX?7DL%2W_X?:_2$"H`'@W#J6RHH!`EUW MV#D%R86U*"VQE?.0J*,*I)S0S>^/=[-E2HY)%NFV>M-Q+?_8L$"DHY0KPUWJ MGHLD-EAT5*:PKTLTZD;[=R9$I`;?4T7'_RSNCK65[3X)5%E@-6:IAP)D$OA4 M.V"_>L!0WFM;82MN-#\SJ:]4-V&V_+:(=T1O:[A?>^5@`%^'#`],8NN4QT(I MYT047R!]1S55[,(ZWDW$\P+(5#'EAZN)>[K:Y\%S;_1DM//SY6GC[,B((!$&BEO-F"1.8N]IM$+VR_56Y*6"%K;, MLGDW+1C5LJK..--?_3Y@I8D!EG@.(5<80"!8;Y58EJ>O%[;/1F_0*:"H9W*? MM+4#MIX8R[U#Q"KM":*NP\%93"ZLW.&DC^IGTEZ#:^\7LZ^+NUT'[^7\\Z:] M^??W]BYBNMY=#`-B)X9.$3C14#*!I+=.:R65Y*B_4BS.S(>][DB:0N!5%IWA M@3:'!P7$H.+15H&0"L*=-[[W"#M)0)[Z52S48GK&'9:,<4A5D85V^>U+L_IA MFZ^;;F%_^'JW^+:+#3SMCSUKGD`X]181"+'E!D0,H.V/4P]8 MM=:#9TM,-D.?RTA!N&I&ZGR<_4Z:Z_`8G:<#0M1S$1!Q9T%'-%?6"@]ZRAC+ M.SJ*W2P%!&$27*I8ZS_N[]K?3;,OV/T2BF-V^ZFQ01$!K8KF*84`"8N4$+T+ M5.C,][EB#N`":YQ%I2M%,,G> MXPDR^V(5\P67.08F`*::0^"LW7]@1!1H'K6KU,&/8^F!%8#"/6V>.)S']&(N MW`),GP:8RA;#Q/$[(V<.5@J$#78&0TLH41[WJI%W1.3UE2_F^BVA258%<)IP MGKVR\!]7K96,7?QA/R>%IBW<3.DO11.E_F(MQ4).IA*H50D'VY6?Z(*6/[81B&:S6&W]LS8QJ9GO"^.F0*?U M(R0'/4!-,G^@VFL%G/42&F:;GV:!EI>PM0*UJP;OESL6J7B9BX MA]KU>E=\]UNSO!DJ=F?.%*(-KZB@&@"+F<$*6-#="1XB?[D6;QD!*PM?Y6RG M6#5/SP;8.HA,$W>WM_H$!=_NO@V0<.):\`U01 M`H"B6/5.`N?RXNQKF-33GRS30/06'O?A<7BOWX[,*^.PLZE6,B/(@49B`LKFW$9X9MG@O9(1"ZDE<"7)R]LSYH#=$L= MN:K]8IIYOY9FWJ_@PZWY/EM^:];OEI^_SU;-$WC[KPXLL/0IN__U]P-:%+S\ M.$1]`%J#,#20*.I3!PN#->3&:A&OHI,Y*X6I.MEJX,F'(:HUP$,?-Y%42$>" M<#)C]M3$;54I&/-H-X$Q3'AQ'8R@?E:V*\`$S-_MKU2FN5UNJ[Z]WC5@T+C@ M(71,2+B,)OKPF`Q/SZ]4DRVE0^N=(07WN'^A5<(G,K\_TN,(? M[7*KPPZHAOWLVV!2FRR-K%,($40T9T)V]%!&+Z2-P40\>=E+;!0:-;C[9=7, MU@^KW\/X^\K7\0I$%GNDD=-"80.])[:CB3&6=XL7"YV9EL/C\:@2AS"?;_&= MW7V<+>;OEOMPGI/D^&S/33%8O:F/@Z+X12#2F)RTM*:&.;W;_? M+5\^-WQJ[^Y\N_K/;#4_(BMGSA0$5(H`A#7VV$$!#%!LCX6D_-(ZX$SHXRT+ M5)6'X/1DLO[PL%EO9LL4@73,A_O\VP"8,L!P0N(1Z01"R.N>'N?(A?6_*<:M MYR[=D3A=0P"`%4Z`:-$(Q`Q&3&`/._^%!(#GQ947L_6K<7XL4#58_W>SCV]- M@>]'N/[DNP`(M-0F3U6T:4TJR4X[4U:BJ"A=EI%?B^%C,*IF`;ZBQ$2ZF\6W M?;CSS>\OJ]ER/;O9[')OMO]WMROO.?^_AYUR'"G]LD\>,N] M8)O5XF>D,)J!__LPNUO7&# MQ=Q0;R_,5>'.<%2^Q",N:WN1W#:KS6%!&SPVZ&A!*0V1%09(#9U7\7[9D>"$ M-GD7?#$756F)*87;)*S_W-S/=FE,^Y)C?X1UL`@:2R1),R" MCB2G8=[A42S5Z&U$83K\)A&)3BS;VP..^$V;\K&W)U^,>-GGO6$72U9Z&S&J@>S$`O9R/9O6+M9_;L5/S;I9 M_3R81CW)W"'>LD(![B''W%F)16J9N(<`.Y*7+5,N-^JMI:L4L-7\JN_6ZX=F M;A]6T`Y@E/,"4B5]C8>WQ9"H5!'/T0LT_]^ M_0[X0@"^H0!M6ZF/DY\74P1'D&2$"K)[,.^H!29 MCE4KBUY)3B;?KU]`-NF;+%$@"='>G9FD)C%!`N)Y M61KANW?JCPWD^1>M]+N>[6ZEWJ0ZY+M];/:JM?=M@2*%B(%>8VZ1Y1`H^6A' MDLP2W?#=^]/'A_+LZ]9`TG7@92%.-1FM2B8!9W'211*`:ZT$Z_,\5/#=^[=' M1S+#E1`WEG&7.4\;S]0[E09X+^UFMII7R[TZK5O#X`72AC#IJ,>6,P0P@JWO ME;!,)\"[=EH/CMI`E.]D,(/Q9^T"XY+'+A.B&%$D968F3>1/W&V"O.AJ^*Y= MTT.#5N;.5.,KWWRKW[CN\VWVC[NZJN9;'V$]6:<,](6@`0?,&LV5YYX#Z`5I M5*^G"F5NOMZM$_N\\$Y%-'>#^?YR,%^J>S=&];5:_US,JWO=^Z6:US_N)6`W M*WO*;)]/!R$Q<8C2E%\'0^@I:$,N/`$TSR1'[]9G/E'=90!_#B3XD6E6-+VM&V06L. MH49.`>BH9M_]+$=XKGHG=N9U$-LGK"F8,801+)/+Y>LC\P0A]/$LI+ M0-=$DF<6@&G9PNIXCOSZS[/U>G?9TJ8\ M::8Z&E3T5.[WT0BGCEZ%&G7XGQ M'3.:]SP=/,'08BL1\H8[H@QXB)U7!&G`2^7:HV\?N(`?WZX4`]ELA(2P7'5"%%M-`-#`J)/)?3R-9S+SI?INCM"TD) MJ^EY)X\:3/L>#]P+(CB(U@!S3$1L+(0/HQ+8$#==J[D/10?9[H7,1^%]DN3_.G:KNMUA=7]]T]FM)QW^-!:"XA<"S5*8606NG;]4]X*O)*+XYVF-V/ MF)>UEOKC483E:,9TY_C5P\$:XHV5$2)$*+#*(NZ:$1$M)Y9Z;5B&^Z)1@M__ MC%OQW2W5N,D[8H>]?#1(C2@S3J8#\RB>+JYJK!D-AS!O]I[.[=FLL)Z`E*;W MJ"9^_7"`+)4!5()S9P```E'(FQ%!J<1T[:]\<@ZPW`N5C\#WY.RN<])\!FU< MKR[KU:Y*\_?9ZK\OKJZJJ%Y2ES_]H2^^'%?07=H'QVTJ'8D(\<0H**3BIAFW M12BO7,)H5ED?XEYJ[!'@*206/V*?;Y)R^Q:_>D21[WL\:&XTXHI!&0>%XR]M M53,JP7BINBAG4^8#@'(.JH\N\OL;!"8HH=S8E.I7&&21XJU1:XS6TU7L_8@Z MPGHO=#X2_Y-3]%.@_12Z]U=%62_J];=:W:X72TCCC\7A@BAO/!X4AI!+"-FN M0#N1TM!6!2G,B['7L7Q]3[3KP1$I,5._5#_KY<_%ZL=SIT*'&E8'V@5`A8"& M"T@Q9-)P#+!OQHDLGI@_92#FQX`F8_:J]#=?JMOE;+X[+SN5X9/?$2@1CC%- M`6&:&(.$]JAU/2F?5[]JM'C\`>?YF##E,K\+'$^=F2VSF>_ZCL"1I0P#!26+ M5JS4\;]6LSF"\R[@CQ93/S3S(\&4/^>S)_JASB/ME-+80PB!TYX39^A#YZ52 MF4$-H^5Q&7YV#X=-"7W^]VI3S>]B7Q,`1[7XGJ<#U]9"P:PE7F#+HL@"V8Q) M>)SG5QDMMX]S0(DCLG/4#1G(1(N'2R*YK.4IE9 M$GJTC"C#V]S],7D/YY5>"4*4-@([&]C9$$36.>RY1\@4YQ;4#S7@X9GD;IO&25P_.;S\\>GBT[G[<;;8P_IAW M\FB]?#P8)5*I#RRAT(S'$3MB6D'D+C/AV'MR:?6$)(.[^VR;ZB!ASYX)<7,- MA!?[@LYV,ML;DO(D?Y[='#^9>ZM)"CBT@%K!G9+4<(KB:-MML0)PNF>S?:@Z MR'IO=#Z:#$SN?'8*U/=6N]_BSZJ_ZHB"7_Q,2>?FJ0-QOW10$1]I%3BBRB%, MK+'6(X:,>=)M.K73VO[HUV-!D\&HK^_6N^]_K7Y6JU-8[=`R2"<,!,A!BC5Q M$`+VZ*7VGDWL-'909H>')X/=UJE\V!WTUJ,!:*&C%<(]=4`#%RT2`AZ-Q.=,QRT<=%C]V`>)'O38N^K/V/P:`00[4?6Z03`.8XM=W,7-M MM./,46CKC:/^E:$VS[T[VN'GH/07P*N7N;3'R#YL[W9I&B"`PB,@I"6:4$.B;#=(*498 MGM-XM-/0DAA.L]5E5\X.-0DFZ1N')/5$`L)9E*?&3%`4F\SR)^_$*30<,'GV M$P+'U\^7CZ52A)9P;SCB4,1!,LC;M4"#E[7GSW[V.;1QU`>,3)9P-Y;PLQ5; M<.1B#RB%F%BB,(%-1)K"C.1%Z8UW##HX2SW`R&2)/OGB4:Y>/QR@-EQPR;C& M#FA#@97-L:#'/C<'S/OPV0P"2?FCK;@OJM1-?;?:[J'Z6),@C!96:,4T=,YB MQ)AL?%">:U(LQT`.WY\&SNJ7#4MYTG?7XJO--EV'W^5!O7PPF&<_NF=S//22 M$+4[@\3'[35#R`CJ!&ZN\7@G7-XY62$%.[1@#`A4"5'Y:UW/J^IRDRK2I

:S#--\D2CD%;O+QJ#`U0Z M$K]UI,W^6=SAZO:Y_)3?;[#;^9/O[@'"<\IH@E$'$:,.LY\Y[K9UL-@]> M4I)WPZ:0*=%?3$:$*L,V?#ZZ^^(WB_E?L]]/ES>_KO[GKEK-]TG`Z2\)EC$? M=_X.Q.V*59AJ)IKK@-%L`GE'$H5.DO+Y'QVHH=E_5&7UU5_KQ6J^N'W,(WZ* M!.Q]4="21[&&&#)'9+3!/5+M6HAR;TT7.I@:40J&`*N\V?GW:G93K[>+?U67 M=K&9G[3IV-,V"&JBS!.)I$6"2&BT??#94Z"\G]@UOG&-S/[X%+(M?RY2#**O MUQ?;ZVI]K^$^U9O-P>IU!]L%J$2$$"%"'.<48DYE.TX,59X#MM!9UR`6Y6#8 M9&B'?9:*O]O>K2M3K[;13(F#/,%6[/O*(-/UFA2/3BRAB$N*I6@&#(&:V*W` M(35&0=C.M>DP]%VE=5)Y_%"6\)"%J$#0$$4\^%T7%ZFE:2=C9XGC[%0%@E@(KE4ZW77`2+]5E=;.[R^.O4:</7.J,<6@9&0JF'/ODX79B.I?>Q.U3DLYF-Z7N3>9==-">G=7%>O%C ML9HMVQW6FPBNI:LTIKC.5Q>2]G0-@<:Z=R--#O:S`%89"_M3J_:MZ.(W%O<9LU5'@H,H7FW M9N#D/9DCX=-;UB.UM^JJ)`7GQ?+G[LUIJ\VL%[%Y7FR_75TPPY ML9?+N\M[U^N>[[=DO+'@]'MI<(PJJA57UM'X#XR[;H)9"OD%.*41.R:HXPW\ MK5+"_5X8",..>><99@!Y9BQDZF'`4&A0J@#.WFK#)?FLSX#F;*HUBXH6EV*]2QV>TW`KI?"'J,/"-1=.8JOBC(P[ M5X'C*)N1(0_I=',]]2.J6T&6/'0^$O_E><^IPU.8]O)T]TLZ;"5UA#"&E5?> M$2N!8\UXF,69E_W&,O3[DG(TZ?!I<)2AMT_280<<\MX)2+DAU&`I"&K&(V5F M<'KII*CY]/:#(\_Q$@V^^-7#=P-?/A922!.'`@+@C092`L-=TS$M1-[%H](9 M4D_E:0`D,B@Z>R8+QB7WG$D'`'`62.9;E##P>5.R=/F<'*H+H)5W3W2\*CH" M:\.94QI:`3T&U+6R+(3*R\%7NHI.#M6#8U-"T^[?,AXWJ@ZV"T)I2CE,>TZ% MJ`02QY$_C!-PD&=%EZZLDZN!AX2FA`B,4QA1.JVUD-H+[@Q1$F%,VW'*S()I MI\I^M-ZHE9># M?AFSO>71:H%>$FB98=REF?0PNG3,/UU/6A^JNJ;.SD/GH\G`Y+QI4Z"^MW7O M%C^NF_"Z=JMYT*P_T"(8@8PS-H(@A=%>(4]UJ`( MXL`!!5N!)!SFQ9F73[25P^SP\.3,UU_UK@^[1>-)'[KE)NS4.*2BCY(B`H## M2$KJ,37M?H3@/([+I^;*FKUC()1#\\"))X7@A$0TD$6(6D:I`4WP!^)83CI% M1E]*A\.ESVK\7]6Z3K].F:_=&@?*,>-&<"VL(43&%0-L,4)+,+5#Y%.XY(E``K[RSCZQ\LQ!KH5*1 M5@>H@@YKCBAF@D-CO)`L+R=!^63L.43VQ"*#I,^+U2M3O=M6MD/+X(S"$J1^ M8PZHY-%8:##`3F06`"N?9CV'RN'AR5&](Z?1!T8)2P'14@I.F2'.@M;6ES8S MB*M\+O8LO3L\0+T8'J>NE%`"4P=MW,)A2U#$A34A2Y@[DG?(?(9T[?T8'@R@ M3#7:-]4TL1)+`:07400YCO8^:([#H_I7F3=NWHI1A>-PP<0XX(1580`B1W#`OX,%*B@6JWC>+&`CC*5$:^Z,=0RDJ=:`)Y3--/]+ M+!A]*#L88-`+H0S[_VFNVM21AS3X[I_;:K6I9JM#V8%/:A^D@\H1*`$5W@GM M+=7M3(DK89[CK8AV&(#L,:$ZH\GPB,SI5L-CV[A;,IXIZ+GF%!D!++*ME,>_ MSZM5-.H-DA'6@:%A*J44&K6I5I=?KZ-\I_\W]#( M&@Z05I#;UH:VBN5E#AA<0,YH3HR"XQ,)&CL?R,-9TJ+:/,\-\L=AX`YG"&GZ MWK>;NXCA43^2%OZ4%OJNNKRXK=;W,U\EC?"SVFP7NSMFY_Z^VFRJ;?K+3XO9 M]Q0''\GZ]VIYZ>OUU]FRRDO6,LPR%*6DOKFOYW2?!7>9%.O7ZZI*R674Y>4. ME]DRC7-9;])H]._XA]MZ,UO^V[J^N]VT@K8?BT\'4L&&MS#2%>Q`D9DY3`;VTC$;8&<+X`7^D8&9-M8%2 MV4Q:'NOWP-=LJLERQH?KR*6A,AT(&HF4D]P)PIW5##%"?4.7,"PSX^;)TZO3 M1:3)BG+QJ99!79%-RBECZ'91)N^-@5IG%98$,*2$DY!9:1MLL-43SDHT->%Y MN?TI2LC_"^U3C,H+ZY'+7_]'9;6W*SA5)EK/-ML_J\O%++DCJV7<_JU_?_V] M23;>P:P`BDT5PPJTP[5@Q!7G*OD>ZBOQ<3<%C,SRQ?IRF\?6V# MM\!Z)*E&6FDL*90>->,EF-CIVF.#,=E=0GIA]O%E97)FT'1%Y"RBL6)60E1=* M_%/=R9PYT"H0H"QVBACXO^Q=6W/;.++^1Z=POSSB.I6J3.Q*9N>5I9'I1+6. MF*7DS'I__0$D4_8DND(@!5-Y26Q+`(&O/Z+1C>X&@EI0QR40W1RED6E+Q^FG MEZ/:RN3#^X*<.JB6]K:K2$P+D-I)Y;BGEE,$9>=TUP[B)2Z\@]V_?*KI*E1LL4H]B8?R\6[&ETS=#_7>J)NOYM_#U)JVJ?#V0EG]%JQ6,U3>$R4]LHX MBZAQ'4:.)5;'ZBTX=60YQ=0851_-U].YI]G0<^L@P-S,WQW M_Q50E"(:1,6=\%YB:U'GE\`2V+1L@MY*:(V,V-GD4AB?;Y9?ZG8]I3P$?M5A M997UD+-8-]S1Z$53T'3(()-83+VW"F$C8VRZ((:@Z'I@-_3IZBY9G57MO>=V4E M#^H%:R-5KI0B% MR%(BE`34"$01YAN/#$TL)MA;#;J1\?9,:0Q2E>%E=+DV!:E=5I`Y$V^>PTY+ MR[@(;_?&>\BX3_.,]59D[RUP=2!1])N]>4S&X%H8[YO%P@=!;6_R*VUP2,IZ MCI$PPEN!#,*0!^YVT1;"X<.QW&]5#J6D#6+JA6/*0J`!P=!(+S;X,X.&NK&V MF+3!H_EXH;3!T^3U*VWPX8U)A+*)'%BGK<.=.%D3*MZM1(T@:/ MIO)ET@9/$]UU96`9X!&01G!.%/2,*TC-1G1$PC<3YW5Q\F1*Q4H3R"_2OL:H M]`"T:^'J*1R]4-H@89PK+972E@".)31T`QFQHK`R@;T+ZN2TP=/P>]MI@YI[ M#Z1B88Y2>R^(4UWHD-",IYVRCB1M,'4+F!?SMY\*%E8_XAW%PAK&N`>>P2X< M65B)"XZ[SR;)DW/"TC`;/U>*VP:52Y%B4C/.2`7S0%FNN`*"",$5T81L5#%B M)BUL;22I8)D\%&?@_7;3?9"2FE/``%9"`2,,HUWDB*!.DG)54A;IG93WDX;5 M>+E1G`HJCQ)G&\DG'/,N/M3+6%!UFXI)[:I"UABAG0E6)<=:>@CU9H)`^<$X M4-XI_JE'4`.)H+#`*-,L8C#C;TUSM_C4/-SE"8SZL=>**R,=4IIX(2$U%D,F M-Q@YFD;34:1AI9Z4#B>-PAC[6ST//SVL!/$UD")6YU_.OG?7+>0A\(&'5(H) MK52,UU'2&@N#@;1!T!&:=B`YBO2K`?B<5SC]*OV/=;P`9AJ+X,\_FR^3]G.] MV)[#G:?CBL1R+@A[30&U(@(A_>88`I"TE784^5,];PCR"*3O+>@/XWSW]=MD MUG[='L^?K_-*6KCJ*'*G>MZFYA%+8-F`5[9U5 MY[_NL4(`,,XYY2R8GQP9JE@7.RZQ3;SG;A1Y4P,H^#,D<;&BFH%&'`&6&>EB1=.,0=55]E6>FS3 MRO*/(M_J#+87(JV+O1%AJ.[^OIXN;^X3)W[JVW#^$RM*B!24,.N<0V%[QC3; M8*LE2#O6&T4&5]8W87!)O36]$"R'F_OA%$+WN(H`IHRDEC(/&0;.0]>5;902 MZ+22EJ/("BM!$R2*Z?(98Q\F[=I'\RLM;%#.JD!5!BGP0"M&O33EK8L7R\4%K8:?(J M-BWL-JS0CV%OU7ZJV^^S:7T@KFG;URLN+4?08N6"0G&*P?![!P75>JAZYT4& M-!U-DR8[T$/L8Y^'&77X\T`7!R-5=K:IN);Q0F*,O*%8\?`?@L_S"ULI5?!= M'.>):[OLLP$T/B(4%ZY4B/S//B"Z^>_3UZ;]]J69U^[CWK2=+=^LD*:&\6*P0.?C+,(,,#3B-?=S?QC'6N! M!H3T9#%;_&O>_+4(;UC$Y=W\V^,R?-S,I[.'V0JPUQ,]J#/Z>F3EN!060@<( M!@XC`0GV';JC(P9A<'RP#Y%Y7SHES<[FE$#+[(SGM[A?&#]YD=:%DQ M8XCQAA`#A*4>8X[M!GRDAJI4=.1V[O(B_WD;GQ'>01;!**[Z_>Q[??=C>>^# M9#K8MM(2"$?"^QQ#-"1@VA+:S==2F);WUEM@=W%TR@WP!9*91EMTRF@"#?;$ M02\I==Y!)CKD,50\B=HC2>E,-82*%-UUU>^QS!&@G6(::,U)6$(LZ[`Q!/IR M;:+2R).ID$^:0'Z1]C5&Q5D_5\K5LWW5_1>=X@92;Q5V0GO*#9*4D&X*86M5 M6,9L[X(ZN>C4:?@E4.#W5V%&>O+ONMTK]!W?KC@(=IA6@GC+A$'<(:4V;X;" M0[FQ"Q1S'L02!/O')/+HH$1__%K%F"!2QFO4E.<`&<_%AG&(X(-13,,F6PXI MRC.A>INE=A@.%C9E7F&LC?::.="Y6#"6)LT3>GJ&XYCMLC/P?KOE5!B*#CN- ML(`6(Z]B2<5NGEI3^F8,HS3IG517)0VK\7*C=/NC`$I8;-"A)&T/,XXZ/8DQP0.)(F&?^Y)BW94!:)8?ZX<` MYMVR^4:T/FGZH]'U&M"`VOT^'7EL'Q4#0$&)@DYP''FNO=&H MFS_P*JVR]SCJXZ2F0/2$_1#,K/";_/-8]OLZ+Q2E!,"C`S@:$*%M0YT+F2!A4P[ MIAM'U9S^K9P\0AG.1Q/?T'6-'UW/@^#W72F^HT5EN50""6<\TAY3JP'KHJ,$ M.R+!><2%:\Y*M3T7Z1*V!%L_/T/A;_V\LJMJ?AYXJS7%'GI"-F\7\SPM`'(< M!6-Z4N0J;,R5-4#KL)H#C53GOQ(4L;0U M;QPE6E(9EQ/P017H/P.3/S2QBLKC=!FCB`_71CRAE\HYR)E4'I"P_!L%@=.= M0TN$,2;>^@>NF77]P3\$!4]>U7:\7(1P!#$5@,*P0R6.*[M9MR$PB>%85WTR MD@7I"RYCYLMD_KE^-W?SR719W\7/`]RG+V3;^ZDDQY@81"#6$G)JK?9=KD;X MW:;5(H97>3XRA``&(F);3Q:UK=?_O^N,Z?>SR5]A-CM.Z$YI7E$:'4A0ACE[ MB0!PCG7>),D)U6FTN^XSD?RX#[?L[?5'+KI*?VJY;&=_/2ZC)^>/YF/]K6G# M5S^[T&#Y='!)S/",*B8S*D^X,`Y38P.0KCM.D@"1Q,3CJSYUN91P+N:5N6V; M[[,8M^2;-D[[MR#)FWF'>FJMT^-ZK8A5@FJDH54<&V&0DAN,M$B]9?K7BKES%>Z75S_UQ%:/;].1=W#S,/-ZZPE-Y3(1372&+A)-.ZFS&R M)''#>=7'(ME13TY5FBX?)P\/3S=_/2$?\KCK>280]0)9#`7T78TRZ3E+C*&_ZF.)O)`/ MJ3'KF#ORD*(Q=[2L2)@J8P1RZV.,H?9NDZ2%_1:\+79GR M*:S$L_O9=#)?FLGB2_CT0S.//_W13N:+8)3$-K^N4QF2FA0!K"R7UG#-#398 M!"-N=>M.T(B4'32:WJH<2KE.!0@3+&G/@60`!+.*AW\Z_#$D5W>=RM%\O-!U M*J?):U+J=2K74O#0`44EEV'79824CB#7W0?,+6,XT8P_^?4JLK#&T52^3,'# MTT1W7;7CJ`1.0PZ%@I8'HU4Z`#>B0QZ\F;H>%R=/IB)R:0+Y1=K7&`U/UC(* M'I;&U4RGB'T6/'3>>VRITI#$ZT*#K.@I6(]N\D#[2LD/=:*B4EQ0!H[:27>#-7(1*=Z]>]!*<\Y9 M^I,(93S@5#)J/-',>K51Q4XE5K8:R94,F3P49^!]04Z=6=[10.DT,QI`ZRG@ M"&J--E8%I@7?49M%>B?5>4S#:KS<*$X%E4>)LXUD6W]KZ^DZJ6S[&KC#0C[< ML+)44"6(8D):[Y5RSKP,WMK!2KN6=Q)_ZO%2+X`GL$5]C3DR_SN=+8<;5@Q1 M!X%V0:=:0[WG.`#Q/'B._!77UDQA2W;`!XD*FGR;+2O;=$_0I2NWXTEZ+#\W\'Z5F7^HU M[E)\63JOPCQC*5&NI8,<8^.UWKQ]A,JTU*51Y'XF*<=+".7RD6PK^W17C%HW MM+-&T4P?(S+Q/M957NR[^7W3?OU'P:\>'NLF[3Q(9A&3'6_K]M.7R4L"SD"/ MVQ__U]=3;YN'V736JTBW/?;3]$M]]Q@SK;I/NT_BK:W3%>L>'I?UW650Z9WF M\:[AY=,E0SY7CL>;^T_+9OKO]T<$9V[]?D6#J>BA9*+D/?PT6ZG'YI6EG_ZOW71FPOV'E/,9>"[^G#P\UC^:>P?)L*N#:,Q;A2A% MD`H-$)`0BLV;9$%:=%YO#N4^29$)HDNM$.\6B\>35X=UHPH[QRDE&@7@#$6` M6\LV,Z2)U75[<_/VOS(DP3*$X%=C_%A_>VRG\:Z0V[;YW$Z^OBQDZFOS.%_" M/2PXLH=*6LT]UXA30J@D`D*HN[D#GWA->6^>U\QF9"\8#<$/]_7;0_-4UY_J M]OLLNI[7SJGZSC1?8S;RNBSJ9/'%/S1_KPO:Q]_^%;[Q1_.I7BX?:O7WI+W; M9TUF>T;E$"`*!1EY'>$R3F+5X2><3G-0]%88+R_'+H5BK^[XM8=P_6_OCLCM M;^G;=T\*(1V6BE%$!!..6`/!ZGA%,`7,X8KD;\4]:3PVR&`E@5=&<*2B/?<\ M3\U=8EW,(=R31TOH!/?D:6B4ZYZ,Z]C/JO.`?W)GHPI:3\)F&R/H+9?,,NU% M!PO",.U&KPLZ*(\6\X_4R071(+O4K8,]Z++:UZRB!'L@O)``.HU54+9$=[., M1GK!7LL,HCN*#6E.?4+(P.YX<[QK]L'\+>[-&#[2K$8L'2H&"]42[N M:Z4RW="Y$(5=6I]'"DU_``WCH,AY/&DT59!!RRBV4!*J@Y'=S0];.U2TZ^6U M?R:$WL(IE7:`.L_#BR(!!QP3@%$W(X:4*UC1GR^EP\=5:?",0?#E:?(2Y#UF M'[10RCJ(N5=>42BTD\IV<[?"\;+T?V9?02\878`?=\]WFZ_N-%\?KQQ/C2V- M*ZHLH`Q"K`P@$B#D$-TH4:;2=H4#GUAF8L7Y\%R:$*N3UD0^K-I6GA.J./." M(*,94`Y)V,U7`9P6U3#PV64?=$A!YW+JXV,=X0N#?UGA7KZ3JE&.Z;0"3)B@ MI9$`"D(6D%=T8T/%@M!OX:`SKY+I`;8!3IUZ#W_WL_ED/IU-'M[-8UY,W/C% M3!,_F;6K=^WW>A)3>E9_+V08'R9M3(GY?B!/H]\7?C.R]:TT8:ROKD=\'NW= MS?QC/7ULX_*UKC3==K_&W(JC*C%G?4[EC91:`^JM9@@!)"UG6"&./#%:ZX.[ MC'*Q/'1FE^T9E;-$86:]`58JP9BBP?Q98Z@TY6GNF\PG?!=B35,&YL6>(S[? M9773/L='''`A;OMZ91U"D',A)7<<4!AV/**#`@9%6>+9X06(\//5=N=".4P( MY&J8$:'G@2X..IUVMJFLEEX9B1U@'E(@G':TFQ]PNN`:O>>):[OLLP$T/B(4 MYX0L1/YGGR)^>HJ7M'^IYWO/#'_X5N4=]`A#I#`DA`E.C)&;14[1PCR$&>!M MAG#GZKW]>?)PSK_?8>VWO*M"GO' M@,/!=)4`2,>EA*X;M:U7ASU^L M/-1A<%8+R#`TW@N-4332,6TRSGZ(K>E&3^BG5UZYU?)_P)X]T+)2 M@:[*"Z&@,Q@J(W",*EK/%7&2%CO=5$=Q+B)]>F"D):;H6]^>"DB MM7.92.BE"AM10`V!0H6=*-/0>04[#)15NCSMG%VZ/QI%O:,WZ%KT,N;HLEP? MYQRVF(]I7@7CPR-M#4`$:."%PQITLY>I::1]&L]]4:8'M*YSM2ECQ]*/6'M< M9BX0_#=IVZ>@I3_6_\_>M2W'C2/9?YD/Z,']LK'S@&N/(]QMK^6.B=@7!EU% M2S4N%35UL5O[]0N41$JR7"P6>"E*[H=NRS)``N$_^34U6G0'MGYU9X7]"O8T[>1M?6 M]\TR`9C5SCD>UC-D,9-85GJXEIR/=56\Y1[?%=VR-R1&B>6`V!GBGN#L@8),?!/823'JOA^:QQYJTP2A`' M2)!6H#'@K+)'-7,NK4;1Z8E\7IC*W1G(\46C74Z"^L^+]\5OYO@P8N,7EU=8OOL;DEK,P MAH]AIWM;YLU!5^TZ9QHBIC5'#(BPIRFNN$2U,2()&HO9EG6^.W-1#HQ0`LV^ MW*WW`_G?8EW&_TZAN5WG3&%CL<(<8@2QXRK>.*HFX2T=JT3W.6@>!*$$FO=B M=O_NVD)LY+:A1R:A0CC69*1!L;7&@)A8NT("@K&*VIZ#T/Y@26#Q]\6JV$O3 MHP6C'9LM>F8@[$-:>PP8D!HZ&D;NZCU*H327R6#7&GMEM7]X4G;<\&_/1A%- M_>:MMKE7QB@0Q$HF8Z%E8JSAMCZQT2@Q(])@&5/[W6-[A:;+YGI1?"U6I[#: MHF<&(9`48Z@]M(A@&O:.VO/#4.)).'L1S/8/3Q=V]WO"XXVAV;79NF]&E$-( M:J1C+O$@K=RAVH4$$4S3C_G+8KA'@%(XCJ+U@Q7D"+O-O3*L8^5%%>]VE13^)E\-HK-%T8O5C\&8RPDQ;E%ETS``33RE.)L36>*`;J2`P= MK/XTQZ9\6=SVAT\G@G^P-[3\;ANZ9DHCZR`3@&L5UAO*`+&UUI!\11V\,(9[ M`VCDJ/KZQW\NBG5X]]7MVS"59?O@^H8'9`YY9\-.)*0'/J`@%*UE6Y%$T3A= M(WMAAQJ#@#NJ6#U.H/)\"NTCI=L\)Z.4A6\5*&PT5TQ0H4`5P6$,]6JZ1R)] M$WU(C@:$\><5J\F=LKPH:3JC%+U9W>RVFST@\&@T1D.OS%##H1!&``$PY9#3 MVM@R@MK1[FJ<&#;=+W^'I*0S7N>2"90D$ZA*)QXF2,-W!$C8[:'4Q/'J7#-\ M98'I)#S3-/N--$8"FT M0U@@R7&]$UJ/T^[A#69A]`A\V3LX"2S^SZ[8;&?E^OU5OK[.9_OWY\LX@E\: MZ3S:+^-`28:0P`QI20'S'E0>8>.@FMB5C6%X[1NE,59N4ZZV0:.)]4K*L+@% MV/(UO)K MOMXN-O$?\M4\_,&:XU@/M<\898`YPGC8/!$0%/LZ\8YQR$PDD]T`T)?]H].! MR(O=ITWQGUV8V+:,[]\NEDMOE;JY68<6RU;DMGI&1JG!!DMIH)*8(XZ)K@$2 M7J49"\,5=1J4\"$0ZTD(NI#_?`I,:N$Y]A`APR1"ENI:CJ'W::0/5[II--*[ M(I5`=IU/LRXO\Z'8!(6A.<3J2*\LV#G.6@R#0448`E1R1^J%*F"31/!PM94& M(;A?C,9T\9GR^E,8<\3@`#25N73;PNEWPM.R&,N&I,'*<2\%Q,3;"I-X$R?M MH&'XP^FSEI`9'N=IR9Y:K_/PV_T)WX?XT[O/[W;;67E=;.X/^RZO>A'+-B_* M#"!0.^;+G3[$-_[:[+N8/7U/B1MWGFS-`HV-#$V8AQ=I+`'45HFX) M4&F9'P93!J85O1*`'E:CWY39^(/7@.LO4]P_,%"!`.&PUBG,VTOK: M!V.AL&G%BP:[M/N2I*HCU`ER]=MB66RVY:HXL@0]:Y1Y M-33@CI>*'?=B[_FEH"N"*;[,702E_'RQN[E9+HKUIOS\QVKQGUWQ(?_V6U`$ MUT'2#KDR6W3-L#"&*.,(\DAQ3J4"-0P6R;2%8+`[P.<7@0%`/==EGG\MME=_ MK,I/FV+]-6IB=U9&U-)6LP!II;,]@>Y>_;HHMMME<6BQ&?ZE&;'(<4:TI.$/ M:,,.#2NWLD4:I26=&.QZ\S14\LG0D;`,?@CK[GHQVP9C(-]<_:`PP($U\&B_ M#!'FG`M;M'9*2$"XK//I6&)P8EJ_P>Y1GW\%[!O246(YPD@O`@+%*M!SJ$1) M4SQ'F_X9MQX!#J'C0@3306"*:YL48)\6209?N?=_"&C'$*FG"0W>K,+6'SZ, MZ)N[V(;_S>\S$N2737+5_B$9$4`;$[XG2Z&AP4Q%^CY0CR(-A4\3KE?NJ!\, MWPZ:_.^[V;+(UV$9+>*5K@]%/@M,;?[8%/./Y46Y"R-JK]N?]K`L++Z$:"!@ M+`TFN%!$H&J2""1F88.OU`T_&LY]"-/=>#X4P2:9ERM?KO<&RFWY.4&6VCPK M$X+B8-X0814@2G&C+*ZF*!5+/.E^I5[QL6!^)$G__?<'A,/`O]S]\NGO[OL^ M`?K;MV^_7.?+\`^S+^MROOUE5E[_?8]T'0;RL*)&'']XRG'];+)=A`&%9SU>7B_HLX3QO_3U?1P?@U\(6VWRQ/#2*@`])T12*QB&D`G"#4/FZ(<_S,PO9E?% M?+*AOFW_XA&:(.2QBF[1E`%@N!*+A'06-D$G7]DU>_(*4-:UZO M='Y?`F8HK/9K6)SP?/M?4?TOYO_X6UANBH=?ED&/^W/K[IP/__C;IKB\.R1Y M,=?1G<&&2Q$@X"!:,U0Q4@'BC1@KX?Q)5XZ&X+OE??/3X'H%=XF)D)!CKPEW M3F)C'=/5?)'U$R[QUYG!TR\5)V'U^F5D?-E(O&]^/M'H;(2]^9('';TQSOQQ MDTP3`QFUGGFD':.(2PSK`7DVL3HC/0)<]@+(&!_MWBVT+Z5^/_N+.^5B>`IH5Q@BYS68:+`UANB]#KMM.ITU]W4]OL^01M%..Z&=W3U?M(N0TY) M21U`FA'"E##(BVH>#D(^W=V\)WZ>U8[LCL[+97MR^_(42.X>6K?.5_,C-[X> M-$\"\N_KLO=34P/M-S-PR3W M=U!BW.NNF+^[N0]Y/:8) M_B@1&J?,H5UMV+0G9IX:)Q#$S"(MB-<(`E5AXR7`TS4!IB8\W\=WC$K(7T+[ M&*/)63(_J:QV5@3C199UOME&=28/.J@MEF$76M]>W&[B"6%S#LTV?3/B+-'4 M*.B4E<'TX(K7D`$TGBBU+%4T-%'EL/B-L4Q5@1#O@^%2!H5EMB[R36&+NS\; M5J/FCAG&BC'',<`."8^UT-)5,S6(N&E)RJ`'[+TBE;`L_*N(U0Z+N0KRF%\6 MIMQLR\\FOUEL\^6!1`!MNF6*N#!:3(-!JX@@S!)8?R9(\#3?RW!QK$-0/`!. M8W[T;ZYO\OUE[=EL=[U;QD#:NU_%;?=MN6FR!5L_(QC2G%%!G9?><$T!]$;4 M\W>).?N'"U4=8RGH&[0QA::%3&146,@T=<)I!AC").RB-3X.I"7%'"ZD=`S* M3\1DT`#0ANC'1WZ,72Q6KJ[+]7;Q?WL=R?UY$S3XXOLNS7&2`T=K/HRW:G3. ML,UJ#&];Q&@^:YL)1+@6T!E(*,+0K;6)13P=U8(A"D`U/XT3-X*>0RT[L'(PKK(+"C]!$"4$R$KIM.,\!H\( MH(FM`:8ZL0#N6.[>1');1DR>ALW+CX:C1%$0,$0NWH[0@$-#JOE2`\1T':R= M&3PY+"X-J]OJI+#4"9($ MG@:LDF25H908#`U2Q$"C/:N&CJE,2P@[F-]E&#;[1NGEABX;*B#!RAHM@#0X M_*AX-4^I$ZLCC1:ZW(^6W2="TXU42,O6\);]HM"%J"HVMQU53UL';5U+*AP+JKE"3@O!5*T%H$C@[3X72AO&?M0T M<\X;QP`&0;='`@.&E*@&*+A-BR48[,"P.U<]@/"2HX.8)D0X$A1W&FPL+8U$ MNE;@?6*$]V";7W]G0KW",KE#?QC3)W'LPRJ#I+28D'HO!WYJWJ/^23T1@#'I M^W7=+IAGWRY3@$?7AQ1A`DYQ:JQQ]_-`S-&T`[G!-L[^B4Q!X?6%;8F('Z?2 M>`.A9-0:5J&(H)5I:_1@6W+_4M`W0J/NU[OU["KL*&'LL=!03(,W__=NLSV6 MZ+M5_XQSQ(Q!''**N:.&&:JJ>6/-TUP.@U4R&6#W[A&=\\=YG1;.=9KQ??^2 M\ON7?+K]+?]WN3;+?-.8S^[TAV0@Z-!AR6;A#R^D1L$NE3`HY4%)1\[3HY9$ M?Q,[%"9UV@,R(RT!1MM@O3DMP[J"+;F?4/B+3,QKWD_4U)#\E".@-=GHJH:0 M5/UHSD=.A$YX2L:#K@,]!IA0824`"&%1\>*)':O>>:OSH:%DXOLZ"X/!-X8N MT##ZA[&WNGAXXI.RZ`H$RD.%!#*(0BV$K[`PWM'I'D`-PGA[J>H1S9];PB9W MZ/42!:NS4]B4US?+(MA-'XO9U:IW1^Z@'FB?4F5($4`P M<2KJ=3Y@%PLJW\^1").6E_$<5PQ[E8G^$!M#*CZN\WEQG:^_'!>%[YMFL:X+ MYAS$U';(&TJX!]5LD&43.SX@/L3&DXLWJGH7.'I`3GY1!J2'!.GPH5$%D#`'( M5%@`"">5X'ED&,F#1,%J0\Z-!DM\4=W4SV1Q!.E MY$2\SBP=C\+F'N>02I.7`P_+.`1"8Q!+3B&/"5*&T0H1SA,S"IWC+&!P">H' MP0G83N[/^S2N=7#;\9TK]9$9U9@I:8R2&G/!!)<$5NA@#-)VLM[E:\2=;"0D MIRAG/Q$/,\5U= MOLY7VV*DETRB4G8]G'>?EHO+NW/.MVW2+S;URX"6,G M:.R'N)X" M0J?!/H:J-ZE:++$T'\6`".488PK7V-B@AD_Y('!:PM-?498$0OX2VL<83?`L M\:>4U][P_3:HG@'I@ M\.!B?[AQQJ'US$L:3"00!NJ@\[7(2F$G6+VP.]X-Q'5"9:(43F8KG@)SG1ES MJZ^+1+[=7^6I^D7\NMK>_Y=MML6Y.)]>Z?^8@T-Q"R@''T@@I ML"355!@QHV5Q/'[0T)6+!+]HU4\[M]3T1=2HTC"G=?N\4C;IG!]WB>37E"M`3?L M_[F[MNVV<63[+_T!:=PO9YUYP'4ZLWJZ,TEZ>ITG+$:B;4[+9)J2DGB^_H"R M2-MI61>(I&CG(1='@(!=&T!5`57%@5%8>JI%AQ@A$RZ`T8/,=N=T[0VEU\>& MR1SW4R1!#^9P?;>()])/FPJ/RW\6RV6UKHL#1O&>-B&.3A(#HX'HD?#4*N=Q M.V0`[,3N?7N`OAH&F3%6\JY33=_]DFVJXNT_Z`\U#50HJP1U`$@BF*)"R%9; M8H9IE,2#T^,5)W/>]PS8I>AQ/^"#^_VAIM%&HA`+("&@6DI%:%,8>#O;N'/J MZ2H!_0GR"(;T@-EK9\KD%(3I$N0R+]!NR^(J'JS-<+L9'!'$L:]AL`2BJ&U1 M;X1N,LDX8$0W4VS2K,GALBOW)K@=K\AZ0VD4VR'.>76GJW)^D`'??S1H"QJ- MFF`HC7:4X4?+!@H_L:PH@\G\3%P2C(1-9/U^-^#CCP0(,19&,D,`(%XQC*," MO1T0PC)-]1LNN7+?@CH3CS&6X>/KXI^KV;X+LT--`C-88^:C1<.L!@I&H+I- M!C*>5H/B]&P4DU'T>P+J4C0X7+WTV48!289$\XMP0)G1B+K6A\V8-'RZ2OWY M0CN"!6>A]!KY,#G5?4HT&%_\FT/KYR+[5"PBZ/F128K^TB`P@22"7DH.=-Q! MXW:INP.3D,145<-5PNU!1+M2$9V+RV@2/R4CU9.L2L0SK'R$!AC$#$2:`-?. M!R"7=E,_7"W=@>1\!B0)NOA67ZGJ1_K*PU\_YO7M,QKZX88!4J.M5%`[A0G7 MG%K1PL#CV"?FNN\W1F(0B"[E>C/KNL[+E$J>^_*C[GP]48=KUT4")%SPJ>U`;!REIDFAQS!"#L%'_U$$. MGSK(?165OO]8,(Y1QN*@A%`,<6D%I=O!,>/T6`6VGZV;=!ZB56\SGVR8\I/( MG$W^DNXN[X`[_D#+P(7`5DNL'2*(:8*(XAU`S([E>CLZRV^ZA/=%GIT-S.A1 MD$]'?%J\XZZV`0`$G((`(ZVLLH01:-OY*HSM='WRO4GR>(:+^W^GVH$E:7:4:J)M!A`@MO986/2E-`!ZPGTIFGTA,A+O-@% MVBEN'8?(0&RXHDRC=H8:6C==I>)\H1U_PYN&TFODP^04ARG1X.P[P7?9YO:A MNOV" MQV4D?41AE=U-@M(@&D6<8$FY\)'$QJMV=H39"4?AGBNN@](_"Z'7QH/)'=U3 M$?\EQ+[*ZS);O,^_Y-'F_)#77XI9_O;]AR.B:?:V#%XR(`RR0FNIA>#10(7= MH6;-Q"SZ\T7V%P[T"4^"!O?;FP]O?!Y1:S29^2;"_!_K>EG,B]G]^X%]JMQQ MC0-@FAAEN64(`.^IK0_VTJ8W M:28C,,;^[*LZ+ZY+?\.ENX M*6,ZTU/CM!O8@1(@]&).G0]"_Z*['\JSVO'W'PG"<^D(`L889Y&%P*K65<^Q M=A.\+3T+]:I7&*8OOLD8,Q>1VMEJJJF^1)TI+]\M9GLUTK]\+BA"%`#:`N*0 MQZJY]NH>_2BF)A*OGXYHU=_D1_'_KY=%F2^7:O;GNE@6QUS_[6X1F)"*>R8Y M,5%'1DY!U)[-/)(X35\9*/JWW]N_7@"YE+";O];YX>PL!]L&[+$USD>*0X2\ M`QH"TY';RPFG^S];@DVP__DB@0'@" MK9/4:LHD!+(SKQO_5UI]Y.&N`/L#N.H%D`0)?;S)Z^R/:K^S[^F'`L51+1'6 M:X^4![J)-^U4"^G\Q)QZPTCI+$A2M.!LGI>S_-U-5M]FLWR]:K)&-F45WNQ7 MB@\T"YZ[J!<:A1P&!#O%C&F]S!PBD;;B!G/I#2/+GD%*D.Z_UOER-:OJ4\5[ ML%U0CA#(G*=0(]^4H150=1N(XFG&Z6"NO6'DVS=*8^A&[^IJOIZM?JVW]T(' M+*5='P_17`2.&T#O^6*OB'9\,G`LD$(22D&]II9!8SHVHJCU3\ODZ5=0Y^,QQAZZ MC84IKW^NELM->/M557_-ZOD^M>GY1L%1@#@A5CDC&&`6,BRV,Q2:T]%>EQ^N M'-1+P'/OB(PA\SAG4^?S8O5XH.JVN6-H4#VSEZ M@]+,X=[7>>]2[P^2%!?4KB__;54LBO]N7M4_YY0ZT"P@JZ6`5,<#A7JJ$3!- MA!T%,/Y8D<3`TMY=&[VF+.@9DU&?%?]4+8IY=J>NK^O\.EM%@W^QR.J#J_FH M]H%S8;6/4`(FL,5&QXUL"Z:2CJ7%"_;N!NE]70\!SJBD>)_/JG(6^;NA[_:A MUL/_-C,IKJ[R)G:FR!;'T.2T'@-5S@+&!65::HV,8;;32[V5:8^4>T\G-!QQ M!H7K@E0R-UEYG;\M79DU>9*V4OJT MW8=/GD:C(99RI5W.ZCQ;YC:__S-^L<[+B//J'^NZ6&Y?]S_>&&=[4FN=W%5P MCC3/P@S#0`-'K0>@NXM2&*05)!&3I<1(./5#!/?M842F6(5D@QSH!M=U'AF$D[:N1+(\006`U!"KO.5U74N^O5UB2K MKMZ6JSC:XM,BO\_JG4J0([H.C%O(&>4`8ZT@(H9KU@+`#4B,N0,OFRW]`]<# M<[:J]J[!?JP>W8\?2Y>C^PN@23F!&,:$(0R1LT:UYJ#`AB?>'TW7]3DF6D-L M*9N"`*F;QJ9Q8-1QP"!E(O[F/`4$M>Y\`4BBE0NGZ_<<#)H>Y/NV?%?GG[-B MOIGCVW*YRA:+)A?(AVQ?DM;C^PC<,VN@-4QX"^,QJ!^N5J/A;M,NL^"T/:-# M(I02>UW6T9JY+HO_;DR7+>.6<=OY_::8W43F;5/!%,M-Q,[B+BOGMHB-5HN[ MILC+(H\_^+U:+^:?HF&T>2(U7U7O\]O&][N\*:Y^J58?UG%6$;7Y,ZP9=Q"! M&!DUK@@JTQ([RS@0W?V1]"0Q3FJZ3MC)0]P?;S=IQN=?FH1([^*:*DI3E66^ M,ZS'9_&R).[#\A@+*.61CD$3@'$H>[<`(2QQ,?_ MT_7;7A"\"[(HMGV7W8W`IXX.E@.<9UPS,S M_7B3K39'_MNH&LQ6G3?\\%5#6H=!"ZN`A-P;J^*Z=)S*#ADI2&(-MNDZE4>% MZX)$:E?`K^4CV+9&[NDLVM=;:!Z&62HIQEPHYYD"KA6!@)@D5@69KAMZ/*SZ M._O:056/!_4^7S3V\&GGVKZ>@I,@'NH\[K1,08NE4J1;'G&MI%U(H&G[F(?' M:=2W$NY;=EN4&U_X_^59_5L99?#H9\<\DSC015#.<.V-MQ3'E0`1$LAT"J"T M:5YF-%TO\\``3>V44;-9O=[I>3JCM\"H,1XTWG9EK%#*6M!9II`F/NE$T_53 MCX?5&/QY\+T^-Y^X-V;+JLP^+>[>59HNFQ'E6SMLEL&7] M`=7=+5?%;?QS_K[YINKJ_AM_^_PYKW6U+I]SE$]JC$$)RYNJD%H2ZR%&A/E. M)$JEZE?3]J._9`DD+`J;7^5UO9G7YOW!9ORS^YN"CW56+K.-W^.7JIS=5X%^ MAK@G]Q,$%1HQYKVPB&DDH//M#8)T0B>>L--VG`^-TMC/G//BRS,%/?=\.ECO MK&,(01H-4JT]IUV2"XF\2'L#@*;KV.X/B^$6N.EC=6\["1YX0C@C4@L,A+=2 MX&[7DJD1C6C:ON1!(;J42=[<"Q>+8G7W/K^*QY&:_V=]7RW&1Q`?_-^_%ZN; MV+`HK[M$R2<:[NE?%"B(ZJ)1S%!C*='2,]9I`:5KN331]E_)%81S'B'NZ MHI;M[**F]4N^>G['.JV#`+&EF#`3[0YMJ"+"@/8)CL2`)T;B3M^A/`@\(Q/C M\9#WJ:C'-@T`Q.E")ZG3G@BH(.O>M4A&$B_=\71=R@,!X&CAV>H.\9Q%_>?@R;GR?T$`:F2QBG!3"2S MYPATCDJI6>KBGJY3=PR4!B)`?]$KB;T'@"204DM)%$%,4!9WP!:&IAQ+&EFF MZ[V]''87428_[DI@<>3IL:^'P)S2$B*!G)<.:F`-XMWR,3HMTQ:>KM-T6'PN MPHU_9XOU?T4'!FD@Y?-]OEPO MFF#NQFWVW0@?^7+/4$"/_(9@F::`6DPD1D8C+A#OO'+$I=JFTW5N7A:_RWDM M_EY5\Z_%8J$V-\A/E.DCS)[>^@Z\$1*5P%`F#!684M"6?U?&^S1G.GY1OM!1 MD+LW;U;9.4J3LS]N2X^/Q-ODMA3$$I*K#`@GH$FDLL@TJXZ18%( M>^5/7JH3M2^<)F0F;Y,6G&\M;SL*E#M++3!"&2F!]1QVZ5*4!S#M#H:\*!]L M_S!=A##/Y8C8WR`XJSG51"CN'2&20^!E.S-"?&)AX.FZ9GN%XS*"?C9_<\+N M<+"S>+X2[ARR\7?OE042,M6=KU"F64]DNN[8T:`:T*.2Y*\_KK,`."!8"R@4 M5!!@JBWL5HBC+.UQ-9FNFW4TJ(:[T3OO'B]@*J1J,KY:'[=%$UFMVS`5A9%- M+#`U72?J<-A,[+SHYZ`(0G@FL2`.J4TM8Z*Z)*_2.I3F8R73];$.C]'$>+)) M0//I/_EL];%RWSX7]:$0P;/[#M1+3>,O"*2S4E&G2'>4$J`2U=+I^FPOA=S$ MF#88S78A99Q7@G'.A)=*8$E95V@PZOHX49.9KH_W(K`E:#6[3?$'NJ_VL^/4 M+@)54GG&O2+4.1O5=HG:)^%*&)'(@^GZ7@<&Z$(NUKLX^/==N-A]W8M?KQZ' MD.UJ]%LY+Y:KNOBT7N5SE]5E7`7+7Z^V%ET$8UG,BZP^^7WCT*,)2"F-#4'& M`BA`4T)/=JM0,I-V84!?I*MW8EA?[HKAR92V$VEG=O(MP[[.@C3>6@2-=EP8 M+IN\2]VE"W,TL6;*BW(;#P/5.$D>>MCS3E@^EF(#O?32<*>5(0:J3B.U7J3Y M#^CT7WV2+^Q^R/NIJOWL1Y M_[A!Z1$$'V8W^7R]R'^]:E*85F5>1EWQZOX#S?V_JCBF2GX;!9R,\GYZG]FBR:WX=]^6-7K_.&'<87%M>+NPP?_]L,R MO[Y_,C`P@3ZLLM7F*[OYJB9]PN:T^W`_A@/EZH_L(4@%D&8.:`B!4=9!8VT+ M&/4P,3'AR80ZJH)][R2HQL!L#)5B.[H=XSY8Y?Q0TP`M)XH+A(F1!KFX/G4[ M6X0-=M.M>M^[/+_GRS#0O7;"C$^4)U-Z@3RY&#]V:9C/5G8_NFT0(BKSRF`5 M]6X?37@FD6KGJZ)6,!9#CJOUWI_X=O.B-Z!&S9;195`XH(CL;A`L8H(8##EB M7!&/`0:@G1F0)#$7SLO4.WJ!Z#+"/WA:/->D2;ZI$'4;]XQL'GQ!@MK9B?C# MZ:H5YXKKH/3/0NBU\6!RVL)4Q#\%L?^2W>8G[_]MHR"(C2!%G0>GB^XH M-IR%U&OEQ0LX'RY+A_%I\+%)#5L7U?S`T?#DD';>2#H M$I^!O,S3X!QD1I7P_[-W;T=BZY6J4+*YV]UO?^0V!%_9Z9YO5*Z>*?6-X?+:H_)FW-/K-Y]JA[2O-YW MH%]S%$^_W!`6]29EQNAX'&;(8@85=]:JV:S.YS@\*$CB..'*:8:D$5(Y!T:S0,T/*M;"'"ZT#"P:A M]![Y4)PU7A(-KA'_JY=ICOUP&IOQ6%S\6?+RV7#Z%:.#]-YJ2[C1P#(L'#!. M-EK6QO-+60'U,>2QF1JD'K(^_/S),.\JXY9104F!E)`8&F$0\:DU;@.)2F&A M3)'R>60[+C@YMN\C&Y^=S]H;-IP=$[AG1%..K.&$,N\=$JA9GZ#G1JTG!I6`"*,.ZTU1)$%.]\&$WC#-0X:K*!"\ MB+`HB"%R#B`'@/>Z69%"II]N'[W^SSR"OQ*<_#[6="]RO8@ZZZ`(7[CMU#[E MG=Y'83VDEHC1?$D.Y.WFC^6NU=]Y;96:/UVJ.F.+O'K_"E$!.8YJE6C/()8Z M6MN8,L0`T4RW-RR\=I+G7&>O/18`CXOP>&M9 M@]H[2[QP@E@((%(4(W5:'5.@7"?74'%U31_LA]![XT%QSJU2Q#^#7_-^%Q7@ M;J<6_[Z/)DZ72,?K(P)@5G(E'**46`FB[6A0LS8C<6LL,.?=@5&W^G$`F4O8 MZ9_;NCT=L'5L<`R2B)U2A`@G<:J"Y)KU4BQ%N;O_8`EV8,086+U_CA2G&+^GZ_7%2K7=P/_^NB2[QU7'`R*DK**!8"&*!= M:LUYFKHF_9SBTP4\QA/%9CJ4'O0"$GNC&!,>NXDX=R"!C//(2N#6:.Y%N:#+NM1X^5"GK40OXN[ M>WZ]QDHU.^[_;9:7(HAC?,"]4-0*(4]'2(/ZW;S)UWA@,`US M(SCCAGBLB?;B"[++J!)23&U9K:[?^MK>&("A5!%JF%'Q_TS2'2<'!;:@L)25 M.4C1;7L<&>@926CKF_M#][K=/^^KU?)V6=]\VFZ.?WLJNG$]%SN^.$@,5#22 MHQ&NB``NSMZ<)*,,Z1=+FBS$7BXEI\%[1F::;]4ZM>S\4^7NJQHF#W]YT)QC M+ITTS@!%B>`1N9,O@#XU62\C%Z!K*FL%#]CL6C=QTJGWECH)N#8\_+=\&OPA!"JXF=H%>8N><4H/VD+9?J=BD?O@E00`_.!W<,U MW,7?]*_E_MNWS>HFHO68YG>VE5;/MP6$N(?,IK+2R&O*#=8G:`WS_:J0C=XY MJ0!.Y0-Y9@5Z:,JQ^[7>U7$BW_IISY?O"``@@C75'CJE%8T','8Z@%&)^U4[ M'+V54@$DFQK:&:GURR;E;:83T.^K^HCL3]_OJN4V)=FE7-D^!]LN;PU<(4WC MMR>THU(1+035#4;"@'ZMO$;OLE0^_28`NS!"CD/``)WC'A'K%1"2(NH5/'G> M)>UY4V'T=DYODW!7@CLCP1Y+9-S\S_UNG[Z/'KO;CV\(5`KL&/?$&`"EY<*X MTTE<*-'S,M3H/9?*9]9`9&<,EET?^0K<&_;5>Q17>?-F\MKW.5*/I M=0?,S)6VSGB%KJ^YE6G_?_*6/GSH4$OJXKC`N/7>8`,%9M@3*CW`R!MC&98, MVU8+(M]:V^I'G1T3L&(:,`"M8919*XQDNEFCECI7O8^+E:-&DM(YE3<0DV+O MRHU9+8HYC"3@\3_*2"481-`UD!#2UYB^FB9758L:0!X6)XZ M40`SP9PVUD;CW@C*D5'-,JRPV6J!#:XEU%D>/>I$70=2#UE/4R'@#&E`&*&VF30$K)&M\(MF."TX/F3:91,O#'/95''!L=+X^%:>Y*-[N+P@6 M:1(M8@X@XE;9M!:.`<4\LA9AV>_^ZV198"-+>C*<>J\/ M"`Q#AK'U@`AFJ7,8"396.-R(!1<9DQC^KZ'*D`!71,((#C MT@`$QA@$CE`IA%R_..[T"?.CGO#'P2:7__)P-)W6P?='W.TVVV6N7\GALSS] MV.3P?=IN[NKM_N%3W)[VT2QT_[Y?WGU_5J,OYV_^4FV3M_J/6>OXGYU=%]=K M^^"`@8.02Z,Y=0"I^+T2@;QFCIOXX9J9JO@_.KFYB#*:F67 MNS3O^VV]TP_Q?]QM=M7J']O-_5W*#5C=IX3*],QC<*N^>8IM=:J6-O4$`M&$ M>^@%=UI'>]M1`7@C+H5(KI8_5WF3Q^?BJ_&(PK#/8?1>M89.+0)[OC$X*:35 M$C$F.9(0(TU9@PU#0I;KY"Z-/)LY!?(W:9]C5)PG_B_*U<%.PW0VWE:[_<_U MS;*JUC>V7L4#P/;A\\,N65D7_86=Q@9,F#:`>\"8H]YAA^UI"93V3/Z>S&DP MN:`VT^*78YORU7*;;JG6^N%P9=6LJEV;$7AV3(@FC8/$6(E-ZDEH#%*Z69\` M+->5][+LMK'@RDJ'Q_O+/]=5VEYO/JY_K9,S/'X]NMHM=[^M-[_OZNVA@>%/ MZ[O[_5R4BS/AWA&#\S/WK!YJC>^UC`P"2LRC[H*:<2R-5)A!(!N/NMEO\XM\ M,R6\63;!)*[Z0S1%TYW\:OTU7?YJX&PA4^O8@(TR0``C5:JT8XES"ITL(@P+ MRQ$ICDYC`SSKWJ0?OL1)M)P<.HP.0C@HM!4Z?CL.1A5!W6G-*1$W4SI*66>( M\8&;E2QISJW65(?1P4C.F2,(&4J$-1IZ#YLU`X8+[DX[JD2[LF4P523_UVO;GY;1_A-=;?<5ZL/4:=?R'OM/C@H;+&7B%/'N?6<<"I. MQY2X:Q?FZ1Q5AC^VR1L;K%GWD']L-[M>%LIA8"!20(^$9U)@"40J"V/C2B6# MU#)*<^5;#*7%\,R+47'*LF$L%O??[P^W>FU]MZT737'1NU5]D,?Z1GW?;/?+ M_SO\O369Z_5NFZ/\1%`*>H&U!='GF`$#O532I-EZD_(BP&H](BK_JM>?OT6 M*:C^J+?5U]IL=OO-[5$/GNGDT&580-QSQ+43B@HCM,"1BLW$/:+]:I9/EG8_ M@3@G0"E+,9E3F:Z/MQ\VZZ\'#\Z3F>0WV]\N5[_J,CY`)2&37"LNHW7%&5'I MVN'1J\1`/U-CL@*E$W[L4\`U,TV^;'3]F)U0WWR\[4>5E^\(6FEJ,$J-'I&, M1C@6_`E=K_IE^4Q6>W0>N@R";-)K'F?QZ.!9?,\9_E0!PD04AP;$`PDPBP9< M:LA.-:.DO>W>V\_PYT(R"H5P\1\"0FN'?69!],_ROPZG8 M#/_IXRO:NVA&:6,<1@@Z)1@2)Z`\S14#GB:^TID%/>(KUP'W/CSE3DNFI37I MKCLDS&,K7;-F93%[V_&5SA+MX3+OA]Q?@S5O,KXR)UGRD^1#M;YI+R=P>BA$ M;"3&2!M%"'36`4)/Z#@L"LLL&E4F/]82Z`M*EBI/]\M#-X56T;Y\,'BEZ1'$.\@8'*(^//F=O^?:IO*LS;_M/4?]6IS0"#Y MU]H#I)W?$0`3J9BTX9H+##$&'O"G]8-^-S7SNZ1'(,94F.7@S,_5XEL\JFT? MKLHVO3`J,"6!Y-A"R0F0QGO+3^<]XU&_5CCY?=LC\&(\E'(PP6S6NW@0/O16 M_"D%U+YNZUW[AG%I6*"0>&Y)U(:869CN/,E+N;+^2Z?D]V2-P8428WG(6 MA9*.IO*JW#+'J4V])DRS4D)TOU;0L(D MPA8!VZ"G*2RL_^Z$+)L)T5EWJ->;^W49%JS2+F[P7AJFO&4D[LNL6:55!+P1 MDW;"W>EZE.8)GDU>\NO7>A%_9O7PTVZ72L$N%IO[0WFZS_MJ?5-M;V;][2)* M@/U2_^=I:E%0Z_C/Q2&FLONX;?HF/W\B+G09]Z4N\FX8-!`BC1Q MULAHO0%`)&#$M1>Y+0NSMICCH/<&23RFJ2Z"A=[%\ZOA3!VQHD#0?E;\R('( MC(S8S(=ML<'+9SW`_&9[`9*6,.95[PG:(BT@T<8RPP'FT&G?@(<0R%5I_JJ` M9B:Z_&@(3HAK#FLOG<`_WJJ;S5V25JM3XK7'@Q\)F$'`+1.6Q?5SHB7T MH,&!:MPOW7+B2D-O8`!P3<76&88.PC$LGWC7K9884 M?(%Y(KG^Z#&?",'WSYS"M5:YA)DA9-^4NOR\J-?5=KEI456O/A^DL3YNQ5!Q M@I30%E#5;-`L_JG?.6CBPAGSJ*0Q\,O"B^/T?EOO[NK%\G99W[3FYYT=$S"W M.@+%$7$ZY<(BKWFS/J\X+5?5#)37GU+*QT7H_3&A.-51"@'R"_ZW=?48FDNQ MN]_WR=F?BB$?&VY?D/[E@<$ZQ9"DJ8N9%P9C'Q5B6JD@'""D(=IIFJO'4* M-'49'CBT%#&'"52,<*6Y4=)A+B7RV`$W>S.:G%(:*ISK0[*+E#JJUM:^(W]^-D#I MXG$.&$68Q9`([AQLI@B)[Y>"-W%STL%P;\9%)<HM M%8IQ1@4R)A5L.1I:""/?SQV1K6O(=+I^#+1F84'K'GYF1!"0.TGCH5P"K".C M"3.\61OG')>KV0?*JDWR@_!Y7QPH3H.7(?K!6OO%#_OE;E&MXC,X3>&B!F\= M%RCG3$H)F>+:$YENMOEFZIKE*P?039L/%L!F.FRR?\DO?2/7:/<_CPP28ADM M6!]M(`PQ8]@PT:R5>-%/SV>K[)])SP_&+5_6W8MYM^[W9\<$:!#56BCG7=P8 MA8$2-HXVE&JUOA&M/T1RKZ;>C8?5^^-$V59`$53(3P'W_6ZU>:CKSW4JYKI> MM*W*=/R%')64>87X<\1SN_WW]NK]#Q_+A`+4MEC M&('0UB($@(+-.JC.ES7<\2S>1P(_UM\9L/XLQ7/!_N7(M,Y+25P3_%S01#!@A:!$(6X)8]PU_LNH:GFN>W`E M,+$`?&4>B>H\1@)2(T^H8"`ZF=\ M3E:29U*638C;+-&%JP(*NV`TU990XB70`$F,.3^MB+">FF^RNI+Y-%\?=&9, M1W_RJ?Q2[R\_^M[SQIUP""D/D8'.$T^,T!XPI32$D'#=ZNI\+WGCB$GIF.)6 M4.6,XE`:T."`0+:^%,/SQCL+=$#>^'5@%9LW/D[^&(#$$"RL\NG2)_2&`-2` MX:+-E(DYDSF5.PN[4_[8=6B]K=PA2J*-0Z0DEBL*C;48T=.G9VW!F>$#9=4Q MB:@?/N^+`^4YJHL0?<'Y8])9QQ#'BCAG,$22.]-,W1.6[;KRL/RQS@*X*G_L M.FQZB%7?[Z)EL]NI13QH[I87JVQ=?#YH@2P!RJ;RP0)SP!G!IZDBU^]B8!Y7 MT4`QCH5)CHWXX_Y;O7VQ^-;(Q+DA@4EMK-+8":(4IP8"#IO5892M(DEFB8\, MR]"M^'B,-M7N6Y<=^-GC(1YBB(*4"\`T<1I&LH(X5\-I*OP,2@L63G$X&Q&? M'H+\LDE=L%\_()PO`=%Q9.!`,P>51HY!8%C<@K^]2!ZEG8X'E9_RX?^:`?"$0)`!T'4BBA5?Q_ M@MDC&`@`G2N/>V[>S(;HR/0Z\/\XTR9DNM_\7G^N]_M5':?=577T>6_@SFH@ M?-2N_\_>M3:WC2/;OX3WXR.>NZF;C5-)IK;N)Y9BT[;VRE)*DF`9!620FY441+1;QW#(B]YJAE^.0Z?"D1`"PT5U@&B8'`6GOH M3,M@:H*!=381@,X*'1`!Z`=6L1&`PZGY=H^\'_.GK@@X^E[EI/!<&.7"?HIB M@10#N@4'2IKK@K'1(@*=E?]6X!VOU>(V7 M5Y^M)(?<:09%Z)+$3@!`#UUT7!1V"60DO*NT*`Q1U-_J9;V>7W=4U8]/5T0T M>PM#'#$8"<^HI++M)O4^;I"-YBI*J*Q!.$2HZ\/C]:*>K=\]S.Z.N=[?>K0R M1`1[4W#NM558(Z_)H8,2@;A1-9IO9KBB$H`P9%!]#%O5A]EU_;B=7\\6'7+YOFP*.2%FO7(L<<\W&)+]/&RY*0(0Z? M\B(7SU&^Q_4Z//QTV?K\S_K+RH:W+SU\P<-VR")BI(?`[ABL[*[G2`H1]:YY6\CHSW80GUS`OL,2.F\0BVLD$DRPU= M#-15QRSV.'PNBP/%!33*4'W:'*FD!QB(]0X('B8^"`#EW`MSF/^@L267ZXA1 M0*\##/VPR1*&'"4EP4+GA-`">NT@!)AI"ULY@7)G7^0^=HU/B5JY06J++"6. M.6D;_RD*_VG]00Z!S^'NS6'Z.1JMCD/G?+5=W`I>@I(+2$DP7N.PK!&*O#,( M8L_;,Y=`:$-S[<.BXC2=X3V9DM`/A6,L8UYH"E8`!+0QA03+=@:*5S%9(?S1'66=F=@EW]T#JO0`?! MQ!,<,.):>Z.%(?(@FP?D[*IU==95QXA''#Z7Q8'B7&5EJ'[PICY=62*>R3OTPR3%B4Y9UT@9I#:PAV'`GB400 M';"2F!=V&"B5QA/#4E2`VB'J$?3*&6"8\4H9]VP$F\C[UK,7ZHH9PZFQR9^3 MG/*&UF"J,DZ5841XQ`ERD+(#A0'(51&J;-M\,&XY.)+V-DXNC9;"`L:PH)@8 MC;TXC`'/SL52'Z*YSM=RQF%U>9PHVW(O@@J3Y3.8U7([7SZ&GEY]:X[A!/C> M#L)V?K="WAK%`#6(2NNQ\@*K`X+49+LC<.BMK9WU]GK"0S*$V]A$S9KS3-E/";:!YW-&[:X&%L0"$M M5%/1HB<7*B\(808)1KUCC&(GZ%XJ#KSV):=&#]%1!]WWA&:H/V%`F6AH+`QV M4]AC"^7#\H8*M;L1/&_U:K)JJUJ+9#6DN,9.622%:<07" M<04R1BN),_H<,BIZ.2:4_7VVFX#(#X(=F4/>>J5RO+FKU'B'L(!::43"2KF7 MCF(?YT9@Y\*-Q/`,G2F>N;@+?'69"GYZI?)A(]L4J#6<802X"MT_=%A)&)%4 MYO.QUYI"!MQYJX2V6!-,H22MI$`Y=5+2'*G.8RCN9_=U.HR*S7!^2\;0ZQ.9 M%2?>K!17W*NP)`A$I$'*.@E;@)@DN;+D>F56I-%X1QK%`94E0O9VCT^&ST^^ M6XDP[)A'4%D//.&8&]3*RQ1!HMS4BF2:[,Z009A=/E>*2[DHER+%4./#["%R M;6G?K)Q!1#`(<9B(H2>`4F-;69'RN4["%[NV1`(U,2EBYXOG=RLF$4?8<8$H MMI1ZY"5HY34"V[-;6_IKLCM#!F%V^5PYE[6E`(H,=L"^T04"X/\<3?0_^5XE MO/-A'20H]-D8"(QP^YD52T!9MMJ"W7QM"56Q&@^E"<>^>_BV6'VOU_^8;:_O M=SE)+WX?%N/&QWR[^V7_N:%[VQ6BC`%L`VR$2Z41Y[NA%O"3`3T;=WPD-ZLR M^$I&@W1""C9I<)_JZ]7='+K]\8K<7 M^1)ZJ$.G_J^'^SS)9RKI#0EKDO6**>8LXM@+K"&7VGLEZ,E)M2`DG\?#R1HD M2=JOF+68@R82YZ777!I,S1X[IY4MXB;A:YBO?]F7=_,MY_";+6\ M^\=J=?/]5,7?UU^H'(8*`P*\@A1+#PQ"JH5#6)NK-DZ,/R87$7ZNKI8"R!Q& MD`OKU7HY6_S:X9/'9$Z]6E',K#>.>F)\V+82W5PRN9JKY5%J0N MG1_%>6A*HT5^.NREGL%];T]QX-7GJV#:,V/#7V%R]8)**@@Y+.[*%E:6.)V: M5NG!R;A1?F.A?&VA[13^Z==>A2"RBE@<1A2AU%-H%6]Q:K75F+W?FUQV6S#:CU;#/?'.KH MZ]7RYBT"]6VF:BXJH<0XR[3@#"FES&'T02_CJ@B,'36:CCPCXQM!G`^/#62K MV_?SV_K=,JR_L^5UO8MYS:ZW38F4^?+3[.O7^9?UX^:U4T>]VZ@(X]PK0*&A ME%F#-!&V%$!/.PE91BY*-H--H1]U)B3ND0C;-TCGS?UK/M_5[\U?(7JA^Q>08T M6@''A'#8``2D13@@J]FS^??#;*BG9RBKU?!3BN'K>;[6QYTQR< MO`N@-]?#).%:Y]8K;)EE7"L-+5>8$HND.ZSJ6,5MV$<[9U\XZ<:"/3G[S&JQ MJ+?U>M8<66[^]QZO.+:]V5KE&6SR]IN-,3$"$\*A.D!,1=RQR=%._1?.KE0P M)W<,?%RO_E5?;P^_O_JZF-_M.A_E''B[NZWC[.UO/9(HR.QX=ONZ(X9>471IV[/_Y^981V MRF)EM30">8Z=AH@ABPFE0O)IC]P7GA&(%-24..,4=LT^0DG.]M@AAEDN]V+/ MC,!!+!@EU:\?CL6F^I41HS><&$L1%$9#YA%F`/$63`QCP1\"[OOF\G6WK MS/`E8,JIS8!_6@3T5IEF`88 M.\:8E98HX:TZ8.*8B_,1YLP#&;ANC8_9-";O/\.(N`_SJ?JS7L_NZA=>OS\V M]%'/[H:;">1HN_R3>2>%>YF;UHN^0#U6>!/N#T4;! M6@JGL16F11)1FNUVOUC&3L"IDSS/J)#SH+;[Z]LN"/5^M;S[4J\?/M7;Q_7R MJE-2UJB?KCC!EGM.C1..>D\U!;Y%6P*2JZ3>;TW_I"HZCP'1C/2KVY.VB\!-CM468*B;@01<8TV4L8",G44[SQ_DLV MPMAV^YL?K"!'#"O$/0%(*",]PKA%5GM1F#>B8),]%<2ES>"_R#6"H7[T&Y75 M&@ENPIBW6B$%*)+/@]_:N%II9=KH"4@T8%I.J8;B:3RZ#=+CBQ4R5#'+J'0< M0*PX%*3=]81_^L+NC+XDBB=3RH2$KV_^7L\6VWLS6]>-(?5E72]O&L$V479% MQS8KRIEH[O?4QG%-.>+&DST^W,O(S6-&FWE!I& M_K'8SA^"$&_(UHN!)]JJC(66$F*(,10VP4?)VW5)>$KC3GAD7)SS,RXMHM,P MK!D*7^YG.]OW4SV[OJ\WK5AQ-.O28&4)T-KM[M'&DGMCK1UM?;Z]NKY;U\Q&6CZN@&G,_6][5[T8Q]I)]M=)"6&6$PV&#&&QF M:)L(^QYCBFA<\#?C$?%QS<&I<"Z-R^WNZFKYN5[_.;^NU3+L#[?UNM[LG,#- M3FRU;"Z$3D3C[A^LN`OP"2F!4-8XS\(BQ0[(BM-W?4YM6D[`L0&\'TTQI5'> MUET%A8DXW^.+59-SQ:E&7F/OO#*&')9&":6,.S&6T;H]+]*/IYG26/\\O-7U M]>/#X^[&[%=S]HZ>I<[UZ4H*H"D6AEE%F[-:D/LV/U`B:^+&04;+^[S&0085 ME38@GH=^=Y'3+P@]OEUY:JAAF%'NK'+6A@FH30605+BXY+B,%OUY#8D<.IJH MC,%#$T37GY%`^BEJ M3GIU?N>*!AY1J`ARBG"E'??B03^`?H_CQ!H#S1%C""LOA08":70`6YTNN#:U"W@H M:<;';*+DP./[[KCDP&YM5A9SKI6$#A#,K+7*.=SB(ZTO\Z[T;!NX<5"<+`6U MWFY^JM?Z8;6\?ERO=SO"?JFGQ]JJ,,,0(P0$#)L0PQD%TK9X``&*OT8GN=Z[ MI*$F1#2C>?3ZWO25R=\\2?)^/OLZ7P3=UL>V^\,;KQR!SBGH%01.6*D=Y+Y% MS,)(AU3.=,"1.9@=XA))^4*:3E-ADO:K8-%B#`E2T'H!3-`?)"UNV,FX>F8Y MLP<+HV8*E(LT_5*:?)5O[H+3U`AIF`LP8$/;/;OV8=->>IAP@D4Y*:+%,&PW MJ)H,EG5]WXRT/^MWR^O50YUJHW&J_0I@8$78?B'(,&&*-PF;+6X015X=/O%A MYE$W'8D1G8B)S^'RM^3Y4&__UMQ3\GX5S.&-NMW6ZR^SO_KQ,?8K8;UP`G&' MO$=(HF!N&T5;#!75N8)%*>?'=+PYS=I,N)?,W8_K^6J]3QC<90GN[IP?D<;' M/U@!S[67E`(HF]OH)9/RH%W"5?'U!\^!T4E5D(/<'<1J!NA/>!RSR'(#B MZO8XRT?^XK1J-[F7I8M)\MR\K78W_Z=<^$,,@IH3#&&``;X M!#5JCQV7*C(A=Y)N'\_EE.!F*!?28NLS\ZI3G$( M7AY3+B07+C]!+BL7S@%HA"%&$,0#7([8?<&Z8&,TQ7-+][OUUEK?7+A^`/T> MN7"T2325A`GJ!'3$,:_;02>0@'%SRP2Y<+&D&1^S2<-53:68?\X7B_X[\\9K M\6[Y8ZFL(8&M<7I24:(U(5X8SR'BWD&(#ALKKT&-C#576027BLL>.[G-C75KK7?:I%2[#,;IIP."A1?_VMH@A(;8DD4,0D M.B^))!-%U#X;J#.?L7ERDL\="F$Z='PY\G$V.5]>-A"%,?(<<94FT#F/+!*U M,`3+(_)MNJY8W?)G]]&HNX7<=M/FA.E^[9%PP[ M"B&%3CN%#.06FD0:')EBB3XY0^.']NQS;02T3`'AE6`2*XKVV*F4;_9Z//N- M6="/9[\5CG]Y]H\ZH+QW3A/LE9=,60H%];8"$REI+]BSWY1&G7CVV^'\^ORU MP$+!)7!<*A7WA](0SNJ5()5VE^;9;RS/QH[;/`0OCRD7XMD?GB"7Y=EGVD&L M&>"(*FL,@KK&3SO*)E]<2YK^,1OGO*EZ^3VSR#^4BX4O5W_,5C>M#J,F"P8+B*10&2QK.>2^E4M6>FQ.0GI'O(E%@,3)1^Z<2CR MM.=W*XX\O3!8JQ1G2@,OI**&<$+KG5)/)E_O/3!)SL!N)-6F7&Y6\T_;W21# M?9_^]'ZVVLROY]]F;2=DG%@K^(B%2%V$C7%.`0T9W&?V#ABPBGM@+G4+ MYUC%AYOM;#6?+;(2`)Y='=)8`L`4X90#0[F)&N3CB]K$4.A?`437B M]?O9O)U9]?3"(+W3@L?'PR%/.$OCO^K'0QN;%^]B%TN5,[`;2P7>;!Z"9NOS M3*AC"P4/F4'08,<`M`PQ*0&OD``$Y5E3_&)9U"&6([U[MNOXE_7:E%\_S9>[ M^T[1/77]^W:^GC\<9[!E?$(`#0FN,B3*,>"<]X+6S%2JDM(>\M7.]9.?6C0(#Z.B0B3'PD9Q8!X- M[PHA)'!>'LG(;9FZ]Y5W#.-([\"7-M'N+??2"@%%$YH0`[V1S$"F*8&5963B M,_YJ_.;="?GTNZP#($?T2RP^%)OM:OENF6636_@! M`(W#F/&"P!CO:1WFNL`'/PWXMO;,!&Z?4S?WYK;C>/.YD M=K][[5Y^09LE\1C10#LOG'=0&RYV+G%D'(>&_E70=J2"ABI"07QF"!&$0@DE M?DC"B=@QYL507<$Z*&AKS()>"MK:X3C9@K8/Q<,XZ]EJ\-@*?_ MHLGRX^> M?S@(8!G`,&X'2J%4&FD+:]`41=.M4.M#;$>8<19>E\"$X1EPH@)MF@1H(_BO MRW_OI`DDHCM9QC\$4][-;^;%\OWB^F`UT(N?"T8R`0"$RA-"F(S6EQ35K7&4 M&?+L+51P#K9E=S",52HZ?%$[]HYIA!Q1`E$$+7!45[@H:X9R_[\BS6`(G%]? MJ;+4A*(T[BM-J:.&6?^XOV@LJ.FJ##W+LW'-4R:D4KX4@PQ.CSZ)V M;J$T6FKE.*84>PN4J78;@9A\S[S64FM;U-X.H!^CJ-UR[Z1R`'E#F5`$$%X[ MIXPS>0TS1BAJSR5-_YB-<]Y4/O>'KGG?>=Y3K[ZK/XK%7?%+N=Q\::2(F9DP-[=#M$\L)\BYUAKSZH^R.;OL%@U?<.A*Q ML4(!B1"VL+),!"9N\L7.([(L#\*IDBM^?[O05+,E`\`.:.VMAP!A"`%6C^A` M;/(2;$:.2P])L`P0)THQ7V[;I?XU6C%P2*US2(/X%`("."/85M@8E=EV?<#J MZ9$)EH'A5/DUO^OX#996##R:.%$>S$-*A#%>*%3YA$548/->8`.65H_-K_88 M3I!?:1>//;K75]'T*69I(&QWA#OX%0$2&^TR(H`!@$#)W+Y?1D)/P,S^$`/F MJ([(P*Y`'2?]Z\4,R\M/_I+:X4@!22RS4=L1CC&$E$)8.6^1/MG,HI^]/XKE MN)/V5))7JW5"FA?!C'8F=3$A5DOCR1X+"Y0;*BC>03)78ZF6P^$UV:2M^LG7 M][\4L[2_]+5^5?R^30G0)\*S#:X.3"N1#F,O,>4$`>L9W0/E8/QABFE:/5&A M[!N](12:^JY?NN>3(;0&5P?!"&2>:FQTFEOGU".>\0CW$YX2VJE$#[&E<^1^ M#-9,+@0[=;),@R3K#\7U=K6:+V]/!M>:7!XXET09:3'G3D"//(PVXG[7*1UK M6M&.3N78@"-GPC52RZ#[VF@QLTUQ6Z[F1?O$LH.K!*(MYP!`08%#Q%IDC*@P M8(X/%;J8H`;3'XJ#9'H\O].3)]'!:P*0PAGNC%&642(YP+1^50LH['2UEEZD M^'WF1\>X71X_)J>?3)L69V>?__;3QY\^)C_9+_,;,_MV-`/]Q<\&C>-;,]Z4 M`)ICS+!#VCTJ9WYBJD0'4)?=(I(IM+>SU6W11&+__<$`.??><\8%!Q0QD929 MZN8HR.RDW5L&0O?B.@N.#%GM6G$_-/^;+8X*ZX5/!NFXMP9;Y2@WS'CK`:]N MCYO,:8F]A?.[E=;Y>`QBKYLM^3%9#!+M8GS;2#E\5$"3224^HC4:, M9@H``JH]*L1/%F,/&V'O3N;=8Y/QN/X\O_WR?_-B<:/+YHVF>JSU;^+3>H\<51JASX> ME'0*"V_CV+*,E/ENFR2;+W43N MHU(\=5EPS!+A@(<040%A&IE3ZV"4G`YJ#MOUIUMI=@S.8/4%#P'W9M4#3S\; MM0+('01&,6(1QL9#7[]CN)5Y(\IZZTO=_8EY+B*#>K7U??WCS_-B%;_[R_W; MXJY8-(^R'ED@1`.+,TD@-MJFR8'1\*YL<,_CD3.0QCQ!-V4O`(X6$'F^A:SX MV<%U`L?,$Z>A)X8#2RS7Q%\`@Q`(PH`H1DN-HCXRJOR5QO7MOQ.)&'UUB-+V@&9X7E]?B._%IO?EJMBMIC_I[A)HSK7:5;G47KD+12,DP8:30'E!E#` M">?U0^FHFGP9?&\L&03/<=XX[[?Q?)^MB_7'V:)(7=V>##9H]>(YME`PUD9% MS\7#G5DCH+-&[I'P@&&99SQ-<4Y)=^^?#O$R*A; MT@HIK&%>Q&F$L>)#GGS]X3M.!6E\4;\O5O/R9GZ]WZ8IUYO++R%E6&F.E700 M".L,()@+3)$TEDBH+3W%_7[V/DX)J5`VPN$$I%)`Z:T%".VQ$(:15U1"VEBJ M9Y60ML-KLB6D6:TD6SUX35I3$C'D]I8"'4%IHQ/!NW;LU#\/*8,KFX MY6LAR/#$Z+.WK\88&*4A\`@Z8+@4T4S<[U8@-MA4B7/;M#:66MO>ONT`&H(. MOT6\'X:U17OKR>V_^_S;1[?TE$PH[XYE6R83A'OL*$VE41 MEYQF#J`>N5]Q=^3I"KGF)0#VV MPG"M4!J3)TS<<@TW9R:O,XZ\%`IU`MHX.52[7_\YWWQ1U]?;K]O=T.AG[H7U MFZ@57A?K=?-6_=5.>KGI?Q;SVR_Q1M5=L9K=%FJQ(]S#`='P_BXA#TQ(BK") M?%))KX)(I]\8LI@H9.EI9\@EY8%I'Q\UX@G$6"'B@)7"[K&`1M"\,VZ4/+#& M4CTK#ZP=7G_E@1U-8X!(*$@I`\PX+9FD&/@*S-2<\/7G@36F2R=Y8.WP?'W9 M/=Y:RI!CU@+BJ52$:E+M#TND+RT/K+$\&Z?YY"%X>4RYD#RPX0GRXR;^:$$< MQL0PP@3FC&&D:84,Y30OUCI"SEAC"7>3\=,.MD%Z'#S4\YR17]APA:"L-]%H MQ918A*P7+@&]WWLT;O,JU4?([,FE3#\X#<&1'FY7F`W"B0?;[.F=GM10#EX3#/2. M2$,02G@9(A2KGRD(G)RN+MN!S+YG0<O3HD$N<)?%]<_W99W?[LN MM\O-ZC[)'E>_)+'C)V+?_SG\S_L7Y/OXC\%A1H6B.+[T%*5*6F-Y=:_QT!S* MI='PR.\`\_),"/H5UZ]OCXCKU[;!:68,N3<-K7MQ MM89@'%=`WU/#*`&>0<:Y8]@IZYB@-641I7GC1B;5CK<[1V17*`Y20_;\3L^8 M"D6$P`(IC"#37FH$4?S/?G^,#Y6'V^7Q8W)*W+1I,3P=W._; M^>:^Q8"^,VXFY"CN04-D#+,-H&I\V+<3]TL>C M_A0?">.U0A)9J!#'`E9Q9P))7JAAA%%EN<+N`)0A1&UFZR]J>9/^E^AY-UND M_+23(C]V6>#,28ZY-]IJYS#E%*)JEYQE1IE&F'N6*_H.P1&,JPLVM]0!"I*BL\(#6 M3KZY<+]$ZA:](5/$=^ZV/K.[*[_?FWGJ?[K#(^I@_[N=+>:?[^?+6W6]<^Z. MFL=]XLY:Y72W7BM@E;KM"0V@<@X@;Z2"F#'(N:9$^I'Z?#;=QZG\[E;K!"`$ M=TI"%4]OI*D&VI$]%L1`-90KXFA^=X\2+H?#;K*YWH^;CB_0/Y).G]IG?RC6 MQ>JN6%_%FS\126FV0%00@8URX=$P<'(WSE&@"BZD35Z%;\_9W#T1XB#M.@1P M"!7I^(V?=)4WN3QH:)5.9WDT*92'5AJGJET#YM!THRI=B[45:\Y"[T?ASN0B M+J^!,L-3I;Y;7ZYLN?VT^;Q=5._@D[Z?N/SQGQ)P96;JS+U2(E_3_WFENM\'AU8+]AH=/!H;D`AK>3`IWX]%2Y, MLHD%)J;#JV[PG!#/=J'@ZBU_/LW^:[F`F?`8><&)CY"C:.[6F@,G>F0*1O" M7@.J30.%:NO*6=FS)!K?4M[ M_>;CEZ+8_'U5;K_%&_?S9?S;?+:HR_;,[-M.\$TBL.P)9WR/@Y;"F>E&8[L6]"$>]0CCCTNKR05J7Q6;1F31F^7_LW=MW6WC M2/H?]>)^><2U.V?22=;IGCUG7W`4F8EUQA8SDIR.]]51?6GBB@12TC0FQB9^8& MXF^?EO3&:U2=T'>/4-&S]:+KJ'Y'RR"8-])'UQ):937E2FE6R^HU3]N_'[A^ MTEA.30;`1CEI7=U&$/'?-%UO?GC80.J^V/7PMP0I!>=6*X6]82X./@IH,^@0 MH&?AR?1C]_E1[,'1&]7,//2Y"D/OUV:Z\\H.:1XTA$!:*)%D$%'%M#*VEAX" M,KUKI(=2F0'0^GM:FXFZ+UEH'=#,C*\Z]5KO1?$]RE%$Q2KZJTA M46WD1`"D0*A>A]56^[00:K`]U4$5:$#:E-IL]M4.N"`SFN/!X2\(,A! M0C&P,;B`E#],^4RD^3`#US0;-&C*@-(IN._T:%]O$*J;K[&0@DA)'!%:"B8; MFXC)A*N5]2.J@_5>Z+PE_B<7PTR!]F/HWG,S_)<8>%5U%UN+T#Q_+!@MK>&* M8>(EI%13*YN)SAJ0=E'<8/%#7W3+;$B,,2(_%\M%N=JFFW0Z;"^>#10)IH"2 M-D(#+;+0PT8>">'$W/I,S.:"8PQZ_URNJUHWQ64E\P&WA[QX.K@HA*(NNB$: M(T(T`P;7,E'!)Y;,F)GB_H",07+5N7?+]69U6RV,=98.?OYP<,YC["$5B'-0 M!1_*U]LM!O'$V?3X%,/I>-.],1J?]0^SFVYO:E^30*"A"`DC-*4$.PRY4;5T M+LHW77^Z#U6MK/=&YZWIP.1\ZBE0W]NG_N.O\E,9,7!532B_^%%\BC8P]J%* MNWU?SI:MGO9AC8,3R!@O.(`8<.$I!*@V@\8;ZZ?E?_?GHAP8H12:X[\5VYX\ MZD3E.K;SV]XJ4`\`E1HPC%2UFA?GN$;=F843.\Z4E]BLT"0PZLO;U8-J;?]X MU(OV"/F@M@$)A+BP`GH9Y9V5W"(!21NW.2MC;XOL9H+E3[#]'^+55G] M=\S\>ECCP+`"E,NJ9!;S$EOF\#H_2UK<&JZL[S$#-B5`"S1\6RQ>S0;/Z MULKQ`2V#HY098[1`&D5!D%>@#OD-P#RM.@8["X+SPY,RB*MO5YWX7/PHEL\F M_(ZI]H"F`1D7C8VE57$@H(51FC6'?!S5:1G<_"SX'0"?!((?S_"'#=N6%D'' MZ5\CIC!!TD'($0'-I(*)3'.+Q5G0F0^6/G/M:[ITV$2[OV5`7!&MO$&8RNC= M&6$>7`5E45H4*\^"U?SP]#'":?9WCVDA'""I))-(MK'8W#-&51U1P(:A%ECI> M7:O1')P%F*01>QZK3MGAZ>4S+7[^\5=YE#4^H&G@C%,$+%32"Z@54T+IQND3 M,G%1\3P6GP8`:)SLF]ER_6EV5^V-O9(QV)J&T]HR.,^W):.-I%80!A1K#FP9 MJ5*M^%"Z<+*B`'EA3#`*_YRM%M7'+Z)H%\6\6/RH_E9?A_-_VWHD>XS"(4T# MX\`:2!P07@(>QQ2R=21HD:9IQ6J&3_,>2P\&PG&LS+VZ%$R#6T?BWHOG@V'4 M&X,,,]7EB%)9;.L56XMAXD[4\%GX9I$8:&VOC_J<'S@0[EG_^V.J M#.7X3H"$0"`4P-$\F*J4=?P3(@$X=AH9V'D68KI8'ER7J.\W@HGAE$3,5JO/ M*AI9`Y3>84B!]F-5US^L>-&X6K/OF.3(F,_.H-S1H_.H?E7\^[98SN^2Z@$\ M:1V$A-1Y3+A@S##!*:,U5901/-:!R[2$O/'4Y*#"`7V0'?7(]VM]3JI4\ZQU M8%1'R3!AFBLHO.8`T5IF@N6$+Z')RN@!56KR(/?WT)K)I0-.75FFH23KQ@`? M7M&HI7G`!F"MG>-2*)KOSDX/&0LE?]X!I5208NWNB8L%P! M3A4`#GLM,:YG=::`&&MIZ'Q]FGS@GLSV#%Z*#UEHG-*,6D:<=JK:7*EQ<'%( MGX6KDX7H7C7YTF#\^ZK5E'VAZ6O3";4H6X5'JKB3`$AEJ5?`@^A,XEI&3'GB M;O>8;E`&_HZH\'@<7J?2"92D$Z@NW,,`L([',:4%])1&[$PM(_783G0S;'2= M2,/K5#J!DW0"UP4`,(SNOR26:LL!!Q9J5R_""F[34L6'WP`;72?2\!I#)^Y# M@5=V[]67]68UFV]:-*.S;3">66N@=XAKIRFH<@%J>1G44RVU=](-BMRHCJ%% M[Y8_BO7FZ7@Z*!.GO6&`R'.B%18,:*Z00P0VXP5YG5:M83#]R8DN#B/VJKV@7&$.RI!=/!W\ADIP<3R<(93@UP(C9)A\V`ZTV:7PUX0C'44 M1?2@55Y;!:B1OI8<<9Z6@S.\6WK2*680:!/R]^I[B$UY4UW`.+O/WFGKVYYL MON-?%#B)'IWT'AME&$"$456';$;0\:ZY.+`04&;&RA&Q&\/:Z-MU'!7K=13B MRV*YE<&4RTT<,E4F6[E<+R(_3T2[:S$]"6\+47A*N#4&"AQG8&R-$CM,J@`B M+6=XN-IAP^C3>`".$B^7JV+Q;6FB[:TVU"H)*E3639^/\V]27A<`E`!QP*!E M(`XV;RR"-2I8XK3#?\/5*QM6K49`\/2N4;)+%"C`CM-JW8D0!#TS$M>P6DMT MVKK^8#49!M:5K%B-E'T_+('IR+G.E3@<7A9*!Q@'I8C5LAN+]'%'G-$F]Z'BHE^22JM&_A^#0, M_(T3E*G&2B+N)5:$`NZ59VS'&-!"CK7,F);,,[JV).0I'P?PV\@XE=)K5*V_ M(D.9)\`)3VJ9L3?J+))W^C.:D'J:AMS?0VNFG)LS2669AI+DSE/V6'LB-842 M`F(8,"!&+CNI!5<3VQC+RF-*GO)Q<(V4*.3&]H1U6A_L`]E_CPJ6RH;XC1<=)@5\?]H^M"X3]GE>U,*WGL_>\_:;&MUJM8V`7+H MH,/`2$8-==XXTH#)()[875,3HK`>U.X9X6`3@JJ>>" M:%Z%61Y&9[>6S:2Z@V/=*WEJ=S`/J*=2F.K'5=%]?TIGVZ"TC^&[P$P[[P`T M7I`Z,*,<6S-=1ZPW@P=H1`ZLWKZ.3,Z%F9YJ]'8^_ONV6&_FY>K3U6QU,YL7 MMYO%?':]?K><_]+J@'2V"X0(Q)E"R%)"XD]W+U5^SU>4X8=/KWP[84$N918QI'/U`B8$'-=Y"@[0KU,_! M-9[43G,6S=7'0#D7F3P9,C%6< M2X]=],JX,L34NX@4J*G=SOSV=#\S00DN[N%IY6H^7Q4MY9\3WA2B0R/C#SI/1OW%P3U`K]_5K,=^47]W/^3;AMJIEO:=7>]3I MB#<$+*&B<8+0MKJF)@H#!=Z)PSQ(O'UKL"SM::K1<'B/DNF]WJ9Q5Q+];].F<+]I#M59]X?D(B]OU%`C#)&!>28L8@\9]@*P)12#E$D96#+5GE5(5!`#J)M==W MNEC.KVYFJW\=[PL^:1JHB>!A&X$31ADKO;&JEE93/5:MFHDYA'TP.HU&U!T^ MW@EXUC1`!XBA,>KBBD+JXA3E<"VMX5R>E7^82&2GAF3![*UKRCGXC!-1D/$5 MX_/LNEA?5+==WQ:_EN7E^D.QZ?0M]C<*$G)"$2..0NW]V;3=+9F=&K"O28"05?X29@XYR8'"PM4K>$1@G<;_ M>'YE+OXSX3.V!=CYQ-6"[%%&X$6[X!72E"@#,(R.,X;.H-H+(U0G%BX8;$MR M%#O0%Z3#E6%=S'_Y5O[XK\MB4>D!J7ZHZ">/Z(^_"N^+;[-KM]PL-OMJ5;SR M5(AJY(2)41:-83*"3MOH5N]Z[:A-.P@^<.Y^IEBA/QSY2;SOREXW[ODCVQ*) M,8#E0'!O(.("2-L$MHKJZ3GVO5`OL\(P??HFXVV?A+7>RZ_F=C7[/%\MOF_> M+>?MQ^->/AD85(IZ1"&G7%L/.!2F[AY">B*E6]-1+7.*G\#.[_-_%.MUE9FS M^EX><(1Q[_-QZHWN-X^B\OB)JJ@G(:[QP@5*F\2R^ZE9F,H%0LIHFJTN%\O9 M]6_%['ISU7G@8]_CP4J+"7468**@]Q8(U03D2@LW#6\RS[C*@T$"6>JF6"W6 MY>UJ7NAB]:TX>)1U-PQ1?NR5,-P9YR102&C>6`8!)Y):EH7`[&B,N,WTP@9? MN>?%9G:S6);?KXIETX]/[]IG[=9&@3HJ."86":X0\-P*W71:23:QA?P,X)<# M09/`YV^_?/I%S3=7L]6OQ74KB:\\&8B(_J!"E`L,B7;Q?[I9JP02I"5W#K8$ MGY>Y_GBD1*7%YNKNNM*5Q>5L4[B+W\SUK\4RNH'S=7MXVMDP(&XDYUYPPZ0T MFGE/&E<11C6<1N0S#)G9X3G)3ONGZ(W&7\R^%;!E5FUK%KAQR%'&G-+0(2N5 MP;645$M5+K^]7_PH+N\O^M)W#ZW4JIBEG?5YU2[6GR^;S\]> M?/[+L\^_;SG=T_N=04,#G(YFWT?S@Y#BDDJ$HJG0&G-'.A-@!Q-[WW&?7N\+ MVA)'J&<.1+M(+6#4\GMQE26`IRV;93H--"*9Y?A83O8LT>=-G$FK+SVV%1VK M/7O;!"FLY1&'&"SQ:&VM--S7H!@"QIJ8#EKR&8G^YPD`F;`;)1/D7@>?S")= MJP%[VP3!+<,&,N>4(U)P"K#8#4\4?YYP`FD&SIYK06:4WIXV3&YM:$I*T#<' M89N+MKJKN,?U7RK:\2/:=[\.?WY^A=^'?PQ&&VD$85Y`ZR&Q@&!8]U4CEG;M MWV"Q2`;,RYX0C#%6W>].=2;L/3P4K(7.<`*DY1`PX9$RH!$^AE/36B+*1V)O M*!)6ASYNKHJ5V6K/MD)%RWK0:X\&J:AW5'JDB4&V*N/$<.WF6I9X5GNP%:!\ M7&4")"5KX7ZH[_&*GST1F**1J"]5>>3QP19TDVA!B M",7(*29=+97F:+3R#]U$CKMTF!&T,53A0[F<;V\BW]P#T:(&SQ\-PE/E/*78 M6Q#MEO&*-8JM@4Z+[[*'!J=3@9Z`G6C[Z>5.D(]8NI^;8K6<79MRO;F]*59K M?;?;P3UEQ;>=%!?%]W)5U:$@.LJ<2\B-1=Q;A1E%M7S6X@G?T]./KH,31-,`>GN*,)EP?F+\3SI#D>AH M\(S1BFI+F)'80E!WWEDWL8L?,I!P7(;BNW1P*&7Q@I`(/,4KM)]YW&7%)I726J9N&I\^&0"GP$B#-(EA)1$6:>CJ M[C$@TU+>Z!E1UPN/!+K/A*I(CV4"*@T@0(+@JK#2KD,*ZK0U M;'8>!/4`(F4@??VZ6-T4/]K'T).'`E7,2U`MS7@08V@EO'V88I%)"P'X>;#3 M"XK1CY$I21W#`&`AN*`2"6K9@^.:>)I3G`=3_?%(H.O=,G;X9RM/CQ\)DE`, M(0$"58?2M=5,V[I#F*JT75=Y'@3U`**OQX`.=QEVCP8!A%1:(N5TU!QG!".- MA-7EWVDA,C@/JC(@DD#91;'^?_:NK+EM'%O_HRGLRR/6J51UEDDOM^X32[$9 M1W=D*2/)F61^_04DD5$2+11(@J3'_=#EV`2)\YT#X.S8KL,7G^(=4'Z^N9LM M8G+#N\7LIC`1N1N+8GX$/I"Z*$Q?[FZ6Y1 MSM:O'FI1PO,!<3Q'@$$)0(6863J`P0XD-:Y!D[$K](!(IGJJC>K M172S!IAW,=[K=QZ<&%`8[5@PB[0EQ!$BE#T21N=5F@'2\TT'.2.4G<`VC$`T M:65_<`\5\F+P+JX?421V"F>MA;(5YUC<,`7A5# M.$=0>J)HC.(C*BFI\^00'6>1>0M&=0!"FT6EU[/E?<,E=?QL$2\V!5X@)@!U M.(B3H_7NP2`827/U'A94"Q2F4M`'#3`4`"\!U%9`++&L_7C6)Q:G][U9]E39 MT1Z?P8NW+FK[/ZD&S[V$RQ&)%-^577*C"2=2AIT5R:`*<O26/!..-?0/7>!&:^C9JQR M\MSR;[Q!V#J"K<)2*6ZQ.P)2L9'U1N^.?3=GX=P&U)12.J(C)2B'DA,ON.7* M:5Q31AU,,W)'F-*1JHMT`MO40OE^=UF/IX+'?BZ*(VA)+>Z.B?&J&FW9U32F MGX;0-\>?F>V4;C"N.@UU0'Y0A#K1##&K**3DYP6LBQMU!6YP+0 M)3C33>AR'B)$M;18"\.\-53*RF_,86*UU0@3NEJ[)CM`;[PI/@(2%&BQTEMO MB8Y9D;JF`X@1=G;NF#\7GY8^!R2/(/<%<4*JH(@I;)R7D04.M MILBD'9FBG@COU=R3VU!HPZAWGV;A,+DKG[8QN:`AQTX.*ASRD$AG),<6<,BU ML**:M/>)]U)D2N]JQ;HNX!@L>Y*'&08S0"GE#0E4*Z1Y'53'/%>V>WZNM<(A M@5U_7ZP^S!:OR_LH)$UR*,\/*+@WF!'O@BU`8VMIYZVM)@O",9'$M-[:1;5G M6F=03"9-SU%LK$+2WRR^BI?+>]6C^5O MJ\TE@_7$TX6EU&)`@Z&/@:;!@H.BILE;EBMJ-0:>MX6`A<50)*<&`2R4PALS5E#H"TS(3^CZU^UG@ MG2*5L-;_6&UGBQ]ZUZCE_?MR<2299U9\@Y&%P0!B331A#DN@J':R5OV)DFD= MD'MK"=G;NN\>J@1.OWK\/(M-]I9;$\RTAW+S9K4]S&&[^G%R=>K-&=:GO*I@ MEM,`''":*2^`LL;C6I2E3XM`]-9]LC=9R(!=B@E=?I[MDZ+BC3?G^/[34P56 MS$*!`58(*8\]I935)@=4:V-I.UBR'.17#^S]<4,I,(HA@82C7`H# MI("U:IE:(=%;9\M^#^841'+PTI:?U]%S$\D,/R_*'=Q!H3S2)"YPNLGP`G(C M-9=ATX'&$*Z"`%!"BUWE'>!6C^\31;;\OUXIN?+V?+Z*".G_]S.7NZGV_CMX:>P>7BT8P3 MZ9\E03\M8__2/!]Y,UM')>I+.6AY;IR.GFW*>[-ZC(;9;+\AK8-9O@]*?_O^ MR+O9M]UR^?=L??];D^+=UB\O))2:!%.1!&N1$4<]#)M%O-H#82&8NKK)]H3: M]QR=:R1NSM%X0\%ONV\4CAG-H*/&(P^(`]XX?<`P;/4\5TCAC1E@Z_C^1>R;NKGRFTL1)H'Q/-J-;4$,=H173L%*1&_ M+*ITG-O5]-NCIPJ@%"&2:RD$9%XBS!2K:6"4C#?#+H$/ISC9"H=I\G1T>71Y M69F?A:\#G(]/CU>9^,-S!3$*">T@%]@810T,AE=%AV")%9&]Y1,D<6#5'?U9 M^#C[VHR/Q\\5+%ZLQ1P)DBPDCNYLB"LZC",C*VCIA(\MZ,]3MQ(S%.KLW=\B MY!'>RXK3A5$%`1)CABWV2G,+J>>VIM$JDI;2!5JCM$!Y2:JTGN%\<5 M7AB"A:+,(*65U5(#5.]R7LCQ*F"=<*^91+3"ZOG*QN@4N?&)Q`"II&5T'C[L M4I5GBQA^N7\,7-AL]R[#*H>J0=>4&]Y3,,*$8,[%RM"XZWI!CXYJ.[*&NAWQ M])?"F?X0RQX(.Z1<7#?\S@XJ+`+::J6DI\A)IRQ5HCZ6O4I+9>Q-\>Q')CJ# M)X<`5&5DZNY?3_/-O(%.>F9$X8-(6Z\XDYRB(-;06EEY5!$A:=EL^'72UAQL(!%=8/7\ M961TNNGX1*-U*N0_GL+I=K=:_U3,&$[2OUVL4KLZKMCU)>)(A:V32.69%4+4 M4T<@V]T:S52'#EFQZ@^E'&L^IB>\F3U>BP$>/U8XP"BE$`AOJ08>\:!B551@ MC]+\D[>7.$Q,5V@!84Y!N+K3__A@83Q&EF"FD""[7OQ6U;NA-=R-]^A/8\@9 MKK9"8\K\'=VQ/01;6Q_,*MZG_?HHB^RG,^3W[>KNG[/E?3A+PFXT_U)>O=*\ MQ1L+35S,SH1:*DPE!(I)4I$+.):7QM,,P2>$C&Y3MER_O&BD4?GRNPE1Q:[IFG6A@K M"-%5SH=0#-'QJI^)TO%S"&,\H+Z(;#?HCDZCGK"DYI=0]_AYL?I6ECNUX.WG M1NUMSXXID*.2*&N<(9)IK0W\KERJH&J.2Q,?EL6K?D#-%LB=Q\*HW6S_#"S; MO/_]SV:QW'/C"DZMDU0!IPVQ4#/!0*WM:I_8H:*_7D-C$IXN@E<%',S4'3+7,T7.C"B, M4!)80H6CF%,E@')U%$,I-+;&A&,2E6X@'>!(NO4HJI:!"*:S@)8AB+FTS!/F M:X<+TVG>X_Z:)(U)5+H`-(M'J6KV=AJ]\XVV;GM!030C2"KBH"$`4"*"_5%1 M3E&^W-:.1*F_(M=>\$SP6U=!]O#Q#X<[*=R_GN;;;V:U_%*NH^GY;K79'O_Y M8E.VY/<53C,+*04$!C2=TMB#>G?U0J7M0L,IPMV+3DYXLZK#Y?K+_'#4_H+H M'[.ONEP&UFY]X,%M>U8W'R@X,(P+A9CA-@#EK<;N@)S4#*0UPA].Z>YO3QL$ M[U$X-,]A^N8I,NL0W-BHI^VGU7K^G^]=9+KLT7'N6T5L!&4YP!:S`*AS1OC* M$):2)*IWPUD"/3:>&!CZ28BRNK_?R<)LD5.HSW^U`$8`'\!4R)BHP!.CJQH" M:1Q+2W0;SGH9L7AWQH11"_KN?W\%NVZ^?'A7KN>K>]B'9)_X3`&`P0R'(TYH MH#&3W)C*"I64NC3W7G\=:B7[!882:>`@]`)#!>*5G[S>*IP? M6WOBD9N"F=DQZ66P7_A^M3[\*CYW22_).Y%".LH8]=@*A+'"/);Q5IQ03J95 M%O77K_D9+HPN^))CA=C(Z4CN?WC:'6J+V?*`R_KU;'OW*19U'_^]7,>L MW;U`UD6'X0UO*4B@TPD-$1<(:(4QMO4^XJQ,[/O_G"*'_:.:$'E.QF$?\'RU MC"U@=OD>;[>?RO4?GV;+`Q%_#Z\(BVA^L)9WZI.?S=?GMMH!9U-H'K#$B`/A M`:'08.:K1&T)`W_3A/GPYU1JRA7D=@?0J^:+IIA)U08`)"507BT)$0: M8UR=NBD#NQ)S[E^BF@,Q:-*^F>]OV@_Z&:=!W)97YE0`KKG3#%/`&7<6.TMI M;7UQG]@+YCG&3:?"HP0=[)=,Y]U$CGY[-HQTP^B"0T?#;"TACGB#>.`#K(/# M0B?J.,\IKMD?FET(Q<%O,WLH5Q_?KH.N-%M_.YKB24,N[46%$XI9"QC"``%K M@&5U%;>,=3QIHO*<@HE9@)WT<3S$<5N$G=I(1C0'GD16QBO3ZXBLD(G.LI?0 M8'\\2-@9$WS>ZG'UM-R>V2"3WU<81R"E-L8_&464&BZJR*=B/+$3+'Q.`;>< M^!Z)4@]W8D9@=A<4?F^64IM9:K-Y>MQKBWZU_OEGM,L/;@)Z-]3+#M-Y6E"F$@.`>&T(\$XI+7!'/<;:+$`;J;=68]1=[ M6]V&X2B8O*8(!3Z"WTEH,)'*4:04K!(32B8ZR M$3LN4BV'WC!-<'R=FLN[LEPW%I3;7U($91=[A8WW$CH8%A[&M=(;.Q8D",>U(4-Z7VZ?UJURF5-_>S\:BTIOW\S:@>_9^;LJ[OSVLOH1M;QX%F\0?HCR3(WD.ORI^ M*Q]F"QJH]_4T:OND*P MN975E._[J9QU[OS\2"$\TI(KBB"R$$ACB;'5?"UG>GP^Q%:HKSJ%8?SL&XT_ M;1"NM;8IS.K+_'Y>+M\M[BY>F//+"EM4WW5!R&["CRQ'8^28Z5YYBF<&'0.CL M[E2B5HULP&>:3$Q0>S/[98;ZE&.YV4I.:7T.[*)AUB M/D"KK;3>!-6'!YNM!EJB_X:RR<;L;5@V>1ND'?2\.S8%WZ\6"[]:1VK/9!XV M'%TXHBEQ!`&"%0L`08)\I0TCQM-2V<8\/S%$<"/.'@OQIT_7#N3L:3E&R_4W+$@]=ES`)3 M]__WM-GNO44GU8A!YE)`Q8G7DC,FC>1(&\$.->$6.U-7.HY)]2O54L)_V M?O[C;0&#[.<_3J&@))R@Q$"C.:3<,VZ4JM!71*85[W9^A<2T]_-6D$];X`-3 M/I;SH67^EUD4FDF)`,=4*0.=)QYC7/$`\\1\K,XO?IBVV+=%?=J2WSQ%X+)O M9:0S#;L8%58J%#8R!@PUA&!?\5)J-K*,QB'#N)-FW'_+(ASYRBO`_[=W;6?'3)3/;7+RB;M.-8$@5>!"JI M>9DD!(7^^@/1W>AN>(.EYD(JC:W#EJNZO9E#DB4F?>47-CTWYS-J?MH+ M]MO01YZK]L0Y%A'$(*W3PC./D,06$=58/<)G$C++B?)Y+]UA]3^5^%W*VLQW ML@7!TD4=56Z(\:BZ7\4VKDFT_-(NWN^V)DY@9(3 MQ;'CKCIBPY9(%TP0C6Z$UV$J55*MV3'*E5U)H/ZD;#_H9EXE-2FFCL_083I, M(JX0-=YX[C@X[C5E#>A!T,RZHYU7U2=UF#P-V#,0Z%3BU/5@G&-EG;"*<&%8 M7*L4&IL%R;1PR?F.%<](F"1`L]@+N\>8LDD^>QG+T@0)Q#T8IH7TU#$;>*T) M[V"LE@WCY98E.[\YZ^5"5DA&Y8:,$&J(TQ0#"\P)1OD3_@2AX#(I-\R=G&>K M7#Q-?=->/AE6+EKN0]S4?0@DCII M;]IK)]\%>8DFH<5BYP*13@$/`V!/7N`Y,H[2N._GM ME#_,TAU6_WE&,\.QX%)^%:(]SKV0POKHJ1B!'(M.B@ M2_A2>3'MK?D2ZT=9"!8[HA%"@`P0R00T43UGT[HU3#DF._&M>5C]3WO]7E;] M**8&:><"14:22$`)X44H4:=ET$XY%CSQE3N@\L]9/UIEG#XFMOXL(#T:8;7< M8:>5\I&:)!)2&//$2DPH]>S8FOY90%H65@(VV'+&O+6.:V"RP="/=V?/T`6D MK:DR6`'I:4!?6`&I!.84TD@SZC2WVF"N:N&EIT=7ZK0+2%NK_F`!Z6D89F%[ M3J`:CQOK:'7KKJ/*,_!.6%FCRIE24RD@;*8%;PN5R.:LZE=I#:H:EO5_YT&:,*AS&LGL/7=>L<'%D&` MIHH[H(&3`$`()_7DC15I_2OS2P9(-_<'P3&+_>RB2MRP$IAZRR/LH(3C'M&Z MI)N;3&610W,UGS@VI.,RE)FRS9 M.Z&=9]+%I$O(/`=#07)0B!"CJ`&N:P5@IM-"1(/JA6E_\O,K^0+B MC8H?'V6#(90''D2#O@.=%HP?Y+Z]27[R.Z$];:[G6J*E-6)6!LFX!64X04K7 M3CJU1&?2UGFRC.\*^+1)?^DE581@*84'CTF@4C*F&*MU*9%/:_Z;7Z)X#Z>X MDU;41A`'!S@:!`2,A:7UP03FPL5(E)II"UIKS&:[=$U4_[05[ MB255$K!T7A,3U4=DJ%I[/KNUG*=E?^:W4_XP2W=8_><9W?O!2ZJ4($"C'I4& MQ,!X;81K/L'JQ0W+/TNJ>EC"E\J+:6_-EUA2);`!X,@8A;R7@!3ESP#YSRSK'3ZR*/U M>GO_2(<_U]5G_#PSV]5-#/I3VT_K\O^W<1GX+]5:&/&G7O_YK!5^W\[E79NZ MO3U#"BL==0J(U"RZV-IJ)!S1VE,D-4;J:)+I*!(>+:Q[X_%"2.N(5`%KH"`5 MXMC7DH%P;*SJI<,U3^[*K>;^=7L;KU+UIDM MHB5[%6BW1L*HZ60 M2F)"O"<*`R%4$&V0$MQ2+-+"*&-QI@<[KK^\]_ MS&\6\\_Q$[?8Z*NK:IKSQ1$4 M?A**2NG.VG=G6"TM1T$LV]C#[U6<_DBTH7FF""+:7\XK",A9+)PCCC1"F]%" M3ZWB"\-I]'6%?B(\H[1OJ.9VO&G#\U.%P\HH9Y4*A"M#O#$1AB<9')TF0G'*:IT^PB`N.J'U7B-\\5FCI#&<'*@D&4>^&)KN70 MFHZFQG:F>9(&EOW)/XH>9W^WT^/+YPJ0/+HD2'$>&-8,(:-M+0>*],[+Q>I% MCQWD'T./T=6+%L7F:Q4#VNC%+CGAX3%[H<5I3(O1!?7QOZJY%! MR;0+7@:S#'O5S;)'8,90\;LJEGR[O+O^]?YAM?SRV$_PJ+X/C"HL?-7[-5U2NR_E]7?BGOECLX['+=@A>M MWU%H1H@EE%:-I0*E1%'[+#_HM/Y=@Q4L#8HI9RS*5UVF(15&M8Q"BDR:_(S!B_Y0&H,)H4*]?#?_4J5%;Z*//H^> MF%ZORZH[[6^S?RU7]FZV7A]Q74]X2T$H1T)'((R2CAIK%*J=?V8!I9T,G_X% MR>ZM6HN?^*;""69EW)!E,(P%82T+S2(51ME\7=Q!--Z>53VB M^6,S+#MW>(K$ZISF]%1V5%Y_+*]N%\N[YY\O'!5"2`/.5*T5.)-< M-)!@RS)+7!M,$"!"U M?(3EYA(/S86^\1J##Q]7L^OR?K;Z]W$:O'ZT0-0*9JSDE%H7L/':->SF8-*T M/YBK.Y;V.\(TAM+M=KU9WI>KW\N[7?GG^G;^<%S_!T85BC'A"5>!,P+QFX'^-7ZYVQQ?5=]O1;7D M'+[;LX_O%*SF:KA/_+*]O2E>NYE]F50'1H4_0Z2\KB"1!`Y94 M8!8_R$(ASVI$D*!I_LP@-Q",1JC!43QK(L"?Z_+S]N[=_/.AC@`M1A>!4QD( M0MY3JYVE1@O][-W)M/NU!NG;/QIS^H?MO,&S5EQI,[R@F&NL&3-!>4VE5-C2 M6FJI?5K6R"`M[\?;M_K'+8/:KVQJP`;OIO/"T%C_WWQS&S>+Z.Q\F*UVQ[OW M#[/%U_/^^O_.5JO=_G3.9CL[YZ_JR14_BR_F_*Y%TYUC0PLK7-#2&AU=4QHP MTX11:K"T2C(,_.A'92!'LFDPM4>`M?GZS;^TOO;^A/<5(@".WKIF)F)!6?25 M,'K"AGH$6;3OZ4_!>R^P'PZR?&OM6HE\K!BO]4L*9JGU(2!A6!"<88FHJF&S MQ*3U,AWMFOM!"/+=Y;H#@3E*'=B+*1X]/?W^X<(;L(:P`,)HB8T`05PM4?#@ M\CV"'T)M!YC1":]+8$)V1^5Y$J"'P_`O\^MYN?AP=W7D$/S5G&]ZX?^ M>,"Q>N@#J'>YW&$/2`G^H1G M#!K\NKA:WI=5#_]=)*NE?7E@5(&>B7FGFN!6$::N<:>3$/&-;LQ?MM6-$)ZPNEQO9V9WY4>(, M*9:/)R!NOJ[.1N:+;7G]/GZ!'Y-#CQX/1]BU`=V")2>\ MIX@&%752.(T"($L)5JXQMJ0.:0'-P6S1H?@R'&*C'$N:@U7^1J1 M"7HXT)TR#8=IZC0[XV]<58ZOPK1&HYARX-B%H`$1J/J>2/,LA\XL.)BD@8.- M1D^3?Q0])C4:):`#ED9;`"&#EU*#;(S)D-C;991&H\EZ["#_V)D:+\R$M)RO MQTX`SA@M+=%`K/848V3JTQ$6+$OKZW1Z_G;.9E-OZ)V1(2>E]7PWKA`\[FD@ ML1;!Q$W.JZ`;.0%HSEW=^]!>.T9TPNIRN9&?T98=)3IG?OU1/LP>`T%-;X:_ MYIO;.L/I8#98J[&%4L8IZ1RF-`*CE"?&-Z=7/+'.9Y0,L0[J6`Z+4H*B/\[^ M_FVVV92K=3.-@\K=^WRAL.)6.C"$.$^5`BL:(Q6GW@8PG''7NT+[0F:<#_>7 M\<441B0!$/0CE)!+/.AD:^Z\'X22_E=YUJ2O@`ZX\[] MX>FJN?4K(;Z>OIGO?57!"!/<*B2$4T!!4XG)$QH1$]("QXR:75P+H:>!^4Q^.Q. MW!+??+ZP2A,>,8Z".>25<,(VIV;O\P6S&#&.F*):<^'!Q[VWGBI1B7?7B\DHLT]P$O3HUYOY M?251]>-_/E3MO78=1../+S^[:L>9?]H>T&OK\862V#MP5-`H$=;<,XUK4;#A M:5%K.2D]#P76D'K7U__:KC>5J_UA]G5W4T^YN+JMFDIV9<3^-Q?1V':46XXL M,=@;'*ALMC!%5%J@0UTF5WJ#<4@6A?DBVK&O9]J506^_M0`3Q76<1;$YMH** MB'\MMH:0%O>$RV1/+Q"F!46;&%[\_X_QT75UC<_^F.B;CQ?:.86Y<9ASKA$3 M6NAF@[3)MYBC22F[)W#&2T"/DWQR8>.W*BK@D!NP9T2T<*6V7D5R7DBT'WPZKF![6R5RS!?O_UJ4JZJU\(=R=17_?G;S5C.E$T87 MX$@T?D"`5P:002R0.JX;B4T23RJG$\H<#JM.)UF_E]46F%CM_H0?B/_ZD>_31; ME_$/_P502P,$%`````@`+HEX1S_"*.H(#0(`9^0<`!0`'`!M;FLM,C`Q-3`Y M,C5?;&%B+GAM;%54"0`#%^!45A?@5%9U>`L``00E#@``!#D!``#476MOW#B6 M_;[`_@=NYDLW8,>BWFITST`2Q46`I!,DZ9E9-!8%N8I.A)0EKR0G]K]?4BJI MRG8]^%2I,8.QQU71/?=<\>CRDKSZ]1\/MVOPG=1-496_O8*OK5>`E,MJ591? M?GOUQZ?+^%/ZYLVK?_S]/__CU_^ZO/QW\O$M0-7R_I:4+4AKDK=D!7X4[5?P MKQ5IOH&;NKH%_ZKJ;\7W_/)R\Z]`_]NZ*+_]PO[G.F\(>&B*7YKE5W*;OZV6 M>=N9_]JV=[]<7?WX\>/UPW6]?EW57ZYLRW*NQG]U\!OL_UT.7[MD?[J$]J4# M7S\TJU>`.EDVG6T.(\/7'UY\_X?3?1M&4735?3I^M2GV?9%>%E[]^]W;3YV? MET79M'FY)*\H&P#T?-35FGPD-X#]_./CFX/PHBOVC:N2?&&4?R!U4:T^M7G= MOLVOR9KBZ*[VM28W^R^QKNLG5V`418PBZ#.*_G;BPNWC'?GM55/'U^0=V`/],13/1"?GE)W:#[FRTK5R;NX>>7U0U> M+V:S-T?5YFO--\>+2QX&O69?>TM_VWR37?Z(#'?6-^*Z#ZY M-BA6O[VBORWNF\LO>7ZW2*O;VZ)ESZ@F+E=I5;;T<48?:P5I4-$LUU5S7Y/X MNFGK?-DNG,2-8XAB-_"2++0=.W03V[>10W_$-K87G9$%*2__^#1@ZOYDTN@K M$;)>QJ$F375?+_MG&47+GN:]`W_?P0GR<@6>(`5;J.#/`>S__GJU=?HI_=5R MWQW58;S)F^L.Z(8@"AAZ5V3=-L-?+ME?+BVX>4S_38K)YQ&IEH8CTA.\9DE+ M50]W^I/[,:Z7H*I7I*8)U?"O\GIY(I2;;UPM*YHBW+673Z+*\JI)G*NFN*E[ M"JG#>^F3&\Z?J4`DE*!O"Q\AST5A%D,')I>RA`04*/;AHQR>;GD'-;UID M5+<'GK^R0_OP()Z$=(TB:H9O4RK*T((.[BQU="1354C%H_)74E()[V2D5)9$ M;BU]4WZG"*KZDYL^2YT;2OD'+Q2US8W1$8$3CC83[T$BR09VHP:3B\&G*"Z`0-2\<1"'\5\JG06 M=L64:A^Q5+4V,&D*P8""\R42O!0>437M49B)TNGWJS)\^W(JXFWYC:8LY8J4 M#6'92E.MBU7.E4/UJF&L[A^='4A>M33"NVB*.2WEL@\K.;8-IY8GJ>/* M+O4%8'8)ID;7#N:8NND[J98K4BS>DB_Y.BO;HGV,'XIF$7F.Y>#`I4FKX_F9 M`P.,!Q-^G+H\:BAS7<-JU\$!/1Z:>5!$O-(F1=)QZ3+-CY@T"5%S1(<:LGS] MI?I^1;UC$N2R7YCRN#O*L\?S/J5^>PB,_/[JJ+K-BW(!HSB. M;11X"`5ADCI^ZH;#];/4LWB'O=!%#8_YX9;NT8B,=S%J3@]V8ZR(C71N0C2, M\EV7#PQQ*59F,+[E<%>*MX/@#.A#SLI4:75[EY>/[\CM-:D7CH-L/X9I8(=^ M"K,4H\P;3.$T%EJ#<18HQOCF*:;+$9*!' M`S9PP)\]H*DG'WLX.3+)4&%P)I,))14:"GE_KHI5D5>/[YIFGM2;ZQ% M@6W%EA-[3H9@$(5N9(VRY;E!(%0UD3,QI9R\*>D5RJX:2I/E?H)&P*?7\6O1 M"HDDG9S%$/-,"JZNC8!`C^A<GZORO^^ MS^N<+;R-E@O2;*RFH>V[:918MIW!S,7("OS!*O*@+2)!BJ8,2]'[]BL=.;NX M!%5'E4D^]9F01#$5HL`N1V1/>#R7'!VGZH@L:>)X)O*DRYO*R(THO%5Z7/2J MRFQ=W!9]PC"8M<((Q2%,:&YF>8&5IF$RJB2"F="V)55;IDLO.XB$]SXKLLBG M55,2*+Q4M$5V`7:QG4NM3I!U1*YTT3P3O=+FSHO]R3II$E&L@RM.:7[7(7A; ME.0-_5NSB)'MVDF,L@2'*$#0"8)Q]2G,W%10OS1:GFRI_/2V%G&UTQD!;NT[ M$_DZ%\TOP(`5_,G0@@[N&:21G\OC0FD@)O.131/.O1118Q3RSUE)F^;-UP]U M];U8D57R^`<%]*9\?T?J3C3B95M\+UJ:C(Y[H"+LNP%RLRSS0S<.7=>':%P! M<%UG\9W4UQ7W3%8_`)$1OHN5?Z!3P`"OJQ\-P*R)Q0@6;-'^(CKE-1`(SFGP M>2,@.#4F+>CH'^""ZT?P$T,,BO+GO9$XWVD><6:/S:3-A6DFLFO2P^?[@=%N-O1B6I4AWQTQ)A,RX5+MV0;CY-Q^;X`6Q_`UHG92OD^QK7(NE(H M_W(2K^:MM-QK(%E5^MG9K>;`0RAQ@]!V791X?DJ?.ID=6<-#"+/JL!:Y5P$P M>>X]@M6?>RL%0DG(IXJ`5O'>%XG9Y=Y'F!47:1UAFKL>^LG"]"-L01TF<^FF<>"A!SH`@ M"YQDL=NJVJ-.^QC%BQ?]0L5'LHI] M";$\U-KTR+CNX#1%O];#QF]1MO3SXGK-9K,ES:*JF[Y,D6^`J^JI4DPD%=5X M'+1IZA9IW]V)LM^EL?%)]J=1U2-,BNBJCH#,55FU^'9*6_41R-4QI=NCO>SW MQ+^M\DT"W&FYYX1!Z(1I[&(_SMS(";-MP2'D.]ZF:,+P'H5=9(!!`UML`BU/ M5#@\KGL3TB>F<#-@CK\KS$0,RK5_D6.2I\?+8;?W"+HFGF;0M46'%Y76FT=` MCFEFO21DU;"JXO;<`"I8D:)<-8O,8EMP+3O-H(-0@"P$T\$DM>CS:K*J'8FU7UJSQRNX6#"A*T(R14:U&2/,L68DP2K"V*D2/$O0P=S+- MJ7@A3J"C^[(F>4,0Z7^^*3]2DW6QI-K!RAT+ M"V5^%F$KPU1:L.5$"1IV&6/'MVR)`JZRS6F*MEM076E64`/5B>73OFG(E*Q+ M])#`3P.XG]EC98?7]"BOAOKI'^?KB,AIHWHFXJ;/GQ<]][42)9S?X:K>S3"[ MP^=[-A,L8!@EGA_$CN_9D4=%U4'1`"/U8:BP.*4+PC12U\&33/*TD2V6ZTU* ML%K*=U/5X*=QGLK&X<^@;XBP;X/4F9(_3CXY4X@;`X@ MT/\.@U[WF0-MP>&3XAG%14R9);:MSOK,`2?C6K:S*H5R)E(^E;?2VUPUD*PJ M])LCR/L/OB6^#<,DB]*0_HAH-H^'9@XXL@-?RYD#%0`BTJ'ES,$(5O^9`Z5` M*`GY5!'0*M[[(C&[,P='F!47:1UAFK/*\)J"+'&Y1 M^DCN-G6(]S=OJ_++9U+?;L[]O&4EW??7Z^++)C%U$89.FGBA!>/`#F'J6?9X MSL#*,K'5\)DG>O4_P]HZ430=A3XZYL'!"N77I#\L-,+:AZ\$QMX2))Y;IF<5B/!GL MX8,V?P#7O0-]7M,P%RZOF0]@N>.$H-0:CA2?^,XG1&)RO(D-!0Z2W=A\VHG- M+OJ+O3/RB35:B>PCJCU-$&>BXQ,Y6YUCG$AN-'A_,QI-JZ9M%E["GB!VYD=6 M$MA>%L2XS\9]R\(1MA1V%`C;FF;K`)N$@)MQB"\9-,F=!.)LBFT9,,.@VMX` MFM)N]3$]3I[1]?_GY'`L]$OS.1-!4_?CP-*](C$2,H0*MK_J^K[+<#]7\1&L8]2UTL0QLE@./53)+]((F?/^/3X M:;&?;("QX=E-D$%U)_/:$@U$BR^@F&=891VE0P-Z M+BJGSZ$C:RPZJ.([8MX+:W7S\A3D(HRA;=L>]*+,3[((6EGB#^;\(!1IG:1J M:IJIY-Z#YCUJD=/1*I0>5[!):%3)T=@S8,\1Z*G8$SA7/A&+DF?*)=GD.D]^ MV/,].JZ+JSF<(]?A1J7W%I)L!K+;AB2IZKKZ06?ZS<+'V,*!$]N6&R=1'&>^ M%X^S_#0,9?J!2)H2&2.JO9K6K$_.]8A-LI&%+*<(W>'.@6HH4DJ>(#VY/?53[8&=9N M9\$BM+PDS6++=ZW(BGV,0CA,""#,,D?D?8**I@P+_K#99CD@$U]U5^52O+A@ MF$:5RL(.M&$CTQFK"B^)XBPI*#`\PWJ"BC='B@G*)''+55>V^$CNZ"WXE:V. MH_N:JN,'4A?5ZI_Y^IXLL!5&"0K2S/7"%"8!Q)X]&':"@*MEG3YKAD5KBXW- MY.BM5)1L'M<529L+\)UA%!0Q#0SSZ=BTY(I)65\6W0$'>G2@AW+IVM3,JN1O/^TV]QBZ>#KC6@\ET[U-#-0Q<4(6U5Z.:Q M^Q;1[?9'W1T]M`6(3XYG%!LQ=98X%#[KCAZWE)V?7?8SU&Z>RWZRL:V3$,?%:+@+'G MT60]LO%8BK"31/#@D4[3QC=2]6B[HYOW=4W*Y2.@H2&@Q]Z`JI3I_*F7?C[A M/AOO8C*])7P`"AA21G2GWNS56-TO.W"G/BHDP.01^342D)F(K1G?GI_[,4<@ MMY#NM]87.Y[W.%U@W\\2U\LBWPH\*XS]P/8&#)F?I2(%!ZV<;6.KUTVJG MP>^FZ6]1;MYH5_;]DP'A&=,3Q(%/4<\6`C%%/2B;%YMJ+-C3A7EB216A\HBD M&HG(3"35C&_5!+>T%DF-:1I=UX\T.^YKR+8=Q!;V<1P[/H0NBNQDU/,L#>+% M70?Z4YO7K8JBBMH5&>J"?(67),O15FR*2M-HGH36L14.`(J*FJ2 M=FWRF;.*0H_R+`M:7-0)RZ4L];/626FGN`12C3+-RH@#!R>6GWA);-,<-TP" M.)8,4@IDHXQ9R7F@4X]5<5T<`.I11792@$,/_\+CE#<"?ZEQRNV4U#@5HXQ[ MG+*&!ZAHENNJN:_)V!S233&&5D9E(;)2RXLC-XB=L-X@!58B&N#[518 M#)=9!A>>-L'K1N?HQ\&>>`('""8)VW$MG&/$Q$13*5C@S\X/P!P!G2='I/8\ M\>,_(3*W.,H=(7D9D>ZE/CK"S/\8W7OR1`._>QZA4T=N!F=7)G6W.L\`D7IZ MO\O;^[I;PU:!&$4VX5D?.@6O"I_K6H>F>\1,% M5^1Y/[^XRC_[%4.J*Q.8*,HR6<'\HBV7(HC:8N:L.&VIR@!44!1A+87)QD*7`_[80;M`-MI MYOLHA+QK4!I-&ER)VD'9U;FW.&=1?A-@\5BQVT`L9E*H,^+:\\*W,?H$RM\W M14E6FV[,'^@]W%`DW7F&#Q4U/4+:_<867M/)S,*+7<_R8.:ZH>O!"$9.:(W@ M&QK-&GXV;/"`#A#-`"DD M47W7R3&?B)^)7C&E%F/6T.NC>'DZ(JD&R)Z);IKP[,6[HPR1)Z6`J+K-BW(1 M6LBW'$C-P"B,XRQU/#AJ;>S9LDK'>?EI%:T'I:)IO*R):YTWJ11KYH65!&&/7=?TH MMJTH'(P$=L*]=4;\RH:U8P`DL!(BP<[I%2NSQ(@6#WLL=`ZY!'_V<$26BB0( MXE_L,4N4W'+-2-@=%V$\JRPOW#RP3B)/QPQ6.A3`5SKN"/5BYX<):YG.UD4XAA:7NHCO#5H)9FR-O-9 M.8/^\HUOV;FT`N'R&JN?:W4=U4;S9#IZ:C:NSOR,]5#0$0[-DZ&&OXDI*1LZ M3>DM/3&^R8,#!*,TB9(X"QS/#ZY.S?G8@K(D:F= M1Q8E:#RBE":#,A/Q-.IB-=T]KCS3W.,QP!I,T M"$?C,/6PVJQ7QN(Y9L"[VZ`94M!!59_J2C$N.^TU3;:&*;`PSQ/-=?=0)S3O M5:%^)BJIV:F3\V%URA24,'NX(\N6K/!]2P$,'VR:Z/].'MK//\CZ.WE7E>W7 M9@'#V$N=*+5H(MR]#`[;T0`+NZ'0R]A,8S&LGIA&+5\#.K!\97'4'`19V3P? M_^J">@$&]*"'O_UTX\`%8"Z`W@?0.W%VN16B7$B(S01SMA)MR-V3XFV29E.R M_C\DKS__J!8X#E#&7GV"PMB*;-M!<-AK'CIN9AE4F4FE[I.*(]$V=V722U). MG%]_`8JDY(DEX9.D\I*Q'5LX?1H\W0":C0,>V\7$M`QS@9A,B,,)A)B/=G-2 MK)WQ*<68@;\".68P-0NRD-NN6)+%[-0@RA+$FI3EE#XXJ\#V29(XL46#A>59 M`?1HG.CA8&39AE69"\-DHAR9%V4^THUILG:^)Y1DAGWYBLQ0ZA5D(9]=KQZ+ MF:DNQQ*T&E7CXB5?!0F,B0=A:OM>B'$:(F=XG2OT+,]TCLR%82HU=JP)U)B+ M='-JK)OO*=688K\"-:8H-:NQB,^N6(V%S-2@QN*TFE)C!F6O0@Q8\_4QK_/L MGDK9RO:(CZ$76MBR/#N"B>>/N7MH1T(EM9.!FDRO;?K<.KY9T5;PC1$5G\8M MT\@ZLP7T[NRL`0=SEJWT)[V@3_K5'7V=L4"#W6K!01?QW-'BMEQ73_G7[(]W M&B&Z:9*&<1BFD179Q$X#.XQ=Z+"[NZ!'Q^<4&94AS.G&'A6@L!;1)?0,26<> M:QW4+N1)U6)*I7_F"?02&8<;^K[A!/H0>AB'(8).$)'0]X':$^V;*\71>:(Q3)*LL$['#WU'$*$MR#47$V.+I)_*]D>_HIQ(7"^@F M(H^]TC`91!>D1?-<-=GVGW6U>\;;K&F*^V*];\7,7H4/PM`E<>3&B>,Y,/8< M#P7CL)"(M316',MT=7X/#W3XP%N`D@U`5-GE7"E.2*S@`E")4S,+NO-DG5NG M::)Y(4F=-G.^7U5II4F'DO6OOUN68R7(MEPG1@01FDK:9!@8N:[8D8;R:/.J MF61##76.E17-`+U:-6VF'AJ7")/3-4&REZ]LH@;Q:YL452+J1HUOBW*7;WYY MSNMNR.;G?+NYKVH**.]?Z$0DLF%L$1@YB1U!&'IQ.@Q/$T=?4..TC&E>Z4:8 MX(#S!C"D/U&H/S&LXDJGAV]NO9N<:F'5XV!YKA?3.?D[+X):/;`<*=1KUE\% MT0!MW+(89W22KO,OCWG>?JR.DDP_=FQ$_#CQ_=B+B&O9GCN,YV+,M;NG/(AA MX>MQ@0X8&)#)K53EB>03N$DX%%,T2?J,Z-LX(EC*C"U$H=3LJS5--@P8- MR6"BZ*/:LT+>&`?T0>[Q'GVJC&%:E/3C0HP,'>`+'?8HT7CX9G8Y!,34Z29[, M/0R*+/*?H$['IMQQJ@JK/(>K9^T_<=*JA[,%'+MJ,J32/9UD:[[0KGVLZJ*_ MHRM)7!(YH9_$MNL'!-.1QA@1)+'0S5F20TQ6MP)&7')K65D*^;+'"=@3TVHI MXLS6R;VAAJ=$3H[+A62+JE:<*HQ3(45!;_JL%,56XGB!YT9^$*94W'"*QAH\ M2(3>,)`>9!;-D5NWRA,IJSL&.-2A//.L6$_1(Z0^@HPN5G]$[;BH0%+$"&@0 M?7;+;/LY?\G+7?XEKU^*=7[[^4N?:J41M$+LD#".HS@,`R].[3'5(ECH4%-U M+..*M(<'>GR@!PA^H!!_%)8D15YYE6DZ2D4%ZAR;1B0@D/*5 MICY*TK&*EZ2(J^6UQN$,BQE#"7X"/=#N$J(.JL#>D2Y>+V_%S4"IF)AU;/Z% M2_`&I,SVG"Z*^??I9J!:\OV'SU]N>IH9X6S??BM,.,_.'1\C)[;P--.Y@+T\ MW195QN8>9XA85[NRK5]7M\DJ2IS0C=*4!$$:!BDA%O2&3TX]S!4"!#[.=+[Z M.?F(/A%.N1&AX;QB&V)`,+V\9/R9]+')UQ\>JI=_](:P[-$=OF'ZX!XEC@=C MWU$`"29F?L)E$%?2;A=NE* M.!99@$H-8/@I[C&]WWPC3.F=AS_RY=33FBGX$Y,;*>K,E(6]S\VYFC!%-A>B.,IF?%\-IH46 M)=UA7]9YWN_LNZE+<))Z'AW121,KMBT\#(S22*CYKOIH,VC1#1@P2A>NJI,L MKU#F^%77*B%J)].M-XP)*I@HBZ_,VWPI3SR9) MY)/8AY%M1>.BD.WR8^ZF/B(?:GJ+I<,BTJ1&B)'+.^/&R!#<;>E@R.QPBQ$B MT+''%#&2N]6\!'$UZCFR[<2^LY3Y"]A=EL-=*?I=0-)89\'LO]6P%^V[Q"$A M2>/40:D5.[%G#0TS@BA)N0\-!3_6L*P-:`2>8U%>+DN;04K$Q&T`(B-OHK3P M"YQ!>N0D[O*DX=&VMV:=4#=)VQ>@;[+(*V7'"V@3N,:N?LG6^:XMU MMFUNR_6'H4@C2&#@8N0DKN6Y"8(8#T4:@>V$W*F<\D"&=;#'![X#>`,81`$5 M4"?TLEQ.RJ68@)ZE4495U?GDU]E)>9537E5^>73Y$@TGE%H;>PO0;GVV5`:F MEX"^_WN7-^VZJD\/BA+/LV&2^G;LI)Z#<&BC,7%&`5<[-CTC&5;X`:"RQ&O@ M]++&3TNGF,B?9U)&Y350RB_STU(KI_/*%/,(_44B3BB]/@(7(/4:C:E,S#'! M,Z:[NMKLUNTO=5]NW9UG>8%K)0%./->)K)1@*QA?&`DBSQ9JN2DU@&%I[S$U M^WK.:/)JAS"(W,CR')R,Q^8)":&$S$B,,H_6R!U6*W`I)#F&:=2B M._.<29\DZ++\*)"Z+`U2,>1](5*FAFMQ^\M]43_E+WU"A4EH0=LE,2+$M5$2 MLT:__0"!;W%5[XE_JF&UZ<$(+*4$2;F\$C7'AYAL]#ADEI>"G/`O)(9WWXQKH3:T$Y!A:P[I,$7JDZ7T#??OYP]P&M6[J$_&>^[8<)W-!!3F1' MH9_&/H$VQF-2YZ1QNGK)ZV\5C\[)?+K(##X&PCV!]X`$'FTICBZ+GFERQ*3O MYP_@[@/8XP$4D(P&2A'%KX2F"9/3P^^)4]/#=VP\H8HJ;"Q`&Y7@5WHFA=RE M@A^+,K]M\Z=FY7MI&"3(M6.5TSA?8M(Y'U525PZ:H4Q./(_9`O=5#8S>0SA:?D)2E4A:@*:JX7__ M3D)9(KCW^OJ[),J'CU73X*RN7^D\^#VK-\TJ\2TG\#R"$AQ""Q(;NF$_8A@' MOE!3=85A3*^_!V1@2Z&!]1$VP:T^%2KY]OHF8E%PU3X2R%"!-[`FWNH[S<^9 MO3X-I"YDLT^')97V&2H23T2`3M*"5A`(F//3SL M,(8I=KA*%76,8UB2V.ONZPZ;BAPI$+7`$4>1]"F5:+R]6)V54BT[-1J;`ZRI3DBKY`HL* MN5SOMES@X,0B5QMU"UCPZK.E,C"W9/NS_UQMBTWVBAX>ZOPA:W-2;;=9W0>7 M(`A)G-(UN`5#E[@XIAEP'UQ0E$"AZP[UC#C91B3H8=(\:@`*]D@O)E8F">?+ M5*?G6G834X%FL_W>SS%W)I/5R_Q"W#3ER M:4INRLQ3VFZ45E6UQX_T"'SB^Y<#AN`WX!CZVX7Y6N0F+#..N7Q2.;M/A'>LK]@= M0J6[\[I%LD?I"?S#\5%.98@[L/VRD[=P+R/4!%B3HZ1BXO0^TA,7K\\]2C%R>C<9CY,R[I*,DESL\4=*O2:4 MFJ)4SZ+XE_8QKU?03P(+VCX,Z7^2U+<\9^A+%%H>7X6ZQN&6LK"]`1U>G4L> M3KXU+$SU4VULMW^ZZ$/B4CG M.8VCSA!0;DO0(][W#&.7EXR@`4.M('B*/A"/+M/1KQYDELR\?,29S@/Z`H^* M)V3"SUF..*.0'IX7&(PT&78F)NFDCBLT_5K6^;IZ*(L_NWK4/A(V=,7UVV.Q M?J01$5=/SUGY6C0?\P<*YC4K-Z2@?]1N7S\6K(BWWE[0/F8M^)V9`>J]%6!-X=-OJ"%MQJYZ+.Y!6;6@&8P14.Z% ML&V%S4?C,ECBIC&[:=!CICZ>3(06\N*!K0&]Q=FS*8#/8V=S_KK*93 M"PQVLX.OSG+`3&<3B1H/OOP-)A)_#K$PY.:3D$5/+)Z,9EJ/G4B)%CIM%I!3 M+969:O'/O'I6QP9'FQ>6%MS1'+,H<566>5>2_7O1/M[5U7/5Y)LO>=MN[;N1XV`]L*T&6$]CQ^&J2!Z'-?UW(9)!$)%+NCI$]7/"E$ZUYW:DIA;K9AZ7!S\P0 MYF3\G9,'8\#!FD4Z4SG9F=>IFM,8$\Y52$N$N15+.,RY;KFIA$&;+R<)I@F? M-/S3O[W;![E5B%W')8D5)#13<6(/6\'PCE8("?]U.#-`,[PY(Y<.G,@&;KIO M^H^:(9J(>'RZ),&0LV=/%VZZS[F["F]/GT48\OIB\@E.[T^97!PH-YQF2/CV M;Y1PR%AO(/60=L*D25CA2]=3/F),(38+K$Q*3O%Y"=#.;-F*((.W_Z/,7D)%A0LL(_&:;,6+XC MWW#:(NOJOU'N(DV!@01&S1WS M]+_:G37G8R=']B$UM4RP@Z8I#Y[/-!;D/%W%)5V]T?X\?X\:'+IL?NU[9D[< M*E..W7<"Q43N6DB+3--65I,^`WH4?8@GOQQ:Y>=-_X[`BMU&2OS(=]T@1$D* MD94,5R2'MNL)73)/:%OEC?ZI MCJ\0R9OAM:5EJ/(Y7L4E68N7EJW'>DSD$V.-=*KL$`XPJF,8G_,MJX]?)9&5 M0!+0)!\BF[@10MX8$&ATX.[/:&)LPPK M]=RN4-[YFLPEVG>UY%VCL%=UCBZQ?2@MQ"]WCTF/>9?WCS32*'[%5?)']E24 MW8S^OSRK?RTIST<_6Z$$!W&*4^*[-(C:CA,Z>#QABPA7,R7M@QJ.6.PA?:6X M^GV#.G]BYTO-[MM_Z"J/O020'[#*7ERES#O?.F$6RL5"U]$M)T>`;@"#29=J M%.?QS^>ZD.H"?V<6`=I=L)#,7[]=IVZ@TDNVV MB'II(9IKU$2%W18Y.KF5^-!FX!0HFB]G356R`[F[JFE8:]*5C7RZ((I@@A!R M,;&3,(Q[,'29%'@B6FP&@6$U'D"S6HG39V,%6VX.T,&`75"<#7F(3Y[G=XZ8 M0)OQBQ&%EJ+VC$:;==5"5-JPD=64LU]@7_Q+08>^+]99.5[^<#*&])'C+B^S M;5OD359NAL#2QY(+1ZQ)TQ9/]-_-9S92=;\?\=?GY[R.*[IJ7*&0!`EQG3CR M2&J[C@?3T4"$^'?<3#T15#9UD[` M5XY:H!LP<@,Z_SNNXLZ:Y@Z1"O]^U]OM99V61=_?DGZNP= M_3WVJIP?Q@Z$:1H2!\9.:"?IT*XG2L*8NX6A_I$G.,WKWP*CLMHTU;KHQ+%[ M9:2LRI]ZG$[9/9GN30'NP2:3IC0$'7Y_6-Z"9(SS;S3X>VWYX>B#\" M?`,^'?PTKQ/X\Z)YG2&7NQAP"D\V(4S5B8AOCO(%1&6#QE53S%K9"I7/^3HO M7EAWNA5)$Y)`Q[%]B*PX3@,?V^.F51IR75:B\OG3[*X,)6`#+-D2$Q'B!*M) M#'$F6SC"29?9"I$#`IYB$`D&%[*[K63"J1(/:3IT9LNX5[342CTO@%X4AZX5 MIB0*W3%?CP(_T9PJ\PX[2YZ\3Y/G3)&YO:(M/S;A$)/),3:5&'-3KSTK-N&" M*5+BBZ[0F`YC';FP*-'7DP@+6R:>!T M;%:GE*-#BX'?J&K3/RS*![1K'ZN:_L'*MY"+,8+8Q\3WXBB%D`PH+=\/5$NY M#4*;+/%^6X(\6@1^V-OT(SA8!=BL/&HULH^4>\O`:)J&^G"3+A?,^Y?G;=DE MPX2.GJPP7=XE@N7K$_A^:8N=B:WG*(6?S`D"99IOHV8S0"SRYE/>#M'2=HGO M>A`CA&+L(R_$UG`=5.1:`1:KR]0RI/%"S''9--3/Y*+E[[K(Y2VIG)Q7U152 M1<-`7752C)0]C9RDBMC"]$/W5;]9?:1P.DR>C=\;B'K7%*&/'M)/*3 M./5"&]EPO"(E@AY*^:XAT3:M'>?V3)%M8^WBG:" M2WT$29&Z<_Z=D5_I+#JN/[!]%.$$A1!3!4P#2M<((H;\5[SH']G\KF5_[_9F MN'?[YG!"QUZR&),MA6O/-3C@\L'&/J24#]!20BR=D4T'GLGBW<4''%!S M6*.F8X/8>S`'D_H]0\V"K,6K>L+EU`XU%D2OVI=Z0^[4/C4>B#7X5E>`YN!6 M(6SK]-R5!'.M)@N&>/UTRQ^"TB\P_9[=H5[7K_=5_7M6;YH53%`0>.8^FS`:51ISLB8.O3K#^W8U^O.[1@?0Q7]8A4EGK),]().-=P M2/K_W%U;D]NVDOXK?$RJG%,`2?"R;[@0B:OBV,=.]B6UI=)(G!EN-.*$DAS/ M^?5+4B+%T>B"*PFO'^SQ>"Q\_37Y=0/=`)JO]S`]*D;V.`73\^S)5$PU^7=O MZY16D6Q0AS#`FO!V4X9KY_G)/Y,15J MP#O,.IZX`"C*`0\]F&0Q,AG`'>G M?J<9CX0OB[4T_/B%C0MU#6^YGS\61PN\S5QXRZ1-#\FOXDS@'.U%F^9HFTMK M[`/D7@O=`:^HK\=,X!T#&Y9>5=\E'**RJB+&D.`BBF&Z'5PS,6WAE242*V3J MED+HX[QZR$]`S+(8Q33$`0I@C&F4,DK"#@,,N?#>6^,#CU_<>"VL>]1O7V(S MJ]Z*SM`J5=CW@WYX<]\%1BH,]EUAK)1PSB76J@-G>9$O`^C1ZV#L,F>;V,*^ M"0*-E>X_YYO=:ENL'YJ-5B>8!IN#9RPB""`6A&G@4^+'B1_WNZS"3*Q'=FQ, M4\_LVM4OK^JLV6^]/)W=#0^<,%ST->9;,T7\*=QJ.&@>:[V],5YCS9LH.CQ( MP56OFBWG3^%=2W'8L)=-%?4%&=8H[)OVH=O!WI[9D@5^.[1K[HKYN2R7_Q2K M%6Y/D'W5;?"F^R"&**0H!11%"45)@%#MI3TP3#F7.HS#/IHQ"V"KX9)5<6P$ MFLLT>8WH*.D*F0,^TJB?G:PHJO9IV=S=(\&J6('-LL?<*[_9-EAH>Y$]JC5U M_E-5/N?5]N53_99L:W39W[OB^:EM)L=I&N``A#P",$Q"ZH==N,$()%A?U=7' M'DO#WXA$![G^J@'=7FW0PS:BYQH.T5'O<7QA2JL5W3"B;E_D4UJE]3WCM"8; M,$](@4W1:+IYEI=57CRL9RC.&&*`)IBF*6`\AHQW*#B`>B<)Z0T]IMK>ZNQ\ MYQU0V^FG%?:&8B_9>(XPT%:FX8,IVVP/X/2[;67=XI[.&K5.K?=6C41UE?VX M?8@11&N)_8PU1O*X#^\%.D>3UJKX%M*=4SX!E5A1O5*2;4 M3\\?(ZGC+5:EE-.8BYQ557,6WE1^+64"U^AWH'QG7C&_*\&B=\QUD)CQDLFM M"DKG/1CV@8,=(*8M5-BJH$6FR9,'9P%*4AS%"6*\GA[1.A@3V@T=^$SX(EU3 MXXT?]*X>JV;^B+O;C,M'M3'(U@YCSO%L_`!!HWR/CF M_(R\AVU/=56=9ER+1_"7]:I";8/WY>B_3,!_4XOW>=K-2+JF2[\_H=AL7P4=G&(>Q1R'*,L8`VGJ M=_>NXX0FPN5HHX-:%O+?+YR5K)_3FZ?_]KK\9,S+B?/EKFZ%1-PRZ>*+]).1 MK[92;]0)(HOU,OQ<6+&W0K$#R_9V["HM/YOZNS]?:@2?\T7YL"[^DR_Q4[E; M;S_>_[&N^N^=^T]_K)?%9EL5=[MMOLSFU;H.L)N/]X?^KMJB3;$LYE5SI9Z/ M,0EHZ%,&8`+"P$_3/J2F$=4]%V!R_&,VS!X/)6D$XFCV.V]O>'/3R-#TBV6_ M5_9['0'-?S]0X`TYT-_2.KF7U+?%3@Y]I!F:<\_66/MT;3M8;$KHW./FWCS2 M/8IN[SEV!ZN)X3J@Z>#-4LH9\R$E69S0.$6,Q?V)%5&&D/Y1$5K#3Q&G MVV,*7NMAIX$=;B/'1>CY13DTCND2`Y%-RQLCGAIQC5.Y8&+*0>[&`F,6"AT? M89!,8266B`4,!13RE*CH1 MP7(ZZG0N;R0%M^`&1]32AF6E]6=84AW);E.L\\V&ED]WQ;I=/-O@NQK3?+&= M04A(RCG+8(``CQ.`H)]E(6$D)80(9SY:8]A[-SM8WA"7]V>'[']&?ANOL73E M_3-"KB-OG!E;2@M/G^1;]67QF"]WJ_SC_7'N^GZ9K[?%?5'/8MO"*E[\O2OJ M#`FOEX,,J?ZWW5.3-MVM\M_S;UM2\_/7C`2$44@`APF/&$HY#'`'$]%4JAE\ M;&R6LY?.G#:FSHNJO<:O_5MGU/RX9]#K#&O/NAN8YAULD\QZ1O>SF."Z[&(Y MC1YZ]VB+=S1&U+'>GZU-7F.4UUHUMKX;=LJ5D#"5^QV)(I.97[KQ%DKTUIR) MC0W6]:(&8V^^TZ+W7L&7:`D9Q56WVW-<\Y)^RO].S%52`60:[XGW^;CF1;7V MG[&\*=(99(#1"PU#8_K*@3ZB4WAOD MZ`WOB-YXR#7I*ZU@.Y'/3(99D[Y3#+#B+(J'5@N><3.HVC#T>CBU1JUJ(&UA M;(KF2UINMB<8*$8TX@FEW,>(U'_ZL,>`($LU8J?>P".&RP%0KT&J)[^:?"M% MQ_&H-A$03_DV'@$U7:`5],9SAZ_?'"?J#2UYE=.:EF`K#E6*C5/[4C]B_G]SHU9\G=J=YJ*N);;3 MO-I^O#]CV@GJ*`X#7C_7*>$(\A13&`9=;@(SDL@T#$T,=<3I[ILSQONV$LF^ MH*F]*]8F]!TY5BY5V!OV4VM'VQ!TM.WPS]N8;K[&P>1[.QJ;)&XGLNNU* M7Y$CSXLC;4:NL%$Z^5(KMJ$/9MR?JI*7U=/\_?J^^:/%TL/(H,_#+&!^''!, M_,B'2=;!2$$H=:VVZ;%'#%@U3J\%Z@V02L8JX]2+!9\I65><>`Z@OCM/_?3! M09)6@8T%IAWDB'Q;,^_"]@,[-$KL@FQVS->D+O]8UPPM6R#SU:?ZF7^<;_*/ M=ZOB8;\W@A6;Q:K<[*KA4F=`>9;@"/`,P2`*,IHUT%B`8$0S+K4UW2Z2,<7W M@-@;0);>-6G5*V)*[(Y#Y'3YB-M[!?RL8[PC]NE%6HOQ*Y(]CB<=$?"1C'VS M8W,\BA6VF]''^@W)WZ_;]/YSOJV3^V9)]@CK))V'C(;43V@`69*AD`"?@PX0 M26"DMK',-(HQ.Q[:Y>8C9@UQM^@5,6%WPR%RHC[TQ1YU\]VV#A4?BG7QM'OZM;F&-:*^'RSQ M6IQ>9XM7&^/]5JY_6LSKIW;5"LK>$HDB\=B^O%WS=]B-ZE%A;\HU1Q[/R&_6 M_@\6'?RIUP@8D;Q)!3A#F"&40QX#[@`?23>OP,T2`1O45+:PR+%=[C21\# M8-,=WG.-IFL551/L.I+)F['EM)IICB#YU^I0(WUU-,.'^OVN02P_-KM#=U55 MO_SU#]2I8]7]E"(F,_]`/,44(!)!Q`0[DMUX8R&RG(V/GAU M#[!;.6TW;N^QMC%\"/X0P44SM0D<*2FF3OE067G-N<^N)NNR+2+@HWG4-;4? MS_!+H6%DZN7C"'D9O"F\RO_>Y>O%"_Y6;&9)"E'&@S!.HHA&28PB!+JAHS"0 M*JR:&,^R]@]P>3VP.FNKH2F+NPZ[DK(]$K%R@JS&J5W%O4R4B)8:H-DUE31A MTB7],T:7O+*=&YB53_-B/8L0J0<(PHC$&":S@(*`D"R+4XR#.$UJ^OQN;)P!N8TW)@:TK'L]'`.R)D^FNJY9Y=&( ML+V:4O^Y1^F"M)TR)ZEMRL0[+&[J-@FHFR9A*M/5_LM?BKRJ/^#QY=?\:\UO MDU)F4<)B#&*$`<@"3M(@Z";+$0:)U%'DAH8<,;7KT6E/6K4XEIZWCD6ONO*) M,VM[ZGJ%*['9JPFR75,[0U9=GL.:(TTOH7N+XY!5^@S2#),(L2C,2(81J[]S M`)'5R:9V9J<\\G@%F\%+:FXVJT&Y1OXW"MO*I149HL?+_"YQ)IL":G/OFCJ: M-4XD*31$H;Q6OE\_[[:;5IOA(2%%.,Y2`%+,$,>`@R@,NCI\%*`XG'W-J[M2 M6AL51I)Y-X>@A%_1?^_*YB*W3U6QR#=M9_IB6WS-O0_SZJ_\T(NVO^-A,5]U M1PO\T-K@P1]5Q5*%EZX!_;..W`X^4SX+5$BZJ=!KVM:IV/*)673 MID=+Q_S#D"`"@&5QG5R2!'*$:OFDW9"(!TQ?QT1'LJYC7XJ'=7%?BU2SEV;[ MF%?>Q[M-7GUM&V7W@#O9\DW(EC#%ZK)E@UM3LN6[)%N^DFS)TNNP;$F;(B!; M:O1HR59P&)(&D)`L#1DB+`8Q8)!DAR%)$HMM^C$QCN5IZ%"R_EB7E^0J,"%7 MPM2JRY4-5DW)5>"27`5*YYNGUEYU)7KF^UJ';VN7]V5CFM:9- MT6LMX7%)W77.V>I*/9Z?G6W*[EUBN3%;WO6N19%QC;?0H*WJ`N%(M<=V9IM1 MO\N(\H@Q"GGFQR0C"`!"TV[@"!*I%FW]T2Q'E#W`_Y(4?P,DB@GZN/S)B?0> MV[OA)>3#,Z>FVIEXD[(K(FJ.;D>$T:!!I:TG4U+`WJ^_YIOMZYK0RK%UGZHJF&:+8$4$S94UI MY3DTE8O-,I;%C(1^2+,PSE`*,.B2/YJF`,ZVS=6\FCG8S5&D!*P')/R.[:^I MGA_F=UOOOGG-OC883:5CMWG43,.,4F@P_7(EYU+)M80Y=422#!@BFEM)4B,L M1(-YZM6,CF7(KW,XR#`G#`-$4]Z-[L\_6F/:?M.II9 M'&+$4LX#BFD$_#!"N.O.H0G*J.A!DQ:&MC[-W"/V%@/(WNJ(6>(X01O$7]=' M!SB7T\F>[B%:[[9Z3NP%\8,;)_:&VN&,OS\6&R]?[3=@5_ES_:/M48S+2:*6?:*`R:G"O M%2W7S_S`.`BK=+&65>;`XP->ER@>[\[?,#+[Q"_*X/@2\373`EP>J5F8)- M'SDR;;!JXH7+INS1*=X"5E9Y\;"F=7!OCN9H8#3SETT_\#GY!S`%?@PBR")0 M!P!.F0\[+$$:`*E.+QL`;#=T[3%[^;?%_NZ+^[+Z9U[M+S$MG]O<=]$9(MNA M9<4A8E(\N2_DM+AS0X?7ZP$/=->-I6859J^U3=ETE".";-?&TR8H^X0:6M:> M(1!D,6HV,(2A#WE$TZ!;66(L))%,D4USJ%$J;8,U&ZURFRZM)E:TC3(J*99U MHK%>%$WIM]_0V>99H*5;>45;6'V'5%`4]9(K6!+DB1^^5W^T"Q#?9>T"77D+=*WX_1F,C/$*%P;>3KRX&9B\G+XQ_U9V1"SB)(X\6LLF&&, M>!!U4$!"I69H-L:W/$$;WDKT]BTD91#.TZQ M?%FD,+/7I-2BGUQ169LF7KP:TA:=0O7X#_GV\67U_)BOB^5\FV>??Z&KG_-U M7A6+S6'?9DCJSZ:48$18V&12#()NU(QE0H>1&1K*LN+^\K*LRD6Y+->Y]P/^ M]/['=IKQ>/SN3\V"V+Q8-^_ZMG&)\,J8*:YOE]Q'IEE./D_`>=EGKX;G_=`! M_%%@-[@57L6+Z"/SJU8T-\&S2!'\-AD7BMX&672@R&W2FM+*HR81$CY^>]FK M7:V`AU$XC3$,PY###$"?I#P)^U$(SX0R<<6/MBSY/:*!X)?=]_3D7H7'V_)N MF4(Y.3]E3T&\55@2%VO+;*F)LSQK(E+\UM0+TJO!B0-2JX.^-/)@2$CI(*$\ MCA-#GE*6@!!&'`4Q2CGDW3@T384V>2M_N&4Y?9MW2$B!&ENW)=,Z47*B^7:6 MH2";:ER)"Z=USM2D4X4[$?$\9^X%^=1BQ@$!U<-?&GI$9/+1YLS(MIA=KE;Y M\LON;K.=UV9V*3`.2`:C&$'&4!8#CF+0KUB#,!1JGC0QCNU,M3TZ<]'C\S8] M0)ET2Y=,@0QU1!XET]66PB,T[XA-*775Y5(BCQV14\6D5HM;H03W.@>7LEU# MS#F@W,9,*S`RN8PD+0+9 MGCU&)!.]`Q"E%$^2%HGLSAX]BHF=.$U"*=TK^RYECN8J M_%NS+BW":Q#@P`.L!;\T\QQ(/,KOU^73_-OA\],0!1"&(/'](.2$D8BP[O,# MA(5NG9?^4,L/[QZ+1&B28^1VO+9&AERTWL-0B=5RA(A':FO$J,5I88)$Y&YH MVP6=4S+?`8%3PUUJ^EUU$;J[4"L!28I)ZN.,U,J9T20*_7ZQ&W'A11:E#W=Y M&5J8(,EU:!O<:"U$BUR>9X@JQ;5H&Y0968Q6N'?P]G+TY?L#M8EQ0"7U\%]: MD58C0D@U/^>;;56/L6L.4>/%9C%?U?X+/M7/1;<.GC7G:<$89#X$$0KKOZ?= MH`E,A`MY^B-9UM,&C?=AOJI_>O%7S?S6>Z[*AVK^)"$7MP7LML`T]%BPU0*B[,XU*KIM*"%!L2[YN,7%!RS$*11O^00T$0H;S8WFF7A/R+SCM!D MMUOK4WI=^*=A4T[\SQ(YU6VP-XDZ(USF279E'[0Y@\X?.V&,*J&L];?=8I7/ MJ_=/\X=ZQ,,X09S`@$:<^S#U`?,#G_9K"B`#0AAUEF2DYX3@E02336FQ'-+ZXRII9/RS(FDC>>,O9`I:O'B0'*HA[\T](!( MIH#-<:[EJMG253\K[1VI^%NQF5&213&+"`O#+`P3S`9:G7$LU+^A.83]9.^( M:G^+L?=G`TSV@!U5!L72O!'(D\[MI'FSDM>=9^9*,J=)I2,9G*X5I='G2UMM M6/DT+]:S-$K"R$]!@$D<1#&)0M1W:=`XEIIG*@\RA>+LH>EKCBB/JJIC@4(# MNG.3O9&49X]#2GLD"756?63MN*D_2L0(*]!A5KI^.,Q7N\DICT'V?]2=78_; M-I>`_XIN%FB!:2'Q0Z3V3J3$119I$B39WO1BX,QHIL8[8\W:GC397[^2;'D\ M8UOF.21EO6B+HD#C<_A(>GA(420CFJC"%$U@QM,TWY57E)80`6%CA'Y/W*?5 M;UX'G=M"L[.3SAC8@*^0#XA=:A+K!)L!X[C2G(APG)M1^[W)H#/LS2"\.]^J M/U.C#]M567FB,YGHE"12QUS04FB^6X>O9`&:77>*%%@]+X\/9H3E"-%R/GTT M?C`'6:,+,WD^1&5HXMP+S8DXR%-CWDZ8>T0$?>/7UU@L%42T6T&;YI?+IL9B MH@\B!`/-\L!^>33?X,970$R@-W8!"&&-^;=J8W`#6N.RR.Q?KXV!#O>ͦYB7;B2:?>,_F"F@"K]J*V#U065,9&DE3&O*1-N)+O2KTTB:VFGO"_/III-UDY20.#9 M8,2PCAT=%L*OP:"YVM4:'LBM^\T]9U84FBEY%=>`8U9U0($^O&OOG(WWS="Z M>ZUP33+>?@5.-.>\+%66)>IEOS-#0#/\7@*.,P8^?H9-]%>;Y^8U&G)P[$@; M-&8>#S1J*.W$>)0#U8YQ.S_T]H-]6B-R3VTZ<^B:!V#V]IL]5*O/U?=J\5S] M5UW?KCY4Z^M$QYK'L74IA-M\[F*NHRNHB:GL5UT!,N0>UPH3L4U3FUXZQ9W(-8N*:J[:KFL M;K_.?N2K5?5RPO2\:L-N#J!>7V="4F6,RDI*9?,O4J3-V)ADNHQCF1)R_;U: M?JMM_>(I*.1)VL_/^H'J\XSFBYOZL8K6LQ_-`_;+S2:_:-;F_NO(#Y<=NX'' MS3/\B3R`OEM5![UC_3ZD'QI$VP189DI%A9$Y3P3$7@E/)=./B@F5/>S=74+ M=B`BEM5CF6T>R_VTK)_._.9F^=P\G-U1=YM#1;8&?'C)%J]!#%ZP^D)Q==?= M7F9;Y^E+"^\0EIWD'"!/3VPNC3DM,V=$C@+;$Z>.N8E-8TVJ9*:$YH4AN[@J MHSXK^OU[,'+:.IL+-`8:I<6:'KUMG\,F^VO-5SIY67V\T_7C4[58 M=>^=/EKZ]5Z]>7OV;+Z-EM5MY]F/S>+S+^MULO9S?HZ3Y+4E#IE[7=V ME(FX3.(XS?.\5,I0?6X+D)&R"/AT[A*/ZKMH/_5HFWO4)7\5=>G_UN4?]0V( M_NJ;,/8;7C?@0T_[.%=R*C(8J;5O73$F9/LWR3=_5[?/#TU.76S5QM[/+E\N MFT>G^VAEI7Z^_#_;_/)_9LO&?M\>JFLA=*Y-;HPT@F5I4N0\ZQ-,CX M685>D;-M2"N:?9F\DLY^:Z)O/X]9)^J:%/W5-0J\>F>\:VSYUGR2EQ?XJGWD M*QOF/;VO"S'T_H)8]RF?JF6W.+^AW*74?YPD8B*II(RF@A)"="R9[,,QDH/F++`Q M`IM]+ZW-\!.Z&@3-SL[,8V"#R?60V*6V`#O!9L"2KC0G(CKG9M1^;S+?)>PI M,[[??3A4I"23VJA2I6FL\B:KDO29%5H*KP6K>SJAIU$M)MC.S*^]QW_\.,+5 M]%3%CGLA@1.F(UW#RQ2[9\F[E+;^+NM$_#YFBZ%EJV_8UKV&FGJM\ MM7I^?.K.42E_/%4WZ^KVS_JAR;-=B_-YMJZN8T998HJL*&B`P;>I)BFU6T6MEO.F0ON^2Q&H=9^X[?1](=(P3;=)1EV6T5Z: M5]$._DNF49OJR"*V9S@@W``78B)B#=&R.OA=#-A/Z5CT3U6U/)&!D8::G&IC MLJ1,I)*4[MY;26-_@JGGL,''_-4RNE_6ST]NJ@P!?%B5%V;M1Y4=?K@O@Z.W MW_#I@I<`MQ.4YTMALTL4C-&1WB@@Z`GL*Q6J977PN]2Q-_IY*+A+3X0,&;@7VDNG722UW"3IZ#\L M75RW,P)8/UW.-M%HG[F'W@9+VZVG&8&ZWUX&3A_;P1Q'`^A<'-E.M&-Q;=69 M3L4+-/L3TS:?O+WKOH3\.OO1=F>+5:6J174W/WK:[FZ1>"JTSI-4R3A-TK0L M%:_7D4GS@>_U*-(#TTHC7+Z)3#.-T=*WI\:-!1?J:5,UL&9:5Q*2EX*0H"Y/V804OK`XE]Q4KL'&+YIJLUO,;G''Q!$%:'04>SIW; MU([+\S)J/$7KO/^<.4]+),$9%GA2%& MLSXLI0)3.Z)C!=;5NT7SAQ9=+S%[0#H+C1'FK#$((IVU26U2SCI!R\)9KIPG MYBSGYIQPEA],GH;"US%7<<%H,PA/!6_WFBM-L8V:B5@RR.XLCJ%`QH)OSM(_ M="_;(T5/R_K[?-4HS.LP]SQ3'T-9KSC]#U&*(TZ3L(QY(0G!WU!!3IO/)Y8 MYVWG"J?HO$%X-L[S0W]JSO/4JE/.\PG-UZ#\FM$T3YDIN#0F,22/LW;#Z4U8 M63*"V>T9&ROPA.*1#=>C7[YM'T7TW*(S8"_#:Z]L`PRAIS5`Q@^"K3E/S&W. MS8$-9H&8K&UV*EQ)E2I,,Q8FC4:U*47,MP5CDL1:I1"+86,$MM>GWD_17;W< M>2MJ+_FOKXZ0`/H+C=3.6V/0A/EJ0IJ"Z\D5YT2TY-R,VN]=!BZJOJW?+5;K M9;>@?K-=J&$T*6C1U&Y&BY+E.J:4JF;TFC.B8@&<)(/_?N`AXO[>O^_KQ?UO MS6\\1FVBT4NF*^1NS2B>MG536)0P]_BB&*AH.D`U6"CAP4[$0DY-."B(7''8 MKQ!IZJ[YVLQNNN_\-ON2&IH1G37EEJ`\)SE34O61WTB?CZP>S8917U* MN`V%,=0LUWV$!09'P3\8A+"]ZNW'"%@;3(=B]*8223 M(HX-2\M4-K)JZJ1M+$DU`Q4QJ`!CFP2W[2^.'<8F`;`Y^N0R.^\>HV+M%"#$ M25H%VH9!KZ"`6)OE?;5N'LV/=YN8VVTGI1)9>WRHYEPF"2\RLZN%I.%VN](X M!0ALEDU.W>%:759`H^"8V1DE."Z84=Z2NM1.L\>P#"C%B>)$E.+6AMKC;055 MRGQ1O8E4:&9TNT)`$,;C(B^(*/M(3&6@(0_BYT/KI-WV$RT3!"U+E80%!13) M*T87T\@!DB&)X/E-12$.+7@K$%<8UOKX<[:0(.; MB#7P^=>>[B`'8VQ'2TD:&TYR*42IXSB6A">BCY1DN<0ZP_+GQ[4&;EX$0PUN MC@#`G-QQF1F10R*6_@#BFZ!!H"T8<`@*AOVPI5[VWV>)?'^_NJJ;: M:>.^?Z<^?MX6/:4H\M)(PIAA.D]DE@O=!R\(`9U[X2=BZ,%-FPIT3.,'I>4P M9W2*P)%/EU^T2S#:9K@1TB]=DK]>;$!D`V]HC.05_D3TY;E1;T=2`9!!)'?? M+F-HWX#O#LI40K?;(J1)UH2BS3^JR/M8,A6@C:!0`4(K[-7BC2N'@VYQ^*P] M%I8<6%MP:*$<=0!F6$EXCM,QD$,;#H7C"@3MEVW)EDK.N-`%E225FA0D%[N7 M5UK#SH-!AKB(8W`C,RQ$G&<"\/-AFLL,U([#`=@&2'.BOH&VXHQQ4%"L-KC_ MM)S7RZ]U_K2C&_;,:-1@ECD!S&+@Y9&<_;[SHQ#$[3*/)VFSJ_RI MAA]QL!=.$]@QWKT-M<<;!UCQ?:Z^UP_?YXO[UZN6MD%C+F6BVXU0:))F6M"8 MFCXH*2CHQ;];I,`^WB47O5F$!ZS]''':E8#CD80Y^B3$2TV/#8(:J`K]`)Y( M<>BI,76(>Q!0*N;M-?YLI&KU0)P/U]\7@XYS';VM#%%JF?L]I7KY?#CRED?-[U-80OB M]=?]C MRV6H__'.=BK]C_^&O>U_`J&#C'^&HA)5YKFB)DF2N%1&L%+S;=0LS^VVQ?`4 M:IR1CK?1C1-5ZR'-6$!1XQC_8Q9P MX.$/DO74_/\L5M7- M;S)I'JTF)^C.:BA6=K/MH3'!;+W+9K.3T84FUH\P&9A.=R$XD4ETIR;4_FXH M^-J*CS?KNHGPZEUB)LHR,S&1.4V(+-L=3V0?C6><`%=78$)<9'V%@*\20.&S M7F$1FAQRC<4V+1^K+%#\P.LL0G-T7&F!X`E8:W&D\<.K+5QH3:#0\]&*PQ47 M[E"L"[LOU:()^:%>5ZM>_Z:4C.5*2UH635\@,]UOY9!EN8@A91W\UP.[>)-0 MU&4$+.L0I.R*NK"08-K=YW.I@NZ`QT`YAV2A*RKOYM MPX='>GA.TQGG.;3AR+IZ1R!6]OWXU-XX^38`TSJ61@I-"6DJ0*D4[_<4SN+, M[D1/^*\&]NPFF2@'Z`%(Y;Q-PP&!*;1G@7$F$(J]*,/!P=D1`,E&AZ^:=\*! M.`03$!\R\=KUZH,5I_JM!"E/>,J-I#HWBF74B'YCL(QI9;7%'_Q7QU&<`C_- MUE1L%1<""$IQ"J\X:RA0Q86`XZ0X&TCVBE,6BH,BF(SBP(D?*`[7=.3A4YM- M$#.92:-T'',CF##-)>NW+VNB,JL1M,//AU^`L7\\$FZ;'0PUNSFXP,!@4H2R M&N$@J3-[ZSC@F\@\G$L+!D^10L!`6N3#[+%Z.12BB'DA19EG7`M.FOB[51]Y MG.!=`@@RKE&NHC8U[-8Z>)(8OP2"Z&09:WXCV.:%C[5S$$@G:1Y,.P;]@P9C M-5S[VMP$U:=ZOEB;^??J4]7<:DW(>EWMOE?@>4DH*W11&)(2K?="49"B<&FK[836#HZ:TIM?];"Z!TT]Q$7<0OU?=J M<3QL5DJ=Q*1,.%6L3)(X??DPP9C4:OL>7[$"JYW]+O@QM1,*D)$7IN?U/C9. MF.+;[+8.ZO+SXWDO:.U=/S9BG.^]H+:1O@6.$^+W"7("\O?:G#K,_0;H!':? MDNPO08R55#&EPO`R5G&I8\IVZXF83K6M]5$_'ECS+Y\_V2Z7]<3LO-6#XX)I M_&*D["4=G!C.RG!R-@H^UM@3SG7B,@')NN5?>[I!(+5TZ^O.WO,?7_^IC^N[ M,;9F,HU9K#7C4I=2]N?E921)K+>4\Q(LL&;Y[REY54[W7S!!"VHO8"TJZK&9 M`DOJKJS;U'GS'U&3H:>BV@M>0%4]-F9D6>T'MU5A;4'D5&7M$^8$K.^W/76@ MNPXR:5XM']_7LT6_4)2+5,J8$L64+K@FQ6[[^ZR(#;>>(X?];M]E$;3J0 M.5L@&(L)[W!,@//;/0[47#:0"V#J.AP?Y$PU@)/5K/2K!IZ:A,91F(`;L9G7 MSK<`PG?%<_5'\P?^;FJ]I(]64EK0,M9:1E^55>6%=^SJ$&,.##^T- MW9:[77)ML9L@'G\,/WM%!D:'U67QBIJ+/3'XX"8-C-'5JF"<$,D>MOV,C\_7\_[I[ZH_9NOVOG\5L7=5W__W\ M\'/OFZ94I27-LK+4A2X%%T2)?HHDU[RP_N0H2/#`(M\=&+ULSV==[EH0K5XU M`2"F,)?@O/$O3A_6%[RD&[W.]RKJ,X[:E*/Z+FJ31G]G&N9ZV'J3;Y?N35:3_IG\2)-"266<$4XYIE@O4+ M:/*4I=9?F'D)%GSR_C7JARYF MYGTDRNXS[WC:L(GWTT#.3KQ[8#F!'L-O>XY.O'L#9=4C?*C^>3/;E7.M.&.I M3)J_2DYYEO6;-.3-6,MZ0`/_Y<"N;Q**,%/P"$3G51Z6#LS;K\!@#(T@9*_C ML*1P[H42L['L03M/*!7/8P+^=$B^]G%+(*;H9XO;PWBZW:J^)!DW+(N92!O_ M]K-/.:?:0"?I44'&>ET9-=E%6'NZ8;2?JP].$#M;?P#/9<(>1Q$^91^%TP8+8A(I,QHFHA= MO:SB)`4OD'!P(3[P@1YC!(0#NC0I'"0L$SE%YQ.:%7-+X) M*!6?>^WA_@&JD[Z::I""E,V/<9Y05K"5$G.O2@MK;?>6T@]O[^:)ZMZX>5]=:B813 M42A!I:DR`,$OCV(VP M<]L.SA'5^,(YR7W;$,T8W+8-BP5I'C.[J?+'^GFQOI9:R4*J/%5)61:4I&G6 M?_!FA&(2KQY`D#'<,]_;^_"N22V:=;DYN0?"$2.?0`B=['/5'C=>1?D9>B/8 MYX6.M7X00"?I'TP[!@6$!H,TT+M%\QQ7J_7GIOC]TI3UV3=#LOKJFVJ0) M,XR4*2%:\E)2TF=0RM)J&\D`80-;:I-/XZE-BMV'!TYV!T-UN<9 MM8E>15OR+[E>5&M#$*U%Y^5*3%)]?EHV*$./\*SU^&E9WU35[*)VDX(F50RD10_A`NLPO[]?5O?M MAR2+:AT];?,%"M$'53L1C@P4)L`^N:A]N*(^O79RJDWPMW6[T&3XC-0@WCO/ M;,!W'H%/Q',^6U0'NSN!7FM'MA_O]+*ZG;=%YOQAOO[YQ^S'_/'Y4=7+9?W/ M?''__]Q=6Y><.)+^*WK;GG-J]B`A$.P;2&B.S[C;-;9[]L$/'"J3LMG-2FJ` M=+OFUR^7A,QRY457DMY^<=MUB2^^2'V*"`6"9L_M5YJ7-(@HPC2F/N,DX3R. MDW`+_2`:$021(WRIBF&SEB5S`M*MZ:EF M?A[02AQ=FB;[^B'P#7G6+)M'K&`/]E!(WX$)\`VY%S].OF$,U(Z93<="Y%19 MCJ0SI\V6F%[`*;0MSTKK'U-3>]&A*U(^WE?%=E4\9YLT#DF[&T(7^@D.0S?F M*)H*"11Q,_N1FNEYS[A/+=(#[F[?FI";$DW%B&AN6O:#87SC6F8<#&U@]N-A M;1.3CHOV1G:2+)7-3(_UI6]HFMZ);FHF2%0\DOQ]FSV555/\.U^SHEX-9Z$> M;?=2'**0H0"'D,9L?T^-YT21*O9DUN@Q-/51B=T!)5CO86J= M2BK1K'(8:9M?S3WI"!Y@5XF=X=SQ!%_"QXTZ7"^DM630H8N'B_I4R9PI?B_J M=H?F9?6A^9970T_K?5G7>9W"*"#00PCCA!`/NL0+)Z,NC*2&3O4L64[+)W#@ ML9O([N"!U=`%WO0`Y0\5=6@5/D^=+^G:T@. M98.!H1QETM5GJSQ;?]B.[XGH9L5AZKA^]T;1*,8H=MP6@`/CJ9%#&%1_[)%1V&55K%,Y&KV3'N48(!)BBW8"+^XT6^9V@=G^=/N(-L(`0+T43S M?EWL)QLC3E$-/^;K_.FY*Z3NJV)U+,8XB!SB\A@1CP11S%P<3V+,HDCH!?*F M;<3HPZ?*B*K\4VVTPC#_MGL6/BA%[, MB4.Y'W,G"3'C4Y,=(>$7%MP`FF6E_< M=L0D"_WI*';#WYV@`[-BE<]-@HU^'L;"KMU`L(M@2#?)E!UVQ;7ZKX`LU MU(TS?J[-?KO0+J'Y?D/ORT6L+^69^W%(Z"AW2:!+$78#&-``^V&,&/)&FQA% M0IUY(X;FJ*:.AQ''`43P+%M$F>'U^K8]*Z6:Y=*(3KXD-<.FZK2[958-S;9+ ML2L_Q?Z6!*&9=0WN%K"-F//E[#RZ-D%*9[%I^UM=E'C<<=W`\T+.0B^:#BY( M+-4KD_K%EB5\.MFN[T"Y:^HFVZ[;OVF-8-TCZ]+"%IJ!\0QUNM7G,V9AVM"`QJL+],"`=E_/+V!$ MXQR3DC,:V@%9H/"9\TU@2L,0@4)%\_')Y[E7TJ>(,\H2XODA(E'B)[$?)*-= MBCU/M'`V8FRNL8Q>(*L)):A?P92H^,Q0?+V&GIU=.5%\-78!#@#!I]L2*UY. MSTZP6DFM3;1(52W"Q9G*VBB-"ZBNS?I36OJ\*3=2/^;/[0?M6U8?'P-SY-.8 M.\2'OD\IAM1C;+0:LD#QLA(E4Y;W@P,F$]U3-3)E^Z?6>=0>.)DX-=!#5>-4 MM8MJG5M#?51)CN4[J:>($.JE:C&X`+TWZF.S`88$>QFVR%%MI-[@)FO!.ZN5J%I*%T$) M^\]=`G4"),:3'XMMONX>LJN*AUU_GM]^4CYW.6=**2,)9U$0MX*#70^&.$)1 MA)+NJ;I$[.CG_P[UW1(%1.2V?B4S?J4J;0T6GR> MIHOSQ`;878@6F?'ES>2P,8*TM:K]+=&/HDXC$A$>410'"(<412QI17-OU@_% M7E5NRM;-%*M#"+YT&$VIEC"]>L)E@UE3VB5$ZJSZM6=+0<)D>5ZXBDF[(RAD M:C29T#)6/F7%-@T<2'R.8,2XPS%Q"46C83_"2/)=D[K6;JQG`TJ#BB9*LK:F M6>#7K*I=I79N71L`J2F;)-O+US99A\3538DJ77W[+7L:9#6A"`<^A&Z;($*. M'<^C;#2+(B[TK)8I6S?3M@ZAT5Q-G%XM7;/"K"E5$R)U3DT;V9)7-&F>EZUG M\NZ(J9DB32:T;"^BW3$LS`O_^:/SWD51KPA+<9 M(4:M-4JA0X-DW\QS0\?S0_&A#UU+M]*U.]""!'\'7P:E?E M[]LOOVORIS:[QIAS3A&)B1^Z'$:4CZY4"H)4`V^;>5"8L3?N<.?$)$N638YU(+#M+UO),+%W6)T]7.Y.GYTWYDE>_ M9LWJ6W=-]?'7A[&^#X_]%U/D^;[CLE;;,0FC&!'2-RQ:D0];B6="KV&8#XUE MI1V1@J<]5+`ZPGHW#F)WC]CUWV%&:$U&2TM_;Q0H8^G\%+[1@5??--U0U(7O MU\OAFU.PQ5F7UW$+$5VVO-MP6$SUK5&MNQG0LFX^YJORZ[9[AUE*7-_U&/%\ M[H<>4W5? M$R>OK(K$+UL]59T24T@MRF14,*^J?/TY^Q'5==[4?ZO*NHX>ZJ;*5DW:-2VZ MF[5C3*(($AA!%_=#[#'BQ'%DS\ET3-G7O1X=:+(?(.OQ_9>\PFEQ*2QM<]$H MK6D#@RTR,$"[`STX\&6$=X.J_P)9EW7,!,O+$3`CWKQ5+G,DJ4M6^S_COR4_ MGO-MG7_,Z[SZGM?1=AVM5M4NV]1I$"(<.BT4-X&<193'Q!O1N`[4DS(S$"Q+ M7(^C79^;(GOH;C`I\AIDVS6H]E!UY4V!;9"JKLSOMM_;0KZL7M+`XQ1AC\$$XS`* MGDLJS^R:EVG3ARY#.(`Q@'D"8F(#]%H/O9@I)L- MJMBT+$[=$MMTU5B750RO^@2K8X"W7FZG:9-,*72(7^I"U'5+(&G0ITUT>O&U MZ63[O:C*;3]"M7E_*$Q2%CJ>!XF'/*_-3G@2)_L+LUKC0236>#=KT?9IZC&N MXQI-;M#.%+V7DXK;,6L@OWC-]/M;,RTUVG@#QI5''(TP+SCG*,;+^7E'P[PN M8^[1M%.ES8^BSBXRUKC9H<;]F#_T]S$.7T@=YGIQ&''7]?W0"Q(8,SBB2&@H M]'"V)=.6]Y4!C6R3SQ;-"MO*O`P;V%].MN^Z?WX8;GI=1"`T=IUY`V)P^]$- MC-)>=)4MT4W)'.U+W)T,>G=IFS)-HF+5\^.Y:/]^7Y7KW:I)0Y=0-PH\3#CF MA!-(0F=JQT(F=#1EPH[M"F=``YX'.%K9MB2!*M6,/>Y,U#![+N_GYU*G7K'' MJE57+E8?.O28G#R@Y5/W9_\IC+;K.-_FCT53 MWY=U4^5-B['[C([_FH81(X&;N+Z34.1[)"#1-"&1.(G4+;ZS@[.\6[Q&!1[V ML,P/*1@.F;'QA=M%R]I@P[%+?1(^PK\#/X4[OAKN6TT]2(5%;Q["SB=@P:<< M\_@O/T-A,Q!J%03/V_!D[3I6^:K)BVWYG"Z_H$'?%SOBR MJM1%##,<)SQ`V`L="BF>#G4@=H7N7)T7D>5]9H^[EZ.Z0SYN-=V#3[L1?#\6 M_#S"[[^YV#N@DWO;"Z-"Q;.("!K8>XXCVGLR[B9=1"=G^A^Y?Q71=XN.J$;= MM8C(&JS0+$98J:93Y5>T^K,>OR76B?:=OE11SD3Y#+7G_E'+5U].*<(8^RA$ M;NA2["9APJLRO_ZD-6MYJR.<,U6>*K%RW;9:3U4 MMR@Z1Z=>?<^?IN0\%1(K!:=6[/_TY::>]\:*30-!4-]L/C3?\BKU&/010TGD M>22&G!&63(4M"QTW_9Y7#Z7RMB%F1$93CO$(2TL/X]8BT(.06AT&A/7I]R)2?%3,>\Q0:R%S^=IFW&9^-EM$<.2J7JCF2 M7@@]`RU)BH;FE.7ZCV*SB?H*M/V<%0^;?/A2RH(@P011XOLNQK&;!(<^-*10 MZ.W/5@Q;KN!.K[`]WK$-M$>\_[JV9.F$057(9HJ`"7E3)'\FW3M/I)0:&HC' M8C72A&]7E=,8@2IZ>C2S/MU@$02A'X8\Y$F0^$'L8L=S1ZN1`V5O_](Q-9=F M=MGWO MTQ4U=0A"*S,<5N8;M.*C97M\=^"Y0]AG)?F(<1$+\RR#TBM5/Q:+7KH&W!-: MRZ9HU%S<%U*D-RD3\1W7"1"EKL-\$D5N$M0\`G!4@F0W M+D'4>)26`1LQ6K0P6'%82"KL42TT*OANNZKRK,Y9/OQ9;$_`?'FWK9MLL^D4 M[%.VR>LT@I$788B#P`\IABP.G7A$@ITXD%`+BRCFDH<)%JA;7'K30FI4G!D- MLLSK`N:`;'M8SO8A59OO/5*2[K:DNND,%]O__E9N-B\?_MCFZT^[A[I8%UEW MS5@*(8(>I@@Y2009B_W$Y2,8!TOM\G:!S+5T1Z2@V(+GK&JV[2_Y5CRKS72: M#L;E]L8"`F"XZ_$Z'`-RT$,'Q]B7$1RE`=L;!LG`0*W98$G.SLI1=WU6UE(H M%K`GSN#DZ5E8JY1*U\+M?ET^Y:]AI0C2]M=3-Z;$"4B`<13X4PKMAW#:`.7' M+I3LJ>QS1F8P-L=K66<00XUFNCU?SM3K M!@@2RNI_RYLWAYP/^6-9Y?_,-KMAP'.S*?_(6DKJU($(DR`*$LIPX,>.&R5H M!``1CT4&Q\Q;M3Q+UH)]K6*_C#+V\AP\K:1_2FT[\XRJO25+9D)- M@^J%I85&7+HVCZ9-EU"2^#'O7G:Y>7E7U[N\NY2NW'4E]M?[JMR6W?T#W89R M-$M"8.1SAAT?MM4U0;"MLY&/F.O[/O;XM3K,@D5["(U5:*[* M.O/B&59:_Y`:D,9/3;9==Z\H^)S_ M:.*6DO]-O2B!#(?,10%*".DNG*:C=2_RL>BU-@9-6I[8O;`D)[`&Q%"%:_4M MR#+-QK:?"2?XTB$%/503>X\*W?K[CF7:%0^JBGJU*>M=6P&7CZ#YEH-L73[W M"7G[]VW^!\@.`7E^O0LUW[(&/&4OH'AZ;L6I_^GNY*)Y^8\:/!;;-IDKL@VH M\N>RZG[^/^UL5F]YE=RH-`*SX$U*QRN!#4J;-.$:^L*HU^'3.^V0L8MBQTNX M[P4Q(]Q#<K?)/SR.<`X2$A"?^(%+7$0\A#!LLUVR-TFH@Z7>'ZQC MQW):.4+K]M@1G.0YLA:+8AHX%X%RBG>*NS9!S#K5$TH3K8C4 M*]6G^LT2?+WXO0FWBDKVX02M4I)FD6GQNO_(V9G>78KRTH/&QQP@P-P\*7#"?9`15-PZS$1VRZ6$`ZYG>%" M).[`<23`B%LX0%8V`$6&+VB][9@M1-:MNUG.NQ1,B74*>01AG#@,N@%-(AKY M(=D;)#&):?J<5T79O2^A:C1%^:HMF77^,RSA)1_G7XOMMCM>CKLW0:PN7`1@ MFDI-%37*GS&=7(H"JFB<,*-+5S%Q1T1U2I(:?26Z[Q?TS[4H6__/;GA45[:S8)QR31V;@6V#6>"` M%HQPP2\CX+\L1?E.\ZFBAYJ16;I*ZKHGJIU&:-17U&BUZEYD.?4%4AA!SX68 M>W[",'2QY])H`A!AJ3<3F[-J6T5'/"`?`)E23WEZ-773*K,&%?/`>'*-\7F% M\F<"5212.0A+%T=UQT1E49,Z?4&D6?WM/BO6G\M/>=-L\M1S&'$3WR5^@'G( M/([\9`\@I#YR%!Z%-&=<:/7J7YN;O1C-*>4YUE1%.[R:5\4.)^B`@J8$`]2E MZ.+/%*KHHG(8EJZ+ZHZ)ZJ(F=?JZR,LJ+[YNZ:ZJ\NWJY7.5;>O-_EUT/H04 M.TG@84P1A+#5ZQ$*C`+'2,JH8=]R\CA"`LT!DRFEU&%=4S-G(MR@>NX1@RD@ MGT4",J^,GF=515`-Q&CITFK"15&1-4:G@3,7YD<11IQ@!CV>R)-D\\+2M!67A2Q8:^Z5\WR\32[NP_Q:&".?>LCQ7:=[ M%8L3D20:K6/713(EB"&3MF>.\TV^:O(U.+6Z6=9DX)??M]EN7;3?<^$4RBKI M!H34#M]F]5/L)HCY95-DC-\>BBE^B_BOUQFT1WCD"OXE1K/$@Q)=$KL4*/0!+GA M*R5?$W&M2I)G;"$BHHK^5#VD2H*D*`R=BV8RYG"BFV7[L;4_.4.@1"-X@4D)T75AB9NE>R)(S[%1I M\Q,JN^,/UY[5W65HK>F'3?Y;WNSE(`T)C/'_47=US6WC2O:O\&UGJCQ5($@" MY"-(`+NNRKWQ];CNRSRH%)M.M&N++DG.C?_]\ENR+5%H?%"8ETP\2=C=I\G3 M#:#1+4/&TI@A(3%)9#3*9$D*#/PFHMPO$7KM@LVHWE6P+B?F.3O`4S$?F`M( M8%HP('A[@&"MV9@HS)T=3,`TE2380-<3XK)CR\>4P1Y`RC353`];UU"^U:(6 M61S1."$D38LHEVDA>4@&&3D*(Q@M@1[MG(8&;=2G&NI!I,8TSK"!,%=,1TZENHNG5:-H<-]O*RYU#FVLP*U&;W/C#*.Y M`>"AHU2#;ZM@\&'[=F9>4T!M@M]L8NX)SUDUJ7+WBFH=)7U]Y*OM2[5=/OWW MIGI]N5[?/[TV19I-Z4_5=-M_+1^^OI2;[G9"KQ%AG!-9)X\BI"PG!2?AN(9$ M*$_`-P'^@!QA7=P-P$RQ5S9HM6WZ M+O;Z!H<*!Z/&5Q>F5GV0SYZ9.?6<)T0\AZ5'3]]F`%>I2WC_Z.MUS5;UNO)E MN7[;[_%M%V&(.2E$A(E,4QR'#.?#H:`HN%3JVVI!C&/:/53KX"P`T*':%,9I M1IT901AC#C'K'8@'JLV(HGIW[QG1U.OIK8^J2B_O:?./1`:+F'G0M]N6)97U M%\JD=FLA.,\1HI0+DN0T1G$HAJQ>L#!.%[MJMWR"Y-"J3P;Q\ZB$\L=PU_P3 MLST"(%*0#-<%2,!36`]24-6L$HJ65XDB6/FIRBL@!(#=QZI.''=O-_4[LJO7 M_TV!R4L3@9I#FC@324)90>O%?\IP%A51.LC$(J'0;4<#43/L-W;:704OC7[M M=E@Y:*A3Z&&&K.H.XTR00K<6!RQO1BS%'LOYCVBG<)K<3+0`KR><9,>63]N' MU@`"S\1<)(PCGD>$B92')$,RYV.:A`AFD%U`Y8.0 M\T@XG=@YP0I@<#QA`+C>)T9H`@T'U'"]GRI1DXCXU6]UC;))%G'!9)0R)D1: M4PS*Y"`[8018_&U%Y`PU7Q^F<^GD(W;05>./V6&%<@$U*4>CM.E+]7Z^Q_UOWNV<0CJU!]JO.F+*^8Z!MVK/W?QG#[0 M4\5U,[C/$U:>Q=2/Q7FSP:O,X%883B-.W,"2!XY;O'KE%+L_C""#SU MRHNY0-0KN]`$4Z7F8L+P$P47-J#RH-K"BAF5W3<(F!,>E%`?)*`1R^,"\5C2 M,*0L0B%*APMO@G$"/$O5D^$\'^SN#VC57&BBII;_N8<+1L/O[UE<;!5\%):) MU,\,1D\2/T,C*IMOEE8%UR+B,BXXE0+'G.4RQHD8>GL)'L4)O'3K["-GJ=DR M:,)W'A,UHG``!XP9SF'@L"CK;#66,BR>?.E0K8_67P&-5OZ6OZR6WU9/J]VJ MW++UPY^[ZO[_?E1/-2+;;B4YMMJB<1YF),69Y"+/6<8RBL<%)(\P+'&P)M9Y M+G&@:5M`].>/Y:;L=?VOH-,6R!7V,%=CDXN`#>.;CRCW^U(7Z]BG"MD$65E' MW1,ZLV]7Y?AUU:?$C_T&,0D994R$89+&5,A"CI>91!8CX'ZZ@2#GM#?3-CA7Y,$\EQ'(81IP6J%0CYF"A*1$`CC>U*=KPA/WQK MS\O=ZZ9+):K'X&FLS7BHC8!2F%WD%5GM8J`#B6Y$MM&T3=MZ78-6V8-I=1>[ MYP/",\E6B4 M1@@PK],4XCRG&QN?OG2*:;:,A6*GN.7E'C3@%MB`5J_1I=O#O@=F:I?,#$E/ M2,G4BA/-8(U`4:_'>GYYJM[*\K9\:H:0?TX9%RQ.0\XP2I(0X91CEJ;CW84T ME\#>L.;RYB"?35-^67-/_9"G-EWH?__'IE,[N*^VX(UW"U"K$=2\&,.X:M!M M1/+8(G3NDJYS>$T5=UG#VA,VLVC0QX(ORU!!4JGF@[ZMWI9/[\11'@M!ZWR- MDKS`35_=;+RF@'`&ZHJF*G(Q%E&F4,VE( MF2UY^MQ\]FFOK4ZEDPZD:B0T!Y8P$NJJG3S(C$Y`'!1T*!+:@\N,UDQ8SIQK&:L!@4Y2TP#;,4Y2PM$ER$ MN6BZBP^24B)`K6,U'@\B8M/^L?K+?!W@P,FN"\Q@'.Q7-@I*,*'@^9`XC@O:^*,B^&4P?>%SRQ;I57^!@1-O;]VN=XV_8CZR5HWU7:W*7>K M3=DDZ+Q\7*W+A[Q,?'"?-,EESI#@,@L+4H@71RSIJ]&5U!RSL;@F^=]N#9@/,X2XUI_?,2C(@/W=.=`+TW(>AM"'HCVE[A MVP_;FQ>[&F\%_0DJG]>[GC#]S$9_;%9^`D2)BB*/AQHL,L02>O]N6[IS[WVEJL$BW#KL:MU\2 M;QB+#P40[P%O=`W>*7M!J@:">;[DR+I;/*%?9^8=+U%R!*-Z?^7]+._C5,X8 MPRBB84&%C!.,>$RSDL MP>O)IVC/GM,#[&T`I71RVZ93_QP/AZ_;-^R]`HL\)BAD19*DDI`PP7DM:A#+ M:)ZKGN#:D.7X4^L6._OO3",]L8;J^9/=N0&%I1\=EK5ZXX7^3L&@UO!PI3@W MKNJ'OG/CJW?XNR>($R_N55".PS$>AE@""R)'CX85X#EQ1&P36`^.BJV:4[EY M_V8JVSR(5CB+LY1BF40Y)ZE,2:W.F!H2H312>D9U'$>6_=G&IEG!H>]22KG]-B2P6=VF!K=:KOBY46&:%(D*9(*6%Q MC!!+HJ'SLD1"*(UN-'G^G+6<38=Z:.<'(^S.Y_QSP`8CT,^MU&_F`TR_'[T+ MX&SUHC\+H$X?^OZA)U)R4W@\2,.-39CH/:\'A_95S0-J)Y(5(A*Q6$N MHDP@F>"QK#S+.>BL5>/QCA=\[WO3ESJ]Z74P4V,%QW#!R.%0F:&+?\!VN\WJ MV^NNR8Z#754O72Z0=GR&:8)####UA$I,+*BLO6"6AV8L"H)25FX,P+(%"`%&FY:PN/OSY.#-H(0\&BG$J$*,4TSYI^"U$>TH+G:9YAI)P! MV!#F,BGH]6OZQA_-$"XVQD$)NLE$P2;TGGR-EHWZE$[8APS^7=ZU6[62$B1# MF5"6,9S'+(F:X[%>BDQ!,QV`CW:]9!F_N;]:?28^+"M``9G*/D:ZE'06'K>\ M:]4'9UKM;0)1`]-()\X!Q)&+W`,W;+,,7A42,<( M5M\XR,R84Y1D`2+U\0?O9?'J>;E:+^(\+_(HPCBCN,CS*(Z245B1Q:`B2CT) M,S-2\%>G%Y22-.%3HR+WR)E1D`)H;L85',-E@GO,9FD4]X3#"(/G:>L(>!`96MUPC( M&G>;<(B1"96]%PK:)^7A8=441B^?;I:KA^MUW\ZK M%QKA@DF2\"+A*))91$0:#T)Y44C0""0C28ZY9:]JVW"V;OE)BN5FO MUM^W@S049@E#11'S)&*D2/)H)$=*0@KA*4T1C@EJT"H8U`+RDBYP:H0T`V8P M)OH$UZ4(Z#@R$\QC"*4GE&-J167U_=*Y^+.GM_?$QDB"L2P? M=X$8!VW^&@ER3#A-R>T5[=ODOE.U[W<$;VMI"W/%%=Y% MX`:N]KX6UR>N&EQLN:<*V]32SSKTGC"@`\,^-ZIT`AV\HNA+G2U>U[_=+BA* M0E[@*"S"F"4R1:R9Y=M+8IE>&9'ZX^>K.FQT"EJEM"N'`*BIT9ACP&!\!<7* M;870B(A*61`L6A'&7=)VH$=DEWP-C-A2><,"`0T@EZ=.4<3[C3F7G5/.\X-'=K3_6_ONZV MN^6ZZ:^V0(05J*!Q7.2)2#'&,A\%"1$7BY=RLZH>ZL"PV2DF<&`9D`_VHSK* MWVY>?E^MFXW-X-NR_H/[\BK8ZM0X:$"HF,M\Z/[@^J6/KRE1A8<+[[`PP,Y>_DGV7?OKH9)K)`<<@3WE0HXH(5(65Y M,IS89SC%H-UBV),=KU%J988F[+\]U?K\#HRJ0)C4(JH[AM`&G'P'P6Z/* M[WXTCWD'SP1SZ,'H"6EH*E_9>)-TCL2/;.?6:X)R];UOAG__=K=9KK?+^UTW M%J[]Z:GMN\H>_O=UNVMV;VIUOS[>+7_=5)OV#P[>MKNJ>]<6C"0%R6):()H7 M%`L:(38:0:($?,;NC>:N#^U[:X+=WH!@.5J@=8+O#7:0D@!OE'9=8W#L<+-G M\JN@-SD87XL#H]LV/`=F!WN[KX(F*E2/S5"8JZ"WWH^X,*MSSU5&>/>2>1+7 M/`7G6.V&?UK:BN.0'?+7Y9" MKGN'FD57KSQI/9`>6!?LS0N6VZ`S\&\8,4T=IA$<9WM'/(^#\^&@&/)F=HR% MZ/9IN#@L&J,BEP67*$(X#SFB<8'DH"]'@BS6Y?>FBLDTNCE64XD3LXX3#RU2 MIL9_K-:KY]?GX*4;]3[.@7AS$N%<.]4TPOG@36L1[K?.JM_;V>-US.H]W*P* MN[]^4VUWFW*WVG0U4[W=06OXU=][M6CJ2JW8-]/;XWWLFPL'Y=@WJV.4QKQ] M/@*J%6F7GH_E9C<(SC&6+`\Q3PN4Y:&0K%Y5=H)%FA?)$,3NU&:_V1&J$9+N M](YT=KUJVX9>7L[0BRN(IT/*S+!:&R#04?J@I`I]N\)7?93<_#CK#9:S@[?* MK#DE1(Z$,OMH>C"'SK)!E:L7SRA*_%G6/-B^CK=E>PMC'\D6>7/O/D2\D#B/ M,IS%A*-!`9&'Q#A:F`B?)VKL-0PVG8H:9V,.D-<)(L[1MAA,#G#OE3U8/EP. M=I/8,A?\-F.,IAOT0LT$0,HAQP;(7H8>*X9-AB![T&F&HB$`5H]=`"RZL:W7 MZY]EI\:N.N@PT#<86."(DYSP5`H:9H3A,,S&*"F24!H'*3=JS1.^QORP>NS7 M.\$PH'@UZM\DC_<'K1NVH-8-L_I2)^Q=T'\6`^*A)_L+T[TAP?4[3^HWX9C5 MDR:1]/(>M1ECW7A6+P1K(:LPO:[)[FMUMVU_L^U","+2 M,&&YY!+G/`Q3A@<%0DP*\-!Q*U(=WZD8!U9T5[*#5:MS4_%9OW+KLBNF_\]J M]R/8_2B#?[W6^=A]M0F6>Q-T;W/;\XM:Y_1Z1> MJ>U79@+46=^:T+\!DYZYR^[8*48\ZM8?]FBTU=-'%OT$()Q$]7W@-X<:V*5& MH:;`V18%R6QPJ8EX MQZS:JA94G59!.:CE(NG4A-]"]ND>>2!_-EK]\6U9:]%N\)?K;7^+=K-I+H2U MV_S?^E%5_=^[6;ZU_YLU7;2N@MZ:JV"P9]M$PLYH/_AV`GK=]-7,CWYSL!4+ M(0FM#3"M9+;'%9&,(9['82$DRF1!8R+'PP?*:&HKQ=63?BE6MIW`:F)OGLFZ MA]UZ2MO]E5[GD7<]8=O3H&JFN68.\IMK;1@(2'QM0&DI`VY^S9M\XC#M6"28 MX;@(91Y1CCD-$;P[**O-8[G:O4[ZZ0*Y[U&PM9-?,]?YSDC@P9PQ')$"5UC,@CB<2X0\(EL98`ZXF_*"=;3X,U76`A#W:/ MOOU$^&_'QQ-0ZZ;'9G[SFXVM6`A)D&V`J51_>#MR2:M/NYG6Q8.BZ7;\U.3E M*Y[=8"IKBTXISGT`DC"^'*O M7+]!T&_0#LGKH.+,J*I7WLV,KEY9G3G**O5RYZ$X40QG$4,/*MUL6E,Y>=$, M&;\-.J-00C-:"XMC1F(6,\I8//1'EURBW(3P89+FYGM(&FT)2SVV=P>C';+O M$V-+7`^$U(SJW4%KE^F5(=8E^G=``'A>#T!/:5[3F#,L;P*1^F3C?3.&NVH_ M5?EFN7JX7O>SE>^6O\3C8WF_DS42)U8=.:*(\"*G3%))42C3>-@!D@G#H'J0 MN71R'#C$K_MRNVVZ]07?^D9NS:O4K1?ZC8#[`WVA\Y'G\IS:=HV/3H.%J0,+ MFJLE!Y/D&R.:0I'>C*NA56UM3Y`?NO;4'L_<(YGM^&)BDV=N;WNR\S.[V1^' M/5\$=JO!I-7HVT>-;LNNRK'\L]S\7-V7W3;7;7E??5^W3VF#X2+-HEC@)"&" MYU$8R@2-/6]EC!+0D>O%E9UCW3)/F''K4WOQQQMW.@M,IP\91BN#WLS^?"(X M,-3#,&7B,L/X-1"R2YO(?O">",/Z MM.BU36*?8/D9FWQ7?6__I^VLR&'.F9!,2TLL(",%S3OI(.8^AG),109F.Z6% MZMQYYCH/4#L-WX1$V=_`3;>]*?7<_QL3F:=YAI[M2*,Y_%.B0(]6F0PNVH+F M95;Q*)PBA!AA"28)1P`*)&5WPCDGU.`.+K^"M3S5^9ZM05KT/9YH@+H3*89` M.M00XM0H\2EVEE.%YMA/FQ!MC3*8';2%3)\.6Z=^OVNVS7PM'?WS+$MA#!G, M,E!RB@6"`O*^T"YI/GMHU2O6FB^`F4LP\;RGRNCO^;6:1+?SE:*YRZE>&%][ MCLR07UFC.!4?LC?@N;\X0F&6*CRYF6R6)J($99*`A*"2B9A2#GM)6`ACYS`7 M<07ON!#QPP6B)\A"V>N("A[2#JAMVUA.TQ7VX7JWJ[VU2? MJC\:+@W[YZPL>2HX8A@#7B"("YR7,(4Y2E">Q7%L]DJRDR@3E[%ZZ;C3;FG< M+G"#4"\?'@T[LS2X5RLZZA7]KC2+6M7^9V3&&8)I@'N\H#L1%O)C2QW@\S-D MIG9.;[=HVGR:K>^ZESX6S?+;LI%NRF[EOS!?-#.>%YP`2EDB!,T08SC.0,H8 MCV.SL=V]=,^[=N>C6CWSM%QW8_;00'?-'_*DS$,0,85H?^ M@$VS[<67ZFZWJM[?GU%%U-MF^TG=^CM#&2<,T101D"'.R[@01:>"X$EAM%'A M46[H4:&#JJHM=]Z96WUE(%4:#SAQ^$70[-9="7_#GIU/Z,,43/HX#E52`59C M(AP:Q+3GM5('FH%LOYJGF\^3+??)TOJEVS7,Q7V]^JK[?59D80Q22' M*2N2%%-$&6-Y)S$MH=98I@Z MZ<84'S@:/+$Q'IZ6;VRYDD+^=T:0/$SDTNPW=]'<'9NI>'<,LU1@BO4PT)#IF'-QK M$GVL/K<7XQISA)^D\ADD`XFC+7@320ZMU:_]?$,N_2V54[899OL6SMOENOJU MJ;YN9S1GE,9$L(3+8KTLBQ3TA7HNTTX3YO`B,#"=/*W+E)*'XJQ5,_I=*1JU MFIJ6Q7[@MN@DCH&T2Q/1$N3P#<0SP.GV#EUQGPBK^;5IJ&/H!S"M(O=3W>U$(FKY^-[KWR`O#E"GAL;,UX;@_K4[9C)ZV^@X9CPZI?$(\- MKUU5?.GKK2[!K%,::T!QIC[V">($BF2OYM1AOC673/@0?MA"W<6BLO"[O'K8 MJ"J^=1?&XI)0AI(4<1&CI,2@4R'-"F#RLG((\5K>YCS;_;;:;O\>S8\Z1G:]=94KJ!;$C_KD6_N%SYF$P=5-G3TLRQ0S:EVE#B;17 M^"S["?N,<<8)XFG.5?L")DR=OBFZW#TMTM)P@L]*1/#)O:=^>LB5WT3KJG%J M$>@B:-,2"`"=4PO@4GTQ0K&_5T&[N#=$<(I49&S#8/%N!8@VN;RMUY]EHO(U MKVY5C^!P&\3;:KZMWM^NEI];9MM^J![VC\!MW]_?2*T6RX?YZM?UN^J/YM/W M:O6M^JU>-U^VLS2C>4JJQ,R MMAP-&HPSRBP99^I)1A?=17$.+]Y7_X>*+_ZMMPHP@1;A*A%&^DHU8TE!,"4, MP;B`><&Y`*+3,X&9T<&%T94;+LLT?ISQOD*3B33*LA\XUBCU1XHV M1M_`3QAOS.P/&'$L%N(:,:>4WCS#*14%$CS.:)PG%&0\[HNOM`C1+_.GVV@1 MAUXOXN@MTN@!Q_OZ3"7>*,-^W'"CM!\GVAA]`#]?L#$S/URLL5B&JX2:Y;=J M)K*896F*69(#E,"TS-FQSXUWE_1GY M)$5%6A9EBE(`RU3D<_1%Z MB0S.<$]CJ2S/=X==,JTCX-;XG1E_'V%!)C`5/X:5]:A?N0$Y2]GR4]_)#_MP M8C7&$)(XBP$H!0>4`D&*@PS(LTSKN1NK7QPX`S_J8\"+YNA<#DA!@3$+,T=5 M;"[W,`='/Q0$!(6%K*"9`K?:ZUQZ^!=.;-\[DSGNA&>,8 MDUA1,(.8`HI@U@D%!!CUT=TD!2;*L\6OZ2T=;G#JM2'&0]*,6<^">+6;/(:` M&BCS_0`\D:+=DS'/[_SP")%6SE8L/W]I;BKYY:V;GAP/XD0&12'R/$YH)GC) M8"F+]KTX%--$JP?K*B,P066_`/#GZ.X8CN]V5?2;1.Z+ZJ\B@PS&"A07F+GA+QG^<]0VQE92J9:XV<-F:71JR2>ZESG\"L":T;E4,&HUC/9$I'3L MV4AI&2DU;=C=%\@&=Y:,#[;EM26^0->ZOD0+E3/1P#.D$P@,OBVJ@WU_)N'B M(&&^OGM7?7\F+\M(DI0,P1Q"G*<8"Y!T\@BB2.\@OK,8$[>R.HS_J0L,SU+Z MV-%_!HP^YS4^<)J"KWBQH_;\`1GXA1I_:EWROZM-K?YZW2,Q02D1&>%9+I*$ MQAQ!V"5P4/!<-XWR)"YP&I6T!?#3-*JL;C<[]4RK]!=H$.1]`7PYD[H"MF:9 ME%+P$-65>OO_\I))^0)9/Y.Z`MAVF90WT'4B@1XJ9V*"9T@G$!U\6U0'^_X, M(L:[Y;IJ)9_D;\_K_4(P1$%<((X(P)3(1(YV8@NIC6ZX\"$K<*R@O^#7FJ7& M<<(+K)>#Q-B(FD4(I=V!K)Y4?$Y-5"_(ZD>&L1&V"PL^D-:)"!IHG`D'/G&< M0"SP:DX=YG,SB`),TAM^5S?=S,!!4I)31#-`RRP5"4&R6@'=Y``"C&E>:><@ M('@-C5N^7RO%GK17(79SE-?M/>,;CN!,P!U<+:B]?2FA!ZW?]G>U%REFF#/" M\@++_\0$DZY\1PDEVEO'@=4(G#`YSO&^-7YD8HR5NYQX36C1S'*RGW*]`L_, MAUDWNTSO=`6B^WH3_:B#]&\''AD9<:4F$#S'LM1UJ-X67*L#MF*WV4CGZ)]1 MSLJ8@;B,40((R;(",MC/'"0XU>I!^)`3>IITKT[TM3^!IOQZU?OUG53Y[PY' M8HUA'0Z%8R-J%NN>TN&;J`/W>+SO>N^W#R`V,%[J`^>)#)=Z,67@=*<;/"Z< M-1.HB'&*@5!'0F6UDB99WZ9E3&B="7+Y_8$YZK);N1/490RMB_G,(XVWGKD-"+4 M9CPU<*''0;EI',>Y3%F>()X(>_FR1N]$CAU(5IG3.VG_LWR-H)C`!,,\2Q)` M29&B+#Y(33C@T#:)LA`U6C[E6MW9P&B>1P5&T"VE*O[H>UX3K?9>PJ>991O>3XM=Y)SD0B$SE..">%R(L4 MJ(JSX\R,Y4:O(S@)&KD6_,>FWIHF6VY`ZO'7:!BZL=<%^()PTQ`T`\SD!=&) M\)(?6^H`GYS!=O9_K.=?ZTVS_#_U!J(4O=WN9!E4'1Z4E?51OMPN6N&TB%F1 MQ!3@K"PR7N:8]^U[F=T!W9UK?Q(#L]2)HON=L4[5[EWJMGSLM#78V/2(^>4] MY^O`;49H/P+2^KO%UT'<;F/8%_(Z&[[:N)S9V_6/ZP2V<0,858?\%/VT((_Y M]BS)19FJ!W2++LT2"]/J0U5$:E?#<(P]9W'[](IE5_%O77V^6Z MNCLD[4!D>0XR`G-!`.0L)GF_N9.SE)@6]1Y$!F:Y?55ZK%)5"M&JVO[CFZC3 M-MJK:U'X^X!=OP4P,N)FS.<-[&!M@LOP76@8>,1_(FSHVZI7F@C>03/@Q7LE MA%=K^8?F1GZMXHO\8JM?UX:-_/'GY7JM-HGK^^BQF@^\L\D1(%R+(,=$)CR+6V MN?Q("IQM'E2)%E(79R8S0M"6PT*!YX.].C3%()HC\=8)4$:,90/P9+G*RIB+ M+&4/D0,__;J6_EUMFU9JGC-&4L9!F5&&14(2W$O%96)T3L115&"&ZG3Q0U%F M(-IR5##\?)!4#^@D6.H4*B.:LL)XLCQE9\U%HG(`R:735Z^;S?)VUQ9-_%'] MZ$968DOU`N*ZVB/"[:6==ZIO=/O8_C@Z5?GJG'@!4K,&GJ?EF2QS>C/P(58J1G]1 M2O[UZCSY`CS6A9\(Q(EBU@F9"4B#+I M69:+''FA.B.)X[!&A";-0-5WE47QSKMO/:Z>$E/#T9$IU:TA<&I'9.D;QO\S7+>D`L\6;H/:_7E M'#H\Z`[AH:PWU?+S>G^KR^*Q^&/1#F!^D%GI?A3S%>5@PK($$@YQEL4YCAFG MG7("Q%SKBO9Q-0H<'#I=]Q%B=8%-KKDRMJ'AVHOB(S(<;(CZU>JLB)09D^K> M6L!M%`A"+N=DXT!0HR^&@?"0>YUS!X0A(>6PG-,4I;1`_6BI@+3HYMR+]9UC M']E`I@EA/%5/OZMR:<:]DHGDQ>GV'W3Z6A?_R7JX@TD6T]=F<'DX'5C.EYO_ MG*]VU?O[=M=INZV:[>FYF*R,RX2HIP*R/$8)(HRDO489TGJ`=@0U0F=C_:&T M!]4CG;?Z^3L>Z+X*UN-$UU@`+W-%_8HHU:-6=\6B;0][K_Y43PM>PMILX,CW M`DZ6B?U;JGURT#.X+K7U:YK,(`,\241<"IJ*..4XB;O1`,&3V,L)0CO)YOF5 MQ2G"E@&^=0QPPM!A3A!:KH%UG1P<>"^5\#D6OCKMOHJ?66GKM`*3)51'LRZ7 MIQY@=0-)_L=%F*R3*DNV5Z MY_)Z;$A;:F"6[/0(>UQ( M'V/KNGX$>+V4\<^/!W6:7IT:SR!H5IP[KL)DB='9,-/3/Y;0A3Q5R9."`Y$S M6,HL-E;76Y9]'@LAGIV^?*JJ*55JGZS\&4_S::[!C^+']@:Z MG^8S@M+7Z98"\Y)(.N$L*T`BH$RV^KX=$!!TD]^.&Y)ZPBR&O,T\MM/&X4S+ M#W4$0Q?PR;JGG35F1S#,0/)S!..T'40+05$.02K2,A>P2(X[GH3DN>^S%P:B M?_Q#%R8XVU8:`;$-=MO^&!V$/!DR+>DT` M]SP*:[&2DR7J,-9Z&'ZU!MG[?(8L:VE.\X0AAC,96"@\CH<(GN;NDZ]V8 M?AV5FCIJ=MN]!C,:8P@80$#$ MI10I`(E[V;&(^:RIU>-'MJYJ+M`HJ>IUT_?15J-HVZJD[98(R@"!"&%)1%#3'<:'ID%YDA7/(7CWE=KV"4:=A M]'NGX]BCXCJX#?BC5]@GXH]^;:H#?J>&_KA/;_952W,4QA#F&424HAQ0@1#- MBX,PQG-@-&MC)V&4ODUS*/T'3LX$<;!7(1GP*#<()^)"CD;4/K\JXQ>,MU_8 M^D[]K?C7;BG+1]6F98V8;S:/R_7GMER8@20360)30`%+2Y3S+"\[X3GDU.P5 M8Q\20SN1U*[=NUVH/U1'/4=_9%<#K`'W\@OV1-S-LU$O'MSU#YE^S%JT[Y5O M/U2+2HJ^757OJN9`!3,4,TA1EN*$\910DA/2Q4D&"4J-0I>+H,#.U^D6;7KE MWD0K=2O0?+6JOZLGWJ/[>A/=U;O;YGZWBN;=_T%FFW]*?B&MY_X)_4+&#GX# MH`[%0!]K,1'?]&/+\XCH#R!M3WS??*DV3T+Q#/`B3A/A&A<+:F^?DDM5.J-Q3$B_>5.M7@X:AT=K?\MOE_':Y6C;+ M2MVW^K&I%__\4J\D(EOE2>#L/CI['V2(Z/1^SMN2\5[F! MH^U'W3G?#]6J/7+X0H$9XX"+.`<)!KE@&`E$NVT'CDH*3=S)75KX?8#-KKJ+ M'N:/&W6]H(ITAS__;;-7NGT[>^QT\")P`Q[G#_2).)Y'@^I0WZ=-Z_\5<5"4 M\H/`+(%I2A,H*$.X$Y<(5!CW_RUDC.1R+WO_JZ.NU^AJ&SF9*[@3<2UG,UYK MR?T7`+A;=@&=`2B(I;3^1HM0;(-W)IM.[#_M@ M.+92\8Y+JK7L]-3\^B'U52Y76452I*3&`C.#=$VZ[KGGBH>7EQ\WB0%*`I!F M*#-E$^3#/7!419WG_/C M/<^_G.K3)@][>9D@WU3YTR/EU1H+@S3B87W<)`NR-$;=J2_F^U#KR(63V9UX&(0:2W,ID'D M>J.K<:)9M#WSH&O.,?6T:(76H2VQ2<.V$&F8V.GK3;89*-E7LP@`S>.=5FT[%HMG M.&?,G#5I&S[3Z20`"QGVSMQ[>?+3(8TF2]DU\D.4\90SGQ,61T&8X&X/)8D1 MC_5VUW5^\T1;[.^7L'!56[$J4[:086,$_?8:5=-]C9NL-W<0XY1SZ'-YWAHD M(&,\P+2SF&29UB0UPHSC^>BU_73='E1C2#PLB;^#'G47H#KJ/'IJ7B251_>] M4^E]W-0ELAFO`1L<3[!`]T)DR(8G+R[Z6B)'XSAI_C47LWYSWJ%YUN1\JDYB MP2DR@W7$`IP&&?`Q35,2QHS'75(OC&*MA]Q&FG)^I+1%YU52MJJ5]Z_@KS[P M'C;MXGKRB+W-M7E=SR*8]>^>24IMB-#8:: MX$T8!SW1>PI!C6S5M&=:>1]4"'5TK'>(JL&#O58X7HC2V?+FQ>%>BR2]J7CW MQ=_6'X[B-V^.C[1.3:H7)OV$Q#A@J0]XZ`>,<1C`SF08^TKGYVW8<:QU'3R/ M]F+W;_\2!3C\"?X5/).\T(':60G$L-1-'0,]G;N@O\'6]J%3TCG[5.[*[;FN M"=0=?9="Z3-4TU![-84(C^MY`<0^JF<%!0I>F1)L$C?S?E=+^=Z7[:D=Y M?U\6]>13%[Y?V$T9\"%,><#E?AD/((%17QC`OM8R?;2QJ>8$[?070K)",%@% M!-3[5!#B%<1@%:"@G2=^JG_F1\$*AG'[=]`J]N,5BJ(1^?+X`*IES)/&3F\N M::!U"7-S?7KVM/DMO@829VM4+R1UMN?/]0,K=HE2%LW/QWQ3G8^/3SG[.H(L M0RB`(BF7%=0DP7%?/PW\B!BTQ#"PHC3&1G>_N)))[UM^V,FF[J<6L'R-5)ZF M7GEPY0=@Y?NP%CSY9X*1IL"9D*TF::X(-A*Q#LRS=?_$FO62D`&5&L'>0G1I MC`>EM4])]RS`;E>_>;@YR$Y`[XKVC-,:)122.&-!A$D:A"A$27<1.(E`P+7V M_`UM.$[/GF#5#:_^(B1GVR#3E!1C#M5T90KZ],3E@CD)28IU\A9S;HY%O$[- MT/&'D60N1&M&NW%]G,$*+01J'1S+$1B5='M]GQ_KF_3R,-1V_UI M'>$`)P`A`C&'20BS-.X.3"2$4ZW;TQ;,.=:B#J&7MQ"]'W8-LA\UQ<@&M6JZ M-#&K>A+5$YKVA%[@\_B;Y#K1J[E0Z^SCU3U=VENI5I%A5 M/ASS;_)`Z/?\7;$M[W-Y4.S7_/3AZ^?-W]>,(":DE0$2AI1C"EG0)W:1GVH> MV[)MW?G1KLM1V5[LNX0L<@N)63?ISKSJ,#I][=1*;A4BI,_=>GGMU2..(@X#K%/J8Q9QCSD$& M?)\E?G^:!R4@U.G88_#KM1)$_?X\S0G8!3RG\Y(:K9-IRCPN9%R-\>#-DVB: M9%A[HFH-`8U20B($$$-Q$-`8]*.24*#5W6JTL4E&SI_P8:J!<66-\X6,,GO^ M:#Y`I4G4^"=%GPZ?HH"D.`RAGT41@2`,L.]C>1K5ARFEJ@W0QAMR>?BP>U+T M8_^D:(]OOC/6;U(V>`C1%MT+&7D6'5)]9]20JO%C[W/^]Q,3SO]MG8C)-O,C M#`GA?H)EHV_06P94ZQ2*!7..BXN_;;_EN_.A[KXZ.":USU:/)WJDRKGAV*K, M?:[OEDB@7HUT,7+7B=_K$+UWP##Q253Q3LI0EKUEXB_4VWU?;0UF=C_F3 M39S$(,QH@E@<`@HY"G%C$Z$DAESK*?]1AAS+7%NS$N"&[HZ5Z[;`M9)0[=W-M"N-08$8()`6%5F^S%P*,=OTS^G M_M;8QHNN7D3^7$JKZ9N9O)H0:**IGX^;HCK45_WH[G_/U4DN1'_)[[_DQW7$ M4D(H"?W`AQ$065\,>D5G`&N]%VW)I&,=;1Y-W3YZ%QC-97(4M]H".16MYM*8 ME<=\?U=X/:B2B*W/;GS;Z0 M.IP)$GA>B<^V5NSC?YXWA_U7V4=;-MC.#N4?_Y'O[O*JQ98E<88"*I;'6809 M8P&BH,?FZ[4!G`208T']O3CFV_*ND/=5/0G?*PN/Y\?]=Q';[]H%N&EBI"V] MRPB/N3#+^H!TH,M0Y.51WA<3%`@`2L,PRI(P\T,4\HSV63LCT+0*8[G"-VW M$@!MA9^:>W,M;Y$^I_M/D6DK<*PFV#:#M3QIMNK=;1&V3Z+MDN][@>_=*;^O M!`Z24#EEY M_&-SW*T1)S[C)/"3!&0XR)(4)AV$)$:AEO!:M+LDS7V^_2Z]\%HWM!789F04 MQ7>FH&CJKD!Y(Z\U8M^-YJI3.22W#@*R%*5UX=JUR#JCS]G%;^@'3$@]AMRG M,4E#%(,G&!`GZX?\N"]WOYTVQY/5%%<9@<[`O@:K/,99?K<58CT:]9LLW;+/\:WG,/^7;PZ:J]E_WVZ838`\I MAH`#F&8PX'N5?TI<;M':^!:^9-3D.D MED95";MN&Z`7Z&1^#&,'U@&I/$<&%*/@DKK[6VWL2>C5>'WMN4.Y% M*4PZ;>/ECW6BTV,,()$P40!2B&,*`O@T^W"4)GK/]TP*34=?S-[VN2_/Q:FZ MT'FQKJ[WH#7Q_\?K;;`%P]TY<2C!/.&>I[S/&`8LRVN_)H8RWY8*TV+DI%KQE M7[]8T$%55J&T?H;]_UV=0)7YA2B`,_?&/D6F1:/R.'ZZ3OGA:_VJ$-M4^4Z" M$4B:@Z['H_B*Z];?%7M\^CL?-X_U>QBR*/ET%3-(`&&^'Z$D$_DN@#$FS55, MPD*0)9%.[6!J;([K"94JHE?>N::/U^X-(4J2CA[S.5\2_ MD92%R&(K_9/_DT=8+;5<)3NKE M;P_[XL/7K_78>4("J!\%C(<)8+%/D`\R'W5(`L@SU0:.CLQ/..74>+T&<#?= M-+Z\-MV(E$1_RG$9I^%992$ATILXGD6GB<1UG.K(2-R>`*XU,4P6&/5ND0L( MD%D32:>!4FDR:<;<*_/N!&%80$M*UQZ6DWW3N@]+MV@N9_'+&;KI#E=CJYMJ M-E.[6'/<-S^[0ADF(>(^Q)0&693&)&(@[5!&.-$Z1S M[S*WE[W@3";3N6*JMGQ;<#A'3,*WEF2KIA%=*_;5ZD:\9U^XV8W*P+IMIO`O M9-DVE_?73[+/&811<]+ERO(2)=V>]M_WI\V15T+U\($8SM`YI/*C+&Q,Y%<.O!B'NF\6.;4H<>]YG3A*+`+ MGB)<>:PP+3@E6WTJ>!7/Q_SXM3S>RTW1^B]4]>1UT;GZ!DC".&01P1F*`(5^ MRC@B+4B$,ZKU,O"TR%Q/$#?5Y\*A1J.J=LOAPB?C:63:X"K.*(N-J^;D8B>D M"YAF;`9D:,:9)?!+F7SFO;^_-&1#3 M8NN7Z^SK4UZ=COOM*6^*P[387?WD]V)_NE458$&8Q2%E%".&4003R)(.LT\1 M'E&&G1;HA.G-$^I6OR1N2Y7:B:-K5,-=;F!=5'F4WM1<_K#UG\W%?W,GG`>G?]]4Z23B'+(UP M"F((:)QA/P284@9!E(90ZU:"F07'4\XS4/7CFM[_2%RZ;SD9TJC-03\>I3**-F;0F0;9:*51)=%0:QSP-UYMWJ1N&KUI8.@HCB:;2]4<73?> M4ATC6LQTI\ZVZNNC25F=Y'_?%5MY`WSWN>3BQW!-4X#B%$)._2`(*"(,\PY% M3&BJ^[:'5>,ZX\SH]8[GPVTK(%;R78X:I-=>O97W+T^EMQ.(QZB7A5`8B-JT M,1BC=CKDY50/ZQZA M8?=.>X3K5B'4-%L4 M046&G2BA`FT#(FB3](7HGU672G??J"W5DX;;97[*8LQBGF1Q1&&(LX#':6>: M\D!K/]R&O26HGEDQT`K;(W7/$=$.=&^>JJ$"<2;*9T#[TI7/Q"55Y3.F2UGY MWHMOKFVD)I0U#@*?)30,86],@TDKK-'ZM8QV32#3U28<3-1ER1(>> MVD@06ST2V!EU]/?\B3S,6N^R//O^>'LDX_9"V^ZVH-<)2F(4@((U$`@P!D@#P! M`+Y6#=R:5<=*DFP>]J?-H>XDW2'5K7G;8UBQZ#T+N7I2U`&K5SS]/US`K/<, MJ[F42IG"H0JX]3`L1-\<.'9=`W=$G;(J_K+9?ML7^?'Q1N*@[U!.X&?7,)V@!)`Q)F M@]J%B)855TK[7YZF,"5ET1R&A6#T&F,,TX#CN MEHV8I)SH*-,H0ZZ3L@ML\KW%#IVF-HWC4DV<)J-13YUN,3B7/`W1-*!/5MA= MB$#9\:5T\/G9VDI[W_>,1Q2$.$HP9R#,0`P"G/;BB,)8ZWZ.!7/S'J22.+T: MJ+5M-`VF1^ZBN2'9XB::(K_3;J'UK)GLH.E3OA"%L^F1ZOZ9*5GCU>[G8UE5 M:QJG"&``"<F;(K?YPS+?[^K:W^'/3'D8` MH??E\;3_1_.@VRV0ZR0,.`$H\^,LQ+$?)-___JR=\.["*TUUG"YN:CJZK%@9*>YEB^!+'U9>[T6MPI=^ MK+PKG5ZI%DQ=-_X<%84!+9\\T`M1_>G]OMU#=$KBQ^?"O^:G-:7"/R58>7.13*\(06289FP['"QFY=GQ1 MS=;T"5(>8>^*[\)`>7S\M/GC%Z$#Q_WF4`G;'\7'^*UYK.YX:IH(?\JK_/@] MK]:$9)"G"*70#TA$$A"3-FU,$P+TNFFXL.]X72J0>O<=U'HT5N>'A\,^UUV- M.N%>+;6:FW:]+*I'N_(D^;\\([^'[-685YY`W3Z<5^.>6!P-F!W03)=Q6HB4 M.G6QG.ZS-Q7>_RZ/?ZMW4K9Y=64ZXQE+N9\FB-%8]FA/`>Q,9\@/C(1VA#W' MPBJ1R;W#AP:;J9J.(513/2?BTE@M.T9;A(O1QMN\J6BA!=:7IGTV7+JE==;H MTM>V;%_LJV_Y[N>RW%V91FDLV+G:%R)WH-O_.^^K?=V-@#U>_%/S?`Q.883%0,N8P!*&1`R^R`]@&O', M]V&@=?O/NG''T_OEZ^X=8N\2\LK[\GCY@]'/7=D*BEI:,&L\]'($!Z%P_"26 M&J4#>N@L.@O13'?^W7PJRPF1&O>J7UA_WY\[HT+>_0A'$`.2^@F)"4M:FT$` M<:)WRWJ$(<>:^MK@'7.X=1RI:CHY&9]ZFCB"2D?WMF_3-*!S5MA=B*;9\>7% M#6]K!(W1JNKCL9^_EP=H&8Y!ED(60DY)Q#!DI)?4%,;6=$W/JF-U:Y!X/QP$ MEA\]^55XXGLY[8NS?`E&'F'9Z+33=<#Z>`ET1[A=(90S3131T3$,DQU`W1BH[^^GF6,@7LS[FQZZ1^WZ[YD&0<9H`$G``HI2& MG)!>LH5HCU3,<<9=+V@E""]OH74"*O32J^K.GBZE=&14C!5UNH#8%=8.KVP@ MW?3K7'DUYOD%=I!2/9VU$YWERJTE_]Y679M$NA!?OC^<3_ENC3)(D!]'"4!! M!&$,61+TTP"/M9X:L0"W,%Y(<"V\3SH\L00KQ\:Z"+L(BWL9;E$O5XA; M@':D6#=&?SXQUO;07([-R%06Y&RS/_[7YG#.V2/;B.]\F__V+<_E9=OS@X#1 M;!DE,0O],,4)#ZD/`6,A20*,(8D@93S4:O)IQ:#KDV\"HU>#K#=>6YQ>#=3K MD!INA]LA7$U7)^=:3TDMT>Q$.U6H&U!+J\PO1!_M^E0Z_%1--?!=\7`^5>_E M*YNP?1]*&/)))K+?@#+"LI`"%K4FF>]C,^DSL.-8\6HL'IQKD+TD1&5LC:!Q M:4-JC"NW1M)H>DR2B%_R374^YG7#(K&0K.I^11'.DCC+(("<?87\S.Q1KZMA4[)HN=#2)=:MI`V2I")L-KI>F;E9\NB5Q]@A3 M?XU&OH13%O34@W@%39L4!EF"4TI2!%`'(?:!5J'=IEW'JM="]38G M[]8X??,]:/?'S<%W>?\@B79$Y]??W@1 M)5FQ9``$2.0EB2]1?_TU^#4``MT]W.XA5FT^8)IG.96P1NB.1BMQ= MD$E;47!$*JVY=]K=P"J-TI+)-]NBJ3#VY5Y"MM,H#<,4XI2S6J;]!$,(>@R, MB&3VDJ_O*EG%-&I:Y5D^1JFQ%E042[,,RRGE9-2JR60/L[D_Z]:,4H7`"UII M)0Z."*4=WZH1!K*D1#Z6?\U$/71OJZ+<\F+YT/UQF]>#N=Q^KK9YWXP&UI9B MS+`O$`D@C0,,^,XP]3F3FD>:LV9[M['^@=>B]%J$NS]W0+T6J>K2VR#5EP5R M&I85=QW=)GA1S9\;:6[/*CI&]!ML8Q-^DHAJ!MKL`A(8MKE%FI)W$HIY.B?. M(A8'V'S^:#&(`DS2)$DAB@/P8`!ST)@,0274Y-&''=HZH M4>V>J.Z?@[5K**\2:6%$2A43@G-L*N2`$5G55/^![$K)_F46S@F^(>Y`C"A1CJ'I"P M&C[+1\3T:)4P=/4:`'LRBGOV,2J":O+3)O!^WJ M>(O\`&]DU?R`K`NB:(IF1S3/F#N5G=&HK%CE\EN^?F3YW>$EY(Q&H:`4TH@V MS=63E"'6[Y`PY#.EHD-Z%JRK4[GTZO_WZ"UJ6,KZI,69K"K9IDM5B\KEIY:I M!M&Q&(VN0.\0*_3%HJO[/S;Y_?/JIGC)-_?5^DT;Q^RHC6-[ M[_9;_GU+:A[^FA'(ZPD#2R*2^F$0L@2!H(>^>`UWK@ MU2Z<=D*6;80\?JP^?I7A4IC45%,_0KMZ`U[CA=>ZH?)&Q'K0Y-^8N!0\O3P%M<-DF51VT\WFWR[ M.8$"DBA-.&RJH;/8;SI$D;"'$O(4Z#6J,6=_RH3;>=%^8^$=_/`Z1[2[U1@, MCMSR8^JXZ&?8#N^G,Q$8(L:F^]9(,WMA/6,S3HXL=*RZ>+:!C2TZI97Y2U=_1D'7(1IE$8,<9""@"!$?5^0V$<^I['2&_>AMBPK M[AZ>U^#SW@#4K'PVF%TY&1V36#7)',:I%67\@*P+*FB*9D<4SY@[E9W1J#K' M[%]5[^VG\VWQ4FR+?/-[OFQ^TI9725(`2<1!4WZ`IHS[E+'>?"A\I1(GIFR. MIFP'>'I%FHR1+#D_G(!?78%3H-;.C$^.JTNS/,-L.Z)SQMTZG]SH3 M[QC?U5GQ61RD,88HH`F%'+"4]'8AHHH=7X<:FT3I]*HY#2=64N3&Y-2$NDU3 MP^DCFBX)FRF&75$T8_Z<2IE9HA0:MC@_F)GL7DWJ*)>`\Q8UJU==Z@:FK?'=N4UZ/3F:4,(E5.MD;A4 MTZL!-%K1K/,D75`K`\PZHE,F/*F,#SLCVK330XYP%/HHXI""@*(X#@G8V8P# M'[#AZB1I:$)]TIM=#:-UB$998-2<2DTSM[I$E+)2*?+KM%:I^B*E5EH$2>M5 M;>TV7Q?5HA7%,"94$('\&")&FPO;..R-0)\'*@*E]LF6%:EY>CHT>C,D19KD M!,<>0VH*HT".%3UYP\,%`='CRQ'%T`1?F1@RNIJPDYX$AT*DW!=^R'C$&4T3 MTIL))0\UZG[VB+J@-S-1)DM1&RSPI*\.T\PW3KB040A%UES3"%7XYU1"BP8# MIP%N]O<^<8`1YDT!6D`Q%R`!2;W.$C2*`4LA5FH/9,+>I*<";K2OT!NA>NCQ M`#LLFSPB($7PR.<$;B3NL9ODW!$M,^J2])D!7;H4]W<:NZ)VF>Z[RG[9-Y4E M>0TFWZ_EVLWP?+,MYC,2L)BDPH>`(P0A"G@8]#)<+^Z4SA+8Q&%9(WL<6EM` MEIA7V2&:GG2M#:1?;@Y]D0_0O0-V[ZX%[QTVG/+-E?=QM"SN,6E1_>$6E-T` M.J*_H[CZ[@;6&/3:U&M1?UDLRYGO,UBG#RQ9BM[$NV-/G6%-L&[V,*]@Z_^WJ]`VI6KE6C]_.JM;*GP\5:CUR; M6OU;4;8O2EJ5JA-)6B[>?DIS=6W[^EN^?:CJG[S4O](<6=G,>!RD`0A3$O$` M`@@99[!W(:8DG&VK;;:R)N[6<"ME@[V+RM*T.DC3_"!-U0_25'2_OVU\MI\\ M[(T&:]G&B8%@-SUU'GB="]Z1#U!&J?FN$9=Z3PR=<8>FR:S_V[1?OE_O02XLP/ M`8@`3GC,0ISX(8IH@GP_PD%,0B:4^KP--&5_6=1?XLT:0%YV!%:==_4"1/JB(>66?EHN_T("+(8X!@3&B$(&$$PKC__#3$4N=#E3_4 MLO)U6!1*F*DQ#A`)E94V MK0^W+'$]IK8&8(U*X=G6X^ICT;-.DYKXG3*D(X-Z5,G+H77*]&11@SH9@7S/ MVS-".8@8!P1S&/[*T`A1$=!5=9>M?LL7Q3Q;73]FRZ)<]MW3":^7[U$2TGK" M&>$$I;79SAH-`95J9##0A&TQ;9%Y.VC>#IN*3@Q@3T)8QR%.45[?Y4Q+9`>0 MIR"UXY"H*;BZ9$K)[EG/SXGO<*I%S72YG>ZEU/YXO!NJKUQ%B$08192ZD=! M$D>4\6B/'@.A<81Y-^@87Z9B<+J6C$).CM9?2=.)J\6B";:8_ M/)7@3*@=V1AVC95WSR*X`T\MVRD!.2JB($+*,?11Q"#!@2#0!VD/1R1`Z4BW M+0SCYR/%1&2-?+G,X@+O!E+%-%>I-J6OQ=K%9=Z:5ZRK[.LTW.\N[OVFH:13Q&`'&(!2*8)+RW M2F&@5%A_H"G;;TAWZ*[ZNF$]0.^7'N(_%,5N*+=R,CR(FIGRIK(R$A56^?^;%\N';;Y(Z_EBMLQIM=E6]S1[*K;9ZFNVS6=I MP&M#*.0,I`$.(A;X^YT%B&/IL[^##5E6KQZ?MP/H-0B;X_D[C%=>@U)A^3F< MV8]7]J.2JJ9=#O(IOY(?E5>]1?Q0?F66[Q_1<&;E;HP]!Q;MYGRI+`POS:GJ M]>-35JQK^_-ZY#VO:HN+[EO-,&RN&,\`B:,0AUPD@L8D!+Z@>`^`ATKK=7-6 M1YO`]E"OO".PW@%M6X52VXO.O.<`=2;G6R^R&#$O->K?9KK/Y=M;H-8X`!")( M>$@%XR3NVB_'/(J%;"E>TV;M/;Y[I.W$XQAB7^/ESQ[E=)TNI4B\\`3;"H9;]GT&PR2"?E.@(&$12",$".PQ^3!&LS)?-O+T3:&ZN4T\4D]^TCWY/T"7 M5H$_RG4^KY9E\>\Z8S@/[?37N MBG==>4?HO0-\+]MXG0-736VNL4NI#V#[@GJ/$D1'I'P<7T^KLH]'L!&1OVV^ M495U]FE_Z[9>?*_S;3V_;`_$YF5^7VQOZP>JQ2=HA!GV@R"*XS1F$<;"[_&! M!,5*?2S&`F5YF?Q&[I=94?9U(6O5O^N@>D\-5M.Z;S9RPW/`9$$;G@]^Z;SX M1[NJ;EXOM9ZT1X&Z7W_KC+?SQKOMXNI6=E")@V:FL!+JGR!KV/%;(8-8)%ZC MBMCGO+?9[-EVU7>^Y=^WI.;SKUG@!W[HAU$2"<((X9'PD]9\#&@D:*A70FR8 M3D;>2\21AU?MY&UW./*JG>IUSGF==\TGM)E4 M4:ZG'09R&O_3C`"UQ'`4\+UC[X>^<O#_/%`F#ZSV`S;A73DQ&AQ)(>Y MP47EX..LO8A('ZOGK_\FQ]FG*B M*`8):*"RB,5$X##J\6.42E7/SN6MT1P_FYC&I5YG0;C9/#\^MV M]9725`A4)7,"]O6ULP/KT?>8=TE'Y4B5$E3#\7%.64W[=U9BK1"IH;7\_CZ? M;[_\N4V6^:W55%NNS?CUV6;#/*%)&"?"(0A"J$`29!@'\*4[-^? M`*[Y_F%LE".J=^=:\Z_:N4\'[SZU[NT.8K6[SYV'5N1^]%&@FA=<'@#Z"40S M]NYG',/ADDI-4PT1YW+89$2<37;3AD9G3V;5QK-M,']V9RA.PR"`8S/14-Z]&3L0`S9QSE'N4DZ0X5-N M4\=D8)Q3;[/>G=_B,4^B?)GO?MN],_I;GC7=@19?RJ_Y_'F]+LHER3;%YH`# ML"`)1<(2'!"?-*H/XOV.4\R4E-:X\1&U]NS[--7"W\8#(">NDW*O)J\'JJ]Z M+>WA-I?3]X"]%O'T.JM*[06EM18E1[36GG^GI<3M$JDQK]W?=I!Y\QE2G(8) M9UBP*&VZKH4^[=&(Q`=Z\UNC$*:Y$6=*AFW%176F.UE(]&>\,M&87I3U*):: M!%N)F2,";=O+LY-BBZ3J;,U_?SJ^D':;O3:%*DYA\+@Y&ME4I?!)P*GO"R!V M,+A/D*9*F[$]YC;Z#O#^4%H/67]/W`S]RCO=HS,_8/_Z'.DN2:\4H7([S$9# MXYS8&G;O_&ZP!1JE&E3T$*K[D\X^=Z^_9?^JUG25;3H8,YJP`%#"6`(Y27R6 M(!;X).1$P/J+1$I5#9L<44Q/&V!Y=Z]>"]=K\>Z>;I4&BB:IOZRH$[*N+Z1N M$R[?[&(BXO7:7B@$8%CO"WE6WDE#EFAUH!^&#:\JJV/17#M+>#OHNG,MA`-MCE4CT*DOO<$P5`<8O; M*/=C-[\\)?+2AK:%<#@R>[?BFGQ'S('TF5#2`X"C'O9^[&.0"C^%&%(8^J0I MW[F#004WI:9:MB=5U*LWSW2#VONSPVU05O5",EA:K4?#I+QJ!6)LC7V/43V= M'10;][5VF'OR>FN`1JF=DN;2_BIO6WC,'\IJ52U?=YW?0S].">4T36.?^/5" M)PKCWAB'J?3&B+X%R_JY!^8=D"FLNPWQY?W:P5#8L!A`G MOS\Q#H%ZVQ%J`T]FW^&LMV>V&8:SX\"N@@$G*I,#1G&F>U/,FU(IY3)=KO.V M,OUF9Q#%.`G]A/*`(!^(Y@PTZ0TF1&Y+>K@5R^J[!^8=D"E.3`$/7MO8$TE1Q=)3FEL4J0FKP''J)\0/$*E%,4Q]2&D`(.UA`-]76EB9MFU9K@YP/ZW.G$70.OAA/`1R M,CTTII[U3A#VJRFOO]R%,$HH1&),4AP*BBE M#/50&(Z43H+8L#^YMIH[$6(E/$8TUWID3.NN.Z=#-)C5U^-!VO^2:O_]=#6BY8_I*OJJ?FE<5NLET;91#`@/M^RJ$?1)`& M^\0`$JJFQB8L6M??3T\=2F^]@]EVR5P<@"JKK!&B975U;(Y5E=3;`?2^'M-[ MA'&JA;P4=1>ETB3USHBC4:=^D$/SE)F[6'A3E/GU-G_K;N(>ZK.'!2TQ+<#IP=M>:9Z+U&7/!,W:GY=5YM->K?9KK/Y M=A8)2$*68,@`B'C`TI"FO?T(H=3051HUHY93U:[M9W,W]+_,78M1Y%5NACX) MI6JIYZ.+,"U.[\\>J4/W7]XP>&&N;CP(CDS7S?LE?]5E"''&5'`6H033-$(Q M25/"*6>8[N\SDH`H]9@9;,RRZHGC+RBOJV;(-'4>@7^?KYX71;G\M:H6?Q>KU7XV&Q(4I0FE:4)0C",<)X'? MXT$(**VIK8&PK+J?J_+3@'6V/>Z-G#@8AW;M8P?G:O[\LL?M]<#_,=W*7)=C M_0,(P\/FB![;]U/M*((I8JUI\RQBR(^2$''A4^8',!)B?YF2\\2J)G]H?.Q3 M8H96_^:#8$>>96ZFZ_K#_6]F'=W\[:^6C=?UO.OPP:= MLDKSI(()J,JLP"6F53Z.F$"@=DN[_C"N-:I#%NVA15ML>ML)3>B4U"<_3"K* MDRZ);K3I*$6GI,FX43.@69Y+U8SMC.18K3I\T?'G3/VT7PO< MGM8L_[2JB5:(C,ION/#+K-X>BY,,FVVB>-7\%V3>+FT!;)6P:$SC8F:I9J5B M>O6GJ_8+\^TRO4^#&44$8%!B!$M0I(@6Z2X-AF6IU`.L/XICA1\*3KL2E-X* M69]"R034"WMJ0JY(G)N,\Q@OI])-8RY#R37-#7F::%JB1O[$Y8-QMODLY3'B M52;2V2+.X@RF,4S&D7!"N-)!R^H?[UEM]-:\.K3)"8UCQLP49II5[7-*3HB+ M`7^!J(J)!4_/2C8E0TM'+G<[2/.\X"))PBA)!PL9DSIU%.]$3RK MR:7R]G5#`M5%Q0UW9KHB19MS;;D\L??<#I,!*HR&$2=$1I<2A;62&.7Y.X.' MS5VS7OS=-]\_K#9@EA-2<@"SBE0$@9SR@I3C\&7.,[65DYTQ7=?U^V?I><'A M(MI#C0:LRJLK2Z3+KK7\\ZU8][=!M:/UF!1W)U=G=MD/1/.LF_5LY>:"-D-= M_%!W.5]W@<\.Q_YW1D0QSIE84R9Y3`#`0J<)VE6U4D#4.C+,.R%53]KMF*;AN MAQ[C=\VF+A?MS;)I'];UQ_JO#16L_6N645Q1E-`258QBAF!!DQ@30BJ<%213 MSWFMC.I#M[=`_R/:MLQW6*,]6!UMML.X@A1[)UM#>5_A.?K4(8UZJ/Y?1$AR M^)JR6O5#2$)JU["7=-,!=5+M,MTPS6JS6#W4M^_OZ_5P+]QN*P;$,>IOAF-) MCDA>@5A\WPDSR9,$%Z5$/X?A".X>RT-@T1Z9U*8AZSS*=W%XY%.OA<.$5YD^ MCM,$'&GBL,1:`!T-\W7>O?:EL[%++JI_[BKZPU9W9+;VT4' M8[[<*V%+OXMO[IMVOOQMW3S"*ES2%@=EQ9C@BC@;(%]$.='3TZ=;:/Q8*G]);U,.`ZS0H6O>\H\WM7EQQ M(N4-;3($DC`'1\NS'?B!X3.*FI>=N\6@?:-3&I,2I'.J5Q'$>G`5JTPQ:-X'1O'#1@5"MN."-33>OU>?2AZ(> M*:?5SH`>4X7:-E&E)86XZ-[=\:Q"98824&P'A90#:$&C)$>:3J5T;^HSXM5( MJ1Q0:DVKIKIB[P11ZGJE2'#8BJ5JC)QF:5$44#7B<7)XG("`LF M=)>`T012I4I[4T+"[5E1+Z*MM5%O;G^'W-[@@YE:4MKN M%6PK[+MLYJOV0WU3+[YU59UW]68&4\021*J<,TXIHA6N=@D()$#IW@6_R!S' MYQ%AM-ZA4HR:GATE%Q?#]9%):?_UT-7?ZM";<]%WJ[1];.Q-BO8VB9_5OGL# MK7KD1.2:QO.!Q*:)C&]">/CWJV\BB#;K[^QAO19?S3!%*,LKF!):$<;+ M!#$^0N(X5:J'N<3A?&TWX%G4JL>5.R7?>H1PRKOK>+`#?Q%MX8G6[!TW5H]A?3OQ.,;U%F$+&B3`!` M)$\S'@/&TA%E#JC2L0^>H3F6]1'B173?@>PSR'J$>1&M3J6.07C.>@#P[337 M,6'OX:N=A_G>PWNKP@T5$BZQ$SUL^O[\`HI5Z_5CC'TGN%DG/+X8Y`!<3!!* M4`Y)QO.J*F!9)LD(KHC+V-F*01N1\[7#LWN/G`86$]\X6%!X<8O[I<6S.T7/ M(70<9]_6>L/8N^<7*&P8;;(&L42YB[#P?G-7KP=RC1UCM]YKEJ5K_LON\QN@L#2KZPKONNW.!:Z`>?D5=\ M,[6N'[!K1\AUW'5^RJUEI;Y4ZY,JK[ MU0.-E=J[7(SO6)4_-ALA"(/Z1C?="6>+SPLA`O,VNJN7M]'G9AT)2^IHL8J$ M`Z/K;?]-V[44*,JU$_?(:?74GG'^\G<*B=8@]80^NW11(.+LU,3&WXQWW]%S M-?_>O08>WRR412:R=TAY7H`L8PD&H!J!L8PKG:_J'HVOSIW[`9;[MAU5;SAK MU7'H"%_M.='6AC-X*_LRZW9;<#0]&HB@>S38O-7&B&IG]9'+Q?QZL5QL%G4[ M(RD"28G2G!0Q8GF"$ICM.GX0==6LJ8QCTDK)<@_4<;E$R35N:B:NO.*G<'(I MXZJI5?XISQ9+*#K>.S]EUS?5L)BB3Z^TFA\,H;:4`)BSF"<5Y+0H<9:+6+-K MWL19I=0IZ0R$E]K*@5Z[+K"X\Y:RP0.7=O9^/Y M45`]7??FKKY]6-;O/[-F=5NOVOKV<'-8?PK._NS*&*0D2S-2H!B1$A092:L$ M)R7$14I862B=L&MU9,>2/8+M[FS9P>V^:IOEXE9X2`C#HRVHJCFX93_(Z?)T M+E`3XSWCC[?Y#H>611,>NJM"X`FY=>.(0#36D7%/#^!U2*&)FC[9>?L$!P9E M`FD%BP*3*DY%?E[P$0?.2Z5TV/K@`6AJ5^1@S=?KX6:#G2'M\#=?[]?UG?BS MQ;UV';1)I(L5L MWMY5R^;/8TCR,B/6XNOWOA_ER M\?E[=Z?0]CWD[JCZJH0B#(A!&059G%5E467]Z%E1@((PR:?;TFCNGN@=P%Y7 M]Q#W/0$:MRW8>9KEN#OQ!%LF/Y"GUK95C=,9JYTQG<91+IY?:@.2/(D33M(D M@3R'F&&$1T@X*92Z95WB\)5#O7T;_1*]^GQK)TH.'*2:,4WK&S6A/4QM7Q?= M/?9)[_/29UHJL7+GOT"TVHNI1U,MU_1*W0M&']K%JFY;E7D,TP1#!#)**PPY`2BI&"LQKL3R.Y'1:[,1G#?#[@!%]\,EEK)R:\C< M:2'U1YJ:1(Z8HD/B/@VP5*Y0,R!._O8T/P3J79RF2:3,G6E'S7Y!\.W0%,!- M:1:,:&S.',6DNF_(^E"+S/WA9O.P%C%@.QYE":5QR=*NJ;9(BP0D=#<>S*04 MV'@0+PVKBO)KSIQ<*NN%-#41'OAZA$E=.NRDG\?8.9%;&A,:2.)H;D=C>:8I M:LZCH5C3=@?DB'^KU]_J_LH86C"<(<)PFE=)EB8[)-AW+L0(] M?I8^BE_7NU[*F%(Y3?+)IIHT:1#I1)=>8>B$/-GB-A"5LF9.XV8**FI6-Z/> M?WXT^/:JF*Q@M,C+&&.8(Y@R"JM\'#"OL-(>3_U17+>$=P]4\_EI[->[8\J` M2SF9\D.CFD#I,NA$I8X2=$*?S$D-1)DL&-+8GF\F&=16_3XTRV75K/^W=?K17/[QV:^WNB+V*O#J#Q@3Q')UV/K+XO5ZF!_A@6Q>IU`?86RRIH% M60I`AQ3%1YK!@!5'W@8)F5$D1.K5XN-EXMU\_:5NNZZR&6`E$,O#JHIS4C&" M$P[C<2R>E=)O%K4'<)P/;:$HO!+3I^KU5XE>6#)1D2VFOF?5"V?R;Q&]<*?W M$K'O\'V12+,WB,=,/O("T9BA`-X?FMO06)PR%A3VQ>W![2RE:0$K1&F9(0`+ M3A'?(2@X(*:ZJSFL'S6^B&X/=^4W.WP6)$>7;WWQ]D"U+4F_.'9C[H3$FT<` M#P[0BPM6'6$2,%YF2#&,&-(<<'`QM4PBY%@ASZB,0&YNU@_S);G]WX=VT\WE M69%0A`!*":.(96E"":*[P8G:\1!V1G0??E;=$[A810+NXNM\4T?=#(FVKNF> M4N5@9)ES_5*$6[HMU";ZTS,[B-$>8P#UBF>\*18P]'D/N*)A8)1$B<.4,O6, M_-C`1W0YCBG*DZID-"L@+DI6\;@7RRMY^VVO:*8Q$_H$$=R M:CW!M^TAS6Q_0D_92/WM>DQY):#&GLRRP)$_0ELCN#+SV(+!*:W2JX>K^??^ MF(BJ>=P&.^,93'+`*IYT-S(2FJ19.8Z'8`5GJ_J+"!.W'H/ M$:G5<^^W\!27`?KDR67^;EG3BDXCI/X0U$>@/&?WQ[@YD=`;TQE(#F]N1V-Y MGNEFZGO5ZQOQ9Q4#D#,>LPS#),Z(&'TW'BD`EQ,=XV&CQ6^,8L95,F M4#%K=L*0:RBE<9*F*80):.`&($I*HG]D=U72_I+_:X M^1YM]N@LE)`U&=8O([LGUTKMXP!F6.7D%_E3+"F;^2"0E-2!81*E91O4F;7K M4ESQ'))*C):D%2TI9,4X5@D*LFW7Y2O)=;+6(.K-NB,>Z0=3_(%4GVZPC:>R M'`;\/,G;(--XJD:(VJ$*CXY_'HZ8O6S:]EV]>?_YX_ROJWX.BG]?U_.V+NOA M_[LSU(JLBBG/TYB)AQ?F*,,<5"PM*<`"+U/:5>@!CN-48WNSV*,#M1?#<<]O MEL**GR^B5;WIMM=MYG_IG./@V%ERR4E@?E++6@87O73F>?3F(L[PB>0GS(@>,C'AA@I+QWG/F"- M9ND(\`*B$GW7S[=+L2=)#W[.W[U4&Y M@M:?FW7=8<4)Q06L($XYJ0K*8DH1)!G`E#."*J6K>28!Z+B@2;YV0>KOH?%# M/-8/8D$_7_;+^4XRG]0U+::X[CQJGO<&X4SKR?!3JP[Z?(9MNYUAGCJ`RQ)(,,88<93D)$D)82. M*%'%E$X2\`S-<;C:2EI71+Y?-]\6K7I7J&]?>0]'MMT42"`ZZPCD+?:H./_' MBSI*UKN+-^I.F"+2[-=S&42HQ*Q(49X`'L>X8"-4C,!4X48:G^.8LRUX+':A M9\IUD+S3O,<=)_X*)/CLBU[G&X,DBF)3SH8?+QJI4^`N)&FZPU-/SNE&2HS3 MK$Q!Q6C)"(<)I&(%MX7,*[4;NZ;$Z;F4UW76C#<]WS?MYI=UO5FLZU[I'O7F M_*>E<.;%UV9A+30WFX>W-X-A/T>=*%Q$5P=.'W[]2KC^P/-;TZ.KH2OK<%-R MR!WT%ASGK`/+SG0)//YYI<)J'Y9-]WA:IVV?8K*Z[3_G\2-\:&[5K(6=O\T7 MJ^Z#]W5.84,*2,XS#M-NWP$OZ,ZJ,D:5OR6=S[K6^KWHYUIJ_C3">`LS6KMYD9>'@/C2VK M*V'/3K:2)!RNYHPMNA(IT/J/>OUM<5-WM]JR=7V[V.SM*TJ$*655QN.$H"1- MLFZ/XF!?42!D*UT(RBC'B4,/+VH'?-%-#\YBZA`4E1:2B*#LF70)_ZB.8S>5 M&.;DEIBH8R9Z,W`3:FKA^#,3'*=?HCO1/:Q`ZAP>N<9 MD2AQV.H963-A%>-D$:-ZGGD0R,U;F`-]PW/U"XAL60.GY&,#AQ.?(6G/6(A3FJ[F]'8`EJ*08%`"4 M68J2/";%KGJ(8FO5M4G`.TYCAW,8MJ4)NX&%IT["Y("@B0#4*#F,>)EFA?IUH*2Q(G4 MI?$!PO[1M^#9]7%0\=BV>\\E$O^P(3B(X*LRJ_Z]PJX2,],$7'7GA19J=UM/ M"DH9+Z&`S'G)4UH!.K["*G,66SE@>BKL/_@>1`?.#BKP.O'SN43?,]WXP0 MX3S/<,Z9^`+T1[;MD@=&@=KM@1Z!>:DLKY]>$]OWR@D[HN$:+^_W<-DC^(3< M3>+'0+1L&MN?W1H,NH@.3HM&F[D2*G551;]9%=&A8U%L6 M/38M^M0;=V(3;R">EUL,!.UTM6Q_*G\[B5JV_7(B/?$#R`FS:5T? M>T^O/;A7-]_6\VSH>?/+A/M)I`V='5I4F9X0=ZFV%5=);2YDS6HC0-6KC?BJ M70CG]0!^K[]>U^L9R``'',:LP(@A7C&>[L(I!A#*[OKLC;8&3Q@8=>>+]RCI8:J$$#+U9DGH$?1EY_D)IX83Y\>+ MK::$N`NT5ERE'G6W:+M2QO\L-G?/0+:/4;:/;=K5,OO/FL6T3&@"RI2@%*<9 MI`SF.[!IC&=#2^)4$@4G1G\*F%P);^R2R#5M''H?#_2NP_G.G"G`V'203U":9$*$% MLFE(.!:\)G2)\X!U!.N5>,[OYFW=SF#*2I)E105YG&<982G#(]Z8`#Q;U5^Z MCO!WM>.098Q42OV*0?V>&"6M@U?_3]VU];:M8]V_HL<6R!GH3NI[HW@I"G2: MH.U@'N;!<&VYU7<<*<=V.LV_'U(W*XFMD!0IZ0`S:)&<>J^]:"[NO4ENKI]4 MFEG.SHGEY6J:,9MCQ1I:L&Z,R+['C$Y?WWO*CSORV(%($F\D,(T!9&/DM3'$6YA@!1) M/;IHR[;E(F0+V>EAOG&N;9[?.!UPA3,)5H;D[>,>*AB">'*<%!F'#C'@P:\S%S@=\F7-_DEC>3IC4RJ&_JJUN-6#3\V%2W MB3=/#L>7.35^!>4TROK;2]?D3&LM66=V6YR.`'I='.. MZ:]'#I'^$A7T[OUS%+K$]T`2@`AC0'P2NKX?^R2(<>2GT@WKM3_?7BAVAN34 MF)S_M*BF/L]SC9V!"3^:T(7,V?%^E(:_:2-GSK?L]RGE'OZYM`G`"G/':8&RT]`I93X9I;?#J"%-1' MG=2%RH^&(V_HCRXU\FV:#S_61?/,J,AKRGV^K6MJQ?:.?PG;%/EVQ_*"A\+Y M>O^5_Z1^5:E31T:#A"8T"B*?1="%H1L"/PTQ14@F_;2CNQ")F-CIERUK9Z!*85:GT5#]+Y=,Y^66<48Z3JI,W(J7Q:?EEN]8OAXCF5JX&\R<:7R;8[! M!=2[#3I3VOB2J6:]V9[_]L>'K,@.ZSU?B]#V/B]RL=R<\E\9_?V0%4=QVZ1J M1B`.W,9N&+A)$H8@9A%+@PZ$3Y0N^)NU;'MEJ,'>.#]JN%4,N7X&6#5?-DN\ M9`X]&^>*:T9+]X<>W<^Q.BU8]:8FAM)M%2Z'4G`K8[*0F-N2?FLX)!F"ZU*E\!)0]1[(W?IP M>OIV6!?']4;8E5S8Q*LBO7]U%+O3_4]<>=0-`C\@&/$4`J"(@+!;\F@$I2HX M"X%J>=E"^^KKG6V=K$&L&-?//9)RB<#?:!#5%L4&AE/A<'H@;QREI*)Z9J_O M8WVC[=G'3_YFE,TQ&\A0%O)E64A*LQ0V7KTTM0Q8"DG3J=S\^;/<\_$ZTK\> M\]/3Y_*4?7W(Q?[(+_Y##N2+6'Y7":30#Q/"XACX/O,]MUMT/=G7.\Q:M+P* M$3%`^??'*HBL#K>JQ._F>)5(DF:A5#%1ZF%T:I".0.D(F,X9I_-E/J85LJ59 M&-?M46CAJ64^'B^4.%[,;I89LX`QBB:2!^-\+N M0J)O,[Z4%KY^^M+%(^S;0W789UO=#;C+#A6,%4F3%$44QVGB^M1+2)*&K>D8 M^DH'CTW8LRQDMP=.^/KPU`C5C?.P/CB_JK=\A'P]'K?BL>;ZMR-43)]N93&; MA.DQFL8!.J*074%LWDWB(&NMFT_=KO$F)W*C65^>UHUWZ;KD&:)+_LA)>ZSQ M=H?7QY]L7_[W?,#1CUGDXRB-`8C]F,:ASXAXXQJX/D/R3YR-LF$S$VU@B8TB M`?LY.P=7N8 M;3\6MP_5]>CB!]J<\E]5[^`.20HB$`"?NH"@.$H2Z'EQBR2&KM)Y+@OF+<<; MO0E8E?L[J,X9Z_]-/"'561R8IA:'9"&3UZ:'Y63?;\6)CK;__W@\51<#OI7M MG>.,X_M8;,K[[%-YY#]7Q4J#-(Z"A'K82QGV"4Y\UF*%;D14I&`6@+8WAL\^ M.:?2.;1>.45VS?BD6LB#-RT&YH%FJ MN*B1[(%K:MTY@_]]GS5WX]!]>3@U]^96*"5^&'LA<%WDD=BE#'61<^`3I47* MB$';^\`]C/65@QXXQ>7$#,%RR\/DW*K)?1_>C=,!K`\$23%L1:YE6!N07Z.D M+T1.S?I46OR6JA;!1(4M77.UQ>6].(-36XM2A!$7V#AQ"?$0-PU1)ZY>('72 M9:0)V[N5`M4?WP4L9]/#I7I]2I,_R?*A?>H4"X<]UK`4:W;*A1=Y&2H4CB-R M(2HTUHN7Q4$3I"@$5KOLMW2C$2IHSVICU@*K&QY.U*JD["83*@=180F6#J`FY5`V@&AJ;W+@" M5X5/_&].@V_RZ&F8KL'(R1#3"]$K<_Z\BIB,$B5?\3P>>=)Z_[#.#R*;Q5Q` M?V3'51S$C"11@E'L4>A2\9)&:\U-W'#U*SM\+Z6KEGI&5&99'X_T9/M<%G]4 M!<:\PR::>`MPJA5%31HE:X+V^5.LZ@E`SAF1@]]BS4X5[B(O0W6T<40N1(3& M>O&REF6"%&G!^5B(GF_EX>G?A_R4D?*_Q4U'P-J,H*\ MA2C)&`]*8]\DU6Z.IY_9@2_=8N6NPZ7FKM4JIHAZ'DD02XA/"(M3V,1(@1MA MYK4OD\A)B;X=J2GR_!D2-4VIH#E%%[Z("]2*FC*"13EIL4R?7N_*BK<&5+?] MV.`:./AJIQ7E-8(&)&<\J0M1'@..O&P#:8@:A4AF<\C6QXQD]9^]S3V\?LA/ MZWVWLQ>Y&/F^%R>,`NC'S"%3DZ>>&L18Q9US'V M3;?^7)Q#%T<\RIW#A\[)JN=(JD8?Z\U?CSQ0JN[+JI[M,#DJLC'4+`.B&EO5 MX)QW+9QTLH# M/HB0%\11R!@.?8(I;HVBF+E&)$_%X#1:UT,T6MZ4Z-35->,4FA0T*38G$K(> M%B4%TR%XL=*EY""8%S" MJVK-[WH][L2!PH1LS1CP:0!`B'#)X1A6%Z3B5,PK%^B:G M]J$OVV.@'\O-1+^A8*]W?*S!?U-=NBIWSW^YH/16A7+%L-'"6"Y6ENUX*Q%X M6B-YS)Z,V!9Z6[_%#'D6&IO@LN`_>.0_:WY9%L<5C\8IBS@&FB0^0)2D<;>Q[H;079U*CE]. M.RU#48I_.]3R)XEE6Q4LMNG))58')OY$P[40,9C*6^W&*`9('BL:HNYXO'*S M'0.:A`"PA%%*H(<#R*(.21)'!KHAC3%O^QS,BVY('=3E=4,:8%%=#$P,R;(% MP(B'')G2$YUG<4V'"R0.9!TRCHFKR^GICG^]3ZC8BL[4#^(_647(@]CU M$C:L9>6!V]YDV;9Z@Z1*+2Z(R`JZO@M9582!,8Q2ZH>DA1%&$5$[ M-&_:^C1'Z6>:II(D2(# M+*J+@8DA6;8`&/%0;M*;(U,^J.]%)1^/QT=N/[O=D>S[:44AA-Q$1"!(``$N M=MOF1CP603A4F=`CS-@^8-*@$<<7LM_\`PJ>:6\YL*E#]ZL,#47IXVE=R.0S MXZ;XLTGL0]W^WV?_V@6[C`.$:,$A2!B MF+@H\E$'`5"7:A2V3)J?IK+5(7XU^ZJ-[$U3^-H+]%.'U0IL#LQ0&V.RD"EK MQ;573^3:HD]Z4M/?F^QX_+;^G69%MLM/0DXNMP.\L'RO`M_#491B/V(!3#@Z MA-M;/?S_D*HLHG:16%YG:_#B(*?SO89?!\I'Y>:B5F;[*&X'YO\T8[8019C( MV7*.::%9+.TDGB_?B8>&3Z5X.9`CGZE@/L"71)'GA\=8L+\8MP'H) MSAI8(@BOEF.GK/'.F`)?I$TR$QY'^5(FHCF'!O)B$U3I;"#SN)Y_-7^*"'[7 M>]=RY4-,81)`/_9`XL5N`D%[LLSS/!2-6!)'6)TL&6[0=1-1][NCO3=78\`L/(&X+`1056_&'.-KW:[T7DK:*O-B' M`4Y!"A(2$Q0@ZG<)$B%*V^Q&#=NN'U98Q1*^>3PO?9WFU[%UF;RZUY/7V;;3_^E^SLR<1S6H7. M@3EM9506,J?M^%9.\+56??/O\>%AGXED8KT70,0)KX\%3ROOJY"@.YW#L`?" ME+HQ!FD2T"!,2!<9A,A3.BMCRJ;E!;D/TR'Y<;,OC^)F2I5EMZ?AG!YPU8;+ MQKB7JVC,0;M:6>,9XQ:2 MD)>,#*J(-GV+$1)]#UYW'AI'AJ*LWJ6;!=J&BP\`G#T0Q,%I.D M2=8$2&T,5@U'L+4131CKQLAI@@!)Y/6EL_*LX/F2;?)=G M6U+>K_-BQ;AHQ2@.0HB@RT*4^(2T!B.8*#V\JV]E(EVY<7K0G/_4X)1E1I]+ M2:F9A$8]N5%ET([Z7"-H2(%&D[H4%1KOR$LE,D2-_/9K>3S=[CZ4Y?;XM=QO M5S"*DP!##`&B_`\6QD'2FD$^5CHHH?K9MBL+'$YU1G2]5SXBJDR3G+S89$A- M5%IR*BR.`#/U_O%S*H:VB#5)6XAH:,-_N=$[B@9I@?AP*(_'NT.YRWF&Y=($ MAV&*?8A00(D74MJ:H`%,5(Y?J'RNY=,5%11Q9))C4=0%)7;D-,$6,6IZ4'-R M]P8G5I2@1\"`"NC0M!`%T()>CO^6J"8JV9[_]L>'K,@.ZSTJMFA[GQ?B#MKZ ME/_JGO/V7>:1`(=N&+H$,X9C+VVL8ZY'3"EK,6/2=@I3H[QQ?M0XJ^-7ZV=( MZZZC@^T7K'(NF=U,3[=BJM,R_:'']'.03H-RZKQ'BKJA),@L]PN1-M->O4R/ M;)"FT*CFF/'_6!RO(]FO;%]6C6-;HW&,$$Y9PB(8NJF+0>IZK5$68*6FZN,L M69:_%EPU&;=G>+J:-Y)6.:F;CE$UA7M&9@_93+(V2-.`FIFA=R$B9LB95TUY MS%'TIF3=%W]RL7Q8UW=P1*IX7(41AC$(H1>G,&(`>XRV^V.8N('4-3F=S[4> MC;5PG(W`(ZD^6@P-:XUMW$07O55./S/G>&:QW%4_N?NY/MRO-]GC*=^L]T?^7_P01O\AK=2< MADI^W<2/*O&]P,L%J1W#WLS".@IZ.?[+HQ[GG0Z/F]/C0;SZQ8?[1W9>=%..(5%V@[_;T?2Q^2:)(PT6#(AU6S#XI>[&5E<&3"+1V^KL1D5JE?0.!FU[]R MHN^PPL+V89T794'RZBD)\6S8RB->$B#F)6Z0D`BFT/-0:T3<"E/HKZ5G0&HF MCFZE)7")CA#;,[*J++7/-\.E*!,4OKWP6*)-;WNTH:J'QBX]\DN!79KT=%Z) M+AG]?N7D%7'6)V,!RCL"?&GB^Z"8-G?OX-8']#^5Q^.*Q"P,HC3U*&R!:Q,EM>]CF3$TUSW0UUW+> M?1JFRTJ!X0(G`_6%,0PNI+PPRH72W!=*\Y)\NT6"".3*Y4:`JQ9-`0,H[6H8 MP/6@VLN8JI^N$8*I:4EW!3Q[:^?/#%MR`F*%IG%7Y.?9&7U!Q(!BZ%*V$+70 MAG_E@KP>#M1]43HRDTC%,((I$$,7>)Z/!7L-E-1BI6.I.E\ON5"8C<3 MZJ!#4RB4"%,3"UM<:0I&#>?&F>-MX0N42$B'#H$+DP\M%ZY(B#X=\LF+^/#/ M95$^CV]:\4I]BEP,`N8FV`VB)(",=.(5`T]%44::LBPN%;I&670Z;HPE4C*O MF8Y#Q12GHJ^/K,MU&G"3ISN#5`UE/F8X7H@NF?+F93YDDB3%-AXB^1+/45SJ MNIQFN_*0]1J+_#,ORD-^>FHU%17;YY\BND6>GOZ9G7Z*1I&B6E1U@U_Y:>"[ MO@^2("74]V+*DNXP+41JY_N7A-MZD-8K"-4OQFPZ?YVR<]CY7GG\K-/1+)U) M)AF5P=AG>=^-A6C7(JFYV)5E81@U>ZTUZMV\C+?"B`1AX*$PC""(&4Q]T-ZO MPJ$70JV&:XHV+*M5U=O_*$XYBJYK[_IO3;Z?7YI>T?6FC.@3O*@I/\*-:RW& M1M%B,$!9Q21)_#1)0^A"YGG,#4%[7QD3EP4J6T,&S%G>*9(-![3Z&X[C6;:V M,RG%JJ6>WG92S>X9H7.&Z*!3_8+B^OL^$Z>+[N9X/O-M*D>%2=+CL"BI,^.1 MZX)/>_E-_*+]E#>1"9).7_X/2T\@E)$(X! M(S1RO1"X"'0I9.1!=_4K.WPO]3(PF[A49GO?A3&2NOT?=U?7&[>-M?^*+GK1 M`DXA\4,4+RE2W`9(FR!V=E'T8C`9R[;>CB7O:"9-]M>_^AC-C.U80TJD1`>+ M8HNFG?..TQR?JG_X*<@^!5?>#_]#-&O MY)>+9MO33R#X-1BEQU;#/D2V78GW:'4_=>1$WYMK;^MX5MY+)5(\$()P'#1`B?08E$++NM7R+$G.M,NO5^V?+\ MNA[WBGNP;+UPJ+2=:!AIC@RW@>"?/R8;YQEBSW=1HP7KJ'Z%62M'^K_.<_BFWJ M1;_H/B\TDE>U2"W#L]TJWDM5CPZ9H=@173+DS-/7 M$0U29+!Q5L%ID#28%LCGHK[WRP\)%%"&?A)UK7!!HTAK8X)IVQ.ML)UK^EPT MP[4=IPUPXSTVS9"8:KC9BX:=[IM&(&;JNSUB=%03;EAL'-%3:^YIM^?&T&BE M5_<84"`3Z"/,)`.42$F#B(M#$N`L&:Z^)E%8UN$79T46>V>:83#?*[,7`5N] ML?:&L:Q\*,KENNZ1*?707%)LC8@8:I8-B[*3*F[%T1'-L#'4CNL"+`0,*(\Y M1S&B&``2()P.8,3V7I7 M8SH\T([JG^?2CU"(@E`"<+@W5P!.Z9B5'%U;EM5S#\?F:HXVN\.F>3:)'3_A MZWAV9DWG"5T:\\"A1#NB<\;<.3,W'$>3V;6=/9:V+"8(@X1B*1.$,&5<'I^@ M%,@7`TX>F+3NU/I.-VJMK?#H!<;@&H^UF-ALCEWI&10A1S36 MHH-#5GM&4&EKO><1I)B(*!908`&#^F6&R&>R@\1(;'/%1PO'#&L^>WQV5WWT M@F%EW<=:'-Q;^7%'Q;6B8F[U9U"LG51V2ZZ.6P$:0>_8#L(B0(&$%`+`D!^( MA#`!>6>.1Y'6^<.A-E[Q.I`RC:-:!$89--8:<*,?H-\'4&;3$04;[89:W:]) MR]A5H5/1.^VC+@(AN1\Q4@%(!$<,"7G84DI1D.B=]#-M76>D#3K/UTTV_MD# M?[/NP-FK6_E-=&3,>DU$K1),$P^H:T3R*J$FG_CK1Z,`XHJ#6 MW%-;*S)$H[+BRF6V^?=RO4OKF>>Z*'>5V:OTZS:N./E[$0;5_R@)0Q)3*24D MTI<@!`(B@4#@(YW:?9PER]6YS/)EOLJJ8N]M7C^;T=R:TU2!-6ROP>W]GBYK MU,V?:8KH2)K5)',ZAO4$\H3"$V3>7S4VKP$W]7I1+U,]VF>&84>4SI`SA8V/ M<&3%>EB7XB0*(L0#SEA(*8I]`&!].!C%`H1!K'I-[^#?G[+8>)%>=T)0`V'KAO#T^JKXL-QLLU7V MT%R=>YFN=IOF6;=V2QD@81!(`"BC$,$$A3X*.UQ0!+'.2+4.QO(X?H3?.Z3+ M_>K/P8G]-3='-[RC'\,VU-J/HMJDQ:D`ZDUNIHB=%94>RWF/AD\63D<4?CI_ MBYG&C<[3T6=STN.KDGAQ?U_DE]NJYKHKUE6DRH7``0@B&$`F8QF'$?<)[E`! MR97V84P$9=)M((8]F<&!\,W9@?'#Q4YC9>KW8K@ MP'>L)XFDTL/6H^G\3M*>.$X./+TZI;?%+(-AMOMLPS#"'!(<(@0#2MOG45J` M%68YXCT1FZBF;].:ZE&O5#M\MYYY&>?Y M*F<10@+C,(Y$G"30IV&8R.0`,DZ4#MG,@VSZRN*E'<9F9Z@SQ/A\J>%V>(UT MI/I#?.A37;WF9&YPL71M7@ MYN0+R,Y580&7@1`)!H3'@!.2``PZ7#Z,PF'M24M@+$\CZE,(CZ<2[,LR6W>O M,GQGJJ"W4C5=T'3[D0[$:W1'/4'0PH@1I[08W M;?N59V1K(5';*C)G-/3RK85`V'_=YCRC/6U=6[%QI'EKS;V^-W2,TSCNA.-+ MAW[8]?_MVA><%U1`"!*4!!*$44!C2J'LX$"$^.@;,`U@L*S!IL_931L?-2%V M(31Z@OQ25!Y=A/$H--X1MPN'(,^SVR/.MN/EB$A;=U/E<*1Q6JT=2Q<"1#", M6<)`P`23&!/6P0`)-7%=\6#;KTRD?[##T*K1<7G):/OB:(( M`9!(GT40\)AR%&*_,Y=$0NO&OZ$V9A@RK_VJ(U5*'1TXVFXH7G6D1XO2@NGI MH9*'I^=\!18B@%'"1&4%1T'H(]P`8X56;/L_7M:5_F+2,9"@E"$@$:"RB1& M;'^Q6SY]DN MF>NAJ6?V9X)<1^9_1EPIS'][X^5I@>*8^8@R$-47BP<@81)VIE`8:=6A0WY_ M,CEJCR#//W+T1HPR?^Z.%'47SH\033J41\;E7H?=@VC>(9DO+ M+_#2(S!CF71$9$:[49C]P#3%)MZ569Z6)2_N/V=Y4UV>E"@?TW5]C)`7Y;9< MQ*$/941Q'$,`ZCMHL0`=`B'5.C06S%J6I!-8WAZ7UP#3U"631*M)U4P5V0_5 M)UR^O_ETV=[6(M*;"N-UG.;5WVSW71W?YY!&//9CS'F44!\3O[WB'B,_)EH[ M]2U!L*R(AE@`*(8D2CT MDR0(0]"9#XG0FI*:LFF[1"ZJ_Q^JK,9X59/2.2C5T\X]PL>J.9-0*K+5HXRF M^79$"HV[]?2M(BNT*8O=8UNU^2?G(%A9[NX?FB7#3V5Z_3;GR_5JMV[:D7^D MVP_I)BNNL]7^!^K)\*%KP.*`41$`'"8"$H!00N@>,@XPUSJ"-"=.RZ+Z]+C2 MFQ-7O-H7+\N]$V^:7EOGC[=WJ*E0-05YUMBKB?AK";N>\.^].L2N]NO">W9L M;?!W,%\GUF*\>E*/"U^)(^G*"2H*]P;QZ+3X!.-9A,TU.[M\^[$J:A82505* MB%E]O1V-DAB*B')L*S.C\93=(0U.6,_$QD:6>)26E MC'3A'0+]L3?0$V6E,2'12D23Q-[9W#.-]V?3S81!F###)%\?TE651-\5^>U5 MNKG_F&YWF_Q]_3OIMEP0!`61!/,D2K"4.,;=,[<84Q]I[6>:':SE+-2A\S8- M+*_(O8>Z&;-LT$V>EL9&=JI$-6%0YTQ=AZ^C]O--]7G=>Q\/WPD[\XDXFM#Z M0V*#^-IT&B@)DR,==I^?\.+^XA4N7"B M6,Z9![N/XM1)[^W9C\+1#/ARP*QF/P/?R0^3^4QP83SK&0O0-&MP^__J_>=U M=MON4#N) M]03+;=.$>9:5MN=Q?Z5+;"_&R-;JVOB/PMEL-RT+)M?43`7%2DWW#-RC;JR( M8Q`17F5>$3/`?`SH,04+06P5<.-0_2"+:"-#8[X4FRXJUNNNYRGF]:R9]8;! M4#5E)M3.)A/KCH^HDTQ2/TW*Z*GA`,#"X34NDEY+HP_ M:///:!@G2#8317"6U/-:>WT:0;*5F`Q\%C]"FC)!@\FD92PL8U-8>OU;NEQO M[_ARD]8-QZM-FE_7Z([7WF`21CZ0/.8)B3$!A$NT!T0D-;)WPP`*RVFHQ;>J MK_ML-C4W"$^5S$PJ,A&.4_Q)C!KP+G7(%'G6SP@&8^>V MYIMT5$W5C5,[0K=?0++'*8O-'^G7K:RJHN7ZSW2Y620<4A0RB&(I?4BQC/@! M&*8,C--OTVBFT_%5K1';1B/J5E6]OZ[1D9MBX^7UC"WYMQ549].`-8?/I@.[5(]( M"Y_6V^R^0O("P`47@<`(<<0Y#NKCNI1TJRF1Q#@>EP;&6I^BB[0MO'_NLM6= MM[U[KOY9>4@`U;]WG:ZJ'Q[?7QH=E*$R/V4\3,AZA[=/WV>7\#.D:DFVJ0`Y M*]'&'#PKR6:I'"'!M>!?W2V;I8B/Z7)UEY8=MB,:@?PX3F)$H8242"Z$C#HT MC$$Z3H>-0+`LQO(XKVZD>->-_2=RO+K+TB_:#U;;"LM0)9X\(B;D^,\V-LMV MM=?;XSZJM$.BK,*OEC(;#9BS\FS6R[,:;8'4$4*=W-RDJ^W[F_=Y^B&MQD6^ M7=ZF'XHLW_*[:G"D;Y6[/G$4"<:C!/I08)H$0@K60<8`C[Q69CJ1609^">ZW]8V% M3"M93?^A.)O19J#B;-J;*SQ6?4?E`N25)`B2OV("9[(L"K`P@/:*!S9;)H$HN6,^%C]WK3JU\&_\-*]3.;> MMGFYK-++LO7(6^;UD8#6IZ:-93$AF@RY^5PX4[2-IT'O61KL/*L_@,N3N'?> MM9GPZ)_#V4\]2(82GX6OXA7F/!LLC$AWUH)B)=.)5!5ML/`#&1`<`QE#F4C& M.3H4K32@%-I*=28QSI'K.OS.Y#JC03>?[.:*]P39KG/M!\AV&E$RE.YL?!>O M,-]9H6%$PK,7%LNU'5NM=O>[YC69#Q7.3;K--FG]X/*S3'OGA?=X+:7'P9))RS^178+/PF^D#F+@$//'2 M>^SF=\[+.)P=A\3->%5HX9-YA?G2+A]&*D5K@;)<,ZKC#A82<\Q#&&*2")8( M4:7^[LIPBJ,$+?+TMOZA*]M%I$G02DI*6R5]YI_YJO))1ITDDUKZ&FR6E9-_ M`?,4F#]*+AT4..,UIXV/YA5F4\N$&*E#[87J;#Z]S_]>O/\GKS3^+GLX`OS/ M7;%>?ZO_X/IR][G,KK/EYML"^9Q6]EA`DS!`@'$_((!3F`1<)$(&*E6E48.6 M*\,3M:KTJ^A0UWL@?G\K+YEBEC++<7^BF8U>O5QQ@'B:$5J07H/2.\*7K MHAJ2]2\TDUCGV'X$;V+6G^37BH,F:?H4X"9EZI#RG:QGA=.9$Y<=GPJ+'Z%& M^KA+\.\)M+5D\ULY`]+.$:#H))W=/AY(?=8H=B!_&/'K\+RMZG9%OQ8 M;]UD7[-R(4,LB4@B*GW!@U`((,#!0(RTWM)3_U7+F:0!XOU50U%5JP',J+6R M[)"B)_)J?%AI"!W<[VG1!#B*01+' ME9KL30A,M*ZPU_G=:4:[*.Z763YHO*ORHS'B+5`S:,R?9<7>J#_[QOT0HEP: M^;K0OS?V![FO//I_S_+L?G>_-\*@B"$"0<1I[$.`1#3T2,(PN1T1@(/C"Q!>C*P3+KR=& M*,%$,C_"6**`(=^/&>^,^-6T0TL(M'[9MA"T8'2%0(\<12&PQHNF$+0X9A." M4QKZA&`07:X(P3#P3X5@!`7*0O"N7DJ]*];7;^\?-L679OFTW)OD%".)&<8` MT4@@%!/0E2`5!#_2D84Q=BR+Q`&:EYU@T]2,43RJ*Y#/K%RGJG6>/)]:1`6?$E6=S<%/T MF-P3\JZ"]':;WI<5!B!#*I/`1U&"49.&.PR"4F%X7XBZ89?VAM2HO0:VA;T* M&K'HG^;/'@:]>?^KC(#Q'2-V(C%LU\@IR\V-\:YN(SF0-FXKB3[WKV<[R0#? M]+>4#"50O8J[RQX>*H._5?.BZE^[K9+HU6:9EP_%IOVVFSGJ@D62BLH8$Q)B M%@-!_*['C2).I4Z?R9!)V^EKC[*Y`42WU62*5;6NTPR$:B:B/<`+KX/83,,? M@VPNW)CZF@TUZOIJ8[/<.S)/-^W5TZK8!FG*DB>+35II+M]M-FF^^M987JYJ ML_]:9OF[HBSCM,K-Z=7RZX)6%;GP!<<8^83XB&-P4-V$PD"O1#9IV7K)O`?K MK?9HO=L*H_?SND+YBZ8<&F5<31/GHEI/&#N..YC>"4[O7PW?-=1?+KS/#5JO M@CNQ0FH0V2.3-L+AB%9:<:VP_S5KJF9GZ'W^!(Q<9IM_+]>[]+?T^C85Z2;[ M4FGXE[1<``(DHP&!88`2@,/(3U"'Q`_U7IVP8-[R!/*9?FZ/42M/Q?3"NSZ@ M]K*\W&YV0Y8W;01(36MGCHV>Y)ZH:GTR_YD"UYB]!K37H/9.8$\LO?J\]BBP MQ2`Y(L0V/2PF^^(U9?G#IGA(-]MO]8'\[6D'_%.9WNS6[[*;="$Q)+)B-$D@ M9X+#F(6'>73`B5('VJ0]R\+;0;SP'FJ0CU=\+KQ=`]1;5T@U%=8(UVJ2.C7- M>AIZ9/C#@>'DR'"+T7O7R[`5Q52@K49GMJ&`68!0RB64<(@(5'`86>;L$3K#6(C!FU/.!N,;]8U MR/H"XSW*^HG)=%MZ;X[*USN5L4BX8ND^-=>:-7M+C1?%]3_9>MU>\'MJNQ19N:KJRMTFO4J_;N.*CK\7 M)$12@KBRBK"D@?`%:A\$)H!2(K5F@(9-6Q;%#FUWM_>CT:I=8AMF7;&\GH]P MS=*ZEVOO"-;[JX;K-7BGWGZLQV9?06TG+(XHIRWOGA;2-DE45E->Y-=I7J;7 ME:0O\U6V7%]NE]MV$_71."4B`MR'H+X@G?$X(#1IC&."_Y^\:UMN&\>VO\+' MGBK/%$D0!'G>P`NZ4I5./(F[3TWU@XJ68)LSLJBB*"?IKS\`;Y(<6P9(`(+G M5%X<6S;67AM8&Y>-#>@A*".B:EK4K)TC2(=]M:O6Y:IHAK/;M'J\9?&/_6^T MP#F8(*FKBO@7DU/SU,NIZ('UEYB]I'0*,7=&,=4R;XE0*C:JTME9)67Q]TU- MEYS`U>\;QL:JY$<7Q?J:==P'7MUSK-V9%*P'+^GG#2GK78,W&S8GKG>\*!N& MD>N%01[CG"`/IR`-F5A'$(:^3^($R6BF`3C:5^CM(^1L>(62"FG"%6+R:9D7 MY+3U`-XY0>\,\(_*,%\YV;Y]%/83%]R;;W3]1)W?JDWS8/H<:#[E9T39H#\M M46R3%E<7&SS:M?XKY9\[AI:GR`M!$).$^)%'LAC[8("6H%#J:1X3>(RI/=*N M]A.,T`'&-B'VD7>WE7Z-)ZK5XP M)?5,O^D[$?OG?"O5^LG.?+=2/]WBV4H_DVR=>SALA#4/Q]!`!OT`YI&7@0!X MD8L2;UQR\'=:-&_B2.,Q)O6Q_ET<>6=HV\;1Z@=#8L^->"=:_Q/?:C=Q)GOS MW:K]#)/G;^/,I%OKGOW=*;(P)7&616F(/1*E7N)&&1F7'$DH55_>`!Q3:N^[ M!O;L95VA;\]>HQ=,:3V_3_-.M/X9W8KWZR?Z\OTJ_62+%>S7SR);O&Y#7S_B M\]T_]T7-=&W]8SPB_K"YJ^K'%E=;,N1P4`Q)XO(3X1@CX(8`XR0(21XAEZ2N M3SRI>-;E'3.XO M[QDYA3]VRDN^.,+<%\%Q+I<$,XG<,WJNUUF62+AF(Y^7ES!`J41N8;VMZJ*A MGZK-5WI_5)P.8@#<#Z,=I'(4YAHE\]-NG\P,D8N5;7Y58;.YOO-9=42^5)@R$]Y?6JH$9:A M#YMV\+8MY>ORD>DAU\"A1'3ND00F'H+`2[`?@L0+AT91`*3.\N:UI%F.CL$Y M1^AD,Y9GTBFF2N:8E%.F5TF\E#B=)>J,0*DAV!*14F1,I:,/2HK5YRVMVZL& M']BJ^Y'R2@N+#,(,N#!-"'`3&'C(BV#?%"),).4J<4UI069`3:JX-8)RRA;5 MF\6VM`RF%Z@Y,X3F$&G)P)EE0J6N7TD4H1ZG#\5FA=L]_X?Q0F=^.T(")NP%S#$E^BMQ>22H&@`[M M$4H4,I[)Z/F`;HC*>5>9[.J4@)Y[/6OR#5ZABS MH#BS(D,JU9U)B`)DB#,0>QBF.1Q-#0;X#@4GR^I:$W[<#O!UT:H MND/H+!^*^I[NKIP-%7\:Y\48)4#$*Y%*)846Q"NEYE1Z>IK$'CE7&GE5H+!J)>^RI#?53FH2JZ+>JC:OH`AYD7`1=@ MW\<$$`CAL%>'7`\3\2@G^Y>U1[0#H+=>ZQ!Z(N?4O%?&RU02+!@*DZ%7\_N` M[#JIFQA"Z*8X]",_RB&*H]2-(V_<0L,@ESF?$OR3F@^BWJH_IF=Q\^8B1HX; M6Q8KDJB?+TJF&"W<@T\4G_V'UD\4+Y=TS3>*Z2JCVYHNRV[/*T\1\>,`I@CY M,(P1(6@<1#D*I"[0JVQ7\U@XLR#AVG+E%`?KOH#'YY-]CV_NZ/+YO/=BS]G^A)[P$6N'Z9A%,0A MR7EJ60@RA@>%02!W@*D'@_:E$$/H_')+-_2N;/XVG-/P=QA.3CP=WK62W&'0,1YG!'3%GQUR.LP\1_?E3QD6XTG4GI%EO:ZR M1*`U&UF9[/V2HMTU6C[1[F2>P?C"XL477G!C6:Z[@($;0ID'NB)[>^:I'RVQ1*#EK\62$R3/W=1TS]R>Q+(LI*-K)K)85FL%VX*(0Y@&J:8 M_4OYD@L/<$#F1DJ6+[-1:%^HM+JRZB$MJ7-+FV^4;IQ-Q7[^CZ__:,\VVR_^ MO:_+W:I6,ACD'RYS>M!]O+XDOXM]9FQQ&?:IYIJG.CR;C@Z`'Y,.$:M?:'2V46RL6 M-/20/#=VI`]L!-$/#!V+7C63S^)[EXWW1['>=S/>];KZQDOK+1*$`(KS.,U3 M%\.`7V$(!F0I!%+)<0;@:-Z.&!&UUYY;2/S>3L4+%NYKGANE1OV5>FA6!+B4 M_L#88%'[V?ZQW(-_1ZOL"@<2[I`/"3I\;7=8T&*Q6&C01_;<\,"^ MT6V.W+/E-(M.GYL'6B]<0E`:10%)@M`G,/-=F([+FPA+9>$H;=CL#G2Q7-8\ M`>]H\YFAOV4F\$#>;C7LFDO\BNO'C/^NRT=\]_(L\+S")Z#-B;L)]EFB[ M$5-??$G`!+U"E\-%$BO_MVP>'JKUBL6A&YYL]XDV"]]'Q`NSW(.!3Q*(4I", MVT-I2*"(XNML7[O2/]%N"L[7[=NB;C;LCSR46XDJ:=JH/R_3MK"N:X)]A-MI M@5\YG\Y5L3'G%_&Z=C;X9UK%.WU^$JG8,)&W%Z*A"2]84`%"NXF5N4ZM;JNI MIBL6DOF=8O;7'A:NZP<@@0GQ5,P"W;_OHE-AI>T<3G6/)XD*# M8>*[1K.HFRNAGZK-JCMEOEW3?NUR*(;%2V'3W0)A/X%,TJ,DAS$.DBB"R0`I M2EVI1V]TXM"]D!CQ=*>V!\!J5%6-+V;IK'$WZ%+>$T.&/9\KYV"+TQECEQJ+ MT"^OSTJ=:K=BJS553,,UT*M#U1=>GB/B!QG!;A1#'Q+LC9>88IA+O0BOLEW- MJGU-Z\=BPSS!9L$GHMUN"[/O-,7W]GG"LJ&/BHY9I_&O7+F54F]8J6V7934R M+.RA]R>[XJ9-EUE)^N;*:GNF>Y31L8!Q!/(0D2!-72_.4)3F8V9-A".ILU15 M;6J6TQ:/&I64IW.60FIE4I-S3N55<;)7[%;$Z6:)J>%,VL1? MPMW7_(82OQ=/\6;UD=&]OGE^&7(!W-CGB>89S'%(@,]:#(?&D>]CJ5=QE;2H M605[D&V%BVXBV>+L:N[U!1)_Z;'*EC%11+F85IIG6TXI%1&MYWE=$>[.**): M[BW10\5&/7^"5P-E$E6A3Q3X[I7TD/S[Y+M5Z3JOY6U*M%#+$+2)BG09`$@9]["78]WW=]+TLA2*7V62\. M5K,"/ZLZ5-TYKV:%.7]RW$X/_$R)"$N]+J;D%\>I+PA(^/K*&0WL)\H[YV`B M3\$?C.SFW)V9PCU$4XERO9X[$X*LZ3261"][^/BI@KHMP)1DJB_2S`5Y#*(( M!(GG9B"!&`W-1<@+%EM:E]6*!?JZ$0MX4UN2D:WGH(05+"G6_"H6+XYW2^_+ M32M&3,?NRAV?S?Z@A>R>RF1BQ:*)"3;E@L"KDF]')K=\EK8PEY9HXVPSQ+*K M)6D1RIQ^N:F,+FM:[.@7NMNO^JIN\%D42ZV45QFLE,.QG"_.;,[3!#KWO8SNT/)ZV>RE5) MS[Q-8)%_SZNI_3Y5*L6\2DIGEC/:U3T+\OK:[,N1YSOSG,Z^=^%^\33Q=]$- MIN617[@[B"2;ZV+_E6STBSO;@G3URW-0633Z9D]6/FS$L=[4Q6;7U87@GSH! MG,(<0==W$Q0'_&7A-,7Y.+MR@="1]>51:MY0'J0F-:=];.ZLQ M3L2;4YO+N$9!`9,6]6Z$31B@_M#WNMU\99^^'NIM+`@,"8@8J#2+4`Q3G)!@ M0!=FB:):)DHA:9ZYX-6J`S(^Q]M4SK)/HN#;S)HJEJAUVZP]ZDMZ3-&6]NLA M9\B'Z>SHZIR\[4S#)4UDZ)??-]?E7[NWV;59+5SS1"/I>N+&-4-5OX`-$("# M/"01@Y/[40[\"`[87`RDTFR,`+I$S-ARK$YWX&DN9DQVF8:(8<);VN-%:\2[ MBQ:O4*\J5LSU['N,%+-MGA,GU!`^-TH,V[UBV##V88Z]!*$@W!6T+B`UU0'C=>.YVP/&E+4RP<-/9ZU.VAH MLEDL:.@D7$_0^$J;9DW;FU>\#!;[/,^YW#[H,1N@F3!R!%-GA)CO+@VAPHR+3,6,(VN<;\P=L\+0Y5VH.AB-%CV/1J.K#U8Y7P]>_RCB=9-!:8YKY$.3D8Y@=X`R0X%8 MF#+HCAD)B+NTV#W@U1._QW1=E*MRDU:;#6V!\PG?=5UMJQU='<(K7[45/_A7 MBQBY(4Z2//,01%F"8Q]G/AF MUMO>#F1-#W M^8VQH;D\2,+^]FB^6KMF14G['Q\?"@U6_T\9;6"]9LEF0!2A,W"T&4NVD> M^Z&?@=!C0YE$BR=:WU8BP5E5BS*#ZQB<>-Y#_]`7KRK4U5D;LJN.P$ID(X\G$4`R^-4C\@293A:&@RB#`2O5$VMQW- M67+=<#JJUSDM2,QF\^W@8))(N:!PCL,IL6`VF>(QP"2IT[1_)KDBDO\&":]( MO2KJ+)!X9:94ZGN6Y-JZCRACPW37!Y4%(F&00.1G*0I@2$CN1_[0((&!U*V: MZ:WH3GH^FOQ7[<@9;LFLI75=`:5B!SMFV)PVT3\(#W]5I<=E>(/B57[.;%', MY]2230H%AE2JN]ML3?K$;._;='$0HCS)DMC%.40Q\?-@:#,-\E1LAT))4]JW M)KI8_O(+Y+-%28;3J;JDB4P5TG2`=G%U.D"1$J@)Y%JK45-L>5.F)A,T0ZD6 M)/("'WO`\_/<]7/7)2096L)^&BV:JBG64]7IS3\O-5\:D0B/I1O^*T>*Q-84 MV^)'(?_XW13FIJJ04M+F:\_%]49*983)LU9;Q"UX4U$DR1#6$5)NRH9^+)]X M:PWK0/QU([S;T6:''ZNZ*?]J-P'Z`O>?Z/?FYAM=/]'?JDWSL%O$&,1!GGE) M'.489C#)(/%)"@*4IW[HYC)+-/E(##\ZDUBZ\0!F/R&^F77S'2M0FP]7B.7, MG"_%$VC5*,:$C9@%B1(,4Q86<`3#+`$Q@G!`$V#=6BP$P9@4Q]JE6(QR74JL MG&UC0LR16Z_#'*12&9;RU[M583DK9XOP!%)U:C#[[()@F,2)BV`61"",LR`` MR8`F\H&K68-%()C28-_5K\%"E&O38-5LF]-@]COV:S#[K%H-EO'7^]5@*2OG M:[`\J<(:G-$[_F1,?[WKFO5^O%SN'_=MO;S^NY]OU^5]EWZ>83` M*,!Y$'OM$2-D/PFC2$9[%3>M/QESP#8\M>)4(SI)&5;-NIC\7I!P.=GM@3H] M)H=#96)[Y('A)Y\%/*!%:^6X/*.QFIQBB;;JLJXRTK-G:^DUDW#6(/^R+>1T M#M7N`]/\)=WM/M^U!G01X7;7U,6R6<0NQF$80X\_+QKE?I2Z:(",,WA MU*S2+RM';U[[O[[TVWDQV?&:%IV5_#H[_[U^SN?\.9@J>@G(!M8G!P@[.X:* M:&*Z3QB*0LH<)A6RS'<3:^/;!:AX,QA>RCT7C9SW]W5;X^CL3,#'$?)=MI(* MHC`+79RX7CK8XWH^O'1856+$^UX964+B!4.H\4Y@67QE2[^!`ML7@6:<;3@V M*^U__\6!6RU/!J*Z!L=:$?))4=9_%.L]/?[I@O@D1@!D;IXF?A22$,%H,`1@ M(G41P3[TNH^<&"CGB:/BXKSEXERTP"R*[Q/=?OG`KM_C%D?TMF?],?2LHP_] M%P7S%QU\H2@^K[/]/PC?,PDR&+=5N%*HOM;7Y0-=[=>TNOOZ4-3T"]TRY7C@ MSQ;L-\S3SUP&$F''VW54.)6E.ZW70^4EKF(;F0-]$Y MSI^M!0XWP6EMD*D-IMM?XJ7#+/+;M,IB/_O!N:MJ9YY;9Y8BFT?J"],#@YZR MH)"9*4LKX\-`J,B3[UV7&\J3"0AQ0^P1.L39>C^(9&6>FZ%-ILV0"/1E^I:;W2`Z! M7^MJM[NN*S8Y7F1IY,$$!4F,89"Y),QP/#018#>5V<>1^;N:IX/@EZ-;^K2/;RKW3-?GK_*UL%UL4:;U9X]5AN2G[VVI1/ MM$\)7>2![\8QQ*GK$X!@Z(7('5K//>C)Z;^B1K6'A1[GE7/?(6W+8A8G6!W: M@34=-<0H/#.T%/O`DE&GVJI*:\>5'*M?Z(ZR#S^P=C/Z1-?5EB]:AD8AC``! M_O^1=VT];N-*^J_H,0?H64B41$GGC==!`SE)8Y+!P6(>#,=6=VO1;?7Q)9/L MKU]2%U^2MDU*),7.8EZ2V&-^]16KBBR253D-`00P#^7UB'[0F`.N9Z+CQK)N MF3V\QB*7!X!3F>-%NBY8H1F:/3$^0\+4-F:B3N:Q?)FOFU2`7&EN9F)Q*3N? MHC3B29J$&.8,]4-PSA1CWY!?=A#@>D#!0B(:F7PX%>]<-F$@"3ZD!X9"K\?/ M`*$X`A3`F@_#,XX'-`25W<(I=D\NE=@CZJ/ M!(X#P0^D7'#]0^GSQ-D/AE^;F44#[:$M7MD4DIX!C+GLSQ0?-\&J M=)TCN\S4!4LR1+$G1F5*FMK*/-386#06+<9XF:^^]]8M=C6\+#>SA*`4$R!" M'LD9YQ#2%/3#I2'-U#<98T9Q$X\Z<,+&NN`D-_'WI5;#L%%<7K]4X(I$O1L# M)^SM0[OL:L@=LJ=^Q.^*Q6'G]T/95-D*7Y#\S+;8!%<>;)&-B%&;G4+:6P49 M!][7FPT7HK'_[*KM]W^5V\=Z>;OZ*H9O.LO/:$PBC+*<$/FF.PXY@?O$$R`) MUCD2-#.BY4MRN`(IO-]G`)U%W=V)JGW9%EJ6*B?=G_F*=/T@)_GW[K%<'=' M>(9X!C(&\CP'*2DXXL4^5YF%`H)NPF38*`X6J?MFH1VTX%T'[A^36-Y/'%VU MM>&L>F5=(\1XU9[&TJ)L01_*[<&"9WE!81SS*$HSDA)(,(OV@\`H`GIVH_?; MUJWEPV$U\.Y)QB[')G)"QP7#&$:;)^8P$'QM8N8,2282L6)?EX_RVM*;C8<&P6-CG"04I12QEJ%_59Z`H MD@'91HMH'*4C%\<2!-+,FH2D7']OY]^FR$L.Y_1:XM*!MCRQ:F?BOI;Z=$:S MQJ7SGQ#U:&8B&J>A=%!ID2+`TBPC43\DI876=GO,.)8WV2?0)@VK%TBZ8,`F MJ/7$.(V(\M/5=5/TZ%P:W*YWB^UN7:T>T&KY1]D\^T2+;?6U:9Q,J\U"3+#= M^NA521HAS$`6%B&($8$Q1YBV[SF3YI6)]EU"\Q!<7#$\H&Z.*#K<`7FO5MEKMRN7']ARZ7LDEV"?Y$&T& M*"$Y9B1#41;C0FS5<`AP0AC*\Q#Q1/41NY7!+:^$9%KARG,\1R1?/RV>G%\] M]]K##1J\-\$><7`,.3A@EHUIM\$G+[2A?OH\N5:&'4O;T8[*H?40PLZ<9EOE MWH-C;KORU8XFL6[]-'4LS=WVXT>Z&2(%`P@G/"^BE-`X@L4>$DN50ID+'-;W M]TH/S=W3K[:/\(5YN_'N)FC`2STU\`.)WW5IL.%,7]A>N-"?)[L,)Z+^6'C+ M&;TV?/:U5ZT(YABAF.$"%930",-LCY`E*;#DPL?"LNS1%=Z(V_/SHU5FW.V[ MU);M*/#[D49/I>GOA?@;%(87!IA`V6\O9!B3?'@$,4N^Z2362=ZM2YB+_
K:5%S7`&3DRQK7RK M%@;+X;G!8B]]JD>W\5RI-:9M;X#;-PG>YT"/^363\!RDL;>7W1PFYO!4Y@A: M=;SPSP.?OK)]]2NTB1)WLOS^Q]WVKEQ7]1*7]_6ZW#\IG(4P9"2DC!8DABB" M+$*TA\QCJE4>?$J!-JU0X=KP:( M5VH9O/[5H)4O:`3\K=YM@U;$F^!+(V3_2Y^=/W*SJ+#+L6CR:>)/O)J>BI]C MVO28#,0]^0[^_KY<;#_>#T0_2Y.DR-,$4L88(&$",=S#Q448CXYY#C"ZB7?; M^;>^&&WP[LO5.A)^:7%$=/-,@68B6U,4I)%*7@\<'>=\"&KC]:0;T!S.#)^# MF4L:5`*9<[5,LGG;/[A-0HA(D=(4\@C&(>,1BWNL18CI5+LV98#>;->42E%X MI%CW6S8K.O5FK_:A5?_;WJ0I5#>8=$;X',F<<6!Q/S90(>J=UJJ'575?+>:K M+5HLZIW$]'!7/U6+JMPF7>P`<'!`'/63-X&**<;5P,0'9>@'@"KE35E%0X^Z"9S9,OB>^ MUK14/W:SLT&:TEVVPW#D44S1W=@P(49N<.=IU5O\^B7^N"B;XL@?URV&V]7Q-ZK5HGIY*ILN MZK,BX7%:4%S0B#/&$I)!U(`JPC3,4ZVUEETDMJ_!EG^?+`E.X(L)V-F:+/Y^ M\K5.!K%TD%*H.C)'RE-;MOFC-[V(8EUEEHKUCF#[POK/C18]618Z$O:GXL'N M*%;V_VCY/[NN&#ZOUQ<@HF_59H8IP'F48$(AD1V9(X9Y#P*`D.OX>[,C6_;O M1V"#>^$;+CN/OR1D76=N6!-JSGLZ)6@N_XWR;\4S:U%YP1/;48DGGM>2<+6+ M6:WI63^+KW^\1\OZ1>[/_E4^?RG7,Y[G8BB$<1H5G&<9CM.\&PL6M-!:,`\: MP+*?E)AD'K)'%?Q%Z^=YM=)UAL/(4_-YUGG3W8.+@81F%&82XSCW&6X"+B80\BQ7$Q?-4V=F3'J[9K.[KQ MR[;1JABR;'.IA7'+MI$*<+!NN\*E\KK-E$X\\926A+NX;C-+H7H3C?/#=DX] M9#`7PQ`8$Q`7`D/"63\P)&HE>,R-YID/';;>,T"ZFN=TR[==;SG-.O$J@Q=\ MI#GV/?&+!@7ZL=.)8:JLGPB]KU;E[;9\WLP(`P7+6,!BY M.!521^/[R9"4)&A$<74\I*%)NT=$=I3H^)A(27]>G17M:;=P7J2O4D\\O4.! M#9T;#:5:.5+\N9H_RR9W_ULN:?EE>[O9[.8"6?\.G3($09$2P`N>DSCF(E;) M4?,D"P%`6F%@Y%"6??P1ND#""WI\UTL\6"%6S2L[Y%3/Y8Z@TXH?O4S4!2=I MB&%//*`I:6HKTW!HA_8_RD59?6V.V$.<(L@(8BS,Q!_B."O:>YHPY"F-XX'= MV35&T+&I,9W9Y8O:]1[65"W9#\1&?3`=:K4RR_MRO2Z7 M8B"TV33<",>-:]T`.W1]F8A- MTW*B;CN_MTBO6J=MZB\ORJ?E7&]]WN-L:CFT:&Z"7@,";%?>KH/;?6,ZXC7* MQ$ZF@('58,TJ8DA\NDB18FPR0[.'<3=V-VB,DC@D M8L_&25Y0,5@!BW[00FSD9MMZ.W^Z'H'&CZ25]=F#4K^X)?\7#;=F@+KK,<0M M:WIQXU"*+CB@:R)UZZ>T`X4!1M6#@UMFAP6$L0RK1("K/)SQ^N;X\\#3&Q2F MMC'%-+-A=V+1+.99'T7NZLUV76ZK=7/*@-N*:Z\V>L]D:_`BQE#( M6CPP3J!>X59K("QG___8@PSNQ`>Z11;L<:]V#.`%[7J!I(-\Y-A.40<][."` M>\KJ#$,IOI`6M:XU3W*G]N6L'9N#QF+[M>9(^/NG\D%B:9X%'H9/4I*3.`-R MU"(OTB+J(D-&.>%%J)[Z,3FJ]<3/I\5CN=P]-2\H3KN<2.?P1_DTWXK]<2=% M\.5[T,FAL72@Y'3M4JZ^Q)^*^H&5/)[E MC0\Y\=>O=<(,JC8OO0R6[;\+=Q:\-)6ZI!UL6JG^:]QF0(.Q,]L"&YQ[L$&P M(E9M=ZKJUF/K7._'^Q,P(G)V;K=IT7Z``2!B.`))R"(6%YRB".UA@"C7>CQN M>FS+6X3C*"5K/5Z-5+J%VDRK0FWK,*46QH2K$\(E1*UH9:>`FQZ5%W8&MI3B MR8;`FG@_UG:S2N-8)RO^4JZ_EOA[^^I48CE`$1L.F-*,AS%!*,:\R'#80PFS M,-.[QV0#P83;@@YWLQ?HGUY+\&8\[CB]C/*ZSA2BYWFO:N)'17CKBR\1K.^/ MC:C+;Y]L1D0UOVR03J74S!D8W?+MMMMZD=WS3@2+ZFOYN:8B:#0S>[O'%9.< M$5)D.6`@0@2%$80M+A:&=\KY:E]+;YU\WGQ_GVW]73$RY1_XY%MDU`BV[V ME]W-K/KY95T^RM.EK^6AP\+MZH-`SJO-8O[TW^5\O:_WFR88)PG/"<\BD'$6 M18"T8I"=?9O*MGI!.16IQ6)3WVMOWZ_>_S:B71S2B+6)ZE)`Q)(?ZCF(&X1U$4:3Y; ME0]2Q,]CHOZ%`Y3@]# M(YU][@T&JA9L\*,R)-XN`DT>92[QJ14DC"C&6Q]O1KJK+MH@B88][-VZJM>? MRO77:E'*["X1.\%J.TM0'`.>@0S)C"[C@()\[_5SJ%50V2H0RWN>'TW\1:(, M-BW,8*%_P&57*R:]KP.%6/3%#?J@@]\>@+UK)?#3-[_.]FA//5*);\IOCY5U MD!!\0'9:@'B\F5,BR06%&.2I`9PM>9`&25>@^"DUWY:D=S6#-']`J6/\I% M_;"2IP>W2S'1J_M*W@-HW\FCQ7]VE<"%5LOWXI^KIVI;E1OQF;")I<0I/F#B M*U_G3_+*R@R1(F*`,105&((HRD$">M24A4#OQO3$8*U?KKY[VFW^V81'>?M' MHI35K^=2C$TEI=5,-4VM7+5DU!O2ZOB(?!,<9`N.A>M*B`2]>,U;FB,!@T[" MFR8H-)\>2>DXHV5791=R7I[,%4^R8KZP47MIT.,CX;FH',UP'+,4)O*.>TC3 M!!,&]UO,B.MU?C,ZL/MMW?B8-(+FP1'&#<,FXL797<+T/O\LB7H>?+PN_/7' M!F2[[EU-$3@T%3;8N_^YDC46[X0]/,XWY8D8LX2D$!<137B1%B!F*$_#O9N' M%/07?@;ESR9!/.""D)YW?B^$_&>P:R`&+QW&0=[:)]J&I>K\U;"Y[)[J5@*= MVTJTL@:]L*>QYBU.E5&)1.^GC,'4A`DK`$E3ENG[9]2=KCDXOI$C^4Y?ZPQ+2>O#@=$4)-[_['J,31 MZ8>.\OT-&V[$MWB^H:\&Y7#S[[)Z>!0K*_15!+B'\L-.7H[[>/_I<2ZL\N-N MN]D*(Q)Q$,\WU6+&0483`EE("@Y1BN,TC4*($`Z+C.8)U3NI-SNV]8/W'NYO M\Q9OL&F`-D4UODB(03E?KP3>3?#NJ7E?_%*NVR\%[ZI5]W77[PJT2+[@5NPH MRQ.G84FXVL5\-V/PM'K:B7_]""#]NFGEH MO;:9(40`A$E!TX1G&4QH'LD$:T0@BF&H5I_5*\"6X]`1E"FO@`]6YP07P5UH MTHN$YVD3XIM`::YXGP@]IS]7=\/'3A]/`IU?G-B\)VY&8;;#Y.]UO?R[>GIZ M509YJ/U!Z+5>;86.Q>`/MRL1+,K-=E^++<$T2@C".:(P`Y2'*8MZ:5(4CKUW M[H,(ED/I*"]\$_32WYQWR)*#X)2$H&=A>$533[5E-[3[--<6][G>",)3,K![=*]>4--LTSCGB"BB(-,:P]DPA2AAKKGP"P:K`218C%%#53)1:-H*RZ[V7VZ:*WQ^G*_Z;<8LCS@%*0TQ#R.$$Q05 M`/="@"36ND_A%W+KH:P'V-WBGS2DC5;S%*'.I88]"8'[.=,?A;5M@K9"['U" M[4W'QRLZ=18W3&B/':IPUJT+E^+O_?01HQ#%(4HY2EF-`2$3W\9TE MFH4!E7_6^DN"'DGP;E6O?MO.OP7+(\,5E]W/7(&3-1 MA9PC^YSE..,P))#R%!0)IG&4%3W4D(;*7:VGPF=YT=A&^WD7^Q?=M1BY7I"F MV/U]HJ(F6FJ\O%Q\*QHU:8Z( M?R5$^Z#F7ZSVS"`*+-6:&:Z.29)=[5=F$4QC!B/"4IXFN!"PHWU:#D(:Z3P9 MG`">Y5>%;774N3=U)U25YCX_94%?7B2AT)5LI?=)IO8KCC))FK/`D[WGE`Q8 MS`D-4L:4SXJ./A"H(9,5VL(4$48+4(2TO^6=9$*0B1\4Z4"U?<>IVQ<_'2!- M_Z1(2Y7NHY5E+7H1N?IY\5YE7G@?QG[6F-N'0T.FRB\8WL:P8?^QT'`E>54H M/4,8IIE`G%("NJ:IJRIT.1/SKE-DJ$0$Q@7,8GS##&41GFQ]]``)&"R:J?# M(3LY$#M:Z+>'TM<]G-=J=K_\=Z1A+[8!!UF//[_1/#KQ;T-P7H>.-@8&)M$O MN$$PP8K-ZJRFE#9),*5EVP;J\_S;T8<'F69)!BB+BHS$F/,XR;*<'%WR2J*I M0NIHX)8#:X\OD/>[GH[=I.QP[DN0':]^]Z'6J>:]"+C[N21$/OG&0>@W'':O MZ=-1\#4VK7[!$&R.&XN!V+`"K;;G80B!A.8)PED2,\;BB.U7!BC-HM$]STO'7RY@3T4";'CTZ_(0&"(!\!`NSUW+3VI#GG/N1!(\M,PHDL>DC9C?_] M)2A2EF-+PB>)>CJ=MFGBO?8"N/;&QL?FF.0$,XCS2.Q"/#L1IGZ5M920.T[" M=X>M!!+?"EEJX^M)/1]HGUV3.Q,OW<0IL^N-?.I/B'08Z+1H MY]2OCI^A[82^VB+<$[VTYD[M9EZJZMG=_;I^*LN_RN:Q6I6]:;ILRUO1(*O< MM+T0DV_?FO+;KWCQV?ZK:M;C+Z\?JMBHW@7@2>/L4D+^7S:WJ9;`)1DA2.;T:'$5M M';`'`_B=OOYV(^`'A_@O@KT'P8$+\[5[,&;]E#1/-J*^B/=T#O\J[Q-3+1T` MCB!IFN[S*<7C,O3I^;=<+Y_$+_4Z=G4O?N-AZ]U=:]X%+'`8L@RD$*.0QRQB M!1Z!%E&D%!"F1^ M!)/!I5VLOP@&K[I_>?;K(MAY-G$DL3XR)R++?+/`DT@S(P&U+Q_D?)'HEY[Q M_&?9K*JVO&ZZT+M@<9%EO"B2"(O_?NV_7@[H M@GL![^(PD.T:LH\A;KZP9C8')@]VDPV_)R%P]#<8'`Y&CX/>Y7]N;#PUD--$ M3"M3Z?W%43NTN(NN%H=-+>;>G(=_HPS_4WFWK$1%4QPR%@O8A^5:'&\""QH3 MSB'/,YP@SCC!4;I?R(H=&^7XZQG^J6-Q,R(-5L]0`W'DTG)<]HQGE1CM&?3W M$*_WW@<'[@?"_SEB][0#?"Z.>SK=?(KIOE+T5GSW%>MLZ^O+#G&U::O5?Y?K MAW(1Y7G(">0_B/W=%_'*HIED#:TX/GR+DO$2X6^<:#5&D&0\1RS`9@4)$DRFCG#JZ2?O2S-HED MK*8)H+H3Y/W%26TFW(5#L\&1CGJ7FU5]5WY>_MR_XKMZ^BSL+R!):)B$$)>*D[9PG,:$:56K7J6W$<;PIM.,?6`55O=+O\.;YR^;39/W3Z1]GO ML#%`XQ`"'$8`,\*2$"$,0P1QPBF`62;;2=.B2<\^LH/ZHJ'-DU8G&]N4 MGU:P&=E6DS,%HH,O.[2R8<(VX[?UZD$D$'V.X2/S+P#.-`(R36#EZ7DCC#CB MUX-6K"Z\JIU.2L7<]^#)O_Y=Y<%:`J,$0E:$<9HPQ#D.B[RSAB%GL$!R?9H- M33B.)B^>UN]Q*6:ZNLS)I;D3D*86%%[SI:X\=A+YR`#4B9-IDRSQNN'JGGF)#B0>'&"'YM9VXHYAK%LFKZC4[ZU'=FR-?+ MMB4_JW9!2`)CRI,<@"B,0<(B%NT,IH"&,5+)-O2MN#[Z(M`$/9S@BP"DNA0R MX$]N&30-=6KBJL*:D_3L*"DG$C1S(CU)T2PX4MN>8[JJL^L&\T>Y%(]EWUZ) MGC$/3=,MM.BRK=K_;.J;MFP>=\I:9E5& MM.<:2-\T?S8>CH6,>0=&.N)<-_5]V6R?KKN/:DLVMZ*ER_W=\TYGDN=Q7N1Q MG(CXEHVJR?)+, MN38KS]!U0F]M$>V);%ISIW8S'U73YFI3;[G9=M.PVC=4'`S3+$QY MW.7L&&.4A0EE,1H-,Q2%2OFOL37'0K8#^%N/,'B&.#1Q5DUIS;F5S$TGI55- MS4XS.I>:`D-$4)%"J^FCR\QU+UR&LH,>EL#.AS=GY39PIZ%*3I-=, MZ6SF:%,FOZ$S!75ZFSI:%,IL[!QQ^=ENR[L# M&TF2QEG6V<"DP"'("YS&HPT00ZD>2EH_V+&L/N-1T`9U=L[KJ%-BU`3T&8J. M<*J3(Z^83DG2DTJ9"22CC+^Z=D02M1GP0`OUL=<6IH#BRIE5[7W=+M>_-_7# M_>5FM7X03QF+/JW]N;Z'\O:J6]#W(0<]9O'6PH`Z.(0=['%?!)(# MY&1QKDOPB36[\S'S9"GOWL]ZXH]!]8+&W?VR:D24OOKZL=Y\ZVL/NXK#YYJ6 M.[@=J*^+)`Q)E(EG%S@&!:9%3L$(("R(U,5C^U8=Z^XST*#^&@BH0V5N*,=M MZ^"F;W/?X^U^C^HU#GOTRXGQ/,RKJ:]%TMU<]I#E\(3`VA\'3Q35@6._7@AQ M1)VT9OY>U[=_5^OU,Y"/==LN(DIS'B4))VG&>"3I@G':CBB MZA*BYT]4`%-4/5T"Y21N`N[4]$R#-B>Z]38Q)T3*D$E/%,G4B]KJ]'*W:B:K M5?,@-HZ&^W+7RZ?^O1J"<80H#%*&>/A6,U,89HIG:N9`([S^N3/L@VZ MH>L2AV9()?K_JC;BD>1-N>I?Y_N[VGX/;GMO*[=K;NUAL[[ZGF+$7*_#!Q^" M@RO"@QO^+LJ/\&YG>6XZJ)Z(^)0>ZR_9[9"M_KH"_RD>7"R'JYT+AC.2@I3G M!:`%1(R&R7A(($U001:;_JW9V\\:SRLHFI+2AFRG#:]0J1P!?*Q:H=M?.U'_ M,-Q8#L0T^M?!6TKEU!G7$=9.K0L->?;D4=A]S2`$9:W$I`HG:CH29*+E>UW\ON\%O+X)- M+:Z4[\Z8JR9&ALQ*)CW3D:J8T(P/O/7(^O1DP!9\&-"=>,303:)RDJM328@= MDCU1+%O>_)H\V"1)6K^.6(MC#"*(TA!%72H2(`J?K;;Q;8 MEMPOG)IHQ:U""QR[6OF=Y>WT,M`>[9XHG%V?7B\0;1.F4J-_70K:ER2*NA$; M!+\OJ\W59JPE_5ENK[YV\KR(&4D1!31B!,,\S0')QBW*C*:ITJD*ES@<:^7+ M`H[`&7P02/\5=+\T@KT(.KCB2$`'6+T>[VZ(I`OQ7HR.<@7^S3J[Q0%S57[7 M9?MTW=WY&'JBUI.X^KK2/A&]*H\6K,KRMBTZ@OY:KLNKK]VOW#ZLMM7C<#%O M`;.L*%":$DQ!!E.>)92.E@&+N>*[!:;FW"MUC[`OK@<"H_C`GU'J7?VU0;.< M#$_,L)K:&I/KZBV#,Y2=D$R+?'NBC#8]>OVH@5VRI.ZF'70973]=W:RK?ANN M>-@^-.6(Z.MQ1#SD119#1DA(R[&ROY"W\>C9G>]4#78R=SM=",Q#>"Y80CX\&U MQ:D\K2>?]@I!5RQCZFX9\UBVVTK`6"0)"BFGW60K28=1]5_ MLNMCXQV@75E@#\GL^WOEX9%/2I\)#[X2`_"UC62F6Z67U;?-L0,[(664 M)"&+,0,IS:($)?LOB3.6+A[+YJ96/3QC:%1E_A_B4]BFZ#Z;31_HENM@1#W3 M08_39$D<^+#$MB?+.=M>'3D`8I4TY:_RF-D4Q!$IDA2@(@4,1FE4C(]+9P5. M$IV3;+JV'$>A_=&K@Z/A^/CLT27]VN?!:9)Q" M\3]5[8]=Y^B8,L!9RFF@#SEBH0R;TX4Z6UF3@B1(96>Z(^I%[75^66J-O3I<_<3^NX169YP M!$"$.V$C20+#F(5[DPPK'?DTL3.][@AH>@UEC/C4%"!'5!JKD!2+TRC1,T4J MX@QB%!"BY!&E(/VM*>QWVF#U M_/[SQ(2J:=5I+G7>@;5!JOQ&\<3DZFT&&Y,LL]MTGHDCVT\6*?1@/\JF-[63 M>:9^M%/L\AZS&F&>%W$*XC@-*8E`'L%HL!IGD5KS54-3[H]T"G3ZDF^+4;G< M=$(RU23_.(\S=J$Z0=7I4YLV./8D3[7ES>O3FO9(,JGVT7*S^GZW;'[TZWB4 M=]DQ9%UFG.8D9UF1,S+:I8@JO?=E;&SZE?4>G[7BGR*]VA5`=\P:+[/E29VJ M%OB"++6"H![/GFB9/7_.EP9-B#+0L]'JL.H7C4ASA$"&"8H0[U)S#D>[.<9* M5R2-CBPUP\=SJP7I?]9*@":MR$C81H6KBM>-Q0'41]+AV-ZMG6E4>9^F$ M9EF@UA.ULN%);7W>*2H46:WJA\VV,[HJJ[XW_+AJC1*Q7(4)!SS#(8$I3T=[ MJ>1M/F,CCM5IQ!4\`[.I4_K4M^.0><@@Q9CIS5H M"K(42TXS\:3P%(!COC3O]ROS)G5C_[6O1PYMF+#BP2D-(_BUG#'"*NZ$$X@ARS/?KWA1(]T?7M^!82$=@P0$R'94P MH/"\ID[#GIJR>D"U&H2*:.W1]T^HKKF-'F@O1:9[FKR*)7T'G'[6.9KRI('$FSN M0VUQVB@(,+DKFVHW2VC9?"O?D'UU^F)F57C5DK83W)P3-3M$.>#H%ORI+8^JTR/M(L=R,MM>=DBN);@<1IU.N!(19]TJ/55 MH;1\.:=1^@1)J]2GY[]>-MNGS\URTRY7PGI+;MK^#?\%[=)F3F.(0AJ& M<<((H05(`(,(D2P'LC=PC>VX^[8&:$&/+3@$%WP9X4V=`)RCZ\1G9HUI3SXU M>_[4CJ:DI4].-.1;U^U#4WXN?VYIQT&WI(*=Q2A/*8X+FC`8YB@<(5!6*+W9 M9].NX[3AQ4?X=[7]'A1U9),7^P2KR9[+GFW)H"/@,- MO@BH08_5%SE\@T8-9309#,]%TL@U2;TTIT^J:'_=3=GMKD40_[GZWLW?\O9K MW5QN;A_$Y;'E>CB'3NO-;;O`F$``,\9I!#+(6)B"$.(4H!P7<4JEWC&P;]6Q M;/9@AZ9;P1YNWS3X&?!X.2/H(2N4IRT/P/G"_WSC7VS.P M.@PR.PA*!!W94'!#L@?["XXBWF;W\]:I&Q+.L6[`6/TQ"#.`Y)RD;+.0^A]).V=LPYCD'[SC^BY<\!SN`` MZ.Z^IOI4BY$@4LULZFG$##ZSH1ENQWZ8KTR&2)$$4_2/(M19P%1UH6LP62((^E%BZD=QR%B MA#=VA+LPTBYC4L\'A2GY5(L&GE$IK_]34JHG_$;4RBC^&0J.2+TMXCS0>&NN MU/;GE6)-_^J^%-MVFV\?RV4KGD38C`C^++<+T4,&YJ(] MIE[45N>7HMK\_K!LEETF5E[=K*MO?=[=TJ<_E]N'9M?^,,\HYR&-8933D.+. M7,QW=M,XCJE2Z)>]ORI'T)C&"8Y"0%)8#'81*5*E1C#& MQN95-+W.">8,ZVN:,W*M:MH\K1/.\:6H:EI4>ZQJ>OY(J)H!4=*J=KFY+>\V MU==JU=O!TM!K%2.GTJ:$IYUL2+]`%Y%M3EJ)J MJ"ABIH3*2=B$7*IN1QRA<:ZW?T\S=4*Z+%'LB7#9\J9V,@]52UG5=M#(?-GN MDKX",TH(0``SEN*$90CCT1)$F=3#:08_WG4):X\H$)#TEHPZK$F6KMP2IEBV M4N3*3OKE5V7%7B5:4L!ACT=#)UWO-0>GDY%/F&R+GE*G5\"W$7G0Q^ M7*;2A:'H(B_NO2?8]VB<.!%B?IC@*/#&C8(!]C&7NI-%.K] M>^:Z;KI=NS#XF-;-8/D@:!Q(0>HD/HD]%B!*4(!8N!?B)7XLNB_,3G3+7O6/ M1A]H!()_-!)!KQ$<1/X'Z+("?5I@S.L*-)E);'VRU##G?6X9;2)G@*=I7X&Q MJ8ZWE,J16)::17R?VN6;1VWWFM5F$MG=I@3NQ)XWNXVP@)UPEA,LYGJ>)7K" M3UE=%E\?\NV;8"@DD',WCGB$,6&NS]NS+H9E`QP+G=JE%\'Z+KE!F*8Y:B"< M[I?FH2?7]RP`G'C/,0]`M=[A&$@]NS^9[0E+UZ>S`-LVD$1A\H&1L-_?-]FV MS-?WV9M@7N3B).;$\VC@0<]IXL(A6.C[Q!>U7_4(MJO7HS"AA]\DN6G7G0>: M9%7Z""\5U]4`)^ZZ\P!4S+M$_:KCVD!]FL@B<+DDR-AO_^URZKZ MMBAOLMM=V7U_^-;T?>S"D#D.@P'B2>AB.HZY(Q^&PCYL()1E0QX5@H-$3:LQ M@7?:K&*$R1M$N`"W-YE-8>4YDSDZ)'W* MUY_3+^DVJ]/-;T^_C3+ZI9G;;%?GM^FF.MP'ZCD^:P1@Y'@>1C'G412/(MQ` MO#LP']ER[]`)!IWB*Y#5H!$-GGX#^U?O!]W=I5XR1U^8;XGIGN.RC2#7D:CP M5^E>+#2$Q'$D%VT0Q9-)[#2,T&$ELKA.]%#VL"^@P[*87#''DRMSLW2Z:?[D M]M]EL:[_RAJ3S[=I^=Q=XI=O-M67HBSB;)-^2\MQ;R!'G&(_#!+*@XA1DF"Z M%X%<*%S2-A_9]578-0M<\NR^7:8[LPNVP1RG9D\?:7+ MKLTW@\0EV!=M#L7+L6TTB]#5V;*P3G1D]J`OH".SF%PQQW,KT9&]+[YEY<>T MJM+\]E/^E)5_9M_^LS7YYR$F;#K/!/K(08CY/*#8'<^/":*80B+:;VD'LKU# MM-4'!H&@4]@>0_(-]"(ES%`?Z707-"M-N1YG`J1*]Z)/5+PWF96L6N>A3UBD MIY@"<:)C,,9O`?V`N5P*"P^82O6EF2)E#\6F818W_UX"#75"G!3`-(E&IF9Z]:M?D)L"L4$4!3Y1ZCD!?0[UA*[%@1R`(ZP1O);\M=M@ZWZ^OZ(2O9KBR[ M?;C[XXG'4A2)PRCT`A3BB$+,(QJ/IYM$D4^$SDTR&<]R+S3([#[_*%JAX+97 M"C8'J;K70`N1./'.F>:X@+?->$J%O<=.]Q#$\>2@Z[O#OW[NOSKU?(]X0<)\ M%!,>.(CR<PQ5/ M$CMB@!:Q+^5;4PN931W,:`J>HBL^OSIWB&(G)LSC*'1I2+TD#*+]UA?BN1KG MP\K%F=GW=,\RTT*JXG7V:.J9VZ4/+SM#2=C0U-@NTL$44SEK63IXQ.9&U9=F M=E94']*Z?;6'(6)[(HCG\8ACQMPDP(P@;PC$?!H+G4VF_NNVYSV#*#"HDECC M4:0UO81F'Y29;V,<4SJ>M=3\!PN5.DS$L6RO)^^[5IOH:A$5 M&^W-!5/.@M4YSGE+^,3LU03:A0SVC*0B=NNW`AY=AQI&F!@'G/C4<5SJE94/)^)0EXV8XEFXR8 M9RDA$IJB?DZ_#V.W_8G'PR`.)Y[+L.=`Y/H)Q0F+XN&"%0HI\X7W"ZI'L.Q2 MC;#])$+VU&Q-=--SUGFHR1G146`JDU<-UP-J?L5B%FTUVGZTWS^^V=V7[1^L_=_V&Y[AY%H*$L2!!H1>CQ(%[%`58;N5)-=D[:NF7:$?U>+-BKO0*]WLN6;B=@ MBE=S3;7*(AW27';G:[YF(:HZ*=ND^6-UD]7UYA#9CPF-FXF]@T,.74C<9(SL M-H-.J;O6#82;?>-*+Q(,*J??76N!&D,,8D9/X8TH,H4KNA1CZ.;6\[?&1S MT'8%!G7*5]4H\!2TLIE02GJ8(D7+U]:\073.L@R`78I7F4CEY/TUNGB4MPQW M5GA]%V=WV7:=-@/#%?%\$D4ABL+$H0YT"()#:9@2[,I=AZP?S;)3]8I`<0?6 M>TV:.X85B"H-N"S#U!UO'[S$53]607=:IB9[JPTE4IA^G#2+*TUO MT?QC/U,?(G,GQ.UX'+6/@[PDRB#*(!?)F#4:V,)LH=VK"$AJ/]+Q=W2;[)UF&W M9[%5416;?-UN:'RWK8O!55>4(X=XE$5A'$'N4PRY.X8/$!?>6&@RIF5GZR3^ ML]_+68';%R)!WJ@$]4,&-KU4B=&64>C3(]A+\98SP,.\N],)!J'@I5+02AU' M9)<"+C[8O11XM:&OP080&0E+P#DQ+K:!=P&C9"MI%7:?2@.EIO"QV&WK51"T M1ULYL1NZ#FF&[R3QAD\0:4`:*;J5)L$PERDT]>(,U)E$8:J7F2QP-%)EFD(X M6Y&I%R)98Y*DNI11L8%,!"I,2G!49_7=N6'IAJ5E^=S\J[_2S2X;#@];01@1 M&D;$YX@[.(AAZ(T%^/:0/HVMW5IA9U^V'<1>@4&AWLQ?B[C2"L!#%'SW:K1F2[(O>U$PU2 MB1FH$L/IJ;UM?'+.U:L!UW>@U7,%>D4`VN8D/B.WS4MMYBW/362"?237$Q-I M'2H+F#!KR2_,/!Q:=NJNW&9N[09ADD#.<>0PR)DSAFFB(W4[G?[MI=CI%RV; M$&"H8J=F\1FQ4]X:9FIZZPG8I36:2=2L@_:Z>R&%3G[I^: MIR&[OOO8_-O\RR9K__1#OLT?=X\KR)(@=+''P\2+8.3%F(PE-(*34&>3J$94 MRQ;\*7O,UGGCP;=%58.RU7D%'GMM>G-V'=)*4_:9(.O.V#N9;2EE%`K:O]-> M*S@!?8X)_&F&XO-W`^VPS.F[B<3.S]Z-H3-IC^GW3H#G^)`01B(*411%R(DP M'04X'M4Y?%LCZD7LL==FWAY%21NS1PN0K=GC%/1+V6.O2\\>)=OAY[%'V<3D M[5$)G;`]#LNI25'R[5->%MMNRK%Y!&^8WY[(-#,EBA*[XPC&F^`A1BB M^;P*RT^NBAUFZ_/!QW)3R-JOT+T`!BSBB"!.'31J0,27FD\;#7PI6[P:[XM3 M\4=CU"4\\A+`%7PR6T]ZY*7JXS(8IPS3=&LLR32-YW;,..T`E-I+'Z[;M;6J M+KMJQW7+MBK:J[6J]C/Y;>,V_2;+5;N)"7,2NM2A81*X`0[&W94D\;DGNZ'> M6&#+YGG8:?Q:,>@EMW\PB`:#ZF[?L<*&;W--,5T\NF@KR#GJS]@`\MON+](0 MNGOO#36(S`Y\44XGREW6<"^@%F8OMR,;\BT!5%TFYE6=/Z;U#VLQ*^;%"#'$ M'"CY,37P?6)+^0T;OAI,ZO_QI!IG(4RQ"XZ;:+N_%^\.<_&C\NROPVW7S. MRL=JA3D+><)]B%SJ$S=,',A&&8@'0@4R6[%M+WGL-;8OZ;CDT;R[#WN=H/E9 MT9*9M1:8'JE?&KXALQQ:XOVA)0ZB0:?ZTDVA?"[,[$UBZK08`TVC<(R,"*X3 MHW>;X!:WNF#:"Q@--:EM0KDFUD:RDPO.%<;6>L1 MQP1`GT'OO=URRN):S&QG.5?+6>\XE5O05#]ZAJ1&GVJB?7Z2_M5(JI)]K3F\ MHK*#6_L_/LU*3NHW1/CWURQCE M*0I>Q7@TZ1-^K\UH`4:NGT-A\*&1K%S9G\ M&(TSJ^):\!:R"*Z70V'P:9)\.=YM;XO';A$]:9+J!TZ[9NQT_34K.\.M5A'" MS3M(:409)*OBH&`UE^<7B/X9=.H_!6TK=V>[C@(!<5>ZX+>>=,9E18>TB-OX\?LS)*J_SVYB$MLQ5"?L)QPGG@T1`%W"&1 M/\B`$8>^Z9=3+KKU-[73`K*TW#8JJ_&-;=2"JA5XYMT%O^1;L*O6A[_\Z^)> MYU>PM=YMM6;[:5YTQ?2DWWH=C&8M(,XWNSI;#T(B!(,HYDD21PYB00#=O9`X M2*@%$Y"*;]T&!C7_GXW@)7!=*U!JO)_)#-025+$##93B$]C;AVR]VV3=[4/Y M-EM'V;;YA_IC\PY4<5[=-@_[KGD[/J=?-EEW*)'/(LZ@[W(OCBA+/#<,713R MV&DFV#);\,Q&MKS:.(H=;N=JY8)!+^@$@Q>*P=^=YO^1W*AGN"G.KT]>OA7D M%BX--X"=M0D9EN<6+:RTR4(\UE)R/RYS6$0H[*UO0T?/[7^'5975+*VS^Z+, MLRK\GE[S9S/92P8)'"?$ZFKO$W&M>RKQU[E*]`)!0>EX.]6 MJZR?&L4OYJ:7(B_GI8:@6_%0"8)G'-1&.RS$/ZVD5MA_C"6]\TBXN'A,\^W* MH0%GA#,6QC[V*'$0QF/```:QC%.J1['LBZVP(V]D+T[6"#58BMG>/!CE3$Z5 MH!57.PGHC(?I0UV(8QE(I##]O$GLL/G7;S>_W3RFF\V'?,W2KQ^R[D:T"#5# MQN:G`RL4H?)`KQ22WYAYM&07#-,\N_M.35M M9?TFN]V5W;&(0T@7>I33Q,,Q#UGDAX[C.6/(T"52QT7JQ+%=3\F?FO]3?I>W MGZVU,L&PWS39;=>R)^=J\11;.9P+I9S=OB)WT"5O(696#\]`.K-^:`+M0E80 MC:12F'_R)$9S?^3W#_^=9YMU5#0OXA`'.4'``B]"D,6A0Q%-_'T<3KA0T5?Y MQRT[4:L)=*)`ITIBL*+&:GI,9QV3G,O\2$AE7*>&2GQ@9QV9VLA.`9W(X.Y8 MMB=&=UI@%C"\T]-?&'I")`R4/V;E?;Z]_Y"6_\[J=C@SQ`HI#U&0Q)3ZQ$IG>UD-, M[L=>P)T$0A<'$";-8'E?'L)>)'0QC9%`UE?E7NMFU MAV:/1E9]*C;M)6+?TG*]\AGR&K]B7N!Z+H)>2(+1O1+,(LDS!"P*D7G#E+XC M[I6"?`M:K:`3VQTZO^^]F_>O50P&R9?_]$(4[IG7=8866\A[/4>FD]]I6((K M-%E\J^;/K/[7MLS23?Z_V?KW--]6[1?/!T$KQBF#+,(.)LS!#O$(<4<5'(?" M!1`+H2V/1]KSLW9[@>"^52@Q`[+!>GJ2>6',<@.;XU^YM=P/BD$G&?S2BO[U MZJ457[@MQ.>G%VX3M1FKK;81FM/^E&UEUM-X*@W2Z(OZ3_[I7WMZ$>M(-!/.C4-T;927'NN='^T\5DQ"_OZ[[NT3+=UUO0C7ZJN5K5R73\* MFIXBQ"Z%B+$H:@(3G\4H\ER83%T+I/'+]E[\@QCP]RAG[E?X+9`S;Z4&O86\ M:#H9%,8>)>4S%/CI+PP](1I..IQB1F"<^`G%3D2=)AJ'//''2#00&RQJ_/P%W%3N8$,==/*. M:H&:OJ?.!TS=5RV`4W/6D1:X:\;(,]GLR?,=#9!:H-7*9G#&;)5@B'U#N'W* MBW+;/4";/[)T4S^DV_5->I?5SQ_2NO6R<=,U="(20TP<@B@+:("H-P;W/29T MR*S9B)9-^970*]!+[4N*G5@PJ)7YA,X<[6G3O@QH.1\79:STO:(YV!(?,%X$ MNN(7C>;@"WWE*(KF1`]A'NT".@T+214VGT;9=>#FD>P*ZK]GQ7V9?GW(;]-- M-W6(&7)@P)$70.:%.&0>&A>>,8(>D5K]58YBN0MYJ4?MQ@8-@()KNK.PDZPR MR6"SLV9[BLJYE5IMDDM9G]5/Y,=564-HQ'TGN_\QW#"&IDF`H\@AS"<."Q%- MM8]:/@RRFM^F'H,XCA(W2'`<\@2-`1TG M%MJ\IQ_%LO>,XL"@[@J,^B3F;IHD4?VU=S@ZS5YU>]&J\G)[D8`S+[1V2)O`2ZPE1TK; MXTFW:-QMY'MQW;2MN^E!>'4]BJ`?]#2'B,.?(\E%(,H:PC]]\?0/5&BUI?ZE@86BP:188>(Y^79L[(T-.`%H9) MU:5'B'J1Y8P8LYI*F2"5^NG4MS/EDI'[$ZB.S'"7/>-NTOOJKL@>BL5IVV], M@CCPTSB./!:A^KV8I9TUA+!^`RQ]$T/('3B!9=(1RX`XM9IH`,X,5/&4KE$; M9+UCYD*5U)/*B=1*?;WXJ%]67U)Z--A#*88TC;S0XP'F?L"0EW2&O""!>KVP M]+]?YT$Q:G%UVDONJEK(J3(WI>?"S(%/6\CI4:%_9/#D@,)=L?)==K51\?U:GQ@0:@[L)53U[5$O-PE&HN M8/5@T^UIS8^(NJ!(=@B>B#I9F^]/OA.56?H!F86]-&<]5\4SSD0-8Y(%NO-^7?Q3+;YLUPK4\!U+]_[J1% M:B/(L_D+>-Z4NW7]<54LBT6V.?Y)]8]^4S^?LW9F0L@BW1.8)K+I3>ED3%JH M;_ENLY$CEF>;S6NQ>F[ZLW3+Y>]VT,YIY(0ND]8"0,$EAZE,NPLYT1+C28J)->\[WB35PP--N M6_<16^\[-5G00&UBS>7/):=6E*]CN4-X`WY?/1;5O-Q)3R[L_!A,`7]B4%/\ M3/F?L.X9NZ0@>?WH4E:[1+YAE#]$+JT4VQF!C!`64-"1=TQ(RLB2B&(?C2QGC1 M5(%O>;7=%/.Z*6-6O=!5\T_RUZ[XGBWJ3$]_*KU("$/NIU&:(#^*DR@5]"!& M1'"M]N&V;3M6DB-<4`-MSN`V/YQ`/KS%:`J.]3"H2=*8$=`3+4OD.]$T318O MJ)ZK>$Q$%YVY5PXSK#5681H(N[E\:Y)6Y&`][7S[FV1+`N(OV>8YKVY7\\7N M4?X5G<_S1;ZI_TR*_B:?%^UD-J+$\Y/(BPDEC,K_(5AXF%+F^S((+)RM\N?Z M/[I76[09$)F2',2M'+QS0ED:[O*J^F^P*E>_U-C!O`5_`XH./BB6ZZS8M&VM M:^'(COZ`JFE0WO:^GI_VR,[_KG^^,/\T:LP_7T.:6IS-9;]SHHG=3ZW+?^O" MSKNP'[P!)^Z`4W\F&E+U):R)AM9LJ6O@$*LL=MGC]\RBV`@!G,#BV1A>EZ,^ M-98*AOMRFRWVV!*9ENK*9EL^Y.U5*!)H7=_,HD0PCZ0Q$F$2LSB"@9=TH+`L M;=2V:0Z#Q?F6S@9F5PLTN;QY=]B6X"$'58NUOM.TCKJE?&`I2OTR^_#AL9S0 MV\#M/0#)V\#]\Q@X/KG`V2E0]U) M\2D3FB;D]8@5/$L3-9R2GY$\A:;OTK!QK%FML#ZD+\RU-S]>[^G*40?A!' M6*;2$'("$94%=V1-9,^_A0&EK'+DKE>\.)R%9S'T!0R\BB9<(RD-,.BR(AU3Y M[B!G`*99,M]IG\!V&R7KM;.;``U2/T\M-LX*:3&Y0-0JJS87S?Y.BL>D_9P0D57CTTKQ/W!IS<= M$6E$PB2`84J#%(:!H"E''0+A>4Q'IBV:=:S->Z3=\8WVP$?9-/B<[QN,9)\T M^G1.O)KRCL2YGMQV=">G=+?]5+M^+BW2L18+U%F\H*H.0C$1*77A6>E\')NT M--[;>]]'.0RYB!#VPCB@L8<)3PC?&T4!3)0VZMBQY%@:O[Q1P46_;NKF=*JI MWW!,Z@G>6VV;2H_UEIFSJO+.U4OD77IS=3.(%6NN9Q,/()N7)QF1 M[:9XV#6_.,#6V4!@AV*%G1R#LZLY%7@D]@`0U`A!!]'DXC!+]&ILQAB<9L-M MS#;H5MI6H4+(N3T45LF-0JQ%K;V..,\39=8P^-[#T9UBM!!Z47+T$T9=71]W$+O-UH02V1O5$ MZE][_KQK$&:5*`U5^Y[+2CN5GIY`*/)JQB"+H\"/4RH@Q`%'2W*D*U1"TZ2I4@PG4S\:;]>J+L[:.=.D,/1<%J2^E MDU&BWHZ\DR`[U/2MJ+[*D?>257GU$Y+7&0H0#CGQ,!8DAC&%D1_L<81Q$@@+ M%9:Y\<&4:MU!M%->]:"[5[DU#-.6RJ\;<(#[7OE>IU&/G254OS[K'YO)J*0K M_]3J-UM$*FNJ^%#`.:%!*"M&(GSA)00+S.'!6(H\'>$TL^!Z/::K2#;[YW+] M645BDSTU'71/G.9:RS2JN`]IN2!9_6B:^?&MJOR`]\UF2 MPB02R$L]%H<(!PP?+!)?Z1B0!3,#:,VV[*\TQBPJR\T0!.IKCN3N)\49JTW^ M>8HNZT]?7J:]$=LA16KJ]717;(EO47?=XMBZVV6)_=F6&N.^AT$,$ M4AKB)$YDE=49"PA2VFGB=A-IF&SVJ40+^AFDQ.M/JNC\. MXV9YP!;S*JE!F9IA3[^WZ[:UH/W:WL9,,M7\Y=E MMOES%L:)@"$//1XP/V%^"J/#%`@)"+:>='I@<9R.CLBZ.Y/!0X?-A23VB8K% MM#100%PFK!MP$KN]%X!--78.$MU`,1PB!9K&TFJ"/,]GW]1I(5+7E%1MN&N2 M;JW1;#<1I\4J6[S#-HN9A")")"&%/L<0<]R=V0AIG"H?G7"-PW$";E"![%T: M=B'@II&PF'@'"(+;I-O&Z[U<3RE>#I+M`'$;)M'JQ\]JDOV8Q[X)MF=TKBFY M]G75)+%:H5BPQL=2 MI9V>EDPY3A4=KKKXDRFB*%6/[]AB4BDS#$FB?E+8H[L!1WR@!EA7TQW$@5G5 M2@5#LFN>!?JQK)@`/J'BO/;;XG`:LF_-F]+)0-/NK5E*:=N^?I5C:DM7C\E? MNV+=-4E9E-5ND]_G?V^9).#/6OGB(LW@B!7\4:,%#=SA6VNJ4WEA MBZ^3B$QDTZ\;W]XUV'1&H'J+S;9WU.KY+F\.8.VVTNJOQ:I8[I;[B9U*[/+# M+;TD8C'&6$C1#KPT1?(G$:0<>4G,TE2O.;%MVXX5]``7M'AUNV_:9EI--\;>K:<;J41MOZVAW_$/4%L`$B?I+`,$01QTG4H8A22!S(JZKI MP=1UL7_ZG]H'O'[@W$BM,NE6E=8%WTZ%]K>Z4+W_D2^^R[\H5]N7H<^^ZA'; M7UIU(W1=RJKMG9FPFI%H6U=O5_<_RKI$J&8>JF%PEA`J/((%"4/8`>&<:36> MLV]]1'7%;M15AWJK`NN(=4<:>U.+;+W@)4$WQ>Q$U?7(:G^!-8C0=6FLB8-F M,FM,I0.EE:,R;Z%$'O8@K\\O(P_&#&%*_0X*1+&+60(M^R.J+7&FMAKTV]9; M-\P[5]P:]L0U]\"L%=75C]/5Z:Z!B\;*:TJG?>U-Y5/1(A%)&*0"BA#B-.$I MAEY$.R0T]F,GTJMN?D3EC5TIKP;YEH77#>^N=;=&/6W9/?!J0W7U@W1MHFO@ MH:GFFI+I0'*+[YWX8Q91QF!*<2CDCWX2IQV2@`:.)%?9_'B2&WC.)%>=?-N2 MZX1WYY(K44]<K4BN=I"N3G+U/3267$,R;4ON_4N^R;,G*5&S.)1B3X1' M?"&E/V)>F/`.B/!"K1;7]JT/+KC;`S8W>JO#O%6Y=42Z4[6]5PC&F%)[Q-=? M:0WB'TFMOP0L]T]X\]ON*+JCC5^?\VY56JU2[G#_P31%M+]T*O-_78*I M[I:93&K2IBR.^R:0BIO%1!#'J4\PHUY,0RY@Y!TV-=3M>W7J3[N6'=>>>[!F M.V`M*;YF]JKVO6A1?4$XWH9J(?CIRKAQBM+O0TFY_6!@$G,5! M&I$TX!*/'_'#K@5$F-:.5ZN&!U+2_KM=[=)M455=,.U05$??YZI#:E\9U8W- M-:FHMF\F(FI&H%T-/=G\Y?L4H0A3YB>0PZA>$SO`H"15:ASNRO9H2JJ[L]4Z MZ1;%U!'?SO1TS"VMFH3VU5*#T%R3G)JX9Z*HQC1:%]7COB[JA0E&PN=!$!$4 M>@EDAU-A5+#4A:RJ6Q]-6"-'PJI!O%UI=<.Y6W$=;?>J-JD6!%8_0%2P1C'0J MSV61K;59RKKQT=15]S2`?=KMJJL3QMVJZUA[4G4IM:"NVM&Y,G75]\]070V) MM*NN)WNU((PC3C@3R$<$AYPE*>Y@8`P3Z^*J87M@;37>A6J=\!@76ZZ^ZX&%=8^$;2EMZZCYE*&;T"''G3PZZF"KY_& M:R2%/L]U+^&V$,*KT7,;OFK+O#6"+:K_5PE(_ONO;+'+OSS]EF]_^GP6D=CW M&<@C;M`"!QURD%6@QEXK2(<>G,`'?S0.7#@I M-6"4+NO_9`*DI_C_(;%1OVAM$C$RNW[-9:Q4+F8SI>Z#M#I()"9PB9M['\L! MA[;.[9XO^2;[LZQNE\O=JJS7'+/UZZ_Y\B'?S`3"/`D%]4F,89#X-"9P;R[U M(5%J\=[7AN.4UT$#;["!/UIT.IK9B\C/4]90'.IEI8G0IW%]YT`T&M[;^2&= M/6_I/._Q&;VWP=$$)-V*&Z7=H:,CS/EF4=23,#(7=%9P$M+ZAD\HO!!#P7C@ M=U:0IW:VV_"K7+%2`@6QJF/"174Z_!0%+B<\U$' M,>%YG]H)T'CA>()!(V1.)H#<1&NX2:`I!LKI;)";@)EEHE/VP5.Y`>:1''QJ MZ,"CO>DA_=!,("<.XV>_:2)38I67W3L,:;$JMOE=\;U>ZW\+\W_RXOEEFS_2 M[_(-Z3G_OHGV(,8M[E\6-?#WHGT# M.O!@CQZT\,'=Q7`Y65;O0_6%!?5!(CB1I?1A?"U'>$0T9?Z#U/(MGY?/J^+? M$MVCK'^*IR)[EYGHZO%._KI8%-LBK^1GLE22SCSF3^=]FP7"HYQ3$B40I0%) M4P_#SH4(^5H]8::$VWD2Z>"!5IV*LUE%,V],B43%-#,ER.ZRTD>O`S?@Z"@X M]?3]>\7J$9QX"_;NUEN$.X=_N?LXSPV]S$@59?%1N%;[,5,%N\JRQRJ=)R9D'+.JL36+RR[U/I]ZC`1L+2T#-KQ'Z>-L;@U,:+1$-RC1)T,,&WD4A6SQECD&V6 M,BR1KI(Q%$DYDS!L4SJ!?&'=I=+="-3(%F(_$.6K3R+?BK:OMZNGD/A`"Q"<(%2Z^LX1 MM^I"-CC'9BIVX#K[D.M^NJ7"P1G1LDK?!!3+KC^EHW&FJ%6/>3%KC7W+GXO: MQFK[6[;,9W[=:CGD29PRY"^,ZA]JE4$GT\W_3]VU+3>.(]E? MP=ON1K@W2(+71Q(DIRNFNNRP/3,/_:"@)=KFMDQX2:JJ/%\_`"^R?)&$!`&2 M%5'1Y;+4Q,F3X$DD;GF,@4]T9319,^O(>/Q44:\!ZP1A"E5E6[Y2^?/O^&N+5]6!"`7WZ-$K1HVHW,/Q$#!=8*\"LB8J%3L*D MU`+`E3*]>$?"2<&0)6PQBB%MP`?)&$>%D&;<5MFF*!]N7I[NZ'9E&R8_IQI: MAA]%CFL[MK=O(#7%JK+!GZI9(WHPJ$,#4`8@-^<501\M,"40943!^__&Y"/O MO1PM"WC?)8'3L3T"\'[WU72[NO:\P$-2;F(^IT)\U[>,*(QP;/M&:B>1N1]_ M)*8I-`T^J@'=\]X=+M0!:\NAL*1[@V+Q>=EQ_)V7@TFH@RF#'&L*=.(8%TDQ3:O"&OB@58OJ\@(O2#"IN84<4PO0B5'P/^04 M8V@04H=AEO26_2^K`!,W("Z_]3]A0QC'#WQC>'YHQX:H+(`>JED/]O/X'`Q` M!V#$G!<`;9Q(+B&=ID/!&W]H\)%778J3!;SC\PZ53/8@R9KXNZ^/,$D1$.9*H1Z\ M(>&,,,@1MB"%D#3@$ZD80P5(,UZ3DI3]IEZ9B1=9O!:$@5E"DH;LA[T\L3&' M\-*E[/.GTHW#)+I%)J$<8.[$M4,G;9+J`6!,H7Z\(^*,@LC2MB`-D3;A$Q49 M1X>$CG2RU37F6M@+/#NQ'(L$L>=YMN4-C6'7%KJ7>%P+$VM)'U['J0F(0:B> MZ")OG**(\:9<4P[($%(5&?(6IRM21AQ5%GE*A+0E9"UMVM:VV`=\319^>:'G3T/5?-X\9ZQF7NZ9NLI*OO:Y2"YNIQ0N0 MIHZ1ACZ)@[VJI,00'D0H:$JS$EQ6#$56O:`.&3J`!M\P-8I2T>6-R=B46NWH MT*$6W@6(5'4[JTX0='(Y1`FS"]`@E=9\W("ECB2`6OTKWV[_7M(?Y4V>U;3, M-U_J>I=7J\B+<&*D"8E2)VB7;%S_=;'&!.[DE&UEFM56CNZWOS@\-.!#'4"P M4DG3*2I24S`II4\R)"I3IB.LG!2EL4PN1H]&&_)!BM10`U"A?]+MKFS8:*%= M,:Y7=A1B;(0Q,7W+";$?)]%^8L=@_X"I#_3ITZC.'E6WD0$RQ2))FJC&Z.1+ M2EO$J5*F*.\X.*DDLGPM1D&D#?B@'..H@&19W1ZTZ_R97YE6/MPT6;.KF4*Y M3FK:CFEA)R(^(:S9_6IT$H?`_$JND6GT8]@^N4>'.GCP[$J22N&\2C^+1F,Z1*B%!-85$%&B8J*+(RD%$:-'F6H5I7O:XT9L4-"T_(LQPZ('X=.A'UL M8#..'-9D(+0[?6P;FM6AAX4J7B!`=,`QFK?3$C$E93"Q&-AZA00O"ZCF[M8C MW'PB)JK87,C=J:/-H&H[&>2JN:JH&[K]XX6]IC?_ORON[OJV+`\'GNO9J1<; M3F`[$6MLWU;@"=?)EFY`L\CTN'YK@:$.&>22,VG>3NO,9)3!1.8SMF0*MLK3 M!K@,;@KZ)&]_DZ-1Z+:W(U9_HKY*2%K`[4CC;:`*>PWDQC:63#[EF[X!@K&+ M+6(;@>\X?NRPASI#`Y&/A6^%ACU5L[SV8"!7K<%(.2^C^OB`:6>/0T8N@9P` M[IG3QHWDA7+"'`G=('=HW1$!E&-@`:HG"9R.=3Y`WZ[RLJRS8F@!>X9I>)%O M^6808,LTK<@86K"]1%C@@(_5K'`#&L#K#.7EO,9II`0F<@,0&96#TB(N[;2CP_ MB,/$84:G=F#%!HZCOJTD27QW]3VO[JB(\$DW`>G0AVB$^S/Y=H,.H?'">^O_ M'=>ICUE[I'N/)F2@OXF%>(S]R81[" MDX@DOC7PB!!*LK``^9-%3D=W`>"BW%7VTL['W]*^WMAP[7]>?\N;RWM^Y?]0 MB6R5)E&4!K;/&HQLPEP:&=:`P61#$,A*G=*&=2=&/59>#ZG'A%[A7B`&&-'[ MKN9%>+;HI):5*@B=)Y:OM'AE(6M:>FRC$W3K\05I"2WK@O';_N.VRLKZ/J\8 MA,N&C:O,%296&!';)GY$4N(Y5HSC`0BV8Z'MP_I:U[UN]GD!FT/,Z`#T!6IA MCR\J.]8GIT=9RW`'<$U.L2>FJN=ZFM`30Q?.)E MD6BK\NV9M$>Z90#JZWR=%]_SJ[QJ?TOO^Q"0KX*88"\V39_)/S%2SW&L=`!! M@@B+YI?J6]:LNAW@_;#I$#/J05_PFR&Z3_CW!N2`!$V#/\[GMO.Z`J:XOZH7 MQ#/I>;TAEVSK\(I(4@[FZDC>KH_S!:3V&HVC4W1;F7!&GYZS\J4[97V(YE_% M=OL.T2JTD@@[Q",D=+%ONE$0V`..@(0!.**I;'RRH+;N4*.ZNW>@/GR%?S#@ MJ!K>XV?V'KX!13H`8^>"G0[REQ3OM-CW65]![O[=(5CA@Q'#F;8L&,1[*;[]4G/3D$3YA-!TAPA M6VRLS_4QDM_04_,;7/C4>M9/K=_UEDI.L>GV&6S>;4'NDIR,.[#@`G4VH,&( M[L:2#5,@-)AQ@3I#N(<[4V::H!O'O,"LW42N7=A4WE16'YG?FY1TL0-'XC./ M-WE9T.H?99VO=^R?WV@S`&O>KQ>M+);">8;OA*:1$M?&B9_LIR<3"WO"QY7F M@3=A'*E;V&@WX$8E!SXBHLSIU?-)V"_@4,W+/IU9:&\7:@T;8M$GB_2_@-\! MI\&6[W_)LV0S]@.A`VE:B#^25L[LY04DGG,S0!?SRNDB^ MMV'JD8IJEVL8LLSH[6G&+KV!B%N(N(EHL'&F88SJ3J%Q/#-CYYAV8*.XDV@9 MX\"-@I`8;A(DV+'=>+]D M;B48M.UU=&.:1R3M3I)=W6G&R)GV\<2*S:%/RBDL[I\[$M#B6\X9@!:.W+Y_ M&-,+F:Q69X_X_GX9HF1SNNM\31_*XM_YYLN&P2GN"S[C'3(833T<+PC+S5?V M:ZZ\15ZSS]C(Y?`W7VGYP!4ZSN^:51+$7H0=[/'3E(G#DE''&V#;!#LC\KK) ML6I64HZE&Y)Q-*@'.VYL/KT_I9*V1;MR?.*&7NU#AP:BSL+]V2[$;$0')@U] MX,WOWG:37ZU[C$K?%MU-U*5PLW07R21.M4O$$[G9.L,RD[GYZ#B=T,WL)AV' M&P^0?2G7_-;SS0&VQVH!#M`\:WP8*0;\RSWW^`G9`MNI-'MQ(9GI5-;*'X\<3[+@13O=]JPO MY:98MQCJV\>L":L\?'ZNZ/=\D]+JMLJSAH_65H;ONE9*?!S'A/%N!J[M[L.) M(79+O(9F-8OTZU;*XA4O:AA@Q$]^93UD=$\KU`R@03?8J'7"^:QR1OYA&MU3 M?WF/#J`BCA4QL&A`BQA<=+L`ZB&7"\WF`MG+AY2Z0NQ^(@A'1[(A340O(+'1 M91G5WDN5I!N\;!)K]$T$#2L60A^ZZ@;7_*?+^\M=LZ9/>?W/;+O+?R\>'E>A M&;JN@7'BQ9831QB;[NOVX]@6*K#11>HM>D"<:L6D>'(N@2< M\6CW_:(S(/W6"V5$$SE!*$/ZH]CF=4/+O%]T_*.3O^ZS[-F8Y5 MF%KO<:&K@<\>&@HG)E$\89F.3+G\9&`PVQ]H?]K3_#QL%&$_M(M#NY+I"MH6 MZ[RL608_5,0:><7T28J.I"=J:%U`-J+($*JZQ\D52$Q^/O.NL8I<;"5N$IJ) MF7B61V(3#V4L$M\C0A>I2#Y:LZIW:/A<]K-XN0E9EL2&XQH)@@GT4/RP1S)/ MP<.^\1-#6$F^%C($E47_>55#.1*DAH#URK#]U/63F)`T#4P_B<)D/Q./;5MZ MV'?^R9I%XMP6.N`#@3XRRH!0(CZS2HBR:?%M\SS=?6%\J M'XH/>UO,E1>YB6FPQF,W"I(T"8Q@?QHSPK#+>I0TJ%EP.XR_M2#9JS&@1%FW M>RT[>Y&]1JK%!FV3LPS3[#<$OP)\OSUPXB&>"&DG!GY*.5_(<%"M351C)P7J M'F$/+YKKC,^A_4'IYJ4.?Q;U*L%FB`W;2$/3P4%J$,L*<61Z090F?AR#5J$D MF]`];]BB0AVL"]0"^Z\:_,Y%A.G2>F%R=1X9K4HUCG&3FB7,K(7HF+J[*&: M>B50V7KMS,R^R:XQ%SLNB=F?&'NI[P2.;]M]8VD8QCY$SN1:T#TQU[U1%XCA MZE\S:+'$D0R*B95^\H!3=E*\:5&E3ZDY(47CJ%R(_HPT@JKL74"EB?/[HLPW M45ZR'YHKUJWJL.SJ%EW1NJGRAJ6-?,;L\!NW?'GY-O_91(R%O[ZR!WQI\J=Z M%:3$M@TS3D,W=)/8\G#J[S'ZCM"57;,`TZQKO2VHAXI:K"@K-UU9,?36H'=? M:VU"W"C46H7^Y':AUC"H*D[K;3$Q7:RC81H\AX^U*+A*?YP0_EGF63/>3T_I8VV?8J+^N"EORS;IISY48DMA(S,&TS23WL M8-L/!AR!)U[D3DOCFJ-,N&T[-E]PI/>HX1C1=?N-?G%F=G>(K[_/[A:Y)7I-[A%9H9=A[,@BOE;R M%[#.K]<^.E$O!L2WK_1'7MVRSE/SHD/WM(J+>LTW?;*T+X^RNJ@)K9YIQ?]% MRPV_[XM8CDV2V(U\S[7","1XP&"F@2L:VY0WK#FNM7C1'G![`GF`S&<[!>MBHQ0U05O6^.!_D9G4#+,#]DAX0CVNS>D(NIJGWB$@X@Q)U))1IXWL! M84R?;72"#@N^5(/>?RWN\R]EO:OX)?3\$%65K9O?\^VF**^SN[OBMMK5SOU2@T.%^WQH@$PXHCY7M$6,VI! M@^]U4.:"\R%K/O9A\>H7(QYZG\8<#AAUG88J1XA?IR%(T9$`I8?F!40G389] MN$M##W601:WV?BE>WY6EZ).E4]=2S0FB3B^^J&!X.!"7!>7JO;A!9,EN(QQ8KZRSD+M)RR%*=)+ZSH=9[@$LL( M%H\OMDSAF@5D!%-92B?O]\KB+J\K55_NFKK)2I:^/(0/65'6S2?0<.S&KA>% MD1E[(7;LV`J2_30;#HF:`*P.S_R1N+4%'1B#>FNTJKQ"CXZ-S?,X4WF0_N7] MJ"ILS^-/;?%;D5_'!W)A7J4BNGJO+3ZT:S!9.,;KHEM!L"=TN\U9K,NV*:WX MK_NA2+U*7=,,[-"/`]\F/K9MSQP.,::AXPN5<-39_OS!G&//6NSM_=CM9P-\ M99H_PD%C8_4TOE$>FU]A+],MJD+O-.[1%FKEW#0^LAZE32J2CG?"XB.G`A.% M(Z4J.A7LN+^JZ/_EZV;_^>7=MGCHWMD$.YYO>L0R$M.,3<\)P_WN?\,6._>E M%<`<.^\'M.ANF/W:XU6VYWN,3X2BX?SN`(?#LWN]]\#WW[I6K\QOSCQ$EMSE?@AV4$1W:CF][OA?YD>>%H8FMR"9)&-II:@N5$=/8O.:0&&7KOQXJ MNBLW[1G8%FKW2K^"E:RNHM('8AM29J8?%@+W55(.T![W`?KS]=3QU">-X;2> MV-*BT4<+V>:BT\(C%4NTD2DLO#?KQWRSV^:\.A>O@Q+E][3*NY]OLY\Q+XW2 M%&N&CB5(>?%0OCVAO'+3.$D3'!@6MG!L>&8=\F6>#&OIYM)".#!J<"(T*\_I//B(<<]=0W07] M=X_^?Y84#:F-[Z\1B9^$O9JXI^+VKXE(Y>#T*U?V;GR8O_'OBA\+<.>N?1!4D_G&PA[=?H MP\6)OTY;CZJ_=H(EY/\?9<7:9V/7?^<;!FA8([^F6[YL_B.K-N\0$3?R4]\S M64:2I+[M)8X3#(A\!W8"5".,":7_$'LK'\.*6\B=730OTLJNWCE079_5+_*J M?LPE+`%CR%$/?4F:#B5:2-&U>6]Q>J[/TJ-JKIE8.^]EN0`%M8%#%_ M?B?1]*3#9/>XU$+451>_XON!IN=9;O./&KY%-OH(,7)D5X]:-A>PA4>Q0517 MQP,$CT$IZ>M45%Y?92^\X5X?6WG\6T5WST7Y\`Z19?!UB8BO47MVC#V'Q.&` M*$Q26S2J:(8Q8;AY,^/36P"0/-W^.!]K%N2*T0N\;[QP\2[@#P:,BU&Z'28> MO!;D.+FH-HD#18+>.":/1,.)W+.`,#F5I73ROC\NL%[GZ[SXSENNL[Y21'=* MY1T:P_4,'(2.8]EA2H@186M8[&<=U1:^AT@CA%D"*CI`?U`9!EP'0*=KI.+K M'%Y1$5M/.D1Y6%7FHU$A=0Y?J0RGZGPF&4D%"12/HJH]LLP(JMS*T]%3#ZD2 M:U/#^4Z&J2_%7FZ^%ME=L2V:(G\/QS0C._:QY<1&8#B)G]KD%4Z<2.Y*4(MA MPMBY/S;=C:-'KT4I=@9T(6H^/\A'RT,7#"K+9?<`]Y*6H$`4"ZT_Z7':XA:? M-)EY=.5))ZW`!.<`2EX+9%MI$`91X'M6:%AV$!D8N_MLRTD3X2)S^A#,)]&C MUZ0TN@62V\SI$35BG=>Z)PR5.T@FL9G34>/S&@T.@Z4U0/K.9C6ZW+&HI$:; MD9_F-'HI%4YIKO/O>;EK=_H]E$5[30W=%NN7@X;]*`Y#QR"I93J^%46)04S+ M-SP_#4W7$]JBH:XUS3&P!X@.$`+3$@6$BB4@TW()BUZ?T'B!.GCHS_[O^?** ML\R=R"#4L;Z07$&A0517!X5.TSP6SUQ!6>[Q.TMJV3 M8$H>X?\J!A)-KAG$RZ(N76]]FC9/]]EOR6P"[7!PE=D:R)\?BJ=,3LV&8B0":]NKUV8@-TA26 M=W7.?_@'M\ZX'*^K)[&SZ3[KVV%81!YE(:"(N9"OIJ3]8)^?^>]0[[[*/L`] M'UG5YOJ$V-J/WTPD>`)'JZE?#46YIEDMLH3X5_+GMGC.UF(,Q6OC`:9)&"'D M!4G@03>E*82]\1@1J:9^LQ9MRS!'U[[U[2\.<"IJL2%ZY71W>F;5-/8HJ3-: MIDIQ>$([S<9@)CIIV*G*YF.KJ']<>(A"IZ)\9BY;UK\=UT!O:OKEB+O]?;3WUOMHXK-I^;^ZW:Z?_ M<45U-$2^G#I.S[N:.K;X#OMOWX9@1CHIQ>8)G30;C9GHI&&G*IL/L*).7I?/ M7)6KS2)F+DS@,(/%!F'I!.NARRI26AMI&+*MACZM0GM&K3YNC,OS(*2K/S:9ZRC?-B[BRHN'R)]:([7'F M:_L@(%SJDM1%+B4!#D+JAKW]R"-2=R89-VI9F7J<5^UM+TV[?!BP*FJ5.:+E MM.LB'*MIV4EZ9Z1OLE2>T#OCT9B)_IGWJ[+\&&M>I$.KQ^]%>7AXN`C#R&,N MPT$4!R$$W&P,#A19J;H\PHSUO2IGO"YT!F6/X4Y.Y":B34W6A@MM#E'-1\V. M'XM&+!]%07AW&?80YHST49[,4P5:\Q&9B3[:\.QUJ=86>0K?EV2;/,[JGZ]W_])?J'A=BBMM MB^=<[,;[):Z'8>"E((Q?N6%;.%_(\6LW,(6OFS M$PO,RZGHI4E7D],=W]_?\'WE?-E?'3M@;D\69[3YUN#ZA-K:C-Q,9->JBV\^ M:+%-IT)!N)L+]4;X/8)!E.(P"<55M;&?@$'X0S]44EMM(]8+PMJWMNKS)EL1 MGH`RU8KP_C;5V>C<,9Y.EH1'4CL3Q1KOQYN2L!%BI(8,W7`%+!LA?UGY(FK1 M=?-NL<5%(4-\@\[$6*.8\I7HL#U'@=S8-X/F;)>!6Y1.!]/9XU280F.*V-,R M=2%.%5M:=O M?&&<%?5R7=7;S>']2T&"*0QB-\`@9-"-<."!$#`8)HC$L=1L;<,F)RR8=Y,G ME^V-QN1AD^>/&I^YF*):NZ9NF^7Q]75G#]'Y-JO:^COFK5L618'L*TF[N'NO\3XZ146D&47?Y8B(2>7EPN"FFJ: MY=^*>BI1>4)$[81D)EIJR;EJBJ=:6UG[[^)$74Q,W]CPQ>Y7_I>1OXMZ@9#+ MB`LB%"8)!A#2%('>.HBITN>#ADQ.IJ5[F.UKW0-U!%+GF\"J+Z+C2%=5S\GX MUI7-451;ULM3Y$D)I1'V9Z>09KPZ*HT&23.DB:QZS(IR$7N,Q%%$8^ACDGH, MTX3TMMTP`>844=+@Q?7PVPZH63&49=N$%%H@VK00GN?X`BJXPZ2M@8JT?P@% M5/5)2?^T")-6O\%D6FWZ\0C]HO1S_O@]WRRP"['OAZZ/8P1AC'$4L\YRX#.J M=.!HP)SMP\:?)D:L^HD1F=[$"!/TRHG=Q,RJ2=V9,1S.MQW"J87N/&5=:>SA$"=Y>M\_HV;[:;LK<:>(A@&%,8>1%-*$%ND/96^18\UA4W M#5.VVRH%(F>SRRHF]$R'374MLTSD&!W;,=IAFX.&O>5*4K]&D#Q#[1KCS0G= M&DW2B"WI.[>E=1!N@KR0[BGPJ+17'1^-F2BB%=?.[EQ-T6>\6/RI*//K M)G^L%Y"X`$`4NQY)$A>D%!-O6&CB5*GAV[SU616-!6RGQ6VK^J-%K>[JV07$?5XA]NN+WYV\`YQVA5N5>)GHI"&G5*J M<>M19D@%Z8]L\Y"OOE;BKD4Q$'-W[=B"H3")$(`>P@Q';AHG,>S!A#A46J': M06!YC=K!:M`+#=B;1: M'7SSV$*S(\"*M!O57WN,VY3?GV^\F:?X_L3L>.W5"]3'DEY-'_64=PRAIIK; M\]5V=YGC@H0125CL1H`R2#'&Q$]Z^YX?>HLR?\@:CMM8G[N\;:FW'N_>^C

(,'X>Z M/L`T2''B(NPE'D,)CH=.A0![W7%H4JY,'H:>LZI^&-H#U#D*Y7]6YA#T`Q_/ MR?+](=Y-9:>TCN?4*).?D;O\P=_\=?[E/LDVXOB]YH]=/SJR6'(@K%AO1587 MWT;OQT_X01)'%##F8Q(2YGD$T';\A`^Y:@"E#:(M#+:;NCO8XEWM@3N_?*KJ M^E>'BX#3>J`Z.-=6..26-W.(A-IJY]T@W/3LBR('Q]TN?SKDW32(2T[-U2/Y MA.C:#MM,9-BZFZ\GZ$Y"J]0DR[N7,EOR36O9-72FB9<"Z`$"/=\/^VY+:PY'H;![/T6E-M$V/HLY-RHS\T$B;#.E-AU1A2F8$ MY"L/WY'A,3S,8*BC-O1J_&.@((%Q4?T[7S:;[+I<]E:\./$PBY$70H^F*8HA MZ*V@&$MUDVO^U9:%<$`DJK\ZK[P.6^?UT#)1:I)X$8[DE=$R5WKBJ,J9C$"^ M=?2(1HY@9`8R.09]9>2Q4-S:IUFQ$6<+^77YM&WJ3_ESO@:=2>`A%,3$=WT2 MA!Z._23R.I,T`!%3V;Z/L6-91ELL#IAX@W>"D!.;.!,TSF2C9L25ROQ39N`% M@IW),/)QXOJ,A,Q#(&`)0TEO,H*,+9[SS?=JS"LD:TGE%3H$I?@2P1F\1%#K M)5(EL-TQPHI2+QENSW=EP$"<5N'*,D1#`E"4F"875"7.@9T#<% M:Y?2M]T;J#>XT@#'H^3-$KV&Y$V2V2G5;4^8NKIID#UO==-Q2$[=M*F2.G#] MO7K.-DU1B]!GY8K_*^R7BD'HAHD?1B#&P$4!3).X-Y8`*GWNJF_!LHKUP!R! MK*T>"VP*1XLCN#M_"CL-;6KJ]#YC.J>R(ZB3/YR=AD*],UIM*F4.:X\Z?N3, M=CQ1,SBZ->!$9?+9T1#AN^WW.O]SRQ^FIA(6FV*]3ADA3T\;_A/K?B9>0"&% M&(MK*F`$(NC'0Q9`*:&JPFS&ZD1B?>7LX8H/1=JW1B!V.&2GQZRA1(:XEQ?V MZ6G7$WLYQL&Z4,P+ED8"X5*$I$BZ4QB,4OTC)*-824`VJ--. M2F\-ASA&:013#P`:8@!8$`_9T$O34U;+` M"0I'-?[I)3D7TOUD7SLHA\Y@),(4FB%",/^BGKH3!*7;0H<\G1AC:L2[UAPX0# MQ0&'HN&FO2NA_4!MN2_A+7\JX6V?Q!SJY9_;HF['SES^HO=SM)ZHZ]D,TDPJ M?59=/'\?O&$Z+;S\9+/AKT$[B;6^%;_ZP/21Y`+&::- M*(G1D'XXD3'KO;;^6`B";J^V&,`OACO=9DV^2#V$O`ABCR4D@2C&.*6#&OJI M/^)C!R4[EO>9/1:'1T-U[L`H^D[O+*=F3FUGV2[06EC.#M>5,_!X>Y+'*;K> M#TDZH9,FJ)V)Z!EQY737^PAZQJR4;O-E]5`6_\M7URNND,5](:8&[*YI(B*7 M;_(5*5?](J[(:_Y[?#^_VJOM?H'G!J*9-?9#Y@4P3K'KQ;"'[;M$:3[RI;': M/G[KW',._+MR]AXZAR[V%ZOU3K;M-P=N.IV?5\Y!.^;@JJ+H7IIX2>&^-$R+ MQXIS>#2F6J*;C)G:FOTB3\M,\MELZ#B_JK]@F.3*2?(;D;+<9NN;;K>\@*[/ M7$]8I4D<^IB1_6E(Q&(D76>R!>`B&?#8]P17S@Z]T\-7*:Q8"Y%$]6H.T3&1 M?SY68!1*87,(D&:-S%:@I,IGFKP=JZO9#L,<"F[6?:PF?*ZMY,B;JA%)?H"S M(*[OH@2R&`A0%+-TZ!-D'F+2(^4L0IA9GASP]R^Z%4%6#Y3)7&DU1G:SY5S# M8R-C6@W3-#E3(5QFL^9K[D;G3>U@?*C,J>^E5NX<2:I<7_M6M,Y4]W?;IZ=U MP1-(=?]'6?RYS6^SOSYG/*-P\PN(*/4)37R0`A)%`29NV#?6,("E\Z018[:[ MVEN,HG5E0"G^8X?3X4"='JE*Z[41EL\GNKMI6QW^4S0__BBK[^*Z!G%@NBLR MBL/4.8?N==5\YV<'V^+.SL7V9H#Z:E^AN7(. M_-1MG[C`>-23X/=)A#CL9+I(;G<`S*3DMTWR)-RY^:N!]0)\!=.0>M>GN`TS(JOS&:EEF]7=%8 MAF5V1&=Y.+(=,L??#/9"!IVI;#QBJB,ON;D[GE?RDG/6VGS/>,12X$:>ET0( M^9`@&,"A`\2%J=I87R,6+6N]`.G4/`_RD#;LU.N9F!8H4ZH2_+Y=KO-L M(R[JY'_NQVV>+3G=]1^UN&'\KGV&#X^DN-[Z?NPB+T6(H`@1'W6W?`0`N(BH MU@T,FY^LDM#A=GK@3H_<$="=KY6S`S_V"-QT>.0+#A>,C&X)XJ,&1;U2<<'@ MC*U=&`Z22D%#C;4S)0Y+(9C!0M^VA^^40:R2J9:E MNC\$@E``00I\Q(CK$Q)1PF`/!)-0NBG;CO4+9,/N5=X!=ZK2X=!WY1Q&9\+/U1(1J3"R4-C+A,:"9%6)I0A3381&@W`'/.@60=/I4$+ M5$H?C/%]YU-59^O?-M7VJ;XNE^OMJB@?V@^.15/;-E]]>>KZV>K])G5_'_C%44P`=\L?^6J[SK_5YO' M%E#\TOWF'DX<,$#"B-*8^-A+B>M&$(2`0>3[(2-*M1);&"QOB7K8;9/F#ILS M('<.H(OK_(9O"[J?5-1_:V&2D_TY1$A-[:6#\&S2O/RG6.4'0&[SYYRGF)33EOS-I:[,UG1;-]4C M5[WXY693K;;+IB;EZB[?/!?+O-X#CF@$/0I31&*<0C\,`I#T@!,/AWI"/S7* M"5/![WGCW&7KO';$4^KTGCB#*T)P>F>TT\#D859-%'..L&I;5PM:)ISM-J_' M/J=L8C@:4OGF4D_`[#+2Q8@XFK,N&QJ-K-9AJ]\%)T;\5.7#I^(Y7^V&_\0O MO^75PR9[^E$L,Q[N/*O;=W&/F$8I2AE.`Q:R."$IWU=%'>+`BQ*I"T%G`/,B M>:T=(\8]^4?K2C]EC,O@H3>.<$<[O4T?;]7\-NM0Z^^5SB6[=V-_]6[P9Y4` M38=+*@->[!F970J\'!-'<^"%@R-?HLGOBS)?Q7G)?]'<\#V!1Y@\9_Z.2Y1B3IJ7T M:[BU8H]26L9Z;,ZF!2=*JT_\!YRLQ:=:<#'*NF1Q97*Z]0HI.YA.A],1H*Z< M@?W;@7WQ&UV&F+IBHL#DJ>J(C8#,1)OM^/:ZZF&/P!'Z21[%2=W_VDW/E_O? MLJ*L/U4<0[U`#"!TJEW,)TEQVE8374C8498)PB"#8UM8??G]8X`[ORR@SXWP7V? MX!':.S)B'T2&QWJIJ,A&2!TASOMY^+_GC4@/(CNP;?ZU.IB?X2TP<8/$(Y[/ M4!!!X+,XB7L\&(=QO\K].D:E#6'16/=^59=K@6TX+ZBUARK9BXBN3$\9!8-" M?7"AB2@["."[I?"O#@_W*PC79*5Q-IPW&8KUZ;]/"O85H@=(=DCZD<-%43;;6U69-HTIKY@&?_,XF49N.'`7!4:5SIIJC[,89V=&C98SR ML.J1;SD74>*%24`B@E&01C!RD=L;)`S[2I/3]:U<1GUVX`SHCRR7V@ID@48C M&G26P:E4:`=$38<429VO$JDZ#(=3#S&%Z+.QJM_3([ZHEV?4S36]@AV7 ME_2JQ`BMZ%O)^UJ^L"GVN&S*VPU_FO3,!)"_2RJK-=IM'^L-O^9&S_5NO5UX M,`ESC^*BB!&D1>0GQ/.9(B(:!M2+A7N`:A_8M%:U:X@#8-`C;LM_M9A!M08' MU*"#+;$8U.^*ZXOT6;T@J78?T`'B2_!9':&V[M;N$)&UMBQ/9Q;8QNAV8%5M MSK;:PGR5B5W]$]SZGHU;/Y<\`XM3<;H6WIM'MC2$<8@#0KT"H1R2A$53'X>D M0"D._1B)U1LU#D/F8ZQ49W3\9K_#/R1(MB_WSU2TE%%5HUX2"'&NN$N6B25,W9SH!O M[#/3YD#CY1/O_?;ML2RW:+U"JU7%OVWY=*A-.ZK_%-(BH0F./9)%6S398K.5FQR$*O*KO=;];"N[JN[Y7K+ M.T(RE?^M7O/??=\LU\WR[M1:`>:QEZ2$(,$1BD9`,$<"[=B-(O"]%GN MN*;W`7[;"KH-ELR"3^T?QC8H;:2,^$AFTSNW>]1WO>*>T;7K->(LE6WOW$Z; MON\UY#RY?:\"C5^YJD5"K"$C;)[XA7X^4.UIL__\+(" MYQ`2%,9YX(5I4A1>$219YA>Y%U(H&CC5?KKA@'@`U;Z4E0EUBFQ=#V'FB9(+ M32..6D`J^7Z*9(F'$/.DJ84&!?)$I/ZDN6'YY MJE_+\EOYBVVIF)7]<)C]+X)A1`(_BZ%7X,*+NN$H^W\N)*A3QS`LJP,LP/[M M<[66NCJ;3)_8F9@-YN1T=D_:'I*\6.@YC3K#S843HZEL.G*J,]F,6N\DDU2< MKV6SW>SNMKL-4SBT7GTMGW@Y)ZYU0]58_GMO@:.$0H\@E`1>$>8^\6'0CQ\@ M7$BU)-(VJ&%-8G,].,Z6?^ER-T`Y%%YNBZ4P/SW(W@WH(UY,O&;A7$[-CB"V MF^`>9+L.&E6[GJ%.BBA]%P1/NP<<44#]=M6&IZ[LY>[C7XIV?:: M+T[0IOW8M^? MQG%2T`%KX">9U)N%.0`:UMX1--!P\.`G1\\$]X"SE>%U(WTM.XL_!>]=77>E MY!DUQ_JI\]P8%AA9U/8"'7U?;Q5HS0+C>7#T$V8(`B:<<^E.=# MM[>B\SM$.&C=;NJ7KH<-J)Y?EM5&H7VT M7@^(A8_9R)<+"P?>;_>\[Z'>@#W8]B]ZN):U7H;)"QINQ"&.:+,9VVH+,WK* M(4E[#+P@.,)Y&(4T@QCZ61`DR7ZD,)YP'"+VXPWKXO%.7.:::PIE"@<9^MF: M$M("^D44^-W]/`I0Z@E5_=$\I&&=:5&VR==[G)(Z MHXM:,>V9@54Y/3I!*%MCM?#`'_VO\Z4LB]%W0;\T\^^(INFVJC8Z:26U[T?# M6Y\WV^J9[7Z;!?;](@N3Q(^*(*;(3T/L#:-`C`H9C9/\T8:UC*'A'[P]'DDA MD^5)3+`,4B0G3&_9<4B5CCFZH#Z*9#JB,JKH:RTS2E(U>-8-FQ>K]ICLK5*E M>1KD05ADV$N(%Z649'`8DP8PE=&020-9R#3<8Y.4DVD$BHF+->[DI.8(ED,Z MZUA M&DGKP[K:EO^L?I6KS^LMFSW5SZ>R>V'>Y_,%!!&80I(AD@51'A8%\GV*XR(A M<1AXGMSK_>GCR7Q>E-[:=Q`_/7&,H-J#!"U(ZQ^5*W1=_/SHHMJ9#Y4V@]Y] MTO12)?SQZ\;@I1M^K!E[9/E2\YN][QKDV#S\F53WE7MWH?]_JEL,Y+6JW&/[+-7 MZ&SUX]$TP#EDLIM3FL0>VQU1G*$TBD(OD[IQL@;*L%2.[`!C0V[`WI0V+65L MS`UXD]%RF+=[K>J,P_Q$MV6#Z"8_@4!6]Y1%+%= M5@RC@N;IH'^P\*4665(_V+!&C+%(=TB6X4=LH62,&KDED1@KAMH8'X:^H%I* M1#FB/&K8W[4<5B9`6`$^[Q-FO]S_LUX_M/N_PV*)UIL?3;GP4.;%68)1DK$U M4A*'R"N&P;,82J44( M/[40P6B3]NF^WGS:7=KM&A$F(>HN*)9>ZAV1,LU&U29GJW(A6,I`_+Y\VO4' M7FSM-2HK^B^V2]QMRM67]=?R;K?A&8AMFL[;BCTT+](0QQXJ(-M'HB*'OA_[ M>9"$F"2^5+:,762&Q71ZZ M5T[+3WOV1L2O;[SJ4HE6#3ZY$"3F\;TCP60FX\\63+7O`O%;R0&:`*(?Z_IG M4VY^<6"?UR^[+?MKYA#VK]K-PP%K0FD>$!3!B&`_3F$8A7NL"-)(*OMA#H`6 M0]4Q1/Z5_N42[_YS',=(6UWW@:]I>8)+M>IK[,KF8]+9D7,HI6 M@B'J!HSM`JUA;R?)[%',A)LNW:_/.2L%B]G M&$>O'5)2)"A*8)P1"/.(Q#X>QD]\+-4R5MN@%B,166XVKUR'NI9C[;KZ.`"U MQRB\&!_(RY^R;]_U^4$RE-AT@7IX^/D*>IB@Q0D&H`ZI_14F111-5_N2=WV]>[6G%_NOU;-O_$K_R]=WC$GC!HJ>9`@C^U7*($^ M2G`>^'"`@E$F=<5G8GQ+FMKT:_8#Z':]SP`K'BYI]8'<$=)<]*L=%)UGOM59 M_AO0H9Y?7!48%CCV,>$O1R37J(EGCG#,T2E44O\HJ^-DEYU%'J412D,4IUE. M*4)%0?JGNDD>Y[G0D8NFH=Q+M-#%X67-G($^]62,&PVM:750*EZ;WS*U:H7Z M)U(L4K3_.@\GXH-F`ATHYZ_3FMK(+),0^'%ZWIE18S\J/(B+)`]R$E&:!%$\ MC)KX5*BZE*:A3&?;CA!*J)$.#J\+O&7ZY`3^./]XNL#KH%1(T$.B#P.JVIC-[62)U?J)M4,.B/[R4*@]`97-P]/$K=C8R"[5R`6%@=81QNFAI*GTA MR-Z%PP[M#G#DA$._76_+8Y@A3NPL8]P\^$KOX-_J]5%%QD,:YX(-[F5^G."L M\)(@(!3CO4:'45:(O96W"$CF0Z[TF)YW![WCW4$/U:G!W>-R(U,G^?2&4PM! MYS:E=MEW8%UCV^)ZMJDN79Z^O"\WFW+U;5O?_;NMFM^@W?:QWE3_5ZX6!0T" MBE(O047$5F5A1'#@4T+RR$<>P5(EOB8.97@MM$?7=3EI;OI?P7(/$?RM6O=? M_;MT#?II-(LMCBPR++E7Y2TQ=6/YHHMB118\N:][5 MBM=(DJ*4W2XW7S;?MOQ];GN5?UMN6B!<2'/D1Y'O12F&/LP\+QU&CW*Y!V^: MAK0N;2_+#?C5)AAQ2=LU*\!"4/>WTY1-G745A;-"^$2E8QC9YQAT*/NL+H:S M4\!95>\<>\+J-YE^)U5PNE47U5`3:9,6>)^;ABT[%T%1)%$48C],((E\F+`- MYW[$*/*F+NX$AYEK85>U\#0OZD2I55_0&6!5SV*N`^;`0JX#(KF(DZ352>E2 MLT1@\:9$CD*W]N)/%M-5-_\I)L777&NY9/]$3%R3?OK<=B1`S M&%[/_4%3:2M7\?;5;CG!R/&>3`.@;!WQBVYN]S%2*] M2-8%Q=1#LB,JJ,F84YWK-%$D_CB(?S9_7F]^_/-M\^,O+\,=TR^&NUS]=UD] M/+)?T:]RLWPH_\%^P#9?;LO]ZZ<%YBF7F1_2+`F3-/,Q\HO!@L(+I6Y_'()M M6$<'@)^6'4+PP"%^6C&,X)X_/OS5/3YL#QU`_2*3(.@@FZ*/FMQ!;"X`G%M^ M@Y&=_#'4^/MZ6[NE]PWHS;T!>X-OP&`RZ&T&K=&`6SUZ+&S[#94UAUX(4@[. M*DOGY>\Z0/_K?-E]VVV2[7 M/$?DMUV[CF"[')RE&$=%EL59XD<)]/;K"-^3>]GK`F##\9?G9(UC*RA;R M;B)!?<"K$G3G)D\FW,Z-U>E`RZ=)9RGH3`4C6UDU=XX`:]B%UT*K M*S/(I:#J#">GPJDSX"P%TO>0MX_EYOOC>R'T\P!% M812%!!)/JH+>AS!HEHTP>+<1WAR.S;JXO5,X>/P0A)L.WJY.'NO!_7U$!RT5 M8,NX^&![[)DG@HDEPASS]*,O(6;A3-<28SZ'"R]!_K%;\K'*LCF4E2F2((,H M#WD!8)]B/\G"O"TK$^:)%Q12U0E5?K[A`'V`)!ELE;@2BWVF:9(+10?V\K-8+0@,_#X,8^6E(\AC2'&7#*#E)I)I82?YH>VK0`5+5`U&F MY!3!`$G*FG"5'Z.JT(TNH`N2E#FF#++HSVB#$@EBI0^9GX)_+9_87]_]>U.O MMK=L9?*\O"MWV^IN^=2TZ8S+]>IS6WZW^E5R2/VR!8=%D82!AS,41)D'49R% M`QPO\1/AFH@&,1C6&XZ\[2\N4];/).67]<@EMN6$JR5ZC!J\@=WG6?.N&7OD MK6<$=E!V7211DM$15ZG5:C3J,J%*CNKTG0A,MASB0(TD*V;6=N>YZDM4/G1W M,]$/Z!=1%J*<%"3,8HPQ\0X#(C:\TLM2Z5$,Q[7NV<\7I8ST"=2)K:;ML"87 MGP[O+UM-Z]/)9CJ\.TO0A?7V=%(=67IK,.3'9&5B491H_\-)/1&DU#VMA&]7FI=^/\U;NZ MD6W@JHMD,6F:@5\YK=H#/%OI!O0@+8N7&',7U$PS]8[(FVZK:J/S5>(&!>^: M:ETV#1ON9[5>'E[/$)[(NFG8GV_9IWW\USV8`L>Y%T4P]`(8%@@'%`YI'RE- MD=#:RRP"T[>U#!77Q0%6UW[DTB?6)OO7KU+<(%Y.-P?,8(1J_TKB@/L&<.2? M1M]T74YM.D?\$L4-)ZE=H1ATEL@%BC)U9ZY/S+O"@WB1*>WY=_ MXG)=WE=;RK@[%:@32.(D17Y,DIR!H3D.AC(-&8ZA_OJ=TR$9#I8,(/C9(01\ MQG4O)#5M+FQY3?*8U1V'J9[,7JW&R=V*QVYU8`NCAW^14V`[#G9D"V3;:I7J MF[I)MU!`IRU'\.7^77,1/XC\/(%!'L0,:5&0E`[9\MD5-0P1_XJ\5$'%;HCI3;WF(^9[7]^ M+YMMM7ZX+3=5O?(6$)(@#MB.,L40!W&6$$(&C%$D5W+%*C##4;%'PQLU,CBV M0I>2APS'*M/.L1ZX`\PTN MBC]?JJZ1>H=P$43(RZ"71"%)0YC@((J'=_49I;Y4ZID]5*9S[O=X)L02.^Z1 M""3.><9Z%!GY=;X0HL,-U^*'55>[%#SL&JZK6<-$ZO6F(.S+3'8=Y;[7V^73 M41NZNMG^5F__I]Q^+>_JAS7?-HT>@#6+P,M\#`O/HVG@(9C&.:\EU\>\@DI= M+[F!V'"X^;'>['&]3UB8U@7)#0)UIC'/TP-;)_J13/38NLB.(X MHD&>^D&`@@0R](,5J,BD&JPZ!MUP;'W78*';T/%^SON@"W8?,0`KSI29(['Y M23)72.;6GHS+G;:MU4=UU_AC"/ MO"+/?:^@21XE;+=?[&\9]9N`%['L!A$GZHYD=3/6[B`M/: M+'0DUG\`HG1=C5IVK?`*("_OR\V&X5C^V;_BX(\[Q@<(/;9RM0C9,$6*/3]) M?8A1$`3Y4"(D*_(LD(G9.L>U_KJN/68<(FTYX)0,MEJ9%PN/Z71+V:X! M+?M:)9G[XC*O`A5+7(5N>N>$+^^<<+]S`OAD/LVY%K+?CUK(_N,PI3H.;D#+ M@E#3V(\SR<0KK[AJ@LQD4ZO;\D$FG4@-F)F<>&)1]1&FE`/U9YRGJ/XX"F'K MI/VJ.=V1PN?3UA`(_3R+J(>S,,P((<6^8'#&3)3J2."H"2XL&?M;4=D5H^/, MFCYT=V=>V,_#/A?"MT^Z9IXCBX`/0)2UU'B] MKA6Z+&)+COMZ\[Q<]X8T[="CK_9OWA*OB-@(>1@6(25^XF78VU?>2+'PY8ZN M\0R'UQ$@^8L6;9Q>OQB9@TZY<#1FLH,X[#/'?W/MP:\YCL7O!>;@6NT<7P_G M(L?L@IR<.1;7S:@#Q]C:3:K-3<`I88)]@3>U73Z4]?V7S:I:+S>O(U#E:E&D M*,YS&/L!]&%.8!X7>%]PEX1"=9`,#6T^>/0`VZSG'F*W#VMXSNK/$BP[J%,4 M3X,+%`*,7?:GQII6\4;.&!`?R>+L;I@0@^RZ0UE36Y;:O9O\+'I*HSER`V8MY` M`LPXE=@]MNN^I*94:C6[K8I:]*4DWV1^_7"5Y%XD@L0F95X2;]4XW_G`RWSAR[F!P?WBVN? M_QM.A*WY/<74#!J8B?QAN:ZAU2=R[G9UT_4S&%T,Y6_S[>++;@&%3SI,M-T.,.>N#?_:.;H,7N M1W*&C^7\2-*X(9W!9`T9VHVF[HT1GOE4>##0LQ!D8;-W6[Y/XL-NN]G.U]5` M]?%CL5IE15G_Y0S$#":20)SQ)$I1A92C%FV$DY`CFY=%C(1HV&?;TP(MQ(`O MMLMO]?;"WVN$00?Q?RQ?!C$VEX8WG=I+H_5-I?MMHT?!#>X#?FT:/9DE$YM" M]70+3\9[KEG0?&F"EJ2X\+#VM949)##E40QE&#'"TPIH'/=`(PS`K-W]\&D[ M+[?636P@1A7A>Q[.8`U,\L?E>EVKUMU\5<]B7ZY' M!2W7SJ,29:=P-ITC=U5S&]GQ8:LFN@OSH%?R8]"%IO2&*_&A211H=J+IZ;!7 M)M<;K]^M%V5>_8.-R+M?]-AG'%((D*0LQEA"FF0'']F$&/^P# M_?%@=A?F#-BO(A7VYW]>;;]=&#=P=-`CQ+L209 MDE#2.&(13??`,TKX&"5P#MJ6<%3(\OM_='BM3]AH2*Z=DM=20IT7O4=Q]M?9 M]Y%>;-%[-G<&RUY]_<87#_.'$,VEK^Y4.5PY%22DD@`)8B3C#%($4;BOTD&: M=BNGUV[T^/\E4W/9NQ+-FD"`\253M52X?N'J)?XL MA3%+6%0-.`B,"<@DWVLJ%4CIQBUO0%O9M?C]DU5-M;;K3S3E1Z\0U7_DQX-6 M([)OI[IWDGAW1?[)YZJ.@KX)VK`OS!N'9M.@96KO4%?BI/IYL?/0U-3$N1@+ M]`\8\_;]XGZB[[9<+O)Z/^A#MQ\TH@B(#(6AD%4)0<(PI&2_T(T(=71*0!=\ M&UZL?__Y3=#''W0$[-]M"AH*@M_YW69;SA=;AP<4M'4QZX<77/0N+PXVZ.E8 M7OJ^>GKM#)IU][4KJ05,,F1NV&TFF?KJ@XW25K=3TZ6O_TF7PM89WLW\H;7,\C-=MXC;[@2;W]K0+ MZ+?MS?BMU6?,VS?'UI?2*5;MH&-=BD>[H$;5G)VESYXK-]ONFG_1[[WKM]X- M"@O"."9Q"`@356`"9?4#7%U8`+',JE,;CL6U>R_>V#4^/^P:OW%K[:8[DR6[ M]Z@?.2P!VEWH[8I/S\-A*_J/5UP;3,N_R7K!4L^\EAK"%EVZZPJK:;97:_0H MAU5,60HD(5$B$\AE$D<1QX=UCA@`JZ6%7NBN*XG^]XYG`C3W!TO5@;NNX+`8 MV`=]Q;:OE%B3+F^FAUV+J1MB1[>'FTRB/T=@3@8524$E$1(`A`5E:2;E_LB> MH(397-\W&XE[0V].TS0;JQ[Z$S5FS=UMS_'D[(VU3N/YN9R+JP5,)M[EH1XM M'?)2*@4_R+)]&$ACBCW:E'\R*BPE2S*&Z90\K6/:X@F\UL*N8*QG==7R9 M)K'1:RZA!CETTST10T,L(XC+%@,,-1QEC]/$W;*HB2@9?L:VK*L.\>$`8-Q(F/ M).KB][3O.:!6S9P\977X^\"6V1WW$/!TEH>\]WN>BE<\43.''KS@JS.:PDA' MLS5@E/_:50C?K2O@3:=MSQ%\_C)?=V[WONB&*=U50B`F`,JT&O=&+"8"RQ"2 M/@`A06+QG4/MV%6^:L,#.J?YM3Z`:Z,-CL+MCM-MJX`/P[M]S)=V MWYUJ-DT,SHSUJ$L?C)DC1M?@RW#J/'#:[V\&F"&&.,$QC`F3*`U3`6E?*4". M(;K-].QO%CS MTDF)&S1O>78-]^Z--=S7L6\/V*M!^&ZUK<97=4:3W6:YSC>;JI&[Y;IIHWU( MD."(D>!`R=7UQ.&3X1<1C_GI]LOKF4.F]WU([AL+"#Y`&]SO/%BB MN"R^B@L5&&\F?]I-!?N*FT4RB:M*.TZS)((XPQG9XQ>,IS9?"=6-?9"X3WXL MM`7ES4R0:GY=SP29R*GG)62W<>[Z9H*^SZ63F:"1W>GJ9X+&\F)M)FA2XCSP MU?U;T?L0.`]12C.*<,KB!$=AS&D?0AIQXI6UJL.WXZ[6G^`VD6C7'FLHN9[; M[#[J*W3:%QEU8K;C^]75^^T$:JQ9[M3T>>"ZS_=B9''*8T@QQHBP1$1,$M`' MP"`7UI[XUHYODZ.)<;;=2RUU/FGDL\/&S=J[J.KR M;+XLFW-#Q_O'HPA02B23(,H@I0C%"/5ATE!"/W:%F8G-\`JVDSV\+^Z!:"@* M:HZ"FJ3V0*:#]U-=]5_7@S+W7=?7@9N97GNI58M*]W!;VQCIR'^?"L@,??;K M)(/=P(-JZN2S>B]CG5$&J)`\2C("(IIE&8&'!6*,];X4XTU4ABNH%_>U-8_' M!O>U+3S4MM!=@M*_*5L>SKQN:H*"W7JYM7;AB?T^Y;JV<=F=?*UJ!KQ:^VIQ M_55C#'B'!U%T)UZ7\XJ9.=VM)T//"81@U7T,6'&2Q$ZTFE\];[N]Z>BK#1$;TX-N%9'_2U/#KL7L\&[%Z?7CQ= M:Y_WZH"&9WW__63I<:(=6BMS^Y+EF<=25?ZY4C0OYVI8I* M9W!Y3$EO;[WZ(L4,:[8/-YE(^N#R1.0/RW5^G^3KZA?;VTJ;^%.QJ\!^S!?% MXWKYOW4)E;3';3Y]R?-MOXUU)B"E"6=`A@@2(2I8$E8E$TL%3)C(0I6*PAP* MPT5`![.R]AYG4&EWE>=ZM7-3K)9U.7#?GU>J;+_"_I^*CF\P1<-,VH_LJ/EJ MASGH0`#U^[Z`'#79W&[5'TWS"L0-UNBY/Y7NT'END6HL.-WCKH7'S!_W?M@=K.M#NU?KZVU5^==U__J^*>-OBTK,\^VR;(8`+U%NTA;.K\OYW7*UW"[S MS4PB("4'&0>AC`5+)*!9CTP`BD;J`3%&.;21HF#[[DI11 M@MV!;]Y,;:>1OLJ+Q-B,NG'U`AEW@ M"-*11?$XA1"@B`.1Q6%:C08`ZL%!R6(+1C`.F!TO.*[,!_F!%W+R*J,:%65: MQBY45"8&/5%7=%!N;B9VEE'(1(+3F*5$5NW#%-,>2!92.-L6V_G*T`SLV=:5 MAN][H,-%(J^&[0U$I"2SS+[6=?,O?K1?%4[Z?W0UA*.(DY1$@$!%.*["R!P>B M9.JDJ@%$]M?(*B&8+Q:[I]VJ4>BB&6:2',2W\X:?!='T`82_/!KL=G\Z/D2V[DT3'4%;6F^)*?0%_08]]!,^11' M.6Z"JRO;G^;(:?53?2K[A#Y7D?I[_60T[9!Q1&659%+$(`IARW$/D.&$C M)@ULPK,T=5"/"A;;W;Q8DQI/NKY^8#_V\JUBBW[BWW);+HOR4E]^6BSPM M-MNTS.^7VSW:,*-)QC`.`8,TBQEA;.^$B/*IV_IL0#0\GFG0!9L67K!HL%ER MF:FY,VLX%M-FV7O:E'>A!75LP0]M=!=H1*?39,"3-/6+"[[Y+*A3RS;-0DT5SX>'&C:EF"`4248PQUF8)A'KO38ED0`J2R*NL3I9 M0!D\,Z?H>*[)'&A]KF&:\\"!;M?.T-T$9[FXL&!"QK.V`D[]*6O M>.*+WM!1^/E)*SKE:ZY=;///^9_;I*+]CQE,409#0`EG"-.X\NHLC:H&(8DC M%E*E@=KDQDPO(0T2+T5+FL[P,$^Q2JZ:*9Q:I*DQ!K_7*(,&INVUFG.TG5!F M;8Q[(JWZXBD,=4U;EV+LS\/RS6;WU!ZCK43ZMWS[I;@O5L7C7_LEG01*!**4 M45K]*@MY0F(2$LZYS&0HP]C*C1<:\1J6V!P!-&XU/W\<2KO*)$UU4.QM+EQC'EGU_S^AJB M?Q9525UONU@6][B"Y-Z[1,Z=2 M8M(SM:3+C6=^7&[^R,J\&B575I%OM@UPP<-01"$!A``:0D@B$A^`N.1=:1!'6K0QWKQ%OE:\FP9Y*2. M7%=WRTP_+=?!7/B\W/X[Q14$+`<-"A?*V31\3NG4./)) MF121OZ8D8X(_^^4OZC,?Y5^S7VYG$A(<M0L+I+]I0_&I?\B_\EK\?]0UO\L5_/!;?_M&%47_"L/]- M_?7"HZ_W$.HK7^T('AQ_K6,0%Z.3KOAUOO]UQ@$,.8]9PD42X3`6B)'^)U.< M1"I?YX`?9_CK?)_7&_>K/[H?NI]4A8IAWZAF%M2^T??R\W_)C[_R]^*3M2_U M_:\GOE0%-CSY4E40%Z-3KUA!M^\\?2]RP"ML"9VK?_PNZ@M];3+;W3+_. MS(E"?"*5GA3E4Z,HM/8OY=M>[K8OVJID2Y(T2WC$(@%X1&$,NK8B!%"B=E?+ MB`8,"TR-:;R\C*-LF+@89TM-6IX1Y4I87F/EA*Q,(M$349D6PXN[/"83,OQ\ M\7SSA:_OZ__52O9MOLK7V[Y-2B2CD&9I(A(I(:881'V;E$1*PC*I(<,"4X-J MSC(MZE_D!WBJ1XDGD3E,PJ;7QPA>]=I%E"[5]2;4!&QRA=7XIY=M$GAP: M&LB')PII)K:SUT)J(W""CO:7C'1WC+P``K*04)HF@`J1A0!$'+,>"!!BXN7# M4UNWJZC_[M#^-.\N9#&CK9-3,E9@;69#A\KR^EF!E:\J>X9-):G5E1EO]59; M@&=%5R^52JL%S5C]Z[*^%S:?;_*-6&X6JV*SJSK^X7XO+B,>$2HS+#B&&2`T M:5ZX7EG&,$#<\"W-BR_Y_6Z5?W@8>/?KY_G=ZNC20RKC%%%! M,XA@0JM*&"'9[K=D*2`R5=H';1B+8:WLX=>';XQFP>H;V MK_`U,03N-'HBZ2>DVU8Z/5%T:^$^WZ-NE>;!^O\Q7ZRJV9'A"T$)N1_\]Y\5C.OWZIEY,:Z=K^*ML MJU7Q[WG%0%:4HMC=;1]VJTJ$^V>T\^6W6F[375E6`&=1C!F*H:C^`Q@B<:6V M60L"2RRPTL,*>ELVK'U[L,%#40;W'=SZO;0&K^J+:'I)'Z:#[OA64\3OJ>Z1 M!CW4X(#U)NC0VGYW3(7)$RII)B.>Z*6AX)Z_\&60PL$:>EOUK;QJX?[3ME+J MYO3^IJIF-]NJ4JK4?":E3),,28321(1IDM)$]LT2")3VB4UMR_1&AAY>>W7A MYJ;[?SWD[#$V5SBU?ZQZA]-DIH=)I4V2U<3QP&\#[::]-FD3'*&S+(9GN#HA M?[I8]D3PM(53F.F,`T7M:?W'[$-9_>1Y^1=O6[N=EQ_*3]MZ4-[<4W2;E\U? MS"`(:0(PS@1DDB1(4![W35,9#GHU1&=[IO?D=S`#OE>WK_/^@J%:U/)=>;BV M=:BV:27\M+ZYXEI-XXYH[M2M`AE\*(,69G<37`6T_6L7--\7BUT]8FLFKKRC M^SMT]FE_9C,5"XUWA"S"C7,HT/**>Y@@U;&#&`FI,-<'QSL)WVV_%&7]VO@L MB7B$0QP#E`@N=[C"-*X8FL*AN$(4*G6L(! MEAW>1BN^(?YT:?P0'D<(^N''#I/P$2SY)]IC@GA;ID=3,D:8WVTVNZHA0)G@ M))11BH44">,(DKXA20@:*)K M@#-=PGN.NQ&BV_[(88*KR(Q_8JL:P-M".XJ*,2)[/&M#:(*`P)C$U<].LA#A M>-\:0=&@-W(F-N%,;J?-!4\E5EEX37$Z57T'S?EJI6ZT#INB4)<8CYD^'Z+( MIR?"-1'EGS:/BN)M@1Y/RO`KL8JGIV)]-,-^5'T+*!B%,2:,(%"?BI:0=TUF M'"5W8TFN=LQ5:^!VV:&>+6C79;E$]6ZT;,>C6=$'6VQR=6*C3P:PG MBW1:0GE^.Y8V>L;+55?#,I!@P=,L2F0BLRQ!*<%]Q#'Q@24X>=Q'3`==?_?A$? M,6UB6Q*(R-.7-O$XTKE'5T=77U<6BIY7+>.(4I;LLO*N4)8CF:ID.M$0U6A5 MDI[JSM.]Q`[H3$*YJ1U-R99SO4V=(.$N=UMF:?6CW`]J33"B#L4!\^+007[= MNR/RW+L#"TKE3E(I?]XA'SQDCRM0=Z9M!W7$H*_$IMB`KYM(N<&^1_/K<#^S M#KU"R0GY&4.@(:HSRH1B.G]2SJ+QH2A6/_/'Q^;270(196%("6:0H=#W(+(L M&%,:(69S`&K9,>3JT*PUPYP*/;#N!NR)*UC3LBBF+W,0**OJ>YF6V&N06:3_B M)P=X:JK$YU*$44!C:MN!AR+J]8($[2@@R29;I^UK[+*2,;YRH>X2M-WE!4Z% MKM,C7OR2'^@`&BS?KFN=95.@VTW7(H9UR0D-.])=IZ9.NBM_JKWW(:VR[HIW MOEF3U;\_JBVOOTHPAAZE$-L8.9@AZE%$^LJ=$$Y$U`#Z?AW3`MG,BH(SHX)67BB[)\R3>L:UWQ MI&C9IFH./9*RK)TUXS6'^\-7/J5[_A'YF9:K]K7:JTVU+9O#DE636>WV(=W\ M_;U)17]=;'9958OYY^+Q,2Y*_D<)@99G(1:$+O$P@OW*HH,,JO:9L%I.B2]5FH=:X M`LZM>'?'S0!#4\'`5G"W!\/O=?:"QN`%Z)X*']C;#:\_O$' M?Q&-+[IWQPM%/4S/RONL;7UJ0=],IS-DH#25G=^W'PR%*7X'J-]`*;Y=9]N; M]#&KTLUJ66S6RWQ7SZ3XJS#5W?Z03Y.46=INL?!DIBZ*/6;%L8LBJYY-80BA M:X[$U=-!@;]*/TP5%]6#!8";(+EKJ[FM3@^4 MYC23^H[OI;>0^.4F,UI*[>Z3[A83N22ES-\KH_T\[6'`%:L9C"SF=''!(;29 M8)?[Y,M-0D,:4-_U8M^.8MN-+->QVY)#&$)/:$8J49SFP8U/"ILT?NGVU#D\ M93).#SB:>)`;/;Y<7]VR"-SJV$=&NH>ZH\AF%+M6$&';\OP8$FKU-2#*I)*? M2A2KN?=R)))+-S*=GC=I9DE.#WP@2$(:)F))(3:&;,;6)&:GR=`%HNDE7]?_+^H\W@#QE M97Y?_YIM[]^/3$SQBM5'IE.C"#)@IC0.?S&1ITC(:%O%GOR75XE'$$9^/4^R M0]^+[1A!2OKB76P)OR@@*\>F^9I(PU:UQ9_ M6NTDR3!'[V2!OU0\)=.U[?(NGR_$A#:U6`A=*R;8@Y#@``4](,QO>`]32;XD@TX+\9C2YU8WAYXC;F?`UE MP"@YDZ$C-XE5J17>>KJNF6J?^VL!)'Z,"(L1\PPGM$*I@\S2 MA6L>,U]T3P]\;=#FQ.D_#Q&?T9_>"24N2&J9PG0GD)A7Z7%!FX8?7=W?B@L+=_O"5\Q<4MH<+"@.C/F;\0MGACF%B$^S&88`] M+Z`!AB'UO:`U)+*81852TIN+?L8A[JG!!M)G<#)K$4:2)[+D9"1PC4M5L]W* M&[I62\#@@OCENY;$\IB1!N@/,8QW-:%EN+=HO&/+=T8[D@%QE>$$%9>B":;' M?/]D^?IAFZW(+BO3=?:AKFP;I=LL3O.R><8Y@3:.:$0L![LALQS+]JC36QI0 M1RC]S06;ISEJ[`&^2UN$8%WRS9%5C1%\JT&"'4>Y`-\O.;J&UL550)``,7X%16 M%^!45G5X"P`!!"4.```$.0$``.Q=67/C.))^WXC]#]Z:9Y=Y@4='UTX`!-GM M"%?9:[NVYXU!4[#$*8IT\W#9\^L'H$1)MF41)$%(5L]+N20!B3D9US.3OZ8D.+'R7V>S4_^R/(?\6-X>KJL=;+X M7Q*G/^["@IP\%?$O130C\_`BB\*R;GE6E@^_G)W]_/GS\]-=GGS.\NF9IBCZ MV:K6NR78I].FV"G[ZE353G7U\U,Q^71"Y4L+#OK+DK\\L2]>E/^IUZ55QW'. MZE]718MX6T%*5CW[Q]>+FUK$TS@MRC"-R">*P%<)@_JRG)'8/.9F1M(@?R3E5UIPQSQC[ M99:3^R^?YND/"H,*%$<##(2_=:!0/C^0+Y^*>/Z0T._.1N29P3.I$G)YSU$8 MDS*,DV*XG$-:W00BCFB3!$YS0IA[;6>;K[HD;K^%>4ZMXI';\/J1DR3-VNC],,[_ M/TPJ^M_S"?V)6C\S!E@4I"QJ,CF9U"3"NSBA%$E!?Z,#Y$0,$"-P(A_#.*4C M8!PFUZ2HDI*5WJCL9D59,#]22T`*X;@-:5TZ5NI_?L#ZLA6O3V)J1+38..C/;> M)*ZYN;R_S$+R44#HW*(D3#B#F2Y$!'&.PNC'-,^JE`T_*"SB@ID2 M*6B#'334D8HDWK]E92OHG6A(XOLJ2^(H'LSZ:S*"N*)?%T,<$;+%Z/1F1*_C5. MXWDUOR!A0:["Y[HT'0"_T;"0+=DDS%G6/XI$HG>C,I&YJO)H1GFX',,66HF/ M+RG78,I=7QB_Z80-UZRI@CK>2<@:K)N>WU&K2:>KN([BX^]HD?Y^@UF+(X&9<,U`N4B_;)9-4JA7\6TI&U.$]O9B$UVRRA4^W" MHU/9\GE5JEU<@8U(DGS3-PZ4;QLIB5)TWI0<1G2ODEU1\TG+&9W,1&$RBIA; M6Y`GLR@%[DMGHZA)KF9>##T=F-]:;VS^^B+=3D00YYCPK/)Z._0E4[0_ M)Q4[Z"1.9C%-"42!*U!\6U`4!W$1U8LF%9E)K6A[[2DLTPZ*_U6G4QN\W#M`@CT6KNTYY,//B<:G=*HF18GL^E M;7F4@?)Y8S>_C6F.JH*X],*<+4$4K#=?D;R>DK=PMZO*B%SQ639'S1%YY-SM MY:DZ(I?K0*GYM?F%[3Q'=>=(JI+W2(_()D:4FLM=M%<4Q6&]WL4)\+:R0OE8 M_,O%QLNB0KFX*;/HQS5Y6&Y+7N79-`_G73#BHB"49SZKVE)4$!>KM>/SM"CS MJMDD71U2_4JG.%7.M479A]0>I.@8WHD@O0RJ/T%!$OV699.?<9+01E\? MUVQAG:/F^#QV-*4>E,:78>.`=<6"VEUEL+3#VY2)2U-(H-CO MD)0IU8A*W;ONN)P?=WU1_%8AG?>6I)VQ-P6%<]#5<;56%,1AOD"D?LL)QM$.LLW1JMC8H/) M/TPY5U]>DXC$C[5?I@Z[ON#9 M9=P20UR*I*2X"I\9+R(D>X_8F)*\OGBS40B6;">^*K/\^3HL"06;?DUGV8]Q M,$Z/O:4XU2;G]5^U_$$G) M?5P*<-B=",N74+0/[]^*>-FYHO%WRPOCYY$:?9:W+ZYO*2F>!U[5OE=!/$>< M6GJGO"!^J%NF7J=\OJ)F6N]>_5G%#QR'1EOKCD)DX>M@T?L]%=]Q'X9%KFS,)^VF@I?92F<=H:]#S$IDJS=QC=V[W1741&R M]F].,AJ[RZ'G&S+E=]KC-KI/9):_TNBR8DL:[B)#%+7EVPS3VB/"TZWE?6)$ M/Y#\D>GOEG+!5O2*,>V&HSDI:'`-_UU("..ZN5S/8HYV!K>6'H<73">1:7T1 MKQQ>-S,=EE68QV%2IP-[Z+`H-(3DZ%+- M68Q77*^6*\[3S56*H0)VHBY)UML,-5O>9,)V2X3E@930\M@8+9>JUK6;2,5XAKU M@9+QT!Q;+CIWN")YG$WB:`EPEYAJ"-&Q):L__A&7LPW'\:8'T:#7>XI(40A4 MJ["&QT;H#Q)/9^SVZ2/)PRF!2;)<9Q<(1I\VQI&;,XC>44<07PTXYS'K_#48 MU'W_7Q4F\?TSB]T7:TFD)ED6GIQVO6@)EH-E-,CSNK4Z#-D\8OKR@F4W M[?2F*UR^C6:WW?);GJ.=P')=,*4Q:97G=7:2(NYHER.T*!R3UUORJ[0=&ZRO M6`SXG2Z<4L2/:.JB%,:2G9: M2!^YU=&QX0KG>*L+XS:IIZHT9LFI#27/JULKK,GO:5A-8OIS*].=J,CEG=>X M^A"3*PFG`?6@)4J.^JXLQ\+ZVX+".>BX#-U>43B'6^+-C95B/\NO2%Y[KWI! ME=;ZGL:\KE)H(R-*?E['7A3LQ2U,^).=0U@<4/C^P!Z>8&TNX\XL7;[!U1\# M$IG9@D21B6BVV',9S,P)9&Q&"]2K4>`KX7;-].A-P]J`N7E2]$>J>X*&ZJ MNX+\6=&!QGODN-G_7O&1N'G]F5/?W:@(XWT^#_/G%W M['O0DBJ'4$WL52-\_J,'*4%2;&;W8AMV["4JDB^R@K+1)4S;$L5TH""/YXZ3 MM0$4.\NT^1*NLQ`H)5.V0WH1WI%7B5RWU4OR_$6U4T:(O;ZKFK4PVZ@)Y/(; M*<4R^IJ@0%X76_!>*AC:[62%\TWCO%PPUN\1%LC[+0W,B%BNWY(4R2][:4XP MOV](BN&WAS&4;UGDT/S#QF-D%[34LBRCR>&?.[]\39Y*PDYN+5[KINTG6;1- MR%K`^["XJZ6LBM-I&#Z<,4]^1I*R:+ZI??NIHBZ?(__;\NM@N49S1^?!U-K3'5G>8#F: M-%M09<<";BF8B+;X8X=\;54#W35\75$M$SH&L&P'`-]M)'842VF3>--^8!Z= M9/F$Y%\^J9].Z"^+?`47"[;>,7E]84GEFXX?YM$;*WQ9<5GB[*$>O4^C69RL M-@KN\VPN1M79J(A2&59]\>QU9Y3418<_VBZI6W.PQQ(\TC#C\OXV?.+H_STI M!HYE*;8)/--4D&'X$%H:]G33<@Q'MS5D[<=1<$I33R^&@U*3"1QL48$!-&W% MT!2@8@-H*R0<&Q^/`QG=5C)I:MCP.J,9X^IMCX7C72>X@$]QLOR@>Z[0/- MQH8+3:Q`I*J:8S1R(1.V>N^/8T2"])N)1U6&M6QTH7K=)UEH;/+/JJB?'?U* MYG*Z1V//0W4_/LCG#AX)1L6'>Y_ MHQBL7LT@13Q-:Z>=KT]S-R_'_4XF4W8(F-_L>I,/?-?Q@0Z18_BVB1#2`516 MJ&FFWM,HM;^041;6=0.XONDJP/3] M53AL(_=X?)^46<+(^$NQQDOW'):+E`8,B]MLL>?7S-:OLR3QLYP=NMEEB/Q4 M`H`M#6%+UUQ7\4W==SW57077#C".)R@V^%H\!^00VR$$;=J&:@:C9-U MRU2Q!AW+,V@`O<9"-?NZP\ZF^/#.GJ1P@QS#3OKYQ)XZD&&/N]A>Y`2_)E$2 M%D5]3J4^,<%AFP.H!HZJ8$7U?`R@0<,9"'RPFNA9"NR[&76(P[8$"Y6G"1G6 M^II7SBPI+LORE2XS-'"8K\AF`EVU&)!`5SS5=*"BJ^L^CX'7U^]VGOL\DOPN M.P*+WJ-RCCM`0)YE8A=CY&D:0EA!M@]7LT?@]YVD&_T"A-?'K3ZBJ8ZK@<,Z M-?!F&+FLRH,_2]#WB!#0`9VY `/M!,#)%FJSJT5!-YKNT8VGYV_G?9V&OU MK->.:O]).\-EBFG'>ZP/O2Y#@_Y!7M_F`E-#IJ/[NFEXT'>0JR`$&F1I`&(> MSX2YKTEU"/`D:6'?\Y2.8DJS:H:D#S7=-4U@NIZA6E`S($0-DL!W6P\3?IS9 MS.'9\1H_(I5J1/^U72N,BKG*A?C)E)T%KIQ!F'\R'PH8P'5 MBZ%"V[,\W;!,3_4#,85U6=^0_+' M."(LE9I+#34NAW98F2P&#@8F0JYO>8H&@69H5'&-]AP']#U9?8#3E8_6=0_8 M#'9WXC>WK^D7$IT4^WM#RC*I?RQXAM'#8C#PH.FZR+1LQP8:TFW--E:+,:YI M]]T0/<#IUB'UR0]M!/L>5@6"BL@AR@]!TF M#W!B>$A=\H.H^X@ZWT%T.Z8!S=%5&H3H%'5/`1XV;,=8:@!#&J/T['#@/QWN M@#I<=T4?45<;?2V_,R>!0Z<`'M8I[IZ'/0/Y*FIF`=AVE;Z!YP%VNH-8YQ]; M0?\YH+?]#)BC`].V+=/V7/H?U06*@E8NQT5J3S,WC];,]XC^(9QYVI:8[\#/ M*V%@J9;BZ#9T(%!,9!FVH9@00L]QF0GLY[Q2IY0SJPM,/!F/!E(.+,]V::AD M^;JA(\O33,/P&KQ4L_>9W0/

AK**]32$@%?!\C&>]Q1FX;%=-`8'N6YAJN MZQC0I><)5N_-A91W@FB>1>GBV/!'(/7KFJ!89K(MUW35VU7UX&&]29EFV<#![9N+DN3 M%,=%E&3LH3<>;\!'('`!-2\=(`4X-&+3% M^_;N7,4?N*][!M6PX:G(I?A[CH-SZU M)=GK2BJ`BF%ZNNOT7%G MU-M6+W!]S[-,A9MX0``V[=LPS!I*`TTX'L8&(U$IJKT38!S@,L3T@:6 MP2C+MYMOX9RT#BSO50E8YC0':[X"J2_3#=K)E%5'TUWKB)(H#5'M3BOIC6:/ M,>:6Y/.++$QWCBDO"P785^DT6W6`HQB.:4"?AO5+IK".T1&]0#!<+YD@%.6L MHC]FR2-+D%F?,/;#*$[B\KDUO^3.>H'E`PMKV-4-B'S?-C5D-\,D=DS_B%($ M";.6,8`=X!MP1;[2ZC--T50N/_&V0H"`;BL:L#'V@6-C%:B*OK)VMW>J@`,\ M%SV*SQB,J`S_<9&E4XKOG"%P2UMM"4"W%0]T&U$Y+$6'GN;JP-!\=R45AJAO M#N0#M!-I(:@`G/=A/:TAZ/8*`8*T-ZF>ZD.@:8Z"/-U1&LDLTSBBU.[#%-MB M);W0E&$GW]."1%7.DBS?M>>^WE(Z<#S=,A!P5)_.W[%O>HZI-C)YU!-.A$QP5F$_A@Y.(C MNA,GV$R&0LG5VP[P'I,@&#_$I-N/T[@D%_$CF9Q3Y:33F,9ZL"A(26/`K^$_ ML]QE)Z!:8ND.5`*D`V3H*O!U3P$*9*EBK56$`.R^YR4/T(ZDA=CCP;]G$USS MSK4JW)%2X&!H:C8"IF=1H.G@1IU:@X5M:$>TDCB*A?!;H0#T>RP@L8.9":D? MB8YF:99DT_<7$W>6#TQ-IZ0='6N.Z3CL)5B[.4."%0,?4<@^FA(S\3C+<$YN M5939G.379/'66#&+']K?X]I1*[!-A%5`.YBN^QAA!^,U8HK7^P'E`YRUC&U+ MXM&685&W>3@A\S#_T6Y&KXL&BH61@4T(=,`RD$-;=[1&&M\SCFAY4I;M#(18 MAL&IG1.]DB2[('K_36N^H&*/,U0=0Q4V\?8009<3^T, M7^F;J/,`PW)9IC4&[E+V8;-G=NIH?6:\?0=V>XU`P<"%JF9IP'!<&T.`]-5P MK@.G[RL!!W@I7)9-B4%:AA6A,`G3B-S,""DOLN4]]MVK".]5";!N>QK&KJ%` MPS2PY^O6:E/!!8JJ&XNC`6\6)A@/[CFT? MQ(JZ*KW#4E$?>&68$PWF)E547C:Y,%L&LVW%`\5`AN>IP/9MW]5)UL/N9"X9+5K'L'?K!'2"ZD#@0%,WL*(9NN5;*_ET MH_=%_@-T/L/4N]U6!@/:[S!C$C/8:6=H.\3XJF#@>L!57`]IG@=-TS*A9:XV M'H%Y3`\#"U!0)A#*'GK^_?/59QB5LS#_C20[%;VE9&`XNN)KMJ68$".L.99E MK::%KJWU#2H.<&U8K*:'8]FG2_^;O6M=;AO'TN^R#S"+^Z5J_^`ZXZKN.)MX M=G^R%)N.-9%$ER1[DWGZ!261EAV+$L&+*+J[TI64#9+`=SX`YX:#AW0Y^9&M MKN;SIT665P*9/%8'F"J>2(2F$'CI`4=".&$!`65W$<:QE<4&Z-IM>9*WAFD$ M!:X6H>,_*V6^WR01E@K@@D++,-*>P*`[EUJM0]$W?`W0R=JND!N`&"%5O9RN MUMGLSU\!I:]!3?WVK5+"AYHGP1Z2G''BN054$JJI?DF1E_SHS8^7X[9J5]HM M`1HA^>O[Z7*>/E>*^U6;Q#HK()4@MX2]\YY@*%\NC)N@&"%8 M]W,R^YY5RG6_24(=,PPYK"'06K&PODA51@$U$I%BY6,7:P,0(Z1JT\=LGMY5 MBO55F\1@''8-0X`4E(:-)*P:Y9BT.%XEZ(!+U61:+=G7 MC1+,`01<"R2@E!A!B'1IVA'N8D4KQR[:1C#V$O_YW8%X+)#X_A.)"I:_(XP@ MS*3`2%E$R@7)4AUK7@]P5>\OCM@*U.>B4?[/97H\L?CHLPF7UF"M*=>2>1G, MDK#KE8XEI494V*:QQ$]@4!-L&WAR3G+>%"HKRFT/)9'_G]+5^C9;OBF5=;6X_5NER(\^ES@--$2`0"\$,,03[XL0MZ/" MQQKX`_3+=L.#MA&..0AW&ZHT3+`,=$['Q M^-J>WN=T^2V[3"ZT`VT_^?AW^?UJ+1R;K?FFH"0Q26C81BWC%N=U(VUAFSMI MHJO3#-![U9O]VJT(!D#'FD=H(]Z6:$^-%M0@;R%F0`)<%HQP7,,1)=1VQI9Z MK&Q!"B?59K@\"31#9B0'>+:7/DP7WVL_?!I/?V^D9_);X@]4E;OM\9A;Q8HV'5&YFN@#AH\H:4* MAS6*]8T.,#+37U&]IBCWSYO3BNH=>"3)3Z@H&R:"5PA*1XC4Y3S#D(W(O]Y$ MM)4LB48SPK#^]/2#)LV(?%&LJ8SUSD,P/+*<,Y0; M"WB?M-J[],EDBW50J0*HX5^K:1#I[A:UR;=-@<,3V%;C;8GW@!,F)>8("Z>$ MA^49-8>$BDW9'N""U0XUCE^PUS+DO1SLFOS::.\WVTE$6-`U,:%?&I0H0"UB$XL':))U0KP.L3[?PO;GV;W16#Q@`%9^SU)'IGD%D(15G(#/*<4^1?G6G0$ M;8!'S-_T[1J4:KTH47:U63V$O7^9_Y^;Y MIZ?<37-]OQWQ]K?UO"`1'TBP#:AA37'`#5-D,/.E!Y$3'VLQ###SO=/MLU!QCV/#^1.Q7-F=V(?U]F[W+XU$<3[R#U6BH#F),.4\)LJ8?GQW-' M%"SIVU\8`W`["V30C;/OB^F_T[NKN]"YZ?UT4F:J%,Y+M;@K7.?3=!5^]S1/ M]W^27W1SL[OHYO1%LNTO![E8'O1ZS/,T7T?##D/+-&]B,(WEY]@#*<.4S\`\ MD'N#NEJ$3:(Z#-/LQ8DP$L.PE02413/YHT1F>H6_GQ2H17I] MO[UFKS+MZ:59PCEAG`F/O5?&$JP0*@[2.FM\=#KU1PFQ-``S*M-I:^A?+>ZF MV]JXJYN'R5HM4_7XN,R>TSN?+6^6Z62=ZQ`',Z'JO"0!@C'DC<#6FH`ZE(RP M2\OJ"[V#II%M?:L7RT#.RPTJ74,NRRW[PI_(I_7N6W>5I8Q74>J]Y8A@FF$O#*!(.02JM*T=EH(N^4G+L<8X608W0 M]O^YGX_I8O5>)LK[#1/-,'+,*>B@XX@;"W%9/D?PZ++1Z*,X M\!O!V<(J<2@"^5N[!!#AF7#6&.\E%$XK]W(`B)#HS.Z/X`IOBF8?*\#VXJ/9 M>\>+"]=\5X^A<'_11G-`=@-P'M38]O)H_ M3O+"VL&T>Y@LOZ=5<>/W'TB&A-=^*ZV^_E,Q8R: M$Z@58/S\(O;'\OL;OVW8,]OX=T_1;@) M!^8%"=*7<@0OYPY]&,C&`W!]7S.B:-/U9#I;O1Y9^G.=+N[2N__HW>&U4M]6 MZ^7DMLI8JWHL\0Q@00P$^4TBE%JEB$'>0,,4L"?&!JL+HJ!+[1!!5L2;+\/=:YH1XZT5VRW>9TJ!CBS/[4!>'TYP9[E2 MU'D$I"K&QJ4;48V'[L1^8GGN>E"?BT;ME><&`G*F-),V;+<&4\*Q*\8KXZNX M#I!:C25>NSQW/6PCS.F8\MP*:R&5MA@:P+SAP(ARPDC)QW0];WL".ER>NQZ< M$3*N6Y[;8*>@YX6P":.&CKJPQ$$DG"L[RF'L29S+R')J@PGM M`'NIQ<9(6/.X=D18PAF1"AA5&/=8R^B2)P/4-A3%B;/55^L MMRVW)]SS)T]A9Y>?3U0`F06X+26>!]RM@.5JGA>V';7%%$&^XWEVYY;1@&=& MGK'S?]/9[/US2.%]G[+%;;98!ZF&+G\OG\9R>O8+>[R2A7/D]F!/)1^/IQ8P;WR1$E) M@4::<`Y*8DCE1KB[#)7*7>Y;3>5^:3/L:O$;#SB?8L5]>=/H=9K5IO+ES<-D40BQM^EUI!^)@#X_ M]P*T!U!IHJ!$NI`#(C@V.6K`[N8/.>W:I4$?T_&$F5+V7B$+O4:$>D6=T,@8 M:,O%Q$4G&==VC/>9X'G7>G/5)P_2S]2+07VG%E%+>8&YC;L"]R`-&WB0ZY M:/7ESJK!\.#2YF/_GL%]UY"2DCMF)6;,4^&(@+A@`(4`C[&F]P><8_$2O[39 M5%WPLN4O)9IK2J7&7%*@@J8@/``%EN'_HV57VJMW_E><:DB2'E*-I##ZQ>UT M,ON2KI["9`RM]QXVV6J]NBYO1EV-K2Z2(,C1L,)99BW`6"(A&:9(&L>4I_YH M&L;XZB(%_CHIPN`#%L`2BJDN$-'<&S?J?/<(8C2MBU0/[\NJB^2E-L08"J@A M7@J',9#%V(".W_Z&QZ7NQ'YB7:1Z4%]^721)`.;"",TY)E!A0C`LQAN,P6B? MVO"HU5CBM>LBU<.VAYHYS"$6OH\1(X8+Y/+#HT6'H))CT10@-O MBXX+HF/]5`-V4[5+C98![JE8'K366.T<],IP*:C33.\Z92Q%'ZI24HS4&\$9 M(^/<#;6O&5<+^_W6B?#:>L0L0U)8Z9TF"A3=Q`['FA4#/CO1LM1;P?5BBR(9 M#C2BRBIO)2/$($>*45(UI@/(YS1*8_'N@U77CYN0?NY-SB^)^R-;G>)'K'@J M"5NC8-X@X,+R&;0F%OXOQB@4C%5,+\-`B1!UUA6T9Z)//=HDN68-B%1(0`(] M1$YY7(R),#$B>[85R1YG2TU$^V#)_C5OG])3"D`=>"(!X3_+@64>.XH-@906 MFK>1%L6J.P/49%H!+#CSRQE@F,`#^J-?HI$X6\&15\'PKX3D4QX]]5>(=I<(: MP[UDDF$LPM_%("G%(]`QF\LWZQ7C/G:'K4K\-8AM,TG_R,5Z/'Y?\52BE8," M:84@$$0#@_3FBH7-&/."^N/@4;?BS[J"^XR4.AK#KWPNL8 M!&!`,1ZG](CNP&I)KEF[B%Y6TADV`#M'K!7".P&P":#MQD:`Q_[RW26];UCM M0'WY26<(2RFADF%X!DGLI2.R&*\Q9$3W/#:6>.VDLWK8GBWV[&U`4P@KM7:6 MH#S=:7!ZM']O1XYY0C@IS4P`>+QY"=@!PU M_&C@[#2K]@"8D]7GR7*=W;_3PZI(<^SK$DTT1)2#L.)Q9'A^+K$<+%=V1.&< M=F2>]8YY'SO,Y[`F/-VNKY=?T^5S6`&.>/#?:YY0`P`0V"KI";,2,NB+((=3 M4$47'!H.D_H1>M8ZUCTR*-]"=AU='?7;'WPFP9A;BHQ"SA'$`A'?&^SY7&@#8X!'@UGS\MLO7F[O9?)YT(?.>)Q!)F'+4*YL4[4%#'I<"[ M[GJ(XPL$#E;^343VSK'`YIC&..H7H>,_JQWU>TT28_,2G)P`*C%#>:UU6ZZ( M5LC8[(`!F1_="+D!B#$3.UW.ICG485^KGL^_-4PL M@.B8VX"\8QU-XZ907E;B!]1.*@6,$1KG3A8OK2K&)F5TY:H!+01GT1S;@?OR MDS^4%PQ!#97WEDH0L+2%0\\;H$:4A=98XK63/^IAVU-Q":6]A,1"S`$.UKM$ MQ!8A+6^M&+G`(P5TN+A$/3A[R/#@0&OG/6**8(P8PL:5=/:ALY>_7W0KWP9@ M#BK#@WC"\Y0V@[U287,4X=-EUQDQXU$ON^%!VP@/*,.#&(VLL`X;1B!0@A") MRC5+NP^5X1%#C98!CF'&8K79AQXW'\\_7G>3WCXLLEGV MO3K"YC<;I9!LUN/EG^.'Z> M\VW3A#%+K6)N`GU;K;)XN-Q5/\IR9 MA^GC"6>!#S^5$![F!.&::0\8U4XI9HLQ4D)CW?T#4IKZIE%[:/=3E^`NO6]% M5:_YIL03I8CS1DMLB%#0$%GHH]YQ'*L?#<@K]>VW#:N;/]H%^Z71URGS=L1"O7ESE`C:PSMC1C90M2 MZ(>9'Y>+V[A:/T7YQB]\4/.)+9_+V>)K"L\^>1#7:A^X%!Q0Q+"34?]PC%/B M][X<[49D.';*BI\8V#[V67%9C<^#]R?>RYW39<#8.R")M9I*#YE05NV-(D70 M"#RRO9["/56WM:=%<7(<`2.!/.$&B@@ZM]J:>,I6THZ!-,5[?4JJFV]^RV7]CH%Q*A13D2@+"M/68 MB`I;)G#N\7']QO/0EDBNR#(L1\"&3M!A6-<>^H@ET)J M(WPU-VK\"/+J=2_VFF^,FT%]_6^,K=0$(RNH)(`;S0U+-<`V\\52LY$_.6TD M\<9OC)MA>R$N';LQK],L*.@0$DQ`!KA#ADNN335+#%GNS>&`KD&&L#GEXGTA M5JTJG7=7WK(9N7YL'1@!!"*M(GI:`N4XTV`_9\5S_:O7L4MEB/XTG\Z$^-*T M^E"N:]7"KMU'T$RF_+F:0*NXT`S&_;J:OX-R!$5\+D:Q<>%=_ZUJW[1K$^^! ML<].9T_KHAIT@*`R@6$,H46+1?CU;F/JD;T-WE4!B8A_B`')GI M5FE^.YU-=RG"-Z653&PVC2(?I5\3B'@B`:V`DXQ("`7FNT=($EO(&Q=NOGZ_ M9J2K,%)9I[UPD!((7Q&1G.4F*!FP*GX>,<[U:S;#^[K\F@Q!`"%1%'IG*1(& M@2K>`E.,X'BXU)W8:_HUFT%]_7Y-APF-L\-4:>D`6:&=+O+G0B0(50#9Y11\2LYH!96 M0^="YMZ%7H?#I`4>M(UP3CJ@CG(G0J\!3WGE#388HZ@[J>IA%";2CR`*NUMJ MM`QP#C-:RIUHE:+$JW3[!AA+F1TYKP;J&!C!2]V.F=`.L-=ZI>T!0H!Q:S@5 M&GN62E)4LX0`Y!H/`]0U+FF7YN+=4GSP6[?EEV4Q7VT%\Z%R[AKRJAU$2@!EAZY_1K$FH[;.,F0\XGHX);QOK:'/&F*\1Y#RN=!*.+2@ M83->'^PF:(P=903P^,=2HHUC>[4%^NS'9]=A-';"T;:P;NR\O$]/ MO*Z'M,,5TN5VU_5T?A\G_=W@JYF^--YDC_86O+`&$">1H=0)$66F]_<.W,+< ME&SU;>]K)6Y_H%^;PMMO*BRFM=`&2`"\@E@+[LTNKYTDB&;G&!_0:^&K46B; MB^/BT5(;-\EX`J`@U%IZ;QW$%'@N`(6I(*BV6FJMZ@XP+]JQ4>U\DU1.T[II33P4'AFTR-IK"H\:;35QN<).H]6!\.G+B&. M]HR5URC*Q2^B*$^RLZ6>`["<:)(*\S(K?/P/:E9-WW.?JZL-T-'=*ALO`W\[ M[*N"DG>^_7ALJ=E&L&?PKGZ?`8E4'X#I3:HE8;!Q>#]EQK+WOP%[8KID7&?` MM\.U-[K2)D5,)KV.=A.,HH9Y8:)6J*B.?R.XGQB%-M>W-^!;_RX9U2;6[9#H MAWPTZG&Q7$__;_.K5]KG4BNC\P"B,9+\FMK%-84QHXY`YUA<10`+GIW98\#! M!5T2KGL)].'M>).Y,ZJ=)_(,[A7434:EFX,9U>O8)]U^<6"<8!\7:-1'*/12 M&4AP)63H=.[%]8!](:V:*X.2SH4?,[[)?E6'V`U["@XB3QRVB&.O-&(("E=A M(0')C=D94'*V3IG:+=R=>^5TW,7MHH@&9#'[''^R=2?6\-^UTG_P#DLG'<44>2J` M((!PI(EQ2@$F3]\WUE+O*O?-XFXCH\5.1J][VP'-[62[P*+Q[*2UG%'*!-82 M4EL-7\DQ15CU+.Y%=U+HXT#:5!8L)^E$?=F$*<3);T,;W_[FQ/O%^IT$`HRE MB)L(`=#$*1#UT0H!+;*?J0R(ARTS8=$3U'V3[>0;QI\_''0J$1[!5D$IZIX%/&98A MIQA3;/9S=#K7]S2@"YMNCY?VL+T@?VK4<3W2+A`>L7)4"F*58!*HE)E[-T_! M[(BRR;8B[7H,RL*V#PY]+I.]?/];.2^7Q2S:"&KR.)U/DQFPGCZ7[MO7%+]R MNC!ZHWX"@I8P0#"0,N6]]-3K_:&MD!U1^H66^/!CG$.':&?H-<X0A$7`$B5&Z8UN72/>Q@YK%XV-<%&D&FPR3JYNG]6I=S"=QC1S9_XXU"Y9# MK8D72CECO+8>"57-$JKL!']7=!*?OWNU"'#/-(K;X\URH\U._EW,GLHJ=VD] M-AUJ'=*UH*+.,"T!B552SA?_%HV[;3_O90]?$N' M4P5&!8#5T8ZD45VQNG*,1GV%7"C];!4K8,O5[7+Z=3>K7XBW29Q'_>1VI;P1[TENU/J`].L+L>A`3$AGHKGX_O,Q`GH[_>\6=(0\UNLH M.V`!XYIPH)UW;"=1Q)@\J0YVM`5M9:EN-^4AHU:UD>3+]O^UMIU:'81H&#(# MI9*0$^_BD4HQVLT>JWSC:K1;36VV_+C5="&./E3G/U;ES5U5"/?8K=[W'PP: M(2<)YX@ZS+Q"@FA8S01H-8*+O&$0ZRS8^[&]WD!2?_\ZUBP(*[#%Q$D-N8%4 M>",K"P-[#'(=D`,RX8=!KA:%T,\CA=5M,8NVXG1QK(;,VX\%I;2PQFC%L6&8 M`*&@K&9AI,RM#SD@PWT85#H#],ZUZ.1XF*ZW\YQ/]KE(+J8X'QE/*A@^6ZR> MEF4-!;E1/\FTB=:,5813[03"Z>Q`#,4EKI%"OG&`=(]8U#M0FG04F+646.&B M?0>U3#6UJ*W0L(*.*(]!1RSYA7.O,_@ON4-\*);;N[E+/L&XS(Z!@(2&,:(] MX.GEK#$*82X0-=Q!34\:C[4N&C_.BOEZ^X#,?;M]*.)X)G>+Y;OYY"D.(QY2 MNP*?>C&?'`K1:-1'X%QAE!*L1M598FN!0&`W+4^$'E&H:D?B7O2#?,:MM=WA M_Z7X]B9URKOY:AV7?<+A=F'Z#E MVSU].H$\@S?OYA'-Q5_4),R)5@%0JJECPDA"XRBIMKA")&($1Q`3UA]3 MVL6Z#VOUYNLF:<[\_GU9K,K5ISC4W>"/IP,\VBY(@BVWS#+L?32NN*-25?.D MEH#QV+/=>&BVIFS.O<))$# M3`+2#X]:@?D";S)T$36XV_+S0UFN-^&(D\W;^6+VBLU*O\1_?%VLBMEOR\73 MUU1.9?:40H'29S9S?BHGNX64WO(W>A[4T0""%Y0X"@E!!*8W_8;RO?/G;'I?[!ZK?RC62?DY?F"?:AJ,U,X!33`T M&F@>%Q5QU6P)R4ZR-4"/2,M';[QA0-C"Y"@D&GEF M%+'(Z6JFD(SIAJ\]H?]D"K2(<"_>D:@N;@$PQ>K4N?;SAX/G5BN%*.+6"LZL MI/O#GV(J:L![B[GB/8H2[+1S+"7W+=R5FP+0W^.;(\VYNK]>X,0*N83!,7':'_. MUZ_#.VI49?45$)3`,VZ)$5AR++!1^RD2ST;TZ.-\*2_Z!3N#3Y_*]7+Q]6$Z MK\F9@Y\/6''H'++:Z6@O&L2<,OM#E-K<`,4A&D]M\J(M0#-D_]NLG"^GD_NR MINP/?CY$Q8EZZS@A4A!(0!PUW`U5,<9'\%2Y$]FW!6B&[/_WJ5RM;Q?+S^7M MTW(3K%"3!*<;!LPH@LH`8*"("GL\7V4%A690Y;)A@%>[K;*A=61SXHZ*YVDJ MS53,RW4Q^]?SOZI!;4^NV_)I'6VH67)#'F5)XWX"`UK::& M1#9I!GB/VRIIN@8Z@T._OXE,_7<9\9S.B^5+',"_?I_.9JL_%\N%C;K0WQ&L MHQQJW$]R#TC*E/#2"6TD]U3NIX91=L73`19):)5#70.=P:'WB[_+Y<=BM2JF MMY^FS^7R0_GW_R147XY2YE2S`"/Y/608X(B/$Y*B*KI*:"MA;OJ+`18G:)4A M+>-ZCKZ2LFMLDP392-3G341[4]6E3A]!&\8$0E@R[KR62$+URG&7K=.*D5.E M2Y#[\*V]O;E_7R]/\*$F`6*LH[[&)92&6F@UMY5?67OA1Y!LIR,O;$N(7HHO M)[VQAQL%YVG:15G\0[RE,BY`O%?QHZXV'O?:^4*NP9HL5#/.)W5[NWS:%)>Z M63^42_.T7&[\>?NW`$=/IIJM`^96:44$5C0E)'5:VNHV56O&1Q0+V(8L%UT# M?)$XZ>IZ_>;N]<>GZJ;4[R1XP@@GPAN&+7<"8.DJKZ,VRN?&+@S1#F_YYK`K MC/MGV4O-0)@CK8*DP')#'%9(*DF\$GKOJN($Y<;E#W"KZD+P1[EU#M#?D^E: M0KW8IW@.ZX?_.JS(5U<$^*TH\8@+^(&A?6S+!Y)OYU5)V^Q`G#$#A-*$@*C84&JEK"(>XA^:Z]48HHNT MW>.]/5`O2)Q&M=!^:AS>^6Z5>3#T\G'F,UZRA`&PSYDS[1>,`F>721N," M4.4@@ASY:L8H&@NY29(&[^'K@EWGX]OOTZ[M2!]?\S@=H]+A5D$R``GTD!,- M)8QGO3*LFB.!.->J&F)L?@<<:@W82]SB;4A^2$\XG1=Q:&]SE_=0V<,*X MU@IKY8$$$'`,=WXOR2G*?M5^#=%,K6]&9\.;%5/[W1#>%W^OGJ;KU<%SZF2; M()PT$0,N#%44`$>=KX:,*,TVO:\A5B"?$6W#>@GMNMP44-R>J(TUZI\;!P<4 M30>NDI)R0KWDC%8S5G%S'?&M5/M:]-GX9NPMV^]9W/EI5*[4UBWU6KNAG+R; MKQ<[EA_8:1KT$*3#@),(C[(:.B8I=*B:CL!N3%'\[>X[W8%\*=U8/:8Z50U5 MXVVC($2*-@<6*01XW'*Y)[O[?BEXG/J(/4/=:,99N%[@_-I$@Q8S4RR7+_%' MF\JMNY#0^N?8D4X"A)I+I3ESV`$J+%2D`C6]=LA5C.0_@UE=X9QQKFWK`-W< M?5X7+S>;PIOPP/GUBT\&(Z0T!%)GXIF+,5?$^@H!S;+?M$(P:AZT@V8KPD:U MA8T"BF`QHN(%W'*$PTUL933O3?`J^P4@O](UV]K.`^$9\6W M\WFV[2-E`X#I1E#+_R?O6I?;QI7TN^P#[.)^^8GK;*KFQ*[$4UO[BZ61Z%AU M%#%+R9[X[1>01,5Q;(F$2!JA9Z;*&HML$U]_!/H"=$.LM<9`TR;_RP&1R=OT MWTEX>""W6#\NZ6D<+?K;Z!:43-&LKHB#(R&C\"R8M-SCX!JS9 MJ\"9%,G=F]]'['@@F$`^H*XHEI\#0MV;&T2RPA<18ULJGB\*FK*[5HJ[8)79X*+;<44,7I! M'5=(`JF\0(**)OC%/7.IQ>S@M"/2(T#]!A98T[3\YX6]O?7U\OV%(19C@QUP MQG'I47!R&HM`>)[>UV7:4>PA,;X\IWIXC*"1ZK8Y7/[XW^$MJ.I8A>NFK%_< MQ9@HJ:#.J-C7&F(D&4?*`VB:X6$GDHWW:4>PQT%[(#+%S2?S;;GP]]M='^+P M8&%6W>7Z+B#6":F%]-B&51X[!Y%1&%&(FG,IPE&<',2<=C![?.33CH0=3R&% MSS?ATDTLV?0*DUZ[O#!:.420L]8BAY!CL1WVX4&!3[:XT?3CW#U!.H95]&+# MH>NZ>EANPH?@G$9H_I@MUU?KIF71QW)[=1N&=<)6ND!JX5T,IG#.`'&,5V MMEQM?G[H\ONV7"_*Q7\,^U9U:NIYXCWJUAQ468.Q(H@++)'1QE*G$4,6,\*T MXV<-QX&"1:]IZ%.UBM&O?V;U0JUGJ\?-M#@(S%)=O_SFU@&XLWSH-(H>A@EH/G:2%)86$"O(-0.6(B%<="6=QV1?U-F[=/C'];S.G;VMN7^9PK?7I94 M"&2H,$@X+H-_P/WN__98""N3MZEDF&K.AG^]:.)-61GS!&7\U!0./I=1 MQ')BV`5GB@GBI:4>,7<8OS0,I9ZY;)^JEGL.KLLO<4OVS?NAXH6J>%,J!E#* MY9?U/C$ZWY?G6"4;AJ]+*PR#T!#@!"7$(`AA>%<;3*`2J?3,,+F=#2][T\;O MYZ!8IH*[YSFQD'KG,13Q)=R/#UF:>GBX)],*XC[GD$V`Y;*O^, MENSU['%W=4#H8YS8U_-R%8N1[+Y\AP&W6)-':$80@9X*Y1`5`ODX]\&C8Z2"L&U9(Q9R`T"WI/PR1[Q\&!"70X& MXDDU)OYCK%LM1W!^KV`W087%PDM$!'0.4TJX88XW2'"/)]1283".I'$Q30$9 M4?'#^N:?ZG_+67UJ+UAG604@$0VC@U%A@6!64(H;/(S1J0VY,XS&94;(9!WD MQ8:*ZVQ M5XS:\!$ZZ1M$D$*IM,PP3INPDI[!(2@\%TPI(18W%'!RC#3Z]=%B& MWO4X@<>#CEW$%+$4GY;(<^&1"8B$=_X872!"3RCD.!`[4CB8!GXV M%&P5;.PHJ8!0$<*9TM!A@WGTW8Y8*.'5A";#?(B8C'].7&P39.PLJU#!%F;$ M0H,0%X0"A_71"%)6IYXCRS#$F![B@I&,Z2,.>*HAU`3S34Y MOI]60"(8-=IYUF#!6'*)VPQ#B1F1,1G_;+AX M*0,+P1025"D0QJN@T<*AXSLH*$R=!#,,(6;$NXZHY\&V#[LB4YOMA_5\=;^( MU:::;RXBX>MB"T\M#V\A\D)PC2GEL9;5`25$D^M@M"_',_;1D5PHVIM.\F#N M]9X'NU+G5[K:*)S>N@@M4;[9JO0Z>4+V9U8\G`+I< M>*&H`)`1)Y7S'"J##;,'U)"7R6&7'/,CP["I>F.5C+&*=A_4YS)>-Q2+?Y%> M.,,APT1Z[9&`WDJ%<(.9YBQU'1)XACCW]X-9E(\EUY@2Q&A3D"+"88" M<`V/"YBS-K724HZIG$QI?*E.,N7Q\G9`&C\37C#CI;7",`6],%`#L6N!M5^^ M-$NM2Y=C!BA7%E^FDK=TS6_B`?QWY7USK:%FG!(H<<2AW110HC$&2<4"Q8%A9AA9PZ5'0-6QOGD4O*__U/H?.?JLS<5O7Q',0LH/0TX'Z6C?W_ MD4)RPK4@"&('.!8*,W4$A1*;&OGY_7WFCO1\<]6,8*X%ZVN]*1<_NK"',>R@ M_/IW&.GZBU^N@^6YG*T^A[]1_I3^:VG"O?A:O?R'7_AC)ZRR)#D%=$H2+$RP MD16`2&J'\5X#G$@BSQZ,'?KKN=O90W,B>>IU0%0S_.=_SBK]YW4TI*HF,.66F,"+P\X"`=&ZW^>V[S M06M^O&[']HS]&#[6IW(5MVU=S^KMOLAH@")ZB/KQZ3?J^_+4!J#V0@I@L.=& MQRF6(!ET"L*L>T``FGJV^SI:GRL7^>G$AD30X#,@` MAC'GS&I*FQ%Q)9)[[N9'I2'4?())2?@FN-FF>E@NEN7Z>C7_5QD[N+ZZUC^[ MKC!>*@$TY8`[JIS1PJCC^T)4ZH;LS%7?52]5?Q"VGP\VY?P_OU0/_[4HEW$J M(/%#5#UY,@.$7Q5_EE]F*Q=\]U=7EQ>N*CQET"+E(208"(8IDO;PU#;\E^K, M9!B$&W+YN!S9_OFP?Y17UX'GEQ2$6PXTH'&6DY(;13QJGM

H% MME&B_/=_;\+<-*L?/VPV]V7]ZE)P^H;".,6ICME8087#4@2@FI%IXR80YTA7 MYG.7I0\$1SFV<&+J,[-O.R/HSZ8K96*D[!AZU]*7\G[MJM7J,7RQ^O!FOV*)M;R]( MC"$0KV#`!A*D#(!-."'@>+[Z?O[3T<`*K@8'/<^HZPOOY*NW_[@K7#W;W/E5 M]4_BD9?,HK5*8P48X!HY2[6T4-.P(CD=V8.\/^O<3R5:*X"E,OCPC@8PB+/` M"G7$P;+4DJX932,#\^.":&TW['-QD27%`'M.J/:8,H'7I:;LQPY?6,1 M/7YBI`8(.>B(MX"S9J26P@D]L-Q"S/G1 MF!>.I&YARFC1&L/%&0/[49:[YT(]_;6(UIN/N;#7?+A^6VS#[ MMCCMU5U8(3TCW!+G'!-$"4(8M,>WG9#4G?>=;>N'LOZ[RBK6VYHKSU?/H960 M%RWW1QCNP^\.7P80>Z'H2X(+Y;U&'"&O(05<,A",U`-27@4O9TIT'9)(R9SM M02MOR-\/ZX=RT]>T>D)8H0D7B!"K*3,!>8/U*GA;:KUPX;??XB4G0V1MA12$2H^@EUH99I2F M5EO<(.`X'KYK^,_U-=]BNNR%(+]$V0;2P)MP4-]OPMNYV92;`.$^%7OX9M&% MA2?$%)HQ#0!`%%-(PJ<`^Q%HYNWP?5/&KO/ZEF3L3Q$).U1VA67G^_CSG]7L M,.)79K33-Q04"RZPB#O#F')$8N%^F!4B.0644UU[%L@BWW/S^L/X6GK9?SH)X(WPG6G;NU`-8Q)SUP/BC>Q^[U MMG&5/&8@-675OF/(A*VFGL$?]!H2M;+`P#*;VWVS?0F3"1!Q6%WG%VOJ)%;<47"`<7&^+?%"%\@!"&0R7 M!BE"DH_8MF\N,EI;AA'I.JI.WI"]AUAF/Y'B$\(*J6/)31W;`H4?00O.-VEQ M+Q%/]6`Z.[F3CQ3WIX11%OLG:T')V)6SW(PMP/Z.-2RBYC".KO^]W,?5.IV]OE:AE4TXY=K]Y=6,N)P<0J M#;7RP@-BCV-64*?Z&+]3V'I8CO4%_=B>Q>=M-?_WU=[QK[MW M%$)!A!"%5#H6X(#`:=8\+N,B=4?(;Q=2[I,L_6)^88[_Z5X#7=5U]4\89)LT M_\LW%BQXS9YCA0!16BKE&%7'==N(U!Q$]VCN9)C2-^9C+UXQP+Q;=,NF@'W+ ME>O7&PL!J#9.`4:`!(IY*V`S>T+HW'@MG*?`KD$P'^5<\6AIZ@9;RR%F1J"!>^:9'WC/O8L M]B3_N\OY=HMY=914(((9%0@:*#R42`?7Q#186*A2`[(PHUH*;SS1]:^%O+*@ M_>3P6PHNH!(V%JT(ZX&GX5\'"6B08@2E6GVP^VG9MTKB#\'7494R2DKA]K:< M;Z]NW??YKAW7I^#37:UW.]_7N^U<<4/APVQU9A]H%S&%1`IR%NT7J"@-BXI$ M_FB^()UZMJ;SUN/I).X'A'^4<@(O/NC>$GF^W?`$";N(*3QC3A/J)`.<`J$8 M1[1!P3&76DP@R_ZV8U!P0/#?CH(JS/9U_1@F\7-.3*O["X2X`IYYI3"#D-A@ MP1Q?/6=X:NRN;_ZNLTVLE!9I5WS$J# MG+0<<*(1YL9AI2GD^&SAO('";Z,7*%92.6&I95)#'OY17JL&!Z3H!!IZ#(*MJ,B7(_@3KWZ6IL4Z"X$WRC)`)[*E`L"&10Q"BM$QYXAS%TSF--OU".1)LW*%#,$&$P8!RP1,)" M`(2W1Q,/R=106T:+UA@NSAC8CV(*S5;EYE/Y4*[ORS^J:A&+BITRA%ZXO%!0 M<("4=)Q`#&AXOTB#'0O?C7;X-+5+@=YG.EKL[VZW3W@YVIUZES! MLRL+H36RGBFN)956N>`?-!X!LP*E.E03*)^:2IG+$!Z#+7_4U69S75>WRU/S MRY.K"AML.:HYT5)18H%G5LEF#$2!U.1W1A;SN!Q)QW:4A:B,Z:`O?Y3KLIZM MU'JA%L&"BP>O@@(?2O<]GB0]F1AH):!P!`$IJ3(`!;.2,L@X:$;N($WUPR:P MKR=YN1H"^'$*)FS*\'=BDM2&U795[6KZGF?:R?L*2D5P6`*"`#$4P*3.\6:< MV*-4^[KSGIWI$*Q/O!../7TN`Q@[=;QV%/R%JXJP_'+F@NL`/:$$:";EP>7HCC29;.O[^79W/L'HO)W?VOW1Y0:RT%GO-`=#4&L*Y M;[(O#&B<6C&@\RZ8WY\S/<*<,&-\^/IMMJSC4`Y_\F.U_52NXDG4;?73(YT\ M!9(JZO_9N[;MMG$E^TNX7QYQ/:?7ZNED$L_,(Y9B,X[F*)*79*>3^?H!))&V M8TNB(!"BY?/2W>D0%+%K`Z@JU"5()D%<&/!V0UIXIK;'3&@*$HF*FVSD)KK)[&[UC M)_'I,%1&<\%W MZ!HN"W6=`ZO5P%*6__$]9GJ-#Q8;J!47T2@4T&/@#>M\E@_IB$5V\!Q5EME8UM_> '\Q(BC/$7=("(&H MD7%FLKM*X"!N&+G$?,=>]S)0CV,?/FG[#)0:8Y@'7'I//8+1P&J#6;E5*+L@ MT[MSQ0^&>7V6V>GJ>O/=S2*<5U8)81*URU"G4+2HI"M"RII%$KH9P;V*DI5N;Z@M`($W%JQ<"7`OMM5KG1DUGJ3_;Y M6]/U$0'BE2O7L<&0\X5<-SBN"J( ML]@!W>(0H^K8'(?L^>O8B&@$\%1-%0`KJ-`$6/SXO3#;[SX>)IPDI5UU;(Z# M[6W4L:%,(V"YTTTUHD.KAHE3`_L:'%2K5;/7`_7Z@X%XJU(/=6`P%T8"1`AM M9\)9=I/F"_#]]Y;QHB#`]:AB'I8)L]Z,^>WY`#QQ4>G#5@OOJ."2&-/.RWI: MS<-2@SBY(GV5&:4\J]+RP``.(18J'M[0@_5]A&WG[4Q^@LMX"90M^:S& M!L?A6V7CN;Y>/,0O_=1<-_&KXW&=.G5M0-FW_^P9%B2'FOBH#@H2CWV/&/7= M+NT4S8U>'&665%D6%82U3@S9CR89DK_V%^A[^EB0!'-"&1/"8)W2<"SL+$P- M8&YAOE%F/)4EQPDPUB"#W:*?`L;6\^ZUD>P9%0PUPG)C'6<&68$!3^VNMLX( MK7)3=4>9^U26*N50K7*+L&SN)M.;;6!V/$77H3K/$-EWJW!X=$#08(P=X](0 M(IA(JZ>=LX2F6L^ZM\>D\NC6,Z<^?+73U=UB-9G]8[EXN/MC?CU[N(FZV*O1 MKCUTGNR7!J:L93[NU@YRI9FQ##ZZXH'.]0L=GVG@%^LA^P()XU6).J:O\] MG[=<#AG(C*49T.UZ8"YG(5:IA-)G?3N/) MUMEU[N=6'>K!B3[#`Y/8.N6Q4,HY$:D/I&]G316[J"[SA1@S`*Y57#;]U>KM MO!;SZ\,NG?RW!D`)MEABR;1*(0DHGM(M1H+!7$-IA+5("C&O'M@U"'E\N9!= MU2$H0Y`:):VEUGB%XNF-NR,;T-R0L%&6NBY$I3)0GE@RZ\_%9'[8C-XS(DB$ M@>)6,R:)D]A[&FV^[>=Z*W++&XS6ALZ6>UD@J^7K'G$2O?I\P$H3`RSQ'$*N M,(!`L,X&M"S7.CK:DGY#6T,)(.NY5@[Z5`*VGAC+O4/$*NT)HJ[%P5E,AB\X M7=F94BA,YDC<:DC\S^GDRW2VKG`>K?;/]XOK?WU;S*(T5IOCK$H.0HNS*T2,<>.H$YSX@1,L``1%7)71$FD-C@R("6H4`I1`@89$2HG.S"YU]ZSW*D,`!6%0:X$H; MT/*AN?FT^#69]:/1CA%!<4N=9#=MW=$67S#;D`%0*WF M^CEJW]DQ(BX&'C5*12-B6'I@!:!P.S=/',XES"AC`0>@3!E8*UMHA2,!3WQS ML%(@;+`S&%I"B?*X4PB](\)>3CC@$+IW5?#+!`9N%;PCH@+;$0%1J@!3$'HA M;5Q)5O,V]L0#[G.SU$=XG5&0*V5!/8\[Z2@W4D`YB2OF0FWZ@1R10V!> M)2PUE2R-`MPF?'Q<1"":^^ER?0-@FZ_3>7.S;:&00B973Y#L=35;Y/V!:J\5 M<-9+:)AQ&B##NU4JY*5Z#H;AZCE$4M'7X.8_ILO%/$TFKL#%:K5IU'#;S*_[ MDO;(-P4(HD$DJ`;`8F:P`A:TYY&'R%?S35P$/8<%OW*&[+';Y:&A02F%`.;0 M1+6'4`0LX;);=ESGFI0C#)PEIT)LVU=].1S=EB2/48&31B` MRE`J/&.0(AT_N?U\Q75N?/>XO0]EJ3(,U&-VBO7:I4Y_>4"22,&1IUA;)J*I M%6'J=FWF+B@#LF801!UI%`C]W7IH>H;];I\.DG'@6/+C4$4(`(IBU;ESG,O- MLJJMU\"/J2%QK<./E MA/=0Y.7#@2/M4H5=`K7#T@%/4>=#EMKFVF0C3+RM$RU\,L1C"$@_(1`]&`9$ M1,T9*0G2#&F`76=.`%&M(-:E$*HPX$_H-:(675?/;I[?:-,M!PR"&"HJ)$6* M6>L88O%D8>E:#QTD_D#GP\L:V$_[G:V!OXI0Z_CS_]IW=!SSG@`@49QP)2F@ MRD+)%?$M%LK87*?RB`*W!^;(X<9;Q="OHJ6\_/Z-+ZK#Z!0B[GU58-`BK#V6 MDJFHI*48"M>BP83-]=:,J-[]V;E84@!GHF,JBNQGB[^+$/+`RX*P0C%!A'72 M,6B($PZTB#@I.X'NY8^>S!XSH"'/IH#4B%-%,7)?;V=3300WKY^-)!T7UC;)\!:QSVS_<#- MA%-CO,5\O>>]WI.TU[C@(UY,R:C8*8^19PK;;IZ(VMSR(6.FSY$"WL63`G#6 MJS'4?>;.KJ5[GP]$:Z,Q1DAR9+3&!--N7D:27,UWS#0Y3;ZO%ALZ#=4:;(E? M^'TQ7V^O/1K._?9L,*FKNT;6*80((IHS(=OY4$8OH+MI(7F^Z/QU&I(UF'&U M;":KA^6O?MQXY>FXXT:=V".-G!8*&^@]L>V<&&.Y1\V(K.=AV'$ZEE7"3F]N MIDDRD]G'R32:\=O8[X-,V3LN8&249]0::@'V$C,G2#M/:\P%M#H=AC,E4:W! MGD_-_219J6ZR3'[]P]U.7Q\0,("2*F`,B>>R8H9JW*T+SF!NL;,17AF5Y4L1 M.*N%PCRRN^\NLV]84(Q$=`RAE$.BB5-*Z@XTE>W6'6$P<5G2%`0U(Y;N67_X MQP*>.ZEP<$PP#&$G%;.',D>^*0BH%`$(:^RQ@P(8H-@6"TEYO?;: M%?F40807'0Z&!+G*-I3N]E8?'NY7]Y-Y2G[8MPO]_FP`3!E@."'QP'8"(>1U M-Q_G2+76VG?-O9IL:F'*5]_#FV7,!$&BI37YN9)1)'0QIZY"2 M*)H.E^/FJT664_"MYL=Y1:V/\VZFM]LLT^M?5\O)?#6YOM\4:EC_:;:1\LW_ M/FQ,S3C3#U^O)C\_+I;KO[B_7TZ_/-RO8W06&_/TD&.HUG<$Q:AADG`#N#8< M.8Z!ZN3`<&XA_A&Z)VOQ?,SR.^?#9#;]^BN%SJ_^V=S< M-JMAELRI/QF0Q;-M,P4GM,E53/H[JI_S[>K- MZR=#05^$/9^;"-):5MLBZH]\[\VB/>\(.H410&"-1QI+)`FSH)V2TS!W]^I? MH.)]L*F<"(JPJF7VXNN.2\'[12I>MMX_FYO/#\N[V<.NPDZ%WAX0MDPS*[SC M4#*%()3=XHH*2V[\4/]*%^^#B36$4YBC+[_G?F&GJ\?C_5.4_/+'SM)C1=X= MHKH@%.`>"#B6;:I[Y/U:KA^;&/BRCP?9Q MX^)>7RJHZSC3U?106>3>[PA.,2<@5=K;>(A8"(5"[?PA8MEW0".\.:SJPA\` M_#.2[[\GLX?F-.Z]>$5P!$E&*!?(HOC?@,63XO%D<-G=`4<8!'%FZIV*_=FW MO?5??MB42'$_F^7U=-7L"Y\X_F6!:.J]CL99J@M')#34M;Q7980P]GW MRT+,W/.R$)>IC%HTDX"SN&"C$(#K-!OK<]V2<(0!_J/8,4M((/8?[#0Q>(&T(DXYZ;#E#`"/8.>L)R_;7C#"BOX:C MICCBA>BRYF\&6YZ-"XQ+'C^9$,6((JE5%VFC\Z)5#W+SB>`("W6?BRRG`%XG M*[J]D5E=+78DY5Y-?KJO7YOK>Q]A/?H<+/0+00,.F#6:*\\]!]`+TJH+GBJ4 M;>0>713\[9/UO*(9"ZW7D_GR^V0^-1M74_.Y6?Z87C<;?>%3<[VXG:_?LE[1 M)_+]E)\.0F+B$*6IF"Z&T%/0!39Y`FBN^8*.+WC^KA9"19E5LW4^-7P0$8A@510D"MH13(`,R[/8'H7.\/>N^7,R51/S?/#FVE!\<& MK3F$&CD%H*/*2:H?YZM`MN<;O?=[F(*@G]VG^%?S]_JOLB^=NQ<$9Y'5RL3- M7'IJD.).MN5&/(`ZUT&#_GW14A;YV!/VQ?6V*EV7O/N2X:NPOA@7$4N\JJAGG##&7NN/9>!)`#I!74![,]1LL M>SU]ZL?EXLZ)<6V5^C\5EW?3W]L&B@=GO_Q+PN:4XXY"LH,&T\%D9HC"73RE/*2#N/4^Z:QL>< M(86\MXC"<1!7=\,GI^C\>CIKGGWUU:+KJ6??SO6;.M[Z"^IVS=_SMT==IG>%#:(L(@X0`H M:!EP7G5G$4;974U'N+&>ES2+P653S7MP5!C;CN`]K8R*T#$)K(4J3E.H#C:( MLXW!?[-N+^N*2*/.SK<1X@:DJ\G/=4O7^&\3_^?T?I_>>&AH4(ABP(QP2#MO M`>""X7:VE&0[(D;HA!\5]PK+I8K^N5I%K+[?3:;+!**)J^=VKU/^]0&!8>:M MI-(H!IT`#CL@VID!"4@FXX[.9*A1^&=4G"LBCQI,2YGD\RCT7_^SG-XW=O'W MOC/UY<,!`.>P`8P[@*`$7#$)VQD9YG*+X(XP)6%4_#I9$M7J1OT5<8J@;$!R M/]/9OR]T8N>8P)QR$%JIO+11!?5,B^TNC0$U/K>4Y2@K-XV*:Z5$4F<[^_WR MHT-D&P[7PQW3_R6!`J/^G[QK;6X;1[9_">_'1SRS4S4[R69RZWY$*3;MJ%86 M79*=._[W%Y!$^A%9(B$2HI6JV9K9A(#0!P=`=Z/1C1!DTCLN$//("MD@@)R^ MH#H$DZ+D:#-T'HZJJZOZ,0(;8:WF/X^4J>W2/!CG$(B2.L4TT/BTG6FD5.Q[.(' MW?THOP7!\A$_[T;V9?:4O8OMV@8@F8>40.Y]7$L:ZKB4&GDYX+G%PR;H+3GK MWI4'][DVKM:#LQOV)HOHBS_./$'[=!PX$(!Y;Z'#@A-EB!?/2%&2>R/\(=)# M%-GS1IN+,UD@R7YZ"UR4J9\%\DXG@2//G6;"`T0IT)()31H$K#.YUVC='3"_ MQ4$\$/R%PEPZFF$I8]]\^1C_;/>7AY.,G=9QB`>+\S3BXJ1$7#FK6>LL`$3D M:HS]S_,Z3MVEQ",4G9,SLG>;\'2@0,$#G07#G22<^[AE."N@P<+3%A')LA^I M3N]P+QDH.!SB)3@8U8[F26W*W[>JHCAQS3P\I13V#VIYG<*=[]])ZMV_DQ"M M.F$`E(!:@C@64K#V#-$H^Y9NNLZ:,5E2%YJ&LQ!1/Z[GRVJ]WE4222#N_N90 M"KP^W00JN.)64$@%0^GED':P]>E3GFO=3->Q M-PW<(FTMMH(+B1BRV%C52,N,YZ-KAQ=,NX'!+[GS^7H5$;JJJNMURN.R,$WS@3!!-4.$=M@06AVV'3NN]5+X>"XTS`MRV08N[ICQT&) M]-#.*:1HG!Q#M,?MC&@L?DC.SU\^5L>36077V@LTVHB$8( MWJX1`O+SS9_U\C:J M[7<[Y_R?2=/]_'TQOSUZ`/?H)1!&E'=6$4Z]L4!1I%H,N`/N=S&/QZ#>>/-0 M@HONGZMHR7^;_;.K=_E^WLD]V!U@YTG]!HR@H50;1#T6,@*F3!./%/\G4Z\//G9ZKTD@"M@4NPF.$Q`(QR"5D0`K>!&5`"-7EE0P_ MP\8V&/RE][47`FQ\Y_ULB9X]!9R"@)'&3A*#C"4X9<-/PK2`H)^CE;I'5YR"_3HYM`(4,B+F0> M[3/+TNVZ0ZVR;&WN]<<$WPR, M.F"P,Q9+[!L4XG+,O1SI?RT\>KCU*(P;$>OS,4[%G7RU>HH;]+$*%IW:!VKA4IAV&M270S$EL&6I/+6#6AL=UY=I MO4S&T%PO7^\$"V5R=Y^18/V`+D&POQ_O[Q<;-&:+!HT_EC?UZFX[FQT297?K M(7@#.8DJ,3-<2^PPD;;548F"N?O8!,W<40@V#LQE(IHCY-7Z(15,._8B\]67 M03(J/!*&X;@M4Z\5](TU!3%GV26/)TB9H6?WE^CD4Y`M%/?^_"+Y.%'>?AR$ M]UQB0!D7T$I*G26M1U%9E)O)8(IORD;GRHG@OJ#+^6I.U'?Q-WY4R_7\9[65 MZ/4@RU>?V(YB.]ZW8^M7D*)+3X%R@2A%U#%.N>%<*@*\(58GRYV9HPMB-*]F M1GV`E.''>V4]589!22$WJ)$E':`7=!",-1`.R]R$C1/,H0UZ#([ M?J*_WWG!%)Z]\ZZ-FV0H[2*J4W:&]=@GS*D_&03%0E!GA%?"IH01T*@&78SH M^(_:2D=J37*)%)W$R1@8@ZZ$CCT'RREE&FCHC"16&01D,WF">Y:K/4TPA]>D M3(O!9J3(O>"OPC2"'+H-?+]5\!8B150$TE``M'&*R$9&X+(#8OL'SUP,ZX9# M>Z(.U>WJ^%$]S*]FB]I+':&+V\YJ`_-+K32?QWU^(GC#A!60$,93_C`FA(<->D#BW$1:$[37 MIT#F$:=F"B?K&6\GMS_=#J9;V9Y]+0+!$6_*###,.4:\H$I@BJ1Q7GONSG3; MV([SVY%L]:\_#%A#`[C$.H[?(JFU(ZTTD4RY`7$3=&"?/)]OPY1.`;)(P%LS MP+^OJN5L-:_5/_-#%]%[OP\@"B)5"@XU0`AE#$>XD8L3>D$%ZW,G]#U>G`!C M$7KLAO<_R_5]=36_F5?7MKZ;S0]607ZO3?!QY;"H7!&A1#P1E436-O)1(7/] M^E.F2=[\OF7+0(@6W5"B*NHUVU&>#?]>)0YHPW7P9!F<1&&,&5B__RA&'9R**0N:!, MCT-3XS0D2[#BTRK9O*LZ6K4'&/'BJT"`DX80;9!0"CL+B7.-#`Z+\=-!%?/= M#\V&?!2+'")5&0;V3W,2UX3/Y,\'LQH,?-&,`7():7^.,Q=]);]9L/"<7]:8\QW%&'6P7 M&%/*:"\]%01H8+@&L)'38Y-[B3C!]$U#$VE(7`_SYV[YWPTI@$1T0XGX!Y'' M4>P-[._E)-SS52#4",:)@$P+ZKF!WC7"&@MP;BJ0"1;F'FJZ3T>QT.;PL'J\ M>GA2'/V:KVX,)C_9]'K07F$OA($)<&T4YQZB1RG"6>^TWP>>>(VP%I\*9 ML0/\<7<_FZ^2`+N?_*M^^%HMTKW%0_UJ2`>38.5V%;140%M*N%(Z:EX:IUO( MG8"09]>ZGF!:H2'WD@)09W#ITVR^K)=VOJGC$']^GT*Q][L`+918>2@!EI8* M+2!4S=#2&\9G)`S6!397_6R?KW3'=]*#C<,&CD5[6[L@30`4XF%M^UB8#S[2>,$DPL.?N@, MB6RY5"3I<$S98_M>4E*HAZ=_5P\_ MTK.=I*!MHK^.1EH5&45`&B,0+4N)M74(,N=EZY\4*ML!#'\##_!TIZEHUI[= M:MY%8QZE]2\M@E$6$PP5(51PYH5&O+E],022;-7M-_`=#P/I-';6DS;$P*R4 M2$M-!!`>0@\(E\^N5)_M/NCOD?YPIN'@Z);GDYVOK[;CKJZ?A]V\N7K]LN]K M=9\>_"UO76SP\-29=B?\1D#62F48]]91``D'BK>:#H4B.QJPMT_\9[7Z7G_( M3:[\-)2@<5Y2+$<)=5!1;BU0V!.K?>/;LXR:W-LWV-]E_N$VNU.`+$$(-ULM M(V%3*NRFY-W\JL/KC(/M@L(JPB-2L*20R"KN+&CD)"#[2@YU=ZY_6!5K2&"G MH6A%239";,0Y2>MZU5,@P-@40048QQ9[!IQH;!0KA;B@W$\#<:*W'G8*WE-3 MRO)8V*//`+W#@%#E%9+<>PF%L>T\^+>&+XN-XR)_M6.U[G`:+H33:&**) MI`AQ&+6'=L5IFIN5>H+Y6<9AU!"HEF#+_U;SVQ_IV6XTEV:WU5^/=]^KU>>; MS9C7GQ\?U@^SY744Y!B+>O43F.`*8`F-])PS!@!WS76LY8BH8K'<'W2_&A/M M<^Q1=KYX3.+T5_[?M`R>))F,!X(P`IE'J`TBMN\(H5(9__SN,RY>>T'OYP=C1HX9<`+F$S0$LMC8J]>@ MN17:8DNCMI$BYP50OL%(<7W!QL`XO!P3_3,>MOT/V0`)]%ABA!0!T#JN+&Y> M(%LC1*YO[0,8!4,Q:QADSV@8O.3Z2TVSOVGP7D\!6F^`B+HP5\X:HHCUK5(L M"4X'AMQ5ABV M2*9WVT>K;8PCW][3+X5A[`KI[OW[`])G]157__J*KGX,)SI63=52^?+;[4ZWG7:I(= MF@=%D4*.0*&QLB3JD;@Q=9RT]/@Q.([D:KV.H'>0\?6'`1GHDS_<:8JLL=GKK`7$MH3AN![BMS-+E.-S[?5`*4RT0EA);(`U.SS,: MN;0%XR?4+6;$YD[H7EZ%(*@AB00#&/K1;6-W);I'/=P).E M3_:\9U5X[H=ND4WGZJI^C"/]6EU5<=3?%RD+_0Z40WO/@68!0X4D%HP2I1F7 MW'*.VY7(<>X5Z`3]:,-R:$!0RSAP?\:!U:NG8]5XGS^+"\"G&W]$.#?$,>:\ M:J5@WN=J,[T=826TF6')<0*,)6@M5@B:``P0#62>X9S4^M.\`)\6/J,`F^Q)YNOL#A`HE\_3DEF&?,$42`= MTDF\)B6L4U!DEV*=X-NU80ES,I3E3*:-)^:^7L\6GU;UX_T?RZO%8W+.[O7/ M=-!MLCL-R#ELF;,"8N&0,G&;U@U"2F4'?TWPE=K`FD\IR(O;\5WM]R`AY!P2 M:3G2$3JG>!-\$N4`V9'1$\R6-@9U\E`LP88OJ_2R_>$IE2!);WF3=7B_*XQX M@!R'F@7G!67*.(,,YXP[AA1KL<+Y3S6FRI63?3P#HEF",RG_\/_-%XL#_&@^ M"918B"(20"&GXB$,`3&MQL:S@ZDFF+)D("YD(E3N/AO]6ULA.]\_N M$.S`B2[-`^$:22TIT]9#0@WEH'5!&9']XF&200(#,68$7(N8Y-V5J9U<]?+J MN)V>WVN(H&`%.((VE74PT&$`&HR$.EX6\:/98B-]8$VL"&`+&.T9HY1SZ2WQC[[ MPE&N3Z>WK?2!*)"%7(DY?^&'C(KYWP_UU7]_U(LX'^MMGJ,.%^%=NPA:$@UQ M5/*I(<`!#JC8I2AQFI,++8&"HYH5'OD\HW MWB<-C+J@Z_+A)_U]5IV&UWV MJ<-Q'V"O?H*/QD6$%A!HG:'>;W)K[G!P,#_-Y*39EDV&M_P:$>J2D1I?9D\I M-*![C,;K!@%;(Z%'U%I@!0%2F>;%A-.*9J?2ZWT(EE">1J#1(*@6>;UT=[^H MGZIJE_#_5R@.4.=HVZ`TT`9:0"BP1M$HK&R,!XV]O*`2:=%2,^X(*6*(,8D048JW-B\FABH-MP!,(,`VIAVVS@B(X3>PZ0:Z>U M$['/7"R7R"P**R*"V+SKL!C'Q=($S2C$8(7%&D_OOMI M#,2+!!A5RW6:ON7UYJC_4D<@JH?Y:N/^M=5->O^]R_F>PE]>!?YVN84;I/_` M@,!6D;C$N4M1I-*15MV00%RFO3@.4\\Q(04M3+?\.5_5RR1,7'_U>KU-;W1; M+:^Z4K9G3\%A$;5@Q#A)53,P-X3RUMJF(#?U^K0MTG'(.2[TA5^R]-TJCS4- M7!*EF$->:FZI1<@8W*)JQ65:LN,0;6"L#S-K;QW3IG+53@UMZZR\&,X>KG1L M&5Q$A`%F!2/<,L>4PZU2RWSV0]QIVYS#4F4>:#:`8H`-XA# M!;D`KBD/?>58T^`T0!`ZBVVZB[`8^%!]CSZ\=!0.TIQ3#NC$E],U%W:Y4WC$3NTX?N+FZYY:5QVSQ93:__F.YN\@\=%NROT6@1D$NO8XX_3]YU]K< MMLVE_Q+N!_B(ZTQVTJ23YMV9W2\8Q682S6M+65E*FO?7+V";]%VB0)"FU;9I MFY@@B><\!,X-YX"GC#-NVW/Q5B+J3L=9/0)7ZH`Z!6$^-=M%#AFV%=7UV=GN M=F)J#B6=[^[4?'AREH,(BS@$+ARW#P:LVPF/!Z=*59X:.[!%H5!W?B0*Y M[4M>;Z]INTVB^I[#UC^;NQ8A;2.0_8'<8^X4#7"3OBJ#@#'MA,:&=LNQ)+[4 M]S/+@Z%C+%JCPOTZ'J&C/$'18R*,0*/2L!@^WM\S.GVF]#S7`/L> MM2;NL_#ZG5:F:+J`,#,"$^#<$!>TRRXXDFRBI.)Z;-'!0STC:2(7%^M?611A MO7'KW9?MU]W%TRK+/8XR'7.?2"173%*7_H45$Y)Y""T6W/$3ZF]8EQJ/M9$1 M09\^J)"6@8^;:[S.KUT';>.JWL&%EVX0B0B>!N\\XCE,*S'3J)VY$\6GPF?I M41Z1;J.@/3W/;KSC>K?]OMXL_[.W6^'^@9$%'XB4B&*"9&"2&^;:F:;_E&HS MLW0Q3\:K@2B_%I_>75WMCN;2S:!HO?)2AD"Y#LP%YPTE[0P#]:6'5&:873TY MCXH0?BT.E434GS9<]$F]-X%YQJQQR!H+QG??2_J(3LDK/3&;RF$>'ET_0CTZ M8G2D&('!G`='E1=I:04MVVE`LD9/R?D\`EO&@WHX8_:J.'NOCX9HPA%/NIMQ MVO/T=L)TM@+VI<'S&:8O3\6*8G"'\^!%U>3%:R,&Y;1`GEB>\QF59K2;L!=B M.B_ORO^%B?`,.PX%S*]F@F(<=F]K&#%F5A')PJ?#@O*T9TX M':O`&=-C=`R:&'`6*V6ILT@KJEL?5`(32K6-.>8/CZJF+=4*HZ9'/\/R`B,`[%K!S"&F0E(`C]`;/$)S@!W,' MQYO=HW)45W:15-2`S$5-#0:K M&>&:'C28QIO=NU5ZQ5W>'S[GK)4#4WMT=0R,XFRH$!(L>*8MHK2=ETFL/?DO ML[=@G_DRAX$YB=:>\%]NP^(L)SS^UG\O]^E93R^.R=I0Q"K')5"N23);I6EG MI(D\H2XD@^3Y6!L?"N3TU'#KR\5RU9L<-Y='")))0"@PX85,V#B,;VE>=A0A.4DZ>[--L'[\>O.Z?S277YK-OA3V9RZ/TH#"R`O+N<28.Q6Z M#T@&+D^H2L$PH3[.4!^.Y30''E9-?WX\N3@ZRX+-:;5`'QI5(9P8;TR!G"B]K5ET\X&,"Y= M-6;(BYI*QT`8IR;%087CZ<41"Q0XT1+`6X20)!Q#.R.L]`D=?R@7YAY6%*$X MR4:R7IVO5^]6"=4ZBY#U6`\C4(GY`%)(S#M;E:N/2$D=R\Y';F5EK MBD_FSH\DPP1[@"5%:!:D^?VY6:XWG]?ZQV9Y@7GZL7QQ=]EW>=04XV2/82&X M88PI97FWXFD*)RSV8R6UKH[F-+5K?JXO?BY7WQZ:;@=5D;WC(N)28@L2T\B:,G9/%68LT8L!:L&CK_R:?FQ\7B[#H2?RP[CKY'Y.PZNY4C)@RS MED@32.<U1<7\:$N)0U[U9G-_US%A?%K.E[CPC$<4&1QDHDE4V9 M]$^W&WM67%AMADDQM5DS$L3E:TWQ`K/OY8GQ6AL:,,;(FP#,VS;8J;0NCO;. M\(AC_56E'JY3Z"__6ETU9[M-+N;VY;!S_IFK(QCGL!3.L2"I$XGN2+5SDH&> MT`''RKK*<##+[9J/9]MU>EY_R^:9`5&!]RH@DE1O3*3/,4[9OBQ7O/0@]`P/ M,=:W;8;C^5#X;^=`8.6OZ$U$N?YJ5DGJ'];;YNK@&OODV@C!7[=3MY)ZEU8( MJ6SK85-*0VD.\PR/"5;FQE`HIZ%&_^WWR;514&4]!%`D>]2\!N-1.Q^@HM3\ MF^-YO^K<&(;E`)_B[MON:HO3CZ&73_'QY=%JB:P)5&%I!+A\6L-V)`9?:KW- M\5#>"$[%@7"6'!G_<8WT7F$_N"8R:Y$,$BPE)"U+TAC>IHPII$)QOMSI.@"' M8E@L5M-#K*953"C'7/"DVEL=#%,T0!N7A\/%+0W(:H$/< M2?!:<0N<*'GG&M#HQ,Y&E8IV+TN*T2S8'3ZGGS5_KI>K;5C^S$4CSO(+)%-D M[WYQ8%0$PK4GE#GK7"XV8>V]U^:G%$X>+KGU6+`6L"&L=YOKY__5_&Q6QS"B MQ\BHO+08$8\Y-E#XF#9\[<3`*XJ^PI8EBP#F6/7C%O^_?G7^JAUH,?0F`AJF12( M(6L9E]9+V7H^%<&XU!TT>U5RZ$)0']L2C2&92^_7B]5^!>'!1=%R$+ET,S', M6,>31=794\JA4-J6?(:!VKKZP!`4!XC6[9H_TO#O!!'<2\Q/!T3K*774)T.) M2&>E5HK<&<#:E7[C,XRWCB+RP8CVBKO-,(99%_:CN.G!<^_*7V^5_ MKL7PQV*;?_?;+;;-^NM_[2Y^'W2UE]PJ"B,\5\S-&*$92!(*L<,XY8I8"U26K#B/NPSC.&.I)E5 MP[:`'!^:7[V4LR?71BX7>OEK:;8H#.3.,SU:5^U`D!^AH MB]5Y7WGO&Q)MWB,]43PPA1B(Q,56J]">8 M,L`"0A1+F]YYX4,Y/+X[86)"@!!CJD;$<.=6& M)0,-Y15I3MV55@7.Z4.S[Y>KYMVVN>P?NN]&1&L`E M&_WL?7`UX_>E:$[/E+`X:_1E;@':FRIW0Z*T1CIIM##8>T>)$*IU(@[S;>+= M'GH='ARE$<$0S;)O'#''L>GTM"`,.Z'NJ[5I51W<*>CT_MY!FLZ5O_A[>;F[ M-.O-9OTK._H7/])/MK_W$.N8VT2I+6'66.$"Y/85QJO6G`^*L]*S@[-7LH=3 M;$28"RRNA[-+J^9R?;X\^W/Q^_ZR&C;-_^V:U=ES[#G^)M$)$92R'B&"G*;< M"-D>L$X&!2J-@\Y>[2[GSN@@UV;.W?:[_OKG9KDZ6_Y87)2PY]D;1:,@?1*8 M8N&92I9M(+I;@TEY[8S91])'9%`-H*=7T?^U6ERN-]OA.I(G_7%XE887UYN/V>[.Y MV9??KZ^N]C8LVCLN8BT3A(0PY@$XIL!5-T^*=:E?:?;Y!57T[VJX%NQIS^EF M8;?=;1J[7FV38I8F>81F/?264>5#C=DOQQSC!!2G2K83QDB?T/GQFOOH98A1'D!:0P(G+0;>NN*S*K//?1C'NJL# M\_3*E5E<+:_^2A);G']3XZS?0M;S#I$E*Q=H,`0X2&T<9:;[NIS6I<=K MYI_749M?M2`NT<=NSZ+G/**K9*AF9K=VJ[XQ+Z[E\XP-^W&S_+9<+2XZ6_;% MT-\X#XH&D.(F`+(A][#WBKG0*:N$3-?Z]NWP;Q:2&.P*:\W=O:M9GV'18VH) MHQ)+*YE0ACC"VQ=G1!?K82?L91\!UZEU_)Y*?&X80DF"(-DJDG,5G.*Z4Q_! M%&]P)^Q'KX#C:UE\]T/<;I=6N&\WJ^*1)M]+MXG,.!ZD]T9:S*AC!F/5HA`, M*F;3"?O4)\"Y8#.Z;P&\=&+GA0VIS]!(@K/.`Q>*@/;"&]&>IN7(,EYZ$O=D5<+S'AO$: MP?]U]KTYWUT\2I5ZU-;^XY>+Y;?KAYQ"NW@IM.16:T>S"`%++P,5^%;B%1'L/U:ZQV'YA0\ M&58]WRGN&1."ZJ"#9TXA+]KY"$>+SV'/GQW'"O1@]?SCH)R&&D.JYWOD20A> M8@[)+K9424;:^2A5?,)AAK&]ZM08!F69SR'-,SUU_['MQY?%G.F5]#.,4+`& M*84L^/;%C)2E)^YF&#^K).,**!:(]]6+.0E0$$`HCQ#R#BD1.I0H"J5+P0QC M9!5I,@'29&".5 M"1*\95H12GDW3U7`@Z6WK4JS8"7CHZTEL/0:D M!0P8I_&,UT(B*1C53FF;O@)G;?O:AM)2)LQH0QF%"75A+6##N(UGDIW&,087 MD&8$D$<:=V1F@$NSTV?H7*O*BOK0EJP3O];7[W"]6-U[AWZ5;WL-3I-00G'" M$/*4*,4#Y;93UQDMY<<,O6IU5XTQT"VA2.62R%("8PD-X@CA3G!N$6M?&*B: MK&3+]'41AA*B'JI#]I#_;3;K_.N8E:+?X,B!"K`2C'26,976.M+&CRBQIM2S M,4/'V#@[24UT'U+D[?B,JB([V]A&47ER3(W4N8NY1UQC3PT03H4$;&V02I26 M@)A]4O5`$@S$L4#`'Y:K)_9"/SN^Q\CHK:8*Y?>F@+B"1-(6`^IE=. M#Z1!?6A+=N&1.]0@JZ7CB!FE)'!A65J_.H-#N>(LNMF7ZQBZ!=<'=Q`[QNDL M*;6DW&.7;%#J&$FXB#;UBX)GI8'O^=?9J,:.:N`6J@U#.R(PIZB22`69Z`LT MF1RH#=%3I'7QP9NC78!OSGJK`FB!U(O"8^_W=$(8?M/H!=?<:-#.\_07!@[L M;B&$4A?`C#R&$PYQQFK/J"@#U@@'3!D"D-(33>[(D8TB!%U3BVYDR@TQIB>D9T6@F^]E@[*=/^+*+S>9W@N?( M-E4/AT5JI76<&0/>.B]0_DQ;\*1VQ1;_?!A66]Q[D\`&H5M@_-VOG)Y?Y+8- MC?_[1[.Z:A:K?97NCQH?E65N#2V,*,EJ*1B#(FS*^H M(MTA<[R6=##T#B``4ZL1(ZX[@M)?U[:@7-&GH*1UY_:$$^UD;5;O5Z= M__4]?1OY_^WZ\DO:UL][;6F';Q"1E5B-ZMQ^\4ZA)%#3E"#'+*#?88X*Q`A(L0T%:[L5! M[\;XAM2+):&N/C4_;BKZ)K%U!7S?K3XD$7S^U5S\;/Y8K[;?#U6JJ?:<**1R MP2#NP1C-@R'"BQ;+M)^?4&F2H63:8X)-+8:I_0(OS^]N%7IAIO_3+#:??ZT' M\[GO@V)21)22-BW6S#HI3%(:7(LD(K;4*IRALO\JA!Y)#F^-T?G4Q$2_?77P#;"Z0!)OC-HZ7&'8- M[N<$ITG/^'?-[+"'=X[8<*.#`VI]XIC\?_:NK;EM'%G_HSVX7QYQG9-:3YR* ML[MUGE"*33NJD<4<2?Z_GH\EOL_KA M^[S=9U\_EF>4;EL-^NHZ6((MMR3^1SA05L-T<;TFQJ6J#BQSSR([FZ1#IK[W M"9Q?#X2&E7\9LU_-Y]4B_?)B//J:V,;B"OB_U>3&U[.KT:3*.RD:;(W`#%"D M2(PSD*!*Q/4__KR2.$),=KZ8HI\U(D*GOJ^NHMZJU9VUDY0L?*YE*'R0 M5*4N8W@=!V->CX%:9Q66!#"DA(OAD)6VD0VV^H22#$H#VSY^;K8",S9>3/SZ MV6B^^+VZ&8]24FDUB9[J[/'J<9XRO;:6`[^J;7`Q-`>&*,>H\8PY9D&[?`"% M3L!?&4S)]6%E/_C::":C^7Q\.[Y>*7<'E_'VEB&.BTM-8!2DT3$*M->,EF.0RF)6^`NZC M^=`H%:D,D[K2@6]L%DLB/I'92.>ZIY11!^31.K!T\H4/_7K3].@1ER?8TMBDO MMM`8O<%;!*PM1BP1,\-0U\O" MX_F2N2R=8]:C5''3T.)^K+:FM_7Y/0$3:A!57CCCM*;:,]^N8%C!$R+<*1*= MV^*T@75;V!SY,/T1M53/'G?S`NW1:V#I>COA,5':*^,LHL8U,G(L^QZ>L]SU M&A3_>VJR,+1_FM7QX^+Q4U1*4H?[_X?Q]R5!YFLH'_K]HL`QC1XQ@I"J=$X# MH#&DD:2`^H1JMDYL3O2OW,*FR8>(JNG=.-JW50Y8W[-C<_\!*$H1C:KB3G@O ML;6HV1C#$MA<+IZS##,&-A0]Z;2PN7"Y^%;-5D/J!_PO.@Q660\Y2Y?_.IJV M@!4TC620R;Y-N[X2AX#WZL4N;SL,:`NV,WH+,1*"A&JBL*;>0""X M`*WYTR!WMZC`VY".`=B'UV!ABW83M7\:/:8HO=?8=GW?P4H>S1K63DC(N4$, MPB;E"AONC[W45GKFQ1>B:4A4`#@J&17K3R9P;E9AP7=/;8)PC?J!*OFY).(\6E MC$H\Y[AC4&,NH406*^HQ:9$A9>Y%%`5-CV*Q_#:5>-T4?EZ5>`9X!*01G!,% M/>,*4M.JCLCL.Q+/<3)T`UM/E7C=%%AD)1YAG"LM$U4'`1Q+:&@K,F+%"=W; MT&<:C)9A&8\]_#M+'.2]C/\_6KJ^"OQ MXGI+O*-86,,8]\`SV&31"ROQ"=42]*;YSI5XW61\G!52'BC+%5=`$"&X(IJ0 M=C5'S.0FTYQEAEFOH6CK>"BFDI.84,("54,`(PVASHBRHD[DGI`6N:KUH MNU.%5#?9GL;VT45A%5*>8R2,\%8@@S#D()$+/NG`X6P6F[-,72Q](RE7ZQD! M=X<3KOG':I&H&=?-B-RN`K+&".U,C#(YUM)#J-NE!2A_NLMV&;"I!U5?87DL MIIZGO+7?ZOIF?E4_ZVZ_/)9?>PU<&>F0TL0+":FQ&#+9RLC17(B?Y4Y`/L2' MUV1A:/^MFL9/DZ4B[L?3<3JZ7(Q_-'?I]@/^'5\2%!-:J90BH:0U%L8HNY6@ M(S3W..PL8\9!YT*_BCVLH_*Y2K>*7R=>_>F=^3::W57S]>78_70<2*+90=AK M"J@521#2M\]+H86Y+LN$XE[]E)<]AH@:QCFGG`F! M.#)4L28]66*K7-YF#KSK3-K_&P,E1`I*F'7.H>A2,LU:V6H)<@_@S[RPJ==9 M-+B6C\T>Q4CI\G8X0]1\72"`*2.IIN;%4B58H$P5 MEU%(]7$T6^V'%5XMA4TTW@QHG`I5J-;*1N>8&2L(-TC+G7']L9[FEU(M901! MQ'/KE)92H*@)@1KYW( MVEOW>.#2<@0M5BZNHDXQ&']N1A65<$($^<7AI.Y=/0."+IFZIQ>=[\S1V]@F M<"V15A`C;RA6//Z'X-/XHM>A3F#EZT>]Z[&RMT`SSBDN_WR\KV??O]73RGW> M6GFSYLF`-#6<5%3W*&(M#@GTC7<[5":V6/2!L$V;?5BD#N63KN8%W7J.UHV5@ MQA#C#2$&"$L]QAS;5OA(G0"-1SEP^:N+UZ-J!EEYQ]/QHKH8_ZAN?B7FW0G$ MG6V#ED`X$M>"=)HK`=.6T&:\EL+] MI-1Y!YEH)(^AXN^ILT,YR44J_+R89"QS!&BGF`9:"Y:M"*"U>FX;D/"8$\Q'R?I"L,QGJ/,*XRUT5XS!YK- M`(RER=TH/,M2HUZC@#VT=+RD*PRE#2F-L(`6(Z\2JULS3JUIKGTKT`7J1=N= M2%>ZR?8T=EHN2B-=42:N!=$+\$`K1KTWQ#0Z\-3G&NZS+(,K?<\E5^N%UC'^L>DFH=RN@B'8EUI7*X%&J=UNVT=@`"@H M4?0"'4>>:V\T:L8/O,KEJ2YPSZ!D^!Y:;T/@-O$7_7L\F3R/(=7F;`'I^@8! M:FT<9"S5X3@GK)?:M1:#\/>MAT$1V8N2WNMV.U5T,BL\1\@H"X"T&/HV$0=# MFTU>=9;18"^>;P%:+BSZ4]?7LX>4O/-4Q_]T[6@_<>"&SH.BG!!@9!2.)E18 MZT!S[B*PD+F'\>?.GW+XB+`?A0ZW]9AF]XKM15?3ZG:\[<[E#2V"Y5()))SQ M2'M,K0:L26`3+']+[_44)G(%UFEUEP*@+^^8[4U9)7@S:_^^AZ^R]N_!+BGI M//!6:XH]](2T$Y1YGILBVYE!Y$HR!PNME]%/$=LV\J!.^(WVM1<0F.R$T_>CMRQ0]J*E-UP^S;?1]*[Z,'73T76*1.+?H[B[ M+Z#K^PF28TP,(A!K"3FU5ONF!BG^;',IA.'[`5R?2V@ORAL(Q+-J-*]LM?K_ M0[-[<3$>?8VCV7!\W*5YH#3M]D$9Q^QEQ(%SK-GZDYQ0G0O9]T.W7,CVK;/A MEMNM&\_SANQ.+1:S\=>'1=IV^U)_KK[7L_CHG8L-%H\[E^(>OB.DPF+E"1?& M86IL%*1KSBLE0"2;>>#]6&^/97IXQ;[9WMFG6?UC/(\??#U+P_YM-)Y>3ANI MY]*,OJ[70*P25",-K>+8"(.4;&6D1?YEX.]'>OUMHQU$E0.1=5Q7U:NJWH'IWXX"E])X*H;A&$@LGF=;-B)$EV0[V^[E;%GA[UUAV MT>OUXF$TF3Q>?IV,EV=,_B%QU#;O=]L%COMW&AQP7A)LE0+::(((H\U^3/QU M]NT:\-PO#X ML;DGL_#]J"O+*/>KKB&/8)]>N7OBR^LZ"$#;*$E@";=(:`D99>W(G;4BMSRB M\PG7>P[!`?4V)&+SH;IIK`(1J#P3B'J!+(8"^H814GK.LDMXW@^\]D)H/^H: MTLY7J>QMDF/G-[0,)`Z5,0*Y]2E=6'O7Q6+Y;3A5NRG\O#A5 MJ01.0PZ%@I;'N%(Z`%O5(?\^&0X&MIXX5;LIL$A.5>>]QY8J#4FZ_C&ZYKPQ MU391`IX.!@^NY,ZRV5DI)B`+1VTDO< MCE6([-W/\G!6NN'O5U-OC,INMGE=VP`!E<@F^FV"D46,:$B;\2K`LRM/RD-F M;YI_/:*R9'R<1+%$*.,!IY)1XXEFUJMV-7PUM]M#2\1+%&BB= M9D8#:#T%'$&M4>L*8WH"^U"]:KL346PWV9[&]M%%842Q%`&L+)?6<,T--EA@ MW>@`49:;?W262?2E;R3E:CTCX+955/_UJE)K_>EPUK3Y>[NPQ(U`=45@;2U'TJ'OE/=Z3M;A@8H@X"[>+$M89ZSW$4Q-/+ M<^3?F5@'0UKORAHDB6/T?;P8398G^C?+H_%7`[1K%X$QPA0UD%K+--,**-?N MKD')<],ZSC)JRH?J@=668XA?3ZHV_UA/?R(U?F;HW)Q#T4/G(8XS$<]R+1WD M&!NO=3MS"96Y]4"=?=!32^C,,NEOH=(RTI:6[GNQ"4G284NA!U9P3EF4K!=^ M)5&A(3,[?9%7O?C5];?JYF%2U2](2&\WEO,N!?8EBDC'SO_8,*Q]N@R>`$9T MA`],O$[`\!A:-8,F^?1;G5W]0ZX,?>J^?A.Y#^%+-<-94M*]?C',6&ZW`?H- MWR80[[CGFD$CJ<3**,E;$$1$Y.Y$=@Y&CFPN'(_*,KR[YTG^2\[M:&W.;<<% M.Z//`"R#7)@X1LT:+E(JS9HQ;7HTP-BGI,9) MKPE,5((QSFS&`"W,W;PJ:)NT?W76O?/GWZMU;$L; MGPW,)$A(,P+D=]/]U_KR08X M_/1,(``RX:%"0&A-&:&$MV_LHWUTRPW+BS(*:Q`2S&/B+M'Q#-8+_$ M_C<@X>4C06+#I&%(4.7BBD:%%*!Y7T6RN4$*XNLZ*`3VD.7A=+^Z-&J[I5C[ M;,"<"Q#_01)QRQF((2UL1D"PSV7S+H@6:Q`T["/4P\'BV7KY^)MU1]-;G@[0 M<1T7-,\`CG;.J_BA!7=/!\8PEQRXA!% M1EK.HZ/,FY%@1G+3#0LBF1H0(/F"[1\B*K[6S?+5)J.[#;#XZ9F0"L"T+&92-V_LF3J%FTH.BH5]I'FPG:GZ_KZ>7BWJZS^NOD71S"\?%O/%:)J" MY>W;5%L:!H\P],@("CT%7@EC98MM;T`V1^)Y;67V*.)#P>=?U63R]VG][^E5 M-9K7T^KFPWS^L+8P=V>;H+G&#OAT%SN5RT@K!N%MC`5S-SI+NL5C`-#T(]U# MX>6?]>0AJFBV"J\W>2-KGPU$*XR!L@8*1!46UNG6IP+QAUQ\G,L6:!]2/9@9 M6NW$M1<+I./[C<[JMB81YXQZ2"A$F&HCC(G#:J-U9[,3D,YE3[1'X1X*+)\> MOD[&UWY2C]8=&:]]+@#G_\O>M3:WC2O9?W07[\='/&NG*I-DD\R]5?L%I=A, MK%NRZ-'#,]E?OX`LTHYMB13X$*W/K>N_U[&Q(6CC4) MEEH+L7#*>D.I@`R0_13RUEC4>.W(,,EZ591]_&9'^E/`^E,C7MGU` M!E/'#5"<,H(UM<37P_$89R]G;VB&M99H.3S`8^13_ZN8?[_9%-#4-?_WJXW!\Z>=7QC,`@CB"#53&A.4+0O`:ZPH93E^H8F MMO4?CX2]0WYAH+*?KP$-O"L0)2;S7E.,X035(_U188,1S[PH\W:=0;F:+ M"Z!?;U"/03L5M[[7J;OS^^)S<;5=[:K!NK_3*93B.M5@,^7MW?9!NA^^/;?@ MU6VY/:H3>WE_@,H0Z+RSQ@',H\$BHL1J@X7F:LB)^3<&H>@Y!'"6_=G'KD_>`[ABFXA_1AET_5$HOKI_. M>[78";>X_E)^G*TV<16^F^WB:K6YT>2VZ?KJ@#B+QA%"4DE,L",,$%:AA6WV M69$)95<,QL61L<\X5MX\6]3F80"[4\CED]2BO3OT@,W6_<7!4HB@P!`KK[UF M(MKEM!H\\B8W&C0AWTWOQ#L+\F,HR)\'=>"2HF+SX=N7V=\_#Z].17B(1+=> MESM\(S`FJ,$I`D`PE#*N,+P26X34YYZYG%`JR4C+]WA"R-"=KVKWP[UNUOD' M5&GOWPD,,>%IY M(;#D,->1.Z$3E(-1;DB@?ZW\"&DQ1HXXZ!$34&HIL:^PP83DYH--Z)3FN"3L M'?++SH^P%@G,M'(*0665IY2K"@OD9/:ABPF=#!U;"?:$]?A.G=<\51&LG0[_ M*2L_*Z3RTYL"9C@"$/\CC(H06&,8K+"`5F?7D?U/@*4KUE-S)N8Q\(1WA@B. M,$8RI*AV@*9*O*2VATWV$CREXZN3\!9V07T,5KX:T#\A9/Y@[')`*3!(:":< M!9)S2G4U+DUY=LFD2XZ:](GH9-;-IW9`UY7SZ;N"-9I$ZY523XC7VF$#:_O5 M<)-]F\>O%]WH'^T)KIY9/#SIK<$BRT6R%Q&7G(\8WS< MS[&&[KM[PBJZ;Q$D(0@Y#Y3`R&AI"*.@&EN7HZB7')GH%].SY%?V5QFH[SQG M%^6`*2*4,ZNB2!"*GTO)J01KX9J+K@\SX5KGHS86I.CXQD"HT]P@:XE43%D( MU?YR`H*-Q2C[EI?IS-?^*'*P8,J0D`\_GW<'<\^:^+SK09MTYY\>#`@9HUD4 MDN8P_D!D1`]Y8RQ%"@K<>%AVZ+F]"^+I'V8Q6S^4(VDU?U^TB@N`M8`AK1%0 M<5W1#$A9C3/54'[[<[2K@`_.S*Y@CF%]U;63=KW<]SE5E3]&ET-M@O;:1X,C M`L6$85&C6&>K\5&"+^`RD%ZE_)PY/>$Z!F^>=M&6M[/Y\@AA7CXFF5(1Q4X]).YM)D@G[V(11*'YB.P96/E2R>W'^JMIN;@.,-@_,8 M>R4@5XX:FBXJT[A>PHW.OF5T>NSI*.ER0%C')]#'V>K#:J=VK_\Y6VR+YU?$ M-1+IT`M2X62K$*4(4J%!W*I!*&J-;4%N_M<$U=&0A.H)WG-IIMTENZ=JI8=& M`3O'*24:1>`,18!;R^H14IJ[GDTPTC>\1LJ"=)P]5>SCI^)NN[JZF:V+CZOR M^VIV^ZA`'RZ1@$<8U/(-05J=2M@B3@FAD@@(H:[&#CS.38&>8%BO7SH-@^\H MT9+;NT7YHR@^%ZO[>2IU_.#Q*Z[3M27%`R3F)5X2=<=L[6!(-\_?+S7!(8 MR=_[\-\WY>[EF$N;SG$[2J0`3`O`TXT_RC-N'>1G^>L?E8[7S5L&;MN\( M7#.O*=*6>J.9H5AJ5&$@%6_$X.ULIW*%_]HR,P"T(TW3UU?)MQBLB1M6ZKU1 M0EL(I-">.[(KP"Z8\@Z=Z4::_H,UQF.##%82>&4$1RIY%_?CU-QE9]5,?H:V M%O`)P9K3P!QE8Y'L@)=F:T.TYF"C`*TG<8.-$?262V:9]J(:82HY=#ETZ47. MS[G3%[#GHTYCY.98LT`)]D!X(0%T&JMHXL9=^'Z4R15X0?3I0=2MV).%;,8= M`RK]YO4N_%ZD0TD'TIT:VP7$&.7I4'#4QBYM-Z0R5=>Y$-G'P]X**4Z58#D< MN&\O?\!HJB"#EE%LH2142U)/)FRS*]1.T+\^R(+4$ZYO(7\@'0!RGL?I)>-> MC&,",*I&Q)"ZI$R3[E)MSA\X#N[78U M7WY_*.[]$(=L3ZM7&@>J+*`,0JP,(!(@E*YTJN8F4[GV\@1-GD$9U1W:!7`%U`X9WPJY2![OB7O4Y&LN71W3:U9 M'Y_)707;O#0`)DRT0I$`"D(6D5>TWID2J"[H^M0Q%L8!(!\I9I1U&.^\P2&# MT^UB5FFLA,9"*^X@8,90XE5*_#@U./1ZN5Y^>^;@66\C-*O-S5.?SV*V M;#Q[U_VE@3$ID13,I&MWJ10IK7,_<*O#)ZN?+V?)J/EO\ MMHR8[,I(K]7RVL_FJ]V*]WLQ2P'JW>_/,IGKGCQ&R]"0:0H0CY:(AAA3CRA#AO3R[Z MW/-(U7I=[*3R;C[[.E_LKA+?R^7ZP_)3NEX\;3KB`^_+Y:KZWW26NS$AI+=O M!&>)PLSZ.&%D!)(IRM0>0Z4ISPV_O#6ET9I*AY3&R((8YR!$>;V]VGQ8[5-2 M&T)\KST>K$,(N<)509)]$UXU[G2&=",/)3//Y91X]X4 MRZ-9)\^>"CY=Q(PA4A@2P@0GQLAZ4BAZ05&8'D13]H5C>WVP+J[^\;V\_Z_K M8IY4`4D_)-F3)QH@_BJ\*[[/%@^E?PZL)Z\\%;!W##C,XJX9`.FXE-!5O?94 MYTI_@A&3\RTCW7'OGRT/73FX/#Q_)#`D')12"N6Y,=0)2GS57^NR#\=-2$MT MDE+9"VP9.E_/RW\65]'4_FUY=53MOWPP>*ACYZP6D&%HO!<:HZIS0LOLJW*G M)=,\>90](C>&[5=K-_WCB8=BI[0:=A<-+8.*5%=>"`6=P5`9@5,.YL-8$2>Y MCNT)!D+/O]'H5Q:C\NYQ[Y]B>`]AM>;M1YOF(1I5'FEK`")``R\$.<<>@>Y MC^:'])!B5#DUM,`LMZ[*!+.(SF^X]2"`<]"JT3Y[O4%0UG)IO552,QVGJ#*R M@DD#HB[`&]"/8!M8DH5FAI,@?B\.-87ECKH(GC\6!&"I,+/C<2(@BYG$LC(W MM>3\@G*:NDJF[`W%4?)=B^6\7*7K,PX3XN"SP0A&C.>*(DRQLY0;*>OQ$'U! MYPI[8D5?4(Y!C3^6Z[0L%M=IS(WD>.7I()UE@!"FN8B0"X\MJ`)G&DNSVZ;K=)#38)3G,09@B1T#$#I!>*XWLCI2ZJOT$6T1UF2C6:& M7?KEK_)C.5]N7"KDZ^?WZ?+:J]B'+U&IOBMGQ_,8VC4.&B*F-4<,B*@^%5=< MHMI6EZ0QE?&M4B)'CN7`Z&90Q)?;U:XC_UNLRO3O*11IUSBH5*U'80XQ@MAQ ME0X=58/PEN8>]9N@0=LK109!-X,B.XKNOUUOOH[RXDB+(*%"47522:/M9HU) M-=]J)"#(W=U,T'SME0S]09K!@/?S9;%CXA-%U8X)+5H&$-=.K3T&#$@-'8T] M=_6ZJK)/=DW0C]HK(_J'-L?"B'_WHA=I!W[*C`*!+&22>TY(,8:;NMX M@4;9UW)-<`_3KTW1*ZQ=C(G/Q7VQ/(41+5H&"(&D&$/MH44$T[C>UW=\SXWL4E<.B=ZA;4+ M&S[/_XX;Y9,6DA9-`P"":>6IQ-@:3Q0#==Z#!ISE^DCEK\*+_K#M1(Y7UK.6 M^N)(TZ`TL@XR`7BZ:@%1!M+QZ[V5U.%<*?AEV-$;N",G=M<__O>\6,5OW_QX M%X>R:)_??>0%P2'O;%P]A?3`1Q2$HO6\4"2;5A.T7L\?EQE$)*.2\>DM""^' MT#[MN\U[`J4LSG"@L-%<,4&%`E6ZC3'47]`MV'T3XQ#O!H!]5/K]MKS;;M8[ M0&!CDL*15L%0PZ$01@`!,.60TWKC8`2UEWBTH%_9'V)89ZS/Q2>4Q2=4W2D? M!TCC'`0DK@50:N)X%8.-\Y7G6NX3#"6=CT]Y6)^+3SB+3[ARB7(B7;1!%;-0 M(&J=%96#W'!L<_ETW[[O1P;GXE?Z<54T9V$UM@T& M0<((`T@ZQ8P!$I!ZCGJE+\BZZBSQ%@SJ@FV&'\LLUU]NHLZ]*[:;^=6ZZ7Z! M0X\'3[C31&`IM$-8(,EQK52MQ[G'D-X("3*%5O8.;`8#_F=;K#=7Y>KCS6QU M.[O:?7^V2#WXQU$J-+8+'"C)$!*8(2TI8-Z#RLUF'%07=(1@&$[TC?`HIVK+ MY28NKQ&S^--Z'@6V$Y_^T>)\8V/;P#0%)B4/0,Z4$)Y*7X]7R>RT\@F&TLYO MWO0MC3.RK]4AR,:V@6-E)-!:.":P5TXY6B_S"N`+,G1ZE'T[5F6CG)-'6-[/ M5IOY.OW%;'D=_V#'LP$2@UV&`I#502<\0QT35` MPJM<"WF"UM"P9!D"[9X(U(4X+X?`I!:>8P\1,DPB9*FNYP#T/I;Q6B<>^LQ3#N(@A#@$KN2*T@(S:7DZX^ M##GZQ7?4L$.''<&[%E5!>_U.\$9*K0'U5L>-:MS^6LXJ'+76N5']"2:YG7_' M=D[)C>G&-N7MUSAK$R4.*(=JW#]:.+9/>%M(^6A(&JP<]U)`3+RMM$(Z\90; M7FEO\,L'-B^+S>2YG,&D`^[QX20T+=:JU6H6?[N+B'Y*/WWX]F&[N2IOB_4^ M./K]IA="M_E0,(!`Y2Q'CCKDK&$$5Y?H6B=)[N;VY/W*J$'I-\+W`01XALR) M=$-?NK+OTVS3JEC/RU;!0R$@QQ+::/5AH:7TII[NQ%]0L?)I4+0_69Q)]49\ MRN_+5!WTM^N(^OS;/)E<>TP?0C;7/V,;_VY[6UP_SL1,XZ+/+P=`D_M5$V8A MQ=I+`'65&F\)4+E7H$QP^S<-WD]+GCE>B/9KRW*YG2T^SG[\5,GRN7LB\W4! M@VB@P30DXS0CTJI'^XQ;G6M!3_!0]7F).Z*0!F7CQW*3)E?=N/!<<--9( M#QAW4&BH$/*\ZAIPV3ZN"TVZ[,:@KNCG1'JVR2-,/?T< M$4@%W@\6N#F64MBF??A_]JZMN6U<2?^7_0%G<;]4[0NNF53E,IMX=VN?4(Q% MVSJ11:\NF7A__0$E4W9L2R(ADJ*9F8>3,QD`0G_]$>@&NAO<>@0XA(X+$=TL M@2G>^?X`^]2@5CC`,+)AK(9=J*4/.OY:*./]/.HK?E3EV>O7J/U\\E#I(KL^ MQ,GZ@P0B@#8F?HN60D,)4$@_W$-3I*'PJ<0<8,C:,(C9F6Y.\'H^K2]G>;:( MRW=>)F9^R;/+J.7E?RWSR47QM5C'&=7W@YH-%N*B3X@&`I:/X0DN%!&H$A*! MY`J,\._KG0.N4:%__/M3[<2I?]_^]?._?>C_`NS;;!;_ MP^7W13%9_>.RN-TJ:A=4^+B:EUB^FON^B?E:_CK!_.>J-$XF_];[LZY+]2W. M.&)>YV#@E6Z!$<2Q98!3"\OG_#"7$C%D,2>:`.2.?2S=2/KU\B:?K&?YYZNF M#'^,R[N(6M%Q>M\/0-/J[P3@K1-$,Z@<\!(I9S>U#C=8&GX37](.I9Z_ MQ'1&9?1Z*EA#F!]-3A=A<_%[CW%AM%`34:,0$()3M4%?"]19F]48H/ M0">],EW?ZVP6M];\ZTV>K]XMBO5=%*\1>X\,$:@PCBO*`9,&`$L-0[J2GB/= M6S&>M\[(=G'N@V75?K'\?&7BAQ$1W-Y%?[[Z,EU^U_?E__J-.=K$%&@P6O`0 M&`7C1N,-0(IKBZ/5_(")5C+U7F3(CD87&WYWD'?N.;PKBLE?T]DLFBCOXR#S MZ^DNJ.PL+L*!^3QJKH;/T&B0@LL(14:DJ=?$`QO5>B()46/\)]SA?B4+BO"'^X M8X`4``:$=-Q2(2'%S,A*6AIQ^%U7A-HL*#J$NT]3]?.5G\ZGJ^C^_43`E%0(8"1&5'%VWX(UQGT?:;5G%ZNU!ELN!11 M&@[*.W:J&*EDBSO[B)YM[4+A->N1-@/Y7`1JL1XIB6LTQUX3[IS$QCJF*WF1 M3-@F:&,C*/3A:Z(Y1Q./&O)N0 M9R-:05I43M$*F+W8.67<2WE-6DG_-;_>WJ8>WG`.]@L>>$HH%]@BIW44%-C= M"BN]3CUF&Z`UT\.VTR;4O5!J.[VC&\TO[0)R2DKJ`-*,$*:$05[L##T(4Y,T M!KC.M*3/YRPY` MKMD6`$S1\*SX5I;CFY35K=_?9M?3^?5A/>_M$$"T6X!@DIJX9S$AL;*5!6,H M,*DARP.\O&U!VVW!V,>N_7Y>5K=YW)N>7"VKR-;)9&,09[,GUXGZ/O[+7;', M9IO+Y[)N^FP]B4)NJI:46D%P4F;/]E`8A%MER5&U$6+0^;S^)*L+C_>K\L@\@//T=3 MIV\@SA)-C8).61F-5:[X#C*`QL3!SI5<=(M]+[&$^W>;#W7*X];H'C`FG$>[ M&0'O.2&26L$JJ1DRJ1DC`XSCZF$7[P#Q/GA6723^&5VJ(L[\Y=M"@]>7JYOU[,R:7C[5Z5)^J%8'MK9:H\1@.:,"NJ\](9K M"J`W8B>_2WYE=(!.:B]+4-N`]TFX&GP*5%C(-'7":088PB1:F#M\'$A]-VN` MUE`O=&F(YSD#4I]8A^M5&3?U),[._;S+Y\O\19#5;Q>ZRJF1R-IH`BNEHA>F MA<3(F\@29VATRQ'_C&ZA3>)#E2-@8-46$:G$FHI MG**6:DM]A19B8$3F;TK1K^?NVN<](AYB!E2T"NIZ,9C,)8Z8`@\>AK4=4)=)4W][+E?>@1$ MC=/:*.Z0HUHP1`%XD`]JG'PX^N8=U-IZWYLJ=PK.;RLO#@)DI73:<5XF8@B@ MB:UDB\*.*+_W9.W63()KANC;3X*C9%._J7SX#V,5-T=H2"4O[>.ETK,GP=76 M>.,DN&;8]I`$M\DYCN8.%HA09!&.ZVPU(<[YB,Y$6U3.OB2X9F`F:/?B)E]D MWXO#D6V_-@K1?L8:.Z:4)5O3]$G87CFM%C/",78RC*O@Q&`"/`[P9'$HTV+35%X:S`FZ/SA MT8LZVGZM:7#.&\<`!M$@1@(#AI2H)BBX30W^'N"-Z>EZ;@'`/@-M/]3(37K1 M-@A$N!;0&4@HPM!RK>'N$$RYU).A(7[X+=OXIV+YEE.,F"9$.!*QHM'AU=)( MI'>8^>0D]`$:@B=HN5D^43-(!Q?!#\NWFSCV<>=#4EI,R,ZN!7Y,QX_M$Z(A M>'VJ_MVB7D;0IEU0@)?G7U)$`9SBU%CC'N1`S-'42\D![B7MDR`%P?'EC8D2 M/TZE\09"R:@UK$(102N[#^B36P;-\^MR=A=OD$AM@]RKF;)>7-[$S3#.O5B7 MY0BNU>2?Z^7JV$/TM?H'SA$S!G'(*>:.&F:HJN3&FJ<>5PXX&*]%HZ5%9(<1 M7_=W6AF6&BA"I(=>0JXL57$AB*YQ=)6A@N3H(5^]\\@'P(OG@'^[_YC]LUB8 M6;;<6X>^V0#!2$N`T=9*Y+2,2QFVI!+(2ID:;3M@KZ1E11<]P'[F\&_]9/I' M+D<;C!)XM-J@QP`3*JP$`"$L'C`HGX-/O70?$/6Z(D7]".\303\S\1[G7JN< M6L.10GFE`)2'"@ED$(5:"%]A8;P;`0$[94A]%K:`?E(-M-N[6;YQ22YOYL6L MN+X_4O=L3_M`XPZ@C3-*<:AA_!E&>355A]2(-LG.E%BTCW,?B].'Z64^7Y:F M^_4BWSXMOI=#1_L$S(6D4!I'-(8@`N6QKN23.MG8&N")7]<\:AOK/KADHN]7 MW.:++_EL6ROP9GIWG$T'>@6D"""8.%6:"3YBQ[&L9"3"I#ZY,,##P[[XU![: M?3#J8I%-\MML\?TXC9XW#1H*CSD'Y8,#R!M*N`>5-,BR$=UJ]\6=$R'N@S"? M5S?YX@4(Q[ASH%<0P@HDI="6:*FU==SNP-*>I-)H@`>$?=&H/;3[8-3[^22_ M:N7HH.%(`4H-"=;Q(Z,*(F,(0*;"`D`X@O>&>CH^Z!;X`9"PX3%"PF@!8L2D M89H+((7RQAB+*TRL8",Z2NB,+J+)O^(Y\5=Z4_>-2ZJ=4_1.`L`H@X")5#D#!DR([&8$PO'O5)KRZP M3TD`J+/)?C@0*]I\D`"\<0(3%O_P0FH4S<6=-^D\3364J'_;<0KJ0^#<"5P+ M#$MA%,-<*Z6=<5:8W>61)F.JL=(^`1HRK"'69V;6D]"ZIU7'TKBV9[#`(1`: M@_*%;N0Q07*5J`$::>=D7SOH#^!

,II%QIT?+=-'3)0C9F2 MQBBI,1=,<$E@A0[&('7W'1`W>]Q]>]+"$#G:(C<#BUX:DQ0[#XV%!#'O=W>D MSB6'C@]PM^Z>,"@7XV1!M1Y1H6VW%.DHU(8LB4A`!!' M2SAT@\4KN9E1"SK^V/<#DA_H%01GG`G,,>(4HAFUO_E^#W&E2?>`HL5GD2#(:8J-]T,OP.>P][WBHY2LHN?"88YMXGF(11KI9$G@E4H=:[,RBG M>WMHG2VR^2H_E^&S^_DZULV+Q@%1)J6-:P2W$@$N!?';[898#CA!YS%A'B=: MY]M_I75P'$N@+&'ES9#7*)KGMI(+XN1R>T,T64Y0ZO,$Q9.![/%S^Y0MRJ>U M?^1G338\]?-#3`LLO:)(0FR,UEKB\IUYK`F"_NBQ>.<>1#7ES]]FT^MMY&N# M4OW[>@>DL.<$1PL70V6$A]":![DI5W9$C\2?HO3];D-+P/9SCA4_WORQZ&,V MR^:7^=>;/%]%JT--)IM:L]GLT=Y8ZOOX+W?%,BLK.:SORG*QVT.1LDU19DRO M\\GGNWRQE?QH_&`?$PA2(NV89!AKB#2/?IME%?)(B=1[^P%2NE4>OC@>&Z"R M^OA,&LE0*UPQ<<3@J=&*"HH!$86,U2BT_-$`B#XULQ3D4F'"$]/&) M:::S[_GB8/KDGM:!0(N`]=0;8BQ$P`NGJVDZF.QE#Y!GG2NR:!OM!%)-&L&=7WM`H<`01ZD1B"CDP&['$'H$8?M=[I\MP=J"WO?N2_L;!PZM M9UY2H"6($W70^1W1I1B#.W"Z?@XH.@G%!%6[^8]IL9B7>V4V^R//9JN;;#[Y MFEWEJ_N/V:I$[^!.4+M_,YO._2#VL+ MWU[XLZU._72F=1_?>-DG2"^HUH`;QH%16'JJQ0XQC MFN23+.ZC^S;Y(Y]>WZR6'Z?+9;%>3(]X)@?ZA#@[20R,EK9'PE.KG,?5E`&P M(PJ":D%M13>H]K%\O+9XZOM/V>8Z\O`N=*QKH$)9):@#0!+!HB\G9+65,\/T MT>NUMU-,HXJOP:@3,.XK'OAV/KV*JW,YW9T$-?)8#W4,ED`4MWOJC=!E?3<'C-A) MBDVJO?Q&V)2F]%=B>EM#N!>+.%,[YO#AS-,F`4*,A9',$`"(5PSC:/T]3`AAF6JW#-") M;EW))V+9Q^?_]*+K0W%YZ+C^6)?`#-:8^6C*,ZN!@A&HW>(&&4]][&R`=9ZZ MM'!;@O=;-;$ M#]/LVW0V74WSFM7E7G0(3"")H)>2`QT_M?A=Z=UZ3$AR?<(WPI>FZGVMAMRI MF/;&EB9E"'\IAT<\P\I':(!!S$"D"7"5/`"YU/O$QC;JCWSQK7BC+#D!T',= ML'RH\VKCH7X!:%D^;X]81$L3[33D<+<24YI:KHT-;W'I^[PN%>,$9^?AYXO% MDY]__+\7^>)VCPMTO&.`U&@K%=1.8<(UIU94GQ2/W\&(+@5:4F+1(;SG6F?, M>E$B:++%XGXZO_[O;+8^^/YGS2$"B*ZE,IY"`Y1`2`,K424]Q'),#S^V2JZ. M@3X7S3YF/Z>WZUOW\VX3>]J08<]Z!T`UBF)'@X`ZCWURDWZI5T06`NAI0'<15`0)PQ5_@#WBH^H!GPW7#D% MS3Y8\25?KA;3RU4^,=FRK*U9_N'^;SW]D:9TZ=WO-ZH*YZ;JX2YNY,@5 M[)&>@0N!K998.T00TP01Q7>R,CN"B[335'PHN_)D.,],G6;)P*_U#0`@X.(& MAI%6MBSX0:"MY%48CR#EIG7-UV=4$L8]<>J5'-0_\MGDJEA$68Z'%]8<(2@K M(=/`LNCX0,F8(-I7LLZD;7$HYO,;8(:*>X=1PB`['ABK)_D7=E2V[C6/9?Y@/( M><%:[8[JJAPO4S%/"%JB,]DEDVXMKLK^^@&5(C/MT@J1%$W[P6DK"8@X]^#B M+L"%1LT(-;1N.CKG>B&?O[?H,E03$KAWVR'7UT%GY>/K\DN^6A^]L>EDFP`, M=T8B8KW`6&D"!`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`>"N*U/]+Q\)%`A/ MH'626DV9A$"V'DT=ZDB]6>T[$7:B<*I.P$R0[KN'?)G]7AV/"7W]4*`XKH[" M>NV1\D#7QVW;%4XZ/Z'83S\2O@K.%",PF^?E++][R):?LEF^6=POH./*2,@*I57(JG.H0C\OW[Y4;7"`]A1-XMJ_EFMOYUN4MY MG'`R]CT>HJ<%'#>.8"2!MP;P-FQ6WV&=RIL1E3CHU,/H`,,!F;%2Y7SWHJN3 M;L7!-@%@+:-.A()QB24@*+KKS?B<%2>OI?M^+,SKQ+N?*U<#FK#._/JQ6'[* MOQRO\/?RF6"L``QBJY6U&"JGZYVGNU?B%$RHBFP'8JFZ03%!L']_=?=*S=9Q MD?HI7QP5[YXG`\<"*22A%-1K:ADTIF4RBO;P4([$$(60NA7S]6BF1`*>5ZV? MC]0R.O1HH,0+[A2&VCA(XV)G;.OH:)Z\9X"/9TYWLK9WA-\0Z_INEW]Y_W.U M6FV/=G^LEG]DR_DQN^]PH^`H0)P0JYP1##`+&1:[$0K-Z01V1%\OW&^KH76% MYA!\B6,V40;%^N6+JD]UKOL(88ZTBEZ0(%8R*+T5G%E:WQ_7C-$;E!J#&%$L MJG/&=`=G2KQQWY>_7Q>+XC];&1R*0)YH%I#54D"JHYU#/=4(F/K,$@4P?JQ( M\OG`$<6B.N-!#W@.NC?Z[]6BF&>/ZOY^F=]GZ]Q6BT6V/*E%SFH?.!=6^P@E M8`);;'14H#LPE70L]?36B.)6G>N3/H`=E%!O\EE5SB+WMU+;;;5N^0=+U"?4,:FH>L MO,]?EZ[,ZGI*N[%<3K[]_02O1?0WG4)`$*-<) MP$,0S<5I,*N+Y7PU.ZYD77JG@;FX$#@),81*.8H],JZQ-:7TJ5IOO.&`ZRDX M&-IIT:%EGJURFS_]C%^L\S+_6*S_L5D6J]T)AY<*>7:DYM#%707G2+UMSS`, M-'#4>@#:9*G"(/7F'S%!.@V$<3`+D?"*=U5V` M'G,*I3)$*Z089\`VVELX9E*71_GCD*D/G/L@E-WDZRKZ*,OUSO6M/KZ.@BOO MBP^+_.F6@51RG=%U8-Q"SB@'&&L%$3%]`[8-W.+=GW MLN^J%QM'SJ7:V?T%4%?10`QCPA"&R%FC&K=;8,.3<^53#*D/B70?JFQ[,4JJ MLMHV#HPZ#ABD3,2_G*>`H":'*`!)CD3`*<;3>X.U`VZ\+N^6^>>LF&_'^+I< MK;/%HBZ-\C8[5NGS_#X"]\P::`T3WL*X=.OG72B",IN:S(53C;CWB6Y*C8!R M&;W&^[+XS]9%W+%U%=7=;P_%["&R=E=5IUAM3[TM'K-R;HO8:+UXK*_H6N3Q M@]^JS6+^(3J@V_V.\W7U)O]4YQ16#\7'7ZKUVTT<541M?H!QP[Y$($9&"S." MRK3$SC(.1)L/E9XD'U*<8G!_].+ICO/;4O7S+W5=JKLX'XO25&69;]W?/XKU MP]VR^ERM\OG;?+U>Y/4,O8S-%W$PQP3$< MSMVMU\U+52]?ZDV^J",/EZW%QWH*3H)HB/"HX9F"%DNE2#NUXCQ+39.AJ68O M^L=XT!U+[L_L4U%NI?=_>;9\7T;IO?CLG,U*)[H(RAFNO?&6XCB+($("F=;@ ME38U?X&FF+_H&=RQK8QJ-EMN]L86K^@M,&J,!W4>1QDKE+(6M!$`2),WDJ,I M9D"&PWD([CU'Y@^-)^KD;%65V8?%XUVU6A7[;TV[JK\`%8TKO&1.*86-A4ZT M%XO%=3_Y!,V:%QEY?98EWDJZR<-]-G M-V-.N#ENM2X^Q9_S-_4W51^?OO']Y\_Y4E>;\E`*9E3O&)2PO+YW5DMB/<2( M,-^*1*ET>W*J&9KO67H)$\KN1!A?:+N39_O^LZ<6,0T$M#Y)C*FQ2[Y(H%L7Z\4W^,2ZA:OZOS=,55CZ"^)Q7^:U8 M/\2&17G?EIF_,+B2_D6!@F@>&\4,-982+3UCS9EP"2A-K02-IIRJN*D(AG&6 MOYZ-JV9TT;+\)5\?UI27=1`@MA039J*/I@U51!C0;(23&/#D^@Y33E3T`NW` MI'KYRL?,^7.;AB@/2Z&3U&E/!%20M;O+)"/)FU?PQ:F*[V)354^PWHY$%U,G M`"<\%S`Z'\8@AU7T:%WKS0J>?,?BE#,/G4#9P?;W/>_Q?R<#`Q?T$`:F2 MQBG!3)P(GD?TVZ%IEJY6II@N&`+AGLC3W2G!Q-X#0!)(J:4DBB`F*(L";&"H MKPU+)=H4\P*WP_TFIO>[?<6T#HQ3Y174/H[6*FX1>E;FB)O4 MH!>>8AR]/UP[6"2+88V[EKXGF=!8\A8P1$$P!BP2FR0+$V1>"3S\7@ M*8;3!X.Y6X/+/&3+NGA-RGG54]T$QRDW1&&*(5>&26MT1FV)2X\@ M3#%P?EOL;Q>7^JFJYG\4BX7:[L;XRO4XP\'LK._`:R%1"0QEPE"!*8TDV)7G M--ZG)GGP#Q)G'P3UV[&T/NF5+]>/=XNL7,>!N7]OBL\'SO4E]A2$DA(K#(AG MH#YM:Q!I9JRB0*2>B")3/$LP#,8C"F;LRO!<']/8=10H=Y9:8(0R4@+K.6P+ MCRD/8&I>D?P@T?WN(;X)V0Y53#K>(#BK.=5$*.X=(9)#X&4S,D)\:ER,3#'H MWRF4MR')P1LV$K32R!N;_\]G59[8"ID*JNC6]] M5,1K7'=+&Y!",\D%L0AA2P$EJBV'+ZT#J7& M[LD48_?]XSLRCFW+P'WX5SY;OZO M8,7M#Y<\3Y7U<69=VD6@2BK/N%>$.F>CBR-1QSXZ2:V7S^^/"*\K]'[;K6&=!&F\M@D8[+@R7==W$-A'('$V^`?`'24?T`_,P!8\ZT+473#U+L8%> M>FFXT\H0`U5K@5LO4F,\=,JIB][@?4&P__[;2V3C.__^]/&WG^[:_P6H3]DB M_F+V^[*:KU_%L3^!_`*&M[.'?+Y9Y+]^K(NV5V7L-([AZ8%Z+XVIRF@I;^+0 M=E9S5:YT'HV@_$4G-E]GQ6+U]2CR/]=Y.<_G_S70\6E;K&:+:K59YNI#%$LV M.^O6W[^V"I0R3"&,/[R@D"(IH(70:PXQT`J*UPFPMZ',R87M M4).ZXK)"U&WC$++>]08):D8GXH?3T3K7BOKF:91$,1& MQ0RAH=9J[YT&\3_-"!%+/D8T/LX,IVH2P;T=?1)4SG.SX+!@%&+FD`%Q]G%. M=3/K.(%@TFKG-C2%]*YAH\!^7%257RS9-!"NJ];G7(L@`HOHX2D,C'`>U$5TXI@-X]&]1"+U@JD1 M;27N6Y]TC_)PUDO]RN(_5NMB=M*X2>HU:&*Y5A[6%5$P0I@X2IK9%]?N MU$#/"#WU/K(>PR$_4G:>/N.5WFF`T$:O%S@G(9`68Q'_WB$D'*UKLTW%M1L) M-].`'RDU_UF46W>DO<:CKCCPLI?ZX/?Z\9]Y=%OB;[[D3^6F3X(YE1@#:,$D&?V=(V6@4Y0_+2,=#ICJ,<;AFC0*F$TT(0K M!3E4$)-FM!Q,,F9UCZ4()(87DS0L3XA%+&0S$K%=L1%3:Z4('MJR, M<<491,W8-4W>?#=")W)`C74]T`D'!/_R(J[\4BRKLK;"HXMR]#:+B]H'6U\; M!#E%E$9%ZYUVPC5#$8JEGI0:8;JG8\[T"7,7C&F6UNQY:7V3?\C6[9I[+G5. M=A2`Q=$T51YCQB05#FH+F\$Y(U,O:QUAB'\(#G6-=R?JIS[NFL_OHON]V>O* MG=$J2,P-5H(2[HGGGD,N06O8P>2J,B,J_#&HJKD&W)'XLNM:P&.+EIJFAV.ZN[/H>GAZ),"K"WH- M,!LP3'JS,ZAO5V[HLISYGH9!",FD]-([X9C0F`"*FY$J`)-OC MT1"7M2`CI8,60&T0]2H"366+!8:IQT7.7QOE$]'*_#YZ;_-W0YKP5W'CR@M< M+L/]=APO\I.FJ?]22(ADC>&&TH5 M5%01&*U:)@V!5DN@FT$2H%-38N>OO]\YW0:#_KI(\8NA/F^3+<9WM"+=;H^[>>424I;+-'9K4D)1[M%^_`,DJR;;(J@+K M)GJF8Z([%`0*>?(`2"02F4^__;4J[QL2]UW47X`0I?1UJ<:O@M9JYK"O1`4D M>U%K?WE_!2P;"_TQM^#:)CX?*=*F64#01($,UH8#P04A2K!ZN68R]RJL_>7^ M=QP;TP^WB4FLDX1(ZX+D0WM8KK\4B M.[WW;/>]43QG%P,]";E>+*.O%[YJV3(8*@1P0#./!0$.42I-):MGV3$?W<.3 MWM2"-0RZ,W@YIE-,P%WY^^>RW+U+RH[?N:Y79))YY[063H)DTAC&'<`42>,` MH!I/E/6X@4CF<;-I[<$\TT&0//+:>RT=QB+^"UF&*ND%0Z/E,AGC)K@7%G2; M\'DPSV`'>;]>W5W*L><^`HD'!8VY%PI#IYCDCO*C_%!I,;S?<187,0.1+!OG MZ?SAG=:O']L%0#FG<0LU<6)9*AFQ"E9R@G@@'=FQ^)89=3&ZT[&HZR+U:M-@ M`/4@W19A+:3FAEJ/:FFC$3BR^_!*N)0-\`PVOPN.3YH`*X1Q\=_$0(TDH*:2 ME6"=FZ&]^R.@28]/`VUT'=&=YOA4__&VO"L77U/.L_2P>Q\>>!#JNLY/)IZ( MHS:\01#&0S(GT'/$D,4,>&\XF.;\](H6VLCW_.L`-%7,&>4WB^LG^F$,?Q4*R>_M@4JVV4*.KCK.&0U4].Q\PGEK=!D#[3[>0=ULRH=B<5^MY$=3^63(3N<^ M`L=&:T"=A]Q8*@A04%0B:21R':^=8Q6O@4!](IT7>O/]TE=\8P&0>P,K>5%HM%X?CO9M7K1 M>L<2A-W0'Y3 MX93?V[4OO&0G*P%V:!VD]S:NQMQH8!D6#AAWM(2@LM#GWJ[,TO71AS;70T.< MP93]YU^+LCS+D(9604F!E)`8&F$0\5I854&B4K&QZ[G'[9D7_0([QHXS?$T4 MS5$\P'$3S3[#*3-&0U+)#)P>S67V=@V8_E$>@UG'-?+%6;8Y'.!DF\`](SJ> M%ZSAA#+O'1*HDL]3\E.8P1G:7@^#[S3\:14(<*Y9`(HP[G1Z)A5-0BX]]+F^]K,`>#S=NT@DY0R1(I[K.:X& MQQ%MC.Y^.]9!+RIZ[<(D#\HQ5N^^BM<[XP40<6WAW!&*TV4RK22#!.9N_C,B MR64*;5>IOAN*T_`COU*]]L[&LYD3Q$(`D:(8J5HZIJ[QIB93O6TKU7=#=!0G M^^,VVC+;K;K[U^/BD.NTZ7+F]18!,"NY$NF!%[$21"O(H$HV(_$5N#9Z75'Z M@7$JBJ3_W)3-)>D;VP;'((G8*46(9BS7>@D&78)OA MZ*Y39.DO\ZZW-O;!>CB$+PD)*\^ZST_]-"`J(,<",:(]@UAJ*$TU0*9U;M6( M&64R[&5#Z0F_,782]_%CF@PLQSF)N0?$;+SN5T64\-^ZCGJ&\%J?]\3*Y^S*:>3]I> MOQ,DXHQ2;1S"4"N%E&'U3J%P=LJF6;GT>R?PE"H8E@34'3QEE[\ MD8"<(P`K+3Q(K[JI%4+6AV2#KF_?[Y'"8Z,_X5+LUYMR\6GUS>RSB[@9)>07 MQ;+[HMO48P"&4D6H84;%?TS:M6KW#;;@JH+$IJ!4NX6Y9S5-2&%;I@IN"<*_ M/Q;+Q<=%7=5M?PC<%[`_G\#QLHZ#Q$#%DU\\62HB@(NC-[5FE"&Y5T7SS8T\ M7U8/H[()R6T^%ZM/\5!P65+`RSL/.AZ@N732.`,4)8)'Y&K_&LU^U3PC>V+^ M[!Y.7Q,R//[A`.VG,OZQ;"Q-U:6;`+SG1@CB-6'(4XOV>1^.FYA0N9Z(&99G MGB]K^]#,&/S\<[6)X_ZT6OS??F95)=YJJ6[*5;'ZI24Z[A+*3-\[NB?B;WC*2KC%J"->_`?B]WGS^OE?43K$#_Y M:CZB"WH+"'$/F760$N0UY0;K&EK#/,WDXPPK4$_(Q_$4-/&F'[6].)1KCP/Y MG+?C?]M'```1K*GVT"FM:#RSLOK,2B7.+378ON[T?TYBO6EG0G:^7Z=XVG1H M_+`LC\C^\N6A6&Q218L4QYSC3FC3:^`*:1JGK]".2D6T$%17&`D#M':$<@R;'UZPI3B&]QGH7 MM;?L0II6[0..I_UT[V"I4\QC%.=$_!MN3P4;WMM:;^N1X'$:RIHW!U(TA5U%#(`D0`I ML3S6:**LP$>R==AP6\"0WVD@P&+G.8:6P,ANAR*K]R@)2FBT_=Y^A&6O7'E] MZ1@>^!$WJ&,\7<;6=*IEX-0334%2TKD#S7W3M#DHU!B-/LE(+LR/"9O3H;09$ZP?\$8G6_8!V MOF&`@@&N`5=61\TY10Q1E:38B-P2&S/,N3$=S?K!?@R6_5!0N!>;[H)>@S/` MGW]D.@A+4>>)2."X&#F!! M,:DDAY#D)L>8X9(W*?WZ5,(,]N;\_3QXY2Y(C!Q'AL$3,<,X@00-`:AFQCV>]AY/P^H>*)6%[W[[OE8PJ8 M5%_6CZO=]J;<1-VL4@3EVOV[^+)8[7]^6^X>-ZOM[7JY](=4E6?`&OK305(% ML&?.$*+CK')0*U`A'H_.N1%A,[30>^'=>M;JF?`=0_)G144,:[@]<_;,N[35ELR]MR M^[A,#WL2E"?&>)NVOPC(AZ<(PI=R M03+\#&SH_*,U-O;/(@;5NN1[\N1'IB2?I4]&7KZ9C#4<0H0T%P2*3`U M1KEZZ0!XM*JAPYL5;V@J3*/<:1]7[@7>UA+[*,OQ+NEFO^VGIW?K0T:_#!NF MXP>"I\SC>(`UQ@HNJ5':D]K.M#IW6LSPP?#LIL6DFIS='+B)`FV&FP$GN@_8 M8T4<\R("Y9!P&`E:H084SCUMSB@0];KXWX\>)V1_9?T-Q/Y.W0>E$'4*:LZ) M!=1"%U>-"K6XE^:&5;9_X/S3'Q,F5.?L)L'OY6ZW+/?O9])C[_C[I(%C,OSS M&:UZ_4Z0EC.',%784$:!18C5.'*?'3@UWV?5US$M>M;KA//CMD[K]8V`[XJ' M;?G;1_7PL%SOG3U+EWRH2`Y8$IK9R&GW&HED;)'<*PA,#>8I_US\)^>^K-0 M[-NZXY)2`^F]PA!23A%*-RJ5;([H[%SUG9^+'RZYW.K^YZ)LO_J94P#(]M5* MX%<5#2*\QJF<"O;2$RR`D$HC;XQE6`JM)HH&J4?\G';PZ53MQ\8V`2NF`0/) M:TB9M<)(5LNHI1[M$GS:^(O6FCX5UW4AKF-L*J_-UZ8R;B>:!.8PDH#'_RDC ME6`005=)%W&\HN+B/6CX^Y)<_8`Z%66:R[F=;!2\9]!)!+$U&$,)A42RDA#( M[%3B,Z3-Y4INP9HL5#-.;<K!#]6)BL1_#KH@-#F-X6L5SVH&F9ZG1 MOH-@D28`(Q[/8]PJFV3A&%#,(^,1EKFNR1F&_/3,DL$P'L-$>4'J/]+3D)-L M.M\@,`P9QM8#(IBESG'@392,8V>QSR\`,F'-OSM3=[15 MN\"X]5$R`P5FV!,J?9PC1]@8ME>T/_5_&NH3V;?EFH4".B80P'%R``B,,0@< M95,(N6M\^7*9CENZ5+OA.J9+=3]3KL4Y&O=_+;@P&D:4(9;(48DUY$8[((UO MS(X\C)S/7NO#V'7Y<;UYKC,0][ERNUOLIT1]C(WF6Z-6LF-\^%,Y@:>=> M@U8<2LRH8\@CA0FB5%08.2:O*$_9L`P=&OEQV=FF6$L&/;MW&R@`"K)H7G+@ M!*?><8DJE("4N7?9,SS@#\O/P:$?EZ"G`J&>;^TSZ-FUTV"8%EYP&/<8YP5) MN;UKM0B*]>*(Z7@(?2N;E,:]EA M`-$BP%)1BHCRQ@"-476NBJ,FPY>DNR:6#0/ZN-;8#\6;4_&*%]<#W4VQ3CT& M"#6Q`B-J@034"4_,,S;6Y1X2YEQA;A`[;$C4+UKS7@RLW/:PN7;L+WBII):" M(P40D1I@S.KE/1Z,?WI>[5E[\ M'W\>'*-$$L5MQ)+S^'^*.6)Q'R%[]VCCQCVP9,^4:[-9G&L6O-?,:!RW2Z!= M7*(7]3;':I2O=O'U-%Y,W7 MAAK"G7L+G'MH':4.(LP%-T!R4^'"@;RJ^_)+:'%J%@\&]3B!.T_/.7 MUHCL8&]=8!6,GL*$4A0<\FZX8.[CH,^/G7)BN(ZUT50A'M..32(>X;C$6=?Q/>` M0-S'KNBIVF4$.!.GU2.^@T_=E""BW.R>;I;%:A>M8_>OQ\7#R_PBHT[ADZ-I M,9\;VP;)I>'<&8.0])9+"8_[)]'`(-58T'UDF;NY@KIT$Y`FTDJ+XNX#%!'" M(,,K)"RGN2E=9CC)>V3%>C3`IYOU[XM-*AKTM9S2F33L*F"LX<(SR(DF%AEM M)ELL]Q=5 M*6GM(8]0^LVAXEAY_Z+@V/GL&N,,($2-<@^]X$YK#J"C`O`*>85([D%SAC3O MGXRO/E:;F<;&F"N=9'A??"D;LX1D]AB<%'+O*F"2(PDQTI15V#`D#@RMY/2SV8ZR-OEAL_J=8/I;Z:1\I99;%MFGK M/]DFQ"W)06*LQ"9EHXS'L92)[""?`"S7[S3#:ZC!=^N^0!Z51(=@NU_+(BWH M][^M;LN4@2/..5UL%]L_5^L/Z18DX?++ZN%Q]^VKG9>"-N[`0WTR8`6IA!)! M@Y`UGCAF2(6NM.R*BJ[WP+!3G)U6*6-0_N2L;TSATM`R""@QCRL%U(QC:92S ML%XP#`+72,#)Z-+6&YBEFE%6WL5JL2O?15/C_I>H\]6G102I@K.!B(UM`S;* M``&,5$9B:HES"M5[%\X./NR\G8\1?#@[,O:MGDE71?WT1QQ$@UW9HG40PD&A MK=!QYCD8-R?J:IE3VI[KB4P9W,+L'^Y)*9;&W&@VMF@=C.2<.8*0H418HZ'W ML)(9,'Q%2:5[94!;=F4C/0:[#NOK?Y?+^S]746NF>%BD`*-]_9[&#;6Y<5#8 M8B\1IXYSZSGA5-26=9RX5^1\Z57_ZX&!GG3A>M"]5V4SJS:3V8Y=B:QR]E:4I'N7E-6R/;'4W>S3[4WE M<*::-/$#"`($"%B(-"-B$%5,E12[:"0,EI(WXY,Q%^U1Y>L?N^T^2[9.`PNF M%0Y$!:$5U4@QX-I%2K7`W`G./T*@.8/M=24J!^-!#L*[N^/C<9UZ-;EE9-3= MZMPBY=MZ>>+DYMX\;G>'U?^>_KPR`^VMX[*C7U$8@X.BX%#T?UP(4F"=MKDV MBG.&=64QO_=SZ]RCA([$C4'BOR_HN174??%9M!\HC;YU,!Q4JA3M@[O`B#S) M-=0FZ&?V*%,M$,T(G?[W;A],U MW+/;$;:[W_8W6U;5&5]@H['0T3"5.GHK4C"3VJF?ON:)V>LY"C#`+24!<4IT=(BIDL_H!I/K'4ZPH-8XHM8* M[O%2Q6NXTO--(E<GHBUJD$9(3KFB$]A'3]O-C< M5_?,NGQ41&PTI02L80Q[YQ'C%W0\53-21YWR\\>&6;F`#B$2<(RXK#8/E6+Q M^L,B&*#Q;QTPXH*!]&#/95Y`6),M&N_I$KD#T6@%ZB"U7K=?#W]%F"+=Y8]N M^>=RO3TAD*ZFJN/\M>,V0E2$4QI2@@^4P_RGV]]IYND3L0JK[P'D+> M_FL1@=LL=]\;Y0C?&%4(HY&6U&$M6:I6&IPT%QH#X1_@.KH#F>H.X2&DR&XW MT4L]WB6>GMP-J.6P?9F24C-,/[_)*37:2^642<1#T0')C2ACJ#R^E@`Q_T_ M?=5/$KI9/B1BOKQG01V)*:,JR-O%-V\-*YP!'^V7H*TPP0D6S0Y14ND,RRT$ MUMS+[+T8YQC*L3G"XX5S1RS+W7W3_?UFLN2U7Q+AVL0?[TY5>_8W]F[S28K( M-B."8TA@X:DD&+NGTUB(J%)#Y7/B5H1=T*MJKE1_@GC6>.R8=I0HXJ7D6'); M$L2-F$'Z1)]X&=17Y4XWF M*<`14)B!=<)*1"7V$$H<"$$S*ND^D+S\>.?0(S>&D,H4R_CTU=QOOR4.5X:& MWOJ\B)9U),H`<*Q#D!(H5V>JA'9Z!AJN9VYO.P=Y>(5V8X!`"[:FR!O%"1.BNH)51' MTEGP);W"LAFX;CW+P8]Q\(X1'R07K*Q._#GZ<(O=:ENAW][\OM#6A;@3L9'1 M!E;@$#?E_A3QCW(-LPGF>(VCQ[I`?1!I.B_OM\W^V_)N]76UO*_,;[\ZIJ#2 M001*$N8A90F0`+*D+QB9F^4U0?W4DK]_>XW3#:)#2$SN?JJ3J]-Z[L)ZHKU4 M`EO,"3#OK'8E7LR+W.*/$\PS'$>O#_']*E:"K[[__S M;;FY^5[^]L#">2.(YI:$5,N)TA#MB$2I8A(18@;K@CY=62*01H2:Z&\&`*Y'A/#L'M;&R&*)J M<0_RLAV<1C@%+K(2`;#P5&+$'.4ZDU\5%$Q.CM\ZXQ+#WU MJ5_\H'*6(GB+B-6&<&<94H@A?\%!"#4CNZ('V;A:!Z%KW`>IQO.Z7]7/B=6) MJ8V:X+T<52#M$')(&XQ5B#"FQL`EC8Z&&;TU[H7SMYO7M4!Z1&FJO`^Z.2Z> MJIR"9CA:W-Y1)=,;_S.=CBDUHSOK3KA=3X*RL,VH3I@>BAW7I[R*FX^,KWY; M8.TADFX-$XYBIJ3WN%PB9F%&V:`=L6K;+:)#*(Y7"C2EK%8<0&]^7Q#"@^/* M""FX(M:F$G=/=`5"21G[7E1$%Q+^B&D]E>;5` MV(/'_$(;<3-RGSK@[[8/3`U$!EI@-[*'^W.-E,HZPPN) M'2>13H:-8-*`M*:TL*A'/O=5RP2KZHWLZ^9"/KB@O08DI=/=G7_&=87MQA0% M&?/_EU\?U45N6OQ2Y5*UBNHS]W>#TRT7DKOZ:'7U<`4P(YI3@S1#HF MA/3E=6BT0^6,'@/V*L43X,VH1=2^1$+WD=W[^(?G\@4W)+G)-(66`7,>O.(V M4*(PMW!!@2"3ZPY.\!*[5PGM$?-13,A&!N.^L,#!,DY M(@[1`R3&MF9.&8^L<);RDC;DY-8EL MR=N:V6#-\)Q4-ICVS@LBJ6'>6XJ)EMZ62P],S*@J06OF-W$5_:[^Z62+LYO<%*.(8,B[55%=4(BD8O2R5^-PG4U._J6DI`EWA.<3) M\>GPQW+WBOC*J-FU(8708)T!ZA4S1G*+D<0E=93,J3A.5]+2,:1SB:MYY0DQ M`1.+?6"!607A`J.$W.RM":J=P8W8;B!O:Z>=%7",SF$N% M!#`/.&I4%#>%E3RU;$!S-5!;\^V:B9*/;880?$E-0ZY(^O6Z,35'%A*!\-@` M\0(C*^(1RR[*T@>;6]&TN=KHO35*;Z+1/7DXK)=QV75/O9QY"^D=(!6B!SPVCCD-7@]G*%'L@PV3"5#=_@Z^?UX^I/#MQPE3@?,0]8@VS%JMJ(E>G3KS MD3."*Q,!YA*FH@JDH5I0B10%"-C;4IZYC;;B3*WN;F2C19BJ&>Z#)*"5A1K* M6ZZS3JAJ@'%S7.&U"E)9XS$EG"IB!(*23JSYC%J^]L+]:U64.\!Z$)DZ'RN5 M%91??E=$NXXQPB"]8G$:(VEM&2;FA"@R(YGIAI\_2DD+-#-LYL^I1/-B??@. MNVA2W:Z)\^:WA998>A!8Q25IZA5"_+)$+]6:[;=(MB&R?]8;I:[U5U- M-K_^NF`J&<^6>68I44%PS76Y3!Y"[LZ>XOUO=XQNA6$&JW\YWJV7B]U/CXN' M6U&C:Y\6EJD0O)(R@#,42`!V6:`F*'VPZW=!91#V'%VN_NV M3==QU3U[7G]9.(D#LM3&_[+4X-=H=K%T'?&YH>,IOJ1K)1;=X#>7.+%V1FLL MK6$0O?"H#`6Z>.`N>DTSLA,&\!I[@'QR(4(GB>/4W7*0B_+TKITE& M!IM*7/_(#W\8OFY;4GGX/7U>@*0@'*13GC"C'05?(B>\"+FYF(W]IPZ/'Q,W[?'QN#[UNOBR=7'TQXG:X>@.4T>09TA%.UIC3\X9*D@Y MBS_,XS+-G4+1$R3,:4DEHZC<(4A9S.Q\+DQ[D(T64;MFN+^?QV76.H>C8A0> M15_5Z"`(*^GR#`_6;&E:_E9M;M=Z7-8,X_?UN(S8$.+A'$10-%#!;(I`E+1A MDEOX8X+RTY*W-1^7-<-S4H_+F`L>*1EW"T:(2QF4O6P:;-V,WJFV9EZCQV7- M<'V_"2,.>Z\4*!S`8XRH`'Y1U"76TTT8<<1QYH77+EVSD_B_ M+ESH4'1&#UH[XN?-A)%F:(Z2,&(#T*A7&2?!6X)ID.5C;J3`\CG9JWFLJ4P8 M:8;@:`DC0@G)K>;1BF(!488EEN4RH[\WH]*M'3*Z%88C)(Q$6PF,991Z@Y36 M3%O%+Z9-M)WFFC"2P^0.`)QVPH`01AM/<+1QA`*7+G%H20O5V:[DY/-(F@I# M-_C-)6%`6N8=858'C(*4T496PU(^J<,GSP% M33++-K\Q46$\XCH:W"ZU6Z"&2RA?)49M+,U@;V@F$\"K+1KURS>WQWV:H;TS M=GOX_M3O)]'Y<>)YECB$6;1,N0F!&`7<(Q*L=4($9&2E'S>7>)YB1(!BJ?<7 MYDP(`&U+'`BRE7'-]^//]B`;+>)YS7!_/_&\Z-6)>/)K)1#5E@ED!)1T@8$9 M=3WJA=NUXGG-,'Y?\3Q&66`T8B0!@@5EF;[0%M"LNB:UXVW->%XS/#.N8+JK M#!@]!AKW">4XK550;S`OEZH]F='CR];,JE49L!F>0ZB)+BL#@B4`R%E&K?2: M:8+)!2M-Y8P>]'4E+1U#.JG8OR<\$!R,M\@*&XRQSR:;LF%&%[E=ZHZN<1WY M3J]EF_%HDPG)C15,!2(9\9B+B_@C]$&?_G1BNK9&>PC)ZK;-N-06M')("*HX M919H4)>=$\1<#=DVG*[=9KP9M@-FC]CMYK#:'.-*/WU+KT@B[ZY'GVN/+4AP MU@C$+>':!6J"HN:"(+[ M_6)='=NL.4.!"'/1V$/&8@HA.)SB=J758-R,A^TN=8VL*V-_'UEH1WDJ/235R6F5 MQ"M\N2<#F?MT<8)'8K>LK_$&-A_FL42JH1P503$F+%&"!R\$IU[Q,U42!0B# MO12(A\9J>__YL-@=AA.A-ERN(3T-P6U[B]2B[#^V#D>W)`2D3(@6(/$4E0OU MTLWU!K$#_G<(:X?\?]L>:R@5;T]2,&":!@[@),=4^^>0L$3:5S__?3_6S)"R MT@G8(Y;ZV!T7:W/_[^/^D%S,AJ?0W\87F@#GT2PT%KB5+![H'"YT&S>C!-0A M#Z2V.+?54->6D:^NFLU8I/8$*EUR@-14:">T4B6YBM#$W=!=UX847J:>ZC9X0A4&`X3%T_U,':E"X(HJ!+X[*N82TNG$]1?(K@0Y_J?!O9DS%:DR.F#"D,>>ZN`, M-A*Z-\D*W!QVJ]^/:<[3?$?YR6^SIJHNP:UAJ9"M]-&J5^`HL/]C[UJ;V\:5[%_"^_$1:`"[JW*4E:2,Y/]]0O*HNP;VR()\2%2F3LU='IZ-A.:2$)]]/\Y=9P'$GW^TEY0R:E>XQF>FC-?7U%)&"?L^+WQ M"0SA_SA9):'RN4P%'^)0RDC\9@",0/E#-Z,:<3&ARS):I''='<(##CA/OL;[ M&B?^ZC>2%:6>0P`BK12:!FP@E$.Y!"]2_;@+S)3O;OOR_7/_/- M/V:["&EQB.W9[_/-O$ASN]W_LKD$Z[>=$2X$HBYV42:UL43*_900^ZJ./=7U MECXPF#+/$E$]G79&QX#R+0)^G_/Y^FZU^+_\U)G56L]GD@K*G>0B",T=Y2S^ M\X@X\9J+"969&4Z&9T'>]T;WA]EFLP_I7=G6ME4846.4BFZ^Y9IA(JG%4ML` MAO#*7)I.QX!#V&3/S\G`RF.HXFA=96W>5MK/A'-4HB*),^A@I0;*X8"=M\;U M5O?[PC;+ZRKJ]4&D5T[ZF,\@TKC8?8[8K>[^L5Y__5EU/]KK#V2>8D,10\%@ M3G5`0(@I+5/.3:A&=,]*^/5"C3;@[T-8/LY)F]5L^?*#*PL353V:<2I<`,\# M@X`Q9=:S(WAQF3BA&]7.I7O=*;)]Z.A@]0P?OK9*/*_^?1;7=@)<_#?VNJ"X MYHJQ@UW!&#>AF$Q[%*_;![9'#^V-T?>UT;M6>*99>QG!Q!GF:.R-C//`L3/E M.B,4Y0TGY\$--!_VP2YCOFO MH;84Q/M05%AO\L7=ZI#Y]SQ=[O#YE5-IS18R)!RWVNI`P",)6BN-C[8K/*'E M6`O\K_O`>*`1JWK<_]=S8PW"2JV\)M,!&$/8!2.,\"ZZ_D$=5RN*3Z@$_,7- MRGV1EAY,?_8MAS#$["Y?W]ZL=[/EL_YIMMM\]U8-GI2F,F'!Q4E'8X9]D)13 MIG1IH)93N@]I&%V\C,YWR4^"`-^O_\HW-_$/MM_6^\K`^UI!#ZO"?O5U[?$U[29K+A MBH7%^O;]XC9_MXJ#_FPUS_=!LME\5U2H7JP^S[Y\6=QL'K:OQ7,:MY$Q(64P MB&/@7#@@EBE7F@0A.;5H*K-OFW+KDIB>%I=[/I^'=DY.OO4>S(PU%&+_`22Y MEHZQZ`F6EG)*4@_G7^!)U$$EV`D;:2N[$^]W^6SW[6#^>O6BFYQ8XYW1:(:\ M4,I30`1I1VA$UHHG3U&F1LHNL-3BX*-@KTRU+L_WZPC'QX?==C=;?2V.D]_- M%JOBGNE6=%J[]8PZX82TQF(G#>7,$>V/*Q%J4C<3Z]=P_"W8;BEK7;FP7A85 M!S:SHIA8\>/RA'&24M]L+0L"%SFSQ=X;`T49D]@<(>;5]:O.KB?Y6YGM4M3Z MYLVGS?J_\_GN^/N/7Y:+N_W')VW@O-UYAM%K-E[%T/]]_WA:*O*_%3>Q^G,*LM991Z35S0 MCT5J&">2AWD3A352>)G,TZN M)TT&)`/'"59@L0B$"D1DB0M%/G4_Y@*UVK..6DF3:<;.^-)D"#(6*86,5(S+ M:!(.N+0O<-_;'5^7FB93F__::3+-$.]#46?DQU0F;3C-I/&&<&^DEAH$ET=K MK9A2UFD+C+]>L:PMU" MN@DE$W2FNFZ@[D-F5>O89I)+:"T#85%T[(003CMF5'#FB(D7/G7_[0+EU_Y< MVSW>P_@&205,3C^?@;+>.&J?]I?_+.:'!O:7>5?O MK7;XULQ8;+3#A`OOJ"2,>:E+C#&'21_M/4MSE8H>BJ-A^L$OYE4:]SQ#LI'T MSWE1%EA$&RU\I8Z!262A//*R,.8U3Z`'BO[2(]DCJ-;^+^_[\.;[]>K MNYM\<_\YWSUL5A]KI49V^NI,,NIDD!R\\CS.]9:C4**M$9M>H=*)=9U6Z1U' M9RI&B>*ZGJEQXP6[*&W1 M7OQO2*T_,8K1?[S=HS5"!^PL^==_SV?+ MW3>([.WO_(PD?BT,JW-/=W*;&9="(1+`@I>62R(AL`,^,NAD1WL4/D*WRYUN M&!A&H6\8<3`QK#ZIY4'#$BVLS MO2NVNM14I8J[96<8-?^YW"WNHQ%OV-9(O15M9>"PXXP!`^"X2*W0LIP/5>!\ MTC'>_M7:+AO#J+/H1C??9ONU_N=\-O^6;TNSTB1:I\',,62MMTS30+4,X%Q0 M)3+&T$D7U.A?IQU0,HQ8_>UM/M]]O/VXRI\.SGU:+U8[^#9;W>7O.EGAV^3L41Y?6#TI/]./JCWSS8S'/ MS2KZTI'O?+O?Y"^\UO4J/M`LWMK&"S/I(WQ*:Z2,`Q]$G!S%$5F5?'G6*);2 M`^CSC#[3&:F7UEU<7M=0W%)_:?#&K,B"E=R28&GPP0"PXY2LL=:IYV%'L9H? M5X?ICM5+ZS%/0X.9SQ_NBSW2_.NK6;4G*U;T]>I,*V0Y52"L-[,?1&GWC[=AOAN96?+HJ38']_R?'== MI6?/\`K7:LXY:*3W3C)WQ ME9Z)ZVL@%D4R#65(ZQ"4/=AG@8@)C90=\U^[]$PSQ,=>>B8:2A0+P0EB%%B* ME3:EM8KK2>\2-V:\:>F99N!>1_T%2Y&51,25C0E:6:2()4>PS<3/Q9\IN.[Q MGD[]!1RT]QP%H2D+L?M)I\MEB&7FUF MCDIIC<8>,2J<<\9[6N*C74BM2C.*:?@LO51GZG;"P&"YY/EN^TOI]`_KU?QA M4T#?-(?\5%L9%1130I#"<5@`*3C2KL0#*33IRSI;UTR=?/(6V>C1*7E]IGEE M2H)'2]XO9E\6R\5ND9^:XL]O//,,>V]P,!AYY;3U6(82,8>3MQCKS__#ATZZ MEG'O+%VBKI]94VLD;J7]++J3E&)&#'9!(8C\85;B1KU.K1A;/\[^6]U=$'61 M"]\V%[Q9*.Z]MAR4!N$C#!1XN5]G`Y*I"2+-X[9!%9 MV^3?BE[Z(W^WFJ_OZT1X6VD_0Q0Y9<$0+"@31A:YU"5NF-A)GR3NW5UKF8V! M5/R4#O*6/1_RW;\5%[6]7T=G8&MN([DWL[^;:3GU+7&>\HI(3T(@1)/H;(#A M)8:&V^ZCG!>YH&A/>M7"[XFZ2Y;_I\UBO3FD].[S>*-J%KL.>\+I%V8H2!LT MYPAK*H/20NLCNTR:2=>*'D-O:)6^/CI&#;.*SOT+'J<'NZAW3\ MYDQ*+A@C7@MN>$!@B2X'(1#$X:*H&X'!`:$1X8D]&CY,+N3IFJH#HPZAWU<@U`G$+%0VJU02"UX.`Z=#;IL.Y^-0>.A M186Q?RZ6R^;['\7^T+O5OY9V/"=RVLV79)Q9RUA0$"0F,GB,R9&+8%'JCN(H MIORSM%DWQGH1O`W3A\+#KMC1>#1[KY"/MT5HK3"L41GZ&)BJD-+K;)+M,CCY2CZ]?#8V?I^O=F,&4I)D$2:XBIK'X@C MZDB&$JD;4*-8R8Q9YJW0.5P@Z$4YE:=T^KB\#`]%4*>XG_UA&TU]=#^N*?QC M%%>AJ'W&*-/(5 MU,A+;4RTCW@AQ,$^JXU-O6AF'.IKD__:X9]FB(\]_".LQ]0*)`DW#H!@>\3/ M>BXF?3RZ,>--PS_-P+V.\`^A``B"LU199)%Q2N$2D^B&3?J`Q[F"ZQ[OZ81_ ME*">8\RQM]X0P-(=%]/6,9MZB_,X=#;HLNU\-H9185GU]L6^Q^?US\-J51J42SZ5@&-D] MV[EN)+AGSV66*VK`*>%8-!*04@J5=F)B)WW.JV>1I<,^C+R>7RO22%_/'\R< M,T8*8U%0VG!@DO&CI3Q4[\*/^5J,G@5V!NX#+>C6J]UF\>5A?QFV_5G\Z%.< M:Q;SQ?=9TXO#*MK*0L1"%;<,`'AOD,6"^!(/&9++QHSB1KR>==@N%4.=VMX] MS#:+V3(I-^;%TUEQXQ(2ADDN$7`)<=W\-."#J+PRX0WY\1$EQ/2LPG,Y&-25 MV'Z:+9KYLL\?S'3P5LG8PSP)3(KB0M=C#[/@4L.WXK?:.H!_*.=AMUON=YVV MY[FOIQK*`A9`,%`O$':""*V1+)%`C*1ZLO*W$'N@8Z`1\&$;?[+=POK^RV*U M_^YBN]3,__=AL5T\KBG.VV])>$&&/%+64LH,"!:\#D@>(T78T-3:[>KW\G$( M?@9*5%UO\L7=ZK$6Z/RG_WN^![:XJNT1XC.%G=!^1I@ISKY9PI7"+A)H=8D; M(&Q35PKZMZX'H&<:N]](&@I%5,M9+:C0GAZW7H%HG[S[C=*VO_WJZ[1U>2X# MPP8#PVRQ^<_9\B%_S'%^3'\^-R!8U6BF`HXK>Z8E52Z"3:61XHB0HJDYAZ/8 M-N\G*-@R!0/-^*\9T6Q.?ZV%C!AD&0,<0`O`PG*&RYT,B+W_B@*$[OYN M@8H!-S.7G_/=PV;U<96HQ+<:R1C5((SSAC.MO(FS1A'#>D3`R>3Y>A1CX0`R M;(F'BXCX^/OOR_7/DRF,M=O(I/!!"A6!U9YQC8D[)G/&[HE379E111I[U&$[ M-%R$#+L-/%KF+0)G2(C30X3#TW"<(`A)S:=M''C\D6^^K*]0F&<2,N8PD.,2!Q9CABBH"D)O>D!AVG+[TST!\\"I2X+'RUA8QH#YHZ@@2(X(!X M]K2#(*5+]8_'&(#L47YM<'&I6^.I_G.#AC/)=<#<2"J#(8AKCV09MP6#>/?1 MRNM:07;(S;2V>^):13OMF*&&J]B)-7F"'*Q('4T;!Q^'WA`??+.G&1%#EY',P6^>#S3F!-D$$71?XO&`I+X:#4&G!K['L4%!]UN=I\-]G#%9_S?W_/Y M[LF:V<_]NN.Z2LQ@)[4FBG!CO9.,!Z'VDQ(!+X13E87Z>BMP<($E9KAA',4^ MQ)AB'&NLZ>,1B#UV04VH:GLGBNJDQ$PS3OJ8WS[G^^)AQ0;.SYM-_.8(TN.^ MSO/?5-25J=](QKW3@9N(N@.O2##6TA*!0&WJ7'>!JNQ9,>N>*.E;E)6E8U[^ M<::0$XCB:`[6RA@/E.,C:(:G5CZ^0)%U0?,))27A>UHQ]ZO_V MA-=3!XT&+RPAGIFX?"#8(<]MB8MQ,.DX?)]35Q_LC*\.FK:,D^):]V`PXB!< M>+(/V?2LS5&HKTW^:]=!:X;XV.N@28&H=M%&DK0V[;#N?C6%46&Z]/Y:T_V4#OBBD?_-7OOR1_V.] MVGUKIL]&+6=8&0Y4`XI31T!!TD!TB55@:D*^;,O:J51FESQF1M M<.'_R;NR[K9Q9/V/^F)?'K%V^YYTDMMQSIQYPE';M*T91\IH\8SGUU]`%FEW M8DDDQ,WT2V(G(D1\]0%5!=0"`<(0`JR>T8'8Y$9UO`G%/S0Y,P0P4GKZY;99 M^D2M$0.'U#J'-(@K&!#`&<&VQ,:H[!9T;Z):@'W\O9NE5$T!^5?QKFW(K3@08LH)`M8SNI^S2Q!/AV\=<6'9->:]\NRU=SX9/E#CZ2`8@L_BJOM:C5?W)Z\YJWS>.!<$F6DQ9P[`3WR M,/HO^UFGR+0)\JL-#M3@UYE0#Y1I_U@9TV:V*6Z7JWG1/#[OX"B!:,LY`%!0 MX!"Q%ADC2@R8XQ.Z@NA';7:'?2\14C^_Z4FE>?"9`*1PACMCE&642`XPK92# M@&+2G6];D/J/45(MX9P13_[UER^_?$G'`;_/K\WL^]&8\E<_&S2.RRF^E`": M8\RP0]H]VPE^0EJM!3$MVT4S4^`?9JO;HHZT__K!`'GT;#UG7'!`$1-)KY8O M1VOTM7\[&J5]49\%98:<=RUYGFI8S^Z/"OJ53P;IN+<&6^4H-\QXZP$O7X^; M'SN^O^4;XG8E?3Z6O3@[\_\4UQ>+J^6WXDLRG.>;..O3/L[AIP*"1#KI";71 MCM=,`4!`.4>%>&XHX0@O;=OC2_NX9FP3O\UO[_X^+^ZO]7)Q?9@#ASX:,!`B MNF\:0V,5D%AZ5KV@X]EQ3B.\$6UWHV@!S`QINV_%ZC9YR;/5/XM-J@%Q5.*' M/AZ4=`H+;Z.MPAFV&"K,JADSF7L#,,*;Q':EWA*@&9*OYG&QB*[P;)&Z02YV M%Q='&7#JL>"8)<(!#R&B`L+4HK2R5RG1N=W%1EBXJETFM`QL;XDQ3W>_]=)> M7GXV6D&0.PB,8L0BC(V'OMK;N)6YS:Q'V,:F?0OA7#1[O@:L?OQM7JSB=]\] M?B@>BOOZ-X%'!@C1">9,$HB-MHY+Y9@KSU@\CVIR.IY)[Y>![<$^V(W-SU/( MNAD\.$[@F'GB-/3$<&")Y9KX$@?"]80./MLF1IUKG)9@[Y5^%XOOV\UZ!PBL M?T_X\U-!*":,Y@H19*P`,"I]5B%I8:X/W9A:?93K[DCZASAV-MI#,0IE,6K_ M5"``6\T=QP(PH@@0DN%RCHRKW$)GC<]KI\VH/+2'8A3.8A2N3B@4MI0"+XVS M//JJ4LMRCH!FAS",T/H:CD]Y6$\G+5UJAPWUDEAF,83",8;*>5N4?:0PPK/D MH>(6SD=]&+8-VWF/&4PBS(:(:#-@2!07Y8F,IT:S*=EG+7.FO=Y[S80P#$V[ M*L;N*=644LB--HZF#N^FO$CTB,G=MM(1GZV+]979?I,(Z+[K!--KVC@T4C+71G7+1#&;6".BLD7LD/&!8 M3KI:T0#[7HNR&$@+CZ*QCT1&"(^!I`8;#V3TX&B)%-9P0L[,*%C;H6RF94MB M;Y6R1%`GB%6,2F%].7?#8>[18..XG=$W]NG:DFPFB.%RP*.E\GDGJ_G5?DYF MN=Z\KR3P5.+,&L:L(UQ*Z(0D`E,D30K5@*?K)G6#PS!)X$)9%M>`@)&Q4'IK M`4(E%H:1=YH$7ILA9R6!-\-^&,4U1!UZ[CUWB",?C=%HD1H+H2YQ\9#DQAB- MD),=\:65>O/-I#`4._/KS5-J":#46RXH=])9JF`Y/X[%A,H1="S_VO7FFR'> M2S9EA_7F-<;`*`V!1]!%&U"*Z%/O9RL0FY!F;4'B3>O--P.W#RI]7:Q(<'R!@P&:RXT(Y0+*21SP+$2`E$PH[XYE60%C'/?8E)M*XW'.S-W$'<>XFV#W>TPDVB7:Q MYEA)!].L#2"8EPZ;A-K2Z?!L*)?A?-1;N3[]7*RNDJ!NB^7-96KG_&*#;GB! M>GJH@#E"%F&O"/`84F6%L]4$)9B0)]JRP(_>EK8.?.O,^KQ:_N-E<^I/?][/ M;W=2S&+7X>&"-9YS(X#VP%+)`%>F0E0Z)Z>S<0W%L-;`'T9;?BE6#_.45K@^ M=OQ]]+E@D4&,>RNUU5@2DMK`5Y:I([F1(&_BSKT-DG6!\C!LVA6V*-:;QG1Z M^6!@%$N'#*.0$>PLX-''*F=*J,P].GL3M^'=\ND,F((D(S#U'JW_%+9_(MBAN4SOB2=&M-=B'(9_Z MMEQMYO_=B?;3315W5S3CWL%1@K#24<2,QAP#@:.MP$KO27(J;`+E(8\L=BDU956E1V6UPN7P1^PD;4K#=DD"IELRE(K*`< M(V*UJ\Q?*9G.)&?]RB!_W2PO)\?13N0P#$M?CT)KQ,K7APC48RL,UPJE7M3" MQ"E7<'-FRL9;9#K7FA3]6@%\N,#'W:]_FV_NU-75]MOV?O;:B=#Z(IK$ M5\5Z_7X[Y(BT?P@JF!!0*"&91Q@Q%!6=$`;S$F#L\H5K0PQ!\*$F]U=5P>[O:V>^M;>_]O%)`2G`$L$9$,,N` MT@":4CH`HMP`A!$JBE%PO(=UUX'8W_JB/#^+K>-W"1YYR3&VP!F-!/.,4U'* M`RN?6UMAA.KLO2W#-N0]G/?YMV)^>QRV4/<[ZCT=-KY31]-;+*"1 M*6T267A>>M MI0PY9BT@GDI%J";E_+!$$]KY.I9_[2R\9HB_I]0I+8C#F!A&F,"<,8QTJ6\@ MY30W%O>-<+$A.]K)F6H&>1]DW)>>.2,SM.8(05EOC"68$HN0]<(EH/=S5RB[ M$.6;\%7/I5LW&/?!K]T220;OK\7R=C7[?C>_FIWJJ7'PF:"<1C+=M4+-HL_K MJ2&XG!]19D(A@C%JI4(078B MR@B57PLR_I$U+:%:GS7KXNJ7V^7#_UPMMXO-ZC&1!I>_)+[@%WS9_W/XW\^O M$./Y/X/#C`I%<5P?BE(EK;&\?->X*T_)X3M?7LLSX>M6U!\_'!'UQP\A*E>@ ME)!:68TH$);(2BURFAU(.D:UT;JH&\,WC%-^L+UY(S?]<)-T2H!GD''N&';* M.B9H17=$:6[@P`ASRH8Z'FH+^UX*Z?S\IB=MD8//!"($%DAA!)GV4B.(XA_[ M^3'*>ZN0/H1GU(+4?RRFTQ+.??#(_6L[WSPVZ&;]^@-!8YA"7AGR*NWM3"(L MJIEQ.R%KM@7I+CN`M!^E]^>F`55>^WA4Y7$Y&:\5DLA"A3@6<#\K1"#)/7\> MH274/E%:`+0/FIC9^DXMKM-?B=H/L_N4*'&2+L<>"YPYR3'W1EOM'*:<0E3. MDK/L:XL16C_MTZ9%8#,*?U3S:;F#-I16>(<8\R)-`7)&2NV,-."Y'45'F!/? M'B,Z`+:WLFH-E<_!9X(0#C)H',<4$(")=`I4\Q,@]]BE<0GWMT2[P M,,$:2JDBU$K,@'=*.^$J%)28=,7;LUAQDG.M@3X,]7Z,?CV'?R?&"M`#QGF$ MFUOK`81(45GB`:V==->S;DG8+O)]QV+OU,![B:UFFE"'D*-$4J"]PM0\W6UP M8)AP)^M6=AU;_;$H2]FF'/(GV5Q&:>CXQ?^L%55]=(1`(($44B:9CWZD=LQ# M6.&5PFZ/%DD8G?@DP!=%739 M_=^+V2J?TAV]0D",<2!!`MHRR[47E)7H"ZQR>W6,\+!FD#4P#K'UNVB.9=6^ MJL_FQ$8*%-.I`!9S3%&/LJ;$E^A8IE!MR5+_4ZT0YV2;J_3+NMV)V MO[DS$=/DZUY&:*]3_^F<#;/>4$%@#+02<0%B(P77&OA*KSB+M5\. M=@)_OV1T-S?1.?UT\VE1//>V^+R<+S9E!^S=0BNN6V1MR]\9H/98I$K.'D@B M!41(Z4H-+&_KI?7\O9@F7ZT^I,O-VM9HO;O5L/5_7(6+3 MH0*P$6TOK11$0YV6YKXD4[*4N,V^6P?ODXL=X]_OIEB=8;?EX#<9,%`C%)7. M"F^9VK4\W9?`B\AX"7,OW.&[OVSK4`H]&Z_[+C-E+,'L<5>J/L=W<]O'N-& MKZYVF9V#5M\[_F8U@D/J#1`(U\@:%EF`.8DV/G!88L8@YYI8R0:*"SDAEXK) MIVKN-1HG`"&X4Q(JX2#25`/M2(F%@6I"*6)MDV/9'^Q]**KG]X]NR;_33>EZ MMY6NB]5#=([C>YQ(FZXW0!`"6`40%\PYB3`V/H*\GSG2)K>;V)LC7#8C#O*N M1=B')]S)O.DZCP<-K=(I&A,3J3RTTCA5SAK$-3Y%LK5#@T8LRT*[#XY5;^N7 M*[O<_KFYV=Z7"_!DLM+IAX,$J<4M`T1J@;&6DFN[GS$EUN1&H;TY?C4EP+)C MI/OFUI?9?;%^:A_:C%<_/Q@H%$IB;3"'W#BC!*"^G&E4$1/*Q>Z-4V>C/(P^ MW.5T[01V.?M/>41W@EP-1@D`*&$,A\9YYI@`FK(*`TRRM>,(@P\[95IWD/=+ MN^-6ZH<:R9F-QPHX&B,("PV@<@X@;Z2"U;8N?6Z*PJ@WNWZ\@6XDT`[:Z/L+)C-&"958ZPJ3U%L4?.'!8E)@HA;*/3M\N M*S/XLNQ;#L,[K?L0\VRO=?]\X`8"`ZPW2K*H*3A7IES]-/Z:&P+5F'_?=YU. MOVQFJTVG+.R4&XT\V3P)#,\\&"\8`5S7"`, MA;22`Y^Z*I>X,,DFE%<\'DZV(XL1<727A%#JF/,I^I?A`F;"8^0%)SY"CH!5 ME15/#043JDDU0H:>(XKA"6J+Z^W5J5H,=8<(BG'EK`8<&8M30W!%7#E[2$YW M]CH[K4D^$7&Q:QQW??F.^)@MA>$YV)8)"0B2AGKI@)#002NI*_@#V\Q$8@XD4JT`.ZM]/L01BFA5&:8 MX(_GZ*+:YT2-0L8:CYI:;B&`G"+1VW=Q81A6IG=*R9#LS0<=^@RD.7$.!HYU M+83>=I%/-V:V6NU>?I=CG*I`/$=G?E@N;J.U\2U5)!PRG*QZI1=E\&KL(\<> M"]@E>7@/N2($1C4AU),Y(>(O!@VT>U2OK!]?5CGX=;7.'XJ$X MU;2KW@"!,ZREEE1R@YREVBA&RID+BW+[:(R97:T0X3#+VD.[5Y[M=0![K_2[6'S? M;M8[0.#I%I>'GPIQW2+NB>58::X]44"+@!E]WL8,]5:H<2/7Q]4-"M-_-O MLTWQHC9<#O^:#!,42ZUQT\F1C0L/2H$0*%&PVO=6]/6A6/VY?,OTZQ#U/KB7 M#LHW^X/R&@F6KWT\(.0%00X2BH&-%C"D_-E082+79!MAN$NG_D`+V`[!F)-F M_^L/!(\AQ4(*(B5Q1$3/F\EJ'\9D0JUESQ/L"99DH7F<)Z]VZXO?%Z>:[B&. M=N?[\6/!:&D-5PP3+R&EFEI9[:O6`#Q=,3>5S+(U%'LI*E,LYLO5+E;CI&7R MTV<#18(IH.3_LW=EW6W<2OH?9;`OCU@3G7$">&(?-^66-$6E'U0 MXX_Y,M7N*J^3S$?)\<;3P44A%'5QWM08$:(9,+B6B0H^H@3:ENG1',P^")(Z M=S5?KA;K%/$ZXG*^?C@XYS'VD`K$.4C^N?)UL-T@GNTZ#+!:?Z<.9V-D^^?* MQ^+;<8=S7Y-`H*$("2,TI00[#+E1M70NRC<>7Z2):@^R)!O-#)?S][^K3?%< MEVZ[\].[NJAN2NSZ4!7S@X[H:8V#$\@8+SB`&'#A*02H'CO&&YM;"GGPE,C1 M8]4QNCD4B7][J+#\I!/).SK,C<.M`O4`4*D!PTBEN$PTJKNAPFQV(J?M MDJ)56#/8X*OUXI&6FW^>].+PPO6DM@$)A+BP`GH./W%:X\"P`I3+5"R#>8DMXX;LO"R/`<<2U.:!J0<='(69IJS`$MC-(,[("A.C(!7#K5K.-K'-H,<3SV:T\S%@19!1W='(Z8P0=)!R!$!NXD0$YF[_!C@]3RM M4J$]2)OX%F_Q\#3'8G_+@+@B6GF#TK%=9XTPCZZ1LB@W2C'`ZV^Z\2I:@[;) MQ)$W9^PQ:80#))5D$FD.(A@`B)TG1`#+#F4.\!::;N:+5G#-H(-*O_EK^("..-PQQR82HX$)0BRQU'+%M96/;T$_G\7?38O8EZG-SZL`4#S?#?CBAPFK3KPZ46H(M8`80YR%`VO.=.RX1 MRET&#S!&TM/YH5[TT$]N83%??BKN$RYO9-$>3#(\V#(XSSKG)Q%D*UC3!9IFEO/:H`S:.\5#UZ5F=K@= M28=^]7PPC'ICD&%&(!97(!;;>N_+8IB=AS#`C<4+VJ?FP#\A5-?EC9Y4,WHH MWZ_FUQ_B`$FKDFFYNRCUR;&[EW>FCJWP$>30&ZH\A0Y2#CP"'D,D`,>.&BR. M9H5V+.DA+3U137S@8S5?/+_=]M3J2$W?$0SD<-8Z"`FI\YAPP9AA@E-&02TS(WB, M!Z[[X\E)U26:Z*-7#K[5YZS*2R]:!T9UE`P3IKF"PFL.$*UE)EB.T0"VP8`3 MBBTU0_I2[%KNQN#IM98.-`_8`*RU`4P6`PUY+C.M)@2D@QAB)&,)$VIY*+F;M.J]GB"PT3FE& M+2-..Y7VRVH<7#0$([1_+1&C43W#\V#OE7ZMU3.DBCL)@%26>@4\B`Y*O6AC MF/+L[>U!URQI5_MG5#0\#^U+,0IE,0K5M8`8`-;Q."*U@)[2B)VI9:0>V[[F MT7$S*@_M2S$*9S$*UX4:,(PNJ226:LL!!Q9JMY51"VYS\_^'',?OG4]Y6/?* MIP;>ZEDI&&V\)T!"(!`*8""\2;>;QW]K')&!O=4"^T>M)BZ@N3Y&P(-8;\3> M3]C\.=HV&,^L-=`[Q+73%*1D@EI>!O6_`\A->?+R`ON6-=('`Z_F=^5R]7PV M.BF%Z'##`)'G1"LL&-!<(8<(W,TVR.OR=4J@M='M)#7HTV7DSXFE?$(QU%$7TH%5> M6P6HD;Z6''&>FSPTTG!P\VFQ$[5D)#S:K7),]2U=Q[Q-.3K4MSWIC^=_4>`D MKN&D]]@HPP`BC*HZ/&0$'=.]-6UKN^H1]SZLG%XOXXA:+J,0?T[G&QE,-5_% MX9;2]ZKY$FZ-@0)'KP%;H\06DQ1NR$WN'J#]ZXB+ M_8'?2Q2F6I33F[F)-C]M12<)$BK+79_/\^=ROBX`*`'B@$'+0!RHWE@$:U2P MQ+EGN`<84^F8DCV@?WE7,-L%#!1@QVF*K!."H&=&XAI6:XG.W6X]OPQ1YTN* MCGG6*LX]IHE'5[>:IZ.JFV_Z[:NY+:*U7E[-G^2/[['A8\L/=P("!>/JSV'. MC.>;S2:%C,+(4TLN?3'NX97*9FGRQ[SZ,]WAGD+,FPV/Y]H].4V\I5<%%BEN M(J*`>IC&DA#C2T;N^'EJ&4?NN)1>HQ2*1H8R3X`3GM0R8V]&?S=A)@,R,>:T^DIE!"0`P#!@!>2RVX&J.I:X,#.;GCYT'=\TRZ6]N:6;$\X[;> MU^T"=H029SWQ1##E"&;"U7(2`7/#M`,,C0UQ]FRLD%Z)UQRXEQ*?/NMV]>X0 MA[.3PD0C0E+=`$TLAC7>#H[TO%<3WG6WAFE%0QG;9'O"'P=K:AULDXX/.^@P M,))10YW?+`VW7680C^A2LP&IO^I&.WUND:G)O];3Y72C]L.S^IX6`3@JJ>>" M:)Y\;`^CMU++9O+G\P'N*PQF/F]'%9>B6?JX*(]?FG2T;5#:QQ6?P$P[[P`T M7I#:'Z<);,2G7J^FDF"VOYI.? M#LZ#1]L%0@3B3"%D*2'Q$Q=VUW4(](@JJ[6HQJH[A-_9DN'#.<<=6GQ=8``P M:2&3V%CL,966UGX'1<;E!O,&>('+8&;2`>CQG8T.4\PFZ]GFX^=J-O/5XN]B M<=W/4'G[W0$;:BFSB#&-H[,N,?"@QEMHD'M::(#V_K)T[6[LM*+82\7<_V>Z MNGTEW_*Y@,O/+Q)^M\O.8Z49.WE?`-HBC:`EBA)&.-8&BQVN!/16$>%[N9A6 MUU]6Q6+U7H9-4Z:>L#/0MWZ'/&[VB/EIO9C<%LOR)!>MY5<&3(Q5G$N/75QM M<66(J7<9*5`]W!0O'T;/O+PI5N7UQ_+?@^>B&LY8^YZ>U:PFDT5YH$QTQC>% MN%J3D#BA-:=(28T,-;LUH5:YZ^-Q1^Q:XFX_.LN@I/OZM9RLJJ_NQV23KYEJ M7N_IU1XJGO$-`4NH:)R=M$V7745AH,!;<9@'V?<.GK[4?6Y#?_^',K$[E0W9 MJ1B6,TZ\O27VY2 M\-.=08MMEO[GZ?*OL:7?>T"L!A9:J1QW6#*(%6!**8KHIG@WDCX#/L%^ M+(G^[08A6F+DK'`ZW5SB+;/:H)UT?I1U71LIN>H`U3ZFN5<=U?>_QY-B&#JKO$=>R5I&P>6(3M^THNFC%B<7V9S*#--H+Z=_KJ-"7O7CX'[[\8:! M($B9]D!#[8`VD`N\`\19/**9J!455AV"VX==^11]RO5D=3J-3FL8('?&$X$( M$4`KB`S$<"LID9#DUE(;8&9XFS3J!-P+^36ZG$]NOQ6+O\YW;IXU#=1$\+"- MP`FCC)7>V-HI))KJ$=4?ZM[#:8+L97A4=_A\7^=%TP`=((92)+FBD+HXH3I< M2VLX'U%J07N*/\JH1ACWP:@OQ:Q[$]3@$\GTK*<_'13W?W'=3E-'"+I0Z(.>4*=^*OP MH;PI9FZ^FJ[VU;=XXZD0*>B$B6"#IMHV>X[;6C-C??^#W0(L]);@YB M^ZI_Z,I>3_?E(YMJC7&]QX'@WD#$!9!VMPY4=`0G^AMIJ6H%MIPCH>M%\66R MF'Y?79Z.+R*"J/KTB5+0EQ.T]7H%R#/2!?L!4MMP5@SB@N M%M?3>3'[I2QFJ]NC9]GV/1ZLM)A09P$F"GIO@5"[Q;;2PKW_J;F=\=P.?AF* M5M_*Q719K1>34I>+F_+DT7V\88CR8Z^$X_DM\67U?)S8$=U0U$R];W.E,:`Y<\ND M7!7?IO/J^VTYW_7CT]7A>>5@HT`=%1P3BP17"'ANA=YU6DDVHA!T"XJK.H(U M@PN__/3I)S59W1:+G\O900*\\60@(GH["E$N,"3:Q?_I7;0+2)";Z#6@!4,W M6F^.971R)LO#"\:C#0/B1G+N!3=,2J.9 M]V3G",%(X?>_GNB&"*U#>Y$-\0\G5+38WR@@1AFC`G+,6'2].,.VWB:A2,I< M*W+V"85WYV^VANE%6/.I7*1?%#+R.-E1]C#WYR'9_KJ2\2>=EHM']N:QN%L7WVU0RR!:KXGE'>CI,LNW.Y_)[ MM4B'V4XX2+*O2<`",A4G_VC@D8?8,R4A8LAB(H'`ZBB'^Y'P\63$[Q%C'5_Z MUQG"OM$Z:"&M$01!:Z16%C/(<"VWC\P;S]AMKOJ7F\6MPWO!`?QXLJ9`]&)I18P:GDM+@$\ M=]?A/0WYDS5>]0]X+PE(47N;HZ]/S<"1(/7>-D$*:WD42=@H#*(10>YK^0P! M(_#_>M+_RPFF)<1[8=3#4'LVK1R+9N]M$P2W#!O(G%..2,$IP.)!/HWBYQ$E M9+>@X[?=DL:HGI_$M,F_7-PGTN#ZA\07_(0OVU^'/[Z\08S'/P:CC8R.$_," M6@^)!03#NJ\:L=Q[+(?(@.;ZJAK"UX>!<+\Z=33!]?&A8"UTAA,@+8>`"8^4 M`3OAX[)X/$'M]@C0&,:,>/9OJ]MR83;,VQ3Y.!#!?NO1(!7UCDJ/-#'(IHIV M<87TT$%L6?8I]0'&K-O3%^'<-F^.:K>Z\G]^J9H(VAB#HFB(RR2:,)X767%.(C2#S.5L)K M)69AUJU?=N4.^&57+G"(G1!*(.@H`!IR*W?2`D!'4`2@@7ZJAG!EC-``59P@I+JFL1>:.Y#)D0!-Z_T:_3XU3$SU7*U_A85 MIN^W"4ACV0*35,>5(TZ%*XG@0+%45Y,R1(UE'O.CV\`=2;C3QLN.7\V_5HMO M&_7K^^T?CQ58S/BV`)5E1G.!(C#*IB-DF-6X`&'&%X9L0(V72P6M&E$AQDYU?LHQC_.@?G_'/$!<3'(N(3<6<6\59A35 M\EF+1W`"N!WUGGS,XSQ`!Y;O370<(,9H1>.BDAF)+01UYYUU(TK>:D&!Y^5[ MGP=MSK[)C_M)=5W-RV-'?EX_&+SA"A)"/'0`(BV](+O.:>]&L';I1N^-HZ;@',_-W0^2K* M/2NOOZRC%UW,)Z=MC.YK%136#C).H;74<>`I!SL7'!"2>ZYG@$>!6Q[OK>*: M2X=:IN,4>/YD`)P"(PW2Q#E-A$4:NKI[#,CV2GC[Z%(@D[M&XV/7;",8>S]TK21U#$?,A.""2B2H98\+ MA.R""V+L6FZ.98:JK^:QPS\.ZOCI(T$2BB$D0*!T]%-;S;2M.X2IRMW#EF-7 M;@,0FWI7Z'3W:OMH$$!(I2523D?6.2,8V4F8KIC/#9^`L:NY!30SU/VY7*X6 M\8WK=`N;GRXGQ2PE,7V:%8=K<1UM%X#SV"C(@4,0,$KBS[+NNH`B^P#+Z`-I M;4/;XTF5APLPU['?OWW?7GZY?X5V'_9^_:FMO&D?4_VH/[Y1'7J51EDFPF,UOGB:58C*-:6.: M$5H=E`WG(TB$;$N\9]&2Q-$N\++;"!?WNV5RWE0Y\D;F@RE&D$':>ANH))0Q M52TMC$=T^_]R\1;78&FG]_OUXVJVR%>KB]3T$@!#4.Q=GHLH,`- MK;RM6MCQA"*[W+/:Y'F'YZ>ZM_O+-4<81SRF#_HP>1?6'*DR=S@G(TI<:DF> MAX]&2=Q,N5;T+;^;3>;KIUJI2D>>SC0)!P&"&3+$2Q3._<17YP`#W9C*.*2) MIVB;A\]%?4.'A(OY=_7SX^EUHI>3Q;3F*ME_-HO-?8$7B`E`79@?<;12"`R" M$?2`N,(:N8"#'6Z1AXR&MS6*M-9Y/4.2QM@H,I12Y[24\2Y-"6V/4G$SP)R@ M3HVQ]EE_*_F[5ANP6GIM21.2B8]LA0K93VF2`:3G1%NSX;]KT1A[[?@*`,,\L"#6.R< MTW!T":;4CB]`C8NEO/OL_6L[S4`74]2Z='R*A% M(IR#'7>&`^Z%E0Z4M%O`\(B@=DUD'/,QM"Q M9HOB"%I2+1+'1E"PK2WQULT.:,;1&\L.<$!:JSFCGDKN&1.B8I:38ZIW`&=#0VK#@*OKVF_K>_%[5 M.F3:8FH7H'FSV#!X,TDWGSW,%GLMF$\`Y^1[F7'0:ZK#+HZA5HAA#5E))R;DZ2\Q`AJJ7%6ACFK:%2[NCD'";?X1D@@'KQ%[7`\^'F M)`E(4*#%2F^])3JF`^J*#B!&4*NZ97F>S$EJQLU>3#- MRBDR:4=DW2:*YFRN13,.7B+D#U\G0:?=Y8_K&)NL*>V#+V4.>4BD,Y)C"SCD M6EA13MK[Y!83`[106Q1[&ZSL+?&0AQD&VUDIY0T)5"ND>3E-@_F8,I7;D_A% M/$P0]6_SXO-D_GL^C0"K<^'N^`L9]P8SXETPH&DL+.R\M>5D0=C:1I0-=;'` M6V/C6%+I')%(\4UA?BUM&S.7,3;!C*B]N.">I^48Z^=3]^)8O5OGQ M+FDGWLF4E-9S9B!&UG!*<9AJA7&`KU_S4V[QL,COX[QN#P]ML[@+-:(>(@/^ MNZ'\_9?@VB844%VOS=;*\SU?OBO5N#NOB^>2J7*TCP$D9*F.6 MT\`XX#137@!EC!L&?[7_A'OOR>J[N[?!Y/ M__ETGZH30&LP2N8,]T@2:CA'E,D8ZZJTK>,D^5K2`$O%7A5PU^-YCY=F-W[R MV[_]2HPB2`H2=Y)@,Q&KO4<,62R"E+$YZRBX$H7-0A:![SI,Y-^G&)`V8J:I M18KQV!2*2.@5`$'][?C#K$H-$]V`5[\Y1"Z[!9O(\D["0Q4E;K&>K9_^-9OF M>S3LHA7/FL8^KM;%LZ:Q^Q53FP&VY6]F05=C:+`72DN/":,4N9*_#B8[?8:; M&7,-2/S\.M>S+Y?Y[2G>NQL=3,:"X4R7U!"=?5QF@"7@U7!0=,'XHNJ'/ MNDC]J0B!>+!>"`%4"Z\$%B`("+)P1/;F`#)!$<5 M95`GIQ4W7OY=1+:N)O4Z25[-&-V%"?S;LEBM@MG^978*-7M/95I(3R3RWA-D ME+16>%G28&UR"9`!GJVZ@DHZ=[NY(%NFG$6+^%#9DA/`.?]RIC$5B$JI>337 MK9+2J))B`DUG=QK&I'Q:9WOW0(O01"2>YN%HQ5!X32$O^>0]2"[\/,+F^']!V)YLNL!WF M72N+^MESF>`$"H6%4^%/#;TQT.[H"-8"3,78`!ME=X6Q2_@[C,WV0[[4D]7L M[H^O@;$7[;S/1LHP9MY1[YP@,K($<,TJ7CB8ZC(?9';;<+;A2V0P&#S:V?QQ MG4];0>3^6!G6.*Q+Z[RW&F`C!$05/Z)A?/4$N[\K)B^0PE!\5#TF+_3GHH(, M8P<4A+%K!)4<8Q(TBN#`F^AB/+M@KAUF.^T5;1Y!:S!>1KT&\5:=5!P'9BBE M?_(&^>0-;@0^[MJH.1HSNYXXE6*79Q]DQ._ MR8G>3/'S9)5//TR>MN5MSJN.RP;.$%52*^R15$$Z%B!!=QDJC"$%>](DM8G2 M^T35T2D7CIQ9YK7$"EFA(,42TICDM^.7E7Q$A9&[`M;+E-Y.!=2AVGDW64;# MZWO>9U1ML&I(`.V0E$IH+S4FX9\02P\]PAP`=K:RU=5S-RO$[1.G@D07]YO" M9"O]]`LJU?]-EM,&_4PN^T;FF-$,.FH\\H"XL,\Z7?)0AU7PJIJ:@NUX%FBG MHNKD2D*<^9E*EM4SF396`NUC`16J-37$,5IQT%,^'JCU(/.75PX2N=X9:LZ6 MT-U[*@-*$2*YED)`YB7"3+&*!D93+SX-$#D)+VA@ZI"[]LHKBB8T[;$B;864L]M1:-5)#4<,$!\]&]=M">''K%VMF[VR?FK+!5HXE:@W$R M1I@0S+G8#2,N22_HGO:WX\=84SS\4HWS>MSN_,K_KB3.^8/3T9K60WSZL@;F0_+P7K% MF>04A24!K94[V@0B)#4X.L2;@[V;5NW(H"]\Q;\N\_RL:77VW0PB8RR/C>M4 M^$]B!ZDMZ74`C<@O?;'$:R#H$MXF5$S[YV-0E'?%\D4[A:"4_W&RUOW9][)- M&T..5%A/1"K/K!"BFCI*3JR^$5@DBK&X'H>[4#0Q$/IN\G`NT+#_6.8`HY1" M(+RE&GC$PTY?4H$]2O46#3`!O_\MZP+&=PF?LYO2\P`0%2=Q+V&-4^`G^?2]]XH5*^V-=W/U[LI@&U198$$Y[ M<8(G=Y\+1LPT<;$Z%]1282HA4$R2DES(T8ABFZER+OI@="*N:.NX2APQHS*F M5$,N+`80*J<"V16YCH^H)WI+N.J&T5WL6]N=.7SNC-WS[+E,446),LH'/:XA MA]JIRBAD-+FMSP!OA?5O^%S"^4Z6>^:I%L8* M0G09OA:*H527Y0`WUD0TO71Y]R^$+J#M'K[-BZ<\WZCT]]\BC6<=XT??R9"C MDBAK7#CR,JVU@3^-"A5,C/&`K%]X%-<12&>AF%F\6K:9[9^+V7KU\8\_ZT5C MCKV7<6J=I`HX;8B%F@D&*BM'^U&5HAP2\-H42N?:KIF>V]&DC"3`04&LP5K+ M8$P;4#F3G1]3;]@A`>UR473B(MA&FVZ?Y1(2X<`FH&4(8BXM\X3YRCG`=*IK=HB' MW"'!K`UA#.+<>XQG;^LT5[YX\$Q"J8G!@&``&7'40UXF&@G!5&I?C<;55/X. M/IK.Q=6):[#L['F8NN-]$9L-D!'-")**.&@(`)0(!RK**1I3CFN7,'GI1;R& M+!("'V7"0?CXY]EB^^W_/,[63Z98?`\""/_^4*S6^[\^V7\S>;S,:68AI8#` MP$VG-/:@,EN\4*G;^RV>BMN'79>BZ?1LO&TI<9BCGR8_=+[(O\S6V[I&371E M.Q_(.#","X68X38PREN-W8YS4C-P]K+ZB$[@U].EO^Q;6>R<9SG`%K/`4.>,\*5'34J2?%Z[1;?`];#?M]AN M8AFHZ7232CF9=[D@CG\U`T8`'YBID#'Q1$Z,+J\B2.-8:J+B+;HR!KPT6A/@ MH!?)YG]_Y:M8+/E#OIP54WB-57'@,QD`!C,?SY'U^25XP^V;;\J9;XLZ!OHUO9)@J*`'DE!A!`->8LC+/ M5GJ?'"II7+YV_(CO05R#.?B^BP?ZU3K?+N'5IV(]F>__/E:]>E>L_S=??\SO MBOM%W-+VTC%..<([^7Z&H40:.`B]P%`!P:SCE9IQ/O7H(%Z7R=-+:*LT M?+'<_2@^=\J6ZG8BF724,>JQ%0ACA7F\_5Q*0CF9>HM.OBZJ6Y%I%ZO+YE\" M$Z>QBORF'4O<3.>3Q8XOR]\GZR"\Q?VSW^?+F)K__LOFER<6S,5C9\Y8K)1S M"#BD$%'!9BW#UI)ID7S!&+PN@A[E-.CS]6XC_&N[X!?1R-PT*_A4Q!^Y'X'P MV2I&N]7]_3*_GZSS-Y$MB]7L[J_)_/%D0=B^YI012Z&S%D'GN:4\F,FN\G]8 M#U(=6/`U2'R+\NUH7]F@XM/DQRY@$^,X^Z;FCJR33MT&HV0DT.F$AH@+!+3" M&-M*!SDK4Q-VX&M$NAN))&1#)/-A&TA_LXB5@C9Y3>_77_/EIZ^3Q8Z(W\(0 M80'.=IZ%C)`>$`H-)CY\A:2A$&^JTU6GYSPKUI']C/ MD;8OO>13+Z[E,W/*`-?<:88IX(P[BYVEM#IMAHF*TEQ!%O$`]R*)N12"-TLEWV&B^_KB3:`-3./S:YSXLO M[Y?!OILLG_:F>/#0FS90YH1BU@*&,$#`&F!9=>E"QLNQJ3![#5)W)I2;-B'Z M,!&RL$,8R8CFP),H2BEXY?#R0B8[-%]#SD.47X)&3HAIJ(?B<7&H$]Y%XV7& M$4BIC7%U1A&EAHLRHJX83R[,#%\#N5W+9@^&UVXI^?-.9G4L5:O5X\/60O;% M\N6>%,MCO+:?_+4CH(*0>6<843IV1>;`00"84LII[;$Y&T&^DAOMIMI/>:TT!5QH84JN:N%'A.=$-'51(;&9 M$&ZKJ!,'2&"!"68<(X0,$$24M!&D1K1']PN-FD6=FHEC$%JTYWH[EB$IC-=. M,P:T"MQRJ.28-2*U./L0LW=ZW_$[%U<7`#]T4"X3Z?XJ@OT^F\_63Q^#'7\" MR/4'R0#!!'HKK<5`(D>95K#D@%`ZV04Y0,!V")>B(WDDN!0/S>5#GB]K@ZSY M(%E8V=BK<'3T$CH8=B6,JQ4>:[F,2"MV#[*KRZ,ED'W,UX_+Q**KCAS;[*IM MN.=-H"R?_ODMQGD>OLWS^+GH.RM+5+WZI']U$VI'/&&<,2,A#7]L6P?&J$-` M@4#HU2=]WO1U'!H%J>."0L*]H+C,T4/>8S4BATI78+N:3[J9J.H?%5;YW3_N MB^__,\UG$>4D_B6"F^R!._PH>YO?3^8N:*Z@LP[[H`\\E3'"%0<8@G!XQYQC MXU0U:Z/YB'J:]"#IHBV^MX^6[52.>HE?/I()C[3DBB*(+`326&)L.5_+DVM# M#0@G%TFI:(5M"8:T*;[/IK-\\6%^=[+QVR_/!4M/^T@.,\13P"GSINQK`K3& M(V@3F"Z-HCW?XR(6'"D($.1:4`PD(*;-"`(!R3*5M>U/];7!^$&[S&P@^ M!CY*BSU0@C+B(0-.E,FHP"HS(E,F$4U=!!^;":$+:%^G6Y:'S@"E`I':2NZM M5*"BDV@QHN;O_<*D4;>L9D(9A%[M.1Q)<6`0Y008ZP62BCOF*HX9DVK6#]$W MVKL-T+FX!G/?HJKG\=/)4\?_>/'8F=`64`*=@D`'8Q\K3\M"5,`S+?Y&6KI% M<*5\?UZOU9#&=+>ZW=9NOH<:/?2O#2'JE#4%&_3][U];< M-LYD_Q+00./RB.M7>9B:J61F]Y'EL96,=F(IZTMJ9G_]@K+).$YLB9!(`K3> M;-DB@3Y]@$;?0`2T%8&NER>-+O>F]@+5?D+=.W$7I&-1*[J+\>,<^YJI_UZM M/_W5UDY]7=U6'U/L-`->WP3-K&ZC_$%KH26@)+0W(X`NZ$A1X>8S M'I!%TV=OHYS3[50S#Z_1C!.BHU"2H?2><@*>&>2(W!%'<[V@!>YA,QYY*D1Z MEERJGY7OFLN[]=MEDC MC_,08+);8)6GVL;*CIES[[C3P[7"3IC/CWHOM]^_ARW-^V(7DC. M/?#;3>`6>>!`.#,BK0"40^RF`4+F9FS6N&R>$/-76F">!HBB%\S#/5+CA1>& MCJ%)8C9(`S6,(S,$I%5=&6'D3$Y6C?!EUWCWP]W%S=TH=!A%)Z?W96:A5C=K M=O[:VW<'WN([P1`:AEH&[T5$)U$SGZR]SFB,P2TAW;]NMAP%5X;)LC<0_^=+ M]Q'_="9WWV;R!(-?5FVZKKGZG_O;N_9_7S"`9AE+0XWDT6HIA'9:@G5*/'8Y M\"00EWL*+2A2/28C:L&M[GWD^QM<9ME'OA]"@SSMW-Q19R5%&85TQG323^>X MW)+TPZ\$T@^LV>RR*JY^KY(\A:-6-V<2*!]7Z[EI\\,H&BNT!B(9&N-HB#PR MQCH,F,Q.+SS\/I\S$#EM8%D/PCBT''.>BRU%0O*BY_![[P, MT-\*@0MG;4."I=*@D,I0YZE#U;4']43R[/3?)86(YN9+@;P?J#9UD_U[1VN9 MC!\XQB8),4KGC0@\$"*I(Z#Z$XH("W#NET27LFD_KN[4$FG(X76Y@VV`2I\P M:MT--I#VUCC7NR"2Q9E[_6E!L8JE$'PQ2E3W+O^]_[O,77[@&!O&(T<2P0=I M5`#A8W?QFB?IP,DR%X'#0R_G1:"877Y_+;4NDSB#QE@HW6(*IEF MP@DF97MAT[=PMX60>[/NX6&C,^N+8?V(BC-+@?"3?G[G^N`#NMP[[YT,'"(3 MC.SRZ1];S]'HC=_;L_E<'[QJTE[')`HTTD0-!)A6HI,A*I-K1!7H(9U*V<:K M#QX$5;GUP4$[L*@9)4$23=OJ*MK-PTBQ]W;N>E1N!NQ?K0\>)ODBK-X*ZH,5 M4H^^C692!])'&T6/C0AF0?JQ@H,RC?4*7K*J$1J7)>.`4H+$\\9[K?=8C,/6O7&$>;4=FR MP"AB\YZY+!V"]SP$I)1SJ[B4C/M.8MJJ)35_F]W0G!RNHA7\<`]<,2F03SU] M!H@@&+3E1LC`/'<1.R3:U-4W9&2<4&VGSW3*QW0A["HH:Y\#,`O>,*IYY%YP MAH_R3VH;_6**]$M7[]E*`(8I0-T$++#>WV&(R68.,:*FWB;CAG72IXKG5C>7 M:`N^=>(=A7Q1"7WI('C_^6Z]^=2B;.]OD\UQ>YM>\N=ZLWO'MQO7)T_?.WQH M35OT9)FU,A+?-KK2Q'6741/F8ZXU^3:3]8ZA7J4:4?=66%[+`B^]":A]C-9( M)`R\=+TAXD1N_6AY+0LJH67A"E`W_4KM?L"L%E(Q2Y`SP2T:(4AOE1B:VU2X MO.X'9Q*>2`?JYF&)+AGG)&/,>ZT\YR+I=$*@DW^;W;B,1@IG`IX$_H70;Z$] M&:Q$9J*)RA$;.`O)PND/^99"KG=U2>Z=*B(6(X+^5@A<.&L;M"2V=XQ999RV MSH&3ID.-J^SCYY*"BW/SI4#>#U2;NLF^Q)X,UE/E(Y=>:1HCI0%\[W3@AN0V MRES2#OUF:#^N[I09PHG[O.+EM6@XX=@;*5P@3%M!/$^Z2(.CH8,P,LA-DG^; M0:!1Z;]4G:K;)%AB`P<>HZ,>#"%$$ZM!)K>"Z=S`H4+6CZ@X3W7ZW_;F#PZIQ4E-+'7(>G/-H-)>LDV%8U/7$ M4RG;:!TC>N MW7@>YV60OZ5KBD=5BX.*Z(>!4<3Z.7,1O4-/O5$JI),CI/.BL+;?MQ@+N7M] MB7&[V??ZR>'*")4]/^(>?*W[_B\V46C#%'K-(D+4&@"A&[QU(K>M=XU+Y0F1 MWHZ(0=$K9)5)R50)RH+#)':MA,=`6->``WR@BZD3/[4ZSI9&/`RPN@E37ETW MU]R(=&I10@?N2+(59:M(5B5%B[EH@6&$:/HI>^UR0VTE%V. ME.@"B,H9Q20B M14$U)4+VZ5P,-5]0WEL)XL[B2X&\ M'Z@V=9-]B77$4E/I@P&;X`,9V_LUOOG`$'/+!Y:T0[\9VH^K.V6&(-YX';$2 MH%G"41E-N+;!6.'[Y5NQW.XA!04QED+_I>I4W2;!$NN(!;5:([%6D1"D)HKA MM\@R5^>+X(M9$VK7G;JYOZPZXFBX4TI[XDT03D+4LH]2&.]R&PJ=ZX@K9/V( MBC-+'?'NLX>YG-VY"#*JR]LJ-+,!L$P&@N.)XX8WDG7DNQ\L0(=K%.IX:G6PU/B5K1) M\^-$QPO3O_2NA@GF#"@6"&AAVNHSI3IY`M+)KEPN_N:V$ZGE>"S)`K0&@GSO M"/W/S?9VE*K`E]_6I'6.>9(`94A01>=U5Z8)J!A]2U=%UT6/X\&L@2"[`\.[ MS>7-*OW#K5\]_C!FLN1A;VX,DXSR(+5"#,ERB`:_&0_Y-8]+WM_>K*W]_D\3X,-+=+&]W?WR<6OAG=7.Y3M-^C1>#']9H#RH*;WAP M@;3=.@%B)Q'TD'L?>WD)]*5J_-B0U;`3/'$5F%<#8#$J2YSC/!G"FM!O M*R02S#7,"CRF5\J,8R&K@0)/:/XLS-V=V'Z[65_N8O4?IXP:'CB8!B2G/G)" M?$B[NR"$2-'[%;F0RTG4JI1$HV.Z();-3ZU&*V&TD))&ZY5##0S[%4Z:\)9: MB\ZHV/-P<"#X11#OQ;:9A]1SG(Q\IQM%XY.HM>8\"G`4M:-[*&,:6$(E1HG]#R/"+M;I%$RO7Y"L(J MR3JI4E1!X&Z"LV^D@P;21$>#$)!./LP$JP`,?O-8J>PTNP(/AV^)GF/J0!%L M/#8@.-,1\ZAQ-1"\#,('2CEZJ5T,H?=/>"G.M3=%Y_$@V:BZ8$C:%!9CA2I M@6#:JDI%!>]E[VQN^;H\\W%&/HX#_F3$^W/_S/\<#-+[57NC5_K<;3>[.-?] MQ>??5S?7L(^$TXZF228,$/"6-SG3X%VJF5\F]\4&LX^#U9;MZER:XWM^O+ MT5H:[7MGXR)J%Y4$Z0)"6U)+.H^V\*AS-RUU)DUAT-5`C?T;M/GTZ697^C49 M=;+'U(")'!EW&HVDP!)4O`O="F9CKA]3GZE5&;25F7_?SW4B*^_92YO06MB" M*B*#$DKH=#+N]WT/)CMUE)S94QIXLW>P:R?U(3W\_O:/+VUGWNLOGU?M'UHX MNBZ]Y_9V/VJ>-`Z"0%!@B2$JU^K"Z^;J^ M7+VP270+^S<1'"*PHY_=>,+2J041M90J&6X,'>]D%H++#:84F!(_E7)MYX6H M!KMZYOYT41+B-;1WD)'`/?51=O*,E"Y(Y2?4O?&;T`U"K3(6%%XWY7G4.L0H MJ"2,4N4"MYWLD9$%7!J_*,:<$,L:CHKU!]`M-R&PX+04&'Q(9WC5ZTQ[A?ER M*BUFYE?1N%:V9Q40+*#.D6!8".`(M2RPI!*]30ZXH/KX1>Q+1Z%7`SOF;;F" M5DKO0+D8E0X$O9:FDR=#._[5\6S; MM6@Y&5*+8,P)L:SA7%-_!A0)4GM+$9GBA@L&")W.8(O*(-()WMY8%C@%ESB>?HK$6*%$)W<22*XM46#4;BH%/96A/AJ( M11]V?S;K+F_OO[8)J?7G]=V_[Q-B4Q'GYV]O@`05.3?H';2=C!V@?)1YY"'; M25H@<8K2X#'9=1*DJV/7^_7MW_%FU1I;JZ23=U-RZV?O;KPAQ`,15.R"J4R` M4-_D;7(3J@L,B[\99IT`Y^IXU:TF?OUU?95,^SGVK*?O;D0Z,+&(WB-H;Z/G MX&,G;^;,@L+A;X97)\"Y:#?2:W,>S3.[]Z5-U"8=!R23`KSU(CI&?2=A@HHL M)T!>/)-*`'@R"AT4X'N(VQ@GN1"H.4@A-;?$$][-P$MV;HTWG8KF`%*TM5-$ MNKE#)[05@GC-:0#&@/:[G%;[JU+J"3(7K^`SXCJAC__W-B)Q=MH_]8E&CT&W M5QL%H8U)6Z2WN(O'2,NY@;WWM(TOK;WZ^6+CX-\3MC8-\.\#Q7>"-S7,$6D! M%+J($0G50I).GB2ZLS-^L.)M2P+L]4W]>O/W3J.)!MSI<_J@Z0*+VX\/E:O; MIQ6M;1GKAR_KS:\?/^X6I]=4-O]A#3&@F/7<$:M!(I`(O;"379Q[84&!_KB) MM7(R3":Q)K^ON?Z!-$\O]OY9D'RO!H_SHH8[CAYHLC!85$'+A%_H)*F$R[T[ MIT"OV$QK[JQXS:7Y3^7[=(+F\F[]=7WW[U':/NSAC5+12N48\(@VV=',IRWF M46)(=6[24X'>JH(T?%2,YO,._+:Z^;B]N;[8/*:4W3X]H(S(/1D6Z.V:UP:?$[49;)4?HB?O5TF.ZS80LMNTS.;J MV2=_;-9W1ULQ)WUM8QF/FAMK!%J!BCIJ72=E,)A;;E1@.409]LV%K*[Q9_+W/!W%(KO`+7VD,)^FX)#63Z)STX#F!G7Q%6HLLV9M- M-#?-S;I](J),3\_GO&'SV[W[XV0SH-4D1K-M%0$ M:=C-C!&IA>>YGK::6'HPN*^S-$>>DUB7SX:97FS^6=\.4)3';S12*V!()6@P M7"4K1=E^;HRQY>K*0&CWZ$F>.&=2%;]M"V.'*7ZYGRF?]<1@'>$Q>_E*C MTY;"'7I.*5-:I!,V>7!5(4:BW$QYJ*_*_2"'YT$/:%PR^8/@,CB1%-P+5.;! M]8>""&0+\GZ>0@6>[PYCR+@0;L_I$CTYQ9UGCMIT.$CG!>?"_Y=W;V,VZ3:=,YCQC%IF.VDN@CR4Y]?OT!9)&Q'4NB8))BZ.0AR82` ML=]^N.QBL>LI\!`)$`^8V('C.05/C18X2(L]WL]3NPB&:02<0BQ2U%+@F!>P M%BJEKWP?,[>M9E^_L>\:Y2'LAM]3B/D1SVCS3?!Q->/6">F!-9!9BRQJQJ^G MX#?O3Z55-Z`.1HJ][JU7O@H6"BVL$<(C*C1R6D<8=C)8RG,#'T9$C#?H[37- M9^$VA.Y_+9?EXFYQ5/O/O@L*6XT)@L)(#3!US"%5RZ$4GIK^3]5>U1UV@W!@ M]D\[#CS]+DA.HT$+1#SF$J@(`%J96HX4$3`=X[X3#KP!NR$X\'%5W1:KS4/R MD6]2Q=+_WI6WC\]H6URFMF@=L(N_54HRRY`G)#E#]$YF$BV<"?!EL,-$]W"? ME6*MKF!;M`YQ^8SS2`K#5%0;4A195\NL(];3V98Z94!;=F4C/02[]%T$+,ZP MH[O8\P\#MPI'0Q!PESPW!`G(ZV,=<8#GOC']D3B3H]>J0U"'H,=%-C%!EYZ\=T7XV!'&Z0WB0:]?J M>O,UO<-87M5_M<5],:^V<&RCX(]RJG4?01&$#,)8$L4\QDA@\TU^J7*K-)[\ M0/B^6'VN?F".]87X,+99!&Y9K!Z>8M+"4MO;*DCB,,24D"B?=@1S`4$M(^,L MU_5[\J/<'YU5W6$\!(]\N2PWQ45YGPH";*)!6T8#1*W714HV\NOLKVIEYK/U M^HB==T(O`6$*F(I`:,$MUD8+4%O*Q$B0>SDXHO0&@]E[_<%^9NI]&_MOL\5Q M&_#$GH)EQ/!XA.!>$^*9,<0W4YMI,:%;KEX8TIZ%':"?$=:47@+.BVWJS,N; MY3:MW,$@W;W?!XL98UQ+JVV6E\5RG?($ M?%D5;:W"?6T"Y(*1*`DR@&BB'6*2U?(A,B6;L&\>=8WU$%SZM)I=%8O9ZN_C M%'KY:0#8,*(-IQ@;ZZ%VRC8S@TJ=RYP1G9:&9LX;(1Z",.9NO:D6Q6K[BCYE M<;@I;X]SYT"K(`AA#E'A*4$RKK6`R@8L*>6$"F@/1:/NT'Y;$IE#UL7%@< M@D086V`-I01P#HBAJ('823Q87$*?_M!!N=-L@9KQ=0WQPQ_7P>^M[.N>\C/ZZAO MQ;,VS0.&5$%%B/;"J7AP%M#@6FJN7&Z(UHC2I`Z[UW:/^4B>D$WJF2@##E-+ M+99.*V6$\:#6@-+0'?7N]?3NH[@OEG?%[\5E%16QS::;!O[0YH7HT;;!"VV5 MHL!X!*E`6CM0QS@KR/B$[E2Z4/S+1R,=PSNDJR#N=[79F:S,]IQJUT$P4G"D MB-4X53/#B#I/:\F%`1/*;M(#L7K!>)!':E%I\>?7 MJZ.M`X?&,F1$M$>)%E(;;7TC,\NN@30BRZO7!:MK@,_K;5K7'K.=U[_]*I;= M9_`Z0LUPNIH2,/Y2"M=18UH@.`$CK$<"#@7[(/>"LW6:2.F/9#G>S^;IWKL] M!5NU#U0:Q[@0D#H*,?#&XQIIK87*?=T](E.L1[KU`?%@,0IQX!\V-\5JA\LZ M'C.+*$(T'8]NI*W:!Z(!DP8Q%V>3,18ZY.LXZFB$HMQKZ!$6C>B!6GU`/`2U M?EFFU%?5ZJ']0K6O2;"0&0LB<(QB11#SD/IFXGB;NS:-L+)"#P3J"-6S>K;; M(\T``HZBDS(`Z8$QSJ$`FI\2[X%1/*`_S,G1=+HOUVE2+S^7R MZ1GP`*OV-PJ,\53!1-)42P>C**9&3V91KITHWP6/.L-UD+O@JKKZ6L[G:OE= MC%G[]:E])P$1IK#FA`#LF?+<.-4@X(!UN2Y3\"ZHU1O0@YA\U6)1;AZK)D6S MHMI"$PW9^B:DG=W7NI,`A?(4Q0,!,BC*+`T5=7(`+6%^`KCWX9[O#>AA_/2O M%5)\K!*J7J1+/[Y19O06H,04>L0X$,(B[U+*FQH30LC1RE#[R/=>7/A](SZ, MM7A9+5(,V"G6XNM-0C2!)>)>,L?B2JXT<:B98XRP;#Z]#]=]1[!FA+=_W(J< M6#Q;/B2K=;UI9_NU;QP0$,R*N-E;8['6)B[%S58OJ,M.53=MKWIO`(\DNF0; MTS^-V!)$-32&)=G[B.*XITN*Y6S]P"LZ<)%DXK6IS5 M:TCY]XRTDFD%*:%68D!JT3VW$\KWU87^7WV8,@3P@QQJFTJQ!QZ&950-;MU; M`)(IZ9!#2%@.K<9P5^,V8D)=MGOQQSK3GDK&X0#O?>-Y>N/\GW)SXZO5HE@] MVT3/LM_L2C3'@6R>WXH?WW6.-0TZ;A-.$TR!!H`P&P^)?E?[0,EH[YXKKO'U M87\K8MTNPK%U+T'A*#8T0G,2C\86`T-!C4,*71Q*FO?@NP&CVTSA# M+'5`&!1M?][,%V^F5!W]+7JINH-PD`"9V7RVO"S^N"F*S45265+.X2UH7Y/` ML?0($Z[3$T8LI8=0U=)A,:4,:,-N.!T!?BXZ'=UF]C<*'C.OO36(:>@I,XP# M5DO(_92R>+Y=R2U8DX7J,+&@Q>VLO-J]&5K7$="/+SHVN]1>QY*CM>\D*"ZH M0YAZA3RFR"IO2(V`!4!/FU>GTN"[>-">E'./I?S^-0EM,.%K_P1M;5-2MKRV'2@50!6 M08J<1(QRQKQUBOA:1B!-[OW1"&-8ACTY=8?Y&7EU]/QTL%T@*;.,$XI8:A@B MR@BK&SDAG=`1JA-MMV-0%K:#W(477](XT\W)-C+UKKCZ<%NL'H/MC]>G.=XZ M8&LIL])K).-:3"5AN+:$XRHM)W3?U9'N7[JS.\=X&%ZEVZ\O/Q7+.-049J^N M%N6R3*[]=+55GP5;,.R$?D+F0@/QI"3ZI<;+TF< M09`SHB2$V"O1G`2,IKDL&>'^E:&W`_7+3\-M"-WGU2^'F$H*K??1FD0RU7GC M^IL<:D*NGRSM':Q??AIV@W`@JWXYDLI#KI61DG'O.%>2-^YNFITD^<>AQZFJK/I%.(,D MGV;__#K;)`";81PDQM[O@X""&FZE1L@Z+(0TK#EO096]5HSQG-(Y&;I"]8P[ MS<6!VDYMFP;#K(\KK5:4>^PA48C@1EI)4$>9C&\59)A?X86BVS2SM(W)/ M1E\>+&.RMTV(P0G%%W>GZM=3?;\9W#.N41_O5I1@%J MY['CE@`/M*2$(Q]_M`#`2$`B*P4I0YZ;89@1Z'B@3)O4\;H7W9.1&Z!#:#`VZ]*1=) MHO3#_[Q-A6$7M_,B_?#JVJ9=LOQ\=X`3K=L'P:&STF*&HT1044<4K$6!FN;> MIXPPI7;/M"B1R_:4C3/-]7IYUIH(^&>C+93SSOQSI6]GW>J]!ZBBNI22*3:%A MF$7\:[&5]+E>UA$F!C\O\SJ!/^].I[E&B'__%#]=WU3?\X1![ES,\0ULK@N#YE;>UI$:X`K MXT0D-B4"`4VMJ6\L*:$LUTP?8\+NWHRM;K!]X\IA;E(X5KG\\'49D;PI;S\6 MJY2Q>?;EM0^>YEX@ M?L*/5]/3_?M?Z>//LW41__%_4$L#!!0````(`"Z)>$<#2>+XHR\``"5,`@`0 M`!P`;6YK+3(P,34P.3(U+GAS9%54"0`#%^!45A?@5%9U>`L``00E#@``!#D! M``#M?6MSXSB2X/>+N/_`]9?KB1A7^5'5KYB>#?G5[5F[K/%C>N^^;$`D)&&* M(M0`:%OSZP\)ODF0("FI!(T8L;/M$H%$)C*1R`02F7_YS_>%[[QBQ@D-?CDZ M_7!RY.#`I1X)9K\4_CH__^^+QSKFB;KC`@7`N M&48">\X;$7/G=P_SK\Z4T87S.V5?R2LZ/HY[.=%?[]S[F;MSO$`.$H*122CP M#66+*SQ%H2]^.0J#/T+DDRG!GL3"QS!(H4'NLT!LAL47M,!\B5S\R]%GGDY_./A\YDMJ`_RR_?BWT>)\P_P-E M,]GRY/PC?)X@CI/FBU)K(_R`!D&XT(_@"?91K);XHVQT+%MA1MRTG[E3L0,T M\$3:)T_&YX_1QWQ3TD`T";A`@9L2_5Z9I+=SU?KTIY]^^JB^IDVYIVLHP9Y^ M_._[NR?%\R,I`HZCA(`LEI0))Z@P;XKX1'4-^?$,H:6:V..3T^/STR,G$IT[ MZB*A9#5/L[;C1^P+GOQRG('Z('$XF'4 M)$DU^%2[P+^.DW['\-/QZ=F::&2KN!L:2;^-H/'31\1<8+?DG"N.\?O21P$2 ME*UNY+_;H>8S5H!RG0$!''\"'$^_7P='!3K`,]#F[7'*]]HL(ATF)NFQ/@)Z MQ=P&CWS/+U''3:+3#Y4U\-!O(RU74=(!1O[<<4R.W0\S^OK1I6$@V`I4U'D; MW:;KE_SC.`/2%YN0,6D3*;"?.J&3[YC^ZS@#TQ,A#Y/.N"1]X(_U,<#O[KSU MSE/II/[JM=D4X)'@%7/164ARW>*_UQ>1`!%7;<6G73#)>D5_'F<`>N+!B=L9 MBZ0/_+$!#,22=4SBAKZBXB[#,8$`ZON7(RZGV\<)[=^:*`]/NQ(ENY"`6$R3CR9=:9)= ML&\I.4N&NY(CNW#I4O<3/(#P+%LX1#I[(]<-%R#"V'L0<\PNZ4("G^.`DU=\ M&TB?6$*`'B^/M\VNLT*L#;@4G02A3.#^>G9Z=GIZ$NS[E(2_?"R#*X\4I57?OF-Q9>G[Q;\F3%J3 M=^"Q>Z&/'Z8M&E]A@8C/-\SO7B@TRLBGL]-/)V?]9,3Y+L''H=.6??[D?!?C M]:=!Q!KX^XA='W%.IB0R$?A#**P0O+41,XOC^2;$L8*G0T,QR.EFY/0937R\ M:1F+@3;*Q_G9Z?G):5_YB$8X0(;^$1*NX/%1X-T15\X+'LT85I<)'?EH@-5L MD9Q\TEHD&4P'!9X30W4RL`/+BM/\!3$FL7SMI^X[PF[6V">?M`:$D:7.=^E` M!ZULFYF1;;PWB+!_(#^4?]YZ\I/FQ59!K& M,TO+#VM+BQS>4>,[.00&06G!N$?L4FD:^$0A_3!]I@+YE[(;\3#;OMRT']XL M1I_6%J,B-O"+PL"^0=Z/'>!W*\S1L,` MW.0+Q`D'#9Y1U6/)MP5I6,:ZJZ$,M.*C`AXI_0S\X:Y)T\1_H:+;DFP'T'#H MJKL&;L='!7[@8FG2Q]0G+MDL(U.8C;P\.SD]JVK7=KQ,1C@X=E[2Q8((M^G/FKVPD87# M_8:!L;E@%CA3>,2",&4*/DQ\,HLN[3?+\RXCFL6AXN$8Q*$0+*,.XS($G!P& M@[0T\^Y>CK@(%W<8<3Q&*]7ZAK(O-+B$AS(^>!'JX]:DISL&9FFJ'-)UD*88 M'T>-Z208.5/*'(G3L9LB%;48),S`WW'(W+FMZZ'ZDC8=@4M2L+R9RH&"6 MWK4^23J[1SOU&Z#9&9#R_S#-CN?YB=;Q["\^A^N5QA.E`M^C6<)> M.C-RQ<^1]-WY;?`T1U*Y4]_#C%__$1*Q2EMUE(E-C-@D'M)G_7RB_-:T?20= MZ<`YD9#_R%J![HA&=TC@Y,?_/TZ$0=9X$)4BX_+V^B8%H@#7P/9/O=A>LM4' MQE89L%YV@)XC&)A]M@:SARP"/=D^EBHQ$',LB*1C^S)0',XD$)^53;`I@7"^ M*XP^V`95CFU%%;1;_:?]5_^PWAMG?IM+O,>JAO];B]'#.LYFJ^"I]^5M$8B! M?>>&=5KTR0?>Q-.ZD478`-'$-<-66N3:H:^P*SSIY`.K]LTWKZ=GFIM7Z'>( M<[O.E:BV?_/9Y.F9YH83X`QWE0E'LA/A.QK,GC&D>)\(V/31D@CDJ]BM+$ZP M)]]ZCF+F;N7D.>)N_@P91G2$'-+QX)NR,J)1'5^%KM%TW$$6DEA#)$*F,E$4 M.2;M,#^$@@1;DHXUQS7+2^6:K2HO&0Z)]!PKZ5$M28)(*D-1^./#($.1#'6_ M6\CU:KXJ.#W37!5$_#O00W^8"163%TH(R_AQ*@0`7A%(IDRD('?D12N`S0;/ MR;G.X,D!=C+(2AOG80\$K9,2!RR!JW#1^CPY,[ROD-HPM]EVW)4)>QS8)4M>5; M"U)R@B2[\C]%M9%J.@_BU,S2M7RX7@.8!:,2+-A>,`9'L"7?G\@L4(EM`P%7 MK/*K>GK$Y\\,!1RY6]4CG08WRTO5#6@I+W]V=)K'*9ECKQL0E.$^-.TMO"M/!A M[D\)SHG@Y5-`'1J3KA&#Z#@.-M<8,Q7ZU(4YVOX&C^]'C<>7P'&^NU,FEUQ/ M41S6P!#6QW1J`F/8\'[4N&"U[#G<74LWPWV2KC3":635V^9GKL(OE^ANM.74K31%<=Z":1/OFZ#;A@89+O)"T'ZJ6&T!99[D:(?E!!L;6,V"="XBUQFE6H&<_:&R+SHP? M+B2ZBD-W)=P#>K.J/OM!HZI[L/Y`M?JOE'IOQ/4-;^:ADPYQN)JV@0&YLE8A7'SEJ_AIFG;@>W-;/E6RJ._CJ@, M@(<`42;QD`2S+,[R`D\IPSD@Z_%XHRB8Y:/B,13EHYC4,,$GE]I"O4C(<,K' MGT98%0`.4E9D\16>8L:PIWX>N7(A]HLEZ`[<*!FGC;J\*!G)2/&W9*R!V^T9 MF/ MC]C%Y%5YZ:/`>Q!SS'H?*ZTYDME:^*F]5&1?G-S`ZIA"#3T<+C5S"_,Q6L&< M;5P.*I#-?/^Q#]_EEWB@@*#WH[?!JR2`LHY/1//=#+=!/VEO@]+N!SSA MO;1>I;=!@?VDO?I)H1RR`DHGH8\"*G>"+6NNY&IN0KK=4TVR>X.PYD%H7)_;1"$0EWWIJ:#H%39TGW#-(%JWCY/=47V M#`P^T`T5[E@"X:]N.0^Q-W)=&JJB]T]"S@]B7B>NF8$9C']=[8`$J!-!=3*P M3@IWX%IIHM?9;[L#-_@49YHPRS9<'=XK`:?A+:4+*=I5`=+X?/ERCMBLFTHU M0#*LS,_:E9F#J/1I[M:6,#"+5L4#ZRA: MYN:3E1-C-4A8-_[&7V\#-X0(O2M:1) M@I>3(0;W_H#:('#=."W_@=DKZ!&``V\8^#=39DUCFT6K$J^TEF@EN(#N4C.J MWD_P08'5\;3[T5(K>(;KF<^:\Z46?#_8,R9!HIP_T,(57`%V*.PT$(Y,0AH'?>RG;+H`-1_+GGTXU+FF1P;4]L+OIFW ME6#^ZOK,&S;I8$YNM&&=:KBR@)-O_IB&`MX&^0C$C0I`NZ',LJ"Q>AME(1K7 MR09V2%`,(X#+O5J%*>X!:E9 M!PVS1&E<]#82)?WM29J83(H5X.7D$(L?C150BT,Y!XFKLCH.0,[*^\+WM##F M31AXV%./:OC#-+;Z-B=GO0:R7CIZC_X(]H:WJA__D[$/&>1579Y?AM.3[\AJ^FBR_UY>RO_E0ZB7,)LF"2> M]8`?S+7EQ!FQW1U!$^++T3"/B_]X(Y$U#!XQ!%')F88*KNMH_$T.;Y:>BM?8<$20.S3, MH9/40O(@45&^@U0U3HJ6*FQ[R.9;??*IRSD*5'1@CN]1SIT9AL1!`2=>G'9G M+;':P+AF>:H<4!LR7<5(@'=8%+8,$Z>`RB!"F"L^P;LC%K/RD?"O:\A&,T`S MTRMW7BG3>K+)>(X91GX6Y%00, M"UE7Q[Y1+*H'R@JAR$``JU+AE)@-DU4.@@-X#2J@%8,A%.#Z75KH`?+A@#Y< M8"9Y/)8B$[J]O)&-#VZ6K(J=V4NR5+;]!!TGQ0=D*\9HD*E&ML9M'O$2`DV" MV6TPI6RA<+]8782`=E+8N:+,$1]3^`,K]?/>2WEW@FS0R;H$?)T8>\@ZMA4C^BC< M+H`-VE>7VJ\C@P]5&\\1PYV?D.5Z->O44UV.$]7[,!^.91.WSINB!BB&>`A= MEI(<.X9\)$4F:>Y!<@]O;B@;8Z:L<_7:0_9ZD6BLQ="U1C0SOQ(,4V!^S75+ M#@%'CNWD4(C[`Q*#P!38=ZO.F>5"@GQX8C5Z@^Q;46*NER4-X/&$C^/+#QJ\ M8M:SILC&QS8+4?7\I$Z(4D2<"!,G0B5)4`;(.!DV\?E\C,\@3\6`2\VZ7Z.D M0]\AS-)1>=)8*QUZ/3(4<]`+@,J%0,"BW1;_6XQ@9G\E:+>6_=EP`_>[<%]0 M]ZO2H]MC?^T01OY7'WZTXC\,&&T.@P#H!4#]]J"LL`WSO0&R>;E7KMMKV1U] MB,89F&QF,BR&Z"'DUNW%OL.:Q:-ZB=M./)0FB)^!:JQ$,<>#I5@G1%D$;^:W MO7#(2[!QP>DRE%E8*M&CM<("_,^BB//^*8P.`5R#A%0DI,<9;;EO\S'LJ2Z% M5X&'AWK(&DXX_B.41%Q#N9EN/"CW;3YP/3_5';BF,)P(R*$SH/SO/NJP)"B;LY[+J+7ZS*2MCESE3T&&AQO*%IB-I1D? ME0Y'P:H+1]N`,P1FZ4H8Y<%&21\BP$X$V8E!#\RKS/8ZD0=]P!N"LW25C%HR M]^#"%?[R\9U[/Z/ED@13JGZ+?PD"&I$0_0B_83]*BX`F7#`YE[\<"1;B(R4E MB^#K_XSDUG=^G^/R6'KJ"^3B4$"0*E=G\BCPTCM<\.'O\6*"V9$3H`7^Y6@] M$,3W0<$F>''IX@@B5/[A7QD-E[\C@`9!N/C9HPM$ M@EOY`2;GR(D:+E4*H6?5T`NC)UY'SL=N4_)9(ALEE$#^(WZE_BL436#8(^(& MP7-!L:I.0I=.EI*]OB3T!V'IE#SBI2])B%X(M)6$#IVL);L]K7M)H#J2E'P* MF3M''(\9A.8O-/09&EI)WMF)RIU1H:;\NYW(G]<@?[X/R'_.(5DE0?O50D)2 M3RA^#C^*&Z:T-#3H0T[T"X0"!+-M4,.@X&809U.&VD*!*"2P*/"I=7,;&2?M MWP4)Z'*.@_@%(A^-;\L4&EK92-@?(>'*7M8(H_:;?7(HG1?"J=Q(\`5F,QQ< M4K:D$:`2@]JTW!V3,H)4=O`H(X=TW52&#+ET'I9Q;@R>$=2B97^&+6@@)9JM MRA1-HD3XDAP\(6(C=$)@+5R^4+9Z$GCYLGRF\.SW8:H>!.OH-?:PF6ZIY.GT M$O&Y,H/FU/^J)$D+F9Q:1))[J&FOP7"PE@*/#*C"C^9B/21$J^?[^28C"<<$,J>()$A]B`]YQU%07+L%CVJ M$C0VK!*P/>:MYS#_1E/\$O"(>G5HL^F9;0M]WR94EZX1CE1P!*]IMDQ=K764 M.I`C=P?D)T5M>DQ'N?^_P9R,Y0*0'U*RNL^*!L).EDT;/U-#U35B@:2*7ZP2 M?SBK-]#:F.D$Q%;+)GHAG,7LCZ59EO_\OL12;3;-0EL`^[1N;@,I53,BT56I M"_.'2QFW6PM*/VBV2DRNY*8'.F!*4$(9CXGQBNFJU4N1)#6E.N)OF*P-@=^% MM/541KTISOV23QR_C.+Z1+NR$VYCMYN'V;<:S=-]T M^DP%9!'-F^EMM6@/4#M5H76G09=("H.+2Z$ZMX'[H7@HU**=?4==EXAYDE_^ M;QCY8JXCJO:[A<0$_%GN)FBI)I]7#H`;OEM(3/24%TX6W'E`?3HKQ18U-;"1 MG,`#P](##4!]XB%P4])[!7C$K`!4[J[[=+3N8AMP#WT5#2+-;5YFI/ZCE4S4 M.9<58TL@ M3^=:4*QSL)K8SA`7]]+80"CPKK`OZ6"KIQ67"%2EN55C&\0@"AG!$LOX)`![ ML?^;XW)SHSUB8B@9LQJ]DQQM^9_:4>*)GSVR@&KV5''@&ZE/A>B5XGL)^_1' M&]7E*_$(#L9^V1#1?+`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`!4:^0(J)8[8Q.TWTQ MOPX[=+#UE+*7BRX5=H[#Q+ MM6#V8(8@A0Y-WNWW(8BY\^I4&-M;MWW7ZLAWY,]H20T6?[-0L;]C M'T5QHT\N@<=]_.[N\NSL3&KKL],?QPAR*MP1$1_1EJGKUWGW"C^-`LM5#!QC MS.#5`YQ-_X-".G^XJK<:]=1=#J$'[$TG`)^21G#4]PS3<+B5AYTCFFGM2:%?55 M\\T^(FZ_(D90$?G2;[M?T]E-7W)A3,4CN#Z0G+-P)SB"*XE"9'C/OM:=S M(J^C)8E97UV%6-!\+E`Z+24*Y2VFIB,XJ[64D<9X[0DH?H:L$_' MO5XJ49482-,F=^B2&L@]?^PR/^U![L^2N:$,DQF\@XL32L7Q\5(U/--\S;:Z MB>H"8&\$"NXYU0,YM6&VW'Q,G?9'*"0!,1?_)CTA[A$WN52Z(E.Y+N`FL6X6 M6O;=J\DH2G943),$L:DOS1]E6S5,2-O^>SPI:U@F/6'M\605\IFW;KTWVI,$ MNMVS[GEJ[]Y[8Z354=1N>;3N;?."(%#W`\*J+M&2"'AUB8K65WV#_3D]H`OT M7CHY+?YFX7%O28R2%/.(CQ$3=*K)J:XY&ED+AH5'*)WI*1VU].YOU9%,EBXF M28LQ"KP;G-?<34UL5D<9WG"SG^4!T%%6:6'Q/ES$.LXI6D=4]MGBG;2(LB;= M:',3VS:/`F%2I&)+K]XV,C6S3A@;M"IFD;9#?GF7U'W:_34C[%(/TTLEP4E- MQ2BW>O:DYQZ]DT6XN*",T3=XP8J6LJ5($W.N"4[^H;9&'&.B/L()1:^X+>_8<9QJ4Y,BW86J'M`\GDN]UNXH9]2 MEB_%?($XX6DA!A6*5""N6S_[;.,Z#M]+>T,JTZ^,>N("?<6LR-CZS_;YNGE< M_P%I=>56(2<2ZDE)9/F$,GJ%??2&RB];^W2TD7RV@DR(OV&(4N?WA',:,E(F MM;F1A62Y_R5]:7BK%ZVQ2KQM4P,+R<%BOO*7FK)51\P:*2'W."Y4Z&X:E9 ME'W#]^D;C)52V+63;:YXW0J4IHG^@8CN@WT*Y(MT.,N/YVHR-K1K:B&)]!5) M-Y"?G9Q^AI>L)Z??EPAK:&`O.9!W5!7H$(("RD*B>G,U&BV73+;P]22V[;0? M9';=N1R/DQO`WC5H\)WGN=(C!B.9AQ[-Y0],XP* MI^:=>^W.H2T22JU+>SA61'24@2"EZX M-$7IDW187=R&[K:][2%<,88H'?,2$+D/-I!I:&O?8>*7\)5>(EXV4LN_VK?% M/TRG\*+LM8AXY5<;$=?B;3W:*NW)J(1VZ4=;T;[0H7UA`=HIFLQ3YYLCE:&2 MCT(QIPRRY*V"JW(ZG$A6-XURG-;0T-%_CTE:!V#!A"CTS@\+PG"<.#"IL\#CZH5/ M6(@(`0Z)2F"0"W5@^(S>T\FT"2/K#FQKMY9HUJ3'`A4C504;H MWE),37:_:*I MP7!,?>*NGO&[N/"I^]5`3[7U&H2)!,P&:%-Q`'`NEZSE*_)*/!QX&4%-3?8G M9DQ:X0%'I)1/O_*KA`B+B+%"K1ZF,I=?PAEC&K];-=U[< MHXPJ'P%FN5^C".LZRNJ;6Q!;6T&V&!(>.>3*J43V!STQFN_6$O/@"BI1;."-OH4%"PWJ96"/1RF#LJ>*Z6.O;'6U:6G= MDM+1635?M43JFUE'89UH_CV4#H=+651?P\4211?Y7#T+*$AHFX;VK;P$ZR?L MADR=U=4EM&[5TF("P;Z+29BO*I++2&O+3O:1G;V/3O@5/:>\1Y#U5JRN MD)#&[]]"?U7=.GKVM7,2`N&OHBO@D:N>:TD5*]53(/]THRNA<@7'SKUV[O;5 M8?P$=Y/2H>&50Y5./:PX6%$YFXD;E^U*Z^/`(SR?\EQQA#8-]^610D:+2BG< M<$C1JJ4%@EK$$O"*'.]+F#T?U]*C;;G-D(C>]"AI:T-.N:%U)E&!RC1=>GH; M7TAO9FACWZFFEK@X5_S%Z@G/H)5*V*-1GEVZV*,]2RB#>FPB*?Z^'V*9PUF? MI]U$:6TOZ^AOW"P2RFXD.4[3MSP]V[U`4L(8J;O6)IJ+`P7Y.S M`Z\[@[".\=J9D?9:7-<":GARR.P,Z?4BP9;.IQ]ZJL@%[#*0F\"[PDN&75)( MS+=1B'LY;\]4(#^F,4FM`D=-4>B8)+A66_8$9-TLU:L5P>AR3H(Z9[FIP>[5 MR),[QU[HXX=*X:O;F>[C?*\>Y?A(O35Z<4S!?==T2+J:5\+ MUD[GI4Z,$]KH5.5JH=.Q=`!P3:[+MHVM2VK9A'@A>V6;AA:EJYA@+A9(0.3I)/3"E+LXW+;2G.L:N: M&+3=QJ!:-E=95/FTMH*3:69ZP;!R'@KUFWBQ@%.[6>@$P=8YP$F^P3[JHR<4 MR_?$DJV33\`X6<69C7'#-MFYO\4[9RM::C;33GTMV%\[S\9D=8_^2=DEO-!I M+P]UO?9'"O(4M..]KL=><#S)S'J%)W*;B]W]_*Z?54"R6B`X4U4A( M#P@62,SZ,]&PG:X#RC+[(KX>)YAO=(8V!=9R"^0+CI*=2YL2J+PCK]B+L\VM M?L5TQM!R3MP1PZA!Z?0#8K'.:4]0CH_QLJ3!TY($#].I<0JZ];:,]A>.IZ$/.R$<;8X9E;#$ M2KUZD,R\EC[ZLC[V8WTP=FI#O$11M]&,8=7VC8CY)7TE'L&E"[^VC2VX_$LQ M57>S50*2GZV[C4TI@"5V`9LQO(#%4L&H>6<,GN6H=">KK$E^OP8!C.HILE`= MXZN3VF>IKZ(%RW^5(`1<2$=/L]2]=1HMF<[4SH:WFR.3ABF9K/06E'Y*1#8E M.1/K'D.X8!:D4N#'#@;?>:3E3@C_795'D`[3*V9HAI7(PHVW?IG8B-TV+TF!-*WM"?*1L/D?B=QKZWNUB*>W%Z^D4NRKD M![U#O:.X)!?V'F$D.HU&?%E*K"^D1YC&O=N&U+X\_'A:0D"E+U874HR]4A:D MNH_V/=-135M;+`)X('*+D33P:'P(ND'#D)LD2OQ>(] M/?K9MMH*4Q`]Z^31+O`%"W5\,Y4;`(TR#A7H;M'87H>E2@`5&`YKL@WL$<`T M4%S;H3_54I#63MU:Q31S[>.@;(T/U;'3'C$V$4M5FT)Z"Y,07IR%;.E+PLD_I0@O1$[`'B<,-?5RS4 MT,9"HN:8H:^4WRX684#AP!,M2U7"JL1ESM$N3(KN-IE2DS-+"0- MKG/5>P=.U%EZB:3:SQ;LD8!;,9U)^L(;'G0''!?(,#:USJZK9=H;56)V#3=0 M.5FK47UM6ULHG;(KG6:QTJ-WDOKU-=]:Q[-Y9!%5I_EF+S?*&%^I2:NC)_UJ M'UM>/CQ]N,&>U-M2O#U5+.IO(8/DD:Y&A[1N;2>A=_"F_A(MJT15OMA)P-," M^?X]\;0TZ#[N7K6_2`35@SS(63(1D/P.]&BLJJ44J<>]N3N/+AULCVJQ`I4'/!_2C1(P'V)JL;RA:8%6^9M@A_S^8TN5%L0W-RY,ZP!ZW:3^SF M!MFSV56YSD;>JZKN@(BG[O0"K+9,".*%.&;*L9>5S&N>R%[P[,T&N"DBD\"5 M.-YHTW-8!?_O/Z40&K2=V2Q`WKN)E/KH]SEQYV*.XQM'PN_P3-I?*V6@R$[" M7T$Q/A\L%A4_-9&*3^4B\`1]Q`NB7K*0J3J>Y]$V8ICD[8UJ[55/;>!:M!:E MQY>E!GF4G5%V4-"OZ]Z)HO[)3-O&5CZ,>9%VOK1/L0<';F4/5/]M]W[./Q!3 M"P^"(NN2N2=$M&QK[:HLQ4O#@QXZC9_$`TT)G2W:?;.23W_Y")1P=XX72/[S M_P-02P$"'@,4````"``NB7A'.T!J?-ZS!0`K.7H`$``8```````!````I($` M````;6YK+3(P,34P.3(U+GAM;%54!0`#%^!45G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`"Z)>$?V+,+>6#\``$*T`@`4`!@```````$```"D@2BT!0!M M;FLM,C`Q-3`Y,C5?8V%L+GAM;%54!0`#%^!45G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`"Z)>$>T=H`Q0````(`"Z)>$<_PBCJ"`T"`&?D'``4`!@```````$```"D@2,7!P!M M;FLM,C`Q-3`Y,C5?;&%B+GAM;%54!0`#%^!45G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`"Z)>$>2#8_@$8,!`(<2%``4`!@```````$```"D@7DD"0!M M;FLM,C`Q-3`Y,C5?<')E+GAM;%54!0`#%^!45G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`"Z)>$<#2>+XHR\``"5,`@`0`!@```````$```"D@=BG"@!M M;FLM,C`Q-3`Y,C4N>'-D550%``,7X%16=7@+``$$)0X```0Y`0``4$L%!@`` 0```&``8`%`(``,77"@`````` ` end XML 86 R138.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Sep. 28, 2012
Current Assets:        
Cash and cash equivalents $ 365.9 $ 707.8 $ 275.5 $ 0.0
Accounts receivable, net 548.5 476.6    
Inventories 281.8 306.4    
Deferred income taxes 142.7 152.3    
Prepaid expenses and other current assets 207.3 227.1    
Current assets held for sale 299.9 200.8    
Intercompany receivable 0.0 0.0    
Total current assets 1,846.1 2,071.0    
Property, plant and equipment, net 991.3 886.8    
Goodwill 3,649.4 2,401.9    
Intangible assets, net 9,666.3 7,082.2    
Long-term assets held for sale 0.0 111.2    
Investment in subsidiaries 0.0 0.0    
Intercompany loan receivable 0.0 0.0    
Other assets 251.0 234.2    
Total Assets 16,404.1 12,787.3    
Current Liabilities:        
Current maturities of long-term debt 22.3 21.2    
Accounts payable 133.0 110.7    
Accrued payroll and payroll-related costs 103.7 116.3    
Accrued royalties 29.3 67.7    
Accrued and other current liabilities 568.3 529.9    
Current liabilities held for sale 72.8 59.0    
Intercompany payable 0.0 0.0    
Total current liabilities 929.4 904.8    
Long-term debt 6,474.3 3,874.0    
Pension and postretirement benefits 116.7 116.2    
Environmental liabilities 73.3 59.2    
Deferred income taxes 3,132.4 2,399.6    
Other income tax liabilities 121.3 122.6    
Long-term liabilities held for sale 0.0 9.7    
Intercompany loans payable 0.0 0.0    
Other liabilities 245.5 343.2    
Total Liabilities 11,092.9 7,829.3    
Shareholders' equity 5,311.2 4,958.0 1,255.6 1,891.9
Total Liabilities and Shareholders' Equity 16,404.1 12,787.3    
Mallinckrodt plc        
Current Assets:        
Cash and cash equivalents 0.1 0.3 1.2 0.0
Accounts receivable, net 0.0 0.0    
Inventories 0.0 0.0    
Deferred income taxes 0.0 0.0    
Prepaid expenses and other current assets 1.3 0.5    
Current assets held for sale 0.0 0.0    
Intercompany receivable 39.1 13.5    
Total current assets 40.5 14.3    
Property, plant and equipment, net 0.0 0.0    
Goodwill 0.0 0.0    
Intangible assets, net 0.0 0.0    
Long-term assets held for sale 0.0 0.0    
Investment in subsidiaries 14,797.7 586.8    
Intercompany loan receivable 174.4 4,385.0    
Other assets 0.0 0.0    
Total Assets 15,012.6 4,986.1    
Current Liabilities:        
Current maturities of long-term debt 0.0 0.0    
Accounts payable 0.0 1.2    
Accrued payroll and payroll-related costs 0.1 0.1    
Accrued royalties 0.0 0.0    
Accrued and other current liabilities 1.8 1.1    
Current liabilities held for sale 0.0 0.0    
Intercompany payable 9,699.5 25.7    
Total current liabilities 9,701.4 28.1    
Long-term debt 0.0 0.0    
Pension and postretirement benefits 0.0 0.0    
Environmental liabilities 0.0 0.0    
Deferred income taxes 0.0 0.0    
Other income tax liabilities 0.0 0.0    
Long-term liabilities held for sale 0.0 0.0    
Intercompany loans payable 0.0 0.0    
Other liabilities 0.0 0.0    
Total Liabilities 9,701.4 28.1    
Shareholders' equity 5,311.2 4,958.0    
Total Liabilities and Shareholders' Equity 15,012.6 4,986.1    
Mallinckrodt International Finance S.A.        
Current Assets:        
Cash and cash equivalents 152.1 18.5 56.5 0.0
Accounts receivable, net 0.0 0.0    
Inventories 0.0 0.0    
Deferred income taxes 0.0 0.0    
Prepaid expenses and other current assets 0.2 10.8    
Current assets held for sale 0.0 0.0    
Intercompany receivable 128.6 0.0    
Total current assets 280.9 29.3    
Property, plant and equipment, net 0.0 0.0    
Goodwill 0.0 0.0    
Intangible assets, net 0.0 0.0    
Long-term assets held for sale 0.0 0.0    
Investment in subsidiaries 18,838.6 10,645.7    
Intercompany loan receivable 0.0 0.0    
Other assets 0.1 0.0    
Total Assets 19,119.6 10,675.0    
Current Liabilities:        
Current maturities of long-term debt 20.0 18.2    
Accounts payable 0.2 0.2    
Accrued payroll and payroll-related costs 0.0 0.0    
Accrued royalties 0.0 0.0    
Accrued and other current liabilities 77.4 50.9    
Current liabilities held for sale 0.0 0.0    
Intercompany payable 0.0 0.0    
Total current liabilities 97.6 69.3    
Long-term debt 6,299.4 3,693.9    
Pension and postretirement benefits 0.0 0.0    
Environmental liabilities 0.0 0.0    
Deferred income taxes 0.0 0.0    
Other income tax liabilities 0.0 0.0    
Long-term liabilities held for sale 0.0 0.0    
Intercompany loans payable 2,672.6 1,966.6    
Other liabilities 0.0 0.0    
Total Liabilities 9,069.6 5,729.8    
Shareholders' equity 10,050.0 4,945.2    
Total Liabilities and Shareholders' Equity 19,119.6 10,675.0    
Other Subsidiaries        
Current Assets:        
Cash and cash equivalents 213.7 689.0 217.8 0.0
Accounts receivable, net 548.5 476.6    
Inventories 281.8 306.4    
Deferred income taxes 142.7 152.3    
Prepaid expenses and other current assets 205.8 215.8    
Current assets held for sale 299.9 200.8    
Intercompany receivable 9,699.5 25.7    
Total current assets 11,391.9 2,066.6    
Property, plant and equipment, net 991.3 886.8    
Goodwill 3,649.4 2,401.9    
Intangible assets, net 9,666.3 7,082.2    
Long-term assets held for sale 0.0 111.2    
Investment in subsidiaries 10,050.0 4,945.1    
Intercompany loan receivable 2,498.2 1,941.6    
Other assets 250.9 234.2    
Total Assets 38,498.0 19,669.6    
Current Liabilities:        
Current maturities of long-term debt 2.3 3.0    
Accounts payable 132.8 109.3    
Accrued payroll and payroll-related costs 103.6 116.2    
Accrued royalties 29.3 67.7    
Accrued and other current liabilities 489.1 477.9    
Current liabilities held for sale 72.8 59.0    
Intercompany payable 167.7 13.5    
Total current liabilities 997.6 846.6    
Long-term debt 174.9 180.1    
Pension and postretirement benefits 116.7 116.2    
Environmental liabilities 73.3 59.2    
Deferred income taxes 3,132.4 2,399.6    
Other income tax liabilities 121.3 122.6    
Long-term liabilities held for sale 0.0 9.7    
Intercompany loans payable 0.0 4,360.0    
Other liabilities 245.5 343.2    
Total Liabilities 4,861.7 8,437.2    
Shareholders' equity 33,636.3 11,232.4    
Total Liabilities and Shareholders' Equity 38,498.0 19,669.6    
Eliminations        
Current Assets:        
Cash and cash equivalents 0.0 0.0 $ 0.0 $ 0.0
Accounts receivable, net 0.0 0.0    
Inventories 0.0 0.0    
Deferred income taxes 0.0 0.0    
Prepaid expenses and other current assets 0.0 0.0    
Current assets held for sale 0.0 0.0    
Intercompany receivable (9,867.2) (39.2)    
Total current assets (9,867.2) (39.2)    
Property, plant and equipment, net 0.0 0.0    
Goodwill 0.0 0.0    
Intangible assets, net 0.0 0.0    
Long-term assets held for sale 0.0 0.0    
Investment in subsidiaries (43,686.3) (16,177.6)    
Intercompany loan receivable (2,672.6) (6,326.6)    
Other assets 0.0 0.0    
Total Assets (56,226.1) (22,543.4)    
Current Liabilities:        
Current maturities of long-term debt 0.0 0.0    
Accounts payable 0.0 0.0    
Accrued payroll and payroll-related costs 0.0 0.0    
Accrued royalties 0.0 0.0    
Accrued and other current liabilities 0.0 0.0    
Current liabilities held for sale 0.0 0.0    
Intercompany payable (9,867.2) (39.2)    
Total current liabilities (9,867.2) (39.2)    
Long-term debt 0.0 0.0    
Pension and postretirement benefits 0.0 0.0    
Environmental liabilities 0.0 0.0    
Deferred income taxes 0.0 0.0    
Other income tax liabilities 0.0 0.0    
Long-term liabilities held for sale 0.0 0.0    
Intercompany loans payable (2,672.6) (6,326.6)    
Other liabilities 0.0 0.0    
Total Liabilities (12,539.8) (6,365.8)    
Shareholders' equity (43,686.3) (16,177.6)    
Total Liabilities and Shareholders' Equity $ (56,226.1) $ (22,543.4)    

XML 87 R140.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Cash Flows) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Cash Flows From Operating Activities:      
Net cash (used in) provided by operating activities $ 896.4 $ 373.4 $ 135.9
Cash Flows From Investing Activities:      
Capital expenditures (148.0) (127.8) (147.9)
Acquisitions and intangibles, net of cash acquired (2,154.7) (2,793.8) (88.1)
Intercompany Loan Investment 0.0 0.0 0.0
Subsidiary dividend proceeds   0.0  
Investment in subsidiary 0.0 0.0 0.0
Restricted cash 3.1 4.1 0.0
Other 3.0 26.7 1.3
Net cash used in investing activities (2,296.6) (2,890.8) (234.7)
Cash Flows From Financing Activities:      
Issuance of external debt 3,010.0 3,043.2 898.1
Repayment of capital leases (1,848.4) (34.8) (1.3)
Excess tax benefit from share-based compensation 34.1 8.9 3.4
Debt financing costs (39.9) (71.7) (12.0)
Net transfers to parent 0.0 0.0 (515.9)
Proceeds from exercise of share options 34.4 25.8 0.6
Subsidiary dividend payment   0.0  
Intercompany loan borrowings 0.0 0.0 0.0
Capital contribution 0.0 0.0 0.0
Repurchase of ordinary shares, value (92.2) (17.5)  
Other (28.1) 0.0 0.1
Net cash provided by financing activities 1,069.9 2,953.9 373.0
Effect of currency rate changes on cash (11.6) (4.2) 1.3
Net (decrease) increase in cash and cash equivalents (341.9) 432.3 275.5
Cash and cash equivalents at beginning of period 707.8 275.5 0.0
Cash and cash equivalents at end of period 365.9 707.8 275.5
Mallinckrodt plc      
Cash Flows From Operating Activities:      
Net cash (used in) provided by operating activities 207.0 18.2 (1.8)
Cash Flows From Investing Activities:      
Capital expenditures 0.0 0.0 0.0
Acquisitions and intangibles, net of cash acquired 0.0 0.0 0.0
Intercompany Loan Investment (149.4) (25.0) 0.0
Subsidiary dividend proceeds   0.0  
Investment in subsidiary 0.0 0.0 0.0
Restricted cash 0.0 0.0  
Other 0.0 0.0 0.0
Net cash used in investing activities (149.4) (25.0) 0.0
Cash Flows From Financing Activities:      
Issuance of external debt 0.0 0.0 0.0
Repayment of capital leases 0.0 0.0 0.0
Excess tax benefit from share-based compensation 0.0 0.0 0.0
Debt financing costs 0.0 0.0 0.0
Net transfers to parent     0.0
Proceeds from exercise of share options 34.4 25.8 0.6
Subsidiary dividend payment   0.0  
Intercompany loan borrowings 0.0 (2.4) 2.4
Capital contribution 0.0 0.0 0.0
Repurchase of ordinary shares, value (92.2) (17.5)  
Other 0.0 0.0 0.0
Net cash provided by financing activities (57.8) 5.9 3.0
Effect of currency rate changes on cash 0.0 0.0 0.0
Net (decrease) increase in cash and cash equivalents (0.2) (0.9) 1.2
Cash and cash equivalents at beginning of period 0.3 1.2 0.0
Cash and cash equivalents at end of period 0.1 0.3 1.2
Mallinckrodt International Finance S.A.      
Cash Flows From Operating Activities:      
Net cash (used in) provided by operating activities (148.2) (65.0) (8.4)
Cash Flows From Investing Activities:      
Capital expenditures 0.0 0.0 0.0
Acquisitions and intangibles, net of cash acquired 0.0 0.0 0.0
Intercompany Loan Investment 0.0 (298.1) (2.4)
Subsidiary dividend proceeds   300.5  
Investment in subsidiary (3,014.4) (3,735.5) (68.0)
Restricted cash 0.0 0.0  
Other 0.0 0.0 0.0
Net cash used in investing activities (3,014.4) (3,733.1) (70.4)
Cash Flows From Financing Activities:      
Issuance of external debt 2,890.0 2,893.3 898.1
Repayment of capital leases (258.3) (3.3) 0.0
Excess tax benefit from share-based compensation 0.0 0.0 0.0
Debt financing costs (39.1) (70.7) (12.0)
Net transfers to parent     (1,160.4)
Proceeds from exercise of share options 0.0 0.0 0.0
Subsidiary dividend payment   0.0  
Intercompany loan borrowings 703.6 940.8 409.6
Capital contribution 0.0 0.0 0.0
Repurchase of ordinary shares, value 0.0 0.0  
Other 0.0 0.0 0.0
Net cash provided by financing activities 3,296.2 3,760.1 135.3
Effect of currency rate changes on cash 0.0 0.0 0.0
Net (decrease) increase in cash and cash equivalents 133.6 (38.0) 56.5
Cash and cash equivalents at beginning of period 18.5 56.5 0.0
Cash and cash equivalents at end of period 152.1 18.5 56.5
Other Subsidiaries      
Cash Flows From Operating Activities:      
Net cash (used in) provided by operating activities 837.6 420.2 146.1
Cash Flows From Investing Activities:      
Capital expenditures (148.0) (127.8) (147.9)
Acquisitions and intangibles, net of cash acquired (2,154.7) (2,793.8) (88.1)
Intercompany Loan Investment (554.2) (915.8) (409.6)
Subsidiary dividend proceeds   0.0  
Investment in subsidiary 0.0 0.0 0.0
Restricted cash 3.1 4.1  
Other 3.0 26.7 1.3
Net cash used in investing activities (2,850.8) (3,806.6) (644.3)
Cash Flows From Financing Activities:      
Issuance of external debt 120.0 149.9 0.0
Repayment of capital leases (1,590.1) (31.5) (1.3)
Excess tax benefit from share-based compensation 34.1 8.9 3.4
Debt financing costs (0.8) (1.0) 0.0
Net transfers to parent     644.5
Proceeds from exercise of share options 0.0 0.0 0.0
Subsidiary dividend payment   (300.5)  
Intercompany loan borrowings 0.0 300.5 0.0
Capital contribution 3,014.4 3,735.5 68.0
Repurchase of ordinary shares, value 0.0 0.0  
Other (28.1) 0.0 0.1
Net cash provided by financing activities 1,549.5 3,861.8 714.7
Effect of currency rate changes on cash (11.6) (4.2) 1.3
Net (decrease) increase in cash and cash equivalents (475.3) 471.2 217.8
Cash and cash equivalents at beginning of period 689.0 217.8 0.0
Cash and cash equivalents at end of period 213.7 689.0 217.8
Eliminations      
Cash Flows From Operating Activities:      
Net cash (used in) provided by operating activities 0.0 0.0 0.0
Cash Flows From Investing Activities:      
Capital expenditures 0.0 0.0 0.0
Acquisitions and intangibles, net of cash acquired 0.0 0.0 0.0
Intercompany Loan Investment 703.6 1,238.9 412.0
Subsidiary dividend proceeds   (300.5)  
Investment in subsidiary 3,014.4 3,735.5 68.0
Restricted cash 0.0 0.0  
Other 0.0 0.0 0.0
Net cash used in investing activities 3,718.0 4,673.9 480.0
Cash Flows From Financing Activities:      
Issuance of external debt 0.0 0.0 0.0
Repayment of capital leases 0.0 0.0 0.0
Excess tax benefit from share-based compensation 0.0 0.0 0.0
Debt financing costs 0.0 0.0 0.0
Net transfers to parent     0.0
Proceeds from exercise of share options 0.0 0.0 0.0
Subsidiary dividend payment   300.5  
Intercompany loan borrowings (703.6) (1,238.9) (412.0)
Capital contribution (3,014.4) (3,735.5) (68.0)
Repurchase of ordinary shares, value 0.0 0.0  
Other 0.0 0.0 0.0
Net cash provided by financing activities (3,718.0) (4,673.9) (480.0)
Effect of currency rate changes on cash 0.0 0.0 0.0
Net (decrease) increase in cash and cash equivalents 0.0 0.0 0.0
Cash and cash equivalents at beginning of period 0.0 0.0 0.0
Cash and cash equivalents at end of period $ 0.0 $ 0.0 $ 0.0
XML 88 R59.htm IDEA: XBRL DOCUMENT v3.3.0.814
Recently Issued Accounting Standards Narrative (Details)
$ in Millions
Sep. 25, 2015
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Unamortized Debt Issuance Expense $ 103.1
XML 89 R99.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Net Periodic Benefit Cost) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 4.5 $ 5.1 $ 5.0
Interest cost 17.5 19.6 18.2
Expected return on plan assets (22.6) (24.6) (29.6)
Amortization of net actuarial loss 9.4 8.1 12.3
Amortization of prior service cost (0.6) (0.6) 0.6
Loss on plan settlements 6.0 3.8 6.8
Net period benefit cost (credit) $ 14.2 11.4 13.3
U.S. Plans      
Defined Benefit Plan Disclosure [Line Items]      
Allocation of total pension plan assets 70.60%    
Allocation of total projected benefit obligation 73.10%    
Postretirement Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 0.1 0.1 0.1
Interest cost 1.9 2.1 2.4
Expected return on plan assets 0.0 0.0 0.0
Amortization of net actuarial loss 0.0 0.0 0.3
Amortization of prior service cost (4.0) (9.3) (9.1)
Loss on plan settlements 0.0 0.0 0.0
Net period benefit cost (credit) $ (2.0) $ (7.1) $ (6.3)
XML 90 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814
Background and Basis of Presentation (Policies)
 12 Months Ended
Sep. 25, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Accounting
The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP").
Use of Estimates
The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ from those estimates.
Consolidation
The consolidated and combined financial statements include the accounts of the Company, its wholly-owned subsidiaries and entities in which they own or control more than fifty percent of the voting shares, or have the ability to control through similar rights. The results of entities disposed of are included in the consolidated and combined financial statements up to the date of disposal and, where appropriate, these operations have been reflected as discontinued operations. Divestitures of product lines not representing businesses have been reflected in operating income. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments necessary for a fair presentation have been included in the results reported.
Fiscal Period
Fiscal Year
The Company reports its results based on a "52-53 week" year ending on the last Friday of September. Fiscal 2015, 2014 and 2013 each consisted of 52 weeks. Unless otherwise indicated, fiscal 2015, 2014 and 2013 refer to the Company's fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013, respectively. Fiscal 2016 will consist of 53 weeks and will end on September 30, 2016.
XML 91 R131.htm IDEA: XBRL DOCUMENT v3.3.0.814
(Schedule of Carrying Amount and Fair Value of Long-term Debt) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Variable rate receivable securitization $ 153.0 $ 150.0
Carrying Value | 2.85% term loan due April 2016    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 0.0 3.1
Carrying Value | Term loan due March 2021    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 1,978.5 1,996.7
Carrying Value | 4.00% term loan due February 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 7.9 10.8
Carrying Value | Debentures | 9.50% debentures due May 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 10.4 10.4
Carrying Value | Debentures | 8.00% debentures due March 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 4.4 8.0
Carrying Value | Senior Notes | 3.50% notes due April 2018    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 300.0 300.0
Carrying Value | Senior Notes | 5.75% notes due August 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 900.0 900.0
Carrying Value | Senior Notes | 4.75% notes due April 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 600.0 600.0
Carrying Value | Debentures | Four Point Eight Eight Percent Notes [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 700.0 0.0
Carrying Value | Debentures | Five Point Five Percent Notes [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 700.0 0.0
Carrying Value | Debentures | 2015 Revolving Credit Facility    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 500.0  
Carrying Value | Debentures | 5.625% notes due October 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 750.0 0.0
Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Variable rate receivable securitization 153.0 150.0
Fair Value | 2.85% term loan due April 2016    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 0.0 3.1
Fair Value | Term loan due March 2021    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 1,966.5 1,970.4
Fair Value | 4.00% term loan due February 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loan payable 7.9 10.8
Fair Value | Debentures | 9.50% debentures due May 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 13.0 14.2
Fair Value | Debentures | 8.00% debentures due March 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 5.3 10.2
Fair Value | Senior Notes | 3.50% notes due April 2018    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 294.3 290.2
Fair Value | Senior Notes | 5.75% notes due August 2022    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 876.1 907.3
Fair Value | Senior Notes | 4.75% notes due April 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 539.6 563.8
Fair Value | Debentures | Four Point Eight Eight Percent Notes [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 684.1 0.0
Fair Value | Debentures | Five Point Five Percent Notes [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 646.0 0.0
Fair Value | Debentures | 2015 Revolving Credit Facility    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt 500.0  
Fair Value | Debentures | 5.625% notes due October 2023    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long term debt $ 705.2 $ 0.0
XML 92 R65.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Apr. 16, 2015
Sep. 26, 2014
Aug. 14, 2014
Mar. 19, 2014
Oct. 01, 2012
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Goodwill (non-tax deductible) $ 3,649.4   $ 2,401.9      
Therakos            
Business Acquisition [Line Items]            
Receivables 22.0          
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Cash 41.3          
Inventory 23.5          
Intangible assets 1,170.0          
Goodwill (non-tax deductible) 437.2          
Other assets, current and non-current 42.1          
Total assets acquired 1,714.1          
Current liabilities 24.7          
Unpaid purchase consideration (current) 0.0          
Other liabilities (non-current) 0.6          
Deferred tax liabilities, net (non-current) 324.3          
Contingent consideration (non-current) 0.0          
Total Debt 344.8          
Total liabilities assumed 694.4          
Net assets acquired $ 1,019.7          
Ikaria            
Business Acquisition [Line Items]            
Receivables   $ 73.8        
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Cash   77.3        
Inventory   26.3        
Intangible assets   1,971.0        
Goodwill (non-tax deductible)   792.4        
Other assets, current and non-current   172.9        
Total assets acquired   3,039.9        
Current liabilities   32.6        
Unpaid purchase consideration (current)   0.0        
Other liabilities (non-current)   9.1        
Deferred tax liabilities, net (non-current)   623.6        
Contingent consideration (non-current)   0.0        
Total Debt   1,121.0        
Total liabilities assumed   1,786.3        
Net assets acquired   $ 1,253.6        
Questcor Pharmaceuticals, Inc.            
Business Acquisition [Line Items]            
Receivables       $ 87.3    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Cash       445.1    
Inventory       67.9    
Intangible assets       5,601.1    
Goodwill (non-tax deductible)       1,789.4    
Other assets, current and non-current       274.3    
Total assets acquired       8,177.8    
Current liabilities       168.9    
Unpaid purchase consideration (current)       128.8    
Other liabilities (non-current)       186.8    
Deferred tax liabilities, net (non-current)       1,906.8    
Contingent consideration (non-current)       0.0    
Total Debt       0.0    
Total liabilities assumed       2,391.3    
Net assets acquired       $ 5,786.5    
Cadence Pharmaceuticals, Inc.            
Business Acquisition [Line Items]            
Receivables         $ 14.7  
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Cash         43.2  
Inventory         21.0  
Intangible assets         1,300.0  
Goodwill (non-tax deductible)         318.1  
Other assets, current and non-current         18.0  
Total assets acquired         1,700.3  
Current liabilities         48.8  
Unpaid purchase consideration (current)         0.0  
Other liabilities (non-current)         0.0  
Deferred tax liabilities, net (non-current)         292.3  
Contingent consideration (non-current)         0.0  
Total Debt         30.0  
Total liabilities assumed         371.1  
Net assets acquired         $ 1,329.2  
CNS Therapeutics, Inc.            
Business Acquisition [Line Items]            
Receivables           $ 3.3
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]            
Cash           3.6
Inventory           0.0
Intangible assets           91.9
Goodwill (non-tax deductible)           24.5
Other assets, current and non-current           9.7
Total assets acquired           129.7
Current liabilities           4.0
Unpaid purchase consideration (current)           0.0
Other liabilities (non-current)           0.0
Deferred tax liabilities, net (non-current)           27.1
Contingent consideration (non-current)           6.9
Total Debt           0.0
Total liabilities assumed           38.0
Net assets acquired           $ 91.7
XML 93 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans
 12 Months Ended
Sep. 25, 2015
Compensation and Retirement Disclosure [Abstract]  
Retirement Plans
13.
Retirement Plans
Defined Benefit Plans
The Company sponsors a number of defined benefit retirement plans covering certain of its U.S. employees and non-U.S. employees. As of September 25, 2015, U.S. plans represented 70.6% of the Company's total pension plan assets and 73.1% of the Company's projected benefit obligation. The Company generally does not provide postretirement benefits other than retirement plan benefits for its employees; however, certain of the Company's U.S. employees participate in postretirement benefit plans that provide medical benefits. These plans are unfunded.
The net periodic benefit cost (credit) for the Company's pension and postretirement benefit plans was as follows:
 
Pension Benefits
 
Postretirement Benefits
 
Fiscal Year
 
Fiscal Year
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Service cost
$
4.5

 
$
5.1

 
$
5.0

 
$
0.1

 
$
0.1

 
$
0.1

Interest cost
17.5

 
19.6

 
18.2

 
1.9

 
2.1

 
2.4

Expected return on plan assets
(22.6
)
 
(24.6
)
 
(29.6
)
 
—

 
—

 
—

Amortization of net actuarial loss
9.4

 
8.1

 
12.3

 
—

 
—

 
0.3

Amortization of prior service cost
(0.6
)
 
(0.6
)
 
0.6

 
(4.0
)
 
(9.3
)
 
(9.1
)
Loss on plan settlements
6.0

 
3.8

 
6.8

 
—

 
—

 
—

Net periodic benefit cost (credit)
$
14.2

 
$
11.4

 
$
13.3

 
$
(2.0
)
 
$
(7.1
)
 
$
(6.3
)


The following table represents the changes in benefit obligations, plan assets and the net amounts recognized on the consolidated balance sheets for pension and postretirement benefit plans at the end of fiscal 2015 and 2014:
 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Change in benefit obligation:
 
 
 
 
 
 
 
Projected benefit obligations at beginning of year
$
538.4

 
$
501.7

 
$
52.0

 
$
53.2

Service cost
4.5

 
5.1

 
0.1

 
0.1

Interest cost
17.5

 
19.6

 
1.9

 
2.1

Employee contributions
0.6

 
0.6

 
—

 
—

Actuarial (gain) loss
(4.5
)
 
60.0

 
2.1

 
0.5

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Net transfer in/(out)
0.6

 
—

 
—

 
—

Currency translation
(18.9
)
 
(9.1
)
 
—

 
—

Projected benefit obligations at end of year
$
493.5

 
$
538.4

 
$
52.2

 
$
52.0

 
 
 
 
 
 
 
 
Change in plan assets:
 
 
 
 
 
 
 
Fair value of plan assets at beginning of year
$
473.6

 
$
456.0

 
$
—

 
$
—

Actual return on plan assets
12.5

 
59.7

 
—

 
—

Employer contributions
13.0

 
4.9

 
3.9

 
3.9

Employee contributions
0.6

 
0.6

 
—

 
—

Benefits and administrative expenses paid
(21.1
)
 
(21.9
)
 
(3.9
)
 
(3.9
)
Plan settlements
(23.6
)
 
(17.6
)
 
—

 
—

Currency translation
(17.1
)
 
(8.1
)
 
—

 
—

Fair value of plan assets at end of year
$
437.9

 
$
473.6

 
$
—

 
$
—

Funded status at end of year
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)


 
Pension Benefits
 
Postretirement Benefits
 
2015
 
2014
 
2015
 
2014
Amounts recognized on the consolidated balance sheet:
 
 
 
 
 
 
 
Non-current assets
$
20.1

 
$
9.8

 
$
—

 
$
—

Current liabilities
(6.6
)
 
(2.7
)
 
(4.6
)
 
(4.8
)
Non-current liabilities
(69.1
)
 
(71.9
)
 
(47.6
)
 
(47.2
)
Net amount recognized on the consolidated balance sheet
$
(55.6
)
 
$
(64.8
)
 
$
(52.2
)
 
$
(52.0
)
 
 
 
 
 
 
 
 
Amounts recognized in accumulated other comprehensive income consist of:
 
 
 
 
 
 
 
Net actuarial loss
$
(104.1
)
 
$
(115.1
)
 
$
(5.1
)
 
$
(2.9
)
Prior service credit
5.5

 
6.9

 
14.9

 
18.8

Net amount recognized in accumulated other comprehensive income
$
(98.6
)
 
$
(108.2
)
 
$
9.8

 
$
15.9



The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit cost (credit) in fiscal 2016 are as follows:
 
Pension Benefits
 
Postretirement Benefits
Amortization of net actuarial loss
$
10.8

 
$
—

Amortization of prior service cost
(0.5
)
 
(2.1
)


The accumulated benefit obligation for all pension plans at the end of fiscal 2015 and 2014 was $489.4 million and $533.6 million, respectively. Additional information related to pension plans is as follows:
 
2015
 
2014
Pension plans with accumulated benefit obligations in excess of plan assets:
 
 
 
Accumulated benefit obligation
$
368.8

 
$
394.7

Fair value of plan assets
294.1

 
321.6



The accumulated benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets do not significantly differ from the amounts in the table above since substantially all of the Company's pension plans are frozen.

Actuarial Assumptions
Weighted-average assumptions used each fiscal year to determine net periodic benefit cost for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.8
%
 
4.2
%
 
3.5
%
 
2.5
%
 
3.5
%
 
4.0
%
Expected return on plan assets
6.0
%
 
6.5
%
 
7.9
%
 
2.9
%
 
3.1
%
 
3.5
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.2
%
 
3.5
%
 
3.7
%

Weighted-average assumptions used each fiscal year to determine benefits obligations for the Company's pension plans are as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
Discount rate
3.9
%
 
3.9
%
 
4.3
%
 
2.5
%
 
2.5
%
 
3.7
%
Rate of compensation increase
—
%
 
—
%
 
—
%
 
3.6
%
 
3.4
%
 
3.5
%

For the Company's U.S. plans, the discount rate is based on the market rate for a broad population of Moody's AA-rated corporate bonds over $250.0 million. For the Company's non-U.S. plans, the discount rate is generally determined by reviewing country and region specific government and corporate bond interest rates.
In determining the expected return on pension plan assets, the Company considers the relative weighting of plan assets by class and individual asset class performance expectations as provided by external advisors in reaching conclusions on appropriate assumptions. The investment strategy for the pension plans is to obtain a long-term return on plan assets that is consistent with the level of investment risk that is considered appropriate. Investment risks and returns are reviewed regularly against benchmarks to ensure objectives are being met.
The weighted-average discount rate used to determine net periodic benefit cost and obligations for the Company's postretirement benefit plans are as follows:
 
2015
 
2014
 
2013
Net periodic benefit cost
3.6
%
 
4.0
%
 
3.2
%
Benefit obligations
3.9
%
 
3.7
%
 
4.0
%


Healthcare cost trend assumptions for postretirement benefit plans are as follows:
 
2015
 
2014
Healthcare cost trend rate assumed for next fiscal year
7.1
%
 
7.1
%
Rate to which the cost trend rate is assumed to decline
4.5
%
 
4.5
%
Fiscal year the ultimate trend rate is achieved
2029

 
2029



A one-percentage-point change in assumed healthcare cost trend rates would have the following effects:
 
One-Percentage-Point Increase
 
One-Percentage-Point Decrease
Effect on total of service and interest cost
$
—

 
$
—

Effect on postretirement benefit obligation
0.8

 
(0.7
)


Plan Assets
The Company's U.S. pension plans have a target allocation of 24% equity securities and 76% debt securities. Various asset allocation strategies are in place for non-U.S. pension plans depending upon local law, status, funding level and duration of liabilities, and are 39% equity securities, 55% debt securities and 6% other (primarily cash) for our Japanese pension plan and 10% equity securities, 2% debt securities and 88% other (primarily insurance contracts) for our plan in the Netherlands.
Pension plans have the following weighted-average asset allocations at the end of each fiscal year:
 
U.S. Plans
 
Non-U.S. Plans
 
2015
 
2014
 
2015
 
2014
Equity securities
27
%
 
28
%
 
6
%
 
8
%
Debt securities
70

 
70

 
1

 
2

Cash and cash equivalents
3

 
1

 
—

 
—

Other
—

 
1

 
93

 
90

Total
100
%
 
100
%
 
100
%
 
100
%


The following tables provide a summary of plan assets held by the Company's pension plans that are measured at fair value on a recurring basis at the end of fiscal 2015 and 2014:
 
 
 
Basis of Fair Value Measurement
 
Fiscal 2015
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
15.1

 
$
15.1

 
$
—

 
$
—

U.S. large cap
46.2

 
46.2

 
—

 
—

International
31.0

 
22.7

 
8.3

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
198.4

 
196.9

 
1.5

 
—

High yield bonds
11.3

 
11.3

 
—

 
—

Emerging market funds
7.4

 
7.4

 
—

 
—

Insurance contracts
116.7

 
—

 
—

 
116.7

Other
11.8

 
9.4

 
2.4

 
—

Total
$
437.9

 
$
309.0

 
$
12.2

 
$
116.7


 
 
 
Basis of Fair Value Measurement
 
Fiscal 2014
 
Quoted Prices in Active Markets for Identical Assets (Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Equity Securities:
 
 
 
 
 
 
 
U.S. small mid cap
$
16.6

 
$
16.6

 
$
—

 
$
—

U.S. large cap
50.2

 
50.2

 
—

 
—

International
39.8

 
28.7

 
11.1

 
—

Debt securities:
 
 
 
 
 
 
 
Diversified fixed income funds (1)
218.7

 
216.6

 
2.1

 
—

High yield bonds
13.0

 
13.0

 
—

 
—

Emerging market funds
9.5

 
9.5

 
—

 
—

Insurance contracts
119.8

 
—

 
—

 
119.8

Other
6.0

 
2.6

 
3.4

 
—

Total
$
473.6

 
$
337.2

 
$
16.6

 
$
119.8

(1)
Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds.

Equity securities. Equity securities primarily consist of mutual funds with underlying investments in foreign equity and domestic equity markets. The fair value of these investments is based on net asset value of the units held in the respective fund, which are determined by obtaining quoted prices on nationally recognized securities exchanges (level 1) or through net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).
Debt securities. Debt securities are primarily invested in mutual funds with underlying fixed income investments in U.S. government and corporate debt, U.S. dollar denominated foreign government and corporate debt, asset-backed securities, mortgage-backed securities and U.S. agency bonds. The fair value of these investments is based on the net asset value of the units held in the respective fund which are determined by obtaining quoted prices on nationally recognized securities exchanges.
Insurance contracts. Insurance contracts held by the Company are issued primarily by Delta Lloyd, a well-known, highly rated insurance company. The fair value of these insurance contracts is based upon the present value of future cash flows under the terms of the contracts and therefore the fair value of these assets has been classified as level 3 within the fair value hierarchy. Significant assumptions used in determining the fair value of these contracts are the amount and timing of future cash flows and counterparty credit risk. The objective of the insurance contracts is to provide the Company with future cash flows that will match the estimated timing and amount of future pension benefit payments. Delta Lloyd's insurance subsidiaries have a Standard & Poor's credit rating of A.
Other. Other includes cash and cash equivalents invested in a money market mutual fund, the fair value of which is determined by obtaining quoted prices on nationally recognized securities exchanges (level 1). In addition, other includes real estate funds, the fair value of which is determined using other inputs, such as net asset values provided by the fund administrators that can be corroborated by observable market data (level 2).
The following table provides a summary of the changes in the fair value measurements that used significant unobservable inputs (level 3) for fiscal 2015 and 2014:
 
Insurance Contracts
Balance at September 27, 2013
$
112.0

Net unrealized gains
15.5

Net purchases, sales and issuances
(0.6
)
Currency translation
(7.1
)
Balance at September 26, 2014
119.8

Net unrealized gains
12.2

Net purchases, sales and issuances
(0.1
)
Currency translation
(15.2
)
Balance at September 25, 2015
$
116.7



Mallinckrodt shares are not a direct investment of the Company's pension funds; however, the pension funds may indirectly include Mallinckrodt shares. The aggregate amount of the Mallinckrodt shares are not material relative to the total pension fund assets.

Contributions
The Company's funding policy is to make contributions in accordance with the laws and customs of the various countries in which the Company operates, as well as to make discretionary voluntary contributions from time to time. In fiscal 2015 and 2014, the Company made $13.0 million and $4.9 million in contributions, respectively, to the Company's pension plans. The Company does not anticipate making material involuntary contributions in fiscal 2016, but may elect to make voluntary contributions to its defined pension plans or its postretirement benefit plans during fiscal 2016.
 
Expected Future Benefit Payments
Benefit payments expected to be paid, reflecting future expected service as appropriate, are as follows:
 
Pension Benefits
 
Postretirement Benefits
Fiscal 2016
$
40.0

 
$
4.6

Fiscal 2017
33.6

 
4.3

Fiscal 2018
33.0

 
4.0

Fiscal 2019
32.6

 
3.8

Fiscal 2020
31.4

 
3.5

Fiscal 2021 - 2025
143.9

 
15.6



Defined Contribution Retirement Plans
The Company maintains one active tax-qualified 401(k) retirement plan and one active non-qualified deferred compensation plan in the U.S. The 401(k) retirement plan provides for an automatic Company contribution of three percent of an eligible employee's pay, with an additional Company matching contribution generally equal to 50% of each employee's elective contribution to the plan up to six percent of the employee's eligible pay. The deferred compensation plan permits eligible employees to defer a portion of their compensation. Total defined contribution expense related to continuing operations was $23.7 million, $20.5 million and $20.3 million for fiscal 2015, 2014 and 2013, respectively.

Rabbi Trusts and Other Investments
The Company maintains several rabbi trusts, the assets of which are used to pay retirement benefits. The rabbi trust assets are subject to the claims of the Company's creditors in the event of the Company's insolvency. Plan participants are general creditors of the Company with respect to these benefits. The trusts primarily hold life insurance policies and debt and equity securities, the value of which is included in other assets on the consolidated balance sheets. Note 20 provides additional information regarding the debt and equity securities. The carrying value of the 134 life insurance contracts held by these trusts was $57.9 million and $56.3 million at September 25, 2015 and September 26, 2014, respectively. These contracts had a total death benefit of $147.3 million and $145.7 million at September 25, 2015 and September 26, 2014, respectively. However, there are outstanding loans against the policies amounting to $40.4 million and $38.2 million at September 25, 2015 and September 26, 2014, respectively.
The Company has insurance contracts which serve as collateral for certain of the Company's non-U.S. pension plan benefits, which totaled $9.8 million and $11.0 million at September 25, 2015 and September 26, 2014, respectively. These amounts were also included in other assets on the consolidated balance sheets.
XML 94 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Sep. 25, 2015
Accounting Policies [Abstract]  
Revenue Recognition
Revenue Recognition
The Company recognizes revenue for product sales when title and risk of loss have transferred from the Company to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and any related services, based on contract terms or legal requirements in non-U.S. jurisdictions. The Company sells products through independent channels, including directly to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. Chargebacks and rebates represent credits that are provided to certain distributors and customers for either the difference between the Company's contracted price with a customer and the distributor's invoice price paid to the Company or for contractually agreed volume price discounts. When the Company recognizes net sales, it simultaneously records an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of the Company's products and other competitive factors. The Company adjusts these reserves to reflect differences between estimated activity and actual experience. Such adjustments impact the amount of net sales recognized by the Company in the period of adjustment.
Taxes collected from customers relating to product sales and remitted to governmental authorities are accounted for on a net basis. Accordingly, such taxes are excluded from both net sales and expenses.
Shipping and Handling Costs
Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises to the customer's premises, are classified as selling, general and administrative expenses. Handling costs, which are costs incurred to store, move and prepare product for shipment, are classified as cost of sales.
Research and Development
Research and Development
Internal research and development costs are expensed as incurred. Research and development expenses include salary and benefits, allocated overhead and occupancy costs, clinical trial and related clinical manufacturing costs, contract services and other costs.
Upfront and milestone payments made to third parties under license arrangements are expensed as incurred up to the point of regulatory approval of the product. Milestone payments made to third parties upon or subsequent to regulatory approval are capitalized as an intangible asset and amortized to cost of sales over the estimated useful life of the related product.
Currency Translation
Currency Translation
For the Company's non-U.S. subsidiaries that transact in a functional currency other than U.S. dollars, assets and liabilities are translated into U.S. dollars using fiscal year-end exchange rates. Revenues and expenses are translated at the average exchange rates in effect during the related month. The net effect of these translation adjustments is shown in the consolidated and combined financial statements as a component of accumulated other comprehensive income. For subsidiaries operating in highly inflationary environments or where the functional currency is different from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date the assets and liabilities were acquired or assumed, while monetary assets and liabilities are translated at fiscal year-end exchange rates. Translation adjustments of these subsidiaries are included in net income. Gains and losses resulting from foreign currency transactions are included in net income.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects an estimate of losses inherent in the Company's accounts receivable portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectible. Trade accounts receivable are also presented net of reserves related to chargebacks and non-branded rebates payable to customers for whom we have trade accounts receivable and the right of offset exists.

Inventories
Inventories
Inventories are recorded at the lower of cost or market value, primarily using the first-in, first-out convention. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete or slow-moving based on changes in customer demand, technology developments or other economic factors.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are stated at cost. Major renewals and improvements are capitalized, while routine maintenance and repairs are expensed as incurred. Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:
Buildings
10
to
45 years
Leasehold improvements
1
to
20 years
Capitalized software
1
to
10 years
Machinery and equipment
1
to
20 years


 The Company capitalizes certain computer software and development costs incurred in connection with developing or obtaining software for internal use.
Upon retirement or other disposal of property, plant and equipment, the cost and related amount of accumulated depreciation are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds is included in net income.
The Company assesses the recoverability of assets or asset groups using undiscounted cash flows whenever events or circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If an asset or asset group is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value of the asset or asset group and its fair value.
Acquisitions
Acquisitions
Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.
The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.
The fair value of in-process research and development ("IPR&D") is determined using the discounted cash flow method. In determining the fair value of IPR&D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.
The fair value attributable to IPR&D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
Goodwill represents the excess of the purchase price of an acquired entity over the amounts assigned to assets and liabilities assumed in a business combination. The Company tests goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The impairment test is comprised of a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. The Company estimates the fair value of its reporting units through internal analyses and valuation, utilizing an income approach (a level three measurement technique) based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, the Company will perform the second step of the goodwill impairment test to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. The implied fair value of goodwill is determined in the same manner that the amount of goodwill recognized in a business combination is determined, with the Company allocating the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of the value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill.
Intangible assets acquired in a business combination are recorded at fair value, while intangible assets acquired in other transactions are recorded at cost. Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:
Completed technology
5
to
25 years
License agreements
8
to
30 years
Trademarks
13
to
30 years
Customer relationships
 
 
12 years

Amortization expense related to completed technology and certain other intangible assets is included in cost of sales, while amortization expense related to intangible assets that contribute to the Company's ability to sell, market and distribute products is included in selling, general and administrative expenses.
When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset, or the asset group they are part of, to its carrying value. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets, or the asset group they are part of, with their carrying value. The fair value of the intangible asset, or the asset group they are part of, is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, or the asset group they are part of, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the fair value of the asset. The Company assesses the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. The Company annually tests the indefinite-lived intangible assets for impairment by comparing the fair value of the assets, estimated using an income approach, with their carrying value and records an impairment when the carrying value exceeds the fair value.
Contingencies
Contingencies
The Company is subject to various patent, product liability, government investigations, environmental liability and other legal proceedings in the ordinary course of business. The Company records accruals for contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company discounts environmental liabilities using a risk-free rate of return when the obligation is fixed or reasonably determinable. The impact of the discount in the consolidated balance sheets was not material in any period presented. Legal fees, other than those pertaining to environmental and asbestos matters, are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. Assets and liabilities are not netted for financial statement presentation.
Share-Based Compensation
Share-Based Compensation
The Company recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, the requisite service period (generally the vesting period). For more information about our share-based awards, refer to Note 15.
Income Taxes
Income Taxes
Income taxes for periods prior to the Separation were calculated on a separate tax return basis (inclusive of certain loss benefits), although the Company's operations had historically been included in Covidien's U.S. federal and state tax returns or the tax returns of non-U.S. jurisdictions. Accordingly, the income taxes presented for periods prior to June 28, 2013 do not necessarily reflect the results that would have occurred as an independent, publicly-traded company. With the exception of certain non-U.S. entities, the Company did not maintain taxes payable to or from Covidien and the Company was deemed to settle the annual current tax balances immediately with the legal tax-paying entities in the respective jurisdictions. These settlements were reflected as changes in parent company investment.
Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been reflected in the consolidated and combined financial statements. Deferred tax assets and liabilities are determined based on the differences between the book and tax bases of assets and liabilities and operating loss carryforwards, using tax rates expected to be in effect for the years in which the differences are expected to reverse. A valuation allowance is provided to reduce net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities are also recorded for deferred tax obligations related to installment sale arrangements. The deferral of tax payments to the IRS are subject to interest, which is accrued and included within interest expense.
The Company determines whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not expected to be realized on the uncertain tax position, an income tax liability is established. Interest and penalties on income tax obligations, associated with uncertain tax positions, are included in the provision for income taxes.
The calculation of the Company's tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across the Company's global operations. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from current estimates of the tax liabilities. If the Company's estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary. A significant portion of these potential tax liabilities are recorded in other income tax liabilities on the consolidated balance sheets as payment is not expected within one year.
Parent Company Investment
Parent Company Investment
Parent company investment in periods prior to the Separation represents Covidien's historical investment in the Company, the Company's accumulated net earnings after income taxes for periods prior to that date, and the net effect of transactions with and allocations from Covidien.
XML 95 R98.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans Narrative (Details)
$ in Millions
 12 Months Ended
Sep. 25, 2015
USD ($)
contract
Sep. 26, 2014
USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Number of Life Insurance Contract Held in Rabbi Trust | contract 134  
Deferred Compensation Plan Assets $ 57.9 $ 56.3
Deferred Compensation Plan Assets, Death Benefit on Insurance Contracts 147.3 145.7
Deferred Compensation Plan Assets, Loans Outstanding Against Insurance Contracts 40.4 38.2
Non-U.S. Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Deferred Compensation Plan Assets, Collateral For Plan Benefits 9.8 $ 11.0
Moody's, Aa1 Rating [Member]    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Lower Threshold for Discount Rate Basis, Corporate Bonds $ 250.0  
XML 96 R123.htm IDEA: XBRL DOCUMENT v3.3.0.814
Guarantees (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Guarantor Obligations [Line Items]    
Restricted Cash and Cash Equivalents, Current $ 21.1  
Others    
Guarantor Obligations [Line Items]    
Maximum future payments 39.4  
Maryland Heights, Missouri | Surety Bond    
Guarantor Obligations [Line Items]    
Maximum future payments $ 57.2  
Mallinckrodt Baker | Indemnification Agreement    
Guarantor Obligations [Line Items]    
Guarantor obligations, obligation term 17 years  
Maximum future payments $ 71.0  
Escrow 30.0  
Mallinckrodt Baker | Indemnification Agreement | Other Liabilities    
Guarantor Obligations [Line Items]    
Guarantors obligation 15.7 $ 16.6
Mallinckrodt Baker | Indemnification Agreement | Other Assets    
Guarantor Obligations [Line Items]    
Escrow 19.0 19.4
Mallinckrodt Baker | Enviornmental, Health and Safety Matters | Indemnification Agreement | Other Liabilities    
Guarantor Obligations [Line Items]    
Guarantors obligation $ 13.0 $ 13.9
XML 97 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans
 12 Months Ended
Sep. 25, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share Plans
15.
Share Plans
Total share-based compensation cost from continuing operations was $116.1 million, $66.8 million and $16.0 million for fiscal 2015, 2014 and 2013, respectively. These amounts are generally included within selling, general and administrative expenses in the consolidated and combined statements of income. In conjunction with the Questcor Acquisition, Questcor equity awards were converted to Mallinckrodt equity awards which resulted in post-combination expense of $90.4 million in fiscal 2015, included in the above total share-based compensation, of which $80.6 million is included within selling, general and administrative expenses and $9.8 million is included within restructuring charges, net. The incremental fair value associated with the conversion of Covidien equity awards into Mallinckrodt equity awards is included in separation costs. The Company recognized a related tax benefit associated with this expense of $41.7 million, $24.1 million and $5.7 million in fiscal 2015, 2014 and 2013, respectively.
Incentive Equity Awards Converted from Covidien Awards
Prior to the Separation, all employee incentive equity awards were granted by Covidien. At the time of Separation, the restricted share units and share options granted to Mallinckrodt employees prior to June 28, 2013 were converted into restricted share units and share options, respectively, of Mallinckrodt, and all of the performance share awards granted to Mallinckrodt employees were converted to restricted share units of Mallinckrodt (collectively, "the Conversion"). Mallinckrodt incentive equity awards issued upon completion of the Conversion and the related weighted-average grant date fair value is presented below:
 
Awards
 
Weighted-Average
Grant-Date
Fair Value
Share options
2,399,822

 
$
7.96

Restricted share units
575,213

 
38.97



Share Options. A summary of the status of the Company's share option awards upon completion of the Conversion on June 28, 2013 is presented below:
 
Shares Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
(in years)
 
Aggregate
Intrinsic
Value
Outstanding at June 28, 2013
2,399,822

 
$
35.94

 
8.0
 
$
22.9

Exercisable at June 28, 2013
550,097

 
30.94

 
5.9
 
8.0


The Conversion resulted in a modification of the previously issued share option awards. The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards immediately after the Separation was higher than the awards immediately before, primarily due to the elimination of Covidien's dividend yield assumption and the Company's higher volatility as compared to Covidien. The incremental fair value for vested awards was recognized immediately within separation costs, as the incremental fair value is directly attributable to the Separation, and the incremental fair value for unvested awards will be recognized on a straight-line basis over the remaining vesting period of the applicable awards, also within separation costs.
The weighted-average assumptions used in the Black-Scholes pricing model for determining the fair value of the share option awards immediately before and immediately after the Separation were as follows:
 
Pre- Separation
 
Post- Separation
Expected share price volatility
26
%
 
32
%
Risk-free interest rate
0.99
%
 
0.99
%
Expected annual dividend per share
1.65
%
 
—
%
Expected life of options (in years)
3.8

 
3.8

Fair value per option
$
18.04

 
$
16.51

Share option awards
1,745,258

 
2,399,822



Restricted share units. The Conversion resulted in a modification of the previously issued restricted share unit awards ("RSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The Conversion did not result in incremental fair value.
Performance share units. The Conversion resulted in a modification of the previously issued performance share unit awards ("PSUs"). The Company compared the aggregate fair value of the awards immediately before and immediately after the Separation. The fair value of the awards was higher after the Conversion as the performance factor utilized to convert the award was higher than what had previously been estimated. The incremental fair value was recognized immediately within separation costs for the service period to date and the remaining incremental fair value will be recognized over the remaining vesting period within separation costs.
Stock Compensation Plans
Prior to the Separation, the Company adopted the 2013 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2013 Plan"). The 2013 Plan provides for the award of share options, share appreciation rights, annual performance bonuses, long-term performance awards, restricted units, restricted shares, deferred share units, promissory shares and other share-based awards (collectively, "Awards"). The 2013 Plan provided for a maximum of 5.7 million common shares to be issued as Awards, subject to adjustment as provided under the terms of the 2013 Plan. In fiscal 2015, the Company amended the 2013 Plan and adopted the 2015 Mallinckrodt Pharmaceuticals Stock and Incentive Plan ("the 2015 Plan"). The 2015 Plan provides for a maximum of 17.8 million common shares to be issued as Awards (an incremental 12.1 million Awards from the 2013 Plan subject to issuance), subject to adjustment as provided under the terms of the 2015 Plan. As of September 25, 2015, all equity awards held by the Company's employees were either converted from Covidien equity awards at the Separation, converted from Questcor equity awards, or granted under the 2013 Plan or 2015 Plan.
Share options. Share options are granted to purchase the Company's ordinary shares at prices that are equal to the fair market value of the shares on the date the share option is granted. Share options generally vest in equal annual installments over a period of four years and expire ten years after the date of grant. The grant-date fair value of share options, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience.
Share option activity and information is as follows:
 
Share Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
(in years)
 
Aggregate Intrinsic Value
Outstanding at September 27, 2013
2,760,231

 
$
37.30

 
 
 
 
Granted
675,921

 
52.63

 
 
 
 
Converted from Questcor Acquisition
1,292,736

 
25.08

 
 
 
 
Exercised
(878,330
)
 
30.96

 
 
 
 
Expired/Forfeited
(323,769
)
 
41.83

 
 
 
 
Outstanding at September 26, 2014
3,526,789

 
36.84

 
 
 
 
Granted
635,567

 
102.20

 
 
 
 
Exercised
(1,132,778
)
 
29.79

 
 
 
 
Expired/Forfeited
(243,135
)
 
58.00

 
 
 
 
Outstanding at September 25, 2015
2,786,443

 
52.76

 
7.3
 
$
63.2

 
 
 
 
 
 
 
 
Vested and unvested expected to vest as of September 25, 2015
2,649,351

 
50.94

 
7.4
 
59.0

Exercisable at September 25, 2015
1,054,336

 
34.20

 
5.8
 
36.2



As of September 25, 2015, there was $24.8 million of total unrecognized compensation cost related to unvested share option awards, which is expected to be recognized over a weighted-average period of 2.7 years.
The grant date fair value of share options has been estimated using the Black-Scholes pricing model. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. The expected volatility assumption is based on the historical and implied volatility of the Company's peer group with similar business models for periods after the Separation, and on Covidien's peer group with similar business models for periods prior to the Separation. The expected life assumption is based on the contractual and vesting term of the share option, employee exercise patterns and employee post-vesting termination behavior. The expected annual dividend per share is based on the Company's current intentions regarding payment of cash dividends, or Covidien's dividend rate on the date of grant. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The weighted-average assumptions used in the Black-Scholes pricing model for share options granted in fiscal 2013 subsequent to the Separation are included within the discussion of modification expense above. The weighted-average assumptions used in the Black-Scholes pricing model for shares granted in fiscal 2015, along with the weighted-average grant-date fair value, were as follows:
 
2015
 
2014
Expected share price volatility
29
%
 
32
%
Risk-free interest rate
1.72
%
 
1.96
%
Expected annual dividend per share
—
%
 
—
%
Expected life of options (in years)
5.3

 
5.5

Fair value per option
$
30.08

 
$
17.38



In fiscal 2013, subsequent to the Separation, the total intrinsic value of share options exercised and the related tax benefit was not significant. In fiscal 2015 and 2014, the total intrinsic value of options exercised was $89.5 million and $34.2 million, respectively, and the related tax benefit was $33.1 million and $12.0 million, respectively.
Restricted share units. Recipients of RSUs have no voting rights and receive dividend equivalent units which vest upon the vesting of the related shares. RSUs generally vest in equal annual installments over a period of four years. Restrictions on RSUs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period. The fair market value of RSUs granted after the Conversion is determined based on the market value of the Company's shares on the date of grant for periods after the Separation.
RSU activity is as follows:
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
724,269

 
$
40.62

Granted
229,281

 
55.40

Converted from Questcor Acquisition
30,747

 
70.88

Vested
(300,237
)
 
34.77

Forfeited
(94,838
)
 
42.48

Non-vested at September 26, 2014
589,222

 
47.88

Granted
273,733

 
105.68

Vested
(219,189
)
 
49.84

Forfeited
(71,272
)
 
68.15

Non-vested at September 25, 2015
572,494

 
73.45



The total fair value of Mallinckrodt restricted share unit awards granted during fiscal 2015 was $28.9 million. The total vest date fair value of Mallinckrodt restricted share units vested during fiscal 2015 was $21.6 million. As of September 25, 2015, there was $30.3 million of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of 2.8 years.
Performance share units. Similar to recipients of RSUs, recipients of PSUs have no voting rights and receive dividend equivalent units. The grant date fair value of PSUs, adjusted for estimated forfeitures, is generally recognized as expense on a straight-line basis from the grant date through the end of the performance period. The vesting of PSUs and related dividend equivalent units is generally based on various performance metrics and relative total shareholder return (total shareholder return for the Company as compared to total shareholder return of the PSU peer group), measured over a three-year performance period. The PSU peer group is comprised of various healthcare companies which attempts to replicate the Company’s mix of businesses. Depending on Mallinckrodt's relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from 0% to 200%, of the award granted.
PSU activity is as follows (1):
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
$
—

 
$
—

Granted
79,230

 
63.40

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(6,490
)
 
62.65

Non-vested at September 26, 2014
72,740

 
63.46

Granted
77,306

 
125.84

Performance metric adjustment
—

 
—

Vested
—

 
—

Forfeited
(19,072
)
 
92.05

Non-vested at September 25, 2015
130,974

 
96.05

(1)    The number of shares disclosed within this table are at the target number of 100%.
The Company generally uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards. The assumptions used in the Monte Carlo model for PSUs granted during each year were as follows:
 
2015
 
2014
Expected stock price volatility
27
%
 
28
%
Peer group stock price volatility
32
%
 
33
%
Correlation of returns
14
%
 
17
%



The weighted-average grant-date fair value per share of PSUs granted was $125.84 in fiscal 2015. As of September 25, 2015, there was $8.9 million of unrecognized compensation cost related to PSUs, which is expected to be recognized over a weighted-average period of 1.8 years .
Restricted stock awards. Recipients of restricted stock awards ("RSAs") pertain solely to converted awards from the Questcor Acquisition, which were converted at identical terms to their original award. The converted RSAs maintain voting rights and a non-forfeitable right to receive dividends. RSAs are subject to accelerated vesting as prescribed by the terms of the original award based on a change in control, and substantially all of which will vest over a thirteen month period of time from the date of the Questcor Acquisition. Restrictions on RSAs lapse upon normal retirement, death or disability of the employee. The grant-date fair value of RSAs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the service period.
 
Shares
 
Weighted-Average
Grant-Date Fair Value
Non-vested at September 27, 2013
—

 
$
—

Granted
—

 
—

Converted from Questcor Acquisition
1,829,164

 
70.88

Vested
(390,731
)
 
70.88

Forfeited
(6,402
)
 
70.88

Non-vested at September 26, 2014
1,432,031

 
70.88

Granted
—

 
—

Vested
(1,362,823
)
 
70.88

Forfeited
(34,646
)
 
70.88

Non-vested at September 25, 2015
34,562

 
70.88


The total vest date fair value of Mallinckrodt restricted share awards vested during fiscal 2015 was $127.4 million. As of September 25, 2015, there was $2.3 million of total unrecognized compensation cost related to non-vested restricted share units granted. The cost is expected to be recognized over a weighted-average period of 2.5 years .

Employee Stock Purchase Plans
The Company adopted the Mallinckrodt Employee Stock Purchase Plan ("ESPP") effective October 1, 2013. Substantially all full-time employees of the Company's U.S. subsidiaries and employees of certain qualified non-U.S. subsidiaries are eligible to participate in this ESPP. Eligible employees authorize payroll deductions to be made for the purchase of shares. The Company matches a portion of the employee contribution by contributing an additional 15% (25% in fiscal 2014 and fiscal 2015) of the employee's payroll deduction up to a $25,000 per employee contribution. All shares purchased under the ESPP are purchased on the open market by a designated broker.
XML 98 R68.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Financial Results and Acquisition Costs of Acquirees) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Operating Income [Abstract]                      
Operating income                 $ 461.8 $ (75.9) $ 73.5
Net Sales [Abstract]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 3,346.9 2,082.0 $ 1,712.3
Acquisition Related Costs                   65.1  
Ikaria                      
Operating Income [Abstract]                      
Operating income                 47.1 0.0  
Net Sales [Abstract]                      
Net sales                 191.9 0.0  
Acquisition Related Costs                 30.9 0.0  
Questcor Pharmaceuticals, Inc.                      
Operating Income [Abstract]                      
Operating income                 223.3 17.4  
Net Sales [Abstract]                      
Net sales                 1,125.9 129.2  
Acquisition Related Costs                 0.0 47.5  
Cadence Pharmaceuticals, Inc.                      
Operating Income [Abstract]                      
Operating income                 (97.3) (66.9)  
Net Sales [Abstract]                      
Net sales                 263.0 124.4  
Acquisition Related Costs                 0.0 17.6  
Therakos                      
Net Sales [Abstract]                      
Acquisition Related Costs                 22.5 0.0  
Total Acquisitions [Member]                      
Operating Income [Abstract]                      
Operating income                 173.1 (49.5)  
Net Sales [Abstract]                      
Net sales                 1,580.8 $ 253.6  
Acquisition Related Costs                 $ 53.4    
XML 99 R108.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Defined Contribution Plan) (Details) - Defined Contribution Plan, 401 K [Member] - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Defined Contribution Plan Disclosure [Line Items]      
Employer matching contribution, percent of match 50.00%    
Defined Contribution Plan, Cost Recognized $ 23.7 $ 20.5 $ 20.3
XML 100 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 101 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Balance Sheets (Parenthetical)
$ in Millions
Sep. 25, 2015
€ / shares
Sep. 25, 2015
USD ($)
$ / shares
shares
Sep. 26, 2014
€ / shares
Sep. 26, 2014
USD ($)
$ / shares
shares
Statement of Financial Position [Abstract]        
Allowance for doubtful accounts | $   $ 4.7   $ 3.7
Preferred shares, par value (in usd per share) | $ / shares   $ 0.20   $ 0.20
Preferred shares, shares authorized (in shares)   500,000,000   500,000,000
Preferred shares, shares issued (in shares)   0   0
Preferred shares, shares outstanding (in shares)   0   0
Ordinary A shares, par value (in eur per share) | € / shares € 1.00   € 1.00  
Ordinary A shares, shares authorized (in shares)   40,000   40,000
Ordinary A shares, shares issued (in shares)   0   0
Ordinary A shares, shares outstanding (in shares)   0   0
Ordinary shares, par value (in usd per share) | $ / shares   $ 0.20   $ 0.20
Ordinary shares, shares authorized (in shares)   500,000,000   500,000,000
Ordinary shares, shares issued (in shares)   117,513,370   116,160,353
Ordinary shares, shares outstanding (in shares)   116,283,149   115,929,588
Ordinary shares held in treasury (in shares)   1,230,221   230,765
XML 102 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statements of Income (Parenthetical) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Statement [Abstract]      
Tax (benefit) expense on income (loss) from discontinued operations $ 11.5 $ (34.7) $ 21.1
XML 103 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings (Loss) per Share
 12 Months Ended
Sep. 25, 2015
Earnings (Loss) per Share [Abstract]  
Earnings (Loss) per Share
8.
Earnings (Loss) per Share

In fiscal 2015 and 2014, basic and diluted earnings (loss) per share were computed using the two-class method. The two-class method is an earnings allocation that determines earnings per share for each class of common stock and participating securities according to dividends declared and participation rights in undistributed earnings. The Company’s restricted stock awards, issued in conjunction with the Questcor Acquisition in August 2014, are considered participating securities as holders are entitled to receive non-forfeitable dividends during the vesting term. Diluted earnings per share includes securities that could potentially dilute basic earnings per share during a reporting period, for which the Company includes all share-based compensation awards other than participating securities. Dilutive securities, including participating securities, are not included in the computation of loss per share when the Company reports a net loss from continuing operations as the impact would be anti-dilutive.
In periods prior to fiscal 2014, basic earnings (loss) per share was computed by dividing net income by the number of weighted-average shares outstanding during the period. Diluted earnings (loss) per share was computed using the weighted-average shares outstanding and, if dilutive, potential ordinary shares outstanding during the period. Potential ordinary shares represent the incremental ordinary shares issuable for restricted share units and share option exercises. The Company calculated the dilutive effect of outstanding restricted share units and share options on earnings (loss) per share by application of the treasury stock method.
The computations of basic and diluted earnings (loss) per share assumes that the number of shares outstanding for periods prior to June 28, 2013 was equal to the number of ordinary shares of Mallinckrodt outstanding on June 28, 2013, immediately following the distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien. The dilutive effect of the Company's share-based awards that were issued as a result of the conversion of Covidien share-based awards with the Separation, the conversion of Questcor share-based awards with the Questcor Acquisition, the initial equity awards granted to certain of the Company's executives on July 1, 2013 and any other Company grants made since the Separation have been included in the computation of diluted earnings per share for fiscal 2015, 2014 and 2013, calculated under the methodologies outlined above, weighted appropriately for the portion of the period they were outstanding.
 
2015
 
2014
 
2013
Earnings (loss) per share numerator:
 
 
 
 
 
Income (loss) from continuing operations attributable to common shareholders before allocation of earnings to participating securities
$
308.2

 
$
(143.8
)
 
$
8.2

Less: earnings allocated to participating securities
2.5

 
—

 
—

Income (loss) from continuing operations attributable to common shareholders, after earnings allocated to participating securities
305.7

 
(143.8
)
 
8.2

 
 
 
 
 
 
Income (loss) from discontinued operations
16.5

 
(175.5
)
 
50.6

Less: earnings from discontinued operations allocated to participating securities
0.1

 
—

 
—

Income (loss) from discontinued operations attributable to common shareholders, after allocation of earnings to participating securities
16.4

 
(175.5
)
 
50.6

Net income (loss) attributable to common shareholders, after allocation of earnings to participating securities
$
322.1

 
$
(319.3
)
 
$
58.8

Earnings (loss) per share denominator:
 
 
 
 
 
Weighted-average shares outstanding - basic
115.8

 
64.9

 
57.7

Impact of dilutive securities
1.4

 
—

 
0.1

Weighted-average shares outstanding - diluted
117.2

 
64.9

 
57.8

Basic earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.64

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.78

 
$
(4.92
)
 
$
1.02

Diluted earnings (loss) per share attributable to common shareholders
 
 
 
 
 
Income (loss) from continuing operations
$
2.61

 
$
(2.22
)
 
$
0.14

Income (loss) from discontinued operations
0.14

 
(2.70
)
 
0.88

Net income (loss) attributable to common shareholders
$
2.75

 
$
(4.92
)
 
$
1.02


The computation of diluted earnings per share for fiscal 2015, 2014 and 2013 excludes approximately 0.1 million, 5.7 million and 0.5 million, respectively, of equity awards because the effect would have been anti-dilutive. As the Company incurred a net loss in fiscal 2014, there was no allocation of the undistributed loss to participating securities because the effect would have been anti-dilutive to basic and diluted earnings per share.
XML 104 R103.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Compensation and Retirement Disclosure [Abstract]    
Accumulated benefit obligation $ 489.4 $ 533.6
Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Abstract]    
Accumulated benefit obligation 368.8 394.7
Fair value of plan assets $ 294.1 $ 321.6
XML 105 R93.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets (Schedule Of Intangible Assets) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Amortizable:    
Finite-lived intangible assets, gross $ 10,198.0 $ 7,144.6
Accumulated amortization 882.9 332.6
Non-Amortizable:    
Indefinite-lived intangible assets, gross 351.2 270.2
Trademarks    
Non-Amortizable:    
Indefinite-lived intangible assets, gross 35.0 35.0
In-process research and development    
Non-Amortizable:    
Indefinite-lived intangible assets, gross 316.2 235.2
Completed Technology    
Amortizable:    
Finite-lived intangible assets, gross 9,896.0 6,906.0
Accumulated amortization 765.8 235.6
Licensing Agreements    
Amortizable:    
Finite-lived intangible assets, gross 185.1 185.1
Accumulated amortization 99.8 87.3
Customer relationships    
Amortizable:    
Finite-lived intangible assets, gross 28.1 33.8
Accumulated amortization 4.4 0.6
Trademarks    
Amortizable:    
Finite-lived intangible assets, gross 82.1 13.0
Accumulated amortization 6.2 4.1
Other    
Amortizable:    
Finite-lived intangible assets, gross 6.7 6.7
Accumulated amortization $ 6.7 $ 5.0
XML 106 R91.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Apr. 16, 2015
Goodwill and Intangible Assets Disclosure [Abstract]        
Intangible asset amortization $ 550.3 $ 154.8 $ 27.9  
Finite-Lived Intangible Assets [Line Items]        
Goodwill, Period Increase (Decrease) 1,247.5      
Weighted Average Cost of Capital, Rate   8.00%    
Goodwill, Impaired, Accumulated Impairment Loss 119.5 $ 119.5    
Goodwill $ 3,649.4 2,401.9    
Brands        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Cost of Capital, Rate 12.00%      
Generics and API        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Cost of Capital, Rate 11.00%      
Global Medical Imaging        
Finite-Lived Intangible Assets [Line Items]        
Goodwill, Impaired, Accumulated Impairment Loss   219.7    
Global Medical Imaging | Contrast Media and Delivery Systems        
Finite-Lived Intangible Assets [Line Items]        
Goodwill, Impaired, Accumulated Impairment Loss   100.2    
Ikaria        
Goodwill and Intangible Assets Disclosure [Abstract]        
Intangible asset amortization $ 57.1 $ 0.0    
Finite-Lived Intangible Assets [Line Items]        
Goodwill       $ 792.4
XML 107 R122.htm IDEA: XBRL DOCUMENT v3.3.0.814
Transactions with Former Parent Company (Narrative) (Details) - USD ($)
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Jun. 27, 2014
Related Party Transaction [Line Items]        
Provision for (benefit from) income taxes [1] $ (92,900,000) $ (10,100,000) $ 47,500,000  
Covidien | Separation and Distribution Agreement        
Related Party Transaction [Line Items]        
Initial cash capitalization       $ 168,000,000
Estimated cash upon completion of distribution       168,000,000
Adjustment payment benchmark       $ 20,000,000
Final adjustment payment 0      
Covidien | Tax Matters Agreement        
Related Party Transaction [Line Items]        
Tax agreement, tax threshold 200,000,000      
Provision for (benefit from) income taxes $ 51,600,000      
Change in ownership percentage 35.00%      
Covidien | Minimum | Tax Matters Agreement        
Related Party Transaction [Line Items]        
Restriction period 2 years      
Covidien | Maximum | Tax Matters Agreement        
Related Party Transaction [Line Items]        
Restriction period 5 years      
Covidien | Discontinued Operations [Member]        
Related Party Transaction [Line Items]        
Inventory sold $ 35,300,000 46,000,000 51,200,000  
Inventory purchases 17,000,000 $ 28,900,000 38,400,000  
Covidien | Selling, general and administrative        
Related Party Transaction [Line Items]        
Allocated expenses     $ 39,600,000  
Covidien | Prepaid expenses and other current assets        
Related Party Transaction [Line Items]        
Due from related parties 6,300,000      
Covidien | Other current liabilities        
Related Party Transaction [Line Items]        
Due to related parties $ 3,900,000      
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
XML 108 R132.htm IDEA: XBRL DOCUMENT v3.3.0.814
(Schedules of Concentration of Risk) (Details)
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Distributor Concentration Risk | Net Sales Attributable to Distributors | CuraScript, Inc [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 31.00% 6.00% 0.00%
Distributor Concentration Risk | Net Sales Attributable to Distributors | McKesson Corporation [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 18.00% 21.00% 19.00%
Distributor Concentration Risk | Net Sales Attributable to Distributors | Cardinal Health, Inc. [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 14.00% 22.00% 24.00%
Distributor Concentration Risk | Net Sales Attributable to Distributors | Amerisource Bergen Corporation [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 9.00% 14.00% 11.00%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | CuraScript, Inc [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 16.00% 15.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 24.00% 27.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Cardinal Health, Inc. [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 13.00% 18.00%  
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 12.00% 14.00%  
Product Concentration Risk | Net Sales Attributable to Products | Acetaminophen products (API)      
Concentration Risk [Line Items]      
Concentration risk, percentage 6.00% 9.00% 13.00%
Product Concentration Risk | Net Sales Attributable to Products | Acthar      
Concentration Risk [Line Items]      
Concentration risk, percentage 31.00% 6.00% 0.00%
Product Concentration Risk | Net Sales Attributable to Products | Hydrocodone (API) and hydrocodone-containing tablets      
Concentration Risk [Line Items]      
Concentration risk, percentage 4.00% 10.00% 9.00%
XML 109 R119.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Restricted Stock Award Activity) (Details) - Restricted Stock - $ / shares
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Restricted Stock Activity [Roll Forward]      
Beginning balance 1,432,031 0  
Granted 0 0  
Converted from Questcor Acquisition   1,829,164  
Vested (1,362,823) (390,731)  
Forfeited (34,646) (6,402)  
Ending balance 34,562 1,432,031  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average grant date fair value, restricted share units $ 70.88 $ 70.88 $ 0.00
Weighted-average grant date fair value, granted restricted share units 0.00 0.00  
Weighted-average grant date fair value, converted from Questcor Acquisition   70.88  
Weighted-average grant date fair value, vested restricted share units 70.88 70.88  
Weighted-average grant date fair value, forfeited restricted share units $ 70.88 $ 70.88  
XML 110 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document And Entity Information - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Nov. 16, 2015
Mar. 27, 2015
Document And Entity Information [Abstract]      
Entity Registrant Name Mallinckrodt plc    
Entity Central Index Key 0001567892    
Trading Symbol MNK    
Current Fiscal Year End Date --09-25    
Entity Filer Category Large Accelerated Filer    
Document Type 10-K    
Document Period End Date Sep. 25, 2015    
Document Fiscal Year Focus 2015    
Document Fiscal Period Focus FY    
Amendment Flag false    
Ordinary Shares Outstanding   115,947,044  
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 15,146.4
XML 111 R125.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Schedule of Purchase Oligations) (Details)
$ in Millions
Sep. 25, 2015
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Fiscal 2016 $ 125.9
Fiscal 2017 51.4
Fiscal 2018 49.8
Fiscal 2019 7.9
Fiscal 2020 $ 0.0
XML 112 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories
 12 Months Ended
Sep. 25, 2015
Inventory, Net [Abstract]  
Inventories
9.
Inventories
Inventories are comprised of the following at the end of each period: 
 
September 25,
2015
 
September 26,
2014
Raw materials and supplies
$
66.3

 
$
57.5

Work in process
124.2

 
184.7

Finished goods
91.3

 
64.2

Inventories
$
281.8

 
$
306.4
XML 113 R80.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Unrecognized Tax Benefit Activity) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Balance at beginning of fiscal year $ 82.0 $ 100.1 $ 165.5
Unrecognized tax benefits retained by Covidien 0.0 0.0 (153.7)
Unrecognized tax benefits transferred from Covidien 0.0 0.0 84.2
Additions related to current year tax positions 4.5 3.2 3.5
Additions related to prior period tax positions 19.9 30.6 6.6
Reductions related to prior period tax positions (7.7) (33.0) (4.3)
Settlements (7.8) (6.9) (1.6)
Lapse of statute of limitations (1.7) (12.0) (0.1)
Balance at end of fiscal year $ 89.2 $ 82.0 $ 100.1
XML 114 R90.htm IDEA: XBRL DOCUMENT v3.3.0.814
Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 1,870.6 $ 1,669.0
Less: accumulated depreciation (879.3) (782.2)
Property, plant and equipment, net 991.3 886.8
Land    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 49.8 47.3
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 333.7 289.4
Capitalized Software    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 120.2 94.5
Machinery and Equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 1,220.0 1,041.6
Construction in Progress    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 146.9 $ 196.2
XML 115 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Statement of Comprehensive Income [Abstract]                      
Net income (loss) $ 75.2 $ 58.0 $ 98.8 $ 92.7 $ (352.4) $ (24.1) $ 11.6 $ 45.6 $ 324.7 $ (319.3) $ 58.8
Other comprehensive income (loss), net of tax                      
Currency translation adjustments                 (70.8) (27.6) 1.5
Unrecognized gain (loss) on derivatives, net of tax (benefit) expense of $0.2, $0.2 and $-                 0.4 0.5 (7.3)
Unrecognized gain (loss) on benefit plans, net of tax (benefit) expense of $(2.1), $(7.3) and $23.9                 5.6 (15.7) 34.2
Total other comprehensive income (loss), net of tax                 (64.8) (42.8) 28.4
Comprehensive income (loss)                 $ 259.9 $ (362.1) $ 87.2
XML 116 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Recently Issued Accounting Standards
 12 Months Ended
Sep. 25, 2015
Recently Issued Accounting Pronouncements [Abstract]  
Recently Issued Accounting Standards
3.
Recently Issued Accounting Standards
The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2011-11 in December 2011, "Disclosures about Offsetting Assets and Liabilities," which was clarified in January 2013 by ASU 2013-01 "Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities." This guidance provides new disclosure requirements about instruments and transactions eligible for offset in the statement of financial position, as well as instruments and transactions subject to an agreement similar to a netting agreement, to enable users of financial statements to understand the effects or potential effects of those arrangements on an entity's financial position. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-02, "Reporting Amounts Classified out of Accumulated Other Comprehensive Income," in February 2013. This guidance requires an entity to present, either on the face of the statement of income or separately in the notes to the financial statements, the effects on net income of significant amounts reclassified out of each component of accumulated other comprehensive income, if those amounts are required to be reclassified to net income in their entirety in the same reporting period. The guidance was effective for the Company in the first quarter of fiscal 2014. The adoption did not have a material impact on the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date," in February 2013. This update provides guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date, except for obligations addressed within existing guidance. An entity is required to measure those obligations as the sum of the amount the entity has agreed to pay on the basis of its arrangement among its co-obligors, and any additional amounts it expects to pay on behalf of its co-obligors. The guidance also requires the entity to disclose the nature and amount of those obligations. The guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," in July 2013. This update provides guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, to eliminate diversity in practice in the presentation of unrecognized tax benefits in those instances. This guidance was effective for the Company in the first quarter of fiscal 2015. The adoption did not have a material impact to the Company's financial condition, results of operations and cash flows.
FASB issued ASU 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity," in April 2014. Under the new guidance, only disposals representing a strategic shift in a company's operations and financial results should be reported as discontinued operations, with expanded disclosures. In addition, disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify as a discontinued operation is required. This guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 with the classification of the CMDS business as held for sale.
FASB issued ASU 2014-09, "Revenue from Contracts with Customers," in May 2014. The issuance of ASU 2014-09 and International Financial Reporting Standards ("IFRS") 15, "Revenue from Contracts with Customers," completes the joint effort by FASB and the International Accounting Standards Board to clarify the principles for recognizing revenue and develop a common revenue standard for U.S. GAAP and IFRS. Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted in the first quarter of fiscal 2018. The Company continues to assess the potential impact of the guidance.
FASB issued ASU 2015-03, "Interest - Imputation of Interest," in April 2015. The issuance of ASU 2015-03 is part of the FASB's initiative to simplify the presentation of debt issuance costs. Under the new guidance, debt issuance costs related to a recognized debt liability must be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amortization of such costs should continue to be calculated using the interest method and be reported as interest expense. The guidance is effective for the Company in the first quarter of fiscal 2016, with early adoption permitted. The Company early adopted the guidance during the fourth quarter of fiscal 2015 and reclassified debt issuance costs, of $103.1 million at September 25, 2015, and expanded disclosure.
FASB issued ASU 2015-11, "Simplifying the Measurement of Inventory," in July 2015. The issuance of ASU 2015-11 is part of the FASB's initiative to more closely align the measurement of inventory between GAAP and IFRS. Under the new guidance, inventory must be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.
FASB issued ASU 2015-16, "Simplifying the Accounting for Measurement-Period Adjustments," in September 2015. Under the new guidance, the requirement to restate prior period financial statements for measurement period adjustments following a business combination is eliminated. The cumulative impact of a measurement period adjustment (including the impact on prior periods) should be recognized in the reporting period in which the adjustment is identified. The guidance is effective for the Company in the first quarter of fiscal 2017. The Company is assessing the potential impact of the guidance.
XML 117 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies
 12 Months Ended
Sep. 25, 2015
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
2.
Summary of Significant Accounting Policies
Revenue Recognition
The Company recognizes revenue for product sales when title and risk of loss have transferred from the Company to the buyer, which may be upon shipment, delivery to the customer site, consumption of the product by the customer, or over the period in which the customer has access to the product and any related services, based on contract terms or legal requirements in non-U.S. jurisdictions. The Company sells products through independent channels, including directly to retail pharmacies and end user customers and through distributors who resell the products to retail pharmacies, institutions and end user customers. Certain products are sold and distributed directly to hospitals. Chargebacks and rebates represent credits that are provided to certain distributors and customers for either the difference between the Company's contracted price with a customer and the distributor's invoice price paid to the Company or for contractually agreed volume price discounts. When the Company recognizes net sales, it simultaneously records an adjustment to revenue for estimated chargebacks, rebates, product returns and other sales deductions. These provisions are estimated based upon historical experience, estimated future trends, estimated customer inventory levels, current contracted sales terms with customers, level of utilization of the Company's products and other competitive factors. The Company adjusts these reserves to reflect differences between estimated activity and actual experience. Such adjustments impact the amount of net sales recognized by the Company in the period of adjustment.
Taxes collected from customers relating to product sales and remitted to governmental authorities are accounted for on a net basis. Accordingly, such taxes are excluded from both net sales and expenses.

Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises to the customer's premises, are classified as selling, general and administrative expenses. Handling costs, which are costs incurred to store, move and prepare product for shipment, are classified as cost of sales. Shipping costs included in selling, general and administrative expenses in continuing operations were $42.3 million, $47.8 million and $46.9 million in fiscal 2015, 2014 and 2013, respectively.

Research and Development
Internal research and development costs are expensed as incurred. Research and development expenses include salary and benefits, allocated overhead and occupancy costs, clinical trial and related clinical manufacturing costs, contract services and other costs.
Upfront and milestone payments made to third parties under license arrangements are expensed as incurred up to the point of regulatory approval of the product. Milestone payments made to third parties upon or subsequent to regulatory approval are capitalized as an intangible asset and amortized to cost of sales over the estimated useful life of the related product.

Currency Translation
For the Company's non-U.S. subsidiaries that transact in a functional currency other than U.S. dollars, assets and liabilities are translated into U.S. dollars using fiscal year-end exchange rates. Revenues and expenses are translated at the average exchange rates in effect during the related month. The net effect of these translation adjustments is shown in the consolidated and combined financial statements as a component of accumulated other comprehensive income. For subsidiaries operating in highly inflationary environments or where the functional currency is different from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date the assets and liabilities were acquired or assumed, while monetary assets and liabilities are translated at fiscal year-end exchange rates. Translation adjustments of these subsidiaries are included in net income. Gains and losses resulting from foreign currency transactions are included in net income. During fiscal 2015 and 2014, $30.7 million and $3.8 million of foreign currency gains, respectively, were included within net income from continuing operations. During fiscal 2013, $12.8 million of foreign currency losses were included within net income from continuing operations. The Company entered into derivative instruments to mitigate the exposure of movements in certain of these foreign currency transactions and recognized a $24.8 million loss in fiscal 2015, a $6.3 million loss in fiscal 2014, and a $10.1 million gain in fiscal 2013 within net income from continuing operations.

Cash and Cash Equivalents
The Company classifies cash on hand and deposits in banks, including commercial paper, money market accounts and other investments it may hold from time to time, with an original maturity to the Company of three months or less, as cash and cash equivalents.

Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts reflects an estimate of losses inherent in the Company's accounts receivable portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectible. Trade accounts receivable are also presented net of reserves related to chargebacks and non-branded rebates payable to customers for whom we have trade accounts receivable and the right of offset exists.

Inventories
Inventories are recorded at the lower of cost or market value, primarily using the first-in, first-out convention. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete or slow-moving based on changes in customer demand, technology developments or other economic factors.

Property, Plant and Equipment
Property, plant and equipment are stated at cost. Major renewals and improvements are capitalized, while routine maintenance and repairs are expensed as incurred. Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:
Buildings
10
to
45 years
Leasehold improvements
1
to
20 years
Capitalized software
1
to
10 years
Machinery and equipment
1
to
20 years


 The Company capitalizes certain computer software and development costs incurred in connection with developing or obtaining software for internal use.
Upon retirement or other disposal of property, plant and equipment, the cost and related amount of accumulated depreciation are eliminated from the asset and accumulated depreciation accounts, respectively. The difference, if any, between the net asset value and the proceeds is included in net income.
The Company assesses the recoverability of assets or asset groups using undiscounted cash flows whenever events or circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If an asset or asset group is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value of the asset or asset group and its fair value.

Acquisitions
Amounts paid for acquisitions are allocated to the tangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The Company then allocates the purchase price in excess of net tangible assets acquired to identifiable intangible assets, including purchased research and development. The fair value of identifiable intangible assets is based on detailed valuations. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.
The Company's purchased research and development represents the estimated fair value as of the acquisition date of in-process projects that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval.
The fair value of in-process research and development ("IPR&D") is determined using the discounted cash flow method. In determining the fair value of IPR&D, the Company considers, among other factors, appraisals, the stage of completion of the projects, the technological feasibility of the projects, whether the projects have an alternative future use and the estimated residual cash flows that could be generated from the various projects and technologies over their respective projected economic lives. The discount rate used includes a rate of return which accounts for the time value of money, as well as risk factors that reflect the economic risk that the cash flows projected may not be realized.
The fair value attributable to IPR&D projects at the time of acquisition is capitalized as an indefinite-lived intangible asset and tested for impairment until the project is completed or abandoned. Upon completion of the project, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis over its estimated useful life. If the project is abandoned, the indefinite-lived intangible asset is charged to expense.
Goodwill and Other Intangible Assets
Goodwill represents the excess of the purchase price of an acquired entity over the amounts assigned to assets and liabilities assumed in a business combination. The Company tests goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The impairment test is comprised of a two-step approach. The first step requires a comparison of the carrying value of the reporting units to the fair value of these units. The Company estimates the fair value of its reporting units through internal analyses and valuation, utilizing an income approach (a level three measurement technique) based on the present value of future cash flows. If the carrying value of a reporting unit exceeds its fair value, the Company will perform the second step of the goodwill impairment test to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of a reporting unit's goodwill with its carrying value. The implied fair value of goodwill is determined in the same manner that the amount of goodwill recognized in a business combination is determined, with the Company allocating the fair value of a reporting unit to all of the assets and liabilities of that unit, including intangible assets, as if the reporting unit had been acquired in a business combination. Any excess of the value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill.
Intangible assets acquired in a business combination are recorded at fair value, while intangible assets acquired in other transactions are recorded at cost. Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:
Completed technology
5
to
25 years
License agreements
8
to
30 years
Trademarks
13
to
30 years
Customer relationships
 
 
12 years

Amortization expense related to completed technology and certain other intangible assets is included in cost of sales, while amortization expense related to intangible assets that contribute to the Company's ability to sell, market and distribute products is included in selling, general and administrative expenses.
When a triggering event occurs, we evaluate potential impairment of finite-lived intangible assets by first comparing undiscounted cash flows associated with the asset, or the asset group they are part of, to its carrying value. If the carrying value is greater than the undiscounted cash flows, the amount of potential impairment is measured by comparing the fair value of the assets, or the asset group they are part of, with their carrying value. The fair value of the intangible asset, or the asset group they are part of, is estimated using an income approach. If the fair value is less than the carrying value of the intangible asset, or the asset group they are part of, the amount recognized for impairment is equal to the difference between the carrying value of the asset and the fair value of the asset. The Company assesses the remaining useful life and the recoverability of finite-lived intangible assets whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. The Company annually tests the indefinite-lived intangible assets for impairment by comparing the fair value of the assets, estimated using an income approach, with their carrying value and records an impairment when the carrying value exceeds the fair value.

Contingencies
The Company is subject to various patent, product liability, government investigations, environmental liability and other legal proceedings in the ordinary course of business. The Company records accruals for contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company discounts environmental liabilities using a risk-free rate of return when the obligation is fixed or reasonably determinable. The impact of the discount in the consolidated balance sheets was not material in any period presented. Legal fees, other than those pertaining to environmental and asbestos matters, are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. Assets and liabilities are not netted for financial statement presentation.

Share-Based Compensation
The Company recognizes the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, the requisite service period (generally the vesting period). For more information about our share-based awards, refer to Note 15.
Income Taxes
Income taxes for periods prior to the Separation were calculated on a separate tax return basis (inclusive of certain loss benefits), although the Company's operations had historically been included in Covidien's U.S. federal and state tax returns or the tax returns of non-U.S. jurisdictions. Accordingly, the income taxes presented for periods prior to June 28, 2013 do not necessarily reflect the results that would have occurred as an independent, publicly-traded company. With the exception of certain non-U.S. entities, the Company did not maintain taxes payable to or from Covidien and the Company was deemed to settle the annual current tax balances immediately with the legal tax-paying entities in the respective jurisdictions. These settlements were reflected as changes in parent company investment.
Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been reflected in the consolidated and combined financial statements. Deferred tax assets and liabilities are determined based on the differences between the book and tax bases of assets and liabilities and operating loss carryforwards, using tax rates expected to be in effect for the years in which the differences are expected to reverse. A valuation allowance is provided to reduce net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities are also recorded for deferred tax obligations related to installment sale arrangements. The deferral of tax payments to the IRS are subject to interest, which is accrued and included within interest expense.
The Company determines whether it is more likely than not that a tax position will be sustained upon examination. The tax benefit of any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the uncertainty. To the extent a full benefit is not expected to be realized on the uncertain tax position, an income tax liability is established. Interest and penalties on income tax obligations, associated with uncertain tax positions, are included in the provision for income taxes.
The calculation of the Company's tax liabilities involves dealing with uncertainties in the application of complex tax regulations in a multitude of jurisdictions across the Company's global operations. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from current estimates of the tax liabilities. If the Company's estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary. A significant portion of these potential tax liabilities are recorded in other income tax liabilities on the consolidated balance sheets as payment is not expected within one year.

Parent Company Investment
Parent company investment in periods prior to the Separation represents Covidien's historical investment in the Company, the Company's accumulated net earnings after income taxes for periods prior to that date, and the net effect of transactions with and allocations from Covidien.
XML 118 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Equity
 12 Months Ended
Sep. 25, 2015
Equity [Abstract]  
Stockholders' Equity Note Disclosure
Preferred Shares
Mallinckrodt is authorized to issue 500,000,000 preferred shares, par value of $0.20 per share, none of which were issued or outstanding at September 25, 2015. Rights as to dividends, return of capital, redemption, conversion, voting and otherwise with respect to these shares may be determined by Mallinckrodt's board of directors on or before the time of issuance. In the event of the liquidation of the Company, the holders of any preferred shares then outstanding would, if issued on such terms that they carry a preferential distribution entitlement on liquidation, be entitled to payment to them of the amount for which the preferred shares were subscribed and any unpaid dividends prior to any payment to the ordinary shareholders.

Share Repurchases
On January 23, 2015, the Company's board of directors authorized a program to purchase up to $300.0 million of the Company's ordinary shares from time to time based on market conditions to allow management to enhance shareholder value. The following table presents the number of shares and dollar amount of repurchases made under the repurchase program by fiscal year and the remaining amount available for repurchase as of September 25, 2015.
 
2015 Share Repurchase Program
 
Number of Shares
 
Amount
Authorized repurchase amount
 
 
$
300.0

Repurchases:
 
 
 
   Fiscal 2015
823,592

 
75.0

Remaining amount available
 
 
$
225.0



The Company also repurchases shares from certain employees in order to satisfy employee tax withholding requirements in connection with the vesting of restricted shares. In addition, the Company repurchases shares to settle certain option exercises. The Company spent $17.2 million and $17.5 million to acquire shares in connection with equity-based awards in fiscal 2015 and 2014, respectively.
XML 119 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Property, Plant and Equipment
 12 Months Ended
Sep. 25, 2015
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
10.
Property, Plant and Equipment
The gross carrying amount and accumulated depreciation of property, plant and equipment at the end of each period was as follows:
 
September 25, 2015
 
September 26, 2014
Land
$
49.8

 
$
47.3

Buildings
333.7

 
289.4

Capitalized software
120.2

 
94.5

Machinery and equipment
1,220.0

 
1,041.6

Construction in process
146.9

 
196.2

 
1,870.6

 
1,669.0

Less: accumulated depreciation
(879.3
)
 
(782.2
)
Property, plant and equipment, net
$
991.3

 
$
886.8



The amounts above include property under capital leases of $14.8 million and $16.9 million at September 25, 2015 and September 26, 2014, respectively, consisting primarily of buildings. Accumulated amortization of capitalized leased assets was $14.6 million and $15.8 million at the end of fiscal 2015 and 2014, respectively.
Depreciation expense, including amounts related to capitalized leased assets, for continuing operations was $103.9 million, $94.7 million and $88.1 million for fiscal 2015, 2014 and 2013, respectively.

Long-Lived Asset Impairment Analysis
In fiscal 2014, the Company recorded long-lived asset impairment charges related to our CMDS asset group. During the fourth quarter of fiscal 2014, the Company received notification that we lost preferred supplier status with a significant group purchasing organization ("GPO") and that a related-party supply contract was terminated by the Company. The Company determined that these events constituted a triggering event with respect to our CMDS asset group assessed the recoverability of the CMDS asset group. The Company determined that the undiscounted cash flows of this asset group were less than its net book value. This would require the Company to record an impairment charge if the fair value of the CMDS asset group was less than its net book value.
The Company determined the fair value of the CMDS asset group using the income approach, a level three measurement technique. For purposes of determining fair value the Company made various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a weighted-average cost of capital ("WACC") determined from relevant market comparisons, adjusted upward for specific risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the asset group represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows.
The Company's projections in the CMDS asset group included long-term net sales and operating income at lower than historical levels. The decrease in net sales and operating income is reflective of the notification of the loss of a significant customer, termination of a supply contract with a related party and increased competition in the marketplace. The Company utilized a WACC of 8.0%, which reflects the lower inherent risk with the decreasing revenue trends. These assumptions resulted in a fair value of the CMDS asset group that was less than its net book value. Therefore, the Company recorded impairment charges of $65.9 million and $52.4 million to the property, plant and equipment and long-lived amortizing intangible assets, respectively, included in the CMDS asset group. The Company announced that it had entered into a definitive agreement to sell its CMDS business, therefore the business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified $51.4 million of the impairment charge associated with property, plant and equipment to discontinued operations as certain assets are expected to be retained by the Company based upon the terms of the Company's agreement with Guerbet. The Company reclassified $52.4 million of the impairment charge associated with intangible assets to discontinued operations.
XML 120 R84.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Deferred Taxes Activity) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Deferred tax assets:    
Accrued liabilities and reserves $ 92.5 $ 68.9
Inventories 23.2 21.4
Tax loss and credit carryforwards 163.3 93.8
Environmental liabilities 23.6 29.5
Rebate reserves 48.5 41.1
Expired product 26.3 39.0
Postretirement benefits 33.8 34.5
Federal and state benefit of uncertain tax positions and interest 33.6 29.5
Share-based compensation 18.9 28.1
Other 20.2 32.0
Total deferred tax assets, gross 589.6 427.4
Deferred Tax Assets, Goodwill and Intangible Assets 105.7 9.6
Deferred tax liabilities:    
Property, plant and equipment (140.1) (121.6)
Intangible assets (1,550.7) (2,177.9)
Installment sale (1,465.3) (93.6)
Investment in partnership (187.9) (191.3)
Total deferred tax liabilities, gross (3,344.0) (2,584.4)
Net deferred tax (liability) before valuation allowances (2,754.4) (2,157.0)
Valuation allowances (233.0) (76.9)
Net deferred tax (liability) $ (2,987.4) $ (2,233.9)
XML 121 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges
 12 Months Ended
Sep. 25, 2015
Restructuring and Related Activities [Abstract]  
Restructuring and Related Charges
6.
Restructuring and Related Charges
During fiscal 2013, the Company launched a restructuring program designed to improve its cost structure ("the 2013 Mallinckrodt Program"). The 2013 Mallinckrodt Program includes actions across all segments, as well as within corporate functions. The Company expects to incur charges of $100.0 million to $125.0 million under this program as the specific actions required to execute on these initiatives are identified and approved, most of which are expected to be incurred by the end of fiscal 2016.
Prior to Separation, Covidien initiated restructuring programs, which also applied to its Pharmaceutical business. These programs were substantially completed as of September 26, 2014.
Net restructuring and related charges by segment within continuing operations are as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Specialty Brands
$
36.5

 
$
57.0

 
$
5.2

Specialty Generics
4.5

 
9.8

 
11.2

Nuclear Imaging
(4.6
)
 
13.7

 
6.9

Corporate
4.3

 
1.4

 
3.0

Restructuring and related charges, net
40.7

 
81.9

 
26.3

Less: accelerated depreciation
(0.3
)
 
(0.5
)
 
(2.6
)
Restructuring charges, net
$
40.4

 
$
81.4

 
$
23.7



Net restructuring and related charges by program within continuing operations are comprised of the following:
 
Fiscal Year
 
2015
 
2014
 
2013
2013 Mallinckrodt Program
$
7.4

 
$
27.3

 
$
8.5

Acquisition programs
33.6

 
56.4

 
—

Other programs
(0.3
)
 
(1.8
)
 
17.8

Total programs
40.7

 
81.9

 
26.3

Less: non-cash charges, including impairments and accelerated share based compensation expense
(10.1
)
 
(38.0
)
 
(2.6
)
Total charges expected to be settled in cash
$
30.6

 
$
43.9

 
$
23.7



Non-cash charges in fiscal 2015 and fiscal 2014 include $9.8 million and $35.1 million, respectively, of accelerated share based compensation expense related to employee terminations, primarily related to our Questcor acquisition, and fiscal 2014 includes $2.3 million of property, plant and equipment asset impairments.
The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of $8.5 million in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:
 
2013 Mallinckrodt Program
 
Acquisition Programs
 
Other Programs
 
Total
Balance at September 28, 2012
$
—

 
$
—

 
$
8.9

 
$
8.9

Charges from continuing operations
8.5

 
—

 
17.6

 
26.1

Charges from discontinued operations
6.4

 
—

 
3.3

 
9.7

Changes in estimate from continuing operations
—

 
—

 
(2.4
)
 
(2.4
)
Changes in estimate from discontinued operations
—

 
—

 
(0.2
)
 
(0.2
)
Cash payments
—

 
—

 
(15.1
)
 
(15.1
)
Reclassifications (1)
—

 
—

 
(1.5
)
 
(1.5
)
Balance at September 27, 2013
14.9

 
—

 
10.6

 
25.5

Charges from continuing operations
32.9

 
22.9

 
1.4

 
57.2

Charges from discontinued operations
25.3

 
—

 
1.1

 
26.4

Changes in estimate from continuing operations
(7.6
)
 
(1.6
)
 
(4.1
)
 
(13.3
)
Changes in estimate from discontinued operations
(1.8
)
 
—

 
(0.7
)
 
(2.5
)
Cash payments
(34.8
)
 
(13.4
)
 
(6.8
)
 
(55.0
)
Reclassifications (1)
(1.3
)
 
—

 
(1.0
)
 
(2.3
)
Currency translation
(1.0
)
 
—

 
(0.1
)
 
(1.1
)
Balance at September 26, 2014
26.6

 
7.9

 
0.4

 
34.9

Charges from continuing operations
15.4

 
25.3

 
—

 
40.7

Charges from discontinued operations
1.0

 
—

 
—

 
1.0

Changes in estimate from continuing operations
(8.3
)
 
(1.5
)
 
(0.3
)
 
(10.1
)
Changes in estimate from discontinued operations
(0.6
)
 
—

 
—

 
(0.6
)
Cash payments
(22.5
)
 
(21.7
)
 
(0.1
)
 
(44.3
)
Reclassifications (1)
(3.0
)
 
—

 
—

 
(3.0
)
Currency translation
(0.6
)
 
—

 
—

 
(0.6
)
Balance at September 25, 2015
$
8.0

 
$
10.0

 
$
—

 
$
18.0


(1)
Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.

Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:
Specialty Brands
$
4.0

Specialty Generics
15.6

Nuclear Imaging (including CMDS)
67.3

Corporate
10.0

 
$
96.9


Substantially all of the restructuring reserves are included in accrued and other current liabilities on the Company's consolidated balance sheets.
XML 122 R60.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures (Income (loss) from Discontinued Operations) (Details) - Contrast Media and Delivery Systems - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales $ 413.8 $ 495.8 $ 549.3
Cost of sales 306.4 352.9 346.7
Selling, general and administrative 97.5 97.1 114.0
Restructuring charges, net 0.3 47.2 9.5
Non-restructuring impairment charges 0.0 204.0 0.0
Other 4.7 4.1 8.4
Income (loss) from discontinued operations 4.9 (209.5) 70.7
Income tax expense (benefit) 10.8 (34.7) 21.1
Income (loss) from discontinued operations net of tax $ (5.9) $ (174.8) $ 49.6
XML 123 R110.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Stock Repurchase Program (Details) - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Jan. 23, 2015
Class of Stock [Line Items]      
Stock Repurchase Program, Authorized Amount     $ 300.0
Repurchase of ordinary shares, value $ (92.2) $ (17.5)  
2015 Share Repurchase Program [Member]      
Class of Stock [Line Items]      
Stock Repurchase Program, Authorized Amount $ 300.0    
Repurchase of ordinary shares, shares 823,592    
Repurchase of ordinary shares, value $ 75.0    
Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 225.0    
XML 124 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures
 12 Months Ended
Sep. 25, 2015
Discontinued Operations [Abstract]  
Discontinued Operations and Divestitures
4.
Discontinued Operations and Divestitures
Discontinued Operations
CMDS: During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business to Guerbet in a transaction valued at approximately $270.0 million, which is expected to be completed during the first quarter of fiscal 2016. As of September 25, 2015, the CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.

Subsequent to the sale of the CMDS business, the Company will continue to supply certain products under a supply agreement with Guerbet.
The following table summarizes the financial results of the CMDS discontinued operations for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013 as presented in the consolidated statements of operations and comprehensive income:
 
Fiscal Year
Major line items constituting income (loss) from discontinued operations
2015
 
2014
 
2013
Net sales
$
413.8

 
$
495.8

 
$
549.3

Cost of sales
306.4

 
352.9

 
346.7

Selling, general and administrative
97.5

 
97.1

 
114.0

Restructuring charges, net
0.3

 
47.2

 
9.5

Non-restructuring impairment charges
—

 
204.0

 
—

Other
4.7

 
4.1

 
8.4

Income (loss) from discontinued operations

4.9

 
(209.5
)
 
70.7

Income tax expense (benefit)
10.8

 
(34.7
)
 
21.1

 
 
 
 
 
 
Income (loss) from discontinued operations net of tax
$
(5.9
)
 
$
(174.8
)
 
$
49.6



The fiscal 2014 non-restructuring impairment charge of $204.0 million includes charges of $51.4 million associated with property, plant and equipment, $52.4 million associated with intangible assets and $100.2 million associated with goodwill. Further discussion of these impairment charges are included within Notes 10 and 11.
The fiscal 2015 income tax expense of $10.8 million was impacted by approximately $10.0 million of tax expense related to taxes paid, or anticipated to be paid, in connection with the disposition. The fiscal 2014 income tax benefit of $34.7 million was impacted by receiving a tax benefit of $36.2 million on impairment of $204.0 million, by $3.0 million of tax expense associated with the rate difference between U.S. and non-U.S. jurisdictions, $2.5 million of tax benefit associated with nonrecurring valuation allowances, $0.9 million of tax expense associated with accrued income tax liabilities and uncertain tax positions, and $2.0 million of tax expense associated with permanently nondeductible, nontaxable, and other items. The fiscal 2013 income tax expense of $21.1 million was impacted by $0.7 million of tax benefit associated with the rate difference between U.S. and non-U.S. jurisdictions and $2.9 million of tax benefit associated with permanently nondeductible, nontaxable, and other items. Fiscal 2015 reflects $14.9 million of International current income tax expense, $4.4 million of International deferred income tax benefit, and none being allocable to the Domestic income tax provision. Fiscal 2014 reflects $10.4 million of Domestic current income tax expense, $6.6 million of International current income tax benefit, $35.6 million of Domestic deferred income tax benefit, and $3.0 million of International deferred income tax benefit. Fiscal 2013 reflects $5.6 million of Domestic current income tax expense, $10.7 million of International current income tax expense, $5.4 million of Domestic deferred income tax expense, and $0.5 million of International deferred income tax benefit. Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and 2013.

The following table summarizes the assets and liabilities of the CMDS business that are classified as held for sale on the consolidated balance sheets as of September 25, 2015 and September 26, 2014:
 
September 25, 2015
 
September 26, 2014
Carrying amounts of major classes of assets included as part of discontinued operations
 
 
 
Accounts receivable
$
68.5

 
$
68.9

Inventories
86.3

 
90.2

Property, plant and equipment, net
60.3

 
62.4

Intangible assets, net
27.7

 
30.0

Other current and non-current assets
57.1

 
60.5

Total assets classified as held for sale in the balance sheet
$
299.9

 
$
312.0

 
 
 
 
Carrying amounts of major classes of liabilities included as part of discontinued operations
 
 
 
Accounts payable
$
22.0

 
$
18.0

Other current and non-current liabilities
50.8

 
50.7

Total liabilities classified as held for sale in the balance sheet
$
72.8

 
$
68.7



The following table summarizes significant cash and non-cash transactions of the CMDS business that are included within the consolidated statements of cash flows for the fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013:
 
Fiscal Year
 
2015
 
2014
 
2013
Depreciation
$
15.5

 
$
18.9

 
$
16.0

Amortization
2.3

 
7.5

 
7.5

Capital expenditures
9.5

 
12.3

 
17.4

Non-cash impairment charges
—

 
204.0

 
—


All other notes to the consolidated financial statements that were impacted by this discontinued operation have been reclassified accordingly.
Mallinckrodt Baker: During fiscal 2010, the Specialty Chemicals business (formerly known as "Mallinckrodt Baker"), which was part of the Company's Specialty Pharmaceuticals segment, was sold because its products and customer bases were not aligned with the Company's long-term strategic objectives. This business met the discontinued operations criteria and, accordingly, was included in discontinued operations for all periods presented. During fiscal 2015, 2014 and 2013, the Company recorded a loss, net of tax, of $0.1 million, a loss of $0.7 million, and a gain of $1.0 million, respectively. These gains and losses were primarily related to the indemnification obligations to the purchaser, which are discussed in Note 18.
Other: Prior to the Separation, the Company provided and accrued for an indemnification, to the purchaser of a certain legal entity, to indemnify it for tax obligations should the tax basis of certain assets not be recognized. The Company believes that, under the terms of the agreement between the parties, this indemnification obligation has expired. As such, the Company eliminated this liability and recorded a $22.5 million benefit, during fiscal 2015, in discontinued operations within the consolidated and combined statement of income.

License of Intellectual Property
The Company was involved in patent disputes with a counterparty relating to certain intellectual property related to extended-release oxymorphone. In December 2013, the counterparty agreed to pay the Company an upfront cash payment of $4.0 million and contractually obligated future payments of $8.0 million through July 2018, in exchange for the withdrawal of all claims associated with the intellectual property and a license to utilize the Company's intellectual property. The Company has completed the earnings process associated with the agreement and recorded an $11.7 million gain, included within gains on divestiture and license, during fiscal 2014.
XML 125 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements
 12 Months Ended
Sep. 25, 2015
Business Combinations [Abstract]  
Acquisitions and License Agreements
5.
Acquisitions and License Agreements
Business Acquisitions
Therakos, Inc.
On September 25, 2015, the Company acquired Therakos, Inc. ("Therakos") through the acquisition of all the outstanding common stock of TGG Medical Solutions, Inc., the parent holding company of Therakos, in a transaction valued at approximately $1.3 billion, net of cash acquired ("the Therakos Acquisition"). Consideration for the transaction consisted of approximately $1.0 billion in cash paid to TGG Medical Solutions, Inc. shareholders and the assumption of approximately $0.3 billion of Therakos third-party debt, which was repaid in conjunction with the Therakos Acquisition. The acquisition and repayment of debt was funded through the issuance of $750.0 million aggregate principal amount of senior unsecured notes, a $500.0 million borrowing under a revolving credit facility and cash on hand. Therakos' primary immunotherapy products relate to the administering of extracorporeal photopheresis therapies through its UVAR XTS® and CellexTM Photopheresis Systems, which accelerates the Company's growth in its Specialty Brands segment.

Ikaria, Inc.
On April 16, 2015, the Company acquired Ikaria, Inc. ("Ikaria") through the acquisition of all the outstanding common stock of Compound Holdings II, Inc., the parent holding company of Ikaria, in a transaction valued at approximately $2.3 billion, net of cash acquired ("the Ikaria Acquisition"). Consideration for the transaction consisted of approximately $1.2 billion in cash paid to Compound Holdings II, Inc. shareholders and the assumption of approximately $1.1 billion of Ikaria third-party debt, which was repaid in conjunction with the Ikaria Acquisition. The acquisition and repayment of debt was funded through the issuance of $1.4 billion aggregate principal amount of senior unsecured notes, a $240.0 million borrowing under the Revolver, which was repaid subsequent to the transaction, and cash on hand. Ikaria's primary product is INOMAX® (nitric oxide) for inhalation, a vital treatment option in neonatal critical care.


Questcor Pharmaceuticals
On August 14, 2014, the Company acquired all of the outstanding common stock of Questcor Pharmaceuticals, Inc. ("Questcor"), a biopharmaceutical company, for total consideration of approximately $5.9 billion, comprised of cash consideration of $30.00 per share, 0.897 ordinary shares of the Company for each share of Questcor common stock owned and the portion of outstanding equity awards deemed to have been earned as of August 14, 2014 ("the Questcor Acquisition"). The acquisition was funded through the issuance of approximately 57 million common shares, proceeds from the issuance of $900.0 million aggregate principal of senior unsecured notes, proceeds from a $700.0 million senior secured term loan facility, $150.0 million of cash from a receivable securitization program, as further discussed in Note 12, and cash on hand. H.P. Acthar® Gel (repository corticotropin injection) ("Acthar"), Questcor's primary product, is focused on the treatment of patients with serious, difficult-to-treat autoimmune and rare diseases. Acthar is an injectable drug that is approved by the U.S. Food and Drug Administration ("FDA") for use in 19 indications, including the areas of neurology, rheumatology, nephrology and pulmonology. Questcor also supplies specialty contract manufacturing services to the global pharmaceutical and biotechnology industry through its wholly-owned subsidiary, BioVectra Inc.

Cadence Pharmaceuticals
On March 19, 2014, the Company acquired all of the outstanding common stock of Cadence Pharmaceuticals, Inc. ("Cadence"), a biopharmaceutical company focused on commercializing products principally for use in the hospital setting, for total consideration of $14.00 per share in cash, or approximately $1.3 billion ("the Cadence Acquisition"). The acquisition was primarily funded through a $1.3 billion senior secured term loan credit facility, as further discussed in Note 12. Cadence's sole product, OFIRMEV® (acetaminophen) injection ("Ofirmev"), is a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The Cadence Acquisition added a growth product to the Specialty Brands product portfolio and provided us the opportunity to expand our reach into the hospital market, in which Cadence had an established presence.

CNS Therapeutics
On October 1, 2012, the Company acquired all the outstanding equity of CNS Therapeutics, Inc. ("CNS Therapeutics"), a specialty pharmaceuticals company focused on developing and commercializing intrathecal products for site-specific administration to the central nervous system to treat neurological disorders and intractable chronic pain, for total consideration, net of cash acquired, of $95.0 million. The total consideration was comprised of an upfront cash payment of $88.1 million (net of cash acquired of $3.6 million) and the fair value of contingent consideration of $6.9 million. This contingent consideration, which could potentially total a maximum of $9.0 million, is discussed further in Note 20.

Fair Value Allocation
The following amounts represent the preliminary allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Therakos Acquisition and Ikaria Acquisition and final allocation of the fair value of the identifiable assets acquired and liabilities assumed for the Cadence Acquisition, Questcor Acquisition and CNS Therapeutics acquisition:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Cash
$
41.3

 
$
77.3

 
$
445.1

 
$
43.2

 
$
3.6

Inventory
23.5

 
26.3

 
67.9

 
21.0

 
—

Intangible assets
1,170.0

 
1,971.0

 
5,601.1

 
1,300.0

 
91.9

Goodwill (non-tax deductible)
437.2

 
792.4

 
1,789.4

 
318.1

 
24.5

Other assets, current and non-current (1)
42.1

 
172.9

 
274.3

 
18.0

 
9.7

Total assets acquired
1,714.1

 
3,039.9

 
8,177.8

 
1,700.3

 
129.7

Current liabilities
24.7

 
32.6

 
168.9

 
48.8

 
4.0

Unpaid purchase consideration (current)
—

 
—

 
128.8

 
—

 
—

Other liabilities (non-current)
0.6

 
9.1

 
186.8

 
—

 
—

Deferred tax liabilities, net (non-current)
324.3

 
623.6

 
1,906.8

 
292.3

 
27.1

Contingent consideration (non-current)
—

 
—

 
—

 
—

 
6.9

Total debt
344.8

 
1,121.0

 
—

 
30.0

 
—

Total liabilities assumed
694.4

 
1,786.3

 
2,391.3

 
371.1

 
38.0

Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7



(1)
This amount includes $22.0 million, $73.8 million, $87.3 million, $14.7 million and $3.3 million of accounts receivable for the Therakos Acquisition, Ikaria Acquisition, Questcor Acquisition, Cadence Acquisition, and CNS Therapeutics, respectively, which is also the gross contractual value.

The following reconciles the total consideration to net assets acquired:
 
Therakos
 
Ikaria
 
Questcor
 
Cadence
 
CNS Therapeutics
Total consideration, net of cash
$
978.4

 
$
1,176.3

 
$
5,470.2

 
$
1,286.0

 
$
95.0

Plus: cash assumed in acquisition
41.3

 
77.3

 
445.1

 
43.2

 
3.6

Total consideration
1,019.7

 
1,253.6

 
5,915.3

 
1,329.2

 
98.6

Less: unpaid purchase consideration
—

 
—

 
(128.8
)
 
—

 
—

Less: contingent consideration
—

 
—

 
—

 
—

 
(6.9
)
Net assets acquired
$
1,019.7

 
$
1,253.6

 
$
5,786.5

 
$
1,329.2

 
$
91.7



Intangible assets acquired consist of the following:  
Therakos
Amount
 
Amortization Period
Completed technology
$
1,170.0

 
15 years
The completed technology intangible asset relates to extracorporeal photopheresis treatment therapies. The fair value of the intangible asset was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of the asset based on market participant expectations of cash flows the asset would generate. The cash flows were discounted commensurate with the level of risk associated with each asset or its projected cash flows. The completed technology intangible asset utilized a discount rate of 17.0%. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.
Ikaria
Amount
 
Amortization Period
Completed technology
$
1,820.0

 
15 years
Trademark
70.0

 
22 years
In-process research and development - terlipressin
81.0

 
Non-Amortizable
 
$
1,971.0

 
 
The completed technology and trademark intangible assets relate to Inomax. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, trademark and in-process research and development ("IPR&D") terlipressin intangibles utilized discount rates of 14.5%, 14.5%, and 17.0%, respectively. The IPR&D discount rate for terlipressin was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, future product and device development, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

Questcor
Amount
 
Weighted-Average Amortization Period
Completed technology
$
5,343.3

 
18 years
Trademark
5.2

 
13 years
Customer relationships
34.3

 
12 years
In-process research and development - Synacthen
218.3

 
Non-Amortizable
 
$
5,601.1

 
 
The completed technology intangible asset relates to Acthar. The trademark and customer relationship intangible assets relate to BioVectra, Inc., a wholly-owned subsidiary of Questcor. The in-process research and development relates to the U.S. development of Synacthen, a synthetic pharmaceutical product. The fair value of the intangible assets were determined using the income approach. The cash flows were discounted at various discount rates commensurate with the level of risk associated with each asset or its projected cash flows. Completed technology, customer relationships, trademark and in-process research and development intangibles utilized discount rates of 14.5%, 10.0%, 10.0% and 16.0%, respectively. The in-process research and development discount rate was developed after assigning a probability of success to achieving the projected cash flows based on the current stage of development, inherent uncertainty in the FDA approval process and risks associated with commercialization of a new product. Based on the Company's preliminary estimate, the excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. The majority of assets acquired are included within the Company's Specialty Brands segment. Assets related to BioVectra, Inc. are included within the Company's Specialty Generics segment.

Cadence
Amount
 
Amortization Period
Completed technology
$
1,300.0

 
8 years
The completed technology intangible asset relates to Ofirmev, the rights to which have been in-licensed from Bristol-Myers Squibb Company ("BMS"). The fair value of the intangible asset was determined using the income approach. The cash flows were discounted at a 13.0% rate. For more information on the BMS license agreement, refer to "License Agreement" below. The excess of purchase price over net tangible and intangible assets acquired resulted in goodwill, which represents the assembled workforce, anticipated synergies and the tax status of the transaction. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.


CNS Therapeutics
Amount
 
Weighted-Average Amortization Period
Completed technology
$
73.1

 
13 years
Trademark
0.2

 
3 years
In-process research and development
18.6

 
Non-Amortizable
 
$
91.9

 
 

The in-process research and development projects primarily relate to certain investigational intrathecal pain products. As of the date of acquisition, these pain products were in various stages of development, with further development, testing, clinical trials and regulatory submission required in order to bring them to market. At the acquisition date, the total cost to complete these products was estimated to be approximately $18.0 million. The Company expects that regulatory approvals will occur between 2016 and 2019. The valuation of the in-process research and development was determined using, among other factors, appraisals primarily based on the discounted cash flow method. The cash flows were discounted at a 35% rate, which was considered commensurate with the risks and stages of development of the pain products. Future residual cash flows that could be generated from the products were determined based upon management's estimate of future revenue and expected profitability of the products. These projected cash flows were then discounted to their present values taking into account management's estimate of future expenses that would be necessary to bring the products to completion. The goodwill is not deductible for U.S. income tax purposes. All assets acquired are included within the Company's Specialty Brands segment.

Financial Results - The amount of net sales and earnings included in the Company's results for the periods presented were as follows:
Net sales
2015
 
2014
Ikaria
$
191.9

 
$
—

Questcor
1,125.9

 
129.2

Cadence
263.0

 
124.4

 
$
1,580.8

 
$
253.6

Operating income (loss)


 
 
Ikaria
$
47.1

 
$
—

Questcor
223.3

 
17.4

Cadence
(97.3
)
 
(66.9
)
 
$
173.1

 
$
(49.5
)


The amount of amortization on acquired intangible assets included within operating income (loss) for the periods presented was as follows:
Intangible asset amortization
2015
 
2014
Ikaria
$
57.1

 
$
—

Questcor
301.4

 
34.9

Cadence
162.5

 
85.9

 
$
521.0

 
$
120.8

During fiscal 2015 and 2014, the Company recognized $44.1 million and $25.7 million, respectively, of expense primarily associated with fair value adjustments of acquired inventory. This expense was included within cost of sales.

Acquisition-Related Costs - Acquisition-related costs incurred in fiscal 2015 and 2014 for each of the fiscal 2015 and 2014 acquisitions discussed above were as follows:
Acquisition-related costs
2015
 
2014
Therakos
$
22.5

 
$
—

Ikaria
30.9

 
—

Questcor
—

 
47.5

Cadence
—

 
17.6

 
$
53.4

 
$
65.1


Unaudited Pro Forma Financial Information - The following unaudited pro forma information presents a summary of the results of operations for the periods indicated as if the Questcor Acquisition and Cadence Acquisition had been completed as of September 29, 2012 and the Ikaria Acquisition and Therakos Acquisition as of September 28, 2013. The pro forma financial information is based on the historical financial information for the Company, Ikaria, Questcor and Cadence, along with certain pro forma adjustments. These pro forma adjustments consist primarily of:
•
non-recurring costs related to the step-up in fair value of acquired inventory and transaction costs related to the acquisitions;
•
increased amortization expense related to the intangible assets acquired in the acquisitions;
•
elimination of direct acquisition transaction costs from the period of acquisition;
•
increased interest expense to reflect the fixed rate unsecured notes and revolving credit facility (utilizing the interest rate in effect at the date of the acquisition of 2.6%) entered into in connection with the Therakos Acquisition, the fixed rate unsecured notes entered into in connection with the Ikaria Acquisition (assuming no interest related to the revolving credit facility which was paid down subsequent to the Ikaria Acquisition), the fixed-rate senior unsecured notes and variable-rate term loan entered into in connection with the acquisition of Questcor (utilizing the interest rate in effect at the date of acquisition of 3.50%), and the variable-rate term loan and revolving credit facility entered into in connection with the Cadence Acquisition (utilizing the interest rate in effect at the date of acquisition of 3.50%) including interest and amortization of deferred financing costs and original issue discount; and
•
the related income tax effects.
The following unaudited pro forma information has been prepared for comparative purposes only and is not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor is it necessarily an indication of future operating results. In addition, the unaudited pro forma information does not reflect the cost of any integration activities, benefits from any synergies that may be derived from the acquisition or revenue growth that may be anticipated.
 
2015
 
2014
Net sales
$
3,755.8

 
$
3,598.1

Income (loss) from continuing operations
359.9

 
(63.1
)
 
 
 
 
Basic earnings (loss) per share from continuing operations
$
3.11

 
$
(0.55
)
Diluted earnings (loss) from per share continuing operations
3.07

 
(0.55
)


License Agreements
Ofirmev
As part of the Cadence Acquisition, the Company acquired the exclusive development and commercialization rights to Ofirmev in the U.S. and Canada, as well as the rights to the patents and technology, which were originally in-licensed by Cadence from BMS in March 2006. BMS sublicensed these rights to Cadence under a license agreement with SCR Pharmatop S.A. ("Pharmatop"), and the Company has the right to grant sublicenses to third parties. Under this license agreement, the Company may be obligated to make future milestone payments of up to $25.0 million upon the achievement of certain levels of net sales, of which $10.0 million was paid during fiscal 2015. In addition, the Company is obligated to pay royalties on sales of the product. During fiscal 2015 and 2014, the Company paid royalties of $43.9 million and $13.2 million respectively.

Exalgo
In 2009, the Company's Specialty Brands segment acquired the rights to market and distribute the pain management drug EXALGO® (hydromorphone HCl) extended-release tablets (CII) ("Exalgo") in the U.S. Under the license agreement, the Company is obligated to make additional payments of up to $73.0 million based on the successful completion of specified development and regulatory milestones. Through fiscal 2015, $65.0 million of additional payments had been made, with $55.0 million being capitalized as an intangible asset. The Company is also required to pay royalties on sales of the product. During fiscal 2015, 2014 and 2013, the Company paid royalties of $3.2 million, $22.0 million and $24.0 million, respectively.
In January 2014, the Company purchased certain royalty rights associated with Exalgo for $7.2 million, which have been capitalized as an intangible asset.


Depomed
In 2009, the Company's Specialty Brands segment licensed worldwide rights to utilize Depomed, Inc.'s ("Depomed") Acuform gastric retentive drug delivery technology for the exclusive development of four products. Under this license agreement, the Company may be obligated to pay up to $64.0 million in development milestone payments. Through fiscal 2015, approximately $22.0 million of these payments have been made by the Company. During fiscal 2014, upon approval by the FDA for XARTEMIS™ XR (oxycodone HCl and acetaminophen) extended release tablets CII ("Xartemis XR"), the Company made a milestone payment of $10.0 million, which has been capitalized as an intangible asset.

Pennsaid
In 2009, the Company's Specialty Brands segment entered into a licensing agreement which granted it rights to market and distribute Pennsaid and Pennsaid 2%, a formulation of diclofenac sodium topical solution which was approved in February 2014 by the FDA and indicated for the treatment of pain associated with osteoarthritis of the knee. The Company was responsible for future development activities and expenses and were required to make milestone payments of up to $120.0 million based upon the successful completion of specified regulatory and sales milestones. Through fiscal 2015, $15.0 million of these payments were made, all of which were capitalized as an intangible asset. The Company is also required to pay royalties on sales of the products under this agreement. During fiscal 2015, 2014 and 2013, the Company paid royalties of $1.8 million, $4.3 million and $3.9 million, respectively.
During the fourth quarter of fiscal 2014, the Company reached an agreement in principle with Nuvo to settle various claims associated with our license of Pennsaid obtained from Nuvo. As part of the legal settlement, the Company agreed to return the license to Nuvo, which resulted in the Company recording an impairment of $11.1 million during the fourth quarter of fiscal 2014.
XML 126 R137.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidating and Combining Financial Statements (Narrative) (Details)
Nov. 30, 2012
Covidien  
Condensed Consolidating Financial Statements  
Percentage of ownership in MIFSA 100.00%
XML 127 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes
 12 Months Ended
Sep. 25, 2015
Income Tax Disclosure [Abstract]  
Income Taxes
7.
Income Taxes
In May 2015, the activities of the Company's principal executive offices were relocated from Ireland to the U.K. which resulted in a change in the Company's tax residence to the U.K. Mallinckrodt plc remains incorporated in Ireland. The tax regime applicable to holding companies resident in the U.K. allows Mallinckrodt plc to continue to have flexibility in structuring its subsidiary operations and enhanced global cash management. The Company continues to be subject to taxation in various tax jurisdictions worldwide. As a result of the integration of acquired intellectual property, the Company's income and assets are no longer concentrated in a single tax jurisdiction. Accordingly, in 2015 the Company reports the U.K. tax jurisdiction as its Domestic jurisdiction and the International jurisdiction represents areas outside the U.K. tax jurisdiction.
The Domestic and International components of income from continuing operations before income taxes were as follows(1):
 
2015
 
2014
 
2013
Domestic
$
(107.0
)
 
$
(159.9
)
 
$
34.7

International
322.3

 
6.0

 
21.0

Total
$
215.3

 
$
(153.9
)
 
$
55.7


(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.

Significant components of income taxes related to continuing operations are as follows(1):
 
2015
 
2014
 
2013
Current:
 
 
 
 
 
Domestic 
$
0.3

 
$
40.9

 
$
49.3

International 
95.1

 
17.9

 
12.1

Current income tax provision
95.4

 
58.8

 
61.4

Deferred:
 
 
 
 
 
Domestic 
$
(0.8
)
 
$
(49.7
)
 
$
(18.3
)
International 
(187.5
)
 
(19.2
)
 
4.4

Deferred income tax (benefit) provision
(188.3
)
 
(68.9
)
 
(13.9
)
 
$
(92.9
)
 
$
(10.1
)
 
$
47.5


(1) Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.

The fiscal 2015 International current income tax provision reflects a utilization of $7.0 million of net operating losses (primarily in the U.S.) and $14.3 million of U.S. credits. The net operating loss utilization is comprised of $4.8 million of net operating losses acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to net operating losses carried forward from fiscal 2014. The U.S. credit utilization is comprised of $7.2 million of credits acquired in conjunction with the Ikaria Acquisition and the remainder utilization relating to credits carried forward or generated during fiscal 2015.
The fiscal 2014 Domestic current income tax provision reflects a utilization of $221.3 million of net operating losses (primarily in the U.S.) and $8.6 million of U.S. credits. The net operating loss utilization is comprised of $187.8 million of net operating losses acquired in conjunction with the Cadence Acquisition and the remainder utilization relating to net operating losses carried forward.
The Company has a provincial tax holiday in Canada that expires on April 1, 2017. The tax holiday reduced International tax expense by $5.1 million and $0.3 million for the fiscal years 2015 and 2014, respectively.
The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:
 
2015
 
2014
 
2013
Provision for income taxes at Domestic statutory income tax rate (1)
$
43.1

 
$
(53.8
)
 
$
19.5

   Adjustments to reconcile to income tax provision:
 
 
 
 
 
U.S. state income tax provision, net (6)
—

 
(6.1
)
 
3.7

Rate difference between Domestic and International jurisdictions (2) (3)
(138.6
)
 
(10.6
)
 
3.3

U.S. manufacturing deduction (6)
—

 
(4.1
)
 
(2.5
)
Valuation allowances, nonrecurring
(2.1
)
 
0.1

 
3.4

Adjustments to accrued income tax liabilities and uncertain tax positions (3)
(6.8
)
 
(1.5
)
 
5.0

Interest and penalties on accrued income tax liabilities and uncertain tax positions (3)
0.2

 
(7.9
)
 
4.7

Investment in partnership
—

 
20.0

 
—

Credits, principally research and orphan drug (4)
(8.1
)
 
(0.8
)
 
(6.3
)
Impairments, nondeductible
—

 
41.8

 
—

Permanently nondeductible and nontaxable items (5)
16.4

 
13.8

 
15.3

Other
3.0

 
(1.0
)
 
1.4

Provision for income taxes
$
(92.9
)
 
$
(10.1
)
 
$
47.5

(1)
The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014 and 2013.
(2)
Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
(3)
Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
(4)
During fiscal 2013, the U.S. Research Credit legislation was extended, with a retroactive effective date of January 1, 2012. As such, fiscal 2013 includes approximately $2.3 million of credit related to the period January 1, 2012 through September 28, 2012. Due to the December 31, 2013 tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014.
(5)
Includes the impact of nondeductible transaction and separation costs.
(6)
For fiscal 2015, U.S. state income tax benefit of $36.4 million, and U.S. manufacturing deduction tax benefit of $5.6 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.

The rate difference between Domestic and International jurisdictions changed from $10.6 million of tax benefit to $138.6 million of tax benefit for fiscal 2014 to fiscal 2015, respectively. The rate difference between Domestic and International jurisdictions would have been $32.1 million of tax benefit in fiscal 2014 if the referenced rate would have been the U.K. statutory rate of 21%. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the $128.0 million increase to tax benefit, $21.5 million of tax benefit can be attributed to the change in the referenced rate from U.S. to U.K, $35.0 million of tax benefit to the change in operating income, $22.5 million of tax expense to the change in amortization, $31.8 million of tax benefit to the U.S. state tax benefit associated with the impact of recent acquisitions, integration thereof, and legislative changes, and $62.2 million of tax benefit related to acquisition and other non-acquisition related items.
The rate difference between Domestic and International jurisdictions changed from $3.3 million of tax expense to $10.6 million of tax benefit for fiscal 2013 to fiscal 2014, respectively. The rate difference between Domestic and International jurisdictions would have been $10.0 million of tax expense and $32.1 million of tax benefit if the referenced rate would have been the U.K. statutory rate of 23% and 21% for fiscal 2013 and 2014 respectively. This change was predominately related to recent acquisitions, which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was predominately due to recent acquisitions and the benefit of intercompany debt transferred to the Company at Separation, both of which resulted in more income in lower tax rate jurisdictions and less income in the higher tax rate U.S. jurisdiction relative to income in all jurisdictions. The change in the lower tax rate jurisdictions was primarily attributable to increased operating income partially offset by amortization. The change in the U.S. jurisdiction was primarily attributable to increased amortization and the cost of financing recent acquisitions. Of the $13.9 million decrease in tax expense, $10.8 million of tax expense can be attributed to the change in operating income, $14.0 million of tax expense to the change in amortization, and $38.7 million of tax benefit related to acquisition and other non-acquisition related items.

As of September 25, 2015, September 26, 2014 and September 27, 2013, the amounts of unrecognized tax benefits for which the Company is legally and directly liable and would be required to remit cash if not sustained were $89.2 million, $82.0 million and $100.1 million, respectively. For periods prior to the Separation, the Company's operations had been included in tax returns filed by Covidien or certain of its subsidiaries not included in the Company's historical combined financial statements. As a result, some U.S. uncertain tax positions related to the Company's operations resulted in unrecognized tax benefits that are obligations of entities not included in the combined financial statements for periods prior to June 28, 2013. Because the activities that gave rise to these unrecognized tax benefits relate to the Company's operations, the impact of these items (presented in the table below) were charged to the income tax provision through parent company investment, which was a component of parent company equity in the combined balance sheets.
The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:
 
2015
 
2014
 
2013
Balance at beginning of fiscal year
$
82.0

 
$
100.1

 
$
165.5

Unrecognized tax benefits retained by Covidien
—

 
—

 
(153.7
)
Unrecognized tax benefits transferred from Covidien
—

 
—

 
84.2

Additions related to current year tax positions
4.5

 
3.2

 
3.5

Additions related to prior period tax positions
19.9

 
30.6

 
6.6

Reductions related to prior period tax positions
(7.7
)
 
(33.0
)
 
(4.3
)
Settlements
(7.8
)
 
(6.9
)
 
(1.6
)
Lapse of statute of limitations
(1.7
)
 
(12.0
)
 
(0.1
)
Balance at end of fiscal year
89.2

 
82.0

 
100.1



During fiscal 2015, the Company made a payment of $8.9 million ($7.4 million of tax and $1.5 million of interest) to the U.S. Internal Revenue Service ("IRS") in connection with the settlement of certain tax matters for 2008 and 2009. During fiscal 2014, the Company made a payment of $35.9 million ($27.3 million of tax and $8.6 million of interest) to the IRS in connection with the settlement of certain tax matters for 2005 through 2007.
Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:
 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
1.3

 
$
6.5

Other income tax liabilities
80.0

 
70.7

Deferred income taxes (non-current liability)
7.9

 
4.8

 
$
89.2

 
$
82.0



Included within total unrecognized tax benefits at September 25, 2015, September 26, 2014 and September 27, 2013, were $87.4 million, $82.0 million and $96.3 million, respectively, of unrecognized tax benefits, which if favorably settled would benefit the effective tax rate. The remaining unrecognized tax benefits for each period would be offset by the write-off of related deferred and other tax assets, if recognized. During fiscal 2015, the Company recorded $5.7 million of additional interest through tax provision and acquisition accounting and decreased interest $9.3 million related to cash payments related to settlements as well as reductions related to prior periods. During fiscal 2014 and 2013, the Company accrued additional interest of $7.0 million and $2.4 million, respectively. The total amount of accrued interest related to uncertain tax positions was $41.7 million, $45.1 million and $62.1 million, respectively.
It is reasonably possible that within the next twelve months, as a result of the resolution of various Domestic and International examinations and appeals and the expiration of various statutes of limitation, that the unrecognized tax benefits could decrease by up to $17.5 million. Interest and penalties could decrease by up to $8.8 million.
Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown.
 
September 25, 2015
 
September 26, 2014
Accrued and other current liabilities
$
19.8

 
$
13.1

Other income tax liabilities
121.3

 
122.6

 
$
141.1

 
$
135.7


At September 25, 2015, other assets includes $52.2 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes $8.7 million of tax payments associated with current deferred intercompany transactions, and $81.3 million of receivables associated with tax payments on account with the taxing authorities. At September 26, 2014, other assets includes $14.8 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of $60.0 million associated with the Questcor acquisition and tax payments of $0.6 million associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.
 
September 25, 2015
 
September 26, 2014
Other assets
$
52.2

 
$
14.8

Prepaid expenses and other current assets
90.0

 
63.4

 
$
142.2

 
$
78.2



Covidien continues to be examined by various taxing authorities for periods the Company was included within the consolidated results of Covidien. In connection with the Separation, the Company entered into a tax matters agreement ("the Tax Matters Agreement") with Covidien that generally governs Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including, but not limited to, ordinary course of business taxes. For further information on the Tax Matters Agreement, refer to Note 17.
As of September 25, 2015, the earliest open year for U.S. federal and state tax jurisdictions is 1996. Additionally, a number of tax periods from 2009 to present are subject to examination by tax authorities in various jurisdictions, including Ireland, Luxembourg, Switzerland, and the U.K.
Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:
 
September 25, 2015
 
September 26, 2014
Deferred tax assets:
 
 
 
Accrued liabilities and reserves
$
92.5

 
$
68.9

Inventories
23.2

 
21.4

Tax loss and credit carryforwards
163.3

 
93.8

Environmental liabilities
23.6

 
29.5

Rebate reserves
48.5

 
41.1

Expired product
26.3

 
39.0

Postretirement benefits
33.8

 
34.5

Federal and state benefit of uncertain tax positions and interest
33.6

 
29.5

Share-based compensation
18.9

 
28.1

Intangible assets
105.7

 
9.6

Other
20.2

 
32.0

 
589.6

 
427.4

Deferred tax liabilities:
 
 
 
Property, plant and equipment
(140.1
)
 
(121.6
)
Intangible assets
(1,550.7
)
 
(2,177.9
)
Installment sale
(1,465.3
)
 
(93.6
)
Investment in partnership
(187.9
)
 
(191.3
)
 
(3,344.0
)
 
(2,584.4
)
Net deferred tax (liability) before valuation allowances
(2,754.4
)
 
(2,157.0
)
Valuation allowances
(233.0
)
 
(76.9
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)

Deferred taxes are reported in the following consolidated and combined balance sheet captions in the amounts shown:
 
September 25, 2015
 
September 26, 2014
Deferred income taxes (current asset)
$
142.7

 
$
152.3

Other non-current assets
7.0

 
13.4

Accrued and other current liabilities
(4.7
)
 
—

Deferred income taxes (non-current liability)
(3,132.4
)
 
(2,399.6
)
Net deferred tax (liability)
$
(2,987.4
)
 
$
(2,233.9
)


The Company's current deferred tax asset decreased from $152.3 million at September 26, 2014 to $142.7 million at September 25, 2015 primarily due to changes in inventory valuation as a result of profits in intercompany inventory, the increase in deferred tax assets from the Ikaria Acquisition, and decreases to operational deferred tax assets due to normal operating activities. Additionally, the Company's non-current deferred tax liability increased from $2,399.6 million at September 26, 2014 to $3,132.4 million at September 25, 2015, primarily due to $623.6 million related to the Ikaria Acquisition, $324.3 million related to the Therakos Acquisition, offset by $54.3 million of decreases associated with the amortization of intangibles, $105.4 million of decreases associated with the payment of internal installment sale obligations, and approximately $44.0 million of decreases related to other impacts of recent acquisitions and integration.

The Ikaria Acquisition resulted in a net deferred tax liability increase of $596.9 million. Significant components of this increase include $620.2 million of deferred tax liabilities associated with intangibles and $17.5 million of deferred tax liability associated with property, plant and equipment, partially offset by $21.7 million of deferred tax assets associated with U.S. tax credits, $13.1 million of deferred tax assets associated with financing repayments and $4.9 million of deferred tax assets associated with U.S. net operating losses.
The Therakos Acquisition resulted in a net deferred tax liability increase of $324.3 million. Significant components of this increase include $334.1 million of deferred tax liabilities associated with intangibles partially offset by $13.5 million of deferred tax assets predominately associated with U.S. net operating losses.

As a part of the Questcor integration, the Company entered into an internal installment sale transaction during the three months ended December 26, 2014. The Questcor internal installment sale transaction resulted in a decrease of $1,488.7 million to the deferred tax liability associated with the Acthar intangible asset, a $1,515.9 million increase to the deferred tax liability associated with an installment sale note receivable, a $25.3 million increase to deferred tax charge, and a $1.9 million increase to prepaid taxes.
At September 25, 2015, the Company had approximately $126.0 million of net operating loss carryforwards in certain non-U.K. jurisdictions, of which $91.4 million have no expiration and the remaining $34.6 million will expire in future years through 2025. The Company had $19.6 million of U.K. net operating loss carryforwards at September 25, 2015, which have no expiration date.
At September 25, 2015 the Company also had $16.3 million of tax credits available to reduce future income taxes payable, primarily in jurisdictions within the U.S., of which $3.1 million have no expiration and the remainder expire during fiscal 2016 through 2034.
The deferred tax asset valuation allowances of $233.0 million and $76.9 million at September 25, 2015 and September 26, 2014, respectively, relate principally to the uncertainty of the utilization of certain deferred tax assets, primarily International net operating losses and intangible assets. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets.
The tax residency change impacts the Company’s analysis of its cumulative unrepatriated earnings. As of September 25, 2015, the cumulative amount of undistributed earnings of the Company's subsidiaries that may be subject to tax, but are considered to be indefinitely reinvested, was $369.0 million. It is not practicable to determine the cumulative amount of tax liability that would arise if these indefinitely reinvested earnings were remitted due to a variety of factors including the complexity of the Company's global legal entity structure as well as the timing, extent, and nature of any hypothetical repatriation of unremitted earnings. The net decrease in such undistributed earnings as compared to the period ended September 26, 2014 was attributable to the impact of the tax residency change and associated jurisdictions that could be remitted in a tax-free manner as well as the removal of the earnings for the entities classified as held for sale. These decreases were partially offset by an increase in unrepatriated earnings associated with income and losses attributed to the current year activity.

The Company has accrued a $0.7 million deferred tax liability associated with approximately $13.4 million of unrepatriated earnings that are not indefinitely reinvested on assets from continuing operations. The Company has also accrued a $6.5 million deferred tax liability associated with approximately $41.3 million of unrepatriated earnings that are not indefinitely reinvested related to assets held for sale.
XML 128 R64.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Narrative) (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 60 Months Ended
Sep. 25, 2015
USD ($)
Apr. 16, 2015
USD ($)
Aug. 14, 2014
USD ($)
$ / shares
shares
Apr. 05, 2014
shares
Mar. 19, 2014
USD ($)
$ / shares
Oct. 01, 2012
USD ($)
Jan. 31, 2014
USD ($)
Sep. 25, 2015
USD ($)
Jun. 26, 2015
USD ($)
Mar. 27, 2015
USD ($)
Dec. 26, 2014
USD ($)
Sep. 26, 2014
USD ($)
Jun. 27, 2014
USD ($)
Mar. 28, 2014
USD ($)
Dec. 27, 2013
USD ($)
Jun. 26, 2015
pharmacy_indications
Sep. 25, 2015
USD ($)
Sep. 26, 2014
USD ($)
Sep. 27, 2013
USD ($)
Sep. 27, 2013
USD ($)
Business Acquisition [Line Items]                                        
Payments to Acquire Businesses, Net of Cash Acquired                                 $ 2,154.7 $ 2,793.8 $ 88.1  
Net sales               $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5   3,346.9 2,082.0 1,712.3  
Non-cash impairment charges                                 0.0 381.2 0.0  
Nuvo                                        
Business Acquisition [Line Items]                                        
Non-cash impairment charges                                   11.1    
Therakos                                        
Business Acquisition [Line Items]                                        
Contingent consideration $ 0.0             0.0                 0.0      
Business Combination, Consideration Transferred, Other 1,300.0                                      
Total consideration 1,019.7                                      
Cash used to acquire business 1,000.0                                      
Long Term Debt Assumed 300.0             300.0                 300.0      
Ikaria                                        
Business Acquisition [Line Items]                                        
Contingent consideration   $ 0.0                                    
Business Combination, Consideration Transferred, Other   2,300.0                                    
Total consideration   1,253.6                                    
Cash used to acquire business   1,200.0                                    
Long Term Debt Assumed   1,100.0                                    
Net sales                                 191.9 0.0    
Questcor Pharmaceuticals, Inc.                                        
Business Acquisition [Line Items]                                        
Contingent consideration     $ 0.0                                  
Total consideration     $ 5,915.3                                  
Amount of Cash Shareholders Receive, Per Share of Acquiree | $ / shares     $ 30.00                                  
Amount of company shares shareholders will receive, per share | shares       0.897                                
Issuance of common stock to acquire business | shares     57,000,000                                  
Issuance of senior unsecured notes to acquire business     $ 900.0                                  
Issuance of senior secured term loan facility to acquire business     700.0                                  
Cash used to acquire business     $ 150.0                                  
Contingent consideration, potential maximum 190.0             190.0                 190.0      
Net sales                                 1,125.9 129.2    
Cadence Pharmaceuticals, Inc.                                        
Business Acquisition [Line Items]                                        
Contingent consideration         $ 0.0                              
Total consideration         1,329.2                              
Net sales                                 263.0 124.4    
CNS Therapeutics, Inc.                                        
Business Acquisition [Line Items]                                        
Contingent consideration           $ 6.9                            
Payments to Acquire Businesses, Net of Cash Acquired           88.1                            
Total consideration           98.6                            
Contingent consideration, potential maximum           $ 9.0                            
Acthar | Questcor Pharmaceuticals, Inc.                                        
Business Acquisition [Line Items]                                        
Number of indications that are approved for treatment | pharmacy_indications                               19        
Bristol-Myers Squibb | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Contingent payment, maximum additional amount                                 25.0      
Royalties paid                                 43.9 13.2    
Ofirmev | Cadence Pharmaceuticals, Inc. | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Milestone Payments                                 10.0      
Exalgo | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Contingent payment, maximum additional amount                                 73.0      
Royalties paid                                 3.2 22.0 24.0  
Milestone Payments                                       $ 65.0
Depomed | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Contingent payment, maximum additional amount                                 64.0      
Milestone Payments                                   10.0   22.0
Pennsaid | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Contingent payment, maximum additional amount                                 120.0      
Royalties paid                                 1.8 $ 4.3 $ 3.9  
Milestone Payments                                       15.0
Finite-Lived Intangible Assets | Exalgo | Licensing Agreements                                        
Business Acquisition [Line Items]                                        
Milestone Payments                                       $ 55.0
Royalty rights | Exalgo                                        
Business Acquisition [Line Items]                                        
Finite-lived intangible assets acquired             $ 7.2                          
Debentures | Therakos                                        
Business Acquisition [Line Items]                                        
Long term debt 750.0                                      
Debentures | Ikaria                                        
Business Acquisition [Line Items]                                        
Long term debt   1,400.0                                    
Revolving Credit Facility | Therakos                                        
Business Acquisition [Line Items]                                        
Borrowings, outstanding $ 500.0             $ 500.0                 $ 500.0      
Revolving Credit Facility | Ikaria                                        
Business Acquisition [Line Items]                                        
Borrowings, outstanding   $ 240.0                                    
Revolving Credit Facility | Revolving Credit Facility                                        
Business Acquisition [Line Items]                                        
Interest rate during period                                 2.60%      
Term loan due March 2021 | Revolving Credit Facility                                        
Business Acquisition [Line Items]                                        
Interest rate during period                                 2.60%      
Term loan due March 2021 | Secured Debt                                        
Business Acquisition [Line Items]                                        
Debt instrument, face amount         1,300.0                              
Interest rate during period                                 3.25%      
Term loan due March 2021 | Term Loan                                        
Business Acquisition [Line Items]                                        
Interest rate during period                                 3.50%      
Specialty Pharmaceuticals | Cadence Pharmaceuticals, Inc.                                        
Business Acquisition [Line Items]                                        
Total consideration         $ 1,300.0                              
Amount of Cash Shareholders Receive, Per Share of Acquiree | $ / shares         $ 14.00                              
XML 129 R120.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance $ 65.7 $ 108.5 $ 84.9
Other comprehensive loss before reclassifications (71.9) (44.7) 23.6
Amounts reclassified from accumulated other comprehensive income 7.1 1.9  
Ending balance 0.9 65.7 108.5
Currency Translation      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance 131.0 158.6 157.1
Other comprehensive loss before reclassifications (70.8) (27.6) 1.5
Amounts reclassified from accumulated other comprehensive income 0.0 0.0  
Ending balance 60.2 131.0 158.6
Unrecognized Loss on Derivatives      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (6.8) (7.3) 0.0
Other comprehensive loss before reclassifications 0.0 0.0 (7.3)
Amounts reclassified from accumulated other comprehensive income 0.4 0.5  
Ending balance (6.4) (6.8) (7.3)
Unrecognized Gain (Loss) on Benefit Plans      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (58.5) (42.8) (72.2)
Other comprehensive loss before reclassifications (1.1) (17.1) 29.4
Amounts reclassified from accumulated other comprehensive income 6.7 1.4  
Ending balance $ (52.9) $ (58.5) $ (42.8)
XML 130 R85.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Deferred Taxes Balance Sheet Location) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Income Tax Disclosure [Abstract]    
Deferred income taxes (current asset) $ 142.7 $ 152.3
Other non-current assets 7.0 13.4
Accrued and other current liabilities (4.7) 0.0
Deferred income taxes (non-current liability) (3,132.4) (2,399.6)
Net deferred tax (liability) $ (2,987.4) $ (2,233.9)
XML 131 R66.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Reconciliation of Total Consideration) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Apr. 16, 2015
Aug. 14, 2014
Mar. 19, 2014
Oct. 01, 2012
Therakos          
Business Acquisition [Line Items]          
Total consideration, net of cash $ 978.4        
Plus: cash assumed in acquisition 41.3        
Total consideration 1,019.7        
Less: unpaid purchase consideration 0.0        
Less: contingent consideration 0.0        
Net assets acquired $ 1,019.7        
Ikaria          
Business Acquisition [Line Items]          
Total consideration, net of cash   $ 1,176.3      
Plus: cash assumed in acquisition   77.3      
Total consideration   1,253.6      
Less: unpaid purchase consideration   0.0      
Less: contingent consideration   0.0      
Net assets acquired   $ 1,253.6      
Questcor Pharmaceuticals, Inc.          
Business Acquisition [Line Items]          
Total consideration, net of cash     $ 5,470.2    
Plus: cash assumed in acquisition     445.1    
Total consideration     5,915.3    
Less: unpaid purchase consideration     (128.8)    
Less: contingent consideration     0.0    
Net assets acquired     $ 5,786.5    
Cadence Pharmaceuticals, Inc.          
Business Acquisition [Line Items]          
Total consideration, net of cash       $ 1,286.0  
Plus: cash assumed in acquisition       43.2  
Total consideration       1,329.2  
Less: unpaid purchase consideration       0.0  
Less: contingent consideration       0.0  
Net assets acquired       $ 1,329.2  
CNS Therapeutics, Inc.          
Business Acquisition [Line Items]          
Total consideration, net of cash         $ 95.0
Plus: cash assumed in acquisition         3.6
Total consideration         98.6
Less: unpaid purchase consideration         0.0
Less: contingent consideration         (6.9)
Net assets acquired         $ 91.7
XML 132 R102.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Amounts to be Amortized From Accumulated Other Comprehensive Income) (Details)
$ in Millions
 12 Months Ended
Sep. 25, 2015
USD ($)
Pension Benefits  
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]  
Amortization of net actuarial loss $ 10.8
Amortization of prior service cost (0.5)
Postretirement Benefits  
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]  
Amortization of net actuarial loss 0.0
Amortization of prior service cost $ (2.1)
XML 133 R63.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures (Narrative) (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Non-restructuring impairment charges                   $ 0 $ 151,600,000 $ 0
Provision for (benefit from) income taxes [1]                   92,900,000 10,100,000 (47,500,000)
Tax (benefit) expense on income (loss) from discontinued operations                   11,500,000 (34,700,000) 21,100,000
Permanently nondeductible and nontaxable items [2]                   16,400,000 13,800,000 15,300,000
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount                   21,500,000 32,100,000 10,000,000
Income (loss) from discontinued operations, net of income taxes   $ (14,800,000) $ 2,400,000 $ 23,600,000 $ 5,300,000 $ (178,900,000) $ 4,900,000 $ (8,600,000) $ 7,100,000 16,500,000 (175,500,000) 50,600,000
Gain on Divestiture                   3,500,000 15,000,000 2,900,000
International [1]                   95,100,000 17,900,000 12,100,000
International Deferred [1]                   (187,500,000) (19,200,000) 4,400,000
Deferred Income Tax Expense (Benefit) [1]                   (188,300,000) (68,900,000) (13,900,000)
Domestic [1]                   300,000 40,900,000 49,300,000
Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Consideration   270,000,000               270,000,000    
Non-restructuring impairment charges                     204,000,000  
Goodwill, Impairment Loss                     100,200,000  
Income tax expense (benefit)                   10,800,000 (34,700,000) 21,100,000
Taxes paid or to be paid in connection with disposition   $ 10,000,000               10,000,000    
Provision for (benefit from) income taxes                     36,200,000  
Valuation allowances, nonrecurring                     2,500,000  
Permanently nondeductible and nontaxable items                       2,900,000
Other Tax Expense (Benefit)                     2,000,000  
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount                     3,000,000 700,000
Increase (Decrease) in Accrued Liabilities                     900,000  
International                   14,900,000 (6,600,000) 10,700,000
International Deferred                   4,400,000 3,000,000 (500,000)
Deferred Income Tax Expense (Benefit)                     35,600,000 5,400,000
Domestic                   0 10,400,000 5,600,000
Mallinckrodt Baker                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Income (loss) from discontinued operations, net of income taxes                   (100,000) (700,000) $ 1,000,000
Tastemaker                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Provision for Loss (Gain) on Disposal, Net of Tax                   $ 22,500,000    
Property, Plant and Equipment | Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Impairment of Long-Lived Assets to be Disposed of                     51,400,000  
Finite-Lived Intangible Assets | Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Impairment of Long-Lived Assets to be Disposed of                     52,400,000  
Oxymorphone ER                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Proceeds from Sale of Productive Assets $ 4,000,000                      
Contractually Obligated Future Proceeds from Sale Of Productive Assets $ 8,000,000                      
Gain on Divestiture                     $ 11,700,000  
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
[2] Includes the impact of nondeductible transaction and separation costs.
XML 134 R92.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets (Schedule Of Goodwill) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Apr. 16, 2015
Sep. 26, 2014
Aug. 14, 2014
Goodwill [Line Items]        
Goodwill, Period Increase (Decrease) $ 1,247.5      
Goodwill 3,649.4   $ 2,401.9  
Goodwill, Gross 3,768.9   2,521.4  
Goodwill, Impaired, Accumulated Impairment Loss (119.5)   (119.5)  
Specialty Brands [Member]        
Goodwill [Line Items]        
Goodwill, Gross 3,442.4   2,194.9  
Goodwill, Impaired, Accumulated Impairment Loss 0.0   0.0  
Specialty Generics [Member]        
Goodwill [Line Items]        
Goodwill, Gross 207.0   207.0  
Goodwill, Impaired, Accumulated Impairment Loss 0.0   0.0  
Global Medical Imaging        
Goodwill [Line Items]        
Goodwill, Impaired, Accumulated Impairment Loss     (219.7)  
Nuclear Imaging        
Goodwill [Line Items]        
Goodwill, Gross 119.5   119.5  
Goodwill, Impaired, Accumulated Impairment Loss (119.5)   $ (119.5)  
Ikaria        
Goodwill [Line Items]        
Goodwill   $ 792.4    
Therakos        
Goodwill [Line Items]        
Goodwill 437.2      
Questcor Pharmaceuticals, Inc.        
Goodwill [Line Items]        
Goodwill       $ 1,789.4
Goodwill, Purchase Accounting Adjustments $ 17.9      
XML 135 R129.htm IDEA: XBRL DOCUMENT v3.3.0.814
(Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - Recurring - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Assets:    
Debt and equity securities held in rabbi trusts $ 34.6 $ 35.7
Total assets at fair value 34.6 35.7
Liabilities:    
Deferred compensation liabilities 20.0 15.0
Contingent consideration 174.6 202.8
Foreign exchange forward and option contracts 3.3 0.2
Total liabilities at fair value 197.9 218.0
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Assets:    
Debt and equity securities held in rabbi trusts 24.2 22.9
Total assets at fair value 24.2 22.9
Liabilities:    
Deferred compensation liabilities 0.0 0.0
Contingent consideration 0.0 0.0
Foreign exchange forward and option contracts 3.3 0.2
Total liabilities at fair value 3.3 0.2
Significant Other Observable Inputs (Level 2)    
Assets:    
Debt and equity securities held in rabbi trusts 10.4 12.8
Total assets at fair value 10.4 12.8
Liabilities:    
Deferred compensation liabilities 20.0 15.0
Contingent consideration 0.0 0.0
Foreign exchange forward and option contracts 0.0 0.0
Total liabilities at fair value 20.0 15.0
Significant Unobservable Inputs (Level 3)    
Assets:    
Debt and equity securities held in rabbi trusts 0.0 0.0
Total assets at fair value 0.0 0.0
Liabilities:    
Deferred compensation liabilities 0.0 0.0
Contingent consideration 174.6 202.8
Foreign exchange forward and option contracts 0.0 0.0
Total liabilities at fair value $ 174.6 $ 202.8
XML 136 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814
Schedule II - Valuation and Qualifying Accounts (Notes)
 12 Months Ended
Sep. 25, 2015
Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Financial Statement Schedules. The financial statement schedule is included below. All other schedules have been omitted because they are not applicable, not required or the information is included in the financial statements or notes thereto.
Schedule II - Valuation and Qualifying Accounts
 
 
 
 
 
 
 
 
 
 
(in millions)
 
 
 
 
 
 
 
 
 
 
Description
 
Balance at Beginning of Period
 
Charged to Income
 
Additions and Other
 
Deductions
 
Balance at End of Period
Allowance for doubtful accounts:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
3.7

 
$
1.9

 
$
—

 
$
(0.9
)
 
$
4.7

Fiscal year ended September 26, 2014
 
3.6

 
0.4

 
—

 
(0.3
)
 
3.7

Fiscal year ended September 27, 2013
 
9.4

 
1.1

 
—

 
(6.9
)
 
3.6

Sales reserve accounts:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
404.9

 
$
2,187.8

 
$
1.3

 
$
(2,194.7
)
 
$
399.3

Fiscal year ended September 26, 2014
 
287.7

 
1,720.9

 
30.6

 
(1,634.3
)
 
404.9

Fiscal year ended September 27, 2013
 
235.0

 
1,171.9

 
—

 
(1,119.2
)
 
287.7

Tax valuation allowance:
 
 
 
 
 
 
 
 
 
 
Fiscal year ended September 25, 2015
 
$
76.9

 
$
155.4

 
$
0.2

 
$
0.5

 
$
233.0

Fiscal year ended September 26, 2014
 
28.3

 
33.9

 
14.7

 
—

 
76.9

Fiscal year ended September 27, 2013
 
15.3

 
10.0

 
3.0

 
—

 
28.3
XML 137 R51.htm IDEA: XBRL DOCUMENT v3.3.0.814
Accumulated Other Comprehensive Income (Tables)
 12 Months Ended
Sep. 25, 2015
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income
The components of accumulated other comprehensive income are as follows:
 
Currency Translation
 
Unrecognized Loss on Derivatives
 
Unrecognized Gain (Loss) on Benefit Plans
 
Accumulated Other Comprehensive Income
Balance at September 28, 2012
$
157.1

 
$
—

 
$
(72.2
)
 
$
84.9

Other comprehensive income (loss), net
1.5

 
(7.3
)
 
29.4

 
23.6

Balance at September 27, 2013
158.6

 
(7.3
)
 
(42.8
)
 
108.5

Other comprehensive income (loss), net
(27.6
)
 
—

 
(17.1
)
 
(44.7
)
Reclassification from other comprehensive income (loss)
—

 
0.5

 
1.4

 
1.9

Balance at September 26, 2014
131.0

 
(6.8
)
 
(58.5
)
 
65.7

Other comprehensive loss before reclassification
(70.8
)
 
—

 
(1.1
)
 
(71.9
)
Reclassification from other comprehensive income (loss)
—

 
0.4

 
6.7

 
7.1

Balance at September 25, 2015
$
60.2

 
$
(6.4
)
 
$
(52.9
)
 
$
0.9
Reclassification out of Accumulated Other Comprehensive Income
The following summarizes reclassifications out of accumulated other comprehensive income for the 2015 and 2014 fiscal years:
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
Amount Reclassified from
Accumulated Other Comprehensive Income
 
 
 
September 25, 2015
 
September 26, 2014
 
Line Item in the Condensed Consolidated
Statement of Income
Amortization of unrealized loss on derivatives
$
0.6

 
$
0.6

 
Interest expense
Income tax provision
(0.2
)
 
(0.1
)
 
Provision for income taxes
Net of income taxes
0.4

 
0.5

 
 
 
 
 
 
 
 
Amortization of pension and post-retirement benefit plans:
 
 
 
 
 
Net actuarial loss
9.4

 
8.1

 
(1) 
Prior service credit
(4.6
)
 
(9.9
)
 
(1) 
Plan settlements
6.0

 
3.8

 
(1) 
Total before tax
10.8

 
2.0

 
 
Income tax provision
(4.1
)
 
(0.6
)
 
Provision for income taxes
Net of income taxes
6.7

 
1.4

 
 
 
 
 
 
 
 
Total reclassifications for the period
$
7.1

 
$
1.9

 
 
(1)

These accumulated other comprehensive income components are included in the computation of net periodic benefit cost. See Note 13 for additional details.
XML 138 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt
 12 Months Ended
Sep. 25, 2015
Debt Disclosure [Abstract]  
Debt
12.
Debt
Debt was comprised of the following at the end of each period:
 
September 25, 2015
 
September 26, 2014
 
Principal
 
Unamortized Discount and Debt Issuance Costs
 
Principal
 
Unamortized Discount and Debt Issuance Costs
Current maturities of long-term debt:
 
 
 
 
 
 
 
2.85% term loan due April 2016
$
—

 
$
—

 
$
0.4

 
$
—

Term loans due March 2021
20.0

 
—

 
18.2

 
—

4.00% term loan due February 2022
1.0

 
—

 
1.2

 
—

Capital lease obligation and vendor financing agreements
1.3

 
—

 
1.4

 
—

Total current debt
22.3

 
—

 
21.2

 
—

Long-term debt:
 
 
 
 
 
 
 
Variable rate receivable securitization
153.0

 
0.8

 
150.0

 
1.0

2.85% term loan due April 2016
—

 
—

 
2.7

 
—

3.50% notes due April 2018
300.0

 
1.7

 
300.0

 
2.4

4.88% notes due April 2020
700.0

 
11.3

 
—

 
—

Term loans due March 2021
1,958.5

 
44.1

 
1,978.5

 
52.4

4.00% term loan due February 2022
6.9

 
—

 
9.6

 
—

9.50% debentures due May 2022
10.4

 
—

 
10.4

 
—

5.75% notes due August 2022
900.0

 
14.4

 
900.0

 
16.4

8.00% debentures due March 2023
4.4

 
—

 
8.0

 
—

4.75% notes due April 2023
600.0

 
7.1

 
600.0

 
7.9

5.625% notes due October 2023
750.0

 
13.7

 
—

 
—

5.50% notes due April 2025
700.0

 
11.9

 
—

 
—

Revolving credit facility
500.0

 
4.9

 
—

 
5.5

Capital lease obligation and vendor financing agreements
1.0

 
—

 
0.4

 
—

Total long-term debt
6,584.2

 
109.9

 
3,959.6

 
85.6

Total debt
$
6,606.5

 
$
109.9

 
$
3,980.8

 
$
85.6


In November 2012, Mallinckrodt International Finance S.A. ("MIFSA") was formed as a 100% owned subsidiary of Covidien in connection with the Separation. MIFSA is a holding company established to own, directly or indirectly, substantially all of the operating subsidiaries of the Company, to issue debt securities and to perform treasury operations. At the time of the Separation, MIFSA became a 100% owned subsidiary of the Company.
In April 2013, MIFSA issued $300.0 million aggregate principal amount of 3.50% senior unsecured notes due April 2018 and $600.0 million aggregate principal amount of 4.75% senior unsecured notes due April 2023 (collectively, "the Notes"). Mallinckrodt plc has fully and unconditionally guaranteed the Notes on an unsecured and unsubordinated basis. The Notes are subject to an indenture which contains covenants limiting the ability of MIFSA, its restricted subsidiaries (as defined in the Notes) and Mallinckrodt plc, as guarantor, to incur certain liens or enter into sale and lease-back transactions. It also restricts Mallinckrodt plc and MIFSA's ability to merge or consolidate with any other person or sell or convey all or substantially all of their assets to any one person. MIFSA may redeem all of the Notes at any time, and some of the Notes from time to time, at a redemption price equal to the principal amount of the Notes redeemed plus a make-whole premium. MIFSA will pay interest on the Notes semiannually in arrears on April 15 and October 15 of each year, which commenced on October 15, 2013. The net proceeds to MIFSA from the issuance and sale of the Notes was $889.3 million, the majority of which was retained by Covidien per the terms of the Separation and Distribution Agreement.
In March 2014, MIFSA and Mallinckrodt CB LLC ("MCB"), each a wholly-owned subsidiary of the Company, entered into senior secured credit facilities consisting of a $1.3 billion term loan facility due 2021 ("the Term Loan") and a $250.0 million revolving credit facility due 2019 ("the Revolver") (collectively, "the Facilities"). The Facilities are fully and unconditionally guaranteed by Mallinckrodt plc, certain of its direct or indirect wholly-owned U.S. subsidiaries and each of its direct or indirect wholly-owned subsidiaries that owns directly or indirectly any such wholly-owned U.S. subsidiary (collectively, "the Guarantors"). The Facilities are secured by a security interest in certain assets of MIFSA, MCB and the Guarantors. The Facilities contain customary affirmative and negative covenants, which include, among other things, restrictions on the Company's ability to declare or pay dividends, create liens, incur additional indebtedness, enter into sale and lease-back transactions, make investments, dispose of assets and merge or consolidate with any other person. In addition, the Revolver contains a financial covenant that may limit the Company's total net debt leverage ratio, which is defined as the ratio of (i) the Company's consolidated debt, less any unrestricted cash and cash equivalents, to (ii) the Company's adjusted consolidated EBITDA, as defined in the credit agreement. The Facilities bear interest at LIBOR plus a margin based on the Company's total net debt leverage ratio, and the Term Loan is subject to a minimum LIBOR level of 0.75%. Interest payment dates are variable based on the LIBOR rate utilized, but the Company generally expects interest to be payable every 90 days. The Term Loan requires quarterly principal amortization payments in an amount equal to 0.25% of the original principal amount of the Term Loan payable on the last day of each calendar quarter, which commenced on June 30, 2014, with the remaining balance payable on the due date, March 19, 2021. The Company incurred an original issue discount of 0.25%, or $3.3 million, associated with the Term Loan. The Revolver contains a $150.0 million letter of credit provision, of which none had been issued as of September 25, 2015. On August 28, 2015, in connection with the Therakos Acquisition, Mallinckrodt Enterprises LLC and Mallinckrodt plc, two wholly owned subsidiaries of Mallinckrodt plc, MIFSA and MCB, entered into a $250.0 million replacement revolving credit facility (the “2015 Replacement Revolving Credit Facility”), which refinanced and replaced in full the existing revolving credit facility, and an additional $250.0 million incremental revolving credit facility (the “2015 Incremental Revolving Credit Facility” and, together with the 2015 Replacement Revolving Credit Facility, the “2015 Revolving Credit Facility”), such that the 2015 Revolving Credit Facility has an aggregate facility size of $500.0 million. Unused commitments on the 2015 Revolving Credit Facility are subject to an annual commitment fee, which was 0.275% as of September 25, 2015, and the fee applied to outstanding letters of credit is based on the interest rate applied to borrowings. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the 2015 Revolving Credit Facility was 2.6%, and outstanding borrowings totaled $500.0 million.
In July 2014, Mallinckrodt Securitization S.À.R.L. ("Mallinckrodt Securitization"), a wholly-owned special purpose subsidiary of the Company, entered into a $160.0 million accounts receivable securitization facility that matures in July 2017 ("the Receivable Securitization"). In January 2015, Mallinckrodt Securitization amended the Receivable Securitization with third-party lenders to increase the borrowing limit from $160.0 million to $250.0 million. The terms of the Receivable Securitization, and the determination of interest rates, were largely unchanged. Mallinckrodt Securitization may, from time to time, obtain up to $250.0 million in third-party borrowings secured by certain receivables, which may be increased to $300.0 million upon approval of the third-party lenders, subject to certain conditions. The Receivable Securitization agreements contain customary representations, warranties and affirmative and negative covenants.The borrowings under the Receivable Securitization are to be repaid as the secured receivables are collected. Loans under the Receivable Securitization will bear interest (including facility fees) at a rate equal to one month LIBOR rate plus a margin of 0.80%. Unused commitments on the Receivables Securitization are subject to an annual commitment fee of 0.35%. As of September 25, 2015, the applicable interest rate on outstanding borrowings under the Receivable Securitization was 0.99% and outstanding borrowings totaled $153.0 million.
In August 2014, MIFSA and MCB issued $900.0 million aggregate principal amount of 5.75% senior unsecured notes due August 1, 2022 ("the 2022 Notes”). The 2022 Notes are guaranteed on an unsecured basis by certain of MIFSA's subsidiaries. The 2022 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2022 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of Mallinckrodt plc and its subsidiaries. MIFSA may redeem some or all of the 2022 Notes prior to August 1, 2017 by paying a make-whole premium. MIFSA may redeem some or all of the 2022 Notes on or after August 1, 2017 at specified redemption prices. In addition, prior to August 1, 2017, MIFSA may redeem up to 40% of the aggregate principal amount of the 2022 Notes with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase the 2022 Notes at a price of (a) 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain asset sales. These obligations are subject to certain qualifications and exceptions. MIFSA pays interest on the 2022 Notes semiannually in arrears on February 1 and August 1 of each year, commencing on February 1, 2015.
In August 2014, MIFSA and MCB entered into a $700.0 million senior secured term loan facility ("the New Term Loan”). The New Term Loan is an incremental tranche under the credit agreement governing our existing Term Loan and Revolver, entered into in March 2014, (collectively, with the New Term Loan, represent "the Senior Secured Credit Facilities"). New Term Loan has substantially similar terms to the Term Loan (other than pricing); including the determination of interest rates and quarterly principal amortization payments equal to 0.25% of the original principal amount of the New Term Loan. The quarterly principal payments commenced on December 31, 2014, with the remaining balance payable on the due date of March 19, 2021. Mallinckrodt plc and its subsidiaries (other than MIFSA, MCB and the subsidiaries of MIFSA that guarantee the Facilities) will not guarantee the New Term Loan, and the New Term Loan will not be secured by the assets of such entities. The August 2014 Term Loan bears interest under substantially similar terms of the March 2014 Term Loan, including the use of LIBOR rates with a minimum floor, except that the margin applied to LIBOR is not dependent upon the Company's total net debt leverage ratio.
On April 15, 2015, MIFSA and MCB issued $700.0 million aggregate principal amount of 4.875% senior unsecured notes due April 15, 2020 ("the 2020 Notes") and $700.0 million aggregate principal amount of 5.50% senior unsecured notes due April 15, 2025 ("the 2025 Notes", and together with the 2020 Notes, the "Ikaria Notes"). The Ikaria Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries that guarantee the obligations under the Facilities, which following the Ikaria Acquisition includes Compound Holdings II, Inc. and its U.S. subsidiaries. The Ikaria Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the Ikaria Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the (i) 2020 Notes prior to April 15, 2017 and (ii) 2025 Notes prior to April 15, 2020, in each case, by paying a “make-whole” premium. The Issuers may redeem some or all of the (i) 2020 Notes on or after April 15, 2017 and (ii) 2025 Notes on or after April 15, 2020, in each case, at specified redemption prices. In addition, prior to (i) April 15, 2017, in the case of the 2020 Notes, and (ii) April 15, 2018, in the case of the 2025 Notes, the Issuers may redeem up to 40% of the aggregate principal amount of the 2020 Notes or 2025 Notes, as the case may be, with the net proceeds of certain equity offerings. The Issuers are obligated to offer to repurchase (a) each series of Notes at a price of 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) the Notes at a price of 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the Ikaria Notes semiannually on April 15th and October 15th of each year, commencing on October 15, 2015.
On September 24, 2015, in connection with the Therakos Acquisition, MIFSA and MCB issued $750.0 million aggregate principal amount of 5.625% senior unsecured notes due October 2023 (the “2023 Notes”). The Notes are guaranteed by Mallinckrodt plc and each of its subsidiaries under the Facilities, which following the Therakos Acquisition includes TGG Medical Solutions, Inc. and its U.S. subsidiaries. The 2023 Notes are subject to an indenture that contains certain customary covenants and events of default (subject in certain cases to customary grace and cure periods). The occurrence of an event of default under the indenture could result in the acceleration of the 2023 Notes and could cause a cross-default that could result in the acceleration of other indebtedness of the Company. The Issuers may redeem some or all of the 2023 Notes on or after October 15, 2018 at specified redemption prices. In addition, prior to October 15, 2018, the Issuers may redeem up to 40% of the aggregate principal amount of the 2023 Notes with the net proceeds of certain equity offerings. The Issuers may also redeem all, but not less than all, of the Notes at any time at a price of 100% of their principal amount, plus accrued and unpaid interest, if any, in the event the Issuers become obligated to pay additional amounts as a result of changes affecting certain withholding tax laws applicable to payments on the Notes. The Issuers are obligated to offer to repurchase the 2023 Notes (a) at a price of 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events and (b) the 2023 Notes at a price of 100% of their principal amount plus accrued and unpaid interest, if any, in the event of certain net asset sales. These obligations are subject to certain qualifications and exceptions. The Company pays interest on the 2023 Notes semiannually on April 15th and October 15th of each year, commencing on April 15, 2016.
As of September 25, 2015, the applicable interest rate for the Term Loan and New Term Loan were 3.25% and 3.50%, respectively, and outstanding principal under these agreements totaled approximately $1,978.5 million.
The aggregate amounts of debt, including the capital lease obligation, maturing during the next five fiscal years are as follows:
Fiscal 2016
$
22.3

Fiscal 2017
175.0

Fiscal 2018
321.2

Fiscal 2019
521.2

Fiscal 2020
721.2
XML 139 R115.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Share Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Jun. 28, 2013
Sep. 25, 2015
Sep. 26, 2014
Jun. 27, 2014
Sep. 27, 2013
Share Option Activity [Roll Forward]          
Beginning balance   3,526,789 2,760,231    
Granted   635,567 675,921    
Converted from Questcor Acquisition     1,292,736    
Exercised   (1,132,778) (878,330)    
Expired/Forfeited   (243,135) (323,769)    
Ending balance   2,786,443 3,526,789    
Share options vested and unvested expected to vest   2,649,351      
Share options exerciseable   1,054,336   550,097  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Weighted-average exercise price, outstanding share options   $ 52.76 $ 36.84 $ 35.94 $ 37.30
Weighted-average exercise price, granted share options   102.20 52.63    
Weighted-average exercise price, converted from Questcor acquisition, share options     25.08    
Weighted-average exercise price, exercised share options   29.79 30.96    
Weighted-average exercise price, expired and forfeited share options   58.00 $ 41.83    
Weighted-average exercise price, vested and unvested expected to vest share options   50.94      
Weighted-average exercise price, exercisable share options   $ 34.20   $ 30.94  
Weighted-average remaining contractual term, outstanding share options 8 years 7 years 4 months      
Weighted-average remaining contractual term, vested and unvested expected to vest share options   7 years 5 months      
Weighted-average remaining contractual term, exercisable share options 5 years 11 months 5 years 9 months      
Aggregate intrinsic value, outstanding share options   $ 63.2   $ 22.9  
Aggregate intrinsic value, vested and unvested expected to vest share options   59.0      
Aggregate intrinsic value, exercisable share options   $ 36.2   $ 8.0  
XML 140 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Transactions with Former Parent Company
 12 Months Ended
Sep. 25, 2015
Related Party Transactions [Abstract]  
Transactions with Former Parent Company
17.
Transactions with Former Parent Company
Prior to the completion of the Separation on June 28, 2013, the Company was part of Covidien and, as such, transactions between Covidien and the Company were considered related party transactions. As discussed in Note 1, these intercompany transactions are included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The continuing relationship between Covidien and the Company is primarily governed through agreements entered into as part of the Separation, including a Separation Distribution Agreement, a Tax Matters Agreement and a transition services agreement. These agreements were filed with the SEC as Exhibits 2.1, 10.1 and 10.3, respectively, to the Company's Current Report on Form 8-K filed on July 1, 2013. The following discusses the related party transactions and those agreements.

Sales and Purchases
During fiscal 2015, 2014 and 2013, the Company sold inventory to Covidien in the amount of $35.3 million, $46.0 million and $51.2 million, respectively, which is included in net sales of discontinued operations in the consolidated and combined statements of income. The Company also purchases inventories from Covidien. The Company recognized cost of sales within discontinued operations from these inventory purchases of $17.0 million, $28.9 million and $38.4 million during fiscal 2015, 2014 and 2013, respectively.

Allocated Expenses
As discussed in Note 1, the combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were $39.6 million for fiscal 2013 and were included within selling, general and administrative expenses.




Balance Sheet Impacts
Subsequent to the Separation, the Company and Covidien maintain an ongoing relationship in which each party may provide services to the other party, including the distribution of goods. As a result of these relationships, the consolidated balance sheet as of September 25, 2015 includes $6.3 million of amounts due to the Company from Covidien, within prepaid expenses and other current assets, and $3.9 million of amounts the Company owes Covidien, included within accrued and other liabilities.

Separation and Distribution Agreement
On June 28, 2013, the Company entered into a Separation and Distribution Agreement and other agreements with Covidien to effect the Separation and provide a framework for the Company's relationships with Covidien after the Separation. These agreements govern the relationship between Mallinckrodt and Covidien subsequent to the Separation and provide for the assignment to Mallinckrodt of certain of Covidien's assets, liabilities and obligations attributable to periods prior to the Separation.
In general, each party to the Separation and Distribution Agreement assumed liability for all pending, threatened and unasserted legal matters related to its own business or its assumed or retained liabilities and will indemnify the other party for any liability to the extent arising out of, or resulting from, such assumed or retained legal matters.
The Separation and Distribution Agreement provided for the initial cash capitalization of Mallinckrodt in the amount of approximately $168.0 million at June 28, 2013. The Separation and Distribution Agreement also provided for an adjustment payment to compensate either Mallinckrodt or Covidien, as applicable, to the extent that the aggregate of the Company's cash, indebtedness and specified working capital accounts as of June 28, 2013 ("the Distribution Date"), as well as the capital expenditures made with respect to the Company's business during fiscal 2013 through the Distribution Date, deviated from the target. The target was calculated pursuant to a formula set forth in the Separation and Distribution Agreement, which assumed the Distribution Date would be June 28, 2013, that the Pharmaceuticals business was conducted in the ordinary course through that date and that the Company would have approximately $168.0 million of cash upon completion of the distribution. The Separation and Distribution Agreement also provided that an adjustment payment would only be payable if the amount of the adjustment payment exceeded $20.0 million (in which case the entire amount would be paid). Upon final calculation, no adjustment payment was required by either the Company or Covidien.

Tax Matters Agreement
In connection with the Separation, Mallinckrodt entered into the Tax Matters Agreement with Covidien that generally will govern Covidien's and Mallinckrodt's respective rights, responsibilities and obligations after the Separation with respect to certain taxes, including ordinary course of business taxes and taxes, if any, incurred as a result of any failure of the distribution of Mallinckrodt shares to qualify as a tax-free distribution for U.S. federal income tax purposes within the meaning of Section 355 of the U.S. Internal Revenue Code, or other applicable tax law, or any failure of certain internal transactions undertaken in anticipation of the distribution to qualify for tax-free or tax-favored treatment under the applicable tax law. The Company expects, with certain exceptions, to be responsible for the payment of all taxes attributable to Mallinckrodt or its subsidiaries for taxable periods beginning on or after September 29, 2012. For periods prior to September 29, 2012, the Company is subject to a $200.0 million liability limitation, net of any benefits, as prescribed by the Tax Matters Agreement. The Company has made $51.6 million of payments, net of benefits, for periods prior to September 29, 2012. To the extent that the Company's liability for such taxes, net of any tax benefits, does not exceed $200.0 million, it may be responsible for additional taxes attributable to periods prior to September 29, 2012, taxes related to the Separation and a percentage of any taxes arising from the Separation failing to qualify for tax-free or tax-favored treatment through no fault of Covidien or the Company. The Tax Matters Agreement also assigns rights and responsibilities for administrative matters, such as the filing of returns, payment of taxes due, retention of records, tax reporting practices and conduct of audits, examinations or similar proceedings. In addition, the Tax Matters Agreement provides for cooperation and information sharing with respect to tax matters.
The Tax Matters Agreement also contains restrictions on the Company's ability to take actions without Covidien's consent that could cause the Separation or certain internal transactions undertaken in anticipation of the Separation to fail to qualify as tax-free or tax-favored transactions under applicable tax law. These transactions include, but are not limited to, entering into, approving or allowing any transaction that results in a change in ownership of more than 35.0% of Mallinckrodt's shares; any merger, consolidation, scheme of arrangement, liquidation or partial liquidation, or any approval or allowance of such transaction with respect to certain of the Company's subsidiaries; the cessation or transfer of certain business activities; the sale, issuance or other disposition of any equity interest in certain of the Company's subsidiaries; a sale or other disposition of a substantial portion of the Company's assets or a substantial portion of the assets of certain of the Company's subsidiaries; extraordinary distributions by or to certain of the Company's subsidiaries; or engaging in certain internal transactions. These restrictions will all apply for the two-year period after the Separation and in some cases will apply for periods as long as five years following the Separation. Any taxes imposed on the other party attributable to certain post-distribution actions taken by or in respect of the responsible party or its shareholders that result in failure of the Separation or internal transactions to qualify as tax-free or tax-favored transactions are the responsibility of the party at fault, regardless of whether the actions occur more than two years after the distribution, or whether Covidien consents to such actions. Any actions of the Company or its shareholders that directly give rise to additional taxes are not subject to the $200 million threshold noted previously.

Transition Services Agreement
Mallinckrodt and Covidien entered into a transition services agreement in connection with the Separation pursuant to which Mallinckrodt and Covidien will provide each other, on an interim and transitional basis, various services including, but not limited to, treasury administration, information technology services, non-exclusive distribution and importation services for our products in certain countries outside the U.S., regulatory, general administrative services and other support services. The agreed-upon charges for such services are generally intended to allow the servicing party to recover all out-of-pocket costs and expenses, and include a predetermined profit margin. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services are rendered may not be as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.
XML 141 R95.htm IDEA: XBRL DOCUMENT v3.3.0.814
Debt (Narrative) (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 24, 2015
Apr. 15, 2015
Mar. 19, 2014
Apr. 30, 2013
Sep. 25, 2015
Aug. 28, 2015
Jan. 20, 2015
Aug. 31, 2014
Aug. 14, 2014
Jul. 28, 2014
Term loan due March 2021                    
Debt Instrument [Line Items]                    
Frequency of interest payment     90 days              
Debt instrument, unamortized discount         $ 3,300,000          
Quarterly amortization payments     0.00%              
Debt instrument, discount percentage     0.25%              
2015 Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Borrowings, outstanding         $ 500,000,000          
New Term Loan                    
Debt Instrument [Line Items]                    
Debt instrument, face amount               $ 700,000,000    
2023 Notes                    
Debt Instrument [Line Items]                    
Debt Instrument, Redemption Price, Percentage 100.00%                  
Prior To April 15, 2018 | 2025 Notes                    
Debt Instrument [Line Items]                    
Debt Instrument, Redemption Price, Percentage   40.00%                
Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity     $ 250,000,000              
Revolving Credit Facility | Term loan due March 2021                    
Debt Instrument [Line Items]                    
Provision for other credit losses     150,000,000              
Facility fees for letters of credit         0.275%          
Interest rate during period         2.60%          
2015 Replacement Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity           $ 250,000,000        
2015 Incremental Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity           250,000,000        
2015 Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity           $ 500,000,000        
Debentures | 2020 Notes                    
Debt Instrument [Line Items]                    
Debt instrument, face amount   $ 700,000,000                
Stated interest rate   4.875%                
Debentures | 2023 Notes                    
Debt Instrument [Line Items]                    
Debt instrument, face amount $ 750,000,000                  
Stated interest rate 5.625%                  
Debentures | 2025 Notes                    
Debt Instrument [Line Items]                    
Debt instrument, face amount   $ 700,000,000                
Stated interest rate   5.50%                
Prior To April 15, 2017 | 2023 Notes                    
Debt Instrument [Line Items]                    
Debt Instrument, Redemption Price, Percentage 40.00%                  
Line of Credit                    
Debt Instrument [Line Items]                    
Borrowings, outstanding         $ 0          
Senior Notes | 3.50% notes due April 2018                    
Debt Instrument [Line Items]                    
Debt instrument, face amount       $ 300,000,000            
Stated interest rate       3.50%            
Senior Notes | 4.75% notes due April 2023                    
Debt Instrument [Line Items]                    
Debt instrument, face amount       $ 600,000,000            
Stated interest rate       4.75%            
Senior Notes | Unsecured Notes [Member]                    
Debt Instrument [Line Items]                    
Aggregate net proceeds       $ 889,300,000            
Senior Notes | 5.75% notes due August 2022                    
Debt Instrument [Line Items]                    
Debt instrument, face amount               $ 900,000,000    
Stated interest rate               5.75%    
Secured Debt | Term loan due March 2021                    
Debt Instrument [Line Items]                    
Debt instrument, face amount     1,300,000,000              
Interest rate during period         3.25%          
Secured Debt | Variable rate receivable securitization                    
Debt Instrument [Line Items]                    
Debt instrument, face amount     $ 160,000,000              
Maximum borrowing capacity             $ 250,000,000     $ 160,000,000
Line Of Credit Facility, Future Contingent Maximum Borrowing Capacity                   $ 300,000,000
Facility fees for letters of credit         0.35%          
Variable interest rate         0.80%          
Interest rate during period         0.99%          
Variable rate receivable securitization         $ 153,000,000          
Secured Debt | New Term Loan                    
Debt Instrument [Line Items]                    
Debt Instrument, Periodic Payment, Percentage of Principal                 0.25%  
Interest rate during period         3.50%          
Secured Debt | Term Loan and New Term Loan                    
Debt Instrument [Line Items]                    
Long-term Debt         $ 1,978,500,000          
Prior to August 1, 2017 | 5.75% notes due August 2022                    
Debt Instrument [Line Items]                    
Debt Instrument, Redemption Price, Percentage         40.00%          
Option A | 5.75% notes due August 2022                    
Debt Instrument [Line Items]                    
Repurchase percentage         101.00%          
Option A | 2023 Notes                    
Debt Instrument [Line Items]                    
Repurchase percentage 101.00%                  
Option A | 2025 Notes                    
Debt Instrument [Line Items]                    
Repurchase percentage   101.00%                
Option B | 5.75% notes due August 2022                    
Debt Instrument [Line Items]                    
Repurchase percentage         100.00%          
Option B | 2023 Notes                    
Debt Instrument [Line Items]                    
Repurchase percentage 100.00%                  
Option B | 2025 Notes                    
Debt Instrument [Line Items]                    
Repurchase percentage   100.00%                
LIBOR | Term loan due March 2021                    
Debt Instrument [Line Items]                    
Stated interest rate     0.75%              
Letter of Credit | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Borrowings, outstanding         $ 0          
XML 142 R49.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity (Tables)
 12 Months Ended
Sep. 25, 2015
Equity [Abstract]  
Schedule of Share Repurchases under the Repurchase Plan
Share Repurchases
On January 23, 2015, the Company's board of directors authorized a program to purchase up to $300.0 million of the Company's ordinary shares from time to time based on market conditions to allow management to enhance shareholder value. The following table presents the number of shares and dollar amount of repurchases made under the repurchase program by fiscal year and the remaining amount available for repurchase as of September 25, 2015.
 
2015 Share Repurchase Program
 
Number of Shares
 
Amount
Authorized repurchase amount
 
 
$
300.0

Repurchases:
 
 
 
   Fiscal 2015
823,592

 
75.0

Remaining amount available
 
 
$
225.0
XML 143 R105.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Weighted Average Allocation of Plan Assets) (Details)
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
U.S. Plans    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 100.00% 100.00%
U.S. Plans | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 24.00%  
Pension plans, weighted-average plan asset allocation 27.00% 28.00%
U.S. Plans | Debt Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 76.00%  
Pension plans, weighted-average plan asset allocation 70.00% 70.00%
U.S. Plans | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 3.00% 1.00%
U.S. Plans | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 0.00% 1.00%
Non-U.S. Plans    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 100.00% 100.00%
Non-U.S. Plans | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 6.00% 8.00%
Non-U.S. Plans | Debt Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 1.00% 2.00%
Non-U.S. Plans | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 0.00% 0.00%
Non-U.S. Plans | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, weighted-average plan asset allocation 93.00% 90.00%
Non-U.S. Plans | Japan | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 39.00%  
Non-U.S. Plans | Japan | Debt Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 55.00%  
Non-U.S. Plans | Japan | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 6.00%  
Non-U.S. Plans | Netherlands | Equity Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 10.00%  
Non-U.S. Plans | Netherlands | Debt Securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 2.00%  
Non-U.S. Plans | Netherlands | Insurance Contract    
Defined Benefit Plan Disclosure [Line Items]    
Pension plans, target plan asset allocation 88.00%  
XML 144 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Tables)
 12 Months Ended
Sep. 25, 2015
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Charges by Segment
Net restructuring and related charges by segment within continuing operations are as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Specialty Brands
$
36.5

 
$
57.0

 
$
5.2

Specialty Generics
4.5

 
9.8

 
11.2

Nuclear Imaging
(4.6
)
 
13.7

 
6.9

Corporate
4.3

 
1.4

 
3.0

Restructuring and related charges, net
40.7

 
81.9

 
26.3

Less: accelerated depreciation
(0.3
)
 
(0.5
)
 
(2.6
)
Restructuring charges, net
$
40.4

 
$
81.4

 
$
23.7
Schedule of Net Restructuring and Related Charges
Net restructuring and related charges by program within continuing operations are comprised of the following:
 
Fiscal Year
 
2015
 
2014
 
2013
2013 Mallinckrodt Program
$
7.4

 
$
27.3

 
$
8.5

Acquisition programs
33.6

 
56.4

 
—

Other programs
(0.3
)
 
(1.8
)
 
17.8

Total programs
40.7

 
81.9

 
26.3

Less: non-cash charges, including impairments and accelerated share based compensation expense
(10.1
)
 
(38.0
)
 
(2.6
)
Total charges expected to be settled in cash
$
30.6

 
$
43.9

 
$
23.7
Schedule of Restructuring Reserves by Type of Cost
The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of $8.5 million in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:
 
2013 Mallinckrodt Program
 
Acquisition Programs
 
Other Programs
 
Total
Balance at September 28, 2012
$
—

 
$
—

 
$
8.9

 
$
8.9

Charges from continuing operations
8.5

 
—

 
17.6

 
26.1

Charges from discontinued operations
6.4

 
—

 
3.3

 
9.7

Changes in estimate from continuing operations
—

 
—

 
(2.4
)
 
(2.4
)
Changes in estimate from discontinued operations
—

 
—

 
(0.2
)
 
(0.2
)
Cash payments
—

 
—

 
(15.1
)
 
(15.1
)
Reclassifications (1)
—

 
—

 
(1.5
)
 
(1.5
)
Balance at September 27, 2013
14.9

 
—

 
10.6

 
25.5

Charges from continuing operations
32.9

 
22.9

 
1.4

 
57.2

Charges from discontinued operations
25.3

 
—

 
1.1

 
26.4

Changes in estimate from continuing operations
(7.6
)
 
(1.6
)
 
(4.1
)
 
(13.3
)
Changes in estimate from discontinued operations
(1.8
)
 
—

 
(0.7
)
 
(2.5
)
Cash payments
(34.8
)
 
(13.4
)
 
(6.8
)
 
(55.0
)
Reclassifications (1)
(1.3
)
 
—

 
(1.0
)
 
(2.3
)
Currency translation
(1.0
)
 
—

 
(0.1
)
 
(1.1
)
Balance at September 26, 2014
26.6

 
7.9

 
0.4

 
34.9

Charges from continuing operations
15.4

 
25.3

 
—

 
40.7

Charges from discontinued operations
1.0

 
—

 
—

 
1.0

Changes in estimate from continuing operations
(8.3
)
 
(1.5
)
 
(0.3
)
 
(10.1
)
Changes in estimate from discontinued operations
(0.6
)
 
—

 
—

 
(0.6
)
Cash payments
(22.5
)
 
(21.7
)
 
(0.1
)
 
(44.3
)
Reclassifications (1)
(3.0
)
 
—

 
—

 
(3.0
)
Currency translation
(0.6
)
 
—

 
—

 
(0.6
)
Balance at September 25, 2015
$
8.0

 
$
10.0

 
$
—

 
$
18.0


(1)
Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.
Schedule of Restructuring Charges Incurred Cumulative to Date
Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:
Specialty Brands
$
4.0

Specialty Generics
15.6

Nuclear Imaging (including CMDS)
67.3

Corporate
10.0

 
$
96.9
XML 145 R107.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Expected Benefit Payments) (Details)
$ in Millions
Sep. 25, 2015
USD ($)
Pension Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Fiscal 2016 $ 40.0
Fiscal 2017 33.6
Fiscal 2018 33.0
Fiscal 2019 32.6
Fiscal 2020 31.4
Fiscal 2021-2025 143.9
Postretirement Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Fiscal 2016 4.6
Fiscal 2017 4.3
Fiscal 2018 4.0
Fiscal 2019 3.8
Fiscal 2020 3.5
Fiscal 2021-2025 $ 15.6
XML 146 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated and Combined Statements of Comprehensive Income (Parenthetical) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Statement of Comprehensive Income [Abstract]      
Unrecognized loss on derivatives, tax $ (0.2) $ (0.2) $ 0.0
Unrecognized gain (loss) on benefit plans, tax $ 2.1 $ 7.3 $ (23.9)
XML 147 R88.htm IDEA: XBRL DOCUMENT v3.3.0.814
Inventories (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Inventory, Net [Abstract]    
Raw materials and supplies $ 66.3 $ 57.5
Work in process 124.2 184.7
Finished goods 91.3 64.2
Inventories $ 281.8 $ 306.4
XML 148 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Background and Basis of Presentation (Notes)
 12 Months Ended
Sep. 25, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Basis of Presentation
1.
Background and Basis of Presentation
Background
Mallinckrodt plc and its subsidiaries (collectively, "Mallinckrodt" or "the Company"), is a global specialty biopharmaceutical and nuclear imaging business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and nuclear imaging agents. Therapeutic areas of focus include autoimmune and rare disease specialty areas (including neurology, rheumatology, nephrology and pulmonology); immunotherapy and neonatal respiratory critical care therapies; and central nervous system drugs. The Company also supports the diagnosis of disease with nuclear medicine imaging agents.
During the first quarter of fiscal 2015, the Company changed its reportable segments to present the Specialty Brands and Specialty Generics businesses as reportable segments. The Company historically presented the Specialty Brands and Specialty Generics businesses within the Specialty Pharmaceuticals segment.
During the fourth quarter of fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its global contrast media and delivery systems ("CMDS") business to Guerbet S.A. ("Guerbet"), which is expected to be completed during the first quarter of fiscal 2016. The CMDS business is deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The CMDS business has been eliminated from the Global Medical Imaging segment, which has been renamed Nuclear Imaging.
Prior year amounts have been recast to conform to current presentation.
The three reportable segments are further described below:
•
Specialty Brands produces and markets branded pharmaceuticals and biopharmaceuticals;
•
Specialty Generics produces specialty generic pharmaceuticals and active pharmaceutical ingredients ("API") consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients; and
•
Nuclear Imaging manufactures and markets radiopharmaceuticals (nuclear medicine).
In May 2015, the Board of Directors of Mallinckrodt plc approved the migration of the Company’s principal executive offices from Ireland to the United Kingdom. The Company remains incorporated in Ireland and continues to be subject to U.S. Securities and Exchange Commission ("SEC") reporting requirements and the applicable corporate governance rules of the New York Stock Exchange. 
Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien plc ("Covidien"), which was subsequently acquired by Medtronic plc. On June 28, 2013, Covidien shareholders of record received one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien held as of the record date, June 19, 2013, and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing its legal separation from Covidien ("the Separation").

Basis of Presentation
The accompanying consolidated and combined financial statements reflect the consolidated financial position of the Company as an independent, publicly-traded company for periods subsequent to June 28, 2013, and as a combined reporting entity of Covidien, including operations relating to Covidien's Pharmaceuticals business, for periods prior to June 28, 2013.
The consolidated and combined financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the U.S. ("GAAP"). The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ from those estimates. The consolidated and combined financial statements include the accounts of the Company, its wholly-owned subsidiaries and entities in which they own or control more than fifty percent of the voting shares, or have the ability to control through similar rights. The results of entities disposed of are included in the consolidated and combined financial statements up to the date of disposal and, where appropriate, these operations have been reflected as discontinued operations. Divestitures of product lines not representing businesses have been reflected in operating income. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments necessary for a fair presentation have been included in the results reported.
As a result of the Company's classification of the CMDS business as held for sale and the change in reportable segments, certain amounts from prior years have been revised to conform to the current year presentation,.
The Company's combined financial statements for periods prior to June 28, 2013, including the nine months ended June 28, 2013 that is included within the Company's fiscal 2013 results, may not be indicative of its future performance and do not necessarily reflect the results of operations, financial position and cash flows that would have been had it operated as an independent, publicly-traded company for the entirety of the periods presented, including as a result of changes in the Company's capitalization in connection with the Separation. The combined financial statements for periods prior to June 28, 2013 include expense allocations for certain functions provided by Covidien, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, employee benefits and incentives, insurance and share-based compensation. These expenses were allocated to the Company on the basis of direct usage when identifiable, with the remainder allocated on the basis of operating expenses, headcount or other measures. The amounts allocated were $39.6 million for fiscal 2013 and were included within selling, general and administrative expenses. Management considers the bases on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, the Company during the periods presented; however, the allocations may not reflect the expense the Company would have incurred as an independent, publicly-traded company. Actual costs that may have been incurred if the Company had been a standalone company would depend on a number of factors, including organizational structure, what functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. The Company is unable to determine what those costs would have been had the Company been independent during the applicable periods. Following the Separation, the Company has performed these functions using its own resources or purchased services, certain of which are being provided by Covidien during a transitional period pursuant to a transition services agreement dated June 28, 2013, between Mallinckrodt and Covidien, particularly in relation to areas outside the U.S. The terms and prices on which such services were rendered may not have been as favorable as those that were allocated to the Company by Covidien. The Company terminated the transition services agreement during the first quarter of fiscal 2015.
The combined balance sheets prior to June 28, 2013 included certain assets and liabilities that have historically been recorded at the Covidien corporate level but are specifically identifiable or otherwise allocable to the Company. Covidien's debt and related interest expense were not allocated to the Company since the Company was not the legal obligor of such debt and Covidien's borrowings were not directly attributable to the Company's business. Debt incurred by the Company directly has been included in the combined financial statements. Intercompany transactions between the Company and Covidien, prior to the Separation, have been included in the combined financial statements and were considered to be effectively settled for cash at the time the transaction was recorded. The total net effect of the settlement of these intercompany transactions was reflected in the combined statements of cash flows as a financing activity and in the combined balance sheet as parent company investment.
Prior to June 28, 2013, Covidien's investment in the Pharmaceuticals business is shown as parent company investment in the combined financial statements. On June 28, 2013, Covidien completed a distribution of one ordinary share of Mallinckrodt for every eight ordinary shares of Covidien. Upon completion of the Separation, the Company had 57,694,885 ordinary shares outstanding at a par value of $0.20 per share. After Separation adjustments were recorded, the remaining parent company investment balance, which included all earnings prior to the Separation, was transferred to contributed surplus.
Under Irish law, the Company can only pay dividends and repurchase shares out of distributable reserves, as discussed further in the Company's information statement filed with the SEC as Exhibit 99.2 to the Company's Current Report on Form 8-K filed on July 1, 2013. Upon completion of the Separation, the Company did not have any distributable reserves. On July 22, 2013, the Company filed a petition with the High Court of Ireland seeking the court's confirmation of a reduction of the Company's share premium so that it can be treated as distributable for the purposes of Irish law. On September 9, 2013, the High Court of Ireland approved this petition and the High Court's order and minutes were filed with the Registrar of Companies. Upon this filing, the Company's share premium is treated as distributable reserves and the share premium balance was reclassified into additional paid-in capital within the consolidated balance sheet. Net income subsequent to the Separation has been included in retained earnings and is included in distributable reserves.

Fiscal Year
The Company reports its results based on a "52-53 week" year ending on the last Friday of September. Fiscal 2015, 2014 and 2013 each consisted of 52 weeks. Unless otherwise indicated, fiscal 2015, 2014 and 2013 refer to the Company's fiscal years ended September 25, 2015, September 26, 2014 and September 27, 2013, respectively. Fiscal 2016 will consist of 53 weeks and will end on September 30, 2016.
XML 149 R58.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Schedule of Significant Accounting Policies [Line Items]      
Shipping costs $ 42.3 $ 47.8 $ 46.9
Foreign currency gain (loss) 30.7 3.8 (12.8)
Foreign currency transactions gain (loss), derivative instruments $ (24.8) $ (6.3) $ 10.1
Customer relationships      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 12 years    
Minimum | Completed Technology      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 5 years    
Minimum | Licensing Agreements      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 8 years    
Minimum | Trademarks      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 13 years    
Minimum | Buildings      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 10 years    
Minimum | Leasehold improvements      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 1 year    
Minimum | Capitalized software      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 1 year    
Minimum | Machinery and equipment      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 1 year    
Maximum | Completed Technology      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 25 years    
Maximum | Licensing Agreements      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 30 years    
Maximum | Trademarks      
Schedule of Significant Accounting Policies [Line Items]      
Finite-lived intangible assets - useful lives 30 years    
Maximum | Buildings      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 45 years    
Maximum | Leasehold improvements      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 20 years    
Maximum | Capitalized software      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 10 years    
Maximum | Machinery and equipment      
Schedule of Significant Accounting Policies [Line Items]      
Property, plant and equipment, useful life 20 years    
XML 150 R82.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Schedule of Income Taxes Payable) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Operating Loss Carryforwards [Line Items]    
Total income taxes payable $ 141.1 $ 135.7
Accrued and Other Current Liabilities    
Operating Loss Carryforwards [Line Items]    
Accrued and other current liabilities 19.8 13.1
Other Income Tax Liabilities    
Operating Loss Carryforwards [Line Items]    
Other income tax liabilities $ 121.3 $ 122.6
XML 151 R106.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Fair Value of Plan Assets) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Insurance Contract | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year $ 119.8 $ 112.0
Net unrealized gains 12.2 15.5
Net purchases, sales and issuances (0.1) (0.6)
Currency translation (15.2) (7.1)
Fair value of plan assets at end of year 116.7 119.8
Recurring    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 473.6  
Fair value of plan assets at end of year 437.9 473.6
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 337.2  
Fair value of plan assets at end of year 309.0 337.2
Recurring | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 16.6  
Fair value of plan assets at end of year 12.2 16.6
Recurring | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 119.8  
Fair value of plan assets at end of year 116.7 119.8
Recurring | U.S. Small Mid Cap    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 16.6  
Fair value of plan assets at end of year 15.1 16.6
Recurring | U.S. Small Mid Cap | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 16.6  
Fair value of plan assets at end of year 15.1 16.6
Recurring | U.S. Small Mid Cap | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | U.S. Small Mid Cap | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | U.S. Large Cap    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 50.2  
Fair value of plan assets at end of year 46.2 50.2
Recurring | U.S. Large Cap | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 50.2  
Fair value of plan assets at end of year 46.2 50.2
Recurring | U.S. Large Cap | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | U.S. Large Cap | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | International    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 39.8  
Fair value of plan assets at end of year 31.0 39.8
Recurring | International | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 28.7  
Fair value of plan assets at end of year 22.7 28.7
Recurring | International | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 11.1  
Fair value of plan assets at end of year 8.3 11.1
Recurring | International | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Diversified Fixed Income Funds    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year [1] 218.7  
Fair value of plan assets at end of year [1] 198.4 218.7
Recurring | Diversified Fixed Income Funds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year [1] 216.6  
Fair value of plan assets at end of year [1] 196.9 216.6
Recurring | Diversified Fixed Income Funds | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year [1] 2.1  
Fair value of plan assets at end of year [1] 1.5 2.1
Recurring | Diversified Fixed Income Funds | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year [1] 0.0  
Fair value of plan assets at end of year [1] 0.0 0.0
Recurring | High Yield Bonds    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 13.0  
Fair value of plan assets at end of year 11.3 13.0
Recurring | High Yield Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 13.0  
Fair value of plan assets at end of year 11.3 13.0
Recurring | High Yield Bonds | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | High Yield Bonds | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Emerging Market Fund    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 9.5  
Fair value of plan assets at end of year 7.4 9.5
Recurring | Emerging Market Fund | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 9.5  
Fair value of plan assets at end of year 7.4 9.5
Recurring | Emerging Market Fund | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Emerging Market Fund | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Insurance Contract    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 119.8  
Fair value of plan assets at end of year 116.7 119.8
Recurring | Insurance Contract | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Insurance Contract | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year 0.0 0.0
Recurring | Insurance Contract | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 119.8  
Fair value of plan assets at end of year 116.7 119.8
Recurring | Other    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 6.0  
Fair value of plan assets at end of year 11.8 6.0
Recurring | Other | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 2.6  
Fair value of plan assets at end of year 9.4 2.6
Recurring | Other | Significant Other Observable Inputs (Level 2)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 3.4  
Fair value of plan assets at end of year 2.4 3.4
Recurring | Other | Significant Unobservable Inputs (Level 3)    
Change in Fair Value of Plan Assets [Roll Forward]    
Fair value of plan assets at beginning of year 0.0  
Fair value of plan assets at end of year $ 0.0 $ 0.0
[1] Diversified fixed income funds consist of U.S. Treasury bonds, mortgage-backed securities, corporate bonds, asset-backed securities and U.S. agency bonds.
XML 152 R69.htm IDEA: XBRL DOCUMENT v3.3.0.814
Acquisitions and License Agreements (Schedule of Pro Forma Information) (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Business Acquisition [Line Items]    
Net sales $ 3,755.8 $ 3,598.1
Income (loss) from continuing operations $ 359.9 $ (63.1)
Basic earnings (loss) per share from continuing operations $ 3.11 $ (0.55)
Diluted earnings (loss) from per share continuing operations $ 3.07 $ (0.55)
XML 153 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Guarantees
 12 Months Ended
Sep. 25, 2015
Guarantees [Abstract]  
Guarantees
18.
Guarantees
In disposing of assets or businesses, the Company has historically provided representations, warranties and indemnities to cover various risks and liabilities, including unknown damage to the assets, environmental risks involved in the sale of real estate, liability to investigate and remediate environmental contamination at waste disposal sites and manufacturing facilities, and unidentified tax liabilities related to periods prior to disposition. The Company assesses the probability of potential liabilities related to such representations, warranties and indemnities and adjusts potential liabilities as a result of changes in facts and circumstances. The Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.
In connection with the sale of the Specialty Chemical business (formerly known as Mallinckrodt Baker) in fiscal 2010, the Company agreed to indemnify the purchaser with respect to various matters, including certain environmental, health, safety, tax and other matters. The indemnification obligations relating to certain environmental, health and safety matters have a term of 17 years from the sale, while some of the other indemnification obligations have an indefinite term. The amount of the liability relating to all of these indemnification obligations included in other liabilities on the Company's consolidated balance sheets at September 25, 2015 and September 26, 2014 was $15.7 million and $16.6 million, respectively, of which $13.0 million and $13.9 million, respectively, related to environmental, health and safety matters. The value of the environmental, health and safety indemnity was measured based on the probability-weighted present value of the costs expected to be incurred to address environmental, health and safety claims made under the indemnity. The aggregate fair value of these indemnification obligations did not differ significantly from their aggregate carrying value at September 25, 2015 and September 26, 2014. As of September 25, 2015, the maximum future payments the Company could be required to make under these indemnification obligations was $71.0 million. The Company was required to pay $30.0 million into an escrow account as collateral to the purchaser, of which $19.0 million and $19.4 million remained in other assets on the consolidated balance sheets at September 25, 2015 and September 26, 2014, respectively.
The Company has recorded liabilities for known indemnification obligations included as part of environmental liabilities, which are discussed in Note 19. In addition, the Company is liable for product performance; however the Company believes, given the information currently available, that their ultimate resolution will not have a material adverse effect on its financial condition, results of operations and cash flows.
The Company is required to provide the U.S. Nuclear Regulatory Commission financial assurance demonstrating its ability to fund the decommissioning of its Maryland Heights, Missouri radiopharmaceuticals production facility upon closure, though the Company does not intend to close this facility. The Company has provided this financial assurance in the form of surety bonds totaling $57.2 million. As of September 25, 2015, the Company had various other letters of credit and guarantee and surety bonds totaling $39.4 million.
In April 2015, the Company terminated a letter of credit to guarantee decommissioning costs associated with its Saint Louis, Missouri plant and placed $21.1 million of restricted cash on deposit with a trustee. This restricted cash is included within prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 25, 2015.
In addition, the separation and distribution agreement entered into with Covidien at the Separation provides for cross-indemnities principally designed to place financial responsibility of the obligations and liabilities of the Company's business with the Company and financial responsibility for the obligations and liabilities of Covidien's remaining business with Covidien, among other indemnities.
XML 154 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 819 763 1 true 214 0 false 17 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.mallinckrodt.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated and Combined Statements of Income Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementsOfIncome Consolidated and Combined Statements of Income Statements 2 false false R3.htm 1001001 - Statement - Consolidated and Combined Statements of Income (Parenthetical) Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementsOfIncomeParenthetical Consolidated and Combined Statements of Income (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated and Combined Statements of Comprehensive Income Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementsOfComprehensiveIncome Consolidated and Combined Statements of Comprehensive Income Statements 4 false false R5.htm 1002501 - Statement - Consolidated and Combined Statements of Comprehensive Income (Parenthetical) Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementsOfComprehensiveIncomeParenthetical Consolidated and Combined Statements of Comprehensive Income (Parenthetical) Statements 5 false false R6.htm 1003000 - Statement - Consolidated Balance Sheets Sheet http://www.mallinckrodt.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 6 false false R7.htm 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.mallinckrodt.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 7 false false R8.htm 1004000 - Statement - Consolidated and Combined Statements of Cash Flows Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementsOfCashFlows Consolidated and Combined Statements of Cash Flows Statements 8 false false R9.htm 1005000 - Statement - Consolidated and Combined Statement of Changes in Shareholders' Equity Statement Sheet http://www.mallinckrodt.com/role/ConsolidatedAndCombinedStatementOfChangesInShareholdersEquityStatement Consolidated and Combined Statement of Changes in Shareholders' Equity Statement Statements 9 false false R10.htm 2101100 - Disclosure - Background and Basis of Presentation (Notes) Notes http://www.mallinckrodt.com/role/BackgroundAndBasisOfPresentationNotes Background and Basis of Presentation (Notes) Notes 10 false false R11.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.mallinckrodt.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 2102100 - Disclosure - Recently Issued Accounting Standards Sheet http://www.mallinckrodt.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 12 false false R13.htm 2103100 - Disclosure - Discontinued Operations and Divestitures Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestitures Discontinued Operations and Divestitures Notes 13 false false R14.htm 2104100 - Disclosure - Acquisitions and License Agreements Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreements Acquisitions and License Agreements Notes 14 false false R15.htm 2105100 - Disclosure - Restructuring and Related Charges Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedCharges Restructuring and Related Charges Notes 15 false false R16.htm 2106100 - Disclosure - Income Taxes Sheet http://www.mallinckrodt.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2108100 - Disclosure - Earnings (Loss) per Share Sheet http://www.mallinckrodt.com/role/EarningsLossPerShare Earnings (Loss) per Share Notes 17 false false R18.htm 2109100 - Disclosure - Inventories Sheet http://www.mallinckrodt.com/role/Inventories Inventories Notes 18 false false R19.htm 2110100 - Disclosure - Property, Plant and Equipment Sheet http://www.mallinckrodt.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 19 false false R20.htm 2111100 - Disclosure - Goodwill and Intangible Assets Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 20 false false R21.htm 2112100 - Disclosure - Debt Sheet http://www.mallinckrodt.com/role/Debt Debt Notes 21 false false R22.htm 2113100 - Disclosure - Retirement Plans Sheet http://www.mallinckrodt.com/role/RetirementPlans Retirement Plans Notes 22 false false R23.htm 2114100 - Disclosure - Equity Equity Sheet http://www.mallinckrodt.com/role/EquityEquity Equity Equity Notes 23 false false R24.htm 2115100 - Disclosure - Share Plans Sheet http://www.mallinckrodt.com/role/SharePlans Share Plans Notes 24 false false R25.htm 2121100 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.mallinckrodt.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 25 false false R26.htm 2122100 - Disclosure - Transactions with Former Parent Company Sheet http://www.mallinckrodt.com/role/TransactionsWithFormerParentCompany Transactions with Former Parent Company Notes 26 false false R27.htm 2123100 - Disclosure - Guarantees Sheet http://www.mallinckrodt.com/role/Guarantees Guarantees Notes 27 false false R28.htm 2125100 - Disclosure - Commitments and Contingencies Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 28 false false R29.htm 2127100 - Disclosure - Financial Instruments and Fair Value Measurements Sheet http://www.mallinckrodt.com/role/FinancialInstrumentsAndFairValueMeasurements Financial Instruments and Fair Value Measurements Notes 29 false false R30.htm 2128100 - Disclosure - Segment and Geographical Data Sheet http://www.mallinckrodt.com/role/SegmentAndGeographicalData Segment and Geographical Data Notes 30 false false R31.htm 2129100 - Disclosure - Selected Quarterly Financial Data (Unaudited) Sheet http://www.mallinckrodt.com/role/SelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (Unaudited) Notes 31 false false R32.htm 2130100 - Disclosure - Condensed Consolidating and Combining Financial Statements Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatements Condensed Consolidating and Combining Financial Statements Notes 32 false false R33.htm 2131100 - Disclosure - Subsequent Events Sheet http://www.mallinckrodt.com/role/SubsequentEvents Subsequent Events Notes 33 false false R34.htm 2132100 - Schedule - Schedule II - Valuation and Qualifying Accounts (Notes) Notes http://www.mallinckrodt.com/role/ScheduleIiValuationAndQualifyingAccountsNotes Schedule II - Valuation and Qualifying Accounts (Notes) Uncategorized 34 false false R35.htm 2201201 - Disclosure - Background and Basis of Presentation (Policies) Sheet http://www.mallinckrodt.com/role/BackgroundAndBasisOfPresentationPolicies Background and Basis of Presentation (Policies) Uncategorized 35 false false R36.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.mallinckrodt.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Uncategorized 36 false false R37.htm 2208201 - Disclosure - Earnings (Loss) per Share (Policies) Sheet http://www.mallinckrodt.com/role/EarningsLossPerSharePolicies Earnings (Loss) per Share (Policies) Uncategorized 37 false false R38.htm 2301302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.mallinckrodt.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Uncategorized 38 false false R39.htm 2303301 - Disclosure - Discontinued Operations and Divestitures (Tables) Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestituresTables Discontinued Operations and Divestitures (Tables) Uncategorized 39 false false R40.htm 2304301 - Disclosure - Acquisitions and License Agreements (Tables) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsTables Acquisitions and License Agreements (Tables) Uncategorized 40 false false R41.htm 2305301 - Disclosure - Restructuring and Related Charges (Tables) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesTables Restructuring and Related Charges (Tables) Uncategorized 41 false false R42.htm 2306301 - Disclosure - Income Taxes (Tables) Sheet http://www.mallinckrodt.com/role/IncomeTaxesTables Income Taxes (Tables) Uncategorized 42 false false R43.htm 2308302 - Disclosure - Earnings (Loss) per Share (Tables) Sheet http://www.mallinckrodt.com/role/EarningsLossPerShareTables Earnings (Loss) per Share (Tables) Uncategorized 43 false false R44.htm 2309301 - Disclosure - Inventories (Tables) Sheet http://www.mallinckrodt.com/role/InventoriesTables Inventories (Tables) Uncategorized 44 false false R45.htm 2310301 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.mallinckrodt.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Uncategorized 45 false false R46.htm 2311301 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Uncategorized 46 false false R47.htm 2312301 - Disclosure - Debt (Tables) Sheet http://www.mallinckrodt.com/role/DebtTables Debt (Tables) Uncategorized 47 false false R48.htm 2313301 - Disclosure - Retirement Plans (Tables) Sheet http://www.mallinckrodt.com/role/RetirementPlansTables Retirement Plans (Tables) Uncategorized 48 false false R49.htm 2314301 - Disclosure - Equity (Tables) Sheet http://www.mallinckrodt.com/role/EquityTables Equity (Tables) Uncategorized 49 false false R50.htm 2315301 - Disclosure - Share Plans (Tables) Sheet http://www.mallinckrodt.com/role/SharePlansTables Share Plans (Tables) Uncategorized 50 false false R51.htm 2321301 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.mallinckrodt.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Uncategorized 51 false false R52.htm 2325301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Uncategorized 52 false false R53.htm 2327301 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) Sheet http://www.mallinckrodt.com/role/FinancialInstrumentsAndFairValueMeasurementsTables Financial Instruments and Fair Value Measurements (Tables) Uncategorized 53 false false R54.htm 2328301 - Disclosure - Segment and Geographical Data (Tables) Sheet http://www.mallinckrodt.com/role/SegmentAndGeographicalDataTables Segment and Geographical Data (Tables) Uncategorized 54 false false R55.htm 2329301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.mallinckrodt.com/role/SelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (Unaudited) (Tables) Uncategorized 55 false false R56.htm 2330301 - Disclosure - Condensed Consolidating and Combining Financial Statements (Tables) Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatementsTables Condensed Consolidating and Combining Financial Statements (Tables) Uncategorized 56 false false R57.htm 2401402 - Disclosure - Background and Basis of Presentation (Details) Sheet http://www.mallinckrodt.com/role/BackgroundAndBasisOfPresentationDetails Background and Basis of Presentation (Details) Uncategorized 57 false false R58.htm 2401403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.mallinckrodt.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Uncategorized 58 false false R59.htm 2402401 - Disclosure - Recently Issued Accounting Standards Narrative (Details) Sheet http://www.mallinckrodt.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails Recently Issued Accounting Standards Narrative (Details) Uncategorized 59 false false R60.htm 2403402 - Disclosure - Discontinued Operations and Divestitures (Income (loss) from Discontinued Operations) (Details) Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestituresIncomeLossFromDiscontinuedOperationsDetails Discontinued Operations and Divestitures (Income (loss) from Discontinued Operations) (Details) Uncategorized 60 false false R61.htm 2403403 - Disclosure - Discontinued Operations and Divestitures (Assets and Liabilities Held-for-Sale) (Details) Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestituresAssetsAndLiabilitiesHeldForSaleDetails Discontinued Operations and Divestitures (Assets and Liabilities Held-for-Sale) (Details) Uncategorized 61 false false R62.htm 2403404 - Disclosure - Discontinued Operations and Divestitures, Significant Cash and Non-Cash Transactions (Details) Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestituresSignificantCashAndNonCashTransactionsDetails Discontinued Operations and Divestitures, Significant Cash and Non-Cash Transactions (Details) Uncategorized 62 false false R63.htm 2403405 - Disclosure - Discontinued Operations and Divestitures (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/DiscontinuedOperationsAndDivestituresNarrativeDetails Discontinued Operations and Divestitures (Narrative) (Details) Uncategorized 63 false false R64.htm 2404402 - Disclosure - Acquisitions and License Agreements (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsNarrativeDetails Acquisitions and License Agreements (Narrative) (Details) Uncategorized 64 false false R65.htm 2404403 - Disclosure - Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) Uncategorized 65 false false R66.htm 2404404 - Disclosure - Acquisitions and License Agreements (Schedule of Reconciliation of Total Consideration) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfReconciliationOfTotalConsiderationDetails Acquisitions and License Agreements (Schedule of Reconciliation of Total Consideration) (Details) Uncategorized 66 false false R67.htm 2404405 - Disclosure - Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfIntangibleAssetsAcquiredDetails Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) Uncategorized 67 false false R68.htm 2404406 - Disclosure - Acquisitions and License Agreements (Schedule of Financial Results and Acquisition Costs of Acquirees) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfFinancialResultsAndAcquisitionCostsOfAcquireesDetails Acquisitions and License Agreements (Schedule of Financial Results and Acquisition Costs of Acquirees) (Details) Uncategorized 68 false false R69.htm 2404407 - Disclosure - Acquisitions and License Agreements (Schedule of Pro Forma Information) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfProFormaInformationDetails Acquisitions and License Agreements (Schedule of Pro Forma Information) (Details) Uncategorized 69 false false R70.htm 2404408 - Disclosure - Acquisitions and License Agreements (Schedule of Intangible Asset Amortization by Acquiree) (Details) Sheet http://www.mallinckrodt.com/role/AcquisitionsAndLicenseAgreementsScheduleOfIntangibleAssetAmortizationByAcquireeDetails Acquisitions and License Agreements (Schedule of Intangible Asset Amortization by Acquiree) (Details) Uncategorized 70 false false R71.htm 2405402 - Disclosure - Restructuring and Related Charges (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesNarrativeDetails Restructuring and Related Charges (Narrative) (Details) Uncategorized 71 false false R72.htm 2405403 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring and Related Charges by Segment) (Details) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesScheduleOfRestructuringAndRelatedChargesBySegmentDetails Restructuring and Related Charges (Schedule of Restructuring and Related Charges by Segment) (Details) Uncategorized 72 false false R73.htm 2405404 - Disclosure - Restructuring and Related Charges (Schedule of Net Restructuring and Related Charges) (Details) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesScheduleOfNetRestructuringAndRelatedChargesDetails Restructuring and Related Charges (Schedule of Net Restructuring and Related Charges) (Details) Uncategorized 73 false false R74.htm 2405405 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring Reserves by Type of Cost) (Details) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesScheduleOfRestructuringReservesByTypeOfCostDetails Restructuring and Related Charges (Schedule of Restructuring Reserves by Type of Cost) (Details) Uncategorized 74 false false R75.htm 2405406 - Disclosure - Restructuring and Related Charges (Schedule of Restructuring Charges Incurred Cumulative to Date) (Details) Sheet http://www.mallinckrodt.com/role/RestructuringAndRelatedChargesScheduleOfRestructuringChargesIncurredCumulativeToDateDetails Restructuring and Related Charges (Schedule of Restructuring Charges Incurred Cumulative to Date) (Details) Uncategorized 75 false false R76.htm 2406402 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Uncategorized 76 false false R77.htm 2406403 - Disclosure - Income Taxes (Schedule of Components of Income from Continuing Operations Before Income Taxes) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfComponentsOfIncomeFromContinuingOperationsBeforeIncomeTaxesDetails Income Taxes (Schedule of Components of Income from Continuing Operations Before Income Taxes) (Details) Uncategorized 77 false false R78.htm 2406404 - Disclosure - Income Taxes (Schedule of Significant Components of Income Taxes Related to Continuing Operations) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfSignificantComponentsOfIncomeTaxesRelatedToContinuingOperationsDetails Income Taxes (Schedule of Significant Components of Income Taxes Related to Continuing Operations) (Details) Uncategorized 78 false false R79.htm 2406405 - Disclosure - Income Taxes (Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfReconciliationOfIncomeTaxesAtStatutoryRateAndTaxProvisionDetails Income Taxes (Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision) (Details) Uncategorized 79 false false R80.htm 2406406 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefit Activity) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitActivityDetails Income Taxes (Schedule of Unrecognized Tax Benefit Activity) (Details) Uncategorized 80 false false R81.htm 2406407 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Balance Sheet Location) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsBalanceSheetLocationDetails Income Taxes (Schedule of Unrecognized Tax Benefits Balance Sheet Location) (Details) Uncategorized 81 false false R82.htm 2406408 - Disclosure - Income Taxes (Schedule of Income Taxes Payable) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfIncomeTaxesPayableDetails Income Taxes (Schedule of Income Taxes Payable) (Details) Uncategorized 82 false false R83.htm 2406409 - Disclosure - Income Taxes (Schedule of Income Tax Receivables and Other Assets) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfIncomeTaxReceivablesAndOtherAssetsDetails Income Taxes (Schedule of Income Tax Receivables and Other Assets) (Details) Uncategorized 83 false false R84.htm 2406410 - Disclosure - Income Taxes (Schedule of Deferred Taxes Activity) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfDeferredTaxesActivityDetails Income Taxes (Schedule of Deferred Taxes Activity) (Details) Uncategorized 84 false false R85.htm 2406411 - Disclosure - Income Taxes (Schedule of Deferred Taxes Balance Sheet Location) (Details) Sheet http://www.mallinckrodt.com/role/IncomeTaxesScheduleOfDeferredTaxesBalanceSheetLocationDetails Income Taxes (Schedule of Deferred Taxes Balance Sheet Location) (Details) Uncategorized 85 false false R86.htm 2408403 - Disclosure - Earnings (Loss) per Share (Details) Sheet http://www.mallinckrodt.com/role/EarningsLossPerShareDetails Earnings (Loss) per Share (Details) Uncategorized 86 false false R87.htm 2408404 - Disclosure - Earnings (Loss) per Share Schedule of Earnings per Share Basic and Diluted (Details) Sheet http://www.mallinckrodt.com/role/EarningsLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails Earnings (Loss) per Share Schedule of Earnings per Share Basic and Diluted (Details) Uncategorized 87 false false R88.htm 2409402 - Disclosure - Inventories (Details) Sheet http://www.mallinckrodt.com/role/InventoriesDetails Inventories (Details) Uncategorized 88 false false R89.htm 2410402 - Disclosure - Property, Plant and Equipment (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/PropertyPlantAndEquipmentNarrativeDetails Property, Plant and Equipment (Narrative) (Details) Uncategorized 89 false false R90.htm 2410403 - Disclosure - Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) Sheet http://www.mallinckrodt.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) Uncategorized 90 false false R91.htm 2411402 - Disclosure - Goodwill and Intangible Assets Narrative (Details) Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets Narrative (Details) Uncategorized 91 false false R92.htm 2411403 - Disclosure - Goodwill and Intangible Assets (Schedule Of Goodwill) (Details) Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillDetails Goodwill and Intangible Assets (Schedule Of Goodwill) (Details) Uncategorized 92 false false R93.htm 2411404 - Disclosure - Goodwill and Intangible Assets (Schedule Of Intangible Assets) (Details) Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsDetails Goodwill and Intangible Assets (Schedule Of Intangible Assets) (Details) Uncategorized 93 false false R94.htm 2411405 - Disclosure - Goodwill and Intangible Assets (Schedule of Future Amortization Expense, Intangible Assets) (Details) Sheet http://www.mallinckrodt.com/role/GoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpenseIntangibleAssetsDetails Goodwill and Intangible Assets (Schedule of Future Amortization Expense, Intangible Assets) (Details) Uncategorized 94 false false R95.htm 2412402 - Disclosure - Debt (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/DebtNarrativeDetails Debt (Narrative) (Details) Uncategorized 95 false false R96.htm 2412403 - Disclosure - Debt (Schedule of Long term debt and Capital lease obligation) (Details) Sheet http://www.mallinckrodt.com/role/DebtScheduleOfLongTermDebtAndCapitalLeaseObligationDetails Debt (Schedule of Long term debt and Capital lease obligation) (Details) Uncategorized 96 false false R97.htm 2412404 - Disclosure - Debt (Schedule of Maturities of Long-term Debt including Capital Lease Obligation) (Details) Sheet http://www.mallinckrodt.com/role/DebtScheduleOfMaturitiesOfLongTermDebtIncludingCapitalLeaseObligationDetails Debt (Schedule of Maturities of Long-term Debt including Capital Lease Obligation) (Details) Uncategorized 97 false false R98.htm 2413402 - Disclosure - Retirement Plans Narrative (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansNarrativeDetails Retirement Plans Narrative (Details) Uncategorized 98 false false R99.htm 2413403 - Disclosure - Retirement Plans (Schedule of Net Periodic Benefit Cost) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfNetPeriodicBenefitCostDetails Retirement Plans (Schedule of Net Periodic Benefit Cost) (Details) Uncategorized 99 false false R100.htm 2413404 - Disclosure - Retirement Plans (Schedule of Benefit Obligation, Plan Assets and Funded Status of Plans) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfBenefitObligationPlanAssetsAndFundedStatusOfPlansDetails Retirement Plans (Schedule of Benefit Obligation, Plan Assets and Funded Status of Plans) (Details) Uncategorized 100 false false R101.htm 2413405 - Disclosure - Retirement Plans (Schedule of Amounts Recognized in Balance Sheet) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfAmountsRecognizedInBalanceSheetDetails Retirement Plans (Schedule of Amounts Recognized in Balance Sheet) (Details) Uncategorized 101 false false R102.htm 2413406 - Disclosure - Retirement Plans (Schedule of Amounts to be Amortized From Accumulated Other Comprehensive Income) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfAmountsToBeAmortizedFromAccumulatedOtherComprehensiveIncomeDetails Retirement Plans (Schedule of Amounts to be Amortized From Accumulated Other Comprehensive Income) (Details) Uncategorized 102 false false R103.htm 2413407 - Disclosure - Retirement Plans (Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsDetails Retirement Plans (Schedule of Plans with Accumulated Benefit Obligations in Excess of Plan Assets) (Details) Uncategorized 103 false false R104.htm 2413408 - Disclosure - Retirement Plans (Schedule of Actuarial Assumptions) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfActuarialAssumptionsDetails Retirement Plans (Schedule of Actuarial Assumptions) (Details) Uncategorized 104 false false R105.htm 2413409 - Disclosure - Retirement Plans (Schedule of Weighted Average Allocation of Plan Assets) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfWeightedAverageAllocationOfPlanAssetsDetails Retirement Plans (Schedule of Weighted Average Allocation of Plan Assets) (Details) Uncategorized 105 false false R106.htm 2413410 - Disclosure - Retirement Plans (Schedule of Fair Value of Plan Assets) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfFairValueOfPlanAssetsDetails Retirement Plans (Schedule of Fair Value of Plan Assets) (Details) Uncategorized 106 false false R107.htm 2413411 - Disclosure - Retirement Plans (Schedule of Expected Benefit Payments) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansScheduleOfExpectedBenefitPaymentsDetails Retirement Plans (Schedule of Expected Benefit Payments) (Details) Uncategorized 107 false false R108.htm 2413412 - Disclosure - Retirement Plans (Defined Contribution Plan) (Details) Sheet http://www.mallinckrodt.com/role/RetirementPlansDefinedContributionPlanDetails Retirement Plans (Defined Contribution Plan) (Details) Uncategorized 108 false false R109.htm 2414402 - Disclosure - Equity (Details) Sheet http://www.mallinckrodt.com/role/EquityDetails Equity (Details) Uncategorized 109 false false R110.htm 2414403 - Disclosure - Equity Stock Repurchase Program (Details) Sheet http://www.mallinckrodt.com/role/EquityStockRepurchaseProgramDetails Equity Stock Repurchase Program (Details) Uncategorized 110 false false R111.htm 2415402 - Disclosure - Share Plans (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansNarrativeDetails Share Plans (Narrative) (Details) Uncategorized 111 false false R112.htm 2415403 - Disclosure - Share Plans (Schedule of Incentive Equity Awards Issued Upon Completion of Conversion) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfIncentiveEquityAwardsIssuedUponCompletionOfConversionDetails Share Plans (Schedule of Incentive Equity Awards Issued Upon Completion of Conversion) (Details) Uncategorized 112 false false R113.htm 2415404 - Disclosure - Share Plans (Schedule of Share Option Award Status Upon Completion of the Conversion) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfShareOptionAwardStatusUponCompletionOfConversionDetails Share Plans (Schedule of Share Option Award Status Upon Completion of the Conversion) (Details) Uncategorized 113 false false R114.htm 2415405 - Disclosure - Share Plans (Schedule of the Valuation Assumptions Used in the Conversion) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfValuationAssumptionsUsedInConversionDetails Share Plans (Schedule of the Valuation Assumptions Used in the Conversion) (Details) Uncategorized 114 false false R115.htm 2415406 - Disclosure - Share Plans (Schedule of Share Option Activity) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfShareOptionActivityDetails Share Plans (Schedule of Share Option Activity) (Details) Uncategorized 115 false false R116.htm 2415407 - Disclosure - Share Plans (Schedule of Restricted Share Unit Activity) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfRestrictedShareUnitActivityDetails Share Plans (Schedule of Restricted Share Unit Activity) (Details) Uncategorized 116 false false R117.htm 2415408 - Disclosure - Share Plans (Schedule of Performance Share Unit Activity) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfPerformanceShareUnitActivityDetails Share Plans (Schedule of Performance Share Unit Activity) (Details) Uncategorized 117 false false R118.htm 2415409 - Disclosure - Share Plans (Schedule of Fair Value Assumptions for Performance Share Unit) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfFairValueAssumptionsForPerformanceShareUnitDetails Share Plans (Schedule of Fair Value Assumptions for Performance Share Unit) (Details) Uncategorized 118 false false R119.htm 2415410 - Disclosure - Share Plans (Schedule of Restricted Stock Award Activity) (Details) Sheet http://www.mallinckrodt.com/role/SharePlansScheduleOfRestrictedStockAwardActivityDetails Share Plans (Schedule of Restricted Stock Award Activity) (Details) Uncategorized 119 false false R120.htm 2421402 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details) Sheet http://www.mallinckrodt.com/role/AccumulatedOtherComprehensiveIncomeScheduleOfAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details) Uncategorized 120 false false R121.htm 2421403 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details) Sheet http://www.mallinckrodt.com/role/AccumulatedOtherComprehensiveIncomeScheduleOfReclassificationsOutOfAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details) Uncategorized 121 false false R122.htm 2422401 - Disclosure - Transactions with Former Parent Company (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/TransactionsWithFormerParentCompanyNarrativeDetails Transactions with Former Parent Company (Narrative) (Details) Uncategorized 122 false false R123.htm 2423401 - Disclosure - Guarantees (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/GuaranteesNarrativeDetails Guarantees (Narrative) (Details) Uncategorized 123 false false R124.htm 2425402 - Disclosure - Commitments and Contingencies (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies (Narrative) (Details) Uncategorized 124 false false R125.htm 2425403 - Disclosure - Commitments and Contingencies (Schedule of Purchase Oligations) (Details) Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingenciesScheduleOfPurchaseOligationsDetails Commitments and Contingencies (Schedule of Purchase Oligations) (Details) Uncategorized 125 false false R126.htm 2425404 - Disclosure - Commitments and Contingencies (Schedule of Asset Retirement Obligations) (Details) Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingenciesScheduleOfAssetRetirementObligationsDetails Commitments and Contingencies (Schedule of Asset Retirement Obligations) (Details) Uncategorized 126 false false R127.htm 2425405 - Disclosure - Commitments and Contingencies (Schedule of Minimum Lease Payments for Non-cancelable Leases) (Details) Sheet http://www.mallinckrodt.com/role/CommitmentsAndContingenciesScheduleOfMinimumLeasePaymentsForNonCancelableLeasesDetails Commitments and Contingencies (Schedule of Minimum Lease Payments for Non-cancelable Leases) (Details) Uncategorized 127 false false R128.htm 2427402 - Disclosure - Financial Instruments and Fair Value Measurements (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails Financial Instruments and Fair Value Measurements (Narrative) (Details) Uncategorized 128 false false R129.htm 2427403 - Disclosure - (Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.mallinckrodt.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails (Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Uncategorized 129 false false R130.htm 2427404 - Disclosure - (Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration) (Details) Sheet http://www.mallinckrodt.com/role/ScheduleOfReconciliationOfChangesInFairValueOfContingentConsiderationDetails (Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration) (Details) Uncategorized 130 false false R131.htm 2427405 - Disclosure - (Schedule of Carrying Amount and Fair Value of Long-term Debt) (Details) Sheet http://www.mallinckrodt.com/role/ScheduleOfCarryingAmountAndFairValueOfLongTermDebtDetails (Schedule of Carrying Amount and Fair Value of Long-term Debt) (Details) Uncategorized 131 false false R132.htm 2427406 - Disclosure - (Schedules of Concentration of Risk) (Details) Sheet http://www.mallinckrodt.com/role/SchedulesOfConcentrationOfRiskDetails (Schedules of Concentration of Risk) (Details) Uncategorized 132 false false R133.htm 2428402 - Disclosure - Segment and Geographical Data (Schedule of Segment Reporting Information by Business Segment) (Details) Sheet http://www.mallinckrodt.com/role/SegmentAndGeographicalDataScheduleOfSegmentReportingInformationByBusinessSegmentDetails Segment and Geographical Data (Schedule of Segment Reporting Information by Business Segment) (Details) Uncategorized 133 false false R134.htm 2428403 - Disclosure - Segment and Geographical Data (Schedule of Net Sales from External Costumers by Product) (Details) Sheet http://www.mallinckrodt.com/role/SegmentAndGeographicalDataScheduleOfNetSalesFromExternalCostumersByProductDetails Segment and Geographical Data (Schedule of Net Sales from External Costumers by Product) (Details) Uncategorized 134 false false R135.htm 2428404 - Disclosure - Segment and Geographical Data (Schedule of Net Sales and Long-Lived Assets by Geographic Area) (Details) Sheet http://www.mallinckrodt.com/role/SegmentAndGeographicalDataScheduleOfNetSalesAndLongLivedAssetsByGeographicAreaDetails Segment and Geographical Data (Schedule of Net Sales and Long-Lived Assets by Geographic Area) (Details) Uncategorized 135 false false R136.htm 2429402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details) Sheet http://www.mallinckrodt.com/role/SelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (Unaudited) (Details) Uncategorized 136 false false R137.htm 2430402 - Disclosure - Condensed Consolidating and Combining Financial Statements (Narrative) (Details) Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatementsNarrativeDetails Condensed Consolidating and Combining Financial Statements (Narrative) (Details) Uncategorized 137 false false R138.htm 2430403 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating Balance Sheets) (Details) Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatementsScheduleOfCondensedConsolidatingBalanceSheetsDetails Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating Balance Sheets) (Details) Uncategorized 138 false false R139.htm 2430404 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income) (Details) Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatementsScheduleOfCondensedConsolidatingAndCombiningStatementsOfComprehensiveIncomeDetails Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Comprehensive Income) (Details) Uncategorized 139 false false R140.htm 2430405 - Disclosure - Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Cash Flows) (Details) Sheet http://www.mallinckrodt.com/role/CondensedConsolidatingAndCombiningFinancialStatementsScheduleOfCondensedConsolidatingAndCombiningStatementsOfCashFlowsDetails Condensed Consolidating and Combining Financial Statements (Schedule of Condensed Consolidating and Combining Statements of Cash Flows) (Details) Uncategorized 140 false false R141.htm 2431401 - Disclosure - Subsequent Events (Subsequent Events) (Details) Sheet http://www.mallinckrodt.com/role/SubsequentEventsSubsequentEventsDetails Subsequent Events (Subsequent Events) (Details) Uncategorized 141 false false R142.htm 2432401 - Schedule - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.mallinckrodt.com/role/ScheduleIiValuationAndQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Uncategorized 142 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Balance Sheets (Parenthetical)'', column(s) 10 are contained in other reports, so were removed by flow through suppression. In ''Consolidated and Combined Statements of Cash Flows'', column(s) 1, 2, 3, 4, 5, 6, 7, 8 are contained in other reports, so were removed by flow through suppression. mnk-20150925.xml mnk-20150925_cal.xml mnk-20150925_def.xml mnk-20150925_lab.xml mnk-20150925_pre.xml mnk-20150925.xsd true true XML 155 R117.htm IDEA: XBRL DOCUMENT v3.3.0.814
Share Plans (Schedule of Performance Share Unit Activity) (Details) - Performance Shares - $ / shares
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Performance Share Unit Activity [Roll Forward]      
Beginning balance [1] 72,740 0  
Granted [1] 77,306 79,230  
Performance metric adjustment [1] 0 0  
Vested [1] 0 0  
Forfeited [1] (19,072) (6,490)  
Ending balance [1] 130,974 72,740  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average grant date fair value, restricted share units $ 96.05 $ 63.46 $ 0.00
Weighted-average grant date fair value, granted restricted share units 125.84 63.40  
Weighted-average grand date fair value, performance metric adjustment 0.00 0.00  
Weighted-average grant date fair value, vested restricted share units 0.00 0.00  
Weighted-average grant date fair value, forfeited restricted share units $ 92.05 $ 62.65  
[1] The number of shares disclosed within this table are at the target number of 100%.
XML 156 R130.htm IDEA: XBRL DOCUMENT v3.3.0.814
(Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration) (Details) - Recurring - Contingent Consideration - Questcor Pharmaceuticals, Inc.
$ in Millions
 12 Months Ended
Sep. 25, 2015
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Beginning balance $ 202.8
Payments (29.0)
Business Combination, Contingent Consideration, Accretion 7.5
Effect of currency rate change (6.7)
Ending balance $ 174.6
XML 157 R126.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Schedule of Asset Retirement Obligations) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Asset Retirement Obligation [Roll Forward]    
Beginning Balance $ 39.2 $ 48.9
Additions and adjustments (1.0) (11.5)
Accretion expense 1.8 3.1
Payments 0.0 0.0
Currency translation (3.1) (1.3)
Ending Balance $ 36.9 $ 39.2
XML 158 R74.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges (Schedule of Restructuring Reserves by Type of Cost) (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Continuing Operations      
Restructuring Reserve [Roll Forward]      
Beginning Balance $ 34.9 $ 25.5 $ 8.9
Charges 40.7 57.2 26.1
Changes in estimate from continuing operations (10.1) (13.3) (2.4)
Cash payments (44.3) (55.0) (15.1)
Reclassifications [1] (3.0) (2.3) (1.5)
Currency translation (0.6) (1.1)  
Ending Balance 18.0 34.9 25.5
Discontinued Operations, Held-for-sale      
Restructuring Reserve [Roll Forward]      
Charges, discontinued operations 1.0 26.4 9.7
Changes in estimate, discontinued operations (0.6) 2.5 (0.2)
Acquisition programs | Continuing Operations      
Restructuring Reserve [Roll Forward]      
Beginning Balance 7.9 0.0 0.0
Charges 25.3 22.9 0.0
Changes in estimate from continuing operations (1.5) (1.6) 0.0
Cash payments (21.7) (13.4) 0.0
Reclassifications [1] 0.0 0.0 0.0
Currency translation 0.0 0.0  
Ending Balance 10.0 7.9 0.0
Acquisition programs | Discontinued Operations, Held-for-sale      
Restructuring Reserve [Roll Forward]      
Charges, discontinued operations 0.0 0.0 0.0
Changes in estimate, discontinued operations 0.0 0.0 0.0
Other programs | Continuing Operations      
Restructuring Reserve [Roll Forward]      
Beginning Balance 0.4 10.6 8.9
Charges 0.0 1.4 17.6
Changes in estimate from continuing operations (0.3) (4.1) (2.4)
Cash payments (0.1) (6.8) (15.1)
Reclassifications [1] 0.0 (1.0) (1.5)
Currency translation 0.0 (0.1)  
Ending Balance 0.0 0.4 10.6
Other programs | Discontinued Operations, Held-for-sale      
Restructuring Reserve [Roll Forward]      
Charges, discontinued operations 0.0 1.1 3.3
Changes in estimate, discontinued operations 0.0 0.7 (0.2)
2013 Mallinckrodt program | Continuing Operations      
Restructuring Reserve [Roll Forward]      
Beginning Balance 26.6 14.9 0.0
Charges 15.4 32.9 8.5
Changes in estimate from continuing operations (8.3) (7.6) 0.0
Cash payments (22.5) (34.8) 0.0
Reclassifications [1] (3.0) (1.3) 0.0
Currency translation 0.6 (1.0)  
Ending Balance 8.0 26.6 14.9
2013 Mallinckrodt program | Discontinued Operations, Held-for-sale      
Restructuring Reserve [Roll Forward]      
Charges, discontinued operations 1.0 25.3 6.4
Changes in estimate, discontinued operations $ (0.6) $ 1.8 $ 0.0
[1] Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.
XML 159 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Sep. 25, 2015
Accounting Policies [Abstract]  
Schedule of Useful Lives for Property, Plant and Equipment
Depreciation for property, plant and equipment assets, other than land and construction in process, is generally based upon the following estimated useful lives, using the straight-line method:
Buildings
10
to
45 years
Leasehold improvements
1
to
20 years
Capitalized software
1
to
10 years
Machinery and equipment
1
to
20 years
Schedule of Useful Lives for Finite Lived Intangible Assets
Intangible assets with finite useful lives are subsequently amortized generally using the straight-line method over the following estimated useful lives of the assets, except for customer relationships which are amortized over the estimated pattern of benefit from these relationships:
Completed technology
5
to
25 years
License agreements
8
to
30 years
Trademarks
13
to
30 years
Customer relationships
 
 
12 years
XML 160 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Intangible Assets
 12 Months Ended
Sep. 25, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
11.
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill by segment were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated Impairment
 
Gross
Carrying
Amount
 
Accumulated Impairment
Specialty Brands
$
3,442.4

 
$
—

 
$
2,194.9

 
$
—

Specialty Generics
207.0

 
—

 
207.0

 
—

Nuclear Imaging
119.5

 
(119.5
)
 
119.5

 
(119.5
)
Total
$
3,768.9

 
$
(119.5
)
 
$
2,521.4

 
$
(119.5
)

During the fiscal year ended September 25, 2015, the gross carrying value of goodwill in the Specialty Brands segment increased by $1,247.5 million, attributable to $792.4 million from the Ikaria Acquisition, $437.2 million from the Therakos Acquisition and $17.9 million resulting from adjustments to the Questcor Acquisition purchase price allocation.

Goodwill Impairment Analysis
The Company has identified the Specialty Brands, Specialty Generics and the Nuclear Imaging businesses as representing both segments and reporting units. For purposes of assessing impairment and the recoverability of goodwill for each reporting unit the Company makes various assumptions regarding estimated future cash flows, discount rates and other factors in determining the fair values of each reporting unit using the income approach. The Company's projections of future cash flows were then discounted based on a WACC determined from relevant market comparisons, adjusted upward for specific reporting unit risks (primarily the uncertainty of achieving projected operating cash flows). A terminal value growth rate was applied to the terminal year cash flows, both of which represent the Company's estimate of stable, sustainable growth. The fair value of the reporting unit represents the sum of the discounted cash flows from the discrete period and the terminal year cash flows. The fair values of the reporting units were assessed for reasonableness by aggregating the fair values and comparing this to the Company's market capitalization with a control premium.
The Company's projections in its Specialty Brands reporting unit include long-term revenue and operating income at levels higher than historical levels, which is primarily associated with revenue growth for Acthar, Inomax and Ofirmev. The projections also reflect the potential impacts from the future loss of exclusivity related to Ofirmev. The Company utilized a WACC of 12.0%. These assumptions resulted in a fair value of the Specialty Brands reporting unit in excess of its net book value. Should the Specialty Brands reporting unit fail to experience growth in the aforementioned products, revise its long-term projections for these products downward or market conditions dictate utilization of higher discount rates, the Specialty Brands reporting unit could be subject to impairment in future periods.
The Company's projections in its Specialty Generics and API reporting unit include long-term revenue and operating income at levels lower than historical levels primarily attributable to increased competition. The Company utilized a WACC of 11.0%. These assumptions resulted in a fair value of the Specialty Generics and API reporting unit in excess of its net book value.
In fiscal 2014, the Company recorded goodwill impairment charges related to our former Global Medical Imaging reporting unit (which included the CMDS business that is now included within discontinued operations and the remaining Nuclear Imaging reporting unit). The Company recorded an impairment charge related to goodwill in fiscal 2014 of $219.7 million, which eliminated all goodwill balances related to the Global Medical Imaging reporting unit. In fiscal 2015, the Company announced that it had entered into a definitive agreement to sell its CMDS business, therefore the business was deemed to be held for sale and the financial results of this business are presented as a discontinued operation. The Company reclassified $100.2 million of the impairment charge to discontinued operations.
The gross carrying amount and accumulated amortization of intangible assets, excluding held for sale intangible assets, at the end of each period were as follows:
 
September 25, 2015
 
September 26, 2014
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Amortizable:
 
 
 
 
 
 
 
Completed technology
$
9,896.0

 
$
765.8

 
$
6,906.0

 
$
235.6

Licenses
185.1

 
99.8

 
185.1

 
87.3

Customer relationships
28.1

 
4.4

 
33.8

 
0.6

Trademarks
82.1

 
6.2

 
13.0

 
4.1

Other
6.7

 
6.7

 
6.7

 
5.0

Total
$
10,198.0

 
$
882.9

 
$
7,144.6

 
$
332.6

Non-Amortizable:
 
 
 
 
 
 
 
Trademarks
$
35.0

 
 
 
$
35.0

 
 
In-process research and development
316.2

 
 
 
235.2

 
 
Total
$
351.2

 
 
 
$
270.2

 
 


Finite-lived intangible asset amortization expense within continuing operations was $550.3 million, $154.8 million and $27.9 million in fiscal 2015, 2014 and 2013, respectively. The estimated aggregate amortization expense on intangible assets owned by the Company, excluding held for sale intangible assets, is expected to be as follows:
 
 
Fiscal 2016
$
693.7

Fiscal 2017
691.9

Fiscal 2018
682.9

Fiscal 2019
682.6

Fiscal 2020
682.0
XML 161 R101.htm IDEA: XBRL DOCUMENT v3.3.0.814
Retirement Plans (Schedule of Amounts Recognized in Balance Sheet) (Details) - USD ($)
$ in Millions
Sep. 25, 2015
Sep. 26, 2014
Amounts recognized on the consolidated balance sheet:    
Non-current liabilities $ (116.7) $ (116.2)
Pension Benefits    
Amounts recognized on the consolidated balance sheet:    
Non-current assets 20.1 9.8
Current liabilities (6.6) (2.7)
Non-current liabilities (69.1) (71.9)
Net amount recognized on the consolidated balance sheet (55.6) (64.8)
Amounts recognized in accumulated other comprehensive income consist of:    
Net actuarial loss (104.1) (115.1)
Prior service credit 5.5 6.9
Net amount recognized in accumulated other comprehensive income (98.6) (108.2)
Postretirement Benefits    
Amounts recognized on the consolidated balance sheet:    
Non-current assets 0.0 0.0
Current liabilities (4.6) (4.8)
Non-current liabilities (47.6) (47.2)
Net amount recognized on the consolidated balance sheet (52.2) (52.0)
Amounts recognized in accumulated other comprehensive income consist of:    
Net actuarial loss (5.1) (2.9)
Prior service credit 14.9 18.8
Net amount recognized in accumulated other comprehensive income $ 9.8 $ 15.9

,DPVW@<8]B,=U\`X%[#=U,?G(!F5M9URS&C)*,'21_6M..RM M6-02`7(^`S,$R;_M48/D42MLFKA*F\S\S1Y6%BP5".K5;>D_'69!P54,RL(XEA]H?XBUC2(@=A5H`R3I+XKYP)N*2B)EMM=M75 M?6^SL98<)+*^Q8H=&N^\@3>$NB$0,]\%5,F<"Y('T!R4.8B,G)VJ%#Q,7>^] MZDBR\>"DADW?M*9AMS=W2Y&:3OJO:#AXP...TK(RBA!&2R&B%0$C5+]DXCRCC=T5!E%) M!UZ60W"I.LV89IY9BZWLK52?(B?LR_U M@,&YFWMM&Z])'ZQ2R,#^<]WXFA^O6E?JLUQP*_F\@4!?P)>4[!?QR#[Y<[Z6 ML?KHV.$,_H0YQVEY&$#B"RG>)'^L37XYJ&PQ:)JJU]M8W;M#.:D:RX]7H_%W M+R8!YM,1XQO;!]YWFO>=]]"?]EKJ"JP]4VI@79C)>'6 M.`A5!.+JTA)GV.R35B.M=C#_O)M.A:7VM](4?140T,GUA2#OA6:=%0/@JT%S M:`R!.Y*&5"6YVKNXVO%&L#%7T71)\K.^N+%*T[HXZB^6YA[AR9^(V(6[^>UA MKSDH1ASO0W&JDC[YP"ZV!-O0X/7';+V+^D;O.@$B7#NNZ$QW.S]X,@PBO6?U MBQ^RGY.M+M!&[W&GZY^X0578O`O=)%>YS#P(GM1FV5S7TZ&1C%O6*C48_\#\ MD`?N(@4:R[*[0%@"O@9`9+Y<\">U"Y04R,WY'[ZJK<:BU6WI%=D4:I5#]\V9 MHW&>V4><"(M',MD&='"?U0_":]S7QR)G6(_\?F1:M"KU%,#+GJG2)<]>IK8X M'IMP#^NK=6H($F&9"PUS68B@P>;`VT])C74ZT65:2+8*W0G5?B_N_\9IY"I- MTE?_-G2.`P9W?.0[=T=E_N3Q*G&8@!+X\G$E,MW*%1.K+[6O#7L7% MN:\W94D'`C._U6ZINM&1F7OQ_4B1E!?2V];X^J"]Z<&@V36[-XT$./9)N]=W MC9LCP\,WD@&\ZP3V,9I+OQK[;+8=,ID&0F61UB>DH&JHQ.B0)R5TF#H*:[@Q MO2R7,.:_G#"6E5U_E2`0IU@W#&I&793O'(`8=;3Z44"62J!B\I\";6,YHCWK M7#.ILKE\J>7K8UIT0,'WWU0YB0X"F`43KFELML42;`1AC*2501Z:4:G?7G^'9?:9TSA?%J= M9'8D$IMQS1)>2CMGZ;K$=8N;1VZ$?3K-4=],4IP15,7Y]2U#!">2PMZ@ ME+(.IH_V$\I]D&0@G523`1W_X@N,B\)4P'G4FBN^6V#$:QJW_@+:^/:;DP=[ M*7?]QZOVX,CD]7ZWELGKY[N/YE>.<99[?OME?)RM?7QQ61QXVY&M]M.A#\N= M?84M&T1@AG;JT]K^9)%Y,&7@/9,4).X[!??M6?!4/7%8:I;LGH$E7Z#LN9GT M-O&/=G533CJZE[-&2%03+HK@/)6T1)@@3!`F2%<0+@@7]=<5!SD;!1:FEBBH(HMEQKZJ`[E9!([NR7Q( MT'-K'Z,C&H^^%,(\<_<,+:1'G7;'F)2N"\#*AZ72:>NZ=KLD5!`J"!6KMW6; M;4(#H8'00&B@K>5]F:7?^BZNEX8'P0)N@A`I"!:&"MG],,X6LU]LM0)#@0'@L-EP8%V?K9QBSIH+WM&GM[_*<[QJ(V;3SX^!=!*I:=J M@RSJ&$C((F21SB)D$;*J@JP>U?T4ZXW5R>E2QQMGRWZB^TB&M-<3NZ14]T,! M/0KHI;>-A@.J^R$\$!Y(/Q`>"`\;\#`TURJG+GB@'9^MYH1*-UO;\8DK?O9A MI(OS\GL4/J/P69DT55V`U:=>;P0L`E8!L0/:2B5@$;`*V4JE#9]"G;$Z^5R] MU0V?I,];(>Y6Q:`TH'@>Q?,HGK=TAKKCYC['@Q$>"`]UQ@/I!\(#X2&C'P9= MJO`QXF*4R*,O,MELT,DY'[]:H3\1`>WVO%1E3&;?AWSBBDW7GVQ@&:*YCB>N9T)! ML=UI?9?CO1$P6NFH6H+!ZX]X^1LGA,=;^IM'/9*)[]KZT;>^9PDO#'CH^![S MI^Q6.Y_87+SWCL<]R^$N5\MN!/^&!F"Y<_P>@_QI\="5\MA%IA%BU@-CC`:;HR M$F2-"G,HEM,4?H0!S8"3I-13]Z58OO^OS%,K`O<*(+T_A^^:K)H,BJPQ!0[P M'S'NHZ0NDS-0)\P38;QN/(1I3R+](Q#:!EY37_A!S,LQ-\`23F%!URBQY\!B M[=92_]'3MX'0&@9O4`(F9;;?'?LJ]1QDPKD/S+3&Y:$/DFM)B3VT;KTD?K!?3$JX;7_/C5>M*?0;CP4H^;R#D%V<. M+/&+>&2?_#E?,RT?'3N*,9 MMT-$5XWEQZM!_[L7+:2\&1;?"/QUX(VGOH\&2AE%J[<=Z>JF0Q^]Y+%IF,=4 M:2^^,>F[CLT2^5VPXX8&D@C,T&ZS@?K>D3!I]B^@Y0&>3#49\/S.X%Y!@P)8 M<)VR\5N4+EU[1:DXMM-J[Y,Z6#*NK'#PBOAPE0^-]40D/B0^/((/=RYFW4]U MSX$U7%&FT/^J3L^-H-U9\1NOU3?F#,_;*."?KL9U$:$UEY1/8"6P$EBK`5:36_,$ MVR+,Z4NSFG^V_E=(Z7OLU@\6\3Z7*=8\.OQZ/J"VCV]DM4*$O6!8,:11`.5B M@=(QYBP24`@H-09*>TQ`*=AV*Y$?=N90*`_@;=QE_ZVRVDH<#RT+.(_?*RK$ M':L8:BE04H5`24DPM]>9XH0YPAQA[GC,D9ZCR.*)C-";.?PB_2BPQ%L1W`L* M,>9O(W^0`B<4.#FE;T9`(:#4&2@4BC_,AMM>\5V).DJ\[Z15VF>J"MU4]WNY M]:'@?,EM-%&7"L_&NP2W9FP!+_#M-\45"F_C`"HB_?%J<&01Z7!8[I)'JLW, MJL+VFL'4WE,Y;GC@LYY\*?1)JI%IDX>2=.'CS+R3N[\E7OE&N.AXM,T#1&,,2UL=3AYV6&]IH+%!IEW",Y M(7V+ELFTL7GN$%VL;K' M@Y1Q#9%7/I!52ZW6'7#'1R$(<.3C5CA?O6J`W;GOS&G]V!HBN4*@K99./5L. M[KFQ:ZS\^'QYNA7!;D4E8&Y3G281D7G.=8F8%>O.]UD*JBPS+4 M)SHL@[)]7Z;LN9F2SL.H\SD$96,U.O*"6*W:IUJ4;\>LP,B[!5[YSK9*:??* M+O`HBG+P#^U/GSO*7D?,E?1`"8(<0:ZND"O]L1`5`U_EPSK'6Y8BA(L\?S$3 MWG(3Z-7-QP^O37%8A?%VOMJ!\K`(96+4)!.#6A023@@G9\6)N53[2P`*!02W M]GH0X>S)19O-L7DHV+M/Y#5MIU8)^S24AY4H4'%N?59'R+5;A#G"'&&NDD[8 M14-NI_3V@YC8/7&V^7(0X\.(-S[;T`M-E/_9=Y\F\.AH?CT>LU=7/_OP[]5K MYDC&V5?QQ`+^R.9@5@<.=YGCK>20_^Z&`;_^(JR9)[[ZC^SNRSL6JD^A$\W9 MO?!$P#-MA0.!:1XVFSPQ)Y3LETB1D7V8\WL@`9/B?@[3;+(O,&*A+O<]]^GH MI'LU545R(T]B,EHL7$?`M%16/1`K1Z9'/W#M1\<6:B()N=B,`U'O`R%PCIA_ MS_Q)R(&FBNAL&OAS,S,-9_`2,S/UXA4*A(1_K!G\P2VUH-RSX0-00;)%(&Q_ M[GC<"V&QHH7O&9K'HV]F%KKV08KEZ+&4`SE0DUZMYU.3W5B6CTT5[MVG!O"_ M[<@@6F!A1L+YEC^?B\#"1=;W8'D%9Q+`ZDQ!><#8',^"M\"[TEMDF+))RB)J ML?68=!6IA`LC0,:,/P#C+R_D-N@EN`I4CK#@0:L(G"+9U8`LW[,='&P#5RMR M0\6=_D+HVA*]8A:7,X:FB7RA543\]]^^C^3U/>>+-^^Y$_R3NY&XMWM[.^SVAL/.H'-[^_9V/.H/NU=_7Y'$6?9YH?!C MDWZF,AB#93"](\M@1N,3%WNY"FZA[*2S8>EHH#IO&*O1(JUV@5GL7QS.F#,,!PK,PU!B"MSKCWGTQ MR#MO*;=Q73AH'M]]?4_2D*HD5WL75[NO7&UCO8_S[-D%]K3]"$-;AT+W65_\ M;(<'E-51?XGZQWCRYSL)PRRUV\->\_@$^8WB>!^*&R-G1!Y-U**4-Y8?T8.O/E&?N1!^.OT M;20=3TAYZ\\GCJ??@F_?9S=D^/ZF/;X=W8W>]4;O6KW.^\'X5N^&O&UUQ_UW M9]\-*71;>TEAQA6)&8]IC*2#10V3?FAI;[@W;,?,FF,F_>+^#NT1K1E@J:`Z M^DC8;BWWB`S>22V3"48`Y4 MLAE&HN[C*V&4<-5B$?C(%*^(=K'QP;6^Q[ M3,C0P;3F-/*R-A@]@@F7\&)XUIP'7^'S@B-HG`4F5^/&O!7&^ M\*@2J>/:`Q%//7/E(]86V(Y,VOJKI&Y/1FK_\=$)9^I9KG@0+KXC<.17?+)O M.1PO5U<(($'\NCB3'*;Z!XQ-Y'*LXW?OM+Q1Z+C`&K9./%>#TUNB,(8U6!S" M:>UAT]"A`C"OM\DJY=/1%U@2@*4`P5.ZX`UUC?AF":D6;1$%U@PSY!>!8\'T M0"JJ8PB6]/#L-?)D(G@ZNUW@->S>]^U'QW43=@S$`DL55'U%S!!S>(:--1E? MIWY@P6BF41@%(FGPH]YFBP<.30PZB M%#@QD@GW`B(]R2WD35WWD8P-,>+Y(3P=WZ>FA.4'OS<_-Q-4X=.`+`M?*JS> MP$VKL\9B&+C:C>R8!]>*<3X#-ASNAD_L+0S%EFDY36'A3(I64K22HI7E];QW MC59^^,H#AU.LDF*5U7.>*%9)L4J*55*LLOJQRE&'8I44JRRYNJ58Y3&QRHOS M0'2(,^"VP&C>(1Y&S4K83.Y'78JT)J%<-OH4*5X[G1.(UQ(9`,7)W0_>]2+P M5=@][=\31[N3,#>[!A\GD$OG%]ZZ3V!AF!]3+5*\8RYDNWRO*4RQMZ&M7`E8^!#8>%J9$-Y71 M42B,I!?19V>56-=,.Y73D\2H-F0>Z<0[S+O[X/ES_JVY8S)=DFJV0SI=\Z4D M-1["NP+'CV0^.TP6FKZV:2>LD:&5SM1ZV_B_NZO7.:\S0SBY M3(-;F::Q++A>LV\F"ZY1O@$AWRBFEG%%R60^CCS&\FFW.%O/7 M,X@USG#_I[X0]O4-D`BM74HDK4HB:1']YZGGG;GF]'5I:==O='O=YO&']%)" M:K7$8;5T>8$=6(UNF^UO`1AN4#FBI-42)*T>H;Q?J'!\RX(*Z(U.>V10<;Q` MOTO1'Z0FR'TX7]4#62]TFE$5=W;H-*-=MGX&K7:S78S"IO.,R$\L6-(2X796 M^'6MZ7BN>_(-N'8\T#G$^5H&:U/4\-F*D+>._T]AP5,:[(-G-1N,L\>9[[I/ MU_XC5GS(:"(=V\%T;7_*DK2XN#'P+J43F7%C.K)*:L[^#D]-O55\NWSRX$]` M`UO`).?<$I&"QC*S_+*+5S8NL3RDJ.6RJU9:Y@I$2C8@@U4T@R*K:';AT7QM M#9725*V4YGPU,GCSG/_A!S$S&*R78>PFJT;M#7ITK\?_`UO].Q85Y%!!#A7D M4$%.^2*_)2C(N07K%I3M(?M9U..=ZG7.&\>A'N]4FG.II3F7N$=SQ!9,A799 MVHUNZQ0=WVF?A/0KU="8Z/!ZJ6=4[G&*86:[XM>I$\S%@PZI*7907^O@UXP_ M"#81`IL_78/;(CR,T4T#?\[>!HX,???ZYR<12/;YS\B93)*X#WMU]?;GSU>O M=]W%V/D\RUWV,+BAJ'#76*1:'7!Y[*/674C]<"-#?.\'#.Q7I/<4PT,Z1*MC M>;"2+%YZQN\#(71T.!!3$2"G7/T4_WB3_'@%+`.K$V^?49C6>"NC]46OA(`Z M>>BT7K.A0#`%@BD0?"&!X%\^H\8)^$(EAAQ4$D<188H(ERB'VDP)39Y^U.&) MPLAU"B-3'0!U>%J];=@UF.-/*?S5D(454_14ZGW2WB!UTLW4P6D_>K6H@Q/Y M:52"?62''&K@=+)&'47(]9.=5EH!A=`>-0?&+&`ZT;0RH*Z6CB$7@4X]+2-; M%M+F@Z)XAQ'Y_#0M7%N/V\UQ,=J:CDXE$4CT.4&;C>3OOWT?R>M[SA=OWCN> M$XJ?G`=AWWCV!\\6T^4W']*$-EU/>Q,G@-W(CSP(?YV^Q6Q'<*!N_?G$\=3& MWQ<Z*.39\P:WP^J;=;=\-!X.W[V_?#5KCF_;;NUYGT+F]?7OS[NW[=W=7?U]9 MFRR=7TCCV;2TQI*:]EQ[_?'EO`I-/O8OD#7/\D=IL\Z^+#,$,><1K$BIFFOH MW,A,?3]G5_W.=;_+'H7X>J7B'4QX./`DL=/E,F3O`\?FJG3\LUB$8CX109/% M5%JCT)X#C@W]6-\HLMC"\@/%XV]0TL=])X%QCWV7>M#Q32KV&'+/R)!5M,1, M$B^,:;U[YT%C4KU;0+A(1^*F.3!'OZ/X2#;9[YZKTGF!@X)'1V(.JPU*!:YK ML"GQS4GYYH2C-L19:=9X/M,Y9AP5E$4I)4XWMU3L+2V'3K_!*LA;FV8R4#.I M(,MMFLQ03<8,)ZZVZHE5'CQ_P%2*?RS^E/#32E27"J@?@451BZ:#9-V6&MO@ M^:8FFRS'I3F7M_/\`$P.[U9UZ+&>OBQ+$228F.ICW!CK(WAU<$%B+>Y@%+;? MWHQ:[<[@]FVK_>YVV+KI=MK:*'Q[=SL0EG/$S+6["+O;BC'6;G![*1UK(`#%Q' M]Z)2I31!7#2C&P8Y'@CZ[(UQ85=&VE\CDL0W"UYQ+W0WMB;[)!Z$%\6E.>+; M`JN+UAZ.$\!"GSAO,O\,G)*83@'>S(Z"I)@L:60T!\K%I618?A1?J(M^Y/(E MF(')[3\B&DR8U_AR(&4P8Q%)<2@2R"58UMWS^0J#`A&G!4&;` M>R[6^$WUF%6C+._!"7Q/OQCN?L1.7FK0FY;9P89_0`35[$L5]RGWP+F7 MRY$I.WO^R?OJFD-52DXQ_2.N@5.!CGQDXPYH"G.,`K&/-GIWT^L/N]V;?F\T MZKT;#M\/QAVMC6[[[WIORQNBH+HKM5%_5-U5[]#RJ4&!94FP(@:BHOO6)A1I M!*V9/.WV"Y;J#O'C"R!3(NR4^%Z*N[@S8F$1YM+:EZKZ7NE)F5I!/`B>4)EQ M55N%"C(MDYX\)27+L08'3Q\$#:SUFR+LZWCK?E7VUD9^SWEPCWT8<)`\"OWD M"PTD]4T!(KY];&UM_U`A7_O:V@/O&U5DG+1^YYP?Y0L=MEF>#G=XAOKIW3,V MGC>-BB^EWB=N3ID)E6/&_7*NGC&I2E-JO0S6;]T5HY:!+Y]W M(,\ULMO8H2OEX*B!!V'T=,R6V9_Y,%]P;)1(S$?,1PJ"%`1AE#!ZI(*@JN)M M13*KC4^/AG.M>C49\Y,-5WE5LE>366)V&[U>I[ES8(':-15"'=+:YJV:<[+B M^470@]T."R)5HV&K8DF@-S1T?61=TU?[7"2]DEW/"L0Z@S'R9.98P'_TFYT>L-F MG\&5[J:3C0YY:(/Q,`R<2:1[G8>^H;$.QYUFS^A(EP?:?/C*`XWA.?.[?;Y&0 MH>4'N2DMHL":`>.S1>!8@G$7SQ_"7YX_J**TXN/DPM#0X/5'O/SY0]/2HS&6 MC:_8CS1"/H!^BC?O&WR'-"J<\$`\@L?+P? MSQ+#!ZG3U9SE>B2O#H2%CI$^#^LIIX^F\!QUW&O^#=E3Y-B!HAVYJH1VC0*HP#/!9$SAJX84,4&_:D.!]&'L^&P]'EG M4VZ%?J#.$K%%*(*YXZ4Z%R:A]:>:WZ8QZM/D\&)](A;CBT7@PX7Z;+?E(7CP M[1\B/E`+GK4V0GTZ"3S(2X>*"GAYE/+_W=S>IB/$.:)D"X0K'CC,:LZ#KR)4 MA[T[! M2^AU1`/-5W-#_**AQN_O$0KA)N:-3P9$UE"_.G+]_-N$@_A"R=Q_ZW/G'AT@ M/U='J`6^"PLOYDXT/UX?EE"ZKH`4Y`&2?LU*7F&6^&`\YOHX!5AHN$`=':E% M3.:41"T>0@:(%:Y49R8F)UO"@H`,0N\V_K41\[N#8TH@"0S@PUB0^]2R)"^* ML355U@P\+VBP#YX_Y]_4$'Z=HB1^T+R6G2!WI8^'(;MX""+RPL(/4?C#(%!^ M6V&&LV-QA:<'QJ9(:KQ0K6@4M2'W>(=\@,EYF"R22T.1"/L)#$R>^_U4_ILD^S_S(W:S" M5Y\%;W>1O'@,:>`($,K)DL>>',?S&U';PM!AR+#(=@3+A^<+/ZCCT>']2_[, M\L!4']:J3%Y]$[/]1T^I"_@IU2J>[>@;;,?"XT3C5=4R`F88,W->R39VFIVE MZ#!1IUG^H5C1S]H/,,68^;10E1W*6W,W'#\:D$*BAK4(H*WI6/.UEB`#5 MB@@5=YP(]^URX/[E)7E!`M2&CS]X270*3S1IY.QV-/L#C%8MHT]+;(.S'=RK MTVA3%>)'`0JE.3#E/UQ_`L_\6=B*)Q.?987,KV)%F9Q/JU[^\]WGU+?1!TT[ M>`SUX_(R5*!.;&JCPQ,M;5G?DQFO9$Z:-2JLXQA`LL#%[G+047E5A5)N=-R-EF.F?IY M9N*>YZ-/8L=K&H)#;#/58CLYZIN#BS2%%0OQ\&H.%K'2BS@&*9#,@,,<=Z@7 M@!'DQV=3IUR#3HJ-=ZL)@'J:"3=VH;@K4@99'K.M)4=LP@.[I4_"XY-CAP)I MA4=P;V:[-1YR03)I3]]0H*W5,ATCA-EJ[W>-RX%J6]!5T6C:E_78>GS>*#)# M]B!U^!I8>FD=.'=FMY-F/=SYZD^55[?A7I=E>Z;)^S'M=8W1,9Z0A1XLD2\R0=%WI: M1BW'25/U.OUVK^/D2C?Z?8^<*]T$Z%@Z$A;5$1:9<^VJC+@T#D2X(]Q5@6=) M29];9)"2)F%1$6%QJ4J:6MMN*SE*J#EQQ?IVE`F4GI"(51!OI2%6??4"<1QQ M''$<<1QQW&5P7$7V3HJSX3`#S14J=4]8,P\8XO[I:+B:.A*GU`7WQAI&G)0J MA;=\&#=&XP$=&T31F_,?P$VRI.*R9#CH-T%(4<7W]11TR-^LUVX9'DNN"Q M0M`KG77RYFXC M"4,4@>YX@QU.9LZB$-^NAE#KC,PINKH@JGS@J:#:.H)69W2[>N;.!R(T$!I* MJ4`,']#:I7P`@@Q!9@_(M&BORH@34Z*X0H''MP?<%M@(FG:KCHTJ="BF1S&] M4NBVFFU6#9H=`A8!JP3`ND"UUNZ:2Z(D]!'Z"'W[!0S)IBS4R:N3+_U<.`-FD-CP'N!>G7!7_F@5D$=5V"[JK-Z<(0F0M/Y+,8JZ"_#Y6^$ M.$(<(>Z$B.L;C)-<".+JMBV7YZZ.4?;ZXH?^74,/KN:2/U9ICME]\[[KH@W$*H%=U]1#MQQ'_$/\0_Q#_G)L^Q#^F#:,2 M>:4E*SI]UBLRZG)>HE=YA--8);_09)).W>LI*B2JRB7XZ6RV@BPNXCA2CZ0> M23V2>JRXL"+U>#*'LDY^XP?O>A'XEI"2!4(";JT9XY[-;/$@7'\Q%T#"`YCP M`GN$==L&FZI-%,'+F+T2@CV1DCURR-4H<,K"_]/NM9I?!=2X\V,@C&T>/+)8)L691 M"V,+R]>3?X.\$`^^W>\U1T8'KS983S;^SK`Y-CM\X)BI(T'@GFP2G5:[7S&^ M@2&O'TQ8>FZ!4:^?XWL8H0,A%\(*01JY3TWV92:8D*$SYR%()WY_'XA[^'.S M6((_5^679/ZC!W=.GE@(C[KUYZ!ZGQIPB^5&*'/93+@VF_H!DQQN6KN_P1RI M7F#A`$*?3?`7N,$%)2V?KS`L0E]ML/R50=)*GA&K"?R6@LAL)J0G7VVA$[;`5H<;RX]5H_-V+MFS>>HQO;!]X MWVG>5Y&DI%4+-T&%:;NFCCM\Y:%5W7;[S$5$WFL;!U2BL;X'E#1><&"D'DGC M@W'78*_QNF>-5T1=GD)0[<,T+^>-'2&TRGX4S;AMKCWC1>-HHW2Q:FL)['-P M^LX`NZ33UP9&&Z.2:KL8U;8/TURT:AL9[--VT3BZ+">WLT^9*JFV+K]'>Y$_=;[UY>[*^;8\`6W MPNONS6`X'/7ZK=MW-[W.W6@T'@\Z@\[M[=NW=Z/>N_;5WU?698^H^Z9E/=>> MN?Z(E[]Q0GB\I;]YU".9^*ZM'YT05^U&$6%U-9\# MRN$Y7$J8A-Z;BK>\D'ZNPR>.ZX2.4)=$<[6YSSB;1!)H`V^U_/G$\=0.FMYG MBS?'6"@D/.0^&3/NC3GPBQ-@52^SHP"WS7`(4S\*PAG[,^)!"*."`0MNS9)- MWB=`>(/!S7,_@&L#\6<$][M/S)EFGP0XNDJ\G"F/)70B+I"[($R[9J)0;;L*GK3U]!I+Z?H:; MCB+P.#(^=Y^DT"N(MZK5:;`HA*7\-][(<8L39B/2:;-7G+E8=8V/$X+-!4?Y M%9/.FGD.T/TUFW!%.4]SFF;"Y>BF40CW`%$D+!]N;#;9AVUTXBOS4%PL;*FF MN)QT([OARA0G+40`S#17/T@!`M+6"Q43/^6XU<6'58AGE>%\1=3EA2"U<:\6 M,1-O&^_S!LT?\<+!CZX#Q,HOX.JT_YJ!".;#J.GGJ96R\H;'+8>. MIR&JJ,-AA4&L>PKL/%R9]_U2GEC^O0?"YAEPY]_0T(/-K@UW06'Q,$7UL]-6 M8@;>'%-TB\11O\*P\8X&YU+7+5U\+$9M]E$B(P(?$9^W2#\%:&._KQI4LYS[)$L2;.:&NK#6M[$RU0'>2T4!P8VYF:$.?`_SIQ-Z12Y MQ_I*QX>"URQR4W-MR*%!9)6(1 M*HUI11+L<7A.(%R=&#=S%A+)@ITR`I$95_JZY4L6/$25@,^?P*BGP+73P)_' MJB?W2$I!J60*2O_`E)#>B>\;%I^"+.`X MGNX1K.TC+)G9D?'^DMY3P`T##)MC-:=,MB$V5HMF1K&^3:%VKS"%(W`F42B2 MC>!XR^RODNEMH2?\00K7;3"T-K%>'IM@.S*Y;Q'X=F2%:O,H.TR\!Q:ED6Q* MJ/NX/7<\O)=C^6LR4-E<+^.MQ-K_WPPW[QB0XOY>J*0!\8`[KKYE10&N#4Q1 M;W(#G?P0$QQX;FL6-Z:?:TX@L:Q7;_C'&_QJBP_(;^'&'MRQW-#&.WS+42N> M[H"JIZ@#=OD\-JWP>"AWK[5N_I;AE8 M8V5O=R,EX'GQ#K@J95[.=F-V0KH?M=/$$FK`0S9M7Z\_?749=GP/UE%G=M$V M9S.D!,V\%FYT<>LQI>3FW(T#AY6A?F8W?27I!&)^#*%3,G6P^3D7Z0!PUZ.=$(+T, MFD?`I<`]1P5'B62RG,"*YA*NM'"C6Z?DB&7JP88L$"^>UYP_,<\/L2X^'8DK M5J?C>9':>=6Y17JY;/'"0%<680_&?YG1GN%[15F]"2W5GR"_-)B1$/.$@5(??)/ASWVJ-WO9N[N^YMY[8SZ/1'K9LX^W!X M<]ONE#;[D+:?5?[T4=O/A^X&CP<%;@?#BAAP*?:MV2TRZ74MQ;4]>D$F[.!\ M70"9EA+-J#M6":OY@X?^P\)7>@L5;=S&)DASL(3,YU;.N&0S[I[#;EC*%5\``*UH\D"QSY=2T)+IO, M%WE?/?\1ALOG_#YUD5(5[#TX@>^AV@2[23_,\1Y\]R&;YN@JU0VFLHLZ&S1V M(WW;D_;,'E"7ZYX_2BW/A8U6_,KS4=\!;9/$M!"[D(4BIB3\+ITPGC,(Z&@* M"E"G,<-?Z[#:O-B4P[1>37IP[8(X\>Z!.RY"L9':D6`8P6N5989# M\-U(W:-26=&&G'%P>SG#WP,<-[>!(<%5%V!M6Z'J[X1F(2RS9SEZU6U'ITCK M&:F,O$PO.C6995)S-?WH#ZK3GB>LF%BQ\YJ`!__^O!!($."JVYF8HQA89FR^ MPL41`:R(ABLPP,\!$_S)5&RJZQRYZKMVOWM/9P M2^SQ$&Y)$T45@R01,(F^3\PL24AM.Q$U';R,CZ9HHJF_#%7@PY;2.DOY98:X M?'ZYLC$Q/:Y<&KFW$G4#'*C6ODH^3KB+`HK)F5"9Q>')%NRS6(1B/A'!,@S9 MZ3>8L7:#)^W=MVDR`S490XT(S34$;?>;PPJWU&P/F@/#[4RSW1(;"#F=8&Z( MW-UFJ\KD[AKN8+I*[HRAMJN*T2(T%[-Z\=;$OGM22%K&@?,57:EA&;M36$6P M6N:E(E<^VH8K'2U!#*/=IHL(;3M`N^'%<5DN=^:HXFT5W(Z+&-+1QMHB;=FY MJ8CN.=5@.[8R"G6LE6&)CKI0&9>)DH-'+M^P&L8CA5!*A=!D-_*4YE71BZ-M MY3G_YLRC>5)*N>!/\[3.-[&C+3]R;1TICZN@L+01[.\E?EX`A3E=.FP;%NYY M/Q$'FITET,/0P+LMTUK)\5#L@9\@KV MXVIKVW&S9W;X>MLKZQLDL;!X#X:<@15*)2M*\4S.6LZ%`=UU>K\'OS;#JH%!6:( MP0A@0!/@*MS]P,XT,%4SNKP_;'8,&U=F;.83&L3+Q;'3<'`#J=$V;*E7-T`-U<;,('!7R[^=73?<+T:=NQ`N662\`Y7*Y M5J6%CC"LYMNA`/D,]ES(?O(C)RL[%B!3-`O`7Y8XWMC1J]QI-]MF#5*U4XFI MG5::P@?"S!9JXT_/$M,=(PE400&EQ'?^^FP::'R*TB(0"^[8:;IG9MND=J^-5]K/6,!H3\!P4Z2S!.`59M6\92.!:D&\W9O-N55?)#6I3!7\Z.0R M7Z_0+:H)1ZA-8K5UMGQ.K$*T[0:NH)37V;U50`JHE(7:8H>KTI8QBFLS&@%_YM0PN^';+9VJ-W[?&[T?M>YZ[] MMM=[^W[X=JRSV6YO;X>W(\IFHVRVM?LHF^VX-*TA);/M0"4MV1B(M@M-9_N9 M/V4,3.ST];!%[:4:%HPA846J"L:?3AU,2G\4JC68:E6'"?JX`?0!=^"TCZA] MXO]MQB$2'2!(NI?I)*?$?EJ^#W-,X$I,^;)$[BFY#)F%:\6*4EEO?K#`P)E^ M>#P$[8_JY]T[.L_U2 M$/3\7IE,><\Z>:V,-PKAL7_$*3XPV;B_H)?Z=TB`/V`0TG;BAFZ/?N#:(&^% M\F"SF6=QS8:XCZTOS'5<-H<+05'!B[#F`LPRF('*"/CK$Z8J*7;-F5VZA:!<+M7J,U0? M0[C@#H8D0<*M_!@'5C[H3I_X'4PL=TFF-2Q,`\WW*)3+:,^&5U;5E$?^2LF$ ME,E3!3'B>[HR99HLLH+[YO-F)V**#6;C"T,4LUI8+(]I-.+^X7TR6CRCR-;( MO'S,E:W;LP*@#X#F,UO:Q5NO@T!:`Y3Z%\GSWT?PN^!11 MDPJJV)-#8P&T/&V"J1@>2S9G"Z#E\RZ0R:XXFUV@C3L+E6DZ0:Q6+59;SU0@ M5B-6*X35=NZ71JWZMC7>23W!RAI/EX.`9S\E61&P`#KID[?, M$>I5NS4\P4E;ZT`[$_T,\]GKDU'N@O4M23:2;(=(MO[X!,?CDF0CR4:2C23; M"25;M]<<%DZK$S!,J0Y.+7-ZX*2 M\@&B=(J\KG@8F(L-$!H(#15'0Z=-<*`@_L[G[6"!EC$[/;>5U`6+W/8CS`LZ M9B^)O,5=*%MW=[+3[INS>0^GYD4XG!42C*6S*D@^DGP\TT9"U^!&PM'DI)T& M$IXD/$EX5D)X]OL&]RK(MMS1$Z_XZ6LY<=,;Y4JMCM?FKY>%5H&88D&=U+5D MN6[??=W[7K44F@H[/8],->3/7]J+&Q`DG[L%%J$529J3KW.A%76?E[U1-Y?/ MZ:JXW+E[FTKI.%7-&5CJ;62@JCFJFBO??30_JIHKP?89U9=0U1RQ&E7-$:O5 MG]6H:NYH__56=X9\WHDYE"E/2,`JH+DTQ*JO&"2.(XXCCCL7X0PXKZUJJ],D M2GY$9'%D).+9CR.>*XNX+?!Y0A.]'`ME;+>RN!F;WE9L494&N:#G+[GJ!9$B&+D'5YR.J0SBK6ALTQ1+L>N]B9+&5]!I_< M=&2C"9@54ORS<\'%R>U'8SD]+Y>C7$+5"46="(J'58:-FB."(D&1H'AV*`[: MI!5+8,:6R&LL,*M$3`48N#9E:9Y[OZM$[%8ZPA''$<<1QY6?<)2E25F:E*11 MUB2-5RUS+OXZ_BJS\L8:7)&:).%0'^'0&YMK#472@:0#28Z*N)\,34"5\7FT%:IU08L#'/[7A6H#\^Q:S.H-=J!;/! MR%RY$:&,4$8HVZC,#!Y<=/$HJWI.9^DP>88$;#J3B,XD^N'5N$/GN95`H)+L M)-E)LK-BLK/=,EC-3K*39"?)SG*S),E.8QLZ)K,7Z"S,'7UU.@N3SL++P)GS`.Y'C@V!(LC/KQ6_FIE*N]?L&I^+ M`IT5"-L)99/A0J[/+KHU1Z=9)F[]&3EZ'QL/9/TC\BPU MK4L=<5#")D[>L4M4/V+WPD/3PI1T%>'E& M)C7K(%E[2W5Z5J':Z;0+$$5G$JNCYJ"N4A43FLLB5V\Y(,02!0K6XR$>NSOM MX8K;?1;8WP(_<.^)S3CB6(';LQP0!(CU&;I57&'BEGO;![(VP5)$%M,N;:G@%/$-X4K#)DR$N[#?;9GG0'/9;IL48 ML*+BZ%AF/X%Y+[5-C(-&$=X`TLL%2&?G0;A/%59+@0"<6P!7C=:)"!^%\)8: M:JF94#R$BBSHT46A'P#_H6N7X#]F];_*C`Y#2N8>X2O!`OB/4`3$PL#W),I. M@,C4=UW_4=(1\W3$_"[WT1'LY1AGN>='1\S38O9#]P3'H%Q$<@/E?A64^T6RBV37YD29?M?@8164U$J"C00;";82"+;V^`0- MM2["**M()+HXS&6DUH:_;NP_(AG.A1=*3!=(]B8%?MB4(E/(\2"G">O47S74 M3'42_Q#_$/^4Z82.,L62S6E(E728U$RLJ[R&2J(K3WQX<&A\^.(Z]6E4C#KM M3O$QO+K8R^3K&U`XEP*P5X,3[!T<%'XKA^]%$39"G7G4=I_[^6$>$,W<^D"V(JBC>VJVM3J-I7T*62HK.*%\+BK;&2,;Y[-BC:X]4^9 MHFOQI@YYV!1OHGB3E@_#,Y^Y7C/#DZ!26ZCTS!48U45Q5#XT6YQ$^>`]"!V1 MQ5-5%CP(/1'(F;,@3XVR+RG[LF*JJBX`Z[0H%D+((F21ZBH#P"XOV'BK#W%L ML$6`Q^\MN.OBX7D2"&C-5$31#Q8S[C$[B.Y+%$7L411Q)6XRH@1/BIM0W&07 MJ+3,I9H05`@J=8;*P%RU^25`A>*/V^./\P5W`I41JJISXK+TB2O(BR,OCL(D M%5-D=0%8KWV"O&-"%B'KXI!%JHL"D"]SR4<1S+D'5J'[E+<*5?`1O@GY-XX? MG5#,RY3'V*<(9/ZV]H!*!2ET0J&3!`X&SSPD.!`&*&.4+>[>6@N=E![=5:5(&%Q,NAC M/L0?%W4T>^[$K#B1\"_&G?, M%:SN3+2][(8*L!WEHIFS'4BND5PS/<2 MS4[`0*5R1[\/,55CX_69O]5%S!*N&_/0CU>M*_49*&`EG^-99-EN!#R6G=47 M9RXD^T4\LD_^G'L_L&W3V^0F/SIV.'O3&^TB%O,\L?O%^WGJ,,5]>.*9)!7D M]KS`Z^$TCS('CE=EF%ESU`2+$Z-?9@+NX&$4^L&3:IT6X/F\@9BZPL(6QO#[ M[\W_;6ZZR)\:R4J""9IXC(J(3!T)9&>=5KO?4'E4>OR?FVPJ0"#!3\7-H]LO M8AX]-0WXH]L\6BZ1_*F@_.G46OY\\"PWLH46-,X%ADRS+]SRACTY]=,*9`N=GL>"!0A8AZ2*1U*LUDN[T MF<%+PZO;6!J/GY*^(+IK"'/%O2-=K8X>N60P*H$9_`T-%X[`"GS`G_,@F)A. MA?[+CJW-_^%>Q,$";3?P19TFNY%,1M:LD7W]$LI\L0C\;\X<[G:?C)BJ?^DT MNPPNQ1!(`'?SY1'EGJ=ZD0I>V` MW@Z$"GI,1/@HP$_;.?#!WF\RD%Z>6V\Y-<:E]"U'*5,ULER`TOHS:(;=$;JB.4F)S/TAE/WQT?=!`RUVQ/$L@R[A"RLSU2+@9"++L34JI9.^, MXXX/RJ5?WLO=-26%G!M/+G[XLP-:)X"MXP8;)S_Q06?!BM:2".",!\`]C(=A MX$PB;5CK-P6"2YBG#YZOCO[&;\=3$!S5\M:?3J4(,0#,@12A\V\=XMTPDO5I M[?KZ[)/375ET(W!)IK!^'MK[FU:NR7[5*#8DK3NC9LNL#$IFJ6(,2V'4,#3B M3KO9+U1H6MR#O]/%6P9+\HN_*D65LE<<`9>#^#0UWV[?]`*M:_[\[%:Q86SE M.@6MG/BV$)X4ZS/)PLS8>K2;HU.L1\8;R?ZZZG;D0Q8;1?T&YZ,12^XX3OJ0 M$$WJ'\Q0:M!I=@JE5$;!9V:L6Y7C1#&"N_N91SSG^2LT*I)*O5=\; M)*0>4IH@LRQC[/15ILQZ9=DA4SY>+A0^W3@QJ#Q6:>$S'NK\,T,+C.(4A&CD MA8J](P]4MG_OP65V5E[IU'YM:V6-,C"&77&OS`XDGNW`[=A`V75XTCE9^R@3 M=%Y`F@6)=3Q7L4XY0]?&\V'DD8QSG]6^NQDQ/AH;C@&5#!%_&75,:]S280`L MII9A[WHU"()Y)CH745F_F!3JK^38-[)L_U>9F%!HLL^XK;WO.)7#3BS'0(11 M`!=,'7D%34J((`S/"<2/@-[&XA%1YR#\N]&CQ0\.PQ@V>9G1*;W'$] MG5"'VZC,41Z[1@TFT4M0%G_D)2_'42[\Q$-;R<[<.-FLH[5=6(0S\-8XP-B? M@':.;X69IH4.FV;X[&24_%E;H_^)/)'FZC;96V'Q",U$%&JXNOIE:C3W&"0! M3R/7E'B.$(V5T+=^HB[M>+7`T MSF3\+-*64DD>+/`@>E&)H^RDYZE7M0](9/:Y2>09,7'Q<_:EL73-OK;=RB8=[I7UF5V1U2S/E9'K M/$X0W=\EO0=`*;A\(<6;Y(^UR6].#%UF(W8VM@7<(;%3#>;'JT'_NSUS2N,; MVP?>-S[Q^TY]'\W/Q/N.[Z)XF6UXTN%V7VI-FNN.LM[_I`!:;J!?1MIA4%0$ M&4H>MZ[!137!>XD1*][\#N.6A=/J(IK>54BD ME4[7DNPBV;4_H=1^!`DO$EXDO$AX54YX#?H&VPY?M/"BTV]^?V8#=;V1W2%! MD)J=/?K_S)]$7Q3NU^MSDTS2AU/N>33K$^P%++5ERI M>MPBS;6Z'!):@,:J_6&A%.LY@8XC@!'`"&`$L)H%&Y[U<7K:8^;8_)Z*)Y0'LU5%V1U6\T!(8N01<@RC:P!`8L"=3MS MRZ?D:*,S6HL5`]BK(:59W.^19D&!B\N%2K=KKFZ/L$)8J3-6>LV=B]4)*A0! M?(:>48NKH/'GE*SQIRHY.YX'6&(L4G*#ZQQQG$)XBI$^H(=82Z7'7("<*" MEX`Z"AG^A,U8L0&4/C1*_>DZ[B&[/]"$\22)K\&"7[[NV$3@M@ M/%[(F!-V,$4OHME2A6!>7?U)J%:H-MF;EE!-J"94EP#59KNV$JQW--2_5P=, M;;K^9`/+$*U\MJ_ MC$P?`,Y>F1G8L-DKY`AIL`7G\2#\"(\ M63-X<,!C?77UX=/GJ]=X,J'E>YZ(CZ%W0GW.K$PS7_#9V6,KYSR$1^IS(3NM MUDB1!?X8-]D:)_9.PXG=OFE6-,2)G6&S6W)6'#4'Q;,BL-K1C-9/C^6$#\/J M'9FY;IE,U7_T`[?VB=MT#&9#'?$:B(4?9,XZ71[%"716]HVJ0L@=->BP,'B@-W/JJ2-ANW]B.QK"`"BPZ-?Q^,MR!M!.!1.O5;5S@,6^8* M0^H"!W*8UE4EMU`5;O M!`TTZ@*LBKA*I0/5<8F5Q::DUB!>LRL!*WZ.^6E+;RXA:9=$%XDN$EVUJR^Z M!-%%]087.)L/'N:C"EOE\&(:J1]RET5;#SKFX=&IRK$C$Z-'S&P97D4@3"5$&^Z?.1XIHD' M!NK+;*J^N2J"\JAP"SBB;[,L-\^CEW/,R?WR[+L!9!<'A7W-(_ M>3J,;PIO9),G]8I'F):XAN]PW,EQ`'82A5[F;ZE2#@DWPAP@:""[5;D/\'$,8,UU+E#U1ELM94I>5.\!B69X#BER" MG'5=_#=X\;0+>486KJ"*-*@+L\#C2 M8&F.9(A^+1PMD;)/C'NNRGS3U88>-MZVW0BTE-&7Z'FT^:(%(M<,H[6' MAHO#XR)P%#-(DH4`JF%67<'S'AJ=1481D*BWFWR'MJD$C1'I\@7?4B$B@J)-1*IX1)=I'L.D!V=0UVH[UH MV541]Y5*EL_5^+ECL,E(74!3/GR43J_7%P\=>,Y1*D-EL MXJR'JMO5O38=\U`2(X+D(\E'DH\EDX_=OKF6-20?=S4JJ2QM^VQN#&6F%U]U MI;>Z=*5$G#HE3&7#]CO-3B%G=*3I]#!NWW)4+I8Z]B+;=\A>MB8*16#%:=MA MP#W)=8)]DWT,Q((#3,6WA?"DD!MV_XHAS:B`.HMG*;,[51HFCT!I%W!*2R`L MX3R@\%F?9HX&RPJ2Y:$H<($J)XG"F1^H>&*3%8E6DY6%Q:*UW3.<5EH&M/(, MMY@[%6G0,EYTLX7)34VJ9?JXHL-%$$#2=9.T=3X! M3X"ARJ[BZ7#CR4H4496N>QHDWZZI2A19X^R4>2C_61C\,1B@+KGILK+2L:!;2+Q(D^H]*9EAM=GL>!!VAUS^2*UEZD3I'S& M5;[7G(?PG63\/A"J:31[=86W?('??HY_NTE^NWJMWY$20K7>O!>>"+CK/K%[ MU+R>3'__JXY4_0P_POR^!KX=_E5FFJ@R)?"D[JL*DW626FP=X)K`NB9=0J1X/'C"IIJ!5%E\ MDTC",DJIG]!D[V'!IE$0%XU/,8-*-R75Z[.11CB9*8[59[_XH6#M87$Y8L7F MFAO)`2S/.2"JL2P/7$=UTEX`]S[!1P7*WYN?FVPJ;&1CQ7K8:E8W"/@C"AQI M.W'G=,=04FQ[/%ZO*S[D04UV8R=]PO'0!2`J06`#:2<[4SA M8N%9<,5$A(]"9+O)JA;G.M,5R9)IBY$YXD)A90H+XUD.`$4WLW7B0Q04MT7! MPI\6A[BK%_/XE;.`N7_5!_<$9]&H-"J3HWA M,FZ<*]^-,6H;MB@NZI,MWUG'6Q\%($3RO M.DF^XT[3F!5;EWTRLM9)`%R,`!B,FNNQ\@L7``4Z2U4W(CYX#^#N^D%!S:B- MFJQG3&GN=*E`CYS!,M4$U`99;7/%`K5'%CF]F/_B^E)[NE8@;`T'9OZ-O"P6RZ1>#;D162I?:,I38P%W:KO:5&/A#Y0#LC MJSLVUV"M]L@B'^BC+\-`A*"W5'7Y1'ABZE"G0@02A<+)%R)?*(5#CT(#Y`OM MS"[OU]HUQ*H%Z\8C+],+A"U\?RJ1,JL+LF@' MB;RG/=CE\XP'XGK"I;!5/Q7A2=46A^S%']I47$'N$[E/J6(9T582N4][U!J% MW+MWL.=4<4>'U,5H:[?ZS2%9;>0/E4<[U05:8PHTD#NTWW&>9.S]T&F9*X&M M"SK(][E8.'0[=.;;"7T?`L_S1'RAB:)1(N]^N,9I(=D?F;3L#J7H11P]0J`F M4)\H7;TS--@@@D!=J*]7<5E7,F8J'7V(?\[C8%0] M3/4Q\!RUSVY@O4F7)-_N2Y6RL M]9J\@C)Y!;7!7:=]@HV82\`=;=*<)+6@<@!K]/LM0EP(7_L&8TD0^ZZJ@!50*?BLINH-^B=HGG`)F"0GC)RPW9$W/D75 MW27`CGPP/$I"ADKA.1Y;\"#T1"!GSJ(0`!9P:N19->#(H.FY*W'JC$?RY`AL M6\$V;ALT-@ELE/A76FA>1([0JVZCV^L9;!%V+%'WPOH)(XDLPMLL'K>JJTNK!I=T?FC-T+P$N5?=-BR/A/T^DDTYJKYX5G=UN M59W05P8'!OY9)A1YN!?@#XU%A];'/T.UB@UWD?)-H(]%V&M&&[E1!.3$DVIXU[KX/.9!F MX_69OS/#=QU/7,^$(EV[T_HN1[L1$*IT?0^.&;SZ['@@;8%1>G"!R=EDFQ`( MR7B`A[DN_"`4>(X$"V>"37V,U\`(@:D\Q7,^YL>KUI7Z#-BSDL\;5N2+,P=B_R(>V2=_SM>TZ*-CAS/X M$^8<0Q[@[/*%%&^2/]8FOQQ4UE5*Q\@[.EQO+CU7#XW8L")B\?XQO; M!]XW/O'[3GW?:>97D=W2TEF5._?%*")9\05:/J_/+8&G_YC1Z.K3HQ:&$]^U M]7,^BT4HYA,1+"G;Z3=8I]4V=NX'<2!QX)X<.%`S!C#.V3:M/([Y2ZQ8<8>\W>N<,?#*8FU@4NY4-&Z51Z7='0 M[IK;F:\+',C+W\8M-Y851/$NCJ]43*)>,IVHBT!5;=+\>B?P3R\ARZ]"<*RN M+JL+ZC251IUVI_CPQT4KP3KINBT1[:Q/M4RK)4L2&QRTNQTJDS2IQ4A9U1)4*L4\JQK459"XI/$Y^D+44A\ M'E6A2,\C5_CM\906"2_AN&OCS=MPX-J1&!%W[X"H/A[,;Z,W*D@V]LJ!W'!#P2AX@G2:K1<'?C MT^*9Z&JLY&KOGG$K=![4/F63W8#(T(]PXS$N09R-\]J;SMQ]2B=D%,QQ6*@Z MG%A..,?!Z.J0T22@&^N(-D/50:=KFC4#X:K"4!CC-NP;XHA.S[267!D[6`$! M_^K+_.C]Z10U_^3)T#SZQJ\A']KX0]7.^E) MAM+4ZK1;?=-H?7%:"_ZD3@+1,Q(!JA)GY4@LYD_`AE0SEUH+\07HNV\`KU"X MIM84&X,7./D,G^JL'0>TG`5*$JX*A*720YUF:T>.X@]X8Z M5\E!H]JX\NNT33MIJY..W8?5&?_>_-Q4OP.#@M-@3N]UF^VS3&CJ>-S#;A/8 MN4,K0I/%261$E]F6+'7E.16#>T7#;5=% M4)R,!)%2L&*(L;>`S_X\;%"0/N28R+@9BQHP!7"A\4S@(AV!Q&,Y/P-!N>=0?. M`L8M6!+U::*PR@_FY7?D15GBIIB35^U&;S0R;2?$/OZ.!A)>>F.%,QYD0*]Q M`UZDL7GVVWW3>C:5O/M-6#'8RII[?BB4?^D\X$:8N8EW^J9#(-E9YV9LP1+> MB]CS-[5N1:[9`LTY)^[,=KBH/>MVVDUEXJQ9@3OCQ02'VIU!`=&A=.2!K79S+/#Q./R+>R&_-_^WR?X`[2!MQXK#8?"8QYECS0Q-=-PV'0*< M\0<40TQ\6SA!O'<%0,95"\0Q']X8(WVEUS.!!6P-9/!A"@/$-,>!X*WV3S#\H8+\G$\EB_($[KNI)"N8#?!=9(A$VN=*G!7_29MQR MUJ9H7[*9G(N!R+RE.!&N(QXPKVL&7.&$VO2]%QX^2C`93:>.Y6!<(=9+,!BE ML!+]A'H+9,._A0Y8#W%.7SI M5G_&0DG+X8<_X/)P]TDZ2HXAO:QH'@'%@(6`2S"6$`8ZS`-^!](-T^;,";W3 M>.B9.>FF\CC^R+,="9.;1-G9)7!8)@+*:`(D=8#?$P:=!!JA,^]KN'-0@TTTV02X'/@.E43"`0F!8IX9U@LG-IRBX:C`WKCB;[`%#$ M/,@0\(Z16RNQ$6T!H)\#^V\G;CY8J*CVZ$>N#01R<%='$5EN)*DN`U[BFYXINS%'#+%;UW_0E(*U?IEL<+2C901&\A:>A*&HG-I@*<=`RCJ^'8?E*Z&=%+?S M4,\N8265%ZPD5+),&X68BKXN(\YYGT-QEZ6X:Y+A%;6Y`$^[GJIM#.Z!-EE= M7+C8?\#T8/WNE.#@_NLOD#D0]Y8+KW>F#O8^DFPFX%UX#8:YU7)*D4FW4CR[ M:7]/!1>S$W>&T@]P M)F%MDA99AB1[R_1&UJX;.D5$LKL%Y'AN09&2"JB.48%M4S.JEF%9?`":&RS7 M"'5(6EX@5X.:4@=X3*_SP/2F_3D7NM7W/^>+-!R62O_!O=XZT0"B#-?`%A,Q;U[>^_OV__O,__K9VX4??=:RG]"+% M:O#ADYC^>/7^#NW=WWK_^G)WQ1P;O@`)?CWNMX:=_MW;?GLT'`T'M^V;MYW. MH'-[^_;MNW%GW+WZ^XH^)I026 MJ,'20L>SBKZ;QIN+GE4U% M\"XMRP]PD=QEW5@F"`VV(6:VV)L)^#\1>"6=D3);N\SVE5#PA"6DU`&+0$Q= MY;0IZP_S4&36/5'A8-]2YI0R]93)9HN%4#S18(MH`BSJ/EV'`4=BQ+5N3?9_ M2=J'^&:)Q6H8)9UL8E'FMXYMQU8CQ=B$NCX7<5=Y^X%640GETRAU\@BTKFTA MYEK(@8@+7>V?@>$;P=(D%J(*CNASU\!GFL/UCI;\:=Z*]HO0`X MLK^,,JVNG;:$] MG/,+JZM`JE:HR78==>KVX\%]4HLCE2'D3.$!>I03$3[BH/#[B>]_U6RJ6$[J M26Q[`7:4?68CML%`L*%OCT($QBZ7%$N"+$S`.`#:"4GU3CE\KS>@5H>*4\H^ M(P#R!A+5+A]^FS&D$F?*;2 M!@'ZR2:VDW&C5/0XUCSQ[F)RN5H^@$A%I476K4BQ!8LY$[I&ZP7>X)JZ?IP? MKGA`124E:I"$\\0WKC)TL8R+)4'BV!I(`EBYY^@(IQ!QR!C??ZW??XWOO\;W MQ_(KOAZ68@96&HXV8ZO$$187T^=@J>+0H`[PQ]-2\^FWODOF!\.9"%V1H'E8 M3P&>[[M1HE%7MB]@4GXL0$-5QP8"5!%"SS`.8*[(BO3Y,333Y^5(T8CC-;'Q MD4VQ!^DC,8;ER!DB[4/"D,BMP))@8B'._-SM^4+"%2=L\PCPPD#D+"\5^T,Y M))$>4Y5SNS2/*HR$A'4RR[PT3E$5H&Z_\($#45%$>[EQX]*2I+R$`=!@X:-L M<[15OM&:#&+Q$)?WK@NM6!ZMV8>Y(YC53D.R`JNB,U:^OJ0R=O;3G_8Z@_>]\=OV]WAW;M>)PZ9W-P.V^-Q:4,F=-:TZN][ MU%G3O4./5![4\6SD(H-U:Z&Y\0O"H,P-KT]*J$2^[7%*RD[]Y"IAY64F'^=) MS!>8#6`G:GGJH[>MFC2%\?:K^DUP\`FUMGWS_W9KRWD@$=8.(:ZXF)Z#O>5X M>I`\"OWD"PT5]4T!DGQTI"0?#D]RRGU&!9SX?:>^[S3SJXAF+%W38#JS?;\S MV_NZ]\:FE)&->8.5,46(,RO.F8-G.7/GYO;["=(Y,(LKS+5E;Q_-QQL>N&I! MY`8UR!F:QW9J_L0?T[B8WE>2$<8`]SJ8\%E2'T)1(^>%[4O8ME'"'M^N?5=6 M?8:.YLBE>[`72*_!X`3'>9?`U3T\B9-.G3"BIDE8D;`ZEE[]8=.8Y5Q[8760 M@79I=MC_^<%7E>05^+C/=8C;4;,C_]J=7K-C"F1UP1*YX0;P<(2(>0D/>^NE MGE$ITAX9/#&]+IBA`,$Q+/7>\53>%KOW?;L0O?12.*PNYZJ/VP8]W$-I5A=0 MDP=\`@UY,F160+4.#%JC%X]><@EWX+@#TE]>M&I,'ZJJXE^FSJ.L2PQL5R*? MGZ:%!\HZHW9S5(S8W'3.:O$GHYY?=E((@&0@R<`*RT8&U#D5:A)W:LNH]9U=:K>&Q^BGJU/95P.3E=U^]@Y*Q3S3-N7M#@* M!H&]%R0VII^`E!"AJIV6,(7KN?^`3T[KUC--"*Q(@N`16``-3&DW6"BLF0=. MZCV6Y3X(UU_H^F5XEBZO`A)Y_MRQDM9S^Y=";<9?#J0?A8>_2N^]".0 M/Q"A$ZA:Z[=Q;=IA95(W-]V[M^\'[UKO^F]O>^]NQMV[;E(FU;X9WI46Q)7+ MOZ7R1U`63ZE,HX]M'E7CG+I$YL9-QA2S/0 M6['4WX$PI34WLKI?+K`0.<"3S;Q(G2JFSYG3'6;BN2YUGCIJ%!NA`BA0ER<- M$^*^Q;J[TGSA^D\B[B>S;+J4?&VJ=W$RZK9$/8"R1A^RZX$VA15C0]6 M,+*\1K4'@7]3_O^!S<">!P`ULO#)CWH%2*J/+;:/#U6/I3)P+&S M&'9$3D:3=`?3EZ+E'GG3"/L75[AK"?9_TI6IX`XDQ%"NTBM]O,KKM!U5AB]B MAE;=8IZCI^J8+..Z6/FF"#)1Q:L1H[QWI%7>.74)*I6\EF.<-#^:7YG'6>[Y M4^5!![B.91TU93+,A]?\A5CL=JQE+@2-6(U9[GM6,E=D1 MJQ&KD0(E5BL%JY$")58KFP(]R"TM46WV]ERU8ZL^/HO@P;&$2F\X&K@'5L"J MJ,@V8I^@4*0\Y4@'MB7;+ZRT.YU,MY;HG:`=V444%E5(=)5.IY+H(M&U/Z'Z MS3:)+A)=)+I(=%5/=+5(=)'H(M%%HJMJHJM%5A>)+A)=)+I(=)'H(M%%HHM$ M%XFNZHBNBF3#%@>Y#[@)+&2X[_9B88&WA M,&X."`X$!X*#AL.(3I(B.!`<$C@TQX0&0@.A0:>[FG/*"0V$ALJCP5B905W0 M0#GNVYCEW;>%[M@8B#`*/)9O.UD$FNIR%N"K3L>`A[XK499\LR]5SL9:KTU) MH1(!L;I*K#ZPZQ'L"'8$NU/#SD0\FF!'L"/8[<%5FDJC3KMCS/.O_9Z\M"(I,50]:8 MXOS[SI,44&W1,*(]8$(#H2')#^HTC770)#@0'"H.AP*<$$(%H8)00:@@5-0, M%2VRG(S$HTH4!3Y=H&H1.'[`Y&&-8R\N-ORJ13D%E%-0%3U&J"/4$>H(=8>: ME<;*N6N__TG`(F#MKLYZ!GJXDCHCU!'J]D'=V$"8A%!'J"/4[8>ZX[,<"'64 M8??#3[Z4:;&O%&'HBKGPBJGXK1C(!N;.!+@4AXQT46W1T&V."`V$!D)#K!L( M#80&0@,E$!$J"!6$"D(%H8)0<20J*+UN&]/\(D*V@!]]V['81'ABZNCS$M@K M*Q"V$QX?9D^BH?K,C9@FW<4W9O__[/UK<^,XDOX-O]Z-V.^`J.E^UA6A4HLZ MJVIZ(GSLJ7NK735ES_YC7D(D9'&;(M4\V.7Y]`\`4B=+MDX@!9!714R/98NG M9/XR@40B,TB&'IOWW3A$K.@(LXMDR]XRQFJK*UU^N#`KT53&(*.IW<`#YA'F M\23FT5)7QP#F$>81YA'FL4SFL:5N/QK,(\PCS"/,8XG,XUE38?;WT<+<*V7. M`#U%%BM,IV8J"=.IS'3V%"83PW3"=,)TZJV2,)W*3&=7X>XGF$X%NSA^B2F7 MV:;O%Q9)6)*-Y_KLPYC)]V(U&S^OO)@^?PO:A4&.N7GYV?6Y1^!:V.9?4/DT M]V-&1H''O0Z_!2+?,@G9-&21V*Y"8OYG>TS]!Q81UY_G"`1#?GNR*D]46VYH M1ZCOR&-D1>D)AXK_+F1V\.#SRSIB1XP\(S].@$%%9[PAY5B>3[&OQ>,R,B-./YD[47L*9?,"F3, M2ND[_!%"^;P?Q0M/1==L6)UCKR5/))^SP+M>7P\ZY*X_%D[KTCE7QA:-V3DR M2,3GY8OZ03BAWLIE+?&=^8E3M;>9YV7?^?5=XYW\S`VT/?N\03[W[H2#< MR/=@0M=&;$^N$X_YC_R9,[_`WY)'IQ'[./MA[>$7-[6LP.M`X\;%'R]HH_#\^EQGWH_GR$[8K6;@LYOM_=:ON[& MQ;?UL7?.^;PV=SPL5#-*EY^>4M\U##PG/<^W;%!TD8Z`]ME*#"6#DNVH9*NC M[7UU#5;N2`5LG4`!UV6Y>Q#CU/JZ<0YV4D.H+``$)2V1DBI+P82QU$T/=5,U MS>PA5*V\JK:S5<,6O-?$*K_]T8WYR>WT1)'-8`6``+8`$LXR9>99I??19YE"R*?0:*:?WVAS5G)9-@6ASL3UW2@673P> M&6$_1&<4%I$I=1V$`=YJ6VH5D..).8U63)KKS\J$G;+\'V`'[(#=3MBU0!VH M`W6@SDCJ*K_^]$TTT(Q8''NRZPZ6GL1(LJ4N!ZD*$.G'B[D>RC16K!Y8`2M@ MY33Y064)R8,*4`$JE$Q.-(H3Y.=N;UE,XI#ZT8B%Q/5_.0N2^/UZ&WM$#+"M M`EG?>KJILH"%K&\`!L``&``#8`"L*H!5?MWH,@E#YMO/Z33,D\W$$,WX=&;U MU:W,(AZ.R%^961FHRY,%*D"EQ*@@2`XJ0`6HR'=^LMN$UC)\YK*U'3+S'=6- MD(=!Z+!P)AUK^H-$@>\@\%Y]6]G%Q*'K5]+C'2CKK+9-L%M5^BT! MYR!'Y9VE!BV%O:4.%68!&G=ZDXJ8ZN$C$!A'&,?BC:/2CO8PCC".,(XPCJ4Q MCDUUG7YA&V$;81MA&TMD&Y55U(-M5!ZG/+U='#-Y&JO'SW-R&SF_]58.X?UU MN>VNEZ8)$DH'I8/2:2PK*!V4#DIGI""QEW'#9"/])+[]T8WYR>TLMW9,_0=& M7)],1746&D4LCC[FH;)%"MC\<(,^VJB=X*!QT#AHG!&"TT98T+@J:)PA$;[\ MHO(WU`W)(_42)K(*ET9T(M=PR!YWK3KC\.A47O-7,?)[8N59?#V%%0?+ MLC2@GXW0R[#"`I3)`G2Z:.(%"P`+4%D+@,U,L`.P`[`#L`-80SJLB[1'0A8G MH4^"E86C0R)<52E]9#45[IXK>\TC@TC3SC]7CJS.H-X#62`+9!DP0`1@``R` M`;#2[^/(;P9V/9EZP3/C(N1_"]UA(LO)Y(&98319+2QL(*")FF6SA3YUY6%! M`V@PG`:%;6Q!`V@`#66C`4L^6R8<+/\)1UGF]6B!AH"95NX)8`$L@`6P$(D& M8``,@)D!6.67>B[2M@$1H;Y#J#-Q?3>*0QJ[CXRP'U/F1RPB4^HZ"&E\.FM: M:/+T@"9/"/_MQ@IZ!X(5L+(#*PICY4`%J``5H'+,_$:CJ$*.G=/$IJ*(Q;'' M)LS'SJ*W!W,*2WIL%4J9>30(/7-]6FFPLWK`#M@!NV*Q0QP="U4`#(!I!5CE M%ZHNDS!DOOU,XI#ZD2<[7.<"60Y]N$X\AE2V9K6K;*H\E(1#JRYK?:`&U(": MH4/(+1(JRT@25($J4*7%_&RW";UE^,SMS9X!S'=TZ!:0<_Q`F]*AQS0[UJ2F M:+O54Y<#4/JX$0*SAP\#8&4J;&54=C&!E8&5@96!E<%*&&P-;`UL#6R-(;:F M\JON-_S=,O&\-$[RBM>LA@A;TQ_$"9*AQXZ*HN[>>;X$QFE7`18L+^7KJYV. MPCG9KD+;:X75`+7#\FM!XRG8-=BUW>Q:MUWOPZ[!KL&NZ:Q@L&M[C]>:]2;L M&NP:[)K."@:[=H!=4]8&!'9MCR#<+S'EHMGT_<*B@TNR\5R??1@S^5ZL9N/G ME1?3YV]!N]!F'C>_=,X5`]F8GU//R]?U`_""?56+FN)[\Q/+-\UL9GG M9=_Y]5WCG?S,]=6>?=X@MGMWPB)RRY[(]V!"U]S.D^O$8_XC?^8,$XZ`1Z<1 M^SC[8>WA%S>U'`9>H-/=F+6Y0R19WLRO[SJMG[=2N6I4L@.M`X\;%'R]HH_# M\^EQGWH_GR'K.]J-H^>WV],[0=[FCH>%:@8M\M-3ZKN&@>=D9828'[F!3V9U M5#%9@Y*I5[(@BD,6NZ$L5;6WKL'*':F`K1,HX+HL=Y_3G5I?FPVKHYBDI]%"='NJF:IK90ZA:>55M9ZN&XK"OB55^^Z,;\Y/;Z8G.)_R1 MXXB$S`X>?/YEA_!97SR6+0NE5M&8_VY(/>K;C$1CQN*/N>AT@?(WP1AH(ZSR M6E%H'#0.&@>-@\950^,,B1?FEYIP&_@?;%EO,LY*E9QR]J:'3)1E">7WQ*KS M?)H-=?7\RK(C3C\SH)?MA`$HD0$8J-N6`?[!/_@WC/\V&%3'Q7#IT/3=V&7H,OKD)&KW.T.M,EWAQ9:AKUGN@#M2!ND*I:\/7 M@3I05SAUZJKL5)DZK`\OK0_G/+TSC;'N0-V::158T@\;NBD36`$K)6=%6=F]*K""WGVOSW183*C<^K37SB=ET^Q<2O*]]N8, M*)I67*V^8SI>F%'$K\AB\FKC108H*D*XI\XP@NV$[&3\*_QSNJSM1C$)1BC@>6ICJ9'^:BT13M.:.A2CWA!A`*>5:S;;#(RE+=UR!`M?/UE:NOUE7G$0$6P`)8L\.L-L@" M62`K![+Z!90$+0M9QZ\JE[,:SLZ9A?E,2U3ML--_?U)Q&^E.)"_E0:I!O\`: M-P>%L0Q0.P3`BTJ$@UV#7=LQKZ=?8!$%X-A@V&+;\#9O"AL/;RQODKS^G MG[/",L"AV)S*42+-MS/&8QN3)]3PR9.*7 M'!H1>!R%P6373/T8#77OC2.5?<8F-VCDQKQ.?EB_I!.*'>RF4M\9WYB27^Q&:>EWWGUW>- M=_(SMVWV[/,&<=V[$Q:16_9$O@<3NC;8>'*=>,Q_Y,^4U@+F9[6]RZ_O>KV?MQKP55>2'6@=>-R@X.L5?5PQSV?( MCD/M!M^[[V_=DHJ6@RS?'B_9W)*Q4,T(4GYZ2HWA,/"<+#%2>+#`)Q>IHSKI M%DZH7774CH^'0A:[(9N(_H[[:A\2G5^;(IZG`U?_2XM*$P43]D&E/"M\)W?K6B_H+2_1S5;= M@B&_@=3SCKC3I9Y'IEF\<^I1/R(TECUVF>\(UZQH36ZVX+;NT0Y;<.,WI^J6 MVFINZ8E&:F[IIW9_4&\3_CV/OQ3-Y/53I]6J=Y7>7(V$+)HR.W8?F?=<)^<< M&J&>7.MZ8'R;65X]N3&XRT3D4@D_[$?-HLB&0WDQ_$A M7<3B+<,Y5&PO(`]?'QW63G#0N$,$AVH.YV]:PU..?O203P6K>K:Z"@O"E&6= M%.-[6(#J6(!!N]Z#!2ALVF7Z(.*&NB%YI%["7LR9#AG`5J7L6G.@L"U/Z>NN M86Y80*I%6=!J-2V%);_*CE9Y,C"PQUIE2H98J!^]YMEEPL9T/;HZ#8/_8_:^ ML57B!,0/^$/PAW='G$$_]IZ)XXY&+$QW>(LTD-E.<'X6\3%=E*9#;F_Y@;[- M_YL,HY@?ZU*/'R[22?AEQ%OBYS/MT:=1U$RF4HU,O-5_3]Y(\SY0+F?H0]BE_[\B4@2<6(8M<>S)*=G M_D)%?HG#8A9.^(.\4;=`H+A-RY&6LOR>BD]+L8[-2VD>G$?1,"11!#>*&\6- M'AYKPDQW)0NP\!03K1)*_EF_JY-OPOVKF@=#O:!><_6Z#?P/^ZL8S%K>`;Q" M,N=VWQA[:C75+X-3V:9B*&F)E'3GW$\H*93T5$K:TDM)H8<5U4-X="BI]DH* MCPXEU5Y)=_;HV'+T6JK)E1O9:2]$&JOK;:A2*9::$/C_*[`Y:A40-8A& ML[P:%3UA6ETM#M M5''>B*+.XKCR%(4_MD1U5I4Z6JGYKD%UZK5B"H;7IY[0\,'UTYND21S,?I': M#/D;E+`N<7E@W"AN5/<;-60+@':#:M081@EKJ!=*6)=5[U"F#04OH:3E4U(4 MO(22:J^D*&$-/=1!#^'1H:3:*RD\.I14>R5%"6N4L-8D-T#9EEK4%=)"ZTHV M7@>NP!6X`E"(QZ_N))3ULFZE/S9OMVW)/7`?!92SWM>5*=Q MR/"9A.S194_\G1/Y_?"94%\TZ7L0XHJFS'9'KDT>A%#\"7_M\L^K(B.N2&MF M47JQJ+XN/"/4[[,_%XT0AY`BV]"T<*E43]:\L+;\/KAL^!<<%D;RMR$3FO?( M2)JJ+4[,=7#I8/$.;(__+`7+G\U]=)V$>NF?LS]-N5\3I75\>W9/62DARO\6 M!OR(]&5R\?#7)`YV'MTHX/?@^OP6J#U.7[!O>TDD#^1/0*?\T&GHBM>X5-:H M3N[Y?;O^(W^A\H5'L7BM#\_SND6KU8JX;L4!"88QY=>BQ`O$^^-2W-SHD9^` MQN(8*:8H%A=XL.K6^50NFIP9.6J;D?O8CO&5`4RYD8-6?[5;@ZHV5XV MW;:K:;;Q%ZI67E73;/LN5*V\JH9-N$='UVY?FWZHHKB"69+*5@*1):F%UI7, MJ0#7U1U^#>`*7(&K&;AJV_2I3+@:$H3*3U(7V4!X*?Q^REFM-NPIJUU1A7P$ M_8`QR[<938JRG7(@!:24F!2%TZ\JD%*>'#>E1!5]\[FFD?R=42\>VR)_0^:! MQ"'SG966:"(3!+D?FN=^=(_,_>CU],Y40$I%R8<<6'Q$2@5430=5VSFE`NO< MKXVP-P^JPGE6-G/DJ,KG-[#<9U85XY6+T_?J5F&RJVR+%[D0ZL%5W98]=]L@<+8>>FC#9;#3S[WJB1FM.M!B%29UADSJ0 M91Y9Y5D\SW7]N5Q/+Q;]!')H<"Z;HZ?R3"\6!VC!7VDZRP]X^MKG#P"ONAQ[5-69G7^P$-":1I M-SR:WVX+RZPOEUF_$EODDO\5F#M@/0P6KKX!7;3P<1T7EMLG0M!VNR MCF$04UD"+6+AHVNSK"I<5E]/Y?;W@Q8,7WL9!BR&_538;-WP%=<<2NR?4F]. M/[LWR,1IYY1APF#"8,).;L(,F=<6,4)[97O+8D/V(5..;=G%1R\$%,M?H]Y7 MQ5U9"-(/%NU\?5EI.&M@TS4_[/T!S@:K81H]C:*;3S^*KW]T8WYZ^Y68TS=1 M-?Y<5HTW\P7=;^AEL5(Z7R[;41+3\('%A'I>8,_;5*P]\IYWD`U2LW&H?$Z' MV:)I`[_`1Z$MV3I]>STCZY"')>S/Q(V?2<3LA'_'96D1_J(>H]=5]!@.&\9+ M#U$G_TM#-TBBK!_#TDO*^B*X68\`5[Y5.VT]LFC)L?+"'<8_"X4DR93_4IS* M(QY]JO&3T3B):F24I']/6R$("3I).%<*SZ5#UY,W5I-_%!=6\MRM05YJ4%-S M@YU./B]8B9;*,ZO2P"#F?R1GT]"=<-7SGHE-H_%[J59!$I+_CW*#PB+VHA.) MJJ>P&IHK0E-W/>CW\U($5S0GD4U@;/[]D-IQM-`+J09NV@GIEHE#^2^5J?LM:.Y.7]IF_T3AMXB.ZE8R(Z(*SO($2F3&GR(RQFD>FQG1:>M=T M,*;X!&X4R3^:Q7TZ)TB\T"K-0DX9Q+SWI$4]H5XE5:_;V:QT+Q6#64/I&%0I M@JJ9JVIH_`15@U6#JI5+U5![[?BLGITU5+FDTEELBQ.83N9?C MD7K,W[(5K^(U;UNY"ZJ8Q8Y=\`"%@!J\IA5621)``&P``8`,/: MSC:E^2IV;B-6D0<\96%$/QS,\C4&4X%H-E@`"^EA`V7A-L``&$R'`6O^*F82 M&LW?\YMBW(L>$\IFI"M[[UK3'\0)$E&.:)9<6+D,4*NAC,7CA5O9)%#?+ M20)X``_@`3R`UT.X`![``W@`7W[@R],7XN1QDF-N/O>>"8LBS_(M1V0:!H^N M(UHE1,ED0L-G4<\Y+7LNVT.0,?,<,GR6Y9X7'1=6:^_'8QK+>OD31J,D9(ZH M#SVB;D@>J9@^\+B!*56H\7QX/A0?UVPF-+_=;5W?H:1W_#+NB(N"GTIN/"!?AQ$+'V6XXK,_379OO5KH?6>< M-,$)."F:DW_Z@4F,M`YINXV$R97#LC+Q=_.*>V^'I@_E*E]1[KX2:(*U,D4I MM1,?SFW!ZP`-X2'FH*RLB"!I`@^$T(,I]BBBWZ;.CO_/[(<^N[-L1\/E0'B"5)7/- MLM0MJY8^90VA+N2$@BR0!;+*-BH$8``,@`$P;&TOO MG(K/\2VKJVY[:>EG]P819JZ7*@M:")\!,``&P``8`#,3,`P.!NJ4DT`2:*DY3$S2!)M"D<8BB M(E1AB>LUI;H/XKT*!>^A3BVN3DZ0##UV%'&OOH;=FPZ;WRQJJV2W*NM;$LY! MD,H[>;1ZZC;U'R[-`G3N]-;2(,.HW>`$]A'V\13VL=48J*MT#_L(^PC["/M8 M(OMH-15V@H-YA'F$>81Y+)%Y5)J=`?NX8S#REYARN6S\_M+/2\^U5B!U6?_Z M7-F6'MQFHAG8Z1_]P-M_\[TMG7/%Z#5FYW!];L_3S\L7]8-P0KV5RUKB._,3 MRQ=";.9YV7=^?==X)S]S;;-GGS>([=Z=L(C`YZ7DN:.1&)!B1&^J&Y'^IES#R.Z-1$K()O_@!(UE8LCPL61Z* MN+^E*U0U;]R(BX$T&Y:RW#%H'#3N#8W[1Q+$S"'?0M?F,SC7)^=V[#YR@RAK M3D5D%(3DLYA-"FF1\R@2OSS[PAZ91[)F)%!2*&F^2GK'+^..N"CXJ>3>&/)U M&+'P488K/OO39$MI@E/==\9)$YR`DZ(Y^:1!([W33G#0.&@<-,X(P6DC+&A<%30.M;__6;^KDVA"/8],^)S%IM-3 M3B'UD(FRA*?\GEAY9E*WWE7UU&7)($*,!`8`!@`&``8`!J#\!@"ENV$'8`=@ M!V`'3K$@5(HP@D?#![9G"*%R%5H[#85;),M>H!41804189`%LD`6R-)J3`C` M`!@``V#HVWRXUGP6*9,^C=W`WZNZY,YX&491:Z"N2G]9*$'LLK(X-/OJBHT` M!^!@.`Z65;>``W``#ECGR6%FH=%\/K\9QQ4;\D.P[:=(`Z2-L(RUW-`X:!PT M3F?!:2,L:%P5-`ZAXRN7/V3DCESFD)'[@__7]>U@PLB(:TA$U@1YR`2#'Q8E MTU>$RF7V::U.Z>(LG6DL3W*6E7[A)]IS7EO6>5O30E@/<0S$,18\8.<*>``/ MTLCFXK/\2U+X7;K MTL_N#2+,7"]5%K00/@-@``R``3``9B9@&!SF/BHS\I2'_'22Y5U]#=C5QJ,4O%06>Z\ROI(=TE35+VBK9 MK>RCRI)(,(\PCS"/,(]E,H]*DQ-@'W<,1OX24RZ7C=]?^EE^B=C, M\S+M^O5=XYW\S"5@SSYG3[&LD'VN?].6$1NV1/Y'DRH_XF\]GB;@J1/ MKA.//[;[NYC85679_TH M)D55V:.D=+**NW;@1VX4DV!$9"_M^Y#1*`F?TP)4-3()POB!/K`/PISP@Q=- M&&K\V'`:A#1FLR_3*&+Q^C<)]9WT[/Q$OIV=N[Y>[7=?EM^2Z$M$M3-6Q]R\ M_.SZ?#254:3H:=*/XNL?W9A?S\XVR/^9N/'STAO=\.X.D=O:> M<5IGOTMW^?-GN!]S"J@;DD?J)4Q<*1ZSB*V>,B)#&G%U#GSBLSA5\94#^,VX M_(MC4;6-WX#X3?"ZZ%:C8#WM,_0?^TYG''IE'K/XU8^"B]9%8GP:$QG5V\^;Y>%FU_T6Q&D:Z_.*M4AH6VIRHGC?/;ZKYBPE_H MOC2Q#V*ZY8O?2>5?V&B'WT`M_8X3>!X-^6_\@+]^^8)GW&PY_!4+_Y:?>,WZ M[TN?T-E#"5&:/+8,)'2\_R#;E1E*1O(H.#?^>* M>=S6?/&"9VY-*7GBP_(/?_C!DU\C8RY.\8YHBL_B.O*,;^G9^BW-]2V99AHW MY9HD8)@?/.)T\INT:30F(JH1I73*+PO-BF9*N3BK`$`D&C,!66I[-]R/U&LN M% M%G\22NYB?G(:.D3&H\3_R+<@"/EQ,P%P8Y(*[;PTUD(FSRNR#_)?+Q,5MUQ=(@0)94%WO5Z M[O$A=_UVP\@#-=9FPL^]JJ)+9UV)>C5F9\GT7'Q>OJP?A!/JK5S8:BP'RO:* M5+X5F7QQYUS['UP_O4F:Q,'L%^FJC_Q-&IZT&EPP6139%E.):<0^SGY88WIS MO',>'VMO3.;=(5PI[^77=_W!SWM&2K,#K0./*^9ZAFS-TVYM;WZ[6QO3K:R? MK"^$Y"#+MY=0ULS)$9%?^>DIM2?#P'->3L(N@ST+S2"W^[7X^@7UI$CY,.". M36,V&;)PH;G-7HUP+]92M>J'Q>>\\B&,7UMN%E"UOVI+QSJ[WOR@NV5B!B/F MJG+"^\#GQRB'S!'KH`(LQ@7[0#1-0GM,([$^$E$O6PH1X6TQ8D"1O[V65*721C*94<^X?$C3X:8OG MN:MHP&$5'>6F"31I=N6\>9_*$Y7SD:AUAED=9G5'4]14MZ6STJQ4PEEA5G?D MK$[=H!*SN@H[LZ)F=:8!9G74>3.`5&5/MV5=LR/G9\KBX=AUBUVWN4V3N_7> MZ:59M:73UW?=%G9CVF:BENMI?J<>OR'[CS!P^+%C&F:[F_P@)I0X;LCL>&E7 MSRS!-DOI_^]HGH,O,Z(_D7'PQ#A]:6KTRM_(A(JM4NDIY:XIF5=--MQ!NMN` M/CR$[$%D6R\2_\59W[IEL6<@=*E'0B;&E8],[$60NSM$%<>5&\KV;!B:#UVX M%BJZ^?3C\G8$^9NU=#>9Y.8.$[G_QV M=6;VJ')KA&US?R,'<'++C-!?C\YVZ"01]U[SC4J/-'2#)$HW[LA=+?P$Z2:$ MY:TWP92)'0)RF[?<@"7^?W8#CAO9(9/;)<)G\AAX_%3BI]4;&X7!1.S&29'B M_R]W2V2I\&(X*6]/Q/UK*Y>>4`[YVAL\1*`_6:UZ@_"O>9LFC(><44E"?'IO M[?I`[:WQ][CR`FI+^R*]Y]K,L*U;XBD?^V+29ZK_VR/SO M8E>JPT9R!\^*:,5&;?'':1#%`IMT-\EB$YK\CI.$Z8Y?L^5FJG?<+?O<(']X M_4.@SU7Q)MWZ>)%IV[=LRZ.9[^GBQ<9-PF:/R0$<\@$D=1UA]T8"6LE3^O3S MKXE]6JX(='#G.)V&P92;LIC5Y'B0_R[=,1;ELH/H32TP;O]0#IN#^D=N#NKU M2KDYZ'3'8?,3-C^9N?GI6S;^ROS%/NNT4#NHW<%JMSK"WU?[L#[U6EC_9AXU M4)8HCC4F;*[;>%B[@;UU:A:(##)=VKE9V"[8K@-L5P$;J2IAN@R9E!8QXMHG MG:*LJ78MA:W2RH*(?C1HY\3+BD.[KJS&25EHP-Q]NR?99_]:Y;9+3_[2S M++09!):Y3JDL9+4!%N8]^WNK`09ZGUI-S'LP[\&\9X:#NA(,9:$!\YZMGJ2Y MS_"C^;>RB(?Q/_MHSME'>]9 M[59]GVE@)49\^E%AKJLQC8<.P@%O>`[#=\&?7*H:W'SZ47S][>U55]E&O^5M MQ^3[(O7WF]C4E]O#%K4-F4RHZXN.::)#&B,T[>47TQ\?_DSX[V&=?;' M>[*4]BPV-,J-LDO'<`U8.L9A(Q:&S)%]&YD?R>V(Z7%9!R[90E1N27WE_/-> M7J*_EKA>PHT*%8U_9_>^O$$SW?T<,E%B(+2SN@3\*,9EZHH-4FPR]8)GQL2V M6/I<2_=1TT5S-SXT6L@DML=B;]G*!1Z8ST+9/8Z)YQ3[T=9>_R%OH]/X6[%3C\_8FD]AW1?H/B[ MZR?BE:7;VN6.W2<:*=K)W6S5>TJWM'28X)?K*IBZX;WDX[/O=#ATR7V81%E+YK3G M[.=%NW$SW]OFP5DD2BB)(D;RJ6/YU&E1E:S/]+S1K-CG+AN8BI;+])FLUZ/( M*H$LG6IV$G%LE,B6SK-!@NU1=U%;9E%:)&V$+%K/9N,Y?H.;BD'QFP^\1U'; MLRZ'S$0TDI8%1_SL@MFX:NF,JR=)1VH9D=EM_^C"I1)::C(^YHA`^&%WN M2"T+[E/L"UK(S.R_Z]67DJV:LX;=T[D[T_ZQ`N4^73 MOKM9O<5HS$1)*7(;Q(PT&TL=:A?C3M7ECM]JG++54N0*7KR$C0WCH_D;5#=HZ_14U]]1-^#I=%4/>&BLYM;V M*0YZ6B%NNM/7VDPH&`4(WJ(5]:4.G\C$V42%XHGA5!B7-7XK\O%6,4!7'X_X(DCF*:EJ+S`E&IBLIF$G$:))C[3%EQ43HF M18&/G]J->EM7[6[UZTTHMU'*;?YX?TRCC2.E=`@J*EO)&E:R_%(L!\TBSF&S M4$P2UL?>(B0KPZS+Q>KF`^?:K"BD\&!,%3>#>E]7I"U+>:W(/9!6%.30B_X< M'RK_H5SJT43Q4^$)O2@X:H;WIO69_?S77Y+HPP.ETX]9_:)SWY%QB]6Z,K.R M,E=N9'L!MP?LGLONP@OL/_[V7__Y'W^=GR04X>[X64RL8WZJ:SY+G(H3;#A0 MFA/^X3L;_?KNYDHHS#_:_[J_>D=PV+R\O+AO7G8OK=W][84GW4(5-B[ZHK:>PME[SR-IZ[4-+R'7+6`LNS^#F M6BC3:FRQ'CJGYA0JJ9G!J\E88AH:FQN]766X4SZ',6/'AS"(HD4@,"N,+P1# M;3N9).DBJ<.F(;-=.EMTGO16Q9"](-!.R=>5AZ:_8&Z$BAEX0'3]M?4Y9).Y=:'?XMV=L$H M?J(ARX.BLI1!L9J->C/W85Q9N#,(,7,=5%G0&K118@ASH%VUY7Y+L584^%$<)K9,87-E?1B; M1;F$V[:MPY=E=&>UN^JJWQTLM+*@:Q"EYGJYRJ`YZ"J,:50=34-F9N9B:1I= MM7ZO@<$GIF,@8DY$MSM`@`+3L9US2_GXQR&?J59&AWUN\-"D@[6E>< M?<5R,MUZCRF71IZL--SU^LT"UHFKP)TA\ZG\)/7MK?VS->*S?1:]]IB[M_C< MW0D2L5?UF$U!E=-,XH)?^R(12H+ MU.I8[F_GGAA65WF)Z..+?)I9"3"'A\FO`F!-5O)S(UG.=E$SGF,QG.WBJI/S MI=`FAXQ[FG_/RR?92QGZDBEG5BE07?URSE;79+8ZRDW#2E6J?;N['/D\9F*5 M6P5-,_WEU7(5M*R/5"WSF>Z\>%JTTEKJ-=)K:>W=(-_.4U:CI=A%[=%5Z%@3 M,&@K+Q!?I`7K]^O6Z;M2Z6*WBM.;$W6A.OZN<^D^E9^I-7I>I>CFTX_BZV]W MF_H2\'OYPM^(0\Z%^2>?)U/JAK):YKE/O6<^FCSZ6;.(1?=%'*Q;M)O\[,^L ME$"QMM*,*12Z+TID>T(BGI2(=(C$74C$'M/P@:WXT2`)R>7O5W?9E\7*V;1. MKI+0S5H=C?@WXC'Y,Z%AS&>LBQ'>QGM@\L)^$+LCUT[]>3SF`\0GQF\LBOF@ M?M:A,DJF4\_E9XQB&B=1UO>31%R4\E@_NQDR34)^WY%TY>$#]6?#_;-WOWW[ M^NZ]-";R&G3V7!]$+ZOG]`K/\W+]TOO'H@NFG]8)?UZ^^;1OT^Q)')9^D66G M3ELAR59:D9RCQ&ZRI8[%#$%_FK$4$GTYJ31F(B0=-:WRXU6;D`65_?X/8C#?2(Z M@_K\C\,@^"-M6B4NQX]Y"A+/X7?X9^+R`Y;?-G^T5.E$M]8U)2-N^A0C_NO5 M+EAKLA#OY241#,F^<@XF#!"I],PH/:XQM70X\KG99UV)WP\ MG&2]Y6)FCWWW3_$^;_@HA\,T#;)0T^P.Q%F7+K_\CB?4$1W70C=(I/HDDVDZ MDEZT0V.B(_LCS!WQ?)^C6C+>;?Y>2D!IM["8ZR6.Y)C5`T:T7-7P$'25QWR_E<84]&LY;8 MV2M>&4-DO_-$276A_2O#!)LK%S^-:)Z5>??L$+H^!$@'&;/Q3SI.$/?$[R1, MHPBRX77LSG:SB_QVIQ5*=XHDZ)X M=_(P0:\P-ZE@XL5K$V\G%.,9X1#XUYQHWIUEQ0M$B1>G?5GH+BXL'0MN\_?B M2OR.@Y"],L;=,*15MG32[6C[8/:JGO!\+196-:[NE%,T=9ZUB>@M\M39O/N])4T`<^W$F'.0&) MF.=);9+7&(HQ`E>RK*.>4"9Y`[/?"Z/CB(.EWQNRM.NI],-4/$WF,?BEJ&^[ MHL.OU/7%8'I^(M&K+_-3GQU+-7J MD7&\/KKG=QZ(@"US4M/QM@)Q"6\6B6Q:,>N3MM3L6,2`[7C^;K@OIW)DM3IG MRP9JR31K`R7,_X:6R`LMD;?Z6\+"(8OK)/?7H9S6G5_'&I=OO(*].V3MT=QJ MMZY8WT0OR^=].F)=]ULW-S?GUN55KV5UKF_Z5X.;M"/6Q=7UX+*C;4>LG,)@ MA_??T79-Z,U,WK0C>IRN`<=R4E8GO]/_X^:;#U;8$_72H28G)0P>)?RI85E: M-I)C(PX(=T.<"98V=6>^[!TGCN6S#T[9PA[YZ1J3<&F)BR&FLD;LWIJ]2[O]K$["DXB-$CX2Y^Z1'[V8 M*/.S4_%F/WCR65D\#ART"3I%FZ#VD6V"^OLU=CN^D]RAQQ70@$ZC?41Z53"& MU"QE>V;U%)?*%C#RL#@HM\`4ZU>[(Z.(.T-9^:U97T1\;+:2V#'EWVN MC*@PY,*0JX@AE^%;/G.-^)?L:>8;YI:7&1?K#XMU3Y%QDHC)/>F"7_;M-$F6!$-Q8O%A?DJQ/"'6-T*1_I1$S-2M M0O\4BQ\AB]TLOU$\K5Q/<=QH&D3\X8+1V^LP:4Z)S.-+EWGF6PE%HJ+,K=M< M.RU="?+<60+Q/-TLS6>02SFO'FK+?+7HY28"F2GECD8B%<<6>Y[XY7U^WT,6 M/S&6+O.([)CT$FERS2PW0:X1,4>F,BSG68COIYE5QV?.GFS[]#PE)$V4CEY) ME,Y6M[D6+"651-FZUVOYT$]CYG->PEE"M]@OYH;\S46Q6/T3TG1$YAE;I%;; M-`R?Q3GG^4TT2UAX<6TRH<\B=RU-6\ANU^.X?7[]$/[^1F+LGF4[I,O[8H$R MGN\CE^=Z\.7<5**\2`'@1W/=YHJ?Y?(LU&E%B]:?8*&Z+^Y'KIQRN2P2N@Q5 MI(,\RAX9#R\2%W;+=M@GS^%\T#AO]!J#SJ!W<=6T&JU>OY'E.31;CM+7;',"+#[T# MUZNM`X\;%'R]HH\KYOD,B=9H5^AK?KNM(SLTY"#+XJ(5\M-:6MP^I5B,B6M` M`PW7P-?JYV#!;M^,`CZL.R7'KPJY4J40MVF:X240VP.%%1!/J#"GKWQHD,W2 MSL?"=L%V'6"[>@7TLZB$[3)D=JI7$GI9>S*U6JUZ3Q5792%$/QBT<^)EY:'9 M']1WGLY6A0=,VW/*LZU=` MQ^=3EW4$:-6:W$FA2RWF1)@3S8AHM"UT,L>L:.=9T>8*,+F,WK:LPY=E=&>U MN_6!LN'=H4(K"[H&46JNEZL,FH.NPIA&U=$T9&9F+I:FT57K]QH8?&(Z!B+F M1'2[`P0H,!W;O5I5%'U\=8]1+D._D@SMSOJ]00%I1^N*LZ]83J9;[S'ETLB3 ME8:[7K]9P#IQ%;@S9#Z5GZ3>++Y=$Q4&\IF[M_C4)_]D:B[(0("^Q1UZ;>[EQ?-P45O<#/H75PVKLZOK[*B M+H-.MW>9>U$75"/9O1I)\\AJ)*U#BV[L5\5DOQD+?R,*G+NE;+IR?(^DM8WW MS>:6OE8Z#X,*E=0=\])>:W,#1^86CES1F)*S?_HT<5S^G4-FT+N99U13RL=^ M6=TC#5CG4`NF=[FALI=3PO.9_7R&A""UF[`O;K=S@FI$6M4>NG$CT91;3$'( MV?"9_)GZ][)%P?550=3#6M/)?QA<:!^*9I*B*5L)A:)!T=Y2-&6+4E`T*-I; MBH:*D40Y=+.H<)XP7@=D*]@ M*=PK`>,%XP7C!>-5F/'JH>HMC!>,%XR7B<:KWU172K7:QLN0YNDUUU;'``W@PG(=.HP7_`![`P\P_ M\*F(LFRMLO"`I?77U.6S;P<31D9A,)%[X%P_X;=)Q!8[N4,NGTJF):G=T>\5 M,.LO"X,&X6:NLRH+6;T.>J>`+)"5PWRIHZ["*,@"62!K7NI(82N5TI-5^66> M;.)UY@51]#Z=?SENE$W!F)/S#,PPM#KJ4D/*`I!^K)CK@0RCH=E"D7C@`!QF M.*"+,6@`#=EA9Y;"?)GU=[[OPY>T:K1&$_]\MUVZAQZV(^\X!5H\41=I"F681.IK9=!)?=%)O8U.ZCJF8E6Q'2PZ MJ4/1T$D=BG:,+'=O!'1R+6RMA[FAAB510[TT#7W6T6?]U`+48LG:@ MGG_^<24:YAEDN;1SJ#!>,%X'&*]VOX"23S!>,%XP7C!>JDO_M!KJ^H/!>,%X MP7C!>!5EO+J]%D9>E4K21I_UHJJH6UUUE^.B"JX#JP]+2] MC7LVAT'@X`TWU%$W8D,D7!^\S/5<92'+LD`6R`)9>:PQ*4S-JW2L&]@!N]VQ M:W6:]?S[6U6!.T/6F/2MEHH&N&BL#+TZN:R@5]`KZ!7TR@A9F1XQ5S=./:`1 M?!FZ=RFG`PT-7+'&[4>^B&6H![K%DPX?RXM!"YWC@ M`!QRF*M684`(5JK+BLI9515869H\_1+3H<R<]<)>S9Y^Q&7C[=\HW=NQ,6D5OV M1+X'$^I_(J_)>]/T]\EUXG$JCZVJN;P;.'W$?2-Z848KWLVJ@VN(Q MC[$?UO%>1DR#CWK`_,S"/])F]MXSH;[#_^I]]OGS M3J1L[OE;N?`"^X^__==__L=?9X=\9[9'H\@=<040W_J:Q%]'Y[:=3!*/\N?Z MRI\[O.02#MF8^9'[R-+*0/?B3N:GE"$;_N$[&_WZ[N:JV;`Z_VC_Z_[J'7$= M_@MJQQ\ZUY>]CG79:5Q;_5ZG-;BZ:%PWN\W+RXOSJ_[E=?/=WS;%FUZQ(*\9 MD&/LK_SL2F5).50YR+D7VA-X?`@EHEI<\R9CY_"[/-S?SU2M44(I=0\!_:,T5]YN8^^IB'QUIK;?SJ>UBQ;XW963(Y MB\_+E_6%LGHK%[8:RR9Q+Y^TAP;QU_'@^NE-TB0.9K](AT[R-ZDCLAI<,%FO M'&X6/3J-V,?9#VLZM=FS+!QJRQ*#O-!.]Y]=ZSY_+X0]9#""XHY++-[OZFV+O=LF=RC$-61G4 MD'14@PA-\>A4#8U-\W!H9\':"?GL-N/$:,'Z!+CBYP^FJ:]A\BM40[^X/A\DSUYTKBU ME[,]2I9I.D2.PFP44$Y1F:Q,SL?3R$B:-1*!"80)A`F$":RP"=1(<'DVR.+3 M(A;%A/V8BIE6R8*KN7<6B^D/,@V#1S?B,Y1#HEA;*Z[F$!(X;1:]NFZU.XJF MS(G#^B&GG9&O,&KJ*HL#-:!FG'SR4YIO,Y@@J5:QEGVC@$+VF"S#N%<0+%3``UB(0NDI.$,B4*_4$.],3UU"7+_D9IU% M!:V"5D&K("KM166(6RPN94PL:XD?Q:[B:1#%'T(6NV&:J3=D/ANY,9EZU-^R MP]@H&P=:-9S*!6&O^;\+?O,76BM'8P M72=.8QL@^(Y0EQ;!]PK"UR^@=3K@`WRF""Z_@8,X3'G%><0V]D\[<8.01"Q\ M=&U&[)`Y;JS4B1PALU-FNK75;29`)ALFD&5&95`?`!6@4MY8%`9!51VD?O.H MSP='<>S)U1TDC;XAJVX]_[Z+F#K#.50.K%:]#[``%F)2&(Y58U1\+_M*#&5' M"K%91Y=)MJK"?*H=A-50Z"%0X`)3\*J"U%0XA0%'X`CR0>#I,$ND2RV8LLRA MS]K%5:[8*K,JKVYH1*]>MA#4;J!694D_4`MJ$38K4>F:U310PV584(4:PQQ` MM]Y312+FW)6QR&6EP5*W,P0T5(8&R"?7@<=)A*9-;0#]-Q[K)"IH%;0*6@51 M:2\J+,R\G9L2SAL8V[(J3"0C'Z*_W)0?&#CY!"U;TQ_$"9*AQXXJ('[*YB;Z M-,S9)ME#.^KLE]^PNR!53R9[>2V([2-+9$GH93?UFIS!.L(ZGL@Z6NKV-,(Z MPCI6?.E1+\$M36Y^B2DG<>/WEWZ67R(V\[Q,#+^^:[R3G_DSV[//V7TO"[,_ MF\AESW'O3EA$;MD3^1Y,J/^)O":(39.N)]>)QQ][.\E^54UV__)^\S[^B/MH MP1M[)X3=75'+MA#=@09\7?%'\M^GE>T9QQ`F=H(<]>3*AP`'V&.50KT?LX@1 M:MO))/%D0_6`3X;Y7023:?%5GT69Y-JUYY75[6#**Z3.\;(;1"O=Q@\P.&O=X`_9-30TN%6WGY5(E`A M2!/RI1YQ6$Q=+ZH?<4UU8X%7+?-;++TTN*^S-3B,K<%QCY?]_-=?DNC#`Z73 MC]]?!(^^)O'7T?F"G:\"G8/_QM__ZS__XZ^*4\LAO M-(R?[T/J1]268:DK-[*]($K"Q7&<'5^(Z#L;_?KNYJK9L#K_:/_K_NH=<1W^ M"W[@AXO^1?>\TQAUA]\\2%C.>=BPE+&#CY?W\NN[]L][CBZRXP;=O0[<>Z2A8-BZ M5G_P--,F^?$IU;QAX#F9[^BMV^!#QB4E%].R=>.J%X_)#8>7#S6X[1/UUX7= MI/YS;G.!8\S6L@EJMA4O\J2%W.)@/H;RV&P()7YSQZ8TS`95/OG_$I^19K]& MN/EOU>07,L&1)QH1_E69C7@9/+J.RV2E^QKA?X@2>\R_OOP.ABQ^8OPKR]]= M/2$+Q0UQ1\;M&Q_FA:FODA=Y7CE7G9Q'Q.$N*XFB=#PH1G?$DC<8B9%BS$([ M.^W*3;PRCASR-^20D>M3WQ;EB2,^K$P+N>[8%4F:XH?%74C)AEV MF;G\'83NA(;\K9,',7T6#Q*/^:CN@=_$0\BRQV"RV;9X9G[S2V]N]977,N&( M&Z'+JL#'!W'H#A/YX7QV6OZJR3W]07ZG,3][M/B#O$^:/K0<0,X*!T:+>Y)/ M+B8#BYN4Q5 MU&:JG8GHOR-RF802^>]L&HBG]J4I(/T/_Y-=3"HZ%Z"5ZGGZ3D;5]7R^SM!"L/55\?I1MA)@X:P^8Q5CO$&\BO?W1C?GK[%?]P1SV6OK%O M26B/:;0ECUK;%W65A$))1UQ)N>4Z=GJ6302SV+&\<4>8*FD&/@HUR'9`\^F` MDJE@K26I=84>-?'!`N6!;WL."(.`C?VCUPE@_!9V,RYC\G<(IT$ MB2]]A)++_]3JU%N$?\W;M$/U-)J3WEB[6V\HO;%"]>.GCE5O*I;KJC]]&KOV M6(PTE@=.(MH621/*%40XR'0$(YSIE(59KLM\@.7+)2GI-H5LYB.NI7'6?$]+ MZGUG>DJ]*"#3F86>:ZS+?QZ%P62NM:M'B='5@\\?RY$10''R]&;%L(+?U6LW M+$\Y&T/.V%A<71D+?`ZG5N6*LZ(_-?OU@<&XM/KUMMK;=^"`X8#WMJN8%^@Y M+SCGLSY;>JKK'Z)_GZG3@C!"&BQ:"03-1@*$I2+B7EH* M;9[@:K,PIORBH\3/IL:R.(D8.PR?YSY[*=I0(\,D)GX0$\^=N+&,L=3(`_.Y M:_;X_893`>;\@M%\%LYO+7T(5B,>>Z">..E(A.EEV"%F]MCGH#_P<1?HC$- MV80P8R+N3)YJ%MF8WZR,:]"Y8JT&*$3T07SDYW&ST10?OL0DB>@#XX,O M,2(7*N*.7!%WK"U"(R&;4*$^X=*Y7YXL&]QP_S2[&RX(1AT['=R'V?KKA%&Q M^!.EPZATZ!\MG58^@:)YP*#>5>N`A<8I\KYJ+?XB>#@?.F<#T(CQYQ=J/U-Q M&3!S)JXO`FU4J-O\A;T=[M?6`)GJ*'#SN/D=V"N\.'@(]JY/(1%2.!Q)LM@D1L MY1ZBVGKD8IB]N4B^.:HD'+#K)(0+E@_/ABQ<9#$V.W(PIF82.'-0D2(GWU4< MZQ.RGHU*G(2]'$*MA()J,R<[#;DZNLYB'";4,,LWRY:$*!\>Q_QEJYA09L,; MU=&1I2=?&34^\0=Z.9)>##"H;8=)%FY+']GCPT?7JMX;9O7 M7,U\=5_?3"5879PF.\EA2;.75Y#%W&CN:?C9TD7ZEYD-XMB9-Z'<>M`)>PK" M/^:;,Q=KQRM.X<7IZ8C?]HM3;UC53I?E%VO'+Q?W?Z=B+F#_$09.O.HIHS<< M[,HSS.Y;9`L^^)/L@)43"1"A1+;V4 M&#G)H#=WO#69[;/Y5I:?QU"O<[_SJY_'N&8X\ME\+()K,B/(IE-I_?\]SUA? MX7-MU95.^?E^N%QX(L&HL/41J]M7OAP:KQK_-,BT(TYR_6]9L'S60)W_2Z(X ME3E]GIF[>0B.JZXK%7S5`(9+PR4^>N?RY:XX#:FM:GP\SK*WZ`._CP=QPBQ3 M:N$7Q"NM2:J&'%&)I`P)3IGMCEPQ#N/^1!"2O78Q(,N":G+BL!I//7LGSKXB M@BM^V7?OY9T^,0XP38=_L]/),:WCQB)HQP'C/D#ZIFR%83T':FXX5E>KY-5G MZ6(;[Z%&'/;H2CLT6QTE,0T?6)K`E?TL<]KX">UL5\)I=WXCDB+6]MG)&]S&]C&DZHS1*9"+LD$7GK M@>\D=KQ("@Q";G%H^,S_PA^%+1=C^LA*Q*\8.@@+ MEDRYL-C+46YF>U4J('/QQBWI\K7DY'263T#DCHPH M33$0B>JO3^4V3%K7Q@ZSF:(L+[P<4WWI%KG9G?M1^>74+6:'C<3$0AXNPFV. M''4MA5UEY(ZZ'A_#;/(E:T-DN=XJH[Y_)EP!^%Q&GI!?[<.(2W;U8#%4_&?] MKDY&W/B+%39WJ5-&$DZ#:)$.)JX\8=273SCB@DE?=ZO3F=V7/--G\7*%2?W. M'IF?")/DL-IB$74QHI17\>B3_..+QYS)UIV=;26%/!'KN3'](\W#Y",HUW:G M]#5WNRP+.>F8B6+V,WT,Y(8%,>&4FB?/G[K*M;M=S:$3(TQ;J)14CME="V\Z MS=;+TVT0PO]E&-`BQPS*!PV+ M";W,J+B3L!57&2\I`-4DU6- MF_A8KM!M,`=+6\@WFX'=&)6'+@7$-LP>J3B5R-41>3,+D8M+9B&L^01VZ4AA MF>5JX;Z6=#8C]`-^CLRCS5WZ:APYA>:5G5)B%I3&;:/,B\NG67/DJ3!7,D2R MP-H\`">O.4J?A]]-R.(D%(9ZR1RG`G$2)H8*0ILSSY+N1XNDI/D'L5%*G&4: M"L=D9WX]FR5+X?+Q@-!B]H.KAY^-+83JTX&NS'Z3^_]> M[")-994.8^4>!TKL,?4?1+Q7!.GY>Q/+._RI)[(O+?];8<:]U:DW?E;F.E], M-]+Q]R<\25:FEP M/I_4B&L]2@.<'BFVD7!W%XGHILT68W\^*N=3"G>F[W(`S1^.0RAQX;@*[=CQ M%JF\S.LGEU^/!6-<3M)4!QO.F2[L23F^=<#L:Z-=[XXK7TCG$\'EZ4@DAHZI M$]_Q7/S+S'^@#RF";YN8&>$KMD].EL4<0UB$Y_D$I"C>XBEU_RD#:] MPFRV*@SB./`Q"#_"&-&2KMY@Z_NRB,W&D`U0QXGN@ MH>/)]>.12"V?!U=GYPML.PE/X+=4<91JX1)!RZ];^IC94\^'ZMD(2(H_'4?/ MBTP(=S03S(H=>UT!TN1]48PACW2#),)&)VVC](OB''>SA%K#H_6O9U*]R#![LS")'(B\&?1?6=Y. MU^5>O[1TT[-$+9E5)'U5C4BGGKH"=Y+&S>>WQ0V%W,)3(X]\I,0Y6MSGECU3 M(D`1)7Q@MAPK2"N[;-H6-3]OC9_)_\!^\)/+&HRK?E(,/B9BX$A7A28&'D$B MI_LB,A`M#^)DOH,,Y/(YIRB=,X^D2T\DUB2#\'EI"\QJ<&/Q8N:)?E$RE15< M9G_*=BN)%^=\2%>GQR(=(5I$X19GX19WL<8BI.X[:2A)SC+2P;W\LHQ[S!*_ M1%SD,=UA)1[C0S#Z,`WL/UA:6C*]N<7.JFR_F-P;1X4-=!A_NQ.9"\5%-))A MLI"/=D5X>O,89S4>+0*L?&`GWER:^<#]R6)372*C6K/&E,GF54A&*O6QKG6=^>-TL5H:MZF0U25S,\W@8JS9]_D9BQ-?VQELX3Q>)U M*%_9/'U27E/H^9IFI2DI7.11EA\I[R28K9ZOJT0HU$!8!A&^%"P-Q8R(R,&6 M'#_*J%H@`R+*MQ\E0)TD-FQ:!>EU8J]C26%_*)(Q\4AG$Z/UVD M[72V5(';4$URY]*/+TI&1MP#VN-SW[EBC\P+IN(NL\VQW_CH53DH&?= M=/N-=O^\W;^XN.I9G78C*Q5Y->AVK[4M%9F3]YU)-4V066-F5R/JB;B#^-[2`M9B`RRWUF*#:^HV M^'2&`R@U-!+?L[G<1/H71]#-=EW.%A7F?^(:EHRXSJ88S@[D3RUBX9OMG!NF)<^$/T]CL%RYT\W?BTC?ZV^8 M)-.9M9P&;KH6L1@$+$7]LIEK.IZHD]]WOJ=I.K5>S9G?=`EQB_-DW"PK08[# M^%.XJEK8[#)%-=?E!F\\_G0]F\:=_<#'HWW>MV M9KPOKB[:J/.+.K_KQZ'.[UYCAK410A=E?G>0THK%DS8[LWGD,IT*[BK$\A3X MO5K+\%^=4WJ43R#'PO&E2RESZ7$G]1#2"1]^B6R$;./11'A-)B>9T@'.#F#9 MI@6Y@V!E#OW#\>6D^L:U*EN1)"SIGY7&R_73I0(\Y-3+)1FR+:$>J M&?,2SO/1:9;RQL28?GF6W34U>OUM*9MJ'EE:*O$I)2B+;&^P`-%\RXU,3A*Y M%HMMB*O[:.8KY;/5V=DITE#)TKJS]SS;.Y*.N5454]Q4&J$K@TQJBLV9J@&W M+'[Q=E=FNYE%'#[/3.W"NLYKD2]5QA3PB+B8C%I&'PM?!,%(GH^VCAW*=SL' MCN6M0^<`!5^OZ./P?"JN=U`3\:HW)UPQ#-:[MX6UVEITO4?H(<+<:(LV3P-M MN?RZ].!'=%W=/`V\24=L_V(T/&#"!ZT[1.M:)U"Z=5GNWOOVU#JZL5C7@3U; MH8?0PR/T<'UF!#V$'A:OA^ME=I4XZPE7#8_IU-CZY4QOY0ZLYHM)[`?Y&R6B M3T,D(KQ&O?B97(34=W:.B6\3\"%R/&43^V/E^),JP6W5S+<$F(.[ZDV8+A6FZZ#Y M9G6GE;^)C36NO<_$A\T@`;0(`^S M+'7CL[+@@,C^,1IUFTC!D\\364,G#\:4ROJ$\)VUZ]W"YI$+7=I7*">;9+]' M6$[8I7%%X(LD+4S6=WZ`&`AG*=.H2YGV^IRH>ZT&U8U[U)4EG((&T&`X#2UU^25EH0%!P&,4:KT&QHM=OK(+ MB?9S*569Z\K'>HT"0AB5R*I`?,.T^(:N3/:M`J(?8!),@LF=F6QV%09%*LTD MPI4[J-L7%D4?15MUYHDJ-4R4C9V&(B,QWE2Q"C',M07QA@)>]Q1-E=?%X3"K MC-KQ6<%`#:@!M:VH-16F>0$UA&85AF8/#,?NH:,MKJ-.D(B2AL?PB\V"NTBV M[+L)VPUUZ[:'"[,2,WY$X0X?Z<`\PCR>:`T"YA'F$>81YA'F<<-RD,J='S"/ M.\[17^]=4]B-+0E-KXX(Y7J:G?L[S'JM;.WO(-ISB([ESJQ[W6C6HQ;]'M#O M89?CT`]!C_O4^_E0>1_]'G8>2\I/Z/>@@=:AOKGI_1Z438:@I"524LV:04!) MH:3H%'&B?(57F_6J"HLBGHS2Q1L/ZRE<3*MT,!AK93FME<%TP71M=IH];'R" M[8+M@NTRSW;UT:@+>S8+FUZ>VW\F;N2*)>?9LC1Z1L2?6BT%>U9*5A((*S.5 MQ:'31;TXX``<5H31;UI-9=I2%BH0[#]&L;[&_$^YCL.V+625I19WD:4TT'L" M`:+35@0H#;66@NYDH!;4@MH"J;5ZZGH*'BRS2@^@3S].5J=-]T%,/<0B\ZEV M7!9*$'RI+`XJ"PT#!^!@.`XJ:_R6!0<$(8_1J+2,+Y?Z!YM&XT6)-->WO43< M!W$G4^J&$W[Q2&YQ7B[Y&XW%QN4A%9N6Q?9EYD=R0S-A/\3/)VEE5I:)UIG5 MJ%N(CR`^4@Y/6QEL6WT%#::`+;`%MD5B6V#=XDI3:VC(L]A1>1H6G141$H-I M6PRWXX`,&8E8''O\DR@FQ,?L^6BMJEIT5LMQKJTF6W5Y:K0O(Z M(GHP73!=1:RNM13V+83I@NF"Z8+I*FCII]!ZOE4P7>4IVWMRJ1YS\_E6Z7VQ ML"4FS:.T>*&H#R<7M!:?V]FR%R-K3WO(Q7\:U/N$?\O;U!#SD!/*VU5S:ZU. MW5)Z;S51#5G$*=Q'YCW71`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`#_#M M`]]`87F9LL.'M;2-4T0_*[#"HMB=T)AA74W#86E9&$3($^2`')`#DVE%ZN.&R:NHE;\E#[+>OB(-F%I M!$LCNOA!D`-R0`[(20>*5D?!%B0L<8`Y,`?F3)N$5759\3NS/1I%[HB+1*X; M'M-4:^5FHF3ZBLBYY#ZM=:):G*4SC3,XTE?.3[3G,&?W0-"6RN=5"A3EL=9R MJ'BK,N1&-!?1W)-#"@@!(3RITE&]@EIKJN1:]=D`Z(<+UI=NT)O#7+[D4_8M M39=ZLNG2/MOTJQR!L]KJJA=79<`,SY@O,KL7N]:/I_RB2.6N_0WFX*;>%6U1@2\6%97/E+'`>.2@NJ^* M:^"+H#&0PP(EEEM`3EZ%_H]O#PYG!>2`W!Y-(965@@%R1TSO*KM"FG=OC4J% M<5IM==,]A'$0A3V]SZT4OE9+78MFX`M\@6^A^';A?$$OZ#64WDZGW@"^.L^1 M2SX5KG8CDS*:%$M=4@4,!^+90`Z+KUA\!3EY.2MEPU\X*R`'Y'99?,7X4(>) M96477Y,P9+[]3.*0^I$G9YVYQ)'06BL7/XO66H@BZ^^Y03]:U*)")B`N#<1G M#85[7>'"X<+UI[]*=*NHDX9U8*P#'RJ\+=TQN[([YCYY@KG&V(SNH=15UY.L M$CV4$-`&;(?"UE/8<06L@36P]CIK#84-5L`:6`-K;S3R4]A_O1*P88EVGR7: M8AMQYA$TV\;O&JSJI&=UT&D,ZRA:>,>2D:6R$ M;16ER*I"'Q;QMLS;BJAA>T2DZI03-`7)L-BG!9=5#AJP>Q%4@`I0`2H,6;?2 M?!:#T96:N4J%%Y].U;ZR9$&]LWX!X?*]DXKW->[Y:1K2_;5PA66CSE)0W1S4 M@3I0MP]U#?@Z4*<]=15J;),:O"9BHB5& M!2L%H`)4@`I0@?4S;89>*-")!;B#ITNY=4?+`#M@!.]4%*$$=J,,*F^H98[NMKJ<#5MCRF$N6?,I8T2Z"9H9FSUKJ,K3A MKQ&O+3$J6,4`%:`"5(`*K.UI,_3"VA[6]@Z5:N[-]V8QK*(Z]YQZ+J4P3[*X MKCPEG(0A:`IJT1!/XY$O``6@`!2`EA30*BX[*DQ4Q:IC'K/ M=<<7NBA>4'^F9MF=W;L3%I%; M]D2^!Q/J?R*OW>*F0.J3Z\3CC^W^+K9[5>%V__)^L5S^B/LHW!M;(@1*JU:Y M+1[S""9GFRN6W^FA"G,4UV(SR%%2RG-OS#1DD:BE0.(Q(^&+K3(D&)$I\R/Q M(_4=$O`OA60:1''(8C=DH@H#&3*?C=PXZ^S$3Q>'B1TG(7^3XA,+'[G&Q\'* MB5Z<(ACRATLWY]2/-A!O2?(EFMI9P&-N7GYV?3X\R^A1^32W+'[Q;L5[#)E' M8^80.VWN52.N;WN)(_\<18'MRK_R'_G1[F1*W5`6[I#?$]E^_,ADDHA4OT>I`[$:_)FS M002W1!Z=1NSC[(>UA]_LD>86K+UQ(7@'AR+OY==W_<'/>_JR[$#KP..*N=Y^ M;E2_+(?\7,[=E'&SX,7/Y"+D)F2?(C[*,_*5Y-6493JW3?D*R6G(OX^IPHE: MV;.R#C)BY;15O_%!;NC:*+\T`/1>6J&G5[!?0-J32"92+M,@BG0J$1$WD@? MAR7,U]\&UC;WE/XQL^6R+'H.NO5!/D9T'X%C-;3P&]-VD>(N&48Q]6,^9_>> M"?^/6,!*%[8VKDJ)!81T/L([H6S MKJ\:W4;S_+)Q==WL-B\O+RZN.EZ$%>RQ![+3@6=`R7?I1?/VC&_/3 MV^EOGM([&0:>,ULEE3(E2T(UDX_[A=J*M5[Q,/_F+RO,GF\4A&0:!@[7/Q)1 MC__E:7/]=(F.V@#=,GEE8 MX^=R[3&9T&?.748QH)X%D4S:XZ.Z=XU%1$Z4*D ML!:N+98WAS02W=A\"5'(62$Q"R>1N*C''JC'#_DSR5:U94\W;E$__+-^5R?_ MQXF.'-=.%[G)\IN(Q+K>[.(1X;?"_=S#F`@MF#*I"F*!U?>9M[+"ZO`+V;$G MA1:RF+H>F8YI.*&VL%+B(?C!)(FD&4L?.OWU[`*.RXV-.TSB(!2O.I"&D1O- M)5E$&T\N[B+B:I&D]30W7ZI.+KFKIUP(\W,)>\LM96I@YU=GSLJCC(-H*G`4 M)Y#+RL+U1]ER\Y"_$*&P6=H"L;GBN3)[@<;R]/Q:CZZ3KA[;V?57GE.<9R$. MH?+,E:9>/+7CCK@R,V&_ARQ^8FR#J9?OG5]@&G*=($_\8$(76I7*ERU?\[^% M)CP&XMOI,5/JSE>W9TK`[T/K!'D+&K_08>,ED=K#L"YAP]:J3_S=> MO;]EIGV6,]XPL2"(O_5[H"%D0ZOP?OW69A2'?],(2S-H1SE;W MY6NHS=Y!;4X+UXXDS+0@=9JI[>`O(5E2]RA[-U&J,OQ5+2Z08B5MPIC++0C% M`)&P'X)?\3)J2]\=)?QRPO!PC8N6_S!_!5S8_'$";DT\_CB"F9D77WI[Z3VF M],IW.->)6GJ8,#1:223+H25XO=` M)T)MQ'/,=6.A,,[,D,[NU/67+2@_:''6M\R% M616I2BM.,+4\$S?.DE(>A'_QA22X]&D2C[F^RH&AS$>Q)9WB_,(3<<"DN+F& MNUP7SFT!'K^*]UPCD7A9L;PKB<./;"`J;XS/A,9++TJ:V!\BA8H=,*;<,B1< M&4#>V6,.KL>^COC-ILDYS/DJU%NH1LC&(HWKD7WVN;*S+WP@<"_F(_L,+SO6 M1?O\XL9J-1I\.-FZ.&]=7:7#R\O!I75]YC,&$G^%1+`"K(6LAYR8[, M)2T\/AF.W5:I4QW.MUQ>#X][E/OYS-D<5"[)8KY[;9.L#ZX M199OAW!M[HI8J";:O3DJ-"]7>G]0N5*H'E3O4-7[I[\T<1-C<#'1N.*'/\I, M^N-S:J&&4,,]U?`W$6D[$\KX7FCC1;HKB'SSN'&$/D(?"]#'I8`%D1$+LA*R M(&G,XH`U5R/S74Y6VZXO:]LU3PG]*;,%3I_$LJLNOB7`'.2D/A&]5T#7STKD MEQADUK3SR#!>,%[["RJ/VDDP83!A,&$P847U%^HUZ\I&^6H;"!F@9N@N!,,& MPZ:E8>NW%6YLJ/2@S)!UU_R8^_IZ/L^9R*)^7Q-)7H?$?ZNV8[-^?+.,BFW8 MU(\S[<8'5:7I3&5E@1U%4^4.H$"MLJ@U!_4V/!<\%W!2@U.KN*;69<$)F0P' M9C+T9";#/B.ERM6HLCI]A4"6O4B50=`9[/%*@I;229K2Y14]C#=64$!=#M2U MF_4^L`-VP*[0<62CKS#"7_9Q)-;53K:N9AA79\V>NOD9O!9BCR5F)8>%KM(MNQ-+[H-AI<-D/MA.V$[93;Y6$[52W M3J6!Y:S$I'PIQ/E+3+E<-GY_P\]__26)/CQ0.OUX9X^9DWCLZ^C&SS%#X$D31O;C./1?*A1?8?_SMO_[S/_ZZX5P>_Z-,>O@Z^N91 M_SR*6/SB4"YW7PCW.QO]^N[F2H0<_]'^U_W5.^(Z_!?4CC]<=*][K?:@?=&Z MNFD,KOL7-[U!L]N\O+PXOSB_;+;?_>W%RUH6_+T[81&Y94_D>S"AK]OCI<,] MUVNG4;LX^R'M8=?W-3RNL/"S#0W M+A3ML'0A;^;7=YW6SULMV*J1S0ZT&H<>6/1QN%$S;]20)#_MQNKSV^WHW1K/ MYL:9A6H&B_)3ZL/XTWE.>IY_UN_J1(P9(E6#2*@7U&NN7K>!_V%_%8-9,[#C MYQ99GEH35>980-6@:F^KFK*%0*@:5`U6#:JFA:KM;-60#/I:M/[ZS\2-GTG$ M[(1_PV7*IEU*I6?"ND=3736@JJT'_ZRETI7,EX#6%5HUK1$$6D$K:%W+]`>L M@!6PF@$K/&ONL!JR()&?I*[8,,YATGKT^M;IJ.LI:U!0EO0X_7@PRW$!!L`` M&,R'`:4AP`)8R,)^8$'!3$*C6$!^4XQ+&HT)]1UBBQ_8GXG[2#WFQWJND&G" M5RMWX90%/(,8,\L[E1&K_"M_`RM@53FLT+0"@`$P`*858)5?VY';SQ&K0!E\ M1/`0P4,T&RR`A5=8&"@+MP$&P&`Z#%CS5S&3T&C^GM\4XSZ(J:=L1GITQ;>R M98!:#64LHG@F,KIU``/X/40+H`'\``>P)+45GW>HTOQ:@><) M?SMQ]-G?M6IT<,&^,SMX\/ES.U^Y7MSR*]S(4L3_8C3Q.A-P)35\&B<(]O=6"W/7C@/@L)E-^[X2BEYG!%":5>?A0QKWFUG_5-X(?(CM!05,K.ZFA'J(%]BAK8_2-+ M8/=Z!==/'IA2YUGKYS,DM46[L>K\=ELH`_>R#-RL3<)%ZJA0-AIJ5XC:\?%0 MR&(W9!-^K;VU#TMSK\V%SM.!JQS_B:8E8C3*1_P)#5T^W/3X9.*4A*/%U2YZ M:'RLHYY_#9M*=*@RR*)IYWUANV"[]A=4D3LN*F'"#)FS%C<@FX9N$)*(A8^N MS61<\)`IQ;:"YDVAZ,*J*A= M\\MUX>[MU<+%>3[[%]2COLWNQHS%>R_^G5^V.S=7_5:[<=WJ-@>MJW[S]D^^^(>EG[7AT@*S[LG:GVJ]-E+VM1\\G]G/9\@\2-]A7*_JO3>Q4@ M+5;Y[8]NS$]NSQ<,Y7Z$-@\950^,,B1?FE\9P&_@?["0,1;"5R@W$IYR] MZ2$39,?S0I@ M!V`'8`=@!["&M'^KU2R`X+ETZ'IN[+)]H@@[;Y3)K\-6L8R==>OKM;#R"HF6 M>6N-0?!IY[*K1UVSW@-UH`[4%4I=&[X.U(&ZPJG+OP)2%:C#^O#2^G#.TSO3 M&.L.4`A!I0>#HRHO*SVK/@`K8`6L[#!VZZF;,H$5L%)R5II@)>?YS&ZS8LOT MF8XH5"VW/NVU\TG9-'M;5Z5#T$3)6"7]J@RO*7O6Z2@,PJ+[%T*XFF48P7;" M=N86Y5,92H?MA.V$[=1;)6$[U8T[F^IFY["=L)VPG9JK)&RG2MN)CMVGMYV& M)("\M)NS:O>]J=K.U?F6ILA!;J;)"GH%O8)>0:],D17T"GJE1U4FC6:Q)Z[6 MZ?J$+MI#D4#TA^)WO-0@BG]%=(B2R]IN%)-@A`*>IS:6&NFO=H*#QD'CH'%& M"$X;84'CJJ!QAL3GUH^T3V]3,2>EE6 MF(=2F0>K`_,`\P#S`/.PR3S`.,`XP#C`.&PT#DWLW=_'.&#UZC41?@O=("01 M"Q]=FQ$[9(Z[S_[)W M$6`!+(`U.\QJ@RR0!;)R(*M?0$G0LI!U_*IR.:OA[)Q9F,^T1-4.._WW)Q6W MD>Y$\E(>I!KT"ZQQOH%%E&`88-A@V=3JLW^1%FR^$_6:[\7Y[[DP+KS`_N-O__6? M__'7#>>(HF0RC=W`C_X9,6?U&+%K5DCS.QO]^N[FJMFP.O]H_^O^ZAUQ'?X+ M:LRW;UJMZT[CHMEM7EY>G%]TVXW&N[^]>#O+DKYW)RPB MM^R)?`\F]'6SN72XY_KLPVS_=K/Q\PIJ?<[5R[9(WPYP/E"L^?6#$<2,[#2?2F)&$2Y7$`7%8S,()OWOBLYA,^2D#Q[7)D/EL MY,9WN=\C$AW>$TK'J0Q.T?V&L3GY8OZ03BAWLIE+?&=^8DE M*<1FGI=]Y]=WC7?R,S<#]NSS_@KVY#KQF/_(GSFS/MRR>'0:L8^S']8>?G%3 MR^'RN44:;%SXV"'@+N_EUW?=SL];;=VJU6PJ00X(KB4ILE=9$-A)?"[Z>!_V%_%8-9*T6"S>Z+"*=64_UR"I4MP$!)2Z2DFF4C M0DFAI$?D,<*C0P_AT6$LJZRD\.A04NV5%#L3CEX3O5K>.*V*^0KF2^9?_;3R M^9(&\:J=EP&NJ^DP2&\&KL#5$%Q;"AO1`%<=M`ZXEAC7)G`%KL#5%%SA78$K M<#4&5^RD+P!70Q*]\I/4]8\ILT43GI#%2>B3;"^&V//!8NS2%3T:L:,*>P^Q M]W`74I0G/(`4D%)"4GJH_`!20,I.(4:0`E)`RB[1/0ND@!204F0Z#3-.@1T@*Z\T"DKF%YIZ/:N#[UT M^WH5=1;'[=U;7=NG.;9$=5:5.MK6$+SHZM1KQ10,KT\]H>&#ZZ+RP+A1W*CN-VK(%@#M!M6H,8P2UE`OE+`NJ]ZA3!L*7D))RZ>D M*'@))=5>25'"&GJH@Q["HT-)M5=2>'0HJ?9*BA+6*&&M26Z`LBVUJ"NDA=:5 M;+P.7($K<`6N1N+:KBL+W0!7+;0.N)885Y2P!J[`%;@"5^`*7"NS#:5,N!J2 MZ&5X&9ZCLPA+57/@(.CTT!94B"O(VX$8$`-B0`R(`3$@9L/__I)$'QXHG7Z\L\?,23SV=72^J$#RSX@Y]^)\ M]_P9+[S`_N-O__6?__'7]6,NTC(D7Q=%2#[[US]L%D5?1S?4#?^7>@G_FMCW M>2[[L:V>E4O8%V+\SD:_OKNY$NGZ_VC_Z_[J'7$=_@MJQQ\ZW4ZGU;BY:G2O M.A>#9N/ZHGW9[#8O+R_.+ZW!5>O=WUZ\EF49;RGNL>FMZE4FYIQ?6XB5>L3U M1Z((BHP-ALRCHN5='+RH\.)&>1=X>:'JAI=WR:%VR[&E6WJ]@JM4'%PJQI#C MBGD^0Q8QM!O)S&^WI<6.#-TV76BV?0VJ5EY5VWF.BOT]KXE5?ONC&_.3V^F) MOJT,SY[<>$RH;2>3)!W`967\5JKXN3YA<@@MEH276AF_/9P[5-4+?"TFV`AM MA%5>XPJ-4SEJM,PUF>D,]TUK:&!(3+%\?E(M`@."@-U^O:_JL=6\Q1.5+\;X MWL2@."S`T19@T%:7>%L6"Y#CM,OT0818:B"/8JWAQ9SID`'LUM(@N;5;*!:R M)H=,6^'[-L ME9K?`DE7=Z=A\.@Z_+DHB9+)A(;/PIF+?B:VE+Z,C*ZV-Y%.GH3S]['6#27K MG[*FB7O><\9=%OZ7DG&8'83R2A^%QK^Q8'.(?`CUG2+O>CWV?\A=(^$`"0?: M+,@CX0!1HC<'HT6O`EL'K5=L.,GZPO#J9'[%5R,I`>I8:CLXH"^)G\MJKB M&W)4)ZXT6)*CO%J#`MJU2\/64D/U7-/`_8#O,=\N?BW2 M.%0L[)W=AY6#?)&RT;1I3LJVQ2I;(+8FB!VG^U2EJ]SJOZ4N>[7T(T),7Y%6 MLT=U".2K8:IUN/Y\H\^862T;'*7E[LI"#B91H`)48+ITA!Y=)F'(?/N9Q"'U M(V_?K8R5&]B=%3&RJT)0`],I3*?VB:YKVNK-,.H,2<4L)'V(^8[ZQ*'5W+?6 M]`=Q@D0D:!^3_*:LA4I9%NQW%?+I99I_"E)7X:K^-KD6T,OG]/,'_=*U6M]D?6(/S MP54WV]1Z?M'M7IUC4^NKFUI'BQ(6$T:C)'V=$?\;'U0G$>.$\:=P1QPN?F>) M'PPC%C[*:[C^-.'?///8(_-(ZSUVOI9CY^M:U4_#][YR[7]P_?0F:1('LU^D MPS?YFQRVQ[:/W![;+WJ[*K:/ZCQ(1Q'AU_?B??:YWY*!H$O^]Y"/"'9>:L?6 MO!UB:W=L&K/)D(4+S6WV:H1[,65QW$,D]^IK,*!)L;+B>H=N=VFJG#+FF=1H M-=7EXI]28[2:!^KL>O.#[I:)&4S(^,G_S2NHR^"O-"N5&!<( MB*9):(]IQ*(:B:C'TBUD;A0E8L2`XI=OK7TW"BC0A[7O"CBSPG*]R=1'MUT6CUKUM7@\[EH-V]O.HU6K/.,(W.9:-5[B3:NZ4L5WLN79$TZTKY MDIC^X$\8LK1E;!Q(B;I^(G)N@RD+L^XO-.2N)(FO!3X+'*+K M\:*4K<#E]\2JE\H:Z@H.EF5%"U-0\%\9_ML-=67U8`!@`&``3#,``XP`BHP, M&CZ7^2PBN+[,Z*!>>28TE5`5&UHV7D/0>'C1V4Y/:A%CJ@34#P8Q4Y?84T0 MH`@4@>*A*'8M>$4-AK$:S1ISS"IA(\8'N`ZR-$^]WJ61NFDG.&@<-`X:I[_@ MD*6)+$TD:>B:I''64#?%7^?/F#>OK.DZW"2,0WF,0WN@KMH1K`.L`ZQ#F:R# MU5>7X%D%ZX#D3R1_ECR1AMN$GKK&5I4NRXQ('1+8]N!NH*Y6,[`#=L!NIRU. M"A?ED39:]K31V;KZ>!M1\1\SJ!'ZM5)AU M^^JV&X$R4`;*-CJS%B@S(L):229/D("-/COHL_/I;-!4N-?Y:&E6UJ#"=L)V MPG8:9CLME9U183MA.V$[]59)V$YE"SHJLQ?0WG''N?KK[1T+N[$EH>W=.&_% MW+3%-U0Z\_=DMG^$A&SD,3N.R#_K_U,GKD]&;L353C;/K@A%SLD[!=V/&]N^F MV;H97#9N!IW&Y66[->A8YQ<7YVDWS8MSJS^XRKV;YEL=:8XB3GYK>_+MR^7!&E[P?5]^O;VZOKV[OB+\I[NO7SY?G=]_OOV-7)Q_ M.;^]O"9W?[^^OM?O8>1QY[(_Z=K-'7*J?5IA'W+^M[$^G3[(KW]T8WX!.[-R MW$#QPSS1S?7M\?7I7KQRMU+:VUTZRXIKU+9A[(2&#ZZ?WB1-XF#VBW0R)7^3 M0T_99N/(GK+M;L$]2?N&]$[%\^'Y=+Y/O9\//8'1/?/P6>LK,Q7*!W>^_4<8 M.#&9>NNE$)`V`[7+6>U6]IB1&]<7@09R5S^O0QNAC05HX]>8?Y?<)O9F+@N\F\5['D4L MWH=EU*X[$')MA%5>ZPB-@\9!XZ!QT#AH'#0.&J=E#6)C)Q#I="SK6)7.&W(I M[%]%O=)/A;23#_0'^@/]@?Y`?_24#_0'^E/LN'JWF8GIQ;XN:326&RUL\0/[ M,W$?J2W[*4%$5#2R/_#QAAC8ZP.^M[# MRL#*P,KD:66:5DM=%R%8&5@96!E8F?7#I,+TFU8S?]1@:V!K8&NJ:VM:W8[" MZI1EMS)H_'!NV_S]QA$)FLK2ZA3Q=<37M71/``R``3``MCT/I6_5^T`+:`$M^"X`!L`,`@R^*_=H1ZF" M&E=LQ,*0.<2537E(3'_D$]XPC".$S!$R1\@<5(`*4+%U=UR[J6[?"G@`#X;S M`"\!*D`%O$1>$_!JI!M\"]F4N@YA:9/<2-:("61G$#LKTD@/+NY>E7"856\A M&):W`."TJ@=6H]X$6``+8"E?P&ETL(`#M("6$7$)``;``-C"=_4PW\HW]E&J M$,?E2AR#C)GGD%$0DHAZ#!%#Q-$/?TYX'U`!*D!%9:AH#@;J*DV!!_!@.`_P M$J`"5,!+Y#4/KT8.PF<_9J$=3/BUGY=J$N82`PM"AX4SH5C3'R0*/-F*D&DU^_4NT`2:0%,W-`>U+A^Y*BO6!3@! M)^!4!>?9H-;O]A3F`QXKMX6B[2NXDTVTWH-OQ61W-AME!H_L@ MIEX!>U0,@ZW=0+59+$5@*6*V%-%O8"D"/("'6?31JK4&%I``$D`BI\`"X@/` MI<2X6+5^NZMN<;DL#B3']`[#LSN^A<&4/_USC4P]*J;JOD/8GXD[G?")>VY] M)Q$\VU\T96'1(.S,=5L`#(`!,`"V/:MB@/)(0`MHP7+-H`+<,%[ M`3``9A1@\%Y(.=A+8;X$XKY9.$%["X32$4I'*!U4@`I0`2I`!:@`%:`"5(`* M$R;E&H7!\DQ(>&11+`H?$-EHZ7$&J!YRYV#;8-MTLFU6M]9NM`LT;948FIF>Y*B=L9O? M;JO(Y;8M0C1!<-H("QH'C8/&0>.@-G.`0X!&T%!XV#QD'CC!"<-L*" MQD'CH''0.-6"JWSQR,LD#$7GC*59Q<<\M*Z*RJ6?'FDG'^@/]`?Z`_V!_N@I M'^@/]*?8P?5NTQ.K),/N"8V3,(WE!R/BS?O..VP8GQ+3G!><],GYW*9MZFN3 M8KGQ],N-"#1I-"2`K3'&UC31=`U&!D8&1B97(U-`YSG8&-@8V)CJVAA,FF!K M8&M@:PH9SV!`L[N1.3XAP_30\+EM\_<;1V1*G]'",R]O719>L$9762H::%<( M&D##K*I)JUGO@P?P`!XP9@(5H.(5+]%2MX)9%AZ0I_769#Q,F"/FXF'@>7+# M=?;SAY!Y-&:"E0C=.]%<$$%V8YQ66<#"*A8``V!Y#A<;+84=.(`6T`):\%T` M#(`5X[MZ0"O/&$@I0QUA\$P]L2,-X4($T0]_3K@<4`$J0$5EJ&@.U*5Y`@?@ M8#@.0T]:Y6^H%(.PAB_C5B9X5CO$6]1@3!W@B"J0X9!2&)*(H?Y..TR@(0`NF@`E2`"E`QB\JA!@)P``YP$J`"5,!) MY#P5KT8.PF<_9J$=3/BUG_.L23@,0H>%,XE8TQ\D"CS7(7]IR'^EB9$-:MW! MH-Y1%B4[5&QE01RR=9[D`MR,>HM@6L]/KFCV3`[<'0?Q-0K:L.*8<0- M:KV&I2Z#OBS08%6BND3TU%7:`P[`P70H2N48[RA34^,;\R`W\M&=G$,4A MB]V0340RPI#Y;.3FT[73,*RP1Q+Q<\3/006H`!5;PP=65]WF"_``'@SG`5X" M5(`*>(F\9N,:Q;_RFZ9?^X]N&/AB7DX]]+5`M!G19H-]%0`#8``,@&VO0M;" M6@[(`EEP70`,@!D%&%Q7WH&/,L4WKMB(A2%SB.O;P821F/Y`"81\W%19F-$/ M#W.=#J@`%:#"<"I:-:O5Q(96$`$BX"=`!:B`G\A]#JY1R"N_R?G7F/]I:6:. M_`/$F!%C-MAA`3``!L``V/8LU::%51R@!;3@NP`8`#,*,/BNW*,?90IR+*H[ M+D4WR)AY#AD%(8EH/@T]#8,*$75$U!%1!Q6@`E2`"E`!*D`%J``5H$*OF;E& MD;#\INR??3Y?MX,)O_8S\0+J1V1*G^DPGYEZ6>)B"#PC\*RERRH+8,U:M]=4 MUY<.<`$NP`7O!<``6`&`G17EOM8595_!F-]<$N2!/+@VI"T%-/[0,]EN@"E2!*E#U9C"QW:EWP!-X M`D_P4J`*5&E)%;R49HD=#6.C&O+3$Y,W-`P\)SW/?5!$WXLMBJ5CL`G`^H`&OK8B6#>Z`X6K>L`:6`/KDV/=KO6[ MEKI&?]71?Q/V9^+&SWFP;5@HNU-K65:]J0K"LN"B'QGF>CO# MB+`:M4:G46\`"2`!).1AK5:MV^JJ*R\')("$X4B"DQ+YAG M("E&25+,EZ5RI=1WR.J\_GK?>?T>(:76]`=Q@F3HL:/RUDX9ASJ6XI\*D^Q6 M'2\X'J]\EMFI-2R5^XX/%F@EPI]8UCA\2`(3"1-Y$A,YJ%E6;DE<,)$PD3"1 M,)%&F\A6O]8>]-6M5:[//HS391.KV?CYT]*#VDQ4 MCU?UJ)L7:'X___+E\^WE_WS_>G5/OGVY?/.9-;KORZ^W5]>W=]=7A/]T]_7+ MYZOS^\^WOY&+\R_GMY?7Y.[OU]?W^CV,/.X\(L&(W+%IS"9#%BY<2[-;(\V& M]?;.YM.]!/GUCV[,+V!G`S77)_PPSPW\Z.T1Q>FD?1#=:FYWZ2PKSERL\LJS MN#X?IZ2?ER_C!^&$>BO>R!+?F9]86AEB,\_+OO/KN\8[^9F;4'OV>8.@[MT) MB\@M>R+?@PE=&R)-:/C@^NE-TB0.9K](QV/R-T^N$X_YM[D@,N/.#;='IQ'[ M./OATTMCO;COY?7R1=I$8V.2PPY+[O)F?GW7MG[>ZDM6W5UVX*''#0J^'IX/ MSX?G*_KY#-E_H]VT=WZ[K1.4F-HBR[>G%FO^7'E"U.^4CY9\^X\P<&(R]6Q5 M4S2H'=1N5[633M3WV;DKGY>AS9"&PO0QK0B_%TRC%S'I>%^ MM=*@>%"\0Q7OVG,G;FKYH')0N2)4[I*KFGA&&C-G5Y&BG^K.XCV/(A8?5&IS MJZX6*$\3(-=&6.6UCM`X:!PT#AH'C8/&0>.@<>H%9\B21GY)9I=)&/(Y'TGG M#1_S4+@JZI5^*J2=?*`_T!_H#_0'^J.G?*`_T)]BQ]6[S4PLTT?<-!K+JC^V M^$$4\7VD'A^"GW0!+N>N\_ILA3EBIXLFFUD:ZNKUY?S63[\3!0$EC?P_;(PQ M-L;J*^P-"B,#(P,C`R/S\K!N?Z"PZ@NL#*P,K`RLS-IA4F'Z3:N9/VJP-;`U ML#75M36]1D]A_\>R6YGCBWDX+;+P@W6YD`%J``5H"([K-WKJJNP#A[`@^$\P$N`"E`!+Y'7'+P:>5J? M_4?FQ\&>U3AVID=I#+5K*;5`5I`"V@9 M$9@`8``,@,U]5[-7MX!6GL&/4L4X+E<"&63,/(>,@I!$U&,(&2*0?OASPON` M"E`!*BI#1;.A,"(''L"#X3S`2X`*4`$OD=<\O!I)")_]F(5V,.'7?EXJ2IA+ M#"P('1;.A&)-?Y`H\%R'_*4A_Y4F1F:U%.8D'"JSLJ"+Z'01T>F*D)G'\A`` M!:``5-7HM5/O@4R0"3)U(_.L-:@W3X[FNI;M*[633;3>`UM@BQ%O"?SJ\5D= MS8;90:/[(*9>`9M4#(/-:F/_%Y8BL!0QF\P-@`-P``XS'&J-+NJ1@P@0D4M, M`:$!L%)B5KCWZ%GJFF>7Q7ODF-EA>&+'MS"8\J=_KI&I1\4LW7<(^S-QIQ,^ M9\^MYR3B9ON+IBPL&H2=N6X+@`$P``;`M@+6[W=190)H`2WX+@`&P(P"#+XK M]QA(F4(=OP6!\^1Z'L*$V!1Y^'/"T8`*4`$J*D-%L]9N6/4!B``1(`)^`E2` M"OB)G*?=&H6Y*`"W`!+G@O``;`X+UT@ZOR*0=?`G'?+)R@LP5"Z0BE(Y0.*D`%J#B,"LNR MU(V]P`-X,)P'>`E0`2K@)?*:B&L4^LHS">&11;$H=D!PY!5I`"[X+@`$PHP"#[\H] MVK&J$0UCHQKRTQ.3-S0,/"<]SWT04X^<[QOF>%N/@M!AX4PD/X@2)*$/Y MEX;\=Q!DV4G%-RQ^QBCP7&=^PI,+5Q[V4^$"+%A>.60+][L*LX6WB:T`'3J] MD<-"!ZP7K%<1>0F-6K>G,($-Y@OF"^8+YJLH\S6H=;L#A9M)8+Y@OF"^8+X* MRH%K-FN==JO>+EQP>V7)&:!Z2*&#;8-MT\FV6;GE@E&79/:)R$:2P_&!%OWKW=8[6+,! M6D`+O@N``3"C`!.^2UVA[+*CA7R#6:@C#)ZI)W:B(5R((/KASPF7`RI`!:BH M#!7='E:6@`-P@),`%:`"3B+?J7>UT@]$VD$0\Z\1.RL8XRWJ-"((]M:.`:0> MY"X`^*OJ@=5IU`<@"V2!+-5DM7L]H`6T@)81,0D`!L``V'Q4V!S`=^4;^"A5 M?.-R/9I!QLQSR"@(2411]"`?IU46@!!(!Q6@`E2`BMGX:Z"N9B9P``Z&XP`G M`2I`!9Q$3E/Q:N0@?/9C%MK!A%_[.<]:A,,@=%@XDX@U_4&BP',=\I>&_%>: M&%FSHRX%Z&"9E85;1*>+B$Y7A,P\EH<`*``%H*JR^5KU#L@$F2!3-S+/6@.% MA5*.%=I"R_:5VLEF6>^!+;#%B+<$?O7XK(YFP^R(T7T04Z^HG2J&$=?LJ]N1 M4A9BL!9161RZ*-H/'(##[+!^NUOO@@?P`![4AQ40'0`K)69ET&C7^_`="B;C M&H70\C,I7P)QWRR<$(<-XUR":`B2579KDT&(F>N@R@)8J]8=M+!O$'`!KAQR M)OIHOP2T@!8&A@`,@)D%6*O6[[75;58I/5P*4@_,#FI\8W[D!G[:IC.(XI#% M;L@F(@UAR'PV@`E2`BD([8(('\&`X#_`2H`)4P$OD M-1O7*/Z5WS3]VG]TP\`7\W+JH94%HLV(-AOLJP`8``-@`&R7PF/J]HB#+)`% MLN"Z`!@`@^O2BJS*IR%#"2,Q_8'B!_FXJ;(PHQ\>YCH=4`$J M0(7A5#1KK<$`Q1!`!(B`GP`5H`)^(OEF3GR#Q!C1HS9 M8(<%P``8``-@V[-4FTUU`T6@!;2`%GP7``-@\%V:H57Y#(1%=<>EZ`89,\\A MHR`D$N*LJ]@S&\D"?)`'B9E2%$X7&G2 M?1@Y;[X`2&7A13\TS/4[H`)4@`K#J6BU6ZBY#1[``[P$J``5\!(YS[UW#-8T MC)V5RT]/3-[0,/"<]#SW01$]&H+08>%,/M;T!XD"SW7(7QKRG]I`678Q\8WU M*YVRDDE?8:/N0P6ZNW`,YA_![2*"VV`Z_M2I]9J#>A]8`VM@71ZL^[5VJZ>P M(CBP!M;`^N18BPR2;D<#=WU0ADD!Q@#I)V"^9,SW:GT^0F^='/E*N/+*)[W< MC6G(QH''7W7TWX3]F;CQ,Z+4G]JU0:>O+B^Z++CH1X:YSLX\(MH=K-R`"!`Q MVYAFU9JM9KT-)(`$D$CC%5:W9O5ZZK:\8&<+>"DQ+YAF(!U&23K,EZ6BFM1W MR.JT_GK?:?T>$:76]`=Q@F3HL7EPZ*!HW`G#4,=2_%-ADMVJXP5'XW.PA_UN M7DE'^\BS$L%/K&DHL@LA/V$_83]-,)^6LU:K]_+*TD3 M0\S7UX-^B65!\DW?W_#S7W])H@\/E$X_WMECYB0>^SJZ#'QNNR+F7%"/^C:[ M&S,6WXNSWG,17'B!_#=S&-V83Y+P[GDO:%.+^S MT:_O;JZ:#:OSC_:_[J_>$=?AOZ!V_*%MG5_VK0MK8)UWSV^NV[USJ]7L-B\O M+R[.K95'?NQ,6D5OV1+X'$_JZ&5XZW'-]]F& MM\U$X7=5+WSS*M7OYU^^?+Z]_)_O7Z_NR;8WN^_+K[=7U[=WU%>$_ MW7W]\OGJ_/[S[6_D[O[\_OKWZ]M[\O6&7)[?_9WRQYW(T;<9-# MGCE^A'$==LC:C1YRVCLVY>H_9"%I=FI$J+E^SY]^%%__Z,;\`G8V`'9]P@_S MW,"/WAZIG>ZM'60UU=SNTEE6!DEB\5R>Q166,/V\?!D_""?46_'REOC._,32 M>A.;>5[VG5_?-=[)S]PUV;//^]N\"0T?7#^]29K$P>P7Z3A7_N;)=>(Q_S87 M1.8TN4/TZ#1B'V<_?'KI!!?WO9R&L,A&:6S,'=DADT'>S*_OVM;/6WWTZC`B M._#0XP8%7P_/A^?#\Q7]?)7?U73LA&/9R+>.W+28@US?EN6:;U>><_8[Y2,G MW_XC#)R83#U;U308*@@5/$0%9>N+^;UY*Y^7C=7,[6+M4(; M7]?&M'3\73*,7,>EX7Y%Z:!X4+Q#%>_:$8:,V=7 MD:+IZN[BI=&8B,6%B-R$P81\G;*0\^T_D',[=A_E%H^/N:ARON(^JMR*=@;" M%,753G!01ZBC1H*#.D(=-1(H[V,+.P,[`SL#.K(YD!MV\2A&4U\(@I^;@G)K/_B.+2I!38];2 MAT&ZJ9W@H''0.&B<$8+31EC0.&@<-`X:IU\*B[GSBVPZ,16U1`C[,66^X\9) MN%>*RJ)\1+F:F>00+2S+7%T_.O0R*:`"5("*"E$A4V>49>*TRYRCSL!'D@ M#ZX-K@V`Z0`87-NI(RIE"IS(RLMV,.'7?B9>0'WBRMQJT10),4H1HQRHV]E0 M!:+T@\=X,%P'C"D M0C+$`7/ZV0R>3^9)-&MJ\XRH&L+6"%L;YK#*`MA9J]:PV@JKA%0Y;`WR0!Y< M&UP;`-,!L*(\&^`"7)6#"]ZKH-!(F2(@WUD4AZX=,T=N^D`@$8'$PY\37@=4 M@`I041DJ6G4+-(`&T``?`2I`!7P$$A*.4Y:O,?\3@EP(BRP6W'/II9N<4W]C29K%8)-567=A5$5@>E&3%4GO@)4 M@`I0-@\;I+#AMA`6-@\9!XZ!QJ@57^>WRGZ,HX?,')IHD M\HNPT*<><=@0'0!B;/]"9`W;O]8.:];Z@X:Z0#6(`!&&$V$UP0-X``\8-X$* M4/%6J4CX"34S<(T"07E6LIO29UG*_^7;NC'_!1=\E%/>>4FV>6`? M%?91:>G!R@+86;/3K[<*4RV4]P=WX$YP9]4Z@X:Z7:90RO4/FT41B>D/,F0^&[DQ&8GDZ6A,0_9A2,6&?CN83)D? MT=@-?(0K$<0__#GAKT`%J``5E:&BU49):.``'.`D0`6H@)/8^74C^>$U;;D2 M:0ZC^=YF.XABY#@@((V`M&E>JBR`G;4&6&C%0BNP*Q@[E;7K0!VH`W4836(T M"$ZP$5H`)45(8*444< MJTX@`D0L4JG5(H&I/G`I,2X85B%UX9!6%$EHC^G2O@*D++SEDP;->C/WN!@\ ME5;XF>O"RH(=@M)8;05@``R``3``!L``&`##S"RGF5GELQF^QOQ/N;`6A`X+ M9R*PIC](%'BN0_[2D/],0RX/G[9%0E5Q;?!@H`I4@2I0I6IXV.PKK/*ZHVS* M/$H$:V`-'@P>#%3!@YGIP7+,"K$,CX#U#O`$E@"2WVP/&O5>E:_WL`(%R-<,&L&LU:MT2VB>4DE M7&GEDVBN1R-FQV)7D9V$(?/M9Q+2F!%[3/T'%I'`EQ$F4P*_ND)[@K662O"K M'ZH&>T_P"![!(W@\Q434LA16D$UP:/>/,)KEB01J1"F ME8A,?GIB\@:&@>#.5BO MH;!F1%EX,#UY0I=9/^._+W"^W^*S6B=(AAY;9.1589-=(Z\:3OL(%+F/>MD` M_E%/_ MGW_Y\OGV\G^^?[VZ)]^^7)IRWY=?;Z^N;^^NK\CEU]\O/M]^OOV-W-V?WU__ M?GU[3[[>D,OSN[^3FR]?_]^=?H\DC[MQ(VX7R#-7'!$C90Y9N]%#3GO'IC&; M#%E(FMT::3:LMI+3KM__9Y@Z#NW0F+R"U[(M^#"5T;&4UH^.#ZZ4W2)`YFOTB'8?(W3ZX3C_FWN2`R M_\A]GT>G$?LX^^'32W^WN._EQ9W%H*BY<:RQP_J0O)E?W[6MG[>ZX]410W;@ MH<<-"KY>V9^O`;E`+AH?5\SS&9+BKN_LNG6";/4MLGQ[-K@V?E">+O`[Y:,S MW_XC#)R83#U;U:P::@>UVU7M/HNK^33FLP0^";N1'8@8N:N?U_,(H14C36BC M0=HH>X&3NV08N8Y+PYQ:7D'QH'@O%._:MFO8=OUI2R@;O9TG$?W#]]R283TT.:O5> M^,1:#Z'^5+2(U$LDASHOZNI-HRP2HG@P,#`PRX>==3L*NPSGT:E"#]79IPHP MEJU@?6!]=A%)NZFRGT9UQC>P,+`PL#!:;%8MM9W!/`IV!G9FIWVSO59]?0L: M+(SZ.+)&2QLG3'[Y[#^R",DOQXP,B&O%9+#I;R>TN5'PSW+V\014[S^>1P(P'0`#*[MU!&5,@5. M9'EE.YCP:S\3+Z`^<65>]H1QV2%&>=94N+F\"D#IQXZY'LLX5@9]=4VP*P(+ MEH0K"LO`ZF#Q"[``EEUJB-6:K;ZZIJY5"1M@K%5:(I!1A"2)O95FWL/FF?#K MN1Q01U3_Y`_JY++]H2P1-X2T$=+6TFF5!;!6HU'O`"W=-:1*,Z2RH`7?!<`` M6)Z!O&*<5T4B?-JPAC&CYMS!L:'PPP'9#K/$^RDM M%6>M6J_543>^J\@P#@NUU<0%3@14@(JU\+9:'U(B(C"LJB81\!-(7]A;:;[S MJ7OHVC%SB*@EC^`8@F/(6##,3P&P2@.&954`MAM@;74[B0`6P-),% M,Q%9TQ\D"CS7(7]IR']JHV+9Q<0WUJ]4EBJ+1TMTK]SLW45J1.(VPMQY^U$` M_Y!MJV@I#)2#^0(V:V#M&,P?Q7R_T:UWP;P&S)]H)79WV1@0)2G]ZBQ,W+Y+ M_[5NKZ6N3NG!,BW`6&FAG=J,5C!;*3/69\U:?]!0V'$%(Y<#1RY5SA>2GYZ8 MO*%AX#GI><1.*'+#;4M$;L)@0FYS^.6'P^Q#"TM5A'ST[F\W0^\ M#'0I#X]<]5@+=`FZ!%V"CX,NF:5+J&OP:E'"*$KXF)V18$3X15CH4X\X;)A+ M_\6R[+)!/!<1,STC9B4!3,2\6O46X-)=1\HT(*\*7%9[H'"9"&@!+;T$AX&A M:8!I`Q4&AIH#UJHUVJUZ$W#E&?@H4WSC.YO29]ESX66`@U"?`T2G;LQ_P>4; MY;/'PC#`L*$/`>D"_)%A5)PI#$8CAS%%%P:@LAT5"QU+P`I8P6`+@RU0 M<9`'::M+=ZZ"!T%VPVLBO/YALR@B,?U!ALQG(S3 M*?,C&KN!C]`;8MN(;1OFW@!8I0'#ZBP`VPVP/M(>]-6/!<&!H",'@N M+<"J?,K#E4AN&,VW8MM!%".S(1'-QH_U=NX1LHH,X$RAT%Q/5A;J!FV5O5;+ M'IC&FBK0.LUL"F@!+XPR:OT)%@J"S+ZT6&NZP$5):("2[/5I*)5Z[4Z6)P%$2!BGMFC%@E,]3&L M*C$N&%8AE^&0;I)):(_I4J4%Y#"\&9?N%;#D`T^E%7[FNK"R8(>@--9;`1@` M`V``#(!5"#!MH,(047/`,#,[:8W*,@5%OL;\3[FP%H0."V-B M(EIO%@4BYJ*`%)#":>KD-#&(!8]PFCH[3530V2!"^>F)R1L:!IZSR+-R?3MD MHJC.F;R%?007`GQ*[=LQ2.:I%H!K3T$ES)XC<5`$P;J#!DU!RP=JM9 M;P&M/",JI0Z<7+X6'2$T)D/VX/J^V*@6C,B4GS-P3`F@GA!)E8/)BNP@U0]! M#.\QD6WPFZP3)T&/'94F=<"/9L0C_5)ADMZIXP>E4JHUA M0V$`]&!9(FM4+V.JW5`$UA'6\231Z+["#@TPCZHF',B,@'F$>3R]>>SV!PI3 M+F$?81]A'V$?RV,?<]^`"2N)23:L)*RDT5:RUU"X:@_[N.LRSR\QY7+9]/W" M;FQ):)[KLP_C=*G%:C9^_K0D19OY,0M/+T?<+FX7MXO;Q>WB=G&[N%W<+FX7 MMXO;Q>WB=N5Q\N-:ON#OYU^^?+Z]_)_O7Z_NR;+S[>?;W\C=_?G]]>_7]_>DZ\WY/+\[N_DYLO7_W>GWR/)XV[>>:* M(Q(SF4/6;O20T]ZQ:&_C1V^5E*FD^ELZR$AYO3'^D9W&Y4OKIY^7+^$$XH=Y*?-<2 MWYF?6(;NB,T\+_O.K^\:[^3G:$KMV><-@KIW)RPBM^R)?`\F=&W184+#!]=/ M;Y(F<3#[1;K"(7_SY#KQ^..@76^O_/MY%C^U`\^CTXA]G/WPZ64\=/$4RXGF MB\7MYL;UY1URU>6M_?JN;?V\-5R[&E'.#CSTN$'!URO[\S4@%\A%X^.*>3Y# MRFUHMXP]O]W6"2IG[)\L]=9H0OG6I=\I'ZOY]A]AX,1DZME[B!5J![53HG:? MQ=5\&O,Y`Y^;W8?Y?<)"\6[]MR)FUJ^?50.GA74\?@G&,G?&(P\3K>%DF;-I&#RZ(H-F^$S.DHC_X/KO M23"?[]#Y?$<9ZWD7-B_;UL'71:1>(LJ;=UEY;0%4U!I3#\U1UCD/_A+&!\9G M9GSZ]3:,#_K5P_C`^!1?8K#=K5M%B:4L90Q@86!A8&%V%$GN5:A*;6S'E/F.&R>A/AO!T#-6Q[FZ?G3H95)` M146IP%I<-:DXL]H]=2%?I,8`EA+#`A>"@16H@`LYUH5@Q?`U$9[;?R9NY,KZ M&H3Z8HM*3/T'=^BQJ$9\%I-@E.YFH>*;X>XE$4X6$"Z7OWI5-%5Q9!IA:*Z' M`V"5!@PK`'UB2NSJB>,RP[12<3L$;-'S'[-_S35U4NH@I?!HF]U46DW!O4N M8`$L@&6KCK2M9KV!<1;&6>`!LX\<)NX:!='RG-'/YN]\*D^B69>;9P34$+%& MQ-HPAU46P,ZZ?74CNTI'K+$2"^S@UY!A!,!T`*P0MU8BLK2A"2-&SXN(X,M`<+:182U@7;\ MZ:S7**Y1I=HLBP(L`5(P`'S9@.^VV^J&WB#^".)/M.A:KJZ!95^`A8';4\G: M_8;"!!I,4W2Q89BF5!CJLV:K7>^=G.K*CUJJG`XD/VWM('GC^M2WW?P[2%9T MMJ>9IFDG'^B/(K];=?E`?Z`_T!_X+^B//O)!B8)72Q1$4<+'W4RT8^`78:%/ M/>*P82X5![$AIM+Q6%-HT\MV51&P_J"(JKHE0@N+X$`+O@N``3``9B9@VD"% MP:'F@&%PN`]:55YYE(=]9U/Z+&LPO@QQR+Z4-IVZ,?\%EV^4SU8(P_#"MCN$ MH35=Y@$5FE*!Q;UJ4G&F<#?J03EB>@PQT%`!J,"!8%@%*N!`-,PCUBAZEI\( MKW_8+(I(3'^0(?/9R(W)2.051V,:L@]#*NH?B.:*S(]H[`8^(FP(82.$;9AW M`V"5!@R+L`!L-\!:"HMS`"R`I9?@X+E,`TP;J#`TU!PP>*[=P:I\;L.5R&(8 MS7=.VT$4(X4A%R=5%F3TH\-%R%)(:WVC7$(?6C$0LC$@=D2D/FHQ8#`M((2)OFQ'M5:0MWM'^W:[WH%3TUU#@)9Y:&'4B%$C`,MSU-BQ.O4!QHRH'7^\I+Z% M`7_;3I1NZ&`_6&B[D:Q8*3=WD&`J-G0@\2'^U*AW52%7%:\%YU1:&K!:773S%F!'=P;+J%1,H4^;C,>DC8_$^A.TSRJB\)ELJ"C'YTF.MZ M0$6)J,#Z:S6IZ/;5S7:``W`P'("Y#OE+0_Y#H"P'T94%5X/(-->[`5``BB5<`'IR0!L*NY@# M3(`),.$Y=094&R@QM#4<4'A.G9(W+,-#0:+HIDVC,9F&P:/K,(<,GY>::E`[ M=A_=V&7:%)C(=%9\8UUA3]JZ1EW"XLZ/:#!Z6+,`1YL.LUH==5VQ09**%:W= M96/`9*1$;[V2]J%GM>L]V`>--*5*4:`RD736[C=.G&=3`'](P@%FIYT8]C`U M1.*.&EVZ'HV8'8OBGW82ALRWGTE(8T;L,?4?6$0"7P9SC`^OZLJR3HLCE3`% M!E%OKK<%VD!;[VDILA:`]A$A9>4!92`-I($TO'6ET-8&9PS$RXPVO+7.8;:2 M1-/DIR,XB&!P_@`3P@CQ&#)E"QV4OT.A@U M*9F5:Q1]*W"Z?OG:])S0F`S9@^O[8@]3,")3?L[`,3YD5RX/5OG=AP91;:Y/ M!(#[BZ9$@&$]&H`!,``&P`"8F8!I`Q6&B`"L=(`A"6*OJ`KCOS\DGK)'(*`U M_4&<(!EZ;!X)R#>]Z62[N7XJ7(`%RTOCG).M(JM$"IA^ADZ[400L%RR77OE! M,%W[#O`K&F&`Z8+ITBR7"[8+M@NV"[;+X(@8+!@FCK!@L&`&YDC"=KT(^?\2 M4_[X&[^_X>>__I)$'QXHG7Z\L\?,23SV=709^-S:1,P18?,;;G_N8AJS"?/C M>W'J>RZ'"R^P__C;?_WG?_SUC<,_^W8P8:\ MO*%E:=^[$Q:16_9$O@<3^KKM7#K<^>95 MBM_/OWSY?'OY/]^_7MV3;U\NWWSY&MWWY=?;J^O;N^LKPG^Z^_KE\]7Y_>?; MW\C=_?G]]>_7M_?DZPW_T^_?OE__G7_O\_]>$_Z87W^_UN\!Y7$W;L3-#'GF M+(K%(>:0M1L]Y+1W;,I!&+*0-#LU(A1>R6G7;^[D4DP_BJ]_=&-^`3L]TYGK M$WZ8YP9^]'8)TM.]^X,,L9K;73K+RDBIP=VZ/(LK[&KZ>?DR?A!.J+?=[?ADYH^.#ZZ4W2)`YFOT@'N_(W3ZX3 MC_FWN2`R/\Q]K$>G$?LX^^'32[^ZN._EQ>M%<*&Q<>*_P_JWO)E?W[6MG[>Z M_=4!2';@H<<-"KX>G@_/A^%.]0Q;OVW(F;6CZH'%2N")6[Y*HFGI'& M;.=4=51?V*M88D2]TWJ04U;PU&KV#28,)JQB)JQ5:[6[]0',%\P7S!?,EVGF"R,PF#"8,)@P@TT81F"H M"J1.FRZ#2+89WS?`KZQN\B'"+%GIK2T2*@MKR+_2I\$@J`-UR*VH.%56K3UH M%=>$$T2!J)(3!3\%JD`5_)061.68XFB9&_60G]9R''\+@R@BTS`8N7$N1*+R M>&4KCV.)I`B7!\``&``#8-L'D_U.J]X%7(`+<,%[`3``9A!@\%[([]A+8>Z8 MJ$KQ4",/S&H.X">4S,8U MBG_E-TW_SB(N4SOMQ^RP1^8%4]$>(M>Y>5F"8H@Z(^JLI=<"8``,@`&P[>/% M?J=N`2V@!;3@NP`8`#,(,/BNW$,@)8MTQ&%BQTG([X[88QH^L*A&?);+O@O# M6$+,<._GA,LI+0U86P(5H.+E8:V&NOQ/X``<#,U():N%6X50`*0.%6 M"W>KQZ>$E*X3,"Z)HGX%*60.[9U:SJR[=J@IX816D MPK`H+%\!5L!*B5GI-A36%:O*A`H\E)8'Y)6`"E"QEE?2M9"BKGX"7W%(6CE` MLD56)L@'^@/]@?Y`?Z`_>LH'^@/]P20!4^>\IPH:+=OG%Z/^[, M')5F:7[05;>]H])K[P:A9Z[[*@UVS5:CW@1WX`[<%9ZJ;*@E4?='0`&P`#8?'>4>Z`M(5 MP!T<&QP;`"L-8'VT^PBQ[(1B1*!E&KN/2T,UG"E^5U@HME3V@:XVV!INYH-CL-#3H6`4V@"337%KMJC5Y/8D%."G!+@LG_* MNL(2VF5Q'\@I>4U=?J.N3\Z\((K>I]-VQXVRF3MSEB;NLN^**&22>]Y)6>)P M#85AN"J'V0S"U%PG5Q;J4,D>RT\`+,_*J2I+$8`LD(6%W1.Z-F1>`%"XOEU= M7U=AC:RRDU7E+B[RTUINQ.V\'NPIO.`AHLW.*;ZQ?L*39E`H+-^_U0?N+`2# M:3U62&K`529J@WUEA3`NMN@D,,:R'TA\)>6DV2TP9Q@D@D20J$>UUX,6$`L@ M6)O518`*4#$'U39BI%&`-C]C]C7F?R*B(W#(QLR/W$=&1,;./":_J#.$$R]%A!`=&3J>-/A0NP8'FISX10 M.63?)K1*1)-/PF:54II@^6#Y%,R:^IV\EM%@^709SL%VP7:5T';U.KE5L(;M M@NV"[8+MRK%*<+M9X,`+:88P;#!L,&P(I1DX*%M:-/@EIOSQ-WY_Z>>EY_)< MGWT8IT%WJ]GX^=/2@]K,CUFHZE$WA_=_/__RY?/MY?]\_WIU3[Y]N7SSF36Z M[\NOMU?7MW?75^3RZ^\7GV\_W_Y&[N[/[Z]_O[Z])U]OQ*^_?;_^.__.Y_^] M)OP1O_Y^K=_#R>-NW(B319ZY^A'F.\PA:S=ZR&GOV#1FDR$+2;-;(\V&M;YI MXI#3KM_1:7ZZ*??EZ^C!^$$^JM^$-+?&=^8FD#B<- M@KIW)RPBM^R)?`\F=&W(-:'A@^NG-TF3.)C](AW?R=\\N4X\YM_F@LA<#W:NG6_6YV8&''C#$ M9.K9B-Y`[8I6N\_B:KXLJLTG13>N3WV;D;OZ>1W:"&TL0!O3W:1WR3!R'9>& M[EYEW*%X4+Q#%>_:NOW%7TE5K:VZ9_AB_I%=G3H1(+>@89-.V\+4P83!A,&$P83!A,6*5,6+/6Z#<5 MYKO#?,%\P7S!?&$$!A,&$P83!A.&$=AIDMIU3B_*#[O+()*U@_>-X9^T&GBU MVB^6A37]L-)N1`"J0!6H`E6*JNK4&DU+8%4]-H=>`DE\W"-(E_Y3="_LXC+U![+B;G#'ID73">, MGR;/67E9PF&(-R/>K*7/`F``#(`!L.T+.MU6O0.T@!;0@N\"8`#,(,#@NW(/ M@90LTA&'B1TG(;\[8H]I^,"B&O%9+CLN#&.IU<%2Z[[/"9]36ARPM`0J0,7+ MP]K=N@4<@`-P@),`%:!BXV%]J[[>XKSB."#]X#5MN0W\#^'*Q-R=3*D;BA0$ MI!X@NHSHLFGN"H`!,``&P+8OWW2L>A=H`2V@!=\%P`"808#!=^4>_BA3E... M36DH6\KS6XCR"6P81E!37>I.63#1CPAS'8UA-&`I"52`BO7R'T@W``V@`3X" M5("*S50,U,W#RT(#L@U>4Y;?J.M'A,_"^=58%+MQ$C)9^,!S;5'L()>0UY9V M'V4)B>41G)`SRR%E;N.%MI"R_:5VLF&=^^! M+;"%7X5?!:``%'ZU>+]Z?*)'Z3I[?ITRD?GA/Y`S+XBB]\3U[6"22Z3)-"Q[ M'74Y(%6@"ZL<%69%77D6H`)42HQ*MSY0I255F4V!AM+2@*014`$J-DT]E'F) M*HRG3$\IT9>L5I$[IK8(L5#=0X@8V@?M@_9I(D1H'[0/V@?M@_9IKGVF3T7R MD^QG/V:BEMZL=5\>$_VRY`2@0@KLOI:1M+(`=M;OJENRK'12#;`#=O!K\&L` M3`?`6O4>P`)8`$O]@+%90$F]*@P8*U]N;QX(0:XUTH"0!H0T(%`!*D#%CE1T MZDW0`!I`0SHM43CAK\+D`ZA4%A4+);V53,4U"HOE9U"^QOQ/V02=G&49"^]K MQ&IM!_@`;08#@-\!&@`E2`BGQGZ!K%P_*;DEW_F;BQF+2+ M'(59YD(P(E$RC%S'I:&;SP2^,FT:FMVVP@4B]&G((0X)GPANU[BU>I:ZE'%P M"V[!;3&9[8T&N`6WX-8L;GNMK@;8EF6^"S2!ILYQING_"[)D'::##P(S)DHR!DLQ!53'\@LT2.=ZU^O:UZ=:#*PU:XP/+" MHC08"U@`2YEA:344=AT$+("EQ+`H#5^499(#'BK+PYG5:<%Y[.,\D*+RF@@O MF,]&;IS&!O*>_B.HAZ`>HNX:.T(`"D`!*``].:!G5D/A'FDDF@!;8`N_"K\* M0*L-*/RJUB&G2B>A(+*+A!,L"V(9!`DG@`6P*(=ET`4L@`6P(.$$"2?@8<^H M0;L%YY'[[%^C2%Y^(EP$`1PWRN(`S%D*`\B&+J)*2N[9*&6)Z171X*4*T!K$ MI[FNKRS4H4@^EK(`6+Y%@MKU+AP;'!NX@V.#8P-@)0&,.[:.NKZWE79L56X. M(S^MY5C40;JCY/9B=7?1Z0^R?LP: M[">KA&FA%:"!*3`%IH=@VNY9ZO(:@2DP!::ZY[ULW1V0/W#Z!X9`(DC$]//D M#A/I.J^)\&O,_T1$^^&0C9D?N8],QI?F63HQ_8%@[ULCWZ;"^6F58[T&X6BP MCP5VP`[8`;L#L>NW%6XO!W;`#MCMH%564V$Q:23K`"V@A8&D%C&6DH12Y*>U M7)W+M:A*/@&_UO0'<8)DZ+&"8J4G4\:?"A=@P?)2'V?N-O,J"/6&U"H;:-;/ MWFDWQ(!A@V%3TF"GIW#W$`P;#!L,&PR;!H:MTU&Y>P2X-A@V&[?2&K=]M M%3@31?8A;!=L%VP7PF@:Z=TA:PF_Q)2+9M/W"[.X2[+Q7)]]&*>!?JO9^/G3 MDK!LYL&/^/7W:_T> M3AYWXT;>OW% M?2\OYB_R0QH;DS9VR`>0-_/KN[;U\]9!R>J8*COPT.,&!5\/SX?GP_,5_7R& M9"%I%R>9WV[K!+LTM\CR[3GJFC]7GL?U.^7##]_^(PR^[$]?=N(0F5@\H=JG*7P63H^LS959PH+[%7_=*(>J?U'J^*WH`U-'5KM]OT MS_`UVR+KG"/;1"^#IIVWA0F#"8,)@PF#"8,)JY0)LVH]JZFPTB',%\P7S!?, M%T9@,&$P83!A,&$8@15HO@Q)+\H/N\L@DF6A]XWAG[0*?,FZ;6Z14%E8TP\K M[48$H`I4@2I0I6B'_J!1;X`G\`2>X*5`%:C2DBIXJ:+B%KO%8BUS(QKRTUJ* MXF]A$$5D&@8C-\Z%QY*43B]R;:0L'&+YHPB'!\``&``#8%N'DLTB%L:`%M"J M'%KP70`,@,%W:8)6Y?,V[I@H)O%0(P_,9R'U"/4=0IV)Z[M1'-)8=*AB/Z;, MC_))ZS",KDZ]J8JMLB"D'RWF.B'#:&BHJWT,&D"#X32T!PUUG:?``W@PG(<< MIOJ@`E083D5[T%'7L[TL/*!0TFOJ\IU%7*;V6,[+'?;(O&`Z8?PT>4[*RQ(+ M0[`9P68M?18``V``#(!MWZ3;Z:D;+0(MH`6TX+L`&`"#[](,KY;+8PC"7$TA%+1RP=5(`*4+&-BF:KW@,.P`$XP$F` M"E`!)Y'G%%RCD%>>NP2F-)2MUO@M1#&2#MZ054O=%H'2![T,@LMJ`$U.#`X,%"E&55P8&H=&+I=[-[MXNN4B8P/_X&XOAU,&#GS M@BC:9ZQ0N6#D6;^`=;0J<(HE`"P![$Y=0UTF(Z@#=:!NMS+CR,92-]4%62`+ M.2,`#(`5D3/2JG=`5IXAD]-3-4[#&5U^>`:^6PA6R+V`P3%;0*6@6M@E:9 M("IH%;0*6@6MTEY4A@SA\XN`?_9C%K)H7C,_C\FQ87-@%$4QV`CK8WE+1L69 M-5"WJH$E0[!28E;0^Q$T@`:,IT`%J'AK/*5LJ:T*XRE4H-LZAT^SD?.`JRSK MVT@@00*)EMX+@`$P``;`=H@MM``6P`)8\%P`#(`9!!@\U^Y@53XOX6O,_S3? M7ITE)[Q'R[L92LHJ.Y:%&/W@,-?C&$8#%IA`!:AX>9@%'P$:0`-\!*@`%:_Z M"&5%F)_3`,@H#";\IOS8]1-^WR1(>^,% M?D2&;!2$;!8IB>D/9(F\Q6VG7T"SKK*0BG`_POVG"3F"+)`%LF;1QQ9\%L@" M6=J'3)`U#.[`W2ZSL`X\6K[QDC+EA'P+@T\!0#O5SVRD`("LD!6+@/*3GT`LD`6 MR$(*B+%K8>`.W,T/ZZNKG%UZAU;Y#)#?J.N3,R^(HO=IT,-QHRSNP9REL(=L M72+*A>2=%6(8;&<*>YG`DR&T7V)44,,>5("*M9AY0UW6!7``#H;C`"*=*_ENP),@39K M>R`>Q&.V;987KWR"S->8_XF(OL$A&S,_5:S\?.GI0>UF1^S4(-'S7[^ZR])].&!TNG'.WO,G,1C7T>7@<\- M<<2^\\6E0]=S8Y=%J^>05>KYA^]L].N[FZMFP^K\H_VO^ZMWQ'7X+Z@=?^B= M]Z]:S>YEJ]-OG??.+_J=9K/9;5Y>7EQ>7O6O^N_^]D+ZRV*[=R]_F7U#Y;N_'3*;O\I?JQY',U^6_$:F[ M3B9GDN9J0)Q8R_DTR"CSN M>J./;^K*,=+90>(K'K,Q.T]WL];S>VJ1\@.M`X\;E#P]8H^KICG,V17@G;C\OGMMD[0-6B+ M+-\>W:PY?>4CPSLVY3YZR,*%9)N=&A$.5=6`$1H(#=Q3`[M2`W>.L2,O[+4L MPJOEP9X2TE-$[ER-#@EG;RL'/;#D7M=F\1,2"4 MSV%#%K'P<:^B[?EFD9],0LK"J_D]L?*R-TUU;3/+$I_$:!T&H#(&H-M7U^:L M+`8`?7%?59?/_B.?[@:AFT^3E[*T6FJVT&L)D\$B)X.5(G=6EWOZ M@X@F9G*F:X?,<6-BTS!\'@7A$PT=M"J+/UG=5KV%,2`F@:@KD,9$6NB\A"G1 MSNIR[3^Z8>"++"[J+4=7,8Q[ZW(UIR#X,:<0< M64^%^1$5K@SCQ4\6-E=@^H3IT]RQ]+&4A.G3'GN-8NH_N*+F5%J7`8.V-UQ- M0V$CQ=*/VC`?PGQH]WQP!!HP'=JO+SP&>Y^:#75;8,M"!^8^E<6AU527DE`6 M'$PO2FGJS5Y>G<<`M>JY MGN%3O972L4L;?W.I'YN#X$RP?IHIDW;R@?Z<9H)A>ICJ6QA,^>,_U\C4H_QH MD7;&_DSV&NF5,M7WW]%`M=-+3:E90&NZ:5@$+,57@#HLT MA:06&`=8K=-IJ$LBJ`))F*!4%Y=FS>KUU.5W5@$7S,?>\$A13#U/;D"-J,

`(1KKZJ=>0=FN2^EE@)YH M+DB624<2A*-)&4^UTGF.TTM!(02N#A0V49T5:+<8)&:'9/QSO\(:0X2>HS-* M6774Q?LRH+HZ%-0G6+-@6:*$)NGPRD9<$$PZ6X_J?<-$?VMVZ/%,>S@U/"@C M)#@87OG2@P<&.\6=;69]"-F+J9!2,P>^0Y):)L%,@OU6V.3@#%5'B#)N;-_+ MT8>M8#*0@$W\PB3)M`PF%'X"J[FOPJPWEDIS5J!=;(6B8"3`,\?9UY9P%90H M(9;"6K#Z3,D>+?[S!R$$HV1PFJBS*K'(F=7%]371NMIU8M;0_@`>JL$+C@I/ M&=:]*VNRU5061YWJ>O)]GT+VXV`(`ZZY@&#+0^R;P+-+A8*(4A.JW)\FO,=[ MM\=X)"4;<5X9B<[PJ(0@I;<\*KC%JFT'41D[*]`N1D-8EFWBG#'FJ"%@]VV9 M+DI3JE<1XA';XU7\_.&(Q;?RH*.CUB4BL!6XC.VD5M:7V^FX+@8/6!#?<:HP M"3)0,`A9J@"`Z6:URB2IR ME/4#[QNFP/+UI/T^+``/U+O@(UPI!JY.X9->)KH\TO0<&Q?V!JO3P??X=$NU M8A`$>HIP;'YG[?M/EK&?($'"Z?<^&:V3,@;)8`L^ M2UG-@7G0#>@=Z8G&@%IJ-(XN-R*!%<]PVY?@VU#NZL(F*^A9<7:R#B)8X^%O MVGIOD4-3E@R8=JQNHA+<[$TM]`ZN*R\.N#F9P25,%#@(`OY8GIR"8:XV%WW! MVN#) M4B\AF`5\A<$9+K8M\[FH%ONR";UCZV@HJ'8T@"^1;2`J9<57UUFPGA[K)NV$ MUWN,WMQ6Q*_5]PK%EB.ZYEW_;35Y65"RV*] M$/EL4K_T3D772T&]#$'J*/0'SSWAIK4A"'>5< M:!--9@8;M$ON48/Y1JW(#EIYA&:7)MX-?L[NAW>S#_/-NF7TE7#W7_$/*]A@ MN19&[G/=0OI],KA\VF>26_VI`E[]QH*2*)Y[!)Z;,,R>E$486@G8O::P\Q_+L MV5J3;N!:K;P?CG`;CINEG5G:ZRV6=/O\W-.FE[T;@C&;(;==:369/;KA=@X9 M\%/#X:%=A^\VDE@%=P$UR+V7E2NU MLQD"R;J2ASQ=>;-M=]VGYO8./MS<319_6KOVUJEHWTT6LP,V)_#NUNTSC8#L M>P_CFPYXM'`3P3)HGR!0I&4=M*B[G>5>P[G[RNFJ^E=K+CGGB6@EF'5"!`!" M9"F+SCRI*D_,V+^MPH[:8,*E+!D5/(M$O*4L4E;T15P]`%;]^VZP(TVC#]8% MQI,D@F@/(1-7RSJ02'!TP/YI7*=J;#LS]RL]A(P)EJEGT5EAB`AH]'D)[HC'1]N/3.&<3+4]B MR4I7/VPRNN1V7DK=2;;G0K3O@2EI;K4"U6I0OE916]5.,X[:5U?*&Z;E1O+^ M1$3S5,/'&SBMRSE2L\_?!G=NVKC;V^D$#FZ>3#]/F\'.BD'^@COZM[<7;QUL MZ<'T'\WHT)3V2+)',B)B0)DR$R9YN7*H278]+W.[$.GAS^%*#?A(O-1L)QT] M4NWDQEU_!S,XNT.*BA_-QRGR(D\PLS:#WT[S3#]:Q\E!<[$C8;4^=>N?#7S< M<(P/*JC6X6@T^S*93F(S&OP<3)M#*G,IN.2)EMEZB/R2Y67$%<31?&.D]@1Q MM(FLKE@K)66P(M=NP<2Q>L-<_/(R+5;Y0FSI"RG\\R$ME=U7WBR:V;[\WJ9: M%);F)!$5-]$@F:OPV5O&3:)*AXT;8T$F\LNO8E,O1\`[HTIPT/:"L#O"[ODQ M7[MCLY]:Q.PE3=9&+[P/-#-;LKU>;+S$%-W(I^OFW?`&7\7NIVC-,(,ZA0__ MK1E=#\>7@R]?AI^G][.CF@8V%YJ"%392*2^-X`)NEY5?'X05ZPM]M?Q2I%Q\ MM-A'"5=!^G!_-6H&T\L&?GDRG5TVHV%S/1EG?-V^O1T]3&XN!S_?#_!\#T;= MH8$)9#)K+:D,TB5E,RU9>4=)7J\(GBY$J`YW)PEWXYLU^$15/N6/&=Q7DT^3 M^^E5\R2`D0F)W+HDSJMCDB*E\36XD!G;!I#O`'B4B!7"N1:&0$%I+S2`2U))?,H2&4^.5,0Q(/;G[Q"^B/GVRH";W+8:-1Z#CGGE0U==QM9@;SE2$$`3//+HR%EK`$2B(]-*?"1^)+9Y4FPNQJ73H@P^FR[@MNP8IY9TS6#")U(L!AS+HU M9T95*9>NLB+]*%;(@1N+N:,?S6IVS65SA2FF=DRRN_[?^T4G&?*\NX_A]PO\ M3^`'RTDJ%Q,(7YJ[X70QN&]!<'HQ&HQGX.C@/S\U=W>C16(*!T'CE_AYG`UA M=^?N=LZW'^+I3A0LA=MX-%FKYUV MGAJM7"FS=A&+1JND/OD;+,4'B/D6PR#:X4&ELJ::.7B0^'](G`M>>)<^#O.,Z%TZTG;IG+%272:\%[ M*JND)BPG;E@`-\099:PMD2(^==5M>Z]LF;L43&G!UCU\)IG#X=$G-1&,<)^L9E29,S]72,EX*YMS&3@G>&A:A7I8%F64O^0V[*L3@^*HCT0UF!NNM`,7NQ0OA"RSW^DKG1OOR9U;1@$V MHZQ#5MYYAW#9FEK51%FO;9F[6!L;F(,;5'@*-R<852ECN4@RRW870>+9,7:T M-A$<_!`4^/DT@2\E`/KE?R M5DT._+_IA\F/C>SXLKYOS*S^(0)&W&UYV#$F?@GI<0Y"ME"+<1HDO1IB:4W>7P[!'A*6+V M8F6UQ#D>TCH6+:.:)-=2+6CK:HAOP.BL=^B<`^N)%C8HZSVQC`>6%!P#E@=[:C)CN+4%F3> M-I[)(%6;QQ3:5$4.79`U4P@7OR\*0>=Y[)^#Z?7:OUTT].R.H5>EQSYI;N%W&PE6N2&UC[I<29[RQ/Z)4Z0VFQV M6!39'GH"#B3`/49TS,I:ZPP.DB^U^%JJ;>U2;`?J@RA>6`'#\3$*,.!V49FU M1*9/9HF741<%2+[!"_RH7^QI"H`-\?'FT]W@X>,MVG6Z=7+*$542UD$(17L<45BB_:QR'W`Z?AV MO\9+&UE22E`3!5Q\2:R>@952@9X.A9UC99CPVC,6+`1&L"(O,-E.@4?" M`YD#MU0E#SOG\4+O22X$' M(I7..L!-ED*4W"P.KY94,5^Q-CVB'.\9[X'86GJ>H@S*2/A;=@0?:Y44P04J MX,]Y,0Y$93GX/=D`@84 M(KORQ.`U9^),-JA'LFP'@9MT$*HY(?$1A2I1)A,I'!E:;*YG/GGY])6 M%NL7Y^,3K&8Y&2YY8=K(U%8O@\^SB>LL8G>G)UMJ(%"WS"7E:%3,B-0F4+9T M?VZ1>(L83Q6W'^9M(ZV5F!P#)X8QN`U96R/)":W>,ZN'A3-B/C7$@C@JD9B% ME\D9'D(V[0`3'FJ*_E>`M)-GHY@U!+.\F".`:SR6[)^W4NV<^79.>%W'`5D? MP$5E7FD6P'+YU7N?SA!==7!4]R&];##)@PQ7..0X#X;3>44G$OZ,)K/['>7( M*UZ*\A_XA_:/OPV;*;9J/+QK?C2C31J+\CN__S][U]+<1I*C_\O>>R+?B;QL M1+XPX8CM'D_;CHDYTE)9XHY$:DBJMSV_?I$E%D4J215%L21*]L4A2V15XDL` M"2#QF-S<+N;M!_B#0L.U1_[:C,H2VH2[TG5H4QF,9K/OI"%_;VZF,UK_74N. M+13T)0"HS'0@RRL[:72*.JX&C3J=L&Y+X]:-QE[\GH.T?E]()V6,TRXY%TCK M,N5<7B$MT53=P8V1ST3ZTV)Z]J_V`N/N+B.6"X^K/:YDVHSQ@D;^]RT)$N>BN>PSF1=2OLO7&RE M?A=-CY+?0M5'_6XC)WCGI73U<30^_S!9#G7OZ_D5#`J;-9EZX%E`[T#1Y@7'49&-6_%MW[Z]+@;[ M,ZVC$R>7NH`(6HBHL!3M$=.BSS*DL*7_\.&$WYZ51J63B_L\[#;U:&?H\CY1 M:.W+<=H.R"RU@K,_'K8QO;ANK8O2V.^6/ONWFV:V7Y1>6.<4V?7:9>E\LJ!7 MEZS,^3K#6C]$80=M)P;`]B>6VZ'[;GEU)X&^D(PMQ;M:<6,8:I;`Z,Z*$6G+ MY-IW"=O&7Y#.J]%565#Y3!_O$492L1B-S1(4L:'JX),IUVG?[PZ^[J_MJC8^ MTA==,J@3%]*A4HH<71F[WO#>!PEUIO+`4JM>7&V53.6<`RO7&:(T#DRR8QW) MMLS[J&RMMP'`(&K+9*\D2&:Y0,*G8",D MC=XZW[5L(+4EZ@@G?Y^\=[#R:$Q63D;0$7@Y.0*U@TC(=W/Z_GB[Y3W#E9>9%Z0U@_%8[*HC+?> M0,=^/.==\[N>CER\',TN2OQC?GD";F(L'=?IP$,5B-Z,-L%*ZI!LSWJ^&M_% M-VN$G1#E@^@JDC01G6&"K'4I/'*[NIF1QOA=TV/>!UR'ZRBMO=0&E;=@("C' M1#=IU7N_I4,![/1NWB1X!^LFYG1&1>Z/Y:;`%W@WDBY(KJ&.Y5@S#'`O[@ZZ MF(WS6@F;`J3,+;37'$9I@D'6N3':5L&\TZ9\F/"5=P8#6FUY%"):%I/I4`M0 M5_N0;_/N4#M<2P5%UCI+SCG+$F3MF,H=>DKK2MKD.T/O8#65;>88A9Z$`FHU>!`\YT%;12S+XMR@?14I(; MG1GS,I'AG6V47'6A/D$F>&UZZIWQEC>+VN%:JHQW]D9%SV,F]R2%M.I,)\H` MI3I2_,:D;;`0>R(#/7KKF$62UVPLPU643\M=51P'(]8.H6J);,[O:3R:4;K] M\:5%[+?I;#ZZZLMND"&1Q@X^5VYM?^J``?KF49R-*@F40==(X\)F]]`3ID%VU2]37]7K;[>\;[8#7+ M4\Q11RV2R1!,&5P.+4\+I//-5B$POD^`?F"D#_0)GJUF.932"!N8<(1,CKZT MZ[=H34G],W7VS,X[L/<"U2!:5C/&D7%RW[6PDI5VPZR%F0,CE^K$;-E7!_AP M+0N!3"EC;)"HLT04D9>47C080LBICOO_Z/Q\L)+5(7H@AT%8!JX4'4NM6I96 MG*Q;OE?FU($8=VB!^\XL2CQGCE=!E]YV0D]@2' M=2W^SHN9IP'P%D$+0M;BBZJ2MJ?&_%< M92YYC(Q#(B.&.ZFDHHUH]T`%5:ILZX84)[P%KQ3^,#%PL@'!HS0R*"U5;,,? MGNP2(^M65/&3BZ+DC^>4R3/-A]9ZWX1*'IZ-"D#B=PRR$*7(6B) MD%GEPRD+]9@`V!FX/'TL>II0B!2MH>VG@T"0*LJ.YZY?E0X8MQ3%[;R_&1Z+ MS]/%Z&KYP/SG35/Z("RF7YN[(7'T],?RZ7<[ZD9'\)D\S$P8E!&JMF,'4"%5 MQZ*0.ZV[0]8[).6]'5J1:6:RT0I,*NF.IFN1+D'5@J#DSE3B4Z.\A^VM`68@ M(``R8#Z&W'4+C+*8IW4YVK[J\&F4?VIN1G>'1/OE)_.N%DI(CRF6F9I,2Y+> MKM)'^12K';1J/62CXKLT@P0$II2]16]X9D7UX'$=%>+M2%) M.;!9G(I`BU=&9(&(@M0,&J*$)4O^(ZNO("Q3+[0W3^D)IT5D03@;.%,V$F-9 M7QP(@8*4HY35?LB78K`G=GZ3*4D%%K5.B:<@A.*6Z,!2^>RA;N=OCDC&5IGX ML&BN'_80FMU,R\E(#+?,/^[;',@\)A>U:?4X0ZNZ?J`ZB2U],H\C_CW'2A`R M".4,6IXEEP%X[&I]>0BAL--E4E8XER7:`!I,`)M7MC/MP*Y^.T.2 MH24Y2^T-4]12;Y,I5&8I$!EM:==L=W\ M$$G6?*58-RX%AB3BJ2J)?'[D2,97!!+G+D85`E/!F!2[X?$"@MQ5"_W,Y0P',FH& MILR:"4X#^?+HLEU9?*(&N8^>TNTPC.;%>KV^:2;S]C-^-BL3:]K&E=_O/[*< MM]9VG;OKAO=A4BSA\LMY&X?Y?#F:W(WIF?^U**=B\-Z-\&GMXE5_R5[_[]G=?B-+Y[Y^^],[-,R'&E`DLT@]E;)XUW>!50R9!I2\VAC*\ M$D*;._3UD?=__7[_D?[W+^[?OS:N[->FX'H?Q^I5'MOWIQJ`UC=KC:L<@#E= M3(68B\I`SLI8RF0Q)K7.S5T'S_5M>6E83FU3]A*:)V]*UJ0RD<7BD*`F=X6G MSMSAR67\N2EK;_]',[ZX+.U[_VAFHXNFE>E$"OT157MDF>K.O0P^ MD#_#R`US19`\$T)J?%!33P]O'TH;]Q?VFGO7B]Z;V]QCB:38T)*RF(3&*)L1 M(C>QZ\ONLS,/RQE^;N[:\LABN+U:E&NZV?2ZNS*EEWQ=NGYDG]'JYO334(+\ MP&9Y?*W::M!'HR%]QV9`BSR`A66*+GQSP]-5^ZUOM4*+--L+!"3.:B"6VC2PK MYT0KVN2(&BOC%JN*@W#3+9-:<3>G7_VG./X_^#,VD^4:H M?)B<3:\;^L7'9C*BMS3ST>2\G:=$$+:I#_3QR]'B']/;J_,/US<$5/[VK3DK MXW_I6[^3N.?Y@M`DK-MIW--O=V_\5TCMT)[180.&8+Y,%[ MF76*74L6Q`15'!;6,R%/BN[[W2@\^'MS)R.BL+O)L/L@%8P+QX,HFZ?W!)?QI@3>?ND.!GA(^T00QE$3BIXC?0;XU%SLF.J:,M= MN28'`<>(G3S M]*+*KK[^(@/./:2F;U''(>%^PQ\=6%&V?2/8_H$TQ)V]WI>''+7,WFF+4AL& MQIE5[W.R6>O^6<>&8KIH/MV,UU3:[T7%U1I$_ET^$G!JHX#H([,>%)=$`^0L M'-/))+\QHW5RV\)!7A07>B<-VU=U##H>:$*Y;DLX+7@9Y9TC"`LB.>S2%Y2W M0@Q/Q7T\>9G\\%B8JD?&T''EC"%=P0TC_R<&N4QBB#XF5W?:XLH^REB/+.ZX M)`TOKPD]R'!^7N5.#9F6KG9W=7M^VSVYMG/*Q M67-)MA*=.G<'Z M'F0GB0LFOHP6Y[O/5NZKJDJU/ MF(?OZW]9/3!._QB?CYO)QZNS&G"YX0=G'K1!QE)$DTO[`]=EP7G82-2XM]&E M7H*])SA;P:2?/U_.FGG9J[>$WJ:GAM:Z*%+T+&O"4H7(N^1T$[.IFJ6)S3C" M+D#6$8NSAF2H'<3Z;3HK`;<-#V@BE)$+9(QV:6DDO+3?7^^AR'E_WG#RX3[=?_[F(R-FP:/,2D6/3DJGN\P_B`9&%7E1ZEL&,RWW(OV%>$YQVC`]B1 MI8QMSC;":L)(F211%^%MJ(C^%1UC]0,FB,HD2H&9E9:1#AB3N0TG!;Y MQRR]5NACP#*5)QFRNJQ>M>"//(DZ)?[D2#Z\Y%EEB$!B2:=W0#"^!-$[Z4RA M'IRV,57G-``XN-38Y\"833P#(QU%#G)0*Y-`$S_4DW'@%8E?.1\=?R^E^MZ9 M^^WV[*H9S3Y9:^4*3%&TY4_>21YJ$)`&Z,. M!R>]IW;+T'XEEP`'.&SBGA=*DZM0#@ MNE*!4"+$IT7^,2T4ZYFRG'@V&QLE.NY==TP+JWCE;NN-'O"G0_GAADKF$@0= M6II<78D)C.ONM[T/`NN`@WU1ZW0O!`ZV5$H[(!V\C&1^T5G$@855=%!!71#_ M"W]12T4-:JF`01:9MSHA66H@B1&Z844LD/JK)VO;DR;^:::*0B.XD#(GS;(! M+STSW7DEHZU4OK:O<&`-:*OXD)DA]YL+(0-WJ+G(=[9*0FM952'H3I?SGVRJ M>)N"E&24.>"B3$7!U&T]\Z9JA<1?5.?WQ%N)67/6((/,Z%DRPH8N0$R'63T2 M>7.LW0NM?CA3A4YK1PPKD4GO14EEXKX+IKADJF#*ZY)_5%,E2:6R)`_#1>^T M`&\ZA97%EI)>*)9FK(#K:Z?`2U=7P+R]JI>E!#169/0].9@'<*Y)RU-!-6F82;-U3 M6KTFYQ_;4$$L`Z:=Y3HIISE9+,YUIU60KFY%8UXTE'@X]7L:*B(H]Q$P(@%#Y)2<*5BZ%<,N, M#?H(_7L[>]CA="MBY+#XU?S23]G]WR*TQS/^S=VW-;=U(^K_LN[=P!WH?I@J-RTRF',>1,[NU M^\9(QS8GM.@A*7OU[Z=Q2%"6P+O%BURI3*JF8I,$/C2Z^VOTY;GES)7G=\6( M[H%W,L=DU4+.2H.>UIWDCR)?EXO@\/]_^SI^`N%Q$-12&>5,]D)2UK8I-Q8N6?0J M?O_73<;EWP5\)<'B];B2FETAO":MUZ]RFU<$3(WD9SA;);^![[CRAY`5 M$R)Z!CXHQ9`XXAQ"PYG/ZVHNS@;>6O7=EV-?=5_&HR]E@D*?3DL['(Y(E6U+ MN`C6E@1S&X#GZ(+1T61;7N^)>+*V*$SK2Q"CC0*P*&MX7>J^?_E]-/RP4Z]6 M1O>''`(P9-'0FA`0YLHH<2)&["(LVZ8D['+II2+&JQQXD9GWCBFELF`YN^B; M#`3^N.+SU/O8)53`CDC>(*7,F.;D.!L9I&2YY%2KS)%K%G/#>SF7%X[6\0,K M(B>1--&TF$$%``1R_PIFV5OR@9I$!\XO6<).$U_1(%F,C#2J+FV'=22;W6.6 M#%D;O(CXR@Y@G2.^@MYI':37I2$."N]]-CUT$57.QVMDR9P5N(K)GL,!G0;H7J4GW)Q")X^S)(DTMTM(XFQ;YV1,C&67N,Q M)&/;B."CMN<7B]])PRR*<-LT3E4)9& MND"4F`GEA9K+72G`5?HBF,D.H#UKF(5'AE9;XX,G=D;`6)P+$@AR3-JA0^Z" MK^(IHRQH29HX\;MLG=ZHU"4KL1-'68A0A9""LTX[9T0@ MM85S5F@!13LR@E^R`3U/E"7R4%(.7(0R0##H"&0Z^WM;PJ6VN;?G!N\841:A M4"B7`H+)`9-QS/ELI4^A]/,4;1K"11"G(T19+)IH+'GO-HE8?"D-?AZET))' M\9S"<%/[O'0W:3"YI2.;ENZSJR=M^M%H?%WR.GXK#>5FP^OAYT%ICUGMU@'M MEC0:X0U&F6R(7H=L7`T M=O-FFH^:QZ[IA7K5S0;D,M_\?I_'DT_=Y,`VFMPSC8D[+M#'F&UI[C//WRHQ M%=?:7_V$PAYG'V<`:EO]'>@8N.6!Q(@K[^AB806*Y[">9OTP`&VY:(JX)Q'Y M(+6/,EL>L_85($%>R64!5/O6[O(#M9L2.23E;WW7?2,'5VB7Z:X)ASJ'PM(K M2BKIABRX1X,!C[J7(QH](_%;'RGKV77+UPJ+9<06=< MC$2D('+N$;5EHN9A0WE!N$"HIF7JKK_Y4KS-TB2R;W5[V_4M9[X.9Q_?3L:? MQ]/N9CZE=W5?TPT#`#^MZE"S=+&7_<07O:N?3`WL.XO?E@SE+QU9^G?=Y,OP MNOOIZMW6XBT?.?G?PFJ9B-F6C(':KLF2']*DPVO8>L?WQ^D$P#_)+#\2G,&4 M?&.G'$.!6C/A4^VIS""W9?ON1:!9V]8OI@IABGD7FT*:LBMJ1MG8QB&ZL![/)"$%^FH_)>9FU]$LI=#ZVSH9@?P*Z M*6TN!X5:&6=*GS44I$3'I@RCBD=0_(F[-#E[/B\/YG M^NJ[R;R>=#`=/BDB+1UGB3E>=9_'DUD=#+3\=(FBCL;3Y?O^^M>=F,GV>L@: MLQ-T0^VR!1)XGM>Y0Q6L739\!G3J**I?WB\_L3\T5@?.,F:=B.1S\D2,KV.0 MP"C;.":GA^9(:0S/7BMAK'+)6R!.:2P95,$7C>TQ@L8F?$F7]XQ`GOH&H@J) M:XA6H.$H(=G:CR:45A]M"E!DB'^UNM^:(;/%O-, MMRWG.]:]=\^&=8TJ'F]7,"C9*2N^2(`X(TC$=@=6`42M=V?>/+#DJ;EW'H2E?&(5;VCTJCX:?% MA,]MF1I&"6M+[8C/`C71LB2JY?:81*,WSK.[-^/;O]X-RI#@\:0,K"0230IK M>_DT,2CAE8!$=RPFB<'6,3'@L.V#Q-G2O3W#)A\-2=F:8,,1A39EFA`GC\$1 MI:[-S0RNZ,PFSK>OY8'=EX2>6K6R/IH`D3,C=%:.:6"6"%MM,4ODI/4EC[BS M38PR32X!YGI4=1#^2$LA!L*7(&##&9J!8= MI4)V.JVJ:SG#[@Y4#X[LCPD9N8J<6VM)N*H[F24+S9LNE\*=[PCW40\>E2&I M9%EZ"!$L][P^P6+V;>3^/#O:4S$`*$[*SK,`9+,$F6:LIHK4.6NG8QQ^5@\N M\)MN=I#WP%0JD]Q-4C+GC(415^_!%DKWISJQ:%,L94J(ROHDL\;J9T`,.YFV9][@ M)GX0(<=HM:CG MDP.YAF^H317Z_EJ5NSX,Q)F;C\](],>U`P@,W.+D;C/)X MDFZ_#"?CVQ*.&8Q>CZ?3T&>"?^ANKYO\]&VZ19`/'(&8O[+$?P531+/J*$4# M;7][:U;(WT[K>K[-?!-X?_+7\?Y-"=AWO[Q_^,\/.1NOQU]+3N!T.AA>7PV_ M=),WW=>_=Y-IMTU^DP(/TJ0R!T,''6Q)$0`N":NF[TN)1/?3BA<_(R_74L>2-+QX$>#0F&3#Z6;F\F M,&FE5LNX:UHQSO"%2TXP6GM%9+XCF+EBB#\%C^^0H]8KW\"=+ MV'N%&WLC0M$TAJ,OM9^)"9?JN*K@5DR!X(JOI"3[K'!CM/(D3"/QX,LX0JV% M)T:6''=U+B%R`RN(Z?9-;^`5N^S]9"S+>*>R"`8-RZ4"VB^#2N2*^[;M'H<5 M#W@'[7V;[[33]OM-+[]TCR-W8%S@+AGA5'#@>?6F?(BA[3-2B/G6?>^L-K:I MRJ-N76J1R=F2FMOB3WNR(+4$1I=^@>W6^1I[NO/6K\;W@]%L4U1AD]JD@Y%" M1X]EEEXH0R2Q#H\D/['U?(U=HS6?+N/@I1['Z[-,8C_#FBNKB/V6R-C\7)Q9 MD7]XKOT=Z,5Y(O%"D-4S3@B-R4A?M^>3;,N_SWR*^WAE*H(ARQXD.:I)9J-C MI3'!!V56#4@XRY[V99P&)2B.*K*<(R/J86M0VRO6SC\\UK8V.2R,6V&%!H`R M5!=0Q%1+M(,F$M6$4%>EISWK4H^B&\@A4WUS-841E6/N(8FHS&3<(09RFOT= MJ!L"RPH""5J2"C&+,MY]^7XG5..$G/D4]TH"\"8E)94J8FIXCDJSY`R\[0+!]0K"\9(PWOAN'!/)%<:L6(:D?%>$[=R9Y,NH_= M[73XI9M3JQ*8BMW[4M*ZJ`Q]6_ZX_\'^,V_'T]F$EC`OC"J_-WW3S7YY3YQL MVWB91]]:/OA0*/7T-\N?MB.%'__VHV]Z]/%MED0P#*V)TAAD;HW6`1DF;G5[> MJ\B;5XQ7X#88IDLYHO60BPV.D$,40>AH-4A;)H];4&7.07#6 M=E1X93=1EA<&''WM7P?#V_(+?3/?;CK\<-NO9?+KW6`T?%\JYDMWD#P:?_U; M=_-A.SE1.H`CE>DR9V"U,U[7UY#HQ):0UPN%L6_Z.)H_+NPJ=\$7M>53+W+H MA7)15187/:SPVNR*-[/S`;:I&9-"4LL!.5,V.15%Z5I:]V9([[0UKZNRR<^Z MM_,HH^@"1,U&YB$Z22C-50!K(62"2>$R8=BGY$/[IJL/]:>.`]BF MT*3/D"0HE:TLC0M%BK$6+WDIVM"D694YH M).:44TF4`E>%I&\@Z9IF0O^TLW)K9M&E`+:Y?4,FYQC*4S[(!*2&8J6O'GAJ M*-M%$39]+H6DP>8RT=1$01HH)*-RKD;*P(H;1!#_,,`]OT+R*&70+H;LR29F M9:*NA"T%%U!GVO.&">>/./*0? MZ5[3!VY^NIT-;C\,?Q]U\Q>>)TVJ_C'MWM^-7@_?/^ZU-1_0P7^YGCU4Y]46 M6_V/3(>/_SSXYW@21H/I0]NNLNM1 M5PZAN_YX.QZ-/RP3`1ZN>N1$'S-C*CMN4_'@Z[L3DU:;__C+6R[_]UMD#T?G M!X2Y?H;$_*;[-)C\,6T1MDDYIQ/RC-9%HD0*!)E+!52H*5_%D2\N]^I"*291RG;^\=2\` M;N7O/G"U$]R_WG73V?5X-$J7/P)^[-H\"022AVB M"M+&F&QP*)=Q#>/3R["1^E?I/T^&(VYV0ONG/TJOV%,H$!>LE]:A0(,A)=(@ MQ$:SMX!:2(8%7?TGNON+K==D_VPP7DHG#*C26IJ`)=*A9$Q:$K#B\E4$L8]W M<2=,>Z_NC_'T!#*;N''D62B&26/@/#!BR2(392&O6;%X/)F]N>DW/1B5$2,_ MW2Y2S/:+T])=8X&<4"8E6,%(AZD:\,E"RZ:%F^96-(QT]4(.6^RF"$Z(4CF? MLC;,>,99L.JAC#*U_>:TU+:)F.^TV,I.I[^-UWS@'5F>[O?!M+LI0D)LLC?0 M_:0'DL4Z?>9M-QF.;Z[F(Q/*7^A;?.\]O!&R2"%;VC)*H@WRW^Q=6V];.9+^ M+_/>`Q;O?!F`9!5W`_1T!M.]^^Z.Y8P!MYV5[6QG?_U6R3J*;,K6)>?(E-G#W5[:=IN\2?@.;\=O9GW1Q,?MP)X\/BW^Y M//V7]U;`B1TE%S1A-=Y[9;).P,YJ].`5-MT7+G:O.>,L_)A@'.<`MI228^^T M%08T"8?ID#V'ZJES3M\VL%M48V:OM&3(ABV)`V@68N!3AIJ#I6A\5_YA;%=M M]_;0.,HQ\\2Q.S&^49[IFY!1#49'482.7.A(R%Y="=W#['SSS]*?\N7^<4^L MK+R%5!6"<=)7E\WP6LK:W?8#67RGTW=:V"BR;%&\M;9,4`+P?K%QXO_,4/E< M<_`]GT!?BG(\6;9<[\#H5TRMN.PL($>@:B`&XE-H.^);`-^=PL.$^5_A%VDW M<[RY__WNXOZJY]$]B++#Q1*M31:,=*POV(F'`#L*D4=WJSI/>)^UC2G52_F2 MU*H-!+PAF&H+'G'H#RXQ8^JJP^V(4JVU%[Z_>)K@VC\!DEW3'#%B$*XGQUM5 M5IW.3?63F73HK.N+"QIA[9LY$]ZQ(7CRIG,S_W0SYY/_R\WU_Z*?4.OL9&1UPR()O0M&K'O%ST)`-:?*9XW#))QC;J1 M,HZ=OT*>1%CEP*4`/;W)R4FY]6'QA7G#L0"?Z6`-!:U+D4I*V>?4I-"[.^FF M[P@["01^NV'_;^T;6TML%0(:#G":R:%!P&3+0F[ALTFI]P6T>KT;/KINCIGO MM0XY!0K-5`;!#G7N#K"G1#^N?MOBQB67JE6LG@&(;8N2(>V#Q M,?7BIU7.@2^A=^"-MTD:@51"X,.K@;1)T$_-8NW=Y?-/`H&=M#,X8[!DK:Q. M1NIZV:L@`PT3M*AB3^7>]\"=A+"'*^E0&8!&2:;F\FGGR-+$Q7[7HH*U77N% M$9J'4X1@7RVMC="S\U[S;H>0L49-(C@YI1OT$ZR<[@O[CR;XZ%K:>+1:F9*( M@X7*$=%*T15IONK9Z;]-T5W?79Y?7O&I_+R:ISR[I3\_7-V?S\XEHR*1[OW= M\K/H;'Y]>?WQ]A^S^2(6?AB5O7>(E(5\-_F@^1AS((M6WB9T0U]C(&O6+_>M M_#.W+.93&<=8^#&@V!)TM*"J<@IKII9]L0`K/G*;V17=!$47^KX5++;8^,*G MH:D%(6HS#"GP@(]LO$#%IW2'Q\*N33O_OAT=CF7VUOYQSX^I7[>X<@W MX*`R6,5.9S`9*.JOA8^YQ1=Y+#>NX*!%;CN,33CGB@%;"UC;E%\M,E#IR9I- M["?WCKW8;1."?KG_?"-_L9%ON M`;7*3BVV(/PREKUPS"O:)BRJ,P$'+/*?*U*2][]?+6'=KY,?.7A.5NO6FN%( MPB1%PXL\1];]@$+;/R(]MY!#E_OBQ%-?).B1>5"\XI9:I&$\:V`7LW_EZ8>^ MC+W<%\GK?"+C.=P)E+7U*KBABJI&E[%[H3-^9'2%27+V+6\(J&2JBK0(&Q>+ MC.A<#K0:C$H;)4'_*?>K4EVG<1"73!\[@" M22^?/(3]=O/K[.[NZH`=\B4ECA(YH#(R/(X%=*L1:3%W6:!=1'FZJ+%$V;(W M2@.P0DK-9[X(,1O4JWEF8/HWD>E$:3?SV>7'ZX=WA@]?UOH(][?&QGFO6FX` MUL1B2LQ#/CI0,EW*XZ>>2W[_58XOY9:M8^W`NME1L9DX+F"[BRLI_0:6Z9]V M5Q3?*N5#:0R'ZG.APL39PY_[[V,,-4>OR6)$"!SWQ$$3RH3"3G'\!-!%._LM M<5SQMFR@KXHB>6=`AY13T?)4L-2+16^D,!Q;NCUGQ2B=L=I2P+.596\E>O1# M[U=5IO<%=8@]_\N&8/KYM4S"7*[YQF02PL&B"*UX84.\%$+^H;$M.)-ZXKEA]/C'TXR#%;EZ)ECS*0=:$: MM9H#'5UIW5FR*?;U!>,M?4^J\921O?P4A!DV5-T@MB&K'GD;>I]&^>`V7M_= MEO\BYP4?X6!C10[1HE>YF#J46V>9SMKGMZWJ"X;V6LLDMS**AF=E7R%D'\%7 M#C2&D6H4R8F(W(LFDPYA+U<*'OEQ[">Q5]4]=DNB8;NU[7LM:D%V?V$I$OFY68?&# M.XM$U%^%!+"[0CRHZBAPF"!%^`51M6!5TQ2'U%#QM3O56H7-=G[S3(*M"YOD MJBJ3C52>X>29K,`4,AUX:VTPS<5&QJ(V;)22'D8`U))T M[C2Z5E):?229]AK'V)31*8<0LN9@5"C&!J>`?1O=A70<(QU+C#UO,SLSA6S1 M+3L/[.&T3+CF(G19U0T36`Z5Y$5[*__3-5C6?8E45M8--]J)#];G,^PS5NJP MA4TSZ`LR>\'..6U!:VV2'08:%_;X4Z?XA?8S5E4AC]G$*`(XOSIH$$RO9Z/:=T?:V>5\T8SSE3#]9=J]U2^4+ZLO__-R M-C^;?_C7EY]GGV=7CR1>_+'X"G7>A?/_+O''O?/T3H;3[[GWM) MJ6S^O+6?E-);%O#R^N-6,DFDE'+F8\`15")6]\/3D_6F'T2L>^JVYT`[$6CU M:T&+IE8EEK2$`.S%!8\#M)KCE`U#*3=FKD\86O-:T'ILQMG4&F)HAFUY6KW4 MV:CZ(V`Z+0`%@1SP*?+9(]K-?LSI0OMJ&G'1JF64AE*2R2'FM'J;;,WU1*&@-B=- M3Q?:5].(&'(H&F)+R19HSI:A.ZFVG/OLURM@.BT`8"F53*95'\@S`CD.*=5F MJ6>6-_U$M#UP>'_!W_YTW\_.WW_BH_-L MQ<3723WK'[3@%KJ\N%R;B[WV<_U'+Z;'7=S,^?=G3X[>`V_IJL]T?>ZVS'9; M-76NC04J7QXMYO9EL=8YD*[OYF>W=W^?L2-_=GV.LZO+S[/YEU^_W$IEYM82 MH8@N0W1H5+;@@U7>8S+5&734IT[,LOBIV[J]-F7\377_WM0U#ZTH]+E":\HU MEV*J&7E3=77!Z]"ZZZAEW/&K;^I!*5HCO>NE>G0Q*ZK>&AV\"E1:,F!+GV=2 M?7?+P4N=4N)I,D4U5&6$/5X7S[XZP]4`HE>H@J>^(/!MHW1@YLF'$%D;IJB( M?4[0KK2P`*FP"Q5C/P+\NSA2^V2TH"5E?<10^;HU#>RC(R/D4L482C%(*1C43`IH`JB4D6AR?7&S0V\NR3@NX-K'Q=JZYQS%IKIUF*F>WEQ]V*5?5CUZK,16O3%4R8*EI-MQ#7T?1[FDY MY_!/_>5O/ZF_.O>BY"\N2K6;SD04%7NYC$O-"U\%Z#D9 MS5\!CB\B2C_;DXNPPT8:2R&X:-D]+%5R9V!4OLS!QGPU:KNO;Y=BR*=:U M6$LD*NB\DO!>9G/(IJBH2]]W;L*"Y6X4.=C=^WT9.JS]ZF*2B%"MW1Y`YE1U M314B>F`W*-N8#0C52XV(4EG<#^-RSVW*]L6-+-.T-"*.Y(&V(!1QFKU2%=4" MF!I]3=1SX'2T]*<-S$[L(MY92U9)`82++1G7K%N`D.0=W[W4^G;:TA].-Y)\ MC>0)'9*6WN=HI055R]`8OC*F(XNWX6EIUFDC\WC,QO/4%)8UMW#BYIR<1Z28 M\P*&Z'PQ_1"_UY7_&+Q#RFB$1`F5,:;EDFQ:%:,[*ETK\IM!9#<>HJR%"<$I M-%%YJ[,T*^GD@6I45'KSWI7YG38(ARN,2C(AT#N-Y*HR1"WXX5RP`NGR4V\& MDATU185`16801]]L+1@XP#+4T!?^/]UK"MW1<9TX#'O2-BE-"M$!VU!K;76$ M9NA[PJARY]6[KA-Q/#PD,7UYOLQ-+?I^+V;S^>P<)AG!^?S[!SCKR9O,L0X6 MRY:D+&M!,OM??5%KBCOX6L_*-AXHHX[-?#[B,*J"B62U\B$9)0-S!W1*CGU9 MN]%=^\UW@$]/Q3Y\VI(P[&LIQ*^?&,FSJ[LO3SYL`]!Q75.Y$`+K9';Y:\U$ M\C;Y`#2"Y]BH!UJIYS*9QP9ZLESO(R//7F^SA6+2M@5P)<.R:"W+`.S.R+L$ M[FF/SNL`]`WS^YY'PZL47$U.F#5M)/;V,IOWHH-#'5,7"8!VYC3TUJ%#]YXO M;TZ63T#UD90K-L3,L`@4AHU;VE#_``K2TP+G8T#Q\^79[Y=7"ZXS/N[R%M._ MFXPQZO'GF^N/=[/Y'SC[_>ZW+Y]FCQZH_NOZ5FHD9^?RW2TJ*>5<:O4-HL:< M^`0E*;W-S3G?3%-=K=*2VO)08#?@,RW4WSC\\9MP?A358U+-E)B`DI,)WE*; MJFO6M65MGR;'__*WH;O_U6%^?\?(3*?OUL\B'\7(_D>P6(SU-6AVVO@L%@L9 M?-E0:/]MYO%!LM%Q&4'SK8/BH^3H54D^$;ORX("5GJ[LJI7HL][@G!T'E+O+ MZX^+`H&US\ES_J"/RS)M^>K]Q?O[.WD!N%W6SG_\U\MELA-%R%A*:QP20;2F M6MU4'"*B;-G9Z-OX=X3P4!".A>^[J0.KQMX:6NTR9B>/?X&UV<#F:$!W.:ET MDK@.ZO++]]O6R?ZC*8Y:U2T*@8@$',,,S0!AS^3A-AQ/?A]>K>-)RBTU>8@I M-L=13K9IH+PRC:_2#[8/K]8>%6LS1I5@)\'U/W MEE5Q2BRQ+=5450X#RV.QMJK>43M1\)ZK]!-36"YO_GOVX6Y^MC*"4X\9,('A M)-'UE5I-GW>`Y!A5"I(<=CR4V1`;JPGPZ;)ZQ*&5Q<)(JQ&[XD9U+UIXW'Z\O_V]V M_HXOPMWEQ>79:E;40L3Y[#Q?K^?V^7OW?_!?OD"&.J(K'IUU:(K4&E5?2LJ` MK*LQ9J<\:.K9H0-TM,#CBWU,5"=7^II:;C9F#K"5]X7#GK*>5\8P@?QV@(A6.H-44JE4H,VN,`M23F^H=/!GJ'4H,WA_51;`^[+S7EUH1# M61@,$&'(MI%JM8L>(X2P0\;HC8$]28U(C<_GUU)S#&YV2O6`B'[3"XM6HK863`/I2;W0S2-ZJWBOHM<1'G?V#WP@>@DM M#9O6$J1W?&"=KEGRA!WLDVJ:'HJW`?OA>H922RE0"#H9R#9&IX9T=JH;GG<6 MI(P_Q@Y\U?9F-T?G&UH_DZ]9YN]5DY%]^<8>S=#"'@'[*N?DOIM=>."M>?A) M_I09*SS^S>G=>Z]J<8!!>0P8#02;@#0[F'PAM.GI>73'-7H,&%X7]^E=_8"A M@DVYJ1#8Q0'O#&]":='&_V?OVGK;R)'U?SGO69`L7HHO"Q1OLP%FDNPD6&"? M%IJX)]&.+1F2G!W_^U-LNQ7'E&5+24MR,LB#[6%TX*5"H5#*+<))E0:=S0S'T(Y7/GA6/Q>OS4DV5> M2U]7GA7IBB.*8LB'1&@WD.H#P*`3X?MAS*X3K%)(LN.+63$@DDX-*[D*1FKG MON`!=,W)2.`@IE89$U@$NFZYK;??61C25(%4:VJEQ3%S*:0/N;W;#/E-^I^ZFW>[=Y,\[+[Z:WS1K/C25]AO:62=+ MJ'MD=21=O"(_%'/8XG%#G!-4L];SD/PX#4&,;H2E\D6R3G%U5@LCSA3]NB@A M8SOD2+DQH_W/1RB'L=!9DI%L'CS_"V#1,2(=S$.R;L/^6/77,W-`\RV([897 M,FJ5C8FZ#OP9Y&,IMC797M@Q,=3S$=`8MMW*HNI4,FL=D#"Z=E_WMKWN*4_M MN#JK1DW@'TT8+V=GW>]3)K7[>?JI_KB:S#Y,UW\[BH&YLQYJZX>'ZU\F_YTO M^GU47Y3WOZQ#E]_SI_[:+;O:CT%UW].G[GQ^62O]'WL040M7V(!!MB'Y1"X/ MDPJ%[PY\^4']>(UW'R>SG^;SL_]-S\]'!_HRL.HU01GII)7"I$BI!_J`Q=G[ M:P3JSG+WE,;2\3AR(K(8'>M34%"GNJ"6+)\B?;1NC28W*,EVD_R/*I;#H'U0 MD!1IFXST1J*._+P,OIBSMBT0?]K@G1]$0@RQ"S9G]9 M-06*Q@HYIL/\G$0T2C@O&=1%DG7>!S0,]S/48G17@(RC=J2]OXU??,?R&!G@ MEQV0W.=:Q5IT-/4A0,%9J' MS#VX]N0;,_;'$M[P-^\6;-`N)HL_'@5^,DH7LI)&B^CY(00WK!T2V;EV;=UW M++5QY@2/_^QY(;UW5E'=T),C:@B#%Y7!I=:1/A@&.98<1W&1QQA1:]S^$N3GW:E7R]7\HEOT8^WY8Y/Z=:"5@:? MI=2:12K(9CU$FBDEW]A$Y]I.P5"$9$HA*7($[0SI08)DL/'NS/=L M'L?P!;*H`VM#Y2SSCATU$NP-B`2`V:/`X]!2VUF/995L$C*[XJWUD"P_;2PPG;3RQ;>CE`X5 MW'V^XCI.OD065S#GJ`I[V2X%B:GT\=#+98MGBJQ3K M?4;M=]S8]RSY>YC,A"H1@[2(1D$HT2?G_1#VCL6V56(CZXIC\OM`>8;:^^&] M=E9+RT96Q&%H-_L1KF&X=>.FZH['\#$\A8C*2;['.B"6K%7RTO=9@X2U$;`9 M8:/LN,[TV-P]9#N-,A!0.+!&%>.<*!:H-WUHBQ*V"0);K\?L*#Y$:?71.FB8 MK\';(GRH5>K!B%"&&%^I$_*:H!".J9:/S>H#--7W?B-+Y(`@E=96N5#((E*NCK@ M1PL9=%%MC<+3-@E^#;VVNB39;"$R;"''#.P=FLVC MH`XH5)*PQ7J&''5`O#3]^#L,.ID-U>)/6SE\FCQ=]_[<>:TN?'UWN_!U="Q" MQ1HV<2:3=2'RY2P@>N_<,1`I<4,9@1ZS7^U1AIR(*$8WDHEB$.CKK.0$)FIP MQC+VU@P=&2N*'?<"_!#R.)"[KXPEQ&QSUN2D-SXZ%HP,,17AVG&H,"XP?%;R M.8A-IN@4!,D/$``"RREEZ@5$.6U:)_Z79$8QX\DG9XHKV@0D)V>;GL@@6LDZ9QE-#E8AZZXK!([NR*AW77OT7QLNKI:=&FZ?-^/B;[J MSEY?=C_X^=79=/9A\Q'N!*!GJ\5DN?JE M.YM.)K4F[WSZJ5M\H<_.B=+8V'7`L#K"&S&%1OS7)3)@FV(C!O61-W/ MGS^59]^(T?J9,EH*5D6D)&/5I#$Y64S/Z%@;G9BN-O)T/]MU8$:;9\IH(2B2 M-+6:*87LBI4>*J.Q.#`V-[#4WX^9?@V??^XFR^[U;^?3#S>_$Q\:=\?7^&%@ MG41=?4R>$N8<$$@/77$6V?5I!U1OIN"!PWS5N M/P#:#6MO'[CA7W'N;1,&M[']\`:**QJD*_-D=(S=T:]D82Q-F;5SA_4^_+%?U`?EE.IM>7%V\F5SW>Y+3 M5;<;!WFWW9P'S[0[%7L]!N0-.'8`/,.>A'7O M*@W5(]KG=F7=UL?@L:/M3M/+66%M^N]NLMAU`5V3#D8$1)5F*P[#6`NFTC5[7`[1M0-1QL'ZK> M?5QT^PBK@!2%KV'0B<7&V)N]GUNR$)5IE]GN&YU`^!J8_W[JVYU[_4=]8M+D<4:A:/"@#1%YX?- M4XH@M8/B=K<&CQWX'OW]RK7ZY<[:-5K%R6)QS=B\?Y>61+5-K!)4$5)$+8HD M%F_&`3QY8'=_JUB?<)IO=/[_G'73__SG$;<7C,V]#!5>L>";-PF6]TL,4:=%A3=U(V;MTITLXX[Z>KR6)2VP+>7OVV MG++;M9AVCY$.3A>MZMI8S>`M5:B9>M*U1)',MGZHDR']S:2"J%K#-YD]5K=7 MUW-`[?_"H)5D?QZDZ^F5BOPSH7F0'^FLI0Z@?8S`M/8D MURB>S0V*.`;)L`VR4G#*LV(*)$T*N;AU0-Y[W;IURIDV&G`X.D;14$DK*D`0 M:GV8#%VQ&%T6>L&;RC9;&4_ M&1;LHJG8[;=9!1-CW20M&$8.'F@T0FT8JW2_.O-DJ-Y17R76319MB%"2B?R3 MMVN!"R,;?66:@LF#4;XM&I5B].2U22PVQOTNLDV]?611V[;`UHGCW5L]DMHB MY9QA1-FW?2CVS*,?5#>+-IX$J'R,]GW5%CCI8J%$H0`261N'0(N4H>WG'[;T MG"(+=E%;2J'6GOTEREZ!EB+38*E2\;EM=CM5HG?46D8&,#9%OMC)VB2K\S#( M.T,++"4>36MM]^X]1&L-(RY?P*/.-&R7BFC:[;Y@31N:.1P=X[B#AMUZ1LNN MCT69HM,ZD"TCQ)-P!Q^C?5]WD&]OO;!6%U;8*AEV'H;P<+9QPT1\N-]Z*DZP MP2+R*5N74+&N%P0]+U(-)F#;%_Y4?_(4>+*+SF/*V;ZI`I+X84=V4YSM&<%@ M5;/CLJ>#>0ILV%$+"BW9VW314"X!%;)G(GI.,/1QLC31E:=ZG*.S0F_7A>B* MJDNA@T82BBV[4.O]-L5@$T+0L"%Q<43"1M&%L7;GU*Q59`ZP=;>,Q(=06LE[ MH+M38,:>NI#1K!%,N:9D($')4JPOB(W83-+4[E24P!-XLHLN+!FB)@:]VBK/ M3S][JL,>%9^D;((U+Y[F])P"&W;4A:SW/&VKQ`\ZQ:]&UTFTYMO/A=H;PYL#M2N_R!K9?\+<'^VSN>W_(6/S$>X*25?3N^M++CU_W_M+N>+57=& M%_.KV6H#!8]%XU+0#%<9II2"(6+=,G*;#O+6Y::@RKI-S^2C?/P6G#??%^>] M)\$.$5_T.@%".%:(PW(>$M!H\@>.<]7'GY;*%Y)9P+[I-%I M(>M^VNCRH(1!MCNMVHG0^QZ>3<7K1=\ENJMQ\GFVX\_!/NGO_EJW(7 M6T2O1"F!_6@)E!S&]1BGVG!_CX#A0QAC_$UM)N*A9TH:,C)ZR*=-+%`5G'-:W83-IQ92BNM M``-;SGQSEOW.NY7'A0\F4`>P$EQ*1B,,,U:139C8>%['#S.X;3Q^RGFW*OBM M"A)SK9E6("+?$%!4^Q<&!9GQBUSY^F(X!N2(9LN9GZ#@GW#PK;=#%`J.T+/C MF*S-";)=K^W3/MJ-W#9>>8,X^LFWZ\!@06+0EJ?W8`(4">=-M]KA2"U MW^_DEXON8S=;3C]U-]V7K[K5Z]_?3?[<.;.E"WGT6E63D[13GLR0V6)HXYL< M);H-8.:ATWSMJ<=)Q`-JG7R=7@;P)3**TP/8_E9IG,M:UNZI$,SUO%$H?R1Q) MRK7>%"1;)@TZB*R']L?`X*4-A;&U;0H#QCOW*-K&>@_L;J%4F>DTQNLT-#8Q M[F];(]$V2X2/1?*>RD8KE7S.U,>LM%4%W%!BK(/%5K\:TQ9+'(GD7;0-@Q54 MP$0A.J96!3'TXDCJ9H0@349-;#2'`JX(1+XIGGX!PC4! MRS%(?20[PZY0BDJ$$+TF_I[T.O8>9&B'P2GCF^3,>,<>)_42,T/^`'673#%, M)<1;=[;N+:`FO/:"L5\38#L2S?OFFY,QUK`[)G26M>$PT^#!"Y0MRJ08:2M!UAB&[E\)F%S"ZP:]3CAJC?T*7>5=UX]DO$EDHY1C.!4:K8AWB M2\JTTT+0['^%9^^[.E.FGR$U7?[QIEO4_YA\Z.1.2*Y.IZ&+;C%=SJ_X'4*W M^-#-XGQQ.;]Y[WM1]^9SPW7H9N\_UL677[)NP32QZB_2AEI]O\YN(WRQ8V9V MU;_1W\7?I+PKAH?9.YX?!?4'".QV3==8%\`ZT M->O:`O7%5J7/W%?ZZ-R_6DS>OE],+U?K"97/C/$9DC3_S][5-K=UX^I?E`Y? M`?(C29!M[DV;;)/NA_VFVJ>)9ETI(]G=9G_]!64?V3+U8MDZDIRYTVGKM+)- M/@`!/"`(!#:R1D8+!4AD*@0ZVBQC6'$H]\"O6I]3`/_SQ?]V\_GTU5L=!XBJ MQ*QDG;%X->#[^ MV/O9QV[VU_CB7B;AHKL><20Y_\>Y3\_#A[79Y6*-\S:+4C#=[Y*3,_&:DX`E\,CFG$&"9W?68-[B)D\OA M<&3AA&<@11U,UCK4T<&67834?2Z2K',;B)K[?K`_J>9+=(J@UF`X)LO1%]*T MI,F4UZ.OU,G1/P11.Z'2"V>ET(9C4^]""CZ`S[W2"R?6\V-IOPO83ZKOA,7X MHBWZK*4`QWS`W1*T%,':#;$HG!KX`_+C$VH]:J^$*=H5(V,M--(I+\,=C&F] ML<'O"/R3ZCX'-4Y%\IG];$J.#$AQEYS0M3/)>OB'3XF:5\_#GIN<,,AN`#5: M4AHY\LE];PE%1N.).=@KEL<>R8G:@]9E5P*09=L$[!CX7,3,=*Q$;=<'0,=S M"*]8",]/3H3LP&L06N2<0TI*J4473A1&6H0-6=3A$T9;K@N_P^2$U1#J"Q9I MF9\5S&)909RR9`>R7@K#4X,32.&D;KL4+RU(FW4U4Q(5+#OOLR!T.96;V"&' M[R(Y40"*!-9_1,5\V"2T2YZFR)WL_N!HV)]4\TT.&H.,T8`P9)4`6A9X^RS# MJ=)RN]!_Y.DDB0R^<(":>L.O5AO:/X!]^)#H&+"?-@U=H!!*+Z"H M',B64.(M02-7:,/ML1Z>H.T`_OM(3D16=5"8"E+6IJ@D:)F'SE&O-S9'*%DY M'OBGC7("2E%"[466+>M^,J3N"E?JR"%SJFL`^^IYV/.2$U[*Q&I?.ZL'*02& M^TFCT@A],E[\^N6Q1W("(Q1-MG;X=V`AE*!L34YXYL+%I5,[A%*S80%MJ)QXGI^87[__8V&)/TZO+C<5L&QN5R&*$DDZ MS-YK%Y6(M)QI!H8K$0O8G)2C!&*M'V#G&Y)%HWE'2:G8X#L MTO(UO5()!CO=PSTLI((B&>N1C`C)^A""[U^A@=)K7KT>7UK['&]AE"4?;`QR MT2HS\Y^60_UTV3KS;N!M['N\:W;)2@J.]V!<2LL>*DD'],TY.M1.=CS_*R!T M+`J5\M'\@S M#QP6\B&.=RGDD:,JX..@#+LY$9?/^$349R&MO48MN9A3=(19^^@Q*+Q_EA@Q M;FV".?`V]GV/IYT/P+S))5M[1D0^4OU[/+-F?L-3=W([I[ATE]UL=/5I]/=B MKOJ\8]K3_3&^WCM4%P$2:G8/4GM*4K(UE?TR8RS-,EE_'JO/]A4=8O5+&=P^ M2ESTN;IMN'3S^BGT]TG=:65*\^N?.Y;Y:'))W=7XKV[V[>.W.?_RG0U,F2E'[62) MD"G4+F6&P]!::R>B#:718]N\_!X2U1T17O:U(E-G;9CA8'92^7X`.K%7:,RD M$%7__IT`HR/E($)I*HN7S!I9,-MHN%8VI=VKJL433^9(6'=$1<$"T#. M:"\SIFBP*$.,+OFM MP>PSX)S.NO'GR/),@VT^8D;G(:`Z[^]2E%%BH&82,:J;-D[QM=#21D5%K6/JA-:Q+8%$D, M`NL.I^'97R@RPND4G.!UZWX$5,A4VN[EWA[54KPBM[%J@&OF'P-X]A0*;#'( M7!U1Y*QS-JE1BMH9Y,6PWJ+SEG+#6'0 MA@6]:.T[C)Q@RR:!/$$R'-0GA=[V"02TL6%+UC6YM.'6ON,LDN<%&EM"A)(L MN^D4^^[MEHE)XUZ\?3GNB[/$9^?=].(09!4$JXU4R:1@9$ZL1*S_RCN.J3D( MU8W>MQ,1G[*L0VQDAQX1&6>,)`/,L'(=>I55W8@.I#65IH'H&]A@%X??R0ZM MLE%'B!0%6L/AGXJ\!]X)&@)6M];"OV@+U/W.VC>_GMTLV^U__#KK1I?O)_\< MS<:U:N=7_F&[[XU7?]#2*M\7_WSL+FYF;.[_>UO7,KJN?_I&_,.G?_S/S=4W M_I'XZ,;WW73R^;J;_5E_=G-KO/AYW67]?ZUM7^V+JW3`%`JS;@ZA%(=5HL]P MA\QF?_T+/2$>%*0\%:8MV/:#"VX'%NS7ZI^/9_:..0U;OY@C!MD_,8S5^3VM?QRT;%O-RY:]2P>"$LK^,KWN4Z_[27DRGLX>?/,6"D7(CMOJD@++M(9) M"B0+W*5$KFP;QWTZ:/+X\Y?KNYH!_@C_\V;VN(1B+3Z+`JW^&W:W&B9M-3@0 M**51!5#V%Q!`V#8\;89>G0Z@PC'W]F0$V_OO3?Z:/$!L&L(B2XX5L/&2;P?HZ0*6P84K, M5VLEX%D>O3*]F6W4K&%P$E&6VI)=6,OT7;)FZ7X>F6&E:UK2PEDI5H_7O[K9 MM/Y]!]HJ*$NC)U8YR7?4\#"Q:;L.Z,W-XOX\GM M27R@6\/9>([T04/M\!P=*%D]8<\!P05F';W$E)SP[Q?)#Z,NN:XS6IQ:.`-A&NQLJ MP_VU^VMZ]1?_J,0['E_SKL97;(YV&2"H(Q55%DZQ3T_\)1!'0\D$)O4Q;JMX M&VC'VP:Q>1=D+$5QU*8*JW3-/O0.5K%U:&(2RQLZCJ#LTZBE&)`*"`#411.Y M0)G/?9UJ43MO>!,]LX#W.DT.P)`)V"?]>QE@BF9O^- MCR))H7"9KBCM;,CC\>^]`#L>_P:TX*F.C.7XO]11E`G8XU@#&)TU322'1PMY MGP+8\7EXB5)G[W)BAF14]$JZOO"&W6%[5W`\'KX/7D?EX>P!8T@YH7=0`/C( MX3*8JV`VD#V^'CT=8,?EX2A\U&B+TDII6V3QHI]18QB[MI+G6#S\"4@=E(?; M$!&"43($80!D2K)/2%A-V%:OW(V;/PLDCLG#F1ADE"09*SY;166*R\L=RU"U M/-P>BX<_!:GC\G"J_HWY%2C#>I64\!H6/)Q\`:3F\/A3L#H)#P\0,8-# MSQC)9"E(:Y>90;)-.'5S:0_TTJ,1_6XEF-% M&3356C4A5#9J6:B&NGWH"F<"7F^AZ:;CSU]\44+)PT'D5IYK+,1:N$ M93GKJG90;./'(RB8"3>?M3S'5`$;=N0H.SH(TINHK;']XS8*L;U1W9DJ.!98 M352Y95J]0HZ>010L%DP*49KEVR&)N2E'V)E@>^D>[3_TPC9+.TQZ]K?)_,D6 M!6+Q%-%C@OH8B+V59KI!E8)A5KA_@O:XX#PW/;L/1)23PR*T]I`IBTC,1RM$ M+@?A7&CN(XX`D?GTI9N-_CV=U^]Y"DYZ4"4*V9%1!,2DO8CLDC6R(+B$1B?O MFOJ5G?FS)R'TEE&9=?/K6CBXJ-B\O&\>,U@RNXS&LW^.KFZZ^&WYY4]C%@8[ MM6_OV'!?K:"X_,S;R=>;Z_GB`^H0.9-5$V>,S2`A!0[5D_;%9-TWB0@18$-; MU(WUF=N0/:9`EAYQAS,\@%#VBD9VG(U'LJD)Y:@DB\2XY*U@*@DRUO)\5!CC M>ME8N_%PG)UTGI*I/VL1!9*4G8CH,(2(UD!RA8P'D191PP81@;)G+Z.>"B]L MVT,#]^K.41*4L@XE:;"+W!6+A\]1R)X$N^(-Y\@X?#U">D*^XM@BVDHE5@54 M:6DIQ&[(.G;[,3MWU[6KNZHQ/C8@R!Y=!9?0LH52P;\K"T5S]K],E$,'JV[N"BU0 MUS=U.@A&*QA#@/=IM[)I"O!IE?3,\IBKB$;&L+9Y4,I0$=J#6SX-(2=6.E4\ M#.%/B^B)$X$K)79,@0)$+54IVI'R@5)-6-9O.$T?79)`L?&LQLF4$J M(K0+?VXS.2U,[::/P>I(9T?VSR6?^.@T].3X]R?KR_N+ZRE_?I/&/,(MD.:0)`2@X$JHI;"&=08% M""$SKG>CI]"9/5HHO#P>>7CZ;C[?S*_E^OJ]52P]&WU+2:6B0ZQ50[*4GHE` M7JN#C.4AH?QM,OIS.KL>_Y>M;FW^\])JOC92WGROJ).H!9QDR1CK8RZFOUC. M1>:F:*II`;MS)\V^>]&%R>7'+_SA^G6:_OG[>-)=/J=I!"F=3:"8.#3"%'(F MU=\;FP2I:7:NO1./>^L\;5T'VT2.CT7/XP!U:AL<@8!U M)9)[;^5BUHWFW=O);Y-9=S']/*D"_#3Z^ZZ3ROSM_%?^_],)KZ?TB$@!^!2U9%+)K*0'/3MG.J@BN;<6&@/SK;5O&CAVP2AC<+H MBV'8ADT>J@\8J"*"]C$%Z6+.0;G^+5_2K&?- M/?8;Z3:AOWUE!]G,KH9.8*(HE(KTR2>7C'1](3W'A;YMZ&1\^X#T:)O9U2G, MYBJ*8K,7E`,:56A97^FP.19O6D/\_*W<=J0[E)(E(Z0P*4>F,DI&6>Z?]1*P M,7O"8[:GK.N`6UF&!Z^F&Z&.(D5K%VX;8HFJ&*\!&.@H,*K&W[UIG<+1,-YQ MC(W.M2VS@#NJ4KQ6%U,Q54%S])HD:!7KK$V:MLY$;/6O^[\>CW^G9M MW.W)J(LS)`-:9@S>L%-GSP[]+&/AJ"%URKJ-MGK=:EZP[*TI&TTIH:18F):1 M,)"T[9>MPYJ&2?INU0=9=C?GP\/_OGTV.-_;LX1D*_$4-EKEHLFLWWW""3VS MGD9=_,ZU/UK2"]>_PPA"HE`L.N?)U:M74;LAWXT+91;=/-=_(\7&(.K_V+OV MIKAN)?^)DI+4DEKZ9ZM:K]ULI>)4_$^8Y9>[C4XAU#P M[OKWU?H-VW$3M*A5%>U)))/YOZ`$'B^N3B8RU&3JDS6NT`K9$&V`UY"EZ+"%3'?17[)]%!GFS!A3S\ M:#/2M,MD&HTY00&.6&)=#R7Y7Z9)&J-31M=OGA-FK.(U`U7KRZLC9>)$0:>= M5IY3_&*-4G+P5,1?ZU(*A6..ZN$Q)IUT9]5=9&ESY-@E!25C5"JUVF*VT?55 M:G?`_=E_TA\N_ES5;81_'_F04Z3$DD,-8*P@Q:D.-+Y:2=UI5;?>8?PDDP^\ MB[TRU_*EI:@ER5QG667K"66S;KH07,%8R>?8`]\+$'Y:'?E>QODPRES8$I)* MP>DX;%;A4]O^^GZG%(SFDR,G>MSI=QJ/+&+)*J.QNB)!!94_AXE!]_Z2K]%^ M]9M^^LTJ@B.M.I8@A?5)&X$5>""&%G9Q,":ZH%$:-1:D[S[6+)3L$@<;F!+Y M(U9(:>K4E$HM`%.XI>S)^?9>6_YH2GZZO#B=(A9*#F.LN9)$'\OM$OK!7+K0 M.R8X\F)]/MAM4B$C<6[J0JX[&H1N&;.C`EL`LY8AUF.6$2>=47*PSFZ*+(7$T0LU M&G/HD7E>FK8C-Q1;R`@Q2AU5B24"2-,,9?!.=G`43TW>3@_E+*E:$05V1ZJ& M:;99D9QE#VU[B(>:ZO.([\TG1.MB"R$ M5NN2L:1D=56X%L66Y/LKN!2Q'F-%V,=I=N%H(_MN(*NPJ5F(D-.NI?,O0MN1 M5B3*6E?7"#DJDW4,1>0F0FG3K@5@D\G;E)DN/O[(6>PMW-F'R_5?)^OWVS/K M+\I>]=O<7/]^N?Z2\LWC8*RM=>M]8A5)4Q+*HTK`YA(KFFWKA2O,D'X)KMT; MF8W3-94?&Y)VLR7<7)U=K*ZNZ/3_;LZN;DM_0_GNAW_7J:Q]GB22U\R(+$TP MM0$^4UU.R]IM0DK0UU+V)J)[*7HQAK3AC7VQ`Q3GJ#[F@<>@K2!;69(X&TE: M^BX,E#!6N7QZGOQT>$C(( MHXQSSF-->]D2/RO3ZJ/%<>DV"+29?+9""F)%L2122S^EUUW#XZ:8N9.@>HI)!]VY MR@/82>BD^%B20X>VG5YO`41(!81C>$S.RU3'F02>F!5#V.=OWN. M-0\INZZ70PFLT+=+QHK*3D=JI%0?YG9LZN>V-%LD4224HA6ZECS*W\%EUR/7,.<@S/R9Q?5E>K]9^W M+35T>KJ^81J/NQ\&"WDPENUG-A4"$F,K5>7DJ>OT'F_4/.Z43T+H+ED'#H&C MYS@R,V4E.4G#3I`$*?4+A4=[;N8DM")$W=V,\_/+OVJWTI%+R2%%#LCJ7'>0 MJ=QVWK1`GSQUKX*X92?,WB,]GH2=QILIM!A"J-#1*5+B`+HIH>%8NF]4&!V< MF$##1G!E??GIU^O+TW^_NQV/OLK_6:U/SZY6[X_N^L-B@RVHJ>X;=*Q.)J?! M23OH=\#NRE3VG6X^JO9T`L8LK0VDB&G1GDV#+$HA^-ITK/D"]I9R1^@QE:I] M?;#SA9B%ZK24"X"D?#&@@-H;DN2DIU_%H&!'`KVO8_;A1R8]1U?KYMAIH=)6 M9D[4G&O=/IFO8W?@O0?=4[`^Y+R[E#X*Y4EH)*'0A^+YMWGH9K"Q.Z_>$<)/ M.O6.GKS'-45J[YG]JCAODN1_;"C#DYY56\R9Q-$IYLE'?FH&['S3Y%3;B1(( M$^9,QB0]9"G(8NZ?T(TX3+K+8L!\UD80!U]@G;6*$[JD5!8@;-9)NJ)%7S.R M.XM&KYMA![Y#D.7<-NGHLD%;A,.:XZ.PB!8K3-&6R88=#NG)6#:UV4N2-UKD MS.%J8?,M$*G-7Q)P]-K'1'Y7V7OKB1Y__"=I$1"^KA4K&;SSFN,_8ENR,1]8 MDNC*C,NA>&*S`#K+%M!"Y.@W*Q]+$4,GF0K]`\<"97U,WX#`*("]`LA,6A&R ME6L%":>H'QI8#I5'=A"`*A&UMV!K,[,([`=;B./0PX$=!$]!Z$X(EI*SU5@* MQL)1;[#*M+Y,%]DU=895@MKQ;/E$QW\2R^-5E-E%XH#4J5+OY@!P%"Q',B\J ML*>P/-Z8ND/=9.,K\@XEV1ZH6?;1=%YF@;(^QO)(MJ["N=L15`,LTD@PE$(I M'=C"^A)4'FMYLHD%K*=D4TJDC"4:RN'0[^>HH('U^D'1]C:C"_2R+MAFSG]KR*G3P.@;O*_0M""AZ"OSGUU=K\_^>7,]@&ODD_7%V<7'8T>P27C/&4GME;("E$F*PWE%06@3=>P> M*P_+A'>=[RG(^PSN>']8-IZ?7%V=?3@[/1FD?N]S6Z9G_V=U_O[#Y9K__FI? MGUE-Z0J'22@U^&3K?/7=/\_//DYX*L?`'T@A&%,1,-ABQ+S) M,BCJ$CJU,["M@'O$\6:E;&?E--?1&Y%S"%%RH,KI4\/R"E#ZF7S-:?0S47;; MSE-CL?7J]]7%U=F?J[N>MI]6U_]]B6'^+@_[K:OWGV>DJ\O6\Z[U[=8Y!%R*+2K("!&]0:1P$HT#U@G%;NH>> M@'^O7$23%46&4@+'12)CH8B<.S;@@FC(]X\FVUIAWHHXENE##.JB.8FSLC8K M9>$2#A+*E'J/OFVBZIN(YG,MQE%V!0SF4EQ62N16`#8H^IW;9DN6_1+BN+XY M.?]E=7VSOG@WBC6_!1YL.8J@BO6EEJ"%*0YB2M`6#$9)$#O&[V'Y=GXLDXV3 M+ZL')7.`$+2+SIFDTF>>(82N3FBV0=$_-^NZ[3)+N8$&3=0&8O:W.AV!0FN9 MEQKZ`ML;8N/D&YATX!R3-9:Y51MP;`SM11VW1QH_#-/*Q9,-&4/D4+)EA(:@4O2)O`];?QXZ%L6^ZT;/95`CH"C*KI0F9 MKUI34XNRQQ#=3.,_-[<6:^>$5TD+:[$(G1*6DG)KD%=!4)>D?:<.29Z7S;_) MMRT+E2-G4-%H!2!KM;,Q2TJ)?5?N$VCFW8JNV\KSNP_W"A![D=V7<^=4Q&0` MA`H1P27)9JVUL$$="NCNW)81S4/9LE!V3KZ"0GE90D*31`89I<,!9PQL[%^# MOY/;`+B>GWN+];:F`O*2%<&K@L%83=""%B5+CP/ZIACYB&3#I,C9AN-?T2>? MH;0%2R:YOC7JNVVCML_/O,6Z84`AJ=2.W@0Z04D2&Q2GT;H'I'A3C)Q>T22G M"P=\HFB0V6NE3(O^M+?8+TPXY*EW%N9M+^"\(A]M8JFMK2ES#I)"YF0$3;N0 M(O6ASG?^6`7?SJ+EJPX+=8%4)?:0XPN^ MMXOU_RHK=%17XVG!OLL+L&WJ@VU#[,/Z;7MHWB27)]];9/M:^S`L66DLU=I9 M>[S1F4J_U/&Y[NW-Q?75YR;"'R[NKV%Y+6_[R0A?1`'O'4ET-A;3[*QU?LM] M-=O&^(_CS7(Y._F.&A+&<^RON<7E75!!&15;2RLP:]+).2Q#VRSG7,=E_+MYLER. M3K><2D;)T3YD1!OKMG4:FE^5-CU')^6MN/SBX^;C[T>9+A=BB)+?,O)]=;,*I@-NYN!E^.83(\>#YR1$E)Y7SQ MB8Q7#7J>R.L'HST7-[??Z+_$]P)P#X^G<.GU\?Z1MN*^''Q&<"R$)%(*M5E4 MQS3T*7@[(@>][ZY_'7+XC5FSND/[OKJO".\^_/;KW83S,:+@6,P3!V941`)' M*FJ[R77)<^#K1D0!KU@4\\4@CS1'G`4[9SRE7"B;HO70=T?>FP>5\GN\5^8; M[^Y59&P"U M<%]]]#>Y/+>_,4'K*(-&+5!)ZX;2OLH/H/2_!O593&CL*$:(A@-B'P@B4&YI M":M/B'Y$?>PWN3RK^H",042=1+&4C%.Q>!PRF(I$[VI]=OG^['3S M^=HO,AY,S]ZS^%B_DP2;LL2J(X,0)`.T8.;!+-8-6;-U#>A/*WYTE$)9"_O@RY>IN)56T$7G!,AS9OC M+$PNL[:L/M)J1:R8DNA--L96Z^4'!7$%1?@FB!>P6MFH("-H+-Z8(K1*;4=? ML(+#LC?M2F85RKQ6JRJ$*BH$0UIALM&&364F8$Q>C,CE;7B361N6'VFU..#- MV696!E_J$'LD-0C"!#%2-YY:OW_+@IC1:F%!=B3>26-!@,!47[4VL9;-2R5RJ8O@3IE=/UY>?/S':OVI MP:",P<`L*6>T3G$>+VVM]KN2,KFV(BZ@44S)7$P8:U-LF)DR:R'N`(AYY&HVWX]1G))D7FR`C+H:)3QWK-N23E$YE[K M.!*9?SU6<K`3:U(/[B2(.LG;7L\*RR._0A:&EA8U99 M>`F@G8\!$H)NV_XX_15VI/5@:A?GL;Q[*T*:N5W$),]F$;(AQ.`<@0^# M*;1.?;![13);4IBH0G$VNIRS)4Z9R1:@IE@E@'F.?.SM"VGFE_`H$@$GR\9P ME(@:*`W]/LF8D:>DKT"QEA06>N5"4DI8R(Z<\L&V17P!E79C/8VS5L[?OI!F M[]!*!NH.2"^M$A1L&!0K"C4RNK80Q=K\[ZX%68N9%WPX6XP0=/A%!59"FF7SP@Y'XP]R=@ MU6(&P1X":(N`UFDMK+::-3R[AJH2I3"F`ZTX!)MFTQ0%`VX_@N(3L&HQ$SY?8&=+E%(*Q(>^8%2:MSC`F]#>P(&O1A":*W_-K#?NCLB:RZ^OGD[/VR&V8>6C.IG7$2 MK,C%L#4KIFU5",4'ZF`C8?].H/N<6`[3IL/`UG)>*4PX6_L0G8/20#>4M+G? M0"F?D45+:FEX>*^T=7R5#`A+#E7Q&H9H#(KHH$J>\UXM`T'02%V`A/!%AO]G M[VI[V[J5]"]*P>&00\Z7!8;D<%N@;8IM=Q?]M-"-%<>XCMV5[=YF?_WR.#XG M29E$LF)91[*;%G5L2?!YAIQYYAV:K@^DXYQZ\`D^'N_'T=UBVP.CSX MMU]MPX\;0;BLO]QHO/%NO9JEH7"J=&IZUQ04QE+=-B)$`3 MTS/\#W?4'912FZIN"KHY-EE2HFF?`^74#2Y?/ZYP!X#GAMWM/OC;-[_3MW^< M7[Y;K@Y(>T="IM+4B@,W])YD;Z;]:/'3XOI-V<,70)DEE-M[0L-20_(*U1C, M-G`88V"-P7KIUD1OL.%SQ[C-5ZN:[#FIA!#9!`J.W4C[C:NA"Y+M_PC.0T.6 M%!L!L-D[4Q,EDQMHP]< M%;X$^Y>W55#2XIH7DZQOO"\1C!-8DXL8N[NZ/C?UP$_T`/C=+79H1/^'!DX[ M7;=)VR%=>WG1WG!U?]1`J%0@1D_JE#PX&>>E.A_R_9SP!WF$K6$:,]7W$,-#S$$ZP#Z:XFMMY<-PT^_F#Q;@#\JI[]N:Q-O2_.?U\N5E>_-9.X M7+R^_CNSGF^"$"7G&*4`LE)0T2`C*^3*L4M[P0;+$[9#[.#$L+6MMJXITP*2 MU4D:5M=9SQ/F`7*'N=O`+WQ\T']NN/[VK^7YG\N?&LAOK@[ER&?GF[:VC<8W M)11TV&4Q1IJ94^H4D/O&$_]WG`X%\^V34F@UQ-MQW\Z4;(-,GN:P`+,K;KE; M%#8/A(<+,ER70SG-QC1/R20F9U)6S;8=[1%L#=SGWM=7+6R$S]PQWEX[(Y(B M1B&LH<2:JB\3H+YV'!AA?;W1XR!Z>7,PM$-)F7C8@]F0:QK"A#R![)/V@=$- MF/,F^,P=X^UU;M!8+10?2RQD32*D$=!0>W\7[3=:M8="]+"P$B^#*.2-&L_S%F/,JP9#EDH.)EJ_ES[ MMZMHVPC4'I&Y0KE]A:DU!@J20QHJ=UAKFG9@YU+[M6Z\^9G<*7RS39@Z@$:2 M.)9:B@4%#':O'^%JD\(PM`!+&FKYTCB:O^$7.]SL/0(L M.X5OMNE1'12A]=X;%W/-.OBET]T&U]'.(X-RZY,X3(6,:)I*C%2DHJ2)KKMB M^OIQ>P^GZ-[PU<79ZK\6YS?+EZ^_A-SZUK[W>=C;]^;%]?+T%A"G>BE"OD]F>;BY.'O^#PY8_\:;D89#F<[+I: M_N_-\N+5N\]_WD>O'):IWZQ6PV^]1FM3K<:R;?]3K=BHEAEW8-1HN7-6>7U$ M^PF+T>Y+C(42X!`S'ZX9H#<\C=&NT9O[T>Q!E.[/-[A:KWOST[?_'ZV/#]) MEQ+;L*+*M'T18NAS,)E7K3U2&>[-:1IU1@FQ5?"X2;79C M\$(M]L&+9^'-R&*!*2EB=1E3\.AJ5IPNH#=]7/Z8A;?C:P(,"=77YMVK9P": MIMH/4PZZB-0!J[K;HM'W/96+\R.R5D/B#XRB!W5LA4LQXTC,2CYTA,/&]37R M3U.$>S-67$2'!IFL1DU`P:;_/LRLB5VG)FPP_>%IBG!O)LL5%L=!(2:*`2M4 MFM:V."]'P3'"HD/76'9TTX:PK1*(.IWOKB(*/-XM.4+]%$U+<3 M/3&![A9][Y,U+.!L`-$82&'B%2FZ+EMUR.C_YW>_?O?C8G6ZS(L_CHA*1$D) MD94=0JVE?57'L)$6Q:[CPYOU0U*?I`3WQB&\H#8FB":J5_'>PUCHDRI0/^;V M672SL5[99O"&#'BM8)L[7/,4LTTG]06-3U6(>S-6&C5! MLU?1"KI8'0K8*1)EPM$8JYU*;W_>%M=`R1E''(.O%4.8PA7%UL[;.FKI[1;J MI%K$Q@KBR++X&!-/(;[&$HY$VTU8G?VU//GAXM7EV^6O`T)GU^T51V2\M&(" M=22*GFI*=EA+?R?.FJ6[.?99GK.V8^(M5_%LBQA)0[%,Q%$32J6NVL(>9/+Q MD:6Y-[NF0:TV3ZQY75)"C'8JGV_?T<.W:UO*<==D0FORV1(AFB@,F-WDE,70 M\7D+AUF$,;[GMC7F_8UG>/ZH3]/589[,V')$=KFCV4OM;IJQ,!$,"W; M;FKX44MOQTE[SR6X8JSWR!$\.3-=%TG003WG5KN]36X3C-A.J?--Q32SS\:/ M4T0@>)Y-;^<,ED#6V^&D7*ID#AXA\M0&"Y'Z^>`N;#!QY9$@.V1F4UUTA4M2 M2)2AU)1I2LY8GSNG`#',)FMPT&PD9X$2/S]VS M+O[ZO+#]]_?N3;F+2=((AR,M7CU9M.[.J$HV8#M!AKVZ/',7X]YL!:!855/! MVB)4,H6Q@$**PW*_W2E/6(![LSI$Y`,$AAB;Y4&%`#(*,$KLK,ZQ"W#'-EY= MS9ERP5B)G83$;M1Z&?K)PX>K]8ZVSSX:ITX*93&Y1%,IR71AAG'S/4U;/\[T MB)9$$PC6O,)(=L.W)WP*KN6/OLA7VR48&-388"YVPF M?BZFWP%K[5Y3O#,6X?Y<+!.&H::0A:/12.#2=`N;_NM:%./S)9R9Q7+H0G`2 MASTC8DM%K6&48+3^*)SD6;39*Q0MWL62?)$H.>'8#B_I M9\?<9A^=-5*0J@M1"5%11M57;,:NMN59D#.U838K-DDJ!K6>R`PAIU$#E@*S MF8UU*()Y%M^,:Y&%[Z;"X8!A[7QV%CVAVC;X+%1VX MDCO.-OL"WAE/'L!FXT+PI/9#CIB[ZF;P>VUMF[40]V:L2+.X%"")Q!P]Z+2& M3#()'D7([WC;[`6*R1S!*)A@R`_-B5/('_;`)O`8JZ(;L<8$:/\0I4C\.D(F?Y3E?.Y:"4XHA M.:\Y9Q2'XU:1=CUSO]0`]KH8YD"DN;]B3PG-!_,V!Q\*IAR,IC$(TJCE;-KL M'UF..^;SEHH'"28FSJY08_<3F)!5G^-[CK/-O@I8EL"H.3BCS9@9 MF6JAJ';Q0WZ6X>R,&5C0P!H:@Y>(Q03QDPP!H"L/L,\RG)T)$\Z:%4KR-7-* MF7R:M*F/=C8#VQ]%>CM>"JA8M2+5,.3KV:!Q9KHNHI_).>ZU'_'KB.^KS[Y2 MPA"2E529H@'CQZ[.#)%I-A-F'PZ]K?OL2PQ0+/J"D(A+5-4P0F6LZ=BIPS`; MW_&0J0TF3E`A&9.UJ=",SD^MF-[[KD88#<^F;.Z0Z0C%8H<>R>R;4ZUD7"A3 M0M/6SP3Z[6RR-8?,($*!4"@P>9]]$&?]5!*?F?I:M#D5\X`WR#/,$W,_UM!L+9-IOZ&+SWURQ(=*= M0Y$-:>]0/'GPMS[MR:3JQ:HM($Z\3U2FT\Z-:'2GO?DBLSSN7S*,&RF6V=4- M?SDRI9G0<8TQ^12JLUC'4:P4O7:-#B_"0VBG!S3"WR2G?>FCJ"DX,DC".0T% MOLY-V[.*]D753Q#NK350\V"21)9J0:,GDVN9Y@O6`EV7]HMX0"=ZK9(_',W3 M#CZ2.E>*@V*9T>21@09,N2M4>@%^`R_T8`2U+]4C7GU)I;H<3,P`WKEI#4OS M_@]4]\/UG5[2GE[N;H^^[];!_#E MZW]?G%W\>'EU2,8Y-R/1?KU0*7%EP.*G'6FE&>U[EDE]!9/YPKD][\\>O?&E M4(SM((K%/`YH+3;5_B""V43K/2B&OZS.+E>_+E=_G@W,^^HZKY8G9]<'=$!# M,Q^63=+V!7H)9,-T0"O$+FS\8I/M1QL#=2B(;WV&R21(;)2;/^2$Q0&,6_:* M0.V2'R\V*'I]*'2_7R[.K]_DQ>KV+;\U,GHR<-!&/&_>+D\:2_VY`5H;2(OS MWY>+U;RC,?@QZ,/V(03(;`6+0JT\KH!J%#Y_S-HO;FX_Z-_,=R;`UU"_)UB[ MAGY.^N1CZ+F15$>)'%1H&ELI^#$.YCR2V3_TM].%ENV*M,_J<<49X?II\4_3 MT^!N%ZTV\L\5DHQA71^1^^EKZPL./T9B/J!MK6JM2JV)J9:,%`2BQ3CR5N$^ M_-1>\'@0S4E5?AJXML/B#:$YVX-,TE+-JFZ)*6B5P+B'SI*_(]?.V8'W2 M<)Z@;1_425`0##4_.YC(CKT=MWPU2]FO38*PGAO>`Z*?E]>_+!MM/#E[=??= M`[.(WC#';(PB)@R<0/.X5=DUZM`V,; M#Y/:.@N02744;C+4.4DQV)'06(O34Q*UW%+:"[>,G^.^SZS?RZM7- MVYOSYMN.K_I0_G3UPX7^]6IY=?5QP:NU36WE2OJ_[/>IDM1JJ?5EJ_2: MS>[<)#7)U'Z<ROWY;A&(@.-A@,MH>JJ8P3#!P_C[K5[XUK MT`XNVE0/8Y8.6'I-[%O0`A27VBG#AC:'N(\,[7O6MJ\[U,:56(1!=N-8-4:3 M<^A'2;@`;4TF%\SVTC*&BR?E(8C*J83=7F:A9RDBSXKF:!O,@@&:"`+?P^!VIZ&/[J3 MZ=>S\?]UIVSH].G2=-Y]FM[X&?*`@@=&$Q6)*NL@^5)U4O?+!@/&V`:+UP)[ M/W0.`>*M;6IM*$>RSGAG:^];DD:NG+I`S1JLW\QF.^9%8=W;J(.0)HND#:`$ M$L$HW2?L(TB$ART<.QZ(MR_Q%,9E93$XJ)6>#&6?L8Q:Y390_1OL^!>.N3:]E7U$"QVFHE`9_C?@9-U`%L>W+- MYO#/D\!ZHQ#E@$R"+&4P&5+TAH+*)`AZP[?"V39S;P3S!@Y[@]C6I\UKJ57D M/[,([$J#3KFOQD,/J8$'-Q^V)\)G;Z]J2"AJI48((K-GS&9[GUL/VJ?6E7JV M$[4?-V\).9M"I0Y.<$Y%[40_I`4"M1WK]QC7^D3X[.\5*@)`P(2IJ+KPC26P M%T(M5+N#\3`1V[YBV"H^2X#&.CY!H$KLARWSB;*ZL8WUYHSZ0_!979`;HL)[ MK;0H1(Q"0S`>6-4'&52?5!(F/'"PYSI,]A?.[:M]<\FD7;$Q&BIU0H3M+3(A M15)M2J`9J^P5'Z!_96'R:Z4AMMO99LK@B%3*9T<;6K@)W8X=M.KG4?7CE\G/R8*?<-'=T:B^W_&MF]W[4F-1$/GR M\3$@62BRG^"GLX;A*TCHM9;>!G">&MI]"N+-'!AE+^^BWL6- M=9F<`25CJ2\<$O1%P3%1N>,Z6>MUOG*S&S%*6<1L2R1!,@=9$$,_C"!*#<-& MKSTFS;EJ!4E;%HK1&="9+'XJ7*X$B&X:#:@=DXNWXZ+]]5V[&38BTR"D))QU" M$=Z*U47O"L4!,(\3R<>?T=O`NB"U]PJQ:-11!@^E'Q4?BH2A-.<^`?O8);/[ M[]P7D(5]^\*,6/8_K$_:]@2QWWA''GJ?U/X!8^Y>5HQ\KYH(JE2 MG8MLBR\!5G>^4F'8X-TKY_ZQ5.VSF5G M5Z(4A90N&N,]U45O!AW<<.[+D/G,SKT](K+VW+G7:-C!D<%9#RH:'9Q^[L#>?^F$R&PW+N,WI$X:7U*,A3S-'UHZ-B]/D.$^]P[J9G=>XI`(,67);" M*:6-4**/;$4A<`C,PS'(7M*Y1\MV4B%R29?L"O!-W8\+BH95S?,"6[<ZHC-B#/7#7&EIKDB#97U#@9):(V&<%-6L`^+=_YU.[ MMB3N/I]_)Q"^\':S:[^89'1U;!5%=I!#$3FMAG2F(N3N(%SVE8P_GR^N)*H6 MG%S/#+GO[(I??\J[T?=NU5>RKV\;CD[S\FTXMN]H_1XN3;^.SK MK:]WLQ/6#^^_++^X\2SY_QW-3C]=_.AN^UB7OZ#[N)B>_'-#+8`RQ1MCHL%$ MHJ1L1#\AG@UJ&BZME&VEVO:?<=>(X1,C)C*@\YB`;-`FD4?9SYU(&8T:]@H/ M&+$GE\M?S"WM(K)`&BSXH3'?6ST7KG\NU'Q-691U(8K217F(?1<,<^_;[0`"VLTQ]W@P?CWIZ@M_ M=GISE]Z#"?:&`)(*F`,6A1DUY"M;K)H@[31Y&-@/M/FYGNR#7&>#V-&83L:G MRW>_773??[%0?[!KLF`I^=A]_3Z0)UJU6(3S.0O;?-Z_;Z4`WDRFGT>3?W2G MM?GB[??15_YA&SO=K=5(P24D58H#[P6PV"#_"?Y65?_5#J_64CE*+#_^J,\X M65R$V>CL=+YI&FMD3<,Z1Z,1+EDVB`U4[7;[D=JF77B=#QPCC&W:%9N.3 M34`&*GJIC$34L5A?0J$ED$5C";X1;JO6:Y9G0:VAGV%E](:/3^ZW'%*CQGXMO0)RN"C!A5/15\ M34J9;#OY96"MQ5%B^3`]GIPW)2O*$!%T8&<,S1)&Q]8&83ON#]7?Y$P^5)$# M6]LF)E;CBF0QVA,C6I'TR":Y:"';:X,'49GVV20GH1;'`RGLY_\$%.VR%V/5BWZ0O5;DB2W(&O6Q M-3+/1P3*4I'[E(HW:6!9V\#>X:/$\F&*W$&2-I@D=8BB.'[BZ!A&"JRP*<5& MD2.Z%](_+X;C/16Y#%HYF97W4ME$?!7J='D@50F`S1!Y&E@L^Q)`/I\BMTAL M-_BZ95=DHPKBTFCP*4<,+C0B:W!@&=-#(1K/3RZ?M#M=/>C;LY/I]ZX.D"^S MZ??!MZ3S&7^T#W4KS?OSJPUZH?LRG767W_QI]*^-OL[E.Z]/VFA2!Z!]_-9U MB_K(IZ?C^IM&DQO9N7#!?_DQG8\F;V;3\Q]S_A&3\U-^DL&'O#ZLEU/5YHNJ M0D@=.4.BD<\V:':`;+[K%N^_')6:K=-+R&JEBD&OO(0<8LZE MCJ#%F+&9T:O;>/P.\'T!`@]5L9I2M-%UB8WS&#*8Z.)2L68#8$N[@5!:W5C+ MQT'AH:I2B^A=-K+NMO48$Y&H=R-??Y'=2-'$_WYK8ZDO0N"'V?3GN%8+ENFL M_IJZ`>G]68_@/O+T:53Y&/VSFVVZW8046;CBE#*B6BG1L1^:V;&7&J1H'"?5 M1D6V1VPS\ORF_.5+=\+O'_SZ@_.R#JQ%D!&"-Y;/(JL14R*2\-H!YB:5J&3C M!6WSG+OXI!LR%[+6NZ-.(5J=-<5(HGY2FP2[&U:UABBTN?Q]^:@;8GL>P1LD MY[42G@]NA+KD!2TY,$;<:K*]RC;=ZQ`_Z2?=4DD=CP&6TLX3*NDT*+)[&ZA M5@Z*QT.UQ90H.>42LK$IFA!%=LNQIDH;K'G%MJ+J7L;TT]-XC[!>C<].UFC<^]NOQ*)(!J,TM15 MTB2DC490%B$ZZ_2`,R_5(S[Z+\^ZT\_\UVDW_NOW[NMH)O_?-^6@V.EM,9Q_//\_' M+%ZSU32#-6D\8P(6S5*$J*364L4E3$@JP\`2UB,Y5A]&LV7!R/_ MM29CC";S:2))!MCD8XRH_J?6;Q0\1&Q6Q^?B[7Q^OC%6'FJM/P@VBI4-IHX: M6R['5X6GJI'QJ>#B:R#]46R#LE9U"F2=2H80&4A&[?<@&55$_*_ZG;; MTG2ZA>#V-,P7\_=?WDRGI_./T\D1I=&T*37KDA%33L5C'>'8EXN2SXT1`MH, MY%^VQ7%W?!QJ/DRHG)S,X+Q*(+%.(8>>CSKLN>%CH!EK'_DXU+P6:H6FJ*"S METGIS$+A>CX"MGN^09BF-^7Y^5BV.8PF2RC9]!S/%_7??W;Y7S^ZL_G`0K-# M55]1!RT4DD7RUB@7G2*MM&3?`A*XM@54ZD?<)1M@?3:V#E6YH8W&"*R+FFR. M$I5@KI9LB4S)-V:[LP,U&X=&UJ%J/DE8R$1V&:2CB.Q8L97,9(&7S@MH.GS8 MI-L[LMZ>+49G7\>?)]W]HCNOB9S>B<2@O#&I1!M"\9$4.9,<1"#R)K1FR&-, M]+M9>@[>7Q-X-]T!0M(Y19VR8`,T&.`3;9$V4=X`[O@_6=70TD7 MK^GY>UE/!4#F&)7@5V2$5:"7)3H)?B;T1:%==`_ MI*Q%L);`J0+9"_04PXX?C4J;L9U)$:KZL!U'7(0(K.,0H["Z)2D+DV\'(?:=)Z;XP^S M*;]<+'<253SK)J\?%>?7<-Y]RW^7HR^51(H&E35&.5PZ^AFU":;MQ6D'K#TI M7<]Z$EX5P$VO0J"DZ*0Q)3NV:.MLN!H.2"EH4FT^T[3;2W9X$LZ[VMOW1S=A M'$\_C&:;-?I-I'^?#C#YX?_9N[;FM(YE_5_VNU-SG^F77377?7S*3GQL.:>\ MWPA:D3A!X"S`MO:O/SW`0L!PT4("))*DDHIC&::_Z>GI[NG^NJZ^=GK7=8V<^G[[Z_JSF"$P.4M^22%/ M`;*]."ZCMF333P5=N,>MW'T$*L MS&^,^!,0(]')IBV`T@ZC,>C-L\U7_^"?]B;"'%6]OW)>/OLJ:WSBTG(<[\3U>ABV2!1;\ELN29*;NQAFC!? MS&$+WJ,--%\%D$GH(]69X-:P9L',6WJ@-CQIQ;LU@B2E.'JO5K!HC17!"#U; ML4XLNK1#(V3+!<\[T>./[FUG<%-]1%ORRV#SO//V(URLP\N`VN!]S-5%0D$S M4M1:7A;BT?6[HQVYE!R=$\6U9=)[&I0T&@\]I485-O]5@'%@ MQ7LP>02D(D1CY.:,CR+P*1::4L=M.0'A]:A'F^)V92DX8KWPZ,7F3'BB;`I# M+B0R?%?U]LL%H&4%NY;.2(E^A`P8PT5I8J13#*05-*Q?V"\!@SW44LI;ZU@N MOGI`- M#CJN^[ZO1"=:&C\I'#K1+$KGT$&2F7.O&1MI*"F'3IT?@SUD+$; MM.)PHU@\_7L5DC0Y"9=:0$`C,00D!([V7NLM' ML7[!H!LL\,Y7QN"%Z$DS;]@%M(0%=<.K4I`VY@_=.\J(#8D)B`+CNQ@;-X$@ M-@40KP*`EN;/!N7Q;RJ(CT8;:9@5S:!/GD)A+9X/@]ZW!Y[PC]-YWBANM]>? MS6^PXU3E)KM^3H%/<@78R@^W39MPAF$-DU8R'ADZ]V@`\#^IH8$D;>GR^7\8 MS`F2N,CR^#O&L@60T^G:EX'![MP.U`GULN**&(@<=8!Z__S2./"Z4_+09^>KS>#N(`1:BN#SP")@854$8G=5"1 M*04FHN$W-J=">*";1>?M1-^\U*-)O%OA"0T*4M3#H@K#=XF2 M-@&*H&7@CMM=1*OG%KV-5Y9"KDKEVEDP9L[KN`C(A"H*)-A6<$[B!K/+7H;,S3EK8A6H;!H=87.KY8S>:TC0I?O(R]-V)9F*(+Q M(I-%*98`G.94L*8>PM-4,*L^6=1/5?VMEPM$9L_EU77>EVHPFGE5&#ZF_O#[ MS`/+O_J,/W$U_%2-Q_W*?N_4U^V?!:B4/!>H<1M$L'AT0S+H2*`"1X;>0TFQ M5S0@/]O:3X7(GEQADF`)8UH*;Q6))MDX101,XM1".2=5;W,MSH`(&K)OU0@5 M;O8!5\-QI[_RKD'7=U_K5:M1E7_/JSO M9M5,N)"]N49)@J54NH2&`JV')WR>:_3>REBD5`J:\J-)_W(Q_HA?4O=R`/5I M/.S^L<]%A$@"2YHG*1SZ&LZ$>=+*6FUY.11H6_SS2A'^,!U$D(;U_'_EGZ-[ MVT(V([]89,;]EZ_YHQKT']P=U&:179LD+?<.-=HT[T0>@VGYCW]^8%_,^Q/@ MNU'RUP?Z5I/RX'X$FS/3G#%.M=,NVY!&Q8.@$2&G7^!OR!\-^18+LU1BJ1(G MR@#C46K!K)>^`=S8X*V).!OW1-?_BDV1^:%D=?W78&,XN\IV;]H`W8YB0G(80,"H"2I`(#0>=U M(A:T8X7WPHMZ_K.!=**M>K@H#]J6'1?NMBW12DM$F7IEO=*6"DT:TP1$%QE` M5LP5/0D8[>&_ZOQPU:#ZO3?.30C+O[.G[7L'BWH4B@E.?2#$">4X;3R5R#>P M3\IM*:FGK?LD4.R)=D6RW(E`9&9*CY9'KIJ\L9>R?-EE18_S*\)B3YQKE'*1 M:4HD:,GP7M?-"?)YV&2A%H*>0B_^G/3&]^^K\>WP^NWTZ-V5K_Y['X-8$$8+ M2V+0EG#M4VR"38SAU:[I"EN^_^`U'J=D6UKE\"KR5'(JC+"+*G:OT1P6::DW M5%&MB\SC*44]M"`;*.,RD^$E0Z,&*T-3E`BY*Z4<`"YD<6)/*6>KR0TB*:!! M@%<8/^+Y3?5683!9V&6CBCOLE+*UG;R@0QY$EI1..F"P9M"`-&\XAI>S M0RE1HKQZGE/`72\WZ-=IS24-Z$DHS4@P3C2I_,3HKMD)S[W&H]@,Y8@V,49A M,*H0'J^_14T3BN<*97LCN"I9JDXJZJ%#8QA+DG'P0))48!Q?%#(G$5R9OR5S MMJ:S"=JJ-P/-/O.6>3Q1%GP`E*FYM?&4E84.0D-!'WA2Z=J:C0!664Z,RY.' M`P&5=',0'9'E4['FJ#Q_7M;FQSGFMP5?WR6[]W MTYGWZ?[<&4_JU1#H[>"ZNALL&N47?^Y\/?#O._U^;]#]HQY>X_?L'TMO41%- MT(8%EPA!!S><1"07"I">9O@@LDQ(%`.:;;HHH2X8%7ISSIRSW M^((?9^0?-U1E9J]\83G"LYNII$&WV+NDUQ>H<<=Q# M4_X(2?(B%KTH%6N5Z"#H`&,LV:N4+]I^+4:N61CJY(`S:*1`1 MG6,($4SS."/1=][9>OA24=KS!J-S_8KF%"")"'@\["+K*(TNF2)Y^1[ULB4_ MBI6.H!@(H[GT03/OB!:+V#6Y0QFH]])&/5L**5.K_ZUTY_DH3:3NUFM17Y/SI4]OP[[^!E]%'-7@^33 M"YR7VRH#&B++P.;B9@\D"N$,T0`8NP8P*_V'2VV52V1YCQ?HV7!X6E7FEEYB MC-B-C8K1R)@0S-'4O&E&:>D6'/3SX?!V\'4R'DU3=Y/!^%&"N\FH-T"]M-T_ M)[U1;Y$OGG)G#D97MU7=^5I-QKUNS@V6\K_].2T'Y)$;$:?C=&5R"3AZ?LVK M;E`KST\/"!"Z`8%2E).(_#^3:C3N#NL/N-UWG>Y4<)031?]IG^PL6:TP4I*" MZZ`YT"2;%C`KI-TBN]BT_2]5^&7G98SV:7JY+`T_=O>+(Y0_S_6&OZ+NUIVY M0>OT/U:C27^\X1BMJQ$P\";Y:!,13@'$!91X3?DM:L1/"V6H?AN_'8S&]21G MVQ=2I]ZWZL.P-QA_JKY5@^FOJKI;94KB<<%F^VXXN!E7]5W^K,+\?*H&O6&] M],=V(6:MT`(53T%4*LB8&C(OJ[7;W,M/Y#(_Y3DA&T[J*63_KNIA_F>.V!4B M\V[8V5`.N2H]#4`5!I52Y(FYF;)D:P=.Z9:S'H`-]1;[/'H5VZ'EL![ECT:;?F>Z6?MJ1OY:QY:H2*)5AHNB";>1;R6 MFNX5+B0MJZS1%C^33NSFUB[N=1]?ND_Z[W^W[_9ON'C!#DSO\-Z_6-NOO:KS)#4M6] M'0S[PYO[]5$/F4AI92O>=W[T[B9W1E)-;27"T`/-!HP:;F>26Y:%+NGF6O4OYW/8P61CE9>%-7,]MT M\#'R$"C"H@T8@2&588DUO2-.$R(0)4[^.BAM.4J6\^2I)S):DB>%.+T@1N'* M4X,HF5<)TE7=N:[N.O4?AVL0388"49Q+RH@&!5XW[7;))["O5X/:@+-%<;3D M(EJ=!TN`U&B(@I@;H4!\;NA!(\2/`PZZ7=W)W61*QV/OAO6X]Y^IM6S76Z8= MB][:E+A47NE`1&BZYIS@J2CCXYP5SDSK)1Y#PN>_DK>7/^`WAB0H4"M#T@9] ME"8SYUQ,1?D#0VPO![-'W=+;.OT"DW3:RJBHX2JWA3GJ'?,F)9)$\2)Y@;!M MO;9VD$.:W%#G,8PPRAH#0B_2@=Z9HMC/Z/4VIPN`;=KDL/[3>TG0B4B-]A(,:AM&%1JT2F6C>)')>?VXK=]QV[M=K)5"!JTQDK`1N"*+ET[G7"J* M4(JJBA<`UDXJ2RMSVS`H'=&;D`S^7*5<5$*:0Q;+^][&1*>\*)CQA"K MI.+.*4>$2C0MG`,?RG;E:0/`Q6#VE(M.Q*AE\.A-*<589$#EHED8!!1%)6*] MWO\"<&M_T]FH@X@8R!/)F$@Z&=YE4P)HK6A;$$FHG!OBSL&)6T33VU?YA,EO;K%ZZ"=J(%9+BQ8@@Y\\DP8 MU3`E9O:C\[5CG4V7]/FPG*?4QKYN")Y1H)F-R"S<5O;`BMZ"`/H.D MWX>/E?-?]7#4DKY(.)`$A*%2NI`P=$U-:W:.+&(166@JR@>S/2MZ^O)/Z%9[ MF9275`0#B7!CJ8N+"\B36-[6&+"TL%'G!.1)R2$P'#C@*4?_)1`;64HY.82Q M>B2F+,3FO(7W]Q)`:>\0:Y^$5L:AUHBK(HKCWUO7"R#`?#F$!H#H$:Q90$3H$OP;MZ&_.A_PY MZ=75]2K!^*QKC?UW9T#H&TZ?!,K'X7VG/[[?6@3RH1Y>3[KC7^HYJ^O"/L*V2F/P685S&%=]6X&LZDZW?M< M^UCC2AYJ_1:U@P^<3WMOJCMU]_;^7?6MZF^NC9P5($Y_@)ZK MUI(9Q='/C93GD#$75]AF`!GS@13X%_`?@.;+WPYVMDIHG4226F8^PT0T'HRF M,\4)9TOB^(O?"7ZV@Z&<(CQ)!I1&`2;II@O><:5W\KN^[)TX%'9S$\>%C6,@S//$>P*!&Q8@+8:V)B%ID1'[?_:NK;FM&T;_EWU/AR#! MV\O.`+RTF6EZV71_@!HKJ;>NG56<;O/O%Y1]9%N4CWP425::/#3-.+;%CR"! M#\3MX`I%?+;+#_(+6H_7V?GEC^([\?RM?,]OLW\F-RK5+F(;:0G.Z6J-UDRU M:'%%C*,84YXW8$=7PKS]?KOV&.R4X/WLWS_/% M^=^S:_%,IW?,#>1`*X)"+(ZQ%1LA<.4@8K,;277)=*#6'QBF+W+O&+:@G(:A.;VUH7M: M?=&/G?IB]'2I(4I9+U2F_PR'8L1\;Y\BM%*)F(&\I5;6:NT1> MFN/!8B]0]KWIBWS)#0A#14PS,D>0J MN%6T*+967?M;^&@4C[P3^VU)[B%6B@J&86SM/`==F,2IB_G(#<1D5'E MK"&QSYJ]H!CR5%()_0"QPR'8M4F MFB)+EX-<1;%7ZS*5NC)&0J+&NLKN>=53NW$+$5?`&&-PJ$A."P].ASC3M;.B MG[?P89%CW1>6/=[^O-JJNN6^DES7Y*H838>&1066'`A5\BIVCXAHNOC&TP&\ M7-)*^/G--3P)PU-:U3V,$Q<*UML8L[`#T(F=NXUZ<;%BE7I#9#\+#/ZJ7\T6 M$)^&9G8FI&@^O1V-B`-1_(>DY!8D2&!P&$Y10XY]NU/HPM]382%]?`=[:O/Q MN'^4H8#E*N.B->?V(QX6=;BU[D M!'DY.6V&`W@AS2;#$I?..6V8[JDAXF/\^5C`OI]?BC_W9CLTY4S(-:18R464 MFZ*6T"Q&X5H;HBU^/9]I9V1CI-5ZK%X4D*A6-K9=X%8=H92OJ0W2[72/Z*BN MU__G+.Q05T2.3ZSHV=L0A7DX8@A+7*4*L3WL%9D&:]H5260#5Q\RLJN-#9I2 M&RXELO.L>GDA/JIFCP7LB5=$%W:BKI-<]<3%V5;D?2,R;8W(;"]7Y*70[Y9I M9+;>T_3K8P2JMFJ@-8T-D6"\7HY;46"IS+AM>_QX_9UI7M$<]*BD<< MJG83/_AP_6HN[H2<]+Q,!5I\>OWI@WSX>J[2]N/U_<75[[.+]MN$9CU-*<2B M,#B;BTO>N6(Q6]%^C!PL5=,71`E[?(SD/XNT#K(IXAF'@G+%:JI4V8E[*19` MV^J%/*4-@],AKC_/G_BF3#(L1N;U?2E[,-3 M?38E=+3JDI2F8FLM.JF;DP&@O!E+/-G'3FR&O6',R:F1N)&<*D[<2A(2VJ@C MFB"$WY`2[F%]ZAOK;.5?H[OXB\BXS0A_LYC//LSS_.;_DP/#B5#\1R.Z/T)5%)=OWN-6M+F?SJCI;28<-#Y6-/!:/H'NY'<^5^65R]79\W_90D MH2BT3:ZO=:GUAHT^UN'!V%#NHT!!ZRYQX>[CIR[K()$Y81V@DEP:8>FAL,F. ME8/20HW8TD?'=-*!H.P8HDL^))^RRQ'%ZV!G,(,@41G9N\K=O3JB<*:$ZK)! M0P!.,?EHM4EB,QUD;:TF%>S8_-E#+7]BS"Z*KQ=BJN"%W`8G+E^L@J"2DK]! M'_KZ7`3X*_PZEBW6DED*^*IC#JR-\6DH77-%Y[ZE)'1=:79Z'9>%H[NEM:,>VXK%&3$$'<++0J6P5! M+I'6N&L MAMK4UCUH[PKH4SA234)6KF,2Y*A@H]CB,L?Z))*+&`%4^:0DZMVQ#GH8TK<196O`N"FP,QG__\^\7Y MNYN3?9,R?YUFB\6G\\MW(Y.XELE]G][/K][>_?A=1X/+O\^O%I?M.6%V\<-\ M=G']Q^SR[/7L[?SZTZO9]?5\L1YPO/]J]N/5F[M?-WS#L@W'4/MTWLVZW`2& M/_TTN_ZX>#@_X>7EV?ROR_.WYS>?L?JYM=]WQ$>]5[.+B_/+-W\NKL[D<_[< M>A02M!1:X32):O884IOC=SNDW=H^$`*F,WM/E/P>C\LW.4^6,SM,0-94L8-9 M%&OPZ`8YF]CW(`;7J=[CRME^4PO/>%PL0:F577LA%S8,XFFOCDLR_6S`O@7; M,QR7;W*>+.>:G(7@O%UVVS(V1QK*.;W0SCY#PG8/8?N2\^V@IO+/^R=47F\5 M4=N,I9BW]QP+XK"87-I[DK+L90N&'0#QIKK7K3Y=>SN8(X/_]YS/F&K1VH,' MEU3QP"8--=0^*NX>D#T\10^=AG1>RQ>N/_'5Y=EC^7+?SZ_>+6;O_V@QO7M; MN/@D`CK[8=[F<']X=?[AP]7'Q?FV6%,2=PH!A>*AP^I,S2N%'MEUQ]SV)3$3 M-_(NJOOSVS8\?MG_[*9%V`_SB[-ZM?CO31')6+D1LN7R'L'W@G'>.'`G@VL6TYSE^BT"P1!"H)G)8= M23'&8EKR!8"%/O9ONV*F'86VW*"69U,75W^E&WP"]@[@Y,P,2]J;Y(R8WI+1 M),5ZL-'!ESZ:&M8MR_8U[0G"01YH61BT-JRQVJQ$>"S`6Q:'#C:T'MY]]QIO MUA_#3V,'=GS7A5*6(RRH!A9;6J/&U)(_"E3%N79A:^Q-QDG`G_(&[$/P.K>` M6@AMY+!!UZ9Y5U-RQ!SZN$QB$**"56#+:2AP>[8 M@7>=UCH\["TY*5Q)0!2R53NGX0OK&8!'P3`:K:Q5[$0-2!FR M!@@A&QZ"J.#Z&3FZBZT?!<-X:#-ZYQ`)N00T-C@:@A#@"E6/`GK5F"SJ9&20L^Q#'U!48D'U:$V M$)[%H.W;CA.Y%EU7T;I2#!8KAF0`KE/?W.J%=ET6SA&`;TDETJHZBLQ1A5)" M)54&*TB,I6\F&OPS"&]+WI%A&V(;@%U5P$3.Q0%#"JSZ*2#>/H/>V9*DI"#D M'%3QV4<+08<:!^7AA)ITRM-V<^./@F'4D"<5H1409U35>>X>55Z(E)]')QRL$,,%7Z+0_9A*8!!P>4C,$V72#_8(JBN`/`W\ M4\PX%F`C^EXS"V970`^]#KGU!^D].OU,"FC/5MR!81\L6)M<%)VE"(>W^NIK MW%`OH`XN[)O>O3??]]OLG_F'+'_Y<'W^9O*S8G&)*EE+@%:)4`G][5&F+'>[ MUV:X'IK^C-4>#O465\RG7'5!-M[40)ET'"H`*!<3^]:UT!)POP#<6VP7MJ>S MFIW@UF*%JS8\Q.)R$#NV275/M\`'PWW;)'CR(3>>LLVM%-NYFL0#-SD/L,'J M#5VR]@#Z=K$'P[SEB.>`\FT@VHNB2N"\K7K`;*#WNKIA@"<(>_YH8?.6RQ"Q9!"E%WS-UF`K.%NE[XM"['2`[9*1CHCNU';U,!7*266J M3$[IVI+;EQYJBVVYE@78%XGO%MOZ.F6R(\/76`)F]LYE+R;3.Z"\++4N5?A! M/ULHFF^7Y`"5XI03^QB4J[8-^&YOQPZREVNBG*..IMGP30H'B4AFT,$H2A[! MHJ)(X@:TB"3+'\!]F]%=(I+_0D%LH6C"P>44IV2]L'`?`NO5;&*#SG=*1KR0 MKB[D*][7@]CB8C.WZGO2BBRH5M\XO+(BI[ZX<:<0U=4!(6,$[54IILA9=Y7S,+"; M:U&A3_@1@_QM6P\:;"I&9=4R'ETTVI@:HEF5LP?%W9O.CL&FKU,HNXX*2L$S M^9*=C9FKR$3!4+T03=^MQ1L]/2+R=4IDBD%FZVN;?LP(,81D%`Q=2U@E;?OY MQZIK0_U-#'NQQUA)9[D#23N#I!1X/<2#P=D^LV^G$.%S2>*7^8)G'\[?O/YC MMEZ4M_FU6=\G[RI4Q0!&W"02KL()0BEM!C')#^,:>9>/6G[*?_RG^@YPRN8\ M6.1^`?:)SOM]5\:`>C\R0!%!\':.S)`%Q/K-(/WK:*AY(LMDJN(#XE#6-,B2*L-W^Z`_A" M?6"#(EQ/N[J/$!5"S3:E7%W+111FZX>T6Q76LZ[N(=3?J=.YA:-J)J1L M#0=&PZ4X*D;^6ZJ94%0A/X)0ZQ-!V*=AWD?(51PX#K'J;#0%#&+\!SWC\WH? MQOO7T)_*->QS-!]<0S2>BRB4U'(QJA7[`"M%FD,<4:2G#T_VXFO98/B3QB5*&2G MENGY:8#H3=HG7[N_S'V#W,+9@C5:KB(@E123-<)+ARSDELPZHFK<28$)_< M[;`HQQ2KCVVNH&)F01J=85CU*UYF;^Z3OQT8Y8CJ*4;4C4K+/Z/*GKRZXW"P MWF#A\SC<(5&.\SC*AA%U`::,XE(9@,&=\F#6JS@>&,E3$N4XEZM-\03"1#I8 M6[+V,+A4+.S@48=C!RYW6)!CND>\*ET#!].F+]@V"2D.>73607GTO.[`YPX+ MUOLW_H^GIQ_OO'Z]GO%_/?KOYK_OYJ(=_Z[N8= M-CLQ"3/TF5%6C8>W M_QV;.2E;@\2_*9$58>M6984YMB$[$<`JGVA#WX>O8`,GAG58U*$.1!4+$Z7* M%I99C]7'2,&,M2#_4G=OV*F;3SK)9I7(E:)--9"8**LH!=>F>\7Z_]Q=6W-; M.7+^+WGW%*X-X"55`+J1>&MG,I?=I/*4XDK'-C<::4)2WO6_3X/2H2\XY.&A M>!$]#QZ5;%'X<>U^C^6H9D?5N_,%++S0C*D!$'HI` M143LKNUBD)7D@C!8VT%)7@J^@PZ$*X,U+`[ M_SW,R2XB((3SD31J7QOR(0+F/C0AI6[[>/.A`A&H@%,!5"FI M:$"-L4^814/?%14X8?JW]:1#S?L+I03'_ICJ'Z^M4JV$)^]*\QV8\Z.2`9&4 MKA7^"56MIQ+1^XWY#ZYM)/7F.S%UQR0#FF^&`F@36*\L8#*AEWW1&MO2^>]@ M]JZ`#&!2,67GO#&:+452QE`E`SG[VG&Y+4K8G0%Y!6LSHM85I'?.F&RQ@,_: M:V7Z?#25Q4#D9'<"^U5,R$XR@,D')6)BMZ9FEZ#+FR(["+X5P%1--[0KG)'= M0F))QA(B!$P`M1U5WL@D$)G0JF'L3J>_B@G9+2]:2PH$B%1R<<+J$'&C&U$H MM[$R.5)-^X'N[Y4JK'BM'ZH"^ MC\F<]"A`)B6KBI?L'BGK9.AUZV*QH94NO'X>_@]F[`AX0"AM4B(:\EPH263"F\@`;A?3)-A;VS>N+@8^DIN[.VTS@ M4F3_Q0LMJ"@VE!J>4AA<2>G;>.:7>1K>'S8)^R:IO@CT[HPQ,)YT*428F(`C MJ-+G;00J!-NS_]0/[L"E/POJW=DJ5EJ5`_&5)U#IVI2`.>]SMHJ+>2OJ72FZ M9P+]DLQD4RRPJZ0MV]OHR6LA95])5C##27;X4=)U7I@7RL8;.&M0.'JTWT^HQ0P_?M27;ZGL"/I<:G MT#L`\C)XR"&RRD(I)N9$V2B;5 M_JNM#C[LCEN?$/S(HW&64#2JXD3B$VP,8-STN+`>FT?CRT$XB?T2:*Q"H>U: M&=R8)'LVF"V;JB:Q8E0N[++3<*#Y,MD)1!UT#KH`W]JRP$8:RK4M7MGLC[3* MNNPT3-*HK!"+Q)QDY$]GQY0VLE@)8MO=9E2+Z;+8)UHR0DI"6`D87"W?D=Y] M;NDD[5!K+GFQI1\)>K.?+5,T,F9PD3`:T3>VB,2W5;.4EX-PFA:;*H$C*?DV MCDB%[;H2?=4.4ZTV;6Y<:NFR$W&@-?-%1QD+VS-?.[L47\#VNCJVA/;%<$S- MY;*S,,68!95=I=FEDD[ABH"^T5XLM?E>(RFD1XI!+@M]:HH'&JE)%T&@L]?9 M4%^A'XN#@1:K`7:_GN^/GKDG_7/6G]0_SV=_F]_QC_+O>JR1U;\_/OUH_=#? MNM7J;AV`_:_YZ@/_X/S^?7SD7[%H8KAOGZ9I^\-GM)ASD8X@VJS992E6*'3& M1L>;H%EN+X?Q'FOTHQ/SW]UL\=?[VV[QQ??V#%O7N&W_>]:;Y.;A\7ZU^/0_ M;^G+LR]+3C8F+7-242!SDCX'TABRHC;Y%&$W_J%!GA59#:#_]8???B@=?UX- MTM^N8_9_>ES4TW#SU5WP.9BJ>8=+7O>:9B>8A[(CVR//Y/*__*L,H:GI.QSY M']W]LDO=??=NOIK>M29F-L\R%6L136WN(#?/T\9A$S8P;MA"-R-YR6A/_*RKHK%/0NXB7>FJ]17 M^(CL[C.SX?_"4R3#\<[U[45.$BU%(92V[*$)<.Q[,_?>Z.9+ MPM>XF),B"@483D)95!)!&%',IIX+0FZB*1>$-=%86*TM^%#UPB&E0+D*)CS' M2IRTX[D3QT5V@;P&/M2KQ6RY^K'C66/'#+N[^<=N\>FW3TO^Y6,;OTCO"%%" MD4H6`XD`F8,#Z<1GPC:E^F^V11N/-(\C\93$KG1"-CM$/GJ#4?F-.@\SK;:@ M**CAA*.C#O=#.L7H1FU,"LPEA&?JHXIDC[2'E\JW,J=/'2$O#&^J M2''27AB/@8(W?(T$"WV6:U6G_["NW(Y6Q/4C<7D M3_QQMEIUBV5\O^C6!OH)Z-@GL(W^\F^^,,$?>=:Z^Y_O;L;VA*N]?9DY*B`I MHT]YH^UKM"EM+84<#H;M.7'_OC8\G^)[QOF>QXT/=W>S1?R]QBDF.[R&MR>[ M$)XIE.SR2:]# MC)I7HFT!MM73FP[DU^ZFFW^L67YM6(VG?[,!T^-R?M\ME_'F_Q[GR_E7V_>7 MQVZYNGE8_/QAMOA]=M,]KN8WC))_QP]C*ONAD)=5-UL%OE*D9Z]>U,P^)W/@ MC;FE@><0],]`M@)]N+^9W\W7=UW^,+M_W[V]Q^Y=MUATMS6^M%QVJ^5_SNX> MU_\BWMT]_*/Z2),#-XY(U7>%HKP5TB'1IG>X<:(E^WKX?>$E8S[Y%(R%>3.@SPZON,C MNSZB9',P8)-,B7U5YW)5=!.N6E21M&K3RH:S:RXPX2.V@[V0H(WFD^*42EX6 M+R-O)>TR:A=\LY7TU)-S:F37MY5,\"^!29)D]DUG)26WOJ$<"QEVMX]/OOLOC[.[^;LY M^^Z+A^?O1?[S(^^*;GJ2K8Y&@-7D(SM0X'+V(BL5HBBB,"MJ:O>WM"LZ=+PG MA3X6^,:8D4`896(-'6F=!4,/%"$XW;8T,WL:C-<`?:P=O(@F>[2J*&3[:&UM MT,/0LR!&&,85&TX)^KEK_.>_K8QD_H[]%K:&\]G=Y#T>-:$M?#%8PYY%,EGX MOG>=R\4T$2B]E?%-&^AIP([LZE";[11M((=LG!%9]@I?.58IM($7@*W4_#7` M'=G)V>@(S!1X'S-.MEHQ]Q*MGOEPJ]\B]19)LY/@W1+EB*OG!(1ZRS^N'A:? MOOHMTZUXUN`*9!"ZH$Y!:^K#R2`SM,)_84\S?MCXSSDS(\>A&)6%2`8QY.+! M^=A+4<W31?.WN^[YTRBEPVS MPG^K<,][:%^KR,O:T'9XEUL*CTZ*ZNWO?\SF MB[KG:R[I`90',%)FJE/8WX\^\O'>]'R#5%J!R\/@?3O,T\$=V:I>*%Y5PRNI MR254&$O?)MB0]FT2F7S!5CT?ZK&"!0I1J:K48T%5-0]*O2)*`D$-A3\?W/]8 M?>@6GS-_I^]?229EAPQ&8Y0B6NHST;.L;;J;4[KG(?UV8,]PFJA"U,,Q-BN\KGG1X043L$##\ MC;R^U-]W_,UNN?Z,Z=P90S2F%F9E:0I1@=17\?'J4'-[VST1#8[NB+!&MAV! M"YG8*#J1^/PP*E\V[]>D!FCCGH3IU+C&S%[MMEN",]IZXZDN62_>K`6TX;PW ML*>Q?Q&N!3N.J^6OW;*;+6X^?`6J8E*_F#_-[H5;I0NWIM[=#/!(P\XMD1*MZRE8/V-W4+[8_S+#5D#X5 MEU45JT]*EL)7-Y::<&,&M.HO#JZN6OWB:=WXB^WQB:K,(FR0M<N8"93PEB3CDAL=?3D@%[:E&NJ,@,:\1(J) M=`@J6F!3Z"1B7]D']4F@J7>Z-)ZQ"+=306MKJ*3L'1K+YJ(/;M@LFP7R>\8V M]@74+7^>S6]_ZJ87\,2`8$TMM`TB2R;-,O?1:BUTRY?E]BMW,XC)8QS9+3:3 MCD1HL_<^QU"WSJ863)66*"I_@D&.;(%8;W9M@+*B!)&GS_5E6U!T*T`@U7:2 MOG60BVZV[-BTK___]C[>K&OG^%]_:I.C]JG>$M85(W)A_F)\"+Q7?=]QS&$; MFW(#2P3BC,IF5:*=AFZ+_10_&>TT(8,QV\7S1: MIE:%K7M]+:+^`$:KO^VV6!PC641!LR[+;8R,A@&%[X9C]LS-(PH>^K0EO M?FQ36J4?TAX8'=<1@(QE:Z8DD]`1K0&/1K!?VQORG`<*<>U0(>XY<(P]5`FG MG=,:%&7T:$OJFPXG";S)]I%C/P*,Q6-WVU$9M M*E$X%X$B.YRAH=Y[69UO9FMD>K^Z+=;G?"V>]L6W7W"@#3BG8I92%R$TKG63 MG_=/*NP"M#FOXQMHRH!/BGW$!H"3656E;:=]L8X]GMR?G6@A7,=36JS5,#ZK9^1@_I!YT2^\>NULLNQ]I"^8W*K`O[$P MX`&?9NAC_DT2L23OK0`J9%!'_>P7L[=FO^T,7V-$>URI^P]]'3EZ-O_W[_/L MC_EJ=G<(40+P$8-FYL;7*CN9$J"W"LYBJTG"/S`*8]O@CH9IE(:G$#,J#TH6 M7I?$MOYY6R42K=OV1IHP?I.='-7(C@/M`D4'[(C*'-AJZ4U>?TS&-F3B3;\<*@#ZQ)U8Z,!UTK;OF:`B<QTT%3)3)]Q%LD-=-X>RC@[_?A/8H2\#(6=5^ML9NO#:E_2*/@F;8W0*USO24;(58/KT+'O M%DM!:7/_*B12C(V?\ZJ`3E8W]4EC M?^QNW]ZO9O?O:PK.4_DB_?,YN/1O#P^W_YC??9-!_ER/O!U%*M:11V4].KVN MC=ODTH!.3;A:N0%V/6V`QT?W1;!NYZ>E3S_._OZPR'>SY?*KI7][__/BX:9; M;MZT8HV^?>SN'O[X+"JP?0YS!,N&C1F[H.2#4Z*O.$A!M2V\E+;?X1S^93&[ M[7Z?+?YWM&HNK`D$.I$MU.J%HGHRE+(KC3>J!][W+CI;NV0S&967S@D=?!#H M/832!ZN8J;;J[=H./#M<&MV%SU,1L?99ET[Z1(DG*,0^/U5FZQJ;I.6`E-'5 MS^'>Y\DF*0W/2Z*80P(,:I/.*Y5I4YZ.?IZ^_M<_=:L7WDG6(I-U'K]APU"0 M*:LQ&R]"MVV]^-(\YKP_Y MH>T"8L`JV"J1B1+D'#%M%#!0F8'J_%>[]E,<9X:;A==8U<$"LC-98E]X$'1J MM4]>']J)WG,HP+Y1[6]2\ZZBJRI*?434JC8B>G[`NVYY95.MXBE6ANK]ARJ% MWK]EXX!*20`82(`[%XR36*BL93:R%.]5I,0[UL5>:+-X1[MCBJ\"^8$6RK)O M(AU?3;9$=NABB'VI::ZO24T,YQ6O_;3XH@J)73',*DOV.##T6SY3\':WBN&K M0#NUF2N[H;:@6[6?6R27R0XI%)]WJ:98A9*KTD($:X/C\Q%]@BIA;GPP M4@?7)*:<$<;$XUZ8KNO_9^]:>^,X=NPORJ+(>G]9H%[$S85]D^L$6&"_3:2Q M/8BL<4:2O=Y?OZRQN_6HGA[U:%JO+((D2BR-BJ=8+))%'EHMR+-USR82%%_) MRD-Q8$@-,`BTC^D/$&@?58O+23KE=(G2H2U:0)=(!HMM%Q)?Q<=?W3S/`B2\ ME:"#1!%S-;.QYWV&TDYN_TFV%3#S2G8P*:XMF+&41'5TE":07>.8BM2R"SRB M1)-F,68?--_\$9S$P/\HJ+J&*HUV3V0RJQA30PX0IL3@C98)7)9DKZGA=;"- M!^.&W+;#!=KW-.@UU"FV040=,5ID$]3Y5RJTPSS8_SSJ$9_QY<\#'W(K@X)< M,D5,5J2N%5F9V`X/\P/YO'E%.W3:@`S"LRE6'E4)2JL'R,,>6[!) M1SW4@CX='`15VPMMI4#X,0C#QM*4$/@!]H-YI9GZ1*>#CSJC4=DKK:-P718M M%.7:`ZJ=FV(!4G$J^52L-C+S6?&5/(W=^3IMQ)#;DW9^%'&FCA5)T3NK M*9F4)`1*VF[=^BC`.;8+Z0',+=\D.Z#K'!F=`+W-TFG27?-Y78!X`2 M7.KK7#CN;#ECCBW1'N_?5PXM$;$@LJG*@B,2V?43"X^-X1T@@3G:(F<*\XT& MYX71I;Y7(X>2'1U1H93:,']W##"WB`<:`G+:24A2*`^H7>5P+[TI!]UD*KW= ME=B;6\`IEL`5XC"X".T$^P`ZLX+Z?M]TN$\68VYQIA8/FZ(UDF.?#6O3E534 M$6(6Y,AG_XR%^XEU*/V!H^0-!2#O,3GAI.H8;&K9>IOQ;AO];OW^:6O;QQI$ M"AV'?62=);[62:GN-C>(;?>''FC/?\#J]C4*LNFT15`FR^O2"G7NJJN]-"V5 M%J]MESLUO+SO'5[?:'6^NOBX/*U/.1?;OL%:YK3Y+X3N(XQD5)(7B53=:)%@LS<.M%`/YC>M?/FU5LURJ05&L M([HI2XL`CI3O4LR1;]GQUY=9)#GT[F0M"V@4F&W-I.&#VZE1=+EM4'J\K9DT M)XY#%^0]T5O*JE*TU-=%6\F,C["<9?63@V4-F<^R\N6Z`N//05?59;ZTV`^0J+21M>@I=.%*BK9ED'V\K9ER7K6EVGI469$2 M1<\>0E)B0_Q>@*)*+/V8"Q;RH2/(:8Z5:A;8QW)T?IO`[/''KS&/=&AJ\PQH<3`/D7.-K@H^_[3 M(-N7MFF+^\%+3(O5I@X47%[308UW6_4_$+_U7_YCM=S4IIEO;VK+S*T+HO^> MG\\_7UU>;+\![LR\O?&1;Y>+NH2Z--HL_[I:GI]\&_Z\&]]9J6^N-IO5^8=] M7KMB&*74UH-((#`7V^TZN@S-VPH.,-V-(?><0,:G`CGRU9XAF`1DV/S:VA_1 M$ZWJU`Y:P"%/ZV6`+)\*9/;%I1>`?#F0,22%[UAGV$C$O,\3?%QTYX7">^(K MID[\\XFLYZ\[OO.HDI,M@[L>NN=G0D2_$LNI6-?(&@YN(R9%KDC9%7L1_T$# M\K`C\C)`?C++*4I`LYWN6CCNENADWV=,#MH@%09H3%\*R$]F.46B(+".S)2D M0@`K9/>N2C*F\?K\QT9WYIN:#68LQ+%?`([\LBRQZ^$C\&VIDU1M`>>]$=E) M8;HOD',VL)_.%CYEDTQ(+KDN!Q64C2T5F4-_-SK=Q0BZ;U&S)-64]"X6K5RR MK']20M*QS[JB:*M+C33ZKH\TBT2')L-#A,0!B2"60LN`/=EG<`W__"PB3$RP!:]T0"A.DE$Z:>6Q MWPJM;6/=M$5_%-4:2V,4([("JUUP(BK^A7R&KRG2VV=#@%I!ID9Q ME#-PUX^>19XI9[@V?K"#JJ#.,G=H0S]G*U;^LB9CXJUH1FW-(L3$4\PA-%]A MD&P=1T7!JA"[AZ1L!M3+"],T=]U#CG!^^MOE^N3/C^NST^7FHOQUQ>N>F&5E M?]5C=H8$WUU.(Y_UCM'5:M$>;;3.CMS.@TMZ^/IG,@*)8T[>#J.--C*8KJ,O&N#)2-*,_V\7F).]$&(1M'E6.J&?O$)YRRZ=X:BP-H M+@00QC8\/3.+/.9T!.E3*H:<+DKS<41I>Z9RON@&)Z,VC*KSKW\>J@LE#?M9 MI4[>D"(GL/T\E(P0AZC.V7(],^$/Y>,13JA(F8.K4@('M0EZ'R"45F^E4[X9 M=?3$HD_R>02[;+6",%I7^WL(^$K^<4Y#4&W22`MH>JV?6-ZI77)U,@NJ6A-+ MT8L27%*G*XV=7.FN4G9`KO+H`U0%!E0^;[N+=1Q[JU# MUXS#:)=PR`KG8>MFUX^]GP3D+=\6X/4U%Q3+W4CWDVS8XA]!ND,[9C64H#@D M+:5X#WR^>G[$F*UMQ]*I9FC!(P@WR9?1@F_PX#`X1X+]%^G[[<)8<^"KR M'1]&TK[-@7CT(Y'"`U8XBP70(DE6*)VUC>2!E,Q=7=<@5?9/[!Z/I0#GDN]` M&Q!5';HB!>H2-(<^Y%-?B0$R-KU8WML9;,!1R;&<-7QO$OM&EMBQ9YWLU3'E MW#S2[\F4S"721"N01BOU79C#-9)4(DR294RAB1KLMFBFQL3#M$]N6` M_&2/O\%Y9T4L[,VQDRH!DH-KD$,#,HJF..GQ49X7$IV2SK71"%GMG&'W5O:5 M1-*8M@<-QJ+E8T/R6NIG,'OEI""4'+IJ3%'V_>ED;6Q9UD?.\9-94!1! M6YL9V9!J,U`QH<>8<*#]1KQ<17XR"^HA&^55AF(]PVPUY-[%BM*WZ2;;%(T\ M/LIS.T=%<`3G$V3^BV_NZ'M(!,GV#KTZV/W@+J.&!P/]8GIV^7V_XYY=W]/+%#",NQE7F(`D)"P"QP3"Q%`K% M\B5(U`1$QHV\?D_:F)EV5___[MY,#_%Y-%Z[0$4IWKN$N=M=:=L6+COF]CW^ M[AZ4<[:2_3<9!'FI#97$X3`84=.TGB]*U\1LVH]!U:&JL>&6Q5GLX1\EF*[+9PN4B6A.:VK]7IF63 MNNV+J/PH9)0JT6AE)`>B#)6R_)6-8^0'+QJCJ84''!]A)E54RB*"XG^$K499 MJ)1^8\17SQJFL=>!&"F15FA\H%C0*["FVFI?0B1/S:/U\>ZGQQ)])GH"39FC M:5\H&A7CEL<"@D;G;=;4$*2\%KP.M=60LD&7?!)%RSK)+LDM7&R1:JS\RK5L MBJT6`6.(-B5"#=8%*5+90@66C'=C4\-?-$93;;6HD*AHDE/1&Q,*G[\*D\SL M.^4Q/H?G`!.?HY-#7&NJO0%.YA2#`ID<*>G87&OOT%<.FH'7L^.I$Y'G-.Y4(BU(H`KU6&7$);P?_B))]GPA6Q]2Z! MP[1@.'(UV;&/!,'HI$1"-8=O](Q0.Y2`S"E1*?5B0.!`3Q9,L`7-$[L-98RP MX16`-HWD++%;4%GPL['%"EVY92M2*M6ZLJ:(YW4A-;7?$]%2$:Q%*NLL(%>> ML@J6117T**'FT<$Z7_[R/FV6IZL=8G+G??SGC4L7:6P4+ MB4U7-`8$"9"8,VL=IN3K-.K4YGE_E-O<=JJN13X0B]M+OB76F^4EB]Q]S"R` MB%M>0-(FH,(;,Z`W.O@_OSGWP++N8_MH7ORR1C)N)0VRAV M5UTA"J4V5A"9IL47U6';VBV'[ZQ/JRW#!2V7ORXW)_S5XL/N85![%/K=\F2Y M^K+XXVSY6ZTN8`S_=VM4WRXNZW]]RXO+Y?K]/Z_.OO%'VBEP;C]O>5K_;)\N M\+$#5+0SH=H1P[]C MC2M62;R<=?.RFD[V=C).7S#AWU_H5`?.C1O_FSXP@"YE1' M0UK0O"IRBOJI,.PGR1T(\L7]RA&<;#SES;:-.H,Y&&5\;S?IK%67QF?_D3O?U]VPQ MLMJ!G],KS\DF"-$[76NDHL2^(SL4E^/`6-E1KWR?C,<$1_&-B^Z97MYW.$B0 MM"TY2ATH*!/`54Y.8S%'@-R67IMG`K+^-_YS<8[B)8"?SD^\U[HNSP\Y[R,*P%D;KO)2:9.V) M)ZO]M@0'6X*J%XG2N^7GL\7)%J<#4XRU!]W%P"YWS?<'`X7(*JG`14.^;;1_ MF2@=`DVRE6).QPR>W3T.F(WBZU77OG@.2MIV^#W9N8G07*X^;`W+;\O+R[/M M!H=/ZZN[Z?KO;HF\Z99<_VA:7%P#\>\KOL%/UIO.;"TOKK]Q7SY+N:ADA*)3 M!AU$G?$5/6J9DO,F-49=#G3?[1)GK]3[)IOO$?O=\G*S_OQQ=7YO:=D/=48# MQYH<0-DZ08ZJM*"=J-75+6U8,QIB1(S;XK+#??'KXEN]328W7^ZXGVA]M?EU MO3J__._E9EW__I&.V9$7&6Y`BHN+U<7M=]C%9O.-E97MS7ISN3S]OGD#B][W M;UU$W3AB(IKQO'+27"G"YN&2\+ME:]#\Q'=W$WCXA MU`25<:2@SI+H1XW)`3ZQ9X?N/>+0QU99)".4D(&#ZS'4=1`:(75()5D9$E#/Z0S)-F28$`E^GMNF'Y=;^U`67WX>$FK+\OG M96EE`F-23E%%+*G4(G3J(68'IKFT&P*EUXGO5&:X@5Z20Z" MTHZNOLP1[8$VXR0(0\IV>U_/UD@'[04 M!/)!>`1`'VR%13?N]J@6P%&DN08C7Z%\M3A)I""'%( MM#KJ&R-.*E M-1_#Y$!G-:Y#N3QX.JTV'V]T<.3H^S![4Q0`0ZA^QR0YH=\[=.%\))[;9]-* M"BJY[QO-;=U,;]G.%HQ^B.N=C>/\[J6D/V@\E*LB7%Q))J#/QG"M4[VRY#0N M4;`P#/6=<[@CB[7,8L;2EV`&WTPMJMN!J4Y#Y)TOL'>:P;EB<2B])<,N5?5, MK3HGT"*GR5I[2#AN43G,.S\!(+.HSB92N0-#H@C-I8#EXZ;.1V+-,Y5_[BHZ M,KU)KA1;2P(F`K_-8@2?!K973^A<-&&?"]=X,Z^T,9?JHJG9A`?]3D9L'?HF MK3W,@5M&K&661C7]SJ9%EZM3XT8M3%]:DA0S5*)<`A:'+L.LQI6^<)B#I"H^ M^>VZGD(B8SGKQ2C''/8#=6O)6O7P<=-I%]!MLTH19>]TA'.5?^Y\([)-PU54 M>;.#:%(PVY'2T&@W/84[CQ]CS5(2-2??S%LWGVXG8<- M16@0#MQ7Y5=H(*K5<4AF-8$)V)Q@U^U_T(\9BGVQ@7'+:PXTN,5:8@1$Y#T MIM22U-X&2QIUM-AIU8V+;TX%SW.^Z/45N]@*L'6QCWAA\70/BDU1VMCKLS?L M6A25>6_%1\(G&E]2-%RXJ9?>QWQ$WN`3:N$\)B'WY>(.1F-R8M9?2ON6(YWGK^W"GF#VFA+Z2J2W;:0&=4Q][**&$?99P M27B>\]9CKAAB)E;O4DIA(U(F4]%2GAEN+(K*26Y]8DMBA),U48`(G9DN%9%_ M(&D@Z-&-&>P:6`UYFP,-<*3% MC^T.(9B!8,>VI%V`7@#DHNZ$PY2A"P1 M<9P6]D)P/YZR'P)Z\RU0A1BP(&VFS'E1T'MM12AAW,9X:M#_OOICM3YGC?_[ M:GWS[O:38^V9;Z^$#J$HM]O*3B#5V`I)Z\L4'(\;C5^,B/\'QE?_I^%M? M;=\QUB.Z)%8RQ:KX)Y-2"AH.C_C[??'!\^%_\V]U_;[X`.=T!>;P3Z0^_BKD M*F*Y1J7]ZO0C%"B^66OWCKR\=/!/R_R*+Y<^W*F%XFL+WDCJR)-^!%O&=X#=`V,M4WR>))#$^Y@S[R MV0T!K3NQQ[/`%SBEPZ..#CNRS=A(U;E^.!SG)SP?_*]NUD.@ M=;G)'*R*<<8<$R=;76&-KK8MU8W'(JX=`P$N&_L3976:KRZ&"$5Z76E5TH&I M@%`PVB&A"W3*K,[FM7Q7>N$<%'X^Y03.)6=19:_)JWL/WD./<8LMK6$>7I7Q MM(Q_;/1/R?8!O3?$A):B$4B9,]U#7V.N92R@B\NE,X^R9N`\=']61C.;&"%6 M%TAR=6!]1OT$%7*-"=-`/;LFK%WV)SBMIV]SPEQZ;WW,O4,$HZL]R*K@R)D\ MV-P3X_\R7JU8`]K>4)FY]XHFL4Q39Z7D%(:R"5K,SWEFR$_DWP!C(.>PI=S$ MI03$VU>KFMSHU2^6Q'Q*H<-+>[3JVVD=EA)+)"#I??3FWLHVTSP/VNY/2S$O MZ_'*-(R3WSOKG`/Y+>L3RL0^1#:*>?>0"#H+=AK4: M=CWG(]:I/L$IO7SV(?5]#:KRB4HSU?EI,%.@EH=RG.#=O@D.SX?_2WK$]Q7UK4@%#7PY`%'?O;>! M/F1+`]O;N'<*W->@O[O+FQWLOZS6K_^2UZ]O/UR_G91N\_-[^GCPH\Q'WUP# MCAM``,OB!2,77_LN%Z<^((48QR'X.UI$GBK;/DCRV^N;W^[NM\&\>;79O'?H M0IOZ[]7;ZQ]^O;[][?KOKV_T#U7W M6X#'_M[:O5G_^]NKU;[1HA$C[K:G%)'5)/TEK3 M^-B6-)D&3VELJX"=4=D31-L'QCUD638YP"]WB]._J#7W_O4,OX^M:/K1?FJ[*,D MWR#WC'LQY_M_*G\H29G0!9M;KSF*)H1ICLYF?<8G\M\?4J]7C\R/!,#]?;V3 MMV]7OZS>O/WKN_7/?<'F3I;H8,!&"S[^_?F:N0/"%-%R3S0+-4!UM![*[ MDN#3--Z#6&I0OHK3(Y+O!4V![2_P&\+91:=?6OK/_WNU(.FO5WW^1%_.]@FY M;Q_Z[_ZE)N==GU&A-GB'C?U4@:@E$TW9K&-4A[Z/#)[&T*G)_>+(CRG.H:A]L)@%3\=FQ MRYRC4B-@D!3[IC'"*#!T8]G'S>2B0#V+[]`7"I.)!;B4PKZ3X-9X!AP3NFB? M$92;]?S;T&)N0MXVFXS&!T@`V_M,/,Z-PCA60#_Q8$<4YUDNPV?%RLY4$[$U M9Z*MI1KT3B^#C<;7@#Q,D**`8R+G^7!:["Y\EMN*,394U8G.I9*]\NI6=6J4 M477)?CUA]MW?]R\6;U)?_WS;O7FNW6[65^K#JQ_D=?O;_[8 MQ(WW?_8'_7??_[ZZW366N=R;2_4WOY[-:`%SB\E1R.3U?FSO?.J/S>/T,#_D MDK[MQ,\@_#+#.TO>-(^:0M"<`RE"CH/WUC3B<5;C%86!+"\;N0-'?2;L8Z^5 M630^%4*]6B9N@#.A)>^&-RL/].4"RLO&;'^E3%U>:A`@OTS::R42T-[$`Q'$<><9XT7XF3^!%KTI- MTA([[C/5IQT9(E(&X6WD8=W'V4N_")6S50J/OD',551]U+Q/:S4XA[J#RIU_ M8=`=R.71%4S6DX/20-WKVK8MGCZQ&>DI./C2Q;YLX&:1N;5*1\+%2M]JS2Z9 M:0);$%N&W"R_+!V;2>:1U>Y!)->2M5D,&MS>2@8_-I.I(_%E+N.,`>/];-ZH M=[!D+LE*#95ZF>&#KB2//"Z8,RY>D+KPAH>RRX;N0#;7.#`G=0J0O+-8*F\]"&E,:1R!RA2_7&IXV<#-87.TR+$8 MA[&V5KP5YQ_F]26?=LS3[,7;+PJLN>OH*$&SF`*"TIHH6^.$%T#SP^,]JK'\ MLFIW><"^6_^QNGM__#R++\5GJ9!N258-'/KD$MB^4 MVN#F!)R,G8)7CH9JFRW3^(9A[R:RRP9I)HMK MG.PD-V[59P#GBX>\P8DM),"A`^G*#T6?9XS7(RF66LB$W-L.JTNA>6P5)I-? MP[AJX\KV"HQ+$W\1%B]20"P8;)&[:ZY:-#U,ZHAN7Y$7OXZ>-G M6B22A,(4.)*J2,P3+R7QI@[M^:I$3W0TGWCB9Q!^F<2Y1]-:R7W5(@?E]FQS MJQG$Q.:)!EOX8@`[N)"ESS!'[)$*^)8D.-_QBK89-G94-!J&<5PV;G-8/$'P MD7,)EB6+AM$LQD$-WA1,2NTCBS_1XET(5C,YG')Q@A;(VQ@5L$@:QZAN!;"5 MLQ_"Y:OP1`(_![@>R;)T[T@YVT4;^JJY0@R3_?+0XB"[1B07)_PB!![Z?I$> MM35GHX)E7-BF"D31NTP"7RZU0GU`MEXL51T'Z@1ES]-*>M'8;ZQ[ML/,U,O& M;0Z!FY(,!/15+Z$PL+KD<=L81&Y#69R?C@L6!HTKJ:37#% M$H=:GZNQ?OR,\7HDJT(M,%0,'DS(UF:;PK15,1?*@_`AN@MB\`5S*K$&BE$- M8&V!Q+40B+;92XI#)>*+`>Q`!J_>!=&_E:C1BJLVEFRG-=9%TK@SL1>)O21% MF^6"5]>;W2`J,V-KC#9/MS*ADM.XZ]1?'"4=-8_2"F+-):./V%VJ&+8%*RV- M3\)70`O;O._6K]_]-@X6>$I6!-DF9X$Q@X;X2?V=XBTG5EOD',+@5'/8$7]] M_/_//]DB?*D!9-_A60R%VANX0V_@A0I6$-&$\34:_*['B\7D.C2SX-GJ+>TS M5;L1!8Q]U&KMDU=M-N.;7W0[2H46$VI6\E;]Z.!J:X:Q1.C3S/JG:S@W*C9@:B5$;/J9=(8J]\;Z$4T^PX\'"75_--PFP/_O[Z_68^3_V_ M#RI4_Q;OUIOY`U/CXVZHQAF&7W[# MT6COT6)Q-3OU2)WJFU-ORVZC/[#CC+!NGH_&%8_UB5GOJOK,M=C<,%*Q//6) M@>1Q+=L5ZK<_[MD6ZN+B/@*[-TI0J1&`<,I^(5`>+K?'7>7%BXEU:(1358>J M2&]CJ":0QM-;J8K=46]''HZL24=S!I0:FOIJX)/D:IMDO\V)8,KEY)HW-SYP MQ6$ABYB]@9!(K\^V00H'JVL04?&GZR^+C5.EH M#:?A63`>S^7E_0:3@V-/ZI1V#SR[B'%BR%3UB,/[`.^JUSGT9'OM)5A3^FIH M4F='@FVM;TE_8(86QJ=G/\QS_Y:3[9^/(=SKG)Q!@!)<:?C16BIIC5TKN]HV MON5HR[SU1];(LO5^\>#%*7N%J=4KJ;M37'=>/H7^0M@A>0?.0-V53-;+P3[\,\;77D=JP=1ROW[!ELY) M8K1T^ASW15+&57;)9;E%@"3P`00^.!@"F)RTD(N%WE'\<32IYGC+R.@1BDL1 M@TXN8:WNX<$E59.3B,5.?/)F.DO@ZVW(%U5*#RVU3TX-TC1=).&64PMCK_1Y M=7FU^N%J_>Z&%?W3S?7W=S<7__AX<_5^O;GM?+87LY-GF2VF1Y5R4P#)6^IL M`=8$B%1*B*)X82*+,;W"PTHW$1!8QRX(:^:0)13RT:6$+)V/$0%M%`YKTLV? M6KX)$ZX-.,/0"U*KEF+B**&Q?&A\J;RCDC97ZR?CQ+GBW5Q?W'/JIMO;]9>4 MH`^C2A^/)*MK&0)'AZ`3-A=Q\(P9>X6VG+ADA=/^8@'S5[?-*)7.LKVY-P(7 M]U__][=-(M!OUC<_;E8_?[R\6%W]D3GZKRU-F6\.FOLDD88*`T>FI8YI$$^9 M1+0C/-+7BSHMSR#\?WW_1*))YZJ1D"$J"V)9^;$OZ.HF>(C"$9K./8!%]862L@4;$[CBN$/MS` M,,"VW!F:H:D:8^LUO3L"TC/MW9S8E$^=;>0PM48JVT[ET9-*IO6D2"79E"K* MDT\EUJF_9Y/TQJSM^ MY/?K'[LUG,R1I."A5;8A'/^4Y"SIH;[:%)!EKT8^E#P?*:4SR)]N+Z_7M[?# M]_V.#O[FA]757]?ONYOX]J?5C_QA4VP'NA-MVLH6N!>:D79VF.[F"E3QIJ2% MNWN1FOK^9U;'ZNKNU\SV[OWT#+;&H8#9CD,-*;1*8[T^!B.+!MZ\DO,T:NF; M]?5ZII(!Q5(O8F^ M.L]&VW-,I]O(GQ:KEITZ7O3/'7"9QWDJ5K%4CSEX'VO!2I&&*2D:HW1?9Q!M M*85;JRFR"W.F9B"^?=8\U'@62RB?Q43V^U3RS2I<];7V^EZM:W::L10CQ&&[ M&!W*9BCOCF*&#_^$3!%48O<+N2:*`3N]QR`9![^RA,5_F7@]I&"#$(/%2Q?_ M^^GR]K+?J-'HE=7[/GGG?@S/Q?K377>FM_SA_S9U,B-;.;9]!7TPQ/@Q.=., M:CEFG\(.R(A'/9O[R/KM/_C*K:;05'6I&2S%4;8450/=MG)YAE>!GB*..K4\ MP^BY^9MGM+>FSP")E9&P9D1(=BMD0%1!]B6`>"L\M:SO;NY65[_[A\G>.5=B M1`4A19:2@0S@O82ISQM4\D%44E\>0\0#0W\.T6SH,P2;Q>KXS^*&%@#-O^1# MEA.4NL]'RN-"_Q1SM,B>-*A6V*&TJH9,MP^D9`,7B"+L%ZFJ>=C?^3Y6IS@/ MM?04)RMA>.BP.LJ7489>1\EOG$U+>V+_"I51#%N8_O!M,=I0X0'[8_)!F!<\ MD@6=>"KUND(F,+2MBPA%039C:@!)5'Q92>=^P&4>!?M3X2T(0"GXZC3[LI2& M>F;%/UB(>`;1%F+_D"#V2D2,S2E+G5T;[DCN)C MW`GP/P9,9!D5YY91$<=R:HBY6V8'(F2-QXEU9LBZ%_XONE7-^"!!2D%'-#W3 MKZ,KA*F;%V$R_3$/YW'#`';R/0]J^Y1=G8WGPSCN89\>)]*A'"F<6=BY<8#J MW#U\(U5313MO@@]#!4JS"B6ICVPH/(:(!XX#J@DF\QXFZS/O9']Y&SC57$/8 MP9%EXBDLSW,,!!PH9QIZ8C?:S3.[G`'B?WW]6HSLVY,]TQ6M52Q6'#6NVS'^B,L2>2513WO_`4NE._FTV:!?,7$'I_R M'>(OL)&M0S4Y;UZ4P!D>MS9[KW"9@.\^;M9+=A")[6;HW&>5[2>@A8HC7'9R M)B\LO7"_7^)"$7^Y62"@ZU`RZMY.CXKM'P4_=Q MO5FO/MQ],8A^4KP(E#T%;T%#(LBH1]9:FU'V;>K'\V+[+O`I\?[66P/_^?/Z M^G;]'^L[Z3 MLF3EC";*:K/Y]@^8ENEMC15RXB.I:VF.`[A!P%1VS;1?*&"O MGKZO^WT4ACYU8T(!OBR=$S>:SA*H@ATY*&V0+W):R_R16,+L%3YU5&Q5F`P4 MW9*KJ;7>.#H@DZ_PMUKJ>6HT6??WV@8!"F")J/10J.<9.$DU M&BOL_*Y5+%SG<8JD,[#R$Z5$T>?(F'#D.PEYQY$^AVP+GRZ05-&)*H,ER*5H M-9:DE@1*3F`^Y_;->;MHT0/CCYBJ:7PK4G!A2)BFY.1TE7/(,Y<$RS;76\1! M%]='SH+)@^?8-H.<0J0G6Z92UKPZ"\HW]FS6!C]:@E2KN"7:B1:U0Z[S.#2A M"DAA0#9M'D%CLF,VID3^EQ/MP5$FBA<+%JEB4!0Q5SW23942FMK5)R[*Q$XE MXAQ+0)5!5K:],#%W1`QV:)SB\TKER3*Q4\DSVQ)$8H^+6467G>??0Q*F4(A. M,D(OVZ>NW\WZ(X__Y],]Q1W'-M]] M>+?ZY]N;S18VWMUM+G_X='??L'V_9;/C7PQ]HA$H"OUYW9A:1UY>MGY5MH4\ MXI^.(,M9%3:3?RA=7'SZZ=,5?^O[QU8Z^3P7.:`J05<"'QE]:O<`ZU/!B#MZ M#5[[1DR1.[".2HT.E0O.YT#LM,RH,'B-^CKYP:7_#1/8KN1B:5TGKFI)&#@OL\#R3^?9+4A)!B/DJ]77R<^M- M:U[K9%KO>,,*5(8.!=,LRA*EY[8/F\O/C*D_KV__\]/JZO+#KYUT^_;?U^]_ M7-\>`RGTOIM.HZG1F5XYXM&X@3./0PU1#K2CH^-(HIQ57Z>WMZ1M2ZS8XK75 M/:60QR;7J.3STJO?APF?05NG/[71H/(9 M>_8ZQ%@:CKS!H(J,$E_Y+DQ@A%R*ZV7<`:IVG='8CE5L&946SRZB+NLU:NOD M9S:@,A0Z&HC66]>9N(>>(F.S?.E^5KM`-YOUY8_7]Z\2%[^^VS`*8:'Z1UZ_ MW_[M:IN1.W)ZH:5M(*`L0&UD7:,1-"12XMK#OO?^*.(]/\6>_,P7@/Y``:X5 M#JZM,_#;\VFG3_S7ABV$(0B^%8227)\64DUU/HTP)$B3_D:+@4Y_/B47 MC4^%S;X)VE>=%6_>4!K:<$=C][^V;%^`$YTRK01E,6(E%5G-X\2NGH+>P48D MRAC^W*H]^6W`5$UIK3AMJ3+ZB:C"B."U=.4O8LNVK+<_]0_YOR]^`FUN?DK? ME6_?]F_?+F3[&6]O;N\VZ[O+S7WU_.]2/"P$K^KMYO)F\_UZ\_GR8EWX>\MF M_?Z2O^\#B\CKG3\R."/I8#P1N=@<*4\M.@M]V)1O669=XLY'PV<@^@O9CZGL M;=;%6]Z!S$XA84:G_/#:J<*.T3QV7Y?P;/?C_G_\;7UQM;J]O?QP>7'_DC]< MP=DQ@0>MC7/&-,7:Y/"6!N+G5'3,\B%<-O,N7^VQI5YNEI_,&D^5:;ILR">; MH3ACO6H(P]"#%I*7549QWUCU1:N4/_F;U>5U_]G]#M7U+7N9K0O<_!9X]RF6 M='7SRWWX/57$X7W@(XO*0RS&]\G:=5!TI5V$3?LF7U^THG?ZZ*F,(%!./E1K M@O+H54(SF(&&U3[6!_+,-3DUHLRA=H'`@,O4,%",0Q38J,DY?7WLQ\L1^SS& M3V7/)T>A@=2'DN?$RAT.4FM)/JC"[D+CUZ;3PUL_B\$EPJ(]GUO=M.W<^`_@ MAWW/9-'G:]/P$K-7*/I2B^.X5U'`3-4,`++:1)*.:_^DPEEU.8&;;9\#6D*Q M!MC=D`:O:!2[.`'Z&"7."63.+/:94!_U`1RL)K1L`J-3D$>T:7F+W&.(1J\Y!S)I,IJ*&MJ5< MK-C[E&AWD:,(]Y9U:YQ$%GH"X M.ELL0652)F+J?5]JG.F@;=S15;7_+I]1Z@G_UGB#F_(A-D)B6.^R&Z56WLOY MXN>0^A@OO*`"PT!$5PO',YC[1.(ADU\RROXT.3#AZU9\"NF/U/7F%4=_E;"Z MTF(O-7!]-(C.$(%V3&1`,>7[I:MNZ>CH@MJ#)^.#Q:I;[6LDFK'- MWB7'+T5Q.2@$&>-4;B*2" M5SY:%_JH%&(7;DCF^%^8PB;\=])&5\:U_=DI-&M4@<&390VRS?"-U7.`VC,1 M_R@6W9;&,2Y8E6KV&5-+89Q14)1D$00YH_>EJVZA13?)^]IO':D&KGB7:*!A ML5Y)E/PFO"Q?>.BY$2U2ZX/=:HDV!M7R6$VK79.S4U_A'9UITW-)2'W8(@$C M]&8HXU#+8T.3[)3FRYPW.*EYY"9J;8]2]341\V$A['9W/T:4\EI:`_3/6VUM4L<^JTGB&ZICR_J6S.^C0E`G)-LUW M)8PIV22K5O0<;'T4=7R9R)?%<-]=_RXMNKR^LK.]-\^_L%GG@`@=;.LK/P=2P#@"R>2>8D MUIZ9CI8<(5,!+8%3N6(I#`1CYQOB(U2\]4F6QKZ98ZCGK_^DJIDBC2U%^1I5 MY>,3C>V\L6,!280LL=Z<%[:SJF9O![KFWJFF`%-"'W74*FO9FF05AM$]JB93!+-*&UZ+?N^[$H;2G.6' M66NM@@LJY$2(/NFH]=9(MN(PR,E\X;!&\FOE?=:JGSCHVIC$<7;('2!GU+7Z MH6:[DBH"+<]J,WB=JE\,)T/4,1?#L1OHVOHH;QNW-IN#%`I&&I4SZ?H(..H` MRITBV'"U.@VI9NK#$G/-<:S";<[)T4=S4KJO1+F+^AL8U"ME&:*E;HT=I?1P M:)UM#7:D?,^CU^>DTBEP450P%KJB4C2E7:Z7L5T6GE3KYVAHF$G&-#G76>]^0Y#K6+S6XQ`?6\T1,,5: MV+VR66K%#]W5/D*8+#$^E7P+GX)Z;T,C8[)WVF1C%)6!USDFYT1EA.U/E&?< MQCGO-@F!HZKFC%/!$FEGRD#LG`-*V797X9]*LIE/+`F2A13(QJIU#J6:(>PN MD4C6M3Y"6GTHZ9X*1=:#IT2=AJ$K)(A33:5,I1?>HOT3+=T5HD( M^V'V;2;K6OS_DW=]SVW=.OI_V??>(4B0(%]VAN"/.WW83;KM[+O'5FX\3>VL M97=N]Z]?4/$Y-PYE24?VL8Z\#^U,(DSU*QT6.:63K$=H#KMCJI M;4LY=L'[:F1D:=X$.3U:1ULM_XNT)`:UQ=QM)VQZS17OHQ=L`*?$S-GGY#`X M^<.PXACZJ38VO&S%MT\GEQ][,I0R)'8G.ML(GWU+1@\G`RJJ?J3)5@#]['I> M8>FS.!@OZ,52551L,4"Z=39L&B%-"C:5O1.D3B;PD;Z&(N00#=K,C4:EA("J MM2_F%$S0MM_FYPS`::2>!EA!=E!EPE"0.3M?1-1LM>!Q@:Z]Z5B4I!.=4$A( MOLC935:`85+5F"9L98@2&/?#ZL6[DIB%R/PL2W3(;>D.YJL`8I3V0PA M2T+0H<.W/^E^D/-)Y9YD=2Q#9N]MT,:67&NIX^86J[JG<[,]:7TR62?:G=9? M0Q*$AI:W$L1CZGB6C>#?O>!W'CGW0+04$53`-F#<6V3G$PVI4"#NNUVV5_', MN?1Y6H0A2/P+FKB^^_/WN]N'K6K[BR\.5+*[] MC/RZZYN'U=6';RN6N[Y1W1\WOS=K<']WL;[_CY7H[N+F*J^^7/^YNOOKU[_6 M\LOWOOV'!*&1(4=%)I'@9!\4V9R]ME#[A,#VZMQ.04]T^/'BKZ:$5AGW\>[V MA/6Q21;-%-B6]@KQZEI@[,!"ZDK6S@C M-4ST)E"CTEP#F^H0*61N?52BB1)J*#V5V%(TL:^0-Y5&NDB-MHR?%T8A% MC*964]%+N/!X6`1=N;X#[/P.RQ3CZ$JV215E32LB=HT\>.`%,G\R/X78!TL]C&6*)%B9HC!Y+#[X#&>4@KG0D%F[O#;MJ@9:NAJF%AZT@ MUOK4BJ,T.C"Y#.?"9:Z=SWQ]3?S7ZNO#W>7GB_7JPR?9O3]N;WZ]O[W\?7(4 MC;F24;[-6./H8U"LAA)F]I1V90?WK^;%B]^#X>UX%(+[+5G08>*SG/3P/S&*ZJ58K`C5G= M61NUU\/-TR1HJ3J0QR^")@',"0`+R^GMATS(3O0XM' MFS%=%"H3126"):O',O;GB#G+?2>YFUE_]JVM6$Q(40X1"8K0WHP8C[V M#4J(.UY)EJR!6:P8MV%CR17+5#*KBG%\F0[:]GWC;2#9>]7>\59,:U^Y@)+# M9U'E[-+8?6\B][Q_6N\,Z`B98VF!ILS)")P`P6RQ`:]&W@1%/OP M*5^OOW'4-LE^NXV?/EU_N;ZX/^(]WT:5=$1-)EIL]/)DAIHR+MPW#%JP/];0 M';"LUQ)CGH?[G*"1PXCY8%4JM&)>9[T*D*H`["[^7:#H1R9:GG*=&N#L2E MB#OUR1TE(I1`*9>"H60EX1)N)"X2-<6>2PW$?CT']V<5?1_O4"Z>$(O6RKE* MWD8S!+W)[&XA>9/E[Z.C4FP-.,Q*O$/.IDV.&>KH..E#:D"F+[^*';RY?'2< MTSU$#(%`ZZ!#J*E@E3!G2'"U,:1=@@NZLK7GEO*B]<[3`IO(4\H@2$AN3/59 M!;>Y)HQMEF MOX3[.+*C0U=+$.N6@C,9[-CA2"'W50ST;%CVJNN=Q6@8+A0K,JJG3K-1T1X"SKG:E+2*2+5KRN"8WVO`8UE(R2',A# M:CO>3LAC\892Q"Z#%ED#B\?2:7AG(.]K5Q;[7'[W[02=5+CH@`NZ)/$(RKUB M;&[ZL7H+2^BD.ZE@4T&'8BUG,TBH''T57.SKD)IWCFW7YVPZ@K9)(DHHT]*^ M=ZLA"[Q:__WN=OU4U$<;&1_^`3C*M25M/"9%?WE8K>\O;^\^?KZX^^/BGQ>WR/^<:"_3@_W%Q*]W MUU_`':2)GW^7ZWJQ16C_O:,721D;%VNU3D)4-#F*B4JU%+%-?672`#3?4FK\ M-1\D\&^?5W<7O]]N,U#^B1%.7F)<3)O!-RIH*J6TFJ9B8PFEWVQ.";$&!@-908M7(HI'AR.N0 MNVRP[[IUI\CV.DHY)(=17>L[QFRS8/,,6*JB(8<1Q4PO7*YYF!&(VI-_HY[) M.LM^ETUW5F&':+;4CYR%,H[$*)A;-A'%?R4E&$S@]Y8!_L&O8M!EWV$JO,FKDAN"*@:K9?OF]4IF.=`^$DDFZ0-:GC*.96T7C&L;/ZS$W$9GVZCT'E,$%FU?@G)>)V12 MDRXB@4X^NV@`N`H4'#@P74R\V,O_JAUH8N]4"-6+^)Y061,&`DD)`/T"=;`G MHR30OL0<6UJKL.<,"7`P@!K[OA$-MAOM?5+)YDE;)ZLUI41$&=OS3X6QRPHD MV%OJ-L_""EL"%N^M0[8ER'CNX>GU(5O;E.BCR_WO9K?O/MU??.M0V MGT]O-4.TJ?@0@S@R-@9TY4:V8$/*P?73:G<)\\R:7E6066R=-8!&4$X0;Z:C M0/O$;J,$;[-+/03^Z;'*>-'*.-;680W1L->VFH@9C'.TT87+K&+?B;UH'4PQ M;>V]P=D2:FZS5)!+,'$CN,DE!3JD4VLY@D\U:=:;I,B@.#9`PG5J[.8(E<&1;L(R4XBR#RSQ,"(I[(%7`@9 MB\5:_*,2*!GH.?<,F8[-?GGJ.+9$06R9JZP%QGKFW"8FI4=M%%7L).1R.[G@4^U:R>Z(\_0W8$ZR"8BW'-YNB=7'JY>>3GJ.-*RM8K;4,F23T60:Q7`.L0C7A2U(,OVVC2K)L2B MQ;X5358%MGDDFP1/ZI!J[^4(/CD+QY!U-`XJ5U>!BA]:LFQ,IK=LL]V`CW>- MN_7^K]8EU1JOVI=\;3\R?>Z%!)]..8@U66NQA'&>4B*Q=/U+.W;300]?W2L+ M-<]$#/%<$GK2$ MK5AZ6?+OB5A-9FI"8*HU@3(`;F@PX,;UW3OO_<+#W%&+/KK=XX:>V'[5!"$K<'(J?CQ0+^3J:>E2'M)M.E7]ULVY5 MT#=7&QJ/C[?K^[O5O?SS]I-Y]>GZ9G7U.#JC?=$P??R[T:#;1R`/"MCR%=^- M%MGR:4\M\G1-3[[IR3_?.[&WRI71V68?(!!&DP?=!H&;W0-`SSWU8E6=D>8? M5S==S56'&-%P%M<,MJ5C1XZO8%*?DM5=:YBFI)LBM%3*F6"+48CP/ MA:.ANIY%[#WJ[MA12:V)M/6@2+2OJ:(QM8SC$53H5/>>C]\4=!V@$)H('",) M],GDXV,B(26MZLZA6^]%7U,?EGPHNO7W<00(VH=$9BCO3C'M?&`^)Y4M#\TX M"XWSJ>H$W@";B&FXY(ZY?])#.NL[?FK4GIV@=`F)G-*0*7L5:-1VBIVV";HG MI7/1MMT!;!()H$M9YZJ\2I18QP'8."ZE9VZ!?M#4&>EAGF?:U/+5OEH?V39& MF$:(]NTH54+W+KS,/MT="6RXY&`Q!>.PQ`1R_&AX\J]!Z2[3_9Z/WQ1@D[@6 M)E^Q)NM:W:X;)N;%F%#OY!5Y+_J:.AZ]`&N.5H<$U"C%4[(#%@3`=Z.RY0$; M'3-[4E"4:%NYUD$]#'=KA[>C341Z:0+A'6S`\<#&&=\>E0(&707&6X5JU+;- M7=&0ZVEY7E_;=ZM/*_GKJ\WD(S%T'^XV`[FO_OOBR\/JX^KNU\]B_/:F9'[^ MS_I]R4";=6:L9]0E%QTU5I+&[I+$&"FI= M`YC"*FD`&'*9GL./O&:S2;/Y?!T?[C_?WEW_[X\-=7OW1-:;J5:#6J%'JZGX M<4]2>C+E>KWY3?_V[P,MTK-2_+BD%ZU^YQY$VV8TR9%*!4,&(C>^2'K!__5- M5K]Q9E/U'EIUF(O%,R6"9%3@H8<94`39LO(]*_ZVC*-7NU//OI4R5HH*?.6$ M!2J->DX"9F9;[8>'^_7]Q3%'WTX)/`0EB#TN.FN1(-+[E MP1@F#[SS57CG,EZTXEUQ-%F4M;;IM90$8$9P0X:VD63MYHR?M.*O%]=7Y9]? MQ46O!@<=U^O5_?!H,DW157R+MK$H7[(/$2W@D)-GE7,7NFI-'5K8OZ97D6$> MEBN#WG&(RLGVB=-B'-YU4B2)%'9OV^GE/G:\>$%JQ28U!T@Y*T8DN#PDMCU@AXN[/K`E"#PQYM7>&E^C#Y9B M23XY'B@ZDU>U)[8#=9)MWF5846)V;C5"51`R!V019LAT@.E;>=N(FA/)\'_D M75MS6SF._B_[/E4$"?#RLE6\]J0J,]W3E]W:1[6M)-I2I)1D9SK_?D'9E)U0 MEG04'TO>/'3;L269`'%```2^;Q0/!<1VFBOYMP%=LV<2Y#[1 M0Y%,?"@I"II\*9SH@6CQ5A([YARE.(^'>LZB'DIKLT2,[*@H&BQ)M=O*#'D' M"\M%&OI0%X6>K,:B1NQ=R3,L>IR(*:*/014HV;"@ MG&QJW`@,8/E([8[175@I9Q7\5#(L3DG8%YF<:OL*A\>D*O<+0/&RV!X7Y=+$ M'G2[$%T!G[3R-MI0^ZXU;62-/F;1/Y,7(^1`W^.$B@A!B$R"LI#6Y[L]S=)Q M.K1WI&P\.0^,CE'2?!HZCN>HD)%*2_[!'9`%YYEA[U#HV(L>!YW)%D)%E8@( M^6"DH'B;-B`.("F8'IUI)XK#644_M>U+Y!"D*E$6,)H%5@7OMUJ"Z*D'+T_P M(5XG88Y.9ETAP#]9A:T'S8@U[H-=1(N3`88X3CBVZPE?D)F>HS%OG MD?/`%)?$.G$-3JD0.*Q!*;<5N93X[#_GHD?"A!/>*\-.IP2T.G-0VGA)0/C8 MG8&[,4;.*OJI>")VP_"+WA#5(]&8+2!TBK+OT[T\P0>5A2`9=CC"8,J5;Q', MMK!?(9_/^C0^I]>QM;3)CVZ";$G6WC?9*->2]G[OU.%IF? M)Z"!Z)#X>-<:5>00`#V:+6^:+CW0NG4]ZOZ3J_G.18_#]I2"3IXT9$+M169G MFRJ)GZGI9>HSJ[,+>BKC$Z<5VE94.B%*+><1^HV<5#,.=6S4_7)R#G$GN:A* M]"3`.C326BWRACO8R")EV`^?>1;AAI9KHI5\/H0DHDFVA`(5'I3E0W)N1R_/ MRSR5!U*F6J)`&TJ0QBOG$I!HEW.&PZ_N+%<"55]G&FG5XY"6>S[2I*T(WHH] MOM(<6K8F('F`M/PL@I[*S*(]H16AUL5]#'QVVW9_J5V`[OX2L*<#/(N\@WR* M-#*6K%SEXP@>I:?&-%81D/;?+9]#N*$)46U@E>#0%7(JL^5N^P,YQU!]K=]R M&C+^+A[(B!(?T890*G;PG*93$KDE"%H:NPN!;4>KT$BK'F>`3TG,&J)TQE82 M(/O0W&54W$\-?19!3VU*I\)QF(504*`C:[&TYPW4CEZ.+4=XE0$4HP; M_L;@J%"6LMV[!)%#>>$H;`2`Q)KC&,>Y#H@$AG.-0N_.?-F\7Z9G5;VVRW)'U_+-;3J]O5]/J?RYMF MN=OWU+]Q<_\W?O_R:?JUPJ:+V7+UZ&U/GZ+1DF=WII5!-@5G,;=^O$PQ=94W MRP[X*%4]UL&3*FLX'F6YVMS=;;E`_=7-[/..L?@CDL?@R03E$T(LQ7B,1C17 M%8+J&USVQ:A'K&\,V<9!SM7\K(.RM;BB8.)<+"Q@@51M4*[5Q` M@D;9S![='GNQ>R:QQAG>%-[Y)"`*X9PLSCG=6B&U!'ULP>8257)JIT-(FB/? M(DAYI)2QF)93D_#JV'NX2]3((.KVK$0R0DI;M`"(,9=F&);S@V,+YI>HAH'. ML$23G)%2NI0!V346VU(%=B'[433.J8D#"3Q50T_@,E8/7P<1M^A1(>W`S?^; MW%O*/)-XXUQ^%L$!-(A4#?C6GD7HO2LR%JV&@33QVV3.N3;_Y/JVOGAZU_S:U1SP7Y"F5P+^IN!AS^_>]//J MM^GJ\^QJNBT[_/S7EX_+U:9J9\_;9Q:_FNZNIJMG^8!?WH3A4S:8(@5A*+2!&UY?8,P_&W7 MW+E/@%TK>I[UCU/5#28C`A]^_"SS"4@.-C>6SI(J6(Y-^LXE]JD34$A!.;(Q M:'YHC1=1ZXW4.LFBX-@+LG-)/>CZ*`A=(6F\)+1D0N'H9B.JRAA=/P1TB<8] M%%4X6&N4-AJ=\-+4;F;:B$P:C0O'QB^C2'LH15=6@41,VME*0&],@ZP+`-03 M`,@=MKUJV1!!SYKBE-[6T%'5&" M<6(C1)0$&^Y(68+7J3R@/I2>0O7"Q#XU-O)>9GF/=`=^4Q%!'`^1A))>Q73%J0GL3M^ MSOW=3Y?^ M.*G>_=[PI;NDOTMO_SZ=7_^QN)ZN[GNJWTXGZ\-44=GF&B-ROFTS9ZE6Z/O* M@P\NB[Y-1>]H?;LT?83;V;S"GAPJ4'I3+&&.UGCG%9H2V]2PMEEULDOK=CRX MER9\/:9N5K7NL5R\6?`[WZ^FZ\/TKZ:RM`OE$X?(G/?P\[P-+G3H+[!=CPU^ M>:IX.UE<'\H55,A@-2KCEO*V]Y1,[F(6Z,F,+D\? M1QYV1I9L`@*R=]=D.0&#EC-3T:6S!J54!Y)\><*?=-@I4(K#&&2%`/@2!(;M M@Z&QQRL#?,F@YU15'''8A2RC0JU,"85#GLRIV;:$(&(?\*![!?9_RF$7T*K, M$9^MP/6)S3_JO`UW?$]&!')G=_:EJ>+[#[M86%!*1D$1A<-CG[;LZ1JA[]*H M`T(CZ.6?TX$0A!*U)<`*$NTXL2M$S;L%I-0S`+(//-JT>3'?M^IQ6LXL%9?J M"54'JJE$0B2"D47?UW.U@ZJ M(25.J)1E#XU*)N+G3K7*A`W6'.@`.(=T0YMA)1\[Q3H#,CK429HVB1V3('/@ M-FT,`??%SMDY':-F^Q)15#(C2NTN/W!XW]5LG=N!HS;6JD?Q)]$HSOI+M-H8 M2"D%":V(R1MT:'#\')*>6IA6(99"D("COI"UE[XENA4LL#O[+V=K!Y&6*9`5 M.1U-]EB185QLEP[1Q9[L[?S2#?0G*8(+GGP1WI@*ZIG;?%U,M6P[JH"_L]6M MWTU7:_YA_#!9O#^AC=X1>\,H8O2$1@.?9.T2,]2NKZYY1!YMA3M6=YQ8?ZRG M[V[G;V?OID_>('Q_AKK]\:]U9=^$\G_-/MY^;#O_$-V)K),I.2F)'+%SI-?( M<9-(Q;C_^,]?D/[G",T\"/A*%#);[%1("!JDBYX],UJ,!7,C98Y94=2L$!"O M2"&;ZLV'Y?SZS<=/J^7G#4?(MV.*QYL+N!I`Z6@"'V8>?'"F=4)D32FP=N0/ MH)TG;,<)J2N.?_#(>BD)5>N.29OA\FH[KT@Y>]+_$TS'.6&BE8Z/3TXBDW1; M4HF8J`XTOS+3.5$[3Y@.H4C:.6]3[6<-A&K;8I1\5/#*3.?HL*LHN)SF[7*]GNYJ<)?_F*S`'1JIKQ/I;Y>31;J=\NNO/D@A8NF"Y:34.H<69+*1G\<&P.9\/U,#M*MN^;0ZOE+< MK].K^62]GKV;76U2R-JOX:^N;C_>SBL;U-V;.1M933]4LJ_/TS>+J^7'Z3U@ M]B_3U6QYS2'US^]^G_PU.#Q&"<@>-Y7H'<;@@I$<%&.=.[6ZJ)ZM^ML2_7.N M_L75\O#<5>*M:GC5RF^^U,]=+NKY__6=V,.?WT4)=_V_M^N;8^Z`5<`LBLJ. M_U=*C":IK+1Q*MMH2]=7"=^V0_R@.N=/_FDR6]1'J"XL3=>S]XO-NE;_NIW, M9^^^U.=\LOY0YLM__WUZ_?Y@D<*#S=%GS*48P:=LL`XW.\$/NR^N*U)\>^7\ M@V[$)O.=;Q9VM-$'T,ES&EG1Z+$(UJ3)&U6#"(GTOA'=5ZKE`]VZ*$W2PB.` M3>@PE!):2UARTG>]0!V9TZM6RWD\+U2X^`KXF#%5LA8^[=KT6V*[[(RP(S#^ M077^_)X7@]$1?27X5=9EE+;UJOOL;`^L_?_D"/S>C3C%\RJA(B=#.FIR094Z M2[>EYP&A]ET)C:CES0?\,N$$8R/39--;\LLMA_BUPZC^H<>O>7(0K>GH[@]O M]?EV>;?@;T"VWM??56)?_K39XI8EX!3G\;W-H[QAYP+7X](?I[ID5CZ]4\0JALI/%))*Q M1,FB:\/?P>D>`[*!S%V,XNF5*MXE21Q,IQP!@BF.=&S%/N.I1R\$\VTN/8;B M?YO.YWQH_<1AQ&HR]XMK?_UQMIBM;ZIV/D_O.:HV'_U8&_\]N_DP@F,Z:BTO MM6&@H79\("E=I#565^Z:^T*1MGU-0+EO^UG'U?DWV_OI'H[A`<+P<;/JSW_. M9^_O#'XPU("F:&H;!0&[9G">O-WB4AI%'9M-=X,]8''/+=0XW0O!8TRU#AV" MA"2=BV&#*)[15"Z\O:'$9:KB5"A"'6U(!H71`"KR/R1N-!&CRZK'UWTUIC&, M>RQEC`:LY91*:]0^R8T2G";(9A\>VZ6*/Q2\((:2L'8VQ^1KEV]2=_P(/J'= MT>I[;@T=H*R(0T%3 MF09,%+*Q\FH^'O8![%VJ*DX%/C`B5C`M:<%*X96WI=U*&E-D5Z]2T%=++U,A M@Z"X?93>.U],+I0YH=!MMF6CA?UES,L4?RB(%H?PA42Q)DEE+`2;&S>W)A%Z MHKN+./D.%&.C\)D3<,LY8N('W6>"-K)AV/![\FV+._+RL\DU#K!@0DZ4B\'D M`5D30C5LT:!WP4F\`E608V_0V4A_G\+DI^FK]9:ID M4+LK_B@(JQ2QOQ?90+,$&T.7 M&DNRS^?^UM/:`<%I\Z.6D/N<>7!J6\ON5%1BPR8BX80WK1KFK>G+D$"F+X?M M6=#W+WT!Z=Q3G%/]%LB1\4)NLG*IXH` M*H.MTHK$D:O;03]\89L\"*N*/;/*#D0A#LEBUB60AB1#TM6B]S7BGU/$@>XG M@^<N0]X6,RB&C1A$J(W*:`?=HQ MUP]:]7G#J$L?Q='X.@0O"[K@P.D$;((M;T1RBBA76HAN!Z7],(V>1!"I[)%!U\[3GE/R;MHMZ!XUATH")Q/Q*&P4S&'3#Y6 MAB&5T0GWL*%"X[ZQG]&D/)#"64!?N&0GT)CL6&0^E()[\ZW4Z,4H9*1/G(*`GS@.^!8!M(6RSR'#MK] MPC9YB*/QWDAE+0+$DBOK8BFE=D=5*@_O=F M<55[<:Y_7R;^,>S'P/CJLVICW?;N^*O?E-GZ:C*O\6U]S<$;PY"U5EEF&1U9 MC?EA_))*'QFX#@-FF(27J)R^W2O+Z7I]WY^QWG[6/V^OYFS4;SY.WA_& M&K(.40OV$%H;$/7P"PU^.A0^`OMNQKX6\0/I]K=/K,;)_.9+X&/G^N#%C]8B MY,"Q1,A@(D<0I0WJLY9%5^OJB!)^3-UN>CMF5X>TFR#;G-CK9[)6^@(Y%@T$ MJBJ8,X:^,M&WF/P@ZGT($%>?EBM^Y:&B3S0E)`['FD90?;MVL9)Z]SG.+W_Y%W=F4K;`G&QVTMNIQ)H7P:!Z5M-25$4&N\@JX/* M]UEL7R/@O#;E^#+MR%G[$"&C36A*7T4MTMP(2GUR,CV4L*%#\XC?N0RQB37< M[I4@#J#8*A?;1A[3.3_O7'\2X0XT!C5E[N-:U(S'9$G-]YJD@YGF30'ZHI[L M_/9;R(*%U`80U;ZY#Z&&,;T.F6<##K0UX%M4KGWGUH%U#8%++(SZ](*^OC$J M%%W9-ICO2#+M2"_K3R379]B6)/ID$`'7-D&LKRQX8R_=F''65;!H+K906K=KUF M1.-<'=.#12#)+//65/"G;WLN4C\BM![I';G\OP_OWK_K?WE773UDC%;5)7TN M2.4"HTLZ]:DT.U@MYZRKP],0UI=0.1';B*)>NOCQLD2HM!VEZW/5V?C3^Y;L M/_W(+K_H8Q4`!X!!A+.!.(H(P"E.P=A2CQ).:HK4.3H7K"5++I=F)(RQIB(A MMPGI.-IJ?Y^9V(O8(E_8@"OBBBK-^^;)C+PRH&+BY=_54^GJ<%ODN+><:W1@ MU=?UV0MEO:O:A61G3@J>T^M:RB0UJJ'F0H4(H@$T8`;PD^KGBKK=#M4/UQJ> MU"9A<\VTE@LD4I.<]>(,`I.##:/!8:G+LHC8B]BD7(E$#;@K'JM5(\U^F'$- M9F-+6293.&6NT#+H1"5!*,BRMDMZBS;TQFTMZSTS ML9>)VTQ!RMBPE5*-"5G\*"([QS!/!]A>"3T_E1UNF$+U(AB;Y-R7@S8?8:TZ MKJRY:'\?WZVWG M_G0I]ZZZLS-&P_/H$H?2-]9D@9'B:\;/,YD>XX2^\'''$VI']=`2YQ;1:B19 M7/6LV'^XUJ;N8G(2CXDL%Y=I1_6CH:T<]$1<9L]!R/,`6BWC?%!;ZTY?+]/M MAXNKS_/O=LY@6MY'DFW4)^)D(\'I[SH;85@MU=1D\%^YQT"#2=+GK)M%'&G` M6@,+2:K!M@QY7[F8!$Z#-TDT2NZ0!P&@;24Y![;Y9TI>D MV(.]<+)HO2-'O1,\1QMB7>#[>7375**1J(W'N]E+!V1>`G-LBK932[<0;],X"8$9IOTFGR]S/Y6DCK5E.@ M,(\T>K6Y$?^UC\=9)QNCF%HN_J&*_`FJV[#5T MK"*=!>U"\F[-%M`[/=6]7]G'Y+Y?HIX/-J%2`MI0;/6EH;K^%N$SM8#\!N__ MU!H^.?)T)00VW-<1^5`D-N]P34/@>2?6J\?$.V>IHF6L:!7":FLJ:!FSK;"N MID*T]M'-3R]+L'7H3-$8-A"4J((XFR.-U$DRKSI\::CQTF:*2HJJA9^=3AE7,6/W77]0;6 MASK]@I(.5>6Y[EIBJ!C4%IBD\9@B5Y_#F!4?J99I%`#Z&697GNCW).-)P MWS?KT1>LK30>/9\!DIF7\6SH^7R4*F_^Z/-;=@TS_:R_-WT/X[N[U=_?_;9Z M\_KZ[N+Z[;N?KE;R_OWJ3L7^[N)_;FYSWQ[W)YW^_=UEWQ1W_5;>WJ[N5?]0 MD]_?WKQ1%_'/VQ_5.^A/KW56?[^X>GNS*_U4`_@H*30+OH_?ZFF^3QLL4IWW M"KIY;L^?%'%F.OI^=:U7[]V;7:D2SU*32Q5-C&R3S7;TR#07PTPUGKS'X4J: M;-K)E91NW[V_N[GZ[H_5[?L?%;?_]-,NQ!.R=G/ MY!G.65^/?'@EYI*PD7,^`K`WHYC3)^E,=3+GCOCPGEY'CWQX+A8"9TD*ZTMK M0C(V"12#I4[56IR,^>%*FCS@\W]X65$8,6$!@9`]8&5!%SES185G4\H1CVFH MGEY?CWIXB;FF$`DD6I%8,WT>`,NI3E748]JFIU?18]]=25$@]M4UQC2%\X)K MAU<5+WR!P_XH)?UX<;5Z_PED?7MS\^;]/U9?)#-]V<5`R0D\@0:E6/5WM8RR M&>5:YP_40/6A;=CT(0=_Z3)#9RB[9*--U>A%A<"M3Z!29*8/G'!V$D\BW($# M)H+3(V-3,M1@L?2F;>ZRB<*L9FGF_#_I">XS8J)SLTEM2Y8^M-^):YBZ9#:C M9`U+GL6I[3MW.%<#:A,X811DKP@E=IE"I:H'N6W\T7%EVOBD7FM4^H7IC__H M:U3OX])=I];A?]_D-0;6>`_3B$WBA[6.)Q%4G8:B@X\2_IMEV24L M,8M"2K#"G3CCRWHJ?]6P[]D=YZ<\PO7;,>IS5]VJ=9U44;B MO'3->J*'?OXY";H?]OG\R(\\Y!>DYN0K8_2FV-A\2=EWL^:R:RSS:FHW30H[ M+ZW^[9OOOY'+NY\O;K]=72VLW%)5+.*LYJ?/S*IVO3\NIY:W[H\[,Z7^\>;V MYO+FS*F+J_4G`AV3DH)1(%A@+H<08:.'47GI=^7U_?_'+Q M^\*WM28)T3/:HII,KH#:@G%;%>;M^#=!?')..XSU-E342^5S,>[FQ$W9+,M3O3`\]+V/__UKW>WOZQ^6_CV MVB(^-,5U+@;;VV0+C"U;.;FP;3'[F>FS5ZM[S?OVYNIJ]::C_KN+Z\O5\E>W M[WGWY)M4BST9K&C3?KRZ%4A#V2D7A5,'RQFJ^M.?OG<+7V`R>DT5OS=O3/.* MV5OEM?DM81Y#95Z0_N_=PUE=;>ZX%A=#[]O'N)M20:1[-CM-(G3-3[^]_ MG`Z0U4:83<_48;0UN69C'99![<2&\E`\"T"V6U/?7MW\=*%QQ)MWEQ=7CUM: MXUQKSOJ@(2RUJF!`S#HMHG_\ M]W_]N&7^,==4K#X+:CX69X$':9Y8389]-V;T>5@;9G>!&)XN`WE:!\*VSXTURQ@/>LOX!L[KM*&1CLU?JI1 MP')'C]L^-#;R&L]E!2U@@@=MNU-,)=^@N;9"T3>6E]*'E7JJX\V%[4%==Q$AW,XLYA,X_LW="1]9AU?O%E=7ZZ^__GB]I>+ MR]6'N^ZNW[^^OOQF9WDU%'%-0"]C2WK=N(0*IB;,KL8RCX!TN!#*WD/:U_^K MS^UB5S@J(8I/:D2"!A#5!`FE2X95:LEP`F[#'A+]\&'U_N[RYG;_`VP&4/V! M]S4W41^AR"#='R!$[N3#^0#C0MA_#W'_\^9.T>3G/]@]8\@JH/#8NY,*`[+B MR7LAO4FQA-GW$2P$DW%A;H=DXT.S[-"63)TY6L8RHKZ;=EX$Q:=YCHMP.Y*M MEB@R9XEZ8175PMCFI3"K`^N-BY'1R#1I7SMAE>BMIQ(J6>DMJA<;FJU+O" MU06G\;`;'919X0#-;%6-0LY;N:>E>"BJ9&FU52L*FD7]F9>/%06A:&C*_L;X M+.S[\V9X((,/D'U5R!IL\A;&",(.V\NVSOOSTN;3,CQ``9A)A*(AK(8)>H-I ML),*SXO-G(GG[%J0[")77,932LC`Y6Z9WNR$.SE,3VJHBYFHI:I M%(6<%`(,ZXMMOL(4<+$\[\MC>H`J-((C(L&DJ,R:-L:CEQIYTFY<,.7[\I@> M$+AFI*017]80L3>>E'%W:YR)\);,HHGJE\7TZ`"BB:16/6J@UL<9R'!N04'% MK-VE6/C'U>XB3`]J,45]Y_JHO1$@4\>LK<1@P[R%&^Q97,4C,SWTH;(H_F3N M\PER1;6(([T1O)T72[\8->WG-U)5O22]3RF'5#@U=="C3*Q/;R8.63@+KWQ\ M*Y4!,&=C^A:BD+$Y\K8S/4B84>:LE5![JW*;`/BSD MYVD[TZ-2Z;OH6HWH?'$M!QHC@4WU<2H$!+L4]92V,ST4*^GW>"OD`8A-BX[7 M!`J8YYEK`+;8T6]E>A0%+:WFC"XTE@8>W2=WW,L-,[4@A&F+Q_$^=!O30]%\ MRIZ-=:"GGBO7]087R&9FB*I3\`N90UJ.Z<&9@J^HZ"B7XDITD4:ERQ1()VAL M>81P!S(]JD*:6J-/K?,]*@<>CU>*FQY3.#V9ZE.8PBS<6 M0.]:[/W0951V"LS1B/.PF$,Y+M.C`)+B#'!Z):'V'H04.D.3!7O):FZACW;9 MQ_88R0YG?*`#\8Z;4+.V$P2"K`\2:9XT9:W"LB>7=U_*!QN(!=E0B'IS^6\I+`68:6'.!Y2^!L8%=I!8_\=DTL"DG%N>.T*6XO3N)^AAG(]B M6W42BDF]K:-Y!;:#5J=1@TQAT%-+N2_GHY;FQ39)P"JJQ1#S0)GH*4^P!EQ< M+L)X.9P/"AP@11:*+44GS=@^S\,J_DC%S)4;6"KO<2*EGI+S$=2BNHC1HD9F MD17>M9'.E9[]GON'8,$0[@62/DK00-Y9+BY40RV*-9\JYY$D;/#8GL_;))R$ M]:&H795G7:/4''#R:G&')_&US:W/8:F2S8FT^J3L#Q0B6[!@1RN*2SR2'XWF M>IUG8ACXA9+T)]+VB=@?`AS8!PVI3<^;:6C".-@?Q>&4D#Q96/;RV!_"H68B ME-ZL@AU;0QQ7&/VL:F)WW@;CI.P/%W)4]];8IP)L$SB2-=D9YA)`Y-,$I2^# M_=%2:C5Q,J8%-0NIUFP&A.`&,_G.33OPSDR])V5_,'!T2=6**#E6Z3///PVO MRA)FYT9+\?2/J]U%V!_ZM&MO0FWZQ'W1&,SBZ,O'EN=Q`^C@621F3LW^:%"X MHF47.#Q9@SM$9C@'?""G-OE_7.O31% M/=),Q6*%"Q2KS\_9IB;*FD[_,/>@<-X(;QTM-1&#CDC_4.AE0TM%@CHR[/R? M,$;@>H7#XMA]:%N:=Q\Z\/N?X.KJ2E_;_5O1+_Q_]JYU-XX;6;_+ M/L"`Q2*KR#\+\+KP`IMXL]DL\E.1)HX06\I*LL_)>?I3;+E'FIGNN=@]HY$E M$6=-J?A^K6%6LR]5%N/AP>75Y>]>D\--\R^R>\5?/,3B*6MPOCW+\1Z)> M3Q?F]0YJQJ_?INST9A,NYB`7\JWZFTHN4=:O`KD""@A*D\U"?GV\XLD"\*5M M_K&%XSA3`%&S5J*=K+Z*`ZNL;(/U"/B3+7Y+ MEQ@7=4*55(3HDM4!C.F[Q.BH>.V8X<\%+D^YF(-H,_'B8H6BQ:A$%N>YC3A? MM.]`M>8PGRP`7ZC-E,H*?,PBUR&7JL1+ZX\U#&Z]L=C]E?();X1]M!DT[]VP M\HF`6J^X:OO,>[1RLJUW45B[43^IM>^ISL"9-NQ/VYQ2D*U/>M%\J\V573O) MUV_SCK?Z+;F0-IG"\O(@OHX#]BQ,+?)U82`R`^37O,-CK^8@"LUA\I6S\K5- ML\FE=,?3?>:=TWICD?-)`?"E"BV7Y&PM!;$UZLXAU\\.E)CL6:T[4`KYM'?" M/AHMZ1`RD^R!J"H7"VG1#55%\;`&Y.#)A7K2;EPB]28#LX;JK`$LN@\Z*H\# M\USL%!K]-V$HGMW.+QI)\M^=H.[M8=:<:DWW]TT6M*^1^BL^!HSK.FS=-QY\ MD2]ZURWV8Q*QL2GE$),MR@<+I=>W5L>Z]JZT?G).]ZY;S@:Q`U$^=+7S;^_/A1]Z>_=F^%?[G[.8BG)_/W[<0 MX?(GT_7M]J*<'^:R+S^>WWV\D2W;/B'[5;XWO_DT7P[-?/CC_?6?\_F_YI_D M-UV=S[==@1I7562OP5@1D6P3U2+VL;7*$ZZW($2[YNH<`(XGP-L>!^]40LPD MYK;2EF,""GV'JQB3+FMJ:]UV.5VXVS\_"6Z"V-OYS>7U!6R%N?O,CW_^,0+J MW?7Y[]__\3B)]%&.;-#L?2DJ$[*28S"81?:Z,O4O?WUK?IX"MO55G1IZ`5UJ26!F.<&7;*D M4G\G'YH?S`.4,.@7(1T?9;7_F5^^^TW>(#1?Y]W\;RUDE\6AJ&>7-S^=O?\X M'LO^:BVF']NQK>J]NFQ*RRH`IR%A9VQ1#H2K=?OR\.ZANU]\>^S@'Y8:.5O;2FR$ M&JNS[H)_.GEV+N.0U^`U'B7ZMXS(01P-1JK;U6G*Z&92.M6%$ M/T#"*P&'\*%5)+"BO.2XR:6FG*P%D08G!J('&X9"X6UPG8,7R\9A(GTQB#X* M0`RM>(T2ZMQ/ABQ9*3.DE1C54<)+SY>&/;42$ MX>5JI4-&]A)59\`[<6^,)?(!2]\;`B,MM71;:"46:QI?"!LG$MISI-7IR9)Q"*.SIQY)?.P9.ZE9X$!JAR/*,212AK% MRNDM3&>*>=6S)T/D;GJ6'>M8;AM0H#)9,[M=`K6-=B924HMSZ M3^?P95`46B&VPJ/$O[\5%G953$$Q`C06G*@D ML:04ZK[GE@Z$IEC28W-IBY:^B<`"]U+K1)[#:!-31 M%W)<%I-Q5^8.+_226$S^)0C$GM[X9*[=4H`LJX)@F1(7)0=W=+9TCEVDG#P] M>51E=["^"?;V2RV.%$V0ZF>=7NO>F>^+3LO4P884HQB(A M16L98V_>HRZC&K?=VA\EW^B%T;?7<:EM$,(*!ZI5]'G)5&(?L%"1Z;LIT.!3C0&*IP1%V-24%KVPG,,T>E[R*XG[DSA)A.0Q?>(!LHA:U%X3I2[9D2^%/W-L>NM;$0?+8YBL-0D3P;0]V- M>P`*60]&DH_BU"^C\9PHV#.*7$S.%IF-2R;E8C$6ZJ(KM;(#,T0`^G8+\\K" M(=+:8\:H`BDY@#`:G6+KUN*]26P\Y<&8OE(:C^(TGR0;ARFV08'4`2;1135Z M6\4=[H\/$\Q2+]I7M72(0AM7G'5%O%=N08AJG(U]=W-KLQ[*!`(D[?11"CR^ M&1IV3@@"V?7<^K2P9::X]Q;1PCM,R@B7J/?A4ZWPQ!X\*STAT:*H".)053 MA2Q$ZOU)$1]:&]2@UT=ZO1R>3J1NC0KZF`,82%"PI>%;[MP2%#-9CQ=4'.O. M<4_0OBDJ]PKF1$..R6JQ(>0XRD%YOF\?JAD+YM&+QZ,%RDTV`E%I> M)A6(*)2:SD7*54X^/7J_@6;&3^`F?3.,'J)NK>I@0G(&,CE@J`1JD4?HP3QY M:L=+IG+/')VBBHO:H(AF3<:I?F1PLAE69RR^JMFG9'+'%`Y?LM>UC3,MQ1M? MK.NM5DU&CUI`QA^IHO1)&%T\+MS>?OQP_R)ML$P#-U]^NKR87UW\(+]VB:E& M%/P3__[Q2KL-@=B4(^HJ^`;#@=OHR07@65R\1X!?=7FBMW?6@5ME_C!ABZ_>VZ&6OW%+0_4&$<8KTT-T7]>0@#BC")4,L MU9Q\;;5ICFV,J;@^;@XL!_D@AGJ*I+UG@N&((EQ*OF)(RLA.K/)7"8S&V4X- M$J=HV+SX?3BB#9<":+I"S:JRUR'G6G)U"UTH>A&']^$4UP6G@.$/E[>_UYOY M_(U@)D[PW<[JT#RV:#C7'&IB(WLN&^,@E%Z4(?K!XT3\8G\H$(<6]<00#BA# MLY3;0++U2#LQ"W6@0H2A1[!Z3R\75^_&*\:?H&1EV7S/5I'/XN>@<9$",_M^J'92XE<.UG!: M#5-D'.R!W41D=<_Z_M=P<7'9/G+V_CY>&S[>_79]<_E_\^T)!F_?GUU]=_9A MON`IM)_YQUF;PGO^^\WUQ=U;>>2'L_/YQ[O+N\#B:/6GZ,IU#S4A^3S=.9)*3AYX"??_-WL8Q,YN!15"<;I MH&7SVZ:;>+E'XV+S?YZ)_@R0_[XWSNW9[^\GV\X'3;D3*96XJ2"%J1B M;5.(2A\V<%Z%H=PD:\7*F^(R<&P)QP9(MN:&@PU)U#U,'T<&95\_B`,#0S/84J>T(X M'PU6"5<7Y7__N+SIGK!UH,.&SF"!*D="T,HY<1:4"ZV?!6Q#5 MM1YU(29$`%!(AIWI=B@49O3C'1]@YJ;PJ*98\RFCOR7\6C-9\8)*,1E)B:U8 MPT+;VCK>W-M-DUESW^6M=5KQ)R41:\H>1CYK:GR49*NNJA M";_$UNLI:J7&UW%\G+9IUDP8R5*V%L@Q<@W])90<]&4IK6N!$UI+$UKDA\:I MRT817^YF+C]PF^>?O]CG1%>//>Q0;4X5'$6/CI)"%4"7%#QI=&KH/`?=;V8RFUNL0;:VIF%IJ1A]RLGU@PJE@5VST M;C#55*GUVQ;R5'"MF.!+<$$QR>7(HKYLKN19&]O+)7%VJW`1ZN<.UX;6R1OB M71XA^(`)-5!)15,-G9[W/HM4#A6?:2:E)RF*'5O#L1':&'-!HIR#$@N#7,5@ M0E;]8%*P10U5#6OTWDW2B/6$$-K]SF)#UA49=.*+D$D>7'%8#?7150%MJ.;W M6\1RDSQ6UO*WV!I5=`4=Y+*P9KT>:LN/HMAXDO+#4T%H8XC/4G%B.^A6KN18 ML;-@>H34V\YT3%F,I,*85N'#S9D+!&/UYPP[-)9N+N MM[33@'-#7%G92E"CF!':IQA+`=TW]7>&[*AKCG;2N/(S@W-T=R+D[,D!9JNB M@G8OS(NS@H4GB.<&\+TUHBX:V]]0<#J%#J_$I? M]`G@O"\HN8]3==F"/UZW;SVZ,0COWMV(K76\ZH2AF=H)^^*%GBK8KVM&7(2@+V+[<2WFL5^#JBY.+4*M^SW MEP3W(T&;!&Z'XB1[*%FLT-8XKQ7E+D(,=FE`<@>WO0_('![N[0L],MQ?9.<' M9LBFQ!2J\5H9CK!0SZ&6(4](_$J/=L+(Q*Y+.S*>DQV!QA9E4NOZ$%4V[?:J M+KQ-S&;4WK737OQ_W8KW`_]VMUOS^4%N"C/HFL!;$+316.>K:.#N+ENDB3PK?S7>!0>6".JJ0Q-JHXFP$L["0=<#1FUCM9[Q/`.6$\=TX MX?*K-F_RR?ML*F$H.BE1QJ9TSG%R0<<\6B8M]C+M$WN9;H6G@^SF;5NU2AY5 MF\?9\K"50:_[;6LHC6Y;4'J_C*%3A;:[C^M^HK^4Z^_D#K&1/4;-G"Q[2#H9 MIE"2*&9T5NQEL#BJ)>Q,[1,>.^RJUQG8/T!3H`92WFL*E(-Q*>6^A%*3N`>C M&X]F:V;6OB\U:I34D(0<<5M,RWNG6!/>UR0*75'>=?2E>(:K].SW4ILL)=DJ MK5P\>ZK9N*)#613Y9811$963>VW/[/Q28Z'>I1D(RJE2J("Q$%KY@.=%);&A M.AH4`C=3JR;P,&*=-G_YZUM0/Z\L=8HU38/4IB+.'^6#2DL& M?(DVZA`*5@17^RDTNG!1@@'^[/\!+D^`P]8W?BI@%C62#R5I5?P8EU41-YU- M%/EU"^FP$.G;QV7I/'R4-.=,FZ@8,9;6ZS0DB)V.=0ZT^7_NKK:YC2-'_Z)4 M-1K]^K%?=U.5W9O?OV.[E M7)KM:O?[2^]&QT\2QS*@E4VU*&Z@URD>J6'>'4R`OXES6/'3,=V43/M-G"2: ME'U!YZHA*BUSB7N5-!']3I+^'";N1L1XL=F";W;Z\0"FJ&A\A:A$Y3+U?F`HJR7G MQ5Z%^/3C;ZOED#$`Q#^MM`(5)+*F!ISP44:O')E6DV)?3=LAEWJY^.FA_<;) MO(?U'T/`8=!2I>10*GGLJV#XJ?%F$8[9/!1]LU*:0"86:Z9`CTO99`:YH\FL4'8/JVSZB/+VAS&4ACMF_2$@4ZB@,WX&36KIBR9A[ MS$ZH&J&OVN#<"/6$FRB3=B)&G;/U2A-&GCGWM(DU0%_G"`#;6Q]T68AC-E%D M3GH7-$)7PED13==CO9;@^AXMPMA=7'S_3C_\*_W9/=?7+#_]1DYY\WVUWNY\ M=%IMMCW/"+&YD'J=*;A_FG_+"F[SS>-CPJ9KBCP[+9M6=Z?"F,ZLR*6)KP5H6 M2`5BB?O'80%ZS6H/M1F$;;@X^B^F+ZXMY%F4LX5,&W$][P)?+9,91N=4H2BH MCS?;RA]04CSJD]<:;17.1$'FT&&T.3AH&GD, M1#&*)PZ#,!WE4:GHZ&0%!Z3B5BG7C9S&6MLQH0!-(N*F);$K['P^_,../854 MM:2+FJ84R+HIX&U8MF0@>^28O"P7-Q3I@=8].D&LK M\D1U/YW4G@#N(F8?L$BG8]36^YB,2$)SN*2Y79\3K:!^@!';?\OB&L&)D@4T M@J\31"2U@B@SBTAHD:J)[1&Y/0D=23@!.88<;=#.0U"63DK5?%HH*$C1Z.8) MYRV"N\AIP613J-;9+))2N]>NK`J1[(LPYG`T*IV6@2'SS8MK^&E10/PB>4?V MI%IB3KAK'A8H\HI&0FV(QB4E-"S$.L*D4/A4E3`)P<4`Y#15EYU%Z[4Z!#@F MA/A8=#0*WT7.BZXJ:>VA&.6X8;W)W<"VF"WZQK#):2+@B-?QD3@%]$/D>(!NE_U@:JV>7?@DBR MR.X^.(3@&^>@QH34%T1XD?.2I;791VN%A6B5K\D\LHW$G<52XVEZ&IG\*:4U MHL:GZ)Q2M<6J&@V`*,+NR(8WTI?:A/03R.>7^?>']=W7&;^/7'U9S[X]#_$( MWU8/RVU_^?ZS2)C3M'_)JZDG_9\Y%K84@9HX&$_YK"ZI7$*I#J%6S$3JF[#E MD8BUXCD.\,-">92)_/6=*W$IE<.<:B4#0OMK,,7J9*J@O`CM(Y`K@S'_"0=? M35^YB/)YUQ]^W\S_]X%/PC_I/_L7B&<<=//Z#MUAM5DJ?@\2T4DT*L@0!1^> M*@^'0^P?T4PCOWW9Y_.7GS]SW4.#%*40B_?<43L&!)&,XD)"KD?V^;!W'/<[ MUL/D-`3S>Z+KN4HY$SL94^HD@^:"/`NB>AM#Y7%59&^)Q5%@+!WV7`_UFMQW M<7U8#(=.YYS*8E[QV2A1%!>Y<"_SC"1)EA;)O'+]I>J3!IT\[>41E;F$3,ZN M&C7D)$)V19`@++'YDCCN3X$HG,JVKZ4S3"B'GL8#2;/J-H?Z9SL5RRR=XMOSCF/UVM+M5DE(C*)')HPG> M8.`\73&A<6\WJM_[S?UCQ]W71U"'F(#BRVIB%2H9!_P"@#;89>>)5#9QU!70 M3F>7`]GB&*RNE7X9&3)X)+L$,(E5+K'DHBH?6X]@B5]T739"16V;?J8W!OM$J^RC]*KF M8&M64=L0-(C.%6,N]<91C[+*M(LZD^_)&BDX1\+9O9(0WINF].9&]7ND538J MH4I`0974.FK4(CWUO0A$R0_GEUUE@R?YNO-(XK> M5Y=O7VKQ<&9)I-C)X'2*SG2C(&C_T#:Y%'`>FH+`76$=?66/?MP] MR^?/'PL(^&U00$%6."23C"IIW^")?M[P18H;;*^&7@KJ/N%^=_?P[>&>/OII M5Q;%'UO/O\Z7F\4_N>_=ZMO\6#PK?56Z>&^A^*`*\'X_09,='C`D-T=U4@S>"N^%$KV(T MIA1L$L?71G92$5^NWEJVBC:Z2&S)(/=&]89V,VA3&EV]-LA?YMO98CG_5&9K M3HD>HX)H2U18JBS%8!)D;S'OM#,EGD)T-"UQ:7BC7G`CNBHB:@IP"A;"HQ1C M*X"F&-UPO_-BP_?Z^BM52G#&@+!!ZZ1<-T\ZBEQ[;#_1N-[[^@\O<7(W%[T@ M\5.@G!)`+%!EU\LQ`NW#T5CC4@C/Y]U"IJU*B4`'H6PQ`"ET14S<9;FM:72] M68&+(S_)O5E7JI"A<.5W#`Z=L>0.0H!2Z0>U*=,!"C5[JS@O#7=$<;M.PD0E M7+02(^@@E2>(3CF5`U&6@77OD?/5!9)[1P%TOC,D"Q-'( M\=(@1[J[2@RLV$2\R]988M9`AC=QQLX'3DHW=]UX$ULYQNLE!^@)G)=55Z_9 MNS_V+9$UHC@<@G3N'7QO>%#1EJMZ!5_^.#I,Y!C2_@9(MP-OE==MP\FS+'&2 M7*),GE^^N$J.7?DLM/-=,TV*:4J;2@4#UD[@UH\!/#%K6#E4S19,(C;B,1`9 M5EUK-K)X+6D!B;*WQFQ:>&/2@XH.12HV&I>E%CZ#ZX9])V>T:MMT7$T&_HDTJUBZ^#H/"E1:5T;][GXZBFII?<)4PI41X+QW7QHDHRZ)'L M>D%1CMX_70KA^>AE\<0\LHZ5:&7*G,'O;FPHTE&NB=B,[NU.<7'@)['+2@X+ MA!'>$5J?A()N_$LD'BF;(D0-=BJ3,Q6[Y+9B13AEK,PFER2EZ?*`P(6I35E4 M.]?\&@!/8I?,H%TAADGL,H,5L8@=-^$G/DJUZ=UK@QS++H&3FCH+B\4ZLCY@ M]WW5I#'-DXP?I.M_M'!IG&/XI;4A2E5]UA3,AJ`1N&&S]%;:3)'2X#J'CV%\ MKTNW3%I2$*J]!U.PIH*QZ[V5M&I?QA"$_D8+'U[B-#PS,W$VJA11`07/,'G2 MLI23S^U#.87&F=ZW8-,"/)%G.MC-E$\&@&(RHC&D8T_XBD'3OG)#^ND5X(WA MF;9:5W4TUA%K3JD43H0]8>+\Y(VHY&B>*="*`$2W8JGDPN0^(N#KS>:@@1"Z MO_;YX["F)II!"(E:*,-(2ZC(6;WH'0&VQK><^EH(ST"6JD=+37G?M*Y0^'+G$QU-/$;A/V2ZT M>AF!7R>$(A+DHB-V-3_"2FA*`>04F:_Q`$]+8I(+,5Z*4#SHZ(-QR>[.*F!T M*C0YZ6N#'$DSK6&@:&[B:,YAF06H.`'P)L0KT%V!3,)*B`--LASNT'.^LY/05OSOG.O.8'T'A)L7*I@21L'MF7PN6 MMOM20Z^F6O)>6>+#AD[$YF7[T+T#__%_B$;.CA4G(&U`IF"%3XO%5*0RM"M& M4TP=:YLFL8=T:S#$EVK=]T2D1W]>M\^S6*L.B57>V@Q(Y+XSS89?M?>]_$%! M4%XLMEW$^$6^.[Q;A>"JCFW! M`'>C)-;B0N2^*^XI`Q]Y3%Q3J]%&INT*1B_PW?E1B4R$589L=TFQ>`K7.LLM M3#T<'<.$N;%J1U;X7\O9M]5ZRV_@\OSW+=/XV?)NSE,CEIN1JT69,E3'O9^5 MJ][RP`LDXT4Q3)30)M^`*]I>K_;]Y1RL_--BLUTO?G_8/GO"GU9D`N[O5W>S MW<@+HN[;Q=WB.\7)RR^_SN\>UF09YILXVRSN1C<;X9IWBL."#9%;3&`E=:T4 M>9*UTTA\X1V6\-&U3@S\R$NL8*(A-E^TS]H89V4IF8!;K[V/Q!#_O,"//'8P M+HN@!7D_"L%M(C>-AH"KPAU42`?:)AF-.D\-_S\^U]5ZOOBR?)DP&7=L:U5U M=P%)T,B^H#44SY`^BVBJ][8U,GB8,1^^LG,"VOO^O-A\7VUF]W]9KQZ^I_O9 M9K/XO+B;[3G`B\_QW[-8/E",^WW^.,AU\]?Y_2?RUO3]8P%N#`*+K8$$0\X" M2&*D0Q9!F9)C;=.UJNG2?+*@UO.[U9'#:S/U8J+1&01WSF M'*/B@9\4NC[/(FSKV\'H5IU[UW':6M^K=Z-UAH@\J54%'TMPJ)[')978%@D1 MI9YRK>_2^:(54?D,6E(4$E$2J>C62O2X<0NN>7)\[J4^D^+9/7O/7[_.Y]N? M5B].Q.ZEQ-W=^F$W(NHQW_.PYC373XO9[XO[G04Z1IAER#DH[U,-4FN71.P: MWXM:2Q/&F$FU:3#L//\\7S-/WZ6TMK-_W3\A_F.Y6MX]"N%8B6_.TAM0F4?H M0DBU=N%0$B&UG:;4X9W-=9#OMODQDT=_X?"-SB!D<5S1YB(HQ7<&W5!;S=!UZ@_&TUX/HX!8_10%95\WS;E&Q7DB/H7#?5;!.?Y75E9W8@A?;VQ!YF\:Z#_%2S$T*T1+VQHB>Z M5007='0;;2`TU?A=FYQKXCW1["0+)>J,%:2/2@-?+'10D;S-I&K]>.K/?KLSZLW&[\?"9II#S6`\5I@T-7I@';/.C%A MZRL''M=1J[Z`&(Z$T*@IE#*&&+[^[N=C\]V+[E3[_W$5JV\2I`XX' MF?*B*?Y2:*.T7-XLY#XH\VTQ%QS>!9QU^9<4S)$#D\G9802#)01G=\V<]H(Q MUK=5BP.=W>T+YM@)HGA3:@%.0+69_`9YQDXP,K7#(YK9>A<7S-[W_SQ?SN[Y M6X$;YFWGZ_EFVYMH'G!PR'44"24H4:2H*7M1NIHM35:E+<0>:$B&+'8ZT,=: M',LD(7BGO7!>&;(/^HG[1NLAM_UCAE+`ZZ(^UA$?H2I3HW.1NT"AR;&KDG2U MM$6@`[G1&3'W')RGN.8,#$K$6DDSBJ&X+GM#7PFFZ\U10VQ')0W,LXQ<]T5$ M<43_(\7F%`$5$H!,)D&-?C^C'A*TUO6T;R_KSO<#]#X1[>IH" MML-])YVFP))+`KTHDI[$Q<']2$N4S482!9)*ZO/K[RPERB]4)$NF)%):H&A$ MF5SM#N>9F=U]=J9UHE@#"AMYMG)<%4#X1#U;I_&N5DA1H.J!`VV;5C0UP2!8 M>+9'0TI#Q1"X`847@8+/<@]B6`,-V]=5,"B34F_CV&YHNXO` MV@'UJ"?E[:@"ZHYMF]37]8\!*\=J-ZBB\T/<=4FBQ\X MCBLI)TAPX=NNP[E<++F']:A7%SAOX1!7DJP=*N9XFO[S5OW,GF![DN=:W' M;:8(!*R<.`O,A%_MY#,Q(G8O8#B%=WT7% MO]/IL/_;:`+C"`:#N*<+(<`MGZ)B"8-P523C2YM)6^J4R(Z+0R(%K6CKI<[&>BJ>,9CQ-'E?#U7@5U4&%[F8J.947][TL@A!KHJJO&XXVJ6 M(,2FRE5"P@RE6J<+$?'J6UOBA0Y_\X%F_;C_)[B4\>+$SSQ'Y<>;87);:OQ\ M8^_C.$P&Q9TYC?8]()]0JXHH'R74XQKC9#(&"JKQ)4QS([)IWZ[1\'%84* M/+S,\WBM&ODE0=,A'F7$M2EGBXA:I_LA=:88>QY,[DU2Y"`X\QWL*E^%7-@H M(,SU758=Z]-[S+49/'F^9-PU^6R`,TX\`MJ#7)>#^T:`,.9*#*G$J0XQ@DN'BJL"U)ZFO:CN=HL:)VINDV&'B1B1LWY%>@*FM0LI= MMJ@&[V))ZN>S#H:SAN2S`@=9U#V:E7R&= M)G#&0AX(%:+0!3\&T[A`UR>K3)+KU?E&=;)NTZ+R[Z+L5A\6]5.]TM%?L_MV M"!]G>\B5/`28$>(SG4%T/F?SE._4^7CH^4[(5@)HMP@W@"=V?80)!Y7CGA.J M4!"FJG"3!762%X)8:S/KWAD)-@%A.V!4>L0'^-*`.8)045D[Q7&=+C"O?MI& M8=*#(1IS1DGH*2<,'(5]^']5ZLYG3IU5LMDB3"0WB5G MM)*>1V1]_@@S`KNU@'Z=!!N)?2%$80I,I#Y<+91''_;+P%63VKX"S-;;*DQV M*$#KY$"^0(BZ7+HLKI(G(,(-$$T#&Z9>#.RAL)$=`< M96T*N@/E"UT[1U>R#Y!-F5TA6NIZ+"OVF;<9>:M%MU&PC24CPO4=S4$`<^@L MTFY+%7BK4K,>A=B:@&_`%<8B"$,/<(N]-D@<+KZ5G M$PAG&,2)C"OB(%J=_)2^X'Q5F<>C$]U&<34+.%?2=5U"P.+A15$9S]4%Q-:? M;"(6L"4V"&VAQ7, MD"&F=I!#%Y,\3E:5IS@ZT6V`80B+?:H++=@A12&2(E"4<-^UO9!C[BY).'>, M>M?(4K6G"%A`1RGE4HF5AT2UZBJEK=8>C=VQ(-6">]RBH%EGA'8%A^D$D3#O MH!`U5Y&+DC2HR6S#7;2',;=.4!M`E(!3\%PJ0@%>PK49#1=56'6*ZAIM%R%4 MRTG3*3DU@49'\%`)@4.%N/!=(IA`#_,*NJI^\)YE=;BHUQ?*P9IHA2%:$S!O M<%!UF)V[3CT/SF%UZB`AKO1#+!Q"/:*(QSES<&#/W2.E%-7K)G)2RYK4*3DU M@CT_M#$A*A`^P8[RA2L7G&/&Z:HZM'N6U>&B55VT$BD=;OE8B4#Z=L4?<1W$ MZX=K#JM3AUGD)5)Y7,@@Q#)@ONNIT*Z"`T*=>L9GY&XX*VJ9G)K`'F8.#V@` MLR&=DP?[,EQ,)"66M":TYZDHMA+8O^/D]JZ(^_)KG$6W\8>I[J)*ACJS\JQ4 MP,=ID1?1N*\S%O7_FLZJ-FU^PE,$`867K&N,8<4Y%M0KL[Z7">R>G,M;U#%X M-KXMN[J;X:X[NHP%IB[GQ':$)R%,=L`=Z5SO'F9AB/&2X;9UI&L.7&);^6`1 M0^+ZH,`2*6[;97)W24*EL%SV8I_O0.QLO`#"[[2RL0)+WP,%UM,=X3BVBSQ* MO"!P'8'=@#PM,EF-D]4VKC;L9+,#7)<5"&:^DH5V$-J,>((AK.1L@%+9WI,E MP6J`O$8B/>@`UVBJ[W+?QQ#[^9*+0!^N0_9L@$Y@!T]2WBXT%=7JT^Q@A+6' MMBNL02G`S;8)#B73#$6D.4_5"T3A,A/+:FS[C;K8Y.#69?YT`^9I,B5RD8_= MT//#A79*KL+7:.?N![=&,R56C.CJ<#"=TT>90\;X;'">8NH))?E!,VLE;#/QAFGOR_<']^`2*`^)M!D*822N MM!W7K:*_H*SW\>L_A\6[?O+5RHO[8?S^;`!-7@RB43*\O[I.1G%N?8B_69_2 M431^5_XM3_X37R%[4KP[^^=M\>[9XT,8P,5=.?HKA.T?WTVBOA[H19%.KIS) MW^]T?R^B87([OAK&@V)VG8S[X$.N,(4;OO]Z?@:/7U_DDZE77FVOQ*,IND_&LD]&T2*LO MLK);Y3??DGYQ!W>#8&[T`=;LH@<"UNDFKJH/-;U^Z'>V^*0U0?=V_/[,.;,R M>$/E9[2X]VW1?_B8+6VA[,O[,R%^?-+"0\M+6WMX$&WYG+OGW]OW<_L9W_?> MZEQMP5L4"6!^KD@W:5&DHW=/<(0!$X]!\OAZ=O^3KV9:K+]9V\U'R'VNS`^0 M<;8SR4YED;_-T'Z3#OMU@_S$7JZT74]?Q6(PY&RU).?HGL,XRMZ? MC=-Q?/9V,SYC9$[7R,P4QL$([QYJQV)K3GFJ5SXVJU&_36R-U\36 MVTAI@TBY:?00^])M"C;'@H[V`:%U#O=8X;`#9W(LJ#"SXN\IS;^F<5[TTFP7 M^&E4@,<%K*./TCH$KNXZJ&,!&!5FK<7,?UZJ+7X$*.W%)N(S$9^9!^W%S>Q@ MR^V`J$'BDC?F;=:(YEC@U/4)5.O`MX%6$="J?CK5+*W7(.Z[;V/^:R4S;$<* MW)X]@W62?)MIS*,QC\8\=LL\G]2S[_\G:;,QVK#H,$438&9^;>-3X8$ M/F9$!,)V=*ZX,&2R*DPH0^S;^-1.AH0@Y'$OB8;6I[*J9&[5-&0;];NPKN]B M*QKIX^SZ8,WR2$<\?Z/Z<,APVI\=#M%G/^"M`USN?\JM;-X;?3I$ M_V52EN;.K0G\05,Z^^;4ASGUT>U3$>;41RM6_O9XZN-#906W60@C37;'8-A#:L4"S(U.KUL'R`!PU0T6K"[#CC#-T MSAS[TMF;V$Z"6V:LE[%>QGKM8Q+$R*X.4YVJ[3JV58I&E*V\JE$F/D[B+"J@ MJYKFF8YBZ\TPS?.?S:K%BKVG0\WCCP6>'4)BZV*.E]._]BC$U@NN(_/SD^)T M'=PA-ANN=H<[045S![1.Q249SV,,P-$8`)/SYF1FCATE3QW+5!%C6F?_ND9W5,2"]<45S/JK^_CLS$=ADS;MEN.FP-SJN MO(AO.&_P\-L+97/,6.OZ?*QUR#P`9\%D!3-9P2!<)R8MF)E'&_MH[*.QC\LB M1^HV6,#AU=+<**;L@*)N$W`VE%+QY9D15^57_&U<1./;!&Z7>1X7'AC=/M!BHT&;(=QU'$FD'@2`J"+C'.<'8Q7ZK$BTB9])8HL7RN:?9#Z-' M(K7@OV@F5)WVL!*]%6G9/\J(^"TI[A*X>SF);E5>Q"A_G!:QGL^QN;R(3WS2 MLJ2'+WAO:]LPB1.?6363.-$D3FS#TN`>J<2_/;.33RSJ-HN')L.=2:;8%C;M M2:J:2:9XC,1;D^:L,TP]UB!5]^A)#AVR-ZUSA,;(G*Z1,;D4#:&JW73@CK%` MB(V:XR8>"V+:!X[6.>&CQ0,UB47-C'EK]3&)%->S:SANM0=0#66?LY.R:3V*:KQ1@UF$[99!(SMLO8+F.[]C2# MP2:#Z^Z"L9=165M+U%333),K!TD.K]K2')BR0K5F*)P_+DEM97$OO1W#P_UF M*F3_@])+9,%MPV44IFU:+#O>3-\PNQ2-]NU<%_2>Q+TB^1H/[\\U*3;^>Q*/ M\]B:9,DHRJ`!3>U*>TE4S-FOUB!*,NMK-)S&5M3_:YH7(U"!O"34/A!HO\)W M:79_:5W?)?FB44V"?4ZE[:5YR<8M*_!>KE;U=`Z+:*AGX[SI%_2?[&).&=*&EJT7X(%[XKJQ1/V=A5_JUDZ+R*ZUYYYC1.Z`]8_N5O&?" M]\TGMCM"8#8#-`-L>T?;/4"S#MDQ/C3:B@^]I)$UYY]04SN3Y56-,PT1319] M27.SO&14LB4J>7B^N5%(HY"/%'(+HJ!12:.2NU3)S1E&1B.-1NY4(S]\MLI@ M,, MG`R<3AQ.E+)=U4@R>#)X.CT\D087BPV<#)Q.&T[DDALTG7:6O^:4:0D=;R<0 M/)(L9.C<1NZE,*N%NQ:`\6^G""[,FG1N!EP&7`9<"]*.B]@>F(,&7`9<)P\NRN/=+W!T M#%,[J#5U+`AJ'UBZZX(,*@PJ#"HZCHHW"#O-Y82NO_3=$84;#BU^-F`Q8#$N MQ+@0@PJ#"D--V,],7B=OA][%\+AA*1P.;D>_<-8AR'77;1F`&8`9@!F`&8`9 M@!F`&8`9@!F`'2G`WO`]U*L^A<7TDV'P2V:LE[%>QGH9Z]4QZ]7T MT3ACO8SU,M;+6*\]G3U$9M%K9WS'MT4$PU]Z_Y+/O[P=C;]<>=,\&<=Y[J>C MFV1<,@$_Q;UTW$N&27F5#LJ41OYCKN"U_IUK$(HW3'M??OV?__ZO7W1;?T19 M/"Z@)9#D_6_CKW%>C."+/T#NO?O%[24#$2X^Q8/W9Z'"-F+_HO]WKBSLZV04Y]:'^)OU*1U% MW[>M!M"N5Y#4#+*^3,7@>,-=T\G>C*C\?3F\^G&0Q')WX>P*/I?WEH.HR*N%\6S`0`CD$F\(=!$6?P,'0PMHKH;U"G`?1E2<^BPNK#\^=6 M-.Z7K9?M#`9QKZR_6631.`>%AG[GUK>DN"OOBX8`@VCVY2!+1XMQ7*[&_!/< MO@QK"V@"IN&OP_O?\GP:]V6OETY+&O#G`GH49?U\$W@&3D@(<6VEE(]OL+")JV%YZ,VGP0D=M7&7./U]>,?':?9*!H^^5FD[UDT7!I>JQ)5>=;VY-+XE_>(./L*8Y\X,'-4PFN3Q5?6A-OB'3CW>W7W,%UBR MA_^"_>&R+^_/Z(]K/>=3'SY_SN4;/;C9+C6\D09B=-38%O7KO4+-!Y`UUN$% M<=,)2*FR<];,T%D/ELY:F+J=15:M=;C7X)E"B.X@J@,'N4PFEI?"/]:;LU!^ M]LY^MI+OB\_ZK0/JC&_"=^KMSZTPE>6^8YE-P MV%9TDTX+Z^-@D,=%V:"<4S#`(_Z>1#<0;Q9)G)^?6=_NDMZ=]2W*(2B.LF20 MS"J"_&\TGD;9O6Z;6#?W%OQZ^?G"1M:97]YYK]LMXX5>.HFU!]ZB!Y=GUC6$ M$];M-.F#Q&+P]]H_0P-C,-/]18,0B93DD5$9B\P:3\9YD4WGW^B0X'$`$,/; M3K2?T,%$6G:CBE#R`B1:ABS0Y\'B34W26044B"\@?@!OHO]=^1OY].8O'7Q` M=!*-K>@VBV?-Y@DH251&+9$.4LKQ+_Y\_O_L?6N/X[BQ]N=S@/,?B'FS2`_@ M<23Y/LD&\*6]F&!F9S+=>P[RD9;IMK*RY(A2]_3^^K=(2;ZT[6[+IFR)J@#9 M:=L219;JJ1N+5>)[YDDE%G$6\.UIK&;'Q741,&G`P]3BB:T=N`,,)#^$B\0= MJR_!!IK[G!$:P"P?DD'`BH/)B4M#88?MKKL2O7X!@A7A$YS&FWH8AEY)P MYL"DR'^`183Q)N?/A3D(+-*,QZ-3?RE-R"FX@9X?DCF%X2A9P.H"\7@'!A2& MF_?"4%Q/$&RC:?)&@*,B-UXB\%J0V'."*K*5C8C=\-=%=F'%A9`!*PFP0ID% M@/[.EGX08V"?I%T-.(<7 M-V:38`7J^@O<)?CB:V81[)=8_S7"'#EX\K9FU&8QN[U`4V+&`]/PV(E@[HIG M@`D83WV,??Q>VV9Q3]KWZ8@S0-6#!VNW*3R*)@0)F+U#$D9!H`EW![S[>%:; MOHF M;S-V;1!V>V%W69@U`69?)X#T9&G?Y8+%2Y*^XC]\1S`;K/>.@7D'Q$E5%VC$ M32$KWM?_24TJJ!J7I8Y!F\)D_12PEL`^^`'S`(=6_+3&^4BXMP>Q&L6FP$I# MKG@GY1;@31\P$K^[!:-"<4IDBA5LZ%+Q.C<6'6PO^M^K1?-DT>YJT?3EHI]6 MBP[EHNG6HM=/`=(#BVTL>@V'V*=G/VRV#&-MO3$W8!&8'F=3Z=$#8=@/A\O; MTM7727\EL1R^!=>$!`FHMX;E,3"C13K59.)2`L6#S>$BJ;3E6$OZG()F0KDC M,>%($;&BB!@#)B:^M?T/\G%^P.-PA0"Q8'?Q^!69P+P(84%+*>_6SYBP.75G MZ0,VAGHA,JC+_;7*)Y"N M:@=(P_Y;K(1C'`EUYI'?O`3K?\#5]_0'&3"/S8";_@]T&E!79%U_C0D$'/G9 MYV`[`*<^PVM\`K<">)+<)4:JN%M<4!-:F\J/0\`/C+5Y![D5N..Q%%"U?JK1;EB4?:+1:TL;[A;7B#7)#[9 M\9HV;XAE"8_M<1?N],0J@$'`XG9B[;T,A*UOI[I]9]:'ILSC&P3"A`\V=G;!@P(9+#X,4W.3)[Q\*R5Q M#)?^,G!2&^TWX<\EP>NG%2\`]CR`U'0UY"KN+CU'6*DPI1\HQ<%ST$LP&-LT'("%/WDK M-59[85(D^/@@8)!8Q#0,`V<2Q0%;Z0VG2Y1DVC+IP5T($^+YP0,%2,4HB^/^ MOH@(^!()KC-[%M.G!Q:P:06\Q)QS'N3:*6UHX#ZOD0=/7CAAR!*;/AUOXRH6 MN^^K>4RC((V>S/PH@"'W0SQ^G+@L]3KLE>R14_\RNB.39%=1$&7.X#V+A0&- MF59`[4F@/C)XV>E&CA<*\9QL]@PC'@+/!8F.^D*?-]PB,5JLD6:;0TJX?/*` M[O%F+%!]';E;2X5U-.[FW:?Q][MW[XG9RC`=@527A8F1%MO7P(8PN@BMR>6F M`9[MR;P2/`0TQ0&[YP1X`#D'GA*;Y:E6$G<&R2RE$P!_N_XREAX+N<$7_\B3 MX>7=O]7OZN27?O];3!]8\6'!M0X7)$)FI1!78PMSE"T=.[:N901M%G,Z6`P+ M1QCW#[[8ZY-A@^`1]*TTA^V4A%+>>6L3'01"P&9N;#;/7]3'%7>NO9)D;AM& M]B3YTHT#G>!WS(4!GT@#H;%W)@.K7"[=YS5B75"#XA,/V9)_)#?F>^((+*1O MPTYXX8:_3W8B5XOY*[FQ7EP-XF,F]KPD?VXX*8D\2@>#.QOO@9*AD#8>6Q,S M#D<*%K`97-1\GVYZ'K@F-06.?J[@@IO6^SVO5EIF-\+(@I5NT)O#4'SFB'#2 M@<>\\#;.%,R].KG=ELDPX$HL'S%`=UMTIVI%EZ033SWSX+AP*"@ M\M4#N<&&7[IKN;9M<$_9)%R/;OM@OQ^637LN!LZ-XX#2&MDPWN6UZT#'`N`J M1$7R_#4/3:@K1^-S)D^V2C,D$+L`8"M%,PD"(99>3 MOL\%`V$WE=!^81:N+A%"T^-,+5+?-J&4VU!BC5MAVSU\41,W[8#W%"S]R30: M=9/`=>Z^0F^G#"EB9G<,*!!O]X'I(=85!Y;VF.DZ"2$9`+E+)$+ZNK]LA#:E M*`)E%/K!\W9TXC51)'90CQ!%`#EA>8-1()A0T$%>N]A^OI,^'Y`4/C'0B$?: M3NL;4W&3C+R*DH*=$?.S8%(YH@B"!`SF\H=TJAZI&P%"?]WSK5BA5,D\=!92 M#,`R7+D!$4@3*P&K'\`[%Z%FD#8!EW1*/8H:<87F@Y&Y+S8LGX4\G((E%V?@ M2.$C)R?MV]0GE`Y>;;U=*D1+#CJ_LZVR'9XHZI1+JJ2KA5C=@T(64D@`YQ;AS!7^W("ZP(E1%'`9U5^M[^;6TQF4T( M)=?2]60V3&RZ=F_M==:LY)TT9)>XWG]S06[UP^OJ3R`VX36XT7:G'U>[8 MYC+`MMV,H*QLAH1'7^[LB>_7'LC&PV#2B>'OL)?[?X4&PW8VY/'IC1L9D2*- MP@ZERA[.:?#`^.#YCCT(NFPG.!^1$MD8-SKC1J]G#MK#VW:G-1A824KD8-#M M=LRKIT3F*@!B6;]!S\3`B4T].R:N""SPF+SISEEB'HH;-@.&8F,H!1S_F)M, MQ"S1PUFBYKEIHNW6B7FBYJGYI1=^WJ7OP_6I>%Y)BE\5[O3?>KKF6_7FMDYE M[9Z[RKGLG+`#6*#FQ-K^%.-Q;.'\B]'@A$QBY+I3N*YQ!:;;I>7QYPFOS:/" M1#W[N`#R(?+A^7S81#Y$/BP`'Q[=J3V;LEX`:[BL2*6*7WIZ6S,PK1=.[`?Y MC1+2R]ONEDP$U\)G,@BH=_QAJ[<(?%(!B4,OI1*5)8[ES))7E&BH+.5U18:Y M?B4)+,>NNCH.RBZ47:]6(NS4#91=*+M0=J'L*IWL4EB#L-*BZR1_L[INY2_, M@XOL+([EV[URSJ#J%5OB--5Y/KJ`"8.(E45#K]Y%-"`:$`WR-M-49Y_I`@>, M[)_#4;]&DO#DTX(^P%/SP)@VO0J;"IKC'$L3G7L58ECG`II-%]29#86UQ;'W M+B(+D97<=HG6N[H`"\-Y1S#4T`^6OB@@DPOJKIN!K#[*=W3J4K:.&?J&U#'N M4=VX1UU9PBFB`=%0PU#?WSKE6Q/E(`KO2ZG*7%=NZQD7 M"&%4(JL"XQMEBV\4%9-=\P+1#\0D8A(Q>30FK;;"H$BE,8GARB/8[3/C_*/H MV<)<4:5&UNM;!B(C,=Q74`]CF#L;XH8"O&8D397WQ5%A5AEJYV<%(]00:@BU M-Z%F*4SS0JAA:%9A:/;$<&P&'FT`CT[]2)0T/`>_>%CP&,KJ?IJP::C;MSV= MF)7P^#$*=[JE@^(1Q>.5]B!0/*)X1/&(XA'%XY[M()4G/U`\'NFC_T76L]][ M_9Z_TT8-1W==6'5JN+/G;!JY[.OLDQ=2[\&!J_JNM!V]K<>6EK5?]T=:T M3MLQJC*)D2>1)\_FR;;DR:.C6"@\L45`X?CZ%^$\O?HRBCS[8>+TE78!?>FL MHE9#85$*;EW'4\J,N%4<"'&'N"L#SZ*2OK;(0"6-PJ(DPJ*J2OHD][I`J0_Y M[B]()$+(-X*PRQ]-4+R''(<1GPPW] MQ=)E(I$I9/;<`X9X>#X;KB?6/MC9P'N#*J^[%WO.E:ER+M3FI%Z4*G$^:8YD MZ=6ZO3;6TL/HS76;*Z(LT4"6=-HM[%2%D@0E"4J2,\G2KO4,M$I0EJ`L05ER M_A&ZEH)B-II)$MPE.U@1T;&9QUDN79B5$?#\W.D]L%.VF2MO,[NMNIE[)%D7 M/)8(>H53^6_#+P\B7K,?M,*&T(@L1!8J-E1L"#^$7RG@U^UA#]"'ZL@4,T:;,U.Z^F&?IVOR@>U$JHXW(L5W55#P[1A&C2IK5R"38!$'&(.$3< M)1'74A@GJ0CB=-N6V^8N2RE[W?LA=<]FL+S:30HHY=_[[W6$E^9P;&XM*>5; MN`RQGIE$S>]V\9"JVKL3(M3*K"$4MBMHRB]INUZKW4,ZBG$4YBW(6Y6QN MU.[4S&9377(N2EJ4M"AI4=*BI-VYK=&P4,X6.8A[_5BM.F;[U?<^Y-T8)P=Z ME5A^GJ)$HJI8@A][L^5D<2''H7I$]8CJ$=5CR845JL>+.90Z^8V?O`_+P+<9 MYR1@''!KSPGUIF3*'IGK+Q<,2'@"$U:P1EC#5%A4I2H2'04W!OR0?RYS@$Q# MF2NZB*',1+]_O+/G M;!JY[.OLDQ=2[\&!$?JE@\*H]\>$[F_W\;CRR#+/U MS^:_[D?OB#.%+Z@=?C!&G5:_.39-\W;4[)CFJ-%N66UK.!P,!JVVV7GW]Q=O M99/"]\Z"R+?_04]_(8V;G<=CWV8,\D$IF7\M,4ZW3WJ47YV/&``X)KM M(X]EN-)4_<^[;COR5BK='G,62.H'8 MY(NODV^%V*O70D*?3.'ZU:#P.9PS`N^B0;Y0%^AA_Q[XTY!\"_R'@"X(#1B, M36:^"[S/7S^X:XIK5@-+U!";N6YR MS<_OC'?R,P@!._VG&DXAS]AS8GN`VGETB5G'],_=A:_GE2P3S(V]\JF M(R)\1&\\3[+O,\W>*:ZFR_NR4#L>"&SV00@`C!%/*B M."[5R)%K8HILJJ7Y@'%]EJNZR=0;$K%@,W6]B@$-7]T:?K(TE4\FE! M'X1;<+/V$(9?1G?O\P"4-HW3.O4&*BM45L=QR]`/EGX`GG,ND-*KH85I8+7O MJNFX8@5)<1>OT,XP[N*]3>U>&\O.7E[V'MY2N=C$"KM)\3HY#^PRG;YIM+,# MY<]&;,;$C??T!^,#ZE+/9G=SQL)?@'>7\(#M/:PCMIU:G8;5,=NWG7:O/>[= M=@VCV8^WG8;#T:C?TWO;*:4G"05!Y8Y/P,#,%?M#CB?WA^+M'^%0`C$E_.-- M)T^8MXL)+&=*)O&;(%R\"F+39>C`M>D(=`%R)>3PJ__DX3;2-;:1NF=N(W4Z M6FXC7>^^`F^3H>N0(3$E![\]>W[*AC"P09*Q0(T5*C\]Q<)PXKO3)&C/EB%; M3%BPIJS5JHDT@I8J:Q4Y$#DP(P>V)0*+Q. M$%XMZP(;RY407B5Q8/,#W=<0?B)`N`];%A@F2H5_[:C;8]8%+L5#1N%4NJYH M,!OUH[W?JL`!O?Q#W-*W[2!*=G%\J6)2]>(Z=.*X3NBP7'2,+KF#-\T+^*>[ MW).5*%=C,&4AH@+!L;RZ3!?4Q53J6J:5?_BCTDI0)UUW(**]Z5.E2N\YEWSY MDH'LIE$S&Y8Z:Q*U&#I>.L/%JC5Z/75GMJH`%W3,#I[G8B&9;B3ED9NU;B+* M;![5R>^XM7%VGK4F>Q\@#7O=CCKCX7R"9I*C)>!5]*ROO?&+XA/%9W[BTVHT MBG#NI_+B4U&9MAE'812P+X[G+*+%9T8Y^T:?9:6OF1]\7;*`AC`, M]:9#NG1"ZLI+>.:C,*/.<-"][?1,8V!T^KUNH].\38["=)H-JZGW49C[K;,N M#B>4\.0-$']&%C'UB2MH2Y8)_>&.9'=>O%57'@B15W!1.0UNV^&VC%-+0)E` M2!)@RFQQ#MWQO8\B&I@]*_L4ZN"Q'3RV4YAC+7AL!T.,KX88\=#$SJ&)E9E` M8NL`(]O(=A=@N\0B/=9ZN.CL*!T/=]J$N:$#?_6U-TLT#.KHC^%$DWZ0(LK&B`;E!FIKF'7QB=A2Q`L^^OEH'],M$+RE'3Z-6:+P^%@QWZ MSC54S+)K)#\$+VK_&:E\V`R/W>*Q6W7NK^(4]@FFR-&'NBYS:*MPL@C]RVJ&6W"7 M#?W#[%SS#22R*+3Z2-WHE7(:>+FEZ.%[%I,J;O9:_ZU38[P_:M:?:& MS4Z_"QJW1L$I5O^+24#Q:+&@`UW'9OG[F>-2S'>H2,&(B M-Y1UO<0/PR^C.S+=>`O$7[T&61@LOELF&#T#2W+"8!53LJK51=(27;7-[Y)6 MMK(WR\;7'?EU0]056\;6E"QI+Q\",Y"(I.(['L(_<74RF.C&E,2`P$!P]YQY MW'ED247\7&I[)>4[MM3>OM)=1W#,FV,4HOP7L,R#X\63I%'HIU_$UH_\)H<* M8:9U9HFP=DO+$EJZEPC3?7TER?$IG).RGJY9[+R&_,L[):F]_P+->[D8>GGC M-/N)^(7^&PP9H6")`U8%EZ9&Z(21+"67=-2Y<<$D?4^$47K0'LHEM%.]>FI[ M"[IBE/YL<8FLMH_5E/>`0E9#5MO/:D?'N/`LTVN]@SAUKUO;%6/6%:ADUC0; M]2SU0DXC5B5BSB627(53J2B\4'B=(+QZ+11>*+Q0>*'P*I_P:C4O<12_$L*K MRL%>>=O0YZ'8(L[J,^J:VMHPVNH:E^J"DN(!HG":7%L\M"PL)8MX0#RD>&BV ML=`XAN./99<[YKHPKQIY8!X+J"OS[^A4G'S@H=@6?V1Y@$J7LY^]3EW93K?V MAS]+!+CRJBN-D(4UEQ%9B*P<*C(WL4\`!N".99?O#`S!R`ZC0"13VG,:/#!> M(QX+T=OZJX'%S3'V@+&'=-.Z4[<0#@@'A$/LPJB+#>B"!@S$'-R7\-Y/JTU M-.LET%27#E&5'@+%@U&)=91N:%*W*XMH0C15&TU==:G<54%3GA%$H[06H?RT M4['@T]&5;UZE_D7,6052MG)^8U-=YKOV_B(&9#`@;=FU19LTE6 MLEPM^O`><8>X4XZ[CJ$P6*.[1JM\!#0Q;T/Z@[`?2^9Q,'4GS&,S)\PBGG1- M/S$-=15$=,%,\>!17J53,CC<-!3N!*#EAEC1&"N6J2[,KXOJ*(FY]1(C2<<) MT?BB.'`I9KO*(I$*N0JY"KD*N:KPI,+]N#SVX\3Q2MG!B_Y0%@_#YH_;MV'S M1V6N=4OA1N39Q,SDDY>`3W&KY=J6$8I.%)UYB4ZSTU18Z!N%)PI/%)[%9DD4 MGLKRWWKU]O6)6;4ZY.=U'<_>'OQ@C_%[^N,[LYGS*"[GU)O*(U%]SEF8ON-&_W1P&@W^CVK;0V'@Z'1[H^Z>G<8[X>[O2]/&6?5"GRM1]+V MX4K&KQ%?O&-"Y4L6K3W=:,KV-.X\9?`_M:RZ1>`R%YA0R8A)"(XC#@@CS1VI9HW3V64CRTFN`X:8=6NL$M8CYJ M2-4VZH9:4NWP,;#J/R/&0]N']VW_)W*X(Z@@E[S-Y*H69=3;^:XIRZONNZYD M'R`#G8"#EC2B9C_D>R5T(5#-X>6Z?R\[M.YZ'.) MA$SAE"(*F>H*&5-E-H'N0J8D?E]^R#DZ0'F*2:[9F:B>H:[\K2X`*AY6"J>, M=85#NX%MJ'5SEPL''DPLP\2RZUC1*GUUS"Q#3Q_E(\I'?>1CIXOB\?(VI8K$ MV^-S9E]+NV7\&WT65P^H2SV;WML;B0S;]FWKMMT9CELM ML]WKQJFW@W&_/1[KG7J[KF(&ZUC&9*TE"6$B\R\"^@8A=;PXC(K'I M,AX_N2G-7.)S_\FK[Z9N85K2BYEC6A*F):EY7DG"TX6SBC$I!-.2D`/+Q(&8 MEJ3(,>L+^P]LNMU]/->A$\>5!TBN"72,'YR99U"&\(#9NT`20B6\_Q()M<(I M891=*+M.D%T-A1WN*BV[2N*^YITC[JR[%)QF@^F:06):9KVA"FJZ@*9X^"B< M7M<7#Y:Z:50JRJG*D!"U)Z_JL^\]A"Q8C-@D7"7^#.G2":G[F5'.ODZ`D+(V8N;D MJGZW,30'M[>#D=GNC!N#GG$[3I*K;F^M\4#OY"I!4?)$.1%5FP*'BR8+LQ?) M4#247S!/_L:H/2=+&-"??GR5GS#9*9]D)[-]9K93Z]+91]V29"WA^O;?UR[) M/(O]_DH2[B^7(*&?=;P'XB1),Q>>;.;+D[]Y=.$#O?X`)UOV=1!US$4BJG3" M/W$>R6-&0Y]?MV0>LFV>HO3X`"+*6618E+/%D+-E3[/(;X=KF)R?6-`PBOMO MB"BQZXO5L&!!ID#TUP/%IW+_!:E;!K%1&&+I*V^1XY#CD..0XY#CJL%Q)8E> MYF?<6?5NZR2"->N&\7)K=\PF042#9^&*99'6 MVE8(14-X@)Q47HMH(PHKN9%7%'. MB_BK>E[RX-8C\Z9^0&:.1SU1C(G0AX"Q!?,R'90M763@?,6DK'RX]O&`$H&P MO*JL*,`JI(Y#B"'$]('8^;I+65HA`@N!I0^P4'>5QG&[OG^V-0-3C*9.0M_[ MPE]+VV>*,@]%B7Z<56(GSP0^2Z%#5H4ZY,4#6'GU5Y&`5$P=AHA"1)4546>K M)H6;6`@D!%)I@82JJ50N5H%"&_GMC7W&8GJ7EEV%(59IA3YR''(<GD/V3&4U$\K&MN_K8: M>/("(P[%B3B<7P<_ALC6W&?4N(@814Q3$7%V#*"R6@GA`/)0=#X@& MC#=?O.IWZ9+K"E@,3_O4NA)!KKSJ2AD12^`)(0@1A'J#\,I:SJIW$%@(+`06 MFH_7!UCEMY4:]9;Q$_'\D/%M3RU+//AMJ"U`*+BL&/:BLJ;&,0$-C!5BK+!` ML<(2^%BF.A,0$8.(02V#F$',(&9V`@W86TJ%NU.@($.>!8V[W7U^D)5%ZAZ- MMF('U-7"L*-2=6D?D"@1&$NH["JXGV5B'3]$7S'05T'EAS%Y!"&"$$%8.A!6 M?F/L,DU&]8V^F+5>JUMO800&8Y:X,W9\&*I9SR)@$#((&50TO0XJ&D0-HB8+ M:EJX.Z;&YRE0-$*7=I\5#%&TZST,36!\L``JKX);9!@?1!`6"X05U("]>I:S MX0@^!!^"#S5@V;Q%G9S"GCPZ-F43YH51P-)]LOP<0@V!9QH8AL'()6Z175=7 M(7(0.:AL$#((&80,*IL\_9\"12;R)@,XX0% MT7H5W"DSF^HL2$0?H@^5'RH_A!_"KQ3P,]NH_/+U#G5R`KLR97)G=RPY19;E M2'YNP?X=8KU.(-7U2A7:DKJ@IG@`*:%JPJTO1`XBISIZI(N5$1$-B`;4$;AC M=;HI_F+'*JU^F(N?HDO#A3;&XS`>5RQE5>QXG%IOJ*.N5`:"#\%7(/"A7D-H M(;1TA%8'S_GGZZ[IY)6UZFUKRRW[:H?^A`6X@92`J85-43#T5Z#07PF<)K.! MO;<0,L6!#$;+$16("D1%65"!>TB'O97]G82M+*59JQ<0P%@;QMJ*I:RJM(=D MFAB00_1IB3[];$@$&`(,`88`PRVEDYGF.WOTW4>8&;$#-G5",J.VXSKA,T8] M_MI2Z8KI@ICB@:.\FD=#_ZFISGU"Q"!B2JY!,&Z.J$!4[-D80#0H\$,*Y/WG MYZ`,Z=()J4N`LIP1?P+/H*'C>X1Z4_+(O*D?D)GC4<\63@Q]"!A;,"_D&"EX M)H/PRMI-85%S!!8""X&%FJMR&TQ;,S`MI0;0 MO2_].5^L1S00GK))6)2HR,0/IBR05X!=2+CO.E/R_PSYOZN>P*VUNLUZEFKQ MK\/NZ&66&'K%0UEY59A.6#*-GL(BV5;7H12XBEJF*IVT(@ M57K+;'L&:F/.L%]_O'.WO.II'+_-EG MWWL0Z1\C-@D=SW8CL:XDV?^SR/7_NDKUOQ=4NX>5#5S?_OWO__/?__6W[;&^ MT#""23N,GS$NL)@GR/>=S7Y^-QY9AMGZ9_-?]Z-WQ)G"%]0./S2:8W/8;K;& MO;$Q'G6'HW&O8[6MX7`PN.U;(^O=WU^\OTW*WCL+QLFO[(E\]Q?TL.XI[.N_ MGS-"'QX"!M2#OQ8`Z)`3?R;CRC6R(C8)X4+[P+&-&EG(EP673>-_Q-4>S)O, MG$<&_^$@8,@SL!@G-(#G<#+S7=#9_..K?'8.V8YX%5NJUDC'2$@M/F\^U/.# M!76W'FN*:U8#2SE`;.:ZR34_OS/>R<\@Y.STG*FX1S^A#4GLA7DIDN7 MG'U,_]A9_'I2F[LH*WG;W+LG=L0^C)S+S^^ZO9_>E.3;RB:YT3SQOLL\3[?= M)W6FQ3A&,,A/91:&4CNW&%129\J>8:D6Q!BUK'J6ZO684)Q9\.@I7[+4+=?U M++79:6&-&E3.V<&3)3I:N9,N#P8VF&]\]`_!'1!0I^DQ"#14GS<(GGLWB(>?`."P@C]2-6)T0L9T2[VS( M71"Y(["$!XOB5?&F2+00O1UAHLF,1,6KJ0CC!\GNB_@M6+,?/'P*=!=@EP.L M?UJ]H,GSY@Z+'#&^54YKYP>9`5.[XW+%ER.3LK%;,,?4\ M>-\&6K#@>.XOW7X-,-*#X\63!$#YZ1>QC2:_B;=T>NUZK]4U.\V>T>PUK5Y; MW09/Y\P-GD[GU`T7X\([0Y>^K\`[49AZM9YN^RT/8BN_93=1)6='(A&"2CR) M_7:,D-_DI3%#OL4J0[,@4''9\*`CNX"9NDPY&YIOT_(5O;J_>%["J]O58U2= M9-S/O+^NK"3)P5GJ?B)K'LF:#63-4UBS+VWI?`1H2GF5A3//8]_7R;][Q+FM M](1S?^V.;GHKF=[`U<**V7F]<+*B,,0JFY!]%=ZGH%A);#* MQV/+")]%KCTEA=72JX$]8T_;&SA>T59-GVY$M5_/N[[@GK;N:A*UX1$N1X7Y M!SV$":WS(,KGANT&K56#_,0"LDCNNJ"HNHC(= M_&2ZZH)>]!2.\A0.Y0Z@WX!^0Q&B:,KK:,@PFZK:!;J$VHXE\O5IFGL\SK)R MT\+[RFM@%8U7_GZ9-M*:D\,A\.1U;QZ\FVN M.:HR6Y*NR4#)[\8L@'AG2P/7)PI\R5R8M?KO[C9.'@,)OT[36!*/V M/,Y\?&+YUY;8R=RI2K:BT@(4;V6[YO.Q[(Y,S@]7GAD/(Y M]::_^I[XZSZ@'J?V:7ON;:/1'%G-P6!D-7J#8<>TAN/;L=F'_S=ZP\%8[SWW M?06*X(TLJ#AFRPE?DYS80&E93,CSO0_R0[A!]U6MI2^C.S*).*R2BQ)'-)0= M'N)J9TSL2H;S9$L?WHT,7M`XU`S_+%C2;4(.+\0KE]O\XNJMIA',$V/M5BBJ M;7[7EM\UY9PWON[(KQOY=9IXN:^O36Y`#AO_IG7FSG^[I67!']T+&NF^OI($ M-@MGQ:ZG:U:]8E-R6NU?H/!R#6D@UQU_(K6:*168O8.L5K3L'60U9+7S6.WH MS1+<*#@49!JQ9WGJ5K%,HNE%THNU!V%4-VM2]0=[(2LJLDX=G\,-=?^+#$/[+ZB[D6 MCKEBNS>%+;%U@4CQT%`X+:XK&CKJW'M$`Z(!T:`;&C`.?S!A/VXA2MB/)1/M M"J-L/7*.KRB@29_=W@4BR;J@KD0`*Z]RT@58ID*7!I&%R$)DK4^[U/,_8Z8+ MLBH?:/LU/:+A+);4"62K:GM.@X=\[,*282F6.%W+M)3):EV04SR0E%?UE`P5 MEM%4M]&#>$`\E!P/J"6.L:_./#.<_4COOH/!(0TCGIQ`_BI/$_^V]+V[I>-] MG=;KO7-+MI%6ZS;8[T/A'<3\[_/JKFD[NI\ MKP\6I??\9TZX;";O2W(3*H]UDPC(#A1>+%V65@^);_(`$%Q^XY%_1!Y;2QJK M&Y_')0XGRX!Q)FMY3Y@0<:_RXXD4Q(+=2L[M-LX\M]MJ%+L0MNX'5!77-GH/8("9?P%0-%_>`C8`PT/,_TGX&C'XXY]\`I1Q.UH(8[)6X?BC%^C MD(?4$W,C-)31$9(&192I@,H5[Z\U>KU:U\J_BWDE3JZ4"*B%4T/*U32>NJO` MJ;M&J][+/^$'A1<*K\(2K@PP[5[@;"RR(>I0U*&G.`$65MW`A%HEK)1$M.4> M?EY.^MGY4==#6JMEU(R>LH8,NL"F>`@IG&;7-7NP82CTWQ`/E<%#P>B3I\Y0 M9YPAWV@K1Q4ZV+I(T])(O^-LUGD?G8>&9_YP;?` M7P(3/7]SJ2S:YT6GW^L/QN-=K=;NWAF6,AG$V^6!TV^Z8 M>F>3;U:(EJV(WX(0XKN41YQQ17B_Z)=5!A$ M\DP`<3PQDLTX7.QP\L`\%E#7?2:R`5F:O9BM.:L0H\Y$$^\S` M>IG[[E34;0C`QY0-,3L0A5H432XTN:YC:D,/YJ.^`W+V"V_^`)`^>>_A@PC\VV9K-!K<]AI&Q^R.3+/; M2DK(R,_:!OUWM>Q,_B\><).\)*0_R"0A<(VP'[8;B2D31P"4\;!&1'V9@"W] M0$3MG9'1YMR@*6X9L,6'!1@VQELS$Q3[UR('7XL"V MY,"C,SXQQ'BP1YQM!Q&+4S[B-!`["@*1'.(Z=.*X3NAD*F)]N:-#Q:!?(4X' M%23%U,1N%%ED?EF$3^&4)J47'^4AN&;$9`T=YNJ%>&"?XOYEJ3W2[([-M--2S'>H2T>`P M/FE)YO21D0ECHKH$6](XFD)^J]_5@?-=EP9<#@+?47@YP53FG#XYX5Q^CE\6 MW.K`P$N7;=:E@-]%UL@JCU6.>?/NEW[_V[OW=?(Z+Z[X*1N';#.5*'3!.._; M_XD<[HC\V&^!/Q8YII^\F?A'?)6%NUK]8>/6:`T'1N^V.3#;/:-I)=QE6E9_ MK#]WK9.1(X]&4T>\WV7@$TE.>-,KL@)C\1=\)8JAB$Z9-(`K@.N64;#T.=#$ M]]SX-(K#B>>'Q&.BS`D-8$(PY!2DM+P^::T9,!ZYH6S/*5+=:9SW#$^#'Y_) MDQ^YTPVNGM-IG!"]9@+BVS(\."5)R13*>;2`CP(S-9A!(";B;,^#>JNIQ%T^ M9U$8R6Z@<@I`D&1>=?()L`*O25Q8D^._1:JIS^*%!VSF,CN4-]D^#\5SJ/2@%L`&TA3>JO0O9$ML7FI(5(-K]T\G>W)$GCQ5Z? MFJTA]$05)O]>A+JONQ/YIP.KS#Q'=D1V/)\=,0W][##*KPSNH&Y!4\TK%;C3 MO$M%H]9IM2ZP,UJ)6%V)9%?AU"R*+Q1?IXBO5J];S[^N427$5TFR/O*#W:NH2%74!4/&P4C@UKRL>;MH- M=6IH]YWG=R)-L0@].K>[),KF)8"2/8V6XOV\?"-3EXDS%9E4R%7(58I)A='+ M@_T0*'=L`C:4![/CJ3D-UC/AHCN.&L/Z$/>>'(X3:H@"C(5->].S:- ML=$QK8'5Z=^V1NV!T8^///3AAL[UZ[H?,68Y,L=S2`NWSDP+/[7)9R_/+I_P M1A1H&E.92#E+T\B/.PF-K=>/6APC:BM`I0VY&!]2^^S8S..,]!\"EJV1X$4; MC.=*E%3PDTWJO$J&HBQ%7OY1-ENS#RSN'NZFO_N\1CYY=B['D?(_1??5(ZMJ MVB0MXQZ?$QN*PW'>G,G] M]CS%,K]R:PWR,1Q M77B2D@%KQ&/RC)U-^7Q-]9MW8OWI*C>!),ZMPEORN#--7&5YJ%%?$[ED>@#_$)<,G] M"U@*0HF1GH5>$L\6CY'CSR*0--,M/#M`37G0&JY30[U.RP">6:BD'WT`-?L` MKS@]_@V\DK0=@FESYCD`C0CT\?]G[TN;&T>2LS^_;\3['Q#R3HPZ@LWEI:O' MXPBUI)Z5W9=;O6O[(P@416R#``>'U/*O?S.K"A=)220%4`#X=-@[(HFC*BN? MO"HKTXH959X?\9%5LZ0)'?5*GQ!9W4%RMIF8FX8:B#O?O9/BCZ;@1,:$#'RN M)J@.UC-BY$EGSU8K+AGA5Z;'S`P>#&.Q](BD#&XB4'*)S`M/YC[@2"2SJ<^Z:DI-XARY!EG>I@ZWZOXA8___OT? MY]^,__Y^HT,6)Z/ED,6V\:(PGC]A82ZIUNPQ)_-(D54.A1ZS,M*TS;"8]A?D M;HF?]9GE]T^E3]/X6ECYFP?BD5F82":NKN"R$I*LD-H.OX;)(6Z25\P:-W/! M)1^(9=^3AK)#`N8MBZ!G"C#4UGS:*H;9(!/W^H<9.&;##=QSDH"NT3]^TKC- MSY1L+O7QY88MOX?WO(R_*+U[)H^]U^Z1:M7M\7V+/+'-*MFS';[X[*)=SKFK*#4>6F+*_#-VG,BF`% M+X3Q.!1_QKR8VBK-8;^SPMA53$+&1F+J:N.6"^=7B=-A4L82P MPZP:7OD6ZEGYT`:AS+R+92?R#*/YBK,4(3)1/AM9C),23`[B&]5X4G^B84*%ZP< M/V2E8S_XOI*.EWSIN0Z;:XUU>/#A\OQ`6>`T!R9I*4O<7SYOOF4T(JD=*K=- M+3>6TEP&&HAJ4E9[(@Y\U[\EC@^F(B:1JC]Y8CY5O\CYSV.7Y)G\W,U$.5DR M/CER\[G+NP-A&O;E%*^`/#EC9GHQ82J*Y48#K>"=8W'P6#E\MZX_EKL-!9.' M7T>&4"2LJ7HA3X042O!0V'^XG_JN^_!6*3!V)AW;(>;J&.\=_Q^TPH&I;*RZ M6]A[X1Y(0VJ8N@?W_&0\@+4GZ#"!B+ MSO\ZLE2VW@5,M;C[D)=:/,*I'\YEW"`4$9<6?M+C*$DYCLHWU),0;(=+##SB2;)#5/B.)?)DXP$W<,*=;\_!BB*ET>R+K7`?DU M'ID:LFQV[&:.=OZ)Z98%Z3CS5B0V"U%#^D8S7P*&]WX<79)[X<+D`KHX%'V"I)S!?*YXSMLA)CNK0@=*]LM(.+%5EH:G!^A&&8%+W%Q<)9(R49M M$CK5BGAIPS;YG1W"B4^>^PQ:*^FYRN1AM5N(7Y*HBN?D@=-+](9ONBU9SN1.3[O]RVQX!*[;="#"J^#"O_`0/J'!-*YZ_HJ M--1,/5YL"Z32)F1F@;0953,;^MMU9FJ3Q$SGFWCD1:DB(_(\5%*>4L69Q,GT MQ,P>(&&4]/7F6%?2OB=Q`E9E9,N;EE-;Y-?<%\NM?E@K7('.RIT8^:1%ZR7O M>K[;.0IPF/+W@T'OA:4VO(=UR,$%,L.X#K?<$&U+NIK[U.E[: M:&=36O:W*DRYXB'+G78*0^D7K+W26^\DMM8&)`=+@B6K9$EEY8,AP9`U8XHD[EAY]>B)*KUUV8X?3%F-K&T&G8' M$%805A!6$%:U%U;#[C%D597;!2W?%;CV[H3'120VX**V]CD:#+NEM3EJ"V:P M^[N_<#@N+_X(.``.#8?#\4EWN1X0X``X["<*&._;'(].[=;(SQE5@JU3BOB+H^IW^2:\\-=3Z`%B#0-=< MQ=4><)V=E&CC`5P`%\"5W';4.>[UD1,#<`%<56BN80]F(<`%<%4`KK-^>6'P MUB,+&0?+M_WA^_:]X[K&(='S;63^-&Q5/WGLBC>()/XV&IZ4EW_8%B`ALKZW M>#@Y&W1'P`/P`#QH[^;D]`R(`"*`B"0'NG]:7B@->``>&HZ'P0AYS"_SQ.L7 M^"J/.[[(G@`JN:!C6'$0<*%V+CO._KC^O$36+5[$MVW=MOU(MVW/@'W85]&! MQUJXEQ&C>Z8\5UMB>*-!B5M/V]*L+9*E04*DN1IX7Y#9/QF4&%X'-`%-0+,L MJ_ID5&(])D`3T`0TR]*:IR5F>P"90":065:V2/<$P'S-$%;+DTF^J]:B\?NW-':O3SDE_M,,($4J08CL&6'QD;[/3&Y[M,"0$+`*+P.)J+)YV M^BG^[@ M&#Q`"5`"E.NGM9^6&)P%)H%)8/+EF-Q!'::]@"2R?Y9O^[LW-VFIYW%@3?IY0:4`%4`%4[`TJ^H,2_2C@`7AH.!Z@ M)8`*H`*HJ-95KU%(;:<^O"I'D\O=4'5AJ_3=VW*XKH?>SZ7)GAK!K[DJK"W` M.D-G#@`+P*JB4,/Q#K9H`2U`:^^@58$_!H`!8``8`(:DA3+YZ%),1!`(V^#6 M-[FX1\?P1%1]\*-AJ!L.2JRZUQ98U0]!S55/#``>&HZ'?N>L M5V),`8@`(AJ.B,'9`!83\``\)'@X07.H4OSR&D7#=NJP7]!7]#(N,;%PP`") M"@B=(3;=8%4&@`%@`!@`!H`!8``8``:``6`M!=CQ#NH5M0582%M8ODUU6K'% M>+DW<$W+Y;YFUL)HM+LZ\6U!7?T`UF"MU2X\]3O]07]W/?Z`*""JY8BJPM\" MJH"J_4;5L`O4XGV=8$',]&W=&N8-OZ MD&2#H-M>]=D6:/8[)Z?'.VR>!W`"G`#GFN`<=(9G?8`3X`0XZP?.X4F_Q-I0 M@":@"6B6!6X],9,`LW_991!P7$E%HF-:?L1-L%!]:3;D921-7+/#; MD/C-]N.Q*[8.W#(E2FN+LP:5"^/C"\HC^U]V3N37IZF2C142M=_I]2MKVKV" MM'O1HJE^\K%V5@ND(*1@G:3@X*C$0@I""+9>"$'1;";H&R;*S_@Y#>VV15;DMC[]&)LUPU?4[ M&UB.:*[CB;=3(<5=?]#[I<"LH^<0>3(HE;6VFHPDIV$)U]5#^_V@=R`_$Z]8 MR><%["2SRP_LNS,3H?%9W!O?_)GI_68\1N]5FU;WCAU-%3V>Y=DB0-:_>+-] M,YKB)NA98H3B^A26?73*TWS!0A_V-REI]^C\-A(/2Q.L,.5[ZH2&.?-CNM/Q M+#>VB;&6)KR-SAH,NCV#KG(=WROC@9URAG4R[)[6<%BG)]UAN<,J9US]4?>D MS'$9ANG9)8UM6"[)#']BF);%4`B-0%C"N9/R>N('1C05QG>ZT_SAA\8Y[WJ' M#M>^[!C7/\S`,8O?_64F&BTV<95+[A<-@5G-]RS')<'+:QO)0SC%"JN1 M+YNB+&1=O*ML]H]-=H5I+U>[ESQ#4XP_YU_J^<',=`NO[??RBGDCR^@I2VAA MY,K6Z?=HSMJ`)\WKFO-0O$O^6)K\:N,IRS/KK4SN6L/XD8/Y_6!X_,N&=I>^ ML;_M?;U=OQ`3Q`0QP5>88$/R%6L7?4R'.]SQR?+^\[1\0OFNCJM9I()%4%%@ M37ZZ5VI][+MV:M%(V_C%KC)8$BQ9#DLJQPP,"8:L"4,F40&P)%BR)BRI0U+@ M2'!D73AR(1:Z142SD75^JB[J4X@GJA;+_L2PS'#ZFN!_=`%VD!7T^DD9ZW+A M4P2L@$YE'T@].SDML0#2*W+,Z^=F-$B@U4XS0WA!>&U.J'ZG?U)FB2B(+XBO MFHLO2*C593Q>3P@==48GO1)S\MM>M0-R!G(&EQB]2#(&<@9R!G( MF:6(T!&$S-I8:4A*3W7(^>K&X3L9JD[*T1N.IY)@51;U!JQ46K7`;0C\BD4! M1SNLI-L6X-4/8[53XOL*IY,3P`EP`IS*TDZCH]U5DP:>@*>VXVE850$7P`EP MVCLX558:L[UH0CK>!NEXE4"P)=T,RB[0W?9H88,PUF#]UAIPE5OW&>`"N`"N M-&GGK'^T@\Q!@`O@VCMPE5VE%N`"N`"N)#WC%#9AM9&.-@4T/HHP?&?$WMQT M;&,>!];4#$7U`8Z&84I)GM-!?U":S&X+@NH'EN:J(*`"J``J&HZ*P_[@M'M: M-J-DBUY=HG#)IL7+*V\#+&T'"U0(4`%4`!75.NPUBH]5[G!K?>"L09!KKMH"P``P``P``\``,``,``/``+"6`NSPN'NV,\9JD% MZ07IM:N36R>GQ]TC2"](+T@O2*^&2:^RC\9!>D%Z07I!>NWH[&$?0:_*\AW_ M&IDT_577[VQ@.:*YCB?>3E4#R/Z@]TN!A4_GA4Z4DJKRL^.1M",1,9K_?'TR MUW8VUUYD>K<.,_O"3H9*Z@QE^\=H*HR)[Y(6H8&^,]84^R^9=$',]Y(+-!5Z M3Q`A]])GGY$?E><',],MC*O/UZ0/EI`P+.&Z^IK?#WH'\C/AW4H^KR#_=V^^3-S20'?.W8TI3^)*%K,D`AQS7DHWB5_+%$G&U1^WRT5/<]8W]+>\[V_'[MK[O:*,;]WF#5'WBJ]\Y$3W<4M\L M]?&5/7Q_^&OW[WW-ULEKD/II\NH^R>41>(F]EO;"D6Z0&&N8NJV6<%4P9YE*6"'UR'@@OES;7EXKJM.(4`5Y"D3W9>5H M.`LQ#",0KAF1SQWY!@TH,"T_F/N!,%UC/O5I[/0.$3KT.WT7S?@`:\1>R-P1 M8=.3:-V?0,$4;.C":01EZ6!J-&,#9# M>C$]:V8&/^CSW&30.,27$$YT,VPDM]BED1&A&U`ICOII2XQ!HVT3,9G!%H>BW!8AM.ZY]T>[^4 M\B2:U_MDE9A6;-R9WL.O3`7A.L0Z9O"0+GA'7B-^6B*4BY8629L'CD73(ZEH M>$2`C!Z>O42>7`2/N#QV(]4&[];W[7O'=1-V#`2-("3>SQAB1L^@5?.#'Q,_ ML&@TDSB*`WZ[;\=6)-]FBSL>BLUK[L\9.QWZ7K$=ORE\(&:Z=20CV_+)D4FB ME#@Q#A/N)41ZH6DQ;W;ELB=C8XQX?D1/Y_?)*=%(C+]W;[H)JOAI1):Y'TJL MGM--B[,V`XE!-[8U#SJ+M+\A;#BF&ST8[VDH=FB$XI:GTJTLG(EH):*5B%;6 MU_->-UIY_<,,'!.Q2L0JF^<\(5:)6"5BE8A5-C]6>3I`K!*QRIJK6\0J7Q*K MW#L/1(4X`],6',W;QL-H667*,O>C]D5:0RC7C3Y5BM?!8`?BM48&0'5R]]I[ M.P]\&7;GH+@9\)Z%BG8G86[C+?DX@>MPU#QTJBER^HR'WI8"/*?]$JWW;6FV M+RJA1OAMEJZH$>&J5"*??>]M$AOC[(!VF>H-8SDY)#4S MHG<%CA^'Q>RPL-+TM54[89TYN'!]==ODO?X_R\/WA2\SASAPBP- M;F&:I67!C;I'Y63!=>HW(*9[.8,J+5>PPUS!69L.L<.#XO,",RQD.W)J7($Y M5$:JY"7&P81^9-8EF<%8,IESQ^:8F"9Z8"8)8TOR(J&5F-P1=PGB5G%XEFS* M5UAQ$`@Y0_-6@KJ0#R@GR3_'GD6:PB2FY2Q.>>>'RW,%Y3O.QM5HX,5@](5+ M\).0#3A9+]FZIY>9AB?NDZS$+A(L*TRP;$I^9;M._#\V"&2+(ENTF=FB,S+0 M7;&QB]!_L8NPXH%/EIHHRHZS[43'V089I?\9DW*R_&";#87GX7$/.H,1\/NL+1H/!)2FR$.FZ7+2R/<:J-\1V!> M90&4B^;^*9)6:Y"T^@+E_9S#\MKJHKR:R_LB]"';FQ57V8&4'B+WM237*PYI MB")0F[=<+V3JS+?DVIF! MRB$NGF6P5D4-GSP1\M[Q_R$L>DK'N/:L;L62F?_T`\T,)9Z7,8SSO!JU5^C1C1[_!Y?Z=RP[NH^(Y] M$NA7G*$IH\+KOO:HW*"+86Z[XLO$"6;B3H74)#O(KU7P:VK>"6,L!!=_>DMN MB_`X1C<)_)GQ/G#"R'???GH006C<_!D[XW$2]S$.#]Y_NCEXL^XNQMK]+-?9 MPS!+B@H/2XM4RP:7+WW4L@NI'E[*$#_X@4'V*]-[PN$A%:)5L3Q:24,OO6'> M!D*HZ'`@)B)@3CGXJ'\\3WX\():AU=';9PC3EE[*:'G1&R&@=AXZ;==L$`A& M(!B!X#T)!'^^88T3F'.9&++5D3A$A!$1KE$.=3E':(KT0X4GA)';%$;&.0!4 M>%J\[6188HX_4OB;(0L;INAQU'NGM4':I)M1P6DS>O50P0E^&HY@O[!"#@HX M[:Q01Q5R?6?=2AN@$/JGW>/2+&!T-&T,J)NE8^`BH.MI'=FRDC(?B.)M1^37 MIVGEVOJLWSVK1ENC=2I$(.A349F-G3%V;=.=UCW+KD^=\\%M9V8&]-A<'0Y] MCIP>=,=GN6_E-J?I#8_A,\X'2^?;YH3 M[N(VIOGXP0.7#9DY8;KC0.>QSO@3!SE%1#.*5(IB-@TY M-96!&_D1O<[RPTC22V]<)M-,9VB&Z6%X>3![K'-D?\JOB.9+3+;AFFLC7>L* MR5FVL/Q`KM@[9F9M))#[V3/H22Y]_]*7RB>J5,LDDUC\G$MNBJ9FE"=]4GR` M:,$)F;YEQ0%1(;KG9.5!KW\LUXK^.%//X_SCM/)`M"8OKTI+[ACFS*=5]27; M3$R+AA-VY'A,)^0!98Q?*+:0RU).$YB-F8BFOKV;M.9UEW184@T3F?>C08'L"O&>IX+)/DQ7?"BU7VLF)7NI,> M/'&B7)F._-OD>H>/5.B0(^$Z07D&4'6%G,#06Y+5 M1I5N`]5HV_(ID[0_*#76?OV#W'#S-3%<\7[YZ^_PK,M?3]!H2U*HG9H2TRA* MW9E!GD1M!$[M-"&DS/Y*&<4PIX/^H'JHM476--35J]"P20K4;V-^/YI:^0+" M;6!,EZZV._W!47F*NRV8J1\\:J>&6XN(P1F.B,!KWII_7E"#^#DDE4K05X38 MX'B(BI#P%>NDI'9V(N;5M=NHNW:L%,==VN%:U0Z6+TO+WBK&4WTJ=WWB/"\\ M+U`5O]W3G9$-QP$@O2"](+U*N'X9O$+5X8N_IM?SXML"S04BLG\(UQ#_? MJYRN5U>(Y9JKS'92GHY:7O_&.`*;Q+QK MAIL&:Z,*#JF^)I:.CZLJ2_@X;=J,M:;[8[5#YBOD++QBKYS:!(>>WY=_P9F\ M)F0Y]$MMO[0U-?.: MSJ9_6O)LBF40S7SK6/J_M+"FXT6F=RNKW]=D.#9(WM5.$$#+[*V105!&95?7. M"VY8.LBPUR\O2;$MB*D?.&JGA%N+AQ$JC,)CWII]4%'Q^32;XT&)V\AM-]X: M!+/FZJBV0.NTQ/+8K4=60]RBVJ'J%=+/ZI^\@Y)BFT:+!_T2ZRJCI!AD%V07 M9->./)@!2KE69XP]GM/:B$3-RUCV4Y\X(2VUP3DPLE4U9RAT\KVIC4!8_JU' M-]OEM,K^RVC4[1MTF;LJA6F;)\J!ES.VP5'WI-2Q=;BS]UQ8D7,GW(<.)\7J M9O?&/'!F9D`/X-0NWW+,2&>_&A/3"8P[TXV%8=K_C,.(.\J',J$V2Z"]H^_\ MX*%K?)\Z8?I03H)=3*6U_%!FX\I6O-TG61U9TE7/1GWDRPM]Z<]Y84.'T_K> M?A.NY(4+6K?EULE;(>2MD7]!H%_`C"'9)0X43ZT4!S+E6IC6E'F()TAAQ2N)E*JJU,F;4$%O&*4[J\5L%IOI34(7,U54&T!V.@$L1;X M/S4X^],PW,#B@Q^T"S73KLK\_9.JFFSO1=YH(QVHVH'O%3+D45P:Q:5_.QJ6 MV"L+M??A`D,\0CRV1SP>'Z$UR>Y-RA:5UR_SG)/ZN'34XN^>&=L.Y_-^#7SC M`^?W&Q\KX?-9BL2`^$9*PQ,_GHT#JSF27(G\*1![= MT+&@PO=3TS;&0O"YH=G<%?I)]-(;,8_$;"P"8W#6X5,?`_D,?H':4U]Z?)(S M6/QA\6&G\F'#KL'7YZ@R21,_(#%QR,W)`32!]HZ M>K"=C"HY2G0,T_5IE>0Y+(ODDNEXN2'ECF/QP2L1BM4_$NV\D`:6.^3E3YX^ M]K+1.9)%2.59%0BIV`I='Q%3LAD7 MB#O?O9-6(?W@1&3\68[K1`_&81S1'__+/VF=I=XC'T5J2DPF$J;J-39_JUW= M/'+IJU+<\$'W^)=2'O3&D$<6%>5\0U;8\#RA9(MT''D*JWS?SG/T7.?!*WSM M0[(!XAG3V?-S9"Z:#(^OT_W4L::R=,C<=&S#]N\](XS'H?@SI@$E]R^_]TUN M/F_E?$+A.>10KV*3.[Z;)**ZD(8X,US?]-::\@([I([[=@Q6!7,-NT>]DKBK MDT95'B/9TZA;AZ"KXCZM)*8NAN/(/I)Z0DR^8F=*LAC$1,@B*#J&E/JX?+$? M.+?TM6LX!#,AJYMPATM9>`AF`LR$-IL)2G,H1:([L4;F3RT,GJDFM0[[U[%& MTQ91^RDI3QDTGP=B;DI!0OJ)(^@F!^KOR,N(@[D?$D)]SU7Q+R=D]6B0WT8^DN?W8M>GE=+U\.\?NEQ2FI>L[Z8"YM!7H(TOP#HT@ MX($XQ7&0DDF&HN3C)(Y(G^>Z\NIQ=8UKTD>T3)EY\QRI;%^HB>=MS*1&&5>< M8T%]JV9JL,=V1P\788=FZ(F)DWAN?&7XX(G@EGZD9Y!>FID/=!')\H`(:&<. M7H$:`:M.X9$2:$T%*FJ19&J71>-.FU(L:EZSZ^< M)$JD!Y58+6@GU%U!T<:6J@([@AU?SHXH9_7B3+7/(E(%<=DZ.C$@NQ[W768X-D5^W4+,07Q-'S:Q5"/G3] M,'RC(G067>5X,0<5LPCG-MY#RTZG#X_.4)]K%VJL96J^K7@X/!Z6IX:6UWS3 MR;^:"'W3,F6S"""]IW%4\GY>M9&IW<29ZDPJ/&G'*X:!))0RBSBQ!K?$S=]TX0:FR:3_OJ MRKNM<"A5,>V9_FEX,:)7ET`U&+S\N)1W]M&QY.G0\]M`"%GEIK1YE#EN>7E2 M\&GU3+Y,G&`F[LI=AJK.H9SSJ@DATRY$WARGDX>>'GK*KZRC?%#.CMI MMKW_=,-#^&0&=..@USONRJ_">)S>$LD23-D`DOO)"R";SS3TA8:9\*PZ`GES M\2''1]/$3GYYVFYS9G9D_1'+NAKA$A!$)$'KX@ZHP1?P0S_FZ M)3;>ALO^,CCJ]O@U+K%"*4^DT24'CJRI0]PGR4^C3JIJNDHO9X4^* M4$Z=+8H[J-XQ+K34.!F6K1$*U2C#V.)3M)/83ET;A\OBED2B75B+91MD98F0P:!L_)5GQ0Y&)8^MLRLSMFK;Z=]-+^;J MURN\G3BPIE+K)KZD8N:'Q&HBV>>3C<76AQ3CRIJ1)3G*6;63TCE=>;U9)8\U M9'O=PF^[<4CV<;#K>DN78N[/Q-,UJ6H3V-S4/4J#?O=^X-KWCIUWDE3M,F%H M"G2,:\_JTM,.#_0WY,J<6S%7H3%N3?:B+)*3'*F4P5%VG&SATM\D<+*H95H[ M?G4OB^'&06$DOCOBQ+59F3.^X;-W"WF">`,MAR=+]EK)-17-.J_73F1'- MW8?:VA?*_`Y%WCM)-`.[)QPKSW%3UU@.%9+.E!%8.>$[^D[?\N'R7++U?Y]_ M^W[UZ?I&5S(;G0Y^,_[[FW'H_WRP?%M'"E2M/$M$-&;/GT^%E\4.C,78P<7U M->'MO\T@$C,"P']_.WBSR/,TR*Q3Q3/:Q&."YG2S)F'(?BB^,G@T9)A23WZZR$OANK6J)IT5@E853E^0]B'*16>U[DR()W:6N: M1*]&@3"C1`3(<.:BZ>Z'D?!)I$R)LDX:E_CA"5&,;?!`V/'AOBL,17Z#WCPK M!-S2>G)R1+KBL?H@]R;SL1$9MJQ^ZXVXL9J89+H#MT94,A>%9%JH*%"%\B\E&L*8L#[V< M]2/;LCF>Y9`V4Y;"Y_C.9_%',C)R5?%T/P[)X#6=V7)(D/WVQ$6GEZ?FD#_F M@&)2/9:?2<[50@Z6*V[9$I+O6?;LY1AMU42![`^OL&%*W_(S$[="5='-FO9D M4[;\P);V'FD`^HX3LDIUE/K=?KE0L==2 M\4*D&>L6+Y?T--R;!_?G1Y=7IQ?'Q\>C4X'EQ< MO+_H79R=G![\VP*D\A1ZIESNJNS=NF=@Y!(-RTOXW.E>POF,J_7KM"WV"_*M ML0P^%D)VF&_E>V4\VER+%8+KF&-NM2"="%U,.Y\$X`0&6;]$GZW*,#YAX03%:R\F4-Z*7&89UA&`EM;YW4Z(^BR4\OWCT0]I=5D:U5W"I;L^Z M6#8]X5G'>TL.A%J5P/\G]P!0!=1E?%)5=5?:.HVBJ]:LPB2_7#8HZ>HVKX[L M;4NLX:@FML0;(I@YGM0BC]V<\Z>2U\MD(U;:CBQ+G[FQ.O#9X,5=P%E&^T=7 M^/#@^NLW&=+E_[_D!*XPI2R'!,)$22==3'@7U0S)KW?]>V,FHJEORT36PG(L MC:7PEJ+](UO?DFM)DL6<<2]=GWX-N#\-+4NH(O"F0SYIV-%M0\U;^&"J*R8\?TKI1` MFMDMV79A+(Q;X?$IPGRS@<3N3%];2(27;IB67TZ0L^&3Z_D,(U'0GSF6P?M1 M6CXFJZ7;1JFV72RV65*J+XD(VN!4MJ5I64KOI<$V,DZR%:2E$0^%7/[`"7\D MRZ3FF>_0D(Y*7B9_EHT;,M)D,^#-+98%8XZGJ6A&.U!H1BJ8*E4=*9`"#')+ M'F4$7^B11'!<%>.QQ82@%HFWKJ,BJ46UI9DH3&*G.9>`EMAQ\XPN7Y&V[F9S M9TQWTVH3KO\^][W'<=;1C9^>&XP3:A/%2B2(M*J8$Y^?A>Z\I.P!D]:#A`&M M]5M>=ZT-)$"XT4<&1>)XCEZZSD20=)HLSC>=X@93(&49W"H[0(>!2W!-M)^Q MTAVY%*$5.'.^[-RSN81+^&7R52ED>7/JS:SAIAR?](YZ[P=71\,/P^/AQ=&P MUSM1;LIE;W`U/*^MF]*X'B<5-#`9O+"!R6C+?AMGQQ4VW.`V5B\_$]TO[?!K M!4<@^VOWN]IG*KU/*W%(@?]>R?2)D1=UZ])QK8/%#3W;DM&IF;;1)W+6R0C] M$?AV9,Q=2SG0[J2M&@GY-#H=BAR$N;R%0TW*NY[X%GD(VH`W MN$V6,YO%GO)!`HY(T;!D;DTV)'7S81:L\40=KB9#,4D;D$PK. MA.U8;`PNDK*9*,GO>3A!&*T.BQ\M^-!3,E>%0E,@F'K2N-'9(3+'0T=RY&U+ M:22\2MF7?["7ZEAA"@\9N%SUX.+J30D;?L!LX#XD[]/'T[9X(R^RWN;(+OQ: M@%2:_]*&Q7YB$V1AM4W/(RU@2=*2V'(B>19I(05(>S0<*LAVP>1V%WGOS"=: M9++K$)C$9XPC4P>(=&:K`BIGQ5Y\NKPY>).3E[[Q1RR",;E&^CB\_L@26<43 M"++L)UDZ3#X6.2_37HO)CS5[T;NS-\OXE)BE#YT*5_F3G+60!F5T6UXEI9*& MF#)W(7T0"ZJ,2:4W*J,FLN(3NYM)P:=5HTCS^XA4,_;E\B&=/Q1E/[%@HO]> M:[FD>74I13`0GLGS^:P%FKZ^H1&0KP%W]'[@B9AZ(R7+10V$Q:Q&*T=TELG5 M_">W&Z47S7/V7E,!S9P230EN*\6P++7*,!<M^JZ!33$I/1ZDCU>'AP_O6:K$RY(QC*MN%DM1&& MY1X>.^+*U:/;_+GC.S9]%3YXI$[96Y:&+,<.;!E0B,C^8^>]ZOTX?E^&ERD(;OF3FW@9G?I-71@H2/^R>_ MA4D*+`E0\5-8L92`_F3BL!27[NMU(%SI0ZN\MK_SGJAM_`>1QO9GW:SH:S[L M$XB9Z7@R/ND'^BQ5/E"YU:'VVDE"R[U8^B1+!=W0:(+LG,W53Q71 MXG?,G##D:1T>W%Q=D'90CI5*WI&I6;.L?B!G(G*J!=;+'RP+=/"BAT*%2H/D_0F[AOU1JK5L`B?XH M1T#*!&Y>!%5Z?!'PO"1"1N5V-3/)S%7,K<@G,H"791'J=>0$PHY:_/Y9LO@) MQM?B/^:SB'S#<"("G;^Y"`LI;0,Q?DAS7(C!.3::9.S/32U3I7!,'WTH]Z!N MTI\/WC0U7L7WM;D>X.:;R;5=JN\RQ=922E>6\R(WB;O>2GFN:_2.U5F4-/I- M;E"D%60^.:]P:W8UR7IGA0F1RSJ;"SF[#FD&KF3K/KPEB''T18]+BJDYS<&W M\U*>P;<@R*5EP$'W=-298N?\<)6FF4`NGW6>=6+@D@*FO(-K^>I+?PT?E0^= MPO#F,E*].+*&AMV_+Z[J\PR1A>7G`8LR915(<\SF1*4@U"GQDNT"6YI/Z4J-;8IX[IB2?>7CPQ_GY5Q:5*I\[$ZZ:VS8_*;>7Q?FRMD.# M#9)-)S;2TLDI"F],3I5=$&DQDXPH)PD]%%N/?O/1UI25,WY)@9NOS! M2?**Z0$$Y7N/3>9$^Y*WE+'0X1LEK\JA MZ11NM84D'Q;ID^:A0R@AEU'5-5!$R.W^I2.C]6*C5CI8;&GIF:?)Y7B;F+>4$\D^-ET94E/\RX85 MA]"*H\_MABIX:D(RRB4Q-(G]N>-IY&